Citrus Sinensis ID: 047705

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-----
Protein Sequence
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Secondary Structure (PSIPRED)
cccccccccccccEEEcccccccccccHHHHHccccccccccccccEEEcccccccccccccEEEccccccccccHHHHccccccccEEEcccccccccccccccccccccccEEEEcccEEEEcccccccccccccEEEcccccccccccHHHHccccccEEEccccEEEEEcccccccccccccEEcccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccHHHHHccccccEEcccccccccccHHHHHcccccccccccccccccccccccccccccHHHHccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccEEccccccccccccccEEEEcccccccccccccccEEEEEcccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHHHHHccccEEEccccccccccccHHHccccccEEEEEccccccccccHHHHHcHccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccHHHHHccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHccccccEEEccccEEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHHHHHHHHHHHEEEccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHEEccccccccEEEHccccccccc
Coil and Loop (DISEMBL)
eipleignlqnleelDLRQNKLIGTVPVAIFNVSTLKLlglqdnslsgslssitdvrlpnlEELVLWGNNFSELNFLsslsncksltviglsnnpldgilpktsignlshSLEDfqmhncnvtgdipeeignltnlitidlggnklnGSILITLSKLQKLqglvlddnklegsipddICRLVELYKLElggnklsrsIPACFNNLIALRILslgsndplpleigNLKVLVGIDfsmnnfsgiipkeigglknlEYLFLGYnrlqglipdsfgnlISLKFLNlsnnnlsgaipaslekLSYLEDLNLSFNklegeiprggsfgnfsaesfegnellcgspnlqvppcktsihhpswNISLLLGIVLPLSTTLMIVVIWLILRYRqrgkqpsndanmpLVAMWRTFSYLELcratdgfsennligrggfgsvykarlgdGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLeympqgslekhlystNCILDIFQRLNIMIDVASALEYlhfgcstpvihcdlkpsnvllddnMIAYLSDFGIAKLligedqsmtQTQTLATIGYMAP
Flexible Loop (DISEMBL)
eipleignlqnlEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRgkqpsndanmpLVAMWRTFSYLELCRATDGfsennligrgGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Low Complexity Region (SEG)
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGnnfselnflsslsnCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGnlislkflnlsnnnlsGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Disordered region (IsUnstruct)
*********QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQR*******ANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED*****************
Disordered Region (DISOPRED)
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP*********************LGIVLPLSTTLMIVVIWLILR********************RTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Disordered Region (DISEMBL)
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Disordered Region (DISPRO)
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRG*********PLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	585	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.977	0.566	0.385	1e-103
C0LGT6	1031	LRR receptor-like serine/	no	no	0.993	0.563	0.371	2e-91
Q9SD62	1025	Putative receptor-like pr	no	no	0.996	0.568	0.358	8e-90
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.979	0.584	0.347	6e-87
Q42371	976	LRR receptor-like serine/	no	no	0.974	0.584	0.340	4e-75
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.994	0.465	0.341	2e-74
Q9FL28	1173	LRR receptor-like serine/	no	no	0.982	0.490	0.335	1e-73
O49545	1003	Leucine-rich repeat recep	no	no	0.972	0.567	0.343	3e-73
Q9LJF3	1164	Receptor-like protein kin	no	no	0.958	0.481	0.334	1e-72
Q9LP24	1120	Probable leucine-rich rep	no	no	0.984	0.514	0.329	1e-72

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  377 bits (969), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 246/638 (38%), Positives = 357/638 (55%), Gaps = 66/638 (10%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWG 68
           L NL   ++  N   G++P  + N+STL+ LG+ +N+L+GS+ +  +V  PNL+ L L  
Sbjct: 258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNV--PNLKLLFLHT 315

Query: 69  NNFS-----ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           N+       +L FL+SL+NC  L  +G+  N L G LP  SI NLS  L    +    ++
Sbjct: 316 NSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLIS 374

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVE 183
           G IP +IGNL NL  + L  N L+G +  +L KL  L+ L L  N+L G IP  I  +  
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFS 240
           L  L+L  N     +P    N   L  L +G N     +PLEI  ++ L+ +D S N+  
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN-----------------------LISL 277
           G +P++IG L+NL  L LG N+L G +P + GN                       L+ +
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGV 554

Query: 278 KFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG 337
           K ++LSNN+LSG+IP      S LE LNLSFN LEG++P  G F N +  S  GN  LCG
Sbjct: 555 KEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCG 614

Query: 338 S-PNLQVPPCKTSI-----HHPSWNISLLLGIVLPLSTTLM-----IVVIWLILRYRQRG 386
                Q+ PC +        H S    +++G+ + ++  L+     + +IWL  R R++ 
Sbjct: 615 GIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWL--RKRKKN 672

Query: 387 KQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKV 445
           K+ +N     L  +    SY +L  AT+GFS +N++G G FG+VYKA L  +   VAVKV
Sbjct: 673 KETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKV 732

Query: 446 FNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-----EEFKGLVLEYMPQGSLE-- 498
            N+Q R A KSF  ECE +K IRHRNL+K++++CS+      EF+ L+ E+MP GSL+  
Sbjct: 733 LNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMW 792

Query: 499 ------KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI 552
                 + ++  +  L + +RLNI IDVAS L+YLH  C  P+ HCDLKPSNVLLDD++ 
Sbjct: 793 LHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLT 852

Query: 553 AYLSDFGIAKLLIGEDQ-----SMTQTQTLATIGYMAP 585
           A++SDFG+A+LL+  D+      ++      TIGY AP
Sbjct: 853 AHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  336 bits (862), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 231/622 (37%), Positives = 341/622 (54%), Gaps = 41/622 (6%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDV--RLP 59
           IP  + N+ +LE  D+  N L G++P++   +  L  LG+++NSL  + SS  +    + 
Sbjct: 282 IPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVA 341

Query: 60  NLEELVLWGNNFSEL--NFLSSLSN-CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
           N  +L      ++ L     +S++N   +LT + L  N + G +P   IGNL  SL++  
Sbjct: 342 NCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPH-DIGNLV-SLQELS 399

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
           +    ++G++P   G L NL  +DL  N ++G I      + +LQ L L+ N   G IP 
Sbjct: 400 LETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQ 459

Query: 177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGID 233
            + R   L  L +  N+L+ +IP     + +L  + L +N      P E+G L++LVG+ 
Sbjct: 460 SLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLG 519

Query: 234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA 293
            S N  SG +P+ IGG  ++E+LF+  N   G IPD    L+SLK ++ SNNNLSG IP 
Sbjct: 520 ASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPR 578

Query: 294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI-- 350
            L  L  L +LNLS NK EG +P  G F N +A S  GN  +CG    +Q+ PC      
Sbjct: 579 YLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASP 638

Query: 351 --HHP-SWNISLLLGIVLPLSTTLMIVVI----WLILRYRQRGKQPSNDANMPLVAMWR- 402
               P S    ++ GI + +++ L+I+++    W + R ++      N ++   + M+  
Sbjct: 639 RKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHE 698

Query: 403 TFSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVEC 461
             SY EL  AT  FS  NLIG G FG+V+K  LG +   VAVKV NL    A KSF  EC
Sbjct: 699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758

Query: 462 EIMKSIRHRNLIKVISSCSN-----EEFKGLVLEYMPQGSLE--------KHLYSTNCIL 508
           E  K IRHRNL+K+I+ CS+      +F+ LV E+MP+GSL+        + +   +  L
Sbjct: 759 ETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSL 818

Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
              ++LNI IDVASALEYLH  C  PV HCD+KPSN+LLDD++ A++SDFG+A+LL   D
Sbjct: 819 TPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYD 878

Query: 569 Q-----SMTQTQTLATIGYMAP 585
           +       +      TIGY AP
Sbjct: 879 RESFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  331 bits (849), Expect = 8e-90,   Method: Compositional matrix adjust.
 Identities = 249/694 (35%), Positives = 347/694 (50%), Gaps = 111/694 (15%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           EIP +I  L+ +    +  NK  G  P  I+N+S+L  L +  NS SG+L       LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query: 61  LEELVLWGNNFS------------------------------------------------ 72
           L+ L +  N+F+                                                
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query: 73  -----ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                +L+FL +L+NC  L  + +  N L G LP   I NLS  L +  +    ++G IP
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIP 394

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL----------------- 170
             IGNL +L T+DLG N L G +  +L +L +L+ ++L  N L                 
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454

Query: 171 -------EGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLP 220
                  EGSIP  +     L  L LG NKL+ SIP     L +L +L++  N    PL 
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLR 514

Query: 221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
            +IG LK L+ +D S N  SG IP+ +    +LE+L L  N   G IPD  G L  L+FL
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFL 573

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-P 339
           +LS NNLSG IP  +   S L++LNLS N  +G +P  G F N SA S  GN  LCG  P
Sbjct: 574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633

Query: 340 NLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVI-------WLILRYRQ-RGKQPSN 391
           +LQ+ PC   +     ++  ++ I +      ++++        W  LR +  R     N
Sbjct: 634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693

Query: 392 DANM-PLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ 449
           D +  P+ + +   SY EL + T GFS +NLIG G FG+V+K  LG     VA+KV NL 
Sbjct: 694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753

Query: 450 CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYST 504
            R A KSF  ECE +  IRHRNL+K+++ CS+ +F+G     LV E+MP G+L+  L+  
Sbjct: 754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPD 813

Query: 505 NC--------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS 556
                      L +F RLNI IDVASAL YLH  C  P+ HCD+KPSN+LLD ++ A++S
Sbjct: 814 EIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVS 873

Query: 557 DFGIAKLLIGEDQSMTQTQ-----TLATIGYMAP 585
           DFG+A+LL+  D+     Q        TIGY AP
Sbjct: 874 DFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  322 bits (824), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 235/676 (34%), Positives = 352/676 (52%), Gaps = 103/676 (15%)

Query: 1   EIPLEIG-NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP 59
           EIPL    +L+ L  L L  NKL GTVP ++ N + LK + L+ N LSG L S    ++P
Sbjct: 181 EIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMP 240

Query: 60  NLEELVLWGNNFSELN-------FLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS--- 109
            L+ L L  N+F   N       F +SL+N   L  + L+ N L G +  +S+ +LS   
Sbjct: 241 QLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEI-TSSVRHLSVNL 299

Query: 110 ---------------------------------------------HSLEDFQMHNCNVTG 124
                                                          LE   + N ++TG
Sbjct: 300 VQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTG 359

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
           +IP E+G++  L  +D+  N L+GSI  +   L +L+ L+L  N L G++P  + + + L
Sbjct: 360 EIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINL 419

Query: 185 YKLELGGNKLSRSIPA-CFNNLIALRI-LSLGSND---PLPLEIGNLKVLVGIDFSMNNF 239
             L+L  N L+ +IP    +NL  L++ L+L SN    P+PLE+  + +++ +D S N  
Sbjct: 420 EILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNEL 479

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
           SG IP ++G    LE+L L  N     +P S G L  LK L++S N L+GAIP S ++ S
Sbjct: 480 SGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSS 539

Query: 300 YLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSIHHPSWNIS 358
            L+ LN SFN L G +   GSF   + ESF G+ LLCGS   +Q   CK       +   
Sbjct: 540 TLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKK---HKYPSV 594

Query: 359 LLLGIVLPLSTTLMIVVIWLILRYRQRG---------------KQPSNDANMPLVAMWRT 403
           LL  ++  ++T ++ V  + +++  + G               KQ  ND   P +     
Sbjct: 595 LLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI----- 649

Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDVECE 462
            SY +L  AT GF+ ++LIG G FG VYK  L +  +VAVKV + +    F  SF  EC+
Sbjct: 650 -SYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQ 708

Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMID 519
           I+K  RHRNLI++I++CS   F  LVL  MP GSLE+HLY    ++  LD+ Q +NI  D
Sbjct: 709 ILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSD 768

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA- 578
           VA  + YLH      V+HCDLKPSN+LLDD M A ++DFGI++L+ G +++++   +++ 
Sbjct: 769 VAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSF 828

Query: 579 ---------TIGYMAP 585
                    ++GY+AP
Sbjct: 829 GSTDGLLCGSVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  282 bits (722), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 212/623 (34%), Positives = 313/623 (50%), Gaps = 53/623 (8%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
           ++  L  L   D+R N L G++P  I N +  ++L L  N L+G +    D+    +  L
Sbjct: 207 DLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIP--FDIGFLQVATL 264

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L GN  S     S +   ++L V+ LS N L G +P   +GNL+ + E   +H+  +TG
Sbjct: 265 SLQGNQLSG-KIPSVIGLMQALAVLDLSGNLLSGSIPPI-LGNLTFT-EKLYLHSNKLTG 321

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
            IP E+GN++ L  ++L  N L G I   L KL  L  L + +N LEG IPD +     L
Sbjct: 322 SIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNL 381

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSG 241
             L + GNK S +IP  F  L ++  L+L SN+   P+P+E+  +  L  +D S N  +G
Sbjct: 382 NSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKING 441

Query: 242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS-- 299
           IIP  +G L++L  + L  N + G++P  FGNL S+  ++LSNN++SG IP  L +L   
Sbjct: 442 IIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNI 501

Query: 300 ---------------------YLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 338
                                 L  LN+S N L G+IP+  +F  FS +SF GN  LCGS
Sbjct: 502 ILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS 561

Query: 339 PNLQVPPCKTSIHHPSWNIS--LLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMP 396
                 PC  S      +IS   +LGI +     L+I+++ LI   R     P  D ++ 
Sbjct: 562 --WLNSPCHDSRRTVRVSISRAAILGIAI---GGLVILLMVLIAACRPHNPPPFLDGSLD 616

Query: 397 LVAMWRT------------FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVK 444
               + T              Y ++ R T+  SE  +IG G   +VYK  L +   VA+K
Sbjct: 617 KPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIK 676

Query: 445 VFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY-- 502
                  ++ K F+ E E++ SI+HRNL+ + +   +     L  +Y+  GSL   L+  
Sbjct: 677 RLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGP 736

Query: 503 STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           +    LD   RL I    A  L YLH  CS  +IH D+K SN+LLD ++ A L+DFGIAK
Sbjct: 737 TKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAK 796

Query: 563 LLIGEDQSMTQTQTLATIGYMAP 585
            L    +S T T  + TIGY+ P
Sbjct: 797 SLC-VSKSHTSTYVMGTIGYIDP 818

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  280 bits (716), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 227/665 (34%), Positives = 330/665 (49%), Gaps = 83/665 (12%)

Query: 1    EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            EIP  IG L+ L  L LRQN+L+G +P ++ N   L +L L DN LSGS+ S     L  
Sbjct: 471  EIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF-LKG 529

Query: 61   LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT----------------- 103
            LE+L+L+ NN  + N   SL + ++LT I LS+N L+G +                    
Sbjct: 530  LEQLMLY-NNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFE 588

Query: 104  -----SIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ 158
                  +GN S +L+  ++    +TG IP  +G +  L  +D+  N L G+I + L   +
Sbjct: 589  DEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCK 647

Query: 159  KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND- 217
            KL  + L++N L G IP  + +L +L +L+L  N+   S+P    N   L +LSL  N  
Sbjct: 648  KLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSL 707

Query: 218  --PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI 275
               +P EIGNL  L  ++   N FSG +P+ +G L  L  L L  N L G IP   G L 
Sbjct: 708  NGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQ 767

Query: 276  SLK-FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR----------------- 317
             L+  L+LS NN +G IP+++  LS LE L+LS N+L GE+P                  
Sbjct: 768  DLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNN 827

Query: 318  -GG----SFGNFSAESFEGNELLCGSPNLQVPPCKTSIHH---PSWNISLLLGIVLPLST 369
             GG     F  + A+SF GN  LCGSP  +    +++       + ++ ++  I    + 
Sbjct: 828  LGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAI 887

Query: 370  TLMIVVIWLILRYRQ--------------RGKQPSNDANMPLV---AMWRTFSYLELCRA 412
             LMI+VI L  + R                    S   + PL    A      + ++  A
Sbjct: 888  GLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEA 947

Query: 413  TDGFSENNLIGRGGFGSVYKARLGDGMEVAVK-VFNLQCRRAFKSFDVECEIMKSIRHRN 471
            T   SE  +IG GG G VYKA L +G  VAVK +       + KSF  E + +  IRHR+
Sbjct: 948  THNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRH 1007

Query: 472  LIKVISSCSN--EEFKGLVLEYMPQGSLEKHLYSTNCIL-------DIFQRLNIMIDVAS 522
            L+K++  CS+  E    L+ EYM  GS+   L+    +L       D   RL I + +A 
Sbjct: 1008 LVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQ 1067

Query: 523  ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL--ATI 580
             +EYLH  C  P++H D+K SNVLLD NM A+L DFG+AK+L     + T + T    + 
Sbjct: 1068 GVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSY 1127

Query: 581  GYMAP 585
            GY+AP
Sbjct: 1128 GYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  277 bits (709), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 213/634 (33%), Positives = 338/634 (53%), Gaps = 59/634 (9%)

Query: 1    EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            EIP   G + NL  + + +N   G +P  IFN S L+ L + DN+L+G+L  +    +  
Sbjct: 423  EIPRGFGRM-NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPL----IGK 477

Query: 61   LEELVLWGNNFSELN--FLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            L++L +   +++ L       + N K L ++ L +N   G +P+  + NL+  L+  +M+
Sbjct: 478  LQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPR-EMSNLTL-LQGLRMY 535

Query: 119  NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
            + ++ G IPEE+ ++  L  +DL  NK +G I    SKL+ L  L L  NK  GSIP  +
Sbjct: 536  SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595

Query: 179  CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN-------DPLPLEIGNLKVLVG 231
              L  L   ++  N L+ +IP     L +L+ + L  N         +P E+G L+++  
Sbjct: 596  KSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE 653

Query: 232  IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD---------------------- 269
            ID S N FSG IP+ +   KN+  L    N L G IPD                      
Sbjct: 654  IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713

Query: 270  ---SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSA 326
               SFGN+  L  L+LS+NNL+G IP SL  LS L+ L L+ N L+G +P  G F N +A
Sbjct: 714  IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773

Query: 327  ESFEGNELLCGSPNLQVPPC--KTSIHHPSWN---ISLLLGIVLPLSTTLMIVVIWLILR 381
                GN  LCGS    + PC  K    H S     I ++LG    L   L++V+I    +
Sbjct: 774  SDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCK 832

Query: 382  YRQRGKQPSNDANMP---LVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDG 438
             +++  + S+++++P        + F   EL +ATD F+  N+IG     +VYK +L DG
Sbjct: 833  KKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDG 892

Query: 439  MEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVIS-SCSNEEFKGLVLEYMPQG 495
              +AVKV NL+     + K F  E + +  ++HRNL+K++  +  + + K LVL +M  G
Sbjct: 893  TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENG 952

Query: 496  SLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY 554
            +LE  ++ S   I  + +++++ + +AS ++YLH G   P++HCDLKP+N+LLD + +A+
Sbjct: 953  NLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAH 1012

Query: 555  LSDFGIAKLL-IGEDQSMTQTQTL--ATIGYMAP 585
            +SDFG A++L   ED S T + +    TIGY+AP
Sbjct: 1013 VSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  276 bits (707), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 205/597 (34%), Positives = 296/597 (49%), Gaps = 28/597 (4%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
           E+G L +L+ +DL  N   G +P +   +  L LL L  N L G +       LP LE L
Sbjct: 282 ELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIG-DLPELEVL 340

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            LW NNF+  +    L     L ++ LS+N L G LP        + LE        + G
Sbjct: 341 QLWENNFTG-SIPQKLGENGKLNLVDLSSNKLTGTLPPNMCS--GNKLETLITLGNFLFG 397

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
            IP+ +G   +L  I +G N LNGSI   L  L KL  + L DN L G +P      V L
Sbjct: 398 SIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNL 457

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSG 241
            ++ L  N+LS  +P    N   ++ L L  N    P+P E+G L+ L  IDFS N FSG
Sbjct: 458 GQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSG 517

Query: 242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL 301
            I  EI   K L ++ L  N L G IP+    +  L +LNLS N+L G+IP S+  +  L
Sbjct: 518 RIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSL 577

Query: 302 EDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSI------HHPSW 355
             L+ S+N L G +P  G F  F+  SF GN  LCG P L   PCK  +       H   
Sbjct: 578 TSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG-PYLG--PCKDGVAKGGHQSHSKG 634

Query: 356 NISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLEL---CRA 412
            +S  + ++L L   +  +   ++   + R  + ++++       WR  ++  L   C  
Sbjct: 635 PLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESR-----AWRLTAFQRLDFTCDD 689

Query: 413 T-DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS--FDVECEIMKSIRH 469
             D   E+N+IG+GG G VYK  + +G  VAVK      R +     F+ E + +  IRH
Sbjct: 690 VLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH 749

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLH 528
           R++++++  CSN E   LV EYMP GSL + L+      L    R  I ++ A  L YLH
Sbjct: 750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLH 809

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             CS  ++H D+K +N+LLD N  A+++DFG+AK L     S   +    + GY+AP
Sbjct: 810 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  274 bits (701), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 213/637 (33%), Positives = 310/637 (48%), Gaps = 76/637 (11%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            +P+E+G  ++L+ +DL  N L G +P  I+ +  L  L +  N+L+G +     V   NL
Sbjct: 418  VPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNL 477

Query: 62   EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
            E L+L  NN    +   S+S C ++  I LS+N L G +P   IG L   L   Q+ N +
Sbjct: 478  ETLIL-NNNLLTGSLPESISKCTNMLWISLSSNLLTGEIP-VGIGKL-EKLAILQLGNNS 534

Query: 122  VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN---------KLEG 172
            +TG+IP E+GN  NLI +DL  N L G++     +L    GLV+  +         + EG
Sbjct: 535  LTGNIPSELGNCKNLIWLDLNSNNLTGNLP---GELASQAGLVMPGSVSGKQFAFVRNEG 591

Query: 173  SIPDDICR----LVELYKLELGGNKLSRSIPACFNNLI--ALRILSLGSNDPLPLEIGNL 226
                  CR    LVE   +     +    + +C    I   + +    SN  +       
Sbjct: 592  GTD---CRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSM------- 641

Query: 227  KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
               + +D S N  SG IP   G +  L+ L LG+N L G IPDSFG L ++  L+LS+N+
Sbjct: 642  ---IYLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHND 698

Query: 287  LSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 346
            L G +P SL  LS+L DL++S N L G IP GG    F    +  N  LCG P   +PPC
Sbjct: 699  LQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPC 755

Query: 347  KT------SIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSND-------- 392
             +      S  HP    S+  G+   +  + M +V+ ++  YR R  Q            
Sbjct: 756  SSGSRPTRSHAHPK-KQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIES 814

Query: 393  -------------ANMPL---VAMW----RTFSYLELCRATDGFSENNLIGRGGFGSVYK 432
                          + PL   VA +    R  ++  L  AT+GFS +++IG GGFG VYK
Sbjct: 815  LPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYK 874

Query: 433  ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM 492
            A+L DG  VA+K       +  + F  E E +  I+HRNL+ ++  C   E + LV EYM
Sbjct: 875  AKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 934

Query: 493  PQGSLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD 548
              GSLE  L+         LD   R  I I  A  L +LH  C   +IH D+K SNVLLD
Sbjct: 935  KYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLD 994

Query: 549  DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             + +A +SDFG+A+L+   D  ++ +    T GY+ P
Sbjct: 995  QDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPP 1031

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  274 bits (701), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 207/628 (32%), Positives = 316/628 (50%), Gaps = 52/628 (8%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            IP E+GN++++  LDL QNKL G+VP +  N + L+ L L+ N LSG++         +L
Sbjct: 406  IPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGV-ANSSHL 464

Query: 62   EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
              L+L  NNF+   F  ++   + L  I L  N L+G +PK+       SL   +     
Sbjct: 465  TTLILDTNNFTGF-FPETVCKGRKLQNISLDYNHLEGPIPKSLRD--CKSLIRARFLGNK 521

Query: 122  VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
             TGDI E  G   +L  ID   NK +G I     K  KL  L++ +N + G+IP +I  +
Sbjct: 522  FTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNM 581

Query: 182  VELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNN 238
             +L +L+L  N L   +P    NL  L  L L  N     +P  +  L  L  +D S NN
Sbjct: 582  TQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNN 641

Query: 239  FSGIIPK-----------------------EIGGLKNLEYLFLGYNRLQGLIPDSFGNLI 275
            FS  IP+                        +  L  L  L L +N+L G IP    +L 
Sbjct: 642  FSSEIPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQ 701

Query: 276  SLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 335
            SL  L+LS+NNLSG IP + E +  L ++++S NKLEG +P   +F   +A++ E N  L
Sbjct: 702  SLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGL 761

Query: 336  CGS-PNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVI-----WLILRYRQ----R 385
            C + P  ++ PC+  +  P  N +L++ I++P+   L+I+ I        +R R+    R
Sbjct: 762  CSNIPKQRLKPCR-ELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGR 820

Query: 386  GKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKV 445
               P    NM + ++   F Y ++  +T+ F   +LIG GG+  VY+A L D + +AVK 
Sbjct: 821  NTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKR 879

Query: 446  FNLQCRRAF------KSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEK 499
             +             + F  E + +  IRHRN++K+   CS+     L+ EYM +GSL K
Sbjct: 880  LHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNK 939

Query: 500  HLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD 557
             L +      L   +R+N++  VA AL Y+H    TP++H D+   N+LLD++  A +SD
Sbjct: 940  LLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISD 999

Query: 558  FGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            FG AKLL  +  S   +    T GY+AP
Sbjct: 1000 FGTAKLL--KTDSSNWSAVAGTYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	585
255585401	843	serine-threonine protein kinase, plant-t	0.991	0.688	0.536	1e-159
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.991	0.398	0.482	1e-152
359483198	1087	PREDICTED: probable LRR receptor-like se	0.979	0.527	0.528	1e-152
224139658	1019	predicted protein [Populus trichocarpa]	0.981	0.563	0.503	1e-151
359485453	1202	PREDICTED: probable LRR receptor-like se	0.991	0.482	0.488	1e-150
255572272	1089	serine-threonine protein kinase, plant-t	0.996	0.535	0.476	1e-150
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.991	0.472	0.479	1e-150
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.991	0.408	0.483	1e-150
224116832	1061	predicted protein [Populus trichocarpa]	0.994	0.548	0.469	1e-150
359483688	1197	PREDICTED: LRR receptor-like serine/thre	0.993	0.485	0.485	1e-150

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  569 bits (1466), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 330/615 (53%), Positives = 412/615 (66%), Gaps = 35/615 (5%)

Query: 1   EIPLEIG-NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP 59
            +P  +G  L NLEEL + +N+ IGT+P +I N S L +L    NSLSG +   T   L 
Sbjct: 114 HLPSTLGYGLPNLEELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIPD-TLCNLK 172

Query: 60  NLEELVLWGNNFS-ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           NL+ L L  N+F+ EL FL+SL+ CK L  + L  NPL+  LP TSIGNLS S+E F + 
Sbjct: 173 NLKRLNLADNSFTDELGFLASLARCKELRRLVLIGNPLNSTLP-TSIGNLS-SIEYFNVQ 230

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
           +CN+ G+IP EIG L+NLIT+ L  N+L GSI +T+  LQKLQ L L  N L GSIP DI
Sbjct: 231 SCNIKGNIPSEIGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDI 290

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--------------------- 217
           C L  L +L L  N L   +PACF +LI+LRIL L SN+                     
Sbjct: 291 CHLSNLGELFLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLS 350

Query: 218 ------PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF 271
                  +PL IGNLKVL  +DFS N+ SGIIP  IG L+NL  L L +NR +G IP+ F
Sbjct: 351 SNSLSGHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPF 410

Query: 272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEG 331
           G LISL+ L+LS+NNLSG IP SLE+L YL+ LN+SFN L+GE+P  G+F NFSA SF G
Sbjct: 411 GELISLESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLG 470

Query: 332 NELLCGSPNLQVPPCKTSIHHPS-WNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPS 390
           N  LCGS  L + PCK + H  S  +  LLL  VLP ++ L I  I + LR ++   +  
Sbjct: 471 NLALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYVLP-ASILTIAFILVFLRCQKVKLELE 529

Query: 391 NDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC 450
           N  ++  V  WR  S+ EL +ATDGF  +NL+G GG+GSVYK RL DG  VA+KVFNL  
Sbjct: 530 NVMDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGV 589

Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDI 510
             AFK FD ECE+M SIRHRNL+K+IS CSN++FK +VLEYMP GSLEK LYS N  L+I
Sbjct: 590 EGAFKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNI 649

Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
            QRL +MIDVASALEYLH G S P++HCDLKPSNVLLD +M+ +++DFG+AKLL GE   
Sbjct: 650 QQRLEVMIDVASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL-GEGDL 708

Query: 571 MTQTQTLATIGYMAP 585
           +TQT+TLATIGYMAP
Sbjct: 709 ITQTKTLATIGYMAP 723

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  546 bits (1406), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 323/669 (48%), Positives = 415/669 (62%), Gaps = 89/669 (13%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            IP E+GNL NL+ L L +N L G +P AIFN+S L+ L L  N  SGSL S    +LP+L
Sbjct: 678  IPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDL 737

Query: 62   E------------------------ELVLWGNNF-------------------------- 71
            E                        EL +W N F                          
Sbjct: 738  EGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTD 797

Query: 72   ----SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                SE+ FL+SL+NC  L  + + +NPL GILP  S+GNLS SLE F    C   G IP
Sbjct: 798  EHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPN-SLGNLSISLESFDASACQFRGTIP 856

Query: 128  EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              IGNLT+LI+++LG N L G I  TL +L+KLQ L +  N+L GSIP+D+CRL  L  L
Sbjct: 857  TGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYL 916

Query: 188  ELGGNKLSRSIPACFNNLIALRIL-----SLGSNDP----------------------LP 220
             L  N+L+ SIP+C   L  LR L     +L SN P                      LP
Sbjct: 917  FLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLP 976

Query: 221  LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
             E+GN+K +  +D S N  SG IP+ +G L+NLE L L  NRLQG IP  FG+L+SLKFL
Sbjct: 977  PEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFL 1036

Query: 281  NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 340
            +LS NNLSG IP SL+ L+YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 1037 DLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPH 1096

Query: 341  LQVPPCKTSIHHPSWNISL-LLGIVLPLSTTLMIVVIWLILRYRQRG--KQPSN-DANMP 396
             QV  C  S    SW   L +L  +LP   +++ +V++L+L  R+R   + P+  D+ +P
Sbjct: 1097 FQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP 1156

Query: 397  LVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS 456
                    S+ +L  AT+ F E+NLIG+G    VYK  L +G+ VAVKVFNL+ + AF+S
Sbjct: 1157 --GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRS 1214

Query: 457  FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
            FD ECE+M+SIRHRNL+K+I+ CSN +FK LVLEYMP+GSL+K LYS N  LD+ QRLNI
Sbjct: 1215 FDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNI 1274

Query: 517  MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
            MIDVASALEYLH  C + V+HCDLKP+N+LLDD+M+A++ DFGIA+LL  E +SM QT+T
Sbjct: 1275 MIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKT 1333

Query: 577  LATIGYMAP 585
            L TIGYMAP
Sbjct: 1334 LGTIGYMAP 1342

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  543 bits (1400), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 325/615 (52%), Positives = 402/615 (65%), Gaps = 42/615 (6%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL-SSITDVRLPNLEELVLW 67
           L NLE L L  N L G +P +I N S L+ L    N L+GS+  ++  +R   LE L L 
Sbjct: 364 LPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRF--LERLNLG 421

Query: 68  GNNF------SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
            NN        EL+FL+SL+NCK L ++ LS NPL GILP  SIGNLS SL+ F+ + C 
Sbjct: 422 VNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILP-ISIGNLSTSLQRFEANTCK 480

Query: 122 VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
           + G+IP EIGNL+NL  + L  N L G+I  ++ +LQKLQGL L  NKL+GSIP+DIC+L
Sbjct: 481 LKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQL 540

Query: 182 VELYKLELGGNKLSRSIPACFNNLIALRILSLGSND------------------------ 217
             L +L L  N+LS SIPAC   L  LR L LGSN                         
Sbjct: 541 RNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNF 600

Query: 218 ---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL 274
               LP ++GNLKVLV ID S N  SG IP  IGGL++L  L L +NR +G I  SF NL
Sbjct: 601 LVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNL 660

Query: 275 ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 334
            SL+F++LS+N L G IP SLE L YL+ L++SFN L GEIP  G F NFSAESF  N+ 
Sbjct: 661 KSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKA 720

Query: 335 LCGSPNLQVPPCKTSIHHPSWNISLLLGIVLP--LSTTLMIVVIWLILRYRQRGKQPSND 392
           LCGSP L++PPC+T     +    LLL  +LP  LST L + +I++  R R+R       
Sbjct: 721 LCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQ 780

Query: 393 ANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR 452
           +   L A WR  SY E+ +AT+GFS  NL+GRG  GSVY+  L DG   A+KVFNLQ   
Sbjct: 781 SESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEA 840

Query: 453 AFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGLVLEYMPQGSLEKHLYSTNCILDI 510
           AFKSFD ECE+M  IRHRNLIK++SSCSN   +FK LVLEY+P GSLE+ LYS N  LDI
Sbjct: 841 AFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDI 900

Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
            QRLNIMIDVA A+EYLH GCSTPV+HCDLKPSN+LLD++   ++ DFGIAKLL  E++S
Sbjct: 901 LQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEES 959

Query: 571 MTQTQTLATIGYMAP 585
           + +TQTLATIGYMAP
Sbjct: 960 IRETQTLATIGYMAP 974

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  543 bits (1399), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 309/614 (50%), Positives = 401/614 (65%), Gaps = 40/614 (6%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGS-LSSITDVRLPNLEELVL 66
           +L NLEEL L  N + G++P  + N+S L++L L  N ++G+ L    ++R   L+ L L
Sbjct: 290 DLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRA--LQVLSL 347

Query: 67  WGNNFS------ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
             N+F+       LNF++SL+N + L  + + +NPLDG+LP  S+GNLS  L  F ++  
Sbjct: 348 QSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPN-SVGNLSSFLTKFYVYAS 406

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
            + G+IP EIGNL+NLI + L  N L G I  T+  L+K+Q L L  N L GSIP DIC 
Sbjct: 407 KLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICL 466

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALR------------------------ILSLGSN 216
              L  + L  N LS  IP+C  NL +LR                        IL+L SN
Sbjct: 467 ARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSN 526

Query: 217 ---DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN 273
                LP ++G ++  +GI  S N  SG IP  IG L+NL    L  N  QG IP++FG 
Sbjct: 527 FLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGG 586

Query: 274 LISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 333
           L+SL+ L+LS NNLSG IP SLE L YLE  ++SFN L+GEIPRGG F NF+A SF  N+
Sbjct: 587 LVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNK 646

Query: 334 LLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVV--IWLILRYRQRGKQPSN 391
            LCG   LQVPPC       S   S LL   LP   ++++VV  I+L++  R+R ++   
Sbjct: 647 GLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPI 706

Query: 392 DANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR 451
              +P+ A+ R  SYLEL  AT+ F E+NL+G G FGSVY+ RL DG+ VAVK+FNLQ +
Sbjct: 707 PEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQ 766

Query: 452 RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF 511
           RAF+SFD ECEIM++IRHRNL+K+I SCSN +FK LVLEYMP+GSLEK LYS N  LDI 
Sbjct: 767 RAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDII 826

Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
           QR+NIMIDVASALEYLH G  +PV+HCDLKPSNVLLD++M+A++ DFGIAKLL GE++S 
Sbjct: 827 QRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESF 885

Query: 572 TQTQTLATIGYMAP 585
            QT+TLATIGYMAP
Sbjct: 886 AQTRTLATIGYMAP 899

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  540 bits (1390), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 326/668 (48%), Positives = 410/668 (61%), Gaps = 88/668 (13%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            IP E+GNL NL+ L L  N L G VP AIFN+S L++L L  N LSGSL S     LPNL
Sbjct: 423  IPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNL 482

Query: 62   EELVLWGN-----------------------NF--------------------------- 71
            E+L++ GN                       NF                           
Sbjct: 483  EQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTN 542

Query: 72   ----SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                SEL FL+SL+NC  L  + +S+NPL G++P  S+GNLS SLE     +C + G IP
Sbjct: 543  EHSASELAFLTSLTNCIFLRTLSISDNPLKGMIPN-SLGNLSISLEIIYASDCQLRGTIP 601

Query: 128  EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              I NLTNLI + L  N L G I     +LQKLQ L +  N++ GSIP  +C L  L  L
Sbjct: 602  TGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFL 661

Query: 188  ELGGNKLSRSIPACFNNLIALR------------------------ILSLGSN---DPLP 220
            +L  NKLS +IP+C  NL  LR                        +L+L SN     LP
Sbjct: 662  DLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLP 721

Query: 221  LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
            L++GN+K LV +D S N FSG IP  I  L+NL  L+L +N+LQG IP +FG+L+SL+ L
Sbjct: 722  LQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESL 781

Query: 281  NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 340
            +LS NNLSG IP SLE L YLE LN+SFNKL+GEIP GG F NF+AESF  N  LCG+P 
Sbjct: 782  DLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPR 841

Query: 341  LQVPPCKTSIHHPSWNISLLLGIVLPLS---TTLMIVVIWLILRYRQRGKQPSNDANMPL 397
             QV  C+      +   SLLL  ++PLS   +T+++VV+++  + RQ   +     ++ L
Sbjct: 842  FQVMACEKDSRKNTK--SLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSL 899

Query: 398  VAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSF 457
              M R   + EL  AT+ F E+NLIG+G  G VYK  L DG+ VAVKVFNL+ + AFKSF
Sbjct: 900  PRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSF 959

Query: 458  DVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIM 517
            +VECE+M++IRHRNL K+ISSCSN +FK LVLEYMP GSLEK LYS N  LD  QRL IM
Sbjct: 960  EVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIM 1019

Query: 518  IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
            IDVAS LEYLH   S PV+HCDLKPSNVLLDD+M+A++SDFGIAKLL+G  + M +T+TL
Sbjct: 1020 IDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTL 1078

Query: 578  ATIGYMAP 585
             T+GYMAP
Sbjct: 1079 GTVGYMAP 1086

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 319/670 (47%), Positives = 410/670 (61%), Gaps = 87/670 (12%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL---------- 50
            IPLEIGNLQNL+ + L  N L G++P A+FN+ST+K + +  N+L G+L          
Sbjct: 303 RIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPN 362

Query: 51  ----------------------SSITDVRLP----------------NLEELVLWGNNFS 72
                                 S +T + LP                NL+ L L  N  S
Sbjct: 363 LIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLS 422

Query: 73  ------ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
                 EL   SSL NC++L  + LS NPLDG LP  S+GNLS+SLE F   +  + G +
Sbjct: 423 SKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPH-SVGNLSNSLESFLASDGLIKGSV 481

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYK 186
            E IGNL++L  ++LG N L G I  T+  L+ LQGL L  N L+GSIP ++C L  LY 
Sbjct: 482 HESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYN 541

Query: 187 LELGGNKLSRSIPACFNNLIALRILSLGSND---------------------------PL 219
           LEL GNKLS SIP CF+NL +LR L L SN                             L
Sbjct: 542 LELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSL 601

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
           P EI NL+ +  I+ S N  SG IP  IGGL++L  L+L  N+LQG IP S G++ SL+F
Sbjct: 602 PSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEF 661

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 339
           L+LS+NNLSG IP SL+ L YL+  N+SFN L+GEIP GGSF NFSA+SF GNE LCGS 
Sbjct: 662 LDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSA 721

Query: 340 NLQVPPCK--TSIHHPSWNISLLLGIVLPLSTTLMIVVIWLIL--RYRQRGKQPSNDANM 395
            LQV PCK   S    +    ++L  VLP     + V+ ++I+  RY +R  + S + + 
Sbjct: 722 RLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDF 781

Query: 396 PLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK 455
             +   R  SY EL  AT+GF E+N +G G FGSVYK  L DG  +A KVFNLQ  RAFK
Sbjct: 782 LALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFK 841

Query: 456 SFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN 515
           SFD ECE+++++RHRNL+K+I+SCS   FK LVLE+MP  SLEK LYS +  L+  QRLN
Sbjct: 842 SFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLN 901

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           IM+DVAS LEYLH G + P+ HCD+KPSNVLL+++M+A+L+DFGI+KLL GE+ S+ QT 
Sbjct: 902 IMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTM 960

Query: 576 TLATIGYMAP 585
           TLATIGYMAP
Sbjct: 961 TLATIGYMAP 970

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  538 bits (1385), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 321/669 (47%), Positives = 404/669 (60%), Gaps = 89/669 (13%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            IP   GNL+ L+ L L  N L GT+P  IFN+S L+ L L  N LSG L S     LP+L
Sbjct: 452  IPTSFGNLKALKFLQLGSNNLTGTIPEDIFNISKLQTLALAQNHLSGGLPSSIGTWLPDL 511

Query: 62   EELV------------------------------------------------LWGNNF-- 71
            E L                                                 L GN    
Sbjct: 512  EGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTD 571

Query: 72   ----SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                SE+ FL+SL+NCK L  + +  NPL G LP  S+GNLS +LE F    C+  G IP
Sbjct: 572  EHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESFTASACHFRGTIP 630

Query: 128  EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              IGNLTNLI +DLG N L GSI  TL  LQKLQ L +  N+++GSIP+D+C L  L  L
Sbjct: 631  TGIGNLTNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYL 690

Query: 188  ELGGNKLSRSIPACFNNLIALRILSLGSN---------------------------DPLP 220
             L  NKLS SIP+CF +L ALR LSL SN                             LP
Sbjct: 691  HLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLP 750

Query: 221  LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
             E+GN+K +  +D S N  SG IP+ +G L+NL  L L  N+LQG IP  FG+L+SL+ +
Sbjct: 751  PEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESM 810

Query: 281  NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 340
            +LS NNL G IP SLE L YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+
Sbjct: 811  DLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPH 870

Query: 341  LQVPPCKTSIHHPSWNIS--LLLGIVLPLSTTLMIVV-IWLILRYRQRGKQPSN-DANMP 396
             QV  C  +    SW     +L  I+LP+ + + +V  I L +R R   + P+  D+ +P
Sbjct: 871  FQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP 930

Query: 397  LVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS 456
                    S  +L  AT+GF E+NLIG+G  G VYK  L +G+ VA+KVFNL+ + A +S
Sbjct: 931  --GAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRS 988

Query: 457  FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
            FD ECE+M+ I HRNLI++I+ CSN +FK LVLEYMP+GSL+K LYS N  LD+FQRLNI
Sbjct: 989  FDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNI 1048

Query: 517  MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
            MIDVASALEYLH  CS+ V+HCDLKPSNVLLD+NM+A+++DFGIA+LL  E +SM QT+T
Sbjct: 1049 MIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKT 1107

Query: 577  LATIGYMAP 585
            L TIGYMAP
Sbjct: 1108 LGTIGYMAP 1116

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  537 bits (1384), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 323/668 (48%), Positives = 400/668 (59%), Gaps = 88/668 (13%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
            IP E+GNL NL+ L L  N L G +P AIFN+S L+ L L  N  SGSL S    +LP+L
Sbjct: 424  IPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDL 483

Query: 62   EELVL------------------------WGNNF-------------------------- 71
            E L +                        W N F                          
Sbjct: 484  EGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTD 543

Query: 72   ----SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                SE+ FL+SL+NCK L  + + +NPL GILP  S+GNLS SLE F    C   G IP
Sbjct: 544  EHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGILPN-SLGNLSISLESFDASACQFKGTIP 602

Query: 128  EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              IGNL NLI + L  N L G I I+   LQKLQ   +  N++ GSIP  +C L  L  L
Sbjct: 603  TGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYL 662

Query: 188  ELGGNKLSRSIPACFNNLIALRILSLGSND---------------------------PLP 220
            +L  NKLS +IP CF NL ALR +SL SN                             LP
Sbjct: 663  DLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLP 722

Query: 221  LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
            LE+GN+K L+ +D S N FSG IP  I  L+NL  L+L +N+LQG +P +FG L+SL++L
Sbjct: 723  LEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYL 782

Query: 281  NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 340
            +LS NN SG IP SLE L YL+ LN+SFNKL+GEIP  G F NF+AESF  N  LCG+P 
Sbjct: 783  DLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPR 842

Query: 341  LQVPPCKTSIHHPSWNISLLLGIVLPLS---TTLMIVVIWLILRYRQRGKQPSNDANMPL 397
             QV  C+      +   SLLL  ++PLS   +T+++VV++ + + RQ   +     ++ L
Sbjct: 843  FQVMACEKDARRNTK--SLLLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQVDLLL 900

Query: 398  VAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSF 457
              M R  S+ EL  AT  F E NLIG+G  G VYK  L DG+ VAVKVFNL+   AFKSF
Sbjct: 901  PRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSF 960

Query: 458  DVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIM 517
            +VECE+M++IRHRNL K+ISSCSN +FK LVLEYMP  SLEK LYS N  LD  QRL IM
Sbjct: 961  EVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIM 1020

Query: 518  IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
            IDVAS LEYLH   S PV+HCDLKPSNVLLDD+M+A++SDFGIAKLL+G  + M +T+TL
Sbjct: 1021 IDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKRTKTL 1079

Query: 578  ATIGYMAP 585
             TIGYMAP
Sbjct: 1080 GTIGYMAP 1087

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  537 bits (1384), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 313/667 (46%), Positives = 405/667 (60%), Gaps = 85/667 (12%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           IP E+GNL  L+ELDL  N + G++P   FN S L+ + +  N LSG L S T + LPNL
Sbjct: 275 IPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNL 334

Query: 62  EELVLWGN--------------------------------------NFSELNFLSSL--- 80
           EEL L  N                                      N  +LN   ++   
Sbjct: 335 EELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTS 394

Query: 81  -------------SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                        SNC+SL  +  + NPL G LP  SIGNLS SLE+    +C + G+IP
Sbjct: 395 KSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIP 453

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
             IGNL+NLI + L  N+L G+I   + +L+ LQ   L  NKL+G IP++IC L  L  L
Sbjct: 454 RGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYL 513

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSND--------------------------PLPL 221
            L  N  S S+PAC +N+ +LR L LGSN                            LPL
Sbjct: 514 YLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPL 573

Query: 222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLN 281
           EIGNLKV+  IDFS N  SG IP  I  L+NL +  L  NR+QG IP SFG+L+SL+FL+
Sbjct: 574 EIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLD 633

Query: 282 LSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 341
           LS N+LSGAIP SLEKL +L+  N+SFN+L+GEI  GG F NFS  SF  NE LCG   +
Sbjct: 634 LSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRM 693

Query: 342 QVPPCKT-SIHHPSWN-ISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLV- 398
           QVPPCK+ S H  S      ++  ++P    +++V+   ++ +R+  K+  +    PL  
Sbjct: 694 QVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPP 753

Query: 399 AMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFD 458
           A WR  SY EL RAT+GF+E NL+G G  GSVYK  L DG+ +AVKVF+LQ       FD
Sbjct: 754 ATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFD 813

Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            ECE+++ +RHRNL+K+ISSC N +FK L+LE++P GSLEK LYS N  LDI QRLNIMI
Sbjct: 814 SECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMI 873

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           DVASALEYLH GC+ PV+HCDLKPSNVL++++M+A++SDFGI++LL GE  ++TQT TLA
Sbjct: 874 DVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLA 932

Query: 579 TIGYMAP 585
           TIGYMAP
Sbjct: 933 TIGYMAP 939

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera]

 Score =  537 bits (1383), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 318/655 (48%), Positives = 404/655 (61%), Gaps = 74/655 (11%)

Query: 2    IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL--------SSI 53
            IP   GNL+ L+ L L  N L GT+P A+FN+S L  L L  N LSGSL        S I
Sbjct: 434  IPTSFGNLKALKHLQLGTNNLTGTIPEALFNISKLHNLALVQNHLSGSLPPSIGNEFSGI 493

Query: 54   TDVRLPNLEELV---LWGNNF------------------------------SELNFLSSL 80
              + + N+ +L+   +W N+F                              S ++FL+SL
Sbjct: 494  IPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLANNQLTDEHLASGVSFLTSL 553

Query: 81   SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITID 140
            +NCK L  + +  NPL G LP  S+GNL  +LE F  + C   G IP  IGNLTNLI + 
Sbjct: 554  TNCKFLRTLWIGYNPLKGTLPN-SLGNLPIALESFNAYACQFRGTIPTGIGNLTNLIMLH 612

Query: 141  LGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA 200
            LG N L GSI  TL +LQKLQ L +  N++ GSIP+D+C L  L  L L  NKLS S P+
Sbjct: 613  LGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPS 672

Query: 201  CFNNLIALRILSLGSND---------------------------PLPLEIGNLKVLVGID 233
            CF +L+ALR L L SN                             LP E+GN+K ++ +D
Sbjct: 673  CFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKYIITLD 732

Query: 234  FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA 293
             S N  SG IP  +G L+NL  L L  N+LQG IP   G+L+SL+ L+LS NNLS  IP 
Sbjct: 733  LSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESLDLSQNNLSRIIPK 792

Query: 294  SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHP 353
            SLE L YL+ LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C  +    
Sbjct: 793  SLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPHFQVMACDKNNRTQ 852

Query: 354  SWNIS--LLLGIVLPL-STTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELC 410
            SW     +L  I+LP+ ST  ++V I L +R R   + P+  A+  L       S+ +L 
Sbjct: 853  SWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIASW-LPGTHEKISHQQLL 911

Query: 411  RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR 470
             AT+ F E+NLIG+G  G VYK  L +G+ VA+KVFNL+ +RA +SFD ECE+M+ IRHR
Sbjct: 912  YATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVMQGIRHR 971

Query: 471  NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
            NL+++I+ CSN +FK LVLEYMP GSLEK LYS N  LD+ QRLNIMI VASALEYLH  
Sbjct: 972  NLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIYVASALEYLHHD 1031

Query: 531  CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            CS+ V+HCDLKPSNVLLDDNM+A+++DFGIAKLL  E +SM QT+TL TIGYMAP
Sbjct: 1032 CSSLVVHCDLKPSNVLLDDNMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMAP 1085

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	585
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.849	0.492	0.341	1.3e-62
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.851	0.493	0.325	6e-61
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.976	0.557	0.353	5.8e-82
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.914	0.545	0.364	4.2e-79
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.847	0.490	0.315	4e-57
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.823	0.467	0.330	1.4e-60
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.849	0.484	0.357	2e-66
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.982	0.490	0.328	3.9e-72
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.969	0.565	0.333	4.6e-69
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.976	0.569	0.324	1.5e-66

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 645 (232.1 bits), Expect = 1.3e-62, P = 1.3e-62
 Identities = 179/524 (34%), Positives = 263/524 (50%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSL----SGSLSSITDV- 56
             IP  + N+  LE L + +N L G++P    NV  LKLL L  NSL    S  L  +T + 
Sbjct:   275 IPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLT 333

Query:    57 RLPNLEELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
                 LE L +                   L  + L    + G +P   IGNL + L+   
Sbjct:   334 NCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY-DIGNLIN-LQKLI 391

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             +    ++G +P  +G L NL  + L  N+L+G I   +  +  L+ L L +N  EG +P 
Sbjct:   392 LDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPT 451

Query:   177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGID 233
              +     L +L +G NKL+ +IP     +  L  L +  N     LP +IG L+ L  + 
Sbjct:   452 SLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLS 511

Query:   234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPA 293
                N  SG +P+ +G    +E LFL  N   G IPD  G                G+IP 
Sbjct:   512 LGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLS-GSIPE 570

Query:   294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKT---S 349
                  S LE LNLSFN LEG++P  G F N +  S  GN  LCG     Q+ PC +   S
Sbjct:   571 YFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPS 630

Query:   350 I--HHPSWNISLLLGIVLPLSTTLMIVV--IWLI-LRYRQRGKQPSNDANMPLVAMWRTF 404
             +   H S    +++G+ + ++  L++ +  + LI LR R++ K+ +N     L  +    
Sbjct:   631 VVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKI 690

Query:   405 SYLELCRATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEI 463
             SY +L  AT+GFS +N++G G FG+VYKA L  +   VAVKV N+Q R A KSF  ECE 
Sbjct:   691 SYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECES 750

Query:   464 MKSIRHRNLIKVISSCSN-----EEFKGLVLEYMPQGSLEKHLY 502
             +K IRHRNL+K++++CS+      EF+ L+ E+MP GSL+  L+
Sbjct:   751 LKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 630 (226.8 bits), Expect = 6.0e-61, P = 6.0e-61
 Identities = 170/522 (32%), Positives = 262/522 (50%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS----GSLSSITDV- 56
             IP  + N+  LE   + +N++ G++      +  L  L L +NSL     G L+ +  + 
Sbjct:   275 IPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALT 334

Query:    57 RLPNLEELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
                +L  L +                   LTV+ L  N + G +P   IGNL   L+   
Sbjct:   335 NCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPH-DIGNLI-GLQSLL 392

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             + +  +TG +P  +GNL  L  + L  N+ +G I   +  L +L  L L +N  EG +P 
Sbjct:   393 LADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPP 452

Query:   177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGID 233
              +     +  L++G NKL+ +IP     +  L  L++ SN     LP +IG L+ LV + 
Sbjct:   453 SLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELL 512

Query:   234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPA 293
                NN SG +P+ +G   ++E ++L  N   G IPD  G                G+I  
Sbjct:   513 LGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGVKNVDLSNNNLS-GSISE 571

Query:   294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPC-----K 347
               E  S LE LNLS N  EG +P  G F N +  S  GN+ LCGS   L++ PC      
Sbjct:   572 YFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPP 631

Query:   348 TSIHHPSWNISLLLGIVLPLSTTLMIVVIWLI-LRYRQRGKQPSNDANMPLVAMWRTFSY 406
                 HPS    + +G+ + ++  L++ ++ L   + R+  ++ +N A   L       SY
Sbjct:   632 VETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSY 691

Query:   407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
              +L  ATDGFS +N++G G FG+V+KA L  +   VAVKV N+Q R A KSF  ECE +K
Sbjct:   692 GDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLK 751

Query:   466 SIRHRNLIKVISSCSN-----EEFKGLVLEYMPQGSLEKHLY 502
              IRHRNL+K++++C++      EF+ L+ E+MP GSL+K L+
Sbjct:   752 DIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 822 (294.4 bits), Expect = 5.8e-82, P = 5.8e-82
 Identities = 219/619 (35%), Positives = 315/619 (50%)

Query:     1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS-------GSLSSI 53
             +IP  + N  +L  + +  N   G +      +  L  L L  N          G +S +
Sbjct:   288 KIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDL 347

Query:    54 TDVRLPNLEELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLE 113
             T+     L+ L L                  SL+ + L  N + G +PK  IGNL   L+
Sbjct:   348 TNCS--KLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPK-DIGNLI-GLQ 403

Query:   114 DFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGS 173
                + N N  G +P  +G L NL  +    N L+GSI + +  L +L  L+L  NK  G 
Sbjct:   404 HLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGW 463

Query:   174 IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL-SLGSND---PLPLEIGNLKVL 229
             IP  +  L  L  L L  N LS  IP+   N+  L I+ ++  N+    +P EIG+LK L
Sbjct:   464 IPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNL 523

Query:   230 VGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXG 289
             V      N  SG IP  +G  + L YL+L  N L G IP + G                G
Sbjct:   524 VEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSG 583

Query:   290 AIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPC-- 346
              IP SL  ++ L  LNLSFN   GE+P  G+F   S  S +GN  LCG  P+L +P C  
Sbjct:   584 QIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCP 643

Query:   347 --KTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDA--NMPLVAMWR 402
               +   H P   IS+ L   L + ++L +++ W     R +   PS  +    PLV    
Sbjct:   644 LLENRKHFPVLPISVSLAAALAILSSLYLLITW---HKRTKKGAPSRTSMKGHPLV---- 696

Query:   403 TFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECE 462
               SY +L +ATDGF+  NL+G G FGSVYK +L     VAVKV  L+  +A KSF  ECE
Sbjct:   697 --SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECE 754

Query:   463 IMKSIRHRNLIKVISSCSN-----EEFKGLVLEYMPQGSLEKHLY-STNCILD-----IF 511
              ++++RHRNL+K+++ CS+      +FK +V ++MP GSLE  ++  TN   D     + 
Sbjct:   755 ALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLH 814

Query:   512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
             +R+ I++DVA AL+YLH     PV+HCD+K SNVLLD +M+A++ DFG+A++L+ +  S+
Sbjct:   815 RRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGTSL 873

Query:   572 TQTQT-----LATIGYMAP 585
              Q  T     + TIGY AP
Sbjct:   874 IQQSTSSMGFIGTIGYAAP 892

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 795 (284.9 bits), Expect = 4.2e-79, P = 4.2e-79
 Identities = 210/576 (36%), Positives = 310/576 (53%)

Query:    29 AIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGXXXXXXXXXXXXXXCKSLTV 88
             ++ N S L+ L L  NSL G ++S       NL ++ L                  +LT+
Sbjct:   267 SLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHL-DQNRIHGSIPPEISNLLNLTL 325

Query:    89 IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG 148
             + LS+N L G +P+  +  LS  LE   + N ++TG+IP E+G++  L  +D+  N L+G
Sbjct:   326 LNLSSNLLSGPIPR-ELCKLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSG 383

Query:   149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIA 207
             SI  +   L +L+ L+L  N L G++P  + + + L  L+L  N L+ +IP    +NL  
Sbjct:   384 SIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRN 443

Query:   208 LRI-LSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRL 263
             L++ L+L SN    P+PLE+  + +++ +D S N  SG IP ++G    LE+L L  N  
Sbjct:   444 LKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGF 503

Query:   264 QGLIPDSFGXXXXXXXXXXXXXXXXGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
                +P S G                GAIP S ++ S L+ LN SFN L G +   GSF  
Sbjct:   504 SSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSK 563

Query:   324 FSAESFEGNELLCGS-PNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRY 382
              + ESF G+ LLCGS   +Q   CK    +PS    +LL ++L L  T ++ V    L  
Sbjct:   564 LTIESFLGDSLLCGSIKGMQA--CKKKHKYPS----VLLPVLLSLIATPVLCVFGYPLVQ 617

Query:   383 RQR-GK---------------QPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGG 426
             R R GK               Q  ND   P +      SY +L  AT GF+ ++LIG G 
Sbjct:   618 RSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI------SYQQLIAATGGFNASSLIGSGR 671

Query:   427 FGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLIKVISSCSNEEFK 485
             FG VYK  L +  +VAVKV + +    F  SF  EC+I+K  RHRNLI++I++CS   F 
Sbjct:   672 FGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN 731

Query:   486 GLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKP 542
              LVL  MP GSLE+HLY    ++  LD+ Q +NI  DVA  + YLH      V+HCDLKP
Sbjct:   732 ALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKP 791

Query:   543 SNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
             SN+LLDD M A ++DFGI++L+ G +++++   +++
Sbjct:   792 SNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVS 827

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 4.0e-57, P = 4.0e-57
 Identities = 166/526 (31%), Positives = 259/526 (49%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS----GSLSSITDV- 56
             IP  + N+  L++  + +N + G +      V +L+ L L +N L     G L  I  + 
Sbjct:   275 IPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLT 334

Query:    57 RLPNLEELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
                +L+ L +                   L  + L  N   G +P+  IGNL   L+  Q
Sbjct:   335 NCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQ-DIGNLI-GLQRLQ 392

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             +    +TG +P  +G L  L  + L  N+++G I   +  L +L+ L L +N  EG +P 
Sbjct:   393 LGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPP 452

Query:   177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGID 233
              + +   +  L +G NKL+ +IP     +  L  LS+  N     LP +IG+L+ LV + 
Sbjct:   453 SLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLS 512

Query:   234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPA 293
                N FSG +P+ +G    +E LFL  N   G IP+  G                G+IP 
Sbjct:   513 LENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRGLMGVRRVDLSNNDLS-GSIPE 571

Query:   294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPC-----K 347
                  S LE LNLS N   G++P  G+F N +     GN+ LCG   +L++ PC      
Sbjct:   572 YFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPP 631

Query:   348 TSIHHPSW--NISLLLGIVLPLSTTLMI---VVIWLILRYRQRGKQPSNDANMPLVAMWR 402
                 H S    +++L+ I + L   L+I   V+ W   R R++ +Q +N     L     
Sbjct:   632 VETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWF--RKRRKNQQTNNLVPSKLEIFHE 689

Query:   403 TFSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVEC 461
               SY +L  AT+GFS +N++G G FG+V+KA L  +   VAVKV N+Q R A KSF  EC
Sbjct:   690 KISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAEC 749

Query:   462 EIMKSIRHRNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLY 502
             E +K  RHRNL+K++++C++ +F+G     L+ EY+P GS++  L+
Sbjct:   750 ESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 627 (225.8 bits), Expect = 1.4e-60, P = 1.4e-60
 Identities = 167/505 (33%), Positives = 250/505 (49%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITD-----V 56
             IP  + N+ +LE  D+  N L G++P++   +  L  LG+++NSL  + SS  +      
Sbjct:   282 IPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVA 341

Query:    57 RLPNLEELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
                 LE L +                  +LT + L  N + G +P   IGNL  SL++  
Sbjct:   342 NCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPH-DIGNLV-SLQELS 399

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             +    ++G++P   G L NL  +DL  N ++G I      + +LQ L L+ N   G IP 
Sbjct:   400 LETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQ 459

Query:   177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGID 233
              + R   L  L +  N+L+ +IP     + +L  + L +N      P E+G L++LVG+ 
Sbjct:   460 SLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLG 519

Query:   234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPA 293
              S N  SG +P+ IGG  ++E+LF+  N   G IPD                   G IP 
Sbjct:   520 ASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPR 578

Query:   294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN-LQVPPCKTSI-- 350
              L  L  L +LNLS NK EG +P  G F N +A S  GN  +CG    +Q+ PC      
Sbjct:   579 YLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASP 638

Query:   351 --HHP-SWNISLLLGIVLPLSTTLMIVVI----WLILRYRQRGKQPSNDANMPLVAMWRT 403
                 P S    ++ GI + +++ L+I+++    W + R ++      N ++   + M+  
Sbjct:   639 RKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHE 698

Query:   404 -FSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVEC 461
               SY EL  AT  FS  NLIG G FG+V+K  LG +   VAVKV NL    A KSF  EC
Sbjct:   699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758

Query:   462 EIMKSIRHRNLIKVISSCSNEEFKG 486
             E  K IRHRNL+K+I+ CS+ + +G
Sbjct:   759 ETFKGIRHRNLVKLITVCSSLDSEG 783

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 2.0e-66, P = 2.0e-66
 Identities = 188/526 (35%), Positives = 263/526 (50%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDV--RLP 59
             IP  + N+ +L +LD+  N L G +P++   +  L LLGL +NSL    S   D    L 
Sbjct:   290 IPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALT 349

Query:    60 NLEELVLWGXXXXXXXXXXXXXXCK---SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
             N  +L                        LT + L  N + G +P   IGNL  SL+   
Sbjct:   350 NCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH-GIGNLV-SLQTLD 407

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             +    +TG +P  +G L+ L  + L  N L+G I  +L  +  L  L L +N  EGSIP 
Sbjct:   408 LGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPS 467

Query:   177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGID 233
              +     L  L LG NKL+ SIP     L +L +L++  N    PL  +IG LK L+ +D
Sbjct:   468 SLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALD 527

Query:   234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPA 293
              S N  SG IP+ +    +LE+L L  N   G IPD  G                G IP 
Sbjct:   528 VSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLSKNNLS-GTIPE 586

Query:   294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLQVPPCKTSI-- 350
              +   S L++LNLS N  +G +P  G F N SA S  GN  LCG  P+LQ+ PC   +  
Sbjct:   587 YMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPR 646

Query:   351 HHPSWN--ISLLLGIVLPLSTTLMIVVI---WLILRYRQ-RGKQPSNDANM-PLVAMWRT 403
              H S    I++ +  V+     L + V+   W  LR +  R     ND +  P+ + +  
Sbjct:   647 RHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEK 706

Query:   404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRR-AFKSFDVEC 461
              SY EL + T GFS +NLIG G FG+V+K  LG     VA+KV NL C+R A KSF  EC
Sbjct:   707 ISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAEC 765

Query:   462 EIMKSIRHRNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLY 502
             E +  IRHRNL+K+++ CS+ +F+G     LV E+MP G+L+  L+
Sbjct:   766 EALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 736 (264.1 bits), Expect = 3.9e-72, P = 3.9e-72
 Identities = 201/611 (32%), Positives = 318/611 (52%)

Query:     1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
             EIP +I N  NLE L +  N L GT+   I  +  L++L +  NSL+G +       + N
Sbjct:   446 EIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR----EIGN 501

Query:    61 LEEL-VLWGXXXXXXXXXXXXXXCKSLTVI-GLS--NNPLDGILPKTSIGNLSHSLEDFQ 116
             L++L +L+                 +LT++ GL   +N L+G +P+        S+ D  
Sbjct:   502 LKDLNILY--LHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLD-- 557

Query:   117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             + N   +G IP     L +L  + L GNK NGSI  +L  L  L    + DN L G+IP 
Sbjct:   558 LSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPG 617

Query:   177 DIC---RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLV 230
             ++    + ++LY L    N L+ +IP     L  ++ + L +N     +P  +   K + 
Sbjct:   618 ELLASLKNMQLY-LNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676

Query:   231 GIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXG 289
              +DFS NN SG IP E+  G+  +  L L  N   G IP SFG                G
Sbjct:   677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736

Query:   290 AIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC--K 347
              IP SL  LS L+ L L+ N L+G +P  G F N +A    GN  LCGS    + PC  K
Sbjct:   737 EIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIK 795

Query:   348 TSIHHPSWN---ISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLV--AM-W 401
                 H S     I ++LG    L   L++V+I    + +++  + S+++++P +  A+  
Sbjct:   796 QKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL 855

Query:   402 RTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDV 459
             + F   EL +ATD F+  N+IG     +VYK +L DG  +AVKV NL+     + K F  
Sbjct:   856 KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYT 915

Query:   460 ECEIMKSIRHRNLIKVIS-SCSNEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIM 517
             E + +  ++HRNL+K++  +  + + K LVL +M  G+LE  ++ +   I  + +++++ 
Sbjct:   916 EAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLC 975

Query:   518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQT 576
             + +AS ++YLH G   P++HCDLKP+N+LLD + +A++SDFG A++L   ED S T + +
Sbjct:   976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTS 1035

Query:   577 L--ATIGYMAP 585
                 TIGY+AP
Sbjct:  1036 AFEGTIGYLAP 1046

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 702 (252.2 bits), Expect = 4.6e-69, P = 4.6e-69
 Identities = 200/599 (33%), Positives = 287/599 (47%)

Query:     5 EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSS-ITDVRLPNLEE 63
             E+G L +L+ +DL  N   G +P +   +  L LL L  N L G +   I D  LP LE 
Sbjct:   282 ELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGD--LPELEV 339

Query:    64 LVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSI-GNLSHSLEDFQMHNCNV 122
             L LW                K L ++ LS+N L G LP     GN   +L    + N  +
Sbjct:   340 LQLWENNFTGSIPQKLGENGK-LNLVDLSSNKLTGTLPPNMCSGNKLETL--ITLGNF-L 395

Query:   123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
              G IP+ +G   +L  I +G N LNGSI   L  L KL  + L DN L G +P      V
Sbjct:   396 FGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSV 455

Query:   183 ELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNF 239
              L ++ L  N+LS  +P    N   ++ L L  N    P+P E+G L+ L  IDFS N F
Sbjct:   456 NLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLF 515

Query:   240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPASLEKLS 299
             SG I  EI   K L ++ L  N L G IP+                   G+IP S+  + 
Sbjct:   516 SGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQ 575

Query:   300 YLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSI----H--HP 353
              L  L+ S+N L G +P  G F  F+  SF GN  LCG P L   PCK  +    H  H 
Sbjct:   576 SLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCG-PYLG--PCKDGVAKGGHQSHS 632

Query:   354 SWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLEL---C 410
                +S  + ++L L   +  +   ++   + R  + ++++       WR  ++  L   C
Sbjct:   633 KGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASESRA-----WRLTAFQRLDFTC 687

Query:   411 R-ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS--FDVECEIMKSI 467
                 D   E+N+IG+GG G VYK  + +G  VAVK      R +     F+ E + +  I
Sbjct:   688 DDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRI 747

Query:   468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEY 526
             RHR++++++  CSN E   LV EYMP GSL + L+      L    R  I ++ A  L Y
Sbjct:   748 RHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCY 807

Query:   527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             LH  CS  ++H D+K +N+LLD N  A+++DFG+AK L     S   +    + GY+AP
Sbjct:   808 LHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 1.5e-66, P = 1.5e-66
 Identities = 194/597 (32%), Positives = 284/597 (47%)

Query:     2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
             I  E+G + +L+ +DL  N   G +P +   +  L LL L  N L G++       +P L
Sbjct:   279 ITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIG-EMPEL 337

Query:    62 EELVLWGXXXXXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSI-GNLSHSLEDFQMHNC 120
             E L LW                + L ++ LS+N L G LP     GN   +L    + N 
Sbjct:   338 EVLQLWENNFTGSIPQKLGENGR-LVILDLSSNKLTGTLPPNMCSGNRLMTL--ITLGNF 394

Query:   121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
              + G IP+ +G   +L  I +G N LNGSI   L  L KL  + L DN L G +P     
Sbjct:   395 -LFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGG 453

Query:   181 LV-ELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSM 236
             +  +L ++ L  N+LS S+PA   NL  ++ L L  N     +P EIG L+ L  +DFS 
Sbjct:   454 VSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSH 513

Query:   237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXXXXXXXXXXXXXXGAIPASLE 296
             N FSG I  EI   K L ++ L  N L G IP+                   G+IP ++ 
Sbjct:   514 NLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIA 573

Query:   297 KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWN 356
              +  L  ++ S+N L G +P  G F  F+  SF GN  LCG P L   PC    H     
Sbjct:   574 SMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-PYLG--PCGKGTHQSHVK 630

Query:   357 -ISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLEL---CR- 411
              +S    ++L L      +V  ++   + R  + +++A       WR  ++  L   C  
Sbjct:   631 PLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKA-----WRLTAFQRLDFTCDD 685

Query:   412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS--FDVECEIMKSIRH 469
               D   E+N+IG+GG G VYK  +  G  VAVK        +     F+ E + +  IRH
Sbjct:   686 VLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRH 745

Query:   470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLH 528
             R++++++  CSN E   LV EYMP GSL + L+      L    R  I ++ A  L YLH
Sbjct:   746 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLH 805

Query:   529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               CS  ++H D+K +N+LLD N  A+++DFG+AK L     S   +    + GY+AP
Sbjct:   806 HDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 862

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	585
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-60
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-42
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-38
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.001
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.003
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.003
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.003
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.004
cd12094	44	cd12094, TM_ErbB2, Transmembrane domain of ErbB2,	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  215 bits (548), Expect = 4e-60
 Identities = 181/579 (31%), Positives = 280/579 (48%), Gaps = 43/579 (7%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            IP  +GNL+NL+ L L QNKL G +P +IF++  L  L L DNSLSG +  +  ++L N
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQN 309

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           LE L L+ NNF+      +L++   L V+ L +N   G +PK ++G   ++L    +   
Sbjct: 310 LEILHLFSNNFTG-KIPVALTSLPRLQVLQLWSNKFSGEIPK-NLGK-HNNLTVLDLSTN 366

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
           N+TG+IPE + +  NL  + L  N L G I  +L   + L+ + L DN   G +P +  +
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----------------------- 217
           L  +Y L++  N L   I +   ++ +L++LSL  N                        
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486

Query: 218 ---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL 274
               +P ++G+L  L+ +  S N  SG IP E+   K L  L L +N+L G IP SF  +
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546

Query: 275 ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 334
             L  L+LS N LSG IP +L  +  L  +N+S N L G +P  G+F   +A +  GN  
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606

Query: 335 LCGSPNLQ-VPPCKTSIHHPSW--NISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSN 391
           LCG      +PPCK     PSW   I+  LG  L L+      V        +  +  + 
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE 666

Query: 392 DANMPLVAMWRTFS-YLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 449
           D    L       S  + +        E N+I RG  G+ YK + + +GM+  VK  N  
Sbjct: 667 DGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-D 725

Query: 450 CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD 509
                 S   +   M  ++H N++K+I  C +E+   L+ EY+   +L + L +    L 
Sbjct: 726 VNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LS 778

Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD 548
             +R  I I +A AL +LH  CS  V+  +L P  +++D
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  150 bits (381), Expect = 4e-42
 Identities = 62/167 (37%), Positives = 87/167 (52%), Gaps = 8/167 (4%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +G GGFG+VY AR    G +VA+K+   +      +    E EI+K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            +E    LV+EY   GSL+  L      L   + L I++ +   LEYLH   S  +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 540 LKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+LLD DN    L+DFG++KLL            + T  YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  155 bits (392), Expect = 1e-39
 Identities = 105/287 (36%), Positives = 148/287 (51%), Gaps = 26/287 (9%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGL 91
           N S +  + L   ++SG +SS    RLP ++ + L  N  S        +   SL  + L
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 92  SNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL 151
           SNN   G +P+ SI NL    E   + N  ++G+IP +IG+ ++L  +DLGGN L G I 
Sbjct: 126 SNNNFTGSIPRGSIPNL----ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 152 ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL 211
            +L+ L  L+ L L  N+L G IP ++ ++  L  + LG N LS  IP            
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP------------ 229

Query: 212 SLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF 271
                     EIG L  L  +D   NN +G IP  +G LKNL+YLFL  N+L G IP S 
Sbjct: 230 ---------YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280

Query: 272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
            +L  L  L+LS+N+LSG IP  + +L  LE L+L  N   G+IP  
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  142 bits (360), Expect = 1e-38
 Identities = 56/168 (33%), Positives = 86/168 (51%), Gaps = 9/168 (5%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVIS 477
             +G G FG VY AR    G  VA+KV   +  ++  +    E +I+K ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +E+   LV+EY   G L   L      L   +    +  + SALEYLH   S  ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLKP N+LLD++    L+DFG+A+ L   ++  T   T     YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  151 bits (382), Expect = 2e-38
 Identities = 112/314 (35%), Positives = 162/314 (51%), Gaps = 8/314 (2%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           N   +  +DL    + G +  AIF +  ++ + L +N LSG +         +L  L L 
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
            NNF+      S+ N ++L    LSNN L G +P   IG+ S SL+   +    + G IP
Sbjct: 127 NNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPN-DIGSFS-SLKVLDLGGNVLVGKIP 181

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
             + NLT+L  + L  N+L G I   L +++ L+ + L  N L G IP +I  L  L  L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
           +L  N L+  IP+   NL  L+ L L  N    P+P  I +L+ L+ +D S N+ SG IP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
           + +  L+NLE L L  N   G IP +  +L  L+ L L +N  SG IP +L K + L  L
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 305 NLSFNKLEGEIPRG 318
           +LS N L GEIP G
Sbjct: 362 DLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  141 bits (357), Expect = 3e-38
 Identities = 61/169 (36%), Positives = 89/169 (52%), Gaps = 13/169 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIMKSIRHRNLIKVI 476
           +G G FG+VYKA+  G G  VAVK+     R      D     E  I++ + H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  +++   LV+EY   G L     S    L   +   I + +   LEYLH   S  +I
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP N+LLD+N +  ++DFG+AK L+    S+T T    T  YMAP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAP 167

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (313), Expect = 5e-32
 Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 10/173 (5%)

Query: 419 NNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNL 472
              +G G FG VYK +L        +EVAVK        +  + F  E  IM+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +K++  C+ EE   +V+EYM  G L  +L      L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              IH DL   N L+ +N++  +SDFG+++  + +D    +      I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  123 bits (310), Expect = 1e-31
 Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 23/178 (12%)

Query: 420 NLIGRGGFGSVYKARLGD-GMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVI 476
            L+GRG FGSVY A   D G  +AVK   L        ++ + E  I+ S++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 477 SSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNI------MIDVASALEYLH 528
            S  +EE   L   LEY+  GSL   L         F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
              S  ++H D+K +N+L+D + +  L+DFG AK  +G+ ++   T ++  T  +MAP
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (307), Expect = 3e-31
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 9/170 (5%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG VYK  L     G   +VAVK           + F  E  IMK + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           +  C+  E   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   N L+ +N++  +SDFG+++ +  +D    +      I +MAP
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (297), Expect = 7e-30
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 11/174 (6%)

Query: 419 NNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNL 472
              +G G FG VYK  L        +EVAVK        +  + F  E  IM+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHL-YSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           +K++  C+ EE   +V+EYMP G L  +L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S   IH DL   N L+ +N++  +SDFG+++  + +D           I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 6e-28
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 22/182 (12%)

Query: 420 NLIGRGGFGSVYKARL----GDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSIRHRN 471
             +G G FG VYK +L    G   EVAVK      + + R+ F     E  +MK + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC--------ILDIFQRLNIMIDVASA 523
           +++++  C+ EE   LVLEYM  G L  +L  +           L +   L+  I +A  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           +EYL    S   +H DL   N L+ ++++  +SDFG+++ +  +D    +T     I +M
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 584 AP 585
           AP
Sbjct: 175 AP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (274), Expect = 9e-27
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 19/176 (10%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRNL 472
             IG+G FG VY  R   DG    +K  +L          A      E +I+K + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF---QRLNIMIDVASALEYLHF 529
           IK   S   +    +V+EY   G L + +         F   Q L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  ++H D+KP N+ L  N +  L DFGI+K+L      + +T  + T  Y++P
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =   99 bits (250), Expect = 1e-23
 Identities = 59/165 (35%), Positives = 87/165 (52%), Gaps = 7/165 (4%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+GGFG VYKAR    G EVA+KV  L+ +   +    E +I+K  +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            ++   +V+E+   GSL+  L STN  L   Q   +  ++   LEYLH   S  +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K +N+LL  +    L DFG++  L       T    + T  +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 5e-22
 Identities = 62/171 (36%), Positives = 85/171 (49%), Gaps = 16/171 (9%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVEC---E--IMKSIRHRNLIKV 475
           +G+G FG V   R    G   A+KV  L+ ++  K  +VE    E  I+  I H  ++K+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             +   EE   LVLEY P G L  HL       +   R     ++  ALEYLH   S  +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGI 114

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           I+ DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+AP
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 52/147 (35%), Positives = 76/147 (51%), Gaps = 12/147 (8%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
            IG+G FG VYK  L    EVAVK     CR        + F  E EI+K   H N++K+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKT----CRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I  C  ++   +V+E +P GSL   L      L + + L + +D A+ +EYL    S   
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           IH DL   N L+ +N +  +SDFG+++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.3 bits (238), Expect = 2e-21
 Identities = 65/176 (36%), Positives = 90/176 (51%), Gaps = 16/176 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRH-RNLIKVI 476
            +G G FG VY AR  D   VA+KV   +     +  + F  E +I+ S+ H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
               +E    LV+EY+  GSLE  L        L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 535 VIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLA----TIGYMAP 585
           +IH D+KP N+LLD D  +  L DFG+AKLL     + +     +    T GYMAP
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 420 NLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLI 473
             +G G FG V   R        G +VAVK  N       +S F+ E EI++++ H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 474 KVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           K    C     +   L++EY+P GSL  +L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           S   IH DL   N+L++   +  +SDFG+AK+L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 17/171 (9%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHRNLIKVISSC 479
           +G+G  G VYK R    G   A+K  ++     F K    E + ++S     ++K    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
               +K     +VLEYM  GSL   L     I +      I   +   L+YLH      +
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHT--KRHI 121

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           IH D+KPSN+L++      ++DFGI+K+L   + ++ Q  T + T+ YM+P
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 11/175 (6%)

Query: 415 GFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--RRAFKSFDVECEIMKSIRHR 470
            F    +IG+G FG V   +  D  ++ A+K  N Q C  + + ++   E  I++ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
            L+ +  S  +EE   LV++ +  G L  HL S        Q    + ++  ALEYLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLH-- 117

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH D+KP N+LLD+    +++DF IA  +     ++T T T  T GYMAP
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.9 bits (236), Expect = 3e-20
 Identities = 62/167 (37%), Positives = 90/167 (53%), Gaps = 2/167 (1%)

Query: 152 ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIP-ACFNNLIALRI 210
           IT +   ++  + L    + G I   I RL  +  + L  N+LS  IP   F    +LR 
Sbjct: 63  ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122

Query: 211 LSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD 269
           L+L +N+    +  G++  L  +D S N  SG IP +IG   +L+ L LG N L G IP+
Sbjct: 123 LNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Query: 270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
           S  NL SL+FL L++N L G IP  L ++  L+ + L +N L GEIP
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 89.6 bits (223), Expect = 7e-20
 Identities = 55/165 (33%), Positives = 80/165 (48%), Gaps = 7/165 (4%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G VYKA     G EVA+K   L+ +   +    E  IMK  +H N++    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EYM  GSL   +      ++  Q   +  +V   LEYLH   S  VIH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG A  L  +++S   +  + T  +MAP
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSV-VGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 8e-20
 Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 21/175 (12%)

Query: 420 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +LIGRG FG VYK   L  G  VA+K  +L+     A KS   E +++K+++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 477 SSCSNEEFKGLVLEYMPQGSLEK------HLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
            S    +   ++LEY   GSL +          +   + ++Q       V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH-- 116

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               VIH D+K +N+L   + +  L+DFG+A  L    +       + T  +MAP
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 12/146 (8%)

Query: 421 LIGRGGFGSVYKARLGD--GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVIS 477
            IG+G FG V    LGD  G +VAVK   L+    A ++F  E  +M ++RH NL++++ 
Sbjct: 13  TIGKGEFGDVM---LGDYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
                    +V EYM +GSL  +L S    ++ + Q+L   +DV   +EYL        +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAK 562
           H DL   NVL+ ++++A +SDFG+AK
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 10/164 (6%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDVECEIM-KSIRHRNLIKV 475
           +IG G F +V  A+      E A+K+ +   L   +  K   +E E++ +   H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             +  +EE    VLEY P G L +++      LD         ++  ALEYLH   S  +
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH---SKGI 123

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           IH DLKP N+LLD +M   ++DFG AK+L   + S    +  AT
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 29/187 (15%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V+           D   VAVK         A K F+ E E++ + +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYS-------------TNCILDIFQRLNIMIDVA 521
               C+  +   +V EYM  G L K L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 522 SALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           S + YL   HF      +H DL   N L+  +++  + DFG+++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 579 TIGYMAP 585
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 12/174 (6%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG+G FG+V K  R  DG  +  K  +        K   V E  I++ ++H N+++    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 479 CSNEEFKGL--VLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGC-- 531
             +   + L  V+EY   G L    +        ++      I+  +  AL   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V+H DLKP+N+ LD N    L DFG+AK+L G D S  +T  + T  YM+P
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 9/160 (5%)

Query: 228 VLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
            + G+        G IP +I  L++L+ + L  N ++G IP S G++ SL+ L+LS N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 288 SGAIPASLEKLSYLEDLNLSFNKLEGEIPR--GGSFGNFSAESFEGNELLCGSPNLQVPP 345
           +G+IP SL +L+ L  LNL+ N L G +P   GG   + ++ +F  N  LCG P L    
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RA 536

Query: 346 CKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQR 385
           C      P  ++   +GI   +S   + +VI  +  +++R
Sbjct: 537 CG-----PHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 11/171 (6%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG G    VY A  L +  +VA+K  +L +C+ +      E + M    H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 480 SNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              +   LV+ Y+  GSL    K  Y     LD      ++ +V   LEYLH   S   I
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLI--GEDQSMTQTQTLATIGYMAP 585
           H D+K  N+LL ++    ++DFG++  L   G+     +   + T  +MAP
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 59/173 (34%), Positives = 87/173 (50%), Gaps = 13/173 (7%)

Query: 420 NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVI 476
           N IG G FG VY A  L  G  +AVK   +Q    +  K    E ++++ ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD--IFQRLNIMIDVASALEYLHFGCSTP 534
               + E   + +EY   G+LE+ L     ILD  + +   + +     L YLH   S  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-TQTQTLA-TIGYMAP 585
           ++H D+KP+N+ LD N +  L DFG A  L     +M  + Q+LA T  YMAP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 6/165 (3%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK        + ++F  E +IMK +RH  L+++ + CS 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           EE   +V EYM +GSL   L S     L + Q +++   +A  + YL    S   IH DL
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              N+L+ +N++  ++DFG+A+ LI +D+   +      I + AP
Sbjct: 130 AARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 14/159 (8%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIMKSIRHRNLIKVI 476
           IG G +G VYKAR    G  VA+K   ++  +  + F +    E ++++ +RH N++++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 477 SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
              +++      +V EYM    L   L S        Q    M  +   L+YLH   S  
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE-DQSMT 572
           ++H D+K SN+L++++ +  L+DFG+A+          T
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 6/165 (3%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V++    +   VAVK          K F  E +IMK +RH  LI++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           EE   +V E M  GSL ++L       L + Q +++   VAS + YL    +   IH DL
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              NVL+ +N I  ++DFG+A+ +I ED    +      I + AP
Sbjct: 130 AARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 4/150 (2%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           F+    +G G FG V++    + + VA+K+         + F  E + +K +RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTP 534
            + CS  E   ++ E M +GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            IH DL   N+L+ ++++  ++DFG+A+L+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 18/176 (10%)

Query: 422 IGRGGFGSVYKAR---LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           I +G +G V+ A+    GD    A+KV     +  +        E +I+   +   ++K+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             S   ++   LV+EY+P G L   L +    LD       + ++  ALEYLH   S  +
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ------TQTLATIGYMAP 585
           IH DLKP N+L+D N    L+DFG++K+ +   Q           + + T  Y+AP
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 8/162 (4%)

Query: 408 ELCRATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKS 466
           E+ R TD  +  + +G G +G VY+       + VAVK          + F  E  +MK 
Sbjct: 2   EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKE 58

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALE 525
           I+H NL++++  C+ E    ++ E+M  G+L  +L   N   ++    L +   ++SA+E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           YL        IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 7e-17
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 24/180 (13%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
             IG G +G V  A     G +VA+K  +      +  +R  +    E ++++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 473 IK---VISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           I    ++   S E+F  +  V E M +  L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT--LATIGYMAP 585
           H   S  VIH DLKPSN+L++ N    + DFG+A+  +  D+      T  + T  Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWYRAP 175

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 23/182 (12%)

Query: 415 GFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRN 471
            F     +G+G +GSVYK  RL D    A+K  +L      +  D   E  I+ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 472 LIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQR---LNIMIDVASA 523
           +I        E F       +V+EY P G L K +        +        I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L+ LH      ++H DLK +N+LL  N +  + D GI+K+L    ++M +TQ   T  YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYM 168

Query: 584 AP 585
           AP
Sbjct: 169 AP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 32/178 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G +G VYKAR +  G  VA+KV  L+    F+    E  ++K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN----------IMIDVASALEYLHFG 530
             +   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
             T  IH D+K +N+LL ++    L+DFG++  L     ++ + ++   IG   +MAP
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNL-----QCRRAFKSFDVECEIMKSIRHRNLIK 474
           L+G G FGSVY+   L DG   AVK  +L       + A K  + E  ++  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
            + +   E+   + LE +P GSL K L                  +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
            +H D+K +N+L+D N +  L+DFG+AK      Q +  +   +  G   +MAP
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 54/174 (31%), Positives = 80/174 (45%), Gaps = 14/174 (8%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F     +G G +GSVYKA     G  VA+KV  ++     +    E  I+K      ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK 62

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
              S        +V+EY   GS+   +  TN  L   +   I+      LEYLH   S  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
            IH D+K  N+LL++   A L+DFG++  L     +M +  T+  IG   +MAP
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 20/165 (12%)

Query: 421 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIK 474
           ++G G FGSV + +L    G  ++VAVK   L        + F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 475 VISSCSNEEFKG------LVLEYMPQGSLEKHLYSTNC-----ILDIFQRLNIMIDVASA 523
           +I  C             ++L +M  G L   L  +        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 12/180 (6%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCRRAFKSFDVECEIMKSIR 468
              F     IG+G F  VYKA  L DG  VA   V++F +   +A +    E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALE 525
           H N+IK ++S        +VLE    G L    KH      ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           ++H   S  ++H D+KP+NV +    +  L D G+ +      ++      + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 59/169 (34%), Positives = 87/169 (51%), Gaps = 19/169 (11%)

Query: 422 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 480 SNEEFKGL--VLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
             EE  GL  V EYM +GSL  +L S    +L     L   +DV  A+EYL    +   +
Sbjct: 69  V-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   NVL+ ++ +A +SDFG+ K     + S TQ      + + AP
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 15/174 (8%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKVFNL-----QCRRAFKSFDVECEIMKSIRHRNLIK 474
           L+G+G FG VY     D G E+AVK         + ++   + + E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
                 ++E   + +EYMP GS++  L +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           ++H D+K +N+L D      L DFG +K L  +    + T   +  G   +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 25/153 (16%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECE-----------IMKSIRH 469
           +G G +G VYKAR    G  VA+K   L         D E E           ++K ++H
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISLLKELKH 57

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++K++     E    LV EY     L+K+L      L      +IM  +   L Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             S  ++H DLKP N+L++ + +  L+DFG+A+
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 52/149 (34%), Positives = 75/149 (50%), Gaps = 13/149 (8%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK    +C +   S +  E  I+K++ H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              CS +  KG  L++EY+P GSL  +L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 7/161 (4%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLIKVISSC 479
           L+G+G FG V+K  L D   VAVK       +  K  F  E  I+K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
           +  +   +V+E +P G     L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           L   N L+ +N +  +SDFG+++    ED  +  +  L  I
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQI 156

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 48/170 (28%), Positives = 92/170 (54%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           ++GRG FG V+   R  D   V +K   ++   +    +   EC+++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           +   ++   +V+EY P G+L +++    N +LD    L+  + +  AL ++H   +  ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 537 HCDLKPSNVLLDDN-MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLK  N+LLD + M+  + DFGI+K+L  + ++ T    + T  Y++P
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 7e-15
 Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 12/172 (6%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK---SFDV--ECEIMKSIRHRNLI 473
             +G G +  VYKAR    G  VA+K   L  R+  K   +F    E ++++ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            ++    ++    LV E+M    LEK +   + +L      + M+     LEYLH   S 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++H DLKP+N+L+  + +  L+DFG+A+     ++ MT  Q + T  Y AP
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAP 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 8/155 (5%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 73  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q
Sbjct: 129 RAANILVGENLVCKVADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 49/165 (29%), Positives = 88/165 (53%), Gaps = 13/165 (7%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG+V +     G +VAVK  N++C    ++F  E  +M  + H+NL++++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
                +V+E M +G+L   L +    ++ + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              N+L+ ++ +A +SDFG+A++      SM    +   + + AP
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAP 166

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 31/189 (16%)

Query: 422 IGRGGFGSVYKARL-GDGME-----VAVKVF----NLQCRRAFKSFDVECEIMKSIRHRN 471
           +G G FG VYK  L G         VA+K        + ++ F+    E E+M  ++H N
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSDLQHPN 69

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---------------TNCILDIFQRLNI 516
           ++ ++  C+ E+   ++ EY+  G L + L                     LD    L+I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
            I +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D    Q+++
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 577 LATIGYMAP 585
           L  + +M P
Sbjct: 187 LLPVRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 8/166 (4%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIKVISSC 479
           +G G  G V K      G  +AVK   L+   A  K    E +I+       ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            N     + +EYM  GSL+K L      +       I + V   L YLH      +IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +KPSN+L++      L DFG++  L+    S+ +T    T  YMAP
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 6/165 (3%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  + G+  A K+  ++     + F VE +I+   +H N++ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            E    +++E+   G+L+  +      L   Q   +   +  AL +LH   S  VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG++       Q   +   + T  +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 10/170 (5%)

Query: 422 IGRGGFGSVYKAR---LGDG--MEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG+VYK      G+   + VA+KV       +A K    E  +M S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           +  C + + + L+ + MP G L  ++ +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   NVL+       ++DFG+AKLL  +++          I +MA 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 16/181 (8%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ------CRRAFKSFDVECEIMKSIRH 469
           +++  ++G+G +G+VY      G  +AVK   L         + ++    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDI-FQRLNIMIDVASALEYLH 528
            N+++ + +C ++    + +E++P GS+   L     + +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG----YMA 584
             C   V+H D+K +NV+L  N I  L DFG A+ L       T +  L ++     +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 585 P 585
           P
Sbjct: 177 P 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 11/167 (6%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS---FDVECEIMKSIRHRNLIKVISS 478
           IG G FG V+     +  +VA+K      R    S   F  E ++M  + H  L+++   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
           C+      LV E+M  G L  +L +          L + +DV   + YL       VIH 
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DL   N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 10/170 (5%)

Query: 421 LIGRGGFGSVYKARL---GDGMEVAVKVFNLQCRRAFKSFDVECE---IMKSIRHRNLIK 474
           L+G G FG+V+K      GD +++ V +  +Q R   ++F    +    M S+ H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           ++  C     + LV +  P GSL  H+      LD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           ++H +L   N+LL  + I  ++DFG+A LL  +D+    ++    I +MA
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 26/185 (14%)

Query: 420 NLIGRGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDVECEIM-KSIRHRNLIK 474
           ++IG G FG V +A +   G  M  A+K+          + F  E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNIMID 519
           ++ +C N  +  + +EY P G+L   L               + T   L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           VA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++   GE+  + +T     
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 580 IGYMA 584
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA+K  NLQ +   +    E  +M+  +H N++  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 17/171 (9%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ------CRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G +G VYKAR    G  VA+K   L+       + A +    E +++K + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           ++    ++    LV E+M    L K +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           ++H DLKP N+L++   +  L+DFG+A+           T  + T  Y AP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 12/173 (6%)

Query: 419 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLI 473
              IG G FG VY+        + + VAVK        + +  F  E  IM+   H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+I   + E    +V+E  P G L  +L      LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAP 585
             +H D+   NVL+       L DFG+++ L  ED+S    ++    I +MAP
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 37/181 (20%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVK------VFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G GGFG V   ++       A+K      +     +    S   E EI++   H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID---------VASALE 525
           +  +  ++++  +++EY   G L            I +   +  +         V  A E
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMA 584
           YLH   +  +I+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+A
Sbjct: 108 YLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVA 160

Query: 585 P 585
           P
Sbjct: 161 P 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 24/185 (12%)

Query: 422 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYS---------------TNCILDIFQRLNIMIDV 520
              C + +   +V EYM  G L K L +                   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 581 GYMAP 585
            +M P
Sbjct: 190 RWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 20/153 (13%)

Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKVI 476
           +G G FGSV    Y  + G  +EVAVK    +   A K  F  E  +M  + H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYL---HFGC 531
             C  E    LV+E  P G L K+L       + D+     +   VA  + YL   HF  
Sbjct: 63  GVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
               +H DL   NVLL +   A +SDFG+++ L
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 10/151 (6%)

Query: 421 LIGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +G+G FGSV   R   L D  G  VAVK          + F+ E EI+KS++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 476 ISSCSNEEFK--GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C +   +   LV+EY+P GSL  +L      LD  + L     +   +EYL    S 
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
             +H DL   N+L++      + DFG+ K+L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 17/172 (9%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIM-------KSIRHRNLI 473
           IG+G FG V  A+   DG   AVKV     ++A      +  IM       K+++H  L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +  S    +    VL+Y+  G L  HL       +   R     ++ASAL YLH   S 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +I+ DLKP N+LLD      L+DFG+ K   G + S T +    T  Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 13/147 (8%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
           IGRG FG V+  RL  D   VAVK     CR          F  E  I+K   H N++++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I  C+ ++   +V+E +  G     L +    L + + + ++ + A+ +EYL        
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           IH DL   N L+ +  +  +SDFG+++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 45/195 (23%)

Query: 411 RATDGFSE---NNLIGRGGFGSVYKAR-LGDGMEVAVKVF---------NLQCRRAFKSF 457
            A    SE    N IG G  G+VYK      G   A+KV             CR      
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR------ 121

Query: 458 DVECEIMKSIRHRNLIKVISSC-----SNEEFKGLVLEYMPQGSLE-KHLYSTNCILDIF 511
             E EI++ + H N++K    C      N E + ++LE+M  GSLE  H+     + D+ 
Sbjct: 122 --EIEILRDVNHPNVVK----CHDMFDHNGEIQ-VLLEFMDGGSLEGTHIADEQFLADVA 174

Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
           ++      + S + YLH      ++H D+KPSN+L++      ++DFG++++L    Q+M
Sbjct: 175 RQ------ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL---AQTM 222

Query: 572 TQ-TQTLATIGYMAP 585
                ++ TI YM+P
Sbjct: 223 DPCNSSVGTIAYMSP 237

Length = 353

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 16/179 (8%)

Query: 416 FSENN---LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
           + EN    ++G+G +G VY AR L   + +A+K    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI----DVASALEYL 527
           +++ + S S   F  + +E +P GSL   L S    L   +    +I     +   L+YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124

Query: 528 HFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      ++H D+K  NVL++  + +  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 62/173 (35%), Positives = 85/173 (49%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIM-------KSIRHRNL 472
           +IG+G FG V  A R  DG   AVKV  LQ +   K  + +  IM       K+++H  L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKE-QNHIMAERNVLLKNLKHPFL 58

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           + +  S    E    VL+Y+  G L  HL    C L+   R     +VASA+ YLH   S
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---S 114

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ DLKP N+LLD      L+DFG+ K   G +   T +    T  Y+AP
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 20/170 (11%)

Query: 416 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRH 469
           F+   ++G+G FGSV +A+L    G   +VAVK+   ++      + F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 470 RNLIKVISSCSNEEFKG------LVLEYMPQGSLEKHLYSTNC-----ILDIFQRLNIMI 518
            N+IK+I        KG      ++L +M  G L   L  +        L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           D+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 22/175 (12%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRH---RN 471
           LIGRG +G+VY+ + +  G  VA+K+ NL         DV     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           + K   S        +++EY   GS+ + L     I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAP 585
              VIH D+K +N+L+ +     L DFG+A LL   +Q+ ++  T     Y MAP
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 24/175 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIMKSIRHRNLIKVI 476
           IG G  G V+KA+    G  VA+K   L  RR           E + +++ +H  ++K++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 477 ------SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
                 S         LV+EYMP   L + L      L   Q  + M  +   + Y+H  
Sbjct: 66  DVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH-- 116

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +  ++H DLKP+N+L+  + +  ++DFG+A+L   E++    +  +AT  Y AP
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK          +SF  E +IMK +RH  L+++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L +   +++   VA+ + Y+        IH DL
Sbjct: 73  EPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           + +N+L+ D ++  ++DFG+A+L+  ED   T  Q
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 29/187 (15%)

Query: 422 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC---ILD-----------IFQRLNIMIDVA 521
              C+      +V EYM  G L + L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 522 SALEY---LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           S + Y   LHF      +H DL   N L+   ++  + DFG+++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 579 TIGYMAP 585
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 5/164 (3%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+  +    ++VA+K+   +   +   F  E ++M  + H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    +V EYM  G L  +L      L     L++  DV  A+EYL    S   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127

Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ ++ +  +SDFG+A+ ++ +DQ  +   T   + +  P
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 68.7 bits (169), Expect = 8e-13
 Identities = 56/175 (32%), Positives = 82/175 (46%), Gaps = 27/175 (15%)

Query: 422 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVIS 477
           +G G FG V   R     +  A+K+ +       K  +    E  I++SIRH  L+ +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI------DVASALEYLHFGC 531
           S  ++    LV+EY+P G L  HL  +        R    +       V  ALEYLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           S  +++ DLKP N+LLD +    ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 57/179 (31%), Positives = 78/179 (43%), Gaps = 14/179 (7%)

Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHRN 471
           +   E + +G G  GSV K RL   GM  A+K           K    E EI KS +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 472 LIKVISSCSNEEFK--GLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEY 526
           ++K   +  +E     G+ +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   S  +IH D+KPSN+LL       L DFG++  L+    S+  T T  T  YMAP
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 17/184 (9%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRR---AFKSFDVECEIMK 465
           CR+   F + N IG G +G VY+AR     E VA+K   +   R      S   E  ++ 
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 466 SIRHRNLIK----VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA 521
           ++RH N+++    V+    +  F  LV+EY  Q  L   L +        Q   +M+ + 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             L+YLH      +IH DLK SN+LL D     ++DFG+A+      + M  T  + T+ 
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLW 173

Query: 582 YMAP 585
           Y AP
Sbjct: 174 YRAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 28/188 (14%)

Query: 420 NLIGRGGFGSVYKAR----LGDGME---VAVKVFNL-QCRRAFKSFDVECEIMKSIRHRN 471
           N +G G FG VY+      LG G     VAVK        +  K F  E  +M +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC------ILDIFQRLNIMIDVASALE 525
           ++K++  C   E + +++E M  G L  +L           +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 526 YL---HFGCSTPVIHCDLKPSNVLL-----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           YL   HF      IH DL   N L+     D + +  + DFG+A+ +   D    + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 578 ATIGYMAP 585
             + +MAP
Sbjct: 175 LPVRWMAP 182

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 20/157 (12%)

Query: 421 LIGRGGFGSVYKARLG----DGMEVAVKVFNL------QCRRAFKSFDV---ECEIMKSI 467
           LIG G FGSVY   LG     G  +AVK   L         R     D    E  ++K +
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           +H N+++ + S  + +   + LEY+P GS+   L +     +   R N +  +   L YL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           H   +  +IH D+K +N+L+D+     +SDFGI+K L
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 26/185 (14%)

Query: 420 NLIGRGGFGSVYKARL-GDG--MEVAVK-VFNLQCRRAFKSFDVECEIMKSI-RHRNLIK 474
           ++IG G FG V KAR+  DG  M+ A+K +     +   + F  E E++  +  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNIMID 519
           ++ +C +  +  L +EY P G+L   L                ST   L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           VA  ++YL        IH DL   N+L+ +N +A ++DFG+++   G++  + +T     
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 580 IGYMA 584
           + +MA
Sbjct: 187 VRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 40/153 (26%), Positives = 80/153 (52%), Gaps = 8/153 (5%)

Query: 417 SENNLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           ++  +IG G FG V++   ++    EVAV +  L+     +  + F  E  IM    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           +I++    +  +   ++ EYM  G+L+K+L   +     +Q + ++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---S 124

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
               +H DL   N+L++ N+   +SDFG++++L
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 37/186 (19%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F+    IG+G FG VYKA        VA+KV +L+     ++ D   +I + I      +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEI------Q 51

Query: 475 VISSCSNE---EFKG---------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
            +S C +    ++ G         +++EY   GS    L      LD      I+ +V  
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG- 581
            LEYLH       IH D+K +N+LL +     L+DFG++  L     + T ++    +G 
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGT 161

Query: 582 --YMAP 585
             +MAP
Sbjct: 162 PFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 32/182 (17%)

Query: 421 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           ++G+GG+G V++ R   G        M+V  K   ++ ++       E  I+++++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI-MIDVAS--------A 523
           + +I +        L+LEY+  G L  HL          +R  I M D A         A
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLA 112

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LE+LH      +I+ DLKP N+LLD      L+DFG+ K  I E  ++T T    TI YM
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYM 167

Query: 584 AP 585
           AP
Sbjct: 168 AP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 12/177 (6%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCRRAFKSFDVECEIMKSIRHRN 471
           F     IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +IK  +S   +    +VLE    G L    KH      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  V+H D+KP+NV +    +  L D G+ +      ++      + T  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 5/164 (3%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    +V EYM  G L  +L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+DD     +SDFG+++ ++ +D+  +   +   + +  P
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCRRAFKSFD-VECEI--MKSIRHRNLIK 474
           L+GRG FG VY     D G E+AVK   F+   +   K  + +ECEI  +K++RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 475 VISSCSNEEFKGLVL--EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
                 + E K L +  EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             ++H D+K +N+L D      L DFG +K
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G+GGFG V   ++   G   A K  +   L+ R+  +    E +I++ +  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           +   ++   LV+  M  G L+ H+Y+         + +     +   LE+LH      ++
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DLKP NVLLDD+    +SD G+A  L G            T GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 29/188 (15%)

Query: 422 IGRGGFGSVYKARLG-DGME----VAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G   FG +YK  L   GM+    VA+K   ++   + +  F  E  +M  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLY----------------STNCILDIFQRLNIMID 519
           +   + E+   ++ EY+ QG L + L                 +    LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 520 VASALEYL--HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ +   D    Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 578 ATIGYMAP 585
             I +M P
Sbjct: 188 LPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 8/155 (5%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+        +VA+K          ++F  E +IMK +RH  L+ + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V E+M +GSL   L   +   L + Q +++   +A  + Y+        IH DL
Sbjct: 73  EPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           + +N+L+ DN++  ++DFG+A+L+  ED   T  Q
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 28/180 (15%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV---------ECEIMKSIRHRN 471
           IG G +G V  A     G +VA+K       +   +FDV         E +I++  +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 472 L--IKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           +  I+ I      +FK   +V++ M +  L   ++S   + +   R   +  +   L+Y+
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYI 123

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG--EDQSMTQTQTLATIGYMAP 585
           H   S  VIH DLKPSN+L++++    + DFG+A+ L     +     T+ +AT  Y AP
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 23/184 (12%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MKSIRH 469
           + E   IG G +G+VYKAR L  G  VA+K   +             EI     ++S  H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 470 RNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCI---LDIFQRLNIMIDVA 521
            N+++++  C            LV E++ Q   +   Y + C    L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             +++LH   S  ++H DLKP N+L+  +    ++DFG+A++       M  T  + T+ 
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLW 171

Query: 582 YMAP 585
           Y AP
Sbjct: 172 YRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 16/159 (10%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFN-----LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +IGRG FG V+  R  D  +V A+KV        + + A      E +I+       ++K
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH-FGCST 533
           +  S  +EE   LV+EYMP G L   L   +   +   R  I  ++  AL+ +H  G   
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122

Query: 534 PVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSM 571
             IH D+KP N+L+D D  I  L+DFG+ K +       
Sbjct: 123 --IHRDIKPDNILIDADGHIK-LADFGLCKKMNKAKDRE 158

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 7e-12
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCI----------LDIFQRLNIMIDVASA 523
              C   +   +V EYM  G L K L  +  + +          L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 584 AP 585
            P
Sbjct: 190 PP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 14/154 (9%)

Query: 419 NNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHR 470
             +IG G FG V + RL       ++VA+K          R  F +   E  IM    H 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT---EASIMGQFDHP 65

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N+I++    +      ++ EYM  GSL+K L   +    + Q + ++  +AS ++YL   
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
                +H DL   N+L++ N++  +SDFG+++ L
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 59/170 (34%), Positives = 83/170 (48%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQC---RRAFKSFDVECEIM-KSIRHRNLIKV 475
           +IG+G FG V  A R  DG   AVKV   +    R+  K    E  ++ K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             S    E    VL+++  G L  HL       +   R     ++ASAL YLH   S  +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           ++ DLKP N+LLD      L+DFG+ K   G  QS T T    T  Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 46/172 (26%), Positives = 68/172 (39%), Gaps = 11/172 (6%)

Query: 421 LIGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +G G FG V    +    G  + VAVK   + +       F  E  IM S+ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
                      +V E  P GSL   L         I    +  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAK-LLIGEDQSMTQTQTLATIGYMAP 585
            IH DL   N+LL  +    + DFG+ + L   ED  + +        + AP
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 57/183 (31%), Positives = 88/183 (48%), Gaps = 32/183 (17%)

Query: 420 NLIGRGGFGSVYKA-RLGDGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRHRNLI 473
           + IG G +G V  A     G++VA+K    F  Q  C+R  +    E +I++  +H N+I
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66

Query: 474 K---VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILD-----IFQRLNIMIDVASA 523
               +I   S E F    +V E M    L K + + +   D     ++Q L         
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------G 118

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGY 582
           L+Y+H   S  V+H DLKPSN+LL+ N    + DFG+A++     D +   T+ +AT  Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 583 MAP 585
            AP
Sbjct: 176 RAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G +G VYKAR +  G   A+KV  L+    F     E  +MK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           K +N+LL DN    L+DFG++  +     + T  +  + IG   +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 41/183 (22%), Positives = 80/183 (43%), Gaps = 25/183 (13%)

Query: 422 IGRGGFGSVYK---ARLGDG---MEVAVKVFN----LQCRRAFKSFDVECEIMKSIRHRN 471
           +G+G FG VY+     +  G     VA+K  N    ++ R  F +   E  +MK     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN---EASVMKEFNCHH 70

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST------NCILDIFQRLNIM---IDVAS 522
           +++++   S  +   +V+E M +G L+ +L S       N  L        +    ++A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            + YL    +   +H DL   N ++ +++   + DFG+ + +   D      + L  + +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 583 MAP 585
           MAP
Sbjct: 188 MAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 46/164 (28%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVEC----EIMKSIR----HRNL 472
           +G G FGSVY AR    G  VA+K      ++ F S++ EC    E+ KS+R    H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 473 IK---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-------NIMIDVAS 522
           +K   V     N+E    V EYM     E +LY    + D   +        +I+  +  
Sbjct: 61  VKLKEVFRE--NDELY-FVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 523 ALEYLH----FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
            L ++H    F       H DLKP N+L+    +  ++DFG+A+
Sbjct: 111 GLAHIHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 422 IGRGGFGSVYKARLGDG---MEVAVKVFNLQ-CRRA-FKSFDVECEIMKSIRHRNLIKVI 476
           +G G FGSV + +L      ++VAVK   +  C R+  + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 477 SSC----SNEEFKG--LVLEYMPQGSLEKHL-YS----TNCILDIFQRLNIMIDVASALE 525
             C     +E +    ++L +M  G L   L YS        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           YL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 9/166 (5%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VYKAR L  G   AVK+  L+    F     E  ++K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           + E   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           K +N+LL DN    L+DFG+A  +     ++ + ++ + T  +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 18/173 (10%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLI 473
           ++G G +G V K R    G  VA+K F    + +    DV      E ++++ +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF----KESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEK-HLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            +  +   +    LV EY+ +  LE           D  +    +  +  A+ Y H   S
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---S 118

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +IH D+KP N+L+ ++ +  L DFG A+ L     S   T  +AT  Y AP
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)

Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ-CRRAFKSFDV-ECEIMKSIRHRNL 472
           F   N IG+G FG V+K  R  D    A+K  +L    R  +   + E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYS-------TNCILDIFQRLNIMIDVASALE 525
           I+   S  ++    +V+EY   G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +LH   S  ++H D+K  N+ LD      + D G+AKLL   D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 7/152 (4%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+     +  +VAVK        + ++F  E  +MK+++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFGCSTPVIHCDL 540
           EE   ++ EYM +GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           + +NVL+ ++++  ++DFG+A+++  ED   T
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI--EDNEYT 159

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 11/149 (7%)

Query: 422 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V   R    GD  G +VAVK    +           E EI++++ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C+ +   G  L++E++P GSL+++L      +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             +H DL   NVL++      + DFG+ K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 33/179 (18%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVF-----NLQCRR-AFKSFDVECEIMKSIRHRNLIK 474
           IG G +G V+K R  + G  VA+K F     +   ++ A +    E  ++K ++H NL+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 475 VISSCSNEEFK-----GLVLEYMPQ---GSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +I     E F+      LV EY        LEK+       +       I+     A+ +
Sbjct: 65  LI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNF 115

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            H       IH D+KP N+L+       L DFG A++L G       T  +AT  Y AP
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 59/173 (34%), Positives = 82/173 (47%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIM-------KSIRHRNL 472
           +IG+G FG V  AR   +    AVKV     ++A      E  IM       K+++H  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           + +  S    +    VL+Y+  G L  HL    C L+   R     ++ASAL YLH   S
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +++ DLKP N+LLD      L+DFG+ K  I E    T T    T  Y+AP
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST-FCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 17/176 (9%)

Query: 421 LIGRGGFGSVYKARLG----DGMEVAVKV----FNLQCRRAFKSFDVECEIMKSIRHRNL 472
           +IG G FG V + RL       + VA+K     +  + RR F S   E  IM    H N+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS---EASIMGQFDHPNI 67

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           I +    +      ++ E+M  G+L+  L   +    + Q + ++  +A+ ++YL     
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SE 124

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA---TIGYMAP 585
              +H DL   N+L++ N++  +SDFG+++ L  +    T T +L     I + AP
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 26/185 (14%)

Query: 420 NLIGRGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDVECEIM-KSIRHRNLIK 474
           ++IG G FG V KAR+   G  M+ A+K       +   + F  E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNIMID 519
           ++ +C +  +  L +EY P G+L   L                ST   L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           VA  ++YL        IH DL   N+L+ +N +A ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 580 IGYMA 584
           + +MA
Sbjct: 175 VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 29/183 (15%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRA----------FKSFDVECEIMKSIRH 469
           LIG+G +G VY A  +  G  +AVK   L    A           K+   E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGS----LEKHLYSTNCILDIFQRLNIMIDVASALE 525
            N+++ +   + EE+  + LEY+P GS    L  +      ++  F        V   L 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL---LIGEDQSMTQTQTLATIGY 582
           YLH   S  ++H DLK  N+L+D + I  +SDFGI+K    +   DQ+M+      ++ +
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFW 176

Query: 583 MAP 585
           MAP
Sbjct: 177 MAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 26/165 (15%)

Query: 421 LIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNL 472
            +G G FG V KA             VAVK+       +       E E+MK I +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRL------NIM 517
           I ++  C+ E    +V+EY   G+L   L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             VA  +E+L    S   IH DL   NVL+ ++ +  ++DFG+A+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 14/152 (9%)

Query: 421 LIGRGGFGSVYKARLG--DGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRNL 472
           +IG G FG V   RL      E+ V +  L+       RR F S   E  IM    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS---EASIMGQFDHPNI 67

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           I +    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL     
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SD 124

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
              +H DL   N+L++ N++  +SDFG++++L
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 60/195 (30%), Positives = 87/195 (44%), Gaps = 32/195 (16%)

Query: 411 RATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV----ECEIMK 465
           R  D F     IG G +G VYKAR  D G  VA+K   L   +  + F +    E +I++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILR 61

Query: 466 SIRHRNLIK----VISSCSNEEFKG------LVLEYMPQ---GSLEKHL--YSTNCILDI 510
            + HRN++     V       +FK       LV EYM     G LE  L  +S + I   
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
            ++L         L Y H       +H D+K SN+LL++     L+DFG+A+L   E+  
Sbjct: 122 MKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 571 MTQTQTLATIGYMAP 585
              T  + T+ Y  P
Sbjct: 173 P-YTNKVITLWYRPP 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 14/175 (8%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR------HRNLI 473
            +G G F S Y+AR +  G  +AVK        + +  +V   + K IR      H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +++ +   +    L +E+M  GS+  HL S          +N    +   L YLH     
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---EN 122

Query: 534 PVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLLI--GEDQSMTQTQTLATIGYMAP 585
            +IH D+K +N+L+D       ++DFG A  L   G      Q Q L TI +MAP
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 15/170 (8%)

Query: 421 LIGRGGFGSVYKARLGDGME-VAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVI 476
            +G G FG V+  R        A+KV  +      +  +    E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++ F  +++EY+P G L  +L ++    +         ++  ALEYLH   S  ++
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           + DLKP N+LLD      L+DFG AK L        +T TL  T  Y+AP
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 17/170 (10%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G+GG+G V+ A+  D  E VA+K      L      +    E +I+ + +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI--MIDVASALEYLHFGCSTPV 535
           +  ++E+  L +EY+P G     L +   + +   R  +  M +   AL  L +      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           IH DLKP N L+D +    L+DFG++K ++    S+     + +  YMAP
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 4/141 (2%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  + G   A KV   +     + + VE EI+ +  H  ++K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            +    +++E+ P G+++  +   +  L   Q   I   +  AL+YLH   S  +IH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136

Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  NVLL  +    L+DFG++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 26/186 (13%)

Query: 416 FSENNL-----IGRGGFGSVYKARLGD-GMEVAVK-----VFNLQCRRAFKSFDVECEIM 464
           F+  +L     IGRG FG+V K      G  +AVK     V   + +R     DV   +M
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VM 57

Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVA-- 521
           +S     ++K   +   E    + +E M   SL+K  Y     +L       I+  +A  
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILGKIAVA 115

Query: 522 --SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
              AL YL       +IH D+KPSN+LLD N    L DFGI+  L+    S+ +T+    
Sbjct: 116 TVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGC 170

Query: 580 IGYMAP 585
             YMAP
Sbjct: 171 RPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 12/171 (7%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G+GGFG V   ++   G   A K  N   L+ R+ ++   VE  I+  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +   +    LV+  M  G L  H+Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +I+ DLKP NVLLD++    +SD G+A  L  + QS T+     T G+MAP
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYA-GTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 7/144 (4%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G+V+KA+  +  E VA+K   L        S  + E  ++K ++H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
             +++   LV EY  Q  L+K+  S N  +D     + M  +   L + H   S  V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 2/87 (2%)

Query: 89  IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG 148
           +GL N  L G +P   I  L H L+   +   ++ G+IP  +G++T+L  +DL  N  NG
Sbjct: 423 LGLDNQGLRGFIPND-ISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIP 175
           SI  +L +L  L+ L L+ N L G +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 20/159 (12%)

Query: 419 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--------------ECEI 463
              +G G +G V KA     G  VA+K   +       + D               E +I
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           M  I+H N++ ++      +F  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           L  LH       +H DL P+N+ ++   I  ++DFG+A+
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 25/185 (13%)

Query: 420 NLIGRGGFGSVYKA----RLGDG--MEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNL 472
             +G G FG VY+     R GD   ++VAVK     C    +S F +E  IM    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN------CILDIFQRLNIMIDVASALEY 526
           +++I        + ++LE M  G L+  L            L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 527 L---HFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           L   HF      IH D+   N LL       +A ++DFG+A+ +          + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 581 GYMAP 585
            +M P
Sbjct: 186 KWMPP 190

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 40/185 (21%)

Query: 420 NLIGRGGFGSVYKARL-GDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           + +G G +G V  A     G +VA+K  +      +  +R ++    E  ++K + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENV 76

Query: 473 IKVIS----SCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
           I ++     + S E+F+   LV   M    L   +          Q+L+      ++  +
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQI 127

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
              L+Y+H   S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT 
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVATR 179

Query: 581 GYMAP 585
            Y AP
Sbjct: 180 WYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 17/172 (9%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKVF-----NLQCRR-AFKSFDVECEIMKSIRHRNLI 473
           L+G G +G V K +  + G  VA+K F     +   ++ A +    E  ++K +RH NL+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +I     ++   LV E++    L+      N  LD  +    +  +   +E+ H   S 
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SH 119

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +IH D+KP N+L+  + +  L DFG A+ L    +    T  +AT  Y AP
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 15/174 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVA-VKVFNLQCRRAFKS---FDVECEIMKSIRHRNLIKVIS 477
           IG G FG V    +  G   A V V  L+   + +    F  E +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTN------CILDIFQRLNIMIDVASALEYLHFGC 531
            C+      LV+E+ P G L+ +L S              QR+    ++A  L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               IH DL   N LL  ++   + D+G++     ED  +T  Q    + ++AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 11/169 (6%)

Query: 422 IGRGGFGS--VYKARLGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVIS 477
           +G+G FG   +Y+ R  D   V  K  NL      +  D   E  I+  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 478 SCSNEEFKGLVLEYMPQGSL-EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              ++    + +EY   G+L +K +     + +    L  +  + SA+ Y+H      ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+K  N+ L    +  L DFGI+K+L G + SM +T  + T  YM+P
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.8 bits (151), Expect = 2e-10
 Identities = 63/185 (34%), Positives = 97/185 (52%), Gaps = 39/185 (21%)

Query: 422 IGRGGFGSVYKARLGD---GMEVAVK-VF----NLQ-CRRAFKSFDVECEIM--KSIR-H 469
           +G+G +G V+KA   D      VA+K +F    N    +R F+      EIM  + +  H
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR------EIMFLQELGDH 66

Query: 470 RNLIK---VISSCSNEEFKGLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASA 523
            N++K   VI + ++++   LV EYM     E  L++    N + D+ +R  IM  +  A
Sbjct: 67  PNIVKLLNVIKAENDKDIY-LVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL--IGEDQSM-TQTQTLATI 580
           L+Y+H   S  VIH DLKPSN+LL+ +    L+DFG+A+ L  + E+      T  +AT 
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 581 GYMAP 585
            Y AP
Sbjct: 177 WYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 12/167 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS-- 478
           IG+G  G+V+ A  +  G EVA+K  NLQ +   +    E  +MK +++ N++  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
             +E F  +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   +  VIH 
Sbjct: 87  VGDELF--VVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+K  NVLL  +    L+DFG    +  E QS   T  + T  +MAP
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 12/171 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           IGRG F  VY+A  L D   VA+K   +F +   +A +    E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 478 SCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           S   +    +VLE    G L    K+      ++         + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           V+H D+KP+NV +    +  L D G+ +      ++      + T  YM+P
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 21/191 (10%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIM 464
           C     + +   IG+G FG V+KAR       VA+K   ++     + F +    E +I+
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKIL 65

Query: 465 KSIRHRNLIKVISSCSNE-----EFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
           + ++H N++ +I  C  +      +KG   LV E+     L   L + N    + +   +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK--LLIGEDQSMTQT 574
           M  + + L Y+H      ++H D+K +N+L+  + I  L+DFG+A+   L    +    T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 575 QTLATIGYMAP 585
             + T+ Y  P
Sbjct: 182 NRVVTLWYRPP 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 37/195 (18%)

Query: 422 IGRGGFGSVYKAR-LG-----DGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIK 474
           IG+G FG V++AR  G         VAVK+   +     ++ F  E  +M    H N++K
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTN---------------------CILDIFQR 513
           ++  C+  +   L+ EYM  G L + L   +                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 514 LNIMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
           L I   VA+ + YL    F      +H DL   N L+ +NM+  ++DFG+++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 571 MTQTQTLATIGYMAP 585
                    I +M P
Sbjct: 187 KASENDAIPIRWMPP 201

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 10/170 (5%)

Query: 421 LIGRGGFGSVYKA-RLGDG----MEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++G G FG+VYK   + +G    + VA+K+ N     +A   F  E  IM S+ H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           ++  C +   + LV + MP G L  +++     +     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           ++H DL   NVL+       ++DFG+A+LL G+++          I +MA
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 10/169 (5%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +G+G +G V   R   DG +  +K  NL+   RR  K+ + E +++  ++H N++    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 479 CSNEE-FKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              E+    +V+ +   G L   L      +L   Q +   + +A AL+YLH      ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLK  NV L    I  + D GIA++L  E+Q    +  + T  YM+P
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 11/160 (6%)

Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLIKVI 476
           +G G FG V    YK R    ++VA+KV   +  ++ +     E EIM  + +  ++++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
             C  E    LV+E    G L K L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           H DL   NVLL +   A +SDFG++K L G D S  + ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARS 156

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 11/169 (6%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G+GGFG V   ++ + G   A K  +   L+ +   K   +E EI++ +    ++ +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           +  ++    LV+  M  G L+ H+Y+     L++ + ++    +   + +LH   S  ++
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + D+KP NVLLDD     LSD G+A  L       T TQ   T GYMAP
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 8/165 (4%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA+K  NLQ +   +    E  +M+  ++ N++  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   AL++LH   S  VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E QS   T  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 31/182 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MKSIRHRNLIKV 475
           IG G +G+VYKAR    G  VA+K   +Q            E+     +++  H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 476 ISSC----SNEEFK-GLVLEYMPQGSLEKHL-------YSTNCILDIFQRLNIMIDVASA 523
           +  C    ++ E K  LV E++ Q  L  +L            I D+ ++          
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L++LH  C   ++H DLKP N+L+       L+DFG+A++       M  T  + T+ Y 
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYR 174

Query: 584 AP 585
           AP
Sbjct: 175 AP 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 42/165 (25%), Positives = 83/165 (50%), Gaps = 7/165 (4%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VA+K    Q   + ++F  E  +MK ++H  L+++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L +   I L I + +++   +A  + ++        IH DL
Sbjct: 73  EPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + +N+L+ + +   ++DFG+A+ LI +++   +      I + AP
Sbjct: 129 RAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 20/172 (11%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKV--FNLQCRRAFKSFD-VECEI--MKSIRHRNLIK 474
           L+G+G FG VY     D G E+AVK   F+ +     K  + +ECEI  +K++ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 475 VISSCSN--EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
                 +  E    + +E+MP GS++  L S   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---S 124

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
             ++H D+K +N+L D      L DFG +K L        QT  L+  G  +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL--------QTICLSGTGMKS 168

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y    + D    F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 200 RLPVKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 32/84 (38%), Positives = 47/84 (55%)

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
           + N  + G IP +I  L +L +I+L GN + G+I  +L  +  L+ L L  N   GSIP+
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 177 DICRLVELYKLELGGNKLSRSIPA 200
            + +L  L  L L GN LS  +PA
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 22/153 (14%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSF-DV--ECEIMKSIRHRNLIKVIS 477
           IG G FG+VY AR     E VA+K  +   +++ + + D+  E   ++ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR-------LNIMIDVASALEYLHFG 530
               E    LV+EY         L S + IL++ ++         I       L YLH  
Sbjct: 83  CYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-- 132

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
            S   IH D+K  N+LL +     L+DFG A L
Sbjct: 133 -SHERIHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRN 471
           F +  ++G+GGFG V   ++   G   A K      ++ R+       E +I++ +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFG 530
           ++ +  +   ++   LVL  M  G L+ H+Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               +++ DLKP N+LLDD+    +SD G+A + + E Q++     + T+GYMAP
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 5/148 (3%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+  +    ++VA+K  N +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           ++   +V E+M  G L  +L      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
             N L+    +  +SDFG+ + ++ +D+
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 53.3 bits (129), Expect = 2e-09
 Identities = 25/60 (41%), Positives = 33/60 (55%)

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           NL+ L L  NRL  +   +F  L +LK L+LS NNL+   P +   L  L  L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 20/180 (11%)

Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D + +   +G G + +VYK +   +G  VA+KV  LQ         + E  ++K ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 472 LIKVISSCSNEEFKGLVLEYMPQG---SLEKH---LYSTNCILDIFQRLNIMIDVASALE 525
           ++ +      +E   LV EY+       ++KH   L+  N  L +FQ L         L 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLS 117

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           Y+H      ++H DLKP N+L+ D     L+DFG+A+       S T +  + T+ Y  P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 13/174 (7%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEI--MKSIRHRNLIK 474
           L+G+G FG VY     D G E+A K           S +V   ECEI  +K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 475 VISSCSNEEFKGLV--LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
                 +   K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAP 585
             ++H D+K +N+L D      L DFG +K L     S T  +++    Y M+P
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 28/177 (15%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECE-----------IMKSIRH 469
           IG G +G VYKAR    G  VA+K   L         D E E           ++K + H
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLH 528
            N++K++     E    LV E++ Q  L+K + ++    + +    + +  +   L + H
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVF---NLQCRRAFKSFDVECEIMKSIRHR-NLIKVI 476
           I +G FGSVY A+    G   A+KV    ++  +    +   E  IM        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            S  ++++  LV+EY+  G     L  T   L        + +V   +E LH      +I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGII 119

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+KP N+L+D      L+DFG+++   G        + + T  Y+AP
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 46/141 (32%), Positives = 72/141 (51%), Gaps = 10/141 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G  G V  A     G +VAVK  +L  Q RR    F+ E  IM+  +H N++++ SS
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSS 84

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
               +   +V+E++  G+L   +  T   ++  Q   + + V  AL +LH   +  VIH 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139

Query: 539 DLKPSNVLLDDNMIAYLSDFG 559
           D+K  ++LL  +    LSDFG
Sbjct: 140 DIKSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 84/271 (30%), Positives = 122/271 (45%), Gaps = 12/271 (4%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
             +  L L  ++ + L   SSLS   SL    L +      L  +        L    ++
Sbjct: 45  VAVNRLALNLSSNTLLLLPSSLSRLLSLD---LLSPSGISSLDGSENLLNLLPLPSLDLN 101

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
              +  +I E +  LTNL ++DL  N +     +       L+ L L DNK+E S+P  +
Sbjct: 102 LNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSM 236
             L  L  L+L  N LS  +P   +NL  L  L L  N    LP EI  L  L  +D S 
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLS- 217

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           NN    +   +  LKNL  L L  N+L+  +P+S GNL +L+ L+LSNN +S    +SL 
Sbjct: 218 NNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLG 274

Query: 297 KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAE 327
            L+ L +L+LS N L   +P           
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIALLLLLLEL 305

Length = 394

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 21/186 (11%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIM 464
           CR+ D + + N I  G +G VY+AR    G  VA+K   L+  +  + F +    E  I+
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 465 KSIRHRNLIKV--ISSCSNEEFKGLVLEYMP---QGSLEKHLYSTNCILDIFQRLNIMID 519
             ++H N++ V  +   SN +   +V+EY+    +  +E             +   +M+ 
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQP----FLQSEVKCLMLQ 114

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           + S + +LH      ++H DLK SN+LL++  I  + DFG+A+      +    TQ + T
Sbjct: 115 LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVT 169

Query: 580 IGYMAP 585
           + Y AP
Sbjct: 170 LWYRAP 175

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 51/179 (28%), Positives = 78/179 (43%), Gaps = 23/179 (12%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFD---VECEIMKSIRHRN 471
           F     +G G FG V  A+  G G   A+K    +     K       E  I+  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST----NCILDIFQRLNIMIDVASALEYL 527
           ++ ++ S  +E     +LE++  G L  HL       N +   +       ++  A EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           H   S  +I+ DLKP N+LLD+     ++DFG AK      +   +T TL  T  Y+AP
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 31/70 (44%), Positives = 40/70 (57%), Gaps = 5/70 (7%)

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           I + +  ALEYLH   S  VIH D+KPSNVL++ N    L DFGI+  L+    S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 576 TLATIGYMAP 585
                 YMAP
Sbjct: 163 DAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 4/141 (2%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  + G+  A KV + +     + + VE +I+ S  H N++K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  N+L   +    L+DFG++
Sbjct: 130 KAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 30/190 (15%)

Query: 422 IGRGGFGSVYKARLGDGME---------VAVKVFNLQC-RRAFKSFDVECEIMKSI-RHR 470
           +G G FG V  A    G++         VAVK+       +       E E+MK I +H+
Sbjct: 26  LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCI----LDIFQRLN 515
           N+I ++ +C+ +    +++EY  +G+L ++L           Y+   +    L     ++
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T 
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 576 TLATIGYMAP 585
               + +MAP
Sbjct: 202 GRLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 30/180 (16%)

Query: 422 IGRGGFG---SVYKARLGDGMEVAVK----VF-NL-QCRRAFKSFDVECEIMKSIRHRNL 472
           IG G FG   SV   R  DG  VA+K    VF NL  C+R F+   + C      +H N+
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLC----FFKHDNV 61

Query: 473 IKVIS-------SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           +  +            E +   V+  + Q  L K + S   +     ++  +  +   L+
Sbjct: 62  LSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YLH   S  ++H D+KP N+L++ N +  + DFG+A++    D+S   TQ + T  Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYYRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 20/177 (11%)

Query: 421 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 473 IKVISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI---DVASALEYLH 528
           +  +      E K  L+L+Y+  G +  HLY      D F    +     ++  ALE+LH
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                 +++ D+K  N+LLD      L+DFG++K  + E++  T +    TI YMAP
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 21/181 (11%)

Query: 421 LIGRGGFGSVYKARLGDGME--VAVKVFNLQ-------CRRAFKSFD---VECEIMK-SI 467
            +G G FG VYK R  +  +  +A+K  N+         R   KS      E  I+K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF--QRL-NIMIDVASAL 524
           RH N+++   +    +   +V++ +    L +H  S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
            YLH      ++H DL P+N++L ++    ++DFG+AK     +  +  T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKL--TSVVGTILYSC 181

Query: 585 P 585
           P
Sbjct: 182 P 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 12/151 (7%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVI 476
           L+G+G  G V+  RL G G   A+KV + +    R   K    E EI+ ++ H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLH-FGCST 533
           +S   E +  LV++Y P G L + L      C+ +   R     +V  ALEYLH  G   
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLG--- 123

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +++ DLKP N+LL ++    LSDF ++K  
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 19/151 (12%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G VYK R    G  VA+K   L+       S  + E  ++K ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH-------FGC 531
              E    L+ E++    L+K+L S              +D      YL+       F  
Sbjct: 68  LMQESRLYLIFEFL-SMDLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           S  V+H DLKP N+L+D+  +  L+DFG+A+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 9/149 (6%)

Query: 420 NLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLIK 474
            +IG+G FG VY   L    G  +  AVK  N +      + F  E  IMK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 475 VISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++  C   E   LV L YM  G L   + S      +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             +H DL   N +LD++    ++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 14/173 (8%)

Query: 422 IGRGGFGSVYKAR-LG---DGMEVAVKVFN----LQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G G +G V+  R +G    G   A+KV      +Q  +  +    E ++++++R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 474 KVISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
             +      + K  L+L+Y+  G L  HLY      +   R+ I  ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ D+K  N+LLD      L+DFG++K  + E++    +    TI YMAP
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 55/165 (33%), Positives = 80/165 (48%), Gaps = 19/165 (11%)

Query: 420 NLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           N+IG G FG VY+A   D  E VA+K    +  +  +  + E  IMK++ H N+I +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 479 CSNEEFK--------GLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
              E FK         +V+E++PQ      KH    N  L +F        +  AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 529 FGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGEDQSMT 572
              S  + H DLKP N+L+D N     L DFG AK L+   +S++
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Length = 440

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 49/175 (28%), Positives = 86/175 (49%), Gaps = 11/175 (6%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRN 471
           F +  ++G+GGFG V   ++   G   A K      ++ R+       E +I++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFG 530
           ++ +  +   ++   LVL  M  G L+ H+Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                ++ DLKP N+LLDD     +SD G+A + I E +S+     + T+GYMAP
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESI--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 15/174 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVA-VKVFNLQCRRAFK---SFDVECEIMKSIRHRNLIKVIS 477
           IG G FG V       GM  A V V  L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCIL------DIFQRLNIMIDVASALEYLHFGC 531
            C       LVLE+ P G L+ +L S   ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               IH DL   N  L  ++   + D+G+A     ED  +T+      + ++AP
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 59/201 (29%), Positives = 83/201 (41%), Gaps = 49/201 (24%)

Query: 412 ATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-- 468
            T  F    +IG G +G VYKAR    G  VA+K+ ++         D E EI +     
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-------EDEEEEIKEEYNIL 56

Query: 469 -----HRNL-------IKVISSCSNEEFKGLVLEYMPQGS---LEKHLYSTNCILDIFQR 513
                H N+       IK     ++++   LV+E    GS   L K L          +R
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKG------KR 109

Query: 514 LN------IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           L       I+ +    L YLH      VIH D+K  N+LL  N    L DFG++  L   
Sbjct: 110 LKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--- 163

Query: 568 DQSMTQTQTLATIG---YMAP 585
           D ++ +  T   IG   +MAP
Sbjct: 164 DSTLGRRNT--FIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 8/145 (5%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           +G G + +VYK R     E VA+K  +L       S  + E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 480 SNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             E    LV EYM +  L+K++  +     LD     +    +   + + H      V+H
Sbjct: 68  HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAK 562
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 14/155 (9%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID----VASALEYLHFGCSTPVIH 537
           E    ++ E+M +GSL   L S        Q L  +ID    +A  + ++        IH
Sbjct: 73  EPIY-IITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 125

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
            DL+ +N+L+  +++  ++DFG+A+++  ED   T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI--EDNEYT 158

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 31/183 (16%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F++   IG+G FG V+K       +V A+K+ +L+        + E EI + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 475 VISSCSN--------EEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
           V+S C +           KG    +++EY+  GS    L +     D FQ   ++ ++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILK 112

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167

Query: 583 MAP 585
           MAP
Sbjct: 168 MAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 29/184 (15%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVF------NLQCRRAFKSFDVECEIMK 465
           T+ + +   +G G FG V  AR    G  VA+K         +  +R ++    E +++K
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64

Query: 466 SIRHRNLIKV----ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA 521
            +RH N+I +    IS   +  F   V E +  G+    L ++  +   F +   +  + 
Sbjct: 65  HLRHENIISLSDIFISPLEDIYF---VTELL--GTDLHRLLTSRPLEKQFIQY-FLYQIL 118

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             L+Y+H   S  V+H DLKPSN+L+++N    + DFG+A++   +D  M  T  ++T  
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVSTRY 170

Query: 582 YMAP 585
           Y AP
Sbjct: 171 YRAP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 17/172 (9%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G VYKAR     E +A+K   L Q      S  + E  ++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI----MIDVASALEYLHFGCSTP 534
             +E+   LV EY+    L+KH+ S+    D  +   +    +  +   + Y H   S  
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH---SHR 122

Query: 535 VIHCDLKPSNVLLDDNMIAY-LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           V+H DLKP N+L+D    A  L+DFG+A+         T T  + T+ Y AP
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 17/184 (9%)

Query: 416 FSENNL-----IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCRRAFK-SFDVECEI 463
           F  NNL     +G G FG V +A      +    M+VAVK+       + + +   E +I
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 464 MKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVA 521
           M  +  H N++ ++ +C+      ++ EY   G L   L       L +   L+    VA
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             + +L    S   IH DL   NVLL    I  + DFG+A+ ++ +   + +      + 
Sbjct: 152 KGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 582 YMAP 585
           +MAP
Sbjct: 209 WMAP 212

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 10/175 (5%)

Query: 416 FSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRH 469
           F +  ++G G FG+VYK      G+ +++ V +  L+     +A K    E  +M S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            ++ +++  C     + L+ + MP G L  ++      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
                ++H DL   NVL+       ++DFG+AKLL  +++          I +MA
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 441 VAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL-- 497
           VAVK+      + A   F  E +IM  +++ N+I+++  C +++   ++ EYM  G L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 498 ---EKHLYSTNCI------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD 548
              ++ + ST         + I   L + + +AS ++YL    S   +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           ++    ++DFG+++ L   D    Q + +  I +MA
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 43/186 (23%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IGRG +G V  A+  +   +VA+K     F+  +  +R  +    E ++++ + H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 475 ---VISSCSNEEFKG--LVLEYM----------PQGSLEKHLYSTNCILDIFQRLNIMID 519
              ++     E F    +V E M           Q   + H     C   ++Q L     
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDH-----CQYFLYQLLR---- 119

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
               L+Y+H   S  V+H DLKPSN+LL+ N    + DFG+A+    +   M  T+ + T
Sbjct: 120 ---GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVT 171

Query: 580 IGYMAP 585
             Y AP
Sbjct: 172 RWYRAP 177

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 28/189 (14%)

Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +    + VAVK+  +    +       E E+MK I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTN-CILD----IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS + C L      F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 197 RLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 16/175 (9%)

Query: 421 LIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 473 IKVISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI-DVASALEYLHFG 530
           +  +      + K  L+L+Y+  G L  HL       +  Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               +I+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 23/173 (13%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRR------AFKSFDVECE 462
           C     +     +G G FG VYKAR +  G  VA+K   +   +      A +    E +
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIK 59

Query: 463 IMKSIRHRNLIK----VISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRL 514
           I+K ++H N++      +      + K     +V  YM    L   L + +  L   Q  
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
             M+ +   + YLH      ++H D+K +N+L+D+  I  ++DFG+A+   G 
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 27/178 (15%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS-- 478
           +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55

Query: 479 -----CSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
                C    F        +L+ M  G L  HL       +   R     ++   LE++H
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH 114

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ-TLATIGYMAP 585
              +  V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T GYMAP
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 32/183 (17%)

Query: 422 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MKSIRHRNLIK 474
           IG G +G V+KAR     G  VA+K   +Q            E+     +++  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 475 VISSCS----NEEFK-GLVLEYMPQGSLEKHL-------YSTNCILDIFQRLNIMIDVAS 522
           +   C+    + E K  LV E++ Q  L  +L         T  I D+      M  +  
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLLR 121

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       M  T  + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 175

Query: 583 MAP 585
            AP
Sbjct: 176 RAP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 18/173 (10%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-----QCRRAFKSFDVECEIMKSIRHRNLIKV 475
           IG G FG +Y A+   D     +K  +L     + + A K    E  ++  ++H N++  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCIL-DIFQRLNIMIDVASALEYLHFGCSTP 534
            +S        +V+EY   G L K +     +L    Q L+  + ++  L+++H      
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 535 VIHCDLKPSNVLLDDN-MIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           ++H D+K  N+ L  N M+A L DFGIA+ L   + SM    T   T  Y++P
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 37/183 (20%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMK-----SIRHRNLIKV 475
           +IGRGGFG VY  R  D      K++ ++C       D +   MK     ++  R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50

Query: 476 ISS-------CSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S+       C +  F        +L+ M  G L  HL S + +    +      ++   
Sbjct: 51  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILG 109

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ-TLATIGY 582
           LE++H   +  V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T GY
Sbjct: 110 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGY 161

Query: 583 MAP 585
           MAP
Sbjct: 162 MAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 11/73 (15%)

Query: 516 IMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           + + +  AL YL   H      VIH D+KPSN+LLD +    L DFGI+  L+    S  
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKA 170

Query: 573 QTQTLATIGYMAP 585
           +T++     YMAP
Sbjct: 171 KTRSAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.6 bits (124), Expect = 8e-08
 Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 23/150 (15%)

Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECE--IMKSIRHRNLI--KVI 476
           L+  G    VY     D  +  +K+         K  D E E  I++ +  + L   KV+
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINP----SREKGADREREVAILQLLARKGLPVPKVL 59

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP-- 534
           +S  ++ +  L++E++   +L++        +   ++ +I   +A  L  LH     P  
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH---QLPLL 108

Query: 535 -VIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
            + H DL P N+L+DD  I  + D+  A  
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.7 bits (117), Expect = 9e-08
 Identities = 27/63 (42%), Positives = 34/63 (53%), Gaps = 3/63 (4%)

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN 284
           NLK L   D S N  + I      GL NL+ L L  N L  + P++F  L SL+ L+LS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 285 NNL 287
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 42/194 (21%), Positives = 80/194 (41%), Gaps = 33/194 (17%)

Query: 422 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIK 474
           +G G FG V KA             VAVK+       +  +    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----------------------LDIF 511
           +  +CS +    L++EY   GSL   L  +  +                       L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
             ++    ++  ++YL       ++H DL   NVL+ +     +SDFG+++ +  ED  +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 572 TQTQTLATIGYMAP 585
            +++    + +MA 
Sbjct: 185 KRSKGRIPVKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 8/145 (5%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             +E    LV E++    L+K++ S+    LD     + +  +   + Y H   S  V+H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAK 562
            DLKP N+L+D      L+DFG+A+
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 15/177 (8%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRH 469
           F    ++G+GGFG V   ++   G   A K   L+ +R  K         E  I++ +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLH 528
           R ++ +  +   ++   LVL  M  G L+ H+Y+  N   D  + +    ++   LE L 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                 +++ DLKP N+LLDD     +SD G+A + I E +++     + T+GYMAP
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 51/178 (28%), Positives = 89/178 (50%), Gaps = 17/178 (9%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFK------SFDVECEIMKSIR 468
           F    ++G+GGFG V   ++   G   A K   L+ +R  K      + + E +I++ + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKQILEKVN 58

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYL 527
            R ++ +  +   ++   LVL  M  G L+ H+Y+  N   D  + +    ++   LE L
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +++ DLKP N+LLDD     +SD G+A + I E +++     + T+GYMAP
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 16/160 (10%)

Query: 438 GMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKGLVLEYMP 493
           G EVA+K+              F  E  +   + H N++ ++ S          V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDN 550
             +L + L + +  L   +   +M+ V  AL   H   +  ++H DLKP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 551 MIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IG---YMAP 585
             A + DFGI  LL G   +   T T  T  +G   Y AP
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 38/184 (20%)

Query: 421 LIGRGGFGSVYKARLGDGMEV----AVKVF---NLQCRRAFKSFDVECEIMKSIRHRNLI 473
           ++G+G FG V+  R   G +     A+KV     L+ R   ++  +E +I+  + H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN--IMI----------DVA 521
           K+  +   E    L+L+++  G             D+F RL+  +M           ++A
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
            AL++LH   S  +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ 
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVE 163

Query: 582 YMAP 585
           YMAP
Sbjct: 164 YMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 45/139 (32%), Positives = 72/139 (51%), Gaps = 6/139 (4%)

Query: 422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  AR    G +VAVK+ +L+ ++  +    E  IM+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             E   +++E++  G+L   +  T   L+  Q   +   V  AL YLH   S  VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 541 KPSNVLLDDNMIAYLSDFG 559
           K  ++LL  +    LSDFG
Sbjct: 144 KSDSILLTLDGRVKLSDFG 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 40/183 (21%)

Query: 422 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G +GSV   Y  RL    +VAVK  +      +  RR ++    E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYR----ELRLLKHMKHENV 76

Query: 473 IKVIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVAS 522
           I ++     + S E F  + L     G+        N I+   Q+L+      ++  +  
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            L+Y+H   S  +IH DLKPSNV ++++    + DFG+A+     D  M  T  +AT  Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWY 181

Query: 583 MAP 585
            AP
Sbjct: 182 RAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 9/172 (5%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLI 473
           F++   IG+G FG V+K       +V A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 36/170 (21%)

Query: 421 LIGRGGFGSVYKARLGDGM----EVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           LIG GGFG VY+ +         +   K+ NL+     ++  +E  +  +I   + I + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74

Query: 477 SSCSNEEFKGLVLEYMPQGS------------LEKHLYSTNCILDIFQRL---------N 515
            +  N +  G+   Y   GS            LEK + +T    +IF+R+         N
Sbjct: 75  KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTK---EIFKRIKCKNKKLIKN 130

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
           IM D+ + LEY+H      + H D+KP N+++D N   Y+ D+GIA   I
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Length = 294

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 35/219 (15%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
             E+  L NL  LDL  N +    P+     S LK L L DN +                
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE--------------- 153

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
                       +  S L N  +L  + LS N L  +     + NLS +L +  +    +
Sbjct: 154 ------------SLPSPLRNLPNLKNLDLSFNDLSDL--PKLLSNLS-NLNNLDLSGNKI 198

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
           + D+P EI  L+ L  +DL  N +   +L +LS L+ L GL L +NKLE  +P+ I  L 
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 183 ELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL 221
            L  L+L  N++S    +   +L  LR L L  N     
Sbjct: 256 NLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNA 292

Length = 394

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 36/200 (18%)

Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC---RRAFKSFDVE 460
           F  + LC A DG  + +        +     L     VAVKV  L+      A + F  E
Sbjct: 18  FGEVHLCEA-DGLQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDFLKE 69

Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY----------------ST 504
            +I+  +   N+ +++  C+ +    +++EYM  G L + L                 S 
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           + +      L +   +AS + YL    S   +H DL   N L+  N    ++DFG+++ L
Sbjct: 130 STL------LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 565 IGEDQSMTQTQTLATIGYMA 584
              D    Q +    I +MA
Sbjct: 181 YSSDYYRVQGRAPLPIRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 10/169 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVI 476
           L+G+G FG V   R    G   A+K+   +    +        E  ++K+ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            S   ++    V+EY+  G L  HL       +   R     ++ SAL+YLH G    ++
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---KIV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DLK  N++LD +    ++DFG+ K   G   + T      T  Y+AP
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 30/190 (15%)

Query: 422 IGRGGFGSVYKARLGDGME---------VAVKVF-NLQCRRAFKSFDVECEIMKSI-RHR 470
           +G G FG V +A    G++         VAVK+  +    +       E E+MK I +H+
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS-----TNCILDI---------FQRL-N 515
           N+I ++  C+ E    +++EY  +G+L + L +      +   DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 576 TLATIGYMAP 585
               + +MAP
Sbjct: 196 GRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 9/150 (6%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRH 469
           + F    +IGRG FG V   R     +V A+K+   F +  R     F  E +IM     
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             ++++  +  ++++  +V+EYMP G L  +L S   I + + R     +V  AL+ +H 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTA-EVVLALDAIH- 159

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
             S   IH D+KP N+LLD +    L+DFG
Sbjct: 160 --SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 49/192 (25%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F++   IG+G FG VYK       EV A+K+ +L+        + E EI + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 475 VISSCSN--------EEFKG----LVLEYMPQGS---------LEKHLYSTNCILDIFQR 513
           V+S C +           KG    +++EY+  GS         LE+   +T         
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--------- 105

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
             I+ ++   L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +
Sbjct: 106 --ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKR 158

Query: 574 TQTLATIGYMAP 585
              + T  +MAP
Sbjct: 159 NTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 10/169 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVI 476
           L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +    +    V+EY   G L  HL       +   R     ++ SALEYLH   S  V+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM-KSI-----RHRNLI 473
           ++G+G FG V  A L    E+ AVKV  L+     +  DVEC +  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++ S    ++    V+EY+  G L  H+  +    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +I+ DLK  NVLLD      ++DFG+ K  I    +   T T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 422 IGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G FG VY+ R  D   + A+KV + +   A K      E+  +I  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 481 NEEFKGL------------VLEYMPQGSLEKHLYSTNCILDIFQRLNIMI-DVASALEYL 527
           +    GL            V +YM  G L  HL       +   R    I ++  ALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHL 112

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           H      +++ DLKP N+LLD      L DFG++K  + ++++   T T   T  Y+AP
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 39/144 (27%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 422 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           +G G + +VYK R  L D + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV EY+ +  L+++L      +++      +  +   L Y H      V+H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L+++     L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 41/186 (22%), Positives = 78/186 (41%), Gaps = 25/186 (13%)

Query: 422 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIK 474
           +G   FG VYK  L     G+  + VA+K    +     +  F  E  +   ++H N++ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQRLNIMID 519
           ++   + E+   ++  Y     L + L                +    L+    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           +A+ +E+L    S  V+H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 580 IGYMAP 585
           I +M+P
Sbjct: 190 IRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMK------SIRHRNLI 473
           ++G+G FG V  A L    EV A+KV  L+     +  DV+C + +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +      ++    V+EY+  G L   +  +    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            VI+ DLK  N+LLD      L+DFG+ K  I     +T T    T  Y+AP
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 24/174 (13%)

Query: 422 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           +G G + +VYK  +R+ +G  VA+KV +++         + E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 479 CSNEEFKGLVLEYMPQGSLEKH-------LYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
              +E    V EYM    L ++       L+  N  L +FQ L         L Y+H   
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH--- 120

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              ++H DLKP N+L+       L+DFG+A+       S T +  + T+ Y  P
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 12/170 (7%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++++  +V+EYMP G L  +L S   + + + +     +V  AL+ +H   S  +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGLI 164

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           H D+KP N+LLD +    L+DFG    +  ++  M +  T + T  Y++P
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 51/203 (25%)

Query: 415 GFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQ-----------CRRAFKSFDVE 460
            +     IGRG +G VYKA+     DG E A+K F              CR         
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR--------- 51

Query: 461 CEIM--KSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLE--KHLYSTN-CILDIFQR 513
            EI   + ++H N++ ++        K   L+ +Y      +  K         +     
Sbjct: 52  -EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIA-------K 562
            +++  + + + YLH   S  V+H DLKP+N+L+     +  +  + D G+A       K
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 563 LLIGEDQSMTQTQTLATIGYMAP 585
            L   D        + TI Y AP
Sbjct: 168 PLADLD------PVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMK------SIRHRNLI 473
           ++G+G FG V+ A L G     A+K   L+        DVEC +++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +  +   +E    V+EY+  G L  H+ S +   D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKL-LIGEDQSMTQTQTLATIGYMAP 585
            +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++ T      T  Y+AP
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 80

Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 137

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 138 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 38/147 (25%), Positives = 63/147 (42%), Gaps = 15/147 (10%)

Query: 421 LIGR----GGFGSVYKARLGDGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIK 474
           LIG+         + K +  + + VAVK  NL    +   K    E    + ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---NIMIDVASALEYLHFGC 531
            ++S   +    +V   M  GS E  L +     +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH--- 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDF 558
           S   IH  +K S++LL  +    LS  
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 37/182 (20%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLI 473
            +G G +GSV  A     G +VA+K  +      +  +RA++    E  ++K ++H N+I
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77

Query: 474 KVI----SSCSNEEFKG--LVLEYMPQGSLEK----HLYSTNCILDIFQRLNIMIDVASA 523
            ++    S+ S +EF+   LV+ YM Q  L+K     L        ++Q L         
Sbjct: 78  GLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQML-------CG 129

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L+Y+H   S  +IH DLKP N+ ++++    + DFG+A+     D  M  T  + T  Y 
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYR 181

Query: 584 AP 585
           AP
Sbjct: 182 AP 183

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 32/175 (18%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNL----QCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G G  G+VYKA  L     +AVKV  L    + ++   S   E EI+       +I   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS---ELEILYKCDSPYIIGFY 65

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------NIMIDVASALEYLHFG 530
            +   E    +  E+M  GSL           D+++++       I + V   L YL   
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL--- 111

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  ++H D+KPSN+L++      L DFG++  L+    S+ +T  + T  YMAP
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 24/175 (13%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVIS--- 477
           IG+G FG V + R  D      +++ L+  R  K+  V   E+  ++  R ++  ++   
Sbjct: 1   IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 478 ------SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
                 S  + E   LVL ++  G L  HL       D+ +      ++  ALE LH   
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
              VI+ DLKP N+LLD      L DFG+ KL + +D    +T T   T  Y+AP
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 39/199 (19%)

Query: 422 IGRGGFGSV-----------------YKARLGDGMEVAVKVFNLQC-RRAFKSFDVECEI 463
           +G G FG V                 +  R G  + VAVK+      + A   F  E +I
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS----------------TNCI 507
           +  ++  N+I+++  C +E+   ++ EYM  G L + L S                 +C+
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 508 LDIFQR--LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             I     L++ + +AS ++YL    S   +H DL   N L+ +N+   ++DFG+++ L 
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 566 GEDQSMTQTQTLATIGYMA 584
             D    Q + +  I +MA
Sbjct: 190 AGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 36/144 (25%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 422 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           +G G + +V+K R  L + + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              ++   LV EY+ +  L++++     I+ +      +  +   L Y H      V+H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L+++     L+DFG+A+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 19/176 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVI-- 476
           ++G G +G VYK R +  G   A+KV ++      +   +E  ++K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 477 ----SSCSNEEFKGLVLEYMPQGSLEKHLYST--NCILDIFQRLNIMIDVASALEYLHFG 530
               S   +++   LV+E+   GS+   + +T  N + + +    I  ++   L +LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
            +  VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 22/160 (13%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCRRAFKSFDVECEIMKSIRHRN 471
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS-------AL 524
            I+       E    LV+EY         L S + +L++ ++    +++A+        L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            YLH   S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 37/188 (19%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI---- 476
           +G G  G V+ A   D    VAVK   L   ++ K    E +I++ + H N++KV     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 477 --SSCSNEEFKGL--------VLEYMP---QGSLEKHLYSTNCI-LDIFQRLNIMIDVAS 522
              S   E+   L        V EYM       LE+   S     L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQ----TQTL 577
            L+Y+H   S  V+H DLKP+NV ++ ++++  + DFG+A+++   D   +     ++ L
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGL 179

Query: 578 ATIGYMAP 585
            T  Y +P
Sbjct: 180 VTKWYRSP 187

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 22/159 (13%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNL---QCRRAFKSFDVECEIMKSIRHRN 471
           F++   IG G FG+VY AR     EV A+K  +    Q    ++    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS-------AL 524
            I+       E    LV+EY         L S + +L++ ++    +++A+        L
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
            YLH   S  +IH D+K  N+LL +     L+DFG A +
Sbjct: 139 AYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 10/169 (5%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++ +  +V+EYMP G L  +L S   + + + R     +V  AL+ +H   S   I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 164

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+KP N+LLD +    L+DFG   + + ++  +     + T  Y++P
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 10/150 (6%)

Query: 421 LIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           ++G G FG+VYK   + DG    + VA+KV       +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           ++  C     + LV + MP G L  ++      +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           ++H DL   NVL+       ++DFG+A+LL
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 43/189 (22%)

Query: 422 IGRGGFGSVYKAR---LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIR-HRN 471
           +G+G +G V  AR     +   VA+K    VF+  +  +RA +    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 472 LIK------VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD------IFQRLNIMID 519
           +        V     NE +  L  E M +  L + + S   + D      I+Q L     
Sbjct: 64  ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ---TQT 576
               L+Y+H   S  V+H DLKP N+L++ +    + DFG+A+    E+        T+ 
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEY 169

Query: 577 LATIGYMAP 585
           +AT  Y AP
Sbjct: 170 VATRWYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 422 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           +G G + +V+K R  L + + VA+K   L+         + E  ++K+++H N++ +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E    LV EY+    L+++L +   ++ +      M  +   L Y H      ++H 
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L+++     L+DFG+A+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 40/192 (20%), Positives = 78/192 (40%), Gaps = 31/192 (16%)

Query: 415 GFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNL----QCRRAFKSFDVECEIM 464
              E   +GRG FG V+ A+       G    V VK          +  F+    E ++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMF 62

Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--------LDIFQRLNI 516
           + + H+N+++++  C   E   ++LEY   G L++ L +T           L   Q++ +
Sbjct: 63  RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 517 MIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              +A  +++L    F      +H DL   N L+       +S   ++K +   +    +
Sbjct: 123 CTQIALGMDHLSNARF------VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176

Query: 574 TQTLATIGYMAP 585
              L  + ++AP
Sbjct: 177 -NALIPLRWLAP 187

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 21/58 (36%), Positives = 36/58 (62%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRL 58
            IP  +G++ +LE LDL  N   G++P ++  +++L++L L  NSLSG + +    RL
Sbjct: 457 NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 31/182 (17%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-------RHRNL 472
           L+G G +G VYK R +  G   A+KV ++       + D E EI + I        HRN+
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYSHHRNI 65

Query: 473 IKVISSCSNEEFKG------LVLEYMPQGSLEKHLYST--NCILDIFQRLNIMIDVASAL 524
                +   +   G      LV+E+   GS+   + +T  N + + +    I  ++   L
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGL 124

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            +LH      VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +M
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 178

Query: 584 AP 585
           AP
Sbjct: 179 AP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 10/177 (5%)

Query: 414 DGFSENNLIGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIR 468
             F   +L+GRG FG V   R    GD   M+V +K   L  +     F+ E +I+    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
              + ++  +  +++   LV+EY P G L   L   N   D F        +A  +  +H
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIH 116

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                  +H D+KP NVL+D      L+DFG A  L   ++ +     + T  Y+AP
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 6/139 (4%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A     G +VAVK  +L+ ++  +    E  IM+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T   ++  Q   + + V  AL YLH   +  VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 541 KPSNVLLDDNMIAYLSDFG 559
           K  ++LL  +    LSDFG
Sbjct: 145 KSDSILLTSDGRIKLSDFG 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.0 bits (114), Expect = 7e-06
 Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 33/192 (17%)

Query: 422 IGRGGFGSVYKARLGDGME------------------VAVKVFNLQC-RRAFKSFDVECE 462
           +G G FG V+     +GME                  VAVK+      + A   F  E +
Sbjct: 13  LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQR 513
           IM  ++  N+I++++ C   +   ++ EYM  G L + L            + +   +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 514 LNIM-IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           L  M   +AS ++YL    S   +H DL   N L+  N    ++DFG+++ L   D    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 573 QTQTLATIGYMA 584
           Q + +  I +M+
Sbjct: 189 QGRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMK----SIRHRN--LI 473
           ++G+G FG V  A L G G   AVK   L+        DVEC +++    ++   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +  +   +E    V+E++  G L  H+       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKL-LIGEDQSMTQTQTLATIGYMAP 585
            +I+ DLK  NV+LD +    ++DFG+ K  + G++++ T      T  Y+AP
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 59/146 (40%), Positives = 78/146 (53%), Gaps = 10/146 (6%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P  + NL NL+ LDL  N L   +P  + N+S L  L L  N +S  L    +  L  
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSA 210

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           LEEL L  N  S +  LSSLSN K+L+ + LSNN L       SIGNLS +LE   + N 
Sbjct: 211 LEELDLSNN--SIIELLSSLSNLKNLSGLELSNNKL--EDLPESIGNLS-NLETLDLSNN 265

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKL 146
            ++      +G+LTNL  +DL GN L
Sbjct: 266 QIS--SISSLGSLTNLRELDLSGNSL 289

Length = 394

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 422 IGRGGFGSVYKARL--GDGMEVAVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVI 476
           +G G FG V  A     D   VA+K F        K  D    E +I+  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 477 SSCSNEEFKGLVLEYMPQGS----LEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            S  +E +  LVLE++  G     L ++    N +   +    ++I      EYL    S
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-----FEYLQ---S 149

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
             +++ DLKP N+LLD +    ++DFG AK++       T+T TL  T  Y+AP
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYIAP 197

Length = 340

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMK------SIRHRNLI 473
           ++G+G FG V  ARL   G   AVKV  L+     +  DVEC + +      +  H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++       +    V+E++  G L  H+  +    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +I+ DLK  NVLLD      L+DFG+ K  I      T +    T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 29/163 (17%)

Query: 421 LIGRGGFGSV-YKARLGDGMEVAVKVFNLQ------CRRAFKSFDVEC-------EIMKS 466
           ++G G  G+V    R+ DG   AVKV +++        RA    +V C        I+K 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA--QAEVCCLLNCDFFSIVKC 96

Query: 467 IRHRNLIKVISSCSNEE---FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN---IMIDV 520
             H +  K      N E      LVL+Y   G L + + S       F+      + I V
Sbjct: 97  --HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
             A+ ++H   S  +IH D+K +N+LL  N +  L DFG +K+
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192

Length = 496

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 18/172 (10%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIKVISSC 479
           +G+G +GSVYK      G+ +A+K   L+   + F    +E +I+       ++    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 480 SNEEFKGLVLEYMPQGSLEKHLY---STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
             E    + +EYM  GSL+K LY        +       I   V   L++L       +I
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           H D+KP+NVL++ N    L DFG++  L+    S+ +T     IG   YMAP
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 13/161 (8%)

Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFK-SFDVECEIMKSIRHRNLIKV 475
           +G G FG+V    YK +  +   VAVK+  N     A K     E  +M+ + +  ++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I  C  E +  LV+E    G L K L     + +      ++  V+  ++YL     T  
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           +H DL   NVLL     A +SDFG++K L G D++  + +T
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 55/200 (27%), Positives = 81/200 (40%), Gaps = 43/200 (21%)

Query: 421 LIGRGGFGSVYKARLGD---GMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           LIG+GG G VY A   D      VA+K       +     K F  E +I   + H  ++ 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 475 VISSCSNEEFKGLVLEYMP--QGSLEKHLYSTNCILDIFQR-----------LNIMIDVA 521
           V S CS+ +    V   MP  +G   K L  +    +   +           L+I   + 
Sbjct: 67  VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ------------ 569
           + +EY+H   S  V+H DLKP N+LL       + D+G A     E++            
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 570 ---SMTQT-QTLATIGYMAP 585
              SMT   + + T  YMAP
Sbjct: 181 CYSSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 19/175 (10%)

Query: 422 IGRGGFGSVY-----KARLGDGMEV--AVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG+VY     KA   + ++V   + V  L      ++ + E +++  + H  ++K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 475 VISSCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
             +S    +   ++ EY     L+   + L  T   L   Q     I +   + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE-DQSMTQTQTLATIGYMAP 585
              ++H DLK  N+ L +N++  + DFG+++LL+G  D + T T    T  YM+P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFT---GTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 11/167 (6%)

Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHRNLIKVISSC 479
           +G G  GSV K   +  G  +A KV ++  + +  K    E +IM   R   ++    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            NE    + +E+M  GSL++       I ++I  +  I + V   L YL+      ++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYN--VHRIMHR 128

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KPSN+L++      L DFG++  LI    S+  T  + T  YM+P
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 36/182 (19%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVF------------NLQC-RRAFKSFDVECEIMKSI 467
           +GRG FG V  A     G   A+K              +L C +R F       E   S 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF-------ETANSE 59

Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS---AL 524
           RH  L+ + +    E+    V+EY   G L  H+++     D+F     +   A     L
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGL 114

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYM 583
           +YLH      +++ DLK  N+LLD      ++DFG+ K  +G      +T T   T  ++
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFL 168

Query: 584 AP 585
           AP
Sbjct: 169 AP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMK------SIRHRNLI 473
           ++G+G FG V  A L    E  A+K   L+     +  DVEC +++      +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +  +   +E    V+EY+  G L  H+ S+    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +I+ DLK  NVLLD +    ++DFG+ K  +  +    +  T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 22/151 (14%)

Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNL---QCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           IG G FG+VY A      E VAVK  +    Q    ++    E + ++ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS-------ALEYLHFG 530
               E    LV+EY         L S + +L++ ++    +++A+        L YLH  
Sbjct: 89  CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
               +IH D+K  N+LL +     L+DFG A
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 8/165 (4%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 35/134 (26%), Positives = 63/134 (47%), Gaps = 11/134 (8%)

Query: 422 IGRGGFGSVYKA---RLGDG-----MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G+G F  ++K     +GD       EV +KV +   R   +SF     +M  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
                C   +   +V EY+  GSL+ +L     +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 534 PVIHCDLKPSNVLL 547
            + H ++   NVLL
Sbjct: 120 GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 34/136 (25%)

Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE--KHLYSTNCIL 508
           +RA++       +MK + H+N+I            GL+  + PQ SLE  + +Y    ++
Sbjct: 60  KRAYREL----VLMKLVNHKNII------------GLLNVFTPQKSLEEFQDVYLVMELM 103

Query: 509 D--IFQRLNIMID----------VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS 556
           D  + Q + + +D          +   +++LH   S  +IH DLKPSN+++  +    + 
Sbjct: 104 DANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 160

Query: 557 DFGIAKLLIGEDQSMT 572
           DFG+A+   G    MT
Sbjct: 161 DFGLAR-TAGTSFMMT 175

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 35/187 (18%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           D F +   +G G  G V K      G+ +A K+ +L             EI  +IR++ +
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-------------EIKPAIRNQII 47

Query: 473 --IKVISSCSNEEFKG------------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
             +KV+  C++    G            + +E+M  GSL++ L     I +      I I
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-KISI 106

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
            V   L YL       ++H D+KPSN+L++      L DFG++  LI    SM  +  + 
Sbjct: 107 AVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVG 160

Query: 579 TIGYMAP 585
           T  YM+P
Sbjct: 161 TRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 8/168 (4%)

Query: 421 LIGRGGFGSVYKARLGDGME-VAVKVF-NLQCRRAFKSFDV-ECEIMKSIRHRNLIKVIS 477
           ++G G +G V K R  +  E VA+K F + +     K   + E +++++++  N++++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +        LV EY+ +  LE      N +     R + +  +  A+ + H      ++H
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCH---KNDIVH 123

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            D+KP N+L+  N +  L DFG A+ L  E  +   T+ +AT  Y +P
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 19/114 (16%)

Query: 455 KSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY-------STNCI 507
           K+   E +I+K+I HR +I +I +      K  V   MP+   +   Y            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187

Query: 508 LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           + I +RL        AL YLH      +IH D+K  N+ LD+   A L DFG A
Sbjct: 188 ITIQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVIS 477
           IG G FG     +   DG +  +K  N+  + + K  +    E  ++ +++H N+++   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINI-SKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIM---IDVASALEYLHFGCSTP 534
           S        +V++Y   G L K + +   +L  F    I+   + +  AL+++H      
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DRK 121

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           ++H D+K  N+ L  +    L DFGIA++L
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 43/180 (23%), Positives = 80/180 (44%), Gaps = 19/180 (10%)

Query: 422 IGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYS-----TNCILDIFQRLNIMI----DVASALE 525
           ++   S  +   +++E M +G L+ +L S      N  +     L  MI    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 28/154 (18%)

Query: 422 IGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRR-----AFKSFDVECEIMKSIRHRNLIK 474
           +G G + +VYK R  L   + VA+K   L+        A +    E  ++K ++H N++ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67

Query: 475 VISSCSNEEFKGLVLEYMPQG---SLEKH---LYSTNCILDIFQRLNIMIDVASALEYLH 528
           +      ++   LV EY+       ++     L   N  L +FQ L         L Y H
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH 120

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
                 V+H DLKP N+L+ +     L+DFG+A+
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 21/157 (13%)

Query: 422 IGRGGFGSVYKARL---------GDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRN 471
           +G+G F ++YK  L         G G EV+V +  L    R   +F     +M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L+K+   C  +E   +V EY+  G L+  L+     + +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 532 STPVIHCDLKPSNVLL---DDNM----IAYLSDFGIA 561
              ++H ++   N+L+     N        LSD GI 
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 36/181 (19%)

Query: 422 IGRGGFGSVYKARLG-DGMEVAVKVF------NLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +G+V  A     G +VA+K         L  +RA++    E  ++K ++H N+I 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 475 VI----SSCSNEEFKG--LVLEYMPQ--GSLEKH--LYSTNCILDIFQRLNIMIDVASAL 524
           ++       S + F    LV+ +M    G L KH  L        ++Q L         L
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK-------GL 131

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           +Y+H   +  +IH DLKP N+ ++++    + DFG+A+     D  M  T  + T  Y A
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVVTRWYRA 183

Query: 585 P 585
           P
Sbjct: 184 P 184

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 38/137 (27%), Positives = 71/137 (51%), Gaps = 23/137 (16%)

Query: 438 GMEVAVKVF------NLQCRRAFKSFDVECEIMKSIRHRNLIKVIS----SCSNEEFKG- 486
           G+ VAVK            +RA++    E  ++K + H+N+I +++      S EEF+  
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101

Query: 487 -LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNV 545
            LV+E M   +L + ++     LD  +   ++  +   +++LH   S  +IH DLKPSN+
Sbjct: 102 YLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 154

Query: 546 LLDDNMIAYLSDFGIAK 562
           ++  +    + DFG+A+
Sbjct: 155 VVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 12/156 (7%)

Query: 422 IGRGGFGSVYKARLGDGMEV-AVKVF---NLQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           I RG FG VY  R  +  ++ AVKV    ++  +        E + +   +   ++ +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 478 SCSNEEFKGLVLEYMPQGSLEK--HLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           S  +     LV+EY+  G ++   H+Y      D    +  + +VA AL+YLH      +
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGI 125

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
           IH DLKP N+L+ +     L+DFG++K+ +  + +M
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 9/169 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVI 476
           L+G+G FG V   +    G   A+K+   +   A         E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            S    +    V+EY   G L  HL       +   R     ++ SAL+YLH      V+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNVV 118

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 33/179 (18%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIR-HRNLIK 474
           IG G F  V KA+    G   A+K      ++ FKS +      E + ++ +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 475 VISSCSNEEFKG---LVLEYMPQGSLE-----KHLYSTNCILDIFQRLNIMIDVASALEY 526
           +I     +   G   LV E M     E     K       +       + M  +  +L++
Sbjct: 63  LIE-VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK------SYMYQLLKSLDH 115

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H      + H D+KP N+L+ D+++  L+DFG  +   G       T+ ++T  Y AP
Sbjct: 116 MH---RNGIFHRDIKPENILIKDDILK-LADFGSCR---GIYSKPPYTEYISTRWYRAP 167

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 36/149 (24%)

Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE--KHLYSTNCIL 508
           +RA++    E  +MK + H+N+I            GL+  + PQ SLE  + +Y    ++
Sbjct: 68  KRAYR----ELVLMKCVNHKNII------------GLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 509 D--IFQRLNIMID----------VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS 556
           D  + Q + + +D          +   +++LH   S  +IH DLKPSN+++  +    + 
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 168

Query: 557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DFG+A+       S   T  + T  Y AP
Sbjct: 169 DFGLART---AGTSFMMTPYVVTRYYRAP 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 8/151 (5%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVF---NLQCRRAFKSFDVECEIMKSIRH 469
           D F    +IGRG FG V   +  D G   A+K+    ++  +        E +I+     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             ++K+  S  ++    L++E++P G +   L   + + +   +  I  +   A++ +H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH- 118

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
                 IH D+KP N+LLD      LSDFG+
Sbjct: 119 --QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 19/107 (17%)

Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNI 516
           +MK   + N IK+  S +  +   L+++Y+  G L      E  L        I Q    
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ---- 117

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI-AYLSDFGIAK 562
              +  AL  LH      +IH D+K  NVL D      YL D+G+ K
Sbjct: 118 ---LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 14/171 (8%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           L+G+G FG V   R     +  A+K+     +  +        E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            S    +    V+EY   G L  HL       +   R     ++ SAL YLH   S  V+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCDVV 117

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL--ATIGYMAP 585
           + DLK  N++LD +    ++DFG+ K    E  S   T      T  Y+AP
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 22/177 (12%)

Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSC 479
           IG+G +G VYK     DG   AVK+ +       +  + E  I++S+  H N++K     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 480 -SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASALEYLH 528
              ++  G    LVLE    GS+ + +     +L   QRL+      I+      L++LH
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +  +IH D+K +N+LL       L DFG++  L      + +  ++ T  +MAP
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 14/172 (8%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   +L +  +V A+K+ N   +  R     F  E +++ +  ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQ-RLNIMIDVASALEYLHFGCST 533
            +  +E    LV++Y   G L   L  +      D+ +  L  M+    ++  LH+    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+KP N+L+D N    L+DFG + L + ED ++  +  + T  Y++P
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 8/151 (5%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVF---NLQCRRAFKSFDVECEIMKSIRH 469
           + F    +IGRG FG V   +  D G   A+K+    ++  +        E +I+     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             ++K+  S  ++    L++E++P G +   L   + + +   +  I  +   A++ +H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH- 118

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
                 IH D+KP N+LLD      LSDFG+
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVI 476
           +IGRG +  V   RL    ++ A+KV   +     +  D    E  + +       +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 477 SSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
            SC     +  LV+EY+  G L  H+     + +   R     ++  AL +LH      +
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           I+ DLK  NVLLD +    L+D+G+ K  +G     T +    T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 23/71 (32%), Positives = 45/71 (63%), Gaps = 1/71 (1%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           IP +I  L++L+ ++L  N + G +P ++ ++++L++L L  NS +GS+   +  +L +L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-SLGQLTSL 492

Query: 62  EELVLWGNNFS 72
             L L GN+ S
Sbjct: 493 RILNLNGNSLS 503

Length = 623

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 20/143 (13%)

Query: 449 QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKG--LVLEYMPQGSLEKHLY 502
             +RA++    E  +MK + H+N+I +++  +     EEF+   LV+E M     +    
Sbjct: 59  HAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ---- 110

Query: 503 STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
                LD  +   ++  +   +++LH   S  +IH DLKPSN+++  +    + DFG+A+
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 563 LLIGEDQSMTQTQTLATIGYMAP 585
                  S   T  + T  Y AP
Sbjct: 168 T---AGTSFMMTPYVVTRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 19/180 (10%)

Query: 422 IGRGGFGSVYKARLGDGME------VAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D ++      VAVK  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYS-----TNCILDIFQRLNIMI----DVASALE 525
           ++   S  +   +V+E M  G L+ +L S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRH 469
           D F    +IGRG FG V   ++     + A+K+ N   +  R     F  E  ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNI--MIDVASALEY 526
           + +  +  +  +E +  LV++Y   G L   L    + + +   R  I  M+    ++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH+      +H D+KP NVLLD N    L+DFG + L + +D ++  +  + T  Y++P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)

Query: 421 LIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNL------ 472
           +IGRG FG V   +  D G   A+K          KS  +E E +  +R  R++      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 473 ---IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
              +K+  S  +E +  L++EY+P G +   L   +   +   R  I  +   A++ +H 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH- 118

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
                 IH D+KP N+LLD      LSDFG+  
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 33/147 (22%), Positives = 62/147 (42%), Gaps = 14/147 (9%)

Query: 421 LIGRGGFGSVYKARLG----DGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNL 472
           ++G G FG + +  L       + VA+      C    RR F +   E   +    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA---EALTLGQFDHSNI 68

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +++    +      +V EYM  G+L+  L      L   Q + ++  +AS ++YL     
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFG 559
              +H  L    VL++ +++  +S F 
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 6e-04
 Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 43/177 (24%)

Query: 422 IGRGGFGSVYKARLGDGMEV----AVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           IG G FG V+  +     E     A+    L+  R      +E  +M+ ++H+N+++ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 478 SCSNEEFKGL--VLEYMPQGSLEKHL---------YSTNCILDIFQRLNIMIDVASALEY 526
              N+  + L  ++E+   G L +++            + I+DI ++L        AL Y
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133

Query: 527 LHFGCSTP----VIHCDLKPSNVLLDDNM-----------------IAYLSDFGIAK 562
            H     P    V+H DLKP N+ L   +                 IA + DFG++K
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Length = 1021

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 34/193 (17%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           D + +   IG G +G VYKAR    G  VA+K       +     D E     ++R  +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISL 53

Query: 473 IKVISSC----------SNEEFKG-----LVLEYMPQGSLEKHLYST----NCILDIFQR 513
           ++++S              EE  G     LV EY+    L+K + S        L     
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTI 112

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLLIGEDQSMT 572
            + M  +   + + H      V+H DLKP N+L+D    +  ++D G+ +      +S  
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168

Query: 573 QTQTLATIGYMAP 585
            T  + T+ Y AP
Sbjct: 169 -THEIVTLWYRAP 180

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 7/140 (5%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           ++P EI  L  LEELDL  N +I  +  ++ N+  L  L L +N L     SI    L N
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIG--NLSN 256

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           LE L L  N   +++ +SSL +  +L  + LS N L   LP  ++  L        +   
Sbjct: 257 LETLDLSNN---QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLL-LELLLNLLLT 312

Query: 121 NVTGDIPEEIGNLTNLITID 140
               ++      L N I  +
Sbjct: 313 LKALELKLNSILLNNNILSN 332

Length = 394

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 11/175 (6%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F   + +G G  G V K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I  +I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLRE- 121

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 416 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVF---NLQCRRAFKSFDVECEIMKSIRHRN 471
           F +   +G G FG V  AR  D     A+K     ++  R        E +I+    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++++  S  +++    V++Y+P G +   L       +   R  I  ++  A+E +H   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
               IH D+KP N+L+D +    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 14/146 (9%)

Query: 422 IGRGGFGSVYKARLGDGMEV-AVK------VFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G FG V   R  D   + A+K      V     R        E +I+    +  ++K
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM---RNQAAHVKAERDILAEADNEWVVK 65

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  S  +++    V++Y+P G +   L       +   R  I  ++  A+E +H      
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMG 121

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGI 560
            IH D+KP N+L+D +    L+DFG+
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKVI 476
           +IGRG +  V   RL     + A+KV   +     +  D    E  + +   +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 477 SSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
            SC   E +   V+EY+  G L  H+     + +   R     +++ AL YLH      +
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+AP
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD-IFQRLNIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I + I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 121

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 8/149 (5%)

Query: 416 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVF---NLQCRRAFKSFDVECEIMKSIRHRN 471
           F +   +G G FG V  A   D     A+K     ++  R        E +I+    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++K+  S  +++    V++Y+P G +   L       ++  R  I  ++  A+E +H   
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
               IH D+KP N+L+D +    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 29/164 (17%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGM-----EVAVKVFN-----LQCRRAFKSFDVECEI 463
           D  + ++L+  G FG ++   L D       EV VK        +Q     +    E  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCL 61

Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLE-YMPQGSLEKHLYSTNC---------ILDIFQR 513
           +  + H+N++ ++  C  +     VL  YM  G+L+  L    C          L   Q 
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEANNPQALSTQQL 119

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD 557
           +++ I +A  + YLH      VIH D+   N ++D+ +   ++D
Sbjct: 120 VHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 23/78 (29%), Positives = 38/78 (48%), Gaps = 3/78 (3%)

Query: 508 LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           L     L+    VA  +E+L    S   +H DL   NVLL    I  + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 568 DQSMTQTQTLATIGYMAP 585
              +++  T   + +MAP
Sbjct: 291 SNYVSKGSTFLPVKWMAP 308

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 36/190 (18%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNL--QCRRAFKS-FDVECEIMKSIRH 469
           D F    +IGRG FG V   ++ +  +V A+K+ N     +RA  + F  E +++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-------EKHL-------YSTNCILDIFQRLN 515
           R +  +  +  +E    LV++Y   G L       E  L       Y    +L I     
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI----- 115

Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
                  ++  L +      +H D+KP NVLLD N    L+DFG + L +  D ++    
Sbjct: 116 ------DSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNV 162

Query: 576 TLATIGYMAP 585
            + T  Y++P
Sbjct: 163 AVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 14/38 (36%), Positives = 21/38 (55%), Gaps = 2/38 (5%)

Query: 251 KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
            NLE L L  N++  L      NL +L+ L+LS N ++
Sbjct: 1   TNLETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.003
 Identities = 24/61 (39%), Positives = 32/61 (52%), Gaps = 1/61 (1%)

Query: 11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
          NL+ LDL  N+L      A   +  LK+L L  N+L+ S+S      LP+L  L L GNN
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 71 F 71
           
Sbjct: 60 L 60

Length = 60

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 8/106 (7%)

Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNI 516
           +E  +++++ H ++I++  +  +     +VL   P  S + + Y T     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
              +   L YLH   +  +IH D+K  N+ ++D     + D G A+
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 12/149 (8%)

Query: 421 LIGRGGFGSVYKARLGDGME-VAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVI 476
           LI  G +G+VY  R  +  +  A+K  N Q    R   +   VE +I+      N   V 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE--NPFVVS 65

Query: 477 SSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
             CS E  + L  V+EY+  G     L +   +     R+     V  ALEYLH   +  
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH---NYG 121

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
           ++H DLKP N+L+       L+DFG++K+
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 50/204 (24%), Positives = 77/204 (37%), Gaps = 42/204 (20%)

Query: 12  LEELDLRQNKLIGTVPVAIFNVSTLKLL--GLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
           L+EL L  N L             L+LL  GL+D               P LE+LVL  N
Sbjct: 110 LQELKLNNNGLGDRG---------LRLLAKGLKDLP-------------PALEKLVLGRN 147

Query: 70  NF---SELNFLSSLSNCKSLTVIGLSNNPL--DGILPKTSIGNLSHSLEDFQMHNCNVT- 123
                S      +L   + L  + L+NN +   GI         + +LE   ++N  +T 
Sbjct: 148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207

Query: 124 ---GDIPEEIGNLTNLITIDLGGNKLNGSILITLSK-----LQKLQGLVLDDNKLEGSIP 175
                + E + +L +L  ++LG N L  +    L+         L  L L  N +     
Sbjct: 208 EGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGA 267

Query: 176 DDICRL----VELYKLELGGNKLS 195
            D+  +      L +L+L GNK  
Sbjct: 268 KDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 14/41 (34%), Positives = 20/41 (48%), Gaps = 3/41 (7%)

Query: 59 PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI 99
           NLE L L  N  ++   L  LSN  +L  + LS N +  +
Sbjct: 1  TNLETLDLSNNQITD---LPPLSNLPNLETLDLSGNKITDL 38

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|213055 cd12094, TM_ErbB2, Transmembrane domain of ErbB2, a Protein Tyrosine Kinase

 Score = 35.3 bits (81), Expect = 0.004
 Identities = 17/49 (34%), Positives = 24/49 (48%), Gaps = 8/49 (16%)

Query: 337 GSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQR 385
           G P  Q     TSI      I+ ++GI+L     L++V   LI R RQ+
Sbjct: 1   GCPAEQRASPLTSI------IAGVVGILL--VVVLLVVFGILIKRRRQK 41

PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. ErbB2 (HER2, HER2/neu) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. It is activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. ErbB2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner of other ligand-bound EGFR proteins and functions as a signal amplifier, with the ErbB2-ErbB3 heterodimer being the most potent pair in mitogenic signaling. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of ErbB2 have been associated with increased breast cancer risk. ErbB2 plays an important role in cell development, proliferation, survival and motility. Overexpression of ErbB2 results in its activation and downstream signaling, even in the absence of ligand. ErbB2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. ErbB2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. ErbB2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 44

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	585
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.98
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.98
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.93
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.93
PTZ00283	496	serine/threonine protein kinase; Provisional	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.92
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.92
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.92
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.92
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
PHA03207	392	serine/threonine kinase US3; Provisional	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
PTZ00036	440	glycogen synthase kinase; Provisional	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
PHA03209	357	serine/threonine kinase US3; Provisional	99.92
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.92
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.92
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.92
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.92
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.92
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.92
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.91
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.91
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.91
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.91
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.91
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.91
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.91
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.91
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.91
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.91
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.91
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.91
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.91
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.91
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.91
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.91
PTZ00284	467	protein kinase; Provisional	99.91
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.9
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.9
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.9
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.9
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.9
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.9
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.9
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.9
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.9
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.89
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.89
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
PLN00009	294	cyclin-dependent kinase A; Provisional	99.89
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.89
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.89
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.89
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.89
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.89
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.89
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.89
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.89
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.89
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.89
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.89
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.89
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.89
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.88
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.88
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.88
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.88
PHA02882	294	putative serine/threonine kinase; Provisional	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.87
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.87
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.87
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.87
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.87
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.86
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.8
smart00090	237	RIO RIO-like kinase.	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.73
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.71
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.63
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PLN00181	793	protein SPA1-RELATED; Provisional	99.52
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
PLN03150	623	hypothetical protein; Provisional	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.5
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.38
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.31
PLN03150	623	hypothetical protein; Provisional	99.3
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.3
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.28
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.27
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.25
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.24
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.2
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.19
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.07
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.95
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.93
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.89
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.86
KOG1243	690	consensus Protein kinase [General function predict	98.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.8
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.77
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.75
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.68
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.6
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.58
PRK09902	216	hypothetical protein; Provisional	98.58
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.55
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.54
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
PRK15386	426	type III secretion protein GogB; Provisional	98.48

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-67  Score=610.56  Aligned_cols=559  Identities=33%  Similarity=0.505  Sum_probs=394.2

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +|.+|+++++|++|+|++|++++..|..+.++++|++|+|++|.+.+.++... ..+++|++|++++|.++.... ..+.
T Consensus       252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~l~~n~~~~~~~-~~~~  329 (968)
T PLN00113        252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIP-VALT  329 (968)
T ss_pred             cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH-cCCCCCcEEECCCCccCCcCC-hhHh
Confidence            57778888888888888888877778888888888888888888776655432 356777777777777765433 5566


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                      .+++|++|+|++|.+.+..|. .++.++. |+.|++++|++++.+|..+..+++|+.|++++|++.+..|..+..+++|+
T Consensus       330 ~l~~L~~L~L~~n~l~~~~p~-~l~~~~~-L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~  407 (968)
T PLN00113        330 SLPRLQVLQLWSNKFSGEIPK-NLGKHNN-LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR  407 (968)
T ss_pred             cCCCCCEEECcCCCCcCcCCh-HHhCCCC-CcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCC
Confidence            777777777777777666555 4455544 66666666666666665555555555555555555555555555555555


Q ss_pred             eEEccCCCCCccCcccccCC------------------------CCCcEEEcCCCcccccCcccccCcccchhhcCCCCC
Q 047705          162 GLVLDDNKLEGSIPDDICRL------------------------VELYKLELGGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      .|++++|++++..|..|..+                        ++|+.|+|++|.+.+..|..+ ..++|+.|++++|+
T Consensus       408 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~  486 (968)
T PLN00113        408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQ  486 (968)
T ss_pred             EEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCc
Confidence            55555555554444444444                        445555555555544444433 23566666776665


Q ss_pred             ---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChh
Q 047705          218 ---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS  294 (585)
Q Consensus       218 ---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  294 (585)
                         ..|..+..+++|+.|++++|++++.+|..+.++++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|..
T Consensus       487 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  566 (968)
T PLN00113        487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN  566 (968)
T ss_pred             cCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChh
Confidence               45556778889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCC-CCCCCCCCCCCCCCccceeeeeeecchhhhhhh
Q 047705          295 LEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN-LQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMI  373 (585)
Q Consensus       295 ~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (585)
                      +..+++|+.+++++|++.+.+|..+.+..+....+.||+..|+.+. ...++|.....  ......++++++++++++++
T Consensus       567 l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~  644 (968)
T PLN00113        567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLAL  644 (968)
T ss_pred             HhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHH
Confidence            9999999999999999999999888888888888999999998653 34566753322  11122233333322222222


Q ss_pred             HH-hhhhhhhhcCCC-CCCCCCCccc-c-----ccccccCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEE
Q 047705          374 VV-IWLILRYRQRGK-QPSNDANMPL-V-----AMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVK  444 (585)
Q Consensus       374 ~~-~~~~~r~~~~~~-~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK  444 (585)
                      ++ +++++|++++.+ +......... .     ...+.+++.+   ....|...+.||+|+||.||+|+.. ++..||||
T Consensus       645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK  721 (968)
T PLN00113        645 VAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK  721 (968)
T ss_pred             HHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEE
Confidence            22 222222222111 1111100000 0     0011223333   3346778889999999999999874 78999999


Q ss_pred             EEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 047705          445 VFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL  524 (585)
Q Consensus       445 ~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l  524 (585)
                      .++....    ....|++++++++|||||++++++..++..|+||||+++|+|.++++.    ++|..+.+++.|+++|+
T Consensus       722 ~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L  793 (968)
T PLN00113        722 EINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKAL  793 (968)
T ss_pred             EccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHH
Confidence            8864322    123468899999999999999999999999999999999999999963    68889999999999999


Q ss_pred             HHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       525 ~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|+|..++++|+||||||+||+++.++.+++. ||.+.....      .....||++||||
T Consensus       794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aP  847 (968)
T PLN00113        794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAP  847 (968)
T ss_pred             HHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCc
Confidence            99996667799999999999999998888876 666543221      1223688999998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=376.03  Aligned_cols=336  Identities=34%  Similarity=0.515  Sum_probs=297.6

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      .+|..|+++++|++|+|++|.+++..|..+.++++|++|+|++|.+.+.++... ..+++|++|+|++|++..... ..+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~l~~~~p-~~~  304 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIP-ELV  304 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH-hhccCcCEEECcCCeeccCCC-hhH
Confidence            378999999999999999999999999999999999999999999986665433 478999999999999986543 778


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                      ..+++|++|++++|.+.+..|. .+..+++ |+.|++++|.+++.+|..++.+++|+.|++++|++.+..|..+..+++|
T Consensus       305 ~~l~~L~~L~l~~n~~~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L  382 (968)
T PLN00113        305 IQLQNLEILHLFSNNFTGKIPV-ALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL  382 (968)
T ss_pred             cCCCCCcEEECCCCccCCcCCh-hHhcCCC-CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCC
Confidence            9999999999999999988876 6777877 9999999999999999999999999999999999999999999999999


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCC------------
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGN------------  225 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~------------  225 (585)
                      +.|++++|++++..|..+..+++|+.|++++|.+++..|..|..+++|+.|++++|.   ..+..+..            
T Consensus       383 ~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  462 (968)
T PLN00113        383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN  462 (968)
T ss_pred             CEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCc
Confidence            999999999999999999999999999999999999899888888888888888876   23322222            


Q ss_pred             -----------CCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChh
Q 047705          226 -----------LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS  294 (585)
Q Consensus       226 -----------l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  294 (585)
                                 .++|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|++|++++|.+++.+|..
T Consensus       463 ~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  542 (968)
T PLN00113        463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS  542 (968)
T ss_pred             eeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChh
Confidence                       345677777777887888888888999999999999999999999999999999999999999999999


Q ss_pred             hccCCccceEEeecCcCeeeCCCC-CCCCCCCccccCCCCcccCCCC
Q 047705          295 LEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       295 ~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      +..+++|+.|||++|++++.+|.. ..+..++.+++.+|++.+..|.
T Consensus       543 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  589 (968)
T PLN00113        543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS  589 (968)
T ss_pred             HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence            999999999999999999888754 4566788889999998876553

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=329.60  Aligned_cols=333  Identities=24%  Similarity=0.257  Sum_probs=225.4

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      ||.......+|+.|+|.+|.|+.+..+.++.++.|++|||+.|.|+ .++...|-+-+++++|+|++|+|+.+.. +.|.
T Consensus       117 IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~-~~F~  194 (873)
T KOG4194|consen  117 IPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLET-GHFD  194 (873)
T ss_pred             cccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeecccccccccc-cccc
Confidence            5655566666666666666666666666666777777777777666 4444444444567777777777777665 6677


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                      .+.+|..|.|++|+|+.+.+. .|.+++. |+.|+|.+|.|.-.---+|.+|++|+.|.|..|.|.....++|-++.+++
T Consensus       195 ~lnsL~tlkLsrNrittLp~r-~Fk~L~~-L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme  272 (873)
T KOG4194|consen  195 SLNSLLTLKLSRNRITTLPQR-SFKRLPK-LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKME  272 (873)
T ss_pred             ccchheeeecccCcccccCHH-Hhhhcch-hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccc
Confidence            777777777777777655444 5666665 77777777766644345566666666666666666666666676777777


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCc
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNN  238 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~  238 (585)
                      +|+|+.|+++..-...+.++++|+.|+||+|.|..+.++.+...++|+.|+|++|+   .-+..+..+..|+.|.|++|.
T Consensus       273 ~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns  352 (873)
T KOG4194|consen  273 HLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS  352 (873)
T ss_pred             eeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence            77777777766666666667777777777777766666666667777777777765   333346666667777777777


Q ss_pred             ccccCCcccCCCCCCcEEeecccCcccccCc---cccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeC
Q 047705          239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD---SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEI  315 (585)
Q Consensus       239 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~  315 (585)
                      ++.+....|.++++|+.|||++|.++..+.+   .|.++++|+.|++.+|+|..+.-.+|.++++|+.|||.+|.+...-
T Consensus       353 i~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq  432 (873)
T KOG4194|consen  353 IDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQ  432 (873)
T ss_pred             hHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeec
Confidence            7666666777777777777777777766543   4667788888888888887666677888888888888888887776


Q ss_pred             CCCCCCCCCCccccCCCCcccCC
Q 047705          316 PRGGSFGNFSAESFEGNELLCGS  338 (585)
Q Consensus       316 ~~~~~~~~~~~~~~~~n~~~c~~  338 (585)
                      |.+..-..++.+.+....+.|++
T Consensus       433 ~nAFe~m~Lk~Lv~nSssflCDC  455 (873)
T KOG4194|consen  433 PNAFEPMELKELVMNSSSFLCDC  455 (873)
T ss_pred             ccccccchhhhhhhcccceEEec
Confidence            66544335666666666677765

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=322.59  Aligned_cols=330  Identities=25%  Similarity=0.273  Sum_probs=188.1

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKS   85 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   85 (585)
                      |.++++|++++|.+|.++ .+|.......+|+.|+|.+|.|+ .+.+.....+|.|+.||||.|.|++++. ..|..-.+
T Consensus        98 f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~-~sfp~~~n  174 (873)
T KOG4194|consen   98 FYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPK-PSFPAKVN  174 (873)
T ss_pred             HhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccC-CCCCCCCC
Confidence            444444444444444443 33333333333445555555444 3333333345555555555555555554 45555555


Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEc
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL  165 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  165 (585)
                      +++|+|++|.|+++..+ .|.++. +|.+|.|++|.++...+..|.+|++|+.|+|..|+|+-+..-+|.++++|+.|.|
T Consensus       175 i~~L~La~N~It~l~~~-~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl  252 (873)
T KOG4194|consen  175 IKKLNLASNRITTLETG-HFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL  252 (873)
T ss_pred             ceEEeeccccccccccc-cccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence            66666666666555444 344444 3666666666666555555555666666666666655433455566666666666


Q ss_pred             cCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCccccc
Q 047705          166 DDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGI  242 (585)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~  242 (585)
                      .+|.|...-.+.|..+.++++|+|+.|+++..-..++.++++|+.|+||+|.   +.+..+...++|+.|+|++|+|+..
T Consensus       253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l  332 (873)
T KOG4194|consen  253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL  332 (873)
T ss_pred             hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence            6666665555566666666666666666665555566666666666666665   4444455556666666666666666


Q ss_pred             CCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC---hhhccCCccceEEeecCcCeeeCCCC-
Q 047705          243 IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP---ASLEKLSYLEDLNLSFNKLEGEIPRG-  318 (585)
Q Consensus       243 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~~~~~~-  318 (585)
                      .+.+|..+..|+.|+|++|+++.+...+|.++++|+.|||++|.|+..+.   ..|..+++|+.|+|.+|++....-.+ 
T Consensus       333 ~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAf  412 (873)
T KOG4194|consen  333 DEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAF  412 (873)
T ss_pred             ChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhh
Confidence            66666666666666666666666555666666666666666666664443   24555666666666666666433322 


Q ss_pred             CCCCCCCccccCCCCcccCCCC
Q 047705          319 GSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       319 ~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      ..+..++.+++.+|+...-.+.
T Consensus       413 sgl~~LE~LdL~~NaiaSIq~n  434 (873)
T KOG4194|consen  413 SGLEALEHLDLGDNAIASIQPN  434 (873)
T ss_pred             ccCcccceecCCCCcceeeccc
Confidence            2355556666666666554443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=296.22  Aligned_cols=168  Identities=31%  Similarity=0.520  Sum_probs=151.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ...++|.+.+.||+|+||+||+|+++ ++..||||.+...  .+...+.+..|+++|+.++|||||++++++..++..|+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            45678999999999999999999976 6899999999766  45667788899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC------CcEEEeeeccc
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN------MIAYLSDFGIA  561 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~------~~~kl~Dfg~a  561 (585)
                      |||||.||+|.++++..+ .+++..++.++.|++.|+++||   +++||||||||+|||++..      -.+||+|||+|
T Consensus        87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999999876 6899999999999999999999   9999999999999999754      46899999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +....   .......+|+|.||||
T Consensus       163 R~L~~---~~~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAP  183 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCH
Confidence            98752   2234568999999999

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=296.09  Aligned_cols=185  Identities=49%  Similarity=0.757  Sum_probs=162.2

Q ss_pred             cccccCHHHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeee
Q 047705          400 MWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC  479 (585)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  479 (585)
                      ..+.|++.++..+|++|.....||+|+||.||+|...+|+.||||++.........+|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46679999999999999999999999999999999999999999987755432145599999999999999999999999


Q ss_pred             ecCC-eEEEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          480 SNEE-FKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       480 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                      .+.+ ..++|+|||++|+|.+++..... .++|..+++|+.++|+||+|||+.+..+||||||||+|||+|++..+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 889999999999999999999988778999999999999999999999999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|+........ ......||.+|+||
T Consensus       221 FGLa~~~~~~~~~-~~~~~~gt~gY~~P  247 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS-VSTTVMGTFGYLAP  247 (361)
T ss_pred             ccCcccCCccccc-eeeecCCCCccCCh
Confidence            9999754321111 11111799999998

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-35  Score=279.60  Aligned_cols=167  Identities=28%  Similarity=0.426  Sum_probs=145.6

Q ss_pred             hcCCCCccceecccCceEEEEEEe-CCCcEEEEEEEechhhh-------hHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRR-------AFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      ..+.|.+.+.+|+|+||.|-+|.. ++|++||||+++++...       .....++|+++|++++|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            446788999999999999999975 48999999999865211       1234578999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---CcEEEeeecc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGI  560 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~  560 (585)
                      ..|+||||++||+|.+.+...+ .+.+.....++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999998775 6777788899999999999999   9999999999999999755   7899999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+...   ....+...||||.|.||
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAP  347 (475)
T ss_pred             hhccc---cceehhhhcCCccccCh
Confidence            99753   23345678999999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=275.57  Aligned_cols=169  Identities=33%  Similarity=0.466  Sum_probs=150.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ...++|++.+.||+|+||+||.++.+ +++.+|+|++++..   ....+....|..+|.+++||+||+++..|++++..|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34578999999999999999999866 68899999998652   335677888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +|+||+.||+|..++++.. .+++..++.++.+|+.||.|||   +++|||||+||+|||+|.+|+++|+|||+|+....
T Consensus       102 lVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999998765 7889999999999999999999   99999999999999999999999999999996543


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+  .....+|||+.||||
T Consensus       178 ~~--~~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  178 DG--DATRTFCGTPEYMAP  194 (357)
T ss_pred             CC--CccccccCCccccCh
Confidence            22  233458999999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=271.17  Aligned_cols=164  Identities=28%  Similarity=0.392  Sum_probs=146.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-eEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  491 (585)
                      +.+..+.||+|+.|+||+|+++ +++.+|+|.+... .....+++.+|+++++.++||+||.+||.|..++ ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4566788999999999999987 7899999999655 3445678999999999999999999999999998 59999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      |++|+|++.+...+ .+++...-+++.+|++||.|||+  +++||||||||+|||++..|.|||+|||.++.+...    
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            99999999998764 68999999999999999999993  389999999999999999999999999999987532    


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ....++||..||||
T Consensus       233 ~a~tfvGT~~YMsP  246 (364)
T KOG0581|consen  233 IANTFVGTSAYMSP  246 (364)
T ss_pred             hcccccccccccCh
Confidence            34678999999999

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-33  Score=279.63  Aligned_cols=166  Identities=30%  Similarity=0.429  Sum_probs=151.0

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..|...+.||+|+|+.||+++. .+|+.||+|++.+.   .....+...+||++.+.++|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999997 68999999999864   3456678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+|+.++|.++++.. ..+++.+++.++.||+.|+.|||   +.+|+|||||..|++++++.+|||+|||+|..+..++ 
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            999999999999854 48999999999999999999999   9999999999999999999999999999999875432 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       ......||||.|.||
T Consensus       173 -Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAP  187 (592)
T ss_pred             -cccceecCCCcccCh
Confidence             233568999999999

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-34  Score=263.47  Aligned_cols=169  Identities=26%  Similarity=0.405  Sum_probs=144.3

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEe-eeecCCe-EEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVIS-SCSNEEF-KGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  488 (585)
                      .+|++.+.||+|.||+||++.. .+|..||.|.++-.  +....++...|+.+|++++|||||++++ .|..+.. .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4588999999999999999974 58999999988743  4556778899999999999999999999 4555544 8999


Q ss_pred             EEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          489 LEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||||++|+|.+.++.   .+..+++..+++++.|++.||..+|.-. .+  |+||||||.||+++.+|.||++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999998864   3447899999999999999999999211 45  99999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +....  ....+.+|||+||+|
T Consensus       178 l~s~~--tfA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSP  197 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCH
Confidence            75432  334678999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=253.79  Aligned_cols=163  Identities=31%  Similarity=0.430  Sum_probs=148.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|+..+.+|.|+||+|.+++.+ +|..+|+|+++++.   .+..++...|..+|+.+.||+++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56999999999999999999876 68899999998763   345567788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++||.|..++++.+ .+++..++.++.||+.|++|||   ..+|++||+||+|||+|.+|.+||+|||.|+.+.+.  
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            9999999999999875 7899999999999999999999   999999999999999999999999999999986422  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         ....||||.|+||
T Consensus       198 ---T~TlCGTPeYLAP  210 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAP  210 (355)
T ss_pred             ---EEEecCCccccCh
Confidence               3457999999999

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.2e-35  Score=295.09  Aligned_cols=329  Identities=29%  Similarity=0.419  Sum_probs=285.1

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCC--CcCCccccCCCCCccEEEccCCCCCCCccCc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS--GSLSSITDVRLPNLEELVLWGNNFSELNFLS   78 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~   78 (585)
                      .+|+.++.+++|++|.+++|+++ .+...++.++.|+.+++.+|+++  |+++.++  ++..|+.||||+|++++.|  .
T Consensus        46 ~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF--~l~dLt~lDLShNqL~EvP--~  120 (1255)
T KOG0444|consen   46 QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIF--RLKDLTILDLSHNQLREVP--T  120 (1255)
T ss_pred             hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhc--ccccceeeecchhhhhhcc--h
Confidence            47999999999999999999997 77888999999999999999996  6677776  7999999999999999998  7


Q ss_pred             cccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCC
Q 047705           79 SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ  158 (585)
Q Consensus        79 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  158 (585)
                      .+...+++-.|+||+|+|.++ |...+-++.. |..|||++|.+... |.-.+.|..|++|+|++|.+....-..+..++
T Consensus       121 ~LE~AKn~iVLNLS~N~IetI-Pn~lfinLtD-LLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmt  197 (1255)
T KOG0444|consen  121 NLEYAKNSIVLNLSYNNIETI-PNSLFINLTD-LLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMT  197 (1255)
T ss_pred             hhhhhcCcEEEEcccCccccC-CchHHHhhHh-Hhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccch
Confidence            788999999999999999754 5557778877 99999999999854 45588899999999999999865556667888


Q ss_pred             CCceEEccCCCCC-ccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEcc
Q 047705          159 KLQGLVLDDNKLE-GSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFS  235 (585)
Q Consensus       159 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls  235 (585)
                      +|+.|++++.+=+ .-+|..+..+.+|..+|+|.|.+. ..|+.+-++++|+.|+||+|.  .+....+...+|++|++|
T Consensus       198 sL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlS  276 (1255)
T KOG0444|consen  198 SLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLS  276 (1255)
T ss_pred             hhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccc
Confidence            9999999987644 357888999999999999999998 789999999999999999998  444556678899999999


Q ss_pred             CCcccccCCcccCCCCCCcEEeecccCcccc-cCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeee
Q 047705          236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       236 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      .|+++ ..|.+++.++.|+.|++.+|+++-. +|+.++.+..|+++..++|.+. ..|+.++.+.+|+.|.|+.|.+-..
T Consensus       277 rNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTL  354 (1255)
T KOG0444|consen  277 RNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITL  354 (1255)
T ss_pred             cchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeec
Confidence            99999 7899999999999999999987532 5888999999999999999998 8899999999999999999999866


Q ss_pred             CCCCCCCCCCCccccCCCCcccCCCC
Q 047705          315 IPRGGSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       315 ~~~~~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      +...-.+..+..+++..||-..-+|.
T Consensus       355 PeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  355 PEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhhhhcCCcceeeccCCcCccCCCC
Confidence            65556678888889999987766553

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-33  Score=271.63  Aligned_cols=168  Identities=32%  Similarity=0.423  Sum_probs=148.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  487 (585)
                      .+.|+.+++||+|.||.||+|++. +|+.||+|++..+.  ........+||.+|++++||||+++.+.....  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356888899999999999999864 79999999998664  34456677899999999999999999988776  68999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |+|||+. ||.-++....-.+++.++..++.|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999966 999998887668999999999999999999999   999999999999999999999999999999987644


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . ....+..+-|.||.||
T Consensus       272 ~-~~~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPP  288 (560)
T ss_pred             C-CcccccceEEeeccCh
Confidence            3 3346778899999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.98  E-value=5.7e-33  Score=256.20  Aligned_cols=166  Identities=27%  Similarity=0.371  Sum_probs=146.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +.|+...++|+|+||+||+|+.+ +|+.||||++...  +..-.+-..+|+++|++++|||+|.+++.|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56888899999999999999976 6999999998643  23345667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||+. ++.+.+......++...+.+++.|+++|+.|+|   ++++|||||||+|||++.+|.+|++|||+|+....++. 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9966 666677777777899999999999999999999   99999999999999999999999999999998764332 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ..+..+.|.||+||
T Consensus       157 -~YTDYVATRWYRaP  170 (396)
T KOG0593|consen  157 -NYTDYVATRWYRAP  170 (396)
T ss_pred             -hhhhhhhhhhccCh
Confidence             34678899999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.98  E-value=3e-32  Score=247.36  Aligned_cols=166  Identities=30%  Similarity=0.480  Sum_probs=147.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh--hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|...+.+|+|.||.||+|++. +|+.||||+++.....  ......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            56888999999999999999865 7999999999865332  23456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++. +|+..++.....++..++..++.++++|++|||   .+.|+||||||.|+|++.+|.+||+|||+|+.+.++...
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9965 999999998889999999999999999999999   999999999999999999999999999999988654433


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .  +..+-|.||.||
T Consensus       158 ~--~~~V~TRWYRAP  170 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAP  170 (318)
T ss_pred             c--ccceeeeeccCh
Confidence            2  334789999998

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=270.08  Aligned_cols=172  Identities=31%  Similarity=0.472  Sum_probs=151.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      .+...+|.+++.||+|+|++|++|+.. +++.||||++.+.   .+...+.+..|-.+|.++ .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            455678999999999999999999865 7899999998764   233446677899999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+|+||+++|+|.++|.+.+ .+++...+.++.+|+.|++|||   .+|||||||||+|||+|+||++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999999875 7899999999999999999999   999999999999999999999999999999987


Q ss_pred             cCCCCc---------cc--cccccccccccCC
Q 047705          565 IGEDQS---------MT--QTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~---------~~--~~~~~gt~~y~aP  585 (585)
                      .+....         ..  ...++||..|.+|
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCH
Confidence            643322         11  2568999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=269.40  Aligned_cols=165  Identities=33%  Similarity=0.525  Sum_probs=143.2

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEechhhh--hHHHHHHHHHHHHhcCCCcceeEEeeeecCC-eEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  492 (585)
                      ....+.+|+|+||+||+|.++....||||++......  ..+.|.+|+.+|.+++|||||+++|++..+. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            4445569999999999999976556999999765322  2568999999999999999999999999887 789999999


Q ss_pred             CCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-cEEcCCCCCCEEeCCCC-cEEEeeecccccccCCCC
Q 047705          493 PQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTP-VIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       493 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  569 (585)
                      ++|+|.+++.. .+..+++..+..++.||++||.|||   +++ ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999988 3668999999999999999999999   788 99999999999999998 99999999998754221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       ...+...||+.||||
T Consensus       199 -~~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAP  213 (362)
T ss_pred             -ccccCCCCCccccCh
Confidence             334457899999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=266.23  Aligned_cols=167  Identities=27%  Similarity=0.377  Sum_probs=146.6

Q ss_pred             hcCCCCccceecccCceEEEEEEe-CCCcEEEEEEEechhhhhHH-HHHHHHHHHHhcC-CCcceeEEeeeecCC-eEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIR-HRNLIKVISSCSNEE-FKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  487 (585)
                      ..++|...+.||.|.||.||+|+. .+++.||||.++.......+ --.+|++.|++++ ||||+++.+.+.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346799999999999999999975 47899999988755332212 2346999999998 999999999998887 9999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||||+ .+|.++++.++..+++..++.|+.||++||+|+|   ++|+.|||+||||||+.....+||+|||+||.+.+ 
T Consensus        88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-  162 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-  162 (538)
T ss_pred             eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc-
Confidence            999995 5999999999889999999999999999999999   99999999999999999888999999999998743 


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                        ..+.+..+.|.||+||
T Consensus       163 --kpPYTeYVSTRWYRAP  178 (538)
T KOG0661|consen  163 --KPPYTEYVSTRWYRAP  178 (538)
T ss_pred             --CCCcchhhhcccccch
Confidence              3455788999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=8.2e-31  Score=260.16  Aligned_cols=149  Identities=28%  Similarity=0.413  Sum_probs=137.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ...++|+.+++||+|+||.||.|+.+ +|..+|+|++++..   ....+.+..|-.+|...++|+||+++..|++.+++|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35689999999999999999999865 79999999998652   345678889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      +||||++||++..++...+ .+++..++.++.+++-|++.+|   +.|+|||||||+|+|||..|++||+|||++.-
T Consensus       218 LiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999998876 7899999999999999999999   99999999999999999999999999999863

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.5e-31  Score=250.09  Aligned_cols=171  Identities=26%  Similarity=0.349  Sum_probs=148.3

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh--hHHHHHHHHHHHHhcCCCcceeEEeeeecC--C
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR--AFKSFDVECEIMKSIRHRNLIKVISSCSNE--E  483 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  483 (585)
                      -+..++.|+....|++|+||.||+|+++ +++.||+|+++.....  ..-...+||.+|.+++|||||.+-.+....  +
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            3556678999999999999999999876 7889999999865322  123456799999999999999999976544  5


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+|+|||||+. +|..++...+.++...++..++.|+++|++|||   .+.|+||||||+|+|+.+.|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence            79999999976 999999988888999999999999999999999   99999999999999999999999999999998


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +..+.  ...+..+-|.||+||
T Consensus       227 ygsp~--k~~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  227 YGSPL--KPYTPLVVTLWYRAP  246 (419)
T ss_pred             hcCCc--ccCcceEEEeeecCH
Confidence            85442  345677899999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=263.27  Aligned_cols=170  Identities=26%  Similarity=0.385  Sum_probs=149.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech----hh-hhHHHHHHHHHHHHhcC-CCcceeEEeeeecC
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ----CR-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNE  482 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  482 (585)
                      ....+.|.+.+.||+|+||+|+.|+.. +++.||+|+++..    .. ...+.+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            345678999999999999999999765 7899999987654    11 23456778999999999 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeeccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIA  561 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a  561 (585)
                      ...|+|||||.||+|.+++.+ .+.+.+..+..+++|++.|++|+|   .++|+||||||+|||++.+ +.+||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999999 558899999999999999999999   9999999999999999998 99999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  .........+||+.|+||
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCH
Confidence            8753  222344678999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=252.23  Aligned_cols=170  Identities=35%  Similarity=0.515  Sum_probs=146.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--eEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  489 (585)
                      ..+|...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|.....+  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456888999999999999999865 58999999987664333577899999999999999999999855554  689999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||+++|+|.+++.+.++.+++..++.+++||++||+|||   ++|||||||||+|||++. ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999987767899999999999999999999   999999999999999999 7999999999998765311


Q ss_pred             -CccccccccccccccCC
Q 047705          569 -QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 -~~~~~~~~~gt~~y~aP  585 (585)
                       .........||+.||||
T Consensus       173 ~~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAP  190 (313)
T ss_pred             ccccccccccCCccccCc
Confidence             11223467899999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=2.4e-31  Score=263.79  Aligned_cols=165  Identities=32%  Similarity=0.468  Sum_probs=148.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..  ++..+.+.+|+++++.++||||+.++++|++..++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999866 68889999997653  3456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||.| +|..++.... .+++..++.++.+++.||.|||   +.+|+|||+||.|||++..|.+|++|||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 9999998765 7999999999999999999999   99999999999999999999999999999998642  33


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ...+...|||.||||
T Consensus       155 ~vltsikGtPlYmAP  169 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAP  169 (808)
T ss_pred             eeeeeccCcccccCH
Confidence            445778899999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.3e-31  Score=252.16  Aligned_cols=165  Identities=27%  Similarity=0.395  Sum_probs=149.7

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+|++.+.||+|.||.|-+|+. ..|+.||||.+++.   ++++.-.+.+|++||+.++||||+++|+.|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688899999999999999974 68999999998765   4556678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||..+|+|.+|+.+.+ .+++.+.+.+++||+.|+.|+|   .++++|||+|.+|||+|.++.+||+|||++..+..   
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            9999999999999876 7899999999999999999999   99999999999999999999999999999987643   


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ......+||+|-|.+|
T Consensus       206 ~kfLqTFCGSPLYASP  221 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASP  221 (668)
T ss_pred             ccHHHHhcCCcccCCc
Confidence            2234668999999988

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=251.90  Aligned_cols=167  Identities=34%  Similarity=0.450  Sum_probs=144.0

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHh--cCCCcceeEEeeeecCC----eEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS--IRHRNLIKVISSCSNEE----FKG  486 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~  486 (585)
                      .+..+..+.+|+|+||.||+|... ++.||||++..+   ..+.|+.|-+|.+.  ++|+||++++++-....    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            456777889999999999999884 589999998755   34677888888775  58999999999865544    789


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF------GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      +|+||.+.|+|.+|+..+  ..+|....+++.-+++||+|||+      +++++|+|||||++|||+..|+.+.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999987  68999999999999999999995      3567899999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |..+............+||.+||||
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCH
Confidence            9988754443444568999999999

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=251.99  Aligned_cols=177  Identities=28%  Similarity=0.375  Sum_probs=145.6

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--------------hhHHHHHHHHHHHHhcCC
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--------------RAFKSFDVECEIMKSIRH  469 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h  469 (585)
                      +-.+-....++|++.+.||+|.||+|-+|+.. +++.||||++.+...              ...+...+||.+|+++.|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            33445666789999999999999999999876 789999999975321              123578899999999999


Q ss_pred             CcceeEEeeeecC--CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          470 RNLIKVISSCSNE--EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       470 ~niv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      ||||+++++..+.  +.+|+|+|||..|.+...- ..+..+++.++++|+++++.||+|||   .+|||||||||+|+|+
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl  243 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLL  243 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEE
Confidence            9999999998765  5889999999988875432 22223889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecccccccCC---CCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGE---DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aP  585 (585)
                      +++|+|||+|||.+......   +........+|||.||||
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            99999999999998865221   122223457999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=259.38  Aligned_cols=166  Identities=28%  Similarity=0.402  Sum_probs=150.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ...|...+.||+|+.|.||.|+.. +++.||||.+........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            346888889999999999999754 7889999999987777778889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++||+|.+.+...  .+++.++..|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||+|..+.....  
T Consensus       352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            9999999998765  4899999999999999999999   99999999999999999999999999999998764433  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      .....+|||+||||
T Consensus       425 KR~TmVGTPYWMAP  438 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAP  438 (550)
T ss_pred             ccccccCCCCccch
Confidence            34567899999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=245.44  Aligned_cols=171  Identities=29%  Similarity=0.421  Sum_probs=150.4

Q ss_pred             hcCCCCccceecccCceEEEEEEe-CCCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..+.|++.+.||.|..++||+|+. ..++.||||++..+ +......+++|+..|+.++||||++++..|..++..|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            346799999999999999999985 47899999999876 3445688999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      .||.+|++.+.++..- ..+++..+..|.+++++||.|||   ++|.||||||+.||||+.+|.|||+|||.+..+...+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999998653 36899999999999999999999   9999999999999999999999999999877665433


Q ss_pred             Ccc-cc-ccccccccccCC
Q 047705          569 QSM-TQ-TQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~-~~-~~~~gt~~y~aP  585 (585)
                      ... .. ..++|||+||||
T Consensus       181 ~R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             ceeeEeeccccCcccccCh
Confidence            221 12 567999999999

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-30  Score=260.24  Aligned_cols=169  Identities=28%  Similarity=0.390  Sum_probs=148.0

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      ....++|...++||+|.||+|++|..+ +++.+|||++++.   ...+.+..+.|.+|+... +||+++.++.+|+++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344578999999999999999999876 6889999999876   345678888899998887 59999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      +|+||||+.||++..+.+.  ..+++..++.|+.+|+.||+|||   +++||+||||.+|||+|.+|++||+|||+|+..
T Consensus       444 l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999995554443  36999999999999999999999   999999999999999999999999999999975


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...+  .....+||||.||||
T Consensus       519 m~~g--~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  519 MGQG--DRTSTFCGTPEFLAP  537 (694)
T ss_pred             CCCC--CccccccCChhhcCh
Confidence            4322  244678999999999

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.96  E-value=1.1e-31  Score=268.83  Aligned_cols=304  Identities=27%  Similarity=0.385  Sum_probs=234.3

Q ss_pred             ccccCCCCCCEEecCCCccc-ccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            4 LEIGNLQNLEELDLRQNKLI-GTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         4 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      ..++.|+.|+.++++.|++. .-+|..+..+..|+.||||+|++++.+....  ..+++-.|+||+|+|.+||. ..|-+
T Consensus        72 GELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE--~AKn~iVLNLS~N~IetIPn-~lfin  148 (1255)
T KOG0444|consen   72 GELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLE--YAKNSIVLNLSYNNIETIPN-SLFIN  148 (1255)
T ss_pred             hhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhh--hhcCcEEEEcccCccccCCc-hHHHh
Confidence            35677788888888888775 3457788888888888888888886555544  45678888888888888886 67888


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccc-cccchhhhCCCCCc
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLN-GSILITLSKLQKLQ  161 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~  161 (585)
                      ++.|-+||||+|++....|.  ...+.. |++|+|++|.+...--.-+..|++|++|.+++.+-+ .-+|.++.++.+|.
T Consensus       149 LtDLLfLDLS~NrLe~LPPQ--~RRL~~-LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~  225 (1255)
T KOG0444|consen  149 LTDLLFLDLSNNRLEMLPPQ--IRRLSM-LQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLR  225 (1255)
T ss_pred             hHhHhhhccccchhhhcCHH--HHHHhh-hhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhh
Confidence            88888888888888755553  334444 888888888776554455666778888888876643 34677788888888


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcc
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNF  239 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l  239 (585)
                      .+|||.|.+. ..|+.+..+++|+.|+||+|.|+ ..........+|+.|+||+|+  .+|..+..+++|+.|.+.+|++
T Consensus       226 dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL  303 (1255)
T KOG0444|consen  226 DVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKL  303 (1255)
T ss_pred             hccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcc
Confidence            8888888888 77888888888888888888887 344455667788888888887  6777788888888888888887


Q ss_pred             c-ccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          240 S-GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       240 ~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      + .-+|..++.+.+|+.+..++|.+. ..|+.++.|..|+.|.|+.|.+- .+|+.+.-++.|++||+..|+=.-.+|.
T Consensus       304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            4 236777888888888888888887 67888888889999999999887 6788888888899999988875444443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=2.3e-29  Score=240.10  Aligned_cols=167  Identities=28%  Similarity=0.380  Sum_probs=143.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCc-ceeEEeeeecCC-----
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRN-LIKVISSCSNEE-----  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  483 (585)
                      ...|+..+.||+|+||+||+|+.+ +|+.||+|+++...+  .......+|+.+++.++|+| |+.+++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345777888999999999999865 789999999986643  24456678999999999999 999999998877     


Q ss_pred             -eEEEEEEccCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          484 -FKGLVLEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       484 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                       ..++|+||+ ..+|..++....   ..++...+..++.|+++|++|||   +++|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 459999998765   35777889999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|+...-+.  ...+..++|.||.||
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaP  189 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAP  189 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCH
Confidence            999654222  224567899999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=1.3e-32  Score=262.52  Aligned_cols=321  Identities=29%  Similarity=0.429  Sum_probs=216.4

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      ++|.+++++..+..|+.++|+++ .+|+.+..+.+|+.|+.++|.+++.++.++  .+-.|+.|+..+|+++++|  ..+
T Consensus        82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~--~~~~l~dl~~~~N~i~slp--~~~  156 (565)
T KOG0472|consen   82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIG--RLLDLEDLDATNNQISSLP--EDM  156 (565)
T ss_pred             hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHH--HHhhhhhhhccccccccCc--hHH
Confidence            46888888888888888888886 788888888888888888888887777666  5678888888888888887  567


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                      ..+.+|..|++.+|.+....|. -.. +. .|++||+..|-++ .+|..++.|.+|+-|+|..|.|.. .| .|.++..|
T Consensus       157 ~~~~~l~~l~~~~n~l~~l~~~-~i~-m~-~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L  230 (565)
T KOG0472|consen  157 VNLSKLSKLDLEGNKLKALPEN-HIA-MK-RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLL  230 (565)
T ss_pred             HHHHHHHHhhccccchhhCCHH-HHH-HH-HHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHH
Confidence            7777788888888887755544 222 33 3777777777766 455567777777777777777763 33 55555555


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCC-
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMN-  237 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N-  237 (585)
                      .+|+++.|+|+-.+.+....++++..|||.+|+++ ..|+.+.-+.+|++||+|+|.  ..|..++++ +|+.|.+.+| 
T Consensus       231 ~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  231 KELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             HHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            55555555555222223334555555555555555 455555555555555555554  444444444 3333333333 


Q ss_pred             --------------------------------------------------------------------------------
Q 047705          238 --------------------------------------------------------------------------------  237 (585)
Q Consensus       238 --------------------------------------------------------------------------------  237 (585)
                                                                                                      
T Consensus       309 lrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~  388 (565)
T KOG0472|consen  309 LRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSE  388 (565)
T ss_pred             hHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhc
Confidence                                                                                            


Q ss_pred             ----------cccc-----------------------cCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCC
Q 047705          238 ----------NFSG-----------------------IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN  284 (585)
Q Consensus       238 ----------~l~~-----------------------~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~  284 (585)
                                ++..                       .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||++.
T Consensus       389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~  467 (565)
T KOG0472|consen  389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF  467 (565)
T ss_pred             ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence                      2211                       12223344566777777777766 4566667777777777776


Q ss_pred             Ccc-----------------------CccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcc
Q 047705          285 NNL-----------------------SGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  335 (585)
Q Consensus       285 N~l-----------------------~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~  335 (585)
                      |++                       ....|+.+..+.+|+.|||.+|.+...+|..+...+++.+.+.|||+.
T Consensus       468 NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  468 NRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            655                       344455688899999999999999999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=250.41  Aligned_cols=167  Identities=31%  Similarity=0.523  Sum_probs=142.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      +.++.++.||+|.||+||.|+++....||+|.++... ...++|.+|+++|++++|++||+++++|..++.+|||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3455678999999999999999888899999988653 334778899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          494 QGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       494 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      .|+|.++++. .+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+...++. ...
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTA  360 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eee
Confidence            9999999997 4457888899999999999999999   9999999999999999999999999999999543322 222


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....-...|.||
T Consensus       361 ~~~~kfPIkWtAP  373 (468)
T KOG0197|consen  361 SEGGKFPIKWTAP  373 (468)
T ss_pred             cCCCCCCceecCH
Confidence            2222334467777

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-29  Score=249.98  Aligned_cols=173  Identities=27%  Similarity=0.502  Sum_probs=149.0

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      .++....+...+.+.||+|.||+||+|+|-  -.||||++...  .....+.|+.|+.++++-+|.||+-++||+..++.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555566788899999999999999974  36999999865  33467899999999999999999999999988877


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                       .||+.+|+|.+|+.+++.....++..+...|++||++|+.|||   .++|||||||..||++.+++.|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             8999999999999999987778899999999999999999999   999999999999999999999999999998754


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .-...........|..-||||
T Consensus       539 ~~w~g~~q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAP  559 (678)
T ss_pred             eeeccccccCCCccchhhhcH
Confidence            322222333455688889998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.2e-29  Score=224.49  Aligned_cols=166  Identities=31%  Similarity=0.427  Sum_probs=145.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++++.||+|.||.||.|+.+ ++-.||+|++.+..   .....++.+|+++-+.++||||.++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            366999999999999999999865 78889999987542   23446788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          489 LEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      +||...|++...+++... .+++.....++.|++.|+.|+|   .++||||||||+|+|++.++..||+|||-+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999985543 6888888999999999999999   9999999999999999999999999999876531  


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                        .......|||..|.||
T Consensus       176 --~~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPP  191 (281)
T ss_pred             --CCCceeeecccccCCH
Confidence              2234567999999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=5.4e-28  Score=248.89  Aligned_cols=147  Identities=26%  Similarity=0.395  Sum_probs=133.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+..|+.++..++||+|+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999865 68899999997542   233456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||++||+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999998654 6889999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=234.53  Aligned_cols=171  Identities=29%  Similarity=0.342  Sum_probs=146.8

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEec--hhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-----
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-----  481 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  481 (585)
                      ......|...+.||+|+||.|+.|.++ +|+.||||++..  ......++..+|+++++.++|+||+.+.+.+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            334456777899999999999999865 789999999873  344566788899999999999999999999866     


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                      -+.+|+|+|+| +.+|.+.++..+ .++...+..++.|+++||+|+|   +.+|+|||+||+|++++.++.+||+|||+|
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            24789999999 569999998764 5889999999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +...........+..+.|.||.||
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAP  196 (359)
T ss_pred             eeccccCcccchhcceeeeeecCH
Confidence            986543223345788999999998

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-29  Score=267.48  Aligned_cols=174  Identities=29%  Similarity=0.369  Sum_probs=157.1

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      .++....++|.++++||+|+||.|..++.+ +++.||+|++++.   .......|..|-++|...+.+.|++++.+|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            456667789999999999999999999876 6888999999863   234557889999999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      .+.|+|||||+||+|..++.+.. .+|+..++.|+.+|+-||.-+|   +.|+|||||||+|||+|..|++|++|||.|.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999999987 8999999999999999999999   9999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+..+ +.......+|||.|.||
T Consensus       224 km~~d-G~V~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  224 KMDAD-GTVRSSVAVGTPDYISP  245 (1317)
T ss_pred             hcCCC-CcEEeccccCCCCccCH
Confidence            87543 34556778999999998

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.2e-28  Score=248.35  Aligned_cols=147  Identities=27%  Similarity=0.418  Sum_probs=133.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+..|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999876 68999999997542   234456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999987654 6889999999999999999999   999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=7e-28  Score=247.99  Aligned_cols=170  Identities=25%  Similarity=0.339  Sum_probs=146.1

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++..++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999999876 68899999987532   22345677899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||+++|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+...
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999999999765  4788889999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ... .......+||+.||||
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aP  212 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISP  212 (370)
T ss_pred             cCC-ceecccCCCCcccCCH
Confidence            221 1222456799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.1e-28  Score=245.82  Aligned_cols=168  Identities=28%  Similarity=0.430  Sum_probs=149.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe-EEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-KGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  488 (585)
                      .++|..++++|+|+||.++.++++ +++.||+|.+....  .........|+.++++++|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            468999999999999999999866 78899999987653  3444577889999999999999999999999988 9999


Q ss_pred             EEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          489 LEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |+||+||++.+.+.+.+ ..+++..+..|+.|++.|+.|||   +..|+|||||++||+++.++.|||.|||+|+.+..+
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998876 47899999999999999999999   999999999999999999999999999999987654


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .....+|||.||.|
T Consensus       160 ~~--~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCP  175 (426)
T ss_pred             hh--hhheecCCCcccCH
Confidence            32  33567899999998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=247.55  Aligned_cols=146  Identities=24%  Similarity=0.375  Sum_probs=132.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999865 78999999987542   234567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||++||+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999997654 6788899999999999999999   99999999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-30  Score=229.73  Aligned_cols=167  Identities=27%  Similarity=0.478  Sum_probs=145.4

Q ss_pred             hcCCCCccceecccCceEEEEEEe-CCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ..+.|++.+.||+|+|+.||++.. .+|+.+|+|+++..  ..+..+.+.+|+.+.+.++||||+++.+.+...++.|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            346789999999999999999965 48999999998754  345678899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~  565 (585)
                      +|+|+|++|..-+-.. ..+++..+..+++||++||.|+|   .++|||||+||+|+++.   ...-+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999998776654 36788889999999999999999   99999999999999995   44579999999999875


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                       +  ...-.+++|||+||||
T Consensus       165 -~--g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  165 -D--GEAWHGFAGTPGYLSP  181 (355)
T ss_pred             -C--ccccccccCCCcccCH
Confidence             2  2233578999999998

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=1.7e-27  Score=246.83  Aligned_cols=145  Identities=23%  Similarity=0.341  Sum_probs=131.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+.++.||+|+||+||+|+.. +++.||+|++....   ......+..|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999997542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      |++||+|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999987654 6788889999999999999999   99999999999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=242.65  Aligned_cols=166  Identities=29%  Similarity=0.421  Sum_probs=147.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  486 (585)
                      ..+.|++.+.||+|.||.||+|+.+ +|+.+|+|++.+...   ...+.+.+|+++|+++. |||||++++.|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457899999999999999999876 599999999986643   24568899999999998 999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC----CCcEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD----NMIAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfg~a~  562 (585)
                      +|||+|+||.|.+.+...  .+++.++..++.|++.|++|||   ..||+|||+||+|+|+..    ++.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  3899999999999999999999   999999999999999962    3589999999999


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   .......+||++|+||
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAP  207 (382)
T ss_pred             EccC---CceEeeecCCccccCc
Confidence            8653   3345678999999999

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=1.1e-27  Score=243.03  Aligned_cols=164  Identities=27%  Similarity=0.380  Sum_probs=144.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367999999999999999999876 68899999997542   23446788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..... 
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            99999999999998754 6788888999999999999999   999999999999999999999999999999865321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                          .....||+.||||
T Consensus       172 ----~~~~~gt~~y~aP  184 (329)
T PTZ00263        172 ----TFTLCGTPEYLAP  184 (329)
T ss_pred             ----cceecCChhhcCH
Confidence                1235799999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.95  E-value=2.3e-31  Score=254.18  Aligned_cols=296  Identities=29%  Similarity=0.468  Sum_probs=152.2

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |..+.++.++..|++.+|+++ ..|+..-+|+.|++||..+|-+...++...  .+.+|+-|||.+|+|..+|   .|..
T Consensus       153 p~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg--~l~~L~~LyL~~Nki~~lP---ef~g  226 (565)
T KOG0472|consen  153 PEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLETLPPELG--GLESLELLYLRRNKIRFLP---EFPG  226 (565)
T ss_pred             chHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhcCChhhc--chhhhHHHHhhhcccccCC---CCCc
Confidence            333444444444444444443 222222224444444444444443333322  3444555555555555544   2445


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCce
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG  162 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  162 (585)
                      +..|.+|.++.|+|. ..|.....+++. +.+|||..|+++ ..|..+.-+.+|++||+|+|.|+ ..|..++++ +|+.
T Consensus       227 cs~L~Elh~g~N~i~-~lpae~~~~L~~-l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~  301 (565)
T KOG0472|consen  227 CSLLKELHVGENQIE-MLPAEHLKHLNS-LLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKF  301 (565)
T ss_pred             cHHHHHHHhcccHHH-hhHHHHhccccc-ceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeee
Confidence            555555555555553 223223334443 555555555555 44445555555555555555555 334445555 5555


Q ss_pred             EEccCCCCCc----------------------------------------------------------------cCcccc
Q 047705          163 LVLDDNKLEG----------------------------------------------------------------SIPDDI  178 (585)
Q Consensus       163 L~L~~N~l~~----------------------------------------------------------------~~~~~~  178 (585)
                      |.+.+|.+..                                                                .+|++.
T Consensus       302 L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEV  381 (565)
T KOG0472|consen  302 LALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEV  381 (565)
T ss_pred             hhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHH
Confidence            5555554332                                                                001110


Q ss_pred             cCCCC---CcEEEcCCCcccccCcccccCcccc-hhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCcccCCCCC
Q 047705          179 CRLVE---LYKLELGGNKLSRSIPACFNNLIAL-RILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKN  252 (585)
Q Consensus       179 ~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  252 (585)
                      ....+   ...++++.|++. ..|..+..++.+ +.+.+++|.  ..|..+..+++|+.|++++|.+. .+|..++.+..
T Consensus       382 fea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~  459 (565)
T KOG0472|consen  382 FEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVR  459 (565)
T ss_pred             HHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhh
Confidence            00001   223344444443 222222222222 122222332  33344455555666666655555 34555555555


Q ss_pred             CcEEeecc-----------------------cCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecC
Q 047705          253 LEYLFLGY-----------------------NRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFN  309 (585)
Q Consensus       253 L~~L~ls~-----------------------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N  309 (585)
                      |+.|++|.                       |++..+.|+.+..|.+|+.|||.+|.|. .+|..++++.+|++|++++|
T Consensus       460 Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gN  538 (565)
T KOG0472|consen  460 LQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGN  538 (565)
T ss_pred             hheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCC
Confidence            55555555                       4555555556788999999999999999 67889999999999999999


Q ss_pred             cCe
Q 047705          310 KLE  312 (585)
Q Consensus       310 ~l~  312 (585)
                      +|.
T Consensus       539 pfr  541 (565)
T KOG0472|consen  539 PFR  541 (565)
T ss_pred             ccC
Confidence            998

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=241.29  Aligned_cols=168  Identities=27%  Similarity=0.373  Sum_probs=145.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999865 68999999997532   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.+....+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence            999999999999875557889999999999999999999   9999999999999999999999999999987653222 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (331)
T cd05597         157 TVQSNVAVGTPDYISP  172 (331)
T ss_pred             CccccceeccccccCH
Confidence            1122335699999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=2.4e-27  Score=240.15  Aligned_cols=160  Identities=29%  Similarity=0.385  Sum_probs=138.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999998542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ  575 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  575 (585)
                      +|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999987654 6889999999999999999999   9999999999999999999999999999987542221  22344


Q ss_pred             ccccccccCC
Q 047705          576 TLATIGYMAP  585 (585)
Q Consensus       576 ~~gt~~y~aP  585 (585)
                      .+||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05571         155 FCGTPEYLAP  164 (323)
T ss_pred             eecCccccCh
Confidence            6799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=241.78  Aligned_cols=163  Identities=28%  Similarity=0.453  Sum_probs=144.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...   ......+..|+++++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999876 68899999997542   234466788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++||+|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 6788899999999999999999   99999999999999999999999999999986432   


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.|+||
T Consensus       154 --~~~~~~gt~~y~aP  167 (333)
T cd05600         154 --YANSVVGSPDYMAP  167 (333)
T ss_pred             --ccCCcccCccccCh
Confidence              22446799999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=2.1e-27  Score=245.84  Aligned_cols=146  Identities=25%  Similarity=0.358  Sum_probs=131.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999865 68999999987542   223466788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|..
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999997754 6788888999999999999999   99999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.1e-27  Score=230.72  Aligned_cols=147  Identities=29%  Similarity=0.398  Sum_probs=133.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|+..+.||+|.-|+||+|+.+ ++..+|+|++.+..   +....+.+.|.+||+.++||.++++|..|+.+++.|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            56888899999999999999976 46899999998763   334567788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      |||+||+|....+++.. .+++..++.++.+|+-||+|||   ..|||.|||||+|||+.++|++-++||-++..
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999887654 7899999999999999999999   99999999999999999999999999988653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.7e-28  Score=245.35  Aligned_cols=166  Identities=27%  Similarity=0.392  Sum_probs=147.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++-|+.++.||.|+.|.|..|++. +|+.+|||++.+..   ......+.+|+.+|+.+.|||++++|+.|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            466899999999999999999865 89999999997652   22345688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      .||++||.|.+++.+++ .+++.+..++++||+.|+.|+|   ..+|+|||+||+|+|+|..+.+||+|||+|..-.+  
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            99999999999998876 7888888999999999999999   99999999999999999999999999999986322  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       .......||+|.|.||
T Consensus       165 -gklLeTSCGSPHYA~P  180 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAP  180 (786)
T ss_pred             -CccccccCCCcccCCc
Confidence             2233567999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=238.86  Aligned_cols=163  Identities=29%  Similarity=0.417  Sum_probs=143.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999876 68999999987542   234466888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999997654 6788899999999999999999   999999999999999999999999999999865321  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         ....+||+.|+||
T Consensus       155 ---~~~~~gt~~y~aP  167 (291)
T cd05612         155 ---TWTLCGTPEYLAP  167 (291)
T ss_pred             ---cccccCChhhcCH
Confidence               1235789999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=2.9e-27  Score=240.24  Aligned_cols=168  Identities=25%  Similarity=0.330  Sum_probs=145.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++..++|++|+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999876 67889999987532   223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++||+|.+++......+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875557889999999999999999999   99999999999999999999999999999986543221


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.||||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (331)
T cd05624         158 -VQSSVAVGTPDYISP  172 (331)
T ss_pred             -eeeccccCCcccCCH
Confidence             122345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=2.5e-27  Score=245.79  Aligned_cols=145  Identities=24%  Similarity=0.358  Sum_probs=131.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++||||+++++.+..++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999865 68899999987542   2345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||++|+|.+++.+.. .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|..
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987654 6788889999999999999999   99999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=1.8e-27  Score=242.13  Aligned_cols=164  Identities=27%  Similarity=0.352  Sum_probs=143.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-C-CcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|.++ + +..||+|++....   ....+.+..|+++++.++||||+++++++..++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            357999999999999999999754 3 4689999987542   2345677889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence            999999999999998754 6888899999999999999999   99999999999999999999999999999986532 


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                          .....+||+.||||
T Consensus       184 ----~~~~~~gt~~y~aP  197 (340)
T PTZ00426        184 ----RTYTLCGTPEYIAP  197 (340)
T ss_pred             ----CcceecCChhhcCH
Confidence                12345799999998

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=2.7e-27  Score=240.62  Aligned_cols=168  Identities=27%  Similarity=0.369  Sum_probs=146.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999865 78999999998643   234567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.......
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999887567899999999999999999999   99999999999999999999999999999986543221


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       158 -~~~~~~~gt~~y~aP  172 (330)
T cd05601         158 -VNSKLPVGTPDYIAP  172 (330)
T ss_pred             -eeeecccCCccccCH
Confidence             222345799999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-29  Score=246.39  Aligned_cols=161  Identities=31%  Similarity=0.410  Sum_probs=143.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      -|...+.||.|+||.||-|++. +.+.||||++.-.   ....+.++..|+..|.+++|||++.+-|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3677788999999999999865 6788999998643   33456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      || -|+-.+++.-.+.++.+-.+..|+.+.+.||.|||   +.+.||||||+.|||+++.|.||++|||.|..+.+    
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            99 56888988888778999999999999999999999   99999999999999999999999999999987542    


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        ...++|||+||||
T Consensus       179 --AnsFvGTPywMAP  191 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAP  191 (948)
T ss_pred             --hhcccCCccccch
Confidence              2458999999999

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=2.8e-27  Score=243.78  Aligned_cols=173  Identities=26%  Similarity=0.340  Sum_probs=147.9

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555689999999999999999999876 68899999987532   22345677899999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      +..|+||||+++|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999998764  4788888999999999999999   9999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...... .......+||+.||||
T Consensus       191 ~~~~~~-~~~~~~~~gt~~y~aP  212 (371)
T cd05622         191 KMNKEG-MVRCDTAVGTPDYISP  212 (371)
T ss_pred             EcCcCC-cccccCcccCccccCH
Confidence            653222 1223456799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=3.6e-28  Score=221.17  Aligned_cols=170  Identities=31%  Similarity=0.443  Sum_probs=147.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--------hhhHHHHHHHHHHHHhc-CCCcceeEEee
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSI-RHRNLIKVISS  478 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~  478 (585)
                      ....-+.|...+.+|+|..++|.++..+ +|.++|+|++....        ..-.+....|+.+|+++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3444567888899999999999988654 78899999986431        22345667799999998 69999999999


Q ss_pred             eecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       479 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      |+.+..+++|+|.|+.|.|.+++.+.- .+++...+++++|+.+|++|||   ...|||||+||+|||+|++.++||+||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            999999999999999999999998764 6889999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|..+....   .....||||+|+||
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAP  191 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAP  191 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccCh
Confidence            9999875332   34678999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=2.6e-28  Score=232.46  Aligned_cols=160  Identities=32%  Similarity=0.520  Sum_probs=132.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-----eEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  488 (585)
                      .|+..+++|+|+||.||+|... +++.||||++-.+.+    .-.+|.++|+.++|||||++..+|....     +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4777899999999999999865 578999998764432    2235999999999999999999886432     33589


Q ss_pred             EEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeecccccc
Q 047705          489 LEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLL  564 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~  564 (585)
                      ||||+. +|.+.++..   +..++...+.-+++|+.+|+.|||   ..+|+||||||+|+|+|.+ |.+||+|||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999965 999988842   346777788889999999999999   8999999999999999955 99999999999987


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...+   ...+...|..|+||
T Consensus       177 ~~~e---pniSYicSRyYRaP  194 (364)
T KOG0658|consen  177 VKGE---PNISYICSRYYRAP  194 (364)
T ss_pred             ccCC---CceeEEEeccccCH
Confidence            5433   23456788999998

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=4.4e-27  Score=241.96  Aligned_cols=147  Identities=27%  Similarity=0.402  Sum_probs=132.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++..++||+|+++++.+..++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 68999999997542   234467788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||++||+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999997654 6888899999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=249.93  Aligned_cols=167  Identities=28%  Similarity=0.385  Sum_probs=149.4

Q ss_pred             CCCCccceecccCceEEEEEEeCC-CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +.|.++..||.|+||.||+|..++ +-..|.|++........+++..||+||+.++||+||++++.|..++..||+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457777889999999999998664 4456789998888888899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      .||-++..+-+-+..+.+.++..+++|++.||.|||   ++.|||||||+.|||++-+|.++++|||++....  .....
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence            999999999888889999999999999999999999   9999999999999999999999999999876542  22233


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ...++|||+||||
T Consensus       187 RDsFIGTPYWMAP  199 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAP  199 (1187)
T ss_pred             hccccCCcccccc
Confidence            4678999999999

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=2.6e-27  Score=244.08  Aligned_cols=168  Identities=26%  Similarity=0.356  Sum_probs=144.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++..++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567999999999999999999875 68899999997532   2234557789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||++||+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998764  4788888899999999999999   999999999999999999999999999999865322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . .......+||+.||||
T Consensus       196 ~-~~~~~~~~gt~~y~aP  212 (370)
T cd05596         196 G-MVRCDTAVGTPDYISP  212 (370)
T ss_pred             C-cccCCCCCCCcCeECH
Confidence            2 1122346799999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=4.2e-27  Score=234.47  Aligned_cols=167  Identities=25%  Similarity=0.403  Sum_probs=142.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999865 78899999987542 2233567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++ +|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9975 999998776656788899999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.||||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (288)
T cd07871         158 KTYSNEVVTLWYRPP  172 (288)
T ss_pred             ccccCceecccccCh
Confidence            122345689999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=3e-27  Score=241.25  Aligned_cols=170  Identities=25%  Similarity=0.433  Sum_probs=138.7

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC-C
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE-E  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  483 (585)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++.... ....+.+..|+++++.+ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999964      235679999986432 23446788999999999 899999999988764 4


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC----------------------------------------------------------
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN----------------------------------------------------------  505 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  505 (585)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999987531                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccc
Q 047705          506 ---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY  582 (585)
Q Consensus       506 ---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  582 (585)
                         ..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               13667788899999999999999   999999999999999999999999999999865433222222334567889


Q ss_pred             cCC
Q 047705          583 MAP  585 (585)
Q Consensus       583 ~aP  585 (585)
                      |||
T Consensus       243 ~aP  245 (338)
T cd05102         243 MAP  245 (338)
T ss_pred             cCc
Confidence            998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=5.4e-27  Score=237.43  Aligned_cols=160  Identities=28%  Similarity=0.391  Sum_probs=138.2

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999997642   234456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ  575 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  575 (585)
                      +|..++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998887654 6889999999999999999999   9999999999999999999999999999987532221  12234


Q ss_pred             ccccccccCC
Q 047705          576 TLATIGYMAP  585 (585)
Q Consensus       576 ~~gt~~y~aP  585 (585)
                      ..||+.||||
T Consensus       155 ~~gt~~y~aP  164 (323)
T cd05595         155 FCGTPEYLAP  164 (323)
T ss_pred             ccCCcCcCCc
Confidence            6799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=5.6e-27  Score=235.41  Aligned_cols=167  Identities=26%  Similarity=0.389  Sum_probs=143.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999876 788999999875432 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++ +++.+++......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6888888776667888999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.||||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (303)
T cd07869         158 HTYSNEVVTLWYRPP  172 (303)
T ss_pred             ccCCCCcccCCCCCh
Confidence            222345789999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=7.6e-27  Score=236.83  Aligned_cols=160  Identities=29%  Similarity=0.403  Sum_probs=138.5

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542   234567788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ  575 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  575 (585)
                      +|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9998887654 6889999999999999999999   999999999999999999999999999998754221  112234


Q ss_pred             ccccccccCC
Q 047705          576 TLATIGYMAP  585 (585)
Q Consensus       576 ~~gt~~y~aP  585 (585)
                      .+||+.||||
T Consensus       155 ~~gt~~y~aP  164 (328)
T cd05593         155 FCGTPEYLAP  164 (328)
T ss_pred             ccCCcCccCh
Confidence            6799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=8.5e-27  Score=231.87  Aligned_cols=165  Identities=28%  Similarity=0.415  Sum_probs=141.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|+++++.++|++|+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999864 78999999987542   2233457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++......  
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence            999999998876533 36889999999999999999999   999999999999999999999999999999865321  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.||||
T Consensus       156 -~~~~~~~g~~~y~aP  170 (285)
T cd05631         156 -ETVRGRVGTVGYMAP  170 (285)
T ss_pred             -CeecCCCCCCCccCH
Confidence             122345799999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=5.8e-27  Score=235.42  Aligned_cols=169  Identities=27%  Similarity=0.452  Sum_probs=140.2

Q ss_pred             CCCCccceecccCceEEEEEEeCC-----------------CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKV  475 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  475 (585)
                      ++|++.+.||+|+||.||+|.+++                 +..||+|++.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578899999999999999997532                 3469999987542 3345678899999999999999999


Q ss_pred             EeeeecCCeEEEEEEccCCCCHHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 047705          476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIH  537 (585)
Q Consensus       476 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH  537 (585)
                      ++++...+..++||||+++|+|.+++....                  ..+++..+..++.||+.||.|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999886532                  13567788999999999999999   899999


Q ss_pred             cCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       538 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||||+||++++++.+||+|||+++...............++..||||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            999999999999999999999999865433222222334567889998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=238.13  Aligned_cols=166  Identities=32%  Similarity=0.443  Sum_probs=147.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..|+..+.||+|.||.||+|.+. .++.||+|+++... +...+++++|+.++..++++||.++|+.|..+..+|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777899999999999999865 78899999998764 44568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      |.||++.+.++... .+++..+..++++++.|+.|+|   .++.+|||||++||++..+|.+|++|||++........  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999998764 4477888889999999999999   99999999999999999999999999999987754332  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ....++|||.||||
T Consensus       167 rr~tfvGTPfwMAP  180 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAP  180 (467)
T ss_pred             ccccccccccccch
Confidence            23678999999999

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=9.5e-27  Score=236.69  Aligned_cols=168  Identities=24%  Similarity=0.343  Sum_probs=144.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++....   ......+..|+.++..++|++|+++++++...+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999876 57889999987532   223345788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999875557889999999999999999999   9999999999999999999999999999987653222 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (332)
T cd05623         157 TVQSSVAVGTPDYISP  172 (332)
T ss_pred             cceecccccCccccCH
Confidence            1222345799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=229.82  Aligned_cols=166  Identities=30%  Similarity=0.480  Sum_probs=138.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc--CCCcceeEEeeeecCC----eEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSCSNEE----FKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l  487 (585)
                      .+..+.+.||+|.||+||+|+| .|+.||||++....+   ..+.+|.++.+.+  +|+||..+++.=..+.    ..|+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             heeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4567789999999999999998 578999999975543   5566788888765  9999999988643332    6799


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF-----GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-----~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      |++|.+.|+|.|++.+.  .++.....+++.-++.||++||.     .-++.|.|||||+.|||+..++..-|+|+|+|.
T Consensus       287 vTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             eeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999999985  68888999999999999999992     236789999999999999999999999999998


Q ss_pred             cccCCCC--ccccccccccccccCC
Q 047705          563 LLIGEDQ--SMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~--~~~~~~~~gt~~y~aP  585 (585)
                      .......  .......+||-+||||
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAP  389 (513)
T ss_pred             EecccCCcccCCCCCccceeeccCh
Confidence            7653322  2234677999999999

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.2e-27  Score=235.07  Aligned_cols=158  Identities=30%  Similarity=0.370  Sum_probs=137.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++++++||||+++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 68899999987542   33456778899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL  577 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  577 (585)
                      .+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 6889999999999999999999   9999999999999999999999999999998542221  1224467


Q ss_pred             ccccccCC
Q 047705          578 ATIGYMAP  585 (585)
Q Consensus       578 gt~~y~aP  585 (585)
                      ||+.||||
T Consensus       155 gt~~y~aP  162 (312)
T cd05585         155 GTPEYLAP  162 (312)
T ss_pred             CCcccCCH
Confidence            99999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=1.5e-26  Score=234.55  Aligned_cols=160  Identities=28%  Similarity=0.379  Sum_probs=137.3

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 78999999997642   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      +|.+++.... .+++..+..++.|++.||+|||   + ++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9999887654 6889999999999999999999   6 799999999999999999999999999987543221  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05594         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCcccCCH
Confidence            45799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=1.2e-26  Score=236.22  Aligned_cols=166  Identities=26%  Similarity=0.398  Sum_probs=142.0

Q ss_pred             CCCccceecccCceEEEEEEeC----CCcEEEEEEEechh----hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC----RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      +|++.+.||+|+||.||+|+..    +++.||+|++....    ....+.+..|+++++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999752    57899999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 6888999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .... ......+||+.||||
T Consensus       157 ~~~~-~~~~~~~gt~~y~aP  175 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAP  175 (332)
T ss_pred             ccCC-CccccccCCccccCH
Confidence            3222 122346799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=9.3e-27  Score=247.69  Aligned_cols=168  Identities=23%  Similarity=0.303  Sum_probs=144.1

Q ss_pred             CCCccceecccCceEEEEEEeC-C-CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999754 4 6788999876555555567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          493 PQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       493 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +||+|.+++...   ...+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887642   236788899999999999999999   99999999999999999999999999999987643322


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       225 ~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        225 LDVASSFCGTPYYLAP  240 (478)
T ss_pred             cccccccCCCccccCH
Confidence            2223456799999998

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=244.74  Aligned_cols=165  Identities=35%  Similarity=0.501  Sum_probs=140.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------eEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------FKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  486 (585)
                      .|...+.||+|+||.||+|+.+ +|+.||||.++.. ..+..+...+|++++++++|||||++++.-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556678999999999999954 8999999998764 3456678889999999999999999999755443      457


Q ss_pred             EEEEccCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCC--cEEEeeecc
Q 047705          487 LVLEYMPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNM--IAYLSDFGI  560 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~--~~kl~Dfg~  560 (585)
                      +|||||.||||...+.+..  ..+++.+.+.+..+++.||.|||   +++|+||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998654  37899999999999999999999   99999999999999984  334  589999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+...+.   ....+.+||+.|.+|
T Consensus       171 Arel~d~---s~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  171 ARELDDN---SLFTSLVGTEEYLHP  192 (732)
T ss_pred             cccCCCC---CeeeeecCchhhcCh
Confidence            9986432   256788999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=238.72  Aligned_cols=169  Identities=30%  Similarity=0.461  Sum_probs=141.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC--CC---cEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG--DG---MEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      ..++-...+.||+|+||.||+|+.+  ++   ..||+|..+..   .+...+++..|+++|+.++|||||++||+...+.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            3345556689999999999999754  22   23899988752   3556789999999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+++|||+|.||+|.+++++.+..++..+...++.+.+.||+|||   ++++|||||.++|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999999998777999999999999999999999   99999999999999999999999999999885


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  ..........-...|+||
T Consensus       312 ~~--~~~~~~~~~klPirWLAP  331 (474)
T KOG0194|consen  312 GS--QYVMKKFLKKLPIRWLAP  331 (474)
T ss_pred             Cc--ceeeccccccCcceecCh
Confidence            32  111111111234578888

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-29  Score=228.41  Aligned_cols=164  Identities=28%  Similarity=0.385  Sum_probs=147.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      -|.+..++|+|+||.||+|-++ +|..||||.+...  .+.+++..|+.+|++++.|++|++||.|......|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3677789999999999999765 7999999987654  456888999999999999999999999988999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      .|++.+.++-++.++.+.++..+.+..++||+|||   ..+-||||||..|||++.+|.+|++|||+|....+  .-...
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            99999999988889999999999999999999999   88899999999999999999999999999987643  12234


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ...+|||.||||
T Consensus       187 NTVIGTPFWMAP  198 (502)
T KOG0574|consen  187 NTVIGTPFWMAP  198 (502)
T ss_pred             CccccCcccccH
Confidence            567899999998

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.9e-27  Score=239.36  Aligned_cols=148  Identities=31%  Similarity=0.450  Sum_probs=134.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999876 78999999997542   234567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999876 46889999999999999999999   8999999999999999999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=2.1e-26  Score=233.15  Aligned_cols=160  Identities=31%  Similarity=0.469  Sum_probs=136.7

Q ss_pred             ceecccCceEEEEEEe----CCCcEEEEEEEechh----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.||+|+||.||+|+.    .+++.||+|+++...    ......+..|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999975    257889999987532    22345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++.... .+.+..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999987654 5778888899999999999999   9999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       156 ~~~~~~gt~~y~aP  169 (323)
T cd05584         156 VTHTFCGTIEYMAP  169 (323)
T ss_pred             cccccCCCccccCh
Confidence            22345799999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=2.4e-26  Score=232.97  Aligned_cols=165  Identities=25%  Similarity=0.297  Sum_probs=140.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCC-cceeEEeeeecCCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHR-NLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  489 (585)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|++++..++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999876 57899999997542   23456678899999999765 6888999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999987654 5788899999999999999999   9999999999999999999999999999987532111 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       ......+||+.|+||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (324)
T cd05587         156 -KTTRTFCGTPDYIAP  170 (324)
T ss_pred             -CceeeecCCccccCh
Confidence             122346799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=7.4e-27  Score=229.97  Aligned_cols=161  Identities=29%  Similarity=0.440  Sum_probs=137.8

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          419 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      .+.+|+|.||+||-|+++ +|+.||||++++.  .......+++|+.||+.+.||.||.+.-.|++.+.+++|||-+.|-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999865 8999999999764  2334477889999999999999999999999999999999999654


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeecccccccCCCCccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      -|+-.+...++.+++.....+..||+.||.|||   .++|+|+|+||+|||+..   --.+||+|||.|+.+..   ...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence            444455566678999999999999999999999   999999999999999963   34799999999998642   223


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ....+|||.|+||
T Consensus       723 RrsVVGTPAYLaP  735 (888)
T KOG4236|consen  723 RRSVVGTPAYLAP  735 (888)
T ss_pred             hhhhcCCccccCH
Confidence            4568999999998

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=203.10  Aligned_cols=166  Identities=28%  Similarity=0.379  Sum_probs=143.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +.|...++||+|.||+||+|+.+ +++.||+|.++...  +.......+|+.+++.++|.|||++++..-.+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35677789999999999999854 68899999987653  2334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      || ..+|..+.....+.++...++.++.|+++|+.|+|   ++.+.|||+||.|.+|+.+|..|++|||+|+.+.-+.  
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            99 56999999988889999999999999999999999   9999999999999999999999999999999764221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+-|.||.+|
T Consensus       156 rcysaevvtlwyrpp  170 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPP  170 (292)
T ss_pred             EeeeceeeeeeccCc
Confidence            122345678999988

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=223.00  Aligned_cols=167  Identities=28%  Similarity=0.365  Sum_probs=148.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|+..+++|+|.||+|..++-+ +++.+|+|++++..   +.....-..|-++|+..+||.+..+-..|+..+..|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467999999999999999999855 79999999998652   34455667799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||..||.|.-++.+.. .+++...+.+..+|+.||.|||   +++||.||+|.+|.|+|.||++||+|||+++.-..  
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--  320 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence            99999999999887754 6888888999999999999999   99999999999999999999999999999996433  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .......+||||.|+||
T Consensus       321 ~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             ccceeccccCChhhcCc
Confidence            23445679999999999

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=2.2e-26  Score=233.31  Aligned_cols=163  Identities=28%  Similarity=0.405  Sum_probs=137.8

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHH---HhcCCCcceeEEeeeecCCeEEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIM---KSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      |++.+.||+|+||.||+|++. +++.||||+++...   ....+.+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999865 68999999997542   22345566676655   466899999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|..++...  .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888653  5899999999999999999999   9999999999999999999999999999987543221


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        ......+||+.||||
T Consensus       156 --~~~~~~~g~~~y~aP  170 (324)
T cd05589         156 --DRTSTFCGTPEFLAP  170 (324)
T ss_pred             --CcccccccCccccCH
Confidence              222346799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=3.2e-26  Score=231.11  Aligned_cols=160  Identities=26%  Similarity=0.382  Sum_probs=134.9

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 68899999997542   22344556677777654 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999987654 6888999999999999999999   8999999999999999999999999999998643222  2234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05592         155 TFCGTPDYIAP  165 (316)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=3.4e-26  Score=232.28  Aligned_cols=160  Identities=27%  Similarity=0.333  Sum_probs=137.4

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..+++.+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 68899999998642   23345678899999988 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999887654 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05588         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.5e-26  Score=233.71  Aligned_cols=169  Identities=30%  Similarity=0.416  Sum_probs=149.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ...+..|.+.+.||+|.|++|..|++. ++.+||||++++..  ......+.+|+++|+.++|||||+++.+.......|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            445678999999999999999999876 79999999998652  233455888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+.+|.+.+++...+ ...+..+..++.|+..|++|+|   ++.|+|||||++||+++.+..+||+|||++..+..
T Consensus       132 lV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999999886 4455788889999999999999   99999999999999999999999999999998742


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                         .......+|++.|.||
T Consensus       208 ---~~~lqt~cgsppyAaP  223 (596)
T KOG0586|consen  208 ---GLMLQTFCGSPPYAAP  223 (596)
T ss_pred             ---cccccccCCCCCccCh
Confidence               2334568999999998

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=3.5e-26  Score=231.45  Aligned_cols=160  Identities=29%  Similarity=0.349  Sum_probs=136.5

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.+++..+ +||+|+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 67899999987542   23345677788888866 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|..++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99999887654 6788899999999999999999   9999999999999999999999999999987543222  2234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05591         155 TFCGTPDYIAP  165 (321)
T ss_pred             ccccCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=3.9e-26  Score=230.87  Aligned_cols=160  Identities=29%  Similarity=0.422  Sum_probs=137.7

Q ss_pred             ceecccCceEEEEEEe----CCCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          420 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    3578999999976432  234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +|+|.+++.... .+++..+..++.|+++||+|||   +++|+||||||+||++++++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999987654 6889999999999999999999   9999999999999999999999999999988653221  122


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.||||
T Consensus       156 ~~~~g~~~y~aP  167 (318)
T cd05582         156 YSFCGTVEYMAP  167 (318)
T ss_pred             ecccCChhhcCH
Confidence            346799999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=4.3e-26  Score=231.44  Aligned_cols=160  Identities=28%  Similarity=0.345  Sum_probs=136.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++.++ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 68899999998642   23445677888888777 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|..++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99998887654 6889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (329)
T cd05618         155 TFCGTPNYIAP  165 (329)
T ss_pred             cccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=3.4e-26  Score=231.25  Aligned_cols=160  Identities=30%  Similarity=0.380  Sum_probs=136.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.+ +++.||+|++....   ....+.+..|..+++.. +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 68899999987542   23445667788888876 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999887654 6889999999999999999999   9999999999999999999999999999987542211  2234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (320)
T cd05590         155 TFCGTPDYIAP  165 (320)
T ss_pred             ccccCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=4.5e-26  Score=230.83  Aligned_cols=165  Identities=24%  Similarity=0.307  Sum_probs=140.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ .|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999876 67899999987542   22334566788888777 5899999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....  
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence            9999999999987654 6888999999999999999999   999999999999999999999999999998754221  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       155 ~~~~~~~~gt~~y~aP  170 (323)
T cd05616         155 GVTTKTFCGTPDYIAP  170 (323)
T ss_pred             CCccccCCCChhhcCH
Confidence            1223456799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=6.4e-26  Score=230.51  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=144.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999876 68889999987542 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++++|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997654 5788899999999999999999   64 6999999999999999999999999998765321  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.|+||
T Consensus       158 --~~~~~~g~~~y~aP  171 (331)
T cd06649         158 --MANSFVGTRSYMSP  171 (331)
T ss_pred             --ccccCCCCcCcCCH
Confidence              12345789999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=5.2e-26  Score=230.58  Aligned_cols=160  Identities=34%  Similarity=0.455  Sum_probs=134.0

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHH-HHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 78999999987542   223344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|..++.... .+++..+..++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99998887654 6889999999999999999999   9999999999999999999999999999987532211  1234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05604         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCChhhCCH
Confidence            56799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=1.1e-26  Score=243.59  Aligned_cols=169  Identities=30%  Similarity=0.504  Sum_probs=144.8

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      .+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|+++++.++|||||+++|.|..++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            45566789999999999999742      3456999999876544 7889999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          487 LVLEYMPQGSLEKHLYSTN-------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      +|+|||..|||.+++....             .+++..+.+.||.|||.|++||-   ++.+|||||.++|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999997432             13778899999999999999999   9999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+++.+.+.+.........=..+||||
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCH
Confidence            99999999987655544333333445689998

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=6e-26  Score=229.94  Aligned_cols=160  Identities=34%  Similarity=0.453  Sum_probs=134.0

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHH-HHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 78999999997542   122334445544 56789999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999987654 6888899999999999999999   9999999999999999999999999999987542221  2234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (323)
T cd05575         155 TFCGTPEYLAP  165 (323)
T ss_pred             cccCChhhcCh
Confidence            46799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=5.2e-26  Score=230.29  Aligned_cols=165  Identities=24%  Similarity=0.311  Sum_probs=140.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..+++.+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999865 68899999997542   233456778889998886 577888999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999987654 6889999999999999999999   9999999999999999999999999999987542211 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.||||
T Consensus       156 -~~~~~~~gt~~y~aP  170 (323)
T cd05615         156 -VTTRTFCGTPDYIAP  170 (323)
T ss_pred             -ccccCccCCccccCH
Confidence             122345799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=2.7e-26  Score=236.95  Aligned_cols=170  Identities=25%  Similarity=0.408  Sum_probs=140.0

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|++      .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999963      245689999986432 33456788899999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-----------------------------------------------------------
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-----------------------------------------------------------  505 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  505 (585)
                      .++|||||++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          506 ---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       506 ---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                                     ..+++..+..++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           13677888999999999999999   899999999999999999999999999999865432221


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++..||||
T Consensus       271 ~~~~~~~~~~~y~aP  285 (375)
T cd05104         271 VVKGNARLPVKWMAP  285 (375)
T ss_pred             cccCCCCCCcceeCh
Confidence            122223456679998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=6e-26  Score=229.77  Aligned_cols=160  Identities=33%  Similarity=0.439  Sum_probs=133.3

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHH-HHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 68899999987542   122334455544 67889999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      ++|..++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998887654 6788888999999999999999   9999999999999999999999999999987532211  1224


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (321)
T cd05603         155 TFCGTPEYLAP  165 (321)
T ss_pred             cccCCcccCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=4.2e-26  Score=227.16  Aligned_cols=167  Identities=23%  Similarity=0.339  Sum_probs=141.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46999999999999999999876 68889999987542  2334677889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++++.+..+.. ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            998876665443 3346888899999999999999999   9999999999999999999999999999998753221 1


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (287)
T cd07848         156 ANYTEYVATRWYRSP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            222345789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=7.7e-26  Score=229.95  Aligned_cols=165  Identities=24%  Similarity=0.365  Sum_probs=143.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+.+|+++++.++||||++++++|..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999876 68889999887542 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++++|.+++.... .+++..+..++.|++.|+.|||   + .+|+||||||+||++++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997654 5788888999999999999999   6 47999999999999999999999999998765321  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.|+||
T Consensus       158 --~~~~~~~~~~y~aP  171 (333)
T cd06650         158 --MANSFVGTRSYMSP  171 (333)
T ss_pred             --ccccCCCCccccCH
Confidence              12335689999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=5.2e-26  Score=235.44  Aligned_cols=162  Identities=24%  Similarity=0.301  Sum_probs=138.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|...      ...+.+|++++++++||||++++++|..++..++|||
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            3467999999999999999999865 68899999643      2346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ++. ++|.+++.... .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+...... .
T Consensus       164 ~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        164 RYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             cCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            994 68988887654 6788999999999999999999   8999999999999999999999999999997533211 1


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.|+||
T Consensus       238 ~~~~~~~gt~~y~aP  252 (391)
T PHA03212        238 NKYYGWAGTIATNAP  252 (391)
T ss_pred             cccccccCccCCCCh
Confidence            122346799999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=234.75  Aligned_cols=156  Identities=28%  Similarity=0.448  Sum_probs=137.3

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      ....++.+|.|+.|.||+|++ .++.||||+++...       ..+|+-|++++||||+.|.|+|.....+|||||||+.
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             HhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            344567899999999999998 46889999775332       2478899999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |-|...++..+ .+.......|..+|+.|+.|||   .+.|||||||.-||||..+..|||+|||.++.....   .+..
T Consensus       197 GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  197 GQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             ccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            99999998876 6777788899999999999999   999999999999999999999999999999875432   3456


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      .++||..||||
T Consensus       270 SFaGTVaWMAP  280 (904)
T KOG4721|consen  270 SFAGTVAWMAP  280 (904)
T ss_pred             hhhhhHhhhCH
Confidence            78999999998

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=7.6e-26  Score=229.40  Aligned_cols=160  Identities=33%  Similarity=0.423  Sum_probs=132.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHH-HHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVEC-EIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|++. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 67889999987542   12223344444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999987654 5778888889999999999999   9999999999999999999999999999997543221  1234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (325)
T cd05602         155 TFCGTPEYLAP  165 (325)
T ss_pred             cccCCccccCH
Confidence            56799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=3.3e-26  Score=236.13  Aligned_cols=171  Identities=26%  Similarity=0.442  Sum_probs=139.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|+++... ....+.+..|+++++.+ +|+||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457999999999999999998742      34579999987542 23456788899999999 8999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC----------------------------------------------------------
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN----------------------------------------------------------  505 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  505 (585)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          506 -----------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       506 -----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                                 ..+++..+++++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       13677888999999999999999   9999999999999999999999999999998654322211222


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...+++.||||
T Consensus       273 ~~~~~~~y~aP  283 (374)
T cd05106         273 NARLPVKWMAP  283 (374)
T ss_pred             CCCCccceeCH
Confidence            23456779998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=6.9e-26  Score=228.64  Aligned_cols=160  Identities=26%  Similarity=0.391  Sum_probs=135.5

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+++ +++.||+|+++...   .........|..++... +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 68899999997642   22345566788888754 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence            99999987653 6788899999999999999999   999999999999999999999999999998753211  11234


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.|+||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05620         155 TFCGTPDYIAP  165 (316)
T ss_pred             ccCCCcCccCH
Confidence            56799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=3.8e-26  Score=234.37  Aligned_cols=162  Identities=29%  Similarity=0.438  Sum_probs=137.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|+..+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45677889999999999999865 68999999986542 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+..     ..++..+..++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++.+....  .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999986532     3456778889999999999999   9999999999999999999999999999998653221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      .....+||..|+||
T Consensus       224 ~~~~~~gt~~y~aP  237 (353)
T PLN00034        224 PCNSSVGTIAYMSP  237 (353)
T ss_pred             cccccccCccccCc
Confidence            22345799999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=9.1e-27  Score=239.49  Aligned_cols=183  Identities=26%  Similarity=0.452  Sum_probs=151.8

Q ss_pred             cccccCHHHHHHhcCC---------CCccceecccCceEEEEEEeC-C---CcEEEEEEEech-hhhhHHHHHHHHHHHH
Q 047705          400 MWRTFSYLELCRATDG---------FSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQ-CRRAFKSFDVECEIMK  465 (585)
Q Consensus       400 ~~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~  465 (585)
                      ..+.++|+|...+...         ..+.++||.|.||+||+|+++ .   ...||||.++.. .++.+.+|..|+.||.
T Consensus       606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG  685 (996)
T KOG0196|consen  606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG  685 (996)
T ss_pred             ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence            3455666655544433         357789999999999999875 2   346999999865 4556789999999999


Q ss_pred             hcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCE
Q 047705          466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNV  545 (585)
Q Consensus       466 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NI  545 (585)
                      +++||||+++.|.......+.||+|||++|+|+.+++..++.+++.+...+.++|+.|++||-   +.++|||||.++||
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNI  762 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNI  762 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhe
Confidence            999999999999999999999999999999999999999999999999999999999999999   99999999999999


Q ss_pred             EeCCCCcEEEeeecccccccCCCCcc-ccccccccccccCC
Q 047705          546 LLDDNMIAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       546 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  585 (585)
                      |++.+-.+|++|||+++...++.... +..+-.=..+|.||
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecCh
Confidence            99999999999999999775433111 11111113568777

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=215.52  Aligned_cols=171  Identities=25%  Similarity=0.388  Sum_probs=145.5

Q ss_pred             HHHHHHhcCCCCccceecccCceEEEEEE-eCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          406 YLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       406 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      +.++-.-++     +.||+|+|+.|--+. ..+|.+||||++.++....+.+..+|++++..+ .|+||++++++|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455554443     589999999999885 568999999999988777888999999999999 5999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---CcEEEeeecc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGI  560 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~  560 (585)
                      .+|+|||-|.||+|...+.++. .+.+.++.++..+|+.||.|||   .+||.|||+||+|||...-   .-+||+||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            9999999999999999998876 6889999999999999999999   9999999999999999643   3699999987


Q ss_pred             cccccC-----CCCccccccccccccccCC
Q 047705          561 AKLLIG-----EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~-----~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.-+.-     ..........+|+..||||
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcch
Confidence            654321     1122334567899999999

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=9.5e-26  Score=228.75  Aligned_cols=160  Identities=28%  Similarity=0.351  Sum_probs=137.3

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 67899999998642   23445678899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99999887654 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (327)
T cd05617         155 TFCGTPNYIAP  165 (327)
T ss_pred             cccCCcccCCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=1e-25  Score=227.36  Aligned_cols=160  Identities=26%  Similarity=0.393  Sum_probs=135.2

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|++. +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 57899999998652   22345566788888764 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            99999997653 5788899999999999999999   9999999999999999999999999999987532111  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (316)
T cd05619         155 TFCGTPDYIAP  165 (316)
T ss_pred             eecCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-25  Score=223.61  Aligned_cols=165  Identities=28%  Similarity=0.429  Sum_probs=141.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999865 68999999987542   1223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 36889999999999999999999   8999999999999999999999999999988653211 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        .....+|++.||||
T Consensus       157 --~~~~~~~~~~y~aP  170 (285)
T cd05605         157 --TIRGRVGTVGYMAP  170 (285)
T ss_pred             --ccccccCCCCccCc
Confidence              22345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.93  E-value=9.4e-26  Score=233.70  Aligned_cols=171  Identities=27%  Similarity=0.444  Sum_probs=141.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  483 (585)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||||+++... ....+.+..|+++++++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3578999999999999999999752      23479999986542 334567889999999996 999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC----------------------------------------------------------
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN----------------------------------------------------------  505 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  505 (585)
                      ..|+|||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999876421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          506 -------------------------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       506 -------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                                                           ..+++..+..++.|+++|++|||   ..+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13667778899999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.+||+|||+++...............+++.||||
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            9999999999999865433222222344577889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.93  E-value=1e-25  Score=246.47  Aligned_cols=169  Identities=29%  Similarity=0.367  Sum_probs=141.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+++.+|++++++++||||+++++++...+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            67999999999999999999875 68999999986532   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          490 EYMPQGSLEKHLYST----------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       490 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      ||++||+|.+++...          ....++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          123456678899999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCCc----------------cccccccccccccCC
Q 047705          560 IAKLLIGEDQS----------------MTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~----------------~~~~~~~gt~~y~aP  585 (585)
                      +|+........                ......+||+.||||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            99865211100                011235799999998

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=1.2e-25  Score=223.06  Aligned_cols=159  Identities=30%  Similarity=0.412  Sum_probs=135.4

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||+||+|.+. +++.||+|++.....   ...+.+..|+++++.++||||+++.+++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 788999999875422   2335677899999999999999999999999999999999999999


Q ss_pred             HHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          498 EKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       498 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      .+++..   ....+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2336889999999999999999999   99999999999999999999999999999976533221  223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.|+||
T Consensus       156 ~~~g~~~y~aP  166 (280)
T cd05608         156 GYAGTPGFMAP  166 (280)
T ss_pred             ccCCCcCccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=8.4e-26  Score=222.39  Aligned_cols=168  Identities=21%  Similarity=0.354  Sum_probs=141.2

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999753    35689999987553 23346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++|+|.+++......+++.+++.++.|++.|++|||   +++++||||||+||+++.++.+|++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876567899999999999999999999   9999999999999999999999999999876532211


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       ........++..|+||
T Consensus       162 -~~~~~~~~~~~~y~aP  177 (266)
T cd05064         162 -IYTTMSGKSPVLWAAP  177 (266)
T ss_pred             -hhcccCCCCceeecCH
Confidence             1111223456789988

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=8.2e-26  Score=230.65  Aligned_cols=166  Identities=25%  Similarity=0.374  Sum_probs=138.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----CeEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  486 (585)
                      +|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+++++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999865 78999999986432  22345678899999999999999999987543     2579


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||++ ++|.+++.... .+++..+..++.|+++||.|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999994 68999887654 5889999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCC-ccccccccccccccCC
Q 047705          567 EDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~-~~~~~~~~gt~~y~aP  585 (585)
                      ... .......+||+.|+||
T Consensus       156 ~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             ccCccccccCCCCCCCcCCH
Confidence            221 1122346799999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=230.63  Aligned_cols=169  Identities=26%  Similarity=0.449  Sum_probs=147.6

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +...+.++||+|.||+|..|....+..||||.++... .....+|..|+++|.+++||||++++|.|..++.+++++|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3456788999999999999998888999999998764 445689999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTNCIL-DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +.|+|.+++.++..+. .......|+.||+.|++||.   ..++||||+.+.|+|+|.++++||+|||+++.....+...
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999999875433 44556779999999999999   8999999999999999999999999999999766555555


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      .+...+-..+||||
T Consensus       695 vqgr~vlpiRwmaw  708 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAW  708 (807)
T ss_pred             eecceeeeeeehhH
Confidence            55556667789986

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.9e-26  Score=240.59  Aligned_cols=171  Identities=30%  Similarity=0.384  Sum_probs=140.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCC-cEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeee-ec---C---Ce
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDG-MEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSC-SN---E---EF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~---~---~~  484 (585)
                      .++++.+.|.+|+|+.||.|+...+ .+||+|++-..++.+.+.+.+|+++|+.|+ |+|||.+++.. ..   .   -+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3567889999999999999997755 999999988778888899999999999996 99999999932 21   1   25


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      +++.||||+||.|-+++..+. ..+++.++++|+.++++|+.+|| .+..+|||||||-||||++.+|..||||||.|..
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            679999999999999998542 35899999999999999999999 4467799999999999999999999999999875


Q ss_pred             ccCCC-Cccc------cccccccccccCC
Q 047705          564 LIGED-QSMT------QTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~-~~~~------~~~~~gt~~y~aP  585 (585)
                      ..... ....      .-....|+-|+||
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            43221 1111      1123468999998

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=1.3e-25  Score=226.18  Aligned_cols=166  Identities=24%  Similarity=0.398  Sum_probs=141.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999876 67889999987543 22334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++ ++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            965 898888776656888899999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......+|+.|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (309)
T cd07872         160 TYSNEVVTLWYRPP  173 (309)
T ss_pred             ccccccccccccCC
Confidence            22334678999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.93  E-value=1.1e-25  Score=227.28  Aligned_cols=168  Identities=26%  Similarity=0.404  Sum_probs=140.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .+|+..+.||+|+||.||+|++. +++    .||+|+++... ....+.+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46999999999999999999854 333    48999986442 33456788999999999999999999998765 5679


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ++||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999887667888899999999999999999   999999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         163 EKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             CcceeccCCccceeecCh
Confidence            322222233456779988

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.1e-26  Score=240.62  Aligned_cols=173  Identities=25%  Similarity=0.343  Sum_probs=144.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC---
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE---  483 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  483 (585)
                      ....++|++.+.||+|+||.||+|+.. +++.||||++...  .......+..|+..+..++|+||+++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344578999999999999999999865 7899999998754  2344567888999999999999999988775432   


Q ss_pred             -----eEEEEEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          484 -----FKGLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       484 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                           ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|+|   +++|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 368999999999999998653   236888899999999999999999   999999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++.+............+||+.||||
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCH
Confidence            999999875433222233456799999998

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=1.5e-25  Score=219.19  Aligned_cols=167  Identities=23%  Similarity=0.393  Sum_probs=141.9

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+.... .....+..|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4588899999999999999998888889999876432 234678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+|++|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            99999999865556889999999999999999999   9999999999999999999999999999988653221 1112


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (256)
T cd05114         159 SGAKFPVKWSPP  170 (256)
T ss_pred             CCCCCchhhCCh
Confidence            233455678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=2.4e-25  Score=219.14  Aligned_cols=169  Identities=27%  Similarity=0.465  Sum_probs=143.4

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|++.    +...||+|.++... ......+..|+.++++++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            57899999999999999999864    24579999886542 33456788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++......+++..+..++.|++.|++|||   +++|+|+||||+||++++++.+|++|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999998764222


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .........+++.|+||
T Consensus       161 ~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         161 ATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             cceeccCCCCCccccCh
Confidence            22222233456779888

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.4e-25  Score=235.04  Aligned_cols=163  Identities=23%  Similarity=0.267  Sum_probs=140.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999876 57889999632      23456799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +. ++|.+++......+++..+..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            94 6899888766557899999999999999999999   9999999999999999999999999999998654322222


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.||||
T Consensus       318 ~~~~~~GT~~Y~AP  331 (461)
T PHA03211        318 FHYGIAGTVDTNAP  331 (461)
T ss_pred             cccccCCCcCCcCH
Confidence            22346799999998

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=2.5e-25  Score=219.14  Aligned_cols=166  Identities=30%  Similarity=0.400  Sum_probs=144.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++..........+..|+.++++++||||+++++++..++..|+||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46999999999999999999864 78899999987654444567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence            9999999887543 6788999999999999999999   8999999999999999999999999999998653221  11


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~~P  175 (267)
T cd06646         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cCccccCccccCH
Confidence            2345688899998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.1e-25  Score=226.75  Aligned_cols=158  Identities=28%  Similarity=0.358  Sum_probs=132.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc---CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI---RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      ||+|+||.||+|+.. +++.||+|++....   .........|..++...   +||+|+++++++...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999875 68999999987542   12233445567777665   699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999887654 6889999999999999999999   9999999999999999999999999999987542221  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~gt~~y~aP  165 (330)
T cd05586         155 TFCGTTEYLAP  165 (330)
T ss_pred             CccCCccccCH
Confidence            46799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=223.31  Aligned_cols=166  Identities=27%  Similarity=0.412  Sum_probs=145.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +.|..-++||+|+||.||-++.+ +|+-+|+|.+.+..   +....-...|..+++++..++||.+-.+|++.+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45788899999999999999865 79999999876442   223345677999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ..|.||+|.-++...+. .+++..++.++.+|+-||++||   ..+||.||+||+|||+|+.|+++|+|.|+|..+..  
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--  339 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--  339 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence            99999999998887653 6899999999999999999999   99999999999999999999999999999998743  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       .....+.+||.+||||
T Consensus       340 -g~~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  340 -GKPIRGRVGTVGYMAP  355 (591)
T ss_pred             -CCccccccCcccccCH
Confidence             2334556999999999

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=2.5e-25  Score=224.81  Aligned_cols=160  Identities=28%  Similarity=0.358  Sum_probs=136.6

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|++. +++.||+|+++...   ......+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 67899999998542   23345677888999888 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99999887654 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.||||
T Consensus       155 ~~~g~~~y~aP  165 (318)
T cd05570         155 TFCGTPDYIAP  165 (318)
T ss_pred             ceecCccccCH
Confidence            45789999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=220.67  Aligned_cols=168  Identities=27%  Similarity=0.389  Sum_probs=147.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+..|++++++++||||+++++++..++..|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            357999999999999999999875 6889999999866555667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999999876667899999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (280)
T cd06611         159 KRDTFIGTPYWMAP  172 (280)
T ss_pred             ccceeecchhhcCH
Confidence            22345688889987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=5e-25  Score=214.98  Aligned_cols=163  Identities=28%  Similarity=0.428  Sum_probs=135.3

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      +.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999875 78899999876432 33456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL  577 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  577 (585)
                      .+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999776556889999999999999999999   9999999999999999999999999999987543211111111112


Q ss_pred             ccccccCC
Q 047705          578 ATIGYMAP  585 (585)
Q Consensus       578 gt~~y~aP  585 (585)
                      ++..|+||
T Consensus       158 ~~~~y~aP  165 (252)
T cd05084         158 IPVKWTAP  165 (252)
T ss_pred             CceeecCc
Confidence            34568887

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=2.9e-25  Score=218.62  Aligned_cols=166  Identities=30%  Similarity=0.407  Sum_probs=144.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47888999999999999999865 68899999987665445566788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++.... .+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++......  ...
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence            9999999987654 6889999999999999999999   899999999999999999999999999998765321  122


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....|++.|+||
T Consensus       163 ~~~~~~~~~y~aP  175 (267)
T cd06645         163 RKSFIGTPYWMAP  175 (267)
T ss_pred             cccccCcccccCh
Confidence            2345789999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=4e-25  Score=220.28  Aligned_cols=169  Identities=29%  Similarity=0.477  Sum_probs=143.0

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|.+.+.||+|+||.||+|...      ++..+|+|.+........+.+..|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56889999999999999999742      345689998876555566788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          488 VLEYMPQGSLEKHLYSTN------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                      ||||+++++|.+++....            ..+++..+..++.|++.||+|||   +++++||||||+||++++++.+|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999987542            24789999999999999999999   999999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++...............+++.|+||
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCH
Confidence            999999865432222222334567789998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.93  E-value=5.8e-25  Score=219.29  Aligned_cols=165  Identities=29%  Similarity=0.416  Sum_probs=134.2

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCcEEEEEEEechh--hhhHHHHHHHHHHHHhc---CCCcceeEEeeee-----c
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSI---RHRNLIKVISSCS-----N  481 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  481 (585)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46899999999999999999863  46889999987542  12234556677777665   6999999999875     2


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            356899999996 68999887643 35788999999999999999999   99999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....   .......||+.|+||
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aP  178 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAP  178 (290)
T ss_pred             eEeccCC---cccccccccccccCh
Confidence            9865322   223445789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=8.7e-25  Score=218.29  Aligned_cols=168  Identities=28%  Similarity=0.398  Sum_probs=146.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+..|+++++.++||||+++++.+..++..|+||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367999999999999999999876 5889999998766656667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++++..++.+....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999999888765557899999999999999999999   999999999999999999999999999998754221  11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       166 ~~~~~~~~~~y~aP  179 (292)
T cd06644         166 RRDSFIGTPYWMAP  179 (292)
T ss_pred             ccceecCCccccCc
Confidence            22345678889988

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=3.9e-25  Score=216.36  Aligned_cols=167  Identities=25%  Similarity=0.403  Sum_probs=141.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|++.++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4588899999999999999988777789999887432 234678899999999999999999999998889999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++......+++..++.++.||+.|++|||   +.+++|+||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999999875557899999999999999999999   9999999999999999999999999999988653322 1112


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....++..|+||
T Consensus       159 ~~~~~~~~y~~p  170 (256)
T cd05113         159 VGSKFPVRWSPP  170 (256)
T ss_pred             CCCccChhhCCH
Confidence            223455678887

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-28  Score=230.68  Aligned_cols=279  Identities=25%  Similarity=0.267  Sum_probs=215.6

Q ss_pred             CCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCcc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI  137 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  137 (585)
                      .+.-.+++|..|+|+.+|. ++|+.+++|+.||||+|+|+.+.|+ +|.+++.-++.+++++|+|+....++|.+|.+|+
T Consensus        66 P~~tveirLdqN~I~~iP~-~aF~~l~~LRrLdLS~N~Is~I~p~-AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slq  143 (498)
T KOG4237|consen   66 PPETVEIRLDQNQISSIPP-GAFKTLHRLRRLDLSKNNISFIAPD-AFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQ  143 (498)
T ss_pred             CCcceEEEeccCCcccCCh-hhccchhhhceecccccchhhcChH-hhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHH
Confidence            3567888888888888887 8888888888888888888888777 5666776455555566888887778888888888


Q ss_pred             EEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc------------ccCcccccCc
Q 047705          138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS------------RSIPACFNNL  205 (585)
Q Consensus       138 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~~~~~~~l  205 (585)
                      .|.+.-|++.-+...+|..+++|..|.+.+|.++.+....|..+..++++.+..|.+.            ...|-.++..
T Consensus       144 rLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsga  223 (498)
T KOG4237|consen  144 RLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGA  223 (498)
T ss_pred             HHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccc
Confidence            8888888888888888888888888888888888555568888888888888888721            1122222221


Q ss_pred             c----------------------cchhh--cCCCC--C--CCCcc-CCCCCCCcEEEccCCcccccCCcccCCCCCCcEE
Q 047705          206 I----------------------ALRIL--SLGSN--D--PLPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYL  256 (585)
Q Consensus       206 ~----------------------~L~~L--~l~~n--~--~~~~~-~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  256 (585)
                      .                      .++.+  .++.+  .  ..|.. |..+++|+.|+|++|+++++.+.+|.++..+++|
T Consensus       224 rc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL  303 (498)
T KOG4237|consen  224 RCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQEL  303 (498)
T ss_pred             eecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhh
Confidence            1                      12222  11111  1  33332 7789999999999999999999999999999999


Q ss_pred             eecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCccc
Q 047705          257 FLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       257 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  336 (585)
                      +|..|++..+-...|.++..|+.|+|.+|+|+...|..|..+.+|..|+|-.|+|.|.|...+..++++.-...||| .|
T Consensus       304 ~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~-~C  382 (498)
T KOG4237|consen  304 YLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP-RC  382 (498)
T ss_pred             hcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC-CC
Confidence            99999999887888999999999999999999999999999999999999999999999876554444443434443 35


Q ss_pred             CCC
Q 047705          337 GSP  339 (585)
Q Consensus       337 ~~~  339 (585)
                      .+|
T Consensus       383 q~p  385 (498)
T KOG4237|consen  383 QSP  385 (498)
T ss_pred             CCC
Confidence            544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=4.2e-25  Score=228.30  Aligned_cols=165  Identities=27%  Similarity=0.374  Sum_probs=139.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-----eEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  486 (585)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999865 7899999988643  2234467888999999999999999999998776     789


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888876543 6889999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .. ........+|+.|+||
T Consensus       156 ~~-~~~~~~~~~~~~y~aP  173 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAP  173 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCH
Confidence            22 2223345688999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=3.8e-25  Score=216.71  Aligned_cols=164  Identities=34%  Similarity=0.536  Sum_probs=140.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhh--HHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRA--FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      |++.+.||+|+||.||+|+.. +++.||+|++.......  .....+|+.++++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999876 56789999998664322  223456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++... ..+++..+..++.|+++||++||   +.+++|+||||+||+++.++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence            999999999833 36899999999999999999999   8999999999999999999999999999987541  12223


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....+|+.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (260)
T PF00069_consen  155 FNPFVGTPEYMAP  167 (260)
T ss_dssp             BSSSSSSGGGSCH
T ss_pred             ccccccccccccc
Confidence            3456789999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.93  E-value=1e-24  Score=215.99  Aligned_cols=158  Identities=30%  Similarity=0.435  Sum_probs=133.9

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++++..+...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 689999999864321   1234456699999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccc
Q 047705          498 EKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT  576 (585)
Q Consensus       498 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  576 (585)
                      .+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98886543 25788888999999999999999   9999999999999999999999999999988653221   22345


Q ss_pred             cccccccCC
Q 047705          577 LATIGYMAP  585 (585)
Q Consensus       577 ~gt~~y~aP  585 (585)
                      .||+.|+||
T Consensus       155 ~~~~~y~aP  163 (277)
T cd05607         155 AGTNGYMAP  163 (277)
T ss_pred             CCCCCccCH
Confidence            689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=5.5e-25  Score=215.27  Aligned_cols=166  Identities=27%  Similarity=0.421  Sum_probs=140.1

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +|++.+.||+|+||.||+|+++++..+|+|++..... ....+..|+++++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5888999999999999999987777899998864322 235678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      ++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.++...... .....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~  159 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQ  159 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccC
Confidence            9999999876557889999999999999999999   9999999999999999999999999999988653221 11112


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...++..|+||
T Consensus       160 ~~~~~~~y~~P  170 (256)
T cd05059         160 GTKFPVKWAPP  170 (256)
T ss_pred             CCCCCccccCH
Confidence            22334578887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.92  E-value=9.2e-25  Score=216.95  Aligned_cols=165  Identities=27%  Similarity=0.392  Sum_probs=143.3

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+..|+++++.++||||+++++++..++..|+||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999876 5778899998765555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      +++..++......+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+|++|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988765557899999999999999999999   8999999999999999999999999999987643211  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...|++.|+||
T Consensus       162 ~~~~~~~y~aP  172 (282)
T cd06643         162 SFIGTPYWMAP  172 (282)
T ss_pred             cccccccccCH
Confidence            45688999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.3e-25  Score=225.64  Aligned_cols=147  Identities=24%  Similarity=0.363  Sum_probs=131.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .-|..++.||-|+||+|.+++.- +...||+|.+++.+   +......+.|-+||+..+.+.||++|..|++++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45888999999999999999754 56679999887653   334567788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||++||++..++.+.+ .+++..++.++.++..|+++.|   ..|+|||||||+|||||.||++||+|||+|.-+
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999998765 7888889999999999999999   999999999999999999999999999998643

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.92  E-value=6.9e-25  Score=217.97  Aligned_cols=169  Identities=27%  Similarity=0.460  Sum_probs=140.3

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||.||+|..     .++..||+|.+... .......+.+|+++++.++||||+++++++...+..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5688899999999999999974     24678999998643 23344678889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          488 VLEYMPQGSLEKHLYSTN----------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      ||||+++++|.+++....                ..+++.++..++.|++.|++|||   +++++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678888999999999999999   89999999999999999999


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+|++|||+++...............++..|+||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecCh
Confidence            9999999999865433222222334566779988

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=1.1e-24  Score=216.60  Aligned_cols=169  Identities=30%  Similarity=0.457  Sum_probs=140.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-----CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  486 (585)
                      .+|++.+.||+|+||.||+|...     +++.||+|.+........+.+..|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57889999999999999999742     578899999876655566788999999999999999999998654  34689


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +++++||||||+||++++++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876556889999999999999999999   99999999999999999999999999999987543


Q ss_pred             CCCccc-cccccccccccCC
Q 047705          567 EDQSMT-QTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~-~~~~~gt~~y~aP  585 (585)
                      ...... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             CCcceeecCCCCCceEeeCH
Confidence            222111 1112234458887

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.92  E-value=4.7e-25  Score=218.42  Aligned_cols=171  Identities=22%  Similarity=0.392  Sum_probs=140.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|++.... .....++..|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998753      35679999886432 2344568899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN---------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                      .++||||+++++|.+++....         ...++..+..++.|+++|++|||   +.+++||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         13567788899999999999999   899999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++...............+++.||||
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            999998765332222222234567789998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=1.1e-24  Score=217.17  Aligned_cols=163  Identities=33%  Similarity=0.444  Sum_probs=143.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+..|++++++++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46899999999999999999865 68999999987542   234467888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++++|.+++.... .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999997764 6888999999999999999999   899999999999999999999999999999875332  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         .....|++.|+||
T Consensus       155 ---~~~~~~~~~y~aP  167 (290)
T cd05580         155 ---TYTLCGTPEYLAP  167 (290)
T ss_pred             ---CCCCCCCccccCh
Confidence               2345688999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=8.3e-25  Score=240.80  Aligned_cols=167  Identities=27%  Similarity=0.399  Sum_probs=144.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|.+.+.||+|+||.||+|++. +++.||||+++...   ......+..|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999876 68999999987542   23346788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++|++|.+++.... .+++..++.++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++......
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~  158 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE  158 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence            99999999999997654 5788889999999999999999   8999999999999999999999999999998754322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......+|+.|+||
T Consensus       159 --~~~~~~~~t~~~~~p  173 (669)
T cd05610         159 --LNMMDILTTPSMAKP  173 (669)
T ss_pred             --ccccccccCccccCc
Confidence              223456788888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=1.3e-24  Score=216.10  Aligned_cols=165  Identities=27%  Similarity=0.416  Sum_probs=140.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+..+.||+|+||+||+|.+. +++.||+|.+....   ......+..|+++++.++|++|+++.+++..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677889999999999999865 78899999987542   2223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||   +++|+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999998886543 36899999999999999999999   9999999999999999999999999999987543211 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......|++.|+||
T Consensus       157 --~~~~~~g~~~~~aP  170 (285)
T cd05632         157 --SIRGRVGTVGYMAP  170 (285)
T ss_pred             --cccCCCCCcCccCh
Confidence              12345789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=7.1e-25  Score=217.84  Aligned_cols=169  Identities=28%  Similarity=0.540  Sum_probs=141.6

Q ss_pred             CCCCccceecccCceEEEEEEeCC------CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468899999999999999997542      2579999886442 234567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          487 LVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      ++|||+++++|.+++....               ..+++..+..++.|++.|+.|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999987542               34778889999999999999999   99999999999999999999


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+||+|||+++...............+++.||||
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCH
Confidence            9999999999865433222223445678889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=5.7e-25  Score=218.15  Aligned_cols=170  Identities=30%  Similarity=0.484  Sum_probs=142.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|.+.+.||+|+||.||+|+..      +++.||+|+++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888999999999999999753      3478999998755333 457889999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~  552 (585)
                      ++||||+++++|.+++....             ..+++..+..++.|++.|++|+|   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             24678889999999999999999   999999999999999999999


Q ss_pred             EEEeeecccccccCCCCccccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+|||+++...............+++.|+||
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecCh
Confidence            999999999765332222222334567889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=1.3e-24  Score=218.78  Aligned_cols=164  Identities=25%  Similarity=0.346  Sum_probs=141.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.++... ......+..|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999865 67889999886542 23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++.... .+++..+..++.|+++||.|||   + .+++||||||+||++++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999997653 6788899999999999999999   6 58999999999999999999999999998764321   


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......|++.|+||
T Consensus       154 -~~~~~~~~~~~~aP  167 (308)
T cd06615         154 -MANSFVGTRSYMSP  167 (308)
T ss_pred             -ccccCCCCcCccCh
Confidence             12345788899988

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.92  E-value=7.2e-25  Score=226.96  Aligned_cols=172  Identities=25%  Similarity=0.434  Sum_probs=140.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecC
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE  482 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  482 (585)
                      ...++|.+.+.||+|+||.||+|++.      .++.||+|+++... ....+.+..|++++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34456888999999999999999853      34679999997542 233457889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC---------------------------------------------------------
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN---------------------------------------------------------  505 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  505 (585)
                      +..++||||+++|+|.++++...                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986431                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCE
Q 047705          506 ----------------------------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNV  545 (585)
Q Consensus       506 ----------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NI  545 (585)
                                                              ..+++..+..++.|++.||+|||   +++++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence                                                    13566678889999999999999   99999999999999


Q ss_pred             EeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          546 LLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       546 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++++++.+|++|||+++...............+++.||||
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            9999999999999999865332222222334577889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=242.14  Aligned_cols=169  Identities=28%  Similarity=0.497  Sum_probs=143.6

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCc----EEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--DGM----EVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      +.-+..+.||+|+||.||+|...  ++.    .||||.++.. +.....+|.+|+.+|++++|||||+++|.+...+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            44567789999999999999754  343    4899988755 4556789999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          487 LVLEYMPQGSLEKHLYST------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      |++|||+||+|..++++.      ...+...+...++.|||+|++||+   ++++|||||..+|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999987      557889999999999999999999   99999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+.+...+.........-...||||
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCH
Confidence            9965544333322222233579998

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.92  E-value=8.5e-25  Score=216.81  Aligned_cols=168  Identities=28%  Similarity=0.446  Sum_probs=138.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||+||+|.+. +++    .|++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888999999999999999864 444    47777765332 2334677788889999999999999998754 45788


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ++||+++|+|.+++......+++..+..++.||+.|++|+|   +++++||||||+||++++++.+|++|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999865433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         163 DKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             CcccccCCCCCcccccCH
Confidence            322223345567789988

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=1.5e-24  Score=215.64  Aligned_cols=164  Identities=28%  Similarity=0.439  Sum_probs=139.7

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      |+..+.||+|+||.||+|... +++.||+|.+....   ......+..|+.+++.++|++|+.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999865 78899999987542   22234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886533 35888899999999999999999   9999999999999999999999999999987543211  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......||+.||||
T Consensus       157 -~~~~~~g~~~y~aP  170 (285)
T cd05630         157 -TIKGRVGTVGYMAP  170 (285)
T ss_pred             -cccCCCCCccccCh
Confidence             12335789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=4e-25  Score=216.88  Aligned_cols=169  Identities=26%  Similarity=0.469  Sum_probs=145.6

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ...+|++.+.||+|+||.||+|...+++.+|+|++..........+..|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568999999999999999999888999999998866555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +++++|+||||+||++++++.+||+|||.+.......  
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--  158 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--  158 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence            99999999998643 36789999999999999999999   9999999999999999999999999999998653221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++..|+||
T Consensus       159 ~~~~~~~~~~~~~~P  173 (261)
T cd05148         159 YLSSDKKIPYKWTAP  173 (261)
T ss_pred             ccccCCCCceEecCH
Confidence            111233456678887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=9.5e-25  Score=219.00  Aligned_cols=167  Identities=25%  Similarity=0.391  Sum_probs=142.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            467999999999999999999875 68899999987542 2233567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++ ++|.+++......+++..+..++.|+++||+|||   +.+|+|+||||+||++++++.+||+|||++.......  
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            996 5999988876667889999999999999999999   9999999999999999999999999999987543211  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+++.|+||
T Consensus       159 ~~~~~~~~~~~y~~P  173 (301)
T cd07873         159 KTYSNEVVTLWYRPP  173 (301)
T ss_pred             CcccccceeecccCc
Confidence            112334578899998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.92  E-value=4e-25  Score=225.80  Aligned_cols=161  Identities=26%  Similarity=0.394  Sum_probs=138.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-C-----CcceeEEeeeecCCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-H-----RNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  487 (585)
                      +|++.+.||+|+||.|.+|.+. +++.||||+++.... ...+...|+.+|+.++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999865 799999999986543 3456677999999996 4     399999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC--CCcEEEeeecccccc
Q 047705          488 VLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKLL  564 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~  564 (585)
                      |+|.+ +.+|.++++..+. .++...++.++.||+.||.+||   +.+|||+||||||||+.+  ...+||+|||.|...
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 5699999997754 6889999999999999999999   999999999999999963  348999999999864


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..     .....+-+..|+||
T Consensus       342 ~q-----~vytYiQSRfYRAP  357 (586)
T KOG0667|consen  342 SQ-----RVYTYIQSRFYRAP  357 (586)
T ss_pred             CC-----cceeeeeccccccc
Confidence            21     12256778889998

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1e-24  Score=214.07  Aligned_cols=168  Identities=31%  Similarity=0.431  Sum_probs=141.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35689999999999999999988777889999987543 23467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +++++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997654 36789999999999999999999   99999999999999999999999999999987642211 1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05068         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCcCceeccCc
Confidence            11122234578888

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=8.5e-25  Score=217.06  Aligned_cols=156  Identities=21%  Similarity=0.272  Sum_probs=134.1

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEEEEEEcc
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKGLVLEYM  492 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  492 (585)
                      ..||+|++|.||+|.+ +|+.||||.++....   ...+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999988 688999999875432   225678899999999999999999999876    34789999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++|+|.+++.+.. .+++.....++.+++.|+.|+|   . .+++||||||+||++++++.+||+|||+++.....    
T Consensus       105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----  176 (283)
T PHA02988        105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----  176 (283)
T ss_pred             CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence            9999999998754 6788889999999999999999   6 48899999999999999999999999999865321    


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                       .....||+.|+||
T Consensus       177 -~~~~~~~~~y~aP  189 (283)
T PHA02988        177 -PFKNVNFMVYFSY  189 (283)
T ss_pred             -cccccCcccccCH
Confidence             1234688899998

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=7.1e-25  Score=219.26  Aligned_cols=169  Identities=26%  Similarity=0.431  Sum_probs=139.0

Q ss_pred             CCCCccceecccCceEEEEEEeCC---------------CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEe
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD---------------GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVIS  477 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  477 (585)
                      ++|++.+.||+|+||.||+|+..+               ...||+|.++.. .......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999987532               234899998754 2334567889999999999999999999


Q ss_pred             eeecCCeEEEEEEccCCCCHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEE
Q 047705          478 SCSNEEFKGLVLEYMPQGSLEKHLYSTN-----------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       478 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      ++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986532           13578888999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          547 LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++++.+|++|||++................+++.|+||
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            999999999999999765332222222233456789988

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=4.7e-25  Score=229.21  Aligned_cols=163  Identities=25%  Similarity=0.274  Sum_probs=138.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC---CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++++||||+++++++...+..|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999987543     23457999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |++. +++.+++... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 6898888543 47899999999999999999999   99999999999999999999999999999986543332


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ........||+.|+||
T Consensus       241 ~~~~~~~~gt~~y~aP  256 (392)
T PHA03207        241 TPQCYGWSGTLETNSP  256 (392)
T ss_pred             cccccccccccCccCH
Confidence            2233456799999998

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=1.1e-25  Score=227.84  Aligned_cols=163  Identities=28%  Similarity=0.448  Sum_probs=137.5

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEE---EEEec-hhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe--EEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLG-DGMEVAV---KVFNL-QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF--KGLVL  489 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~-~~~~vav---K~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  489 (585)
                      +....||+|+|-+||+|.+. +|.+||-   |.-+. +.....++|..|+.+|+.|+||||+++|++|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34568999999999999875 6878873   32211 234456899999999999999999999999987754  67899


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |.+..|+|..|.++.+ ......+..|++||++||.||| .+.++|||||||-+||+|+ .-|.|||+|.|+|.....  
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--  198 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence            9999999999999886 6788899999999999999999 4578999999999999997 678999999999997632  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .  .....+|||.||||
T Consensus       199 s--~aksvIGTPEFMAP  213 (632)
T KOG0584|consen  199 S--HAKSVIGTPEFMAP  213 (632)
T ss_pred             c--ccceeccCccccCh
Confidence            1  22347999999999

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.92  E-value=1.1e-24  Score=216.17  Aligned_cols=169  Identities=26%  Similarity=0.392  Sum_probs=139.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCc----EEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      .++|++.+.||+|+||+||+|++. +++    .||+|++... .......+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            357889999999999999999753 444    4899988654 233456788899999999999999999998754 567


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ++|||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...........+++.||||
T Consensus       162 ~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         162 DETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             ccceeecCCCccchhhCCH
Confidence            2222222223456779987

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=8.2e-25  Score=214.68  Aligned_cols=168  Identities=24%  Similarity=0.452  Sum_probs=142.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+..|+.++++++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35789999999999999999998888889999876432 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||++....... ..
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YT  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-ee
Confidence            9999999987643 36788888999999999999999   8999999999999999999999999999998653221 11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~aP  173 (261)
T cd05072         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             ccCCCccceecCCH
Confidence            12233456779987

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.92  E-value=7.8e-25  Score=230.29  Aligned_cols=162  Identities=33%  Similarity=0.458  Sum_probs=132.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--------C
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--------E  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  483 (585)
                      ..+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999865 68899999885432    2334699999999999999999876432        2


Q ss_pred             eEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeec
Q 047705          484 FKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFG  559 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg  559 (585)
                      ..++||||+++ ++.+++..   ....+++..+..++.||+.||+|||   +++|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999965 77776653   2346889999999999999999999   99999999999999998654 79999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|+.+....   .....+||+.||||
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aP  239 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAP  239 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCH
Confidence            998754322   22345789999998

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=1e-24  Score=215.04  Aligned_cols=162  Identities=27%  Similarity=0.359  Sum_probs=131.0

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          421 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      .||+|+||.||+|...   ....+|+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            5899999999999643   24568888765432 2334567889999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          497 LEKHLYSTNC----ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       497 L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      |.+++.....    ..++.....++.|++.|++|||   +++|+||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976532    2456778899999999999999   99999999999999999999999999999875432221112


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....+++.|+||
T Consensus       159 ~~~~~~~~~y~aP  171 (269)
T cd05042         159 KDCHAVPLRWLAP  171 (269)
T ss_pred             cCCCCCcccccCH
Confidence            2334456779987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.92  E-value=8.3e-25  Score=217.97  Aligned_cols=171  Identities=23%  Similarity=0.385  Sum_probs=139.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3568999999999999999999643      24579999876432 2234567889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN---------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|+.|||   +++|+||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532         23456678899999999999999   999999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++...............++..|+||
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  190 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCH
Confidence            999999865432222222333456779887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.1e-24  Score=214.50  Aligned_cols=169  Identities=27%  Similarity=0.471  Sum_probs=140.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-C---CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|+.. +   +..+|+|.++... ....+.+..|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999753 2   3479999886532 23456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++......+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+|++|||+++.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             Ccc-ccccccccccccCC
Q 047705          569 QSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~-~~~~~~gt~~y~aP  585 (585)
                      ... ......++..|+||
T Consensus       161 ~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             ceeeecCCCccceeecCH
Confidence            111 11222335678887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=212.05  Aligned_cols=168  Identities=31%  Similarity=0.423  Sum_probs=147.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|... +++.+|+|++........+.+..|++++++++||||+++++++...+..|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999865 6788999999866555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+||+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999998876457899999999999999999999   8999999999999999999999999999987653221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+..|+||
T Consensus       157 ~~~~~~~~~~y~~P  170 (262)
T cd06613         157 KRKSFIGTPYWMAP  170 (262)
T ss_pred             ccccccCCccccCc
Confidence            22345688889998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=5.7e-25  Score=225.72  Aligned_cols=161  Identities=22%  Similarity=0.289  Sum_probs=138.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999876 5788999974322      23458999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+. +++.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.....   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            994 6899988776667899999999999999999999   999999999999999999999999999998753211   


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       211 ~~~~~~~gt~~y~aP  225 (357)
T PHA03209        211 PAFLGLAGTVETNAP  225 (357)
T ss_pred             cccccccccccccCC
Confidence            122345799999998

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.92  E-value=1.1e-24  Score=223.97  Aligned_cols=165  Identities=27%  Similarity=0.341  Sum_probs=137.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----  483 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  483 (585)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999865 6899999998643  2234466778999999999999999999986543    


Q ss_pred             --eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          484 --FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       484 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                        ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence              57999999965 66666643   4778888999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +....   ........||+.|+||
T Consensus       171 ~~~~~---~~~~~~~~~t~~y~aP  191 (359)
T cd07876         171 RTACT---NFMMTPYVVTRYYRAP  191 (359)
T ss_pred             ccccc---CccCCCCcccCCCCCc
Confidence            76432   1122445789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.92  E-value=1.6e-24  Score=213.39  Aligned_cols=167  Identities=27%  Similarity=0.425  Sum_probs=142.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||||.++..   .......+..|+++++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999865 7899999987642   2334457888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +++++|+||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2235788889999999999999999   99999999999999999999999999999886532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......|++.|+||
T Consensus       159 ~~--~~~~~~~~~~~~~aP  175 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSP  175 (267)
T ss_pred             hh--HHHhcCCCCccccCh
Confidence            21  112345688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.92  E-value=7.3e-25  Score=222.99  Aligned_cols=169  Identities=27%  Similarity=0.444  Sum_probs=138.1

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC-Ce
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE-EF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  484 (585)
                      ++|++.+.||+|+||.||+|...      +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57999999999999999999632      35789999986432 23345677899999999 899999999987654 56


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-----------------------------------------------------------
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-----------------------------------------------------------  505 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  505 (585)
                      .+++|||+++++|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999886421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccC
Q 047705          506 -CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA  584 (585)
Q Consensus       506 -~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  584 (585)
                       ..+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||+++.+.............++..|||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             15788889999999999999999   99999999999999999999999999999987643332222334456778999


Q ss_pred             C
Q 047705          585 P  585 (585)
Q Consensus       585 P  585 (585)
                      |
T Consensus       244 P  244 (337)
T cd05054         244 P  244 (337)
T ss_pred             c
Confidence            8

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-24  Score=211.14  Aligned_cols=168  Identities=27%  Similarity=0.444  Sum_probs=142.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....     ......+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999864 68999999886432     2234568889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987654 5788888999999999999999   999999999999999999999999999998765321


Q ss_pred             CCccc-cccccccccccCC
Q 047705          568 DQSMT-QTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~-~~~~~gt~~y~aP  585 (585)
                      ..... .....|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             ccccccccCCCcCccccCc
Confidence            11111 1345678899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=2.3e-24  Score=213.68  Aligned_cols=160  Identities=29%  Similarity=0.366  Sum_probs=138.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+..|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46888999999999999999864 7889999998654 233446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++++..+.     .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997542     4678888899999999999999   999999999999999999999999999999865321    


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       149 ~~~~~~~~~~y~aP  162 (279)
T cd06619         149 IAKTYVGTNAYMAP  162 (279)
T ss_pred             cccCCCCChhhcCc
Confidence            22345789999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=1.5e-24  Score=216.90  Aligned_cols=170  Identities=26%  Similarity=0.386  Sum_probs=142.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-----------------CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCccee
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD-----------------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK  474 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  474 (585)
                      .++|++.+.||+|+||.||+|+..+                 +..||+|.+.... ....+.+..|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3579999999999999999987542                 2458999987542 345578889999999999999999


Q ss_pred             EEeeeecCCeEEEEEEccCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCC
Q 047705          475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTN----------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSN  544 (585)
Q Consensus       475 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~N  544 (585)
                      +++++..++..+++|||+++++|.+++....          ..+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987653          25789999999999999999999   8999999999999


Q ss_pred             EEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          545 VLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       545 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |++++++.++++|||+++...............+++.||||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            99999999999999998865433222223344567889998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.92  E-value=9.9e-25  Score=222.84  Aligned_cols=169  Identities=26%  Similarity=0.444  Sum_probs=136.5

Q ss_pred             CCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC-Ce
Q 047705          414 DGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE-EF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  484 (585)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+..|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5799999999999999999973      246789999987542 23345788899999999 689999999987654 56


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-----------------------------------------------------------
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-----------------------------------------------------------  505 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  505 (585)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccc
Q 047705          506 -------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA  578 (585)
Q Consensus       506 -------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  578 (585)
                             ..+++..+..++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   13567788899999999999999   99999999999999999999999999999986533222222223345


Q ss_pred             cccccCC
Q 047705          579 TIGYMAP  585 (585)
Q Consensus       579 t~~y~aP  585 (585)
                      ++.|+||
T Consensus       244 ~~~y~aP  250 (343)
T cd05103         244 PLKWMAP  250 (343)
T ss_pred             CcceECc
Confidence            6779988

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=9.5e-25  Score=223.21  Aligned_cols=166  Identities=26%  Similarity=0.328  Sum_probs=139.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC---
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE---  482 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  482 (585)
                      .....++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+++++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445688999999999999999999865 68899999986532  22345677899999999999999999987543   


Q ss_pred             ---CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          483 ---EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       483 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                         ...|++||++ +++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence               3568999998 78998887643  5889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++....     .....+||+.|+||
T Consensus       164 ~~~~~~~-----~~~~~~~t~~y~aP  184 (343)
T cd07878         164 LARQADD-----EMTGYVATRWYRAP  184 (343)
T ss_pred             cceecCC-----CcCCccccccccCc
Confidence            9986532     12345789999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=1.5e-24  Score=216.42  Aligned_cols=169  Identities=30%  Similarity=0.479  Sum_probs=142.8

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .+|.+.+.||+|+||.||+|+..      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45888899999999999999742      345689998876555556778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc
Q 047705          488 VLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~  552 (585)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++++||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532               24788899999999999999999   999999999999999999999


Q ss_pred             EEEeeecccccccCCCCccccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|++|||+++...............+++.|+||
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            999999999865432222223345578889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-25  Score=217.70  Aligned_cols=166  Identities=26%  Similarity=0.342  Sum_probs=147.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +=|...+.||+|.|.+|-.|++- +|+.||||++++..  .....++.+|++.|+.++|||||++|+...+....|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45888899999999999999854 89999999998652  3345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe-CCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL-DDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +-.+|+|.+|+.++...+.+....+++.||+.|+.|+|   +..+||||+||+|+.+ ..-|.||++|||++-.+.+.. 
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            99999999999998888999999999999999999999   8999999999999776 577899999999998775433 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ..+..||+..|.||
T Consensus       174 --kL~TsCGSLAYSAP  187 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAP  187 (864)
T ss_pred             --hhhcccchhhccCc
Confidence              34567999999998

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.92  E-value=2.3e-24  Score=212.46  Aligned_cols=170  Identities=29%  Similarity=0.429  Sum_probs=143.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+++.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            44566666779999999999999865 67889999887665556678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCIL--DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++......+  ++..+..++.|++.|++|||   +++|+||||||+||+++. ++.+||+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999998654444  77888899999999999999   999999999999999975 67999999999876532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......|++.|+||
T Consensus       162 ~~--~~~~~~~~~~~~~aP  178 (268)
T cd06624         162 IN--PCTETFTGTLQYMAP  178 (268)
T ss_pred             CC--CccccCCCCccccCh
Confidence            21  112234578889988

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.92  E-value=7.3e-27  Score=244.77  Aligned_cols=319  Identities=29%  Similarity=0.368  Sum_probs=242.4

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCcccc-------------------------
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITD-------------------------   55 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-------------------------   55 (585)
                      ++|.+.+++.+|++|+|.+|++. .+|..+..+++|++|+++.|.+...+..+..                         
T Consensus        82 ~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~  160 (1081)
T KOG0618|consen   82 SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIKK  160 (1081)
T ss_pred             hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhhhccccchh
Confidence            36778888888888888888876 8888888888888888888877522111100                         


Q ss_pred             -------------CCCCCccE-EEccCCCCCCCccCccccCC--------------------CCCcEEEccCCCCcccCC
Q 047705           56 -------------VRLPNLEE-LVLWGNNFSELNFLSSLSNC--------------------KSLTVIGLSNNPLDGILP  101 (585)
Q Consensus        56 -------------~~l~~L~~-L~L~~n~l~~~~~~~~~~~l--------------------~~L~~L~Ls~N~l~~~~~  101 (585)
                                   .....|+. |||++|++..+.    +..+                    ++|+.|+.++|.++...+
T Consensus       161 ~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~d----ls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~  236 (1081)
T KOG0618|consen  161 LDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLD----LSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV  236 (1081)
T ss_pred             hhhhhhhcccchhcchhhhheeeecccchhhhhh----hhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc
Confidence                         00113444 777777776322    2223                    345555555565553322


Q ss_pred             cchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCC
Q 047705          102 KTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL  181 (585)
Q Consensus       102 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  181 (585)
                          ...|..|++++++.|++++. |+.++.+.+|+.|+..+|++. ..|......++|++|+...|.++ -+|+...++
T Consensus       237 ----~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~  309 (1081)
T KOG0618|consen  237 ----HPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGL  309 (1081)
T ss_pred             ----ccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccccc
Confidence                23466799999999999854 488999999999999999996 66777777888888999999888 556577778


Q ss_pred             CCCcEEEcCCCcccccCccccc-------------------------CcccchhhcCCCCC---CCCccCCCCCCCcEEE
Q 047705          182 VELYKLELGGNKLSRSIPACFN-------------------------NLIALRILSLGSND---PLPLEIGNLKVLVGID  233 (585)
Q Consensus       182 ~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~  233 (585)
                      ..|++|+|..|+|...++..|.                         ..+.|+.|++.+|.   ..-+.+.++.+|+.|+
T Consensus       310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            9999999999999843332221                         24567888888887   3444577889999999


Q ss_pred             ccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCee
Q 047705          234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       234 ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      |++|++.......+.+++.|+.|+||+|+++ .+|+....+..|++|...+|+|. ..| .+..++.|+++|+|.|.++-
T Consensus       390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            9999999777788999999999999999999 56899999999999999999998 677 88999999999999999974


Q ss_pred             -eCCCCCCCCCCCccccCCCCc
Q 047705          314 -EIPRGGSFGNFSAESFEGNEL  334 (585)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~n~~  334 (585)
                       ..|....+.+++.+++.||.+
T Consensus       467 ~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  467 VTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhhhhCCCcccceeeccCCcc
Confidence             445555567888999999986

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.8e-24  Score=233.93  Aligned_cols=261  Identities=25%  Similarity=0.272  Sum_probs=208.1

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      ..-..|||+.|.|+ .+|..+..  +|+.|++++|+|+. +|.    .+++|++|+|++|+|+.+|.     ..++|+.|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~LtsLP~-----lp~sL~~L  267 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTSLPV-----LPPGLLEL  267 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCcccC-----ccccccee
Confidence            44678999999998 67887764  89999999999994 443    25899999999999999974     24789999


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|++..+.      .++..|+.|++++|+++.. |.   .+++|+.|+|++|+|.++.+ .   ..+|+.|++++|+
T Consensus       268 ~Ls~N~L~~Lp------~lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~  333 (788)
T PRK15387        268 SIFSNPLTHLP------ALPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQ  333 (788)
T ss_pred             eccCCchhhhh------hchhhcCEEECcCCccccc-cc---cccccceeECCCCccccCCC-C---cccccccccccCc
Confidence            99999997432      2345699999999999854 43   35789999999999996532 2   2468899999999


Q ss_pred             CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCccc
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEI  247 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  247 (585)
                      |++ +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|.  .+|..   ..+|+.|++++|++++ +|.. 
T Consensus       334 L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~Lt~-LP~l-  400 (788)
T PRK15387        334 LTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPVL-  400 (788)
T ss_pred             ccc-cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCccc---ccccceEEecCCcccC-CCCc-
Confidence            995 4432   2579999999999995 5543   3578888999997  33332   3579999999999996 4433 


Q ss_pred             CCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       248 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                        .++|+.|++++|++++ +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus       401 --~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        401 --PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             --ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence              3679999999999996 5653   347889999999999 6788999999999999999999987654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=2.5e-24  Score=210.49  Aligned_cols=166  Identities=28%  Similarity=0.371  Sum_probs=143.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|++|.||+|... +++.||+|.+...  .......+..|+++++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999875 6899999998743  234557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++... ...+++..+..++.|++.|+.|||   +.+++|+||||+||++++++.+|++|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            9999999999875 346888899999999999999999   8999999999999999999999999999988654322  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......|++.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (256)
T cd08529         156 NFANTIVGTPYYLSP  170 (256)
T ss_pred             chhhccccCccccCH
Confidence            122345688899998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=3.5e-24  Score=209.41  Aligned_cols=166  Identities=22%  Similarity=0.346  Sum_probs=142.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +|++.+.||+|+||.||++... +++.||+|.++.. .....+.+..|+.+++.++||||+++++.+..++..|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999865 6889999998643 2345567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++.+++.... ..+++..+..++.|++.|+.|||   +++|+|+||||+||++++++.++++|||.+.......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            9999999886533 35788899999999999999999   9999999999999999999999999999987653221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (255)
T cd08219         156 YACTYVGTPYYVPP  169 (255)
T ss_pred             ccccccCCccccCH
Confidence            22345688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=1.5e-24  Score=217.90  Aligned_cols=171  Identities=28%  Similarity=0.461  Sum_probs=140.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSN  481 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  481 (585)
                      ..++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+..|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467889999999999999999641        24579999886432 33456788999999999 89999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEE
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      .+..|++|||+++|+|.+++....               ..+++.++..++.|+++|++|||   +++++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999987642               24677888999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          547 LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++++.+||+|||.++...............+++.|+||
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            999999999999999876432222222333456789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=2e-24  Score=214.76  Aligned_cols=168  Identities=25%  Similarity=0.455  Sum_probs=140.2

Q ss_pred             CCCccceecccCceEEEEEEe-----CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEE
Q 047705          415 GFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  486 (585)
                      -|++.+.||+|+||.||+|+.     .++..||+|.++... ......+.+|+++++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478899999999999999974     257889999987542 33456788999999999999999999998775  5689


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||++|++|.+++.+....+++..+..++.|++.||+|+|   +++++||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999776556899999999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCcc-ccccccccccccCC
Q 047705          567 EDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ..... ......|+..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             CccceeecCCCCCCccccCH
Confidence            22211 11234566778887

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-25  Score=224.71  Aligned_cols=161  Identities=29%  Similarity=0.459  Sum_probs=143.1

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHH
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE  498 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  498 (585)
                      -++|+|.||+||.|++. +...+|||-+.....+..+-+.+|+.+-++++|.|||+++|.+..++++-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999976 56679999998777777788889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeecccccccCCCCcccccc
Q 047705          499 KHLYSTNCIL--DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQ  575 (585)
Q Consensus       499 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~  575 (585)
                      ++++..=+++  .+..+-.+..||++||+|||   +..|||||||-+|+|++ -.|.+||+|||.++...+  -......
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence            9998875566  67788899999999999999   99999999999999996 789999999999998643  2333456


Q ss_pred             ccccccccCC
Q 047705          576 TLATIGYMAP  585 (585)
Q Consensus       576 ~~gt~~y~aP  585 (585)
                      +.||..||||
T Consensus       736 FTGTLQYMAP  745 (1226)
T KOG4279|consen  736 FTGTLQYMAP  745 (1226)
T ss_pred             cccchhhhCh
Confidence            8899999999

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.5e-24  Score=213.51  Aligned_cols=168  Identities=27%  Similarity=0.423  Sum_probs=139.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||.||+|.+. +|+    .||+|...... ......+.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888999999999999999854 333    58999876543 3345678889999999999999999999887 78899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +++++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999886667899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........++..|+||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         163 EKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             ccceecCCCcccccccCH
Confidence            222222222345678887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=2.1e-24  Score=215.95  Aligned_cols=166  Identities=30%  Similarity=0.404  Sum_probs=144.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++...+..|+||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367999999999999999999864 7899999998765545557788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++.+.  .+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998754  4788899999999999999999   89999999999999999999999999999876532221  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       171 ~~~~~~~~~~y~aP  184 (297)
T cd06656         171 KRSTMVGTPYWMAP  184 (297)
T ss_pred             CcCcccCCccccCH
Confidence            12334688889987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.92  E-value=1.2e-24  Score=213.24  Aligned_cols=165  Identities=38%  Similarity=0.575  Sum_probs=135.6

Q ss_pred             ccceecccCceEEEEEEeC-----CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          418 ENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.+.||+|+||.||+|.+.     .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999865     3567999999653 233468899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++|+|.+++... ...+++..+..++.||++||.|||   +.+++|+||+++||+++.++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 457899999999999999999999   899999999999999999999999999999876322222


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+...|+||
T Consensus       160 ~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAP  174 (259)
T ss_dssp             EESTTSESGGGGS-H
T ss_pred             ccccccccccccccc
Confidence            223334567788887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.92  E-value=2.4e-24  Score=212.35  Aligned_cols=163  Identities=27%  Similarity=0.398  Sum_probs=133.2

Q ss_pred             ceecccCceEEEEEEeC---CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          420 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.||+|+||.||+|...   .+..+|+|.++... ......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999754   34679999886543 233457888999999999999999999999989999999999999


Q ss_pred             CHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          496 SLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       496 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    24566777889999999999999   9999999999999999999999999999987543222212


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (269)
T cd05087         158 TPDQLWVPLRWIAP  171 (269)
T ss_pred             cCCCcCCcccccCH
Confidence            22334577889998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=2.3e-24  Score=215.57  Aligned_cols=166  Identities=30%  Similarity=0.405  Sum_probs=144.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++.+...+..|+||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357999999999999999999864 7889999998765545557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++.+.  .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            9999999998654  4788899999999999999999   9999999999999999999999999999987643221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       172 ~~~~~~~~~~y~aP  185 (296)
T cd06654         172 KRSTMVGTPYWMAP  185 (296)
T ss_pred             ccCcccCCccccCH
Confidence            12335688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=1e-25  Score=208.99  Aligned_cols=170  Identities=26%  Similarity=0.358  Sum_probs=140.6

Q ss_pred             hcCCCCccceecccCceEEEEEEeC---C--CcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeec-CC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG---D--GMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSN-EE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  483 (585)
                      ....|+....||+|.||.||+|..+   +  .+.+|+|.++....  .......+|+.+++.++|||++.+...|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457999999999999999999532   2  34799998875522  122456679999999999999999999877 77


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC----CcEEE
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN----MIAYL  555 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~----~~~kl  555 (585)
                      .+|+++||.+. +|.+.++-+.    ..++...+..++.||+.|+.|||   ++=|+|||+||+|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            89999999976 8988886432    36888899999999999999999   8999999999999999876    89999


Q ss_pred             eeecccccccCCCCcc-ccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aP  585 (585)
                      +|||+|+.+.++-... .....+-|.||.||
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecCh
Confidence            9999999886544332 44567889999998

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.7e-24  Score=213.90  Aligned_cols=166  Identities=27%  Similarity=0.376  Sum_probs=144.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999875 78999999987543  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      + +++|.+++......+++.+++.++.|+++||+|||   +.+++|+||||+||++++++.++++|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999776667899999999999999999999   99999999999999999999999999999886543221 1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+.+|+||
T Consensus       156 ~~~~~~~~~~y~aP  169 (286)
T cd07832         156 LYSHQVATRWYRAP  169 (286)
T ss_pred             ccccccCcccccCc
Confidence            22345688999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.92  E-value=1.7e-24  Score=217.75  Aligned_cols=169  Identities=28%  Similarity=0.447  Sum_probs=138.9

Q ss_pred             CCCCccceecccCceEEEEEEeC--------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      ++|.+.+.||+|+||.||+|+..        +...+|+|.++... ......+..|+++++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            57999999999999999999752        23469999987542 33456788899999999 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      ..|+||||+++|+|.+++....               ..+++.++..++.|++.||+|||   +++++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997642               24788889999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.+||+|||.++...............+++.||||
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            9999999999998765322111111222345679998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.2e-24  Score=212.62  Aligned_cols=149  Identities=26%  Similarity=0.496  Sum_probs=132.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CC---cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .+|++.+.||+|+||.||+|... ++   ..||+|++... .....+.+..|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45788999999999999999864 33   36999998754 334457889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |||+++++|.+++......+++.+++.++.|++.|++|||   +++++|+||||+||+++.++.+|++|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=1.7e-24  Score=215.44  Aligned_cols=176  Identities=25%  Similarity=0.346  Sum_probs=145.2

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeee-
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCS-  480 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  480 (585)
                      ..++.+....++|++.+.||+|+||.||+|... +++.+|+|+++... .....+..|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344666778899999999999999999999865 68899999876432 2235677899999999 7999999999873 


Q ss_pred             ----cCCeEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          481 ----NEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       481 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                          ..+..++||||+++++|.+++..   ....+++..+..++.|+++|+.|||   +.+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34578999999999999988753   2236788889999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |++|||+++......  .......|++.|+||
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aP  193 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAP  193 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccCh
Confidence            999999988653221  122334689999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.92  E-value=1.8e-24  Score=216.02  Aligned_cols=172  Identities=29%  Similarity=0.455  Sum_probs=141.2

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      ...++|++.+.||+|+||.||+|...      ....+|+|.+... .......+.+|+++++++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34467889999999999999999753      2367999988753 233446688899999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYST---------------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..+++|||+++|+|.+++...               ...+++..++.++.|++.|++|||   +++|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999998642               235788899999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++++.+|++|||.++.+.............++..|+||
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            99999999999999865432221112223355679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.92  E-value=1.6e-24  Score=222.66  Aligned_cols=165  Identities=27%  Similarity=0.324  Sum_probs=137.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----  482 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  482 (585)
                      ...++|++.+.||+|+||.||+|... .++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35578999999999999999999865 6889999998643  223446777899999999999999999988644     


Q ss_pred             -CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          483 -EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       483 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                       ...|+||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999965 67776653   4788888999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +....   ........||+.|+||
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aP  187 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAP  187 (355)
T ss_pred             ccCCC---ccccCCccccCCccCH
Confidence            86432   1222445789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=4.6e-24  Score=208.65  Aligned_cols=166  Identities=25%  Similarity=0.371  Sum_probs=143.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  ......++.+|++++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999999855 6889999988654  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++... ...+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999775 346789999999999999999999   89999999999999999999999999999986533221 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......|++.|+||
T Consensus       157 -~~~~~~~~~~y~ap  170 (256)
T cd08221         157 -MAETVVGTPYYMSP  170 (256)
T ss_pred             -cccccCCCccccCH
Confidence             22345688999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=4.5e-24  Score=209.94  Aligned_cols=167  Identities=27%  Similarity=0.461  Sum_probs=142.1

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEEechh------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      .+....+.+|++++++++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            488899999999999999988888999999886431      22345688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|+|   +.+|+|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 5788899999999999999999   8999999999999999999999999999987643211


Q ss_pred             C----ccccccccccccccCC
Q 047705          569 Q----SMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~----~~~~~~~~gt~~y~aP  585 (585)
                      .    ........|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~p  177 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAP  177 (265)
T ss_pred             ccccccccccccCCCccccCh
Confidence            1    1112345688899998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7e-25  Score=217.98  Aligned_cols=167  Identities=24%  Similarity=0.338  Sum_probs=146.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ..|++.++||+|+.+.||++...+.+.||+|++...  +......|..|+..|.+++ |.+|+++++|-..+++.|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            459999999999999999999888888888876532  4456778999999999995 8999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |= .-+|..+++......+...++.+..|++.|+.++|   ++||||.||||+|+|+- +|.+||+|||+|..+..+...
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            76 56999999988765554578899999999999999   99999999999999986 589999999999988766666


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.||||
T Consensus       516 I~kdsQvGT~NYMsP  530 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSP  530 (677)
T ss_pred             eeeccccCcccccCH
Confidence            666788999999998

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.1e-24  Score=216.55  Aligned_cols=162  Identities=21%  Similarity=0.217  Sum_probs=126.3

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC--CCcEEEEEEEech-----hhhhHHHHHHHHHHHHhcCCCccee-EEeeee
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ-----CRRAFKSFDVECEIMKSIRHRNLIK-VISSCS  480 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~  480 (585)
                      +....++|++.+.||+|+||+||+|++.  +++.||||++...     .....+.+.+|++++++++|+|++. ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3455678999999999999999999764  5777899986533     1223567899999999999999985 4432  


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC-CCCCEEeCCCCcEEEeeec
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL-KPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfg  559 (585)
                        +..|+||||++|++|.. ...    ..   ...++.++++||.|+|   ++||+|||| ||+|||++.++.+||+|||
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence              45799999999999963 211    11   1467889999999999   999999999 9999999999999999999


Q ss_pred             ccccccCCCCccc------cccccccccccCC
Q 047705          560 IAKLLIGEDQSMT------QTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~------~~~~~gt~~y~aP  585 (585)
                      +|+.+........      .+...+++.|+||
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            9997653321111      1456788888887

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=1.8e-24  Score=237.65  Aligned_cols=174  Identities=23%  Similarity=0.354  Sum_probs=141.0

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CC
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EE  483 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  483 (585)
                      .....++|++.+.||+|+||.||+|++. ++..||+|++...  .......+..|+.+++.++||||++++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3445578999999999999999999876 6778999988743  23345678899999999999999999998854  35


Q ss_pred             eEEEEEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCcEEcCCCCCCEEeCC-------
Q 047705          484 FKGLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGC----STPVIHCDLKPSNVLLDD-------  549 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~iiH~dlkp~NIll~~-------  549 (585)
                      .+|+||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    .++||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            789999999999999998753   236899999999999999999999211    145999999999999964       


Q ss_pred             ----------CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          550 ----------NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       550 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                                .+.+||+|||+++.+....   .....+||+.||||
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAP  210 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSP  210 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCH
Confidence                      2358999999998653221   22345799999998

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=3.7e-24  Score=213.63  Aligned_cols=168  Identities=25%  Similarity=0.380  Sum_probs=140.3

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999865 688999999865432 22345678999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+. +++.+++......+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||+++...... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence            9995 6887777665456778888899999999999999   8999999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......+++.|+||
T Consensus       158 -~~~~~~~~~~~y~aP  172 (291)
T cd07870         158 -QTYSSEVVTLWYRPP  172 (291)
T ss_pred             -CCCCCccccccccCC
Confidence             112334578899998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=3.2e-24  Score=210.63  Aligned_cols=157  Identities=24%  Similarity=0.403  Sum_probs=132.7

Q ss_pred             ceecccCceEEEEEEeCC-------------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          420 NLIGRGGFGSVYKARLGD-------------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      +.||+|+||.||+|+..+             ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997431             2358889877655555567888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc-------EEEeeec
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI-------AYLSDFG  559 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~-------~kl~Dfg  559 (585)
                      +||||+++++|..++......+++..+..++.||++|++|||   +++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998776667899999999999999999999   999999999999999986664       8999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....      .....|+..||||
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aP  177 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAP  177 (262)
T ss_pred             CCccccC------cccccccccccCh
Confidence            9875421      1234578889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=2.1e-24  Score=214.75  Aligned_cols=165  Identities=27%  Similarity=0.408  Sum_probs=141.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999876 7899999988754 233446788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYST--NCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||   + .+|+||||||+||+++.++.+||+|||.+...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988764  236899999999999999999999   5 59999999999999999999999999998765321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......|++.|+||
T Consensus       157 ---~~~~~~~~~~y~aP  170 (286)
T cd06622         157 ---LAKTNIGCQSYMAP  170 (286)
T ss_pred             ---ccccCCCccCccCc
Confidence               12234578889988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=4.3e-24  Score=208.11  Aligned_cols=162  Identities=30%  Similarity=0.449  Sum_probs=136.2

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHH
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE  498 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  498 (585)
                      +.||+|+||.||+|...+++.||+|.++... ......+..|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998888999999886543 233456888999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccc
Q 047705          499 KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA  578 (585)
Q Consensus       499 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  578 (585)
                      +++......+++..+..++.|++.|+.|+|   +++++||||||+||++++++.+|++|||++....... ........+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            999776556889999999999999999999   9999999999999999999999999999987542211 111112234


Q ss_pred             cccccCC
Q 047705          579 TIGYMAP  585 (585)
Q Consensus       579 t~~y~aP  585 (585)
                      ++.|+||
T Consensus       157 ~~~y~aP  163 (250)
T cd05085         157 PIKWTAP  163 (250)
T ss_pred             cccccCH
Confidence            5678887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.92  E-value=3.8e-24  Score=209.64  Aligned_cols=163  Identities=34%  Similarity=0.561  Sum_probs=141.3

Q ss_pred             ceecccCceEEEEEEeCC----CcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|....    +..||+|+++..... ..+.+..|++.++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    788999998765332 367888999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          495 GSLEKHLYST--------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       495 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ++|.+++...        ...+++..+..++.|++.|++|||   +++++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        357899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...........+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccCCCcCccccCH
Confidence            3322233455678889998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=2.8e-24  Score=215.01  Aligned_cols=169  Identities=25%  Similarity=0.406  Sum_probs=138.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-----------------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-----------------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKV  475 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  475 (585)
                      ++|++.+.||+|+||.||+|+..                 ++..||+|++... ......++..|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56999999999999999998532                 2346899998754 23345688899999999999999999


Q ss_pred             EeeeecCCeEEEEEEccCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCE
Q 047705          476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN----------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNV  545 (585)
Q Consensus       476 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NI  545 (585)
                      ++++...+..++||||+++++|.+++....          ..+++..+..++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987642          13567789999999999999999   99999999999999


Q ss_pred             EeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          546 LLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       546 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++++++.+|++|||+++.+.............+++.|+||
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            9999999999999999865332211111223345678876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=3.4e-24  Score=213.92  Aligned_cols=167  Identities=25%  Similarity=0.401  Sum_probs=140.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            468999999999999999999876 688999999875432 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++ +|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9974 999998876667889999999999999999999   9999999999999999999999999999987532111  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++..|+||
T Consensus       158 ~~~~~~~~~~~~~aP  172 (291)
T cd07844         158 KTYSNEVVTLWYRPP  172 (291)
T ss_pred             ccccccccccccCCc
Confidence            112233567788887

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.1e-24  Score=212.47  Aligned_cols=170  Identities=22%  Similarity=0.386  Sum_probs=141.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357889999999999999999754      24689999986442 23446788899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEe
Q 047705          486 GLVLEYMPQGSLEKHLYSTN---------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS  556 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~  556 (585)
                      ++||||+++++|.+++....         ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999987532         13677888999999999999999   9999999999999999999999999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+++.+.............++..|+||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCH
Confidence            99999865433222222334567889988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.92  E-value=2.6e-24  Score=213.42  Aligned_cols=169  Identities=28%  Similarity=0.466  Sum_probs=141.5

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .+|...+.||+|+||.||+|...      ++..+|+|.+........+.+..|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45778899999999999999632      356789998876655666789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          488 VLEYMPQGSLEKHLYSTN--------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      +|||+++++|.+++....              ..+++..+..++.|++.|++|||   +++++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987643              24788899999999999999999   9999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+++...............+++.|+||
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCH
Confidence            99999998765332211122233456789988

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=2.7e-24  Score=212.60  Aligned_cols=156  Identities=24%  Similarity=0.369  Sum_probs=130.1

Q ss_pred             eecccCceEEEEEEeCC-------------------------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeE
Q 047705          421 LIGRGGFGSVYKARLGD-------------------------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV  475 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  475 (585)
                      .||+|+||.||+|....                         ...||+|+++.........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999986420                         13588998876544455678889999999999999999


Q ss_pred             EeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----
Q 047705          476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----  551 (585)
Q Consensus       476 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----  551 (585)
                      ++++......++||||+++|+|..++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999776567889999999999999999999   99999999999999997543    


Q ss_pred             ---cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 ---IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                         .+|++|||.+......      ....++..|+||
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aP  189 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAP  189 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCc
Confidence               4899999988653211      223567778887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.92  E-value=3.5e-24  Score=216.55  Aligned_cols=161  Identities=24%  Similarity=0.347  Sum_probs=129.6

Q ss_pred             cceecccCceEEEEEEeC---CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeEEEEEEccC
Q 047705          419 NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKGLVLEYMP  493 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  493 (585)
                      .+.||+|+||+||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...|++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999886432  22456789999999999999999998854  456899999995


Q ss_pred             CCCHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----CCCCcEEEeeeccc
Q 047705          494 QGSLEKHLYSTN--------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIA  561 (585)
Q Consensus       494 ~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~a  561 (585)
                       +++.+++....        ..+++..+..++.||+.||+|||   +++|+||||||+|||+    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888775321        25788889999999999999999   9999999999999999    45678999999999


Q ss_pred             ccccCCCCc-cccccccccccccCC
Q 047705          562 KLLIGEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      +........ .......||+.||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             eccCCCCccccccCCccccccccCC
Confidence            875432211 122456789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=3.3e-24  Score=213.83  Aligned_cols=168  Identities=25%  Similarity=0.411  Sum_probs=138.1

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... ......+..|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999753      23568888876443 2345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCC
Q 047705          488 VLEYMPQGSLEKHLYSTN-----------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSN  544 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~N  544 (585)
                      +|||+.+++|.+++....                       ..+++..++.++.|++.|++|||   +++++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999886421                       24678889999999999999999   9999999999999


Q ss_pred             EEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          545 VLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       545 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |++++++.+||+|||+++...............++..|+||
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            99999999999999999865433222222333456778887

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=3e-24  Score=210.86  Aligned_cols=167  Identities=27%  Similarity=0.464  Sum_probs=139.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+..|++++++++||||+++++.+. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356999999999999999999887767899999875332 3457888999999999999999999874 45679999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++|+|.+++.+.. ..+++..+..++.|+++||+|+|   +.+++||||||+||++++++.+||+|||.++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997643 35788899999999999999999   99999999999999999999999999999976532221 1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (262)
T cd05071         159 ARQGAKFPIKWTAP  172 (262)
T ss_pred             cccCCcccceecCH
Confidence            12234466779988

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=5.8e-24  Score=209.15  Aligned_cols=168  Identities=26%  Similarity=0.389  Sum_probs=140.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  485 (585)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+....     ....+.+..|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47899999999999999999865 68999999876321     22346788899999999999999999988764  467


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++|||+++++|.+++.... .+++.....++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 5788888999999999999999   9999999999999999999999999999988653


Q ss_pred             CCCCc-cccccccccccccCC
Q 047705          566 GEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      ..... .......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             cccccccccccCCCCccccCh
Confidence            22111 112335688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=4.2e-24  Score=212.47  Aligned_cols=165  Identities=28%  Similarity=0.397  Sum_probs=139.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ....+.+..|+.+++.++||||+++++++..++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4888999999999999999875 68899999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ++ +++.+++....  ..+++..+..++.|+++||+|||   +++++||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58888886533  46889999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......+++.|+||
T Consensus       156 -~~~~~~~~~~~y~aP  170 (285)
T cd07861         156 -RVYTHEVVTLWYRAP  170 (285)
T ss_pred             -ccccCCcccccccCh
Confidence             112334678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=6.7e-24  Score=208.84  Aligned_cols=167  Identities=28%  Similarity=0.427  Sum_probs=143.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999876 7899999988642   2233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++...   ...+++..+..++.++++|+.|||   +.+++||||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988642   335788999999999999999999   99999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......|++.|+||
T Consensus       159 ~~--~~~~~~~~~~~y~ap  175 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSP  175 (267)
T ss_pred             CC--cccceecCCccccCH
Confidence            21  112335688889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.91  E-value=1.7e-24  Score=215.07  Aligned_cols=168  Identities=24%  Similarity=0.387  Sum_probs=138.6

Q ss_pred             CCCccceecccCceEEEEEEeC------CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      +|++.+.||+|+||.||+|+..      +++.||+|+++.... .....+..|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4778889999999999999753      257899999875432 234678889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc
Q 047705          488 VLEYMPQGSLEKHLYST---------------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~  552 (585)
                      ++||+++++|.+++...               ...+++..+..++.|++.||+|+|   +++|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               124778888999999999999999   999999999999999999999


Q ss_pred             EEEeeecccccccCCCCccccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+|||+++...............+++.||||
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCH
Confidence            999999998865432221122234467789998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.91  E-value=3e-24  Score=215.30  Aligned_cols=169  Identities=27%  Similarity=0.426  Sum_probs=141.0

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ++|.+.+.||+|+||.||+|...      .+..||+|.++... ....+.+..|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56899999999999999999641      34579999887542 33456788999999999 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      |++|||+++|+|.+++.... ..+++.++..++.|++.|++|||   +++|+|+||||+||+++.++.+|++|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999997643 24799999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .............+++.|+||
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aP  212 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAP  212 (302)
T ss_pred             cCCCceeecCCCCcccccCCH
Confidence            432221122233467789998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=3.2e-24  Score=211.23  Aligned_cols=167  Identities=28%  Similarity=0.444  Sum_probs=142.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   ......++..|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999864 7899999987643   2334567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++..   ....+++..+..++.|+++|+.|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   2236789999999999999999999   99999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......|+..|+||
T Consensus       159 ~~--~~~~~~~~~~~~~ap  175 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSP  175 (267)
T ss_pred             CC--cccccccCCcCccCH
Confidence            21  112345688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=4e-24  Score=210.66  Aligned_cols=162  Identities=22%  Similarity=0.358  Sum_probs=130.3

Q ss_pred             eecccCceEEEEEEeCCC---cEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          421 LIGRGGFGSVYKARLGDG---MEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      .||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   345666655432 2345688999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          497 LEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       497 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      |.+++.+..   ...++..+..++.||+.||+|||   +.+++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642   24566677889999999999999   899999999999999999999999999998643221111122


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....|+..|+||
T Consensus       159 ~~~~~~~~y~aP  170 (268)
T cd05086         159 DDKCVPLRWLAP  170 (268)
T ss_pred             cCCcCcccccCc
Confidence            345678889988

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.91  E-value=3.6e-24  Score=220.67  Aligned_cols=164  Identities=26%  Similarity=0.320  Sum_probs=136.9

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  482 (585)
                      ..++|++.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999865 6889999998653  223446678899999999999999999987543      


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77777753   4678888999999999999999   9999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   ........||+.|+||
T Consensus       175 ~~~~---~~~~~~~~~t~~y~aP  194 (364)
T cd07875         175 TAGT---SFMMTPYVVTRYYRAP  194 (364)
T ss_pred             ccCC---CCcccCCcccCCcCCH
Confidence            6422   1122345789999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.91  E-value=4.7e-24  Score=213.32  Aligned_cols=167  Identities=31%  Similarity=0.418  Sum_probs=144.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++...+..|+|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            3456999999999999999999864 789999999876554456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++++|.+++...  .+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999999988754  5789999999999999999999   99999999999999999999999999999886533221 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......|++.|+||
T Consensus       171 -~~~~~~~~~~y~aP  184 (296)
T cd06655         171 -KRSTMVGTPYWMAP  184 (296)
T ss_pred             -cCCCcCCCccccCc
Confidence             12334688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=6.1e-24  Score=209.20  Aligned_cols=167  Identities=29%  Similarity=0.475  Sum_probs=140.8

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh---------hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.....         ...+.+..|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999865 688999998864311         123568889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .+++|||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997753 6788889999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCc----cccccccccccccCC
Q 047705          565 IGEDQS----MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~----~~~~~~~gt~~y~aP  585 (585)
                      ......    .......|++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             ccccccCCccccccccCCCcCccCh
Confidence            422111    111234578889988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-24  Score=223.78  Aligned_cols=175  Identities=27%  Similarity=0.355  Sum_probs=149.2

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec-
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN-  481 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  481 (585)
                      .++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|+.+.... ..+++..|.++++.. .|||++.++|+|.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34556667788999999999999999999854 788899999876533 346778899999888 69999999998853 


Q ss_pred             ----CCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEe
Q 047705          482 ----EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS  556 (585)
Q Consensus       482 ----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~  556 (585)
                          ++..|+|||||.||+..++++... ..+.|..+..|+++++.|+.+||   ...++|||||-.|||++.++.||++
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence                468999999999999999988654 37889999999999999999999   9999999999999999999999999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||++.......  ......+|||.||||
T Consensus       166 DFGvSaQldsT~--grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  166 DFGVSAQLDSTV--GRRNTFIGTPYWMAP  192 (953)
T ss_pred             eeeeeeeeeccc--ccccCcCCCcccccc
Confidence            999988764322  233567899999999

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=5e-24  Score=208.97  Aligned_cols=166  Identities=29%  Similarity=0.478  Sum_probs=139.3

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|++|+++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            57899999999999999999988888899999875432 3467889999999999999999999875 456889999999


Q ss_pred             CCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          494 QGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       494 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.+........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence            999999987643 35789999999999999999999   89999999999999999999999999999986532221 11


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~aP  172 (260)
T cd05070         160 RQGAKFPIKWTAP  172 (260)
T ss_pred             ccCCCCCccccCh
Confidence            1223456679988

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=4.8e-24  Score=209.52  Aligned_cols=167  Identities=28%  Similarity=0.480  Sum_probs=140.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .+|++.+.||+|+||.||+|.++ .++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35788899999999999999865 58899999987542 33567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ..+++..++.++.|+++|++|||   +.+++||||||+||++++++.+||+|||.+........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999987643 35788899999999999999999   99999999999999999999999999999986543211 1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......+++.|+||
T Consensus       161 ~~~~~~~~~~y~aP  174 (263)
T cd05052         161 AHAGAKFPIKWTAP  174 (263)
T ss_pred             ccCCCCCccccCCH
Confidence            11223345678887

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=5.4e-24  Score=213.22  Aligned_cols=165  Identities=30%  Similarity=0.462  Sum_probs=140.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh-----hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR-----AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      +|++.+.||+|+||.||+|... +++.||+|.+......     ....+..|+++++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999865 6899999998754321     234567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+ +++|.+++......+++..+..++.||++||.|||   +++|+|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 89999999776546899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .  ......+++.|+||
T Consensus       157 ~--~~~~~~~~~~y~aP  171 (298)
T cd07841         157 R--KMTHQVVTRWYRAP  171 (298)
T ss_pred             c--cccccccceeeeCH
Confidence            1  12233567788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=7.4e-24  Score=209.23  Aligned_cols=167  Identities=31%  Similarity=0.453  Sum_probs=140.7

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh----------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC----------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      +|...+.||+|+||.||+|... +++.||+|.++...          ....+.+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999765 68899999876421          112346788999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.|||   +++++||||+|+||+++.++.+|++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 6888899999999999999999   89999999999999999999999999999886


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..............|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             ccccccccccccccCCccccCH
Confidence            4322212222345678889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=5.6e-25  Score=236.73  Aligned_cols=172  Identities=28%  Similarity=0.448  Sum_probs=139.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-------
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-------  481 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  481 (585)
                      +-..+|+..+.||+||||.||+|+.+ ||+.||||++... .......+.+|+.++++++|||||+++..|..       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            44567899999999999999999977 9999999998755 33445678889999999999999999765300       


Q ss_pred             ------------------------------------------------C-------------------------------
Q 047705          482 ------------------------------------------------E-------------------------------  482 (585)
Q Consensus       482 ------------------------------------------------~-------------------------------  482 (585)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 047705          483 ---------------------------------EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF  529 (585)
Q Consensus       483 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  529 (585)
                                                       -..||-||||+...+.+++++....-.....++++++|++||.|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                             1257889999887777777765532245668899999999999999 


Q ss_pred             CCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc----------------CCCCccccccccccccccCC
Q 047705          530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI----------------GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       530 ~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aP  585 (585)
                        ++|||||||||.||++|+++.|||+|||+|....                ........++.+||.-|+||
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence              9999999999999999999999999999998721                00112245778999999999

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=1e-23  Score=211.88  Aligned_cols=146  Identities=28%  Similarity=0.429  Sum_probs=131.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ......+..|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999876 67899999987553   233457788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||++|++|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999997654 6888889999999999999999   89999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=4.7e-24  Score=214.06  Aligned_cols=167  Identities=29%  Similarity=0.522  Sum_probs=135.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCc--EEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|+++ ++.  .+|+|.+... .......+.+|++++.++ +||||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357889999999999999999865 454  4577776543 233456788899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc
Q 047705          488 VLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~  552 (585)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++++||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999987542               24688899999999999999999   999999999999999999999


Q ss_pred             EEEeeecccccccCCCCccccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+|||+++....   ........++..|+||
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP  192 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAI  192 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCH
Confidence            99999999864211   1111122345668887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.91  E-value=6.4e-24  Score=209.64  Aligned_cols=167  Identities=29%  Similarity=0.476  Sum_probs=132.5

Q ss_pred             CCccceecccCceEEEEEEeCC-Cc--EEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------Ce
Q 047705          416 FSENNLIGRGGFGSVYKARLGD-GM--EVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------EF  484 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  484 (585)
                      |.+.+.||+|+||.||+|++.+ +.  .||+|.++..  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998753 32  6899987643  234457788899999999999999999976432      24


Q ss_pred             EEEEEEccCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          485 KGLVLEYMPQGSLEKHLYST-----NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      .+++|||+++|+|.+++...     ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432     235788899999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.+.............+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCH
Confidence            99876432221122233456678876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=8.7e-24  Score=206.83  Aligned_cols=164  Identities=30%  Similarity=0.426  Sum_probs=142.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     +...+.+..|+++++.++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999876 78999999886542     23456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 5788899999999999999999   8999999999999999999999999999988653222


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......|++.|+||
T Consensus       157 ---~~~~~~~~~~y~~p  170 (258)
T cd06632         157 ---FAKSFKGSPYWMAP  170 (258)
T ss_pred             ---cccccCCCcceeCH
Confidence               22345688889987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=4.6e-24  Score=215.37  Aligned_cols=170  Identities=28%  Similarity=0.453  Sum_probs=138.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      .++|.+.+.||+|+||.||+|+..        ....||+|.++.. .......+..|+++++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357889999999999999999742        2456899988743 233456788899999999 699999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..|++|||+++|+|.+++....               ..+++.++..++.|++.||+|||   +++++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999997532               24788889999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++++.+||+|||.++...............+++.||||
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            99999999999999865322211111222345679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=6.1e-24  Score=208.45  Aligned_cols=168  Identities=30%  Similarity=0.501  Sum_probs=142.3

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|..++++.||+|.+.... ...+++..|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46799999999999999999998878889999987543 23467889999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||||+||++++++.+|++|||.+....... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997654 36889999999999999999999   9999999999999999999999999999987653211 11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       160 ~~~~~~~~~~y~~P  173 (261)
T cd05034         160 AREGAKFPIKWTAP  173 (261)
T ss_pred             hhhccCCCccccCH
Confidence            11222345678887

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.91  E-value=7.9e-24  Score=209.03  Aligned_cols=167  Identities=29%  Similarity=0.488  Sum_probs=135.2

Q ss_pred             CCccceecccCceEEEEEEeC-C---CcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe-----
Q 047705          416 FSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-----  484 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  484 (585)
                      |++.+.||+|+||.||+|... +   +..||+|+++...  ......+..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999754 2   3679999987542  3345678899999999999999999998765543     


Q ss_pred             -EEEEEEccCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          485 -KGLVLEYMPQGSLEKHLYST-----NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       485 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                       .+++|||+++|+|..++...     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999988543     125788899999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+++.+.............++..|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             cceeeccccccccccccccCCccccCH
Confidence            999876433222222223345678877

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=6.4e-24  Score=211.53  Aligned_cols=164  Identities=29%  Similarity=0.421  Sum_probs=133.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhc---CCCcceeEEeeeec-----CC
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSI---RHRNLIKVISSCSN-----EE  483 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  483 (585)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999876 688999999875321  1223455677777665   79999999998764     24


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ..+++|||++ +++.+++.... ..+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999997 48988887643 25789999999999999999999   9999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......   ......||+.|+||
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aP  176 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAP  176 (288)
T ss_pred             cccCcc---cCCCccccccccCc
Confidence            653221   22345689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=9.5e-24  Score=206.63  Aligned_cols=161  Identities=28%  Similarity=0.446  Sum_probs=132.1

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          421 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999754   35579999886553 2344678899999999999999999998864 57899999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc-cccc
Q 047705          497 LEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-TQTQ  575 (585)
Q Consensus       497 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~  575 (585)
                      |.+++......+++..+..++.|++.|++|||   +++++||||||+||+++.++.+|++|||+++......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866667899999999999999999999   8999999999999999999999999999998653222111 1122


Q ss_pred             ccccccccCC
Q 047705          576 TLATIGYMAP  585 (585)
Q Consensus       576 ~~gt~~y~aP  585 (585)
                      ..+++.|+||
T Consensus       158 ~~~~~~y~aP  167 (257)
T cd05115         158 GKWPLKWYAP  167 (257)
T ss_pred             CCCCcccCCH
Confidence            2335678887

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=8.9e-24  Score=210.20  Aligned_cols=166  Identities=28%  Similarity=0.388  Sum_probs=140.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|+..+.||+|+||.||+|+++ +++.||+|++....  ....+.+..|++++++++|||++++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47899999999999999999876 68999999886432  1233567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++++.+..++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765443 6889999999999999999999   89999999999999999999999999999987543221 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~~~aP  169 (286)
T cd07847         156 -DYTDYVATRWYRAP  169 (286)
T ss_pred             -cccCcccccccCCH
Confidence             12234577888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.91  E-value=3.3e-24  Score=213.16  Aligned_cols=165  Identities=28%  Similarity=0.378  Sum_probs=140.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|+.. +|+.||+|.++...  ......+..|++++++++||||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888899999999999999875 68999999986532  22235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++ +++.+++......+++..+..++.||++||.|||   .++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence            96 5888888765557899999999999999999999   9999999999999999999999999999988643221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~y~aP  168 (284)
T cd07839         155 CYSAEVVTLWYRPP  168 (284)
T ss_pred             CcCCCccccCCcCh
Confidence            12334678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=7.6e-24  Score=208.67  Aligned_cols=169  Identities=25%  Similarity=0.476  Sum_probs=140.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CC---cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|+..+.||+|+||.||+|+.. ++   ..+|+|.++.. .....+.+..|++++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46888899999999999999864 33   36899988654 233456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999988654322


Q ss_pred             Cccc-cccccccccccCC
Q 047705          569 QSMT-QTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~-~~~~~gt~~y~aP  585 (585)
                      .... ......++.|+||
T Consensus       162 ~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             ccceeccCCCcCceecCH
Confidence            1111 1112234568887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=7.7e-24  Score=207.66  Aligned_cols=167  Identities=23%  Similarity=0.442  Sum_probs=139.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|..++++.||+|.+..... ....+..|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467899999999999999999988889999999875432 3467888999999999999999999864 45789999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.++++|||++....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence            9999999987543 36788899999999999999999   9999999999999999999999999999987653211 11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~p  172 (260)
T cd05067         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            12233456678887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-23  Score=206.07  Aligned_cols=163  Identities=31%  Similarity=0.498  Sum_probs=140.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++..|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357889999999999999999874 78899999876543 4577889999999999999999999999899999999999


Q ss_pred             CCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++..... .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            99999999976542 5889999999999999999999   9999999999999999999999999999998652111   


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                        ....++..|+||
T Consensus       157 --~~~~~~~~~~ap  168 (256)
T cd05039         157 --DSGKLPVKWTAP  168 (256)
T ss_pred             --ccCCCcccccCc
Confidence              122344567776

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.91  E-value=5.2e-24  Score=212.25  Aligned_cols=170  Identities=28%  Similarity=0.464  Sum_probs=140.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|+..      ++..||+|++.... ......+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999753      46789999987543 23456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCC
Q 047705          486 GLVLEYMPQGSLEKHLYSTN---------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSN  544 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~N  544 (585)
                      +++|||+++|+|.+++....                     ..+++..++.++.|++.||+|||   .++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997432                     24678888999999999999999   9999999999999


Q ss_pred             EEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          545 VLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       545 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |++++++.+|++|||.++...............++..|+||
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            99999999999999998765322211112223345678887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.91  E-value=4.9e-24  Score=210.50  Aligned_cols=168  Identities=29%  Similarity=0.374  Sum_probs=141.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC------C
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE------E  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  483 (585)
                      +.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++...      +
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567889999999999999999865 68899999987543 2345678899999998 799999999998653      4


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ..|++|||+++++|.+++.... ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6899999999999999988643 36789999999999999999999   8999999999999999999999999999988


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......  .......|++.|+||
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aP  180 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAP  180 (272)
T ss_pred             eccccc--ccCCcccccccccCH
Confidence            653211  122345688899998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.91  E-value=1e-23  Score=205.57  Aligned_cols=163  Identities=33%  Similarity=0.497  Sum_probs=136.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHH
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE  498 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  498 (585)
                      +.||+|+||.||+|.+.+++.||+|.+..... .....+..|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999877799999998875433 24567889999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccc
Q 047705          499 KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA  578 (585)
Q Consensus       499 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  578 (585)
                      +++......+++..+..++.+++.|++|||   +++++||||||+||+++.++.+||+|||.++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556788899999999999999999   99999999999999999999999999999886432111111112223


Q ss_pred             cccccCC
Q 047705          579 TIGYMAP  585 (585)
Q Consensus       579 t~~y~aP  585 (585)
                      +..|+||
T Consensus       158 ~~~y~~P  164 (251)
T cd05041         158 PIKWTAP  164 (251)
T ss_pred             eeccCCh
Confidence            5568877

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.91  E-value=1.5e-23  Score=205.08  Aligned_cols=166  Identities=28%  Similarity=0.464  Sum_probs=140.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  490 (585)
                      +|++.+.||+|++|.||+|... +++.||+|.+....  ....+.+..|++++++++|+|++++++.+.. +...|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5889999999999999999865 67889999987542  3345678889999999999999999998764 446899999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++++|.+++.... ..+++.++..++.+++.|++|+|   +.+++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999997643 35899999999999999999999   9999999999999999999999999999998653222 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......|++.|+||
T Consensus       157 -~~~~~~~~~~~y~aP  171 (257)
T cd08223         157 -DMASTLIGTPYYMSP  171 (257)
T ss_pred             -CccccccCCcCccCh
Confidence             122345688999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-25  Score=241.62  Aligned_cols=172  Identities=32%  Similarity=0.456  Sum_probs=147.7

Q ss_pred             HHhcCCCCccceecccCceEEEEEE-eCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ...+-+|+....||.|.||.||.|- ..+|+..|+|-+..+  ..+..+.+.+|..++..++|||+|+++|+-...+..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3455678889999999999999996 457889999987654  3445677889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      |.||||++|+|.+.++... ..++.....+..|++.|+.|||   ++|||||||||+||+++.+|.+|.+|||.|..+.+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999999887653 4566667778999999999999   99999999999999999999999999999998865


Q ss_pred             CCCcc--ccccccccccccCC
Q 047705          567 EDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~--~~~~~~gt~~y~aP  585 (585)
                      .....  ......|||.||||
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCc
Confidence            43222  23567899999999

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=8.1e-24  Score=208.74  Aligned_cols=167  Identities=28%  Similarity=0.409  Sum_probs=138.5

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+..|+.++++++||||+++++++.. +..|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468889999999999999997542    3468999887553 3455688999999999999999999998875 457899


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++......+++..+..++.|++.|++|+|   +.+++|+||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876556899999999999999999999   8999999999999999999999999999998654321


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       ........+++.|+||
T Consensus       162 -~~~~~~~~~~~~y~aP  177 (270)
T cd05056         162 -YYKASKGKLPIKWMAP  177 (270)
T ss_pred             -ceecCCCCccccccCh
Confidence             1112223345678887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=6.3e-24  Score=208.02  Aligned_cols=155  Identities=26%  Similarity=0.442  Sum_probs=130.6

Q ss_pred             ceecccCceEEEEEEeCC-C----------cEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          420 NLIGRGGFGSVYKARLGD-G----------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      +.||+|+||.||+|.+.+ +          ..|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998753 2          24777876644332 5788899999999999999999999888 778999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-------cEEEeeeccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-------IAYLSDFGIA  561 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-------~~kl~Dfg~a  561 (585)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876557888999999999999999999   99999999999999999877       7999999998


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....      .....++..|+||
T Consensus       156 ~~~~~------~~~~~~~~~y~aP  173 (259)
T cd05037         156 ITVLS------REERVERIPWIAP  173 (259)
T ss_pred             ccccc------ccccccCCCccCh
Confidence            86532      1223466778887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-26  Score=220.32  Aligned_cols=271  Identities=24%  Similarity=0.284  Sum_probs=221.7

Q ss_pred             EEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEee
Q 047705           63 ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLG  142 (585)
Q Consensus        63 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  142 (585)
                      ..+-++-.++.+|.  .+  -+.-+.++|..|+|+.+.++ +|+.+++ |+.|||+.|+|+.+-|.+|.++.+|.+|-+-
T Consensus        50 ~VdCr~~GL~eVP~--~L--P~~tveirLdqN~I~~iP~~-aF~~l~~-LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly  123 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPA--NL--PPETVEIRLDQNQISSIPPG-AFKTLHR-LRRLDLSKNNISFIAPDAFKGLASLLSLVLY  123 (498)
T ss_pred             eEEccCCCcccCcc--cC--CCcceEEEeccCCcccCChh-hccchhh-hceecccccchhhcChHhhhhhHhhhHHHhh
Confidence            45667777888873  22  24678999999999876666 8888987 9999999999999999999999999888665


Q ss_pred             C-CccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC----
Q 047705          143 G-NKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----  217 (585)
Q Consensus       143 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~----  217 (585)
                      + |+|+.+..++|.++..|+.|.+..|++.-+..+.|..+++|..|.+.+|.+....-..|..+.+++.+.+..|.    
T Consensus       124 g~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  124 GNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             cCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            5 99999999999999999999999999998889999999999999999999985555589999999999999886    


Q ss_pred             -----------CCCccCCCCCCCcEEEcc-------------------------CCcccccCC-cccCCCCCCcEEeecc
Q 047705          218 -----------PLPLEIGNLKVLVGIDFS-------------------------MNNFSGIIP-KEIGGLKNLEYLFLGY  260 (585)
Q Consensus       218 -----------~~~~~~~~l~~L~~L~ls-------------------------~N~l~~~~~-~~~~~l~~L~~L~ls~  260 (585)
                                 ..|..++++.-.....+.                         .....++-| ..|.++++|+.|+|++
T Consensus       204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn  283 (498)
T KOG4237|consen  204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN  283 (498)
T ss_pred             cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence                       112222222111111111                         111222222 3688999999999999


Q ss_pred             cCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCC-CCCCCCccccCCCCcccCCC
Q 047705          261 NRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG-SFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       261 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~~~~~~~~~~~n~~~c~~~  339 (585)
                      |+++++-+.+|.+...++.|.|..|+|.......|.++..|+.|+|++|+|++..|... ....+..+.+.+|||.|+.-
T Consensus       284 N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  284 NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence            99999999999999999999999999998888899999999999999999999888653 34566778889999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.91  E-value=6.3e-24  Score=210.37  Aligned_cols=170  Identities=27%  Similarity=0.421  Sum_probs=138.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCC------CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|.+.+      +..||+|.+.... ......+..|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            3678999999999999999998643      5678999876442 33446788899999999999999999999998899


Q ss_pred             EEEEEccCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC---cEEEe
Q 047705          486 GLVLEYMPQGSLEKHLYSTN------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAYLS  556 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~---~~kl~  556 (585)
                      ++||||+++++|.+++....      ..+++..+..++.||+.|++|||   +++++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999987653      25788999999999999999999   89999999999999998654   69999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+++...............+++.||||
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPP  190 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCH
Confidence            99999865322211111222335678887

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=1.3e-23  Score=205.48  Aligned_cols=166  Identities=31%  Similarity=0.403  Sum_probs=145.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  .+.+.+|++++++++||||+++++++..++..|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367999999999999999999876 478999999875533  57889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.+||+|||++.......  .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            9999999999876667899999999999999999999   8999999999999999999999999999988754322  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+..|+||
T Consensus       155 ~~~~~~~~~~y~~P  168 (256)
T cd06612         155 KRNTVIGTPFWMAP  168 (256)
T ss_pred             ccccccCCccccCH
Confidence            22334578889988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.91  E-value=1.2e-23  Score=205.67  Aligned_cols=166  Identities=33%  Similarity=0.546  Sum_probs=140.7

Q ss_pred             CCccceecccCceEEEEEEeCC-----CcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +++.+.||+|+||.||+|++.+     +..||+|++...... ..+.+..|+++++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998653     378999998755332 5678889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++|+||||+||++++++.++++|||.++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999875543 899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .... ....+++.|+||
T Consensus       158 ~~~~-~~~~~~~~y~~P  173 (258)
T smart00219      158 YYKK-KGGKLPIRWMAP  173 (258)
T ss_pred             cccc-ccCCCcccccCh
Confidence            1111 123367889988

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.91  E-value=8.1e-24  Score=215.45  Aligned_cols=169  Identities=28%  Similarity=0.443  Sum_probs=137.9

Q ss_pred             CCCCccceecccCceEEEEEEeC--------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.++... ....+.+..|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46899999999999999999742        12368999876432 33456788999999999 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      ..+++|||+++|+|.+++....               ..+++.++..++.|++.||+|||   .++++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532               24677888999999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.+||+|||+++...............++..||||
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            9999999999999865332211112223345679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=8.8e-24  Score=208.13  Aligned_cols=167  Identities=28%  Similarity=0.437  Sum_probs=141.1

Q ss_pred             CCCccceecccCceEEEEEEe-CCCcEEEEEEEechh------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      +|+..+.||+|+||.||+|+. .+++.||+|++....      ....+.+..|++++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999986 478999999986432      2235678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIG  566 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  566 (585)
                      ||||+++++|.+++.+.. .+++..+..++.|++.|+.|||   +++++|+||||+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 6788999999999999999999   99999999999999998765 699999999887643


Q ss_pred             CCCc--cccccccccccccCC
Q 047705          567 EDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~--~~~~~~~gt~~y~aP  585 (585)
                      ....  .......||..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~P  177 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAP  177 (268)
T ss_pred             ccccCCccccccccccceeCH
Confidence            2111  112234678889998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=8.2e-24  Score=209.25  Aligned_cols=168  Identities=23%  Similarity=0.398  Sum_probs=140.8

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.+..|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999853      3467999988654333 4567899999999999999999999999989999


Q ss_pred             EEEEccCCCCHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          487 LVLEYMPQGSLEKHLYSTN--------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997544        15789999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+++...... ........++..|+||
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~P  187 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAP  187 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecCh
Confidence            9987543221 1122334567778887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.91  E-value=7.6e-24  Score=212.62  Aligned_cols=168  Identities=29%  Similarity=0.455  Sum_probs=137.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ......+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56888899999999999999764 444    57888876442 23344678899999999999999999998654 4679


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ++||+++|++.+++......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999876656888899999999999999999   999999999999999999999999999999865433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........++..||||
T Consensus       163 ~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         163 EKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             ccccccCCCccccccCCH
Confidence            222222234456789987

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.9e-25  Score=211.37  Aligned_cols=169  Identities=25%  Similarity=0.307  Sum_probs=144.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ....+|..+.+||+|+||.|.+|..+ +.+.+|||++++..   ..+.+.-+.|-++|+.- +-|.+++++.+|++-+..
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34456999999999999999999765 56779999987652   23455666788888877 568999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||+.||+|.-.++..+ .+.+..+..++.+|+-||-|||   .+|||.||||.+|||+|.+|++||+|||+++.-.
T Consensus       426 yFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             eeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999999999998765 6778888999999999999999   9999999999999999999999999999998643


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      -+  ..+...++|||.|+||
T Consensus       502 ~~--~~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  502 FD--GVTTKTFCGTPDYIAP  519 (683)
T ss_pred             cC--CcceeeecCCCccccc
Confidence            22  3345678999999998

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=1.1e-23  Score=205.92  Aligned_cols=167  Identities=26%  Similarity=0.435  Sum_probs=141.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|++++++++||+|+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46888999999999999999887788999998864422 23568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999876667889999999999999999999   8999999999999999999999999999987653221 1112


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....++..|+||
T Consensus       159 ~~~~~~~~~~aP  170 (256)
T cd05112         159 TGTKFPVKWSSP  170 (256)
T ss_pred             CCCccchhhcCH
Confidence            233456678887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=1.2e-23  Score=206.21  Aligned_cols=166  Identities=28%  Similarity=0.469  Sum_probs=137.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998777789999876443 23466888999999999999999999875 456889999999


Q ss_pred             CCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          494 QGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       494 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||||+||++++++.+||+|||.++...... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence            999999997643 35788899999999999999999   9999999999999999999999999999997653221 111


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....++..|+||
T Consensus       160 ~~~~~~~~~y~~P  172 (260)
T cd05069         160 RQGAKFPIKWTAP  172 (260)
T ss_pred             cCCCccchhhCCH
Confidence            1233456778887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=1.3e-23  Score=208.76  Aligned_cols=167  Identities=30%  Similarity=0.494  Sum_probs=136.1

Q ss_pred             CCC-CccceecccCceEEEEEEe-----CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--Ce
Q 047705          414 DGF-SENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EF  484 (585)
Q Consensus       414 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  484 (585)
                      ++| +..+.||+|+||+||++..     .+++.||+|.++... ......+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            344 8889999999999988642     357789999987543 23456788899999999999999999987654  46


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .+++|||+++++|.+++...  .+++.++..++.|++.|++|||   +++|+||||||+||++++++.+||+|||+++..
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            89999999999999999765  4899999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCccc-cccccccccccCC
Q 047705          565 IGEDQSMT-QTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~-~~~~~gt~~y~aP  585 (585)
                      ........ .....++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCH
Confidence            43221111 1223355678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=9e-24  Score=211.07  Aligned_cols=167  Identities=27%  Similarity=0.344  Sum_probs=141.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|.+. +++.+|+|.++....  .....+.+|+.++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357999999999999999999876 688999999875432  2234567899999999999999999998877  88999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||++ ++|.+++......+++..+..++.|++.||+|||   +++++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999996 4999988776556899999999999999999999   899999999999999999999999999998865432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .  .......+++.|+||
T Consensus       160 ~--~~~~~~~~~~~~~aP  175 (293)
T cd07843         160 L--KPYTQLVVTLWYRAP  175 (293)
T ss_pred             c--cccccccccccccCc
Confidence            2  122334578889998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=210.18  Aligned_cols=170  Identities=31%  Similarity=0.432  Sum_probs=142.5

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEEechh-------hhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCe
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQC-------RRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  484 (585)
                      ++|-....||+|+|+.||+|.+ ...+.||||+-....       ....+...+|.+|-+.++||.||++|++|.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            4677888999999999999964 468889999854321       2234567789999999999999999999965 467


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeeccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIA  561 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a  561 (585)
                      +|-|.|||+|.+|+-|++.++ .+++.+++.|+.||+.||.||.+ ...+|||-||||.|||+.   ..|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            899999999999999998876 78999999999999999999984 368999999999999994   4678999999999


Q ss_pred             ccccCCCCccc-----cccccccccccCC
Q 047705          562 KLLIGEDQSMT-----QTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~-----~~~~~gt~~y~aP  585 (585)
                      +.+.++.....     .....||.||++|
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPP  649 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCc
Confidence            99875543311     2467899999998

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.91  E-value=1.3e-23  Score=209.68  Aligned_cols=176  Identities=28%  Similarity=0.360  Sum_probs=145.3

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN  481 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  481 (585)
                      +.+.++...+++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566777899999999999999999999875 78899999986432 2235677899999999 89999999999865


Q ss_pred             C-----CeEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          482 E-----EFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       482 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      .     +..|+||||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998763   2346789999999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||.++.......  ......|+..|+||
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  197 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAP  197 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccCh
Confidence            9999999886532211  12234678889988

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.91  E-value=1.7e-23  Score=208.69  Aligned_cols=166  Identities=27%  Similarity=0.377  Sum_probs=140.6

Q ss_pred             CCCccceecccCceEEEEEEe----CCCcEEEEEEEechh----hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          415 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|++....    ....+.+..|+++++++ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    368899999987532    22346678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999997654 6788888999999999999999   9999999999999999999999999999988653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ... ........|+..|+||
T Consensus       157 ~~~-~~~~~~~~~~~~y~aP  175 (290)
T cd05613         157 EDE-VERAYSFCGTIEYMAP  175 (290)
T ss_pred             ccc-ccccccccCCcccCCh
Confidence            221 1122345688899998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-23  Score=207.35  Aligned_cols=165  Identities=30%  Similarity=0.370  Sum_probs=144.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||.|+||.||+|+.. +++.||+|++.... ......+..|+++++.++|+||+++++++..+...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999866 68899999987543 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +++++|+||+|+||++++++.++++|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999865  6889999999999999999999   9999999999999999999999999999998764321  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       154 ~~~~~~~~~~y~~P  167 (274)
T cd06609         154 KRNTFVGTPFWMAP  167 (274)
T ss_pred             ccccccCCccccCh
Confidence            22345688899998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.91  E-value=2.8e-23  Score=204.46  Aligned_cols=168  Identities=25%  Similarity=0.404  Sum_probs=139.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  485 (585)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     .+....+.+|+.+++.++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36899999999999999999865 68899999886431     2334578889999999999999999998865  3578


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++|||+++++|.+++.... .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997654 5788889999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCC-ccccccccccccccCC
Q 047705          566 GEDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~-~~~~~~~~gt~~y~aP  585 (585)
                      .... ........|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cccccCCccccCCccccccCH
Confidence            2111 1111234588889998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-23  Score=211.34  Aligned_cols=148  Identities=32%  Similarity=0.424  Sum_probs=132.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+..|+++++.++||+|+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46889999999999999999876 589999999875421   24567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||+++++|.+++.... ..+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            9999999999987643 36889999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.91  E-value=5.1e-24  Score=212.59  Aligned_cols=163  Identities=29%  Similarity=0.361  Sum_probs=139.9

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      |.....||+|+||.||++... ++..||||.+........+.+..|+.+++.++||||+++++.+...+..|+||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344467999999999999865 6889999998765555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      ++|.+++...  .+++..+..++.||+.|++|||   +++|+||||||+||++++++.+||+|||++.......  ....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            9999988653  4788899999999999999999   8999999999999999999999999999987653221  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...|++.|+||
T Consensus       177 ~~~~~~~y~aP  187 (292)
T cd06658         177 SLVGTPYWMAP  187 (292)
T ss_pred             eeecCccccCH
Confidence            45688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.91  E-value=1.2e-23  Score=208.63  Aligned_cols=171  Identities=23%  Similarity=0.352  Sum_probs=141.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeCC-----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  484 (585)
                      ..++|++.+.||+|+||.||+|.+.+     +..||+|.+... .....+.+..|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678999999999999999998654     678999988644 23345678889999999999999999998765 467


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                      .++++||+++++|.+++....       ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999987642       35789999999999999999999   99999999999999999999999999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+++.+.............++..|+||
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCH
Confidence            9999865433222222233456678887

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=7.4e-24  Score=207.50  Aligned_cols=164  Identities=32%  Similarity=0.436  Sum_probs=143.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999876 68999999987542   2345788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++|++|.+++... ..+++..+..++.|+++|+.|||   +++++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999776 46889999999999999999999   9999999999999999999999999999988653321  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......|+..|+||
T Consensus       155 -~~~~~~~~~~y~~P  168 (258)
T cd05578         155 -LTTSTSGTPGYMAP  168 (258)
T ss_pred             -cccccCCChhhcCH
Confidence             12335578888887

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-24  Score=195.00  Aligned_cols=171  Identities=25%  Similarity=0.334  Sum_probs=142.9

Q ss_pred             hcCCCCccceecccCceEEEEEE-eCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----CeE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK  485 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  485 (585)
                      ..++|.+.+.+|+|+|+-||.++ ..+++.||+|++.....+..+..++|++..++++|||+++++++...+     +..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34679999999999999999998 457889999998877667788899999999999999999999986443     458


Q ss_pred             EEEEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          486 GLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      |++++|...|+|.+.+...   +..+++.+++.|+.+|++||++||   +..  ++||||||.||++.+++.+++.|||.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccC
Confidence            9999999999999998754   237899999999999999999999   555  99999999999999999999999999


Q ss_pred             cccccCCCCc-------cccccccccccccCC
Q 047705          561 AKLLIGEDQS-------MTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~-------~~~~~~~gt~~y~aP  585 (585)
                      +....-.-..       +.-.....|..|.||
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP  207 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAP  207 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence            8865311111       111234568889998

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=1.8e-23  Score=207.80  Aligned_cols=169  Identities=28%  Similarity=0.459  Sum_probs=140.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-----CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  485 (585)
                      +.|++.+.||+|+||.||+|++.     +++.||+|++...... ..+.+..|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999753     3678999998755432 45789999999999999999999999877  5578


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++|||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+|++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCccc-cccccccccccCC
Q 047705          566 GEDQSMT-QTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~-~~~~~gt~~y~aP  585 (585)
                      ....... .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             cCCcceeccCCCCCcccccCc
Confidence            2221111 1122344567776

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=1.5e-23  Score=209.91  Aligned_cols=166  Identities=28%  Similarity=0.506  Sum_probs=135.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc--EEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++.. .....+.+..|+++++++ +||||+++++++...+..|++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57899999999999999999865 333  4788887642 233456788899999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          489 LEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      |||+++++|.+++....               ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               24778889999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||++.....   .........+..|+||
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aP  187 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAI  187 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCc
Confidence            9999999864211   1111112234568887

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=1.2e-23  Score=205.86  Aligned_cols=162  Identities=27%  Similarity=0.408  Sum_probs=136.8

Q ss_pred             ceecccCceEEEEEEeCC--C--cEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLGD--G--MEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998642  3  3699999876644 556788999999999999999999999988 889999999999


Q ss_pred             CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc-c
Q 047705          495 GSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-T  572 (585)
Q Consensus       495 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~  572 (585)
                      ++|.+++.... ..+++..++.++.|++.||+|||   .++++|+||||+||+++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998765 46889999999999999999999   9999999999999999999999999999998764322211 1


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....++..|+||
T Consensus       157 ~~~~~~~~~y~~p  169 (257)
T cd05040         157 EEHLKVPFAWCAP  169 (257)
T ss_pred             ccCCCCCceecCH
Confidence            1234567789887

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.91  E-value=1.6e-23  Score=212.57  Aligned_cols=165  Identities=22%  Similarity=0.304  Sum_probs=135.7

Q ss_pred             ccceeccc--CceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          418 ENNLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       418 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +.+.||+|  +||+||+++.+ +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  67899999865 78999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++|++.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999987542 35889999999999999999999   9999999999999999999999999998755432211110


Q ss_pred             -----ccccccccccccCC
Q 047705          572 -----TQTQTLATIGYMAP  585 (585)
Q Consensus       572 -----~~~~~~gt~~y~aP  585 (585)
                           ......++..||||
T Consensus       159 ~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             cccccccccccceecccCh
Confidence                 11223567789998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=4.1e-24  Score=209.37  Aligned_cols=157  Identities=26%  Similarity=0.369  Sum_probs=133.2

Q ss_pred             ceecccCceEEEEEEeC-C-------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARLG-D-------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.||+|+||.||+|... .       ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36899999999999753 2       234888887655555567788899999999999999999999998899999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc--------EEEeeeccccc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI--------AYLSDFGIAKL  563 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~Dfg~a~~  563 (585)
                      +++|+|.+++......+++..+..++.||+.|++|||   +++|+||||||+||+++.++.        +|++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876657889999999999999999999   999999999999999987664        69999999875


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...      .....+++.|+||
T Consensus       158 ~~~------~~~~~~~~~y~aP  173 (258)
T cd05078         158 VLP------KEILLERIPWVPP  173 (258)
T ss_pred             cCC------chhccccCCccCc
Confidence            432      1234578889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.91  E-value=2.7e-23  Score=204.47  Aligned_cols=169  Identities=28%  Similarity=0.386  Sum_probs=145.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..|+||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999865 68889999986542 23557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  35789999999999999999999   99999999999999999999999999999887654332


Q ss_pred             cc--ccccccccccccCC
Q 047705          570 SM--TQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~--~~~~~~gt~~y~aP  585 (585)
                      ..  ......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             ccccccccccCChhhcCh
Confidence            21  22345688999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=99.91  E-value=9.9e-24  Score=224.40  Aligned_cols=166  Identities=23%  Similarity=0.315  Sum_probs=133.5

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC------CcceeEEeeeec
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH------RNLIKVISSCSN  481 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~  481 (585)
                      +....++|++.+.||+|+||.||+|.+. .++.||||+++... ........|+++++.++|      +++++++++|..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999865 67889999986432 223445667777777654      458889998876


Q ss_pred             C-CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCC--------
Q 047705          482 E-EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNM--------  551 (585)
Q Consensus       482 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~--------  551 (585)
                      + +..|+|||++ |++|.+++.+.. .+++..+..++.||+.||+|||   . .+||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            5 5788999998 778999887654 6889999999999999999999   7 5999999999999998665        


Q ss_pred             --------cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 --------IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                              .+||+|||.+....     ......+||+.||||
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSP  314 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCc
Confidence                    49999999876421     123456899999999

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.91  E-value=1.9e-23  Score=207.58  Aligned_cols=165  Identities=32%  Similarity=0.407  Sum_probs=134.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHH-HHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|+++... ......+..|+.+ ++..+||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999876 68999999987542 2223445556654 566789999999999999999999999


Q ss_pred             ccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          491 YMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       491 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      |++ |+|.+++..   ....+++..+..++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688877754   2346889999999999999999999   76 999999999999999999999999999886532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .   .......|+..|+||
T Consensus       157 ~---~~~~~~~~~~~y~aP  172 (283)
T cd06617         157 S---VAKTIDAGCKPYMAP  172 (283)
T ss_pred             c---cccccccCCccccCh
Confidence            1   122334678889988

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-24  Score=214.68  Aligned_cols=164  Identities=23%  Similarity=0.344  Sum_probs=140.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcC---CCcceeEEeeeec
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIR---HRNLIKVISSCSN  481 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  481 (585)
                      .+|...+.+|+|+||.|+.|.++ +..+|+||.+.+..        .+.....-.|++||+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999876 56789999886542        111223456999999997   9999999999999


Q ss_pred             CCeEEEEEEcc-CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          482 EEFKGLVLEYM-PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       482 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      ++++|++||-. +|-+|.+++..+. .+++.....|+.||+.|+++||   +.+|||||||-+|+.++.+|-+|++|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999975 5668999998765 7889999999999999999999   99999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |......    +-..++||..|.||
T Consensus       717 aa~~ksg----pfd~f~gtv~~aap  737 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAP  737 (772)
T ss_pred             hhhhcCC----Ccceeeeeccccch
Confidence            8865432    22457899999998

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.90  E-value=1.6e-23  Score=209.08  Aligned_cols=166  Identities=31%  Similarity=0.417  Sum_probs=143.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++||||+++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            468999999999999999999764 6789999998755444557788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++.+.  .+++..+..++.|++.|+.|||   +++++|+||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998764  4678889999999999999999   99999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       171 ~~~~~~~~~~y~~P  184 (293)
T cd06647         171 KRSTMVGTPYWMAP  184 (293)
T ss_pred             ccccccCChhhcCc
Confidence            22334688889998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.90  E-value=8.7e-24  Score=211.45  Aligned_cols=163  Identities=30%  Similarity=0.367  Sum_probs=139.3

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      |+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344457999999999999865 7899999998765444456788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      ++|.+++...  .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus       103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            9999987653  5788999999999999999999   9999999999999999999999999999987543221  1223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...|++.|+||
T Consensus       176 ~~~~~~~y~aP  186 (297)
T cd06659         176 SLVGTPYWMAP  186 (297)
T ss_pred             ceecCccccCH
Confidence            45688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.90  E-value=2.4e-23  Score=204.14  Aligned_cols=167  Identities=23%  Similarity=0.447  Sum_probs=139.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46799999999999999999988778889999886542 234678889999999999999999999877 7789999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++.... ...++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+|++|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            9999999997643 35788889999999999999999   8999999999999999999999999999987653221 11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       159 ~~~~~~~~~~y~~P  172 (260)
T cd05073         159 AREGAKFPIKWTAP  172 (260)
T ss_pred             cccCCcccccccCH
Confidence            12223456678887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.2e-23  Score=203.72  Aligned_cols=168  Identities=26%  Similarity=0.416  Sum_probs=140.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-----hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-----CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  485 (585)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+...     .......+.+|++++++++||||+++++++...  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999865 6899999987532     223456788999999999999999999998664  467


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++|||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 5788889999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCC-ccccccccccccccCC
Q 047705          566 GEDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~-~~~~~~~~gt~~y~aP  585 (585)
                      .... ........|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             cccccCccccccCCcccccCH
Confidence            2111 1112345688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=8e-24  Score=210.61  Aligned_cols=166  Identities=29%  Similarity=0.420  Sum_probs=141.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999876 58899999875432  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++++++.++..... .+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.+|++|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            999988888765543 5889999999999999999999   8999999999999999999999999999988653322  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++..|+||
T Consensus       155 ~~~~~~~~~~~y~aP  169 (286)
T cd07846         155 EVYTDYVATRWYRAP  169 (286)
T ss_pred             cccCcccceeeccCc
Confidence            122335678889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.90  E-value=2.5e-23  Score=210.28  Aligned_cols=161  Identities=25%  Similarity=0.347  Sum_probs=128.9

Q ss_pred             cceecccCceEEEEEEeC---CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeEEEEEEccC
Q 047705          419 NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKGLVLEYMP  493 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  493 (585)
                      ...||+|+||.||+|+..   ++..||+|.+....  ....+.+|+++++.++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999864   45789999886442  22456789999999999999999998854  457899999996


Q ss_pred             CCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----CCCCcEEEeeeccc
Q 047705          494 QGSLEKHLYST--------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIA  561 (585)
Q Consensus       494 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~a  561 (585)
                       +++.+++...        ...+++..+..++.|++.||+|||   +++|+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5787776532        124788889999999999999999   9999999999999999    46679999999999


Q ss_pred             ccccCCCCc-cccccccccccccCC
Q 047705          562 KLLIGEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      +........ .......||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             eccCCCcccccccCcceecccccCc
Confidence            875432211 122345789999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=1.4e-23  Score=208.74  Aligned_cols=164  Identities=27%  Similarity=0.364  Sum_probs=141.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888999999999999999865 68899999886542 33457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||   + ++++||||||+||++++++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            99999999887654 6889999999999999999999   5 589999999999999999999999999987542211  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        .....|+..|+||
T Consensus       159 --~~~~~~~~~~~aP  171 (284)
T cd06620         159 --ADTFVGTSTYMSP  171 (284)
T ss_pred             --cCccccCcccCCH
Confidence              1235688899988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=2.6e-23  Score=203.42  Aligned_cols=161  Identities=30%  Similarity=0.449  Sum_probs=135.6

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeee-cCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS-NEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  492 (585)
                      ++|++.+.||+|+||.||+|..+ +..||+|.++...  ..+.+..|+.++++++|++++++++++. .++..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57899999999999999999764 7789999886442  3457888999999999999999999754 556789999999


Q ss_pred             CCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++|.+++..... .+++..+..++.|++.|++|||   +++++||||||+||++++++.+|++|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            99999999976543 4788899999999999999999   9999999999999999999999999999988643211   


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                        ....++..||||
T Consensus       157 --~~~~~~~~y~aP  168 (256)
T cd05082         157 --DTGKLPVKWTAP  168 (256)
T ss_pred             --CCCccceeecCH
Confidence              122345678887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=2.4e-23  Score=206.95  Aligned_cols=165  Identities=28%  Similarity=0.415  Sum_probs=139.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++.... ...+.+..|+++++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999876 688999999875432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          493 PQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       493 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ++ ++.+++....  ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||.++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 8888886543  36889999999999999999999   89999999999999999999999999999976532211 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......+++.|+||
T Consensus       156 -~~~~~~~~~~y~~P  169 (284)
T cd07836         156 -TFSNEVVTLWYRAP  169 (284)
T ss_pred             -ccccccccccccCh
Confidence             12234578889987

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-25  Score=225.22  Aligned_cols=168  Identities=30%  Similarity=0.422  Sum_probs=150.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ..++|+..+.+|.|.||.||+|++. +++..|+|+++........-++.|+-+++.++|||||.+++.+...+..|++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3468999999999999999999865 789999999998876677788889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||.||+|.+.-+-. +++++.++..++++.++|++|+|   .++-+|||||-.||++++.|.+|++|||.+..+..  .-
T Consensus        93 ycgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             ecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            99999999866554 47899999999999999999999   99999999999999999999999999999887643  22


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .....++|||+||||
T Consensus       167 ~KrksfiGtpywmap  181 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAP  181 (829)
T ss_pred             hhhhcccCCccccch
Confidence            345678999999998

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=3.6e-23  Score=202.35  Aligned_cols=166  Identities=23%  Similarity=0.402  Sum_probs=141.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+++.. +++.||+|.+...  .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999865 6889999998753  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++.... ..+++.++..++.|++.|+.|||   +++++|+||+|+||+++.++.++++|||.+.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999987643 35788899999999999999999   8999999999999999999999999999987653221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......|++.|+||
T Consensus       156 ~~~~~~~~~~~~~~p  170 (256)
T cd08218         156 ELARTCIGTPYYLSP  170 (256)
T ss_pred             hhhhhccCCccccCH
Confidence            112234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=4e-23  Score=204.57  Aligned_cols=164  Identities=29%  Similarity=0.410  Sum_probs=140.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      -|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..++..|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778889999999999999864 68899999876432 334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||++.......  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998754  5788999999999999999999   9999999999999999999999999999987653221  11


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....|+..|+||
T Consensus       158 ~~~~~~~~~y~~P  170 (277)
T cd06641         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hccccCCccccCh
Confidence            2334678889988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=3.8e-26  Score=205.79  Aligned_cols=171  Identities=25%  Similarity=0.414  Sum_probs=139.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----  482 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  482 (585)
                      .....|+...+||+|.||+||+|+.+ +++.||+|++-.+  .........+|++++..++|+|++.+++.|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            34456788889999999999999865 6788998865332  222334567899999999999999998877432     


Q ss_pred             ---CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          483 ---EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       483 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                         ..+|+|+++|+. +|.-++......++..++.+++.++..||.|+|   ...|+|||+||+|+||+.+|.+||+|||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence               358999999976 899999887668899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCc--cccccccccccccCC
Q 047705          560 IAKLLIGEDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~--~~~~~~~gt~~y~aP  585 (585)
                      +|+.+......  ...+..+-|.+|.+|
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCH
Confidence            99876533222  223566779999987

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=2.8e-23  Score=203.32  Aligned_cols=160  Identities=27%  Similarity=0.393  Sum_probs=131.7

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          421 LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999643   57889999986442  3345678899999999999999999998754 4678999999999


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc-ccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-TQT  574 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  574 (585)
                      +|.+++.... .+++..+..++.|++.|++|+|   +++|+||||||+||++++++.+||+|||+++......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 6889999999999999999999   9999999999999999999999999999998654322211 112


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...+++.||||
T Consensus       157 ~~~~~~~y~aP  167 (257)
T cd05116         157 HGKWPVKWYAP  167 (257)
T ss_pred             CCCCCccccCH
Confidence            22345789987

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PLN03210 Resistant to P

Probab=99.90  E-value=9.6e-23  Score=236.98  Aligned_cols=311  Identities=22%  Similarity=0.254  Sum_probs=217.2

Q ss_pred             CccccCCCCCCEEecCCCc------ccccCCccccCCC-CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCc
Q 047705            3 PLEIGNLQNLEELDLRQNK------LIGTVPVAIFNVS-TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELN   75 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~   75 (585)
                      +.+|..|.+|+.|.+..+.      +...+|..|..++ +|+.|.+.+|.++ .+|..+  .+.+|++|+|++|++..++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEKLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCccccccc
Confidence            3468889999999996653      3345677787775 5999999999998 555444  4689999999999999887


Q ss_pred             cCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhh
Q 047705           76 FLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLS  155 (585)
Q Consensus        76 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  155 (585)
                        ..+..+++|++|+|++|......|.  ++.+++ |++|+|++|.....+|..+..+++|+.|++++|.-.+..|..+ 
T Consensus       628 --~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~-Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-  701 (1153)
T PLN03210        628 --DGVHSLTGLRNIDLRGSKNLKEIPD--LSMATN-LETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-  701 (1153)
T ss_pred             --cccccCCCCCEEECCCCCCcCcCCc--cccCCc-ccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-
Confidence              5578899999999998765455554  555665 9999999988777888889999999999999875444555444 


Q ss_pred             CCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccc------------------------------cCc
Q 047705          156 KLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACF------------------------------NNL  205 (585)
Q Consensus       156 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------------------------~~l  205 (585)
                      ++++|+.|++++|.....+|..   ..+|++|++++|.+.. +|..+                              ...
T Consensus       702 ~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~  777 (1153)
T PLN03210        702 NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLS  777 (1153)
T ss_pred             CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccccccchhhccccccccchhhhhcc
Confidence            7888999999988755555543   4578888888888763 44322                              112


Q ss_pred             ccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeC
Q 047705          206 IALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL  282 (585)
Q Consensus       206 ~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l  282 (585)
                      ++|+.|++++|.   .+|..++++++|+.|++++|...+.+|... .+++|+.|++++|.....+|..   ..+|+.|+|
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            456666666664   456666777777777777665433455444 5677777777776433334432   246777788


Q ss_pred             CCCccCccCChhhccCCccceEEeec-CcCeeeCCCCCCCCCCCccccCC
Q 047705          283 SNNNLSGAIPASLEKLSYLEDLNLSF-NKLEGEIPRGGSFGNFSAESFEG  331 (585)
Q Consensus       283 ~~N~l~~~~~~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~~~~~~~~~~~  331 (585)
                      ++|.++ .+|.++..+++|+.|++++ |++.+.++....+..++.+.+.+
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCC
Confidence            888777 5677777888888888877 45555444434445555555544

syringae 6; Provisional

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=3.4e-23  Score=205.11  Aligned_cols=165  Identities=28%  Similarity=0.419  Sum_probs=142.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++.... ......+..|+++++++.||||+++++++..++..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999865 68899999987542 34457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++...  .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++.......  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            9999999998754  5788889999999999999999   9999999999999999999999999999997654322  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~y~ap  170 (277)
T cd06640         157 KRNTFVGTPFWMAP  170 (277)
T ss_pred             ccccccCcccccCH
Confidence            22334678889987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.90  E-value=1.3e-23  Score=206.54  Aligned_cols=165  Identities=28%  Similarity=0.369  Sum_probs=143.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999876 68899999987553 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++......+++..+..++.|++.|++|+|   . .+++|+||||+||++++++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            9999999999876557889999999999999999999   8 999999999999999999999999999987653221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        .....|+..|+||
T Consensus       156 --~~~~~~~~~y~~P  168 (265)
T cd06605         156 --AKTFVGTSSYMAP  168 (265)
T ss_pred             --hhcccCChhccCH
Confidence              1125678889988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.90  E-value=2.5e-23  Score=210.15  Aligned_cols=167  Identities=26%  Similarity=0.401  Sum_probs=137.8

Q ss_pred             CCCccceecccCceEEEEEEeC---CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  486 (585)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999864   47899999987632   33345677899999999999999999999888  7899


Q ss_pred             EEEEccCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC----CCcEEEeee
Q 047705          487 LVLEYMPQGSLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD----NMIAYLSDF  558 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Df  558 (585)
                      +||||+++ ++.+++....    ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 7777664321    25788899999999999999999   999999999999999998    999999999


Q ss_pred             cccccccCCCC-ccccccccccccccCC
Q 047705          559 GIAKLLIGEDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~-~~~~~~~~gt~~y~aP  585 (585)
                      |+++....... ........+|+.|+||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCH
Confidence            99986543222 1223345788999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.90  E-value=2.3e-23  Score=209.73  Aligned_cols=168  Identities=30%  Similarity=0.390  Sum_probs=140.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh--hHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR--AFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKG  486 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  486 (585)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.++.....  ....+.+|++++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            4578999999999999999999875 6899999998754221  223456799999999999999999998755  5689


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||++ ++|.+++......+++.++..++.|+++|++|||   +.+++||||||+||++++++.+||+|||.+.....
T Consensus        85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999996 4898888765567899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......+++.|+||
T Consensus       161 ~~--~~~~~~~~~~~y~aP  177 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAP  177 (309)
T ss_pred             cc--CCCCcccccccccCh
Confidence            22  122334567889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.90  E-value=3.2e-23  Score=205.86  Aligned_cols=175  Identities=27%  Similarity=0.360  Sum_probs=144.9

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec-
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN-  481 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  481 (585)
                      +..++....+.|++.+.+|+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44556667788999999999999999999875 68899999986543 2345678899999998 79999999999853 


Q ss_pred             -----CCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          482 -----EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       482 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                           .+..|++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||   +.+|+|+||||+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999987643 35788888999999999999999   899999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||++.......  .......|++.|+||
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aP  190 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAP  190 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCH
Confidence            9999987643211  122345688899998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=1.2e-23  Score=208.23  Aligned_cols=164  Identities=27%  Similarity=0.392  Sum_probs=140.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+..|++++++++||||+++++++..++..|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999765 67889999987442 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++...  .+++..+..++.|+++|+.|||   +++++|+||+|+||++++++.+|++|||++.......  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999988653  5788899999999999999999   8999999999999999999999999999988654221  12


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....|+..|+||
T Consensus       158 ~~~~~~~~~y~aP  170 (277)
T cd06642         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hhcccCcccccCH
Confidence            2334678889987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.4e-23  Score=205.64  Aligned_cols=169  Identities=28%  Similarity=0.362  Sum_probs=142.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC-----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE-----  483 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  483 (585)
                      ...++|++.+.||+|++|.||+|..+ +++.+|+|++..... ..+.+..|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            34688999999999999999999875 678999999875533 346788999999999 7999999999986544     


Q ss_pred             -eEEEEEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          484 -FKGLVLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       484 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                       ..|+||||+++++|.+++...   +..+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.+|++|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             489999999999999988653   246889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+.......  .......|++.|+||
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aP  182 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAP  182 (275)
T ss_pred             cceecccch--hhhcCccccccccCH
Confidence            987653221  122345688889988

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=3.2e-23  Score=203.43  Aligned_cols=163  Identities=29%  Similarity=0.450  Sum_probs=131.7

Q ss_pred             ceecccCceEEEEEEeC----CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeee-cCCeEEEEEEccC
Q 047705          420 NLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCS-NEEFKGLVLEYMP  493 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  493 (585)
                      +.||+|+||.||+|.+.    ++..||+|.+... .....+.+..|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999753    2457999987543 2334567888999999999999999999765 4556899999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc--c
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS--M  571 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~  571 (585)
                      +|+|.+++.......++..+..++.|+++|+.|||   +.+++||||||+||++++++.+|++|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555677888899999999999999   899999999999999999999999999999865322111  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (262)
T cd05058         158 NHTGAKLPVKWMAL  171 (262)
T ss_pred             ccccCcCCccccCh
Confidence            11233456789988

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.3e-23  Score=205.13  Aligned_cols=164  Identities=29%  Similarity=0.427  Sum_probs=141.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcC---CCcceeEEeeeecCCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .|+..+.||+|+||.||+|.+. +++.||+|.++.. .....+.+.+|+++++.++   |||++++++++..++..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4788899999999999999864 7899999998654 2334567888999999996   999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999998664  6889999999999999999999   9999999999999999999999999999988764322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......|+..|+||
T Consensus       156 -~~~~~~~~~~~y~aP  170 (277)
T cd06917         156 -SKRSTFVGTPYWMAP  170 (277)
T ss_pred             -cccccccCCcceeCH
Confidence             122345688899988

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=4.1e-23  Score=204.71  Aligned_cols=157  Identities=27%  Similarity=0.383  Sum_probs=128.2

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHH---HhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          421 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIM---KSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .||+|+||.||+|... +++.||+|.+....   ......+..|..++   ...+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 68899999886532   11122333444333   34479999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++.... .+++..+..++.|++.|++|||   ..+|+||||||+||++++++.+|++|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999887654 6899999999999999999999   999999999999999999999999999998754321    12


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.||||
T Consensus       153 ~~~~~~~~y~aP  164 (279)
T cd05633         153 HASVGTHGYMAP  164 (279)
T ss_pred             cCcCCCcCccCH
Confidence            234689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=2.5e-23  Score=207.15  Aligned_cols=167  Identities=28%  Similarity=0.381  Sum_probs=141.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|... +++.||+|+++..  .....+.+..|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46899999999999999999876 6889999988643  22345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++++.+..+.... ..+++..+..++.|++.|+.|||   +.+++|+|++|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99886666555443 45889999999999999999999   89999999999999999999999999999887643322 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++.+|+||
T Consensus       156 ~~~~~~~~~~~~~~P  170 (288)
T cd07833         156 SPLTDYVATRWYRAP  170 (288)
T ss_pred             ccccCcccccCCcCC
Confidence            122345688899998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.90  E-value=3.2e-24  Score=195.66  Aligned_cols=164  Identities=26%  Similarity=0.338  Sum_probs=138.9

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .+.+..+|.|..|.|++++.+ +|...|||.+... .+...+++...++++.+. +.|+||+.+|||..+..+++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            445667999999999999876 6889999998754 445567777888877666 4899999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                       +-.++.+++.-+.++++.-+-++...+++||.||.+  .++|+|||+||+|||+|+.|.+|++|||++.++.+..   .
T Consensus       174 -s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  174 -STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             -HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence             446777777777789998888999999999999996  7899999999999999999999999999998875432   2


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .+...|.+.||||
T Consensus       248 htrsAGC~~YMaP  260 (391)
T KOG0983|consen  248 HTRSAGCAAYMAP  260 (391)
T ss_pred             cccccCCccccCc
Confidence            3456799999998

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=5.6e-23  Score=201.84  Aligned_cols=166  Identities=28%  Similarity=0.405  Sum_probs=144.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|++|.||+|... +++.||+|++..... .....+..|++.+.+++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999876 589999999876543 3457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++... ..+++..+..++.|+++|++|+|   + .+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            9999999999865 36899999999999999999999   8 9999999999999999999999999999886543221 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......++..|+||
T Consensus       156 -~~~~~~~~~~y~~p  169 (264)
T cd06623         156 -QCNTFVGTVTYMSP  169 (264)
T ss_pred             -cccceeecccccCH
Confidence             11234678889887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=6e-23  Score=201.65  Aligned_cols=167  Identities=33%  Similarity=0.470  Sum_probs=143.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|... +++.||+|.++....  ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999865 788999999876543  3567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998754 5788889999999999999999   9999999999999999999999999999988754322111


Q ss_pred             c--cccccccccccCC
Q 047705          572 T--QTQTLATIGYMAP  585 (585)
Q Consensus       572 ~--~~~~~gt~~y~aP  585 (585)
                      .  .....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~P  172 (264)
T cd06626         157 GEEVQSLAGTPAYMAP  172 (264)
T ss_pred             cccccCCcCCcCccCh
Confidence            1  1134678889988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=2.1e-23  Score=225.67  Aligned_cols=251  Identities=26%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +||..+.  .+|+.|++.+|+|+ .+|.   ..++|++|+|++|+|+.. |.    ..++|++|+|++|+|+.+|.  . 
T Consensus       215 sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~----lp~sL~~L~Ls~N~L~~Lp~--l-  280 (788)
T PRK15387        215 TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV----LPPGLLELSIFSNPLTHLPA--L-  280 (788)
T ss_pred             cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cC----cccccceeeccCCchhhhhh--c-
Confidence            4677765  48999999999998 4554   358999999999999944 43    24789999999999999873  2 


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                        .++|+.|+|++|+++.+ |.     .+.+|+.|+|++|++++. |..   ..+|+.|++++|+|.+++ . +  ..+|
T Consensus       281 --p~~L~~L~Ls~N~Lt~L-P~-----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~LP-~-l--p~~L  344 (788)
T PRK15387        281 --PSGLCKLWIFGNQLTSL-PV-----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSLP-T-L--PSGL  344 (788)
T ss_pred             --hhhcCEEECcCCccccc-cc-----cccccceeECCCCccccC-CCC---cccccccccccCcccccc-c-c--cccc
Confidence              36799999999999854 32     234599999999999964 432   356889999999998643 2 1  2489


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCc
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNN  238 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~  238 (585)
                      ++|+|++|+|++ +|..   ..+|+.|++++|+|+. +|..   ..+|+.|++++|.  .+|..   .++|+.|++++|+
T Consensus       345 q~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~  413 (788)
T PRK15387        345 QELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVL---PSELKELMVSGNR  413 (788)
T ss_pred             ceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCc---ccCCCEEEccCCc
Confidence            999999999995 4543   3578899999999985 5553   3579999999998  33322   3689999999999


Q ss_pred             ccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhcc
Q 047705          239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEK  297 (585)
Q Consensus       239 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  297 (585)
                      +++ +|..   ..+|+.|++++|+++ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus       414 Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        414 LTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             CCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            996 4543   357889999999999 57888999999999999999999888877644

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.90  E-value=4e-23  Score=208.08  Aligned_cols=171  Identities=26%  Similarity=0.389  Sum_probs=140.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----  483 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  483 (585)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++...+    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34567999999999999999999875 68999999886442  222345567999999999999999999886554    


Q ss_pred             ----eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          484 ----FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       484 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                          ..++||||++ +++.+++......+++.++..++.|++.|++|||   +++++|+||||+||+++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                4599999995 5888888766557899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCCc--cccccccccccccCC
Q 047705          560 IAKLLIGEDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~--~~~~~~~gt~~y~aP  585 (585)
                      ++.........  .......++..|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCc
Confidence            99865432211  112345678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.3e-23  Score=224.41  Aligned_cols=169  Identities=22%  Similarity=0.251  Sum_probs=131.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC--CCcEEEEEEEe--------------c---hhhhhHHHHHHHHHHHHhcCCCcc
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFN--------------L---QCRRAFKSFDVECEIMKSIRHRNL  472 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~--------------~---~~~~~~~~~~~E~~~l~~l~h~ni  472 (585)
                      ..++|++.+.||+|+||+||+|..+  .+..++.|.+.              .   ........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998753  22222222110              0   111234567889999999999999


Q ss_pred             eeEEeeeecCCeEEEEEEccCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       473 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      +++++++...+..|+|+|++ ++++.+++....    .......+..++.|++.||+|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            99999999999999999999 457877775432    12335567789999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .++.+||+|||+++.+.... .......+||+.|+||
T Consensus       302 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aP  337 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSP  337 (501)
T ss_pred             CCCCEEEEeCCCceecCccc-ccccccccCCcCCCCc
Confidence            99999999999998764322 1222346799999998

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=7.5e-23  Score=205.83  Aligned_cols=162  Identities=31%  Similarity=0.386  Sum_probs=138.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..|+..+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56889999999999999999865 68999999886432   233457888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++ |++.+++......+++..+..++.|++.|+.|||   ..+|+||||+|+||++++++.+||+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 5787777655557899999999999999999999   899999999999999999999999999998754221  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                          ....|++.|+||
T Consensus       169 ----~~~~~~~~y~aP  180 (307)
T cd06607         169 ----NSFVGTPYWMAP  180 (307)
T ss_pred             ----CCccCCccccCc
Confidence                234578889988

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.90  E-value=8.3e-23  Score=203.18  Aligned_cols=164  Identities=29%  Similarity=0.351  Sum_probs=140.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .|...+.||+|++|.||+|... +++.+|+|+++.......+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999864 788999999875544455678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++...  .+++..+..++.|++.|++|+|   +++++||||+|+||+++.++.++++|||.+.......  ...
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            99999998773  5788899999999999999999   9999999999999999999999999999887543221  122


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....|++.|+||
T Consensus       173 ~~~~~~~~y~aP  184 (285)
T cd06648         173 KSLVGTPYWMAP  184 (285)
T ss_pred             ccccCCccccCH
Confidence            335688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.2e-22  Score=198.17  Aligned_cols=165  Identities=32%  Similarity=0.460  Sum_probs=143.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++|||++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999865 678999999876533  4557889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++... ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            9999999998776 36899999999999999999999   99999999999999999999999999999987543221  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+..|+||
T Consensus       155 ~~~~~~~~~~y~~p  168 (254)
T cd06627         155 DDASVVGTPYWMAP  168 (254)
T ss_pred             cccccccchhhcCH
Confidence            12345678889887

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.90  E-value=8.8e-23  Score=199.52  Aligned_cols=165  Identities=28%  Similarity=0.495  Sum_probs=140.6

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|+..+.||+|+||.||+|... +++.+|+|.+...  .....+.+..|+++++.++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4888999999999999999865 6889999998754  223456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +++++|.+++.... ..+++..+..++.++++|++|+|   +++++|+||||+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997653 35789999999999999999999   9999999999999999854 468999999998653221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......|++.|+||
T Consensus       157 --~~~~~~~~~~y~aP  170 (256)
T cd08220         157 --KAYTVVGTPCYISP  170 (256)
T ss_pred             --cccccccCCcccCc
Confidence              12235688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.90  E-value=8.3e-23  Score=201.55  Aligned_cols=160  Identities=31%  Similarity=0.552  Sum_probs=129.9

Q ss_pred             ceecccCceEEEEEEeC-CCc--EEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|++. ++.  .+|+|.++.. .....+.+..|++++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999875 443  4688887643 234456788899999999 899999999999999999999999999


Q ss_pred             CCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          495 GSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       495 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      |+|.+++....               ..+++..+..++.|++.|++|||   +++++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               24678899999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....   .........+..|+||
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~ap  180 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAI  180 (270)
T ss_pred             Cccccch---hhhccCCCCccccCCh
Confidence            9863211   1111122335668887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.90  E-value=6.8e-23  Score=204.88  Aligned_cols=166  Identities=27%  Similarity=0.368  Sum_probs=136.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCe-----
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEF-----  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  484 (585)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.++....  .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999875 689999998765422  23356788999999995 6999999999877665     


Q ss_pred             EEEEEEccCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeec
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFG  559 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg  559 (585)
                      .|+||||+++ ++.+++....    ..+++..++.++.||++||+|||   .++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 8888876532    35789999999999999999999   999999999999999998 8899999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.......  ......+++.|+||
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aP  180 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAP  180 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCCh
Confidence            9886532211  12234567889887

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.90  E-value=1.4e-22  Score=197.17  Aligned_cols=165  Identities=36%  Similarity=0.500  Sum_probs=145.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      +|+..+.||+|++|.||+|... +++.+++|++........+.+.+|++.++.++|++++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999876 688999999876654456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++......+++..+..++.|++.|++|||   .++++|+||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876557899999999999999999999   89999999999999999999999999999887543221   2


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....|+..|+||
T Consensus       155 ~~~~~~~~~~~P  166 (253)
T cd05122         155 NTMVGTPYWMAP  166 (253)
T ss_pred             cceecCCcccCH
Confidence            345678889887

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=6.3e-23  Score=205.88  Aligned_cols=170  Identities=31%  Similarity=0.408  Sum_probs=140.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----  483 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  483 (585)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...  ......+..|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999876 68899999987543  223356778999999999999999999887654    


Q ss_pred             ------eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          484 ------FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       484 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                            ..++|+||+++ ++...+......+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 777777765557899999999999999999999   99999999999999999999999999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||.+........ .......++..|+||
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~P  186 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPP  186 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccCh
Confidence            999986543221 112233467788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=1e-22  Score=199.90  Aligned_cols=169  Identities=27%  Similarity=0.401  Sum_probs=140.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  489 (585)
                      +|++.+.||.|+||.||+|... +++.||+|.+...  .....+.+..|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4888899999999999999865 7889999988643  23345678889999999999999999998754  45679999


Q ss_pred             EccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGC--STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||+++++|.+++...   ...+++..++.++.|+++|+.|+|..+  ..+++|+||||+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998754   346889999999999999999999432  578999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....  ......|++.|+||
T Consensus       161 ~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             cCCcc--cccccccCCCccCh
Confidence            43221  12345688999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.90  E-value=4.8e-23  Score=204.76  Aligned_cols=165  Identities=29%  Similarity=0.424  Sum_probs=138.9

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|+..+.||+|++|.||+|+.. +++.||||.++...  ......+..|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999875 68899999886442  22335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +. +++.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+|++|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            95 68988886543 36789999999999999999999   9999999999999999999999999999987653221  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+++.|+||
T Consensus       155 ~~~~~~~~~~~y~aP  169 (284)
T cd07860         155 RTYTHEVVTLWYRAP  169 (284)
T ss_pred             cccccccccccccCC
Confidence            112334568889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.89  E-value=1.1e-22  Score=201.59  Aligned_cols=157  Identities=27%  Similarity=0.380  Sum_probs=128.4

Q ss_pred             eecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHH---HHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          421 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVEC---EIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .||+|+||.||+|+.. +++.||+|++.....   .....+..|.   +.++...||+|+++++++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 688999999875321   1112233343   34445689999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      |++|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.....    ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            999999887643 6899999999999999999999   899999999999999999999999999998754321    12


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....|+..|+||
T Consensus       153 ~~~~~~~~y~aP  164 (278)
T cd05606         153 HASVGTHGYMAP  164 (278)
T ss_pred             cCcCCCcCCcCc
Confidence            335689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=9e-23  Score=202.07  Aligned_cols=158  Identities=29%  Similarity=0.423  Sum_probs=134.1

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+|... +|+.||+|.+....   ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68899999987532   22344567899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccc
Q 047705          498 EKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT  576 (585)
Q Consensus       498 ~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  576 (585)
                      .+++..... .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.+|++|||.+.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            999876543 5889999999999999999999   99999999999999999999999999999876532   1122334


Q ss_pred             cccccccCC
Q 047705          577 LATIGYMAP  585 (585)
Q Consensus       577 ~gt~~y~aP  585 (585)
                      .++..|+||
T Consensus       155 ~~~~~y~~P  163 (277)
T cd05577         155 AGTPGYMAP  163 (277)
T ss_pred             cCCCCcCCH
Confidence            577788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.89  E-value=1.1e-22  Score=202.41  Aligned_cols=169  Identities=33%  Similarity=0.410  Sum_probs=146.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ...+.|+..+.+|+|+||.||+|.++ +++.||+|++..... ..+.+..|+++++.++|+|++++++++...+..|+++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45567899999999999999999876 688999999976544 4567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++++|.+++......+++..+..++.|++.|++|||   ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999886546889999999999999999999   89999999999999999999999999999875432211


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......+++.|+||
T Consensus       172 --~~~~~~~~~~y~~P  185 (286)
T cd06614         172 --KRNSVVGTPYWMAP  185 (286)
T ss_pred             --hhccccCCcccCCH
Confidence              12234577889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.89  E-value=1.1e-22  Score=199.75  Aligned_cols=157  Identities=29%  Similarity=0.412  Sum_probs=136.3

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+|+.. +++.||+|++....   ....+.+..|+++++.++||||+++++++..++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999876 58899999987532   23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL  577 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  577 (585)
                      .+++.+.. .+++..+..++.|++.|++|+|   +++++|+||+|+||+++.++.+||+|||.++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99998754 5788899999999999999999   8999999999999999999999999999998764321   123346


Q ss_pred             ccccccCC
Q 047705          578 ATIGYMAP  585 (585)
Q Consensus       578 gt~~y~aP  585 (585)
                      |++.|+||
T Consensus       154 ~~~~~~~P  161 (262)
T cd05572         154 GTPEYVAP  161 (262)
T ss_pred             CCcCccCh
Confidence            88889988

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.89  E-value=5.8e-23  Score=200.67  Aligned_cols=160  Identities=28%  Similarity=0.498  Sum_probs=133.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|.. +++.||+|.++...  ..+.+.+|+.++++++||||+++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4689999999999999999975 67789999886542  235788899999999999999999998655 4799999999


Q ss_pred             CCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          494 QGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       494 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +++|.+++..... .+++..+..++.|++.|+.|+|   +.+++||||||+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            9999999976543 5788899999999999999999   999999999999999999999999999998754211     


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ......+..|+||
T Consensus       154 ~~~~~~~~~y~~p  166 (254)
T cd05083         154 VDNSKLPVKWTAP  166 (254)
T ss_pred             CCCCCCCceecCH
Confidence            1112234567776

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.6e-25  Score=214.83  Aligned_cols=167  Identities=25%  Similarity=0.339  Sum_probs=146.3

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCc-EEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGM-EVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ...+++.+..||-|+||.|-+++..... .+|+|++++.   ..+..+++..|-.+|..++.|+||++|..|.+..++|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            3456777889999999999999865433 4888887654   34456778889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      .||-|-||.+...+++.+ .++......++..+++|++|||   .++||.|||||+|.++|.+|.+||.|||+|+.+...
T Consensus       498 LmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999998765 7888889999999999999999   999999999999999999999999999999998654


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ...   -.+||||.|.||
T Consensus       574 ~KT---wTFcGTpEYVAP  588 (732)
T KOG0614|consen  574 RKT---WTFCGTPEYVAP  588 (732)
T ss_pred             Cce---eeecCCcccccc
Confidence            443   458999999999

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.2e-22  Score=198.78  Aligned_cols=161  Identities=30%  Similarity=0.415  Sum_probs=131.5

Q ss_pred             ceecccCceEEEEEEeC--C--CcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG--D--GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|.+.  +  +..||+|.+..... ...+.+..|+++++.++||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            46999999999999753  2  36899999875532 345678899999999999999999998764 467999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc-c
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT-Q  573 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~  573 (585)
                      ++|.+++.... .+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+||+|||.++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 6889999999999999999999   89999999999999999999999999999986543222111 1


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....++..|+||
T Consensus       156 ~~~~~~~~y~aP  167 (257)
T cd05060         156 TAGRWPLKWYAP  167 (257)
T ss_pred             cCccccccccCH
Confidence            122234578887

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=1.2e-22  Score=198.43  Aligned_cols=166  Identities=30%  Similarity=0.461  Sum_probs=144.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ....+.+..|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999875 68899999987543  24566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++....   ..+++..+..++.+++.|+.|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998753   57899999999999999999999   8999999999999999999999999999988653322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......|++.|+||
T Consensus       158 --~~~~~~~~~~~y~~p  172 (258)
T cd08215         158 --DLAKTVVGTPYYLSP  172 (258)
T ss_pred             --ceecceeeeecccCh
Confidence              122345688889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.89  E-value=1e-22  Score=203.49  Aligned_cols=166  Identities=30%  Similarity=0.409  Sum_probs=136.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|++|.||+|++. +++.||+|.+....  ....+.+..|++++++++||||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999876 78899999886432  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccccccCCC
Q 047705          491 YMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |++ +++.+++..... ..++..+..++.||+.||+|||   +++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 588887765432 3578888899999999999999   899999999999999984 5679999999997543211


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......|++.|+||
T Consensus       158 --~~~~~~~~~~~y~~P  172 (294)
T PLN00009        158 --RTFTHEVVTLWYRAP  172 (294)
T ss_pred             --cccccCceeecccCH
Confidence              112334578889987

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.89  E-value=5.7e-23  Score=209.55  Aligned_cols=168  Identities=31%  Similarity=0.403  Sum_probs=139.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC--CeE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE--EFK  485 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  485 (585)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++...  .......+..|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4568999999999999999999876 6889999987542  223345677899999999 999999999998654  368


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++ ++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5999988765  5788888899999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCc---cccccccccccccCC
Q 047705          566 GEDQS---MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~---~~~~~~~gt~~y~aP  585 (585)
                      .....   .......||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             cccccccCcchhcccccccccCc
Confidence            33221   122345689999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=9.4e-23  Score=208.27  Aligned_cols=165  Identities=25%  Similarity=0.352  Sum_probs=138.6

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC---
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE---  483 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  483 (585)
                      ....++|++.+.||+|+||.||+|... +++.||||++...  .....+.+..|+++++.++||||+++++++...+   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            445678999999999999999999754 7899999998643  2223456788999999999999999999987653   


Q ss_pred             ---eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          484 ---FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       484 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                         ..++||||+ ++++.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+|++|||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence               458999999 77999888653  5889999999999999999999   99999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.....     ......+++.|+||
T Consensus       165 ~~~~~~-----~~~~~~~~~~y~aP  184 (343)
T cd07880         165 ARQTDS-----EMTGYVVTRWYRAP  184 (343)
T ss_pred             cccccc-----CccccccCCcccCH
Confidence            886422     12234678889988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.89  E-value=1.1e-22  Score=202.44  Aligned_cols=165  Identities=28%  Similarity=0.423  Sum_probs=140.5

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEEEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGLVLE  490 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  490 (585)
                      |++.+.||+|+||.||+|... +++.+|+|++....  ......+..|+++++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999876 58899999997653  33345678899999999999999999999888  88999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++ ++.+++......+++..+..++.|+++|++|||   +.+++|+||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9964 899888776557899999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......++..|+||
T Consensus       156 ~~~~~~~~~~~y~~P  170 (287)
T cd07840         156 ADYTNRVITLWYRPP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence            122334578889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=6.6e-23  Score=201.32  Aligned_cols=160  Identities=31%  Similarity=0.453  Sum_probs=136.9

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+|++. +++.||+|++.....   ...+.+.+|++++++++||||+++++.+..++..|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 589999999875432   4456788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC------cc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ------SM  571 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~  571 (585)
                      .+++.+.. .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998755 6889999999999999999999   99999999999999999999999999999876432211      11


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......++..|+||
T Consensus       157 ~~~~~~~~~~~~~P  170 (265)
T cd05579         157 EDKRIVGTPDYIAP  170 (265)
T ss_pred             cccCcccCccccCH
Confidence            22345678889887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-23  Score=183.39  Aligned_cols=166  Identities=28%  Similarity=0.355  Sum_probs=135.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +....+..||+|++|.|-+-++. +|+..|+|.+... ..+..++...|+++..+. .+|++|++||.+..++..|+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            44555678999999999888765 8999999998754 234456677788876655 79999999999999999999999


Q ss_pred             ccCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          491 YMPQGSLEKHLY---STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       491 ~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      .|. -+|+.+-.   ..+...++.-+-+|+..|+.||.|||+  +..+||||+||+|||++.+|++|++|||++-...+ 
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD-  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence            994 47776544   234578888889999999999999995  67899999999999999999999999999886542 


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                        +...+...|...||||
T Consensus       202 --SiAkt~daGCkpYmaP  217 (282)
T KOG0984|consen  202 --SIAKTMDAGCKPYMAP  217 (282)
T ss_pred             --hhHHHHhcCCCccCCh
Confidence              2233445688899998

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=1.9e-22  Score=203.76  Aligned_cols=160  Identities=31%  Similarity=0.396  Sum_probs=137.4

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      |+..+.||+|+||.||+|+.. ++..||+|.+...   .......+..|++++++++|||++++++++..++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            777889999999999999865 6889999998643   223345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +. |++.+.+......+++.++..++.|++.|+.|||   +.+|+||||+|+||+++.++.+||+|||++.....     
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            96 4888877665557899999999999999999999   99999999999999999999999999999875321     


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                       .....|++.|+||
T Consensus       178 -~~~~~~~~~y~aP  190 (317)
T cd06635         178 -ANSFVGTPYWMAP  190 (317)
T ss_pred             -cccccCCccccCh
Confidence             1234678889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=8e-23  Score=203.92  Aligned_cols=160  Identities=29%  Similarity=0.347  Sum_probs=137.6

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          419 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ...||+|+||.||+|... +++.||+|.+..........+..|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999865 7899999988655444556788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL  577 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  577 (585)
                      .+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  4788899999999999999999   8999999999999999999999999999987653221  1223456


Q ss_pred             ccccccCC
Q 047705          578 ATIGYMAP  585 (585)
Q Consensus       578 gt~~y~aP  585 (585)
                      |++.|+||
T Consensus       178 ~~~~y~~p  185 (292)
T cd06657         178 GTPYWMAP  185 (292)
T ss_pred             cCccccCH
Confidence            88899987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.89  E-value=6.9e-23  Score=208.77  Aligned_cols=167  Identities=28%  Similarity=0.377  Sum_probs=137.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----CeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  485 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++... .......+..|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 7899999998643 223445677899999999999999999876544     357


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+++||++ +++.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 5888877654  5888999999999999999999   9999999999999999999999999999988653


Q ss_pred             CCCCcc-ccccccccccccCC
Q 047705          566 GEDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ...... ......||+.||||
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             ccccccCCcCCcCcCCCccCh
Confidence            222111 12345789999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.89  E-value=8.3e-24  Score=195.45  Aligned_cols=163  Identities=27%  Similarity=0.321  Sum_probs=133.7

Q ss_pred             hcCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec----CCe
Q 047705          412 ATDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN----EEF  484 (585)
Q Consensus       412 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  484 (585)
                      .+++|++- ++||-|-.|.|..+..+ +|+.+|+|++...     ...++|++.--.. .|||||.+++.|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            44566543 58999999999999765 7899999987532     3445677765554 69999999998754    346


Q ss_pred             EEEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeecc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGI  560 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~  560 (585)
                      ..+|||.|+||+|...+++++. .+++.++.+|+.||+.|+.|||   ...|.||||||+|+|..   .+..+|++|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            7899999999999999987653 6899999999999999999999   99999999999999996   566899999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+.-.   ........+-||+|.||
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAP  232 (400)
T ss_pred             ccccC---CCccccCCcccccccCH
Confidence            99643   23344567899999998

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=1.7e-22  Score=201.18  Aligned_cols=165  Identities=32%  Similarity=0.375  Sum_probs=137.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  489 (585)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...  +..|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999875 68899999987542 23456788999999999999999999988654  4789999


Q ss_pred             EccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   2335788889999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..    .....++..|+||
T Consensus       158 ~~----~~~~~~~~~y~~p  172 (287)
T cd06621         158 SL----AGTFTGTSFYMAP  172 (287)
T ss_pred             cc----cccccCCccccCH
Confidence            11    1234567788887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.89  E-value=1.1e-22  Score=208.88  Aligned_cols=164  Identities=27%  Similarity=0.335  Sum_probs=136.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  482 (585)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.++++++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999865 7899999998643  223345677899999999999999999988644      


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ...|+||||+. +++.+.+...   +++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 5888887643   788889999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....   .......|++.|+||
T Consensus       167 ~~~~~---~~~~~~~~~~~y~aP  186 (353)
T cd07850         167 TAGTS---FMMTPYVVTRYYRAP  186 (353)
T ss_pred             eCCCC---CCCCCCcccccccCH
Confidence            65321   112345688899998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.89  E-value=6.6e-23  Score=203.17  Aligned_cols=168  Identities=33%  Similarity=0.489  Sum_probs=143.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+..|+++++++. ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999875 7899999998753   2233467788999999998 99999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998764 6899999999999999999999   9999999999999999999999999999988654322


Q ss_pred             Cc------------------cccccccccccccCC
Q 047705          569 QS------------------MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~------------------~~~~~~~gt~~y~aP  585 (585)
                      ..                  .......|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  191 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSP  191 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCH
Confidence            10                  112344678889887

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.89  E-value=6.9e-23  Score=201.93  Aligned_cols=163  Identities=30%  Similarity=0.497  Sum_probs=132.9

Q ss_pred             ceecccCceEEEEEEeCC-------CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997542       2578999875432 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-----cEEEeeecc
Q 047705          492 MPQGSLEKHLYST------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-----IAYLSDFGI  560 (585)
Q Consensus       492 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-----~~kl~Dfg~  560 (585)
                      +++++|.+++...      ...+++.++..++.|++.|++|||   +.+++|+||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998753      124678889999999999999999   89999999999999999877     899999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++...............++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             ccccccccccccCcccCCCccccCH
Confidence            9865432222222233456788887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-23  Score=209.28  Aligned_cols=166  Identities=30%  Similarity=0.478  Sum_probs=138.7

Q ss_pred             CCCccceecccCceEEEEEEeC---CC--cEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG---DG--MEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ..+..+.||+|-||.||+|.+.   .|  -.||||..+.++ ....+.|..|+-+|+.++||||++++|.|... ..|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            3445678999999999999743   23  348899887643 34568899999999999999999999999764 68999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||.++-|.|..+++..+..++......++.||+.||.|||   +.++|||||..+|||+....-||++|||+++.+.++.
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999999998888999999999999999999999   9999999999999999999999999999999875433


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      .. ..+...-...||||
T Consensus       546 yY-kaS~~kLPIKWmaP  561 (974)
T KOG4257|consen  546 YY-KASRGKLPIKWMAP  561 (974)
T ss_pred             hh-hccccccceeecCc
Confidence            22 22222234569998

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.89  E-value=1.5e-22  Score=199.93  Aligned_cols=167  Identities=31%  Similarity=0.492  Sum_probs=132.5

Q ss_pred             CCccceecccCceEEEEEEeC----CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          416 FSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      |.+.+.||+|+||.||+|.++    +++.||||++...  .....+++.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999753    3688999998654  2334567888999999999999999999876532      


Q ss_pred             eEEEEEEccCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          484 FKGLVLEYMPQGSLEKHLYST-----NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      ..++++||+++|++.+++...     ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998887432     124688889999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |.++...............+++.|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCH
Confidence            998865322211122233455667776

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=2.1e-22  Score=198.43  Aligned_cols=165  Identities=27%  Similarity=0.459  Sum_probs=137.1

Q ss_pred             CCCccceecccCceEEEEEEeCC--CcEEEEEEEech----------hhhhHHHHHHHHHHHHh-cCCCcceeEEeeeec
Q 047705          415 GFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQ----------CRRAFKSFDVECEIMKS-IRHRNLIKVISSCSN  481 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  481 (585)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999998764  688999987532          12234556778888865 799999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                      ++..+++|||+++++|.+++..   ....+++..++.++.|++.|+.|||   + .+++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3346888899999999999999999   5 6899999999999999999999999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||.+.......   ......|+..|+||
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~P  182 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCP  182 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcCh
Confidence            99998653322   22345688889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.5e-22  Score=207.02  Aligned_cols=171  Identities=26%  Similarity=0.323  Sum_probs=141.9

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeee
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCS  480 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  480 (585)
                      ....++....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            344567778899999999999999999999864 78899999986432  223456778999999999999999999875


Q ss_pred             cC------CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEE
Q 047705          481 NE------EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       481 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~k  554 (585)
                      ..      ...|++++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            43      3468888887 78998887654  4888999999999999999999   99999999999999999999999


Q ss_pred             EeeecccccccCCCCccccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|||+++....     ......|++.|+||
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aP  186 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAP  186 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCH
Confidence            999999875421     12335678889988

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-23  Score=196.11  Aligned_cols=168  Identities=27%  Similarity=0.333  Sum_probs=146.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  486 (585)
                      ..++|...++||+|+|++|..+++. +.+.+|+|++++..   ..+..-.+.|-.+.... +||.+|-++.+|+++...+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            4468999999999999999999865 67889999988652   23345566788888777 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +|.||+.||+|.-++++.. .++++.++.+..+|+-||.|||   ++|||.||+|.+|+|+|..|++|++|+|+++.-..
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999999998888765 6899999999999999999999   99999999999999999999999999999997543


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++  .....++|||.|.||
T Consensus       404 ~g--d~tstfcgtpnyiap  420 (593)
T KOG0695|consen  404 PG--DTTSTFCGTPNYIAP  420 (593)
T ss_pred             CC--cccccccCCCcccch
Confidence            33  234578999999998

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.89  E-value=2.7e-22  Score=196.06  Aligned_cols=167  Identities=31%  Similarity=0.446  Sum_probs=144.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  489 (585)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+..|++++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999876 78999999987654  24567888999999999999999999999888  8899999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 7899999999999999999999   89999999999999999999999999999887643322


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ........++..|+||
T Consensus       157 ~~~~~~~~~~~~y~~p  172 (260)
T cd06606         157 GEGTGSVRGTPYWMAP  172 (260)
T ss_pred             cccccCCCCCccccCH
Confidence            1112345678888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.89  E-value=1.6e-22  Score=200.93  Aligned_cols=164  Identities=30%  Similarity=0.425  Sum_probs=138.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      |++.+.||+|++|.||+|.+. +|+.||+|++....  ....+.+..|+++++.++|||++++++++...+..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999865 78999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +++++||||+|+||++++++.++|+|||.++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999887654 35789999999999999999999   89999999999999999999999999999976432211  


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~~~aP  168 (283)
T cd07835         155 TYTHEVVTLWYRAP  168 (283)
T ss_pred             ccCccccccCCCCC
Confidence            11233568889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.89  E-value=3.9e-25  Score=231.90  Aligned_cols=176  Identities=30%  Similarity=0.345  Sum_probs=90.0

Q ss_pred             CCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccC
Q 047705          159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSM  236 (585)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~  236 (585)
                      +|+++++++|+++ ..|+.+..+.+|+.|...+|+|+ ..|..+....+|+.|+...|.  -+|+...++..|++|+|..
T Consensus       242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~  319 (1081)
T KOG0618|consen  242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQS  319 (1081)
T ss_pred             cceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehh
Confidence            5666666666666 33466666666666666666664 455555556666666666665  5555555566666666666


Q ss_pred             CcccccCCcccC-------------------------CCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccC
Q 047705          237 NNFSGIIPKEIG-------------------------GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI  291 (585)
Q Consensus       237 N~l~~~~~~~~~-------------------------~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  291 (585)
                      |+|....+..|.                         .++.|+.|++.+|.++...-..+.+.++|++|+|++|+|....
T Consensus       320 N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fp  399 (1081)
T KOG0618|consen  320 NNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFP  399 (1081)
T ss_pred             ccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCC
Confidence            665532211110                         0122444445555554443334444455555555555554333


Q ss_pred             ChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCccc
Q 047705          292 PASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       292 ~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  336 (585)
                      ...+.+++.|++|+||||.++..+.....+..++.+...+|.+.|
T Consensus       400 as~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~  444 (1081)
T KOG0618|consen  400 ASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLS  444 (1081)
T ss_pred             HHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceee
Confidence            334444555555555555554433333334444444444444433

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.89  E-value=3.3e-22  Score=196.89  Aligned_cols=165  Identities=24%  Similarity=0.309  Sum_probs=134.6

Q ss_pred             HHHHHHhcCCCCcccee--cccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 047705          406 YLELCRATDGFSENNLI--GRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN  481 (585)
Q Consensus       406 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  481 (585)
                      ..+.....++|++.+.+  |+|+||.||+++.+ +++.+|+|.+........     |+.....+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34555556778887777  99999999999865 788899999875422111     22222222 79999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGI  560 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~  560 (585)
                      ++..|+||||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            999999999999999999998764 7899999999999999999999   99999999999999999888 999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....      ....|+..|+||
T Consensus       157 ~~~~~~~------~~~~~~~~y~aP  175 (267)
T PHA03390        157 CKIIGTP------SCYDGTLDYFSP  175 (267)
T ss_pred             ceecCCC------ccCCCCCcccCh
Confidence            8764321      224578889998

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.89  E-value=2.1e-22  Score=199.94  Aligned_cols=162  Identities=25%  Similarity=0.329  Sum_probs=134.6

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecC--CeEEEEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE--EFKGLVLE  490 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  490 (585)
                      |++.+.||+|+||.||+|... +++.||+|+++... .........|+.+++++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677889999999999999865 68899999886542 112233456888888885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |++ +++.+.+......+++..+..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++......  
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--  153 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--  153 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence            996 5888888765557899999999999999999999   899999999999999999 999999999998653222  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......+++.|+||
T Consensus       154 -~~~~~~~~~~y~aP  167 (282)
T cd07831         154 -PYTEYISTRWYRAP  167 (282)
T ss_pred             -CcCCCCCCcccCCh
Confidence             11234578899998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.89  E-value=7.7e-23  Score=208.25  Aligned_cols=167  Identities=28%  Similarity=0.348  Sum_probs=139.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+..|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999865 68999999987542  2334667789999999999999999998753    34689


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||++ ++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||++++++.+||+|||+++....
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999995 68999887654 5899999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCc--cccccccccccccCC
Q 047705          567 EDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~--~~~~~~~gt~~y~aP  585 (585)
                      ....  .......|+..|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             cCcCCCcccccccccccccCh
Confidence            2211  112345788899998

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-24  Score=195.86  Aligned_cols=164  Identities=29%  Similarity=0.353  Sum_probs=133.9

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .+....||.|+||+|++-.++ .|+..|||.++... ....+++..|.++..+- +.||||++||+...++.-|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            344567999999999998765 79999999998653 35667888888876555 7999999999999999999999999


Q ss_pred             CCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          493 PQGSLEKHLYS----TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       493 ~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                       .-+++.+...    .+..+++.-+-.|+...+.||.||.+  ...|||||+||+|||++..|.+|++|||++....+  
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--  220 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--  220 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence             4577654432    22357777777888889999999996  67999999999999999999999999999987642  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       +...+..+|...||||
T Consensus       221 -SiAkT~daGCrpYmAP  236 (361)
T KOG1006|consen  221 -SIAKTVDAGCRPYMAP  236 (361)
T ss_pred             -HHHhhhccCCccccCh
Confidence             3334566799999998

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.89  E-value=1.5e-22  Score=198.09  Aligned_cols=166  Identities=25%  Similarity=0.410  Sum_probs=140.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999876 68899999987542  23345778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  569 (585)
                      +++++|.+++..... .+++..+..++.|+++|+.|||   ..+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999876543 5789999999999999999999   89999999999999999775 579999999886532211


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......|++.|+||
T Consensus       158 --~~~~~~~~~~~~ap  171 (257)
T cd08225         158 --LAYTCVGTPYYLSP  171 (257)
T ss_pred             --cccccCCCccccCH
Confidence              12234588889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=1.8e-22  Score=201.19  Aligned_cols=166  Identities=27%  Similarity=0.428  Sum_probs=139.5

Q ss_pred             CCCccceecccCceEEEEEEe----CCCcEEEEEEEechh----hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          415 GFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      +|++.+.||+|+||.||+|+.    .+++.||+|+++...    ....+.+..|++++.++ +||+|+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999974    257889999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++||||+++++|.+++.... .+++..+..++.|+++||+|||   ..+++||||||+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987653 5788889999999999999999   8999999999999999999999999999988654


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..... ......|++.|+||
T Consensus       157 ~~~~~-~~~~~~~~~~y~aP  175 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAP  175 (288)
T ss_pred             ccccc-ccccccCCccccCH
Confidence            32211 12334688889987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN03210 Resistant to P

Probab=99.89  E-value=4.9e-22  Score=231.06  Aligned_cols=290  Identities=26%  Similarity=0.304  Sum_probs=176.8

Q ss_pred             CCccccCCC-CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCC-CCCCCccCcc
Q 047705            2 IPLEIGNLQ-NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN-NFSELNFLSS   79 (585)
Q Consensus         2 ~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~   79 (585)
                      +|..|..++ +|+.|++.++.++ .+|..| ...+|++|+|.+|.|.......  ..+++|++|+|++| .+..+|   .
T Consensus       580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~--~~l~~Lk~L~Ls~~~~l~~ip---~  652 (1153)
T PLN03210        580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGV--HSLTGLRNIDLRGSKNLKEIP---D  652 (1153)
T ss_pred             cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccccccc--ccCCCCCEEECCCCCCcCcCC---c
Confidence            344444442 3555555555543 444444 3445555555555554222221  24555555555543 234433   2


Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                      ++.+++|++|+|++|......|. .++.+++ |+.|++++|...+.+|..+ ++++|++|+|++|...+..|.   ..++
T Consensus       653 ls~l~~Le~L~L~~c~~L~~lp~-si~~L~~-L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~---~~~n  726 (1153)
T PLN03210        653 LSMATNLETLKLSDCSSLVELPS-SIQYLNK-LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD---ISTN  726 (1153)
T ss_pred             cccCCcccEEEecCCCCccccch-hhhccCC-CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc---ccCC
Confidence            44455555555555443333333 3444443 5555555544333344332 445555555555443322221   1234


Q ss_pred             CceEEccCCCCCcc-----------------------------CcccccCCCCCcEEEcCCCcccccCcccccCcccchh
Q 047705          160 LQGLVLDDNKLEGS-----------------------------IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRI  210 (585)
Q Consensus       160 L~~L~L~~N~l~~~-----------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  210 (585)
                      |++|++++|.++..                             .+..+...++|++|+|++|.....+|..+.++++|+.
T Consensus       727 L~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~  806 (1153)
T PLN03210        727 ISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEH  806 (1153)
T ss_pred             cCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCE
Confidence            44555555544421                             1111223467999999999877788999999999999


Q ss_pred             hcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCC-c
Q 047705          211 LSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN-N  286 (585)
Q Consensus       211 L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N-~  286 (585)
                      |++++|.   .+|..+ .+++|+.|++++|......|..   ..+|+.|+|++|.++ .+|.++..+++|+.|++++| +
T Consensus       807 L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~  881 (1153)
T PLN03210        807 LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNN  881 (1153)
T ss_pred             EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCC
Confidence            9999875   555555 7899999999998665455543   368999999999998 56888999999999999995 5


Q ss_pred             cCccCChhhccCCccceEEeecCc
Q 047705          287 LSGAIPASLEKLSYLEDLNLSFNK  310 (585)
Q Consensus       287 l~~~~~~~~~~l~~L~~l~l~~N~  310 (585)
                      ++ .+|..+..+++|+.++++++.
T Consensus       882 L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        882 LQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cC-ccCcccccccCCCeeecCCCc
Confidence            66 577788889999999999885

syringae 6; Provisional

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-23  Score=209.19  Aligned_cols=174  Identities=27%  Similarity=0.439  Sum_probs=145.2

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      +++.....+....++||-|.||.||.|.|+ ..-.||||.++.+ ....++|..|+.+|+.++|||+|+++|.|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            444445556777889999999999999876 4677999988754 44678999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      |||+|||..|+|.+|+++... .++.-..+.++.||..|++||.   .+.+|||||..+|+|+.++..||++|||+++.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999998764 4555667889999999999999   999999999999999999999999999999998


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .++.... ..+..-...|.||
T Consensus       416 tgDTYTA-HAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  416 TGDTYTA-HAGAKFPIKWTAP  435 (1157)
T ss_pred             cCCceec-ccCccCcccccCc
Confidence            7543221 1222233456666

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.9e-22  Score=195.55  Aligned_cols=156  Identities=28%  Similarity=0.392  Sum_probs=129.1

Q ss_pred             ceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHH-HhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIM-KSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|... +++.||+|.++...   ......+..|..++ ...+|+|++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999865 68899999986532   12223344455444 455899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      ++|.+++.... .+++..+..++.|++.||.|+|   +.+++|+||+|+||++++++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 6788899999999999999999   89999999999999999999999999999875421      22


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...|++.|+||
T Consensus       152 ~~~~~~~y~~p  162 (260)
T cd05611         152 KFVGTPDYLAP  162 (260)
T ss_pred             cCCCCcCccCh
Confidence            34578888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=1.5e-22  Score=206.32  Aligned_cols=166  Identities=28%  Similarity=0.353  Sum_probs=138.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----Ce
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  484 (585)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.++..  .......+..|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999865 7899999998653  223345677899999999999999999987654     34


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||+. ++|.+++.... .+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68988887653 6899999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  .......|+..|+||
T Consensus       159 ~~~~--~~~~~~~~~~~y~aP  177 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAP  177 (337)
T ss_pred             CCCc--ccccccccccCccCh
Confidence            3221  122345678899998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-23  Score=217.00  Aligned_cols=165  Identities=28%  Similarity=0.445  Sum_probs=137.4

Q ss_pred             CCccceecccCceEEEEEEe-CCC----cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          416 FSENNLIGRGGFGSVYKARL-GDG----MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ....++||+|+||+||+|-+ .+|    -+||+|++... ..+...++..|+-+|.+++|||++++++++.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44567999999999999964 344    46899988654 3445678899999999999999999999998765 77999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +|+++|+|.++++.++..+.....+.|..||++|+.|||   +++++||||.++|||+..-..+||+|||+|+...+++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999998888888899999999999999999   99999999999999999999999999999998765544


Q ss_pred             ccccccccccccccC
Q 047705          570 SMTQTQTLATIGYMA  584 (585)
Q Consensus       570 ~~~~~~~~gt~~y~a  584 (585)
                      ........-.+.|||
T Consensus       854 ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMA  868 (1177)
T ss_pred             cccccccccCcHHHH
Confidence            333222222344554

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.88  E-value=6.8e-22  Score=199.34  Aligned_cols=160  Identities=30%  Similarity=0.374  Sum_probs=136.8

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      |...+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++|||++++++++...+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999865 68899999987432   23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +. |++.+++......+++.++..++.|++.|+.|||   +.+++|+||+|+||++++++.+||+|||++....      
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            95 5888887765557899999999999999999999   8999999999999999999999999999986432      


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+..|+||
T Consensus       173 ~~~~~~~~~~y~aP  186 (313)
T cd06633         173 PANSFVGTPYWMAP  186 (313)
T ss_pred             CCCCccccccccCh
Confidence            11235688889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.88  E-value=3.2e-22  Score=203.57  Aligned_cols=166  Identities=25%  Similarity=0.287  Sum_probs=134.8

Q ss_pred             CCCccceecccCceEEEEEEeC-C--CcEEEEEEEechh--hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC----Ce
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-D--GMEVAVKVFNLQC--RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE----EF  484 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  484 (585)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+..|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999865 4  7889999886432  22345677899999999 599999999875332    45


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+++||++ ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 68999886543 6889999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCc--cccccccccccccCC
Q 047705          565 IGEDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~--~~~~~~~gt~~y~aP  585 (585)
                      ......  .......||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             ccccccccccccCcccCccccCc
Confidence            422211  112345789999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.9e-22  Score=209.82  Aligned_cols=170  Identities=21%  Similarity=0.275  Sum_probs=128.1

Q ss_pred             hcCCCCccceecccCceEEEEEEe-----------------CCCcEEEEEEEechhhhhH--------------HHHHHH
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL-----------------GDGMEVAVKVFNLQCRRAF--------------KSFDVE  460 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E  460 (585)
                      ..++|++.++||+|+||+||+|.+                 .+++.||||.+........              +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 2356799999864322221              233457


Q ss_pred             HHHHHhcCCCcc-----eeEEeeeec--------CCeEEEEEEccCCCCHHHHhhcCCC---------------------
Q 047705          461 CEIMKSIRHRNL-----IKVISSCSN--------EEFKGLVLEYMPQGSLEKHLYSTNC---------------------  506 (585)
Q Consensus       461 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  506 (585)
                      +.++.+++|.++     ++++++|..        ++..|+||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776554     677777643        3568999999999999998864311                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccC
Q 047705          507 --ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA  584 (585)
Q Consensus       507 --~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  584 (585)
                        ..++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+|||+++.+.... ........+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence              2356678889999999999999   8999999999999999999999999999997653221 111122345789999


Q ss_pred             C
Q 047705          585 P  585 (585)
Q Consensus       585 P  585 (585)
                      |
T Consensus       379 P  379 (507)
T PLN03224        379 P  379 (507)
T ss_pred             h
Confidence            8

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.88  E-value=3.1e-22  Score=203.08  Aligned_cols=166  Identities=30%  Similarity=0.377  Sum_probs=138.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCe
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEF  484 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  484 (585)
                      +....++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+..|+++++.++||||++++++|.. .+.
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            4456789999999999999999999865 78999999876432  2234677789999999999999999998865 467


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|++|||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||+|+||++++++.+|++|||.+...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999999 66898888654  4678888899999999999999   999999999999999999999999999998754


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..     ......+++.|+||
T Consensus       159 ~~-----~~~~~~~~~~y~aP  174 (328)
T cd07856         159 DP-----QMTGYVSTRYYRAP  174 (328)
T ss_pred             CC-----CcCCCcccccccCc
Confidence            21     11234577888887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.88  E-value=2.2e-22  Score=202.69  Aligned_cols=169  Identities=27%  Similarity=0.375  Sum_probs=138.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecC-------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE-------  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  482 (585)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999865 688999998865422  1234567899999999999999999987543       


Q ss_pred             -CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          483 -EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       483 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                       ...++||||++ +++...+......+++..+..++.|+++||+|||   ..+|+|+||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             34699999996 4787777765557899999999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCc---------cccccccccccccCC
Q 047705          562 KLLIGEDQS---------MTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~---------~~~~~~~gt~~y~aP  585 (585)
                      +........         ...+...|++.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCCh
Confidence            865422211         111334678889998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.88  E-value=4.1e-22  Score=203.07  Aligned_cols=167  Identities=26%  Similarity=0.371  Sum_probs=136.3

Q ss_pred             CCCC-ccceecccCceEEEEEEeC-CCcEEEEEEEechhhhh--------------HHHHHHHHHHHHhcCCCcceeEEe
Q 047705          414 DGFS-ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRA--------------FKSFDVECEIMKSIRHRNLIKVIS  477 (585)
Q Consensus       414 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  477 (585)
                      ++|. +.+.||+|+||.||+|.+. +++.||+|++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4577999999999999865 78999999886432111              124678999999999999999999


Q ss_pred             eeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       478 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                      ++..++..++||||++ |++.+++.... .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            9999999999999996 59999887643 6888999999999999999999   99999999999999999999999999


Q ss_pred             ecccccccCCC------------CccccccccccccccCC
Q 047705          558 FGIAKLLIGED------------QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~------------~~~~~~~~~gt~~y~aP  585 (585)
                      ||.+.......            .........+++.|+||
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  202 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP  202 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCC
Confidence            99987654111            01111234568889988

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=4e-22  Score=194.82  Aligned_cols=164  Identities=29%  Similarity=0.445  Sum_probs=140.5

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +|++.+.||+|+||.||+|+.. +++.+|+|.+....  ......+..|+++++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999765 78899999987542  23445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++...   ...+++..++.++.|++.|++|||   +.+++|+||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998762   235788899999999999999999   999999999999999999999999999999876432 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......|++.|+||
T Consensus       157 ---~~~~~~~~~~~~~P  170 (256)
T cd08530         157 ---MAKTQIGTPHYMAP  170 (256)
T ss_pred             ---CcccccCCccccCH
Confidence               12234578888887

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=3.8e-22  Score=198.14  Aligned_cols=164  Identities=29%  Similarity=0.391  Sum_probs=140.1

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      |++.+.||+|++|.||+|... +++.+|+|.++....  .....+..|++++++++|++|+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            667889999999999999865 788999998865432  24467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++ ++.+++......+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            65 898888776567899999999999999999999   9999999999999999999999999999987654322  12


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~~P  167 (283)
T cd05118         155 YTHYVVTRWYRAP  167 (283)
T ss_pred             ccCccCcccccCc
Confidence            2335678889888

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-24  Score=195.24  Aligned_cols=164  Identities=26%  Similarity=0.386  Sum_probs=136.3

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-----eEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKGL  487 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  487 (585)
                      .+..+.||-|+||+||.+.+. +|+.||+|++...  .-...+++.+|.+++..++|.|+...+++.+..+     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344578999999999999875 8999999987543  2235678889999999999999999998876653     4688


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ++|.|. .+|...+.+.+ .++...+.-+..||++||+|||   ..+|.||||||.|.|++.++..||+|||+|+....+
T Consensus       135 ~TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            999995 48888877654 6778888889999999999999   999999999999999999999999999999975433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                       ....++..+-|.+|.||
T Consensus       210 -~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  210 -DRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             -hhhhhHHHHHHHHhccH
Confidence             33345667789999998

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.88  E-value=4.4e-22  Score=198.33  Aligned_cols=165  Identities=29%  Similarity=0.388  Sum_probs=134.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|+..+.||+|+||.||++... +++.||+|.+.... ......+..|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35667789999999999999865 68999999987542 234567888999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHh---hc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          491 YMPQGSLEKHL---YS-TNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       491 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+. +++.++.   .. ....+++..+..++.|++.|++|||   + .+++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            985 4655433   22 2246889999999999999999999   5 599999999999999999999999999997653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...   ......|++.|+||
T Consensus       160 ~~~---~~~~~~~~~~y~aP  176 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAP  176 (288)
T ss_pred             cCC---ccccccCccCccCH
Confidence            221   12334678889988

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.88  E-value=5.9e-22  Score=197.91  Aligned_cols=167  Identities=25%  Similarity=0.353  Sum_probs=123.2

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEEechhhhh-----------HHHHHHHHHHHHhcCCCcceeEEee
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCRRA-----------FKSFDVECEIMKSIRHRNLIKVISS  478 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~  478 (585)
                      ++|++.+.||+|+||.||+|...+    +..+|+|+........           ......+...+..++|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998653    4566777643222110           0112223445566789999999997


Q ss_pred             eecCC----eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEE
Q 047705          479 CSNEE----FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       479 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~k  554 (585)
                      +....    ..++++|++. .++.+.+.... ..++..+..++.|+++|++|||   +++|+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            65543    4578888874 46766665432 4577888999999999999999   99999999999999999999999


Q ss_pred             EeeecccccccCCCCc-----cccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      |+|||+|+.+......     .......||+.|+||
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence            9999999876432211     112334699999997

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.5e-22  Score=185.60  Aligned_cols=139  Identities=18%  Similarity=0.201  Sum_probs=108.5

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhh--h------------------------HHHHHHHHHHHHhcCCCcc
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR--A------------------------FKSFDVECEIMKSIRHRNL  472 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  472 (585)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998754210  0                        1122459999999988776


Q ss_pred             eeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL-HFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       473 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      .....+...  ..++||||++|+++....... ..+++..+..++.|++.+|.|+ |   ..+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            443332222  238999999987776543332 3678888999999999999999 7   78999999999999998 47


Q ss_pred             cEEEeeecccccc
Q 047705          552 IAYLSDFGIAKLL  564 (585)
Q Consensus       552 ~~kl~Dfg~a~~~  564 (585)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=6.1e-22  Score=198.11  Aligned_cols=166  Identities=27%  Similarity=0.368  Sum_probs=136.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||||.++... ......+..|+.++.+. .||||+++++++......|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            467899999999999999999976 48999999987542 22345566677767666 4999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||++ +++.+++......+++..+..++.|++.|++|||   + ++|+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 5788777665557889999999999999999999   6 599999999999999999999999999987653221


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......+++.|+||
T Consensus       170 ---~~~~~~~~~~y~aP  183 (296)
T cd06618         170 ---AKTRSAGCAAYMAP  183 (296)
T ss_pred             ---cccCCCCCccccCH
Confidence               11233577889887

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=8.9e-22  Score=198.05  Aligned_cols=161  Identities=30%  Similarity=0.408  Sum_probs=137.3

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+...   ......++..|+++++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4777889999999999999865 6788999988642   22334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+. |++.+++......+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+|++|||++.....    
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            996 5888877655556889999999999999999999   89999999999999999999999999999876432    


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        .....|++.|+||
T Consensus       168 --~~~~~~~~~y~aP  180 (308)
T cd06634         168 --ANXFVGTPYWMAP  180 (308)
T ss_pred             --cccccCCccccCH
Confidence              1234678889987

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.87  E-value=3.7e-22  Score=202.95  Aligned_cols=166  Identities=29%  Similarity=0.352  Sum_probs=141.0

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-----eEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKG  486 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  486 (585)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+..|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999875 58999999987543  334567888999999999999999999987775     789


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ++|||++ ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58988887654 7889999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCc-cccccccccccccCC
Q 047705          567 EDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~-~~~~~~~gt~~y~aP  585 (585)
                      .... .......+|+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             cccccccccccccccCcCCc
Confidence            3210 122345688899998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=8e-22  Score=200.23  Aligned_cols=141  Identities=25%  Similarity=0.328  Sum_probs=123.5

Q ss_pred             ceeccc--CceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      ..||+|  +||+||+|++. +++.||+|++....  ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999875 79999999987532  23456788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          495 GSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       495 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      +++.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+|++|||.+..
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999987643 25788889999999999999999   89999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=6.7e-22  Score=199.59  Aligned_cols=164  Identities=23%  Similarity=0.244  Sum_probs=132.0

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCC
Q 047705          418 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.+.+|.|+++.||+++. +++.||+|++...  .....+.+..|+++++.++||||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555543 7899999998754  3445678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc----
Q 047705          496 SLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS----  570 (585)
Q Consensus       496 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----  570 (585)
                      ++.+++.... ..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+|++|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999998642 35788889999999999999999   999999999999999999999999999998765422211    


Q ss_pred             -cccccccccccccCC
Q 047705          571 -MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 -~~~~~~~gt~~y~aP  585 (585)
                       .......++..|+||
T Consensus       162 ~~~~~~~~~~~~y~aP  177 (314)
T cd08216         162 HDFPKSSVKNLPWLSP  177 (314)
T ss_pred             ccccccccccccccCH
Confidence             111234567789887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=6.4e-22  Score=202.10  Aligned_cols=161  Identities=27%  Similarity=0.364  Sum_probs=133.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      .++|...+.||+|+||.||+|... +++.||+|++....  ......+..|+++++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999865 78999999886432  223356788999999999999999999886542      


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..++|+||+. .++..+..   ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4689999995 47776553   25788899999999999999999   99999999999999999999999999999875


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...     ......|++.|+||
T Consensus       167 ~~~-----~~~~~~~~~~y~aP  183 (342)
T cd07879         167 ADA-----EMTGYVVTRWYRAP  183 (342)
T ss_pred             CCC-----CCCCceeeecccCh
Confidence            421     12345678889998

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=6.3e-22  Score=196.60  Aligned_cols=163  Identities=26%  Similarity=0.357  Sum_probs=137.1

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-hhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      |++.+.||+|++|.||+|... +++.||+|.+..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999876 578899998865422 12233456899999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                       +|++.+++.... ..+++..+..++.|++.|+.|||   +++++|+||+|+||++++++.++|+|||.+.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             789999887654 46789999999999999999999   8999999999999999999999999999998653221   


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|+..|+||
T Consensus       154 ~~~~~~~~~~~~aP  167 (283)
T cd07830         154 PYTDYVSTRWYRAP  167 (283)
T ss_pred             CcCCCCCcccccCc
Confidence            12334678889988

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=7.5e-22  Score=195.89  Aligned_cols=164  Identities=31%  Similarity=0.422  Sum_probs=139.4

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999876 58999999987653  233466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      + ++|.+++......+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.+||+|||.++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876456899999999999999999999   89999999999999999999999999999886532221  2


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (282)
T cd07829         155 YTHEVVTLWYRAP  167 (282)
T ss_pred             cCccccCcCcCCh
Confidence            2234567788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.87  E-value=7.8e-22  Score=201.48  Aligned_cols=166  Identities=27%  Similarity=0.373  Sum_probs=136.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC----------
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE----------  482 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  482 (585)
                      .+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67999999999999999999865 6889999998766555567788899999999999999999876543          


Q ss_pred             ----CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEee
Q 047705          483 ----EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSD  557 (585)
Q Consensus       483 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~D  557 (585)
                          ...|+||||++ ++|.+++...  .+++..++.++.|++.|++|||   +.+|+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence                35789999996 5898888653  5788999999999999999999   89999999999999997 556799999


Q ss_pred             ecccccccCCCCcc-ccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ||.++......... ......|+..|+||
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             cccceecCCccccccccccccccccccCH
Confidence            99987643211111 11233578889998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.6e-21  Score=189.78  Aligned_cols=158  Identities=35%  Similarity=0.447  Sum_probs=136.1

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      ||+|+||.||+|... +++.||+|++.....   .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999876 588999999875432   2455788899999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL  577 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  577 (585)
                      .+++.... .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++++|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99998764 5789999999999999999999   8999999999999999999999999999988653321  1223456


Q ss_pred             ccccccCC
Q 047705          578 ATIGYMAP  585 (585)
Q Consensus       578 gt~~y~aP  585 (585)
                      |+..|+||
T Consensus       155 ~~~~~~~P  162 (250)
T cd05123         155 GTPEYLAP  162 (250)
T ss_pred             CCccccCh
Confidence            78888887

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.87  E-value=3.2e-21  Score=191.91  Aligned_cols=163  Identities=29%  Similarity=0.409  Sum_probs=133.5

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhc---CCCcceeEEeeeecCCe-----
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSI---RHRNLIKVISSCSNEEF-----  484 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  484 (585)
                      |++.+.||+|+||.||+|+++ +++.||+|+++....  .....+..|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999976 589999999874322  2234566687777665   69999999999988776     


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+++|||+. +++.+++.... ..+++..++.++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 48988887643 25889999999999999999999   89999999999999999999999999999886


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....   ......+++.|+||
T Consensus       157 ~~~~~---~~~~~~~~~~~~~P  175 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAP  175 (287)
T ss_pred             ccCCc---ccccccccccccCh
Confidence            53221   11234578889887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=1.2e-21  Score=210.41  Aligned_cols=166  Identities=24%  Similarity=0.254  Sum_probs=118.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-C----CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEee------ee
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-D----GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS------CS  480 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  480 (585)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++......  +....|  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999875 4    689999987643211  111111  1112222222222221      23


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-------------------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK  541 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  541 (585)
                      .++..++||||+++++|.+++......                   .....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            456789999999999999998754311                   112345679999999999999   8999999999


Q ss_pred             CCCEEeCC-CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          542 PSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       542 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|||+++ ++.+||+|||+|+.+.... ........||+.||||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~AP  326 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAP  326 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccCh
Confidence            99999985 6899999999998653222 2223456889999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.7e-21  Score=179.42  Aligned_cols=139  Identities=24%  Similarity=0.281  Sum_probs=110.9

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhh--------------------------hHHHHHHHHHHHHhcCCCcc
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR--------------------------AFKSFDVECEIMKSIRHRNL  472 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  472 (585)
                      ...||+|+||.||+|+..+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998754210                          01234578999999999988


Q ss_pred             eeEEeeeecCCeEEEEEEccCCCCHHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCC
Q 047705          473 IKVISSCSNEEFKGLVLEYMPQGSLEKH-LYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDN  550 (585)
Q Consensus       473 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~  550 (585)
                      .....+....  .++||||++|+++... +..  ..++......++.|++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5544443332  4899999988755443 332  35677888999999999999999   7 9999999999999998 8


Q ss_pred             CcEEEeeeccccccc
Q 047705          551 MIAYLSDFGIAKLLI  565 (585)
Q Consensus       551 ~~~kl~Dfg~a~~~~  565 (585)
                      +.++|+|||+|....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.86  E-value=8.2e-22  Score=201.38  Aligned_cols=164  Identities=27%  Similarity=0.354  Sum_probs=138.5

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe---
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF---  484 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  484 (585)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34578999999999999999999876 6889999988643  22334567789999999999999999998866654   


Q ss_pred             ---EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          485 ---KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       485 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                         .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||.+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 67999988763  5889999999999999999999   899999999999999999999999999998


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......     .....+++.|+||
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aP  184 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAP  184 (343)
T ss_pred             cccccc-----ccCCcccccccCH
Confidence            865321     2334678889988

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.86  E-value=2.5e-21  Score=187.04  Aligned_cols=147  Identities=20%  Similarity=0.130  Sum_probs=123.5

Q ss_pred             cCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhc
Q 047705          425 GGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS  503 (585)
Q Consensus       425 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  503 (585)
                      |.+|.||+|++. +++.||+|.+....     .+..|...+....||||+++++++...+..+++|||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999875 78899999987543     223455555666799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccccccccc
Q 047705          504 TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM  583 (585)
Q Consensus       504 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  583 (585)
                      .. .+++..+..++.|+++|++|+|   +++|+||||||+||+++.++.++++|||.+......     .....++..||
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 5889999999999999999999   999999999999999999999999999987654321     12334567788


Q ss_pred             CC
Q 047705          584 AP  585 (585)
Q Consensus       584 aP  585 (585)
                      ||
T Consensus       150 aP  151 (237)
T cd05576         150 AP  151 (237)
T ss_pred             CC
Confidence            87

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=4e-22  Score=202.97  Aligned_cols=167  Identities=26%  Similarity=0.406  Sum_probs=137.7

Q ss_pred             CCCccceecccCceEEEEEEeC--CCc--EEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +....+.||+|.||+|++|.|+  +|+  .||||+++..... ...+|.+|+.+|.+++|||++++||...+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3455678999999999999875  344  5899999866433 67899999999999999999999999877 5678999


Q ss_pred             EccCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |+++.|+|.+.+++ .+..+.......|+.||+.|+.||.   .+++||||+..+|+++.....|||+|||+.+.+...+
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999988 4446777788899999999999999   9999999999999999988899999999999775443


Q ss_pred             Ccccc-ccccccccccCC
Q 047705          569 QSMTQ-TQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~-~~~~gt~~y~aP  585 (585)
                      +.... ....-...|+||
T Consensus       267 d~Yvm~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAP  284 (1039)
T ss_pred             cceEecCCCcCcccccCH
Confidence            33322 222334457776

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.4e-21  Score=186.99  Aligned_cols=163  Identities=22%  Similarity=0.293  Sum_probs=137.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC--C----cceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH--R----NLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~  485 (585)
                      ..+|.+...+|+|.||.|-.+.+. .+..||+|+++.- .+..+....|+++++++.+  |    -+|++.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999865 5789999998744 3455777889999999943  2    478899999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---------------
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---------------  549 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---------------  549 (585)
                      ++|+|.+ |.++.+++.+.+ .+++..+++.+++|++++++|||   +.+++|-||||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 779999998754 37899999999999999999999   999999999999999821               


Q ss_pred             -----CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          550 -----NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       550 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                           +..+|++|||.|....     ......+.|..|.||
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAP  278 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAP  278 (415)
T ss_pred             eccCCCcceEEEecCCcceec-----cCcceeeeccccCCc
Confidence                 2358999999998642     122557889999999

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.2e-21  Score=174.19  Aligned_cols=168  Identities=23%  Similarity=0.341  Sum_probs=140.7

Q ss_pred             HhcCCCCccceecccCceEEEEEE-eCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC-CcceeEEeeeecCCeEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  488 (585)
                      ...+.|.++++||.|+||.+|.|. ..+|++||||+-+...+  ..++..|.++...+++ ..|+.+..++...++..+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            445689999999999999999997 56899999998654432  2456779999999975 7899999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~  565 (585)
                      ||.. |.+|++++.-....++..+++-.+-|++.-++|+|   .+++|||||||+|+|..   ....+.++|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 88999998876667899999999999999999999   99999999999999986   34579999999999876


Q ss_pred             CCCCc-----cccccccccccccC
Q 047705          566 GEDQS-----MTQTQTLATIGYMA  584 (585)
Q Consensus       566 ~~~~~-----~~~~~~~gt~~y~a  584 (585)
                      +....     .+.....||.+|.+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             cccccccCccccCCccceeeeehh
Confidence            54322     22356689998865

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.86  E-value=2.6e-21  Score=189.73  Aligned_cols=165  Identities=24%  Similarity=0.385  Sum_probs=133.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech-----hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-----CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      +|.+.+.||+|+||.||+|++. .+..+++|+++..     .......+..|+.++++++||||+++++++...+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4888899999999999999865 3445666655431     112234566799999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |||+++++|.+++.+   ....+++..++.++.|+++|+.|||   +.+++|+||||+||++++ +.+|++|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2336889999999999999999999   999999999999999975 569999999988654


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  ......|++.|+||
T Consensus       157 ~~~~--~~~~~~~~~~~~~p  174 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSP  174 (260)
T ss_pred             CCcc--cccCCCCCcCccCH
Confidence            3221  12234578889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2e-21  Score=211.77  Aligned_cols=246  Identities=23%  Similarity=0.360  Sum_probs=131.8

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      +.+.|+|++++++ .+|..+.  ++|+.|+|++|+|++. +...   .++|++|+|++|+|+.+|.  .+  .++|+.|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsL-P~~l---~~nL~~L~Ls~N~LtsLP~--~l--~~~L~~L~  247 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSL-PENL---QGNIKTLYANSNQLTSIPA--TL--PDTIQEME  247 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcC-Chhh---ccCCCEEECCCCccccCCh--hh--hccccEEE
Confidence            4566777777666 4455443  3677777777777633 3222   2467777777777776653  22  23567777


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL  170 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (585)
                      |++|++..+ |..    ++..|+.|++++|+++. +|..+.  ++|+.|++++|+++++ |..+.  ++|+.|++++|++
T Consensus       248 Ls~N~L~~L-P~~----l~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~L  316 (754)
T PRK15370        248 LSINRITEL-PER----LPSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSL  316 (754)
T ss_pred             CcCCccCcC-Chh----HhCCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCcc
Confidence            777776533 321    12346666666666663 343332  3566666666666643 22221  2466666666666


Q ss_pred             CccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCC
Q 047705          171 EGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGL  250 (585)
Q Consensus       171 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  250 (585)
                      +. +|..+.  ++|+.|++++|.+++ +|..+                       .++|+.|++++|+++. +|..+.  
T Consensus       317 t~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l-----------------------~~sL~~L~Ls~N~L~~-LP~~lp--  366 (754)
T PRK15370        317 TA-LPETLP--PGLKTLEAGENALTS-LPASL-----------------------PPELQVLDVSKNQITV-LPETLP--  366 (754)
T ss_pred             cc-CCcccc--ccceeccccCCcccc-CChhh-----------------------cCcccEEECCCCCCCc-CChhhc--
Confidence            63 333221  456666666666653 33222                       1355566666666652 343332  


Q ss_pred             CCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhh----ccCCccceEEeecCcCe
Q 047705          251 KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL----EKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       251 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~l~l~~N~l~  312 (585)
                      +.|+.|+|++|+++. +|..+.  ..|+.|++++|+|+ .+|..+    ..++.+..+++.+|+++
T Consensus       367 ~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        367 PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            456666666666663 333332  24666666666665 333332    22355566666666664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=9.7e-22  Score=214.26  Aligned_cols=232  Identities=22%  Similarity=0.341  Sum_probs=166.6

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|.|++. |...   .++|+.|+|++|+++.+|.  .+.
T Consensus       193 LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l---~~~L~~L~Ls~N~L~~LP~--~l~  261 (754)
T PRK15370        193 IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATL---PDTIQEMELSINRITELPE--RLP  261 (754)
T ss_pred             CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhh---hccccEEECcCCccCcCCh--hHh
Confidence            555443  57999999999998 5676665  5899999999999854 4322   3589999999999999984  332


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                        ++|++|+|++|+|+.+ |.    .++.+|+.|++++|+++.. |..+.  ++|+.|++++|++..+ |..+  .++|+
T Consensus       262 --s~L~~L~Ls~N~L~~L-P~----~l~~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~L-P~~l--~~sL~  328 (754)
T PRK15370        262 --SALQSLDLFHNKISCL-PE----NLPEELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTAL-PETL--PPGLK  328 (754)
T ss_pred             --CCCCEEECcCCccCcc-cc----ccCCCCcEEECCCCccccC-cccch--hhHHHHHhcCCccccC-Cccc--cccce
Confidence              5899999999999854 44    2234699999999999854 44333  5799999999999964 4333  26899


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccc
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSG  241 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~  241 (585)
                      +|++++|.+++ +|..+.  ++|+.|++++|+|+. +|..+.  +                     .|+.|++++|.++.
T Consensus       329 ~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~---------------------~L~~LdLs~N~Lt~  381 (754)
T PRK15370        329 TLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--P---------------------TITTLDVSRNALTN  381 (754)
T ss_pred             eccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--C---------------------CcCEEECCCCcCCC
Confidence            99999999995 565553  689999999999983 454321  2                     45566666666663


Q ss_pred             cCCcccCCCCCCcEEeecccCcccccCccc----cCcCCCCEEeCCCCccC
Q 047705          242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSF----GNLISLKFLNLSNNNLS  288 (585)
Q Consensus       242 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~  288 (585)
                       +|..+.  ..|+.|++++|+++. +|..+    ..++.+..|++.+|+++
T Consensus       382 -LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        382 -LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence             333333  356677777777763 34332    33466677777777766

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=8.6e-21  Score=178.06  Aligned_cols=165  Identities=21%  Similarity=0.282  Sum_probs=140.9

Q ss_pred             CCCCccceecccCceEEEEEEe-CCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      -+|.++++||+|.||+++.|+. -++++||||.-....  ...++..|.+..+.+. .++|+.+|.+....-+..+|||.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4799999999999999999973 478999999754332  2356777898888884 69999999998888888999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-----CCcEEEeeecccccccC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-----NMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~  566 (585)
                      . |.+|++++.-.+..++..++..+|.|++.-++|+|   ++..|.|||||+|+||..     ...+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 88999999888888999999999999999999999   999999999999999963     33699999999999876


Q ss_pred             CCCc-----cccccccccccccC
Q 047705          567 EDQS-----MTQTQTLATIGYMA  584 (585)
Q Consensus       567 ~~~~-----~~~~~~~gt~~y~a  584 (585)
                      +...     .+..+..||.+||+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             ccccccCccccccccccceeeeE
Confidence            5432     23457789999996

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=9.9e-22  Score=175.03  Aligned_cols=146  Identities=23%  Similarity=0.429  Sum_probs=124.9

Q ss_pred             HhcCCCCccceecccCceEEEEEE-eCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCC--eEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEE--FKG  486 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~  486 (585)
                      ...++|++.+.+|+|.|++||.|. ..+.+.++||++++..   .+.+.+|+++|+.+. ||||+++++...++.  ...
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            356789999999999999999997 4578899999998653   367888999999996 999999999987764  457


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeeccccccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~  565 (585)
                      +++||+.+.+...+..    .++..+++.++.++++||.|+|   ++||+|||+||.|++|| .....+++|+|+|.++-
T Consensus       112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998877665543    3566788999999999999999   99999999999999999 45579999999999875


Q ss_pred             C
Q 047705          566 G  566 (585)
Q Consensus       566 ~  566 (585)
                      +
T Consensus       185 p  185 (338)
T KOG0668|consen  185 P  185 (338)
T ss_pred             C
Confidence            3

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=4.5e-20  Score=176.29  Aligned_cols=166  Identities=33%  Similarity=0.445  Sum_probs=141.8

Q ss_pred             CCccceecccCceEEEEEEeCC-CcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          416 FSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      |.+.+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+..|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999998764 889999998765443 56788899999999999999999999999899999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +++|.+++......+++..+..++.+++.++.|+|   +.+++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999999876533788899999999999999999   88999999999999999999999999999887643220 012


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....++..|+||
T Consensus       157 ~~~~~~~~~~~p  168 (225)
T smart00221      157 KTVKGTPFYLAP  168 (225)
T ss_pred             cceeccCCcCCH
Confidence            334567778887

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=9e-20  Score=169.89  Aligned_cols=137  Identities=15%  Similarity=0.236  Sum_probs=107.3

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-----CCCcceeEEeeeecCC---eEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-----RHRNLIKVISSCSNEE---FKG  486 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~  486 (585)
                      +.-.+.||+|+||.||.  +. ++.. +||++........+.+.+|+++++.+     +||||+++++++.++.   ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34457899999999996  43 4444 68988765444557789999999999     6799999999998873   434


Q ss_pred             -EEEEc--cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCcEEcCCCCCCEEeCC----CCcEEEeee
Q 047705          487 -LVLEY--MPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL-EYLHFGCSTPVIHCDLKPSNVLLDD----NMIAYLSDF  558 (585)
Q Consensus       487 -lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Df  558 (585)
                       +||||  +.+|+|.+++.+.  .+++.  ..++.+++.++ +|||   +++|+||||||+||+++.    ++.++|+||
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence             78999  5579999999764  35554  35677888777 9999   999999999999999973    348999994


Q ss_pred             cccc
Q 047705          559 GIAK  562 (585)
Q Consensus       559 g~a~  562 (585)
                      +.+.
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            4443

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1e-20  Score=172.73  Aligned_cols=146  Identities=23%  Similarity=0.373  Sum_probs=124.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEe-eeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVIS-SCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~  489 (585)
                      .+.|.+.+.+|+|.||.+-+|+++ +.+.+|+|.+.... ....+|.+|...--.+ .|.||+.-|+ .|++.+.+.++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            467999999999999999999977 67889999887553 3457888888765555 5889998776 578888889999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~a~~~  564 (585)
                      ||++-|+|.+-+...  .+.+.....++.|++.|++|||   ++.+||||||.+||||-  +..++|++|||..+..
T Consensus       102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999988764  4778888899999999999999   99999999999999993  4559999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.82  E-value=1.4e-20  Score=196.12  Aligned_cols=162  Identities=31%  Similarity=0.487  Sum_probs=129.7

Q ss_pred             CCccceecccCceE-EEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccC
Q 047705          416 FSENNLIGRGGFGS-VYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       416 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      |.-.+.+|.|+.|+ ||+|.. +|++||||++-..   .....++|+..++.- +|||||++++.-+++.+.||+.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33446789999885 799987 6789999976433   334567899999888 69999999999999999999999995


Q ss_pred             CCCHHHHhhcC--CCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---C--CcEEEeeeccccccc
Q 047705          494 QGSLEKHLYST--NCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---N--MIAYLSDFGIAKLLI  565 (585)
Q Consensus       494 ~g~L~~~l~~~--~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~--~~~kl~Dfg~a~~~~  565 (585)
                       .+|.++++..  ... ......+.+..|+++||++||   ..+||||||||.||||+.   +  .+++|+|||+++...
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999874  111 111345678999999999999   899999999999999974   3  479999999999886


Q ss_pred             CCCCcc-ccccccccccccCC
Q 047705          566 GEDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ...... ......||-+|+||
T Consensus       663 ~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             CCcchhhcccCCCCcccccCH
Confidence            554333 23567899999999

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=3.2e-19  Score=168.15  Aligned_cols=159  Identities=38%  Similarity=0.600  Sum_probs=134.7

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHH
Q 047705          422 IGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEK  499 (585)
Q Consensus       422 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  499 (585)
                      ||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999876 4899999998765332 34678899999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccccccCCCCccccccccc
Q 047705          500 HLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLA  578 (585)
Q Consensus       500 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  578 (585)
                      ++.......++..+..++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876446788999999999999999999   899999999999999998 89999999999886532211  1223446


Q ss_pred             cccccCC
Q 047705          579 TIGYMAP  585 (585)
Q Consensus       579 t~~y~aP  585 (585)
                      ...|++|
T Consensus       156 ~~~~~~p  162 (215)
T cd00180         156 TPAYMAP  162 (215)
T ss_pred             CCCccCh
Confidence            6677776

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=197.18  Aligned_cols=170  Identities=28%  Similarity=0.470  Sum_probs=139.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC----C----CcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG----D----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN  481 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  481 (585)
                      ..++..+.+.+|+|+||.|++|...    .    ...||||..+.. .....+.+..|+++|+.+ +|+||+.++|++..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3344566679999999999999632    1    456999988744 335678899999999999 69999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEE
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      .+..++|+||++.|+|.++++..+               ..++..+.+.++.||+.|++||+   +.++||||+..+|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998776               23888899999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeeecccccccCCCCcccccccccc--ccccCC
Q 047705          547 LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAP  585 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt--~~y~aP  585 (585)
                      +.++..+||+|||+|+.....+... .....|+  ..||||
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAP  490 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCH
Confidence            9999999999999999654333221 1222232  349998

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=1.3e-21  Score=197.85  Aligned_cols=279  Identities=23%  Similarity=0.271  Sum_probs=166.6

Q ss_pred             EEecCCCccc-ccCCccccCCCCCCEEecCCCcCCCc----CCccccCCCCCccEEEccCCCCCCCcc-----CccccCC
Q 047705           14 ELDLRQNKLI-GTVPVAIFNVSTLKLLGLQDNSLSGS----LSSITDVRLPNLEELVLWGNNFSELNF-----LSSLSNC   83 (585)
Q Consensus        14 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~~l   83 (585)
                      .|+|+++.++ ......+..+.+|++|++++|.++..    +... ....++|++|+++++.+...+.     ...+..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~-l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASA-LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHH-HhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence            5788888886 45566677788899999999988521    1111 2256778899998888763111     1346677


Q ss_pred             CCCcEEEccCCCCcccCCcchhhcccc--cccEEEeecCccee----cCCccccCC-CCccEEEeeCCccccc----cch
Q 047705           84 KSLTVIGLSNNPLDGILPKTSIGNLSH--SLEDFQMHNCNVTG----DIPEEIGNL-TNLITIDLGGNKLNGS----ILI  152 (585)
Q Consensus        84 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~--~L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~  152 (585)
                      ++|++|++++|.+.+..+. .+..+..  +|+.|++++|.+++    .+...+..+ ++|+.|++++|.+++.    ...
T Consensus        81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            8888888888888654333 3333322  26667777666652    222334445 6666666666666631    223


Q ss_pred             hhhCCCCCceEEccCCCCCcc----CcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCC
Q 047705          153 TLSKLQKLQGLVLDDNKLEGS----IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKV  228 (585)
Q Consensus       153 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~  228 (585)
                      .+..+++|++|+|++|.+++.    ++..+...++|++|+|++|.+++.....+                 ...+..+++
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l-----------------~~~~~~~~~  222 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL-----------------AETLASLKS  222 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHH-----------------HHHhcccCC
Confidence            445556666666666666532    22233444566666666666653211111                 112445567


Q ss_pred             CcEEEccCCcccccCCcccC-----CCCCCcEEeecccCccc----ccCccccCcCCCCEEeCCCCccCcc----CChhh
Q 047705          229 LVGIDFSMNNFSGIIPKEIG-----GLKNLEYLFLGYNRLQG----LIPDSFGNLISLKFLNLSNNNLSGA----IPASL  295 (585)
Q Consensus       229 L~~L~ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~  295 (585)
                      |+.|++++|.+++.....+.     ..+.|+.|++++|.++.    .+...+..+++|+.+++++|.++..    ....+
T Consensus       223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~  302 (319)
T cd00116         223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL  302 (319)
T ss_pred             CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence            77777777777642222221     23678888888888762    1233455567888888888888754    33344


Q ss_pred             ccC-CccceEEeecCcC
Q 047705          296 EKL-SYLEDLNLSFNKL  311 (585)
Q Consensus       296 ~~l-~~L~~l~l~~N~l  311 (585)
                      ... +.|+++++.+|+|
T Consensus       303 ~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         303 LEPGNELESLWVKDDSF  319 (319)
T ss_pred             hhcCCchhhcccCCCCC
Confidence            444 6778888887765

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.80  E-value=4e-19  Score=171.66  Aligned_cols=153  Identities=36%  Similarity=0.465  Sum_probs=132.6

Q ss_pred             CceEEEEEEeC-CCcEEEEEEEechhhhh-HHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhc
Q 047705          426 GFGSVYKARLG-DGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS  503 (585)
Q Consensus       426 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  503 (585)
                      +||.||+|... +++.+|+|++....... .+.+..|++.+++++|++|+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 58999999987654433 67889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccccccccccccc
Q 047705          504 TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM  583 (585)
Q Consensus       504 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  583 (585)
                      .. .+++..+..++.++++++.|||   +.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            54 3788899999999999999999   8999999999999999999999999999998754321   223456788888


Q ss_pred             CC
Q 047705          584 AP  585 (585)
Q Consensus       584 aP  585 (585)
                      ||
T Consensus       154 ~p  155 (244)
T smart00220      154 AP  155 (244)
T ss_pred             CH
Confidence            87

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=3.2e-19  Score=166.46  Aligned_cols=139  Identities=14%  Similarity=0.115  Sum_probs=114.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhH---H------HHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---K------SFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~------~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      -.++|...+.+|.|+||.||.+.. ++..+|+|+++.......   .      .+.+|+..+.++.||+|+.+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            347899999999999999999766 567899999975432221   2      267899999999999999999886543


Q ss_pred             --------CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEE
Q 047705          483 --------EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       483 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~k  554 (585)
                              +..+++|||++|.+|.++..     .++    ....+++.++..+|   +.|++|||+||+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988732     222    24569999999999   99999999999999999988 99


Q ss_pred             Eeeecccccc
Q 047705          555 LSDFGIAKLL  564 (585)
Q Consensus       555 l~Dfg~a~~~  564 (585)
                      ++|||.....
T Consensus       175 liDfg~~~~~  184 (232)
T PRK10359        175 IIDLSGKRCT  184 (232)
T ss_pred             EEECCCcccc
Confidence            9999987754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=4.6e-19  Score=178.74  Aligned_cols=167  Identities=27%  Similarity=0.387  Sum_probs=134.6

Q ss_pred             CCCccceecccCceEEEEEEeCC--CcEEEEEEEechhhhhHHHHHHHHHHHHhcCC----CcceeEEeee-ecCCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH----RNLIKVISSC-SNEEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  487 (585)
                      +|.+.+.||+|+||.||.|....  ...+|+|+...........+..|+.++..+..    +++.++++.+ ..+.+.|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999998654  35789998765433222367789999998863    6899999999 57789999


Q ss_pred             EEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-----CcEEEeeeccc
Q 047705          488 VLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-----MIAYLSDFGIA  561 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg~a  561 (585)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|+++|   +.|++||||||+|+.+...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 889999886554 57899999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--cccCCCCc--c---c-cccccccccccCC
Q 047705          562 K--LLIGEDQS--M---T-QTQTLATIGYMAP  585 (585)
Q Consensus       562 ~--~~~~~~~~--~---~-~~~~~gt~~y~aP  585 (585)
                      +  .+......  .   . .....||..|+++
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9  43322211  1   1 1345699999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-19  Score=185.14  Aligned_cols=160  Identities=26%  Similarity=0.331  Sum_probs=132.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..+.|+....+|.|+|+.|-++... +++..++|++....    .+..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3567888889999999999998755 78889999987652    2334577666666 7999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe-CCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL-DDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |++.|+.+.+.+....  .....+..|+.+|+.|+.|||   .+|+||||+||+|||+ ++.++++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999999888887654  222667789999999999999   9999999999999999 58999999999999875432 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                          ....+-|..|.||
T Consensus       470 ----~~tp~~t~~y~AP  482 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAP  482 (612)
T ss_pred             ----hcccchhhcccCh
Confidence                2334567788888

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.80  E-value=4.9e-20  Score=172.42  Aligned_cols=162  Identities=28%  Similarity=0.351  Sum_probs=134.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      ..+|.-.+.+|.|+- .|..|.+. .++.||+|+....  .....++..+|...+..++|+||++++.+|....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777888999988 56666544 6889999987543  2334567788999999999999999999996553      


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+|+||||| ..+|.+.+..   .++...+..+..|++.|++|+|   +.||+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            579999999 5589888873   4677888999999999999999   99999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      -   +.....+..+.|..|.||
T Consensus       168 e---~~~~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  168 E---DTDFMMTPYVVTRYYRAP  186 (369)
T ss_pred             c---CcccccCchhheeeccCc
Confidence            3   223456778899999998

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=6.8e-19  Score=168.23  Aligned_cols=142  Identities=19%  Similarity=0.165  Sum_probs=112.0

Q ss_pred             CCCccceecccCceEEEEEE--eCCCcEEEEEEEechhhh------------------------hHHHHHHHHHHHHhcC
Q 047705          415 GFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRR------------------------AFKSFDVECEIMKSIR  468 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  468 (585)
                      .|++.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+..|+++++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58889999999999999998  458999999998743210                        1123567999999997


Q ss_pred             CC--cceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-cEEcCCCCCCE
Q 047705          469 HR--NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP-VIHCDLKPSNV  545 (585)
Q Consensus       469 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-iiH~dlkp~NI  545 (585)
                      +.  .+++++++    ...++||||++|+++........ ..+......++.|++.+++++|   ..+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34555543    23589999999988876543322 4555667789999999999999   899 99999999999


Q ss_pred             EeCCCCcEEEeeeccccccc
Q 047705          546 LLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       546 ll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++ ++.++++|||.|....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999988643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.8e-18  Score=156.45  Aligned_cols=132  Identities=17%  Similarity=0.152  Sum_probs=106.0

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEEechhh----hhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEEc
Q 047705          417 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR----RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    .+...+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998765 677787776654322    12235789999999995 5889999886    446999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC-CCCCEEeCCCCcEEEeeecccccc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL-KPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ++|.+|.+....        ....++.|++++++++|   .+||+|||| ||+||+++.++.++|+|||+|...
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999998754321        11357789999999999   999999999 799999999999999999999854

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=5.7e-21  Score=162.85  Aligned_cols=157  Identities=34%  Similarity=0.509  Sum_probs=89.4

Q ss_pred             ccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccc
Q 047705           30 IFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS  109 (585)
Q Consensus        30 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  109 (585)
                      +.++.+++.|.|++|.++-.+|.+.  .+.+|+.|++++|+|+.+|  ..++.+++|+.|+++-|++. +.|. .||.+|
T Consensus        29 Lf~~s~ITrLtLSHNKl~~vppnia--~l~nlevln~~nnqie~lp--~~issl~klr~lnvgmnrl~-~lpr-gfgs~p  102 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVVPPNIA--ELKNLEVLNLSNNQIEELP--TSISSLPKLRILNVGMNRLN-ILPR-GFGSFP  102 (264)
T ss_pred             ccchhhhhhhhcccCceeecCCcHH--HhhhhhhhhcccchhhhcC--hhhhhchhhhheecchhhhh-cCcc-ccCCCc
Confidence            3344455555555555554444444  3555555555555555555  45555555555555555553 2222 233333


Q ss_pred             ccccEEEeecCcce-ecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEE
Q 047705          110 HSLEDFQMHNCNVT-GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLE  188 (585)
Q Consensus       110 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  188 (585)
                      . |+.|||.+|++. ...|+.|..|+.|+-|+|++|.+. +.|...+.+++|+.|.+.+|.+- ..|.+++.+++|++|.
T Consensus       103 ~-levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh  179 (264)
T KOG0617|consen  103 A-LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH  179 (264)
T ss_pred             h-hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence            3 333333333332 234555666666777777777776 66666677777777777777766 5666677777777777


Q ss_pred             cCCCccc
Q 047705          189 LGGNKLS  195 (585)
Q Consensus       189 L~~N~l~  195 (585)
                      +++|+++
T Consensus       180 iqgnrl~  186 (264)
T KOG0617|consen  180 IQGNRLT  186 (264)
T ss_pred             cccceee
Confidence            7777776

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=3e-18  Score=162.34  Aligned_cols=135  Identities=26%  Similarity=0.350  Sum_probs=114.1

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.||+|++|.||+|++ .|..|++|+.....        ......+..|++++..+.|++++....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67789999765321        11234677899999999999988777777777788999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ++|++|.+++....    + ....++.+++.++.++|   ..+++|+|++|+||+++ ++.++++|||.++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999886542    2 67789999999999999   99999999999999999 789999999998753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=4.1e-18  Score=159.46  Aligned_cols=138  Identities=23%  Similarity=0.189  Sum_probs=110.0

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhh----------------------hhHHHHHHHHHHHHhcCCC-
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR----------------------RAFKSFDVECEIMKSIRHR-  470 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-  470 (585)
                      ..|.+.+.||+|+||.||+|...+|+.||||+++....                      ........|+.++..+.|+ 
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            34888899999999999999888899999998764210                      0112356789999999877 


Q ss_pred             -cceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC
Q 047705          471 -NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD  549 (585)
Q Consensus       471 -niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~  549 (585)
                       .+++.++.    ...++||||++|+++.+....       .....++.+++.++.++|   +.+|+||||||+||++++
T Consensus        95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence             44555442    345899999999998765431       234578899999999999   899999999999999999


Q ss_pred             CCcEEEeeeccccccc
Q 047705          550 NMIAYLSDFGIAKLLI  565 (585)
Q Consensus       550 ~~~~kl~Dfg~a~~~~  565 (585)
                      ++.++|+|||.|....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=1.9e-20  Score=189.46  Aligned_cols=259  Identities=25%  Similarity=0.256  Sum_probs=147.0

Q ss_pred             EEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCcc---CccccCCCCCcEEEccCCCCcccCCc-----chhhccc
Q 047705           38 LLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNF---LSSLSNCKSLTVIGLSNNPLDGILPK-----TSIGNLS  109 (585)
Q Consensus        38 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~~~~  109 (585)
                      .|+|..+.+++.-....+..+++|++|++++|.++....   ...+...++|++|+++++.+.+....     .++..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            467777777633333333456778888888888854321   13455677788888888877531110     1222322


Q ss_pred             ccccEEEeecCcceecCCccccCCCC---ccEEEeeCCcccc----ccchhhhCC-CCCceEEccCCCCCcc----Cccc
Q 047705          110 HSLEDFQMHNCNVTGDIPEEIGNLTN---LITIDLGGNKLNG----SILITLSKL-QKLQGLVLDDNKLEGS----IPDD  177 (585)
Q Consensus       110 ~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~  177 (585)
                      + |+.|++++|.+.+..+..+..+..   |++|++++|++.+    .....+..+ ++|++|++++|.+++.    .+..
T Consensus        82 ~-L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          82 G-LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             c-eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            2 555555555544333333333333   5555555554442    111223333 4455555555554421    1222


Q ss_pred             ccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccC----CcccCCCCCC
Q 047705          178 ICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII----PKEIGGLKNL  253 (585)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~----~~~~~~l~~L  253 (585)
                      +..+++|++|++++|.+++....                 .++..+..+++|+.|++++|.+++..    ...+..+++|
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~-----------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIR-----------------ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHH-----------------HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            33334444444444444421000                 01112334568888888988886443    3456678999


Q ss_pred             cEEeecccCcccccCccccC-----cCCCCEEeCCCCccCc----cCChhhccCCccceEEeecCcCeee
Q 047705          254 EYLFLGYNRLQGLIPDSFGN-----LISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       254 ~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      +.|++++|++++.....+..     .+.|+.|++++|.+++    .+...+..+++|+++++++|.+...
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence            99999999998643333322     3799999999999972    2334566678999999999999743

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=9.1e-18  Score=180.81  Aligned_cols=139  Identities=22%  Similarity=0.274  Sum_probs=113.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEE-ech-------hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF-NLQ-------CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      ....|...+.||+|+||.||+|.+.+.. +++|+. ...       .....+++.+|+++++.++|++++....++...+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445667899999999999999875443 444432 211       1112356888999999999999998888877777


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..++||||++|++|.+++.         ....++.++++++.|||   +.+++|||+||+||++ +++.++|+|||+|+.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            8899999999999998875         34578999999999999   9999999999999999 678999999999986


Q ss_pred             c
Q 047705          564 L  564 (585)
Q Consensus       564 ~  564 (585)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.76  E-value=2e-18  Score=167.74  Aligned_cols=146  Identities=27%  Similarity=0.362  Sum_probs=125.9

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC----CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      +....+.|..+++||+|.|++||+|.+.    ..+.||+|.+....  ...++..|++.|..+ .+.||+.+.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999643    46789999886543  335688899999999 5899999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeecccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAK  562 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~  562 (585)
                      .+.+|+||++.-+..++...    ++...+..+++.+..||+++|   ..|||||||||+|++.+ .-++-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888887765    456788899999999999999   99999999999999998 56789999999998


Q ss_pred             c
Q 047705          563 L  563 (585)
Q Consensus       563 ~  563 (585)
                      .
T Consensus       182 ~  182 (418)
T KOG1167|consen  182 R  182 (418)
T ss_pred             H
Confidence            3

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.3e-17  Score=156.49  Aligned_cols=131  Identities=21%  Similarity=0.351  Sum_probs=107.4

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .||+|+||.||+|.+ ++..|++|......        .....++..|++++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999985 56789999854321        112356778999999999887665555555666779999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      +|++|.+.+.....        .++.+++.++.++|   ..+++|+|++|+||+++ ++.++++|||.++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988765321        68999999999999   99999999999999999 889999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=3.9e-20  Score=157.78  Aligned_cols=180  Identities=29%  Similarity=0.490  Sum_probs=128.0

Q ss_pred             ccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccch
Q 047705          130 IGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALR  209 (585)
Q Consensus       130 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  209 (585)
                      +.++++.+.|.|++|.++ ..|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445677777888888887 55556777888888888888887 66667778888888888888876 5666666666666


Q ss_pred             hhcCCCCCCCCccCCCCCCCcEEEccCCccc-ccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccC
Q 047705          210 ILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS-GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS  288 (585)
Q Consensus       210 ~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  288 (585)
                      +|||.+|                     ++. ...|..|..+..|+.|+|++|.+. ++|...+.+++|+.|.+..|.+-
T Consensus       106 vldltyn---------------------nl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen  106 VLDLTYN---------------------NLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             hhhcccc---------------------ccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh
Confidence            6666554                     332 235566667777777888888777 56777777888888888888776


Q ss_pred             ccCChhhccCCccceEEeecCcCeeeCCCCCCCC---CCCccccCCCCcc
Q 047705          289 GAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFG---NFSAESFEGNELL  335 (585)
Q Consensus       289 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~---~~~~~~~~~n~~~  335 (585)
                       .+|..++.+..|++|.+.+|.++-.+|..+.+.   .-....++.|||.
T Consensus       164 -~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  164 -SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             -hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence             567777778888888888888877777654433   2234456777774

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.73  E-value=4.7e-18  Score=168.22  Aligned_cols=164  Identities=27%  Similarity=0.328  Sum_probs=134.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC------CcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH------RNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~~~  485 (585)
                      -.+|.+....|+|-|+.|.+|++. .|..||||++...... .+.=..|+++|++++.      -++++++..|...+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            357999999999999999999865 5789999999865322 2444569999999952      4889999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAK  562 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~  562 (585)
                      |+|+|-+ .-+|.+.++..+.  .+...++..|+.|+.-||..|.   ..+|+|.||||+|||+++ ...+||||||.|.
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999988 5699999987654  5778889999999999999999   999999999999999984 5579999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....    ..+...-+..|.||
T Consensus       586 ~~~en----eitPYLVSRFYRaP  604 (752)
T KOG0670|consen  586 FASEN----EITPYLVSRFYRAP  604 (752)
T ss_pred             ccccc----cccHHHHHHhccCc
Confidence            65322    22333445567777

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=5.6e-17  Score=159.82  Aligned_cols=132  Identities=25%  Similarity=0.333  Sum_probs=112.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-----C---CcceeEEeeeecC--
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-----H---RNLIKVISSCSNE--  482 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~--  482 (585)
                      .+|-+.++||-|.|++||+|++. +.+.||+|+.+... ...+....||++|++++     |   ..||++++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57999999999999999999875 67889999987653 34466778999999883     3   4799999999654  


Q ss_pred             --CeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC
Q 047705          483 --EFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD  549 (585)
Q Consensus       483 --~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~  549 (585)
                        .++++|+|+. |-+|..++.... ..++...+.+|++||+.||.|||.  +.||||-||||+|||+..
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCS  223 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeec
Confidence              4789999999 779999887653 368899999999999999999997  679999999999999953

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.70  E-value=2.9e-16  Score=159.07  Aligned_cols=165  Identities=38%  Similarity=0.544  Sum_probs=139.7

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEechhhh---hHHHHHHHHHHHHhcCCC-cceeEEeeeecCCeEEEEEEc
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR---AFKSFDVECEIMKSIRHR-NLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  491 (585)
                      |...+.+|.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999876  78899998765332   367889999999999988 799999999877788999999


Q ss_pred             cCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  568 (585)
                      +.++++.+++....  ..++......++.|++.+++|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776653  25788889999999999999999   99999999999999999888 79999999998654333


Q ss_pred             Ccc----ccccccccccccCC
Q 047705          569 QSM----TQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~----~~~~~~gt~~y~aP  585 (585)
                      ...    ......||..|+||
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             ccccccccccccccccccCCH
Confidence            221    23567899999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=2e-16  Score=146.75  Aligned_cols=136  Identities=24%  Similarity=0.261  Sum_probs=98.7

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhh--hHH----------------------HHHHHHHHHHhcCCCc--c
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR--AFK----------------------SFDVECEIMKSIRHRN--L  472 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~----------------------~~~~E~~~l~~l~h~n--i  472 (585)
                      .+.||+|+||.||+|...+++.||||+++.....  ...                      ....|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999878999999998753211  111                      1134666666664432  4


Q ss_pred             eeEEeeeecCCeEEEEEEccCCCCHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCC
Q 047705          473 IKVISSCSNEEFKGLVLEYMPQGSLEK-HLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDN  550 (585)
Q Consensus       473 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~  550 (585)
                      ++.+++    ...++||||++++.+.. .+....  .. .....++.+++.++.++|   . ++|+|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            455543    23589999999854321 111111  11 456789999999999999   7 9999999999999999 8


Q ss_pred             CcEEEeeeccccccc
Q 047705          551 MIAYLSDFGIAKLLI  565 (585)
Q Consensus       551 ~~~kl~Dfg~a~~~~  565 (585)
                      +.++++|||.|....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=5.3e-16  Score=138.42  Aligned_cols=135  Identities=22%  Similarity=0.257  Sum_probs=113.2

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC--CcceeEEeeeecCCeEEEEEEccCCC
Q 047705          418 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKGLVLEYMPQG  495 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  495 (585)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+..|+.+++.+.|  ..++++++++...+..+++|||++|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998754 7899998765433  4578889999999976  58999999988888899999999987


Q ss_pred             CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          496 SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       496 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654        4455677899999999999933335799999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.1e-15  Score=144.56  Aligned_cols=136  Identities=18%  Similarity=0.227  Sum_probs=105.7

Q ss_pred             ceec-ccCceEEEEEEeCCCcEEEEEEEechh-------------hhhHHHHHHHHHHHHhcCCCcc--eeEEeeeecCC
Q 047705          420 NLIG-RGGFGSVYKARLGDGMEVAVKVFNLQC-------------RRAFKSFDVECEIMKSIRHRNL--IKVISSCSNEE  483 (585)
Q Consensus       420 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  483 (585)
                      ..|| .|+.|+||.++.. +..+|+|.+....             ......+.+|++++.++.|++|  ++.+++...+.
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4677 7888999999874 6788999875311             1123567889999999998875  67777644332


Q ss_pred             ----eEEEEEEccCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          484 ----FKGLVLEYMPQ-GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       484 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                          ..++||||++| .+|.+++...  .+++.    .+.+++.++.+||   ++||+||||||+|||++.++.++++||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 6898887653  34443    3578999999999   999999999999999998899999999


Q ss_pred             ccccccc
Q 047705          559 GIAKLLI  565 (585)
Q Consensus       559 g~a~~~~  565 (585)
                      |.+....
T Consensus       187 g~~~~~~  193 (239)
T PRK01723        187 DRGELRT  193 (239)
T ss_pred             CCcccCC
Confidence            9988643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.63  E-value=4.4e-16  Score=149.46  Aligned_cols=176  Identities=22%  Similarity=0.271  Sum_probs=137.5

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeee
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSC  479 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  479 (585)
                      .++....++++....+-+|.||+||+|-|+      +.++|-+|.++.. ++-....+..|.-.+..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            455555667888888999999999999554      2345666765433 233456677888889999999999999987


Q ss_pred             ecC-CeEEEEEEccCCCCHHHHhhc-----CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          480 SNE-EFKGLVLEYMPQGSLEKHLYS-----TN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       480 ~~~-~~~~lv~e~~~~g~L~~~l~~-----~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      ..+ +..++++.++.-|+|..++..     ..  ..++..+...++.|++.|++|||   .+++||.||..+|++||+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            654 577899999988999999982     22  24566678889999999999999   99999999999999999999


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++||+|=.+++...+.+.+.-+........||||
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCH
Confidence            9999999999987665554444444445568775

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.4e-15  Score=163.38  Aligned_cols=146  Identities=29%  Similarity=0.423  Sum_probs=117.0

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC---CCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  489 (585)
                      -+.|.+.+.+|+|+||.||+|...+|+.||+|+-+.....   +|.-=-+++.+++   -+.|..+..++...+.-++|+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            3568888999999999999999888999999986654321   1111223444554   245666667777777889999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-------CCCcEEEeeecccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-------DNMIAYLSDFGIAK  562 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-------~~~~~kl~Dfg~a~  562 (585)
                      ||.+.|+|.+++... ..+++..++.+..|+++.++.||   ..+|||+||||+|.|+.       +..-++|+|||-+.
T Consensus       774 ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999999844 47899999999999999999999   99999999999999993       23369999999987


Q ss_pred             ccc
Q 047705          563 LLI  565 (585)
Q Consensus       563 ~~~  565 (585)
                      .+.
T Consensus       850 Dm~  852 (974)
T KOG1166|consen  850 DMK  852 (974)
T ss_pred             eee
Confidence            664

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=1.5e-14  Score=150.71  Aligned_cols=141  Identities=22%  Similarity=0.232  Sum_probs=100.6

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhhh----------------------------------------HHHHH
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRA----------------------------------------FKSFD  458 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  458 (585)
                      .+.||+|++|.||+|+..+|+.||||+.++.....                                        .-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986531100                                        01345


Q ss_pred             HHHHHHHhcC-----CCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 047705          459 VECEIMKSIR-----HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS-ALEYLHFGCS  532 (585)
Q Consensus       459 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~~  532 (585)
                      .|++.+.++.     ++++.-..-+.......++||||++|+++.+.........+   ...++.+++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            5666666552     34332212222233457899999999999887653321222   2346666655 467888   8


Q ss_pred             CCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       533 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      .|++|+|+||.||++++++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.52  E-value=6.5e-15  Score=166.60  Aligned_cols=89  Identities=16%  Similarity=0.231  Sum_probs=70.0

Q ss_pred             hcCC-CcceeEEeee-------ecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 047705          466 SIRH-RNLIKVISSC-------SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH  537 (585)
Q Consensus       466 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH  537 (585)
                      .+.| +||++++++|       ...+.++.++||+ +++|.+++......+++.+++.++.||++||.|||   +++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3445 5777888877       2234567888987 66999999865557899999999999999999999   999999


Q ss_pred             cCCCCCCEEeCCCCcEEEeee
Q 047705          538 CDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       538 ~dlkp~NIll~~~~~~kl~Df  558 (585)
                      |||||+|||++..+.+|++||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             ccCCchhEEEcccCcEEEeec
Confidence            999999999965444433333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1e-14  Score=156.52  Aligned_cols=164  Identities=25%  Similarity=0.314  Sum_probs=126.1

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEEe-----chhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFN-----LQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .....+|.|++|.|+.+... ..+..+.|.+.     ..... ....+..|+.+-..+.|||++.....+......+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988777543 33334444332     11111 1122566777888899999988888777766666669


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |||++ +|...+.... .+...++..++.|++.|++|+|   ..|+.|||+|++|+++..+|.+||+|||.+..+.-+..
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 9999988753 4667778889999999999999   99999999999999999999999999999887654333


Q ss_pred             c--cccccccccccccCC
Q 047705          570 S--MTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~--~~~~~~~gt~~y~aP  585 (585)
                      .  ......+|+..|+||
T Consensus       476 ~~~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAP  493 (601)
T ss_pred             hhhhhhcCcccCCcCcCc
Confidence            3  455788999999998

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=4.2e-14  Score=154.09  Aligned_cols=136  Identities=32%  Similarity=0.579  Sum_probs=112.7

Q ss_pred             CCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEee
Q 047705          228 VLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS  307 (585)
Q Consensus       228 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~  307 (585)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|.++|.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCeeeCCCCCC--CCCCCccccCCCCcccCCCCCCCCCCCCCCCCCCccceeeeeeecchhhh
Q 047705          308 FNKLEGEIPRGGS--FGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTT  370 (585)
Q Consensus       308 ~N~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (585)
                      +|.++|.+|....  ......+.+.+|+..|+.|.  ...|....     ..+.+++++++++++
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~~~-----~~~~~i~~~~~~~~~  556 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGPHL-----SVGAKIGIAFGVSVA  556 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcccC-----CCceEEEEEhHHHHH
Confidence            9999999986421  23445678899999999764  34775321     123455555555443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.50  E-value=1.2e-15  Score=153.30  Aligned_cols=167  Identities=32%  Similarity=0.481  Sum_probs=120.2

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      |+.+.|..|.+. .+|.++.++..|++|||+.|++. ..|..+..| -|+.|-+++|+++ .+|+.++.+.+|..||.+.
T Consensus       100 Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~  175 (722)
T KOG0532|consen  100 LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK  175 (722)
T ss_pred             HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence            444444444444 55666778888888888888888 445455544 4788888888888 7777788888888888888


Q ss_pred             CcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCc
Q 047705          192 NKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD  269 (585)
Q Consensus       192 N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  269 (585)
                      |.+. ..|..+..+.+|+.|.+..|+  .+|+++. .=.|..||+|.|+++ .+|..|..+..|++|-|.+|.++. .|-
T Consensus       176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPA  251 (722)
T KOG0532|consen  176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPA  251 (722)
T ss_pred             hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChH
Confidence            8887 577778888888888888887  6677766 335778888888887 577788888888888888888874 333


Q ss_pred             ccc---CcCCCCEEeCCCCc
Q 047705          270 SFG---NLISLKFLNLSNNN  286 (585)
Q Consensus       270 ~~~---~l~~L~~L~l~~N~  286 (585)
                      .+.   ...--++|+..-++
T Consensus       252 qIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  252 QICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             HHHhccceeeeeeecchhcc
Confidence            322   12234566666663

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.47  E-value=5.3e-15  Score=151.36  Aligned_cols=155  Identities=26%  Similarity=0.331  Sum_probs=129.4

Q ss_pred             eecccCceEEEEEEe----CCCcEEEEEEEechhh--hhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEEccC
Q 047705          421 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .+|+|+||.|+.++.    ..+..+|+|+.++...  +.......|..++..++ ||.++++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            368999999998752    3467789988765421  12225566888999997 9999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      ||++...+.... .+++.....+...++-|++++|   +.+|+|||+|++||+++.+|++|+.|||+.+......     
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            999998887665 5677778888999999999999   9999999999999999999999999999998754322     


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                       ..|||..||||
T Consensus       152 -~~cgt~eymAp  162 (612)
T KOG0603|consen  152 -IACGTYEYRAP  162 (612)
T ss_pred             -hcccchhhhhh
Confidence             22899999998

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=3.3e-15  Score=150.14  Aligned_cols=153  Identities=30%  Similarity=0.451  Sum_probs=81.4

Q ss_pred             cccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccc
Q 047705          129 EIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL  208 (585)
Q Consensus       129 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  208 (585)
                      .+..+..|+.+.|..|.+. .+|..+.++..|.+|||+.|+++ ..|..+..|+ |+-|-+++|+++ ..|+.++.+..|
T Consensus        93 ~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl  168 (722)
T KOG0532|consen   93 EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTL  168 (722)
T ss_pred             HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhH
Confidence            3444455555555555555 44555555555555555555555 4444444444 555555555555 444445555555


Q ss_pred             hhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCc
Q 047705          209 RILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN  286 (585)
Q Consensus       209 ~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  286 (585)
                      ..||.+.|+  ..|..+..+.+|+.|.+..|++. ..|..++.|+ |..||+|.|+++ .+|-.|..|+.|++|-|.+|.
T Consensus       169 ~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP  245 (722)
T KOG0532|consen  169 AHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP  245 (722)
T ss_pred             HHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence            555555554  44555555555555555555555 2344444333 555555555555 345555555555555555555


Q ss_pred             cC
Q 047705          287 LS  288 (585)
Q Consensus       287 l~  288 (585)
                      |+
T Consensus       246 Lq  247 (722)
T KOG0532|consen  246 LQ  247 (722)
T ss_pred             CC
Confidence            55

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.6e-13  Score=142.94  Aligned_cols=200  Identities=34%  Similarity=0.504  Sum_probs=108.8

Q ss_pred             cEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEe
Q 047705           62 EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDL  141 (585)
Q Consensus        62 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  141 (585)
                      ..|++..|++..-.  ..+..++.++.|++.+|+++.+.+..  +....+|+.|++++|++. .+|..++.+++|+.|++
T Consensus        96 ~~l~~~~~~~~~~~--~~~~~~~~l~~L~l~~n~i~~i~~~~--~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l  170 (394)
T COG4886          96 PSLDLNLNRLRSNI--SELLELTNLTSLDLDNNNITDIPPLI--GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL  170 (394)
T ss_pred             ceeeccccccccCc--hhhhcccceeEEecCCcccccCcccc--ccchhhcccccccccchh-hhhhhhhcccccccccc
Confidence            46788888873322  34555678888888888887665532  111112555555555555 23334556666666666


Q ss_pred             eCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCc
Q 047705          142 GGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL  221 (585)
Q Consensus       142 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~  221 (585)
                      ++|++.. .+.....+++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+.                  
T Consensus       171 ~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~------------------  229 (394)
T COG4886         171 SFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS------------------  229 (394)
T ss_pred             CCchhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhh------------------
Confidence            6666663 2322335556666666666666 33433333444556666665432 2333344                  


Q ss_pred             cCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh
Q 047705          222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA  293 (585)
Q Consensus       222 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  293 (585)
                         .+.++..+.+++|++.. .+..+..++++++|++++|+++.+.+  +..+.+++.|++++|.++...+.
T Consensus       230 ---~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         230 ---NLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             ---hcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence               44444444455555542 24445555556666666666654322  55556666666666666554443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=4.8e-13  Score=140.80  Aligned_cols=146  Identities=20%  Similarity=0.164  Sum_probs=93.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-CcEEEEEEEechhhh----------------------------------hH---
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRR----------------------------------AF---  454 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~---  454 (585)
                      ...|+. +.+|+|++|.||+|+.++ |+.||||+.++....                                  ..   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 799999999999999886 999999998754110                                  00   


Q ss_pred             ---HHHHHHHHHHHhcC----CCcceeEEeee-ecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH-HHH
Q 047705          455 ---KSFDVECEIMKSIR----HRNLIKVISSC-SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS-ALE  525 (585)
Q Consensus       455 ---~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~  525 (585)
                         -++.+|+..+.++.    +...+.+-..+ ......++||||++|+.+.+.-.-.....+...   ++...++ -+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence               12344555555442    33333333322 223457899999999999874321111222221   2222111 122


Q ss_pred             HHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeeccccccc
Q 047705          526 YLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAKLLI  565 (585)
Q Consensus       526 ~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~~~~  565 (585)
                      -++   ..|++|+|+||.||+++.++    .++++|||++..+.
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            234   67999999999999999888    99999999988764

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=3.4e-13  Score=140.53  Aligned_cols=196  Identities=30%  Similarity=0.466  Sum_probs=116.5

Q ss_pred             EEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC-CCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           38 LLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK-SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        38 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      .|+++.|.+...+....  .++.++.|++.+|.++.++  .....++ +|++|++++|++..+..  ..+.++. |+.|+
T Consensus        97 ~l~~~~~~~~~~~~~~~--~~~~l~~L~l~~n~i~~i~--~~~~~~~~nL~~L~l~~N~i~~l~~--~~~~l~~-L~~L~  169 (394)
T COG4886          97 SLDLNLNRLRSNISELL--ELTNLTSLDLDNNNITDIP--PLIGLLKSNLKELDLSDNKIESLPS--PLRNLPN-LKNLD  169 (394)
T ss_pred             eeeccccccccCchhhh--cccceeEEecCCcccccCc--cccccchhhcccccccccchhhhhh--hhhcccc-ccccc
Confidence            56777776643444433  3466777777777777776  3333442 67777777777764421  2344444 77777


Q ss_pred             eecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       117 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      ++.|+++. +|...+.+++|+.|++++|++.. +|........|++|.+++|.+. ..+..+..+.++..+.+++|++..
T Consensus       170 l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         170 LSFNDLSD-LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             cCCchhhh-hhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence            77777763 33334467888888888888884 3433345556888888888544 455667777888888888888863


Q ss_pred             cCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCC
Q 047705          197 SIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIP  244 (585)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~  244 (585)
                       .+..+..+++++.|++++|. .....+..+.+++.|++++|.++...+
T Consensus       247 -~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         247 -LPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             -ccchhccccccceeccccccccccccccccCccCEEeccCccccccch
Confidence             34444455555555554444 111114444455555555555554433

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.3e-12  Score=118.99  Aligned_cols=128  Identities=22%  Similarity=0.247  Sum_probs=96.2

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcc-eeEEeeeecCCeEEEEEEccCCCCH
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKGLVLEYMPQGSL  497 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  497 (585)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+..|+++++.+.+.++ ++++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467899999999999874 67899998754422 22356779999998865444 45555433  235799999999887


Q ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          498 EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP-----VIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       498 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      .+.  .    .   ....++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.|..
T Consensus        79 ~~~--~----~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE--D----F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--c----c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643  0    1   11245679999999999   666     59999999999999 67899999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.38  E-value=3.5e-14  Score=138.74  Aligned_cols=218  Identities=21%  Similarity=0.191  Sum_probs=127.0

Q ss_pred             cCCCCCCEEecCCCcCCCcCCc-cccCCCCCccEEEccCCCCCCCccC-ccccCCCCCcEEEccCCCCcccCCcchhhcc
Q 047705           31 FNVSTLKLLGLQDNSLSGSLSS-ITDVRLPNLEELVLWGNNFSELNFL-SSLSNCKSLTVIGLSNNPLDGILPKTSIGNL  108 (585)
Q Consensus        31 ~~l~~L~~L~L~~n~l~~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  108 (585)
                      +++++|++..|+++.+. .++. .....+|++++|||++|-|+.+... .-...+|+|+.|+||.|++...........+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            56788999999999886 4442 2334689999999999999888532 2356889999999999998744333222223


Q ss_pred             cccccEEEeecCcceecCC-ccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcE
Q 047705          109 SHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYK  186 (585)
Q Consensus       109 ~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~  186 (585)
                      +. |++|.|++|.++..-. ..+...|+|+.|+|+.|.........+..+..|++|||++|++..... ...+.++.|..
T Consensus       197 ~~-lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SH-LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hh-hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            32 6666666666552211 223345566666666664333333344445556666666665552221 23344455555


Q ss_pred             EEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccC-CcccCCCCCCcEEeecccCccc
Q 047705          187 LELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII-PKEIGGLKNLEYLFLGYNRLQG  265 (585)
Q Consensus       187 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~  265 (585)
                      |+++.|.+..........               -.-...+++|+.|+++.|++.... -..+..+++|+.|.+..|.++.
T Consensus       276 Lnls~tgi~si~~~d~~s---------------~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVES---------------LDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhccccCcchhcCCCccc---------------hhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            555555554321111100               001245678888888888885321 1234556777778877887763

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.35  E-value=7.4e-13  Score=118.69  Aligned_cols=124  Identities=29%  Similarity=0.365  Sum_probs=41.5

Q ss_pred             CCCccEEEccCCCCCCCccCcccc-CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLS-NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL  136 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  136 (585)
                      ..++++|+|++|+|+.+..   +. .+.+|+.|+||+|.|+.+.                            .+..+++|
T Consensus        18 ~~~~~~L~L~~n~I~~Ie~---L~~~l~~L~~L~Ls~N~I~~l~----------------------------~l~~L~~L   66 (175)
T PF14580_consen   18 PVKLRELNLRGNQISTIEN---LGATLDKLEVLDLSNNQITKLE----------------------------GLPGLPRL   66 (175)
T ss_dssp             ------------------S-----TT-TT--EEE-TTS--S--T----------------------------T----TT-
T ss_pred             ccccccccccccccccccc---hhhhhcCCCEEECCCCCCcccc----------------------------CccChhhh
Confidence            4456666666666666632   33 4566666667666665321                            13346777


Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCcccccCcc----cccCcccchhh
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRSIPA----CFNNLIALRIL  211 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L  211 (585)
                      ++|++++|+|+.+.+.....+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++.. +.    .+..+|+|+.|
T Consensus        67 ~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~L  145 (175)
T PF14580_consen   67 KTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVL  145 (175)
T ss_dssp             -EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEE
T ss_pred             hhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhhee
Confidence            777777777775433323457777777777777764322 3556778888888888888743 22    23455666655


Q ss_pred             cC
Q 047705          212 SL  213 (585)
Q Consensus       212 ~l  213 (585)
                      |-
T Consensus       146 D~  147 (175)
T PF14580_consen  146 DG  147 (175)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.6e-11  Score=112.29  Aligned_cols=135  Identities=21%  Similarity=0.220  Sum_probs=98.7

Q ss_pred             ceecccCceEEEEEEeCC-------CcEEEEEEEechh-------------h---------hhHHHH----HHHHHHHHh
Q 047705          420 NLIGRGGFGSVYKARLGD-------GMEVAVKVFNLQC-------------R---------RAFKSF----DVECEIMKS  466 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-------------~---------~~~~~~----~~E~~~l~~  466 (585)
                      ..||.|--+.||.|...+       +..+|||+.+...             .         ...+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       4789999875310             0         011222    379999999


Q ss_pred             cCC--CcceeEEeeeecCCeEEEEEEccCCCCHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCcEEcCCCC
Q 047705          467 IRH--RNLIKVISSCSNEEFKGLVLEYMPQGSLEK-HLYSTNCILDIFQRLNIMIDVASALEYL-HFGCSTPVIHCDLKP  542 (585)
Q Consensus       467 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~iiH~dlkp  542 (585)
                      +..  -++++++++    ...++||||+.+..+.. .+.+.  .++..+...+..+++.++..+ |   ..+++|+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  466777765    45689999997643322 22221  344455667889999999999 8   88999999999


Q ss_pred             CCEEeCCCCcEEEeeecccccc
Q 047705          543 SNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       543 ~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .||+++ ++.+.++|||.|...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999998765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=1.8e-11  Score=107.02  Aligned_cols=142  Identities=18%  Similarity=0.212  Sum_probs=109.1

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEE-ech-------hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          418 ENNLIGRGGFGSVYKARLGDGMEVAVKVF-NLQ-------CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ....+-+|+-+.|+++.+ .|+.+.||.- .+.       .+-..++..+|++.+.++.--.|.-..-+|.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999987 5677777742 211       1223567788999999997777776666777777778999


Q ss_pred             EccCC-CCHHHHhhcCCCCCCHHH-HHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC---cEEEeeeccccc
Q 047705          490 EYMPQ-GSLEKHLYSTNCILDIFQ-RLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~-g~L~~~l~~~~~~~~~~~-~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~  563 (585)
                      ||++| .++.+++.+....-.... ...++.+|.+.+.-||   ..+|+|+||.++||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 477888776543223333 3689999999999999   99999999999999997554   458999999764

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.32  E-value=1.8e-13  Score=142.82  Aligned_cols=59  Identities=31%  Similarity=0.480  Sum_probs=25.5

Q ss_pred             CCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCccc
Q 047705          134 TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       134 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  195 (585)
                      +.|+.|++++|.|..  ...|..++.|+.+++++|++..+.+ . ...+.+++.+++++|.+.
T Consensus       140 ~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  140 TLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             cchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            334445555555443  1223334444455555554443322 1 234444444444444443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=2.5e-11  Score=106.88  Aligned_cols=131  Identities=23%  Similarity=0.339  Sum_probs=102.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEech--------hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--------CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..+++|+-+.+|.+.+. |.++++|.-.+.        .+-..++..+|++++.+++--.|....=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999764 444666643211        111235667899999999776776666666777788899999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ++|..|.+.+.+.        ...++..+-.-+.-||   ..||+|+|+.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888888765        1457788888999999   99999999999999998654 99999999985

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.31  E-value=1.9e-12  Score=116.00  Aligned_cols=129  Identities=27%  Similarity=0.347  Sum_probs=39.1

Q ss_pred             cCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccc
Q 047705           31 FNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH  110 (585)
Q Consensus        31 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  110 (585)
                      .+..++++|+|++|.|+ .+.... ..+.+|+.|||++|.|+.++   .+..++.|++|++++|+|+.+.+. ....+|+
T Consensus        16 ~n~~~~~~L~L~~n~I~-~Ie~L~-~~l~~L~~L~Ls~N~I~~l~---~l~~L~~L~~L~L~~N~I~~i~~~-l~~~lp~   89 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIS-TIENLG-ATLDKLEVLDLSNNQITKLE---GLPGLPRLKTLDLSNNRISSISEG-LDKNLPN   89 (175)
T ss_dssp             ---------------------S---TT-TT--EEE-TTS--S--T---T----TT--EEE--SS---S-CHH-HHHH-TT
T ss_pred             ccccccccccccccccc-cccchh-hhhcCCCEEECCCCCCcccc---CccChhhhhhcccCCCCCCccccc-hHHhCCc
Confidence            34445777777777776 444332 24667777777777777774   366677777777777777654321 1223443


Q ss_pred             cccEEEeecCcceecCC-ccccCCCCccEEEeeCCcccccc---chhhhCCCCCceEEcc
Q 047705          111 SLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLNGSI---LITLSKLQKLQGLVLD  166 (585)
Q Consensus       111 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~  166 (585)
                       |+.|++++|+|...-. ..+..+++|++|+|.+|.+....   ...+..+|+|+.||-.
T Consensus        90 -L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   90 -LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             ---EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             -CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence             5555555555543221 34556677777777777766322   1234456666666543

>PLN03150 hypothetical protein; Provisional

Probab=99.30  E-value=5.2e-12  Score=137.81  Aligned_cols=111  Identities=37%  Similarity=0.544  Sum_probs=98.3

Q ss_pred             cchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCC
Q 047705          207 ALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS  283 (585)
Q Consensus       207 ~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~  283 (585)
                      .++.|+|++|.   .+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36677777776   567778889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccCccCChhhccC-CccceEEeecCcCeeeCCC
Q 047705          284 NNNLSGAIPASLEKL-SYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       284 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~  317 (585)
                      +|++++.+|..+... .++..+++++|+..|.+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999988764 4678899999998776553

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.30  E-value=6.8e-13  Score=121.84  Aligned_cols=161  Identities=20%  Similarity=0.406  Sum_probs=124.7

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .....+|.+...|+.|+|+++. ..+++|++...  ..+...+|..|.-.++-+.||||..+++.|..+....++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            4455678999999999999964 45556777654  23445688999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          494 QGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       494 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      .|+|...+++... ..+..+..+++.+|++|++|||+ .+.-|..--+.+..+++|++.+++|+ ++-+++      +..
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltaris-mad~kf------sfq  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQ  342 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhhee-ccccee------eee
Confidence            9999999998755 56778899999999999999993 23445556788999999999988875 111111      111


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ..+..-.|.||||
T Consensus       343 e~gr~y~pawmsp  355 (448)
T KOG0195|consen  343 EVGRAYSPAWMSP  355 (448)
T ss_pred             ccccccCcccCCH
Confidence            1233456788887

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.28  E-value=6.5e-13  Score=138.66  Aligned_cols=195  Identities=29%  Similarity=0.353  Sum_probs=123.6

Q ss_pred             cCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccc
Q 047705           31 FNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH  110 (585)
Q Consensus        31 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  110 (585)
                      ..+..++.++++.|.|+.......  .+.+|+.|++..|+|..+.  ..+..+++|++|+|++|.|+.+.+-   ..++.
T Consensus        69 ~~l~~l~~l~l~~n~i~~~~~~l~--~~~~l~~l~l~~n~i~~i~--~~l~~~~~L~~L~ls~N~I~~i~~l---~~l~~  141 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAKILNHLS--KLKSLEALDLYDNKIEKIE--NLLSSLVNLQVLDLSFNKITKLEGL---STLTL  141 (414)
T ss_pred             HHhHhHHhhccchhhhhhhhcccc--cccceeeeeccccchhhcc--cchhhhhcchheeccccccccccch---hhccc
Confidence            345566667777777764222222  4677777777777777764  2266777778888888877766443   23334


Q ss_pred             cccEEEeecCcceecCCccccCCCCccEEEeeCCccccccc-hhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEc
Q 047705          111 SLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLEL  189 (585)
Q Consensus       111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (585)
                       |+.|++.+|.++..  ..+..++.|+.+++++|++..+.+ . ...+.+++.+++..|.+..+  ..+..+..+..+++
T Consensus       142 -L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l  215 (414)
T KOG0531|consen  142 -LKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSL  215 (414)
T ss_pred             -hhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhc
Confidence             77778888777643  346668899999999999986555 3 57888999999999998833  33444555666688


Q ss_pred             CCCcccccCcccccCccc--chhhcCCCCCCC--CccCCCCCCCcEEEccCCccc
Q 047705          190 GGNKLSRSIPACFNNLIA--LRILSLGSNDPL--PLEIGNLKVLVGIDFSMNNFS  240 (585)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~--L~~L~l~~n~~~--~~~~~~l~~L~~L~ls~N~l~  240 (585)
                      ..|.++...+  +..+..  |+.+++++|...  +..+..+..+..|++++|++.
T Consensus       216 ~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  216 LDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             ccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhcccc
Confidence            8888874322  222222  566666665511  133444444445555555444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.2e-11  Score=119.71  Aligned_cols=90  Identities=26%  Similarity=0.384  Sum_probs=73.4

Q ss_pred             CCCcceeEEeeeecC---------------------------CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHH
Q 047705          468 RHRNLIKVISSCSNE---------------------------EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV  520 (585)
Q Consensus       468 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  520 (585)
                      +|||||++.++|.+.                           ...|+||..++ .+|.+++....  .+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence            699999999887321                           25689999884 49999998765  4455666689999


Q ss_pred             HHHHHHHhcCCCCCcEEcCCCCCCEEe--CCCC--cEEEeeeccccc
Q 047705          521 ASALEYLHFGCSTPVIHCDLKPSNVLL--DDNM--IAYLSDFGIAKL  563 (585)
Q Consensus       521 ~~~l~~lH~~~~~~iiH~dlkp~NIll--~~~~--~~kl~Dfg~a~~  563 (585)
                      ++|+.|||   ++||.|||+|++|||+  |+|+  ...++|||.|--
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA  394 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA  394 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence            99999999   9999999999999998  4444  578999998753

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.25  E-value=1.7e-12  Score=121.05  Aligned_cols=128  Identities=30%  Similarity=0.381  Sum_probs=73.7

Q ss_pred             CccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCC
Q 047705          135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLG  214 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  214 (585)
                      .|++||||+|.|+ .+..+..-+|.++.|++|+|.|+.+ . .+..+++|+.||||+|.++ ....+=..+-+++.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            4555555555555 3344444455555555555555522 1 2444555555555555554 222333344455555555


Q ss_pred             CCC-CCCccCCCCCCCcEEEccCCcccccC-CcccCCCCCCcEEeecccCcccc
Q 047705          215 SND-PLPLEIGNLKVLVGIDFSMNNFSGII-PKEIGGLKNLEYLFLGYNRLQGL  266 (585)
Q Consensus       215 ~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~  266 (585)
                      .|. ..-..+..+-+|..||+++|+|.... -..++++|-|+.+.|.+|++.+.
T Consensus       361 ~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  361 QNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            554 22234556667778888888886432 24678888899999999988854

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.24  E-value=8.5e-13  Score=129.18  Aligned_cols=188  Identities=19%  Similarity=0.163  Sum_probs=133.3

Q ss_pred             cCCCCCCEEecCCCcccccCC--ccccCCCCCCEEecCCCcCCCcCCccc-cCCCCCccEEEccCCCCCCCccCccccCC
Q 047705            7 GNLQNLEELDLRQNKLIGTVP--VAIFNVSTLKLLGLQDNSLSGSLSSIT-DVRLPNLEELVLWGNNFSELNFLSSLSNC   83 (585)
Q Consensus         7 ~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~~l   83 (585)
                      +++.+|+...|.++.+. ..+  +....+++++.|||++|-+...-+-.. ...||+|+.|+|+.|++........-..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            46678888888888875 334  477788999999999997763222111 12588999999999998776432234467


Q ss_pred             CCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccc-hhhhCCCCCce
Q 047705           84 KSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQKLQG  162 (585)
Q Consensus        84 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~  162 (585)
                      +.|+.|.|+.|.++.-.-......+|+ |+.|+|+.|.....-.....-+..|+.|||++|++..... ...+.++.|+.
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPs-l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPS-LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCc-HHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence            889999999998873222223344565 9999999996444444455667889999999999875432 34567889999


Q ss_pred             EEccCCCCCccCcccc------cCCCCCcEEEcCCCcccc
Q 047705          163 LVLDDNKLEGSIPDDI------CRLVELYKLELGGNKLSR  196 (585)
Q Consensus       163 L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~~  196 (585)
                      |+++.+.|..+--...      ...++|++|++++|++..
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~  315 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD  315 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCcccc
Confidence            9999999886532222      456889999999999864

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.24  E-value=8.5e-13  Score=125.84  Aligned_cols=184  Identities=23%  Similarity=0.242  Sum_probs=135.2

Q ss_pred             cccCCCCccEEEeeCCccccccchhh----hCCCCCceEEccCCCCCccCccc-------------ccCCCCCcEEEcCC
Q 047705          129 EIGNLTNLITIDLGGNKLNGSILITL----SKLQKLQGLVLDDNKLEGSIPDD-------------ICRLVELYKLELGG  191 (585)
Q Consensus       129 ~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~L~~  191 (585)
                      ++-..+.|++||||+|.+..-.+..|    .++..|++|+|.+|.+.-.....             ...-++|+.+..+.
T Consensus        87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r  166 (382)
T KOG1909|consen   87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR  166 (382)
T ss_pred             HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence            34556789999999999874444333    56888999999999887333222             23356799999999


Q ss_pred             CcccccC----cccccCcccchhhcCCCCCCCCcc-------CCCCCCCcEEEccCCccccc----CCcccCCCCCCcEE
Q 047705          192 NKLSRSI----PACFNNLIALRILSLGSNDPLPLE-------IGNLKVLVGIDFSMNNFSGI----IPKEIGGLKNLEYL  256 (585)
Q Consensus       192 N~l~~~~----~~~~~~l~~L~~L~l~~n~~~~~~-------~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L  256 (585)
                      |++....    ...|+..+.|+.+.++.|.+.|..       +..+++|+.|||..|-++..    +...+..+++|+.|
T Consensus       167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El  246 (382)
T KOG1909|consen  167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL  246 (382)
T ss_pred             cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence            9997432    235677889999999999855554       56889999999999988743    33457778899999


Q ss_pred             eecccCcccccCcccc-----CcCCCCEEeCCCCccCcc----CChhhccCCccceEEeecCcCe
Q 047705          257 FLGYNRLQGLIPDSFG-----NLISLKFLNLSNNNLSGA----IPASLEKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       257 ~ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~  312 (585)
                      +++++.+......+|.     ..|+|++|.+.+|.|+..    +.......+.|..|+|++|.+.
T Consensus       247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            9999988765444332     358899999999998732    2234455788888999999873

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1e-10  Score=111.47  Aligned_cols=142  Identities=18%  Similarity=0.223  Sum_probs=110.1

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCC--CcceeEEeeeecC---CeEEEEEEccC
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRH--RNLIKVISSCSNE---EFKGLVLEYMP  493 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  493 (585)
                      +.++.|.++.||++...+|+.+++|+...... .....+..|+++++.+.+  ..+++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999877778999998764322 134577889999999975  3467778776654   36689999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-------------------------------------------  530 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------------------------------------------  530 (585)
                      |.++.+.+..  ..+++.+...++.++++++..||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888775532  2456667778888888888888831                                           


Q ss_pred             ----------CCCCcEEcCCCCCCEEeCC--CCcEEEeeeccccc
Q 047705          531 ----------CSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKL  563 (585)
Q Consensus       531 ----------~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~  563 (585)
                                ....++|+|++|.||++++  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0245799999999999998  67789999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=1.3e-12  Score=121.75  Aligned_cols=135  Identities=28%  Similarity=0.288  Sum_probs=104.2

Q ss_pred             ccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEE
Q 047705          178 ICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYL  256 (585)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  256 (585)
                      ...+..|+++|||+|.|+ .+.+...-.|+++.|++|+|. .....++.+++|+.||||+|.++. ...+-..+.+++.|
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTL  357 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHh-hhhhHhhhcCEeee
Confidence            344566888888888887 566667778888888888887 333458888899999999999884 44555678889999


Q ss_pred             eecccCcccccCccccCcCCCCEEeCCCCccCccCC-hhhccCCccceEEeecCcCeeeCC
Q 047705          257 FLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP-ASLEKLSYLEDLNLSFNKLEGEIP  316 (585)
Q Consensus       257 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~  316 (585)
                      .|+.|.+...  +.+..+-+|..||+++|+|..... ..++++|.|+.+.|.+|++.+.+.
T Consensus       358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999988754  456777889999999999874322 467889999999999999886544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.20  E-value=1.8e-10  Score=111.25  Aligned_cols=145  Identities=26%  Similarity=0.384  Sum_probs=92.2

Q ss_pred             CCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcC----------CCcceeEEeee--
Q 047705          416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIR----------HRNLIKVISSC--  479 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~--  479 (585)
                      +...+.||.|+++.||.+++. +++++|+|++....   ....+++.+|.-....+.          |-.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456789999999999999986 68999999986432   234556666654333322          11222222211  


Q ss_pred             -------ecC---C-----eEEEEEEccCCCCHHHHhhc---CCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 047705          480 -------SNE---E-----FKGLVLEYMPQGSLEKHLYS---TNC---ILDIFQRLNIMIDVASALEYLHFGCSTPVIHC  538 (585)
Q Consensus       480 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~  538 (585)
                             ...   .     ..+++|+-+ .++|.+.+..   ...   .........+..|+++.++++|   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                   111   1     235788877 4588877542   211   1223345667789999999999   9999999


Q ss_pred             CCCCCCEEeCCCCcEEEeeecccccc
Q 047705          539 DLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       539 dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||||+|++++.+|.++++||+.....
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~  195 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRA  195 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeec
Confidence            99999999999999999999987653

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.19  E-value=1.3e-12  Score=124.58  Aligned_cols=241  Identities=21%  Similarity=0.218  Sum_probs=150.5

Q ss_pred             ccCCCCCCEEecCCCcccc----cCCccccCCCCCCEEecCCCcCCCc---CCc------cccCCCCCccEEEccCCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIG----TVPVAIFNVSTLKLLGLQDNSLSGS---LSS------ITDVRLPNLEELVLWGNNFS   72 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~---~~~------~~~~~l~~L~~L~L~~n~l~   72 (585)
                      +..+..++.++|++|.+..    .+.+.+...++|+..+++.=.....   ++.      ......|+|++||||.|.|.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3457889999999998852    3355667778899988876432211   111      11124579999999999886


Q ss_pred             CCcc--C-ccccCCCCCcEEEccCCCCcccCCcchhhc------------ccccccEEEeecCcceecC----CccccCC
Q 047705           73 ELNF--L-SSLSNCKSLTVIGLSNNPLDGILPKTSIGN------------LSHSLEDFQMHNCNVTGDI----PEEIGNL  133 (585)
Q Consensus        73 ~~~~--~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~------------~~~~L~~L~l~~n~l~~~~----~~~~~~l  133 (585)
                      .-..  + ..++++.+|+.|.|.||.+. ...+..++.            -+..|++++.++|.+....    ...|...
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~  184 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH  184 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence            5432  1 13667889999999999884 222212111            1234788888887776333    2356667


Q ss_pred             CCccEEEeeCCcccc----ccchhhhCCCCCceEEccCCCCCccC----cccccCCCCCcEEEcCCCcccccCcccccCc
Q 047705          134 TNLITIDLGGNKLNG----SILITLSKLQKLQGLVLDDNKLEGSI----PDDICRLVELYKLELGGNKLSRSIPACFNNL  205 (585)
Q Consensus       134 ~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  205 (585)
                      +.|+.+.++.|.|..    ....+|..+++|+.|||.+|-++...    ...+..+++|+.|++++|.+...-...|.. 
T Consensus       185 ~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~-  263 (382)
T KOG1909|consen  185 PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD-  263 (382)
T ss_pred             cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH-
Confidence            778888888887753    22345667788888888888777322    345566777777777777776432222211 


Q ss_pred             ccchhhcCCCCCCCCccCCCCCCCcEEEccCCccccc----CCcccCCCCCCcEEeecccCc
Q 047705          206 IALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGI----IPKEIGGLKNLEYLFLGYNRL  263 (585)
Q Consensus       206 ~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l  263 (585)
                                     .--...++|++|.+.+|.|+..    +...+...+.|+.|+|++|++
T Consensus       264 ---------------al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  264 ---------------ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ---------------HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence                           0011245666777777776532    222344567788888888877

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.16  E-value=6.6e-12  Score=135.57  Aligned_cols=142  Identities=25%  Similarity=0.268  Sum_probs=115.8

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEEechh-hhhH---HHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-RRAF---KSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      +|...+.+|++.|=+|.+|++++|. |+||++-++. .-..   ++-.+|++ ...++|||.+.+.-+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999988887 8899986553 2222   33333455 566799999998888777777889999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      |.. -+|.|.+..+. .+...+.+.|+.|++.|+.-+|   ..||.|+|||.+|||++.=..+.|+||..-+.
T Consensus       102 yvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCC
Confidence            985 49999988765 4566677789999999999999   99999999999999999888999999986553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.1e-09  Score=99.93  Aligned_cols=125  Identities=26%  Similarity=0.280  Sum_probs=82.7

Q ss_pred             EEEEEEeCCCcEEEEEEEechh-------------h-------------hhHHHHHHHHHHHHhcCCC--cceeEEeeee
Q 047705          429 SVYKARLGDGMEVAVKVFNLQC-------------R-------------RAFKSFDVECEIMKSIRHR--NLIKVISSCS  480 (585)
Q Consensus       429 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  480 (585)
                      .||.|...+|..+|+|+.+...             .             .......+|++.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998899999999975320             0             0123566799999999765  567776553 


Q ss_pred             cCCeEEEEEEccC--CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          481 NEEFKGLVLEYMP--QGSLEKHLYSTNCILDIFQRLNIMIDVASALEY-LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       481 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                         ...+||||++  |..+..+....   ++......++.+++..+.. +|   ..||+|+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3479999998  54454433221   1123445677788775554 58   8999999999999999877 999999


Q ss_pred             ecccccc
Q 047705          558 FGIAKLL  564 (585)
Q Consensus       558 fg~a~~~  564 (585)
                      ||.|...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.8e-11  Score=131.72  Aligned_cols=171  Identities=26%  Similarity=0.323  Sum_probs=136.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC--CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  487 (585)
                      ...|.+.+.||+|+|+.|-.+...  ....+|+|.+....  ....++...|..+-+.+. |+|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            456888889999999999887653  34456677665432  333455556777777776 9999999999999999999


Q ss_pred             EEEccCCCCHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeeccccccc
Q 047705          488 VLEYMPQGSLEKHL-YSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLI  565 (585)
Q Consensus       488 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~  565 (585)
                      ++||..|+++.+.+ .......+......+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999988 4433245555667899999999999995  57899999999999999998 99999999999876


Q ss_pred             C-CCCccccccccc-cccccCC
Q 047705          566 G-EDQSMTQTQTLA-TIGYMAP  585 (585)
Q Consensus       566 ~-~~~~~~~~~~~g-t~~y~aP  585 (585)
                      . .+........+| ++.|+||
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCc
Confidence            5 344444566788 9999998

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.04  E-value=1.8e-10  Score=85.01  Aligned_cols=59  Identities=36%  Similarity=0.452  Sum_probs=29.3

Q ss_pred             CccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCc
Q 047705          135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNK  193 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  193 (585)
                      +|++|++++|+++.+.+.+|.++++|++|++++|+|+.+.++.|..+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34445555555554444445555555555555555554444445555555555555544

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.00  E-value=2.4e-10  Score=123.69  Aligned_cols=133  Identities=30%  Similarity=0.433  Sum_probs=91.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...+|..++.|..|+||.||.++++ ..+.+|+|+ +++.-     +.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-----------------
Confidence            3467999999999999999999887 467788854 32211     0000  33333344333                 


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC--
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED--  568 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--  568 (585)
                          |+-...++..+ .++.        +++.+++|+|   ..+|+|||+||+|.+|+.-|++|++|||+.+...-..  
T Consensus       136 ----gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                45555555433 2332        2278999999   9999999999999999999999999999987542100  


Q ss_pred             -----------CccccccccccccccCC
Q 047705          569 -----------QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 -----------~~~~~~~~~gt~~y~aP  585 (585)
                                 ......+.+|||.|.||
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccCh
Confidence                       00112567999999998

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=7.6e-09  Score=100.30  Aligned_cols=140  Identities=14%  Similarity=0.063  Sum_probs=100.2

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhh-----------hHHHHHHHHHHHHhcCCCcc--eeEEeeeec-----
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR-----------AFKSFDVECEIMKSIRHRNL--IKVISSCSN-----  481 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  481 (585)
                      +.+-+.....|+++.. +|+.|.||........           ....+.+|+..+.++...+|  +++++++..     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455444555777766 5678999976432211           11147789999988854444  445555543     


Q ss_pred             CCeEEEEEEccCCC-CHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-------CCc
Q 047705          482 EEFKGLVLEYMPQG-SLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-------NMI  552 (585)
Q Consensus       482 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-------~~~  552 (585)
                      ....++|||++++. +|.+++... ....+......++.+++..+.-||   ..||+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23468999999875 788887532 123455667789999999999999   999999999999999975       468


Q ss_pred             EEEeeeccccc
Q 047705          553 AYLSDFGIAKL  563 (585)
Q Consensus       553 ~kl~Dfg~a~~  563 (585)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998854

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.96  E-value=6.8e-10  Score=81.86  Aligned_cols=59  Identities=44%  Similarity=0.651  Sum_probs=29.1

Q ss_pred             CCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCc
Q 047705          228 VLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN  286 (585)
Q Consensus       228 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  286 (585)
                      +|+.|++++|+++.+.+..|.++++|++|++++|.++.+.|..|..+++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444555555554444444555555555555555544444445555555555555444

...

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.95  E-value=1.7e-09  Score=99.06  Aligned_cols=73  Identities=26%  Similarity=0.210  Sum_probs=62.9

Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |+|.+++...+..+++..++.++.|++.||+|||   +++      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999876667999999999999999999999   666      999999999999999  9998865321       


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ...||+.||||
T Consensus        63 ~~~g~~~y~aP   73 (176)
T smart00750       63 QSRVDPYFMAP   73 (176)
T ss_pred             cCCCcccccCh
Confidence            12689999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.93  E-value=1.5e-10  Score=116.85  Aligned_cols=164  Identities=23%  Similarity=0.263  Sum_probs=110.8

Q ss_pred             CCccceecccCceEEEEEEeCC----CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEe-------eee----
Q 047705          416 FSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVIS-------SCS----  480 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~~----  480 (585)
                      +.+.+..++.++|.++..+...    .+.++-+..+...........+++..+....|.+..-+.+       .+.    
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v  325 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV  325 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence            4455666666777666654322    2344444444333233344444555555554443333322       111    


Q ss_pred             -cCCeEEEEEEccCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          481 -NEEFKGLVLEYMPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       481 -~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                       ...+.||.|++|+..+|.+|+....  ...++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|
T Consensus       326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence             1235789999999999999997443  355677788999999999998      5899999999999999999999999


Q ss_pred             ecccccccCCC----CccccccccccccccCC
Q 047705          558 FGIAKLLIGED----QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~----~~~~~~~~~gt~~y~aP  585 (585)
                      ||+........    .....+..+||.+||+|
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCH
Confidence            99987654333    23345677899999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.89  E-value=2.2e-09  Score=110.49  Aligned_cols=98  Identities=35%  Similarity=0.566  Sum_probs=90.0

Q ss_pred             HHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-EEcCCCC
Q 047705          464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV-IHCDLKP  542 (585)
Q Consensus       464 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i-iH~dlkp  542 (585)
                      |+.+.|.|+.+++|.+.+....++|.+||+-|+|.+.+......+++.-...+.++|++|++|+|   .-+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35678999999999999999999999999999999999987778889889999999999999999   5455 9999999


Q ss_pred             CCEEeCCCCcEEEeeecccccc
Q 047705          543 SNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       543 ~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+++|....+|++|||+....
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~   99 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLL   99 (484)
T ss_pred             ccceeeeeEEEEechhhhcccc
Confidence            9999999999999999998765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=1.5e-08  Score=94.85  Aligned_cols=136  Identities=22%  Similarity=0.208  Sum_probs=101.0

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEechh----------------------hhhHHHHHHHHHHHHhcCCC--c
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----------------------RRAFKSFDVECEIMKSIRHR--N  471 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  471 (585)
                      ..++..||.|--+.||.|....|.++|||.=+...                      .......++|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999632110                      01234567899999999654  6


Q ss_pred             ceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       472 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      +++.+++    +...+||||++|-.|...-      ++......++..|++-+.-.-   ..||||+|+.+=||++++||
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7776665    5678999999987665432      122333445556666666555   68999999999999999999


Q ss_pred             cEEEeeecccccc
Q 047705          552 IAYLSDFGIAKLL  564 (585)
Q Consensus       552 ~~kl~Dfg~a~~~  564 (585)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999877653

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.86  E-value=4e-09  Score=117.89  Aligned_cols=149  Identities=28%  Similarity=0.342  Sum_probs=82.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCc--CCCcCCccccCCCCCccEEEccCC-CCCCCccCccccCCCCC
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS--LSGSLSSITDVRLPNLEELVLWGN-NFSELNFLSSLSNCKSL   86 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~~l~~L   86 (585)
                      ...+++.+-+|++. ..+....+ +.|++|-+..|.  +. .++..+|..+|.|+.|||++| .+..+|  ..++.+-+|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP--~~I~~Li~L  597 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLP--SSIGELVHL  597 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCC--hHHhhhhhh
Confidence            44556666666553 23333322 256666666665  43 444545556667777777655 445555  556666667


Q ss_pred             cEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCc--cccccchhhhCCCCCceEE
Q 047705           87 TVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNK--LNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        87 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~  164 (585)
                      ++|+|++..+..+ |. .++++.. |.+|+++.+.-...+|.....|++|++|.+..-.  .....-..+..+.+|+.|.
T Consensus       598 ryL~L~~t~I~~L-P~-~l~~Lk~-L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls  674 (889)
T KOG4658|consen  598 RYLDLSDTGISHL-PS-GLGNLKK-LIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS  674 (889)
T ss_pred             hcccccCCCcccc-ch-HHHHHHh-hheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence            7777777766533 33 4566654 6677776666555556666667777777665543  2222223334445555444


Q ss_pred             cc
Q 047705          165 LD  166 (585)
Q Consensus       165 L~  166 (585)
                      ..
T Consensus       675 ~~  676 (889)
T KOG4658|consen  675 IT  676 (889)
T ss_pred             ee
Confidence            43

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.85  E-value=1.4e-08  Score=105.71  Aligned_cols=123  Identities=19%  Similarity=0.212  Sum_probs=102.5

Q ss_pred             EeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHH
Q 047705          434 RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR  513 (585)
Q Consensus       434 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  513 (585)
                      +..++.+|.|...+...........+-++.|+.++||+|+++++.++.++..|+|+|-+.  .|..++.+..    ...+
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            344788999988876554344556778889999999999999999999999999999984  6777776643    4455


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       514 ~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ...+.||+.||.|||+  +++++|++|.-+.|+++..|+.||++|-++...
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            6678999999999985  679999999999999999999999999887654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.80  E-value=2.6e-08  Score=104.51  Aligned_cols=141  Identities=21%  Similarity=0.199  Sum_probs=96.0

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhh----------------------------------------hHHHHHH
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR----------------------------------------AFKSFDV  459 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  459 (585)
                      +.|+.++-|.||+|+..+|++||||+.++.-..                                        ..-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999999999999997642100                                        0112445


Q ss_pred             HHHHHHhcC-----CCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 047705          460 ECEIMKSIR-----HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP  534 (585)
Q Consensus       460 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  534 (585)
                      |+..+.+++     .+++.-..=|++..+...++|||++|-.+.+...-.....+...+.....++.-  .-+-   ..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~---~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLL---RDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHH---hcC
Confidence            666665552     354443333444556678999999998888874332234554433333222221  1222   459


Q ss_pred             cEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       535 iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++|.|..|.||+++.+|++.+.|||+...+.
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999999987653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.77  E-value=2.7e-10  Score=118.20  Aligned_cols=182  Identities=30%  Similarity=0.260  Sum_probs=125.9

Q ss_pred             CccccCCCCccEEEeeCCccccccchhhhCC-CCCceEEccCCCCCc---cC---ccccc---CCCCCcEEEcCCCcccc
Q 047705          127 PEEIGNLTNLITIDLGGNKLNGSILITLSKL-QKLQGLVLDDNKLEG---SI---PDDIC---RLVELYKLELGGNKLSR  196 (585)
Q Consensus       127 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~---~~---~~~~~---~l~~L~~L~L~~N~l~~  196 (585)
                      |-.+..+.+|+.|.|.++.|..  ...+..+ ..|+.|--. |.+..   ++   ..++.   .+.+|.+.+.++|++. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            3345667889999999998874  2222221 134444322 22210   00   01111   1346888889999997 


Q ss_pred             cCcccccCcccchhhcCCCCCCCC-ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcC
Q 047705          197 SIPACFNNLIALRILSLGSNDPLP-LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI  275 (585)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  275 (585)
                      .....+.-++.|++|+|++|+... ..+..+++|++|||++|.++.+.--...++. |+.|+|++|.++..  ..+.++.
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lk  254 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLK  254 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhh
Confidence            566778888899999999998333 3678899999999999999865444555666 99999999988865  4567888


Q ss_pred             CCCEEeCCCCccCccCC-hhhccCCccceEEeecCcCeeeC
Q 047705          276 SLKFLNLSNNNLSGAIP-ASLEKLSYLEDLNLSFNKLEGEI  315 (585)
Q Consensus       276 ~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~  315 (585)
                      +|+.||+++|-|.+-.. .-++.+..|++|+|.||++.|.+
T Consensus       255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99999999998875432 24556778899999999987754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.75  E-value=1e-08  Score=114.71  Aligned_cols=128  Identities=29%  Similarity=0.390  Sum_probs=71.9

Q ss_pred             CCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCC--CCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccccc
Q 047705           34 STLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN--FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHS  111 (585)
Q Consensus        34 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  111 (585)
                      ...+...+.+|.+...... .  ..++|++|-+..|.  +..++. ..|..++.|+.||||+|.=-+..|. .++++-+ 
T Consensus       523 ~~~rr~s~~~~~~~~~~~~-~--~~~~L~tLll~~n~~~l~~is~-~ff~~m~~LrVLDLs~~~~l~~LP~-~I~~Li~-  596 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEHIAGS-S--ENPKLRTLLLQRNSDWLLEISG-EFFRSLPLLRVLDLSGNSSLSKLPS-SIGELVH-  596 (889)
T ss_pred             hheeEEEEeccchhhccCC-C--CCCccceEEEeecchhhhhcCH-HHHhhCcceEEEECCCCCccCcCCh-HHhhhhh-
Confidence            4566666666666522222 2  24466666666665  555543 4566677777777776554444444 4555554 


Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN  168 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  168 (585)
                      |++|+|++..++ .+|..+.+|..|.+||+..+.-...++.....+++|++|.+..-
T Consensus       597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            666666666655 45555666666666666655544344555555666666655544

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.75  E-value=2.1e-09  Score=100.57  Aligned_cols=185  Identities=23%  Similarity=0.254  Sum_probs=88.0

Q ss_pred             CCCCEEecCCCccc--ccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705           10 QNLEELDLRQNKLI--GTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus        10 ~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      ++++.|||.+|+|+  ..+..-+.+|+.|++|+|+.|++...+.... ..+.+|++|-|.+..+..--.-..+..+|.++
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp-~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP-LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc-ccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            56666777777665  2233445667777777777777765555443 24566777777666655443323456667777


Q ss_pred             EEEccCCCCcccCCcc-hhhcccccccEEEeecCccee--cCCccccCCCCccEEEeeCCcccccc-chhhhCCCCCceE
Q 047705           88 VIGLSNNPLDGILPKT-SIGNLSHSLEDFQMHNCNVTG--DIPEEIGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGL  163 (585)
Q Consensus        88 ~L~Ls~N~l~~~~~~~-~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L  163 (585)
                      .|.||.|+++...-+. -...+...+.+|++..|...-  .+...-+-.+++..+-+.+|.+.... ...+..++.+.-|
T Consensus       150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~L  229 (418)
T KOG2982|consen  150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCL  229 (418)
T ss_pred             hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhh
Confidence            7777777443221110 011112224444444442210  00111122344444555555444321 1223334444445


Q ss_pred             EccCCCCCccCc-ccccCCCCCcEEEcCCCccc
Q 047705          164 VLDDNKLEGSIP-DDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       164 ~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  195 (585)
                      +|+.|+|..... +++.+.++|..|.+++|.+.
T Consensus       230 nL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  230 NLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             hhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence            555555443211 33444444444555554444

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.75  E-value=6e-09  Score=107.42  Aligned_cols=168  Identities=24%  Similarity=0.233  Sum_probs=130.3

Q ss_pred             CCCCccceecc--cCceEEEEEEe--C-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          414 DGFSENNLIGR--GGFGSVYKARL--G-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ..|.+.+.+|.  |.+|.||.++.  + ++..+|+|.-+...  ......=.+|+...+++ .|++.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34667788999  99999999875  3 67889988733221  12223334577777777 499999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeecc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS----ALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGI  560 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~  560 (585)
                      |+-+|+| +.++..+.......++....+....+..+    |+.++|   ...++|-|+||+||+...+ ...+++|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999999 67999988877666788888888889888    999999   9999999999999999988 8999999999


Q ss_pred             cccccCCCCc---cccccccccccccCC
Q 047705          561 AKLLIGEDQS---MTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~---~~~~~~~gt~~y~aP  585 (585)
                      ...+.+..-.   .......|...|++|
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeCh
Confidence            8876543311   111233567778876

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=1.7e-07  Score=87.98  Aligned_cols=106  Identities=24%  Similarity=0.293  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHHhcCCC--cceeEEeeeecCC----eEEEEEEccCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 047705          455 KSFDVECEIMKSIRHR--NLIKVISSCSNEE----FKGLVLEYMPQ-GSLEKHLYSTNCILDIFQRLNIMIDVASALEYL  527 (585)
Q Consensus       455 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l  527 (585)
                      ....+|...+..+...  .+++.+++.....    ..++|+|++++ .+|.+++..... .+......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            4577788888877543  3456666665432    45899999988 479998876432 45556778999999999999


Q ss_pred             hcCCCCCcEEcCCCCCCEEeCCCC---cEEEeeecccccc
Q 047705          528 HFGCSTPVIHCDLKPSNVLLDDNM---IAYLSDFGIAKLL  564 (585)
Q Consensus       528 H~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~~  564 (585)
                      |   ..||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   99999999999999999777   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.60  E-value=9.1e-10  Score=103.01  Aligned_cols=179  Identities=23%  Similarity=0.232  Sum_probs=96.2

Q ss_pred             CCCEEecCCCcccc-cCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCC-CCCCccCccccCCCCCcE
Q 047705           11 NLEELDLRQNKLIG-TVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN-FSELNFLSSLSNCKSLTV   88 (585)
Q Consensus        11 ~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~l~~L~~   88 (585)
                      +|++|||++..|+. ....-++...+|+.|.|.|+++. .+-....++..+|+.|+|+.+. |+.-..--.|.+++.|..
T Consensus       186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~Ld-D~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~  264 (419)
T KOG2120|consen  186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLD-DPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE  264 (419)
T ss_pred             hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccC-cHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence            46777777776652 22334555667777777777775 3322333356677777777653 333221113667777777


Q ss_pred             EEccCCCCcccCCcchhhcccccccEEEeecCcc--e-ecCCccccCCCCccEEEeeCCcc-ccccchhhhCCCCCceEE
Q 047705           89 IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV--T-GDIPEEIGNLTNLITIDLGGNKL-NGSILITLSKLQKLQGLV  164 (585)
Q Consensus        89 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l--~-~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~  164 (585)
                      |+|+++-+....-.........+|+.|+|+++.=  . ..+....+.+++|..|||++|.. +.-....|..++.|++|.
T Consensus       265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lS  344 (419)
T KOG2120|consen  265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLS  344 (419)
T ss_pred             cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeee
Confidence            7777777654433334455555566776666431  1 11112234456666666666543 322223445566666666


Q ss_pred             ccCCCCCccCccc---ccCCCCCcEEEcCCC
Q 047705          165 LDDNKLEGSIPDD---ICRLVELYKLELGGN  192 (585)
Q Consensus       165 L~~N~l~~~~~~~---~~~l~~L~~L~L~~N  192 (585)
                      +++|..  ++|+.   +...++|.+|+..++
T Consensus       345 lsRCY~--i~p~~~~~l~s~psl~yLdv~g~  373 (419)
T KOG2120|consen  345 LSRCYD--IIPETLLELNSKPSLVYLDVFGC  373 (419)
T ss_pred             hhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence            666653  34432   344555666655444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.58  E-value=4.1e-07  Score=92.05  Aligned_cols=138  Identities=20%  Similarity=0.194  Sum_probs=107.1

Q ss_pred             ceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEEEEEEccCC-CCHHHH
Q 047705          427 FGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKGLVLEYMPQ-GSLEKH  500 (585)
Q Consensus       427 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  500 (585)
                      -.+.|+|... ||..|++|+++............-++.++++.|+|+|++.++|..    +....+|++|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3568999754 899999999954432222222335778999999999999998873    3467899999976 577665


Q ss_pred             hhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          501 LYST--------------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       501 l~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ....              +...++..+|.++.|+..||.++|   +.|..-+-+.|.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              124678889999999999999999   89998899999999999999999999888766543


Q ss_pred             C
Q 047705          567 E  567 (585)
Q Consensus       567 ~  567 (585)
                      +
T Consensus       446 d  446 (655)
T KOG3741|consen  446 D  446 (655)
T ss_pred             C
Confidence            3

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=1.3e-06  Score=80.34  Aligned_cols=154  Identities=15%  Similarity=0.050  Sum_probs=106.2

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh------hhhHHHHHHHHHHHHhcCCC--cceeEEee
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHR--NLIKVISS  478 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~  478 (585)
                      +.+......+-..---|+|+.+-|++....+. .+-+|.-....      ......|.+|+..+.++...  .++++..+
T Consensus        11 ~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~   89 (216)
T PRK09902         11 NHWWATEGDWVEEPNYRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFG   89 (216)
T ss_pred             HHHHhCCCceecCCCcCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCcccee
Confidence            33333333333333356788889999876443 57777643111      22456789999999988532  24555522


Q ss_pred             eecC----CeEEEEEEccCC-CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc
Q 047705          479 CSNE----EFKGLVLEYMPQ-GSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       479 ~~~~----~~~~lv~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~  552 (585)
                      ....    -..++|+|-++| .+|.+++.+.. .+.+......+..++++++.-||   +.|+.|+|+.+.||+++.++.
T Consensus        90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902         90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             eeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCC
Confidence            2111    135799997754 58888886543 24566667789999999999999   999999999999999986666


Q ss_pred             --EEEeeecccccc
Q 047705          553 --AYLSDFGIAKLL  564 (585)
Q Consensus       553 --~kl~Dfg~a~~~  564 (585)
                        ++++||.-++..
T Consensus       167 ~~v~lIDlEk~r~~  180 (216)
T PRK09902        167 AEAGFLDLEKSRRR  180 (216)
T ss_pred             eeEEEEEhhccchh
Confidence              999999877653

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.55  E-value=2.8e-08  Score=93.17  Aligned_cols=64  Identities=27%  Similarity=0.282  Sum_probs=41.5

Q ss_pred             CCCCcEEeecccCcccccC-ccccCcCCCCEEeCCCCccCccC-ChhhccCCccceEEeecCcCee
Q 047705          250 LKNLEYLFLGYNRLQGLIP-DSFGNLISLKFLNLSNNNLSGAI-PASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       250 l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      +|++..+.+..|++..... ..+...+.+-.|+|+.|+|.+.. -+.+..++.|..|.+++||+..
T Consensus       198 Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  198 FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            3566777777776654432 34455566667788888776332 2466677888888888888753

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=1.2e-06  Score=80.77  Aligned_cols=138  Identities=17%  Similarity=0.178  Sum_probs=90.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHH---------HHHHHHHHhcCC---CcceeEEee-
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSF---------DVECEIMKSIRH---RNLIKVISS-  478 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~~-  478 (585)
                      ...+|...+.+.......|.+-.. +|+.+++|..+.......+.|         .+++..+.+++-   .....++.+ 
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345688888888777666666655 678899998765543322222         233443444422   222222222 


Q ss_pred             ----eecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEE
Q 047705          479 ----CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       479 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~k  554 (585)
                          +......+++|||++|..+.+...     +++    .++..+.+++.-+|   +.|+.|+|..|.|+++++++ ++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EE
Confidence                222235568999999988766532     222    25567788899999   99999999999999998554 99


Q ss_pred             Eeeeccccc
Q 047705          555 LSDFGIAKL  563 (585)
Q Consensus       555 l~Dfg~a~~  563 (585)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.54  E-value=4.3e-08  Score=101.16  Aligned_cols=150  Identities=25%  Similarity=0.241  Sum_probs=116.7

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC--CCcEEEEEEEechhhh--hHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQCRR--AFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      .....+|..+..||.|.|+.|+.+..+  ++..|++|-.......  ....-..|+-+...+ .|.+++..+..|.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            444567899999999999999998643  6778888865433211  112223355555555 58888988888888888


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeeccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKL  563 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~  563 (585)
                      .|+--|||++++........ ..+++...+.+..|++.++.++|   .+.++|+|+||+||++..+ +.-++.|||.+..
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            88999999999887766332 25677788899999999999999   9999999999999999875 7889999998863

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=6.6e-07  Score=93.70  Aligned_cols=139  Identities=21%  Similarity=0.240  Sum_probs=92.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhh-------------------------------------hHHHHHHHHH
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRR-------------------------------------AFKSFDVECE  462 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~  462 (585)
                      +.||.-+.|.||+|+.++|+.||||+-++.-+.                                     ..-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            689999999999999999999999986542110                                     0113445655


Q ss_pred             HHHhc----CCCc------ceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047705          463 IMKSI----RHRN------LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS  532 (585)
Q Consensus       463 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  532 (585)
                      -..++    +|-+      |++++..+  .....++||||+|..+.+.-.-....++...+..-+.+...-+-+     .
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-----~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-----K  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----h
Confidence            44433    3444      44444433  345689999999987766533222345555444444343322223     4


Q ss_pred             CCcEEcCCCCCCEEeC----CCCcEEEeeeccccccc
Q 047705          533 TPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       533 ~~iiH~dlkp~NIll~----~~~~~kl~Dfg~a~~~~  565 (585)
                      .|++|+|-.|.||++.    .++.+.+-|||+...+.
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            5899999999999998    36789999999987653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=1.8e-06  Score=82.05  Aligned_cols=133  Identities=16%  Similarity=0.181  Sum_probs=86.1

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc--ceeEEeeeecCCeEEEEEEccCCCC-
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN--LIKVISSCSNEEFKGLVLEYMPQGS-  496 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  496 (585)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +++.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   24567788876433  2345688999999886433  5778888877778889999998863 


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh---------------------------------------c-CCCCCcE
Q 047705          497 LEKHLYSTNCILDIFQRLNIMIDVASALEYLH---------------------------------------F-GCSTPVI  536 (585)
Q Consensus       497 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---------------------------------------~-~~~~~ii  536 (585)
                      +.+.+..     +......++.++++.+.-+|                                       . .....++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2211110     00011111112222222122                                       0 1134568


Q ss_pred             EcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          537 HCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       537 H~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      |+|+.|.||++++++ +.++||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK15386 type III secretion protein GogB; Provisional

Probab=98.48  E-value=4.6e-07  Score=91.32  Aligned_cols=31  Identities=19%  Similarity=0.196  Sum_probs=14.6

Q ss_pred             CCceEEccCCCCCccCcccccCCCCCcEEEcCCC
Q 047705          159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGN  192 (585)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  192 (585)
                      +|++|++++|... ..|+.+.  .+|++|+++.|
T Consensus       157 SLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n  187 (426)
T PRK15386        157 SLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE  187 (426)
T ss_pred             cccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence            4555555555543 2232222  34555555554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	585
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-26
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-23
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		7e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-04
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		2e-04
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		2e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		2e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-04
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		3e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  119 bits (298), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/188 (37%), Positives = 101/188 (53%), Gaps = 5/188 (2%)
Query: 402 RTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDVE 460
           + FS  EL  A+D FS  N++GRGGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIM 517
            E++    HRNL+++   C     + LV  YM  GS+    +    +   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           +  A  L YLH  C   +IH D+K +N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 578 ATIGYMAP 585
            TIG++AP
Sbjct: 205 GTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  115 bits (287), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 70/188 (37%), Positives = 99/188 (52%), Gaps = 5/188 (2%)
Query: 402 RTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK-SFDVE 460
           + FS  EL  A+D F   N++GRGGFG VYK RL DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---STNCILDIFQRLNIM 517
            E++    HRNL+++   C     + LV  YM  GS+   L     +   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           +  A  L YLH  C   +IH D+K +N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 578 ATIGYMAP 585
             IG++AP
Sbjct: 197 GXIGHIAP 204

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 115/395 (29%), Positives = 155/395 (39%), Gaps = 85/395 (21%)
Query: 12  LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGXXX 71
           L+EL L+ N   G +P  + N S L  L L  N LSG++ S     L  L +L LW    
Sbjct: 393 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWL--- 448
Query: 72  XXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
                                 N L+G +P+  +     +LE   +   ++TG+IP  + 
Sbjct: 449 ----------------------NMLEGEIPQELM--YVKTLETLILDFNDLTGEIPSGLS 484
Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
           N TNL  I L  N+L G I   + +L+ L  L L +N   G+IP ++     L  L+L  
Sbjct: 485 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 544
Query: 192 NKLSRSIPACF--------NNLIALRILSLGSNDPLPLE---IGNLKVLVGI-------- 232
           N  + +IPA           N IA +      ND +  E    GNL    GI        
Sbjct: 545 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 604
Query: 233 ------------------------------DFSMNNFSGIIPKEIGGLKNLEYLFLGYNR 262
                                         D S N  SG IPKEIG +  L  L LG+N 
Sbjct: 605 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 664
Query: 263 LQGLIPDSFGXXXXXXXXXXXXXXXXGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFG 322
           + G IPD  G                G IP ++  L+ L +++LS N L G IP  G F 
Sbjct: 665 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 724
Query: 323 NFSAESFEGNELLCGSPNLQVPPCKTS-----IHH 352
            F    F  N  LCG P   +P C  S      HH
Sbjct: 725 TFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHH 756

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 113/387 (29%), Positives = 153/387 (39%), Gaps = 80/387 (20%)
Query: 12  LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGXXX 71
           L+EL L+ N   G +P  + N S L  L L  N LSG++ S     L  L +L LW    
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWL--- 451
Query: 72  XXXXXXXXXXXCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
                                 N L+G +P+  +     +LE   +   ++TG+IP  + 
Sbjct: 452 ----------------------NMLEGEIPQELM--YVKTLETLILDFNDLTGEIPSGLS 487
Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
           N TNL  I L  N+L G I   + +L+ L  L L +N   G+IP ++     L  L+L  
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 192 NKLSRSIPACF--------NNLIALRILSLGSNDPLPLE---IGNLKVLVGI-------- 232
           N  + +IPA           N IA +      ND +  E    GNL    GI        
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 233 ------------------------------DFSMNNFSGIIPKEIGGLKNLEYLFLGYNR 262
                                         D S N  SG IPKEIG +  L  L LG+N 
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 263 LQGLIPDSFGXXXXXXXXXXXXXXXXGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFG 322
           + G IPD  G                G IP ++  L+ L +++LS N L G IP  G F 
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 323 NFSAESFEGNELLCGSPNLQVPPCKTS 349
            F    F  N  LCG P   +P C  S
Sbjct: 728 TFPPAKFLNNPGLCGYP---LPRCDPS 751

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/182 (35%), Positives = 98/182 (53%), Gaps = 6/182 (3%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS 466
           ++L  AT+ F    LIG G FG VYK  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASA 523
            RH +L+ +I  C       L+ +YM  G+L++HLY ++     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L YLH   +  +IH D+K  N+LLD+N +  ++DFGI+K     DQ+        T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 584 AP 585
            P
Sbjct: 209 DP 210

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 97/182 (53%), Gaps = 6/182 (3%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS 466
           ++L  AT+ F    LIG G FG VYK  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASA 523
            RH +L+ +I  C       L+ +YM  G+L++HLY ++     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L YLH   +  +IH D+K  N+LLD+N +  ++DFGI+K      Q+        T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 584 AP 585
            P
Sbjct: 209 DP 210

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 116/259 (44%), Gaps = 30/259 (11%)
Query: 89  IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG 148
           IG  NN +  I P  +I  L+  L    + + NV+G IP+ +  +  L+T+D   N L+G
Sbjct: 83  IGGINNLVGPIPP--AIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139
Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY-KLELGGNKLSRSIPACFNNLIA 207
           ++  ++S L  L G+  D N++ G+IPD      +L+  + +  N+L+  IP  F NL  
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-- 197
Query: 208 LRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI 267
                                L  +D S N   G      G  KN + + L  N L   +
Sbjct: 198 --------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 268 PDSFGXXXXXXXXXXXXXXXXGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAE 327
               G                G +P  L +L +L  LN+SFN L GEIP+GG+   F   
Sbjct: 238 -GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
Query: 328 SFEGNELLCGSPNLQVPPC 346
           ++  N+ LCGSP   +P C
Sbjct: 297 AYANNKCLCGSP---LPAC 312

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 401 WRTFSYLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 450
           + +FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--- 507
               + FD E ++M   +H NL++++   S+ +   LV  YMP GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 508 --LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             L    R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 566 GEDQSMTQTQTLATIGYMAP 585
              Q++  ++ + T  YMAP
Sbjct: 185 KFAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 401 WRTFSYLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 450
           + +FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--- 507
               + FD E ++M   +H NL++++   S+ +   LV  YMP GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 508 --LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             L    R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 566 GEDQSMTQTQTLATIGYMAP 585
              Q++   + + T  YMAP
Sbjct: 185 KFAQTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 401 WRTFSYLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 450
           + +FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--- 507
               + FD E ++M   +H NL++++   S+ +   LV  YMP GSL   L   +C+   
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 121
Query: 508 --LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             L    R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 566 GEDQSMTQTQTLATIGYMAP 585
              Q +   + + T  YMAP
Sbjct: 179 KFAQXVMXXRIVGTTAYMAP 198

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 88/168 (52%), Gaps = 8/168 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK--SFDVECEIMKSIRHRNLIKVISSC 479
           IG G FG+V++A    G +VAVK+   Q   A +   F  E  IMK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +      +V EY+ +GSL + L+ +     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLK  N+L+D      + DFG+++L       +       T  +MAP
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 8/168 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK--SFDVECEIMKSIRHRNLIKVISSC 479
           IG G FG+V++A    G +VAVK+   Q   A +   F  E  IMK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +      +V EY+ +GSL + L+ +     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +LK  N+L+D      + DFG+++L       ++      T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAP 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 401 WRTFSYLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVK----VFNLQC 450
           + +FS+ EL   T+ F E       N  G GGFG VYK  + +   VAVK    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--- 507
               + FD E ++    +H NL++++   S+ +   LV  Y P GSL   L   +C+   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGT 118
Query: 508 --LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             L    R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 566 GEDQSMTQTQTLATIGYMAP 585
              Q +  ++ + T  Y AP
Sbjct: 176 KFAQXVXXSRIVGTTAYXAP 195

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+  +       F++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            + +    +V ++    SL KHL+       +FQ ++I    A  ++YLH   +  +IH 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+K +N+ L + +   + DFG+A +      S    Q   ++ +MAP
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIM 464
           +  + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 64
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
             + H   +K+  +  ++E     L Y   G L K++       +   R     ++ SAL
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 123
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 585 P 585
           P
Sbjct: 181 P 181

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIM 464
           +  + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 63
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
             + H   +K+  +  ++E     L Y   G L K++       +   R     ++ SAL
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 122
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 585 P 585
           P
Sbjct: 180 P 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIM 464
           +  + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 62
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
             + H   +K+  +  ++E     L Y   G L K++       +   R     ++ SAL
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 121
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 585 P 585
           P
Sbjct: 179 P 179

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 92
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 151
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIM 464
           +  + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 61
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
             + H   +K+  +  ++E     L Y   G L K++       +   R     ++ SAL
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 120
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 585 P 585
           P
Sbjct: 178 P 178

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 71
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 130
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 21/178 (11%)
Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVF----NLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +IG GGFG VY+A  +GD  EVAVK      +    +  ++   E ++   ++H N+I +
Sbjct: 14  IIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
              C  E    LV+E+   G L + L       DI   +N  + +A  + YLH     P+
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 536 IHCDLKPSNVLLDD--------NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           IH DLK SN+L+          N I  ++DFG+A+    E    T+        +MAP
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 130
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+++    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L ++    + DFG+A +      S    Q   +I +MAP
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 128 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 155
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 121 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 122 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 129 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 416 FSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R        G  VAVK          + F+ E EI+K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 466 SIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           S++H N++K    C +   +   L++EY+P GSL  +L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 416 FSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R        G  VAVK          + F+ E EI+K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 466 SIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           S++H N++K    C +   +   L++EY+P GSL  +L      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 126 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +V  AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 94
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+     ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 153
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 416 FSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R        G  VAVK          + F+ E EI+K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 466 SIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           S++H N++K    C +   +   L++EY+P GSL  +L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSI 467
           + F    ++G G F +   AR L    E A+K+  L+ R   K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H   +K+  +  ++E     L Y   G L K++       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 416 FSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R        G  VAVK          + F+ E EI+K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 466 SIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           S++H N++K    C +   +   L++EY+P GSL  +L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 416 FSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R        G  VAVK          + F+ E EI+K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 466 SIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           S++H N++K    C +   +   L++EY+P GSL  +L      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+++    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L ++    + DFG+A        S    Q   +I +MAP
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++E++P GSL ++L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A        S    Q   +I +MAP
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A        S    Q   +I +MAP
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 148
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L +++   + DFG+A        S    Q   +I +MAP
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 195

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 75  EPIX-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 131 RAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 174

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 334 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 390 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 433

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG+VYK +  GD   VAVK+ N+     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
            +  +   +V ++    SL  HL+++    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK +N+ L ++    + DFG+A        S    Q   +I +MAP
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 78  EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 134 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 177

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 411 RATDGFSENNL-----IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVE 460
           R    F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            EI+KS++H N++K    C +   +   L++EY+P GSL  +L      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +   +EYL    +   IH +L   N+L+++     + DFG+ K+L
Sbjct: 123 QICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 251 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 307 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 251 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 307 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 82  EPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 138 RAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAP 181

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 82  EPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 138 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 181

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 22/187 (11%)
Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQ-C--RRAFKSFDV 459
           F + E+ RA         IG+G FG V   +  D  ++ A+K  N Q C  R   ++   
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 460 ECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID 519
           E +IM+ + H  L+ +  S  +EE   +V++ +  G L  HL       +   +L  + +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICE 123
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA- 578
           +  AL+YL    +  +IH D+KP N+LLD++   +++DF IA +L  E    TQ  T+A 
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 579 TIGYMAP 585
           T  YMAP
Sbjct: 177 TKPYMAP 183

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK IRH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 81
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V+EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAP 184

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 156
Query: 475 V------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +           +E +  LVL+Y+P+    + +H       L +      M  +  +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 527 LH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           +H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 253

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 110
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 84
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 182

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 19/161 (11%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 115
Query: 475 V------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +           +E +  LVL+Y+P+    + +H       L +      M  +  +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 527 LH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           +H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V+EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 110
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 112
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 173 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 210

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 104
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 202

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L   T   L + Q +++   +AS + Y+        +H DL
Sbjct: 251 EPIY-IVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 307 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 350

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 95
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 193

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 89
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 187

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 88
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 88
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 186

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 77
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 175

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 80
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 141 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 24/185 (12%)
Query: 422 IGRGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYS---------------TNCILDIFQRLNIMIDV 520
              C + +   +V EYM  G L K L +                   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 581 GYMAP 585
            +M P
Sbjct: 200 RWMPP 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
           IGRG FG V+  RL  D   VAVK     CR          F  E  I+K   H N++++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I  C+ ++   +V+E +  G     L +    L +   L ++ D A+ +EYL   C    
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           IH DL   N L+ +  +  +SDFG+++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 133
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 176

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 13/165 (7%)
Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            ++G+G FG   K    +  EV V      F+ + +R F     E ++M+ + H N++K 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKF 72
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I     ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  +
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           IH DL   N L+ +N    ++DFG+A+L++ E    TQ + L ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSL 171

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ  +AFK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQG-KAFK--NRELQIMRKLDHCNIV 76
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 13/147 (8%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
           IGRG FG V+  RL  D   VAVK     CR          F  E  I+K   H N++++
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I  C+ ++   +V+E +  G     L +    L +   L ++ D A+ +EYL   C    
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAK 562
           IH DL   N L+ +  +  +SDFG+++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 19/162 (11%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ  +AFK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQG-KAFK--NRELQIMRKLDHCNIV 76
Query: 474 KV------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++           +E +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 130
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   +   F  E E+M  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 150
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 193

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 128
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 171

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 422 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 480 SNEEFKG---LVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             E  KG   +V EYM +GSL  +L S    +L     L   +DV  A+EYL        
Sbjct: 75  VEE--KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 129
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   NVL+ ++ +A +SDFG+ K     + S TQ      + + AP
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 174

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 74  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 130 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 173

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
           +G GGFG V +    D G +VA+K    QCR+       + + +E +IMK + H N++  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 476 ------ISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYL 527
                 +   +  +   L +EY   G L K+L  +   C L       ++ D++SAL YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 528 HFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           H      +IH DLKP N++L      +I  + D G AK L   DQ    T+ + T+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 585 P 585
           P
Sbjct: 192 P 192

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAF-----KSFDVECEIMKSIRHRNLIKV 475
           +G GGFG V +    D G +VA+K    QCR+       + + +E +IMK + H N++  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 476 ------ISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYL 527
                 +   +  +   L +EY   G L K+L  +   C L       ++ D++SAL YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 528 HFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           H      +IH DLKP N++L      +I  + D G AK L   DQ    T+ + T+ Y+A
Sbjct: 139 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 585 P 585
           P
Sbjct: 193 P 193

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 22/182 (12%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
            +++  +IG G FG VY+A+L D  E VA+K   LQ +R FK  + E +IM+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 474 KV----ISSCSNEE--FKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           ++     SS   ++  +  LVL+Y+P+    + +H       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 526 YLH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           Y+H FG    + H D+KP N+LLD D  +  L DFG AK L+  + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 584 AP 585
           AP
Sbjct: 190 AP 191

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 9/164 (5%)
Query: 417 SENNLIGRGGFGSVYKARLGDG---MEVAVKVFNLQCRRAFKS---FDVECEIMKSIRHR 470
           +   +IG G FG VYK  L       EV V +  L+     K    F  E  IM    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N+I++    S  +   ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT 574
            +   +H DL   N+L++ N++  +SDFG++++L  + ++   T
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 76  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 132 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 175

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 419 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDVECEIMKSI-RHRNLI 473
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQRLNIMI 518
            ++ +C +  +  L +EY P G+L   L                ST   L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           DVA  ++YL        IH DL   N+L+ +N +A ++DFG+++   G++  + +T    
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 579 TIGYMA 584
            + +MA
Sbjct: 194 PVRWMA 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG+A++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 419 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDVECEIMKSI-RHRNLI 473
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQRLNIMI 518
            ++ +C +  +  L +EY P G+L   L                ST   L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           DVA  ++YL        IH DL   N+L+ +N +A ++DFG+++   G++  + +T    
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 579 TIGYMA 584
            + +MA
Sbjct: 204 PVRWMA 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 422 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 480 SNEEFKG---LVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             E  KG   +V EYM +GSL  +L S    +L     L   +DV  A+EYL        
Sbjct: 84  VEE--KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   NVL+ ++ +A +SDFG+ K     + S TQ      + + AP
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 422 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 480 SNEEFKG---LVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             E  KG   +V EYM +GSL  +L S    +L     L   +DV  A+EYL        
Sbjct: 69  VEE--KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 123
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   NVL+ ++ +A +SDFG+ K     + S TQ      + + AP
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL   C   VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 174

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 21/177 (11%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDVECEIMKSIRHRNLI 473
           IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  IM ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 534 PVIHCDLKPSNVL---LDDN--MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           P++H DL+  N+    LD+N  + A ++DFG+++  +      + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAP 195

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
            +++  +IG G FG VY+A+L D  E+ V +  +   +AFK  + E +IM+ + H N+++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 475 V------ISSCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +           +E +  LVL+Y+P     + +H       L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 527 LH-FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLI 565
           +H FG    + H D+KP N+LLD D  +  L DFG AK L+
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 405 SYLELCRATDGFSEN---------NLIGRGGFGSVYKARL----GDGMEVAVKVFNL-QC 450
           +Y E  RA   F+            +IG G  G V   RL       + VA+K       
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDI 510
            R  + F  E  IM    H N+I++    +      +V EYM  GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE-DQ 569
            Q + ++  V + + YL        +H DL   NVL+D N++  +SDFG++++L  + D 
Sbjct: 151 MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 570 SMTQTQTLATIGYMAP 585
           + T T     I + AP
Sbjct: 208 AXTTTGGKIPIRWTAP 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 94/180 (52%), Gaps = 19/180 (10%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
            ++   +IG G FG V++A+L +  EVA+K   LQ +R FK  + E +IM+ ++H N++ 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FK--NRELQIMRIVKHPNVVD 96
Query: 475 VIS------SCSNEEFKGLVLEYMPQG--SLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + +         +E F  LVLEY+P+      +H       + +      M  +  +L Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 527 LHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H   S  + H D+KP N+LLD  + +  L DFG AK+LI  + +++    + +  Y AP
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYYRAP 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 405 SYLELCRATDGFSEN---------NLIGRGGFGSVYKARL----GDGMEVAVKVFNL-QC 450
           +Y E  RA   F+            +IG G  G V   RL       + VA+K       
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 451 RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDI 510
            R  + F  E  IM    H N+I++    +      +V EYM  GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE-DQ 569
            Q + ++  V + + YL        +H DL   NVL+D N++  +SDFG++++L  + D 
Sbjct: 151 MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 570 SMTQTQTLATIGYMAP 585
           + T T     I + AP
Sbjct: 208 AYTTTGGKIPIRWTAP 223

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 12/177 (6%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
           F     IGRG F  VY+A  L DG+ VA   V++F+L   +A      E +++K + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +IK  +S   +    +VLE    G L    KH      ++         + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  V+H D+KP+NV +    +  L D G+ +      ++      + T  YM+P
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V+EYM +G L   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIM-------KSIRHRNL 472
            +IG+G FG V  AR     EV   V  LQ +   K  + E  IM       K+++H  L
Sbjct: 44  KVIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFL 101
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           + +  S    +    VL+Y+  G L  HL    C L+   R     ++ASAL YLH   S
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 157
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +++ DLKP N+LLD      L+DFG+ K  I  + + T +    T  Y+AP
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNSTTSTFCGTPEYLAP 208

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 86/170 (50%), Gaps = 21/170 (12%)
Query: 422 IGRGGFGSVYKARLGD--GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG+G FG V    LGD  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 480 SNEEFKG---LVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             E  KG   +V EYM +GSL  +L S    +L     L   +DV  A+EYL        
Sbjct: 256 VEE--KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   NVL+ ++ +A +SDFG+ K     + S TQ      + + AP
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 355

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
             +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 AAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 21/177 (11%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDVECEIMKSIRHRNLI 473
           IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  IM ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 534 PVIHCDLKPSNVL---LDDN--MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           P++H DL+  N+    LD+N  + A ++DFG ++  +      + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-----HSVSGLLGNFQWMAP 195

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 12/176 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDG-MEVAVKV-FNLQCRR--AFKSFDVECEIMKSIRH 469
           D F     +G+G FG+VY AR       VA+KV F  Q  +         E EI   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++++ +   +     L+LEY P+G L K L   +C  D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH- 140
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                VIH D+KP N+LL       ++DFG +        S+ +     T+ Y+ P
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPP 190

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 154
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D + VAVK        A K F  E E++ +++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN------------CILDIFQRLNIMIDVASA 523
              C   +   +V EYM  G L K L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 584 AP 585
            P
Sbjct: 198 PP 199

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 164
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY        + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +V EYMP G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 200

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 137
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG+ ++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  S 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 252 EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+ +L+  ED   T  Q     I + AP
Sbjct: 308 RAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAP 351

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 416 FSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRR--------AFKSFDVECEIMKS 466
           +   ++IGRG    V +      G E AVK+  +   R          ++   E  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 467 IR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           +  H ++I +I S  +  F  LV + M +G L  +L +    L   +  +IM  +  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLATIGYMA 584
           +LH   +  ++H DLKP N+LLDDNM   LSDFG +  L  GE       +   T GY+A
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLA 267
Query: 585 P 585
           P
Sbjct: 268 P 268

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 421 LIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS--IRHRNLIKVISS 478
           LIGRG +G+VYK  L D   VAVKVF+   R+ F +   E  I +   + H N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIARFIVG 75
Query: 479 CSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS- 532
                  G     LV+EY P GSL K+L       D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 533 ----TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE------DQSMTQTQTLATIG 581
                P I H DL   NVL+ ++    +SDFG++  L G       ++       + TI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 582 YMAP 585
           YMAP
Sbjct: 194 YMAP 197

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 419 NNLIGRGGFGSVYKARLG-DG--MEVAVKVFN-LQCRRAFKSFDVECEIMKSI-RHRNLI 473
            ++IG G FG V KAR+  DG  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQRLNIMI 518
            ++ +C +  +  L +EY P G+L   L                ST   L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           DVA  ++YL        IH +L   N+L+ +N +A ++DFG+++   G++  + +T    
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 579 TIGYMA 584
            + +MA
Sbjct: 201 PVRWMA 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G+G FG V+         VA+K          ++F  E ++MK +RH  L+++ +  S 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 482 EEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +G L   L       L + Q +++   +AS + Y+        +H DL
Sbjct: 85  EPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ +N++  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 141 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAP 184

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 11/173 (6%)
Query: 421 LIGRGGFGSVYKARLGD--GMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKV 475
           +IG G FG V + RL      E  V +  L+     R  + F  E  IM    H N+I++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
               +N     ++ E+M  G+L+  L   +    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEMSY 139
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA---TIGYMAP 585
           +H DL   N+L++ N++  +SDFG+++ L       T+T +L     I + AP
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG G FG V+     +  +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    LV E+M  G L  +L +   +      L + +DV   + YL       VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+ +N +  +SDFG+ + ++ +DQ  + T T   + + +P
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP 173

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 12/176 (6%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFK-----SFDVECEIMKSIRH 469
           + + + +G G F +VYKAR  +  + VA+K   L  R   K     +   E ++++ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N+I ++ +  ++    LV ++M +  LE  +   + +L        M+     LEYLH 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH- 129
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                ++H DLKP+N+LLD+N +  L+DFG+AK     +++      + T  Y AP
Sbjct: 130 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAP 181

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 20/170 (11%)
Query: 426 GFGSVYKARLGD----GMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLIKV 475
           G G+  K ++G+    G +VAVK+ N   R+  +S DV      E + +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
               S      +V+EY+  G L  ++     + ++  R  +   + SA++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DLKP NVLLD +M A ++DFG++ ++   D    +T +  +  Y AP
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT-SCGSPNYAAP 179

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +++E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 182

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 93/178 (52%), Gaps = 22/178 (12%)
Query: 423 GRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS--IRHRNLIKVISS-- 478
            RG FG V+KA+L +   VAVK+F LQ +++++S   E EI  +  ++H NL++ I++  
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS---EREIFSTPGMKHENLLQFIAAEK 79
Query: 479 -CSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF------- 529
             SN E +  L+  +  +GSL  +L     I+   +  ++   ++  L YLH        
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 530 -GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLATIGYMAP 585
            G    + H D K  NVLL  ++ A L+DFG+A +   G+    T  Q + T  YMAP
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAP 194

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 21/177 (11%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNL-------QCRRAFKSFDVECEIMKSIRHRNLI 473
           IG+GGFG V+K RL  D   VA+K   L       +    F+ F  E  IM ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 534 PVIHCDLKPSNVL---LDDN--MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           P++H DL+  N+    LD+N  + A ++DF +++  +      + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-----HSVSGLLGNFQWMAP 195

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 80/149 (53%), Gaps = 17/149 (11%)
Query: 426 GFGSVYKARLGD----GMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLIKV 475
           G G+  K ++G+    G +VAVK+ N   R+  +S DV      E + +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
               S      +V+EY+  G L  ++     + ++  R  +   + SA++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +H DLKP NVLLD +M A ++DFG++ ++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 7/169 (4%)
Query: 419 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
            + +G G FG VY+       + VAVK          + F  E  +MK I+H NL++++ 
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 74
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            C+ E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 179

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P+G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSYC 129
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +++E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSIRHRNLIKVIS 477
           +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ P
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 179

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 9/183 (4%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           LE     D   +  ++G+G +G VY  R L + + +A+K    +  R  +    E  + K
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMI-DVASA 523
            ++H+N+++ + S S   F  + +E +P GSL   L S    + D  Q +      +   
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           L+YLH      ++H D+K  NVL++  + +  +SDFG +K L G +   T+T T  T+ Y
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 175
Query: 583 MAP 585
           MAP
Sbjct: 176 MAP 178

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +++E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 179

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRR---AFKSFDVECEIMKSIRHRNLIKVIS 477
           +G GG  +VY A      ++VA+K   +  R      K F+ E      + H+N++ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
               ++   LV+EY+   +L +++ S +  L +   +N    +   +++ H      ++H
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT-QTLATIGYMAP 585
            D+KP N+L+D N    + DFGIAK L   + S+TQT   L T+ Y +P
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 74/149 (49%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 88  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 144 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 187

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 89  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 145 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 188

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 82  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 138 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 181

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +++E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    +++E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 9/183 (4%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           LE     D   +  ++G+G +G VY  R L + + +A+K    +  R  +    E  + K
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMI-DVASA 523
            ++H+N+++ + S S   F  + +E +P GSL   L S    + D  Q +      +   
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           L+YLH      ++H D+K  NVL++  + +  +SDFG +K L G +   T+T T  T+ Y
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 189
Query: 583 MAP 585
           MAP
Sbjct: 190 MAP 192

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 419 NNLIGRGGFGSVYKARL-GDGME---VAVKV----FNLQCRRAFKSFDVECEIMKSIRHR 470
             +IG G FG V + RL   G +   VA+K     +  + RR F S   E  IM    H 
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS---EASIMGQFEHP 75
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N+I++    +N     ++ E+M  G+L+  L   +    + Q + ++  +AS + YL   
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL--- 132
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA---TIGYMAP 585
                +H DL   N+L++ N++  +SDFG+++ L       T T +L     I + AP
Sbjct: 133 AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 81  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 137 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 180

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T+   T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPP 175

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAP 186

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 179

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 185

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 85  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 184

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 90  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 189

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 420 NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNL 472
           + +G G FG V   +    G +VAVK+ N   R+  +S DV      E + +K  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           IK+    S      +V+EY+  G L  ++   N  LD  +   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
             V+H DLKP NVLLD +M A ++DFG++ ++
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 75  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 131 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 174

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 86  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 185

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 389 PSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARL---GDGMEVAVKV 445
           PS  AN  L    R F   EL +         ++G G FG+V+K      G+ +++ V +
Sbjct: 16  PSEKANKVLA---RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 446 FNLQCRRAFKSFDVECEIM---KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY 502
             ++ +   +SF    + M    S+ H ++++++  C     + LV +Y+P GSL  H+ 
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 124
Query: 503 STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
                L     LN  + +A  + YL       ++H +L   NVLL       ++DFG+A 
Sbjct: 125 QHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVAD 181
Query: 563 LLIGEDQSMTQTQTLATIGYMA 584
           LL  +D+ +  ++    I +MA
Sbjct: 182 LLPPDDKQLLYSEAKTPIKWMA 203

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 584 AP 585
           +P
Sbjct: 187 SP 188

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 584 AP 585
           +P
Sbjct: 187 SP 188

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 422 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK     C    +S +  E +I++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 476 ISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C ++  K L  V+EY+P GSL  +L   +  + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 389 PSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-F 446
           P N+    L +  +     +   A + F     +G+G FG+VY AR      + A+KV F
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 447 NLQCRRA--FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST 504
             Q  +A        E EI   +RH N++++     +     L+LEY P G++ + L   
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +   D  +    + ++A+AL Y H   S  VIH D+KP N+LL       ++DFG +   
Sbjct: 129 S-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--- 181
Query: 565 IGEDQSMTQTQTLATIGYMAP 585
                S  +T    T+ Y+ P
Sbjct: 182 -VHAPSSRRTTLCGTLDYLPP 201

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI------DVASALEYLHFGCSTP 534
            E    ++ E+M  G+L  +L   N      Q +N ++       ++SA+EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            IH DL   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 194

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 183

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 183

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VA+K          +SF  E +IMK ++H  L+++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 482 EEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    +V EYM +GSL   L       L +   +++   VA+ + Y+        IH DL
Sbjct: 76  EPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ + +I  ++DFG+A+L+  ED   T  Q     I + AP
Sbjct: 132 RSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAP 175

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V E M  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 92/179 (51%), Gaps = 25/179 (13%)
Query: 423 GRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE 482
            RG FG V+KA+L +   VAVK+F +Q ++++++ + E   +  ++H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGA---- 86
Query: 483 EFKG--------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF----- 529
           E +G        L+  +  +GSL   L +   ++   +  +I   +A  L YLH      
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 530 --GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLATIGYMAP 585
             G    + H D+K  NVLL +N+ A ++DFG+A K   G+    T  Q + T  YMAP
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAP 202

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P+G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH---FGCS 532
                      L+  Y   GSL  +L  T   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 533 -TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-----LATIGYMAP 585
             P I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+     +  +VAVK        + ++F  E  +MK+++H  L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFGCSTPVIHCDL 540
           EE   ++ EYM +GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 137 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 180

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 422 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN--------------CILDIFQRLNIMIDVA 521
              C+      +V EYM  G L + L S                  L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 522 SALEY---LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           + + Y   LHF      +H DL   N L+   ++  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 579 TIGYMAP 585
            I +M P
Sbjct: 223 PIRWMPP 229

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 422 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK     C    +S +  E EI++++ H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C ++  K   LV+EY+P GSL  +L   +C+  + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 131
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 181

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 179

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTXLCGTLDYLPP 175

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 186

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V E M  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 420 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLI 473
            ++G G FGSV +  L    G  ++VAVK   L    +R  + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 474 KVISSCSNEEFKGL-----VLEYMPQGSLEKHLYSTNC-----ILDIFQRLNIMIDVASA 523
           +++  C     +G+     +L +M  G L  +L  +        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 174

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
           + ++G G FG V   RL      E++V +  L+     +  + F  E  IM    H N+I
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++    +  +   +V E M  GSL+  L   +    + Q + ++  +AS ++YL      
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 137
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 422 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK     C    +S +  E EI++++ H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C ++  K   LV+EY+P GSL  +L   +C+  + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 130
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++ +
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 422 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V   R    GD  G +VAVK    +           E EI++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C+ +   G  L++E++P GSL+++L      +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH---FGCS 532
                      L+  Y   GSL  +L  T   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 533 -TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-----LATIGYMAP 585
             P I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           +G+G +G V++     G  VAVK+F+    R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH---FGCS 532
                      L+  Y   GSL  +L  T   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 533 -TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-----LATIGYMAP 585
             P I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 5/164 (3%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VAVK+   +   +   F  E + M  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           E    +V EY+  G L  +L S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             N L+D ++   +SDFG+ + ++ +DQ ++   T   + + AP
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP 174

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 407 LELCRATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKS 456
           L  C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 457 FDVECEIMKSIRHRNLIKV--ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL 514
           F  E +I+K++    ++K   +S     +   LV+EY+P G L   L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQ 573
                +   +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +
Sbjct: 131 LYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 574 TQTLATIGYMAP 585
               + I + AP
Sbjct: 188 EPGQSPIFWYAP 199

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 175

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSIRHRNLIKVIS 477
           +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 538 CDLKPSNVLLDDNMIAYLSDFG 559
            D+KP N+LL  N    ++DFG
Sbjct: 136 RDIKPENLLLGSNGELKIADFG 157

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 175

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 175

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 422 IGRGGFGSVYKARL---GD--GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V   R    GD  G +VAVK    +           E EI++++ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 476 ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C+ +   G  L++E++P GSL+++L      +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 176

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 16/189 (8%)
Query: 410 CRATDGFSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDV 459
           C+    F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 460 ECEIMKSIRHRNLIKV--ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIM 517
           E +I+K++    ++K   +S     +   LV+EY+P G L   L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQT 576
             +   +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +   
Sbjct: 121 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 577 LATIGYMAP 585
            + I + AP
Sbjct: 178 QSPIFWYAP 186

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPP 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 7/169 (4%)
Query: 419 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
            + +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++ 
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLG 74
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            C+ E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAP 179

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 422 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK     C    +S +  E +I++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 476 ISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C ++  K L  V+EY+P GSL  +L   +  + + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPP 176

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 4/152 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
             N L++D  +  +SDFG+++ ++ ++ + ++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR 164

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++ +
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT 167

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++ +
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT 161

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 422 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN--------------CILDIFQRLNIMIDVA 521
              C+      +V EYM  G L + L S                  L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 522 SALEY---LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           + + Y   LHF      +H DL   N L+   ++  + DFG+++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 579 TIGYMAP 585
            I +M P
Sbjct: 194 PIRWMPP 200

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 172

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 180

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 141
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPP 192

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 422 IGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTN--------------CILDIFQRLNIMIDVA 521
              C+      +V EYM  G L + L S                  L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 522 SALEY---LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           + + Y   LHF      +H DL   N L+   ++  + DFG+++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 579 TIGYMAP 585
            I +M P
Sbjct: 200 PIRWMPP 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E     +++ + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAP 185

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L D  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+L+       + DFGIA+ +     S+ QT   + T  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 584 AP 585
           +P
Sbjct: 187 SP 188

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVF---NLQCRRAFKSFDVECEIMKSIRH 469
           D F     +G+G FG+VY AR      + A+KV     L+          E EI   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++++ +   + +   L+LE+ P+G L K L   +   D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 132
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                VIH D+KP N+L+       ++DFG +        S+ +     T+ Y+ P
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPP 182

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 83/177 (46%), Gaps = 8/177 (4%)
Query: 389 PSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-F 446
           P N+    L +  +     +   A + F     +G+G FG+VY AR      + A+KV F
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 447 NLQCRRA--FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST 504
             Q  +A        E EI   +RH N++++     +     L+LEY P G++ + L   
Sbjct: 69  KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           +   D  +    + ++A+AL Y H   S  VIH D+KP N+LL       ++DFG +
Sbjct: 129 S-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++ +
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT 160

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 416 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +I+K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 466 SIRHRNLIKV--ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++    ++K   +S     +   LV+EY+P G L   L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGY 582
           +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 583 MAP 585
            AP
Sbjct: 185 YAP 187

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 427

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+     +  +VAVK        + ++F  E  +MK+++H  L+++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFGCSTPVIHCDL 540
           EE   ++ E+M +GSL   L S      +  +L +    +A  + Y+        IH DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 136 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 179

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             ++GRG FG V KA+     +VA+K    +  R  K+F VE   +  + H N++K+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           C N     LV+EY   GSL   L+    +        ++  +  +  + YLH      +I
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 537 HCDLKPSNVLL-DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP N+LL     +  + DFG A      D     T    +  +MAP
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 173

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 4/149 (2%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK 541
           +    ++ EYM  G L  +L          Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             N L++D  +  +SDFG+++ ++ ++ +
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH +L
Sbjct: 76  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 132 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 175

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             ++GRG FG V KA+     +VA+K    +  R  K+F VE   +  + H N++K+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           C N     LV+EY   GSL   L+    +        ++  +  +  + YLH      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 537 HCDLKPSNVLL-DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP N+LL     +  + DFG A      D     T    +  +MAP
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 416 FSENNL-----IGRGGFGSVYKAR---LGD--GMEVAVKVFNLQCRRAFKSFDVECEIMK 465
           F E +L     +G+G FGSV   R   LGD  G  VAVK          + F  E +I+K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 466 SIRHRNLIKV--ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++    ++K   +S         LV+EY+P G L   L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGY 582
           +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 583 MAP 585
            AP
Sbjct: 181 YAP 183

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 420 NLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCRRAFKSFDVECEIM---KSIRHRNLI 473
            ++G G FG+V+K      G+ +++ V +  ++ +   +SF    + M    S+ H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +++  C     + LV +Y+P GSL  H+      L     LN  + +A  + YL      
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
            ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 389 PSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKA-RLGDG----MEVAV 443
           PS  A  P  A  R     EL R         ++G G FG+VYK   + +G    + VA+
Sbjct: 22  PSGTA--PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAI 72
Query: 444 KVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY 502
           K+ N     +A   F  E  IM S+ H +L++++  C +   + LV + MP G L ++++
Sbjct: 73  KILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
Query: 503 STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
                +     LN  + +A  + YL       ++H DL   NVL+       ++DFG+A+
Sbjct: 132 EHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 563 LLIGEDQSMTQTQTLATIGYMA 584
           LL G+++          I +MA
Sbjct: 189 LLEGDEKEYNADGGKMPIKWMA 210

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 7/166 (4%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +G VY+       + VAVK          + F  E  +MK I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 388

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAVK+ +       + +    E  IMK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 130
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++    IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
            + S    +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           VIH D+K  N+LL  +    L+DFG    +  E QS   T  + T  +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAP 185

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVF---NLQCRRAFKSFDVECEIMKSIRH 469
           D F     +G+G FG+VY AR      + A+KV     L+          E EI   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++++ +   + +   L+LE+ P+G L K L   +   D  +    M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 131
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                VIH D+KP N+L+       ++DFG +        S+ +     T+ Y+ P
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPP 181

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 8/171 (4%)
Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++    IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
            + S    +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 185

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 126
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 8/152 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  VIH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAP 186

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 14/180 (7%)
Query: 414 DGFSENNLIGRGGFGSVY-KARLGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRN 471
           D F     +G G FG V+       G+E  +K  N  + +   +  + E E++KS+ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC---ILDIFQRLNIMIDVASALEYLH 528
           +IK+     +     +V+E    G L + + S       L       +M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 529 FGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  V+H DLKP N+L  D   +    + DFG+A+L   ++ S   T    T  YMAP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAP 195

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ ++ ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       +++FG +        S  +T    T+ Y+ P
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPP 178

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 419 NNLIGRGGFGSVYKARLG----DGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRNLI 473
             +IG G FG V   RL       + VA+K   +    +  + F  E  IM    H N+I
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +    +  +   +V EYM  GSL+  L   +    + Q + ++  +++ ++YL      
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL---SDM 143
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
             +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL-EYLHFGCSTPVIHCDL 540
           E    ++ E+M +GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+  +++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 138 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 181

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAVK+ +       + +    E  IMK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G  G V+        +VAVK    Q   +  +F  E  +MK ++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           E    ++ EYM  GSL   L + + I L I + L++   +A  + ++        IH DL
Sbjct: 80  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAP 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKV-FNLQCRRA--FKSFDVECEIMKSI 467
           A + F     +G+G FG+VY AR      + A+KV F  Q  +A        E EI   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 126
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  VIH D+KP N+LL       +++FG +        S  +T    T+ Y+ P
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPP 177

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAVK+ +       + +    E  IMK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 10/171 (5%)
Query: 420 NLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLI 473
            ++G G FG+VYK   + +G    + VA+K+ N     +A   F  E  IM S+ H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +++  C +   + LV + MP G L ++++     +     LN  + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
            ++H DL   NVL+       ++DFG+A+LL G+++          I +MA
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 187

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAVK+ +       + +    E  IMK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVF--NLQCRRAFKSFDVECEIMKSI 467
           ++ + +    L+G G +G V K R  D G  VA+K F  +   +   K    E +++K +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEK-HLYSTNCILDIFQRLNIMIDVASALEY 526
           RH NL+ ++  C  ++   LV E++    L+   L+       + Q+   +  + + + +
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGF 139
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            H   S  +IH D+KP N+L+  + +  L DFG A+ L    +       +AT  Y AP
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL-EYLHFGCSTPVIHCDL 540
           E    ++ E+M +GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           + +N+L+  +++  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 311 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 354

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCRRAFKSFDVECEIMK 465
           D F +  ++GRGGFG V+  +    M+   K++         L+ R+ ++   VE +I+ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA---S 522
            +  R ++ +  +   +    LV+  M  G +  H+Y+ +     FQ    +   A   S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLA-TI 580
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 581 GYMAP 585
           G+MAP
Sbjct: 354 GFMAP 358

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 15/147 (10%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG+G F  V  AR +  G EVAVK+ +         ++ F+    E  IMK + H N++K
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +      E+   LV+EY   G +  +L +   + +   R      + SA++Y H      
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKY 134
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           ++H DLK  N+LLD +M   ++DFG +
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCRRAFKSFDVECEIMK 465
           D F +  ++GRGGFG V+  +    M+   K++         L+ R+ ++   VE +I+ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA---S 522
            +  R ++ +  +   +    LV+  M  G +  H+Y+ +     FQ    +   A   S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLA-TI 580
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 581 GYMAP 585
           G+MAP
Sbjct: 354 GFMAP 358

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCRRAFKSFDVECEIMK 465
           D F +  ++GRGGFG V+  +    M+   K++         L+ R+ ++   VE +I+ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA---S 522
            +  R ++ +  +   +    LV+  M  G +  H+Y+ +     FQ    +   A   S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLA-TI 580
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 581 GYMAP 585
           G+MAP
Sbjct: 354 GFMAP 358

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVF--------NLQCRRAFKSFDVECEIMK 465
           D F +  ++GRGGFG V+  +    M+   K++         L+ R+ ++   VE +I+ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI---DVAS 522
            +  R ++ +  +   +    LV+  M  G +  H+Y+ +     FQ    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLA-TI 580
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 581 GYMAP 585
           G+MAP
Sbjct: 354 GFMAP 358

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V ++   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 584 AP 585
           +P
Sbjct: 187 SP 188

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 11/174 (6%)
Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N +        F  E  IMK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E   LV L YM  G L   + +      +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMA 584
              +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAV++ +       + +    E  IMK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH 469
           R    F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 470 -------------RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
                        RN +K +++   +    + +EY   G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
              +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAV++ +       + +    E  IMK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV+EY   G +  +L +   + +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 15/147 (10%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG+G F  V  AR +  G EVA+K+ +         ++ F+    E  IMK + H N++K
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 75
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +      E+   L++EY   G +  +L +   + +   R      + SA++Y H      
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKR 131
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           ++H DLK  N+LLD +M   ++DFG +
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHR 470
             +IG G FG V   RL      E+ V +  L+       RR F S   E  IM    H 
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS---EASIMGQFDHP 90
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N+I +    +  +   ++ EYM  GSL+  L   +    + Q + ++  + S ++YL   
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS-- 148
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
                +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 149 -DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-------RRAFKSFDVECEIMK 465
           + F   NL+G+G F  VY+A  +  G+EVA+K+ + +        +R      + C++  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-- 68
Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE 525
             +H +++++ +   +  +  LVLE    G + ++L +        +  + M  + + + 
Sbjct: 69  --KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           YLH   S  ++H DL  SN+LL  NM   ++DFG+A  L
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 584 AP 585
           +P
Sbjct: 187 SP 188

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 15/147 (10%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG+G F  V  AR +  G EVA+K+ +         ++ F+    E  IMK + H N++K
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +      E+   L++EY   G +  +L +   + +   R      + SA++Y H      
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKR 134
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           ++H DLK  N+LLD +M   ++DFG +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 419 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLI 473
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  IMK++ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+I     EE   +++E  P G L  +L      L +   +   + +  A+ YL    S 
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 195

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 84/173 (48%), Gaps = 9/173 (5%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLI 473
             +IG G FG V   RL      +VAV +  L+     +  + F  E  IM    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +    +  +   +V+E+M  G+L+  L   +    + Q + ++  +A+ + YL      
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAP 585
             +H DL   N+L++ N++  +SDFG+++++  + +++ T T     + + AP
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  VIH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL  +    L+DFG    +  E QS   T  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAP 186

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 420 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIK 474
            +IG G FG V     +L    E+ V +  L+     +  + F  E  IM    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +    +      ++ E+M  GSL+  L   +    + Q + ++  +A+ ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA---TIGYMAP 585
            +H DL   N+L++ N++  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 419 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLI 473
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  IMK++ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+I     EE   +++E  P G L  +L      L +   +   + +  A+ YL    S 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 183

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 419 NNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHR 470
             +IG G FG V   RL      E+ V +  L+       RR F S   E  IM    H 
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS---EASIMGQFDHP 69
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N+I +    +  +   ++ EYM  GSL+  L   +    + Q + ++  + S ++YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS-- 127
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
                +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 128 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 422 IGRGGFGSVY-----KARLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
           +G G FG V          G G  VAVK          +S +  E +I++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 476 ISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
              C +     L  V+EY+P GSL  +L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+  G   + +  T   +   + + ++ D   AL
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 147 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 584 AP 585
           +P
Sbjct: 204 SP 205

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     IG G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EYMP G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     IG G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EYMP G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 419 NNLIGRGGFGSVYKA----RLGDGMEVAVKVFNLQCRRAFK-SFDVECEIMKSIRHRNLI 473
           N ++G G FG VY+       G+ + VAVK     C    K  F  E  IMK++ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+I     EE   +++E  P G L  +L      L +   +   + +  A+ YL    S 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 179

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 163
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 219
Query: 585 P 585
           P
Sbjct: 220 P 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 420 NLIGRGGFGSVYKARLG--DGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRN 471
            +IG G FG V   RL      E+ V +  L+       RR F S   E  IM    H N
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLS---EASIMGQFDHPN 76
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           +I +    +  +   ++ EYM  GSL+  L   +    + Q + ++  + S ++YL    
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS--- 133
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               +H DL   N+L++ N++  +SDFG++++L  + ++   T+
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVIS 477
            LIG+G FG VY  R     EVA+++ +++       K+F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +C +     ++       +L   +     +LD+ +   I  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 538 CDLKPSNVLLDDNMIAYLSDFGI 560
            DLK  NV  D+  +  ++DFG+
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 20/170 (11%)
Query: 416 FSENNLIGRGGFGSVYKARL----GDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRH 469
           F+   ++G+G FGSV +A+L    G  ++VAVK+   ++      + F  E   MK   H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 470 RNLIKVISSCSNEEFKG------LVLEYMPQGSLEKHLYSTNCILDIFQR-----LNIMI 518
            ++ K++        KG      ++L +M  G L   L ++    + F       +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           D+A  +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 150
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 206
Query: 585 P 585
           P
Sbjct: 207 P 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 130
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 186
Query: 585 P 585
           P
Sbjct: 187 P 187

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDVECEI--- 463
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q            E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 464 --MKSIRHRNLIKVISSCS----NEEFK-GLVLEYMPQGSLEKHL-------YSTNCILD 509
             +++  H N++++   C+    + E K  LV E++ Q  L  +L         T  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           +      M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++   +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 570 SMTQTQTLATIGYMAP 585
            M  T  + T+ Y AP
Sbjct: 174 -MALTSVVVTLWYRAP 188

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDVECEI--- 463
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q            E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 464 --MKSIRHRNLIKVISSCS----NEEFK-GLVLEYMPQGSLEKHL-------YSTNCILD 509
             +++  H N++++   C+    + E K  LV E++ Q  L  +L         T  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           +      M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++   +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 570 SMTQTQTLATIGYMAP 585
            M  T  + T+ Y AP
Sbjct: 174 -MALTSVVVTLWYRAP 188

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 127
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 183
Query: 585 P 585
           P
Sbjct: 184 P 184

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 125
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 181
Query: 585 P 585
           P
Sbjct: 182 P 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G FG V++ +   G EVAVK+F+    R  +S+  E EI +++  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---- 531
           + +        LV +Y   GSL  +L      ++    + + +  AS L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 124
Query: 532 STPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMA 584
             P I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMA
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMA 180
Query: 585 P 585
           P
Sbjct: 181 P 181

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 32/196 (16%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDVECEI--- 463
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q            E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 464 --MKSIRHRNLIKVISSCS----NEEFK-GLVLEYMPQGSLEKHL-------YSTNCILD 509
             +++  H N++++   C+    + E K  LV E++ Q  L  +L         T  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           +      M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++   +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 570 SMTQTQTLATIGYMAP 585
            M  T  + T+ Y AP
Sbjct: 174 -MALTSVVVTLWYRAP 188

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL-EYLHFGCSTPVIHCDL 540
           E    ++ E+M +GSL   L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 541 KPSNVLLDDNMIAYLSDFGIAKL 563
           + +N+L+  +++  ++DFG+A++
Sbjct: 305 RAANILVSASLVCKIADFGLARV 327

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  + G   A KV   +     + + VE EI+ +  H  ++K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F  S  +IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  NVL+       L+DFG++
Sbjct: 136 KAGNVLMTLEGDIRLADFGVS 156

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 15/177 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP 193

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 15/177 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAP 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 420 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
            ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 472 LIKVISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI-DVASALEYLHF 529
            +  +      E K  L+L+Y+  G L  HL       +    + I + ++  ALE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH- 176
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                +I+ D+K  N+LLD N    L+DFG++K  +  D++        TI YMAP
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAP 229

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 31/198 (15%)
Query: 404 FSYLELC-RATDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDV 459
           F  +  C R TD +     +G+G F  V +  +     E A K+ N +    R  +  + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 460 ECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDI 510
           E  I + ++H N++++  S S E F  LV + +  G L      +  YS    ++CI  I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 139
Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGE 567
            + +N          ++H      ++H DLKP N+LL          L+DFG+A  + GE
Sbjct: 140 LESVN----------HIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 568 DQSMTQTQTLATIGYMAP 585
            Q+        T GY++P
Sbjct: 187 QQAW--FGFAGTPGYLSP 202

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  + G   A KV   +     + + VE EI+ +  H  ++K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F  S  +IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  NVL+       L+DFG++
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS 164

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +            E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 254 RLPVKWMAP 262

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 413 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           +D +     +G+G F  V +      G+E A K+ N +    R F+  + E  I + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S   E F  LV + +  G L      +  YS    ++CI  I +        
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 139
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             ++ Y H   S  ++H +LKP N+LL          L+DFG+A   I  + S       
Sbjct: 140 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFA 191
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 192 GTPGYLSP 199

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 30/188 (15%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           TD +     IG+G F  V +  +L  G E A K+ N +    R  +  + E  I + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S S E F  LV + +  G L      +  YS    ++CI  I +        
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------- 114
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             A+ + H      V+H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 115 --AVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFA 167
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 414 DGFSENNLIGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIM 464
           D  +    +G G FG V         K +  + + VAVK+  +    +       E E+M
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 465 KSI-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD--- 509
           K I +H+N+I ++ +C+ +    +++EY  +G+L ++L           Y  N + +   
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 510 IFQRL-NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 569 QSMTQTQTLATIGYMAP 585
                T     + +MAP
Sbjct: 258 YYKKTTNGRLPVKWMAP 274

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 420 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  I++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T T    TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAP 190

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 202 RLPVKWMAP 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 205 RLPVKWMAP 213

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 212 RLPVKWMAP 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           +G G +G VYKA+   G  VA+K   L        S  + E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            +E    LV E+M +  L+K L      L   Q   I I +   L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     IG G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 209 RLPVKWMAP 217

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           +G G +G VYKA+   G  VA+K   L        S  + E  ++K + H N++ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            +E    LV E+M +  L+K L      L   Q   I I +   L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAP 188

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 13/179 (7%)
Query: 413 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           +D +     +G+G F  V +      G+E A K+ N +    R F+  + E  I + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++++  S   E F  LV + +  G L + + +     + +   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAY 120
Query: 530 GCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  ++H +LKP N+LL          L+DFG+A   I  + S        T GY++P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSP 176

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++EY  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 207 RLPVKWMAP 215

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 30/188 (15%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           TD +     +G+G F  V +  ++  G E A K+ N +    R  +  + E  I + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S S E F  LV + +  G L      +  YS    ++CI  I + +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
                + H      ++H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 118 -----HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFA 167
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G +GSVYKA     G  VA+K   ++     +    E  IM+     +++K   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
                 +V+EY   GS+   +   N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  N+LL+    A L+DFG+A  L   D    +   + T  +MAP
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAP 194

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         YS N   +  ++L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 206 RLPVKWMAP 214

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 30/188 (15%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           TD +     +G+G F  V +  ++  G E A K+ N +    R  +  + E  I + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S S E F  LV + +  G L      +  YS    ++CI  I + +N     
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
                + H      ++H DLKP N+LL          L+DFG+A  + G+ Q+       
Sbjct: 118 -----HCHL---NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 413 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           +D +     +G+G F  V +      G+E A K+ N +    R F+  + E  I + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S   E F  LV + +  G L      +  YS    ++CI  I +        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 116
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             ++ Y H   S  ++H +LKP N+LL          L+DFG+A   I  + S       
Sbjct: 117 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFA 168
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 169 GTPGYLSP 176

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 413 TDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH 469
           +D +     +G+G F  V +      G+E A K+ N +    R F+  + E  I + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDV 520
            N++++  S   E F  LV + +  G L      +  YS    ++CI  I +        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------- 115
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             ++ Y H   S  ++H +LKP N+LL          L+DFG+A   I  + S       
Sbjct: 116 --SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFA 167
Query: 578 ATIGYMAP 585
            T GY++P
Sbjct: 168 GTPGYLSP 175

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 18/166 (10%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH 469
           R    F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 470 -------------RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
                        RN +K +++   +    + +EY    +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
              +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVF-NLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G V+K R  D G  VA+K F   +     K   + E  ++K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR---LNIMIDVA-SALEYLHFGCSTP 534
              +    LV EY     L +        LD +QR    +++  +    L+ ++F     
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            IH D+KP N+L+  + +  L DFG A+LL G   S      +AT  Y +P
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSP 171

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 24/179 (13%)
Query: 422 IGRGGFGSVYKARLG-DGMEVAVK----VFNL--QCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G +G V  AR    G +VA+K     F++    +R  +    E +I+K  +H N+I 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKHFKHDNIIA 118
Query: 475 VIS----SCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +      +    EFK +  VL+ M +  L + ++S+   L +      +  +   L+Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH 176
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE--DQSMTQTQTLATIGYMAP 585
              S  VIH DLKPSN+L+++N    + DFG+A+ L     +     T+ +AT  Y AP
Sbjct: 177 ---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++ Y  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVK----VFNL--QCRRAFKSFDVECEIMKS 466
           D +     IG G +G V  AR    G +VA+K     F++    +R  +    E +I+K 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKH 109
Query: 467 IRHRNLIKVIS----SCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
            +H N+I +      +    EFK +  VL+ M +  L + ++S+   L +      +  +
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQL 167
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE--DQSMTQTQTLA 578
              L+Y+H   S  VIH DLKPSN+L+++N    + DFG+A+ L     +     T+ +A
Sbjct: 168 LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 579 TIGYMAP 585
           T  Y AP
Sbjct: 225 TRWYRAP 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 200

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 28/177 (15%)
Query: 422 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G +GSV   Y ARL    +VAVK  +      +  RR ++    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 473 IKVIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           I ++     + S E+F  + L     G+   ++  +  + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  +IH DLKPSNV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMK-SIRHRNLI 473
            F   +++G G  G++    + D  +VAVK    +C   F   D E ++++ S  H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +   +  + +F+ + +E +   +L++++   +      + + ++    S L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 534 PVIHCDLKPSNVLL-----DDNMIAYLSDFGIA-KLLIGEDQSMTQTQTLATIGYMAP 585
            ++H DLKP N+L+        + A +SDFG+  KL +G      ++    T G++AP
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 420 NLIGRGGFGSVYKA--RLGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIK 474
            +IG G FG V     +L    E+ V +  L+     +  + F  E  IM    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +    +      ++ E+M  GSL+  L   +    + Q + ++  +A+ ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA---TIGYMAP 585
            +H  L   N+L++ N++  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V  ++ R     +A K    E
Sbjct: 43  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDE 101
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 102 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 160
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 161 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 581 GYMA 584
            +MA
Sbjct: 218 KWMA 221

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         +S N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 581 GYMA 584
            +MA
Sbjct: 188 KWMA 191

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 581 GYMA 584
            +MA
Sbjct: 185 KWMA 188

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 581 GYMA 584
            +MA
Sbjct: 186 KWMA 189

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 581 GYMA 584
            +MA
Sbjct: 187 KWMA 190

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  +  +  A KV + +     + + VE +I+ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 581 GYMA 584
            +MA
Sbjct: 185 KWMA 188

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 23/193 (11%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 469 ------HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
                 H N++ ++ +C++     ++ EY   G L   L   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 523 ALEYLHFG----------CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
             + LHF            S   IH D+   NVLL +  +A + DFG+A+ ++ +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 573 QTQTLATIGYMAP 585
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  +  +  A KV + +     + + VE +I+ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 4/141 (2%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG VYKA+  +  +  A KV + +     + + VE +I+ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 541 KPSNVLLDDNMIAYLSDFGIA 561
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 476 ISS-------CSNEEFK-----GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S+       C +  F        +L+ M  G L  HL       +   R     ++   
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILG 304
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LE++H   +  V++ DLKP+N+LLD++    +SD G+A     +        ++ T GYM
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 584 AP 585
           AP
Sbjct: 358 AP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 476 ISS-------CSNEEFK-----GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S+       C +  F        +L+ M  G L  HL       +   R     ++   
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILG 304
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LE++H   +  V++ DLKP+N+LLD++    +SD G+A     +        ++ T GYM
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 584 AP 585
           AP
Sbjct: 358 AP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 244
Query: 476 ISS-------CSNEEFK-----GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S+       C +  F        +L+ M  G L  HL       +   R     ++   
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILG 303
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LE++H   +  V++ DLKP+N+LLD++    +SD G+A     +        ++ T GYM
Sbjct: 304 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 356
Query: 584 AP 585
           AP
Sbjct: 357 AP 358

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           FS + +IGRGGFG VY  R  D      K++ ++C    +    + E + ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 476 ISS-------CSNEEFK-----GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S+       C +  F        +L+ M  G L  HL       +   R     ++   
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILG 304
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LE++H   +  V++ DLKP+N+LLD++    +SD G+A     +        ++ T GYM
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 584 AP 585
           AP
Sbjct: 358 AP 359

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 412 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVA---VKVFNLQCRRAFKSFDVECEI---- 463
           AT  +     IG G +G+VYKAR    G  VA   V+V N              E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 464 -MKSIRHRNLIKVISSC----SNEEFK-GLVLEYMPQGSLEKHL-YSTNCILDIFQRLNI 516
            +++  H N+++++  C    ++ E K  LV E++ Q  L  +L  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           M      L++LH  C   ++H DLKP N+L+       L+DFG+A++       M  T  
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPV 179
Query: 577 LATIGYMAP 585
           + T+ Y AP
Sbjct: 180 VVTLWYRAP 188

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +  + + VAVK+  +    +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------YSTNCILD---IFQRL-NI 516
           +I ++ +C+ +    +++ Y  +G+L ++L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              +A  +EYL    S   IH DL   NVL+ +N +  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV----AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNL 472
            ++G+G FG V+  +   G +     A+KV     L+ R   ++  +E +I+  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +K+  +   E    L+L+++  G L   L S   +         + ++A AL++LH   S
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 195

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F E  LIG GGFG V+KA+   DG    +K       +A    + E + +  + H N++ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 475 VI----------------SSCSNEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIM 517
                             SS S  +   + +E+  +G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 578 ATIGYMAP 585
            T+ YM+P
Sbjct: 183 GTLRYMSP 190

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 9/135 (6%)
Query: 428 GSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EE 483
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 484 FKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVI-HCDLK 541
              L+  +MP GSL   L+  TN ++D  Q +   +D+A  + +LH     P+I    L 
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALN 140
Query: 542 PSNVLLDDNMIAYLS 556
             +V++D++M A +S
Sbjct: 141 SRSVMIDEDMTARIS 155

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 14/174 (8%)
Query: 420 NLIGRGGFGSVYKARLGDG--------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  I++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T      TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAP 190

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +VLEY P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV----AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNL 472
            ++G+G FG V+  +   G +     A+KV     L+ R   ++  +E +I+  + H  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 89
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +K+  +   E    L+L+++  G L   L S   +         + ++A AL++LH   S
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 145
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 196

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV----AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNL 472
            ++G+G FG V+  +   G +     A+KV     L+ R   ++  +E +I+  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +K+  +   E    L+L+++  G L   L S   +         + ++A AL++LH   S
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 195

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           IG G +G VYKA+   G   A+K   L+       S  + E  I+K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
             ++   LV E++ Q  L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAP 169

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         Y  N   +  ++L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 198 RLPVKWMAP 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 422 IGRGGFGSVY--------KARLGDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V         K +     +VAVK+       +       E E+MK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLN------I 516
           +I ++ +C+ +    +++EY  +G+L ++L         Y  N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
              VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 577 LATIGYMAP 585
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 26/192 (13%)
Query: 411 RATDGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV------ 459
            +T GF EN     ++GRG    V +        E AVK+ ++    +F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 460 ---ECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR-- 513
              E +I++ +  H N+I++  +     F  LV + M +G L  +L     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           +  +++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 180
Query: 574 TQTLATIGYMAP 585
            +   T  Y+AP
Sbjct: 181 REVCGTPSYLAP 192

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 38/205 (18%)
Query: 416 FSENNL-----IGRGGFGSVYKARLGDGME------VAVKVFNLQCRRAFKS-FDVECEI 463
           +  NN+     IG G FG V++AR    +       VAVK+   +     ++ F  E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS----TNC------------- 506
           M    + N++K++  C+  +   L+ EYM  G L + L S    T C             
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 507 ------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
                  L   ++L I   VA+ + YL        +H DL   N L+ +NM+  ++DFG+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 561 AKLLIGEDQSMTQTQTLATIGYMAP 585
           ++ +   D           I +M P
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPP 245

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVY----KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNL 472
            ++G+G FG V+      R   G   A+KV     L+ R   ++  +E +I+  + H  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +K+  +   E    L+L+++  G L   L S   +         + ++A  L++LH   S
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAP 199

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           IG G +G VYKA+   G   A+K   L+       S  + E  I+K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
             ++   LV E++ Q  L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAP 169

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           IG G +G VYKA+   G   A+K   L+       S  + E  I+K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
             ++   LV E++ Q  L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAP 169

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 28/177 (15%)
Query: 422 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G +GSV   Y ARL    +VAVK  +      +  RR ++    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 473 IKVIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           I ++     + S E+F  + L     G+   ++     + D   +  ++  +   L+Y+H
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 148
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  +IH DLKPSNV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAP 197

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCRRAFKSFDVECEIMKSIRHRN 471
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS----ALEYL 527
            I+       E    LV+EY         L S + +L++ ++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +  S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 581 GYMA 584
            +MA
Sbjct: 186 KWMA 189

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 581 GYMA 584
            +MA
Sbjct: 187 KWMA 190

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 581 GYMA 584
            +MA
Sbjct: 191 KWMA 194

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 581 GYMA 584
            +MA
Sbjct: 187 KWMA 190

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLSFC 119
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVA---VKVFNLQCRRAFKS--------------- 456
           F E  LIG GGFG V+KA+   DG       VK  N +  R  K+               
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 457 ---FDVECEI----MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC-IL 508
              FD + E     ++S  +       SS S  +   + +E+  +G+LE+ +       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           D    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   L  + 
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 569 QSMTQTQTLATIGYMAP 585
           +   +T++  T+ YM+P
Sbjct: 191 K---RTRSKGTLRYMSP 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 176

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 581 GYMA 584
            +MA
Sbjct: 187 KWMA 190

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 581 GYMA 584
            +MA
Sbjct: 190 KWMA 193

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 34  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 92
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 581 GYMA 584
            +MA
Sbjct: 209 KWMA 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 36/190 (18%)
Query: 411 RATDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFNLQCRR---AFKSFDVECEI-- 463
           R T  F E  ++G G F  V+  K RL        K+F L+C +   AF+   +E EI  
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVKQRLTG------KLFALKCIKKSPAFRDSSLENEIAV 59
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGS-----LEKHLYSTNCILDIFQRLNIMI 518
           +K I+H N++ +     +     LV++ +  G      LE+ +Y+      + Q+     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----- 114
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
            V SA++YLH      ++H DLKP N+L    ++N    ++DFG++K+    +Q+   + 
Sbjct: 115 -VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMST 166
Query: 576 TLATIGYMAP 585
              T GY+AP
Sbjct: 167 ACGTPGYVAP 176

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 28/177 (15%)
Query: 422 IGRGGFGSV---YKARLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G +GSV   Y ARL    +VAVK  +      +  RR ++    E  ++K ++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 81
Query: 473 IKVIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           I ++     + S E+F  + L     G+   ++     + D   +  ++  +   L+Y+H
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH 140
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  +IH DLKPSNV ++++    + DFG+A+     D+ M  T  +AT  Y AP
Sbjct: 141 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEM--TGYVATRWYRAP 189

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 11/188 (5%)
Query: 403 TFSYLELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKS 456
             + L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K 
Sbjct: 2   AMALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 60
Query: 457 FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
              E  +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 61  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 119
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
            + +A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++       
Sbjct: 120 CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 577 LATIGYMA 584
              I +MA
Sbjct: 177 KVPIKWMA 184

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 581 GYMA 584
            +MA
Sbjct: 186 KWMA 189

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 581 GYMA 584
            +MA
Sbjct: 194 KWMA 197

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 581 GYMA 584
            +MA
Sbjct: 186 KWMA 189

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 411 RATDGFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV------ 459
            +T GF EN     ++GRG    V +        E AVK+ ++    +F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 460 ---ECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR-- 513
              E +I++ +  H N+I++  +     F  LV + M +G L  +L     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           +  +++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 180
Query: 574 TQTLATIGYMAP 585
                T  Y+AP
Sbjct: 181 RSVCGTPSYLAP 192

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 15/177 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T  LA T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAP 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCRRAFKSFDVECEIMKSIRHRN 471
           FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS----ALEYL 527
            I+       E    LV+EY         L S + +L++ ++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            +  S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 581 GYMA 584
            +MA
Sbjct: 188 KWMA 191

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 10/175 (5%)
Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVECEIMKSIRH 469
           F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            ++ +++  C     + L+ + MP G L  ++      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
                ++H DL   NVL+       ++DFG+AKLL  E++          I +MA
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MK 465
           AT  +     IG G +G+VYKAR    G  VA+K   +             E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 466 SIRHRNLIKVISSCS----NEEFK-GLVLEYMPQGSLEKHL-YSTNCILDIFQRLNIMID 519
           +  H N+++++  C+    + E K  LV E++ Q  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
               L++LH  C   ++H DLKP N+L+       L+DFG+A++       M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVT 174
Query: 580 IGYMAP 585
           + Y AP
Sbjct: 175 LWYRAP 180

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 18/166 (10%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH 469
           R    F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 470 -------------RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
                        RN +K  ++   +    +  EY    +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
              +  AL Y+H   S  +IH +LKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG+G F  V  AR +  G EVAVK+ +       + +    E  I K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV EY   G +  +L +     +   R      + SA++Y H      ++H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH---QKFIVHR 137
Query: 539 DLKPSNVLLDDNMIAYLSDFGIA 561
           DLK  N+LLD +    ++DFG +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS 160

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G       T TL  T  Y+AP
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAP 228

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISS- 478
           +G+G +G V++  L  G  VAVK+F+    R  +S+  E EI  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 479 --CSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH---FGCS 532
               N   +  L+  Y   GSL   L      L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 533 -TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQ-SMTQTQTLATIGYMAP 585
             P I H D K  NVL+  N+   ++D G+A +   G D   +     + T  YMAP
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           +++   IG G +G V  A        VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFRH 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN-----IMIDVASAL 524
            N+I +         + +   Y+ Q  +E  LY    +L   Q  N      +  +   L
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILRGL 157
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE-DQSMTQTQTLATIGYM 583
           +Y+H   S  V+H DLKPSN+L++      + DFG+A++   E D +   T+ +AT  Y 
Sbjct: 158 KYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 584 AP 585
           AP
Sbjct: 215 AP 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L K+  S  +     +V+EY P G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D+     ++DFG AK + G    +       T  Y+AP
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 194

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++ +  +V+EYMP G L  +L S   + + + R     +V  AL+ +H   S   I
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 190
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+KP N+LLD +    L+DFG    +  E      T  + T  Y++P
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+ + RH
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRH 82
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 83  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 135
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 580 IGYMAP 585
             Y AP
Sbjct: 193 RWYRAP 198

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 80
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 580 IGYMAP 585
             Y AP
Sbjct: 191 RWYRAP 196

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++  G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+++ MP G L  ++      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 581 GYMA 584
            +MA
Sbjct: 191 KWMA 194

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++ +  +V+EYMP G L  +L S   + + + R     +V  AL+ +H   S   I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 195
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+KP N+LLD +    L+DFG    +  E      T  + T  Y++P
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             +  ++++  +V+EYMP G L  +L S   + + + +     +V  AL+ +H   S  +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGL 195
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           IH D+KP N+LLD +    L+DFG    +  ++  M    T + T  Y++P
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDYISP 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 9/140 (6%)
Query: 448 LQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKGLVLEYMPQGSLEKHLYSTN 505
           +Q R   +    E  I+K + H N++K++      NE+   +V E + QG + +    T 
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTL 131
Query: 506 CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI 565
             L   Q      D+   +EYLH+     +IH D+KPSN+L+ ++    ++DFG++    
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 566 GEDQSMTQTQTLATIGYMAP 585
           G D  +  + T+ T  +MAP
Sbjct: 189 GSDALL--SNTVGTPAFMAP 206

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+ + RH
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRH 82
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 83  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 135
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 580 IGYMAP 585
             Y AP
Sbjct: 193 RWYRAP 198

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 23/193 (11%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 469 ------HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
                 H N++ ++ +C++     ++ EY   G L   L   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 523 ALEYLHFG----------CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
             + LHF            S   IH D+   NVLL +  +A + DFG+A+ ++ +   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 573 QTQTLATIGYMAP 585
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAP 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G +G+V+KA+  +  E VA+K   L         S   E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
             +++   LV E+  Q  L+K+  S N  LD     + +  +   L + H   S  V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L++ N    L+DFG+A+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLAR 149

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 415 GFSEN----NLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV---------E 460
           GF EN     ++GRG    V +        E AVK+ ++    +F + +V         E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 461 CEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR--LNIM 517
            +I++ +  H N+I++  +     F  LV + M +G L  +L     + +   R  +  +
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           ++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D      +  
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVC 171
Query: 578 ATIGYMAP 585
            T  Y+AP
Sbjct: 172 GTPSYLAP 179

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 137
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 580 IGYMAP 585
             Y AP
Sbjct: 195 RWYRAP 200

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 422 IGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           +G G + +VYK  ++L D + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E+   LV EY+ +  L+++L     I+++      +  +   L Y H      V+H 
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L+++     L+DFG+A+
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR 148

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MK 465
           AT  +     IG G +G+VYKAR    G  VA+K   +             E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 466 SIRHRNLIKVISSCS----NEEFK-GLVLEYMPQGSLEKHL-YSTNCILDIFQRLNIMID 519
           +  H N+++++  C+    + E K  LV E++ Q  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
               L++LH  C   ++H DLKP N+L+       L+DFG+A++       M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVT 174
Query: 580 IGYMAP 585
           + Y AP
Sbjct: 175 LWYRAP 180

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 80
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 580 IGYMAP 585
             Y AP
Sbjct: 191 RWYRAP 196

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKV---FNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG FG V   R     +V A+K+   F +  R     F  E +IM       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +  ++ +  +V+EYMP G L  +L S   + + + R     +V  AL+ +H   S   I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 195
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+KP N+LLD +    L+DFG    +  E      T  + T  Y++P
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 243

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 80
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 580 IGYMAP 585
             Y AP
Sbjct: 191 RWYRAP 196

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 581 GYMA 584
            +MA
Sbjct: 191 KWMA 194

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 581 GYMA 584
            +MA
Sbjct: 186 KWMA 189

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR---LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G+ + +     + +      +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR---LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G+ + +     + +      +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T T  + T+ Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 32/187 (17%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLN------IMID 519
            N+I    +I + + E+ K +   Y+ Q  +E  LY    C     Q L+       +  
Sbjct: 85  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQ 136
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLA 578
           +   L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +A
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 579 TIGYMAP 585
           T  Y AP
Sbjct: 194 TRWYRAP 200

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   + +  G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI-----MK 465
           AT  +     IG G +G+VYKAR    G  VA+K   +             E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 466 SIRHRNLIKVISSC----SNEEFK-GLVLEYMPQGSLEKHL-YSTNCILDIFQRLNIMID 519
           +  H N+++++  C    ++ E K  LV E++ Q  L  +L  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
               L++LH  C   ++H DLKP N+L+       L+DFG+A++       M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVT 174
Query: 580 IGYMAP 585
           + Y AP
Sbjct: 175 LWYRAP 180

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 78
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 79  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 131
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 580 IGYMAP 585
             Y AP
Sbjct: 189 RWYRAP 194

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 147
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEM--TGYVATRWYRAP 196

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 85
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 86  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 138
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 580 IGYMAP 585
             Y AP
Sbjct: 196 RWYRAP 201

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 86
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 87  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 139
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 140 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 580 IGYMAP 585
             Y AP
Sbjct: 197 RWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 77
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 78  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 130
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 131 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 580 IGYMAP 585
             Y AP
Sbjct: 188 RWYRAP 193

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 137
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 580 IGYMAP 585
             Y AP
Sbjct: 195 RWYRAP 200

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 78
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 79  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 131
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 132 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 580 IGYMAP 585
             Y AP
Sbjct: 189 RWYRAP 194

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 176

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 82
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 83  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 135
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 136 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 580 IGYMAP 585
             Y AP
Sbjct: 193 RWYRAP 198

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 88
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 89  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 141
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 142 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 580 IGYMAP 585
             Y AP
Sbjct: 199 RWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 80
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 580 IGYMAP 585
             Y AP
Sbjct: 191 RWYRAP 196

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ------CRRAFKSFDVECEI--M 464
           D +  +  +G G  G V  A       +VA+K+ + +       R A  + +VE EI  +
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMI 518
           K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +Q L    
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 130
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 131 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 180
Query: 576 TL-ATIGYMAP 585
           TL  T  Y+AP
Sbjct: 181 TLCGTPTYLAP 191

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 80
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 81  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 580 IGYMAP 585
             Y AP
Sbjct: 191 RWYRAP 196

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ------CRRAFKSFDVECEI--M 464
           D +  +  +G G  G V  A       +VA+K+ + +       R A  + +VE EI  +
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMI 518
           K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 576 TL-ATIGYMAP 585
           TL  T  Y+AP
Sbjct: 175 TLCGTPTYLAP 185

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++  N IGRG +G V  A + G  +  A K            F  E EIMKS+ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  +  +     LV+E    G L + +       +      IM DV SA+ Y H      
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCH---KLN 126
Query: 535 VIHCDLKPSNVL-LDDNMIAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           V H DLKP N L L D+  + L   DFG+A     +   M +T+ + T  Y++P
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSP 177

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ------CRRAFKSFDVECEI--M 464
           D +  +  +G G  G V  A       +VA+K+ + +       R A  + +VE EI  +
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMI 518
           K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 576 TL-ATIGYMAP 585
           TL  T  Y+AP
Sbjct: 175 TLCGTPTYLAP 185

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 101 ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 153
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 154 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 580 IGYMAP 585
             Y AP
Sbjct: 211 RWYRAP 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ------CRRAFKSFDVECEI--M 464
           D +  +  +G G  G V  A       +VA+K+ + +       R A  + +VE EI  +
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMI 518
           K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 576 TL-ATIGYMAP 585
           TL  T  Y+AP
Sbjct: 175 TLCGTPTYLAP 185

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQ------CRRAFKSFDVECEI--M 464
           D +  +  +G G  G V  A       +VA+K+ + +       R A  + +VE EI  +
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMI 518
           K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +Q L    
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 123
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 124 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 173
Query: 576 TL-ATIGYMAP 585
           TL  T  Y+AP
Sbjct: 174 TLCGTPTYLAP 184

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 79/174 (45%), Gaps = 11/174 (6%)
Query: 416 FSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++  N IGRG +G V  A + G  +  A K            F  E EIMKS+ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  +  +     LV+E    G L + +       +      IM DV SA+ Y H      
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCH---KLN 143
Query: 535 VIHCDLKPSNVL-LDDNMIAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           V H DLKP N L L D+  + L   DFG+A     +   M +T+ + T  Y++P
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSP 194

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 153
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 154 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEM--TGYVATRWYRAP 202

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSC 479
           IG+G +G V+  +   G +VAVKVF      A  S+  E EI +++  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVF-FTTEEA--SWFRETEIYQTVLMRHENILGFIAA- 99
Query: 480 SNEEFKG--------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH--- 528
              + KG        L+ +Y   GSL  +L ST   LD    L +     S L +LH   
Sbjct: 100 ---DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 529 FGCS-TPVI-HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE--DQSMTQTQTLATIGYMA 584
           F     P I H DLK  N+L+  N    ++D G+A   I +  +  +     + T  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 585 P 585
           P
Sbjct: 215 P 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLA 119
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 147
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 148 -SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEM--TGYVATRWYRAP 196

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++  G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 581 GYMA 584
            +MA
Sbjct: 191 KWMA 194

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 8/175 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 171

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 417 SENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             +  ++    LV+EY+  G L   +   +  L     +  M  +   + ++H      +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYI 208
Query: 536 IHCDLKPSNVL---LDDNMIAYLSDFGIAK 562
           +H DLKP N+L    D   I  + DFG+A+
Sbjct: 209 LHLDLKPENILCVNRDAKQIKII-DFGLAR 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYL 527
           N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 171

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 149
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 149
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRN 471
           D +    +IG G    V  A      E VA+K  NL+ C+ +      E + M    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGS---LEKHLYST----NCILDIFQRLNIMIDVASAL 524
           ++   +S   ++   LV++ +  GS   + KH+ +     + +LD      I+ +V   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQT--LATIG 581
           EYLH       IH D+K  N+LL ++    ++DFG++  L  G D +  + +   + T  
Sbjct: 130 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 582 YMAP 585
           +MAP
Sbjct: 187 WMAP 190

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI------RHRNLIK 474
           +G G FG V  A     G +VA+K+ N   ++     D++  I + I      RH ++IK
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 475 VISSCSNEEFKGLVLEY----MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +     +++   +V+EY    +    +++   S       FQ+      + SA+EY H  
Sbjct: 78  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH-- 129
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H DLKP N+LLD+++   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 130 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 180

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI------RHRNLIK 474
           +G G FG V  A     G +VA+K+ N   ++     D++  I + I      RH ++IK
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 475 VISSCSNEEFKGLVLEY----MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +     +++   +V+EY    +    +++   S       FQ+      + SA+EY H  
Sbjct: 79  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH-- 130
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H DLKP N+LLD+++   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 131 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 181

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGXVATRWYRAP 191

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPL-IKSYLFQLLQGLA 120
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N++K++     E    LV E++ Q    K     + +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KDFMDASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCR-----RAFKSFDVE 460
           L + + T+ F +  ++  G FG+VYK   + +G +V + V   + R     +A K    E
Sbjct: 9   LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 581 GYMA 584
            +MA
Sbjct: 184 KWMA 187

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI------RHRNLIK 474
           +G G FG V  A     G +VA+K+ N   ++     D++  I + I      RH ++IK
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 475 VISSCSNEEFKGLVLEY----MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +     +++   +V+EY    +    +++   S       FQ+      + SA+EY H  
Sbjct: 69  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH-- 120
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H DLKP N+LLD+++   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 121 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 171

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 21/163 (12%)
Query: 412 ATDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRH 469
           ++  F +   +G G + +VYK      G+ VA+K   L       S  + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC----------ILDIFQRLNIMID 519
            N++++      E    LV E+M    L+K++ S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
               L+ L F     ++H DLKP N+L++      L DFG+A+
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 149
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y AP
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 144
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 145 -SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEM--TGYVATRWYRAP 193

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI------RHRNLIK 474
           +G G FG V  A     G +VA+K+ N   ++     D++  I + I      RH ++IK
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 475 VISSCSNEEFKGLVLEY----MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +     +++   +V+EY    +    +++   S       FQ+      + SA+EY H  
Sbjct: 73  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH-- 124
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H DLKP N+LLD+++   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 125 -RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 175

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQC-RRAFKSFDVECEI--MKSIRHRNLIKVIS 477
           +G G FG V  A       +VA+K  + Q  +++     VE EI  +K +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             +      +V+EY   G L  ++     + +   R      +  A+EY H      ++H
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            DLKP N+LLDDN+   ++DFG++ ++
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALE 525
           H N++K++     E    LV E++ Q  L+K + +   T   L + +  + +  +   L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + H   S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG 566
             S  +I+ DLKP N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 148
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 149 -SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEM--TGYVATRWYRAP 197

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 83
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 84  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 140
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 141 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 189

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 138
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 187

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 104
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 161
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 210

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRN 471
           D +    +IG G    V  A      E VA+K  NL+ C+ +      E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGS---LEKHLYST----NCILDIFQRLNIMIDVASAL 524
           ++   +S   ++   LV++ +  GS   + KH+ +     + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQT--LATIG 581
           EYLH       IH D+K  N+LL ++    ++DFG++  L  G D +  + +   + T  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 582 YMAP 585
           +MAP
Sbjct: 192 WMAP 195

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA++    F  Q  C+R  +    E +I+   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 137
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 580 IGYMAP 585
             Y AP
Sbjct: 195 RWYRAP 200

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 162
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 211

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 139
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 188

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 108
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 165
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 144
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 193

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 144
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 193

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 139
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 140 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 188

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 154
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 203

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 154
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 203

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 144
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 145 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 193

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 154
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 155 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 203

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 147
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 196

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 13/176 (7%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRH 469
           D F     +G G FG V   +  + G   A+K+ + Q     K  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAP 207

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 153
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 154 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 202

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 84
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 85  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 141
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 142 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 190

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 149
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 198

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 148
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 197

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 147
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 148 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 196

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 47/201 (23%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCRRAFKSFDVECEI 463
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R       E +I
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---STNCILD------IFQRL 514
           +K  +H N+I + +    + F+     Y+ Q  ++  L+   ST  + D      I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL---------- 564
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 565 IGEDQSMTQTQTLATIGYMAP 585
            G+   M  T+ +AT  Y AP
Sbjct: 173 TGQQSGM--TEXVATRWYRAP 191

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN-----------IMI 518
            N+I +     N+  +   +E M    L  HL       D+++ L             + 
Sbjct: 101 ENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGA----DLYKLLKTQHLSNDHICYFLY 151
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTL 577
            +   L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 578 ATIGYMAP 585
           AT  Y AP
Sbjct: 209 ATRWYRAP 216

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 30/179 (16%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +G+G F  V +  ++  G E A K+ N +    R  +  + E  I + ++H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 479 CSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDVASALEYLHF 529
            S E    L+ + +  G L      +  YS    ++CI  I +          A+ + H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----------AVLHCH- 138
Query: 530 GCSTPVIHCDLKPSNVLLDDNM---IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                V+H DLKP N+LL   +      L+DFG+A  + GE Q+        T GY++P
Sbjct: 139 --QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSP 193

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 127
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 128 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 179

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V    + A  G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 122
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KXFCGTPEYLAP 174

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 148
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 197

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           F++   IG+G FG V+K       +V           A K  D+E    +    +  I V
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAEDEIEDIQQEITV 74
Query: 476 ISSCSNE---EFKG---------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +S C +    ++ G         +++EY+  GS    L +     D FQ   ++ ++   
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKG 132
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +M
Sbjct: 133 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 187
Query: 584 AP 585
           AP
Sbjct: 188 AP 189

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 10/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH--- 125
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 177

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 47/201 (23%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCRRAFKSFDVECEI 463
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R       E +I
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---STNCILD------IFQRL 514
           +K  +H N+I + +    + F+     Y+ Q  ++  L+   ST  + D      I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL---------- 564
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 565 IGEDQSMTQTQTLATIGYMAP 585
            G+   M  T+ +AT  Y AP
Sbjct: 173 TGQQSGM--TEYVATRWYRAP 191

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 7/144 (4%)
Query: 422 IGRGGFGSVYKARLGDGME-VAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G +G+V+KA+  +  E VA+K   L         S   E  ++K ++H+N++++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
             +++   LV E+  Q  L+K+  S N  LD     + +  +   L + H   S  V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAK 562
           DLKP N+L++ N    L++FG+A+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLAR 149

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  +  +  G+++AVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 114
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 115 LLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 171
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 172 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 71/138 (51%), Gaps = 25/138 (18%)
Query: 458 DVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIF 511
           + E EI+K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGED 568
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 261 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 309
Query: 569 QSMTQTQTL-ATIGYMAP 585
             M   +TL  T  Y+AP
Sbjct: 310 SLM---RTLCGTPTYLAP 324

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 71/138 (51%), Gaps = 25/138 (18%)
Query: 458 DVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIF 511
           + E EI+K + H  +IK+ +    E++  +VLE M  G L       K L    C L  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGED 568
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 247 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295
Query: 569 QSMTQTQTL-ATIGYMAP 585
             M   +TL  T  Y+AP
Sbjct: 296 SLM---RTLCGTPTYLAP 310

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++  +  + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+ +     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEM--TGYVATRWYRAP 191

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N++K++     E    LV E++   S++   +     L       I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R  G G E A K    +     RR     ++E E  I++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           IRH N+I +     N+    L+LE +  G L   L     + +  +    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 130
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      L DFGIA
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R  G G E A K    +     RR     ++E E  I++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           IRH N+I +     N+    L+LE +  G L   L     + +  +    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 144
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      L DFGIA
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 84
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 137
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +    + +AT
Sbjct: 138 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 580 IGYMAP 585
             Y AP
Sbjct: 195 RWYRAP 200

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKV---FNLQ--CRRAFKSFDVECEIMKSIRH 469
           ++  + IG G +G V  A    + + VA+K    F  Q  C+R  +    E +I+   RH
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 85
Query: 470 RNLI---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDV 520
            N+I    +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +
Sbjct: 86  ENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQI 138
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLAT 579
              L+Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +    + +AT
Sbjct: 139 LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 580 IGYMAP 585
             Y AP
Sbjct: 196 RWYRAP 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 8/177 (4%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N++K++     E    LV E++   S++   +     L       I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R  G G E A K    +     RR     ++E E  I++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           IRH N+I +     N+    L+LE +  G L   L     + +  +    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 123
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      L DFGIA
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 104
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 161
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 162 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 210

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 162
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 211

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 37/205 (18%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIR 468
           R    F     +GRGGFG V++A+   D    A+K   L  R  A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQR 513
           H  +++      N   +    E +   S + +LY               +  C ++  +R
Sbjct: 62  HPGIVRYF----NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 514 ---LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
              L+I + +A A+E+LH   S  ++H DLKPSN+    + +  + DFG+   +  +++ 
Sbjct: 118 SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 571 MT----------QTQTLATIGYMAP 585
            T           T  + T  YM+P
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSP 199

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 138
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 187

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 9/182 (4%)
Query: 406 YLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSF-DVECEI 463
           Y +     + F++   IG+G FG V+K       +V A+K+ +L+           E  +
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +       + K   S   +    +++EY+  GS    L      LD  Q   I+ ++   
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 136
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L+YLH   S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +M
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 191
Query: 584 AP 585
           AP
Sbjct: 192 AP 193

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 95
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 96  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 152
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 153 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 201

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 25/195 (12%)
Query: 383 RQRGKQ-PSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGME- 440
           +Q G+Q   + ++ P  +M R  S  ++    D +   +LIG G +G V +A   D +E 
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEA--YDKLEK 78
Query: 441 --VAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIKVIS---SCSNEEFKGLVL 489
             VA+K    VF   + C+R  +    E  I+  + H +++KV+        E+F  L +
Sbjct: 79  RVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD 549
                 S  K L+ T   L       ++ ++   ++Y+H   S  ++H DLKP+N L++ 
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 550 NMIAYLSDFGIAKLL 564
           +    + DFG+A+ +
Sbjct: 192 DCSVKVCDFGLARTV 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 416 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCRRA-FKSFDVECE 462
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--------------- 507
           ++K + H ++IK+  +CS +    L++EY   GSL   L  +  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 508 --------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 560 IAKLLIGEDQSMTQTQTLATIGYMA 584
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 416 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCRRA-FKSFDVECE 462
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--------------- 507
           ++K + H ++IK+  +CS +    L++EY   GSL   L  +  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 508 --------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 560 IAKLLIGEDQSMTQTQTLATIGYMA 584
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLE-KHLYSTNCILDIFQRLNIMIDVASALEYL 527
           H N++K++     E    LV E++   S++ K     + +  I   L I   +   L+ L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGL 119
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + D+G+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRHRN 471
           F +  ++G+GGFG V   ++   G   A K    +  +  K   +   E +I++ +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFG 530
           ++ +  +   ++   LVL  M  G L+ H+Y          + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               +++ DLKP N+LLDD+    +SD G+A + + E Q++     + T+GYMAP
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAP 354

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 22/182 (12%)
Query: 416 FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLI 473
           ++  + IG G +G V  A    + + VA+K  +    + +    + E +I+   RH N+I
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 474 ---KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASAL 524
               +I + + E+ K +   Y+ Q  +E  LY     L   Q L+       +  +   L
Sbjct: 89  GINDIIRAPTIEQMKDV---YIVQDLMETDLYK----LLKTQHLSNDHICYFLYQILRGL 141
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYM 583
           +Y+H   S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT  Y 
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 584 AP 585
           AP
Sbjct: 199 AP 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-RAFKSFDV-ECEIMKSIR 468
           + + F +   IG G +G VYKAR    G  VA+K   L        S  + E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLE-KHLYSTNCILDIFQRLNIMIDVASALEYL 527
           H N++K++     E    LV E++   S++ K     + +  I   L I   +   L+ L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGL 118
Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            F  S  V+H DLKP N+L++      L+DFG+A+         T    + T+ Y AP
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRHRN 471
           F +  ++G+GGFG V   ++   G   A K    +  +  K   +   E +I++ +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFG 530
           ++ +  +   ++   LVL  M  G L+ H+Y          + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               +++ DLKP N+LLDD+    +SD G+A + + E Q++     + T+GYMAP
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAP 354

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 416 FSENNLI-----GRGGFGSVYKA-------RLGDGMEVAVKVFNLQCRRA-FKSFDVECE 462
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--------------- 507
           ++K + H ++IK+  +CS +    L++EY   GSL   L  +  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 508 --------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 560 IAKLLIGEDQSMTQTQTLATIGYMA 584
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMA 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 78/168 (46%), Gaps = 9/168 (5%)
Query: 419 NNLIGRGGFGSVYKARLGDG----MEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLI 473
           + +IG+G FG VY     D     ++ A+K  + +   +  ++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 474 KVIS-SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            +I      E    ++L YM  G L + + S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
              +H DL   N +LD++    ++DFG+A+ ++  +    Q    A +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 148
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 149 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 197

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 10/171 (5%)
Query: 420 NLIGRGGFGSVYKA-RLGDG----MEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLI 473
            ++G G FG+VYK   + DG    + VA+KV       +A K    E  +M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +++  C     + LV + MP G L  H+      L     LN  + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
            ++H DL   NVL+       ++DFG+A+LL  ++           I +MA
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIKVI 476
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E +IM  + +  ++++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
             C  E    LV+E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           H DL   NVLL +   A +SDFG++K L  +D   T
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSF-DVECEIMKSIRHRNLI 473
           F++   IG+G FG V+K       +V A+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 123
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 173

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-LIYQILRGLKYIH-- 138
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +AT  Y AP
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAP 187

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV---ECEIMKSIRHRNLIKVIS 477
           +G G FG V+  R   +G   A+KV   +     K  +    E  ++  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +  + +   ++++Y+  G L   L  +    +   +     +V  ALEYLH   S  +I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLL 564
            DLKP N+LLD N    ++DFG AK +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSF-DVECEIMKSIRHRNLI 473
           F++   IG+G FG V+K       +V A+K+ +L+           E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 138
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 188

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 108
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 165
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M     +AT  Y AP
Sbjct: 166 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--XGYVATRWYRAP 214

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 15/179 (8%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMK------S 466
           D F    ++G+G FG V  AR+ + G   AVKV  L+     +  DVEC + +      +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
             H  L ++       +    V+E++  G L  H+  +    +   R     ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH      +I+ DLK  NVLLD      L+DFG+ K  I     +T      T  Y+AP
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAP 193

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSF-DVECEIMKSIRHRNLI 473
           F++   IG+G FG V+K       +V A+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 123
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 173

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 409 LCRATDGFSEN--NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS 466
           LC+  +G SE    +I +  F    K R  D         N    +  +    E  ++KS
Sbjct: 54  LCKEKNGHSEKAIKVIKKSQFD---KGRYSDD--------NKNIEKFHEEIYNEISLLKS 102
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + H N+IK+     ++++  LV E+   G L + + + +   D     NIM  + S + Y
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICY 161
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LH      ++H D+KP N+LL++    +   + DFG++       +       L T  Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYI 215
Query: 584 AP 585
           AP
Sbjct: 216 AP 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 43/199 (21%)
Query: 413 TDGFSENNLIGRGGFGSVYKA-RLGDGMEVAVK--------VFNLQCRRAFKSFDVECEI 463
           +  F   +L+G G +G V  A     G  VA+K        +F L+  R       E +I
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---STNCILD------IFQRL 514
           +K  +H N+I + +    + F+     Y+ Q  ++  L+   ST  + D      I+Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL---IGEDQSM 571
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++     ++   
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 572 TQTQT-----LATIGYMAP 585
           T  Q+     +AT  Y AP
Sbjct: 173 TGQQSGMVEFVATRWYRAP 191

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 27/214 (12%)
Query: 394 NMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARL-----GDGME-VAVKVFN 447
            MPL+   +     E+  +   F E   +G   FG VYK  L     G+  + VA+K   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 448 LQCRRAFKS-FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---- 502
            +     +  F  E  +   ++H N++ ++   + ++   ++  Y   G L + L     
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 503 -----------STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM 551
                      +    L+    ++++  +A+ +EYL    S  V+H DL   NVL+ D +
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL 182
Query: 552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +SD G+ + +   D       +L  I +MAP
Sbjct: 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 89/187 (47%), Gaps = 17/187 (9%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMK 465
           L++    + F  + ++G+G FG V+ A      +  A+K   L+        DVEC +++
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 466 ------SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID 519
                 +  H  L  +  +   +E    V+EY+  G L  H+ S +   D+ +      +
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAE 127
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL-LIGEDQSMTQTQTLA 578
           +   L++LH   S  +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++    +   
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCG 181
Query: 579 TIGYMAP 585
           T  Y+AP
Sbjct: 182 TPDYIAP 188

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 21/192 (10%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEI 463
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  + F +    E +I
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 464 MKSIRHRNLIKVISSCSNE-----EFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN 515
           ++ ++H N++ +I  C  +       KG   LV ++  +  L   L +      + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 129
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL--LIGEDQSMTQ 573
           +M  + + L Y+H      ++H D+K +NVL+  + +  L+DFG+A+   L    Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 574 TQTLATIGYMAP 585
              + T+ Y  P
Sbjct: 187 XNRVVTLWYRPP 198

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 162
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M     +AT  Y AP
Sbjct: 163 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--XGXVATRWYRAP 211

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 413 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSI 467
           +D +    ++G+G FG V   K ++  G E AVKV +   ++ +   +S   E +++K +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 528 HFGCSTPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL+    D  I  + DFG++      + S      + T  Y+
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRII-DFGLSTHF---EASKKMKDKIGTAYYI 218
Query: 584 AP 585
           AP
Sbjct: 219 AP 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 39/193 (20%)
Query: 422 IGRGGFGSVYKA---RLGDGMEVAVKVFN-----LQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G+G +G V+K+   R G+ + V  K+F+        +R F+   +  E+     H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSG---HENIV 72
Query: 474 KVIS--SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
            +++     N+    LV +YM     + H      IL+   +  ++  +   ++YLH G 
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-------------------EDQSMT 572
              ++H D+KPSN+LL+      ++DFG+++  +                    +D    
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 573 QTQTLATIGYMAP 585
            T  +AT  Y AP
Sbjct: 187 LTDYVATRWYRAP 199

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 413 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSI 467
           +D +    ++G+G FG V   K ++  G E AVKV +   ++ +   +S   E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 528 HFGCSTPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL+    D  I  + DFG++      + S      + T  Y+
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRII-DFGLSTHF---EASKKMKDKIGTAYYI 201
Query: 584 AP 585
           AP
Sbjct: 202 AP 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 413 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSI 467
           +D +    ++G+G FG V   K ++  G E AVKV +   ++ +   +S   E +++K +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 528 HFGCSTPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL+    D  I  + DFG++      + S      + T  Y+
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRII-DFGLSTHF---EASKKMKDKIGTAYYI 219
Query: 584 AP 585
           AP
Sbjct: 220 AP 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 21/192 (10%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEI 463
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  + F +    E +I
Sbjct: 12  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 69
Query: 464 MKSIRHRNLIKVISSCSNE-----EFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN 515
           ++ ++H N++ +I  C  +       KG   LV ++  +  L   L +      + +   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 128
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL--LIGEDQSMTQ 573
           +M  + + L Y+H      ++H D+K +NVL+  + +  L+DFG+A+   L    Q    
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 574 TQTLATIGYMAP 585
              + T+ Y  P
Sbjct: 186 XNRVVTLWYRPP 197

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 413 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSI 467
           +D +    ++G+G FG V   K ++  G E AVKV +   ++ +   +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 528 HFGCSTPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL+    D  I  + DFG++      + S      + T  Y+
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRII-DFGLSTHF---EASKKMKDKIGTAYYI 195
Query: 584 AP 585
           AP
Sbjct: 196 AP 197

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 21/192 (10%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEI 463
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  + F +    E +I
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 464 MKSIRHRNLIKVISSCSNE-----EFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN 515
           ++ ++H N++ +I  C  +       KG   LV ++  +  L   L +      + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 129
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL--LIGEDQSMTQ 573
           +M  + + L Y+H      ++H D+K +NVL+  + +  L+DFG+A+   L    Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 574 TQTLATIGYMAP 585
              + T+ Y  P
Sbjct: 187 XNRVVTLWYRPP 198

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRNLIKVI 476
           +G G FGSV    Y+ R    ++VA+KV      +A  +    E +IM  + +  ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
             C  E    LV+E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           H +L   NVLL +   A +SDFG++K L  +D   T
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    +  FG+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 138
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M     +AT  Y AP
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAP 187

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 422 IGRGGFG-SVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           IG G FG ++      DG +  +K  N+     +  +    E  ++ +++H N+++   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQR---LNIMIDVASALEYLHFGCSTPV 535
                   +V++Y   G L K + +   +L  FQ    L+  + +  AL+++H      +
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH---DRKI 146
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +H D+K  N+ L  +    L DFGIA++L
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 31/182 (17%)
Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-------RHRNL 472
           L+G G +G VYK R +  G   A+KV ++       + D E EI + I        HRN+
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TGDEEEEIKQEINMLKKYSHHRNI 83
Query: 473 IKVISSCSNEEFKG------LVLEYMPQGSLEKHLYST--NCILDIFQRLNIMIDVASAL 524
                +   +   G      LV+E+   GS+   + +T  N + + +    I  ++   L
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGL 142
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYM 583
            +LH      VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +M
Sbjct: 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 196
Query: 584 AP 585
           AP
Sbjct: 197 AP 198

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M     +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAP 191

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + D G+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DFG+A+     D  M     +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAP 191

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + D G+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 411 RATDGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSI 467
           R T+ +     +G+G F  V +  ++  G E A  + N +    R  +  + E  I + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMI 518
           +H N++++  S S E    L+ + +  G L      +  YS    ++CI  I +      
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE------ 121
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAYLSDFGIAKLLIGEDQSMTQTQ 575
               A+ + H      V+H +LKP N+LL   +      L+DFG+A  + GE Q+     
Sbjct: 122 ----AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 576 TLATIGYMAP 585
              T GY++P
Sbjct: 175 --GTPGYLSP 182

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 9/135 (6%)
Query: 428 GSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EE 483
           G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 484 FKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVI-HCDLK 541
              L+  + P GSL   L+  TN ++D  Q +   +D A    +LH     P+I    L 
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALN 140
Query: 542 PSNVLLDDNMIAYLS 556
             +V +D++  A +S
Sbjct: 141 SRSVXIDEDXTARIS 155

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + D G+A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A     G +VAVK  +L+ ++  +    E  IM+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL YLH   +  VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAP 210

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 469 ------HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI---------LDIFQR 513
                 H N++ ++ +C++     ++ EY   G L   L               L++   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           L+    VA  + +L    S   IH D+   NVLL +  +A + DFG+A+ ++ +   + +
Sbjct: 155 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 574 TQTLATIGYMAP 585
                 + +MAP
Sbjct: 212 GNARLPVKWMAP 223

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIMK 465
           L++    + F  + ++G+G FG V+ A      +  A+K   L+        DVEC +++
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 67
Query: 466 ------SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID 519
                 +  H  L  +  +   +E    V+EY+  G L  H+ S +   D+ +      +
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAE 126
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL-LIGEDQSMTQTQTLA 578
           +   L++LH   S  +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++        
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCG 180
Query: 579 TIGYMAP 585
           T  Y+AP
Sbjct: 181 TPDYIAP 187

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 413 TDGFSENNLIGRGGFG----SVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR 468
           TDG+     IG G +      ++KA     ME AVK+ +   R   +  ++   +++  +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N+I +     + ++  +V E M  G L   +       +  +   ++  +   +EYLH
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH 133
Query: 529 FGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAKLLIGED 568
              +  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 413 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
           +D F   + +GRG    VY+ +  G     A+KV      +  K    E  ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +IK+           LVLE +  G L     EK  YS     D  ++      +  A+ Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAY 163
Query: 527 LHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LH      ++H DLKP N+L      +    ++DFG++K++  E Q + +T    T GY 
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYC 217
Query: 584 AP 585
           AP
Sbjct: 218 AP 219

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 18/171 (10%)
Query: 406 YLELCRATDGFSENNLIGRGGFGS----VYKARLGDGMEVAVKVFNLQCRRAFKSFDVEC 461
           Y +    +DG+     IG G +      V+KA     ME AVKV +   R   +  ++  
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI-- 73
Query: 462 EIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA 521
            +++  +H N+I +     + +   LV E M  G L   +       +      ++  + 
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIG 131
Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAKLLIGED 568
             +EYLH   S  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/186 (22%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 422 IGRGGFGSVYKARL-----GDGME-VAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIK 474
           +G   FG VYK  L     G+  + VA+K    +     +  F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQRLNIMID 519
           ++   + ++   ++  Y   G L + L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           +A+ +EYL    S  V+H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 580 IGYMAP 585
           I +MAP
Sbjct: 194 IRWMAP 199

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 422 IGRGGFGSVYKA-RLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G  VAVK  +      +  +R ++    E  ++K ++H N+I 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 475 VIS----SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           ++     + S EEF  + L     G+   ++     + D   +  ++  +   L+Y+H  
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH-- 142
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  +IH DLKPSN+ ++++    + DF +A+     D  M  T  +AT  Y AP
Sbjct: 143 -SADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEM--TGYVATRWYRAP 191

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSF-DVECEIMKSIRHRNLI 473
           F++ + IG+G FG VYK       EV A+K+ +L+           E  ++       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 474 KVISSCSNEEFKGLVLEYMPQGS---------LEKHLYSTNCILDIFQRLNIMIDVASAL 524
           +   S        +++EY+  GS         LE+   +T           I+ ++   L
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT-----------ILREILKGL 129
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           +YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MA
Sbjct: 130 DYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMA 184
Query: 585 P 585
           P
Sbjct: 185 P 185

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 413 TDGFSENNLIGRGGFGS----VYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR 468
           +DG+     IG G +      V+KA     ME AVKV +   R   +  ++   +++  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N+I +     + +   LV E M  G L   +       +      ++  +   +EYLH
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH 138
Query: 529 FGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAKLLIGED 568
              S  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 139 ---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 39/199 (19%)
Query: 420 NLIGRGGFGSVYKA------RLGDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSI-R 468
            ++G G FG V  A      + G  ++VAVK+   +     R A  S   E ++M  +  
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQLGS 107
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-------------YSTNCILDIFQRLN 515
           H N++ ++ +C+      L+ EY   G L  +L             Y     L+  + LN
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 516 IM---------IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG 566
           ++           VA  +E+L F      +H DL   NVL+    +  + DFG+A+ ++ 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 567 EDQSMTQTQTLATIGYMAP 585
           +   + +      + +MAP
Sbjct: 225 DSNYVVRGNARLPVKWMAP 243

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 87/192 (45%), Gaps = 21/192 (10%)
Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEI 463
            C     + +   IG+G FG V+KAR    G +VA+K   ++  +  + F +    E +I
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 464 MKSIRHRNLIKVISSCSNEEFKG--------LVLEYMPQGSLEKHLYSTNCILDIFQRLN 515
           ++ ++H N++ +I  C  +            LV ++  +  L   L +      + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKR 129
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL--LIGEDQSMTQ 573
           +M  + + L Y+H      ++H D+K +NVL+  + +  L+DFG+A+   L    Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 574 TQTLATIGYMAP 585
              + T+ Y  P
Sbjct: 187 XNRVVTLWYRPP 198

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 25/192 (13%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 469 ------HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI---------LDIFQR 513
                 H N++ ++ +C++     ++ EY   G L   L               L++   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           L+    VA  + +L    S   IH D+   NVLL +  +A + DFG+A+ ++ +   + +
Sbjct: 163 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 574 TQTLATIGYMAP 585
                 + +MAP
Sbjct: 220 GNARLPVKWMAP 231

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 18/182 (9%)
Query: 413 TDGFSENNLIGRGGFGSVY--KARLGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSI 467
           +D +    ++G+G FG V   K ++  G E AVKV +   ++ +   +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL 527
            H N+ K+     ++ +  LV E    G L   + S     ++     I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 528 HFGCSTPVIHCDLKPSNVLLD----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL+    D  I  + DFG++      + S      + T  Y+
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRII-DFGLSTHF---EASKKXKDKIGTAYYI 195
Query: 584 AP 585
           AP
Sbjct: 196 AP 197

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 185 GLLPVRWMSP 194

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAP 181

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 534 WPVKWYAP 541

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 479 CSNEEFKGL--VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCS- 532
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 533 -TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-FVGTPYYMSP 185

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 460 ECEIMKSIRHRNLIKVISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNCILDIFQRLNIM 517
           E ++++ +RH+N+I+++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
             +   LEYLH   S  ++H D+KP N+LL       +S  G+A+ L
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 535 WPVKWYAP 542

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 194 GLLPVRWMSP 203

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 66/132 (50%), Gaps = 6/132 (4%)
Query: 419 NNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVI 476
           + L+G G +  V  A  L +G E AVK+   Q   +      E E +   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               ++    LV E +  GS+  H+       +  +   ++ DVA+AL++LH   +  + 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 537 HCDLKPSNVLLD 548
           H DLKP N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 45/205 (21%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 469 ------HRNLIKVISSCSN----------------------EEFKGLVLEYMPQGSLEKH 500
                 H N++ ++ +C++                      +   GL   Y P  + E+ 
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 501 LYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
           L S +        L+    VA  + +L    S   IH D+   NVLL +  +A + DFG+
Sbjct: 163 LSSRDL-------LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 561 AKLLIGEDQSMTQTQTLATIGYMAP 585
           A+ ++ +   + +      + +MAP
Sbjct: 213 ARDIMNDSNYIVKGNARLPVKWMAP 237

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 176 WPVKWYAP 183

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 6/139 (4%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  AR    G +VAVK+ +L+ ++  +    E  IM+  +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             E   +++E++  G+L   +  +   L+  Q   +   V  AL YLH   +  VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 541 KPSNVLLDDNMIAYLSDFG 559
           K  ++LL  +    LSDFG
Sbjct: 168 KSDSILLTLDGRVKLSDFG 186

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 187 GLLPVRWMSP 196

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 112
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 113 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 170 WPVKWYAP 177

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 15/172 (8%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVK-----VFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           IGRG +GSV K      G  +AVK     V   + ++     DV   +M+S     +++ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD--IFQRLNIMIDVASALEYLHFGCST 533
             +   E    + +E M   S +K       +LD  I + +   I +A+     H   + 
Sbjct: 87  YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +IH D+KPSN+LLD +    L DFGI+  L+    S+ +T+      YMAP
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 30/184 (16%)
Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFK----SFDVECEIMKSIRH 469
           F     +G G F  V  A      +   K+F ++C  ++A K    S + E  +++ I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAE----EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASAL 524
            N++ +     +     LV++ +  G L     EK  Y+      + ++      V  A+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAV 133
Query: 525 EYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
            YLH      ++H DLKP N+L    D+     +SDFG++K+   E +    +    T G
Sbjct: 134 YYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPG 187
Query: 582 YMAP 585
           Y+AP
Sbjct: 188 YVAP 191

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK-----VFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +GRG +G V K R +  G  +AVK     V + + +R     D+    M+++     +  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------NIMIDVASALEYLHF 529
             +   E    + +E M   SL+K       ++D  Q +       I + +  ALE+LH 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  VIH D+KPSNVL++      + DFGI+  L+    S+ +T       YMAP
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAP 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 176 WPVKWYAP 183

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 412 ATDGFS---------ENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVEC 461
           +TD FS         + +++G G    V     L    E AVK+   Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 462 EIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
           E++   + HRN++++I     E+   LV E M  GS+  H++      ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIA--YLSDFGIAK--LLIGEDQSMTQTQ 575
           ASAL++LH   +  + H DLKP N+L +  N ++   + DFG+     L G+   ++  +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 576 TLATIG---YMAP 585
            L   G   YMAP
Sbjct: 178 LLTPCGSAEYMAP 190

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 9/170 (5%)
Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKV 475
            L+G+G FG V   +    G   A+K+   +    +        E  ++++ RH  L  +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             S    +    V+EY   G L  HL       +   R     ++ SAL+YLH      V
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 270
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           ++ DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAP 318

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 125 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 182 WPVKWYAP 189

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 191 GLLPVRWMSP 200

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 9/170 (5%)
Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKV 475
            L+G+G FG V   +    G   A+K+   +    +        E  ++++ RH  L  +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             S    +    V+EY   G L  HL       +   R     ++ SAL+YLH      V
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEKNV 273
Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           ++ DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAP 321

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 193 GLLPVRWMSP 202

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 9/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   +    G   A+K+   +    +        E  ++++ RH  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  S    +    V+EY   G L  HL       +   R     ++ SAL+YLH   
Sbjct: 70  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--S 126
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V++ DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYLAP 178

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 114
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 115 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 172 WPVKWYAP 179

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 133 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 190 WPVKWYAP 197

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 200 GLLPVRWMSP 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 422 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +GRG FG V+  R+ D   G + AVK   L+  RA +   + C  + S R   ++ +  +
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGA 134
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                +  + +E +  GSL + +    C+ +  + L  +      LEYLH   S  ++H 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHG 190
Query: 539 DLKPSNVLL-DDNMIAYLSDFGIAKLL----IGEDQSMTQTQTLATIGYMAP 585
           D+K  NVLL  D   A L DFG A  L    +G+D  +T      T  +MAP
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL-LTGDYIPGTETHMAP 241

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 222 GLLPVRWMSP 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS----FDVECEIMKSIRHRNLIKVIS 477
           IGRG F +VYK  L     V V    LQ R+  KS    F  E E +K ++H N+++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 478 SCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           S  +   KG     LV E    G+L+ +L     +  I    +    +   L++LH   +
Sbjct: 93  SWES-TVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLHTR-T 149
Query: 533 TPVIHCDLKPSNVLLD---------DNMIAYLSDFGIAKLLIG 566
            P+IH DLK  N+ +          D  +A L     AK +IG
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG 192

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 12/151 (7%)
Query: 410 CRATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI 467
            R T  F E   IG G FGSV+K   RL DG   A+K        +    +   E+    
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHA 61
Query: 468 ---RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---NIMIDVA 521
              +H ++++  S+ + ++   +  EY   GSL   +     I+  F+     ++++ V 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMI 552
             L Y+H   S  ++H D+KPSN+ +    I
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFISRTSI 149

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 411 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI- 467
           R T  F E   IG G FGSV+K   RL DG   A+K        +    +   E+     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 468 --RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---NIMIDVAS 522
             +H ++++  S+ + ++   +  EY   GSL   +     I+  F+     ++++ V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMI 552
            L Y+H   S  ++H D+KPSN+ +    I
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSI 153

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 190 GLLPVRWMSP 199

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 10/182 (5%)
Query: 409 LCRAT-DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEI 463
           + R T + F    L+G+G FG V   +    G   A+K+   +    +        E  +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           +++ RH  L  +  S    +    V+EY   G L  HL       +   R     ++ SA
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSA 121
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           L+YLH      V++ DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+
Sbjct: 122 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYL 177
Query: 584 AP 585
           AP
Sbjct: 178 AP 179

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 194 GLLPVRWMSP 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 193 GLLPVRWMSP 202

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 200 GLLPVRWMSP 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 9/174 (5%)
Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRN 471
           F    L+G+G FG V   +    G   A+K+   +    +        E  ++++ RH  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           L  +  S    +    V+EY   G L  HL       +   R     ++ SAL+YLH   
Sbjct: 72  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--S 128
Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V++ DLK  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KXFCGTPEYLAP 180

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 411 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI- 467
           R T  F E   IG G FGSV+K   RL DG   A+K        +    +   E+     
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 468 --RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---NIMIDVAS 522
             +H ++++  S+ + ++   +  EY   GSL   +     I+  F+     ++++ V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMI 552
            L Y+H   S  ++H D+KPSN+ +    I
Sbjct: 125 GLRYIH---SMSLVHMDIKPSNIFISRTSI 151

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFN------LQCRRAFKSFDVECEI 463
           +  D +   +LIGRG +G VY A   +  + VA+K  N      + C+R  +    E  I
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR----EITI 80
Query: 464 MKSIRHRNLIKVISSCSNEE---FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
           +  ++   +I++      E+   F  L +      S  K L+ T   L       I+ ++
Sbjct: 81  LNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
               +++H    + +IH DLKP+N LL+ +    + DFG+A+ +
Sbjct: 141 LLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTI 181

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 192 WPVKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 6/128 (4%)
Query: 459 VECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
            E  +M+ + +  ++++I  C  E +  LV+E    G L K+L     + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTL 577
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 578 ATIGYMAP 585
             + + AP
Sbjct: 192 WPVKWYAP 199

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 20/154 (12%)
Query: 411 RATDGFSENNLIGRGGFGSVYK--ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI- 467
           R T  F E   IG G FGSV+K   RL DG   A+K    + ++       E   ++ + 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 468 ------RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---NIMI 518
                 +H ++++  S+ + ++   +  EY   GSL   +     I+  F+     ++++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI 552
            V   L Y+H   S  ++H D+KPSN+ +    I
Sbjct: 121 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI 151

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFK-SFDVECEIMKSIRHRN 471
           D +   +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEY 526
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 527 LHFGCSTPVIHCDLKPSNVL---LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LH      ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 584 AP 585
           AP
Sbjct: 186 AP 187

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 80  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 133
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 134 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 125
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI E       + + T  YM+P
Sbjct: 126 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 127
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFK----SFDVECEIMKSIR 468
           D +   +++G G F  V  A      + VA+K      ++A +    S + E  ++  I+
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI---AKKALEGKEGSMENEIAVLHKIK 74
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASA 523
           H N++ +     +     L+++ +  G L     EK  Y+            ++  V  A
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDA 128
Query: 524 LEYLHFGCSTPVIHCDLKPSNVL---LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           ++YLH      ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T 
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTP 182
Query: 581 GYMAP 585
           GY+AP
Sbjct: 183 GYVAP 187

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 76  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 129
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 130 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 479 CSNEEFKGL--VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCS- 532
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 533 -TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V+H DLKP+NV LD      L DFG+A++L   D+   + + + T  YM+P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAK-EFVGTPYYMSP 185

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 150 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 10/179 (5%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKS 466
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  I KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + + +++       +++F  +VLE   + SL +       + +   R   M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 141
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 195

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFK-SFDVECEIMKSIRHRN 471
           D +   +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEY 526
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 527 LHFGCSTPVIHCDLKPSNVL---LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LH      ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 584 AP 585
           AP
Sbjct: 186 AP 187

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 186

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFNLQCRRAFK-SFDVECEIMKSIRHRN 471
           D +   +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEY 526
           ++ +     +     L+++ +  G L     EK  Y+            ++  V  A++Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKY 131
Query: 527 LHFGCSTPVIHCDLKPSNVL---LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           LH      ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 584 AP 585
           AP
Sbjct: 186 AP 187

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 209

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 11/137 (8%)
Query: 419 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR 470
           N  +G+G F  ++K     +GD       EV +KV +   R   +SF     +M  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +L+     C   +   LV E++  GSL+ +L      ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 531 CSTPVIHCDLKPSNVLL 547
               +IH ++   N+LL
Sbjct: 130 EENTLIHGNVCAKNILL 146

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 77  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 130
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 131 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 422 IGRGGFGSVYKARLGD---GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +GRG FG V+  R+ D   G + AVK   L+  RA +   + C  + S R   ++ +  +
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGA 153
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                +  + +E +  GSL + +    C+ +  + L  +      LEYLH   S  ++H 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHG 209
Query: 539 DLKPSNVLL-DDNMIAYLSDFGIAKLL 564
           D+K  NVLL  D   A L DFG A  L
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCL 236

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 75/180 (41%), Gaps = 19/180 (10%)
Query: 422 IGRGGFGSVYKARLGD------GMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+    D         VAVK  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD---------IFQRLNIMIDVASALE 525
           ++   S  +   +V+E M  G L+ +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++  +    + DFG+ + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 184

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/190 (22%), Positives = 85/190 (44%), Gaps = 19/190 (10%)
Query: 412 ATDGFSENNLIGRGGFGSVY----KARLGDGME--VAVKVFNLQCR-RAFKSFDVECEIM 464
           A +  + +  +G+G FG VY    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS------TNCIL---DIFQRLN 515
           K     ++++++   S  +   +++E M +G L+ +L S       N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 516 IMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
           +  ++A  + YL+   +   +H DL   N  + ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 576 TLATIGYMAP 585
            L  + +M+P
Sbjct: 187 GLLPVRWMSP 196

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 75/174 (43%), Gaps = 12/174 (6%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G   K  R  DG  +  K  +      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 479 CSNEEFKGL--VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCS- 532
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 533 -TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              V+H DLKP+NV LD      L DFG+A++L   D S  +   + T  YM+P
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKA-FVGTPYYMSP 185

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 178

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 183

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +  +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
              +  + +E +  GSL + +    C+ +  + L  +      LEYLH   +  ++H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 176
Query: 541 KPSNVLL-DDNMIAYLSDFGIA 561
           K  NVLL  D   A L DFG A
Sbjct: 177 KADNVLLSSDGSRAALCDFGHA 198

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 10/179 (5%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKS 466
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + + +++       +++F  +VLE   + SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAP 211

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 23/193 (11%)
Query: 412 ATDGFS---------ENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVEC 461
           +TD FS         + +++G G    V     L    E AVK+   Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 462 EIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
           E++   + HRN++++I     E+   LV E M  GS+  H++      ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLS----DFGIAKLLIGEDQSMTQTQ 575
           ASAL++LH   +  + H DLKP N+L +  N ++ +     D G    L G+   ++  +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 576 TLATIG---YMAP 585
            L   G   YMAP
Sbjct: 178 LLTPCGSAEYMAP 190

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 31/158 (19%)
Query: 422 IGRGGFGSVYKARLG-DGMEVAVKVF------NLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +G+V  A  G  G +VA+K         L  +RA++    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 475 VISSCSNEE----FKG--LVLEYMPQ--GSLEKH--LYSTNCILDIFQRLNIMIDVASAL 524
           ++   + +E    F    LV+ +M    G L KH  L        ++Q L         L
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK-------GL 141
Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
            Y+H   +  +IH DLKP N+ ++++    + DFG+A+
Sbjct: 142 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +  +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 136
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
              +  + +E +  GSL + +    C+ +  + L  +      LEYLH   +  ++H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 192
Query: 541 KPSNVLL-DDNMIAYLSDFGIA 561
           K  NVLL  D   A L DFG A
Sbjct: 193 KADNVLLSSDGSRAALCDFGHA 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 10/179 (5%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKS 466
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + + +++       +++F  +VLE   + SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAP 211

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 15/162 (9%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEI 463
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++ + H N+I +     N     L+LE +  G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + YLH   +  + H DLKP N++L D  I      L DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 10/179 (5%)
Query: 411 RATDGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKS 466
           R    +     +G+GGF   Y+    D  EV A KV     L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + + +++       +++F  +VLE   + SL +       + +   R   M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQY 157
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAP 211

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 11/142 (7%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +GRG FG V++ +    G + AVK   L+  R  +   V C  + S R   ++ +  +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
              +  + +E +  GSL + +    C+ +  + L  +      LEYLH   +  ++H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 190
Query: 541 KPSNVLL-DDNMIAYLSDFGIA 561
           K  NVLL  D   A L DFG A
Sbjct: 191 KADNVLLSSDGSRAALCDFGHA 212

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 185

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 15/162 (9%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEI 463
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++ + H N+I +     N     L+LE +  G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + YLH   +  + H DLKP N++L D  I      L DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L      T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 92  VGDELWVVMEFLEGGALTD--IVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 189

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 15/162 (9%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEI 463
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++ + H N+I +     N     L+LE +  G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + YLH   +  + H DLKP N++L D  I      L DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 419 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVI 476
             ++  GGF  VY+A+ +G G E A+K          ++   E   MK +  H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 477 SSCS---------NEEF-------KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
           S+ S           EF       KG ++E++ +      L S + +L IF         
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-SCDTVLKIF------YQT 145
Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
             A++++H     P+IH DLK  N+LL +     L DFG A
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 196

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI---- 476
           +G GG G V+ A   D    VA+K   L   ++ K    E +I++ + H N++KV     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 477 -SSCSNEEFKGLVLE----YMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLH 528
            S     +  G + E    Y+ Q  +E  L +      +L+   RL  M  +   L+Y+H
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIH 137
Query: 529 FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLL 564
              S  V+H DLKP+N+ ++ ++++  + DFG+A+++
Sbjct: 138 ---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD-IFQRLNIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I + I  +++I   V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 184
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 185 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 15/162 (9%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEI 463
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++ + H N+I +     N     L+LE +  G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + YLH   +  + H DLKP N++L D  I      L DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 422 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHR-NLI 473
           +GRG FG V +A      +      VAVK+       +  ++   E +I+  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 474 KVISSCSNEEFKGLVL-EYMPQGSLEKHLYSTNC-----------ILDIFQRLNIMIDVA 521
            ++ +C+      +V+ E+   G+L  +L S               L +   +     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             +E+L    S   IH DL   N+LL +  +  + DFG+A+ +  +   + +      + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 582 YMAP 585
           +MAP
Sbjct: 212 WMAP 215

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 15/162 (9%)
Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEI 463
           +  D +     +G G F  V K R    G+E A K    +  RA +        + E  I
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASA 523
           ++ + H N+I +     N     L+LE +  G L   L     + +  +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDG 127
Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + YLH   +  + H DLKP N++L D  I      L DFG+A
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 71/167 (42%), Gaps = 9/167 (5%)
Query: 422 IGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G G FG V++      G     K  N        +   E  IM  + H  LI +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
           ++    L+LE++  G L   + + +  +   + +N M      L+++H      ++H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 541 KPSNVLLDDNMIAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           KP N++ +    + +   DFG+A  L  ++       T AT  + AP
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAP 219

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 13/171 (7%)
Query: 421 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVIS 477
           ++G+G FG V K +      E AVKV N    +   +  +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +     +V E    G L   +       +      I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 538 CDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLKP N+LL   + +    + DFG++       Q+      + T  Y+AP
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAP 192

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 25/186 (13%)
Query: 422 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHR-NLI 473
           +GRG FG V +A      +      VAVK+       +  ++   E +I+  I H  N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 474 KVISSCSNEEFKGLVL-EYMPQGSLEKHL---------YSTNCILDIFQRLNIMI----D 519
            ++ +C+      +V+ E+   G+L  +L         Y    +   F  L  +I     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           VA  +E+L    S   IH DL   N+LL +  +  + DFG+A+ +  +   + +      
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 580 IGYMAP 585
           + +MAP
Sbjct: 214 LKWMAP 219

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG--SIPDDICRLVELYKLELGGN 192
           NLIT+DL  N L+ + L T  +L+ LQ L+L +NK++   S   DI     L KLEL  N
Sbjct: 127 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 186
Query: 193 KLSRSIPACFNNL-----IALRILSLGSN--DPLPLEIGNLKV----------------- 228
           ++    P CF+ +     + L  + LG +  + L LE+ N  +                 
Sbjct: 187 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 246
Query: 229 --------LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDS 270
                   L  +D S NN + +       L  LEY FL YN +Q L   S
Sbjct: 247 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 296

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 64/163 (39%), Gaps = 6/163 (3%)
Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPL 219
           + L L  NKL         RL +L  L L  NKL +++PA  F  L  L  L +  N   
Sbjct: 40  KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 220 PLEIGNLKVLVG---IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGXXXX 276
            L IG    LV    +    N    + P+    L  L YL LGYN LQ L    F     
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS 158
Query: 277 XXXXXXXXXXXXGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG 319
                            + +KL+ L+ L L  N+L+  +P G 
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 122
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 172

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%)
Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
           +P+E+ N  +L  IDL  N+++     + S + +L  L+L  N+L    P     L  L 
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR 105
Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSN 216
            L L GN +S      FN+L AL  L++G+N
Sbjct: 106 LLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 194

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 122
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 172

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG--SIPDDICRLVELYKLELGGN 192
           NLIT+DL  N L+ + L T  +L+ LQ L+L +NK++   S   DI     L KLEL  N
Sbjct: 132 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 191
Query: 193 KLSRSIPACFNNL-----IALRILSLGSN--DPLPLEIGNLKV----------------- 228
           ++    P CF+ +     + L  + LG +  + L LE+ N  +                 
Sbjct: 192 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 251
Query: 229 --------LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDS 270
                   L  +D S NN + +       L  LEY FL YN +Q L   S
Sbjct: 252 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 301

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 122
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 172

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 122
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 122
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 172

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLRE- 149
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 199

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 11/137 (8%)
Query: 419 NNLIGRGGFGSVYKA---RLGD-----GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR 470
           N  +G+G F  ++K     +GD       EV +KV +   R   +SF     +M  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +L+     C   +   LV E++  GSL+ +L      ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 531 CSTPVIHCDLKPSNVLL 547
               +IH ++   N+LL
Sbjct: 130 EENTLIHGNVCAKNILL 146

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG--SIPDDICRLVELYKLELGGN 192
           NLIT+DL  N L+ + L T  +L+ LQ L+L +NK++   S   DI     L KLEL  N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 193 KLSRSIPACFNNL-----IALRILSLGSN--DPLPLEIGNLKV----------------- 228
           ++    P CF+ +     + L  + LG +  + L LE+ N  +                 
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 229 --------LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDS 270
                   L  +D S NN + +       L  LEY FL YN +Q L   S
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G V  A +    E AV V  +  +RA    ++   E  I   + H N++K    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 13/171 (7%)
Query: 421 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVIS 477
           ++G+G FG V K +      E AVKV N    +   +  +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +     +V E    G L   +       +      I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 538 CDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLKP N+LL   + +    + DFG++       Q+      + T  Y+AP
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAP 192

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +   + +   + T+ YM P
Sbjct: 150 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 13/171 (7%)
Query: 421 LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVIS 477
           ++G+G FG V K +      E AVKV N    +   +  +  E E++K + H N++K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
              +     +V E    G L   +       +      I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 538 CDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLKP N+LL   + +    + DFG++       Q+      + T  Y+AP
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAP 192

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 8/167 (4%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAF---KSFDVECEIMKSIRHRNLIKVISS 478
           +G G  G V  A +    E AV V  +  +RA    ++   E  I K + H N++K    
Sbjct: 14  LGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                 + L LEY   G L   +   +  +           + + + YLH      + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 128
Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 38/205 (18%)
Query: 416 FSENNL-----IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR- 468
           F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++ 
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 469 ------HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--------------- 507
                 H N++ ++ +C++     ++ EY   G L   L                     
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 508 -------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
                  L++   L+    VA  + +L    S   IH D+   NVLL +  +A + DFG+
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 561 AKLLIGEDQSMTQTQTLATIGYMAP 585
           A+ ++ +   + +      + +MAP
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAP 229

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F + + +G G  G V+K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-NIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I +  Q L  + I V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLR-- 140
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 191

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ----CRRAFKSFDVECE--IMKS 466
           D +     +G G F  V K R    G++ A K    +     RR     D+E E  I+K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+ E +  G L   L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           LH   S  + H DLKP N++L D  +      + DFG+A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IG G  G V  A +   G  VAVK  +L+ ++  +    E  IM+  +H N++++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
             +   +V+E++  G+L   +  T+  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAP 316

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 12/170 (7%)
Query: 422 IGRGGFGSV----YKARLGDGMEVAVKVF-NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
              + E    +++E    G L   L      LD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGME-VAVKVFN------LQCRRAFKS 456
           F  ++     D +   +LIGRG +G VY A   +  + VA+K  N      + C+R  + 
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR- 74
Query: 457 FDVECEIMKSIRHRNLIKVISSCSNEE---FKGLVLEYMPQGSLEKHLYSTNCILDIFQR 513
              E  I+  ++   +I++      ++   F  L +      S  K L+ T   L     
Sbjct: 75  ---EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHI 131
Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
             I+ ++     ++H    + +IH DLKP+N LL+ +    + DFG+A+ +  E  +
Sbjct: 132 KTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 18/179 (10%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G GGF  V     L DG   A+K      ++  +    E ++ +   H N++++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 481 NE----EFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            E        L+L +  +G+L    + L      L   Q L +++ +   LE +H   + 
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKL----LIGEDQSMTQTQTLA---TIGYMAP 585
              H DLKP+N+LL D     L D G        + G  Q++T     A   TI Y AP
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 8/176 (4%)
Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRH 469
           D F    +IGRG F  V   ++   G   A+K+ N   +  R     F  E +++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
           R + ++  +  +E +  LV+EY   G L   L      +        + ++  A++ +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH- 179
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                 +H D+KP N+LLD      L+DFG + L +  D ++     + T  Y++P
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSP 232

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 11/171 (6%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKV 475
            +IGRG +  V   RL     + A+KV   +     +  D    E  + +   +   +  
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 476 ISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           + SC   E +   V+EY+  G L  H+     + +   R     +++ AL YLH      
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 130
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+AP
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAP 179

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/175 (21%), Positives = 69/175 (39%), Gaps = 9/175 (5%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           D +  +  +G G FG V++      G   A K          ++   E + M  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H DLKP N++        L   DFG+   L   D   +   T  T  + AP
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAP 325

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 422 IGRGGFGSVYKA------RLGDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHR-NLI 473
           +GRG FG V +A      +      VAVK+       +  ++   E +I+  I H  N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 474 KVISSCSNEEFKGLVL-EYMPQGSLEKHLYSTN----CILDIFQRLNIM-------IDVA 521
            ++ +C+      +V+ E+   G+L  +L S         D+++    +         VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             +E+L    S   IH DL   N+LL +  +  + DFG+A+ +  +   + +      + 
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 582 YMAP 585
           +MAP
Sbjct: 212 WMAP 215

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRN--LIKVIS 477
           IG GG   V++         A+K  NL+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLY-STNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++  +V+E    G+++ + +      +D ++R +   ++  A+  +H      ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           D F   + +G G  G V K +    G+ +A K+ +L+ + A ++  + E +++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD-IFQRLNIMIDVASALEYLHFG 530
           ++    +  ++    + +E+M  GSL++ L     I + I  +++I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLRE- 132
Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YMAP
Sbjct: 133 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAP 182

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 413 TDGFSENNLIGRGGFG----SVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR 468
           TDG+     IG G +      ++KA      E AVK+ +   R   +  ++   +++  +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKA---TNXEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N+I +     + ++  +V E    G L   +       +  +   ++  +   +EYLH
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH 133
Query: 529 FGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAKLLIGED 568
              +  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +IGRG FG V   ++ +   + A+K+ N   +  R     F  E +++ +   + +  +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNI--MIDVASALEYLHFGCS 532
             +  +E    LV++Y   G L   L    + + +   R  I  M+    ++  LH+   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H D+KP NVLLD N    L+DFG + L + +D ++  +  + T  Y++P
Sbjct: 213 ---VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 11/171 (6%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKV 475
            +IGRG +  V   RL     + A+KV   +     +  D    E  + +   +   +  
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 476 ISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           + SC   E +   V+EY+  G L  H+     + +   R     +++ AL YLH      
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 126
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+AP
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXFCGTPNYIAP 175

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK------SFDVECEIMKSIRHRNLIK 474
           +G G F  V K R    G+E A K    +  RA +        + E  I++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +     N     L+LE +  G L   L     + +  +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 535 VIHCDLKPSNVLLDDNMIA----YLSDFGIA 561
           + H DLKP N++L D  I      L DFG+A
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSI--------RH 469
           L+G+GGFG+V+   RL D ++VA+KV   N     +  S  V C +  ++         H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 470 RNLIKVISSCSNEEFKGLVLEY-MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
             +I+++     +E   LVLE  +P   L  ++     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 529 FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGE 567
              S  V+H D+K  N+L+D     A L DFG   LL  E
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 414 DGFSENNLIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRR------AFKSFDVECEIMKS 466
           D +     +G G +G VYKA        VA+K   L+         A +    E  ++K 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89
Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL--NIMIDVASAL 524
           ++HRN+I++ S   +     L+ EY  +  L+K++       D+  R+  + +  + + +
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRVIKSFLYQLINGV 145
Query: 525 EYLHFGCSTPVIHCDLKPSNVLL-----DDNMIAYLSDFGIAK 562
            + H   S   +H DLKP N+LL      +  +  + DFG+A+
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK-----VFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +GRG +G V K R +  G  +AVK     V + + +R     D+    M+++     +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------NIMIDVASALEYLHF 529
             +   E    + +E M   SL+K  Y    ++D  Q +       I + +  ALE+LH 
Sbjct: 72  YGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  VIH D+KPSNVL++      + DFGI+  L+ +   + +        YMAP
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAP 178

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +IGRG FG V   ++ +   + A+K+ N   +  R     F  E +++ +   + +  +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYS-TNCILDIFQRLNI--MIDVASALEYLHFGCS 532
             +  +E    LV++Y   G L   L    + + +   R  I  M+    ++  LH+   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H D+KP NVLLD N    L+DFG + L + +D ++  +  + T  Y++P
Sbjct: 197 ---VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 36/151 (23%)
Query: 449 QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE--KHLYSTNC 506
             +RA++    E  +MK + H+N+I            GL+  + PQ SLE  + +Y    
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNII------------GLLNVFTPQKSLEEFQDVYIVME 109
Query: 507 ILDI-----------FQRLNIMI-DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY 554
           ++D             +R++ ++  +   +++LH   S  +IH DLKPSN+++  +    
Sbjct: 110 LMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLK 166
Query: 555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DFG+A+       S   T  + T  Y AP
Sbjct: 167 ILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 27/188 (14%)
Query: 413 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQ-----C---RRAFKSFDVECEI 463
           +  +S  + +G G FG V+ A   +   EV VK    +     C           +E  I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 464 MKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IM 517
           +  + H N+IKV+    N+ F  LV+E    G            +D   RL+      I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG------LDLFAFIDRHPRLDEPLASYIF 136
Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             + SA+ YL       +IH D+K  N+++ ++    L DFG A  L   ++        
Sbjct: 137 RQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFC 190
Query: 578 ATIGYMAP 585
            TI Y AP
Sbjct: 191 GTIEYCAP 198

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 5/71 (7%)
Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT 574
            + + +  AL YL       VIH D+KPSN+LLD+     L DFGI+  L+ +D++  ++
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRS 184
Query: 575 QTLATIGYMAP 585
              A   YMAP
Sbjct: 185 AGCA--AYMAP 193

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 15/173 (8%)
Query: 420 NLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFD---VECEIMKSIRHRNLIKV 475
            +IGRG +  V   RL     + A+KV   +     +  D    E  + +   +   +  
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 476 ISSCSNEEFK-GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           + SC   E +   V+EY+  G L  H+     + +   R     +++ AL YLH      
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 141
Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAK--LLIGEDQSMTQTQTLATIGYMAP 585
           +I+ DLK  NVLLD      L+D+G+ K  L  G+    T +    T  Y+AP
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSXFCGTPNYIAP 190

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/175 (21%), Positives = 69/175 (39%), Gaps = 9/175 (5%)
Query: 414 DGFSENNLIGRGGFGSVYK-ARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
           D +  +  +G G FG V++      G   A K          ++   E + M  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 533 TPVIHCDLKPSNVLLDDNMIAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H DLKP N++        L   DFG+   L   D   +   T  T  + AP
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAP 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 36/151 (23%)
Query: 449 QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE--KHLYSTNC 506
             +RA++    E  +MK + H+N+I            GL+  + PQ SLE  + +Y    
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNII------------GLLNVFTPQKSLEEFQDVYIVME 109
Query: 507 ILDI-----------FQRLNIMI-DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY 554
           ++D             +R++ ++  +   +++LH   S  +IH DLKPSN+++  +    
Sbjct: 110 LMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLK 166
Query: 555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DFG+A+       S   T  + T  Y AP
Sbjct: 167 ILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 31/179 (17%)
Query: 422 IGRGGFG---SVYKARLGDGMEVAVKVFN------LQCRRAFKSFDVECEIMKSIRHRNL 472
           IG G  G   + Y A L     VA+K  +         +RA++    E  +MK + H+N+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR----ELVLMKXVNHKNI 85
Query: 473 IKVISSCSN----EEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I +++  +     EEF+   LV+E M     +         LD  +   ++  +   +++
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQ----VIQMELDHERMSYLLYQMLXGIKH 141
Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH   S  +IH DLKPSN+++  +    + DFG+A+       S   T  + T  Y AP
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 36/151 (23%)
Query: 449 QCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLE--KHLYSTNC 506
             +RA++    E  +MK + H+N+I            GL+  + PQ SLE  + +Y    
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNII------------GLLNVFTPQKSLEEFQDVYIVME 109
Query: 507 ILDI-----------FQRLNIMI-DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY 554
           ++D             +R++ ++  +   +++LH   S  +IH DLKPSN+++  +    
Sbjct: 110 LMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLK 166
Query: 555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + DFG+A+       S   T  + T  Y AP
Sbjct: 167 ILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	585
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-95
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-73
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-86
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-34
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-64
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-63
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-53
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-48
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-56
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-55
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-49
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-53
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-53
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-49
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-32
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-27
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-36
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-34
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-44
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-43
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-43
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-10
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-41
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-36
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-37
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-19
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-32
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-08
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-30
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-24
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-23
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-16
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-16
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-05
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-28
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-06
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-05
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	4e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  306 bits (785), Expect = 6e-95
 Identities = 117/360 (32%), Positives = 167/360 (46%), Gaps = 18/360 (5%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL-SSITDVRLP 59
           +IP  + N   L  L L  N L GT+P ++ ++S L+ L L  N L G +   +    + 
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY--VK 466

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
            LE L+L  N+ +     S LSNC +L  I LSNN L G +P   IG L  +L   ++ N
Sbjct: 467 TLETLILDFNDLTG-EIPSGLSNCTNLNWISLSNNRLTGEIP-KWIGRLE-NLAILKLSN 523

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
            + +G+IP E+G+  +LI +DL  N  NG+I   + K        +  N + G     I 
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIK 579

Query: 180 RLVELYKLELGGN--KLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDF 234
                 +    GN  +         N L      ++ S            N   ++ +D 
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639

Query: 235 SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS 294
           S N  SG IPKEIG +  L  L LG+N + G IPD  G+L  L  L+LS+N L G IP +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699

Query: 295 LEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPS 354
           +  L+ L +++LS N L G IP  G F  F    F  N  LCG P   +P C  S     
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  254 bits (651), Expect = 1e-75
 Identities = 95/332 (28%), Positives = 142/332 (42%), Gaps = 39/332 (11%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            IP  +G+   L+ LD+  NKL G    AI   + LKLL +  N   G +          
Sbjct: 215 GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-------- 265

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
                                  KSL  + L+ N   G +P    G    +L    +   
Sbjct: 266 --------------------LPLKSLQYLSLAENKFTGEIPDFLSGACD-TLTGLDLSGN 304

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
           +  G +P   G+ + L ++ L  N  +G + + TL K++ L+ L L  N+  G +P+ + 
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364

Query: 180 RL-VELYKLELGGNKLSRSIPA--CFNNLIALRILSLGSND---PLPLEIGNLKVLVGID 233
            L   L  L+L  N  S  I    C N    L+ L L +N     +P  + N   LV + 
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424

Query: 234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA 293
            S N  SG IP  +G L  L  L L  N L+G IP     + +L+ L L  N+L+G IP+
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

Query: 294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
            L   + L  ++LS N+L GEIP+    G   
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPK--WIGRLE 514

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  253 bits (649), Expect = 3e-75
 Identities = 102/330 (30%), Positives = 156/330 (47%), Gaps = 10/330 (3%)

Query: 1   EIPLEI-GNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP 59
           EIP  + G    L  LDL  N   G VP    + S L+ L L  N+ SG L   T +++ 
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343

Query: 60  NLEELVLWGNNFSELNFLSSLSNCK-SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            L+ L L  N FS      SL+N   SL  + LS+N   G +      N  ++L++  + 
Sbjct: 344 GLKVLDLSFNEFSG-ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
           N   TG IP  + N + L+++ L  N L+G+I  +L  L KL+ L L  N LEG IP ++
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFS 235
             +  L  L L  N L+  IP+  +N   L  +SL +N     +P  IG L+ L  +  S
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522

Query: 236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL 295
            N+FSG IP E+G  ++L +L L  N   G IP +           ++ N ++G     +
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYI 578

Query: 296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           +     ++ + + N LE +  R       S
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  249 bits (638), Expect = 1e-73
 Identities = 96/337 (28%), Positives = 153/337 (45%), Gaps = 22/337 (6%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVP--VAIFNVSTLKLLGLQDNSLSGSLSSITDVRL 58
            +        +L  LDL +N L G V    ++ + S LK L +  N+L         ++L
Sbjct: 92  SVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150

Query: 59  PNLEELVLWGNNFS--ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
            +LE L L  N+ S   +        C  L  + +S N + G +    +     +LE   
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD---VSRCV-NLEFLD 206

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
           + + N +  IP  +G+ + L  +D+ GNKL+G     +S   +L+ L +  N+  G IP 
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265

Query: 177 DICRLVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSND---PLPLEIGNLKVLVGI 232
              +   L  L L  NK +  IP         L  L L  N     +P   G+  +L  +
Sbjct: 266 LPLK--SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323

Query: 233 DFSMNNFSGIIPKE-IGGLKNLEYLFLGYNRLQGLIPDSFGNL-ISLKFLNLSNNNLSGA 290
             S NNFSG +P + +  ++ L+ L L +N   G +P+S  NL  SL  L+LS+NN SG 
Sbjct: 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383

Query: 291 IPASLEK--LSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           I  +L +   + L++L L  N   G+IP   +  N S
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPP--TLSNCS 418

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  236 bits (605), Expect = 5e-69
 Identities = 94/332 (28%), Positives = 154/332 (46%), Gaps = 22/332 (6%)

Query: 8   NLQNLEELDLRQNKL---IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
               +  +DL    L      V  ++ +++ L+ L L ++ ++GS+S        +L  L
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK--CSASLTSL 105

Query: 65  VLWGNNFS-ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
            L  N+ S  +  L+SL +C  L  + +S+N LD     +    L+ SLE   +   +++
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSIS 164

Query: 124 GDIPEEI---GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
           G              L  + + GNK++G   + +S+   L+ L +  N     IP  +  
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGD--VDVSRCVNLEFLDVSSNNFSTGIP-FLGD 221

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMN 237
              L  L++ GNKLS       +    L++L++ SN    P+P     LK L  +  + N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279

Query: 238 NFSGIIPKEIGG-LKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-SL 295
            F+G IP  + G    L  L L  N   G +P  FG+   L+ L LS+NN SG +P  +L
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339

Query: 296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAE 327
            K+  L+ L+LSFN+  GE+P   S  N SA 
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPE--SLTNLSAS 369

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  269 bits (690), Expect = 4e-86
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 12/275 (4%)

Query: 78  SSLSNCKSLTVIGLSNNPLDGILP-KTSIGNLSHSLEDFQMHNCN-VTGDIPEEIGNLTN 135
            + +    +  + LS   L    P  +S+ NL   L    +   N + G IP  I  LT 
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 136 LITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS 195
           L  + +    ++G+I   LS+++ L  L    N L G++P  I  L  L  +   GN++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 196 RSIPACFNNLIAL-RILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLK 251
            +IP  + +   L   +++  N     +P    NL  L  +D S N   G      G  K
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK 221

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           N + + L  N L   +    G   +L  L+L NN + G +P  L +L +L  LN+SFN L
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 312 EGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 346
            GEIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  131 bits (333), Expect = 2e-34
 Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 22/160 (13%)

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL 226
           +    G + D   +   +  L+L G  L +  P                   +P  + NL
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP-------------------IPSSLANL 75

Query: 227 KVLVGIDFS-MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN 285
             L  +    +NN  G IP  I  L  L YL++ +  + G IPD    + +L  L+ S N
Sbjct: 76  PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135

Query: 286 NLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
            LSG +P S+  L  L  +    N++ G IP   S+G+FS
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPD--SYGSFS 173

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  211 bits (540), Expect = 7e-64
 Identities = 66/187 (35%), Positives = 98/187 (52%), Gaps = 6/187 (3%)

Query: 402 RTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVEC 461
                ++L  AT+ F    LIG G FG VYK  L DG +VA+K    +  +  + F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 462 EIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN---CILDIFQRLNIMI 518
           E +   RH +L+ +I  C       L+ +YM  G+L++HLY ++     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
             A  L YLH      +IH D+K  N+LLD+N +  ++DFGI+K     DQ+   T    
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 579 TIGYMAP 585
           T+GY+ P
Sbjct: 204 TLGYIDP 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  210 bits (538), Expect = 1e-63
 Identities = 72/189 (38%), Positives = 100/189 (52%), Gaps = 5/189 (2%)

Query: 401 WRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKS-FDV 459
            + FS  EL  A+D FS  N++GRGGFG VYK RL DG  VAVK    +  +  +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 460 ECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---STNCILDIFQRLNI 516
           E E++    HRNL+++   C     + LV  YM  GS+   L     +   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
            +  A  L YLH  C   +IH D+K +N+LLD+   A + DFG+AKL+     +   T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAV 195

Query: 577 LATIGYMAP 585
             TIG++AP
Sbjct: 196 RGTIGHIAP 204

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  201 bits (512), Expect = 8e-57
 Identities = 52/336 (15%), Positives = 108/336 (32%), Gaps = 33/336 (9%)

Query: 2   IPLEIGNLQNLEELDLRQNKLI-GTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
              +    + ++ + +  N L    V  ++  +  L +L    N L G L +        
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG--SEIK 354

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L  L L  N  +E+   +     + +  +  ++N L  I       ++S  +        
Sbjct: 355 LASLNLAYNQITEIPA-NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYN 412

Query: 121 NVTG-------DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG- 172
            +          +        N+ +I+L  N+++       S    L  + L  N L   
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472

Query: 173 ------SIPDDICRLVELYKLELGGNKLSRSIPA--CFNNLIALRILSLGSN--DPLPLE 222
                    ++      L  ++L  NKL+  +        L  L  + L  N     P +
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQ 531

Query: 223 IGNLKVLVGI------DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLIS 276
             N   L G       D   N      P+ I    +L  L +G N ++  + +      +
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPN 588

Query: 277 LKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
           +  L++ +N       + +          L ++K +
Sbjct: 589 ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  199 bits (508), Expect = 2e-56
 Identities = 50/345 (14%), Positives = 102/345 (29%), Gaps = 48/345 (13%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL-SSITDVRLP 59
            +   +  L  L +  +  +  +             +    +      +         L 
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENIC-----EAWENENSEYAQQYKTEDLKWD--NLK 249

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
           +L ++ ++          + L     + +I ++ N                         
Sbjct: 250 DLTDVEVYNCPNLT-KLPTFLKALPEMQLINVACNRGISGEQLKDDWQ------------ 296

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKL-NGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                    +      +  I +G N L    +  +L K++KL  L    N+LEG +P   
Sbjct: 297 ------ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-F 349

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLEIGNLKVLVGIDF 234
              ++L  L L  N+++            +  LS   N     P   +  ++ V+  IDF
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 235 SMNNFSGI-------IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
           S N    +       +        N+  + L  N++     + F     L  +NL  N L
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 288 SG-------AIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           +            + +    L  ++L FNKL   +          
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  192 bits (490), Expect = 9e-54
 Identities = 57/353 (16%), Positives = 119/353 (33%), Gaps = 32/353 (9%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIG----TVPVAIFNVSTLKLLGLQDNSLSGS-LSSITD 55
            +P  IG L  LE L L  +          P  I    + +           + +     
Sbjct: 96  RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR 155

Query: 56  VRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF 115
               +L +  +  +     +   S       T IG  +N +  +    ++  L+  L  F
Sbjct: 156 EDFSDLIKDCINSDPQQ-KSIKKSSRITLKDTQIGQLSNNITFVSK--AVMRLT-KLRQF 211

Query: 116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP 175
            M N     +   E     N         +   +  +    L+ L  + + +      +P
Sbjct: 212 YMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266

Query: 176 DDICRLVELYKLELGGNKL--------SRSIPACFNNLIALRILSLGSND----PLPLEI 223
             +  L E+  + +  N+              A       ++I+ +G N+    P+   +
Sbjct: 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
             +K L  ++   N   G +P   G    L  L L YN++  +  +  G    ++ L+ +
Sbjct: 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385

Query: 284 NNNLSGAIPASLE--KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 334
           +N L   IP   +   +S +  ++ S+N++        +F       F+G  +
Sbjct: 386 HNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDG--KNFDPLDPTPFKGINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  191 bits (487), Expect = 2e-53
 Identities = 52/335 (15%), Positives = 110/335 (32%), Gaps = 22/335 (6%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            + +   +  L L      G VP AI  ++ L++L L  +    +        +      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 65  VLWGNNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
                        F+          +I    N             ++         + N+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
           T  + + +  LT L    +G +      +    + +  +       +   +       L 
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLK 249

Query: 183 ELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-----------PLPLEIGNLKVLVG 231
           +L  +E+        +P     L  ++++++  N                +    + +  
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 232 IDFSMNNF-SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA 290
           I    NN  +  +   +  +K L  L   YN+L+G +P +FG+ I L  LNL+ N ++  
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368

Query: 291 IPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
                     +E+L+ + NKL+  IP      + S
Sbjct: 369 PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  177 bits (451), Expect = 2e-48
 Identities = 51/312 (16%), Positives = 96/312 (30%), Gaps = 32/312 (10%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +   +  ++ L  L+   N+L G +P A  +   L  L L  N ++   ++        
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCG-FTEQ 378

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT------SIGNLSHSLED 114
           +E L    N    +  +    +   ++ I  S N +  +  K       +      ++  
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI-NVSS 437

Query: 115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG-------SILITLSKLQKLQGLVLDD 167
             + N  ++    E     + L +I+L GN L                    L  + L  
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497

Query: 168 NKLEGSIPDDI--CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN--------- 216
           NKL   + DD     L  L  ++L  N  S   P    N   L+   + +          
Sbjct: 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 217 DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLIS 276
              P  I     L  +    N+   +  ++I    N+  L +  N    +        I 
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRKV-NEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612

Query: 277 LKFLNLSNNNLS 288
                L  +   
Sbjct: 613 AGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  139 bits (353), Expect = 3e-35
 Identities = 37/236 (15%), Positives = 75/236 (31%), Gaps = 14/236 (5%)

Query: 98  GILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG----SILIT 153
           G  P  S+ +    +    +     +G +P+ IG LT L  + LG +             
Sbjct: 70  GAQPGVSLNSNGR-VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128

Query: 154 LSKLQKLQGLVLDDNKLEGSIPDDICRLV--ELYKLELGGNKLSRSIPACFNNLIALRIL 211
           +S     +         + +  D   R    +L K  +  +   +SI       +    +
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

Query: 212 SLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD 269
              SN+   +   +  L  L       + F      E    +N EY      +       
Sbjct: 189 GQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDL 243

Query: 270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
            + NL  L  + + N      +P  L+ L  ++ +N++ N+          +   +
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 14/115 (12%), Positives = 29/115 (25%), Gaps = 7/115 (6%)

Query: 235 SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG----A 290
            ++ +       +     +  L L      G +PD+ G L  L+ L L ++         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 291 IPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS---AESFEGNELLCGSPNLQ 342
            P  +      E         +          +FS    +    +          
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  190 bits (484), Expect = 7e-56
 Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 16/196 (8%)

Query: 402 RTFSYLELCRATDGFSE------NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRA-- 453
            +FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 454 --FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN--CILD 509
              + FD E ++M   +H NL++++   S+ +   LV  YMP GSL   L   +    L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
              R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 570 SMTQTQTLATIGYMAP 585
           ++  ++ + T  YMAP
Sbjct: 189 TVMTSRIVGTTAYMAP 204

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  200 bits (510), Expect = 2e-55
 Identities = 59/381 (15%), Positives = 121/381 (31%), Gaps = 48/381 (12%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIG---------TVPVAIFNVSTLKLLGLQDNSLSGSLS 51
           ++P  + +L  L+ L++  N+ I           +         +++  +  N+L    +
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565

Query: 52  SITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHS 111
           S +  ++  L  L    N    L    +      LT + L  N ++ I         +  
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRHL---EAFGTNVKLTDLKLDYNQIEEIPE--DFCAFTDQ 620

Query: 112 LEDFQMHNCNVTGDIPE--EIGNLTNLITIDLGGNKL-----NGSILITLSKLQKLQGLV 164
           +E     +  +   IP      ++  + ++D   NK+     N S  +   K      + 
Sbjct: 621 VEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLS-------RSIPACFNNLIALRILSLGSND 217
           L  N+++    +       +  + L  N ++       +     + N   L  + L  N 
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 218 ----PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYL------FLGYNRLQGLI 267
                       L  L  +D S N FS   P +      L+            NR+    
Sbjct: 740 LTSLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798

Query: 268 PDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAE 327
           P       SL  L + +N++   +   L     L  L+++ N     I          A 
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAG 854

Query: 328 ----SFEGNELLCGSPNLQVP 344
                ++  + + G   L + 
Sbjct: 855 MYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  181 bits (461), Expect = 7e-49
 Identities = 56/340 (16%), Positives = 112/340 (32%), Gaps = 30/340 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P  IG L  L+ L    +    +  +      T  +   + + +      +       
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

Query: 61  LEELVLWGNNFSELNFLSSLSN----CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
           L    L  +  +    +  +          T IG   N +  I    +I  L+  L+   
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISK--AIQRLT-KLQIIY 454

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             N   T D         +    +    K   +  ++ S L+ L  + L +      +PD
Sbjct: 455 FANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509

Query: 177 DICRLVELYKLELGGNKLS---------RSIPACFNNLIALRILSLGSND----PLPLEI 223
            +  L EL  L +  N+             +    +    ++I  +G N+    P    +
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
             +  L  +D   N    +  +  G    L  L L YN+++ +  D       ++ L  S
Sbjct: 570 QKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFS 627

Query: 284 NNNLSGAIP--ASLEKLSYLEDLNLSFNKLEGEIPRGGSF 321
           +N L   IP   + + +  +  ++ S+NK+  E       
Sbjct: 628 HNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  178 bits (453), Expect = 6e-48
 Identities = 53/342 (15%), Positives = 99/342 (28%), Gaps = 44/342 (12%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            I   I  L  L+ +    +       +A+           Q  +   S S      L +
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENEELSWS-----NLKD 492

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L ++ L+            L +   L  + ++ N         +                
Sbjct: 493 LTDVELYNCPNMT-QLPDFLYDLPELQSLNIACNRGISAAQLKADWT------------- 538

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
                + ++      +    +G N L       +L K+ KL  L    NK+     +   
Sbjct: 539 ----RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFG 592

Query: 180 RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLEIGNLKVLVGIDFS 235
             V+L  L+L  N++             +  L    N     P      ++ V+  +DFS
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652

Query: 236 MNNFSGIIPK-----EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS-- 288
            N             +     N   + L YN +Q    + F     +  + LSNN ++  
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712

Query: 289 -----GAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
                     + +    L  ++L FNKL   +          
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (313), Expect = 6e-30
 Identities = 47/275 (17%), Positives = 89/275 (32%), Gaps = 16/275 (5%)

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLD--GILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
           +     + S   N    ++    N  LD  G  P   + N    +    +      G +P
Sbjct: 282 DGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR-VTGLSLAGFGAKGRVP 340

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI----CRLVE 183
           + IG LT L  +  G +    S  +   +           +++             RL  
Sbjct: 341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLEIGNLKVLVGIDFSMNNF 239
              L+   N+     P   ++ I+L+   +G+       +   I  L  L  I F+ + F
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
           +           + E     Y +       S+ NL  L  + L N      +P  L  L 
Sbjct: 461 TYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515

Query: 300 YLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 334
            L+ LN++ N+          +   + +   G ++
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 11/77 (14%), Positives = 24/77 (31%)

Query: 259 GYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
             +           N   +  L+L+     G +P ++ +L+ L+ L+   +         
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 319 GSFGNFSAESFEGNELL 335
           G        S E    +
Sbjct: 367 GDEELTPDMSEERKHRI 383

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  192 bits (489), Expect = 3e-53
 Identities = 77/346 (22%), Positives = 131/346 (37%), Gaps = 23/346 (6%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
                     L  LD+  N +    P     +  LK+L LQ N LS  LS  T     NL
Sbjct: 41  PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNL 99

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
            EL L  N+  ++   +     K+L  + LS+N L       +   L  +L++  + N  
Sbjct: 100 TELHLMSNSIQKIKN-NPFVKQKNLITLDLSHNGLSST-KLGTQVQLE-NLQELLLSNNK 156

Query: 122 VTGDIPEEIG--NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
           +     EE+     ++L  ++L  N++          + +L GL L++ +L  S+ + +C
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216

Query: 180 RLVELYKLE---LGGNKLSRSIPACFNNL--IALRILSLGSN---DPLPLEIGNLKVLVG 231
             +    +    L  ++LS +    F  L    L +L L  N            L  L  
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276

Query: 232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYN---------RLQGLIPDSFGNLISLKFLNL 282
                NN   +    + GL N+ YL L  +          L  +   SF  L  L+ LN+
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAES 328
            +N++ G        L  L+ L+LS +          +F + +   
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  191 bits (487), Expect = 5e-53
 Identities = 71/349 (20%), Positives = 117/349 (33%), Gaps = 26/349 (7%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSG---SLSSITDVRL 58
                  L+ LE L++  N + G        +  LK L L ++  S    +  +   +  
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH 380

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
             L  L L  N  S++    + S    L V+ L  N +   L       L  ++ +  + 
Sbjct: 381 SPLHILNLTKNKISKIE-SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLS 438

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNG--SILITLSKLQKLQGLVLDDNKLEGSIPD 176
                         + +L  + L    L    S       L+ L  L L +N +     D
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

Query: 177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM 236
            +  L +L  L+L  N L+R                          +  L  L  ++   
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGP-------------IYFLKGLSHLHILNLES 545

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           N F  I  +    L  L+ + LG N L  L    F N +SLK LNL  N ++        
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG 605

Query: 297 K-LSYLEDLNLSFNKLEGEIPRGGSFGNFSAES-----FEGNELLCGSP 339
                L +L++ FN  +        F N+  E+        +  LC +P
Sbjct: 606 PAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  181 bits (461), Expect = 2e-49
 Identities = 82/331 (24%), Positives = 129/331 (38%), Gaps = 18/331 (5%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
           + E  D    KL   VP  +   + + +L L  N L   L +    R   L  L +  N 
Sbjct: 5   SHEVADCSHLKL-TQVPDDLP--TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNT 60

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
            S+L           L V+ L +N L  +    +    + +L +  + + ++        
Sbjct: 61  ISKLE-PELCQKLPMLKVLNLQHNELSQL-SDKTFAFCT-NLTELHLMSNSIQKIKNNPF 117

Query: 131 GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI--CRLVELYKLE 188
               NLIT+DL  N L+ + L T  +L+ LQ L+L +NK++    +++       L KLE
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177

Query: 189 LGGNKLSRSIPACFNNLIALRILSLGSN------DPLPLEIGNLKVLVGIDFSMNNFSGI 242
           L  N++    P CF+ +  L  L L +                   +  +  S +  S  
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237

Query: 243 IPKEIGGLK--NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY 300
                 GLK  NL  L L YN L  +  DSF  L  L++  L  NN+      SL  L  
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297

Query: 301 LEDLNLSFNKLEGEIPRGGSFGNFSAESFEG 331
           +  LNL  +  +  I    S       SF+ 
Sbjct: 298 VRYLNLKRSFTKQSIS-LASLPKIDDFSFQW 327

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  131 bits (332), Expect = 2e-32
 Identities = 68/331 (20%), Positives = 110/331 (33%), Gaps = 32/331 (9%)

Query: 2   IPLEIGNLQNLEELDLRQNKL-IGTVPVAIF---NVSTLKLLGLQDNSLSGSLSSITDVR 57
                  L NL+ L L  +   + T+    F     S L +L L  N +S  + S     
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSW 403

Query: 58  LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQM 117
           L +LE L L  N   +          +++  I LS N    +  + S   +  SL+   +
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL-TRNSFALVP-SLQRLML 461

Query: 118 HNCNVTG--DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE---- 171
               +      P     L NL  +DL  N +       L  L+KL+ L L  N L     
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521

Query: 172 ----GSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIG 224
               G     +  L  L+ L L  N         F +L  L+I+ LG N           
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIG-GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
           N   L  ++   N  + +  K  G   +NL  L + +N               + ++N +
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF---VNWINET 638

Query: 284 NNNLSG-------AIPASLEKLSYLEDLNLS 307
           + N+           P        +   + S
Sbjct: 639 HTNIPELSSHYLCNTPPHYHGFP-VRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  117 bits (294), Expect = 1e-27
 Identities = 44/192 (22%), Positives = 70/192 (36%), Gaps = 24/192 (12%)

Query: 134 TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNK 193
            +    D    KL   +   L     +  L L  N+L      +  R  +L  L++G N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 194 LSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNL 253
           +S+  P     L  L++L+L                       N  S +  K      NL
Sbjct: 61  ISKLEPELCQKLPMLKVLNL---------------------QHNELSQLSDKTFAFCTNL 99

Query: 254 EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG 313
             L L  N +Q +  + F    +L  L+LS+N LS     +  +L  L++L LS NK++ 
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159

Query: 314 EIPRGGSFGNFS 325
                      S
Sbjct: 160 LKSEELDIFANS 171

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.5 bits (181), Expect = 7e-14
 Identities = 33/176 (18%), Positives = 59/176 (33%), Gaps = 21/176 (11%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
             P     L+NL  LDL  N +       +  +  L++L LQ N+L+             
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------------- 517

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
                LW +       +  L     L ++ L +N  D I P     +L   L+   +   
Sbjct: 518 ----RLWKHANPGGP-IYFLKGLSHLHILNLESNGFDEI-PVEVFKDL-FELKIIDLGLN 570

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSK-LQKLQGLVLDDNKLEGSIP 175
           N+         N  +L +++L  N +            + L  L +  N  + +  
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  167 bits (426), Expect = 2e-47
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 15/193 (7%)

Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEI 463
                L   +       +  RG FG V+KA+L     VAVK+F +Q +++++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 464 MKSIRHRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID 519
           +  ++H N+++ I +            L+  +  +GSL   L +   ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 520 VASALEYLH------FGCSTP-VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           +A  L YLH           P + H D+K  NVLL +N+ A ++DFG+A        +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 573 QTQTLATIGYMAP 585
               + T  YMAP
Sbjct: 190 THGQVGTRRYMAP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  165 bits (421), Expect = 6e-47
 Identities = 54/168 (32%), Positives = 86/168 (51%), Gaps = 8/168 (4%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG G FG+V++A    G +VAVK+   Q         F  E  IMK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +      +V EY+ +GSL + L+ +     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            +LK  N+L+D      + DFG+++L      S        T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAP 208

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  164 bits (418), Expect = 5e-46
 Identities = 78/309 (25%), Positives = 135/309 (43%), Gaps = 24/309 (7%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            I  L NLE L+L  N++  T    + N+  L  L +  N ++  +S++ +  L NL EL
Sbjct: 61  GIEYLTNLEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKIT-DISALQN--LTNLREL 115

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L  +N S++   S L+N   +  + L  N     L    + N++  L    +    V  
Sbjct: 116 YLNEDNISDI---SPLANLTKMYSLNLGANHNLSDLS--PLSNMT-GLNYLTVTESKVKD 169

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
                I NLT+L ++ L  N++    +  L+ L  L       N++    P  +  +  L
Sbjct: 170 --VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGII 243
             L++G NK++   P    NL  L  L +G+N    +  + +L  L  ++   N  S I 
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDIS 281

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
              +  L  L  LFL  N+L     +  G L +L  L LS N+++   P  L  LS ++ 
Sbjct: 282 V--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337

Query: 304 LNLSFNKLE 312
            + +   ++
Sbjct: 338 ADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (407), Expect = 2e-44
 Identities = 72/317 (22%), Positives = 137/317 (43%), Gaps = 28/317 (8%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            +    L+++ +L +   K + ++   I  ++ L+ L L  N ++  +S ++   L  L 
Sbjct: 37  VVTQEELESITKLVVAGEK-VASIQ-GIEYLTNLEYLNLNGNQIT-DISPLS--NLVKLT 91

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L +  N  +++   S+L N  +L  + L+ + +  I P   + NL+  +    +   + 
Sbjct: 92  NLYIGTNKITDI---SALQNLTNLRELYLNEDNISDISP---LANLT-KMYSLNLGANHN 144

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
             D+   + N+T L  + +  +K+    +  ++ L  L  L L+ N++E   P  +  L 
Sbjct: 145 LSDL-SPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLT 199

Query: 183 ELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFSMNNF 239
            L+      N+++   P    N+  L  L +G+N   D  PL   NL  L  ++   N  
Sbjct: 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQI 255

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
           S I    +  L  L+ L +G N++  +      NL  L  L L+NN L       +  L+
Sbjct: 256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 300 YLEDLNLSFNKLEGEIP 316
            L  L LS N +    P
Sbjct: 312 NLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  155 bits (395), Expect = 1e-42
 Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 26/313 (8%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
             +L       L++  +   V      + ++  L +    ++ S+  I    L NLE L 
Sbjct: 18  DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQGIEY--LTNLEYLN 72

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
           L GN  ++   +S LSN   LT + +  N +  I   +++ NL+ +L +  ++  N++  
Sbjct: 73  LNGNQITD---ISPLSNLVKLTNLYIGTNKITDI---SALQNLT-NLRELYLNEDNISD- 124

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
               + NLT + +++LG N    S L  LS +  L  L + ++K++   P  I  L +LY
Sbjct: 125 -ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLY 180

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIP 244
            L L  N++    P    +L +L   +   N    +  + N+  L  +    N  + + P
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP 238

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
             +  L  L +L +G N++  +  ++  +L  LK LN+ +N +S    + L  LS L  L
Sbjct: 239 --LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292

Query: 305 NLSFNKLEGEIPR 317
            L+ N+L  E   
Sbjct: 293 FLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  138 bits (351), Expect = 1e-36
 Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 24/279 (8%)

Query: 36  LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNP 95
              L      ++       D  L      VL   + ++   + +    +S+T + ++   
Sbjct: 2   AATLATLPAPIN---QIFPDADLAEGIRAVLQKASVTD---VVTQEELESITKLVVAGEK 55

Query: 96  LDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLS 155
           +  I     I  L+ +LE   ++   +T      + NL  L  + +G NK+  + +  L 
Sbjct: 56  VASI---QGIEYLT-NLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQ 107

Query: 156 KLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS 215
            L  L+ L L+++ +    P  +  L ++Y L LG N     +    +N+  L  L++  
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTE 164

Query: 216 NDPLPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL 274
           +    +  I NL  L  +  + N    I P  +  L +L Y     N++  + P    N+
Sbjct: 165 SKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 275 ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG 313
             L  L + NN ++   P  L  LS L  L +  N++  
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  111 bits (279), Expect = 7e-27
 Identities = 42/216 (19%), Positives = 91/216 (42%), Gaps = 18/216 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
                + N+  L  L + ++K+       I N++ L  L L  N +   +S +    L +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIE-DISPLAS--LTS 200

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L     + N  ++   ++ ++N   L  + + NN +  +   + + NLS  L   ++   
Sbjct: 201 LHYFTAYVNQITD---ITPVANMTRLNSLKIGNNKITDL---SPLANLS-QLTWLEIGTN 253

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
            ++      + +LT L  +++G N+++   +  L+ L +L  L L++N+L     + I  
Sbjct: 254 QISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN 216
           L  L  L L  N ++   P    +L  +      + 
Sbjct: 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 35/192 (18%), Positives = 80/192 (41%), Gaps = 16/192 (8%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            I NL +L  L L  N++       + ++++L       N ++  ++ + +  +  L  L
Sbjct: 172 PIANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQIT-DITPVAN--MTRLNSL 226

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            +  N  ++L   S L+N   LT + +  N +  I    ++ +L+  L+   + +  ++ 
Sbjct: 227 KIGNNKITDL---SPLANLSQLTWLEIGTNQISDI---NAVKDLT-KLKMLNVGSNQISD 279

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
                + NL+ L ++ L  N+L    +  +  L  L  L L  N +    P  +  L ++
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335

Query: 185 YKLELGGNKLSR 196
              +     + +
Sbjct: 336 DSADFANQVIKK 347

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  162 bits (413), Expect = 1e-45
 Identities = 58/320 (18%), Positives = 108/320 (33%), Gaps = 24/320 (7%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
              +    E L  + +  +      +      +     D +   S     +    N +  
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQ---WQRHYNADRNRWHSAWRQAN--SNNPQIE 61

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
              G        L   +       + L + PL    P      LSH L+   +    +  
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-QAFRLSH-LQHMTIDAAGLM- 117

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR---- 180
           ++P+ +     L T+ L  N L  ++  +++ L +L+ L +        +P+ +      
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 181 -----LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGID 233
                LV L  L L    + RS+PA   NL  L+ L + ++    L   I +L  L  +D
Sbjct: 177 GEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELD 235

Query: 234 FSMNNFSGIIPKEIGGLKNLEYLFL-GYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
                     P   GG   L+ L L   + L  L P     L  L+ L+L        +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 293 ASLEKLSYLEDLNLSFNKLE 312
           + + +L     + +  +   
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  130 bits (329), Expect = 9e-34
 Identities = 57/301 (18%), Positives = 100/301 (33%), Gaps = 42/301 (13%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
                +   Q     D  +            N +  ++      +L  +   + D   P 
Sbjct: 27  PYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKATADLLEDATQPG 82

Query: 61  LEELVLWGNNFSEL-----------------NFLSSL----SNCKSLTVIGLSNNPLDGI 99
              L L      +                    L  L         L  + L+ NPL   
Sbjct: 83  RVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-A 141

Query: 100 LPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGN---------LTNLITIDLGGNKLNGSI 150
           LP  SI +L+  L +  +  C    ++PE + +         L NL ++ L    +  S+
Sbjct: 142 LPA-SIASLN-RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SL 198

Query: 151 LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRI 210
             +++ LQ L+ L + ++ L  ++   I  L +L +L+L G    R+ P  F     L+ 
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 211 LSLGSNDP---LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI 267
           L L        LPL+I  L  L  +D         +P  I  L     + +  +    L 
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 268 P 268
            
Sbjct: 318 Q 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  160 bits (407), Expect = 1e-44
 Identities = 62/201 (30%), Positives = 83/201 (41%), Gaps = 25/201 (12%)

Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEI 463
            +  E     D      LIGRG +G+VYK  L D   VAVKVF+   R+ F +   E  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNI 58

Query: 464 MK--SIRHRNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
            +   + H N+ + I         G     LV+EY P GSL K+L       D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116

Query: 517 MIDVASALEYLH------FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
              V   L YLH            + H DL   NVL+ ++    +SDFG++  L G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 571 MTQTQTLA------TIGYMAP 585
               +  A      TI YMAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (400), Expect = 2e-44
 Identities = 36/169 (21%), Positives = 72/169 (42%), Gaps = 14/169 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +     G ++K R   G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 480 SNEEFKGL--VLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            +        +  +MP GSL   L+      +D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              L   +V++D++M A +S   +         S      +    ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP 177

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  163 bits (414), Expect = 2e-43
 Identities = 78/348 (22%), Positives = 131/348 (37%), Gaps = 23/348 (6%)

Query: 4   LEIGNLQNLEELDLRQNKL--IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           L+   +Q+L            I           +++ + LQ +    ++SS T      L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF-NISSNTFHCFSGL 280

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQM-HNC 120
           +EL L   + SEL   S L    +L  + LS N  + +  + S  N   SL    +  N 
Sbjct: 281 QELDLTATHLSELP--SGLVGLSTLKKLVLSANKFENL-CQISASNFP-SLTHLSIKGNT 336

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILI--TLSKLQKLQGLVLDDNKLEGSIPDDI 178
                    + NL NL  +DL  + +  S      L  L  LQ L L  N+      +  
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396

Query: 179 CRLVELYKLELGGNKLSRSIP-ACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDF 234
               +L  L+L   +L      + F NL  L++L+L  +            L  L  ++ 
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456

Query: 235 SMNNFSGIIPKEIG---GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI 291
             N+F     ++      L  LE L L +  L  +   +F +L  +  ++LS+N L+ + 
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516

Query: 292 PASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAES---FEGNELLC 336
             +L  L  +  LNL+ N +   +P        S +       N L C
Sbjct: 517 IEALSHLKGIY-LNLASNHISIILP--SLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  161 bits (410), Expect = 6e-43
 Identities = 65/332 (19%), Positives = 114/332 (34%), Gaps = 16/332 (4%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
                  L NL  LDL + ++         +   L  L L  N L   ++         L
Sbjct: 49  QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALSGPKAL 107

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           + L       S ++F   L N K+L  + L +N +  I            L+     N  
Sbjct: 108 KHLFFIQTGISSIDF-IPLHNQKTLESLYLGSNHISSI-KLPKGFPTE-KLKVLDFQNNA 164

Query: 122 VTGDIPEEIGNLTNL--ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI- 178
           +     E++ +L     ++++L GN +   I          Q L     +    I   + 
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223

Query: 179 -CRLVELYKLELGGNKLSRSIPACFNNL--IALRILSLGSN---DPLPLEIGNLKVLVGI 232
              +  L+             PA F  L  +++  ++L  +   +           L  +
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI- 291
           D +  + S + P  + GL  L+ L L  N+ + L   S  N  SL  L++  N     + 
Sbjct: 284 DLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

Query: 292 PASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
              LE L  L +L+LS + +E          N
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  160 bits (408), Expect = 1e-42
 Identities = 62/326 (19%), Positives = 105/326 (32%), Gaps = 15/326 (4%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           EIP  +    + E L+   N L          +  L  L L    +   +   T      
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHR 82

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L+ LVL  N    +   ++LS  K+L  +      +  I     + N   +LE   + + 
Sbjct: 83  LDTLVLTANPLIFMA-ETALSGPKALKHLFFIQTGISSI-DFIPLHNQK-TLESLYLGSN 139

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE-GSIPDDIC 179
           +++     +      L  +D   N ++      +S LQ+   L L+ N  +   I     
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199

Query: 180 RLVELYKLELGGNKLSRSIPA--CFNNLIALRILSLGSN-----DPLPLEIGNLKVLVGI 232
                  L  GG +    I      + + +L + +          P   E      +  I
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
           +   + F  I          L+ L L    L   +P     L +LK L LS N       
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQ 318

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRG 318
            S      L  L++  N    E+  G
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  138 bits (349), Expect = 8e-35
 Identities = 45/278 (16%), Positives = 94/278 (33%), Gaps = 12/278 (4%)

Query: 49  SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL 108
            L+ I      + E L    N    +   ++ S   +LT + L+   +  I  + +  + 
Sbjct: 23  GLNEIPGTLPNSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWI-HEDTFQSQ 80

Query: 109 SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
              L+   +    +       +     L  +      ++    I L   + L+ L L  N
Sbjct: 81  HR-LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

Query: 169 KLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLEIG 224
            +            +L  L+   N +        ++L     LSL  N      +     
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGG--LKNLEYLFLGYNRLQGLIPDSFGNL--ISLKFL 280
           +  V   ++F       +I K +    +++L          + + P  F  L  +S++ +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
           NL  +        +    S L++L+L+   L  E+P G
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  128 bits (325), Expect = 1e-31
 Identities = 66/316 (20%), Positives = 111/316 (35%), Gaps = 31/316 (9%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           E+P  +  L  L++L L  NK      ++  N  +L  L ++ N+    L +     L N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351

Query: 61  LEELVLWGNNFSELNFLS-SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
           L EL L  ++    +  +  L N   L  + LS N    +    +       LE   +  
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL-KTEAFKECP-QLELLDLAF 409

Query: 120 CNVTGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSI---P 175
             +     +    NL  L  ++L  + L+ S       L  LQ L L  N          
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

Query: 176 DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGI 232
           + +  L  L  L L    LS      F +L  +  + L  N         + +LK +  +
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQG----------------LIPDS----FG 272
           + + N+ S I+P  +  L     + L  N L                   + D+      
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCE 588

Query: 273 NLISLKFLNLSNNNLS 288
           N   L+ + LS+  LS
Sbjct: 589 NPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  115 bits (289), Expect = 3e-27
 Identities = 50/267 (18%), Positives = 82/267 (30%), Gaps = 32/267 (11%)

Query: 91  LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSI 150
             N  L+ I      G L +S E  +     +          L NL  +DL   ++    
Sbjct: 19  CENLGLNEI-----PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 151 LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRI 210
             T     +L  LVL  N L       +     L  L      +S       +N   L  
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 211 LSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDS 270
           L L                       N+ S I   +    + L+ L    N +  L  + 
Sbjct: 134 LYL---------------------GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172

Query: 271 FGNLISLK--FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSA-- 326
             +L       LNL+ N+++G I       +  + LN    +    I +G       +  
Sbjct: 173 MSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231

Query: 327 -ESFEGNELLCGSPNLQVPPCKTSIHH 352
             +FE  +    SP +    C+ S+  
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVES 258

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  155 bits (395), Expect = 2e-43
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQC-------RRAFKSFDVECEIMKSIRHRNLI 473
           IG+GGFG V+K R + D   VA+K   L            F+ F  E  IM ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K+     N     +V+E++P G L   L      +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 534 PVIHCDLKPSNVLLD-----DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           P++H DL+  N+ L        + A ++DFG+++         + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (413), Expect = 2e-43
 Identities = 55/311 (17%), Positives = 91/311 (29%), Gaps = 33/311 (10%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            ++   L N+  + L    +       +      + L +    L         + LP L+
Sbjct: 278 IVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK----QFPTLDLPFLK 331

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L L  N     +         SL+ + LS N L      +     ++SL    +     
Sbjct: 332 SLTLTMNK---GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
              +      L  L  +D   + L           L+KL  L +     +         L
Sbjct: 389 I-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447

Query: 182 VELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS 240
             L  L++ GN    +  +  F N   L  L L                     S     
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL---------------------SKCQLE 486

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY 300
            I       L  L+ L + +N L  L    +  L SL  L+ S N +  +          
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS 546

Query: 301 LEDLNLSFNKL 311
           L   NL+ N +
Sbjct: 547 LAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  152 bits (386), Expect = 1e-39
 Identities = 65/345 (18%), Positives = 113/345 (32%), Gaps = 30/345 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSG--SLSSITDVR 57
            I  +      L EL LR N     +      N++ L +  L         +L       
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 58  LPNLEELVLWGNNFSELNFLS----SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH--- 110
           +  L ++ +     +  N  S          +++ + L+   +  +              
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314

Query: 111 ------SLEDFQMHNCNV------TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ 158
                       +            G I  +   L +L  +DL  N L+ S   + S L 
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374

Query: 159 --KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGS 215
              L+ L L  N     +  +   L EL  L+   + L R      F +L  L  L +  
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433

Query: 216 ND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSF 271
            +           L  L  +  + N+F       +     NL +L L   +L+ +    F
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493

Query: 272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
             L  L+ LN+S+NNL     +   +L  L  L+ SFN++E    
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  142 bits (360), Expect = 3e-36
 Identities = 68/325 (20%), Positives = 108/325 (33%), Gaps = 21/325 (6%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
                  L +L  L L  N +    P +   +++L+ L   +  L+ SL S    +L  L
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITL 130

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT--SIGNLSHSLEDFQMHN 119
           ++L +  N        +  SN  +L  + LS N +  I       +           M  
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSI-------LITLSKLQKLQGLVLDDNKLEG 172
             +   I ++      L  + L GN  + +I       L  L   + + G   D+  LE 
Sbjct: 191 NPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 173 SIPDDICRLVELYKLEL--GGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG-NLKVL 229
             P  +  L ++   E               F+ L  +  +SL       LE        
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309

Query: 230 VGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG 289
             +                 L  L+ L L  N+    I      L SL +L+LS N LS 
Sbjct: 310 QSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSF 364

Query: 290 AIPASLEKLSY--LEDLNLSFNKLE 312
           +   S   L    L  L+LSFN   
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  136 bits (344), Expect = 4e-34
 Identities = 71/336 (21%), Positives = 126/336 (37%), Gaps = 29/336 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           ++P +I +  + + +DL  N L      +  N S L+ L L    +  ++       L +
Sbjct: 25  KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHH 81

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L  L+L GN     +   S S   SL  +      L  +     IG L  +L+   + + 
Sbjct: 82  LSNLILTGNPIQSFS-PGSFSGLTSLENLVAVETKLASL-ESFPIGQL-ITLKKLNVAHN 138

Query: 121 NVTG-DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG----LVLDDNKLEGSIP 175
            +    +P    NLTNL+ +DL  N +    +  L  L++       L +  N ++  I 
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQ 197

Query: 176 DDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSN---DPLPLEIGNLKVLVG 231
           D   + ++L++L L GN  S +I   C  NL  L +  L      D   LEI    ++ G
Sbjct: 198 DQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG 257

Query: 232 --------IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
                      +  N       +   L N+  + L    ++ L  +        + L++ 
Sbjct: 258 LCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSII 315

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG 319
              L          L +L+ L L+ NK      +  
Sbjct: 316 RCQLKQFPTLD---LPFLKSLTLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  121 bits (306), Expect = 2e-29
 Identities = 47/245 (19%), Positives = 82/245 (33%), Gaps = 16/245 (6%)

Query: 78  SSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI 137
             +    ++T     +  L  +       ++  S ++  +    +         N + L 
Sbjct: 6   PCIEVVPNITYQ-CMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59

Query: 138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRS 197
            +DL   ++          L  L  L+L  N ++   P     L  L  L     KL+  
Sbjct: 60  WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119

Query: 198 IPACFNNLIALRILSLGSN----DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNL 253
                  LI L+ L++  N      LP    NL  LV +D S N    I   ++  L+  
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179

Query: 254 ----EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-SLEKLSYLEDLNLSF 308
                 L +  N +  +   +F  +  L  L L  N  S  I    L+ L+ L    L  
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238

Query: 309 NKLEG 313
            + + 
Sbjct: 239 GEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  110 bits (277), Expect = 1e-25
 Identities = 49/290 (16%), Positives = 88/290 (30%), Gaps = 74/290 (25%)

Query: 1   EIPLEIGNLQNLEELDLRQNKL--IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRL 58
            I  +   L +L  LDL +N L   G    +    ++L+ L L  N      ++     L
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMG--L 398

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
             L+ L    +    +   S+  + + L  + +S                          
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID------------------- 439

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                         LT+L T+ + GN    + L                        +  
Sbjct: 440 -------FDGIFLGLTSLNTLKMAGNSFKDNTL-----------------------SNVF 469

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN 238
                L  L+L   +L +     F+ L  L++L++                     S NN
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM---------------------SHNN 508

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
              +       L +L  L   +NR++           SL F NL+NN+++
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 97.8 bits (244), Expect = 1e-21
 Identities = 39/171 (22%), Positives = 59/171 (34%), Gaps = 27/171 (15%)

Query: 157 LQKLQGLVLD--DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLG 214
           ++ +  +     D KL   +PDDI        ++L  N L       F+N   L+ L L 
Sbjct: 8   IEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS 64

Query: 215 SNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL 274
                                      I  K   GL +L  L L  N +Q   P SF  L
Sbjct: 65  RC---------------------EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 275 ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
            SL+ L      L+      + +L  L+ LN++ N +         F N +
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  155 bits (394), Expect = 3e-43
 Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 8/166 (4%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
           +  +   +V ++    SL  HL+++    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LK +N+ L ++    + DFG+A        S    Q   +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (412), Expect = 3e-43
 Identities = 60/325 (18%), Positives = 100/325 (30%), Gaps = 20/325 (6%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +I      L N+    L    +      +       + L L +            ++L +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQ----FPTLKLKS 326

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI-LPKTSIGNLSHSLEDFQMHN 119
           L+ L    N         S  +  SL  + LS N L        S    + SL+   +  
Sbjct: 327 LKRLTFTSNK---GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSF 382

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEGSIPDDI 178
             V   +      L  L  +D   + L           L+ L  L +       +     
Sbjct: 383 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441

Query: 179 CRLVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDF 234
             L  L  L++ GN    +     F  L  L  L L         P    +L  L  ++ 
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501

Query: 235 SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI-SLKFLNLSNNNLSGAIPA 293
           S NNF  +       L +L+ L    N +         +   SL FLNL+ N+ +     
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561

Query: 294 S--LEKLSYLEDLNLSFNKLEGEIP 316
              L+ +     L +   ++E   P
Sbjct: 562 QSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  159 bits (403), Expect = 6e-42
 Identities = 69/335 (20%), Positives = 118/335 (35%), Gaps = 27/335 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKL----LGLQDNSLSGSLSSITDV 56
           ++P    NL NLE LDL  NK+       +  +  + L    L L  N ++         
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--F 197

Query: 57  RLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI-----LPKTSIGNLSH- 110
           +   L +L L  N  S     + +     L V  L               K+++  L + 
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 111 SLEDFQMHNCNV-TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK 169
           ++E+F++   +    DI +    LTN+ +  L    +    +   S     Q L L + K
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315

Query: 170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN-----DPLPLEIG 224
                   +  L  L      G            +L +L  L L  N             
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDS-FGNLISLKFLNLS 283
               L  +D S N     +     GL+ LE+L   ++ L+ +   S F +L +L +L++S
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
           + +   A       LS LE L ++ N  +      
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  150 bits (382), Expect = 3e-39
 Identities = 65/327 (19%), Positives = 111/327 (33%), Gaps = 22/327 (6%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
                 +L +L  L L  N +      A   +S+L+ L   + +L+   +      L  L
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTL 126

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT--SIGNLSHSLEDFQMHN 119
           +EL +  N           SN  +L  + LS+N +  I       +  +        +  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQKLQGLVLDDNKLEGSI---P 175
             +   I         L  + L  N  + +++   +  L  L+   L   +         
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 176 DDICRLVELYKLELGGNKLSR------SIPACFNNLIALRILSLGSNDPL-PLEIGNLKV 228
            D   L  L  L +   +L+        I   FN L  +   SL S       +      
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
              ++     F      ++  LK L      +   +G    S  +L SL+FL+LS N LS
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 289 --GAIPASLEKLSYLEDLNLSFNKLEG 313
             G    S    + L+ L+LSFN +  
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  147 bits (373), Expect = 5e-38
 Identities = 68/333 (20%), Positives = 116/333 (34%), Gaps = 27/333 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +IP  +    + + LDL  N L      + F+   L++L L    +           L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ-SLSH 77

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L  L+L GN    L  L + S   SL  +      L  +     IG+L  +L++  + + 
Sbjct: 78  LSTLILTGNPIQSLA-LGAFSGLSSLQKLVAVETNLASLEN-FPIGHLK-TLKELNVAHN 134

Query: 121 NVTG-DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ----GLVLDDNKLEGSIP 175
            +    +PE   NLTNL  +DL  NK+       L  L ++      L L  N +   I 
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQ 193

Query: 176 DDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSL------GSNDPLPLEIGNLKV 228
               + + L+KL L  N  S ++   C   L  L +  L         +    +   L+ 
Sbjct: 194 PGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253

Query: 229 LVGIDFSMNNFSGI------IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL 282
           L  +       + +      I      L N+    L    ++ +   S+      + L L
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLEL 311

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEI 315
            N          L+ L  L   +        E+
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  139 bits (352), Expect = 3e-35
 Identities = 48/241 (19%), Positives = 79/241 (32%), Gaps = 14/241 (5%)

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
           NL  S ++  +    +         +   L  +DL   ++          L  L  L+L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLE 222
            N ++         L  L KL      L+        +L  L+ L++  N      LP  
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY----LFLGYNRLQGLIPDSFGNLISLK 278
             NL  L  +D S N    I   ++  L  +      L L  N +  + P +F  +  L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203

Query: 279 FLNLSNNNLSGAIPA-SLEKLSYLEDLNLSFNKLEGEI----PRGGSFGNFSAESFEGNE 333
            L L NN  S  +    ++ L+ LE   L   +   E         +       + E   
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 334 L 334
           L
Sbjct: 264 L 264

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  105 bits (265), Expect = 4e-24
 Identities = 34/153 (22%), Positives = 53/153 (34%), Gaps = 24/153 (15%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
            IPD++        L+L  N L       F +   L++L L                   
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL------------------- 59

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
             S      I       L +L  L L  N +Q L   +F  L SL+ L     NL+    
Sbjct: 60  --SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
             +  L  L++LN++ N ++        F N +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 26/140 (18%), Positives = 52/140 (37%), Gaps = 2/140 (1%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           +P     L+NL  LDL Q +L    P A  ++S+L++L +  N+    L +     L +L
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSL 520

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           + L    N+              SL  + L+ N         S            +    
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 580

Query: 122 VTGDIPEEIGNLTNLITIDL 141
           +    P +   +  ++++++
Sbjct: 581 MECATPSDKQGMP-VLSLNI 599

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  153 bits (389), Expect = 2e-42
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 13/167 (7%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           +GRG FG V KA+     +VA+K    +     K+F VE   +  + H N++K+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 482 EEFKGLVLEYMPQGSLEKHLYSTN--CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
                LV+EY   GSL   L+             ++  +  +  + YLH      +IH D
Sbjct: 73  PVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 540 LKPSNVLLDDNM-IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N+LL     +  + DFG A      D     T    +  +MAP
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  151 bits (383), Expect = 6e-42
 Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 19/176 (10%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNLIKVIS 477
           IG GGFG VY+A    G EVAVK           +  ++   E ++   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
            C  E    LV+E+   G L + L      +     +N  + +A  + YLH     P+IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 538 CDLKPSNVLLD--------DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLK SN+L+          N I  ++DFG+A+        M+         +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAA---GAYAWMAP 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  151 bits (384), Expect = 1e-41
 Identities = 39/171 (22%), Positives = 76/171 (44%), Gaps = 11/171 (6%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVIS 477
            LIG+G FG VY  R     EVA+++ +++       K+F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           +C +     ++       +L   +     +LD+ +   I  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKL---LIGEDQSMTQTQTLATIGYMAP 585
            DLK  NV  D+  +  ++DFG+  +   L    +          + ++AP
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (382), Expect = 2e-41
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 15/177 (8%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             +G+G +G V++     G  VAVK+F+ +  +++   + E      +RH N++  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH-----FG 530
                      L+  Y   GSL  +L  T   LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAP 585
               + H DLK  N+L+  N    ++D G+A +       +         T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  151 bits (384), Expect = 2e-41
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 15/177 (8%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             IG+G +G V+  +   G +VAVKVF      ++   + E      +RH N++  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH-----FG 530
                      L+ +Y   GSL  +L ST   LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAP 585
               + H DLK  N+L+  N    ++D G+A   I +   +         T  YM P
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  148 bits (377), Expect = 3e-39
 Identities = 72/315 (22%), Positives = 133/315 (42%), Gaps = 28/315 (8%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            +   +L  +  L   +  +       +  ++ L  +   +N L+  ++ + +  L  L 
Sbjct: 39  TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT-DITPLKN--LTKLV 93

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
           ++++  N  +++   + L+N  +LT + L NN +  I P   + NL+ +L   ++ +  +
Sbjct: 94  DILMNNNQIADI---TPLANLTNLTGLTLFNNQITDIDP---LKNLT-NLNRLELSSNTI 146

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
           +      +  LT+L  +  G    +   L  L+ L  L+ L +  NK+  S    + +L 
Sbjct: 147 SD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV--SDISVLAKLT 199

Query: 183 ELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSG 241
            L  L    N++S   P     L  L  LSL  N    +  + +L  L  +D + N  S 
Sbjct: 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISN 257

Query: 242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL 301
           + P  + GL  L  L LG N++  + P     L +L  L L+ N L    P  +  L  L
Sbjct: 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNL 311

Query: 302 EDLNLSFNKLEGEIP 316
             L L FN +    P
Sbjct: 312 TYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  146 bits (371), Expect = 2e-38
 Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 28/312 (8%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
              L    +  L +  +  TV     ++  +  L      +  S+  +    L NL ++ 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVE--YLNNLTQIN 74

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
              N  ++   ++ L N   L  I ++NN +  I P   + NL+ +L    + N  +T  
Sbjct: 75  FSNNQLTD---ITPLKNLTKLVDILMNNNQIADITP---LANLT-NLTGLTLFNNQITD- 126

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
             + + NLTNL  ++L  N ++   +  LS L  LQ L   +   +      +  L  L 
Sbjct: 127 -IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLE 180

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIP 244
           +L++  NK+S  I      L  L  L   +N    +  +G L  L  +  + N    I  
Sbjct: 181 RLDISSNKVS-DISV-LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT 238

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
             +  L NL  L L  N++  L P     L  L  L L  N +S   P  L  L+ L +L
Sbjct: 239 --LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292

Query: 305 NLSFNKLEGEIP 316
            L+ N+LE   P
Sbjct: 293 ELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  141 bits (357), Expect = 1e-36
 Identities = 71/309 (22%), Positives = 131/309 (42%), Gaps = 26/309 (8%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            +  L +L++L    N++    P+A  N++TL+ L +  N +S  +S +    L NLE L
Sbjct: 151 ALSGLTSLQQLSF-GNQVTDLKPLA--NLTTLERLDISSNKVS-DISVLAK--LTNLESL 204

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
           +   N  S++   + L    +L  + L+ N L  I    ++ +L+ +L D  + N  ++ 
Sbjct: 205 IATNNQISDI---TPLGILTNLDELSLNGNQLKDI---GTLASLT-NLTDLDLANNQISN 257

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
             P  +  LT L  + LG N+++   +  L+ L  L  L L++N+LE   P  I  L  L
Sbjct: 258 LAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNL 311

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGII 243
             L L  N +S   P   ++L  L+ L   +N       + NL  +  +    N  S + 
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLT 369

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
           P  +  L  +  L L          +   N+     +      L    PA++       +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTE 425

Query: 304 LNLSFNKLE 312
            ++++N   
Sbjct: 426 PDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  136 bits (345), Expect = 6e-35
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 24/276 (8%)

Query: 41  LQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGIL 100
            QD  ++      TD  L    + VL   N ++     S ++   +T +      +  I 
Sbjct: 9   TQDTPIN---QIFTDTALAEKMKTVLGKTNVTD---TVSQTDLDQVTTLQADRLGIKSI- 61

Query: 101 PKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL 160
               +  L++ L      N  +T   P  + NLT L+ I +  N++    +  L+ L  L
Sbjct: 62  --DGVEYLNN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNL 114

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP 220
            GL L +N++    P  +  L  L +LEL  N +S  I A  + L +L+ LS G+     
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA-LSGLTSLQQLSFGNQVTDL 170

Query: 221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
             + NL  L  +D S N  S I    +  L NLE L    N++  + P   G L +L  L
Sbjct: 171 KPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDEL 226

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
           +L+ N L      +L  L+ L DL+L+ N++    P
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  100 bits (250), Expect = 1e-22
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 20/242 (8%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            + +L NL +LDL  N++    P  +  ++ L  L L  N +S ++S +    L  L  L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISPLAG--LTALTNL 292

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L  N   ++   S +SN K+LT + L  N +  I P   + +L+  L+    +N  V+ 
Sbjct: 293 ELNENQLEDI---SPISNLKNLTYLTLYFNNISDISP---VSSLT-KLQRLFFYNNKVSD 345

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
                + NLTN+  +  G N+++   L  L+ L ++  L L+D     +  +    +   
Sbjct: 346 --VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIP 401

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDP--LPLEIGNLKVLVGIDFSMNNFSGI 242
             ++     L    PA  ++  +     +  N P             V I      FSG 
Sbjct: 402 NTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGT 459

Query: 243 IP 244
           + 
Sbjct: 460 VT 461

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (366), Expect = 8e-39
 Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 15/177 (8%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             IG+G FG V++ +   G EVAVK+F+ +  R++   + E      +RH N++  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH-----FG 530
           + +        LV +Y   GSL  +L      + +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAP 585
               + H DLK  N+L+  N    ++D G+A        ++         T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (359), Expect = 3e-38
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 16/177 (9%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           +G+G FG   K      G  + +K          ++F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL 540
            ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA------------TIGYMAP 585
              N L+ +N    ++DFG+A+L++ E       ++L                +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  140 bits (356), Expect = 5e-37
 Identities = 71/337 (21%), Positives = 131/337 (38%), Gaps = 24/337 (7%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
             E   L N + +  + +  +  +P A+  +   ++LL L D  +   + +        +
Sbjct: 38  GFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTI 95

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           ++L +  N    L       N   LTV+ L  N L   LP+    N    L    M N N
Sbjct: 96  QKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP-KLTTLSMSNNN 152

Query: 122 VTGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
           +   I ++     T+L  + L  N+L     + LS +  L    +  N L       +  
Sbjct: 153 LE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAI 203

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL-EIGNLKVLVGIDFSMNNF 239
            + + +L+   N ++  +       + L IL L  N+      + N   LV +D S N  
Sbjct: 204 PIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNEL 260

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
             I+      ++ LE L++  NRL   +      + +LK L+LS+N+L   +  +  +  
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 318

Query: 300 YLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 336
            LE+L L  N +   +    +       +   N+  C
Sbjct: 319 RLENLYLDHNSIV-TLKL-STHHTLKNLTLSHNDWDC 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  121 bits (306), Expect = 3e-30
 Identities = 63/323 (19%), Positives = 125/323 (38%), Gaps = 45/323 (13%)

Query: 7   GNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
            + + +E L+L   + I  +    F    T++ L +  N++   L       +P L  LV
Sbjct: 66  DSFRQVELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
           L  N+ S L       N   LT + +SNN L+ I    +    + SL++ Q+ +  +T  
Sbjct: 124 LERNDLSSLP-RGIFHNTPKLTTLSMSNNNLERI-EDDTFQATT-SLQNLQLSSNRLT-H 179

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR----- 180
           +   +  + +L   ++  N L+     TL+    ++ L    N +   +   +       
Sbjct: 180 VD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTIL 231

Query: 181 ---------------LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEI 223
                             L +++L  N+L + +   F  +  L  L + +N    L L  
Sbjct: 232 KLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYG 291

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
             +  L  +D S N+    + +       LE L+L +N +  L         +LK L LS
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLS 347

Query: 284 NNNLSG----AIPASLEKLSYLE 302
           +N+       A+  ++ + +  +
Sbjct: 348 HNDWDCNSLRALFRNVARPAVDD 370

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  113 bits (286), Expect = 1e-27
 Identities = 54/287 (18%), Positives = 108/287 (37%), Gaps = 21/287 (7%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSI----TDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT 87
           + +        D  +      +     D+ L N + +    +   +L   + L + + + 
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA-ALLDSFRQVE 72

Query: 88  VIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI-GNLTNLITIDLGGNKL 146
           ++ L++  ++ I    +     H+++   M    +   +P  +  N+  L  + L  N L
Sbjct: 73  LLNLNDLQIEEI-DTYAFAYA-HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 147 NGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELGGNKLSRSIPACFNNL 205
           +           KL  L + +N LE  I DD  +    L  L+L  N+L+  +    + +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185

Query: 206 IALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQG 265
            +L   ++  N  L   +     +  +D S N+ + +          L  L L +N L  
Sbjct: 186 PSLFHANVSYN--LLSTLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD 240

Query: 266 LIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
                  N   L  ++LS N L   +     K+  LE L +S N+L 
Sbjct: 241 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 33/199 (16%), Positives = 65/199 (32%), Gaps = 7/199 (3%)

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL 208
            I   L        + +D    +     +   L     +    + + +   A  ++   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 209 RILSLGSN--DPLPLEI-GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQG 265
            +L+L     + +          +  +    N    + P     +  L  L L  N L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 266 LIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           L    F N   L  L++SNNNL      + +  + L++L LS N+L   +       +  
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-IPSLF 189

Query: 326 AESFEGNEL--LCGSPNLQ 342
             +   N L  L     ++
Sbjct: 190 HANVSYNLLSTLAIPIAVE 208

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 5/94 (5%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            + L    +  L+ LDL  N  +  V         L+ L L  N    S+ ++       
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYLDHN----SIVTLKLSTHHT 340

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNN 94
           L+ L L  N++   +  +   N     V     +
Sbjct: 341 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 374

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  141 bits (357), Expect = 1e-36
 Identities = 77/330 (23%), Positives = 133/330 (40%), Gaps = 17/330 (5%)

Query: 14  ELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSE 73
            +   + + +  VP  I   +  +LL L  N +  +L+       P+LEEL L  N  S 
Sbjct: 15  AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA 70

Query: 74  LNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI-GN 132
           +    + +N  +L  +GL +N L  ++P      LS +L    +    +   + + +  +
Sbjct: 71  VEP-GAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS-NLTKLDISENKIV-ILLDYMFQD 126

Query: 133 LTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKLELGG 191
           L NL ++++G N L        S L  L+ L L+   L  SIP +    L  L  L L  
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185

Query: 192 NKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
             ++      F  L  L++L +      D +         L  +  +  N + +    + 
Sbjct: 186 LNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSF 308
            L  L +L L YN +  +       L+ L+ + L    L+   P +   L+YL  LN+S 
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305

Query: 309 NKLEGEIPRG--GSFGNFSAESFEGNELLC 336
           N+L   +      S GN      + N L C
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  126 bits (318), Expect = 3e-31
 Identities = 65/306 (21%), Positives = 113/306 (36%), Gaps = 53/306 (17%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           NL NL  L LR N+ +  +P+ +F  +S L  L + +N +   L       L NL+ L +
Sbjct: 78  NLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
             N+   ++   + S   SL  + L    L  I  +                        
Sbjct: 136 GDNDLVYIS-HRAFSGLNSLEQLTLEKCNLTSIPTEA----------------------- 171

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYK 186
              + +L  LI + L    +N     +  +L +L+ L +       ++  +    + L  
Sbjct: 172 ---LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228

Query: 187 LELGGNKLSRSIPAC-FNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
           L +    L+ ++P     +L+ LR L+L                       N  S I   
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSY---------------------NPISTIEGS 266

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN 305
            +  L  L+ + L   +L  + P +F  L  L+ LN+S N L+    +    +  LE L 
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326

Query: 306 LSFNKL 311
           L  N L
Sbjct: 327 LDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  110 bits (278), Expect = 4e-26
 Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 53/283 (18%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L NL +LD+ +NK I  +   +F ++  LK L + DN L   +S      L +LE+L L
Sbjct: 102 GLSNLTKLDISENK-IVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTL 159

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
              N + +    +LS+   L V+ L +  ++ I   +           F+          
Sbjct: 160 EKCNLTSIPT-EALSHLHGLIVLRLRHLNINAIRDYS-----------FK---------- 197

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELY 185
                 L  L  +++       ++         L  L +    L  ++P    R LV L 
Sbjct: 198 -----RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLR 251

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
            L L  N +S    +  + L+ L+ + L            L V+         F      
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGG--------QLAVV-----EPYAFR----- 293

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
              GL  L  L +  N+L  L    F ++ +L+ L L +N L+
Sbjct: 294 ---GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  139 bits (352), Expect = 2e-35
 Identities = 63/348 (18%), Positives = 127/348 (36%), Gaps = 28/348 (8%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
             ++    NL+ L L+ ++ I T+    F ++ +L+ L L DN LS SLSS     L +L
Sbjct: 43  HGDLRACANLQVLILKSSR-INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSL 100

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           + L L GN +  L   S   N  +L  + + N      + +     L+  L + ++   +
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALS 159

Query: 122 VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
           +     + + ++ ++  + L  ++    + I    L  ++ L L D  L       +   
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219

Query: 182 VELYKLELGGNKLSRSIPACFNNLIAL---------------RILSLGSNDPLPLEIGN- 225
                ++    + S      FN L+ L                +  LG  +P   ++ + 
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279

Query: 226 -----LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
                   +  +          +      L+ ++ + +  +++  +      +L SL+FL
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339

Query: 281 NLSNNNLSGAI---PASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           +LS N +        A       L+ L LS N L      G       
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  126 bits (319), Expect = 4e-31
 Identities = 61/343 (17%), Positives = 123/343 (35%), Gaps = 27/343 (7%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            IP  +     ++ LDL  NK+       +   + L++L L+ + ++ ++       L +
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           LE L L  N+ S L+  S      SL  + L  NP   +   +   NL+ +L+  ++ N 
Sbjct: 76  LEHLDLSDNHLSSLS-SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNV 133

Query: 121 NVTGDIPEE-IGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
               +I       LT+L  +++    L      +L  ++ +  L L  ++    +     
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193

Query: 180 RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI------- 232
            L  +  LEL    L+R   +          +   +     L   +   L+ +       
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253

Query: 233 ------DFSMNNFSGIIPKEIG--------GLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
                 D ++N      P E              +  L +    L   +   +  L  +K
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSF 321
            + + N+ +     +  + L  LE L+LS N +  E  +  + 
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (295), Expect = 4e-28
 Identities = 64/341 (18%), Positives = 130/341 (38%), Gaps = 37/341 (10%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L +L EL+++   L      ++ ++  +  L L  +  +  L  I    L ++  L L 
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELR 204

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPK-----TSIGNLSHSLEDFQMHNCNV 122
             N +     S L   +  + +         +  +       +      L + +  +C +
Sbjct: 205 DTNLARF-QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263

Query: 123 TG---------DIPEEIGNL--TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE 171
            G         D+  E+G +    +  + +    L   +    S L+K++ + ++++K+ 
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323

Query: 172 GSIPDDICR-LVELYKLELGGNKLSRSI---PACFNNLIALRILSLGSN-----DPLPLE 222
             +P    + L  L  L+L  N +        AC     +L+ L L  N           
Sbjct: 324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL 282
           +  LK L  +D S N F   +P      + + +L L    ++ +         +L+ L++
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV---KTCIPQTLEVLDV 438

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
           SNNNL  +    L +L   ++L +S NKL+  +P    F  
Sbjct: 439 SNNNLD-SFSLFLPRL---QELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  108 bits (272), Expect = 3e-25
 Identities = 55/345 (15%), Positives = 121/345 (35%), Gaps = 42/345 (12%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSI--TDVRLPNLEE 63
           + +++++  L L  ++    + +    +S+++ L L+D +L+    S    D     +++
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 64  LVLWGNNFSELNF---LSSLSNCKSLTVIGLSNNPLDGI--LPKTSIGNLSH-------S 111
           L   G+  ++ +F   L  L     L+ +   +  L+G+     +    +S        +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE 171
           +    +    +  D+      L  +  I +  +K+          L+ L+ L L +N + 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 172 GSIPDD---ICRLVELYKLELGGNKLS--RSIPACFNNLIALRILSLGSN--DPLPLEIG 224
                +         L  L L  N L   +        L  L  L +  N   P+P    
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQ 407

Query: 225 NLKVLVGIDFSMNNFSGIIPKEI------------------GGLKNLEYLFLGYNRLQGL 266
             + +  ++ S      ++   I                    L  L+ L++  N+L+ L
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTL 466

Query: 267 IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
              S      L  + +S N L        ++L+ L+ + L  N  
Sbjct: 467 PDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 45/234 (19%), Positives = 79/234 (33%), Gaps = 28/234 (11%)

Query: 82  NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDL 141
           +C +  V    +     I        L+ +++   +    +T     ++    NL  + L
Sbjct: 3   SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 142 GGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELGGNKLSR-SIP 199
             +++N         L  L+ L L DN L  S+       L  L  L L GN      + 
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 200 ACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLG 259
           + F NL  L+ L +G+                       FS I   +  GL +L  L + 
Sbjct: 117 SLFPNLTNLQTLRIGNV--------------------ETFSEIRRIDFAGLTSLNELEIK 156

Query: 260 YNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG 313
              L+     S  ++  +  L L  +  +  +    + LS +  L L    L  
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 98.6 bits (246), Expect = 7e-22
 Identities = 51/289 (17%), Positives = 93/289 (32%), Gaps = 38/289 (13%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            +E  +       D   ++      +      T++ L +    L   LS++    L  ++
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS-LLEKVK 313

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            + +  +    +   S   + KSL  + LS N +     K S                  
Sbjct: 314 RITVENSKVFLVPC-SFSQHLKSLEFLDLSENLMVEEYLKNSA----------------- 355

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLN--GSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
                   G   +L T+ L  N L         L  L+ L  L +  N     +PD    
Sbjct: 356 ------CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNN 238
             ++  L L    +   +  C      L +L + +N  D   L +  L+ L     S N 
Sbjct: 409 PEKMRFLNLSSTGIR-VVKTC--IPQTLEVLDVSNNNLDSFSLFLPRLQEL---YISRNK 462

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
              +   +      L  + +  N+L+ +    F  L SL+ + L  N  
Sbjct: 463 LKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 89.8 bits (223), Expect = 5e-19
 Identities = 47/284 (16%), Positives = 95/284 (33%), Gaps = 26/284 (9%)

Query: 49  SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL 108
           S +SI       ++ L L  N  + +     L  C +L V+ L ++ ++ I    +  +L
Sbjct: 16  SFTSIPSGLTAAMKSLDLSFNKITYIG-HGDLRACANLQVLILKSSRINTI-EGDAFYSL 73

Query: 109 SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLDD 167
              LE   + + +++       G L++L  ++L GN      +      L  LQ L + +
Sbjct: 74  GS-LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132

Query: 168 NKLEGSIP-DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL 226
            +    I   D   L  L +LE+    L         ++  +  L+L             
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL------------- 179

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
                    ++  + ++      L ++ YL L    L                +      
Sbjct: 180 --------HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 287 LSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFE 330
            S     S  +L  L    L  +++E +       G+F+    +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  138 bits (349), Expect = 5e-35
 Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 24/336 (7%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            E   L N + +  + +  +  +P A+  +   ++LL L D  +   + +        ++
Sbjct: 45  FEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
           +L +  N    L       N   LTV+ L  N L   LP+    N    L    M N N+
Sbjct: 103 KLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK-LTTLSMSNNNL 159

Query: 123 TGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
              I ++     T+L  + L  N+L     + LS +  L    +  N L  ++       
Sbjct: 160 E-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-TLAI----P 210

Query: 182 VELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL-EIGNLKVLVGIDFSMNNFS 240
           + + +L+   N ++         L    IL L  N+      + N   LV +D S N   
Sbjct: 211 IAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE 267

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY 300
            I+      ++ LE L++  NRL   +      + +LK L+LS+N+L   +  +  +   
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325

Query: 301 LEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 336
           LE+L L  N +   +    +       +   N+  C
Sbjct: 326 LENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  112 bits (282), Expect = 2e-26
 Identities = 56/309 (18%), Positives = 111/309 (35%), Gaps = 20/309 (6%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
           +G  Q       +       +   +        + + D           D+ L N + + 
Sbjct: 1   VGGQQRYNVKPRQPE--YKCIDSNLQYDCVFYDVHI-DMQTQDVYFGFEDITLNNQKIVT 57

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
              +   +L   + L + + + ++ L++  ++ I    +     H+++   M    +   
Sbjct: 58  FKNSTMRKLPA-ALLDSFRQVELLNLNDLQIEEI-DTYAFAYA-HTIQKLYMGFNAIR-Y 113

Query: 126 IPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVE 183
           +P  +  N+  L  + L  N L+           KL  L + +N LE  I DD       
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTS 172

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII 243
           L  L+L  N+L+  +    + + +L   ++  N  L   +     +  +D S N+ + + 
Sbjct: 173 LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN--LLSTLAIPIAVEELDASHNSINVV- 226

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
                    L  L L +N L         N   L  ++LS N L   +     K+  LE 
Sbjct: 227 --RGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282

Query: 304 LNLSFNKLE 312
           L +S N+L 
Sbjct: 283 LYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 81.1 bits (200), Expect = 3e-16
 Identities = 33/199 (16%), Positives = 65/199 (32%), Gaps = 7/199 (3%)

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL 208
            I   L        + +D    +     +   L     +    + + +   A  ++   +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 209 RILSLGSN--DPLPLEI-GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQG 265
            +L+L     + +          +  +    N    + P     +  L  L L  N L  
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137

Query: 266 LIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           L    F N   L  L++SNNNL      + +  + L++L LS N+L   +       +  
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL-SLIPSLF 195

Query: 326 AESFEGNEL--LCGSPNLQ 342
             +   N L  L     ++
Sbjct: 196 HANVSYNLLSTLAIPIAVE 214

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 43/311 (13%), Positives = 97/311 (31%), Gaps = 30/311 (9%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            + L    +  L+ LDL  N L+  V         L+ L L  NS+     ++       
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV----TLKLSTHHT 346

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSI--------------- 105
           L+ L L  N++   +  +   N     V     +       +  +               
Sbjct: 347 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406

Query: 106 -GNLSHSLEDFQMHNCNVT-----GDIPEEIGNLTNLITIDLGGNK-LNGSILITLSKLQ 158
              L+  +E  Q      +       +      +T    + L GN+ L   +    +++Q
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466

Query: 159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGG-NKLSRSIPACFNNLIALRILSLGSND 217
           +L    +   +L   +  +I   +  Y+L   G  + S ++   F +L   +   L    
Sbjct: 467 QLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526

Query: 218 PLPLEIGN-LKVLVGIDFSMNNFSGIIPKEIG-GLKNLEYLFLGYNRLQGLIPDSFGNLI 275
               E     K    ++         +  +     +  +   L   +++ L      N  
Sbjct: 527 ARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPD 586

Query: 276 SLKFLNLSNNN 286
           + +  +  +++
Sbjct: 587 TRRVSHHHHHH 597

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  137 bits (346), Expect = 2e-34
 Identities = 71/326 (21%), Positives = 123/326 (37%), Gaps = 47/326 (14%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE 63
           +          L++ ++ L  T+P  +     +  L + DN+L+ SL +      P L  
Sbjct: 34  MRACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPA----LPPELRT 85

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPK-----------TSIGNLSHSL 112
           L + GN  + L           L++       L  +              TS+  L   L
Sbjct: 86  LEVSGNQLTSLP--VLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGL 143

Query: 113 EDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG 172
           ++  + +  +   +P     L  L       N+L  S+ +  S LQ+L    + DN+L  
Sbjct: 144 QELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQELS---VSDNQLA- 194

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLV 230
           S+P     L    KL    N+L+ S+PA  + L   + L +  N    LP+    LK L 
Sbjct: 195 SLPTLPSELY---KLWAYNNRLT-SLPALPSGL---KELIVSGNRLTSLPVLPSELKEL- 246

Query: 231 GIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA 290
               S N  +  +P        L  L +  N+L  L P+S  +L S   +NL  N LS  
Sbjct: 247 --MVSGNRLT-SLPMLPS---GLLSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLSER 299

Query: 291 IPASLEKLSYLEDLNLSFNKLEGEIP 316
              +L +++     +    + +    
Sbjct: 300 TLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  124 bits (312), Expect = 4e-30
 Identities = 65/332 (19%), Positives = 115/332 (34%), Gaps = 49/332 (14%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P     L+ L   ++  N+L  ++PV    +  L +       L    S         
Sbjct: 75  SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS--------G 122

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L +L ++GN  + L         + L+   +S+N L       S+  L   L     +N 
Sbjct: 123 LCKLWIFGNQLTSLP--VLPPGLQELS---VSDNQL------ASLPALPSELCKLWAYNN 171

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSK-LQKLQGLVLDDNKLEGSIPDDIC 179
            +T  +P     L  L    +  N+L      +L     +L  L   +N+L  S+P    
Sbjct: 172 QLT-SLPMLPSGLQEL---SVSDNQLA-----SLPTLPSELYKLWAYNNRLT-SLPALPS 221

Query: 180 RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMN 237
            L EL    + GN+L+ S+P   + L   + L +  N    LP+    L  L       N
Sbjct: 222 GLKELI---VSGNRLT-SLPVLPSEL---KELMVSGNRLTSLPMLPSGLLSL---SVYRN 271

Query: 238 NFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA--SL 295
             + + P+ +  L +   + L  N L      +   + S    +        A  +    
Sbjct: 272 QLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330

Query: 296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAE 327
            +  +L   +      EGE      +  F  E
Sbjct: 331 TRALHLAAADWLVPAREGEPAPADRWHMFGQE 362

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  104 bits (260), Expect = 1e-23
 Identities = 60/286 (20%), Positives = 98/286 (34%), Gaps = 49/286 (17%)

Query: 42  QDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILP 101
           +    +  +  +          L +  +  + L           +T + + +N L   LP
Sbjct: 23  ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTL----PDCLPAHITTLVIPDNNLT-SLP 77

Query: 102 KTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSI--LITL----- 154
                 L  +LE   +    +T  +P     L  L         L      L  L     
Sbjct: 78  A-LPPEL-RTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGN 131

Query: 155 ------SKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL 208
                      LQ L + DN+L  S+P     L +L+      N+L+ S+P   +    L
Sbjct: 132 QLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG---L 183

Query: 209 RILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL 266
           + LS+  N    LP     L  L    ++ NN    +P        L+ L +  NRL  L
Sbjct: 184 QELSVSDNQLASLPTLPSELYKL----WAYNNRLTSLPALPS---GLKELIVSGNRLTSL 236

Query: 267 IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
            P        LK L +S N L+ ++P        L  L++  N+L 
Sbjct: 237 -PVLPSE---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT 274

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  135 bits (342), Expect = 5e-34
 Identities = 65/342 (19%), Positives = 122/342 (35%), Gaps = 33/342 (9%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGS--LSSITDVR 57
            I         L +L LR N     V       ++ L++  L          L       
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 58  LPNLEELVLWGNNFSELNFLSS-----LSNCKSLTVIGLSNNPLDGILPKTSIGNLSH-- 110
           L  L  L +     + L++         +   +++   L +  ++ +   +      H  
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 111 ------------SLEDFQ--MHNCNVTGDIPEEIGNLTNLITIDLGGNKLN--GSILITL 154
                        L+  +      N  G+   E+ +L +L  +DL  N L+  G    + 
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 155 SKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPAC-FNNLIALRILSL 213
                L+ L L  N +  ++  +   L +L  L+   + L +      F +L  L  L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428

Query: 214 GSN--DPLPLEI-GNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPD 269
                      I   L  L  +  + N+F      +I   L+NL +L L   +L+ L P 
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           +F +L SL+ LN+++N L        ++L+ L+ + L  N  
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  133 bits (337), Expect = 2e-33
 Identities = 67/357 (18%), Positives = 118/357 (33%), Gaps = 48/357 (13%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
             +L +L  L L  N +      A   +S+L+ L   + +L+ SL +     L  L+EL 
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT--SIGNLSHSLEDFQMHNCNVT 123
           +  N           SN  +L  + LS+N +  I       +  +        +    + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILI------------------------------- 152
             I         L  + L  N  + +++                                
Sbjct: 191 F-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 153 TLSKLQKLQGLVLDDNKLEGS---IPDDICRLVELYKLELGGNKLSRSIPACFN-NLIAL 208
            L  L  L         L+     I D    L  +    L    + R     +N     L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309

Query: 209 RILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQ--GL 266
            +++        L++ +LK L    F+ N       +    L +LE+L L  N L   G 
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGC 364

Query: 267 IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
              S     SLK+L+LS N +   + ++   L  LE L+   + L+ ++     F +
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  130 bits (329), Expect = 2e-32
 Identities = 73/356 (20%), Positives = 119/356 (33%), Gaps = 47/356 (13%)

Query: 2   IPLEIGNLQNLEELDLRQNKL---------------------------IGTVPVAIFNVS 34
           +P    NL NLE LDL  NK+                           +  +    F   
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200

Query: 35  TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS-----NCKSLTVI 89
            L  L L++N  S ++       L  LE   L    F     L            +LT+ 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 90  GLSNNPLDGILPK-TSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG 148
                 LD  L     + N   ++  F + +  +   + +   N      ++L   K   
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQ 318

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRS--IPACFNNLI 206
                  KL+ L+ L    NK   +  +    L  L  L+L  N LS             
Sbjct: 319 ---FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 207 ALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRL 263
           +L+ L L  N    +      L+ L  +DF  +N   +    +   L+NL YL + +   
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 264 QGLIPDSFGNLISLKFLNLSNNNLSGAIPA-SLEKLSYLEDLNLSFNKLEGEIPRG 318
           +      F  L SL+ L ++ N+           +L  L  L+LS  +LE ++   
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 488

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  117 bits (296), Expect = 3e-28
 Identities = 51/290 (17%), Positives = 85/290 (29%), Gaps = 33/290 (11%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +I      L N+    L    +      +       + L L +            ++L +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFG----QFPTLKLKS 326

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L+ L    N         S  +  SL  + LS N L      +     + SL+   +   
Sbjct: 327 LKRLTFTSNK---GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
            V   +      L  L  +D   + L   S       L+ L  L +       +      
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442

Query: 180 RLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN 238
            L  L  L++ GN    +     F  L  L  L L                     S   
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL---------------------SQCQ 481

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
              + P     L +L+ L +  N+L+ +    F  L SL+ + L  N   
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  114 bits (287), Expect = 6e-27
 Identities = 81/360 (22%), Positives = 129/360 (35%), Gaps = 46/360 (12%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +IP  +    + + LDL  N L      + F+   L++L L    +  ++       L +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQM-HN 119
           L  L+L GN    L  L + S   SL  +      L   L    IG+L  +L++  + HN
Sbjct: 78  LSTLILTGNPIQSLA-LGAFSGLSSLQKLVAVETNLAS-LENFPIGHLK-TLKELNVAHN 134

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG----LVLDDNKLEGSIP 175
              +  +PE   NLTNL  +DL  NK+       L  L ++      L L  N +   I 
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 176 DDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSL------GSNDPLPLEIGNLKV 228
               + + L+KL L  N  S ++   C   L  L +  L         +    +   L+ 
Sbjct: 194 PGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253

Query: 229 LVGIDFSMNNFSGI------IPKEIGGLKNLEYLFLGYNRLQGLIPDSF----------- 271
           L  +       + +      I      L N+    L    ++ +   S+           
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313

Query: 272 --------GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
                     L SLK L  ++N    A   S   L  LE L+LS N L  +     S   
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.7 bits (215), Expect = 4e-18
 Identities = 33/153 (21%), Positives = 53/153 (34%), Gaps = 24/153 (15%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
            IPD++    +   L+L  N L       F +   L++L L                   
Sbjct: 21  KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRC---------------- 62

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
                    I       L +L  L L  N +Q L   +F  L SL+ L     NL+    
Sbjct: 63  -----EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
             +  L  L++LN++ N ++        F N +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 34/174 (19%), Positives = 62/174 (35%), Gaps = 3/174 (1%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
                   +L+ LDL  N +I T+      +  L+ L  Q ++L         + L NL 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L +   +          +   SL V+ ++ N             L  +L    +  C +
Sbjct: 425 YLDISHTHTRVAF-NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQCQL 482

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
               P    +L++L  +++  N+L         +L  LQ + L  N  + S P 
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  135 bits (342), Expect = 1e-33
 Identities = 70/328 (21%), Positives = 115/328 (35%), Gaps = 46/328 (14%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLS-GSLSSITDVRLPNLEELV 65
           NL NL  LDL  +K I  +    F  +  L  L L    LS   L       L  L  L 
Sbjct: 71  NLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH-SLEDFQMHNCNVTG 124
           L  N    L    S     SL  I  S+N +  +  +  +  L   +L  F +   ++  
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV-CEHELEPLQGKTLSFFSLAANSLYS 188

Query: 125 DIPEEIGNLTN------LITIDLGGNK------------LNGSILITLSKLQKLQGLVLD 166
            +  + G   N      L  +D+ GN             ++ S   +L     + G    
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248

Query: 167 DNKLEGSIPDDICRLVELY--KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG 224
            + ++    +    L       L+L    +       F  L  L++L+L           
Sbjct: 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNL----------- 297

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN 284
                     + N  + I  +   GL NL+ L L YN L  L   +F  L  + +++L  
Sbjct: 298 ----------AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 285 NNLSGAIPASLEKLSYLEDLNLSFNKLE 312
           N+++     + + L  L+ L+L  N L 
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  124 bits (314), Expect = 4e-30
 Identities = 81/329 (24%), Positives = 137/329 (41%), Gaps = 37/329 (11%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
           ++  LDL     + ++   +F  +  LK+L L  N ++  ++      L NL+ L L  N
Sbjct: 267 SVRHLDLSHGF-VFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYN 324

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
              EL   S+      +  I L  N +  I+   +   L   L+   + +  +T      
Sbjct: 325 LLGELYS-SNFYGLPKVAYIDLQKNHI-AIIQDQTFKFLE-KLQTLDLRDNALT-----T 376

Query: 130 IGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG-SIPDDICRLVELYKLE 188
           I  + ++  I L GNKL     I L+       + L +N+LE   I   + R+  L  L 
Sbjct: 377 IHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILI 432

Query: 189 LGGNKLSR-SIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI 247
           L  N+ S  S     +   +L  L LG N         L++    +   + F G      
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGEN--------MLQLAWETELCWDVFEG------ 478

Query: 248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
             L +L+ L+L +N L  L P  F +L +L+ L+L++N L+      L   + LE L++S
Sbjct: 479 --LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDIS 534

Query: 308 FNKLEGEIPRGGSFGNFSAESFEGNELLC 336
            N+L    P    F + S      N+ +C
Sbjct: 535 RNQL--LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  120 bits (303), Expect = 1e-28
 Identities = 62/323 (19%), Positives = 118/323 (36%), Gaps = 33/323 (10%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGL 91
            ++T + L L  N +  ++++ +   L  L+ L L            +  N  +L ++ L
Sbjct: 22  VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 92  SNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI--PEEIGNLTNLITIDLGGNKLNG- 148
            ++ +  + P    G     L + +++ C ++  +       NL  L  +DL  N++   
Sbjct: 81  GSSKIYFLHPDAFQGL--FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRL--VELYKLELGGNKLSRSIPACFNNL- 205
            +  +  KL  L+ +    N++      ++  L    L    L  N L   +   +    
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 206 -----IALRILSLGSNDPLPLEIGN---------------LKVLVGIDFSMNNFSGIIPK 245
                + L IL +  N       GN                  ++G  F  +N       
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258

Query: 246 EIGGLK--NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
              GL   ++ +L L +  +  L    F  L  LK LNL+ N ++     +   L  L+ 
Sbjct: 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV 318

Query: 304 LNLSFNKLEGEIPRGGSFGNFSA 326
           LNLS+N L  E+    +F     
Sbjct: 319 LNLSYNLLG-ELY-SSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 94.5 bits (235), Expect = 2e-20
 Identities = 53/271 (19%), Positives = 92/271 (33%), Gaps = 31/271 (11%)

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
            +   N         +   + LS N +  +   +S   L   L+  ++ +      I +E
Sbjct: 10  FYRFCNLTQVPQVLNTTERLLLSFNYIRTV-TASSFPFLEQ-LQLLELGSQYTPLTIDKE 67

Query: 130 I-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSI--PDDICRLVELYK 186
              NL NL  +DLG +K+          L  L  L L    L  ++        L  L +
Sbjct: 68  AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127

Query: 187 LELGGNKLSR-SIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVG-----IDFSMNNFS 240
           L+L  N++    +   F  L +L+ +   SN    +    L+ L G        + N+  
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187

Query: 241 GIIPKEIGGLKN------LEYLFLGYNRLQGLIPDSFGNLIS------------LKFLNL 282
             +  + G   N      LE L +  N     I  +F N IS            +     
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247

Query: 283 SNNNLSGAIPASLEKL--SYLEDLNLSFNKL 311
             +N+      +   L  S +  L+LS   +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFV 278

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 59/301 (19%), Positives = 100/301 (33%), Gaps = 32/301 (10%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L NL+ L+L  N L        + +  +  + LQ N ++  +   T   L  L+ L L 
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLR 370

Query: 68  GNNFSELNFLSSL--------------SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLE 113
            N  + ++F+ S+                  +  +I LS N L+ +     +  + H L+
Sbjct: 371 DNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH-LQ 429

Query: 114 DFQMHNCNVTGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSK-----LQKLQGLVLDD 167
              ++    +    ++      +L  + LG N L  +    L       L  LQ L L+ 
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489

Query: 168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLK 227
           N L    P     L  L  L L  N+L+            L IL +  N  L        
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQLLAPNPDVFV 547

Query: 228 VLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
            L  +D + N F             L       N     I     ++  +   + S  +L
Sbjct: 548 SLSVLDITHNKFICEC--------ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSL 599

Query: 288 S 288
            
Sbjct: 600 F 600

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 38/155 (24%), Positives = 55/155 (35%), Gaps = 26/155 (16%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
            +P  +     L    L  N +     + F  L  L++L LGS                 
Sbjct: 18  QVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQ---------------- 58

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI- 291
                    I  +    L NL  L LG +++  L PD+F  L  L  L L    LS A+ 
Sbjct: 59  ----YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114

Query: 292 -PASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
                  L  L  L+LS N++   +    SFG  +
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLN 148

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 14/200 (7%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            I  + ++ ++ L  NKL+    + +       L+ L +N L         +R+P+L+ L
Sbjct: 376 TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQIL 431

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI----LPKTSIGNLSHSLEDFQMHNC 120
           +L  N FS  +   + S   SL  + L  N L       L       LSH L+   +++ 
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH-LQVLYLNHN 490

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
            +    P    +LT L  + L  N+L  ++L        L+ L +  N+L    PD    
Sbjct: 491 YLNSLPPGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDISRNQLLAPNPDV--- 545

Query: 181 LVELYKLELGGNKLSRSIPA 200
            V L  L++  NK       
Sbjct: 546 FVSLSVLDITHNKFICECEL 565

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  128 bits (325), Expect = 2e-33
 Identities = 55/313 (17%), Positives = 105/313 (33%), Gaps = 45/313 (14%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           I     N    +   +  + L   +     +   +K L L  N LS  +S+        L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           E L L  N   E   L SLS    L  + L+NN +                         
Sbjct: 61  ELLNLSSNVLYETLDLESLST---LRTLDLNNNYV------------------------- 92

Query: 122 VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
                 +E+    ++ T+    N ++    ++ S+ Q  + + L +NK+      D    
Sbjct: 93  ------QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCR 143

Query: 182 VELYKLELGGNKLSR-SIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNN 238
             +  L+L  N++   +      +   L  L+L  N    +  ++     L  +D S N 
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNK 202

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS-GAIPASLEK 297
            +  +  E      + ++ L  N+L   I  +     +L+  +L  N    G +     K
Sbjct: 203 LA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260

Query: 298 LSYLEDLNLSFNK 310
              ++ +     K
Sbjct: 261 NQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  115 bits (291), Expect = 9e-29
 Identities = 52/311 (16%), Positives = 103/311 (33%), Gaps = 22/311 (7%)

Query: 1   EIPLEIG-NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP 59
           +    +  +  N++ELDL  N L       +   + L+LL L  N L      +    L 
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLES--LS 80

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
            L  L L  N       +  L    S+  +  +NN +  +    S        ++  + N
Sbjct: 81  TLRTLDLNNNY------VQELLVGPSIETLHAANNNISRV----SCSRGQ-GKKNIYLAN 129

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
             +T     + G  + +  +DL  N+++  +     +    L+ L L  N +   +   +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSM 236
               +L  L+L  NKL+  +   F +   +  +SL +N    +   +   + L   D   
Sbjct: 189 V-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRG 246

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           N F           KN     +    ++ L   +          +              +
Sbjct: 247 NGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305

Query: 297 KLSYLEDLNLS 307
           +L  L   +  
Sbjct: 306 RLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  108 bits (272), Expect = 3e-26
 Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 8/188 (4%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
           I E   N        +  + L  ++         ++ L L  N L      D+    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
            L L  N L         +L  LR L L +N     E+     +  +  + NN S +   
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNN--YVQELLVGPSIETLHAANNNISRV--- 114

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLEDL 304
                +  + ++L  N++  L     G    +++L+L  N +              LE L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 305 NLSFNKLE 312
           NL +N + 
Sbjct: 175 NLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  106 bits (268), Expect = 1e-25
 Identities = 41/209 (19%), Positives = 83/209 (39%), Gaps = 11/209 (5%)

Query: 105 IGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV 164
             N +   +  ++ + ++   +     +  N+  +DL GN L+      L+   KL+ L 
Sbjct: 6   KQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG 224
           L  N L      D+  L  L  L+L  N +   +        ++  L   +N+   +   
Sbjct: 65  LSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCS 117

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLS 283
             +    I  + N  + +   + G    ++YL L  N +  +   +   +  +L+ LNL 
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
            N +   +   +   + L+ L+LS NKL 
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 24/140 (17%), Positives = 49/140 (35%), Gaps = 28/140 (20%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
           +I +           ++  + L +++ +   +   ++ L L                   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDL------------------- 41

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
             S N  S I   ++     LE L L  N L   +     +L +L+ L+L+NN +     
Sbjct: 42  --SGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ---- 93

Query: 293 ASLEKLSYLEDLNLSFNKLE 312
             L     +E L+ + N + 
Sbjct: 94  -ELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 24/102 (23%), Positives = 39/102 (38%), Gaps = 3/102 (2%)

Query: 219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
           +     N         + ++    +        N++ L L  N L  +          L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGS 320
            LNLS+N L       LE LS L  L+L+ N ++ E+  G S
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  131 bits (332), Expect = 3e-33
 Identities = 76/337 (22%), Positives = 130/337 (38%), Gaps = 56/337 (16%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSG---------SLS 51
           E+P+E  N+++  E     ++     P        + +  L+D               LS
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 52  SITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPK--------- 102
           S+ ++  P+LE LV   N+ +EL       + KSL V   +   L  + P          
Sbjct: 85  SLPEL-PPHLESLVASCNSLTELP--ELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141

Query: 103 -----TSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKL 157
                  + N S  L+   + N ++   +P+   +L  +     G N+L    L  L  L
Sbjct: 142 QLEKLPELQNSSF-LKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQL--EELPELQNL 194

Query: 158 QKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND 217
             L  +  D+N L+  +PD    L  +     G N L   +P    NL  L  +   +N 
Sbjct: 195 PFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELPE-LQNLPFLTTIYADNNL 248

Query: 218 --PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI 275
              LP    +L+ L   +   N  + + P+    L  L+     ++ L  L P       
Sbjct: 249 LKTLPDLPPSLEAL---NVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPP------- 297

Query: 276 SLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
           +L +LN S+N +  ++      L   E+LN+S NKL 
Sbjct: 298 NLYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  117 bits (294), Expect = 3e-28
 Identities = 73/339 (21%), Positives = 124/339 (36%), Gaps = 66/339 (19%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS-----GSLSSITDVRL- 58
           E+ N   L+ +D+  N L   +P    +   L+ +   +N L       +L  +T +   
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEELPELQNLPFLTAIYAD 203

Query: 59  -----------PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGN 107
                       +LE +V   N   EL     L N   LT I   NN L       ++ +
Sbjct: 204 NNSLKKLPDLPLSLESIVAGNNILEELP---ELQNLPFLTTIYADNNLL------KTLPD 254

Query: 108 LSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSI--LITL----------- 154
           L  SLE   + +  +T D+PE   +LT L   +   + L+     L  L           
Sbjct: 255 LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC 313

Query: 155 SKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLG 214
                L+ L + +NKL   +P    RL  L       N L+  +P    NL   + L + 
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNL---KQLHVE 365

Query: 215 SN--DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFG 272
            N     P    +++ L      MN+    +P+      NL+ L +  N L+   PD   
Sbjct: 366 YNPLREFPDIPESVEDL-----RMNSHLAEVPELPQ---NLKQLHVETNPLREF-PDIPE 416

Query: 273 NLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           ++   + L +++  +      + E    LED     +  
Sbjct: 417 SV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  113 bits (284), Expect = 5e-27
 Identities = 77/347 (22%), Positives = 117/347 (33%), Gaps = 77/347 (22%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           E+P    +L++L   +     L             L+ LG+ +N L   L  +       
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPELQ--NSSF 154

Query: 61  LEELVLWGNNFSEL--------------NFLSSL---SNCKSLTVIGLSNNPLDGILPKT 103
           L+ + +  N+  +L              N L  L    N   LT I   NN L       
Sbjct: 155 LKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL------K 208

Query: 104 SIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGL 163
            + +L  SLE     N  +      E+ NL  L TI    N L  ++      L+ L   
Sbjct: 209 KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN-- 263

Query: 164 VLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPL 221
            + DN L   +P+    L  L   E   + LS   P        L  L+  SN+   L  
Sbjct: 264 -VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIRSLCD 314

Query: 222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLN 281
              +L+ L   + S N     +P        LE L   +N L  + P+   NL   K L+
Sbjct: 315 LPPSLEEL---NVSNNKLI-ELPALPP---RLERLIASFNHLAEV-PELPQNL---KQLH 363

Query: 282 LSNNNLSGAIPASLEKLSY----------------LEDLNLSFNKLE 312
           +  N L    P   E +                  L+ L++  N L 
Sbjct: 364 VEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 19/111 (17%)

Query: 219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI--- 275
           +     +   L       +N +  +P E   +K+    +  ++  +   P   G      
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 276 ----------SLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
                         L L+N  LS ++P       +LE L  S N L  E+P
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELP 107

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  126 bits (318), Expect = 2e-32
 Identities = 63/314 (20%), Positives = 124/314 (39%), Gaps = 29/314 (9%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
           +L  +      L   VP  +       LL LQ+N ++  +       L NL  L+L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
            S+++   + +    L  + LS N L  +        +  +L++ ++H   +T  + + +
Sbjct: 88  ISKISP-GAFAPLVKLERLYLSKNQLKELPE-----KMPKTLQELRVHENEIT-KVRKSV 140

Query: 131 -GNLTNLITIDLGGNKLNGSILI--TLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              L  +I ++LG N L  S +       ++KL  + + D  +  +IP  +     L +L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 197

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG---NLKVLVGIDFSMNNFSGIIP 244
            L GNK+++   A    L  L  L L  N    ++ G   N   L  +  + N     +P
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFG------NLISLKFLNLSNNNLSGAI--PASLE 296
             +   K ++ ++L  N +  +  + F          S   ++L +N +      P++  
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316

Query: 297 KLSYLEDLNLSFNK 310
            +     + L   K
Sbjct: 317 CVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (286), Expect = 5e-28
 Identities = 56/288 (19%), Positives = 97/288 (33%), Gaps = 45/288 (15%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           P+   L L  N  +E+       N K+L  + L NN +  I P             F   
Sbjct: 52  PDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKISKISPGA-----------FA-- 97

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                         L  L  + L  N+L     +     + LQ L + +N++   +   +
Sbjct: 98  -------------PLVKLERLYLSKNQLK---ELPEKMPKTLQELRVHENEIT-KVRKSV 140

Query: 179 -CRLVELYKLELGGNKLSRSI--PACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFS 235
              L ++  +ELG N L  S      F  +  L  + +   +   +  G    L  +   
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200

Query: 236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL 295
            N  + +    + GL NL  L L +N +  +   S  N   L+ L+L+NN L   +P  L
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQV 343
               Y++ + L  N +              +  F          +   
Sbjct: 260 ADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (284), Expect = 8e-28
 Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 32/283 (11%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           NL+NL  L L  NK I  +    F  +  L+ L L  N     L  + +     L+EL +
Sbjct: 74  NLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKN----QLKELPEKMPKTLQELRV 128

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPL-DGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
             N  +++   S  +    + V+ L  NPL    +   +   +   L   ++ + N+T  
Sbjct: 129 HENEITKVR-KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK-KLSYIRIADTNIT-T 185

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVEL 184
           IP+  G   +L  + L GNK+      +L  L  L  L L  N +  ++ +        L
Sbjct: 186 IPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHL 242

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
            +L L  NKL   +P    +   ++++ L +N        N+  +   DF         P
Sbjct: 243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNN--------NISAIGSNDFCP-------P 286

Query: 245 KEIGGLKNLEYLFLGYNRLQ--GLIPDSFGNLISLKFLNLSNN 285
                  +   + L  N +Q   + P +F  +     + L N 
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 27/164 (16%)

Query: 160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL 219
           L+ +   D  LE  +P D+    +   L+L  NK++      F NL  L  L L      
Sbjct: 33  LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL------ 83

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                            N  S I P     L  LE L+L  N+L+ L       L  L  
Sbjct: 84  ---------------INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL-- 126

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
             +  N ++    +    L+ +  + L  N L+      G+F  
Sbjct: 127 -RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 26/147 (17%), Positives = 45/147 (30%), Gaps = 39/147 (26%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS---GSLSSITDVRLPNLEEL 64
            L NL +L L  N +      ++ N   L+ L L +N L    G L+         ++ +
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD-----HKYIQVV 268

Query: 65  VLWGNNFSELN-----FLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
            L  NN S +           +   S + + L +NP+                       
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ---------------------- 306

Query: 120 CNVTGDIPEEI-GNLTNLITIDLGGNK 145
                +I       +     + LG  K
Sbjct: 307 ---YWEIQPSTFRCVYVRAAVQLGNYK 330

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (314), Expect = 5e-32
 Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 18/180 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            +G GGF  V     L DG   A+K      ++  +    E ++ +   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 480 SNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIF---QRLNIMIDVASALEYLHFGCS 532
             E        L+L +  +G+L   +       +     Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-------TIGYMAP 585
               H DLKP+N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  124 bits (314), Expect = 7e-31
 Identities = 55/313 (17%), Positives = 105/313 (33%), Gaps = 45/313 (14%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           I     N    +   +  + L   +     +   +K L L  N LS  +S+        L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
           E L L  N   E   L SLS    L  + L+NN +                         
Sbjct: 61  ELLNLSSNVLYETLDLESLST---LRTLDLNNNYV------------------------- 92

Query: 122 VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
                 +E+    ++ T+    N ++    ++ S+ Q  + + L +NK+      D    
Sbjct: 93  ------QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCR 143

Query: 182 VELYKLELGGNKLSR-SIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNN 238
             +  L+L  N++   +      +   L  L+L  N    +  ++     L  +D S N 
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNK 202

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS-GAIPASLEK 297
            +  +  E      + ++ L  N+L   I  +     +L+  +L  N    G +     K
Sbjct: 203 LAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260

Query: 298 LSYLEDLNLSFNK 310
              ++ +     K
Sbjct: 261 NQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  124 bits (312), Expect = 2e-30
 Identities = 53/332 (15%), Positives = 109/332 (32%), Gaps = 22/332 (6%)

Query: 1   EIPLEIG-NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP 59
           +    +  +  N++ELDL  N L       +   + L+LL L  N L      +    L 
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLES--LS 80

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
            L  L L  N       +  L    S+  +  +NN +  +    S        ++  + N
Sbjct: 81  TLRTLDLNNNY------VQELLVGPSIETLHAANNNISRV----SCSRGQ-GKKNIYLAN 129

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
             +T     + G  + +  +DL  N+++  +     +    L+ L L  N +   +   +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSM 236
               +L  L+L  NKL+  +   F +   +  +SL +N    +   +   + L   D   
Sbjct: 189 V-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRG 246

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           N F     ++    KN     +    ++ L   +          +              +
Sbjct: 247 NGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305

Query: 297 KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAES 328
           +L  L+    +    +G           +   
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  121 bits (304), Expect = 2e-29
 Identities = 47/318 (14%), Positives = 101/318 (31%), Gaps = 21/318 (6%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
           ++ +L  L  LDL  N +       +    +++ L   +N++S     ++  R    + +
Sbjct: 75  DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS----RVSCSRGQGKKNI 125

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L  N  + L  L        +  + L  N +D +       +   +LE   +    +  
Sbjct: 126 YLANNKITMLRDLD-EGCRSRVQYLDLKLNEIDTVNFAELAASS-DTLEHLNLQYNFIY- 182

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
           D+  ++     L T+DL  NKL   +         +  + L +NKL   I   +     L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 185 YKLELGGNKLSR-SIPACFNNLIALRILSLGSNDPLPLEIG-NLKVLVGIDFSMNNFSGI 242
              +L GN     ++   F+    ++ ++  +   L  +      V     +       +
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGL----IPDSFGNLISLKFLNLSNNNLSGAIPASLEKL 298
                  L  L+         QG     +     N    + ++         I     + 
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359

Query: 299 SYLEDLNLSFNKLEGEIP 316
                L      L+ ++ 
Sbjct: 360 QAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  112 bits (282), Expect = 1e-26
 Identities = 38/308 (12%), Positives = 80/308 (25%), Gaps = 25/308 (8%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE 63
           +     Q  + + L  NK+     +     S ++ L L+ N +     +        LE 
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L L  N   +   +        L  + LS+N L  + P     + +  +    + N  + 
Sbjct: 174 LNLQYNFIYD---VKGQVVFAKLKTLDLSSNKLAFMGP--EFQSAA-GVTWISLRNNKLV 227

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVE 183
             I + +    NL   DL GN  +   L      +  +   +    ++     +      
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII 243
                 G            + LIAL+                            + +  +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ-----------------GSETERL 328

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
             E         +     + + +I        +   L      L   +       + L+ 
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388

Query: 304 LNLSFNKL 311
                   
Sbjct: 389 TLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  104 bits (262), Expect = 4e-24
 Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 8/188 (4%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
           I E   N        +  + L  ++         ++ L L  N L      D+    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
            L L  N L         +L  LR L L +N     E+     +  +  + NN S +   
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNN--YVQELLVGPSIETLHAANNNISRV--- 114

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLEDL 304
                +  + ++L  N++  L     G    +++L+L  N +              LE L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 305 NLSFNKLE 312
           NL +N + 
Sbjct: 175 NLQYNFIY 182

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  102 bits (256), Expect = 2e-23
 Identities = 41/209 (19%), Positives = 83/209 (39%), Gaps = 10/209 (4%)

Query: 105 IGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV 164
           I    +  +  ++ + ++   +     +  N+  +DL GN L+      L+   KL+ L 
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG 224
           L  N L      D+  L  L  L+L  N +   +        ++  L   +N+   +   
Sbjct: 65  LSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCS 117

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLS 283
             +    I  + N  + +   + G    ++YL L  N +  +   +   +  +L+ LNL 
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
            N +   +   +   + L+ L+LS NKL 
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 24/140 (17%), Positives = 49/140 (35%), Gaps = 28/140 (20%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
           +I +           ++  + L +++ +   +   ++ L L                   
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDL------------------- 41

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
             S N  S I   ++     LE L L  N L   +     +L +L+ L+L+NN +     
Sbjct: 42  --SGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ---- 93

Query: 293 ASLEKLSYLEDLNLSFNKLE 312
             L     +E L+ + N + 
Sbjct: 94  -ELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 3/98 (3%)

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL 282
             N         + ++    +        N++ L L  N L  +          L+ LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGS 320
           S+N L       LE LS L  L+L+ N ++ E+  G S
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPS 100

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 19/71 (26%), Positives = 30/71 (42%)

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLE 302
           I +        +   +  + L+  +     +  ++K L+LS N LS    A L   + LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 303 DLNLSFNKLEG 313
            LNLS N L  
Sbjct: 62  LLNLSSNVLYE 72

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  122 bits (308), Expect = 4e-30
 Identities = 71/338 (21%), Positives = 121/338 (35%), Gaps = 33/338 (9%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
           ++  +DL  N +      +   +  L+ L ++  +    + + T   L +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPL-DGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
           F +L    + +   +L V+ L+   L   +L       L+ SLE   + + N+    P  
Sbjct: 91  FLQLE-TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPAS 148

Query: 130 I-GNLTNLITIDLGGNKLN----------GSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
              N+     +DL  NK+                TL +L  +    +++  L      + 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALR-----ILSLGSNDPLPLEIGNLKVLVGID 233
            +   +  L+L GN    S+   F + IA       ILS   N        N K      
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 234 F-------------SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
           F             S +    ++        +LE L L  N +  +  ++F  L  L  L
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
           NLS N L        E L  LE L+LS+N +   +   
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (302), Expect = 2e-29
 Identities = 76/331 (22%), Positives = 129/331 (38%), Gaps = 31/331 (9%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSL-SGSLSSITDVRLPNLEELV 65
            L +L  L L  N+    +    F  ++ L++L L   +L    LS      L +LE LV
Sbjct: 77  GLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLD----GILPKTSIGNLSH-SLEDFQMHNC 120
           L  NN  ++   S   N +   V+ L+ N +       L      + +   L    + + 
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195

Query: 121 NVTGDIPEEIGN---LTNLITIDLGGNKLNGS---ILITLSKLQKLQGLVLDDNKLEG-- 172
           N      E+ GN    T++ T+DL GN    S            K+Q L+L ++   G  
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255

Query: 173 -------SIPDDICR---LVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSNDPLPL 221
                     +   +      +   +L  +K+  ++    F++   L  L+L  N+   +
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKI 314

Query: 222 EIG---NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
           +      L  L+ ++ S N    I  +    L  LE L L YN ++ L   SF  L +LK
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
            L L  N L        ++L+ L+ + L  N
Sbjct: 375 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 61/291 (20%), Positives = 98/291 (33%), Gaps = 43/291 (14%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSI-TDVRLPNLEELV 65
            L +LE L LR N +    P + F N+    +L L  N +         + +  +   L 
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186

Query: 66  LWGNNFSELNFLS-------SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHS--LEDFQ 116
           L      ++N          +     S+T + LS N     + K     ++ +       
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 117 MHNCNVTGDIPEEIG-----------NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL 165
            ++ N+                      + + T DL  +K+   +    S    L+ L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306

Query: 166 DDNKLEGSIPDDIC-RLVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSN------- 216
             N++   I D+    L  L KL L  N L  SI +  F NL  L +L L  N       
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGD 364

Query: 217 ---DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQ 264
                LP    NLK L       N    +       L +L+ ++L  N   
Sbjct: 365 QSFLGLP----NLKEL---ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 80.6 bits (199), Expect = 3e-16
 Identities = 42/184 (22%), Positives = 68/184 (36%), Gaps = 27/184 (14%)

Query: 134 TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELGGN 192
            ++  +DL  N +      + S+LQ LQ L ++       I ++  R L  L  L+L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 193 KLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI-GGL 250
           +    +    FN L  L +L+L           NL               ++       L
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQC--------NLD------------GAVLSGNFFKPL 128

Query: 251 KNLEYLFLGYNRLQGLIPDS-FGNLISLKFLNLSNNNLSGAIPASLEKL--SYLEDLNLS 307
            +LE L L  N ++ + P S F N+     L+L+ N +       L      +   L LS
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188

Query: 308 FNKL 311
              L
Sbjct: 189 SITL 192

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.8 bits (197), Expect = 5e-16
 Identities = 48/279 (17%), Positives = 93/279 (33%), Gaps = 43/279 (15%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            ++  + L  N+ +ELN  +S S  + L  + +       ++                  
Sbjct: 30  AHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIR----------------- 71

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGS-IPDD 177
                         L++LI + L  N+         + L  L+ L L    L+G+ +  +
Sbjct: 72  --------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGN 123

Query: 178 I-CRLVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFS 235
               L  L  L L  N + +  PA  F N+    +L L  N    +   +L    G  F+
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183

Query: 236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-- 293
           +             L ++    +    L      +     S+  L+LS N    ++    
Sbjct: 184 LLR-----------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

Query: 294 -SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEG 331
                 + ++ L LS +   G      +F +    +F+G
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (306), Expect = 5e-30
 Identities = 44/177 (24%), Positives = 87/177 (49%), Gaps = 14/177 (7%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMK-SIRHRNLIK 474
           F   +++G G  G++    + D  +VAVK    +C   F   D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
              +  + +F+ + +E     +L++++   +      + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 535 VIHCDLKPSNVLL-----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           ++H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (299), Expect = 7e-30
 Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 10/170 (5%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNL--IKV 475
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
                 +++  +V+E      L   L      +D ++R +   ++  A+  +H      +
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 149 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (300), Expect = 2e-29
 Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 10/170 (5%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNL--IKV 475
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
                 +++  +V+E      L   L      +D ++R +   ++  A+  +H      +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM P
Sbjct: 177 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (292), Expect = 2e-29
 Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 12/175 (6%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVIS 477
            IG G +G   K R   DG  +  K  +         +    E  +++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 478 SCSNEEFKGL--VLEYMPQGSLEKHL---YSTNCILDIFQRLNIMIDVASALEYLH--FG 530
              +     L  V+EY   G L   +         LD    L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSP 185

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (301), Expect = 4e-29
 Identities = 56/307 (18%), Positives = 104/307 (33%), Gaps = 35/307 (11%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            I  L  L +L    N +     + +   + L  L    N L+    ++    L  L  L
Sbjct: 59  GIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT----NLDVTPLTKLTYL 111

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
               N  ++L+     S    LT +  + N L  I     + + +  L +   H      
Sbjct: 112 NCDTNKLTKLDV----SQNPLLTYLNCARNTLTEI----DVSHNT-QLTELDCHLNKKIT 162

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
            +   +   T L T+D   NK+     + +S+ + L  L  D N +   +  D+ + ++L
Sbjct: 163 KLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQL 214

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
             L+   NKL+  I      L  L       N    L++  L  L  +     +   I  
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEI-- 269

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
            ++     L Y        + +      +   L  L+     ++      L +   L  L
Sbjct: 270 -DLTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYL 323

Query: 305 NLSFNKL 311
            L+  +L
Sbjct: 324 YLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (296), Expect = 1e-28
 Identities = 53/309 (17%), Positives = 105/309 (33%), Gaps = 35/309 (11%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE 63
           L++    NL  L    NKL     + +  ++ L  L    N     L+ +   + P L  
Sbjct: 79  LDLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTN----KLTKLDVSQNPLLTY 131

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L    N  +E++    +S+   LT +    N     L    +   +  L         +T
Sbjct: 132 LNCARNTLTEID----VSHNTQLTELDCHLNKKITKLD---VTPQT-QLTTLDCSFNKIT 183

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVE 183
                ++     L  ++   N +     + L++  +L  L    NKL   I  D+  L +
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EI--DVTPLTQ 234

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII 243
           L   +   N L+  +    + L  L  L     D L +++ +   L+            +
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL 291

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED 303
             ++     L  L      +  L          L +L L+N  L+  +   +   + L+ 
Sbjct: 292 --DVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343

Query: 304 LNLSFNKLE 312
           L+     ++
Sbjct: 344 LSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  110 bits (277), Expect = 4e-26
 Identities = 57/323 (17%), Positives = 110/323 (34%), Gaps = 50/323 (15%)

Query: 10  QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
            N         ++  T  ++   ++TL  L   ++S++  ++ I    L  L +L+   N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEK--LTGLTKLICTSN 74

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
           N + L+     S   +LT +   +N L  +     +  L+  L         +T     +
Sbjct: 75  NITTLDL----SQNTNLTYLACDSNKLTNL----DVTPLT-KLTYLNCDTNKLTKL---D 122

Query: 130 IGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLEL 189
           +     L  ++   N L     I +S   +L  L    NK    +  D+    +L  L+ 
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177

Query: 190 GGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGG 249
             NK++  +    +    L  L+  +N+   L++     L  +D S N  + I   ++  
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEI---DVTP 231

Query: 250 LKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS--------------- 294
           L  L Y     N L  L       L  L  L+    +L   I  +               
Sbjct: 232 LTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRK 287

Query: 295 -----LEKLSYLEDLNLSFNKLE 312
                +   + L  L+     + 
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 97.8 bits (244), Expect = 6e-22
 Identities = 51/318 (16%), Positives = 110/318 (34%), Gaps = 35/318 (11%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE 63
           +++ +   L ELD   NK I  +   +   + L  L    N ++     +   +   L  
Sbjct: 142 IDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT----ELDVSQNKLLNR 195

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L    NN ++L+     +    LT +  S+N L  I     +  L+  L  F      +T
Sbjct: 196 LNCDTNNITKLDL----NQNIQLTFLDCSSNKLTEI----DVTPLT-QLTYFDCSVNPLT 246

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVE 183
            ++   +  L+ L T+      L     I L+   +L     +  +    +  D+    +
Sbjct: 247 -ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQ 298

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII 243
           LY L+     ++  +    +    L  L L + +   L++ +   L  +     +     
Sbjct: 299 LYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQDF- 354

Query: 244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL-----ISLKFLNLSNNNLSGAIPASLEKL 298
              +G +  L   F    +   +  ++  N      +S   L+   N ++  I      +
Sbjct: 355 -SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGV 411

Query: 299 SYLEDLNLSFNKLEGEIP 316
                  +++  L  + P
Sbjct: 412 YDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 24/149 (16%), Positives = 52/149 (34%), Gaps = 19/149 (12%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            L++ +   L  LD +   +     + +     L  L L +  L+     +       L+
Sbjct: 290 ELDVTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT----ELDVSHNTKLK 342

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L     +  +    SS+    +L     +       +PK ++ N S ++         V
Sbjct: 343 SLSCVNAHIQD---FSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTI--------AV 390

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSIL 151
           + D+ ++ GN  N+   D G      + +
Sbjct: 391 SPDLLDQFGNPMNIEPGDGGVYDQATNTI 419

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (305), Expect = 4e-29
 Identities = 37/175 (21%), Positives = 75/175 (42%), Gaps = 25/175 (14%)

Query: 421 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKVI 476
            I  GG G +Y A    + +G  V +K          ++    E + +  + H +++++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 477 SSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           +   + +  G     +V+EY+   SL++        L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           S  +++ DLKP N++L +  +  L D G           +        T G+ AP
Sbjct: 200 SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS-------RINSFGYLYGTPGFQAP 246

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (295), Expect = 4e-29
 Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 10/170 (5%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNL--IKV 475
             IG GG   V++         A+K  NL+    +   S+  E   +  ++  +   I++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
                 +++  +V+E      L   L      +D ++R +   ++  A+  +H      +
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 130 VHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (291), Expect = 4e-29
 Identities = 48/193 (24%), Positives = 82/193 (42%), Gaps = 28/193 (14%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH 469
           R    F E  LIG GGFG V+KA+   DG    +K       +A +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 470 RNLIKVISSCSNEEFKG----------------LVLEYMPQGSLEKHLYSTNCI-LDIFQ 512
            N++         ++                  + +E+  +G+LE+ +       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 513 RLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
            L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L        
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGK 177

Query: 573 QTQTLATIGYMAP 585
           +T++  T+ YM+P
Sbjct: 178 RTRSKGTLRYMSP 190

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  116 bits (293), Expect = 7e-29
 Identities = 38/169 (22%), Positives = 74/169 (43%), Gaps = 9/169 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVIS 477
            IG G FG     +   DG +  +K  N+     +  +    E  ++ +++H N+++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHL-YSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           S        +V++Y   G L K +      +    Q L+  + +  AL+++H      ++
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H D+K  N+ L  +    L DFGIA++L      + +     T  Y++P
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSP 194

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (294), Expect = 9e-29
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 5/166 (3%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IGRG FG V+  RL  D   VAVK             F  E  I+K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
           + ++   +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           L   N L+ +  +  +SDFG+++       + +       + + AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (289), Expect = 9e-29
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           ++G+G +G VY  R L + + +A+K    +  R  +    E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL--NIMIDVASALEYLHFGCSTPVIH 537
           S   F  + +E +P GSL   L S    L   ++        +   L+YLH      ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 538 CDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
            D+K  NVL++  + +  +SDFG +K L G       T+T   T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAP 192

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  119 bits (299), Expect = 1e-28
 Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 58/322 (18%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNL 61
           I L I N  +L   +   N + GT           +   L   + + ++S + +  +   
Sbjct: 3   IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN 121
            EL L   N S L    +L     +TV+ ++ N L                         
Sbjct: 62  SELQLNRLNLSSLP--DNL--PPQITVLEITQNALI------------------------ 93

Query: 122 VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRL 181
               +PE   +L  L   D   N+L+ ++    + L+ L    +D+N+L   +P+    L
Sbjct: 94  ---SLPELPASLEYL---DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALL 142

Query: 182 VELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNF 239
             +       N+L+  +P    +   L +LS+ +N    LP    +L+ L   D S N  
Sbjct: 143 EYIN---ADNNQLT-MLPELPTS---LEVLSVRNNQLTFLPELPESLEAL---DVSTNLL 192

Query: 240 SGIIPKEIGGLKNLE----YLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL 295
              +P       + E    +     NR+  + P++  +L     + L +N LS  I  SL
Sbjct: 193 ES-LPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESL 250

Query: 296 EKLSYLEDLNLSFNKLEGEIPR 317
            + +   D +           +
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 73.1 bits (179), Expect = 8e-14
 Identities = 43/206 (20%), Positives = 70/206 (33%), Gaps = 34/206 (16%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRL-- 58
            +P  +     +  L++ QN LI ++P    ++  L     + ++L    +S+  + +  
Sbjct: 73  SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDN 129

Query: 59  ----------PNLEELVLWGNNFSEL--------------NFLSSLSNC-KSLTVIGLSN 93
                       LE +    N  + L              N L+ L    +SL  + +S 
Sbjct: 130 NQLTMLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVST 189

Query: 94  NPLDGILPKTSIGNLSHSLEDFQMHNC--NVTGDIPEEIGNLTNLITIDLGGNKLNGSIL 151
           N L+  LP        HS E      C  N    IPE I +L    TI L  N L+  I 
Sbjct: 190 NLLES-LPA-VPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIR 247

Query: 152 ITLSKLQKLQGLVLDDNKLEGSIPDD 177
            +LS+                S    
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (286), Expect = 4e-28
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 12/179 (6%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK---VFNLQCRRAFKSFDVECEIMKSIRH 469
             F     IGRG F  VY+A  L DG+ VA+K   +F+L   +A      E +++K + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF---QRLNIMIDVASALEY 526
            N+IK  +S   +    +VLE    G L + +        +          + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H   S  V+H D+KP+NV +    +  L D G+ +       +   +    T  YM+P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (284), Expect = 4e-28
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 20/178 (11%)

Query: 419 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +  IGRG F +VYK       +EVA          +   + F  E E++K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 476 ISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
             S  +         LV E M  G+L K       ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 532 STPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           + P+IH DLK  N+ +        + D G+A L          +   A IG   +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAP 199

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (286), Expect = 5e-28
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 14/171 (8%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             +GRG FG V++ +    G + AVK   L+  R       E      +    ++ +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                +  + +E +  GSL + +    C L   + L  +      LEYLH   +  ++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 539 DLKPSNVLLDDN-MIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           D+K  NVLL  +   A L DFG A  L  +    +        G   +MAP
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  113 bits (286), Expect = 5e-28
 Identities = 48/199 (24%), Positives = 80/199 (40%), Gaps = 23/199 (11%)

Query: 396 PLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGME-----VAVKVFNLQC 450
           P  A+ R     E  +         ++G G FG+VYK       E     VA+K      
Sbjct: 4   PNQALLRILKETEFKKI-------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 451 -RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD 509
             +A K    E  +M S+ + ++ +++  C     + L+ + MP G L  ++      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115

Query: 510 IFQRLNIMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG 566
               LN  + +A  + YL           +H DL   NVL+       ++DFG+AKLL  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 567 EDQSMTQTQTLATIGYMAP 585
           E++          I +MA 
Sbjct: 170 EEKEYHAEGGKVPIKWMAL 188

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (286), Expect = 6e-28
 Identities = 78/314 (24%), Positives = 123/314 (39%), Gaps = 30/314 (9%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
           +L  +      L   VP  I       LL LQ+N +S  L       L +L  LVL  N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
            S+++   + S  + L  + +S N L  I P     NL  SL + ++H+  +   +P+ +
Sbjct: 90  ISKIHE-KAFSPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIR-KVPKGV 142

Query: 131 -GNLTNLITIDLGGNKLNGSIL--ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
              L N+  I++GGN L  S         L KL  L + + KL   IP D+     L +L
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNEL 198

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG---NLKVLVGIDFSMNNFSGIIP 244
            L  NK+             L  L LG N    +E G    L  L  +    N  S  +P
Sbjct: 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSF------GNLISLKFLNLSNNNLSGAI--PASLE 296
             +  LK L+ ++L  N +  +  + F              ++L NN +      PA+  
Sbjct: 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317

Query: 297 KLSYLEDLNLSFNK 310
            ++    +     K
Sbjct: 318 CVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  110 bits (276), Expect = 1e-26
 Identities = 61/287 (21%), Positives = 97/287 (33%), Gaps = 46/287 (16%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           P+   L L  N+ SEL         + L  + L NN +  I  K            F   
Sbjct: 54  PDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHEKA-----------FS-- 99

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                         L  L  + +  N L     I  +    L  L + DN++   +P  +
Sbjct: 100 -------------PLRKLQKLYISKNHLV---EIPPNLPSSLVELRIHDNRIR-KVPKGV 142

Query: 179 CR-LVELYKLELGGNKLSRSI--PACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFS 235
              L  +  +E+GGN L  S   P  F+ L  L  L +       +     + L  +   
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLD 201

Query: 236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL 295
            N    I  +++     L  L LG+N+++ +   S   L +L+ L+L NN LS  +PA L
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260

Query: 296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQ 342
             L  L+ + L  N +                 F             
Sbjct: 261 PDLKLLQVVYLHTNNIT----------KVGVNDFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  106 bits (266), Expect = 2e-25
 Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 33/283 (11%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            LQ+L  L L  NK I  +    F  +  L+ L +  N     L  I      +L EL +
Sbjct: 76  GLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYISKN----HLVEIPPNLPSSLVELRI 130

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPL-DGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
             N   ++      S  +++  I +  NPL +      +   L   L   ++    +T  
Sbjct: 131 HDNRIRKVP-KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL--KLNYLRISEAKLT-G 186

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVEL 184
           IP+       L  + L  NK+    L  L +  KL  L L  N++   I +     L  L
Sbjct: 187 IPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTL 243

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
            +L L  NKLS  +PA   +L  L+++ L +N        N+  +      +N+F  +  
Sbjct: 244 RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN--------NITKV-----GVNDFCPVGF 289

Query: 245 KEIGGLKNLEYLFLGYNRLQ--GLIPDSFGNLISLKFLNLSNN 285
                      + L  N +    + P +F  +     +   N 
Sbjct: 290 GV--KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 18/239 (7%)

Query: 85  SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGN 144
            L V+  S+  L  + PK     +S       + N +++    ++   L +L  + L  N
Sbjct: 34  HLRVVQCSDLGLKAV-PK----EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88

Query: 145 KLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNN 204
           K++       S L+KLQ L +  N L   IP ++     L +L +  N++ +     F+ 
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSG 145

Query: 205 LIALRILSLGSN--DPLPLEIG---NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLG 259
           L  +  + +G N  +    E G    LK L  +  S    +GI        + L  L L 
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPK---DLPETLNELHLD 201

Query: 260 YNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
           +N++Q +  +       L  L L +N +      SL  L  L +L+L  NKL   +P G
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 27/164 (16%)

Query: 160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL 219
           L+ +   D  L+ ++P +I    +   L+L  N +S      F  L  L  L L +N   
Sbjct: 35  LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN--- 88

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                               S I  K    L+ L+ L++  N L  + P+   +L+ L  
Sbjct: 89  ------------------KISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVEL-- 128

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
             + +N +          L  +  + +  N LE      G+F  
Sbjct: 129 -RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  112 bits (282), Expect = 1e-27
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 15/172 (8%)

Query: 421 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDVECEIMKSIRHRNLIK 474
           L+GRGG G VY+A          VA+K+ +        F++    E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +      +    + +  +    L   +      L   + + I+  + SAL+  H   +  
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
             H D+KP N+L+  +  AYL DFGIA      D+ +TQ    + T+ YMAP
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  110 bits (278), Expect = 2e-27
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 15/169 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           IG G FG V+     +  +VA+K           F     E E+M  + H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCSTPVI 536
             +    LV E+M  G L  +L +   +      L + +DV   + YL           I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   N L+ +N +  +SDFG+ +  + +DQ  + T T   + + +P
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASP 174

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (279), Expect = 2e-27
 Identities = 46/164 (28%), Positives = 62/164 (37%), Gaps = 17/164 (10%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V +       G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGC 531
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
               IH DL   N+LL    +  + DFG+ + L   D      +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  111 bits (280), Expect = 2e-27
 Identities = 43/184 (23%), Positives = 67/184 (36%), Gaps = 21/184 (11%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDVECEI 463
                F   + +G G +G V+K R   DG   AVK             R       E   
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA----EVGS 109

Query: 464 MKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
            + + +H   +++  +        L  E     SL++H  +    L   Q    + D   
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIG 581
           AL +LH   S  ++H D+KP+N+ L       L DFG+   L     +    +       
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPR 221

Query: 582 YMAP 585
           YMAP
Sbjct: 222 YMAP 225

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (280), Expect = 2e-27
 Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 18/183 (9%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRN 471
             +  ++++G+G   +V++ R    G   A+KVFN +   R       E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 472 LIK---VISSCSNEEFKGLVLEYMPQGSLEKHLYS--TNCILDIFQRLNIMIDVASALEY 526
           ++K   +    +      L++E+ P GSL   L        L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 527 LHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           L       ++H ++KP N++     D   +  L+DFG A+ L  ED     +    T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEY 181

Query: 583 MAP 585
           + P
Sbjct: 182 LHP 184

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  111 bits (279), Expect = 3e-27
 Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 30/201 (14%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH 469
           R    F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61

Query: 470 RNLIKVISSCSNEEFKG-------------LVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
           + +++  ++                     + +EY   G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL--------IGED 568
              +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK +        +   
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 569 QSMTQTQTLAT-IG---YMAP 585
                +  L + IG   Y+A 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  111 bits (280), Expect = 3e-27
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 16/173 (9%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG+V+K           + V +KV   +  R++F++       + S+ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCS 532
           +  C     + LV +Y+P GSL  H+      L     LN  + +A  + YL        
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA 
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  109 bits (274), Expect = 5e-27
 Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 15/169 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +G G FG V   +     +VAVK+          F     E + M  + H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCSTPVI 536
           S E    +V EY+  G L  +L S    L+  Q L +  DV   + +L    F      I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   N L+D ++   +SDFG+ +  + +DQ ++   T   + + AP
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAP 174

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (276), Expect = 5e-27
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 17/177 (9%)

Query: 420 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
            +IGRG FG VY   L    G  +  AVK  N          F  E  IMK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 475 VISSCSNEEFKGL-VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFG 530
           ++  C   E   L VL YM  G L   + +      +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED--QSMTQTQTLATIGYMAP 585
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (281), Expect = 1e-26
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 29/192 (15%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIM-KSIRHRNLIK 474
                ++G G  G+V       G  VAVK   +          +E +++ +S  H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 475 VISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNC-ILDIFQRLNIMIDVASALEYLH 528
              S + + F  + LE     +L      K++   N  +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 529 FGCSTPVIHCDLKPSNVLLD-------------DNMIAYLSDFGIAKLLIGEDQSMTQTQ 575
              S  +IH DLKP N+L+              +N+   +SDFG+ K L     S     
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 576 TLA--TIGYMAP 585
                T G+ AP
Sbjct: 190 NNPSGTSGWRAP 201

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  108 bits (273), Expect = 1e-26
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +G G FG V   +     +VA+K+          F     E ++M ++ H  L+++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVC 88

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCSTPVI 536
           + +    ++ EYM  G L  +L          Q L +  DV  A+EYL    F      +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DL   N L++D  +  +SDFG+++  + +D+  +   +   + +  P
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPP 190

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  109 bits (274), Expect = 1e-26
 Identities = 41/204 (20%), Positives = 81/204 (39%), Gaps = 35/204 (17%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL----QCRRAFKSFDVECEIMK 465
           R    F     +GRGGFG V++A+   D    A+K   L      R        E + + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALA 58

Query: 466 SIRHRNLIKVISSCSNEEFKG------------LVLEYMPQGSLEKHL--YSTNCILDIF 511
            + H  +++  ++   +                + ++   + +L+  +    T    +  
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
             L+I + +A A+E+LH   S  ++H DLKPSN+    + +  + DFG+   +  +++  
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 572 TQTQTLATIG----------YMAP 585
           T    +              YM+P
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSP 199

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (273), Expect = 1e-26
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 11/172 (6%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G+G FGSV   R        G  VAVK          + F+ E EI+KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 477 SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
            IH DL   N+L+++     + DFG+ K+L   ++    +    + I + AP
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (273), Expect = 1e-26
 Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 20/177 (11%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G FG V   R        G +VAVK              K    E EI++++ H N+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENI 85

Query: 473 IKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +K    C+ +   G  L++E++P GSL+++L      +++ Q+L   + +   ++YL   
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG-- 143

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAP 585
            S   +H DL   NVL++      + DFG+ K  I  D+     +      + + AP
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAP 198

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (273), Expect = 1e-26
 Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 9/219 (4%)

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILI--TLSKLQKLQGLV 164
            +  S    ++ +  +          LT L  + L  N L+       +      L+ L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPAC-FNNLIALRILSLGSN--DPLPL 221
           L  N +  ++  +   L +L  L+   + L +      F +L  L  L +          
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143

Query: 222 EI-GNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
            I   L  L  +  + N+F      +I   L+NL +L L   +L+ L P +F +L SL+ 
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
           LN+S+NN         + L+ L+ L+ S N +     + 
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (258), Expect = 2e-24
 Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 55/292 (18%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLS-GSLSSITDVRL 58
            +P  I    +   L+L  NK + ++P  +F  ++ L  L L  N LS     S +D   
Sbjct: 21  SVPTGI--PSSATRLELESNK-LQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            +L+ L L  N    ++  S+    + L  +   ++ L  +   +           F   
Sbjct: 78  TSLKYLDLSFNGVITMS--SNFLGLEQLEHLDFQHSNLKQMSEFSV----------FL-- 123

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                        +L NLI +D+       +     + L  L+ L +  N  + +   DI
Sbjct: 124 -------------SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170

Query: 179 -CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMN 237
              L  L  L+L   +L +  P  FN+L +L++L++                       N
Sbjct: 171 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH---------------------N 209

Query: 238 NFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI-SLKFLNLSNNNLS 288
           NF  +       L +L+ L    N +         +   SL FLNL+ N+ +
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (280), Expect = 1e-26
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 7/167 (4%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
           S E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H 
Sbjct: 249 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DL+ +N+L+ +N++  ++DFG+A+ LI +++   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 350

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 2e-26
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 18/176 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLIK---V 475
           ++G+G   +V++ R    G   A+KVFN +   R       E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYS--TNCILDIFQRLNIMIDVASALEYLHFGCST 533
               +      L++E+ P GSL   L        L   + L ++ DV   + +L      
Sbjct: 76  EEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 534 PVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++H ++KP N++     D   +  L+DFG A+ L  ED     +    T  Y+ P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHP 184

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 2e-26
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 11/172 (6%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G+G FGSV   R        G  VAVK          + F+ E EI+KS++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 477 SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
            IH DL   N+L+++     + DFG+ K+L   ++    +    + I + AP
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  111 bits (280), Expect = 2e-26
 Identities = 40/167 (23%), Positives = 83/167 (49%), Gaps = 7/167 (4%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
           + E    ++ E+M +GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DL+ +N+L+  +++  ++DFG+A+ +I +++   +      I + AP
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 354

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (281), Expect = 2e-26
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 11/170 (6%)

Query: 420 NLIGRGGFGSVYKARL-GDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           + +G G +G VY+       + VAVK    +      F     E  +MK I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLL 282

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             C+ E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           IH +L   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  108 bits (272), Expect = 2e-26
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 20/157 (12%)

Query: 422 IGRGGFGSVYKARL---GDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FGSV +         ++VA+KV                  E +IM  + +  +++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVR 74

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGC 531
           +I  C  E    LV+E    G L K L      + +     ++  V+  ++YL   +F  
Sbjct: 75  LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF-- 131

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
               +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 132 ----VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (272), Expect = 2e-26
 Identities = 40/179 (22%), Positives = 78/179 (43%), Gaps = 17/179 (9%)

Query: 418 ENNLIGRGGFGSVYKARLGDG----MEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNL 472
            + +IG+G FG VY     D     ++ A+K  +     +  ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 473 IKVISSCSNEE-FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---H 528
           + +I      E    ++L YM  G L + + S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED--QSMTQTQTLATIGYMAP 585
           F      +H DL   N +LD++    ++DFG+A+ ++  +             + + A 
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (276), Expect = 2e-26
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 420 NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
            +IGRG FG VY   L    G  +  AVK  N          F  E  IMK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 475 VISSCSNEEFKGL-VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFG 530
           ++  C   E   L VL YM  G L   + +      +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAP 585
                +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA 
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (280), Expect = 2e-26
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 7/167 (4%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
           S E    +V EYM +GSL   L       L + Q +++   +AS + Y+        +H 
Sbjct: 332 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DL+ +N+L+ +N++  ++DFG+A+ LI +++   +      I + AP
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (273), Expect = 3e-26
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 16/173 (9%)

Query: 422 IGRGGFGSVYKARLGDGME-----VAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG+VYK       E     VA+K        +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCS 532
           +  C     + L+ + MP G L  ++      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  108 bits (271), Expect = 3e-26
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 15/172 (8%)

Query: 421 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDVECEIMKSIRHRNLIK 474
            +G GG  +VY A    L   ++VA+K   +  R        F+ E      + H+N++ 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +I     ++   LV+EY+   +L      ++  L +   +N    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
           ++H D+KP N+L+D N    + DFGIAK L   + S+TQT   L T+ Y +P
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (269), Expect = 4e-26
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 422 IGRGGFGSVYKARL-GDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +G G +G VY+       + VAVK    +      F     E  +MK I+H NL++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
           C+ E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL        IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DL   N L+ +N +  ++DFG+++ L+  D           I + AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (271), Expect = 5e-26
 Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 22/186 (11%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISS 478
           ++  GGF  VY+A+ +G G E A+K          ++   E   MK +  H N+++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 479 CSNEEFKG-------LVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHF 529
            S  + +        L+L  + +G L + L        L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA----------T 579
               P+IH DLK  N+LL +     L DFG A  +          Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 580 IGYMAP 585
             Y  P
Sbjct: 214 PMYRTP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  107 bits (270), Expect = 5e-26
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 15/173 (8%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G  G V   RL       + VA+K        R  + F  E  IM    H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCST 533
              +      +V EYM  GSL+  L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG-EDQSMTQTQTLATIGYMAP 585
             +H DL   NVL+D N++  +SDFG++++L    D + T T     I + AP
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (278), Expect = 7e-26
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 14/154 (9%)

Query: 422 IGRGGFGSVYKARL---GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G G FGSV +         ++VA+KV      +   +    E +IM  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCSTP 534
            C  E    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
            +H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (279), Expect = 7e-26
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 19/177 (10%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIK---VI 476
           +G GGFG V +      G +VA+K    +   +  + + +E +IMK + H N++    V 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 477 SSCSNEEFKG---LVLEYMPQGSLEKHL--YSTNCILDIFQRLNIMIDVASALEYLHFGC 531
                        L +EY   G L K+L  +   C L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 532 STPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +IH DLKP N++L      +I  + D G AK L  +   +     + T+ Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAP 192

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 7e-26
 Identities = 55/280 (19%), Positives = 102/280 (36%), Gaps = 22/280 (7%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
            ++ LDL  N+ I  +  +       L+ L L  N ++ ++   +   L +LE L L  N
Sbjct: 53  AVKSLDLSNNR-ITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
             S L+  S      SLT + L  NP   +   +   +L+  L+  ++ N +    I  +
Sbjct: 111 YLSNLS-SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT-KLQILRVGNMDTFTKIQRK 168

Query: 130 I-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKL 187
               LT L  +++  + L      +L  +Q +  L+L   +    + +        +  L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI 247
           EL    L                LS G  + L            +  +  +   +  K +
Sbjct: 228 ELRDTDLDT---------FHFSELSTGETNSLI----KKFTFRNVKITDESLFQV-MKLL 273

Query: 248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
             +  L  L    N+L+ +    F  L SL+ + L  N  
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 59/311 (18%), Positives = 110/311 (35%), Gaps = 65/311 (20%)

Query: 19  QNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLS 78
            +  + ++P  +     +K L L +N ++  +S+    R  NL+ LVL  N  + +    
Sbjct: 39  SSGSLNSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEE-D 94

Query: 79  SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT 138
           S S+  SL  + LS N L  +               F+                L++L  
Sbjct: 95  SFSSLGSLEHLDLSYNYLSNLSSSW-----------FK---------------PLSSLTF 128

Query: 139 IDLGGNKLNGSIL--ITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKLELGGNKLS 195
           ++L GN    ++      S L KLQ L + +      I       L  L +LE+  + L 
Sbjct: 129 LNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187

Query: 196 RSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY 255
              P    ++  +  L L              +L+ I                   ++E 
Sbjct: 188 SYEPKSLKSIQNVSHLILHMK--------QHILLLEIFVD-------------VTSSVEC 226

Query: 256 LFLGYNRLQG--------LIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
           L L    L             +S     + + + +++ +L   +   L ++S L +L  S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285

Query: 308 FNKLEGEIPRG 318
            N+L+  +P G
Sbjct: 286 RNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 1/91 (1%)

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
           D S N  + I   ++    NL+ L L  N +  +  DSF +L SL+ L+LS N LS    
Sbjct: 58  DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS 117

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
           +  + LS L  LNL  N  +  +     F +
Sbjct: 118 SWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 28/148 (18%), Positives = 56/148 (37%), Gaps = 13/148 (8%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L  LEEL++  + L    P ++ ++  +  L L        L  I      ++E L L 
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230

Query: 68  GNNFSELNFLS-------SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
             +    +F         SL    +   + +++  L  ++   +   +S  L + +    
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN--QIS-GLLELEFSRN 287

Query: 121 NVTGDIPEEI-GNLTNLITIDLGGNKLN 147
            +   +P+ I   LT+L  I L  N  +
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  106 bits (267), Expect = 8e-26
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 25/177 (14%)

Query: 422 IGRGGFGSVYKARL---GDGMEVAVKV-----FNLQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G G FG+V K           VAVK+      +   +    +   E  +M+ + +  ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPYIV 81

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFG 530
           ++I  C  E +  LV+E    G L K+L   N  +     + ++  V+  ++YL   +F 
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF- 138

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAP 585
                +H DL   NVLL     A +SDFG++K  +  D++  + QT     + + AP
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAP 189

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (267), Expect = 1e-25
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 25/183 (13%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FGSV +  L    G  ++VAVK   L    +R  + F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 476 ISSCSNEEFKG-----LVLEYMPQGSLEKHL-----YSTNCILDIFQRLNIMIDVASALE 525
           +  C     +G     ++L +M  G L  +L      +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 526 YL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           YL   +F      +H DL   N +L D+M   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 583 MAP 585
           +A 
Sbjct: 216 IAI 218

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (268), Expect = 1e-25
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 10/154 (6%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G+G FGSV   R        G  VAVK          + F  E +I+K++    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 477 SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
                   +   LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
            +H DL   N+L++      ++DFG+AKLL  + 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  105 bits (265), Expect = 1e-25
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 11/167 (6%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVF--NLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +G G FG V+        +VAVK          AF +   E  +MK ++H+ L+++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
           + E    ++ EYM  GSL   L + +   L I + L++   +A  + ++        IH 
Sbjct: 78  TQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DL+ +N+L+ D +   ++DFG+A+ LI +++   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (265), Expect = 1e-25
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFN----LQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G G FG VY+       G+ + VAVK       L  +  F S   E  IMK++ H +++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHPHIV 76

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFG 530
           K+I     E    +++E  P G L  +L      L +   +   + +  A+ YL   +  
Sbjct: 77  KLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                +H D+   N+L+       L DFG+++  I ++     + T   I +M+P
Sbjct: 135 -----VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 183

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  107 bits (269), Expect = 2e-25
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 15/173 (8%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G G FG V   RL       + VA+K   +    +  + F  E  IM    H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCST 533
              +  +   +V EYM  GSL+  L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
             +H DL   N+L++ N++  +SDFG+ ++L    + + T       I + +P
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (271), Expect = 2e-25
 Identities = 70/255 (27%), Positives = 108/255 (42%), Gaps = 33/255 (12%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            N   L L  N    +   +S  + + L ++ LS N +  I               F   
Sbjct: 64  TNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGA-----------FN-- 109

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                         L NL T++L  N+L          L KL+ L L +N +E SIP   
Sbjct: 110 -------------GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155

Query: 179 -CRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDF 234
             R+  L +L+LG  K    I    F  L  LR L+L       +P  +  L  L  +D 
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELDL 214

Query: 235 SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS 294
           S N+ S I P    GL +L+ L++  +++Q +  ++F NL SL  +NL++NNL+      
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274

Query: 295 LEKLSYLEDLNLSFN 309
              L +LE ++L  N
Sbjct: 275 FTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (271), Expect = 2e-25
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 33/279 (11%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
              ++   +  L   VP  I   +  +LL L +N +   +   +   L +LE L L  N+
Sbjct: 44  QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
              +    + +   +L  + L +N L  I P  +   L   L++  + N  +   IP   
Sbjct: 100 IRTIEI-GAFNGLANLNTLELFDNRLTTI-PNGAFVYL-SKLKELWLRNNPIE-SIPSYA 155

Query: 131 -GNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLE 188
              + +L  +DLG  K    I       L  L+ L L    L   IP+ +  L++L +L+
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213

Query: 189 LGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
           L GN LS   P  F  L+ L+ L +  +                         I      
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQS---------------------QIQVIERNAFD 252

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
            L++L  + L +N L  L  D F  L  L+ ++L +N  
Sbjct: 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.4 bits (235), Expect = 8e-21
 Identities = 51/188 (27%), Positives = 78/188 (41%), Gaps = 25/188 (13%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELG 190
           +L +L  + L  N +    +   + L  L  L L DN+L  +IP+     L +L +L L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144

Query: 191 GNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGL 250
            N +       FN + +LR L LG                         S I      GL
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGEL--------------------KRLSYISEGAFEGL 184

Query: 251 KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNK 310
            NL YL L    L+ +   +   LI L  L+LS N+LS   P S + L +L+ L +  ++
Sbjct: 185 SNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242

Query: 311 LEGEIPRG 318
           ++  I R 
Sbjct: 243 IQ-VIERN 249

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 44/162 (27%), Positives = 63/162 (38%), Gaps = 7/162 (4%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L  L+EL LR N  I ++P   F  + +L+ L L +      +S      L NL  L L
Sbjct: 134 YLSKLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
              N  E+  L+ L     L  + LS N L  I    S   L   L+   M    +    
Sbjct: 193 AMCNLREIPNLTPLIK---LDELDLSGNHLSAI-RPGSFQGL-MHLQKLWMIQSQIQVIE 247

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
                NL +L+ I+L  N L        + L  L+ + L  N
Sbjct: 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 38/161 (23%), Positives = 58/161 (36%), Gaps = 26/161 (16%)

Query: 159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDP 218
           +   ++     L   +PD I        L L  N++       F +L  L IL L  N  
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-- 98

Query: 219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
                 +++ +    F+             GL NL  L L  NRL  +   +F  L  LK
Sbjct: 99  ------HIRTIEIGAFN-------------GLANLNTLELFDNRLTTIPNGAFVYLSKLK 139

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLS-FNKLEGEIPRG 318
            L L NN +      +  ++  L  L+L    +L   I  G
Sbjct: 140 ELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEG 179

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 23/90 (25%), Positives = 37/90 (41%), Gaps = 2/90 (2%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L  L+ELDL  N L    P +   +  L+ L +  + +   +       L +L E+ L 
Sbjct: 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLA 263

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
            NN + L      +    L  I L +NP +
Sbjct: 264 HNNLTLLPH-DLFTPLHHLERIHLHHNPWN 292

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  105 bits (264), Expect = 2e-25
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 25/166 (15%)

Query: 422 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
           +G+G F  ++K               EV +KV +   R   +SF     +M  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFG 530
                C   +   LV E++  GSL+ +L      ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 531 CSTPVIHCDLKPSNVLLD--------DNMIAYLSDFGIAKLLIGED 568
                IH ++   N+LL         +     LSD GI+  ++ +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (263), Expect = 2e-25
 Identities = 40/172 (23%), Positives = 70/172 (40%), Gaps = 16/172 (9%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V++          + VA+K           + F  E   M+   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCST 533
              +      +++E    G L   L      LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+   NVL+  N    L DFG+++  + +      ++    I +MAP
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 186

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  105 bits (264), Expect = 4e-25
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 26/184 (14%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKV 475
           +G+G FGSV +A+L    G  ++VAVK+           + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 476 ISSCSNEEFKG------LVLEYMPQGSLEKHL-----YSTNCILDIFQRLNIMIDVASAL 524
           +        KG      ++L +M  G L   L           L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 525 EYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 582 YMAP 585
           ++A 
Sbjct: 205 WLAL 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (268), Expect = 5e-25
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 8/143 (5%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG+G FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 482 EEFKG-LVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
           E+    +V EYM +GSL  +L S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 540 LKPSNVLLDDNMIAYLSDFGIAK 562
           L   NVL+ ++ +A +SDFG+ K
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK 337

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (262), Expect = 5e-25
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)

Query: 421 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCRR--AFKS-FDVECEIMKSIRHRNLIK 474
           ++G GG   V+ A   R     +VAVKV      R  +F   F  E +   ++ H  ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 475 VISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           V  +   E   G    +V+EY+   +L + +  T   +   + + ++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAP 585
               +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y++P
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (263), Expect = 5e-25
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 16/174 (9%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKV 475
           IG G FG VYK  L        + VA+K        +    F  E  IM    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCS 532
               S  +   ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQ-TLATIGYMAP 585
              +H DL   N+L++ N++  +SDFG++++L  + ++   T      I + AP
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (268), Expect = 6e-25
 Identities = 56/212 (26%), Positives = 83/212 (39%), Gaps = 11/212 (5%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELG 190
           +L +L  + LG N +    +   + L  L  L L DN L   IP      L +L +L L 
Sbjct: 97  HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLR 155

Query: 191 GNKLSRSIPACFNNLIALRILSLGSNDPL-PLEIG---NLKVLVGIDFSMNNFSGIIPKE 246
            N +       FN + +L  L LG    L  +  G    L  L  ++  M N   +    
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PN 213

Query: 247 IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNL 306
           +  L  LE L +  N    + P SF  L SLK L + N+ +S     + + L+ L +LNL
Sbjct: 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273

Query: 307 SFNKLEGEIPRG--GSFGNFSAESFEGNELLC 336
           + N L   +P                 N   C
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 63/279 (22%), Positives = 102/279 (36%), Gaps = 54/279 (19%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
           N   L+L +N  I  +    F ++  L++L L  NS+   +       L +L  L L+ N
Sbjct: 76  NTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
             + +    +      L  + L NNP++ I               F              
Sbjct: 134 WLTVIPS-GAFEYLSKLRELWLRNNPIESIPSYA-----------FN------------- 168

Query: 130 IGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLE 188
              + +L+ +DLG  K    I       L  L+ L L    ++  +P ++  LV L +LE
Sbjct: 169 --RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224

Query: 189 LGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
           + GN      P  F+ L +L+ L + +                     +  S I      
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMN---------------------SQVSLIERNAFD 263

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
           GL +L  L L +N L  L  D F  L  L  L+L +N  
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 7/162 (4%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L  L EL LR N  I ++P   F  V +L  L L +      +S      L NL+ L L
Sbjct: 145 YLSKLRELWLRNNP-IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
              N  ++  L+ L     L  + +S N    I    S   L  SL+   + N  V+   
Sbjct: 204 GMCNIKDMPNLTPLVG---LEELEMSGNHFPEI-RPGSFHGL-SSLKKLWVMNSQVSLIE 258

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
                 L +L+ ++L  N L+       + L+ L  L L  N
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 1/90 (1%)

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
              ++   NN   I       L +LE L LG N ++ +   +F  L SL  L L +N L+
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136

Query: 289 GAIPASLEKLSYLEDLNLSFNKLEGEIPRG 318
                + E LS L +L L  N +E  IP  
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L +L++L +  +++      A   +++L  L L  N+LS SL       L  L EL L 
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLH 298

Query: 68  GNNF 71
            N +
Sbjct: 299 HNPW 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (260), Expect = 9e-25
 Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 47/306 (15%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L N  ++   ++ +  TV  A  ++  +  L      ++ ++  +    L NL  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQY--LNNLIGLELK 71

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
            N  ++L  L +L+    +T + LS NPL  +                            
Sbjct: 72  DNQITDLAPLKNLTK---ITELELSGNPLKNV---------------------------- 100

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
             I  L ++ T+DL   ++    +  L+ L  LQ L LD N++    P  +  L  L  L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIPKE 246
            +G  ++S  +     NL  L  L    N    +  + +L  L+ +    N  S + P  
Sbjct: 157 SIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP-- 212

Query: 247 IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNL 306
           +    NL  + L    +         NL+      +   + +   PA++         NL
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNL 270

Query: 307 SFNKLE 312
           ++N   
Sbjct: 271 TWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 19/241 (7%)

Query: 72  SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
           + +N +       +   I    + +   +      +L   +         VT  I E + 
Sbjct: 7   TAINVIFPDPALANAIKIAAGKSNVTDTVT---QADLDG-ITTLSAFGTGVT-TI-EGVQ 60

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
            L NLI ++L  N++  + L  L  L K+  L L  N L       I  L  +  L+L  
Sbjct: 61  YLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTS 116

Query: 192 NKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGL 250
            +++   P     L  L++L L  N    +  +  L  L  +       S + P  +  L
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANL 172

Query: 251 KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNK 310
             L  L    N++  + P    +L +L  ++L NN +S   P  L   S L  + L+   
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQT 228

Query: 311 L 311
           +
Sbjct: 229 I 229

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  105 bits (263), Expect = 1e-24
 Identities = 33/201 (16%), Positives = 59/201 (29%), Gaps = 40/201 (19%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIR-------- 468
           ++G+    +  +A     G    V V          A K    E   ++ +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 469 -----------------HRNLIKVISSCSNEEFKGLVLEYM-PQGSLE------KHLYST 504
                             + +I+V     +         Y   Q +L+          ST
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +  L    RL + + V   L  LH      ++H  L+P +++LD     +L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 565 IGEDQSMTQTQTLATIGYMAP 585
            G        +  A     A 
Sbjct: 262 -GASAVSPIGRGFAPPETTAE 281

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (257), Expect = 2e-24
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 20/176 (11%)

Query: 422 IGRGGFGSVYKARL-----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNL 472
           +G G FG V          G G  VAVK          R  +K    E +I++++ H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHI 95

Query: 473 IKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           IK    C +       LV+EY+P GSL  +L   +  + + Q L     +   + YLH  
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH-- 151

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAP 585
            +   IH DL   NVLLD++ +  + DFG+AK +  G +    +    + + + AP
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 3e-24
 Identities = 37/173 (21%), Positives = 71/173 (41%), Gaps = 18/173 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
            +G+GGF   ++          A K+     L      +   +E  I +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               + +F  +VLE   + SL +       + +   R   +  +    +YLH      VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI-G---YMAP 585
           H DLK  N+ L++++   + DFG+A  +          +    + G   Y+AP
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAP 184

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 3e-24
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 11/170 (6%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           L+G+G F  VY+A  +  G+EVA+K+ +   +      +    E +I   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
           +   +  +  LVLE    G + ++L +        +  + M  + + + YLH   S  ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           H DL  SN+LL  NM   ++DFG+A  L    +      TL  T  Y++P
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISP 181

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (254), Expect = 3e-24
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKV 475
             +G+G FG+VY AR       +A+KV     L+          E EI   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASALEYLHF 529
                +     L+LEY P G++ + L           + +       + ++A+AL Y H 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
             S  VIH D+KP N+LL       ++DFG +           +   L  T+ Y+ P
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPP 176

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  103 bits (257), Expect = 4e-24
 Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 24/194 (12%)

Query: 413 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCRRAFKSFDVECEIMKS 466
           +     ++L+G G F  VY+A  GD        +  +KV        F       E +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSL----EKHLYSTNCILDIFQRLNIMIDVAS 522
                 +K  S+   +    LV E    G+L      +  +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY-----------LSDFGIAKLLIGEDQSM 571
            +E +H      +IH D+KP N +L +  +             L D G +  +    +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 572 TQTQTLATIGYMAP 585
             T    T G+   
Sbjct: 241 IFTAKCETSGFQCV 254

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (256), Expect = 4e-24
 Identities = 37/173 (21%), Positives = 71/173 (41%), Gaps = 18/173 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
            +G+GGF   ++          A K+     L      +   +E  I +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               + +F  +VLE   + SL +       + +   R   +  +    +YLH      VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI-G---YMAP 585
           H DLK  N+ L++++   + DFG+A  +          +    + G   Y+AP
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAP 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (254), Expect = 5e-24
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 46/202 (22%)

Query: 411 RATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV------ 459
            +T GF EN     ++GRG    V +        E AVK+ ++    +F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 460 ---ECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL- 514
              E +I++ +  H N+I++  +     F  LV + M +G L             F  L 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116

Query: 515 -----------NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
                       IM  +   +  LH      ++H DLKP N+LLDD+M   L+DFG +  
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC- 172

Query: 564 LIGEDQSMTQTQTLATIGYMAP 585
            +   + +   +   T  Y+AP
Sbjct: 173 QLDPGEKL--REVCGTPSYLAP 192

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  105 bits (263), Expect = 5e-24
 Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 16/172 (9%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG G FG V++          M VA+K           + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYL---HFGCST 533
              +      +++E    G L   L      LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +H D+   NVL+  N    L DFG+++  + +      ++    I +MAP
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 561

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  104 bits (261), Expect = 7e-24
 Identities = 62/364 (17%), Positives = 125/364 (34%), Gaps = 48/364 (13%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLS----------------- 47
           E GN+  L+ L L    L  +  + I +++  K+L +   +                   
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169

Query: 48  --------------GSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSN 93
                          S+ ++ ++ L N++ ++        L+ L+ L     L+ + L+N
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

Query: 94  NPLDGILPKTSIGNLSHS-LEDFQMHNCNVTGDIPEEIG-----NLTNLITIDLGGNKLN 147
                      +  + H+ +  F + N  + G +          +L  L    +  +   
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289

Query: 148 GSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIA 207
                       +       +           ++     L+   N L+ ++     +L  
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349

Query: 208 LRILSLGSN-----DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYN 261
           L  L L  N       +      +K L  +D S N+ S    K      K+L  L +  N
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409

Query: 262 RLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSF 321
            L   I         +K L+L +N +  +IP  + KL  L++LN++ N+L+  +P  G F
Sbjct: 410 ILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD-GIF 464

Query: 322 GNFS 325
              +
Sbjct: 465 DRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.6 bits (248), Expect = 3e-22
 Identities = 56/330 (16%), Positives = 104/330 (31%), Gaps = 32/330 (9%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVST-LKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
           I +L  L  L +  N+ I  + +++F  +  L+ L L  N L      I+     NL+ L
Sbjct: 41  ILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHNKLV----KISCHPTVNLKHL 95

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L  N F  L       N   L  +GLS   L+       I +L+ S     +       
Sbjct: 96  DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGE- 153

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
              E+   L +  T  L            +  +       L+ + ++  + D+ C     
Sbjct: 154 --KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

Query: 185 YKLELGGN----------------------KLSRSIPACFNNLIALRILSLGSNDPLPLE 222
              +L  N                      +L       + ++  +++            
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL 282
             +LK L       + F            N+       +  + +       +     L+ 
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
           SNN L+  +  +   L+ LE L L  N+L+
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 95.3 bits (237), Expect = 6e-21
 Identities = 67/334 (20%), Positives = 117/334 (35%), Gaps = 20/334 (5%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSL-SGSLSSITDVR---- 57
           +      NL+ LDL  N          F N+S LK LGL    L   S+  I  +     
Sbjct: 84  ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143

Query: 58  LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQM 117
           L  L E      +   L   ++ S           +  LD  +   +   LS+     + 
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203

Query: 118 HNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK---LQGLVLDDNKLEGSI 174
           + C+    I  ++     L  + L   +   +  I + +L     +    + + KL+G +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263

Query: 175 PDDI-----CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNL 226
                      L  L   ++  +         +     + I +   +       L    +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL--IPDSFGNLISLKFLNLSN 284
              + +DFS N  +  + +  G L  LE L L  N+L+ L  I +    + SL+ L++S 
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383

Query: 285 NNLSGAIPASL-EKLSYLEDLNLSFNKLEGEIPR 317
           N++S             L  LN+S N L   I R
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.6 bits (230), Expect = 5e-20
 Identities = 58/329 (17%), Positives = 117/329 (35%), Gaps = 26/329 (7%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
             +   LQ+     L            I +VS   +  L+ +++   L         ++ 
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213

Query: 63  ELVLWGNNFSELNF------------LSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH 110
             +      S L              +  L    ++    +SN  L G L          
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273

Query: 111 SLEDFQMHNC--NVTGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD 167
           SL+   +H    +V G     I    +N+   +   +      ++  SK+     L   +
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPAC---FNNLIALRILSLGSN----DPLP 220
           N L  ++ ++   L EL  L L  N+L   +         + +L+ L +  N    D   
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

Query: 221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
            +    K L+ ++ S N  +  I + +     ++ L L  N+++ + P     L +L+ L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSI-PKQVVKLEALQEL 449

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           N+++N L        ++L+ L+ + L  N
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 56/295 (18%), Positives = 105/295 (35%), Gaps = 35/295 (11%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNV---STLKLLGLQDNSLSGSL-SSITDVR 57
           I  ++     L  L L   +      + I  +   +T+    + +  L G L     D  
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 58  LPNLEELVLWGNNFSELNFLSSL--SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF 115
             +L+ L +         F  S       ++ +   + +    ++       +S      
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RMVHMLCPSKIS-PFLHL 329

Query: 116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLN--GSILITLSKLQKLQGLVLDDNKLEGS 173
              N  +T  + E  G+LT L T+ L  N+L     I    ++++ LQ L +  N +   
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389

Query: 174 IPDDIC-RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
                C     L  L +  N L+ +I  C      +++L L SN         +K +   
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN--------KIKSI--- 436

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
                      PK++  L+ L+ L +  N+L+ +    F  L SL+ + L  N  
Sbjct: 437 -----------PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 4/91 (4%)

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
           + S N  S +   +I  L  L  L + +NR+Q L    F     L++L+LS+N L     
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK--- 83

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
            S      L+ L+LSFN  +  +P    FGN
Sbjct: 84  ISCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 39/214 (18%), Positives = 66/214 (30%), Gaps = 5/214 (2%)

Query: 160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL 219
              L +  N +      DI  L +L  L +  N++     + F     L  L L  N  +
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 220 PLEIGNLKVLVGIDFSMNNFSGI-IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
            +       L  +D S N F  + I KE G +  L++L L    L+        +L   K
Sbjct: 83  KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS 338
            L +             E L      +L       +        + S ++    EL    
Sbjct: 143 VLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFH--FILDVSVKTVANLELSNIK 198

Query: 339 PNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLM 372
             L+   C   +   +   +      L L+    
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 37/207 (17%), Positives = 68/207 (32%), Gaps = 7/207 (3%)

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
           +LS       +    ++     +I +L+ L  + +  N++    +      Q+L+ L L 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPAC--FNNLIALRILSLGSNDPLPLEIG 224
            NKL   I       V L  L+L  N    ++P C  F N+  L+ L L +       + 
Sbjct: 78  HNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 225 NLKVLVGIDFSMNNFSGIIPKE-IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
            +  L      +        KE   GL++     L              ++      NL 
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNK 310
            +N+   +  +           L  N 
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNP 220

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 26/113 (23%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            +++L++LD+ QN +             +L  L +  N L+    +I     P ++ L L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT---DTIFRCLPPRIKVLDL 428

Query: 67  WGNNFSEL-----------------NFLSSL-----SNCKSLTVIGLSNNPLD 97
             N    +                 N L S+         SL  I L  NP D
Sbjct: 429 HSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =   99 bits (250), Expect = 1e-23
 Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 8/145 (5%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             IG+G FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 480 SNEEFKG-LVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             E+    +V EYM +GSL  +L S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAK 562
            DL   NVL+ ++ +A +SDFG+ K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK 165

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (257), Expect = 2e-23
 Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 38/183 (20%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIKV 475
           +G+G F  V +   +  G E A  + N    +   + D      E  I + ++H N++++
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 476 ISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDVASALEY 526
             S S E    L+ + +  G L      +  YS    ++CI  I            A+ +
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLH 125

Query: 527 LHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGY 582
            H      V+H +LKP N+LL          L+DFG+A  + GE Q+       A T GY
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 583 MAP 585
           ++P
Sbjct: 180 LSP 182

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  100 bits (250), Expect = 2e-23
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 15/194 (7%)

Query: 399 AMWRTFSYLELCRATD---GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF 454
           +M ++  Y  + R  D    +     +G G FG VYKA+    G   A KV   +     
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60

Query: 455 KSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL 514
           + + VE EI+ +  H  ++K++ +  ++    +++E+ P G+++  +   +  L   Q  
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT 574
            +   +  AL +LH   S  +IH DLK  NVL+       L+DFG++       +++ + 
Sbjct: 121 VVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKR 174

Query: 575 QTLATIG---YMAP 585
            +   IG   +MAP
Sbjct: 175 DSF--IGTPYWMAP 186

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (250), Expect = 3e-23
 Identities = 35/180 (19%), Positives = 75/180 (41%), Gaps = 19/180 (10%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G+G FG VY+              VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL---------YSTNCILDIFQRLNIMIDVASALE 525
           ++   S  +   +++E M +G L+ +L                 + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 10/172 (5%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           ++    IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
            + S    +   +V+EY+  GSL   +  T   +D  Q   +  +   ALE+LH   S  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           VIH D+K  N+LL  +    L+DFG    +       ++  T+  T  +MAP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 185

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 14/174 (8%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
                 IG G  G V  AR    G +VAVK+ +L+ ++  +    E  IM+  +H N+++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  S    E   +++E++  G+L   +  +   L+  Q   +   V  AL YLH   +  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           VIH D+K  ++LL  +    LSDFG    +    + + + ++L  +G   +MAP
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAP 210

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (250), Expect = 4e-23
 Identities = 32/201 (15%), Positives = 63/201 (31%), Gaps = 45/201 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS----------------------- 456
           ++G+    +  +A     G    V V     R    +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 457 -----FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM-PQGSLEK------HLYST 504
                F    +++K  + + +I+V     +         Y   Q +L+          ST
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
           +  L    RL + + V   L  LH      ++H  L+P +++LD     +L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 565 IGEDQSMTQTQTLATIGYMAP 585
              D +   +    + G+  P
Sbjct: 255 --RDGARVVSSV--SRGFEPP 271

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 52/199 (26%), Positives = 72/199 (36%), Gaps = 9/199 (4%)

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVE 183
            +P  I        I L GN+++     +    + L  L L  N L   I       L  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 184 LYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIG---NLKVLVGIDFSMNNF 239
           L +L+L  N   RS+    F+ L  L  L L       L  G    L  L  +    N  
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
             +       L NL +LFL  NR+  +   +F  L SL  L L  N ++   P +   L 
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 300 YLEDLNLSFNKLEGEIPRG 318
            L  L L  N L   +P  
Sbjct: 202 RLMTLYLFANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 56/211 (26%), Positives = 81/211 (38%), Gaps = 12/211 (5%)

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
            +  + +   +H   ++           NL  + L  N L        + L  L+ L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 167 DNKLEGSIPDDI-CRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSN--DPLPLE 222
           DN    S+       L  L+ L L    L   +    F  L AL+ L L  N    LP +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 223 I----GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
                GNL  L       N  S +  +   GL +L+ L L  NR+  + P +F +L  L 
Sbjct: 148 TFRDLGNLTHL---FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
            L L  NNLS     +L  L  L+ L L+ N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 63/292 (21%), Positives = 95/292 (32%), Gaps = 84/292 (28%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P+ I      + + L  N+ I  VP A F                            N
Sbjct: 25  AVPVGI--PAASQRIFLHGNR-ISHVPAASFR------------------------ACRN 57

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L  L L  N  + ++  ++ +    L  + LS+N     +   +          F     
Sbjct: 58  LTILWLHSNVLARID-AAAFTGLALLEQLDLSDNAQLRSVDPAT----------FH---- 102

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
                       L  L T+ L    L     G        L  LQ L L DN L+ ++PD
Sbjct: 103 -----------GLGRLHTLHLDRCGLQELGPG----LFRGLAALQYLYLQDNALQ-ALPD 146

Query: 177 DICR-LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFS 235
           D  R L  L  L L GN++S      F  L +L  L L  N         +  +    F 
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN--------RVAHVHPHAFR 198

Query: 236 MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
                         L  L  L+L  N L  L  ++   L +L++L L++N  
Sbjct: 199 -------------DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           +L NL  L L  N++      A   + +L  L L  N ++  +       L  L  L L+
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
            NN S L    +L+  ++L  + L++NP  
Sbjct: 210 ANNLSALPT-EALAPLRALQYLRLNDNPWV 238

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 29/178 (16%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIKV 475
           +G+G FG V K +      E AVKV N   + + K+ D      E E++K + H N++K+
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 476 ISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
                +     +V E    G L     ++  +S +          I+  V S + Y+H  
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMH-- 138

Query: 531 CSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               ++H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP 192

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 37/186 (19%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV--ECEIMKSIRHRNLIKV 475
           IG+G F  V +      G + AVK+ +           + D+  E  I   ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD-IFQRLN------------IMIDVAS 522
           + + S++    +V E+M    L             I +R +             M  +  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL----------CFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           AL Y H      +IH D+KP  VLL   +++    L  FG+A  L            + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 580 IGYMAP 585
             +MAP
Sbjct: 197 PHFMAP 202

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 30/188 (15%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNIMIDV 520
              C + +   +V EYM  G L K L                     L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 521 ASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           AS + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 578 ATIGYMAP 585
             I +M P
Sbjct: 197 LPIRWMPP 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 38/181 (20%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSC 479
           +G G F    K          AVK+ +   +R   +   E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------------NIMIDVASALEYL 527
            ++    LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           H      V+H DLKP N+L    +DN+   + DFG A+L   ++Q +       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 585 P 585
           P
Sbjct: 178 P 178

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 37/182 (20%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIKV 475
           +G+G F  V +      G+E A K+ N    +   + D      E  I + ++H N++++
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 476 ISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDVASALEY 526
             S   E F  LV + +  G L      +  YS    ++CI  I            ++ Y
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 120

Query: 527 LHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
            H   S  ++H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 174

Query: 584 AP 585
           +P
Sbjct: 175 SP 176

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 14/174 (8%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           F     +G G +GSVYKA     G  VA+K   ++     +    E  IM+     +++K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
              S        +V+EY   GS+   +   N  L   +   I+      LEYLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
            IH D+K  N+LL+    A L+DFG+A  L     +M +  T+  IG   +MAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAP 194

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  100 bits (251), Expect = 1e-22
 Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 51/304 (16%)

Query: 12  LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNF 71
           + E       +    P   F  +      L+  S++    +  +  L ++++++   ++ 
Sbjct: 1   MGETITVSTPIKQIFPDDAF--AETIKDNLKKKSVT-DAVTQNE--LNSIDQIIANNSDI 55

Query: 72  SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
             +  +  L N   +T + L+ N L      T I  L+                      
Sbjct: 56  KSVQGIQYLPN---VTKLFLNGNKL------TDIKPLT---------------------- 84

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
           NL NL  + L  NK+    L +L  L+KL+ L L+ N +   I + +  L +L  L LG 
Sbjct: 85  NLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGN 140

Query: 192 NKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
           NK++       + L  L  LSL  N   D +PL    L  L  +  S N+ S +  + + 
Sbjct: 141 NKITDITV--LSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDL--RALA 194

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSF 308
           GLKNL+ L L          +   NL+    +  ++ +L    P  +      E  N+ +
Sbjct: 195 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKW 252

Query: 309 NKLE 312
           +  E
Sbjct: 253 HLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 99.8 bits (248), Expect = 3e-22
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 24/225 (10%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
                 + +L++  +   V      ++++  +   ++ +  S+  I    LPN+ +L L 
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY--LPNVTKLFLN 73

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH--SLEDFQMHNCNVTGD 125
           GN  ++   +  L+N K+L  + L  N +        + +L     L+   + +  ++ D
Sbjct: 74  GNKLTD---IKPLTNLKNLGWLFLDENKI------KDLSSLKDLKKLKSLSLEHNGIS-D 123

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
           I   + +L  L ++ LG NK+  + +  LS+L KL  L L+DN++   I   +  L +L 
Sbjct: 124 I-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 178

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLV 230
            L L  N +S  + A    L  L +L L S + L   I +   LV
Sbjct: 179 NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLV 221

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.2 bits (210), Expect = 1e-17
 Identities = 55/250 (22%), Positives = 94/250 (37%), Gaps = 16/250 (6%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
           I  L N+ +L L  NKL    P+   N+  L  L L +N +   LSS+ D  L  L+ L 
Sbjct: 61  IQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIK-DLSSLKD--LKKLKSLS 115

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD 125
           L  N  S+   ++ L +   L  + L NN +  I   T +  L+  L+   + +  ++ D
Sbjct: 116 LEHNGISD---INGLVHLPQLESLYLGNNKITDI---TVLSRLT-KLDTLSLEDNQIS-D 167

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELY 185
           I   +  LT L  + L  N +  S L  L+ L+ L  L L   +      +    LV   
Sbjct: 168 I-VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
            ++     L        +       +     +            V I  +   F G + +
Sbjct: 225 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQ 284

Query: 246 EIGGLKNLEY 255
            +  +  + Y
Sbjct: 285 PLKEVYTVSY 294

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 25/183 (13%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG VY+ ++         ++VAVK     C  +    F +E  I+    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL------YSTNCILDIFQRLNIMIDVASALEYL- 527
            I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 528 --HFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
             HF      IH D+   N LL       +A + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 583 MAP 585
           M P
Sbjct: 212 MPP 214

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 38/182 (20%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           ++G G F  V+  +    G   A+K           S + E  ++K I+H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------------NIMIDVASALEYL 527
            +     LV++ +  G L             F R+             ++  V SA++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYM 583
           H      ++H DLKP N+L    ++N    ++DFG++K  + ++  M+   T   T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYV 174

Query: 584 AP 585
           AP
Sbjct: 175 AP 176

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 98.6 bits (245), Expect = 2e-22
 Identities = 22/201 (10%), Positives = 45/201 (22%), Gaps = 45/201 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLI--- 473
            +  G    V+  R +    + A+KVF       R   +           +   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 474 ------------------KVISSCSNEEFKG-----LVLEYMPQGSLE------KHLYST 504
                                     ++        L++       LE        +Y  
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187

Query: 505 NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL 564
                I     +   +      L    S  ++H    P N+ +  +    L D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-K 243

Query: 565 IGEDQSMTQTQTLATIGYMAP 585
           +G     +       + Y   
Sbjct: 244 VGTRGPASSV----PVTYAPR 260

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 24/175 (13%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
            +G+G FG+VY AR   +   +A+KV     L+          E EI   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASALEYLHFG 530
           +   + +   L+LE+ P+G L K L           R +       M ++A AL Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               VIH D+KP N+L+       ++DFG +           +T    T+ Y+ P
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT-MCGTLDYLPP 181

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 40/189 (21%), Positives = 76/189 (40%), Gaps = 33/189 (17%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFN---LQCRRAFKSFDV--------------ECEIM 464
           + +G F  +      D    A+K +    L+ +R F   +               E +I+
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-------YSTNCILDIFQRLNIM 517
             I++   +      +N +   ++ EYM   S+ K          +  C + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
             V ++  Y+H   +  + H D+KPSN+L+D N    LSDFG ++ ++ +       +  
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 578 A-TIGYMAP 585
             T  +M P
Sbjct: 211 RGTYEFMPP 219

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 52/204 (25%)

Query: 408 ELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV 459
           +L R +  F++       IG G +    +       ME AVK+ +               
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------- 64

Query: 460 ECEIM-KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL---- 514
           E EI+ +  +H N+I +     + ++  +V E M  G L               ++    
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQK 111

Query: 515 --------NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAK 562
                    ++  +   +EYLH   +  V+H DLKPSN+L      +     + DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 563 LLIGEDQSMTQTQTLA-TIGYMAP 585
            L  E+  +    T   T  ++AP
Sbjct: 169 QLRAENGLLM---TPCYTANFVAP 189

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 37/182 (20%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIKV 475
           +G+G F  V +      G+E A K+ N    +   + D      E  I + ++H N++++
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 476 ISSCSNEEFKGLVLEYMPQGSL-----EKHLYS----TNCILDIFQRLNIMIDVASALEY 526
             S   E F  LV + +  G L      +  YS    ++CI  I            ++ Y
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAY 143

Query: 527 LHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
            H   S  ++H +LKP N+LL          L+DFG+A   + + ++        T GY+
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 197

Query: 584 AP 585
           +P
Sbjct: 198 SP 199

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
           +G G FG V+ A         D M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHL--------------YSTNCILDIFQRLNIMIDVA 521
              C+      +V EYM  G L + L                    L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 522 SALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           + + YL   HF      +H DL   N L+   ++  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 579 TIGYMAP 585
            I +M P
Sbjct: 223 PIRWMPP 229

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 15/184 (8%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRN 471
           D +    +IG G    V  A       +VA+K  NL +C+ +      E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL-------EKHLYSTNCILDIFQRLNIMIDVASAL 524
           ++   +S   ++   LV++ +  GS+              + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG--- 581
           EYLH       IH D+K  N+LL ++    ++DFG++  L               +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 582 YMAP 585
           +MAP
Sbjct: 192 WMAP 195

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 96.7 bits (241), Expect = 6e-22
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 25/183 (13%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG VY+ ++         ++VAVK     C  +    F +E  I+    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL------YSTNCILDIFQRLNIMIDVASALEYL- 527
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 528 --HFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
             HF      IH D+   N LL       +A + DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 583 MAP 585
           M P
Sbjct: 253 MPP 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 38/192 (19%)

Query: 420 NLIGRGGFGSVYKARL---GDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSI-RHRN 471
           ++IG G FG V KAR+   G  M+ A+K      +    R F     E E++  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGHHPN 87

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNI 516
           +I ++ +C +  +  L +EY P G+L   L                ST   L   Q L+ 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 517 MIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
             DVA  ++YL    F      IH DL   N+L+ +N +A ++DFG+++   G++  + +
Sbjct: 148 AADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 198

Query: 574 TQTLATIGYMAP 585
           T     + +MA 
Sbjct: 199 TMGRLPVRWMAI 210

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 95.4 bits (238), Expect = 9e-22
 Identities = 42/197 (21%), Positives = 77/197 (39%), Gaps = 39/197 (19%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V KA             VAVK+          +    E  ++K + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL-----------------------YSTNCILDIF 511
           +  +CS +    L++EY   GSL   L                       +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 512 QRLNIMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 569 QSMTQTQTLATIGYMAP 585
             + ++Q    + +MA 
Sbjct: 205 SYVKRSQGRIPVKWMAI 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 15/175 (8%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRNLI 473
           F++   IG+G FG V+K         VA+K+ +L +     +    E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA-LDLL-EPGPLDETQIATILREILKGLDYLH---SE 138

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
             IH D+K +NVLL ++    L+DFG+A  L     +  +  T   +G   +MAP
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAP 188

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 50/173 (28%), Positives = 70/173 (40%), Gaps = 21/173 (12%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS 480
           IGRG +G V  A   G  +  A K            F  E EIMKS+ H N+I++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 481 NEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           +     LV+E    G L      K ++  +    I +      DV SA+ Y H      V
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 536 IHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            H DLKP N L      +    L DFG+A       + M     + T  Y++P
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSP 177

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 35/201 (17%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSI 467
           R T  F E   IG G FGSV+K     DG   A+K            ++   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 468 -RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF---QRLNIMIDVASA 523
            +H ++++  S+ + ++   +  EY   GSL   +     I+  F   +  ++++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY-------------------LSDFGIAKLL 564
           L Y+H   S  ++H D+KPSN+ +    I                     + D G    +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 565 IGEDQSMTQTQTLATIGYMAP 585
                S  Q +      ++A 
Sbjct: 185 -----SSPQVEE-GDSRFLAN 199

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 40/189 (21%), Positives = 75/189 (39%), Gaps = 31/189 (16%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           +G   FG VYK  L           VA+K    +      + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNIMID 519
           ++   + ++   ++  Y   G L + L                +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 520 VASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 577 LATIGYMAP 585
           L  I +MAP
Sbjct: 191 LLPIRWMAP 199

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 32/182 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV-----ECEIMKSIRHRNL 472
           +G G  G V  A       +VA+K+ +        A ++        E EI+K + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           IK+ +    E++  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYM 583
           H      +IH DLKP NVLL   +++ +  ++DFG +K ++GE   M    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183

Query: 584 AP 585
           AP
Sbjct: 184 AP 185

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 48/230 (20%)

Query: 383 RQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 437
           +    QP    N+   +M      L    A   F +     ++IGRG    V +      
Sbjct: 60  KLNDAQPKGTENLYFQSMGPE-DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 438 GMEVAVKVFNL--------QCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLV 488
           G E AVK+  +        Q     ++   E  I++ +  H ++I +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 489 LEYMPQGSLEKHLYSTNCILDIFQRL------------NIMIDVASALEYLHFGCSTPVI 536
            + M +G L             F  L            +IM  +  A+ +LH   +  ++
Sbjct: 179 FDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIV 222

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           H DLKP N+LLDDNM   LSDFG +   +   + +     L  T GY+AP
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAP 268

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 20/177 (11%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA---FKSFDVECEIMKSIRHRN 471
           FS+   IG G FG+VY AR + +   VA+K  +   +++   ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
            I+       E    LV+EY   GS    L      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAP 585
           S  +IH D+K  N+LL +  +  L DFG A         M    +   +G   +MAP
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAP 219

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 96.9 bits (241), Expect = 2e-21
 Identities = 67/363 (18%), Positives = 115/363 (31%), Gaps = 48/363 (13%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLK--LLGLQDNSLSG-------------- 48
           E GNL  L  L L   K    + +       L   LL L    + G              
Sbjct: 141 EFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 49  --------SLSSITDVRLPNLEELVLWGNNFSELNFLSSLS-------NCKSLTVIGLSN 93
                     S   ++ +  L  L L     ++ N    ++           L V     
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259

Query: 94  NPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGN-----LTNLITIDLGGNKLNG 148
                   K         +E   ++N  +T  I  E        L +L+   +       
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL 208
           S     S   ++   +L  +                  L    N  + S+    + L  L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379

Query: 209 RILSLGSN-----DPLPLEIGNLKVLVGIDFSMNNF-SGIIPKEIGGLKNLEYLFLGYNR 262
           + L L  N       + L   N+  L  +D S+N+  S    +     +++  L L  N 
Sbjct: 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439

Query: 263 LQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFG 322
           L G +         +K L+L NN +  +IP  +  L  L++LN++ N+L+  +P  G F 
Sbjct: 440 LTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFD 494

Query: 323 NFS 325
             +
Sbjct: 495 RLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 89.5 bits (222), Expect = 6e-19
 Identities = 57/324 (17%), Positives = 102/324 (31%), Gaps = 26/324 (8%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L  L  L L  N++  ++   +F     L+ L +  N L     +I+   + +L  L L
Sbjct: 74  FLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ----NISCCPMASLRHLDL 128

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
             N+F  L       N   LT +GLS       L    + +L  S     + + ++ G  
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-LDLLPVAHLHLSCILLDLVSYHIKGGE 187

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG-------SIPDDIC 179
            E +    N   + L  +  +   +     +  L  L L + KL         +   ++ 
Sbjct: 188 TESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246

Query: 180 RLVELYKLELGGNKLSRSIPACF-----------NNLIALRILSLGSNDPLPLEIGNLKV 228
           R   L  + L   + +                   N+  L I      +        LK 
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
           L+        F             +    L  +    +      +  S  FLN + N  +
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366

Query: 289 GAIPASLEKLSYLEDLNLSFNKLE 312
            ++      L  L+ L L  N L+
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 64/330 (19%), Positives = 115/330 (34%), Gaps = 26/330 (7%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSL-SGSLSSITDVRLPNL 61
           +    + +L  LDL  N          F N++ L  LGL         L  +  + L  +
Sbjct: 115 ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174

Query: 62  EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH-SLEDFQMH-- 118
             L L   +       S      ++  +    N L  +    S+  L H  L + +++  
Sbjct: 175 -LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK---LQGLVLDDNKLEGSIP 175
           NC        E+     L+ + L   +      + L +      ++ L + +  +   I 
Sbjct: 234 NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERID 293

Query: 176 DDI-----CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND------PLPLEIG 224
            +        L  L    +       S  A ++    + I  L  +D        P    
Sbjct: 294 REEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS 353

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL--IPDSFGNLISLKFLNL 282
           +   L   +F+ N F+  + +    LK L+ L L  N L+    +     N+ SL+ L++
Sbjct: 354 SFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410

Query: 283 SNNNL-SGAIPASLEKLSYLEDLNLSFNKL 311
           S N+L S A   +      +  LNLS N L
Sbjct: 411 SLNSLNSHAYDRTCAWAESILVLNLSSNML 440

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.8 bits (207), Expect = 3e-17
 Identities = 44/321 (13%), Positives = 98/321 (30%), Gaps = 19/321 (5%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLS---SITDVRLPN 60
           L+I N   L  +    +     V +++  +  L+L  ++ N  +            R P 
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250

Query: 61  LEELVLWGNNFSELNFLSSLSN--CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           L  + L     +    +        + +  + + N  +   + +        +L+   + 
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310

Query: 119 NCNVTGDIPEEIG---NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP 175
           +      +  +         +    L  +      ++          L    N    S+ 
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370

Query: 176 DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI--- 232
                L  L  L L  N L  +          +  L         L              
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429

Query: 233 ----DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
               + S N  +G + + +     ++ L L  NR+  + P    +L +L+ LN+++N L 
Sbjct: 430 ILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLK 486

Query: 289 GAIPASLEKLSYLEDLNLSFN 309
                  ++L+ L+ + L  N
Sbjct: 487 SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 78.8 bits (194), Expect = 1e-15
 Identities = 54/300 (18%), Positives = 106/300 (35%), Gaps = 30/300 (10%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITD---------VRLP 59
           +  L  L L   KL       +    +    G    +++      T              
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276

Query: 60  NLEELVLWGNNFSELNFLSSLSNCK-SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
            +E L ++    +E       +  + +L  + + +      L          +  + +M 
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 119 NCNVTGDIPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDD 177
           + + T  I      + ++   ++   N    S+    S L++LQ L+L  N L+ +    
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKV 395

Query: 178 ICRLVELYKLELGGNKLSRSIPACFNNLIA----LRILSLGSN-------DPLPLEIGNL 226
                 +  LE     L+      ++   A    + +L+L SN         LP     +
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP---PKV 452

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
           KVL   D   N     IPK++  L+ L+ L +  N+L+ +    F  L SL+++ L +N 
Sbjct: 453 KVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 4/93 (4%)

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
             S N+ S +   +I  L  L  L L +NR++ L    F     L++L++S+N L   I 
Sbjct: 58  SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS 116

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
                ++ L  L+LSFN  +  +P    FGN +
Sbjct: 117 CC--PMASLRHLDLSFNDFD-VLPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 47/257 (18%), Positives = 91/257 (35%), Gaps = 31/257 (12%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVEL 184
           +P+++        + L  N ++   +  +S L +L+ L L  N++  S+   +     +L
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
             L++  N+L  +I      + +LR L L  ND          VL             + 
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFND--------FDVLP------------VC 139

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNL-ISLKFLNLSNNNLSGAIPASLEKLSYLED 303
           KE G L  L +L L   + + L      +L +S   L+L + ++ G    SL+  +    
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTV 198

Query: 304 LNLSFNKL-EGEIPRGGSFGNFSAESFEGNELLC-GSPNLQVPPCKTSIHHPSWNISLLL 361
           L+L F+      +    S            +L       L     + +      N++L  
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258

Query: 362 GIVLPLSTTLMIVVIWL 378
                  +  +    W 
Sbjct: 259 IETTWKCSVKLFQFFWP 275

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 40/187 (21%), Positives = 63/187 (33%), Gaps = 13/187 (6%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG---NLKVL 229
            +P D+    +   L L  N +S       + L  LR+L L  N    L+       + L
Sbjct: 45  HVPKDLPPRTK--ALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102

Query: 230 VGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLSNNNLS 288
             +D S N    I       + +L +L L +N    L +   FGNL  L FL LS     
Sbjct: 103 EYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159

Query: 289 GAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKT 348
                 +  L     L+     L     +GG   +    +     L+    +L       
Sbjct: 160 QLDLLPVAHLH----LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215

Query: 349 SIHHPSW 355
           S++    
Sbjct: 216 SVNALGH 222

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 5/89 (5%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWG 68
            +++  L+L  N L G+V   +     +K+L L +N +  S+       L  L+EL +  
Sbjct: 427 AESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVT-HLQALQELNVAS 482

Query: 69  NNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
           N    +          SL  I L +NP D
Sbjct: 483 NQLKSVP-DGVFDRLTSLQYIWLHDNPWD 510

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 47/205 (22%)

Query: 412 ATDGFSEN---------NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVEC 461
           +TD FS           +++G G    V     L    E AVK+   Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 462 EIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL------ 514
           E++   + HRN++++I     E+   LV E M  GS+                +      
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108

Query: 515 ------NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLL- 564
                  ++ DVASAL++LH   +  + H DLKP N+L    +      + DF +   + 
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 565 IGEDQSMTQTQTLATI----GYMAP 585
           +  D S   T  L T      YMAP
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAP 190

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 34/192 (17%)

Query: 422 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V  A           + + VAVK+       +       E E+MK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNI 516
           +I ++ +C+ +    +++EY  +G+L ++L                     +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 517 MIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              +A  +EYL           IH DL   NVL+ +N +  ++DFG+A+ +   D     
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 574 TQTLATIGYMAP 585
           T     + +MAP
Sbjct: 217 TNGRLPVKWMAP 228

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 34/192 (17%)

Query: 422 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V  A           + + VAVK+       +       E E+MK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNI 516
           +I ++ +C+ +    +++EY  +G+L ++L                     +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 517 MIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              +A  +EYL           IH DL   NVL+ +N +  ++DFG+A+ +   D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 574 TQTLATIGYMAP 585
           T     + +MAP
Sbjct: 263 TNGRLPVKWMAP 274

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.9 bits (239), Expect = 3e-21
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 24/176 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
           +G+G FG V   +    G E AVKV +   ++ +   +S   E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 478 SCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
              ++ +  LV E    G L      +  +S      I ++      V S + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 533 TPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             ++H DLKP N+LL     +    + DFG++       + M     + T  Y+AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAP 197

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 95.2 bits (237), Expect = 6e-21
 Identities = 41/175 (23%), Positives = 75/175 (42%), Gaps = 23/175 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVISS 478
           +G G +G V   R     +E A+K+          +  +  E  ++K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 479 CSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
             ++    LV+E    G L      +  ++            I+  V S + YLH     
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLH---KH 155

Query: 534 PVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++H DLKP N+LL   + + +  + DFG++  +    + M   + L T  Y+AP
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAP 207

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 36/193 (18%)

Query: 420 NLIGRGGFGSVYKARL------GDGMEVAVK----VFNLQCRRAFKSFDVECEIMKSI-R 468
             +G G FG V +A           ++VAVK      +   + A  S   E +IM  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-------------YSTNCILDIFQRLN 515
           H N++ ++ +C++     ++ EY   G L   L                N        L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 516 IMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
               VA  + +L   +       IH D+   NVLL +  +A + DFG+A+ ++ +   + 
Sbjct: 169 FSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 573 QTQTLATIGYMAP 585
           +      + +MAP
Sbjct: 223 KGNARLPVKWMAP 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.4 bits (235), Expect = 7e-21
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 32/182 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV-----ECEIMKSIRHRNL 472
           +G G  G V  A       +VA+++ +        A ++        E EI+K + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYL 527
           IK+ +    E++  +VLE M  G L                  F        +  A++YL
Sbjct: 203 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYM 583
           H      +IH DLKP NVLL   +++ +  ++DFG +K ++GE   M    TL  T  Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 308

Query: 584 AP 585
           AP
Sbjct: 309 AP 310

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 14/172 (8%)

Query: 421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
           ++G G F +V  AR      E A+K+  L+ R   K   V       ++M  + H   +K
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  +  ++E     L Y   G L K++       +   R     ++ SALEYLH      
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKG 150

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           +IH DLKP N+LL+++M   ++DFG AK+L  E +      +   T  Y++P
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSP 201

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 8e-21
 Identities = 48/272 (17%), Positives = 87/272 (31%), Gaps = 23/272 (8%)

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHS-LEDFQMH 118
           +LE L+   +  ++L   + +    SL  + +    +   +   ++  L  S L++  + 
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 119 NCNVTGDIPEEIGNLT--NLITIDLGGNKLNGSILITLS----KLQKLQGLVLDDNKLEG 172
           N  VTG  P  +   T  +L  ++L                      L+ L +       
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIP----ACFNNLIALRILSLGSN------DPLPLE 222
              + +     L  L+L  N            C      L++L+L +             
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLN 281
                 L G+D S N+               L  L L +  L+ +       L     L+
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL---SVLD 280

Query: 282 LSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG 313
           LS N L    P+  E L  + +L+L  N    
Sbjct: 281 LSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 46/272 (16%), Positives = 75/272 (27%), Gaps = 22/272 (8%)

Query: 36  LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS--NCKSLTVIGLSN 93
           L+ L  + ++ +        ++  +L+ L +            +L       L  + L N
Sbjct: 45  LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104

Query: 94  NPLDGILPKTSIGNLSHSLEDFQMHNCNVTG--DIPEEIGNL--TNLITIDLGGNKLNGS 149
             + G  P   +      L    + N +         E+       L  + +        
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164

Query: 150 ILITLSKLQKLQGLVLDDNKLEGSI-------PDDICRLVELYKLELGGNKLSRSIPACF 202
               +     L  L L DN   G         P     L  L     G    S    A  
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224

Query: 203 NNLIALRILSLGSN----DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFL 258
              + L+ L L  N                L  ++ S      + PK +     L  L L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGL--PAKLSVLDL 281

Query: 259 GYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA 290
            YNRL      S   L  +  L+L  N    +
Sbjct: 282 SYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 47/224 (20%), Positives = 85/224 (37%), Gaps = 17/224 (7%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKL--LGLQDNSLSG---SLSSITDVRL 58
           L +  +  L+EL L   ++ GT P  +   +   L  L L++ S +     L+ +     
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI--LPKTSIGNLSHSLEDFQ 116
           P L+ L +   +    +    +    +L+ + LS+NP  G   L          +L+   
Sbjct: 149 PGLKVLSIAQAHSLNFSC-EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 117 MHNCN---VTGDIPEEIGNLTNLITIDLGGNKLNGSI-LITLSKLQKLQGLVLDDNKLEG 172
           + N      +G           L  +DL  N L  +    +     +L  L L    L+ 
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN 216
            +P  +    +L  L+L  N+L    P+  + L  +  LSL  N
Sbjct: 267 QVPKGL--PAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGN 306

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 38/224 (16%), Positives = 67/224 (29%), Gaps = 19/224 (8%)

Query: 115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSI 174
               NC    D+    G  +    +     + +      + K   L+ L +   ++   I
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 175 PDDICRL--------VELYKLELGGNKLSRSIPACFNNLIALRI--LSLGSNDPLPLEIG 224
                R+        + L  LE+ G      + A   +L  L +  +S  + D    E+ 
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 225 NLKV--LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIP----DSFGNLISLK 278
                 L  +  +  +      +++     L  L L  N   G              +L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 279 FLNLSNNN---LSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG 319
            L L N      SG   A       L+ L+LS N L        
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 19/97 (19%), Positives = 23/97 (23%), Gaps = 8/97 (8%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLP 59
                      L+ LDL  N L            S L  L L        L  +      
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT----GLKQVPKGLPA 274

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
            L  L L  N          L     +  + L  NP 
Sbjct: 275 KLSVLDLSYNRLDRNPSPDELPQ---VGNLSLKGNPF 308

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.8 bits (233), Expect = 9e-21
 Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 16/176 (9%)

Query: 422 IGRG--GFGSVYKAR-LGDGMEVAVKVFNL--QCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           IG+G     +V  AR    G  V V+  NL             E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQRLNIMIDVASALEYLHFGCSTP 534
           ++   +    +V  +M  GS  K L  T+ +  ++      I+  V  AL+Y+H      
Sbjct: 93  ATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMG 148

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI--GEDQSMTQTQTLATIG---YMAP 585
            +H  +K S++L+  +   YLS       +I  G+ Q +       ++    +++P
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 17/173 (9%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA-FKSFDVECEI-MKSIRHRNLIKVISS 478
           IGRG +GSV K      G  +AVK           K   ++ ++ M+S     +++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASALEYLHFGCS 532
              E    + +E M   S +K       +LD    +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENLK 146

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             +IH D+KPSN+LLD +    L DFGI+  L+    S+ +T+      YMAP
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 34/192 (17%)

Query: 422 IGRGGFGSVYKARL--------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRN 471
           +G G FG V  A              +VAVK+       +       E E+MK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHL---------------YSTNCILDIFQRLNI 516
           +I ++ +C+ +    +++EY  +G+L ++L               ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 517 MIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              VA  +EYL           IH DL   NVL+ ++ +  ++DFG+A+ +   D     
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 574 TQTLATIGYMAP 585
           T     + +MAP
Sbjct: 251 TNGRLPVKWMAP 262

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 23/175 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISS 478
           +G+G FG V K +      E AVKV N      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 479 CSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
             +     +V E    G L     ++  +S +          I+  V S + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMH---KH 140

Query: 534 PVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP 192

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 41/191 (21%), Positives = 75/191 (39%), Gaps = 33/191 (17%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLI 473
           +GRG FG V +A             VAVK+          ++   E +I+  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHL---------------YSTNCILDIFQRLNIM 517
            ++ +C+      +V +E+   G+L  +L                     L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 518 IDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT 574
             VA  +E+L           IH DL   N+LL +  +  + DFG+A+ +  +   + + 
Sbjct: 155 FQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 575 QTLATIGYMAP 585
                + +MAP
Sbjct: 209 DARLPLKWMAP 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 25/181 (13%)

Query: 416 FSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
            S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  + H NLI+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 475 VISSCSNEEFKGLVLEYMPQGSL------EKHLYS-TNCILDIFQRLNIMIDVASALEYL 527
           +  +  ++    LV+EY+  G L      E +  +  + I         M  +   + ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQICEGIRHM 203

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           H      ++H DLKP N+L    D   I  + DFG+A+      + +       T  ++A
Sbjct: 204 H---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLAR-RYKPREKL--KVNFGTPEFLA 256

Query: 585 P 585
           P
Sbjct: 257 P 257

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 39/197 (19%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIK 474
           IG G FG V++AR            VAVK+   +        F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHL-----------------------YSTNCILDIF 511
           ++  C+  +   L+ EYM  G L + L                             L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 512 QRLNIMIDVASALEYL---HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           ++L I   VA+ + YL    F      +H DL   N L+ +NM+  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 569 QSMTQTQTLATIGYMAP 585
                      I +M P
Sbjct: 229 YYKADGNDAIPIRWMPP 245

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 44/217 (20%), Positives = 80/217 (36%), Gaps = 29/217 (13%)

Query: 384 QRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDG 438
           +      ND +     +W+ +    +        +       +G G FG V++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 439 MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL- 497
                K  N        +   E  IM  + H  LI +  +  ++    L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 498 -----EKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---D 548
                E +  S    I       N M      L+++H      ++H D+KP N++     
Sbjct: 137 DRIAAEDYKMSEAEVI-------NYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186

Query: 549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            + +  + DFG+A   +  D+ +    T AT  + AP
Sbjct: 187 ASSVK-IIDFGLAT-KLNPDEIV--KVTTATAEFAAP 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 49/199 (24%), Positives = 81/199 (40%), Gaps = 46/199 (23%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV----------------- 459
            IG+G +G V  A    D    A+KV +   L  +  F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 460 ------ECEIMKSIRHRNLIK---VISSCSNEEFKGLVLEYMPQGSL----EKHLYSTNC 506
                 E  I+K + H N++K   V+   + +    +V E + QG +         S + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 507 ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG 566
               FQ      D+   +EYLH      +IH D+KPSN+L+ ++    ++DFG++    G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 567 EDQSMTQTQTLATIGYMAP 585
            D ++    T+ T  +MAP
Sbjct: 190 SD-ALLSN-TVGTPAFMAP 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)

Query: 394 NMPLVAMWRTFSYLELCRATD---GFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQ 449
           +M   +  R+   ++L    D    F    L+G G +G VYK R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 450 CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKG------LVLEYMPQGSLEKHLY 502
                +    E  ++K    HRN+     +   +   G      LV+E+   GS+   + 
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 503 STNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           +T    L       I  ++   L +LH      VIH D+K  NVLL +N    L DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 562 KLLIGEDQSMTQTQTLATIG---YMAP 585
             L   D+++ +  T   IG   +MAP
Sbjct: 177 AQL---DRTVGRRNTF--IGTPYWMAP 198

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 9/174 (5%)

Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRA-FKSFDVECEIMKSIRHRN 471
           D F + + +G G  G V+K      G+ +A K+ +L+ + A       E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++    +  ++    + +E+M  GSL++ +      +       + I V   L YL    
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  YM+P
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 199

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 34/192 (17%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKV----FNLQCRRAFKSFDVECEIMKSI-RHR 470
           +G G FG V +A           M VAVK+     +L  R A  S   E +++  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSYLGNHM 87

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHL-----------------YSTNCILDIFQR 513
           N++ ++ +C+      ++ EY   G L   L                       LD+   
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           L+    VA  + +L    S   IH DL   N+LL    I  + DFG+A+ +  +   + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 574 TQTLATIGYMAP 585
                 + +MAP
Sbjct: 205 GNARLPVKWMAP 216

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 8/169 (4%)

Query: 160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-- 217
              L L +N L       +     L +L L   +L+  +      L  L  L L  N   
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ 90

Query: 218 PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISL 277
            LPL    L  L  +D S N  + +    + GL  L+ L+L  N L+ L P        L
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150

Query: 278 KFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNKLEGEIPRGGSFGNFS 325
           + L+L+NNNL+  +PA L   L  L+ L L  N L   IP+ G FG+  
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 60/280 (21%), Positives = 91/280 (32%), Gaps = 84/280 (30%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            + +  E++  +  L   +P  +       +L L +N L  + S  T +    L +L L 
Sbjct: 8   KVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLD 63

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
               +                                       L+              
Sbjct: 64  RAELT--------------------------------------KLQVD------------ 73

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYK 186
              G L  L T+DL  N+L  S+ +    L  L  L +  N+L  S+P      L EL +
Sbjct: 74  ---GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE 128

Query: 187 LELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
           L L GN+L  ++P         L  LSL +N        NL  L          +G    
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANN--------NLTEL-----PAGLLNG---- 170

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN 285
               L+NL+ L L  N L  +    FG+   L F  L  N
Sbjct: 171 ----LENLDTLLLQENSLYTIPKGFFGSH-LLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 39/140 (27%), Positives = 58/140 (41%), Gaps = 10/140 (7%)

Query: 7   GNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           G L  L  LDL  N+L  ++P+    +  L +L +  N L+ SL       L  L+EL L
Sbjct: 74  GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131

Query: 67  WGNNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            GN    L    L+       L  + L+NN L   LP   +  L + L+   +   ++  
Sbjct: 132 KGNELKTLPPGLLTPTPK---LEKLSLANNNLTE-LPAGLLNGLEN-LDTLLLQENSLYT 186

Query: 125 DIPEEIGNLTNLITIDLGGN 144
            IP+       L    L GN
Sbjct: 187 -IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 25/119 (21%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +PL    L  L  LD+  N+ + ++P+     +  L+ L L+ N L  +L        P 
Sbjct: 92  LPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149

Query: 61  LEELVLWGNNFSEL------------------NFLSSLSN----CKSLTVIGLSNNPLD 97
           LE+L L  NN +EL                  N L ++         L    L  NP  
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 18/182 (9%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSI 467
           D F +  ++GRGGFG V+  ++    ++ A K   L  +R  K    +      +I+  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF--QRLNIMI-DVASAL 524
             R ++ +  +   +    LV+  M  G +  H+Y+ +     F   R       + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYM 583
           E+LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356

Query: 584 AP 585
           AP
Sbjct: 357 AP 358

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 49/213 (23%), Positives = 76/213 (35%), Gaps = 52/213 (24%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIKV 475
           IG+G +G V  A         A+K+ N    R     DV     E  +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 476 ISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRL--------------- 514
                +E++  LV+E    G L           +  C +D+ +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 515 ------------------NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL- 555
                             NIM  + SAL YLH   +  + H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 556 -SDFGIAKLLIGEDQSMTQ--TQTLATIGYMAP 585
             DFG++K     +       T    T  ++AP
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 50/224 (22%), Positives = 79/224 (35%), Gaps = 43/224 (19%)

Query: 383 RQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGD 437
                  S  A+           Y       D  S+     + +GRG    VY+ +  G 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 438 GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL 497
               A+KV         K    E  ++  + H N+IK+           LVLE +  G L
Sbjct: 78  QKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135

Query: 498 EKHLYSTNCILDIFQRL------------NIMIDVASALEYLHFGCSTPVIHCDLKPSNV 545
                        F R+            + +  +  A+ YLH      ++H DLKP N+
Sbjct: 136 -------------FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENL 179

Query: 546 LL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           L      +    ++DFG++K ++     M    T+  T GY AP
Sbjct: 180 LYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYCAP 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 14/172 (8%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
           +G G FG V+       G+E  +K  N  + +   +  + E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF---QRLNIMIDVASALEYLHFGCSTPVI 536
            +     +V+E    G L + + S               +M  + +AL Y H   S  V+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 537 HCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP N+L      +    + DFG+A+ L   D+    T    T  YMAP
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAP 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 12/170 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRA-FKSFDVECEI-MKSIRHRNLIKVISS 478
           +GRG +G V K R +  G  +AVK           K   ++ +I M+++     +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 479 CSNEEFKGLVLEYMPQGSLE---KHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
              E    + +E M   SL+   K +      +       I + +  ALE+LH   S  V
Sbjct: 75  LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           IH D+KPSNVL++      + DFGI+  L+     + +        YMAP
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAP 178

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 39/197 (19%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVK----VFNLQCRRAFKSFDVECEIMKSI-RHR 470
           +G G FG V  A        G  ++VAVK      +   R A  S   E ++M  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQLGSHE 109

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHL----------------------YSTNCIL 508
           N++ ++ +C+      L+ EY   G L  +L                           +L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
                L     VA  +E+L        +H DL   NVL+    +  + DFG+A+ ++ + 
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 569 QSMTQTQTLATIGYMAP 585
             + +      + +MAP
Sbjct: 227 NYVVRGNARLPVKWMAP 243

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 34/188 (18%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKV-------------FNLQCRRAFKSFDVECEIMK 465
             +G G +G V   +      E A+KV              N    +  +    E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 466 SIRHRNLIKVISSCSNEEFKGLVLEYMPQGSL-----EKHLYSTNCILDIFQRLNIMIDV 520
           S+ H N+IK+     ++++  LV E+   G L      +H +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
            S + YLH      ++H D+KP N+LL   +  +   + DFG++     +D  +     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRL 209

Query: 578 ATIGYMAP 585
            T  Y+AP
Sbjct: 210 GTAYYIAP 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 9/167 (5%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEI-MKSIRHRNLIKVISS 478
           +G G  G V+K R    G  +AVK       +   K   ++ ++ +KS     +++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
                   + +E M     EK        +       + + +  AL YL       VIH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+KPSN+LLD+     L DFGI+  L+       + ++     YMAP
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 20/177 (11%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIMKSIRHRNLIK- 474
           L+G G +G V +          AVK+   +  R   + +     E ++++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 475 --VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
             V+ +   ++   +V+EY   G  E           + Q       +   LEYLH   S
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAP 585
             ++H D+KP N+LL       +S  G+A+ L           T  T      +  P
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPP 180

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 52/236 (22%), Positives = 93/236 (39%), Gaps = 17/236 (7%)

Query: 77  LSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL 136
           + S           L    +   + +  +    +S++    +N ++   + + I  L N+
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIK-SV-QGIQYLPNV 70

Query: 137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR 196
             + L GNKL  + +  L+ L+ L  L LD+NK++  +   +  L +L  L L  N +S 
Sbjct: 71  TKLFLNGNKL--TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS- 125

Query: 197 SIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY 255
            I     +L  L  L LG+N    +  +  L  L  +    N  S I+P  + GL  L+ 
Sbjct: 126 DING-LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182

Query: 256 LFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           L+L  N +  L   +   L +L  L L +             L     +  +   L
Sbjct: 183 LYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 59/305 (19%), Positives = 113/305 (37%), Gaps = 67/305 (21%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
                 + +L++  +   V      ++++  +   ++ +  S+  I    LPN+ +L L 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY--LPNVTKLFLN 76

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
           GN  +++     L+N K+L  + L  N +        + +L                   
Sbjct: 77  GNKLTDI---KPLANLKNLGWLFLDENKV------KDLSSLK------------------ 109

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
               +L  L ++ L  N +  S +  L  L +L+ L L +NK+  +    + RL +L  L
Sbjct: 110 ----DLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTL 161

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI 247
            L  N++S  I      L  L+ L L  N      I +L+                   +
Sbjct: 162 SLEDNQIS-DIVP-LAGLTKLQNLYLSKN-----HISDLR------------------AL 196

Query: 248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
            GLKNL+ L L          +   NL+    +  ++ +L    P  +      E  N+ 
Sbjct: 197 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVK 254

Query: 308 FNKLE 312
           ++  E
Sbjct: 255 WHLPE 259

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK----VIS 477
           IG G FG V++A+L +  EVA+K      R   +    E +IM+ ++H N++       S
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103

Query: 478 SCSNEEFKG--LVLEYMPQ--GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           +   ++     LVLEY+P+      +H       + +      M  +  +L Y+H   S 
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SI 160

Query: 534 PVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMT 572
            + H D+KP N+LLD  + +  L DFG AK+LI   +   
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNV 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 51/182 (28%), Positives = 70/182 (38%), Gaps = 32/182 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV---ECEIMKSIRHRNLIK 474
           +G G F  V K R  G G E A K      L   R   S +    E  I++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 475 VISSCSNEEFKGLVLEYMPQGSL-----EKHLYS-TNCILDIFQRLNIMIDVASALEYLH 528
           +     N+    L+LE +  G L     EK   +              +  +   + YLH
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH 125

Query: 529 FGCSTPVIHCDLKPSNVLL-----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
              S  + H DLKP N++L      +  I  L DFGIA   I             T  ++
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIK-LIDFGIAH-KIEAGNEF--KNIFGTPEFV 178

Query: 584 AP 585
           AP
Sbjct: 179 AP 180

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 32/186 (17%), Positives = 57/186 (30%), Gaps = 13/186 (6%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
                +   LG +       IT +++  L  + L +  +       I     +  L +  
Sbjct: 21  TFKAYLNGLLGQSSTAN---ITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 192 NKLSRSIPACFNNLIALRILSLGSN---DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
              +   P   + L  L  L +            +  L  L  +D S +     I  +I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSF 308
            L  +  + L YN     I      L  LK LN+  + +       +E    L  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 309 NKLEGE 314
             + G+
Sbjct: 191 QTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 8e-16
 Identities = 37/227 (16%), Positives = 79/227 (34%), Gaps = 31/227 (13%)

Query: 40  GLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI 99
           G  + +   +     ++     +  +      S    ++  +   SLT I L+N  +  +
Sbjct: 1   GAAEQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITE-AQMNSLTYITLANINVTDL 59

Query: 100 LPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK 159
              T I    H+++D  ++N + T +    I  L+NL  + + G  +    +  LS L  
Sbjct: 60  ---TGIEYA-HNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113

Query: 160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL 219
           L  L +  +  + SI   I  L ++  ++L  N     I      L  L+ L++  +   
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD--- 169

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL 266
              + + + +                       L  L+     + G 
Sbjct: 170 --GVHDYRGI------------------EDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 8/140 (5%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVG 231
           +IPD            LG +  +    A    + +L  ++L + +   L  I     +  
Sbjct: 16  NIPDS--TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTGIEYAHNIKD 70

Query: 232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI 291
           +  +  + +   P  I GL NLE L +    +      +   L SL  L++S++    +I
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 292 PASLEKLSYLEDLNLSFNKL 311
              +  L  +  ++LS+N  
Sbjct: 129 LTKINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.6 bits (171), Expect = 8e-14
 Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 11/168 (6%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
            +    + +L  + L    +     +       +K L + +   + + + I+   L NLE
Sbjct: 37  NITEAQMNSLTYITLANINVTDLTGIEYA--HNIKDLTINNIHAT-NYNPISG--LSNLE 91

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L + G + +    + +LS   SLT++ +S++  D  +  T I  L   +    +     
Sbjct: 92  RLRIMGKDVTSDK-IPNLSGLTSLTLLDISHSAHDDSIL-TKINTLP-KVNSIDLSYNGA 148

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL 170
             DI   +  L  L ++++  + ++      +    KL  L      +
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 19/113 (16%), Positives = 40/113 (35%), Gaps = 4/113 (3%)

Query: 204 NLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRL 263
              A     LG +    +    +  L  I  +  N + +    I    N++ L +     
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHA 78

Query: 264 QGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
               P     L +L+ L +   +++     +L  L+ L  L++S +  +  I 
Sbjct: 79  TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 7e-10
 Identities = 21/144 (14%), Positives = 42/144 (29%), Gaps = 33/144 (22%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGS-LSSITDVRLPNLEEL 64
           I  L NLE L +    +       +  +++L LL +  ++   S L+ I    LP +  +
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT--LPKVNSI 141

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
            L  N    +  +  L     L  + +  + +                            
Sbjct: 142 DLSYNG--AITDIMPLKTLPELKSLNIQFDGVHDY------------------------- 174

Query: 125 DIPEEIGNLTNLITIDLGGNKLNG 148
                I +   L  +      + G
Sbjct: 175 ---RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 13/95 (13%), Positives = 32/95 (33%), Gaps = 5/95 (5%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            +  L +L  LD+  +    ++   I  +  +  + L  N     +  +    LP L+ L
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT--LPELKSL 164

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI 99
            +  +   +   +        L  +   +  + G 
Sbjct: 165 NIQFDGVHDYRGIEDFPK---LNQLYAFSQTIGGK 196

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVEL 184
           IP+ +    +   +DL  N L      +     +LQ L L   +++ +I D     L  L
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 185 YKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLE---IGNLKVLVGIDFSMNNFS 240
             L L GN +  S+    F+ L +L+ L     +   LE   IG+LK L  ++ + N   
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 241 GIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF----LNLSNNNLSGAIPASL 295
                E    L NLE+L L  N++Q +       L  +      L+LS N ++  I    
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196

Query: 296 EKLSYLEDLNLSFNKLEGEIPRG 318
            K   L++L L  N+L+  +P G
Sbjct: 197 FKEIRLKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 13/188 (6%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKLELG 190
           +   L  +DL   ++          L  L  L+L  N ++ S+       L  L KL   
Sbjct: 50  SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108

Query: 191 GNKLSRSIPA-CFNNLIALRILSLGSND----PLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
              L+ S+      +L  L+ L++  N      LP    NL  L  +D S N    I   
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167

Query: 246 EIGGLKNLEY----LFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL 301
           ++  L  +      L L  N +  + P +F  +  LK L L  N L        ++L+ L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSL 226

Query: 302 EDLNLSFN 309
           + + L  N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 12/212 (5%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
           + + LDL  N  +  +    F +   L++L L    +  ++       L +L  L+L GN
Sbjct: 29  STKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
               L  L + S   SL  +      L   L    IG+L  +L++  + +  +      E
Sbjct: 87  PIQSLA-LGAFSGLSSLQKLVAVETNLA-SLENFPIGHL-KTLKELNVAHNLIQSFKLPE 143

Query: 130 I-GNLTNLITIDLGGNKL---NGSILITLSKLQKLQG-LVLDDNKLEGSIPDDICRLVEL 184
              NLTNL  +DL  NK+     + L  L ++  L   L L  N +   I     + + L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSN 216
            +L L  N+L       F+ L +L+ + L +N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 30/119 (25%)

Query: 7   GNLQNLEELDLRQNKLIGTVPVA-IF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLE-- 62
           G+L+ L+EL++  N  I +  +   F N++ L+ L L  N +  S+       L  +   
Sbjct: 121 GHLKTLKELNVAHNL-IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178

Query: 63  --ELVLWGNNFSEL-----------------NFLSSLS-----NCKSLTVIGLSNNPLD 97
              L L  N  + +                 N L S+         SL  I L  NP D
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 38/183 (20%), Positives = 68/183 (37%), Gaps = 42/183 (22%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSIRHRNLIKVISS 478
           +GRG FG V++            K       +      V  E  I+   RHRN++ +  S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRL-------------NIMIDVASALE 525
             + E   ++ E++                DIF+R+             + +  V  AL+
Sbjct: 70  FESMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 526 YLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           +LH   S  + H D++P N++      + I  + +FG A+  +    +           Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIK-IIEFGQAR-QLKPGDNF--RLLFTAPEY 169

Query: 583 MAP 585
            AP
Sbjct: 170 YAP 172

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.7 bits (220), Expect = 9e-19
 Identities = 41/184 (22%), Positives = 70/184 (38%), Gaps = 25/184 (13%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN 471
            D +  +  +G G FG V++      G   A K          ++   E + M  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSL------EKHLYS-TNCILDIFQRLNIMIDVASAL 524
           L+ +  +  ++    ++ E+M  G L      E +  S    +         M  V   L
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCKGL 268

Query: 525 EYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
            ++H       +H DLKP N++      N +  L DFG+    +   QS+    T  T  
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELK-LIDFGLTA-HLDPKQSV--KVTTGTAE 321

Query: 582 YMAP 585
           + AP
Sbjct: 322 FAAP 325

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 13/170 (7%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
            IG+G FG V   +  D  ++ A+K  N      R   ++   E +IM+ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
            S  +EE   +V++ +  G L  HL       +   +L I  ++  AL+YL    +  +I
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ---NQRII 137

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           H D+KP N+LLD++   +++DF IA +L  E    TQ  T+A T  YMAP
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAP 183

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 43/181 (23%), Positives = 68/181 (37%), Gaps = 30/181 (16%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDV-----ECEIMKSIRHRNLIK 474
           +G G F  V K R    G+E A K     Q R + +         E  I++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 475 VISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +     N     L+LE +  G L      ++ L             + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 529 FGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
              +  + H DLKP N++L           L DFG+A   I +           T  ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186

Query: 585 P 585
           P
Sbjct: 187 P 187

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 12/184 (6%)

Query: 128 EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
                L N +  +LG   +  + L++  +L  +Q    D++ ++ S+   +     L +L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI 247
            L  N++S   P    +L  L  LS+  N    L       L  +    N         +
Sbjct: 69  HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS--L 124

Query: 248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
             LKNLE L +  N+L+ +     G L  L+ L+L  N ++      L +L  +  ++L+
Sbjct: 125 IHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLT 180

Query: 308 FNKL 311
             K 
Sbjct: 181 GQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 46/235 (19%), Positives = 88/235 (37%), Gaps = 22/235 (9%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
              L N  + +L +  +   V      +S ++     ++++  SL+ +      NL+EL 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAGMQF--FTNLKELH 69

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH-SLEDFQMHNCNVTG 124
           L  N  S+   LS L +   L  + ++ N L       ++  +    L    + N  +  
Sbjct: 70  LSHNQISD---LSPLKDLTKLEELSVNRNRL------KNLNGIPSACLSRLFLDNNELR- 119

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL 184
           D  + + +L NL  + +  NKL    ++ L  L KL+ L L  N++  +    + RL ++
Sbjct: 120 DT-DSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKV 174

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL-PLEIGNLKVLVGIDFSMNN 238
             ++L G K           L     +       + P  I N    V        
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 44/253 (17%), Positives = 86/253 (33%), Gaps = 25/253 (9%)

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH--SLEDFQMHNC 120
           E +      +++     L+N        L    +      T + +      +++F   N 
Sbjct: 1   ESIQRPTPINQVFPDPGLANAVKQN---LGKQSV------TDLVSQKELSGVQNFNGDNS 51

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
           N+   +   +   TNL  + L  N++  S L  L  L KL+ L ++ N+L+         
Sbjct: 52  NIQ-SL-AGMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC 107

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNF 239
           L  L+   L  N+L  +      +L  L ILS+ +N    +  +G L  L  +D   N  
Sbjct: 108 LSRLF---LDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEI 162

Query: 240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS 299
           +      +  LK + ++ L   +           L     +   +       P  +    
Sbjct: 163 TNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGG 218

Query: 300 YLEDLNLSFNKLE 312
              D  + +    
Sbjct: 219 SYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 9/133 (6%)

Query: 4   LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE 63
           L       L  L L  N+L  T  +   ++  L++L +++N L  S+  +    L  LE 
Sbjct: 100 LNGIPSACLSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKLK-SIVMLGF--LSKLEV 154

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L L GN  +       L+  K +  I L+        P      L  +          ++
Sbjct: 155 LDLHGNEITN---TGGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRWIS 210

Query: 124 GDIPEEIGNLTNL 136
                  G+  + 
Sbjct: 211 PYYISNGGSYVDG 223

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 30/181 (16%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV---ECEIMKSIRHRNLIK 474
           +G G F  V K R    G+E A K       +  R     +    E  I++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 475 VISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +     N     L+LE +  G L      ++ L             + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 529 FGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
              +  + H DLKP N++L           L DFG+A   I +           T  ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186

Query: 585 P 585
           P
Sbjct: 187 P 187

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 21/180 (11%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC--------EIMKS 466
           FS + +IGRGGFG VY  R  D  ++ A+K   L  +R                  ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
                ++ +  +    +    +L+ M  G L  HL       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           +H   +  V++ DLKP+N+LLD++    +SD G+A     +     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 45/182 (24%), Positives = 70/182 (38%), Gaps = 32/182 (17%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDV---ECEIMKSIRHRNLIK 474
           +G G F  V K R    G++ A K       +  R   S +    E  I+K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 475 VISSCSNEEFKGLVLEYMPQGSL------EKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           +     N+    L+LE +  G L      ++ L               +  + + + YLH
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVYYLH 131

Query: 529 FGCSTPVIHCDLKPSNVLL-----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
              S  + H DLKP N++L         I  + DFG+A   I             T  ++
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIK-IIDFGLAH-KIDFGNEF--KNIFGTPEFV 184

Query: 584 AP 585
           AP
Sbjct: 185 AP 186

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 40/184 (21%), Positives = 68/184 (36%), Gaps = 31/184 (16%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVK-------------VFN--LQCRRAFKSFDVECEIMKS 466
           I  G +G+V      +G+ VA+K             + +    C+R  +    E  ++  
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85

Query: 467 IRHRNLIK---VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA 521
             H N++    +             LV E M +  L + ++    ++        M  + 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIG 581
             L  LH      V+H DL P N+LL DN    + DF +A+     D +   T  +    
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--THYVTHRW 198

Query: 582 YMAP 585
           Y AP
Sbjct: 199 YRAP 202

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 58/184 (31%), Positives = 89/184 (48%), Gaps = 41/184 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLI 473
            +G G FG V        G +VAVK+ N   R+  +S DV      E + +K  RH ++I
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 474 K---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASALE 525
           K   VIS+   + F  +V+EY+  G L  ++     +       +FQ++       SA++
Sbjct: 75  KLYQVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVD 125

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI----G 581
           Y H      V+H DLKP NVLLD +M A ++DFG++ +       M+  + L T      
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 175

Query: 582 YMAP 585
           Y AP
Sbjct: 176 YAAP 179

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI---- 476
           IG G FG VY+A+L D G  VA+K      R   +    E +IM+ + H N++++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117

Query: 477 --SSCSNEEFKGLVLEYMPQ--GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
                 +E +  LVL+Y+P+    + +H       L +      M  +  +L Y+H   S
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---S 174

Query: 533 TPVIHCDLKPSNVLLDDNMIAY-LSDFGIAKLLIGEDQSMT 572
             + H D+KP N+LLD +     L DFG AK L+   +   
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV 214

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 34/182 (18%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHR-NLIK 474
           +GRG F  V +      G E A K      +R            E  +++  +    +I 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 475 VISSCSNEEFKGLVLEYMPQGSL-EKHLYSTNCILDIFQRL------NIMIDVASALEYL 527
           +     N     L+LEY   G +         C+ ++ + +       ++  +   + YL
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 528 HFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           H      ++H DLKP N+LL        I  + DFG+++  IG    +   + + T  Y+
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIK-IVDFGMSR-KIGHACEL--REIMGTPEYL 200

Query: 584 AP 585
           AP
Sbjct: 201 AP 202

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 51/185 (27%), Positives = 72/185 (38%), Gaps = 39/185 (21%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFN--------LQCRRAFKSFDVECEIMKSIRHRNL 472
           +G G FG V+ A       EV VK                      +E  I+  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF------QRLN------IMIDV 520
           IKV+    N+ F  LV+E    G            LD+F       RL+      I   +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG------------LDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
            SA+ YL       +IH D+K  N+++ ++    L DFG A  L  E   +  T    TI
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTI 193

Query: 581 GYMAP 585
            Y AP
Sbjct: 194 EYCAP 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 41/184 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLI 473
            +G G FG V   +    G +VAVK+ N   R+  +S DV      E + +K  RH ++I
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 474 K---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASALE 525
           K   VIS+  ++ F  +V+EY+  G L  ++     +       +FQ++       S ++
Sbjct: 80  KLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVD 130

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI----G 581
           Y H      V+H DLKP NVLLD +M A ++DFG++ +       M+  + L T      
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 180

Query: 582 YMAP 585
           Y AP
Sbjct: 181 YAAP 184

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 65/197 (32%), Positives = 87/197 (44%), Gaps = 32/197 (16%)

Query: 126 IPEEI-GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVE 183
           IP  I  +   L   DL  NKL+        +L KL+ L L+DNKL+ ++P  I   L  
Sbjct: 31  IPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 184 LYKLELGGNKLSRSIPAC-FNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGI 242
           L  L +  NKL  ++P   F+ L+ L  L L  N                         +
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN---------------------QLKSL 124

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYL 301
            P+    L  L YL LGYN LQ L    F  L SLK L L NN L   +P    +KL+ L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTEL 183

Query: 302 EDLNLSFNKLEGEIPRG 318
           + L L  N+L+  +P G
Sbjct: 184 KTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 17/164 (10%)

Query: 132 NLTNLITIDLGGNKLNGSILITLS-----KLQKLQGLVLDDNKLEGSIPDDI-CRLVELY 185
            LT L  + L  NKL      TL      +L+ L+ L + DNKL+ ++P  +  +LV L 
Sbjct: 59  RLTKLRLLYLNDNKLQ-----TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLA 112

Query: 186 KLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIG---NLKVLVGIDFSMNNFSG 241
           +L L  N+L  S+P   F++L  L  LSLG N+   L  G    L  L  +    N    
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR 171

Query: 242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN 285
           +       L  L+ L L  N+L+ +   +F +L  LK L L  N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 54/189 (28%), Positives = 76/189 (40%), Gaps = 36/189 (19%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFN-VSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L  L  L L  NKL  T+P  IF  +  L+ L + DN L  +L      +L NL EL L
Sbjct: 59  RLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 67  WGNNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
             N    L      SL+    LT + L  N L          +L   + D          
Sbjct: 117 DRNQLKSLPPRVFDSLTK---LTYLSLGYNELQ---------SLPKGVFD---------- 154

Query: 125 DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVE 183
                   LT+L  + L  N+L         KL +L+ L LD+N+L+  +P+     L +
Sbjct: 155 -------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEK 206

Query: 184 LYKLELGGN 192
           L  L+L  N
Sbjct: 207 LKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 24/91 (26%), Positives = 42/91 (46%), Gaps = 4/91 (4%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           +L  L  L L  N+L  ++P  +F  +++LK L L +N L   +      +L  L+ L L
Sbjct: 131 SLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKL 188

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
             N    +    +  + + L ++ L  NP D
Sbjct: 189 DNNQLKRVP-EGAFDSLEKLKMLQLQENPWD 218

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 10/173 (5%)

Query: 407 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFK-SFDV----E 460
           L++      + + + +G G F +VYKAR       VA+K   L  R   K   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
            ++++ + H N+I ++ +  ++    LV ++M    LE  +   + +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              LEYLH      ++H DLKP+N+LLD+N +  L+DFG+AK     +++ T 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 39/187 (20%), Positives = 71/187 (37%), Gaps = 46/187 (24%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSI-RHRNLIKVI 476
           ++G G  G V +      G + A+K+          S     E +         +++ ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 477 SSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILD-IFQRLN----------IMIDVA 521
               N         +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           +A+++LH   S  + H D+KP N+L    + + +  L+DFG AK       ++       
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191

Query: 579 TIGYMAP 585
           T  Y+AP
Sbjct: 192 TPYYVAP 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.4 bits (214), Expect = 5e-18
 Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 21/180 (11%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRH 469
           F +  ++G+GGFG V   ++    ++ A K   L+ +R  K           +I++ +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI---DVASALEY 526
           R ++ +  +   ++   LVL  M  G L+ H+Y  +     F     +    ++   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           LH      +++ DLKP N+LLDD+    +SD G+A  +          +    T+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 36/166 (21%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL--------QCRRAFKSFDVECEIMKSIRHRN 471
            +G G +G V  A        VAVK+ ++          ++       E  I K + H N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 472 LIK---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASA 523
           ++K         N ++  L LEY   G L   +     +        F +L       + 
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAG 117

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 45/186 (24%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSI-RHRNLIKVIS 477
           +G G  G V +        + A+K+                E E+     +  ++++++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 478 SCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILD-IFQRLN----------IMIDVAS 522
              N         +V+E +  G L             I  R +          IM  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           A++YLH   S  + H D+KP N+L      N I  L+DFG AK     +   T      T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYT 226

Query: 580 IGYMAP 585
             Y+AP
Sbjct: 227 PYYVAP 232

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 29/154 (18%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-----ECEIMKSIRHRNLIK- 474
           IG+G F  V  AR +  G EVA+K+ +   +       +     E  IMK + H N++K 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 475 --VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD-----IFQRLNIMIDVASALEYL 527
             VI +     +  L++EY   G +  +L +   + +      F+++       SA++Y 
Sbjct: 80  FEVIET-EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYC 130

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           H      ++H DLK  N+LLD +M   ++DFG +
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 38/181 (20%), Positives = 74/181 (40%), Gaps = 32/181 (17%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
           +IGRG FG V   +L +  +V A+K+  L      K  +  C     +++ +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID----------VASAL 524
           +  +  ++    LV++Y   G L   L           +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAI 188

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           + +H       +H D+KP N+L+D N    L+DFG    L+ +    +    + T  Y++
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYIS 244

Query: 585 P 585
           P
Sbjct: 245 P 245

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 22/147 (14%), Positives = 45/147 (30%), Gaps = 14/147 (9%)

Query: 421 LIGRGGFGSVYKA---RLGDGMEVAVKVFNLQCRRA--FKS-FDVECEIMKSIRHRNLIK 474
             G       ++A    L    +VA+   + Q                 +  I    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           V+          +V E++  GSL++   ++         +  M  +A+A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           V      PS V +  +    L+     
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM 176

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 37/152 (24%), Positives = 74/152 (48%), Gaps = 21/152 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G +G V +A    +   VA+K    VF   + C+R  +    E  I+  + H +++K
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116

Query: 475 ---VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
              ++     E+F    +VLE       +K   +   + ++  +  ++ ++   ++Y+H 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
             S  ++H DLKP+N L++ +    + DFG+A
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 44/264 (16%), Positives = 76/264 (28%), Gaps = 48/264 (18%)

Query: 49  SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL 108
            ++ I      N  EL         +    + S    L  I +S N +  ++      NL
Sbjct: 20  KVTEIPSDLPRNAIELRFVLTKLRVIQ-KGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78

Query: 109 SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
              L + ++   N             NL+ I+                L  LQ L++ + 
Sbjct: 79  -PKLHEIRIEKAN-------------NLLYINPE----------AFQNLPNLQYLLISNT 114

Query: 169 KLEGSIPDDI-CRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNL 226
            ++  +PD      ++   L++  N    +I    F  L                     
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE------------------ 155

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
              V +  + N    I      G +  E      N L+ L  D F        L++S   
Sbjct: 156 --SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 213

Query: 287 LSGAIPASLEKLSYLEDLNLSFNK 310
           +       LE L  L   +    K
Sbjct: 214 IHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 50/311 (16%), Positives = 91/311 (29%), Gaps = 79/311 (25%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           EIP ++   +N  EL     KL      A      L+ + +  N +   + +     LP 
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 61  LEELVLWGNNFSELNFLSS--LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           L E+ +   N   L +++     N  +L  + +SN  +  +     I             
Sbjct: 81  LHEIRIEKAN--NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI------------- 125

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
                        +    + +D+  N            +  ++                 
Sbjct: 126 -------------HSLQKVLLDIQDN----------INIHTIERNSFVGLS--------- 153

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN 238
               E   L L  N +     + FN      +    +N        NL+ L    F    
Sbjct: 154 ---FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNN--------NLEELPNDVFH--- 199

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL 298
                     G      L +   R+  L      NL  L+  +  N      +P +LEKL
Sbjct: 200 ----------GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245

Query: 299 SYLEDLNLSFN 309
             L + +L++ 
Sbjct: 246 VALMEASLTYP 256

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 36/160 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNL--------QCRRAFKSFDVECEIMKSIRHRN 471
            +G G +G V  A        VAVK+ ++          ++       E  I K + H N
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-------EICINKMLNHEN 66

Query: 472 LIK---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASA 523
           ++K         N ++  L LEY   G L   +     +        F +L       + 
Sbjct: 67  VVKFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAG 117

Query: 524 LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL 563
           + YLH      + H D+KP N+LLD+     +SDFG+A +
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.4 bits (202), Expect = 4e-17
 Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 24/175 (13%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECE------- 462
               + + +   +G G +G VYKA+   G  VA+K   L         D E E       
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAI 67

Query: 463 ----IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMI 518
               ++K + H N++ +I    +E    LV E+M +  L+K L      L   Q    + 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
            +   + + H      ++H DLKP N+L++ +    L+DFG+A+      +S T 
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 30/179 (16%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
           +IGRG FG V   R     +V A+K+  L      K  D        +IM       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVA--------SALEY 526
           +  +  ++ +  +V+EYMP G L   +             ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H   S   IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++P
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP 238

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 28/179 (15%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +IGRG F  V   ++    +V A+K+ N   +  R     F  E +++ +   R + ++ 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID----------VASALEY 526
            +  +E +  LV+EY   G L   L           +    I           +  A++ 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDS 177

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H       +H D+KP N+LLD      L+DFG    L  +    +    + T  Y++P
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSP 232

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 9/179 (5%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKS 466
            ++ + +    L+G G +G V K R    G  VA+K F      +  K   + E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           +RH NL+ ++  C  ++   LV E++   ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            H   S  +IH D+KP N+L+  + +  L DFG A+ L    +       +AT  Y AP
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAP 193

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 40/165 (24%), Positives = 80/165 (48%), Gaps = 19/165 (11%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIM 464
           C     + +   IG+G FG V+KAR    G +VA+K   ++  +  + F +    E +I+
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70

Query: 465 KSIRHRN---LIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
           + ++H N   LI++  + ++   +      LV ++     L   L +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           M  + + L Y+H      ++H D+K +NVL+  + +  L+DFG+A
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 48/171 (28%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV--ECEIMKSI-RHRNLIKVIS 477
           +G G  G V +        + A+K+                E E+     +  ++++++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 478 SCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRL--------------NIMID 519
              N         +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGE 567
           +  A++YLH   S  + H D+KP N+L      N I  L+DFG AK   GE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 7/154 (4%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDV-ECEIMKSIRHRNLIKVISS 478
           IG G +G V+K R    G  VA+K F   +     K   + E  ++K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              +    LV EY    ++   L      +      +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT 572
           D+KP N+L+  + +  L DFG A+LL G      
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
            +G G FG V   +  +     A+K+  L  ++  K   +E       I++++    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  S  +     +V+EY+  G +  HL       +   R      +    EYLH   S  
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T   +AP
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAP 207

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 49/175 (28%), Positives = 71/175 (40%), Gaps = 25/175 (14%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEI--MKSIRHRNLIKVIS 477
            IG G FG     R       VAVK      R A    +V+ EI   +S+RH N+++   
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASALEYLHFGCS 532
                    +++EY   G L + + +            FQ+L       S + Y H   S
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---S 134

Query: 533 TPVIHCDLKPSNVLLDDNMIAYL--SDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             + H DLK  N LLD +    L   DFG +K       S  ++ T+ T  Y+AP
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKS-TVGTPAYIAP 186

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 22/175 (12%)

Query: 413 TDGFSENNLIGRGGFGSVYKARLGD-GMEVAVK-VFNLQCRRAFKSFDVECEIMK---SI 467
            D F    + G+G FG+V   +    GM VA+K V     R   +    E +IM+    +
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNR----ELQIMQDLAVL 76

Query: 468 RHRNLIK---VISSCSNEEFK----GLVLEYMPQ--GSLEKHLYSTNCILDIFQRLNIMI 518
            H N+++      +    + +     +V+EY+P       ++ Y              + 
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMT 572
            +  ++  LH   S  V H D+KP NVL++  +    L DFG AK L    +   
Sbjct: 137 QLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNV 189

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 21/152 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           IGRG +G VY A        VA+K    +F   + C+R  +    E  I+  ++   +I+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 475 ---VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
              +I      +F    +VLE      L+K   +   + +   +  I+ ++     ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
              + +IH DLKP+N LL+ +    + DFG+A
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 42/184 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHRNLI 473
            +G G FG V  A       +VA+K  +   R+  K  D+      E   +K +RH ++I
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFIS---RQLLKKSDMHMRVEREISYLKLLRHPHII 72

Query: 474 K---VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASALE 525
           K   VI++   +    +V+EY   G L  ++     +        FQ++        A+E
Sbjct: 73  KLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIE 122

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI----G 581
           Y H      ++H DLKP N+LLDDN+   ++DFG++ +       MT    L T      
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPN 172

Query: 582 YMAP 585
           Y AP
Sbjct: 173 YAAP 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 6e-16
 Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 12/154 (7%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIP-ACFNNLIALRILSLGSNDPLPLEIG---NLKV 228
           ++P  +        L+L  N LSR         L  L  L L  N    +       +  
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS 288
           L  +D S N+   +       L+ LE L L  N +  +  ++F ++  L+ L LS N +S
Sbjct: 90  LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149

Query: 289 GAIPA----SLEKLSYLEDLNLSFNKLEGEIPRG 318
              P        KL  L  L+LS NKL+ ++P  
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 36/204 (17%)

Query: 19  QNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLS 78
             + +  VP ++   S   LL L  N+LS   +  T  RL NL  L+L  N+ + ++   
Sbjct: 26  SKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISS-E 82

Query: 79  SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT 138
           +     +L  + LS+N L       ++         F                +L  L  
Sbjct: 83  AFVPVPNLRYLDLSSNHL------HTLDE-----FLFS---------------DLQALEV 116

Query: 139 IDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI----CRLVELYKLELGGNKL 194
           + L  N +          + +LQ L L  N++    P ++     +L +L  L+L  NKL
Sbjct: 117 LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175

Query: 195 SRSIPACFNNLIAL--RILSLGSN 216
            +        L A     L L +N
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 12/165 (7%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
               LDL  N L           ++ L  L L  N L+  +SS   V +PNL  L L  N
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 70  NFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEE 129
           +   L+     S+ ++L V+ L NN +  +  + +  +++  L+   +    ++   P E
Sbjct: 99  HLHTLD-EFLFSDLQALEVLLLYNNHIVVV-DRNAFEDMA-QLQKLYLSQNQIS-RFPVE 154

Query: 130 I----GNLTNLITIDLGGNKLNGSILITLSKLQKL--QGLVLDDN 168
           +      L  L+ +DL  NKL    L  L KL      GL L +N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 25/115 (21%), Positives = 46/115 (40%), Gaps = 5/115 (4%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            + NL  LDL  N L  T+   +F ++  L++L L +N +   +       +  L++L L
Sbjct: 86  PVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYL 143

Query: 67  WGNNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
             N  S      +   +    L ++ LS+N L  +         +       +HN
Sbjct: 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.2 bits (191), Expect = 8e-16
 Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 27/176 (15%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECE-----------IMKSIRH 469
           IG G +G+V+KA+       VA+K   L         D + E           ++K ++H
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKELKH 60

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
           +N++++     +++   LV E+  Q  L+K+  S N  LD     + +  +   L + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH- 118

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.2 bits (191), Expect = 8e-16
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 24/171 (14%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECE----------- 462
           + +     IG G +G VYKA+   G   A+K   L         + E E           
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREIS 52

Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
           I+K ++H N++K+      ++   LV E++ Q  L+K L      L+     + ++ + +
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
            + Y H      V+H DLKP N+L++      ++DFG+A+      +  T 
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 35/189 (18%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMK 465
              +     +G G +GSV  A     G +VA+K     F   +  +RA++    E  ++K
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 466 SIRHRNLIK----VISSCSNEEFKG--LVLEYMP---QGSLEKHLYSTNCILDIFQRLNI 516
            ++H N+I        + S   F    LV+ +M    Q  +            ++Q L  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
                  L+Y+H   S  V+H DLKP N+ ++++    + DFG+A+     D  M  T  
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGY 183

Query: 577 LATIGYMAP 585
           + T  Y AP
Sbjct: 184 VVTRWYRAP 192

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 19/172 (11%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
            +G G FG V+  R        A+KV  L+     +   VE       ++  + H  +I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  +  + +   ++++Y+  G L   L  +    +   +     +V  ALEYLH   S  
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLH---SKD 126

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           +I+ DLKP N+LLD N    ++DFG AK +         T TL  T  Y+AP
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTYTLCGTPDYIAP 172

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 22/176 (12%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK- 474
           IG G +G V  A    + + VA+K    F     C+R  +    E +I+   RH N+I  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 475 --VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
             +I + + E+ K   +V + M +  L K L +   + +       +  +   L+Y+H  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH-- 145

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAP 585
            S  V+H DLKPSN+LL+      + DFG+A++   +       T+ +AT  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 29/183 (15%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK---VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK- 474
           +G G +G V  A     G  VA+K    F+  L   R  +    E +I+K  +H N+I  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 475 --VISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
             +    S E F    ++ E M Q  L + + ST  + D   +   +     A++ LH  
Sbjct: 75  FNIQRPDSFENFNEVYIIQELM-QTDLHR-VISTQMLSDDHIQY-FIYQTLRAVKVLH-- 129

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ--------TQTLATIGY 582
             + VIH DLKPSN+L++ N    + DFG+A+++       ++         + +AT  Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 583 MAP 585
            AP
Sbjct: 189 RAP 191

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 33/180 (18%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK----VFNLQ--CRRAFKSFDVECEIMKSIRHRNLIK 474
           IG G  G V  A        VA+K     F  Q   +RA++    E  +MK + H+N+I 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 475 V----ISSCSNEEFKG--LVLEYMP---QGSLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           +        S EEF+   +V+E M       ++  L        ++Q L         ++
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +LH   S  +IH DLKPSN+++  +    + DFG+A+   G    M  T  + T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAP 195

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 40/183 (21%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +GSV  A     G+ VAVK     F   +  +R ++    E  ++K ++H N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92

Query: 475 V----ISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVAS 522
           +      + S EEF    LV   M    L   +          Q+L       ++  +  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILR 143

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            L+Y+H   S  +IH DLKPSN+ ++++    + DFG+A+        M  T  +AT  Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TGYVATRWY 195

Query: 583 MAP 585
            AP
Sbjct: 196 RAP 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 37/162 (22%), Positives = 76/162 (46%), Gaps = 6/162 (3%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRN 471
           + + + + +G G + +VYK +       VA+K   L+         + E  ++K ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++ +      E+   LV EY+ +  L+++L     I+++      +  +   L Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
              V+H DLKP N+L+++     L+DFG+A+      ++   
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 15/155 (9%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV------ECEIMKSIRHR--N 471
           L+G GGFGSVY    + D + VA+K         +           E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 472 LIKVISSCSNEEFKGLVLEY-MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           +I+++      +   L+LE   P   L   +     + +   R +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166

Query: 531 CSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLL 564
            +  V+H D+K  N+L+D N     L DFG   LL
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 34/191 (17%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP--DDICRLVELYKLEL 189
            L ++  I    + +    +  +  L  ++ L L  NKL   I        L  L  L L
Sbjct: 39  ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-DISALK---ELTNLTYLIL 92

Query: 190 GGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG 248
            GN+L  S+P   F+ L  L+ L L  N    L                   G+  K   
Sbjct: 93  TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLP-----------------DGVFDK--- 131

Query: 249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLS 307
            L NL YL L +N+LQ L    F  L +L  L+LS N L  ++P  + +KL+ L+DL L 
Sbjct: 132 -LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189

Query: 308 FNKLEGEIPRG 318
            N+L+  +P G
Sbjct: 190 QNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 61/271 (22%), Positives = 101/271 (37%), Gaps = 65/271 (23%)

Query: 19  QNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLS 78
              +    P   F  +      L+  S++    ++T   L ++++++   ++   +  + 
Sbjct: 6   STPIKQIFPDDAF--AETIKANLKKKSVT---DAVTQNELNSIDQIIANNSDIKSVQGIQ 60

Query: 79  SLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT 138
            L N   +  + L  N L        I          +                LTNL  
Sbjct: 61  YLPN---VRYLALGGNKL------HDISA-------LK---------------ELTNLTY 89

Query: 139 IDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVELYKLELGGNKLSRS 197
           + L GN+L         KL  L+ LVL +N+L+ S+PD +  +L  L  L L  N+L   
Sbjct: 90  LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSL 148

Query: 198 IPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY 255
               F+ L  L  L L  N    LP                    G+  K    L  L+ 
Sbjct: 149 PKGVFDKLTNLTELDLSYNQLQSLP-------------------EGVFDK----LTQLKD 185

Query: 256 LFLGYNRLQGLIPD-SFGNLISLKFLNLSNN 285
           L L  N+L+  +PD  F  L SL+++ L +N
Sbjct: 186 LRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 35/149 (23%), Positives = 54/149 (36%), Gaps = 27/149 (18%)

Query: 163 LVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE 222
             L    +          L  + ++    + +  S+      L  +R L+LG N     +
Sbjct: 24  ANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGN-----K 74

Query: 223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL 282
           + ++                       L NL YL L  N+LQ L    F  L +LK L L
Sbjct: 75  LHDISA----------LKE--------LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116

Query: 283 SNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
             N L        +KL+ L  LNL+ N+L
Sbjct: 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQL 145

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 53/219 (24%), Positives = 78/219 (35%), Gaps = 70/219 (31%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
           I  L N+  L L  NK              L  +                  L NL  L+
Sbjct: 59  IQYLPNVRYLALGGNK--------------LHDISALK-------------ELTNLTYLI 91

Query: 66  LWGNNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L GN    L       L+N   L  + L  N          + +L   + D         
Sbjct: 92  LTGNQLQSLPNGVFDKLTN---LKELVLVEN---------QLQSLPDGVFD--------- 130

Query: 124 GDIPEEIGNLTNLITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
                    LTNL  ++L  N+L     G       KL  L  L L  N+L+ S+P+ + 
Sbjct: 131 --------KLTNLTYLNLAHNQLQSLPKG----VFDKLTNLTELDLSYNQLQ-SLPEGVF 177

Query: 180 -RLVELYKLELGGNKLSRSIP-ACFNNLIALRILSLGSN 216
            +L +L  L L  N+L +S+P   F+ L +L+ + L  N
Sbjct: 178 DKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 33/181 (18%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L +++++    + +       I  +  ++ L L  N L   +S++    L NL  L+L 
Sbjct: 39  ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-DISALK--ELTNLTYLILT 93

Query: 68  GNNFSEL--NFLSSLSNCKSLTVIGLSNNPL----DGILPK-TSIGNLSHSLEDFQMHNC 120
           GN    L       L+N   L  + L  N L    DG+  K T++  L+  L   Q+ + 
Sbjct: 94  GNQLQSLPNGVFDKLTN---LKELVLVENQLQSLPDGVFDKLTNLTYLN--LAHNQLQS- 147

Query: 121 NVTGDIPEEI-GNLTNLITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSIP 175
                +P+ +   LTNL  +DL  N+L     G       KL +L+ L L  N+L+ S+P
Sbjct: 148 -----LPKGVFDKLTNLTELDLSYNQLQSLPEG----VFDKLTQLKDLRLYQNQLK-SVP 197

Query: 176 D 176
           D
Sbjct: 198 D 198

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 26/113 (23%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFN-VSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           L NL+EL L +N+L  ++P  +F+ ++ L  L L  N L      + D +L NL EL L 
Sbjct: 108 LTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD-KLTNLTELDLS 165

Query: 68  GNN--------FSELNFLSSLS---------------NCKSLTVIGLSNNPLD 97
            N         F +L  L  L                   SL  I L +NP D
Sbjct: 166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 15/172 (8%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
           L+G+G FG V   +        A+K+  L+        +V        ++++ RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  S    +    V+EY   G L  HL       +   R     ++ SAL+YLH   +  
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN-- 269

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           V++ DLK  N++LD +    ++DFG+ K  I +  +    +T   T  Y+AP
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 318

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 33/201 (16%)

Query: 408 ELCRATDGFS-ENNLIGRGGFGSVYKAR---LGDGMEVAVKVFNLQCRRAFKSFDV---- 459
           E  R  D F  E   +GRG +G VYKA+     D  + A+K              +    
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACR 67

Query: 460 ECEIMKSIRHRN---LIKVISSCSNEEFKGLVLEYMPQ---GSLEKH----LYSTNCILD 509
           E  +++ ++H N   L KV  S ++ +   L+ +Y        ++ H           L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKLLI 565
                +++  +   + YLH   +  V+H DLKP+N+L+     +     ++D G A+L  
Sbjct: 127 RGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

Query: 566 GEDQSMTQ-TQTLATIGYMAP 585
              + +      + T  Y AP
Sbjct: 184 SPLKPLADLDPVVVTFWYRAP 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 22/191 (11%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRR-AFKSFDVEC--EI-- 463
             AT  +     IG G +G+VYKAR    G  VA+K   +           +    E+  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 464 ---MKSIRHRN---LIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCI-LDIFQRL 514
              +++  H N   L+ V ++   +      LV E++ Q  L  +L       L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQT 574
           ++M      L++LH   +  ++H DLKP N+L+       L+DFG+A++       M  T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177

Query: 575 QTLATIGYMAP 585
             + T+ Y AP
Sbjct: 178 PVVVTLWYRAP 188

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN----LQCRRAFKSFDVECEI--MKSIR----H 469
           L+G+GGFG+V+    L D ++VA+KV      L       S     E+  +  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 470 RNLIKVISSCSNEEFKGLVLEY-MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
             +I+++     +E   LVLE  +P   L  ++     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 529 FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLL 564
              S  V+H D+K  N+L+D     A L DFG   LL
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 16/172 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVEC-----EIMKSIRHRNLIK 474
           L+G+G FG V   R        A+K+  L+        +V        ++++ RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +  +    +    V+EY   G L  HL       +   R     ++ SALEYLH   S  
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH---SRD 125

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
           V++ D+K  N++LD +    ++DFG+ K  I +  +    +T   T  Y+AP
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAP 174

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 29/142 (20%), Positives = 62/142 (43%), Gaps = 15/142 (10%)

Query: 456 SFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI--LDIFQR 513
           +  V+   M     +N +  +   S + +  + ++   + +L+  +     +   +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           L+I I +A A+E+LH   S  ++H DLKPSN+    + +  + DFG+   +  +++  T 
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 574 TQTLA----------TIGYMAP 585
              +           T  YM+P
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 20/131 (15%), Positives = 40/131 (30%), Gaps = 2/131 (1%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIR 468
           R    F     +GRGGFG V++A+   D    A+K   L  R  A +    E + +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H  +++  ++      +    E       ++               ++ I         +
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 529 FGCSTPVIHCD 539
                      
Sbjct: 123 TVGQLQPSSPK 133

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 33/189 (17%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMK 465
              +     IG G  G V  A        VA+K     F      +RA++    E  +MK
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 466 SIRHRNLIKVI----SSCSNEEFKG--LVLEYMP---QGSLEKHLYSTNCILDIFQRLNI 516
            + H+N+I ++       + EEF+   LV+E M       ++  L        ++Q L  
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC- 175

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
                  +++LH   S  +IH DLKPSN+++  +    + DFG+A+   G    M  T  
Sbjct: 176 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPY 223

Query: 577 LATIGYMAP 585
           + T  Y AP
Sbjct: 224 VVTRYYRAP 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 40/183 (21%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK----VFN--LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G +G+V  A     G +VA+K     F   L  +RA++    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 475 VI----SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVAS 522
           ++       + ++F    LV+ +M    L K +          ++L       ++  +  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLK 139

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            L Y+H   +  +IH DLKP N+ ++++    + DFG+A+     D  M  T  + T  Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWY 191

Query: 583 MAP 585
            AP
Sbjct: 192 RAP 194

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.2 bits (184), Expect = 2e-14
 Identities = 53/294 (18%), Positives = 91/294 (30%), Gaps = 9/294 (3%)

Query: 21  KLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL 80
            +  + P+ + +     LL + +  LS    +      P+   L                
Sbjct: 258 SVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHT 317

Query: 81  SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH-NCNVTGDIPEEIGNLTNLITI 139
                          L    P+    + +   + F+   +   +  +  E+ +   L  +
Sbjct: 318 FRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQEL 377

Query: 140 DLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIP 199
           +        +I++ +  L  L                D  R   L  L    +K      
Sbjct: 378 EPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR---SKFLLENS 434

Query: 200 ACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFL 258
                   +R+L L   D   L  +  L ++  +D S N    + P  +  L+ LE L  
Sbjct: 435 VLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQA 493

Query: 259 GYNRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLEDLNLSFNKL 311
             N L+ +  D   NL  L+ L L NN L   A    L     L  LNL  N L
Sbjct: 494 SDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 1e-13
 Identities = 44/260 (16%), Positives = 87/260 (33%), Gaps = 15/260 (5%)

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
            +  L+L  +         +       + + L + P   +  +                 
Sbjct: 270 RMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQK 329

Query: 120 CNV-----TGDIPEEIGNLTNLITIDLGGNKLNG--SILITLSKLQKLQGLVLDDNKLEG 172
             V           +      L   +L   K     S L +  +LQ+L+           
Sbjct: 330 ECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTII 389

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
            +   +  L+   +     + L    P     L  LR   L  N  L +E  +++VL   
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL--- 446

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
             +  + + +    +  L  + +L L +NRL+  +P +   L  L+ L  S+N L   + 
Sbjct: 447 HLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD 502

Query: 293 ASLEKLSYLEDLNLSFNKLE 312
             +  L  L++L L  N+L+
Sbjct: 503 -GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 4/92 (4%)

Query: 5   EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEEL 64
            +  L  +  LDL  N+L   +P A+  +  L++L   DN+L  ++  +    LP L+EL
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVA--NLPRLQEL 513

Query: 65  VLWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
           +L  N   +   +  L +C  L ++ L  N L
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 2e-11
 Identities = 41/269 (15%), Positives = 78/269 (28%), Gaps = 10/269 (3%)

Query: 50  LSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS 109
           L    +         V        + F   L+    +  + L  +     +   +    +
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294

Query: 110 HSLEDFQMHN--CNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSK----LQKLQGL 163
                +       ++   +P+    +    +       L         +     ++L   
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354

Query: 164 VLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEI 223
            L   K    +  ++    EL +LE        +I      L  L            L+ 
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
            +      +D   + F            ++  L L +  L  L       L+ +  L+LS
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLS 471

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLE 312
           +N L  A+P +L  L  LE L  S N LE
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.2 bits (158), Expect = 3e-11
 Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 47/248 (18%)

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI---------LPKTSIGNLSH 110
           + +E VL  +      +    +  + L    LS      +         L +    N   
Sbjct: 327 SQKECVLLKDRPE--CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWC 384

Query: 111 SLED-FQMHNCNVTGDIPEEIGNLTNLITID--------LGGNKLNGSILITLSKLQKLQ 161
            L     M   +      E +   + L  +D           +K      +   +   ++
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR 444

Query: 162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL 221
            L L    L  ++   + +L+ +  L+L  N+L R++P     L  L +L    N     
Sbjct: 445 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDN----- 496

Query: 222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFL 280
            + N+                    +  L  L+ L L  NRLQ         +   L  L
Sbjct: 497 ALENVD------------------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538

Query: 281 NLSNNNLS 288
           NL  N+L 
Sbjct: 539 NLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 20/76 (26%), Positives = 33/76 (43%), Gaps = 4/76 (5%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVR-LP 59
            +P  +  L+ LE L    N  +  V   + N+  L+ L L +N L    ++I  +   P
Sbjct: 477 ALPPALAALRCLEVLQASDNA-LENVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCP 533

Query: 60  NLEELVLWGNNFSELN 75
            L  L L GN+  +  
Sbjct: 534 RLVLLNLQGNSLCQEE 549

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 72.9 bits (180), Expect = 3e-14
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 12/166 (7%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV----ECEIMKSIR 468
           + F +   IG G +G VYKAR    G  VA+K   L      +        E  ++K + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELN 60

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYL 527
           H N++K++     E    LV E++ Q  L+K + ++    + +    + +  +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 528 HFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           H   S  V+H DLKP N+L++      L+DFG+A+      ++ T 
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 31/185 (16%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK--VFN--LQCRRAFKSFDVECEIMKSIRHRNLIKVI 476
           +G GG G V+ A        VA+K  V       + A +    E +I++ + H N++KV 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 477 ------------SSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
                          S  E     +V EYM +  L   L     +L+   RL  M  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARL-FMYQLLR 131

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQ-TQTLATI 580
            L+Y+H   S  V+H DLKP+N+ ++ ++++  + DFG+A+++          ++ L T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 581 GYMAP 585
            Y +P
Sbjct: 189 WYRSP 193

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 30/190 (15%), Positives = 67/190 (35%), Gaps = 14/190 (7%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           NL N+  + +  +  +  +    F N+S +  + +++      +       LP L+ L +
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
           +         L+ + +     ++ +++NP    +P  +   L +     +++N   T  +
Sbjct: 113 FNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SV 171

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSK------LQKLQGLVLDDNKLEGSIPDDICR 180
                N T L  + L  NK     L  + K            L +    +  ++P     
Sbjct: 172 QGYAFNGTKLDAVYLNKNKY----LTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLE 226

Query: 181 -LVELYKLEL 189
            L EL     
Sbjct: 227 HLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 32/197 (16%), Positives = 65/197 (32%), Gaps = 12/197 (6%)

Query: 133 LTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKLELGG 191
             +  T+ L    L        S L  +  + +  +     +       L ++  +E+  
Sbjct: 30  PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 192 NKLSRSIPA-CFNNLIALRILSLGSND----PLPLEIGNLKVLVGIDFSMNNFSGIIPKE 246
            +    I       L  L+ L + +      P   ++ +  +   ++ + N +   IP  
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 247 I-GGLKN-LEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-SLEKL-SYLE 302
              GL N    L L  N    +   +F N   L  + L+ N     I   +   + S   
Sbjct: 150 AFQGLCNETLTLKLYNNGFTSVQGYAF-NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 303 DLNLSFNKLEGEIPRGG 319
            L++S   +   +P  G
Sbjct: 209 LLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 42/241 (17%), Positives = 75/241 (31%), Gaps = 29/241 (12%)

Query: 49  SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL 108
            +  I  +  P+ + L L   +   +    + SN  +++ I +S +     L   S  NL
Sbjct: 22  DIQRIPSL-PPSTQTLKLIETHLRTIPS-HAFSNLPNISRIYVSIDVTLQQLESHSFYNL 79

Query: 109 SHSLEDFQMHNCNVTGDIPEEI-GNLTNLITIDLGGNKLNGSI--LITLSKLQKLQGLVL 165
              +   ++ N      I  +    L  L  + +    L      L  +        L +
Sbjct: 80  -SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137

Query: 166 DDNKLEGSIPDDICRLV--ELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEI 223
            DN    SIP +  + +  E   L+L  N  + S+     N   L  + L  N       
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK------ 190

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
             L V+       + F G+             L +    +  L      +L  L   N  
Sbjct: 191 -YLTVI-----DKDAFGGV-------YSGPSLLDVSQTSVTALPSKGLEHLKELIARNTW 237

Query: 284 N 284
            
Sbjct: 238 T 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 34/213 (15%), Positives = 70/213 (32%), Gaps = 18/213 (8%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITD---VRLPNLEELVL 66
           + + L L +   + T+P   F N+  +  + +  +    +L  +       L  +  + +
Sbjct: 32  STQTLKLIETH-LRTIPSHAFSNLPNISRIYVSID---VTLQQLESHSFYNLSKVTHIEI 87

Query: 67  WGNNFSELNFLSS--LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG 124
                  L ++    L     L  +G+ N  L      T + +           N  +T 
Sbjct: 88  RNTR--NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 125 DIPEEIGNLTN-LITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR--L 181
                   L N  +T+ L  N    S+        KL  + L+ NK    I  D      
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 182 VELYKLELGGNKLSRSIPA-CFNNLIALRILSL 213
                L++    ++ ++P+    +L  L   + 
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 28/152 (18%), Positives = 49/152 (32%), Gaps = 27/152 (17%)

Query: 183 ELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSG 241
               L+L    L  +IP+  F+NL  +  + +  +  L                      
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL--------------------QQ 70

Query: 242 IIPKEIGGLKNLEYLFLGYNR-LQGLIPDSFGNLISLKFLNLSNNNLSGAIPA--SLEKL 298
           +       L  + ++ +   R L  + PD+   L  LKFL + N  L    P    +   
Sbjct: 71  LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129

Query: 299 SYLEDLNLSFNKLEGEIPRGGSFGNFSAESFE 330
                L ++ N     IP   +F     E+  
Sbjct: 130 DIFFILEITDNPYMTSIPV-NAFQGLCNETLT 160

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 11/159 (6%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDV-ECEIMKSIRHRNLIKVISSC 479
           +G G + +VYK      G+ VA+K   L       S  + E  +MK ++H N++++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCI-----LDIFQRLNIMIDVASALEYLHFGCSTP 534
             E    LV E+M    L+K++ S         L++         +   L + H      
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENK 128

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           ++H DLKP N+L++      L DFG+A+       + + 
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 42/187 (22%)

Query: 421 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQCRRAF---KSFDVEC-----EIMKSIR 468
           ++G+GG+G V++ R       G   A+KV     ++A     + D         I++ ++
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVL----KKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI---------MID 519
           H  ++ +I +        L+LEY+  G L   L          +R  I         + +
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----------EREGIFMEDTACFYLAE 129

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA- 578
           ++ AL +LH      +I+ DLKP N++L+      L+DFG+ K  I +      T T   
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCG 183

Query: 579 TIGYMAP 585
           TI YMAP
Sbjct: 184 TIEYMAP 190

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 44/210 (20%), Positives = 80/210 (38%), Gaps = 38/210 (18%)

Query: 381 RYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKAR-LGDGM 439
                  Q     +M + A            + D +     +G G +G VYKA       
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPS-------ATSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60

Query: 440 EVAVKVFNLQCRRAFKSFDVECE-----------IMKSIRHRNLIKVISSCSNEEFKGLV 488
            VA+K   L         + E E           ++K ++HRN+I++ S   +     L+
Sbjct: 61  TVAIKRIRL---------EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111

Query: 489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD 548
            EY     L+K++   N  + +    + +  + + + + H   S   +H DLKP N+LL 
Sbjct: 112 FEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLS 166

Query: 549 DNMIAY-----LSDFGIAKLLIGEDQSMTQ 573
            +  +      + DFG+A+      +  T 
Sbjct: 167 VSDASETPVLKIGDFGLARAFGIPIRQFTH 196

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 35/182 (19%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           +IG+G FG V  AR        AVKV  LQ +   K  + +  +       K+++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMID---------VASAL 524
            +  S    +    VL+Y+  G L  HL          QR    ++         +ASAL
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHL----------QRERCFLEPRARFYAAEIASAL 152

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYM 583
            YLH   S  +++ DLKP N+LLD      L+DFG+ K  I  + +   T T   T  Y+
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYL 206

Query: 584 AP 585
           AP
Sbjct: 207 AP 208

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           ++G+G FG V  AR+ +  ++ AVKV  L+     +  DVEC +        +  H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
           ++       +    V+E++  G L  H+  +    +   R     ++ SAL +LH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +I+ DLK  NVLLD      L+DFG+ K  I    +   T T   T  Y+AP
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 32/150 (21%), Positives = 60/150 (40%), Gaps = 23/150 (15%)

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPL 219
             + L+ N ++   P       +L +++L  N++   +    F  L +L  L L  N   
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN--- 90

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                 +  L    F              GL +L+ L L  N++  L  D+F +L +L  
Sbjct: 91  -----KITELPKSLFE-------------GLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           L+L +N L      +   L  ++ ++L+ N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI 291
           I    N    I P      K L  + L  N++  L PD+F  L SL  L L  N ++  +
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95

Query: 292 PASL-EKLSYLEDLNLSFNKLEGEIPRG 318
           P SL E L  L+ L L+ NK+   +   
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 24/146 (16%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI 232
            IP ++   +   ++ L  N +    P  F+    LR + L +N     +I  L      
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-----QISELAPDA-- 75

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
                 F G        L++L  L L  N++  L    F  L SL+ L L+ N ++    
Sbjct: 76  ------FQG--------LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRV 121

Query: 293 ASLEKLSYLEDLNLSFNKLEGEIPRG 318
            + + L  L  L+L  NKL+  I +G
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 10/137 (7%)

Query: 11  NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
            + E+ L QN  I  +P   F     L+ + L +N +S  L+      L +L  LVL+GN
Sbjct: 33  TITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 70  NFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
             +EL  +    L +   L ++ L+ N ++ +    +  +L H+L    +++  +     
Sbjct: 91  KITELPKSLFEGLFS---LQLLLLNANKINCL-RVDAFQDL-HNLNLLSLYDNKLQTIAK 145

Query: 128 EEIGNLTNLITIDLGGN 144
                L  + T+ L  N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           L++L  L L  NK+   +P ++F  + +L+LL L  N ++  L       L NL  L L+
Sbjct: 79  LRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
            N    +    + S  +++  + L+ NP  
Sbjct: 137 DNKLQTIA-KGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 9/137 (6%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
             + E+ L  N    +    + S  K L  I LSNN +   L   +   L   L    ++
Sbjct: 32  ETITEIRLEQNTIKVIPP-GAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS-LNSLVLY 88

Query: 119 NCNVTGDIPEEI-GNLTNLITIDLGGNKLNGSILI-TLSKLQKLQGLVLDDNKLEGSIPD 176
              +T ++P+ +   L +L  + L  NK+N  + +     L  L  L L DNKL+ +I  
Sbjct: 89  GNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

Query: 177 DI-CRLVELYKLELGGN 192
                L  +  + L  N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 38/198 (19%)

Query: 410 CRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQCRRAFKSFDVEC------ 461
           CRA   +     IG G +G V+KAR     G  VA+K   +                   
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLS 57

Query: 462 ---EI-----MKSIRHRN---LIKVISSCSNEEFKG--LVLEYMPQGSLEKHLYST-NCI 507
              E+     +++  H N   L  V +    +      LV E++ Q  L  +L       
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 508 LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE 567
           +      ++M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++    
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--- 170

Query: 568 DQSMTQTQTLATIGYMAP 585
              M  T  + T+ Y AP
Sbjct: 171 SFQMALTSVVVTLWYRAP 188

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 23/176 (13%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           ++G+G FG V  +      E+ AVK+  L+     +  DVEC ++         +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF--QRLNIMI-DVASALEYLHFG 530
           ++ S     +    V+EY+  G L  H+         F          ++A  L +L   
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ-- 459

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
            S  +I+ DLK  NV+LD      ++DFG+ K  I +      T+T   T  Y+AP
Sbjct: 460 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 511

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           ++G+G FG V+ A      +  A+K   L+        DVEC ++       +  H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            +  +   +E    V+EY+  G L  H+ S +             ++   L++LH   S 
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH---SK 137

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +++ DLK  N+LLD +    ++DFG+ K  +  D     T T   T  Y+AP
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 39/194 (20%), Positives = 72/194 (37%), Gaps = 52/194 (26%)

Query: 422 IGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVI---- 476
           +G G FG V +    + G   A+K      R   +    E +IMK + H N+IK++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 477 ----------------------------------SSCSNEEFKGLVLEYMPQ--GSLEKH 500
                                              + S  ++  +++EY+P     + K 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 501 LYSTNCIL-DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDF 558
              +   +      +  +  +  A+ ++H   S  + H D+KP N+L++  +    L DF
Sbjct: 131 FIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 559 GIAKLLIGEDQSMT 572
           G AK LI   +   
Sbjct: 187 GSAKKLI-PSEPSV 199

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 48/189 (25%)

Query: 421 LIGRGGFGSVYKARLGDGMEV----AVKVFNLQCRRAFKSF-----DVEC----EIMKSI 467
           ++G+G FG V+  +   G +     A+KV         K+       V      +I+  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83

Query: 468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI---------MI 518
            H  ++K+  +   E    L+L+++  G L   L           +  +         + 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----------SKEVMFTEEDVKFYLA 133

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           ++A AL++LH   S  +I+ DLKP N+LLD +  I  L+DFG++K  I  ++      + 
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIK-LTDFGLSKESIDHEKK---AYSF 186

Query: 578 -ATIGYMAP 585
             T+ YMAP
Sbjct: 187 CGTVEYMAP 195

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           +IGRG +  V   RL     + A+KV  ++        D++          ++  H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            + S    E     V+EY+  G L  H+     + +   R     +++ AL YLH     
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 129

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +I+ DLK  NVLLD      L+D+G+ K  +        T T   T  Y+AP
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 179

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 40/187 (21%)

Query: 421 LIGRGGFGSVYKARLGDGMEV----AVKVFNLQCRRAF---KSFDVEC-----EIMKSIR 468
           ++G G +G V+  R   G +     A+KV     ++A    K+   E      ++++ IR
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVL----KKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 469 HRN-LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNI---------MI 518
               L+ +  +   E    L+L+Y+  G L  HL           +            + 
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----------SQRERFTEHEVQIYVG 166

Query: 519 DVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA 578
           ++  ALE+LH      +I+ D+K  N+LLD N    L+DFG++K  + ++          
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222

Query: 579 TIGYMAP 585
           TI YMAP
Sbjct: 223 TIEYMAP 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 20/150 (13%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVK-VFN-----LQCRRAFKSFDVECEIMKSIR-HRNLI 473
           +G+G +G V+K+     G  VAVK +F+        +R F+    E  I+  +  H N++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72

Query: 474 KVISSCSNEEFKG--LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
            +++    +  +   LV +YM +  L   + +   IL+   +  ++  +   ++YLH   
Sbjct: 73  NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIA 561
           S  ++H D+KPSN+LL+      ++DFG++
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI-KVISSC 479
           IG G FG +   + L     VA+K+  ++ R       +E    K +   + I +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 480 SNEEFKGLVLEYMPQG-SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              ++  +VLE +  G SLE      +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 539 DLKPSNVLL------DDNMIAYLSDFGIAK 562
           D+KP N L+         +I ++ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 67.0 bits (164), Expect = 8e-13
 Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 22/150 (14%)

Query: 161 QGLVLDDNKLEGSIPDDI-CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL 219
             L L++N+        I  +L +L K+    NK++      F     +  + L SN   
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN--- 91

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                 L+ +    F              GL++L+ L L  NR+  +  DSF  L S++ 
Sbjct: 92  -----RLENVQHKMFK-------------GLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           L+L +N ++   P + + L  L  LNL  N
Sbjct: 134 LSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 33/148 (22%), Positives = 55/148 (37%), Gaps = 27/148 (18%)

Query: 173 SIPDDICRLVELYKLELGGNKLSRSIP-ACFNNLIALRILSLGSNDPLPLEIGNLKVLVG 231
            IP+ I       +L L  N+ +       F  L  LR ++  +N    +E G  +    
Sbjct: 25  KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE---- 78

Query: 232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI 291
                            G   +  + L  NRL+ +    F  L SLK L L +N ++  +
Sbjct: 79  -----------------GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CV 120

Query: 292 PA-SLEKLSYLEDLNLSFNKLEGEIPRG 318
              S   LS +  L+L  N++   +  G
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 6e-11
 Identities = 33/164 (20%), Positives = 56/164 (34%), Gaps = 38/164 (23%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
               EL L  N F+ L           L  I  SNN +  I               F+  
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA-----------FE-- 78

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSI 174
                          + +  I L  N+L    +         L+ L+ L+L  N++   +
Sbjct: 79  -------------GASGVNEILLTSNRLENVQHK----MFKGLESLKTLMLRSNRIT-CV 120

Query: 175 PDDI-CRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSN 216
            +D    L  +  L L  N++  ++    F+ L +L  L+L +N
Sbjct: 121 GNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 20/90 (22%), Positives = 42/90 (46%), Gaps = 4/90 (4%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
              + E+ L  N+L   V   +F  + +LK L L+ N ++  + + + + L ++  L L+
Sbjct: 80  ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
            N  + +    +     SL+ + L  NP +
Sbjct: 138 DNQITTVA-PGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 33/181 (18%), Positives = 63/181 (34%), Gaps = 43/181 (23%)

Query: 19  QNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSEL--NF 76
            N+ +  +P  I        L L +N  +   ++    +LP L ++    N  +++    
Sbjct: 19  SNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA 76

Query: 77  LSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL 136
               S    +  I L++N L+ +  K            F+                L +L
Sbjct: 77  FEGASG---VNEILLTSNRLENVQHKM-----------FK---------------GLESL 107

Query: 137 ITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSIPDDI-CRLVELYKLELGG 191
            T+ L  N++    N     +   L  ++ L L DN++  ++       L  L  L L  
Sbjct: 108 KTLMLRSNRITCVGND----SFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162

Query: 192 N 192
           N
Sbjct: 163 N 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 26/139 (18%), Positives = 52/139 (37%), Gaps = 11/139 (7%)

Query: 10  QNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWG 68
           Q   EL L  N+        IF  +  L+ +   +N ++  +          + E++L  
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 69  NNFSEL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
           N    +       L +   L  + L +N +   +   S   LS S+    +++  +T  +
Sbjct: 91  NRLENVQHKMFKGLES---LKTLMLRSNRITC-VGNDSFIGLS-SVRLLSLYDNQITT-V 144

Query: 127 PEEI-GNLTNLITIDLGGN 144
                  L +L T++L  N
Sbjct: 145 APGAFDTLHSLSTLNLLAN 163

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.3 bits (170), Expect = 9e-13
 Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 17/173 (9%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           +IGRG +  V   RL     + A++V  ++        D++          ++  H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            + S    E     V+EY+  G L  H+     + +   R     +++ AL YLH     
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 172

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            +I+ DLK  NVLLD      L+D+G+ K  +        T T   T  Y+AP
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 23/176 (13%)

Query: 421 LIGRGGFGSVYKARLGDGMEV-AVKVFNLQCRRAFKSFDVECEIM------KSIRHRNLI 473
           ++G+G FG V  +      E+ AVK+  L+     +  DVEC ++         +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF--QRLNIMI-DVASALEYLHFG 530
           ++ S     +    V+EY+  G L  H+         F          ++A  L +L   
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ-- 138

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAP 585
            S  +I+ DLK  NV+LD      ++DFG+ K  I +      T+T   T  Y+AP
Sbjct: 139 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 190

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 15/149 (10%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI-KVISSC 479
           IG G FG +++   L +  +VA+K    +          E    K +     I  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 540 LKPSNVLL------DDNMIAYLSDFGIAK 562
           +KP N L+      + NMI Y+ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI-KVISSC 479
           IG G FG +Y    +  G EVA+K+  ++ +       +E +I K ++    I  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
           +  ++  +V+E +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 540 LKPSNVLL---DDNMIAYLSDFGIAK 562
           +KP N L+       + Y+ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 59/359 (16%), Positives = 109/359 (30%), Gaps = 53/359 (14%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNV----STLKLLGLQDNSLSGS----LSSITDVRLPN 60
           LQ  + + L    L       I +       L  L L+ N L       +          
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 61  LEELVLWGNNFSE---LNFLSSLSNCKSLTVIGLSNNPLDGILPK---TSIGNLSHSLED 114
           +++L L     +        S+L    +L  + LS+N L     +     + +    LE 
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 115 FQMHNCNVT----GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK-----LQGLVL 165
            Q+  C+++      +   +    +   + +  N +N + +  L +  K     L+ L L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 166 DDNKLE----GSIPDDICRLVELYKLELGGNKLSRS-----IPACFNNLIALRILSLGSN 216
           +   +       +   +     L +L LG NKL         P   +    LR L +   
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266

Query: 217 DP-------LPLEIGNLKVLVGIDFSMNNFSGIIPKEIG-GLKN----LEYLFLGYNRLQ 264
                    L   +   + L  +  + N       + +   L      LE L++      
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

Query: 265 GL----IPDSFGNLISLKFLNLSNNNLSG----AIPASLEK-LSYLEDLNLSFNKLEGE 314
                           L  L +SNN L       +   L +  S L  L L+   +   
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 56/338 (16%), Positives = 113/338 (33%), Gaps = 74/338 (21%)

Query: 10  QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGN 69
            +++ LD++  +                   L D   +  L       L   + + L   
Sbjct: 3   LDIQSLDIQCEE-------------------LSDARWAELLPL-----LQQCQVVRLDDC 38

Query: 70  NFSEL---NFLSSLSNCKSLTVIGLSNNPLDGILPKT---SIGNLSHSLEDFQMHNCNVT 123
             +E    +  S+L    +L  + L +N L  +        +   S  ++   + NC +T
Sbjct: 39  GLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98

Query: 124 ----GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ-----KLQGLVLDDNKLEGSI 174
               G +   +  L  L  + L  N L  + L  L +       +L+ L L+   L  + 
Sbjct: 99  GAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158

Query: 175 PDDICRLVE----LYKLELGGNKLSRS-----IPACFNNLIALRILSLGSNDPLPLEIGN 225
            + +  ++       +L +  N ++ +          ++   L  L L S       +  
Sbjct: 159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG-----VT- 212

Query: 226 LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRL-----QGLIPDSFGNLISLKFL 280
                    +  +  GI+        +L  L LG N+L       L P        L+ L
Sbjct: 213 -------SDNCRDLCGIVAS----KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 281 NLSNNNLS----GAIPASLEKLSYLEDLNLSFNKLEGE 314
            +    ++    G +   L     L++L+L+ N+L  E
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 60.7 bits (148), Expect = 6e-10
 Identities = 73/357 (20%), Positives = 125/357 (35%), Gaps = 53/357 (14%)

Query: 11  NLEELDLRQNKL----IGTVPVAIFNVSTLKLLGLQDNSLSGS-LSSITDVRLPN---LE 62
            +++L L+   L     G +   +  + TL+ L L DN L  + L  + +  L     LE
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 63  ELVLWGNNFSEL---NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHS---LEDFQ 116
           +L L   + S        S L        + +SNN ++    +     L  S   LE  +
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 117 MHNCNVTGD----IPEEIGNLTNLITIDLGGNKLNGSILITLSK-----LQKLQGLVLDD 167
           + +C VT D    +   + +  +L  + LG NKL    +  L         +L+ L + +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 168 NKLE----GSIPDDICRLVELYKLELGGNKLSRS-----IPACFNNLIALRILSLGSND- 217
             +     G +   +     L +L L GN+L                  L  L + S   
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

Query: 218 ------PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG-GLKN----LEYLFLGYNRLQ-- 264
                      +   + L+ +  S N       +E+  GL      L  L+L    +   
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385

Query: 265 --GLIPDSFGNLISLKFLNLSNNNLSG----AIPASLEKLSY-LEDLNLSFNKLEGE 314
               +  +     SL+ L+LSNN L       +  S+ +    LE L L       E
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 42/242 (17%), Positives = 76/242 (31%), Gaps = 32/242 (13%)

Query: 8   NLQNLEELDLRQNKL----IGTVPVAIFNVSTLKLLGLQDNSLSGS----LSSITDVRLP 59
           +   LE L L    +       +   + + ++L+ L L  N L       L         
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 60  NLEELVLWGNNFSE--LNFLSS-LSNCKSLTVIGLSNNPL--DGILP-KTSIGNLSHSLE 113
            L  L +W    +      L   L   +SL  + L+ N L  +G      ++      LE
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 316

Query: 114 DFQMHNCNVTGD----IPEEIGNLTNLITIDLGGNKLNGSILITLSKL-----QKLQGLV 164
              + +C+ T          +     L+ + +  N+L  + +  L +        L+ L 
Sbjct: 317 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376

Query: 165 LDDNKLEGSIPDDICRLVE----LYKLELGGNKLSRSIPACF-----NNLIALRILSLGS 215
           L D  +  S    +   +     L +L+L  N L  +               L  L L  
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYD 436

Query: 216 ND 217
             
Sbjct: 437 IY 438

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 8e-12
 Identities = 34/207 (16%), Positives = 59/207 (28%), Gaps = 55/207 (26%)

Query: 403 TFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKV--------FNLQCRRAF 454
            FS+   C  T+       IG G FG V++    D   VA+K+         N   ++ F
Sbjct: 12  PFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 455 KSFDVECEIMKSIRHRNLIKVISSCSNEEFKG---------------------------- 486
           +    E  I K +   +      +                                    
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 487 -----------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
                      +VLE+   G   + + +   +  +    +I+  + ++L           
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR--F 183

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAK 562
            H DL   NVLL    +  L      K
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 23/133 (17%)

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
            L L  N++++  P  F++LI L+ L LGSN    L +G                  +  
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG------------------VFD 85

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN 305
               L  L  L LG N+L  L    F  L+ LK L +  N L+  +P  +E+L++L  L 
Sbjct: 86  S---LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141

Query: 306 LSFNKLEGEIPRG 318
           L  N+L+  IP G
Sbjct: 142 LDQNQLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 24/147 (16%)

Query: 140 DLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVELYKLELGGNKLSRSI 198
            L  N++          L  L+ L L  N+L  ++P  +   L +L  L+LG N+L+   
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLP 104

Query: 199 PACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFL 258
            A F+ L+ L+ L +  N         L                +P+ I  L +L +L L
Sbjct: 105 SAVFDRLVHLKELFMCCNK--------LTE--------------LPRGIERLTHLTHLAL 142

Query: 259 GYNRLQGLIPDSFGNLISLKFLNLSNN 285
             N+L+ +   +F  L SL    L  N
Sbjct: 143 DQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 24/150 (16%)

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPL 219
           Q L L DN++    P     L+ L +L LG N+L  ++P   F++L  L +L LG+N   
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN--- 98

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                 L VL          S +  +    L +L+ LF+  N+L   +P     L  L  
Sbjct: 99  -----QLTVLP---------SAVFDR----LVHLKELFMCCNKLTE-LPRGIERLTHLTH 139

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           L L  N L      + ++LS L    L  N
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 32/90 (35%), Positives = 42/90 (46%), Gaps = 13/90 (14%)

Query: 133 LTNLITIDLGGNKLNGSILITLS-----KLQKLQGLVLDDNKLEGSIPDDICRLVELYKL 187
           LT L  +DLG N+L       L      +L  L+ L +  NKL   +P  I RL  L  L
Sbjct: 87  LTQLTVLDLGTNQLT-----VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140

Query: 188 ELGGNKLSRSIP-ACFNNLIALRILSLGSN 216
            L  N+L +SIP   F+ L +L    L  N
Sbjct: 141 ALDQNQL-KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 254 EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNKLE 312
           + L+L  N++  L P  F +LI+LK L L +N L  A+P  + + L+ L  L+L  N+L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 31/95 (32%), Positives = 40/95 (42%), Gaps = 15/95 (15%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVST-LKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           L  L  LDL  N+L   +P A+F+    LK L +  N L+  L    + RL +L  L L 
Sbjct: 87  LTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE-RLTHLTHLALD 143

Query: 68  GNNFSELNFLSSLS-----NCKSLTVIGLSNNPLD 97
            N       L S+         SLT   L  NP D
Sbjct: 144 QNQ------LKSIPHGAFDRLSSLTHAYLFGNPWD 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 34/158 (21%), Positives = 49/158 (31%), Gaps = 33/158 (20%)

Query: 13  EELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFS 72
           + L L  N++    P    ++  LK L L  N L      + D  L  L  L L  N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD-SLTQLTVLDLGTNQLT 101

Query: 73  EL--NFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
            L       L +   L  + +  N L      T                      +P  I
Sbjct: 102 VLPSAVFDRLVH---LKELFMCCNKL------TE---------------------LPRGI 131

Query: 131 GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
             LT+L  + L  N+L         +L  L    L  N
Sbjct: 132 ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 30/163 (18%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIR-HRNLIK---- 474
           +GRG +  V++A  + +  +V VK+    + ++  +    E +I++++R   N+I     
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDI----FQRLNIMIDVASALEYLHFG 530
           V    S      LV E++      K LY T    DI    ++ L        AL+Y H  
Sbjct: 100 VKDPVSRTPA--LVFEHVNNTDF-KQLYQTLTDYDIRFYMYEILK-------ALDYCH-- 147

Query: 531 CSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMT 572
            S  ++H D+KP NV++D ++    L D+G+A+      Q   
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYN 188

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI-KVISSC 479
           IG G FG +Y    +    EVA+K+ N++ +        E +I + ++    I  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
              ++  LV++ +   SLE      +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 540 LKPSNVLL---DDNMIAYLSDFGIAK 562
           +KP N L+         Y+ DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 37/134 (27%), Positives = 54/134 (40%), Gaps = 24/134 (17%)

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
           KL+L    L+    A F  L  L  L+L  N    L  G                     
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD------------------ 80

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDL 304
               L  L  L L  N+L  L    F +L  L  L L  N L  ++P+ + ++L+ L++L
Sbjct: 81  ---DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL 136

Query: 305 NLSFNKLEGEIPRG 318
            L+ N+L+  IP G
Sbjct: 137 RLNTNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 40/156 (25%), Positives = 62/156 (39%), Gaps = 11/156 (7%)

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPL 219
           + L L    L          L +L  L L  N+L  ++ A  F++L  L  L L +N   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 220 PLEIG------NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN 273
            L +G       L  L       N    +       L  L+ L L  N+LQ +   +F  
Sbjct: 97  SLPLGVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDK 153

Query: 274 LISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           L +L+ L+LS N L      + ++L  L+ + L  N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 50/208 (24%)

Query: 19  QNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSEL--NF 76
           Q K + +VP  I    T + L LQ   L+ +LS  T   L  L  L L  N    L    
Sbjct: 22  QGKSLDSVPSGIP-ADT-EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78

Query: 77  LSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLED--FQMHNCNVTGDIPEEIGNLT 134
              L+    L  +GL+NN L              SL    F                +LT
Sbjct: 79  FDDLTE---LGTLGLANNQL-------------ASLPLGVFD---------------HLT 107

Query: 135 NLITIDLGGNKL----NGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVELYKLEL 189
            L  + LGGN+L    +G       +L KL+ L L+ N+L+ SIP     +L  L  L L
Sbjct: 108 QLDKLYLGGNQLKSLPSG----VFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162

Query: 190 GGNKLSRSIPA-CFNNLIALRILSLGSN 216
             N+L +S+P   F+ L  L+ ++L  N
Sbjct: 163 STNQL-QSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 4/91 (4%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVST-LKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
           +L  L++L L  N+L  ++P  +F+  T LK L L  N L    +   D +L NL+ L L
Sbjct: 105 HLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD-KLTNLQTLSL 162

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLD 97
             N    +    +      L  I L  N  D
Sbjct: 163 STNQLQSVP-HGAFDRLGKLQTITLFGNQFD 192

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 42/171 (24%)

Query: 421 LIGRGGFGSVYKA-RLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            IG GGFG +Y A       + A  V  ++ +        E +  + +  ++ IK     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102

Query: 480 SNEEFKG-------------------LVLEYMPQG-SLEKHL-----YSTNCILDIFQRL 514
              ++ G                   +V+E +  G  L+K       +  + +L +  R 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR- 159

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAK 562
             M+DV   LEY+H       +H D+K +N+LL   + + + YL+D+G++ 
Sbjct: 160 --MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 35/171 (20%), Positives = 68/171 (39%), Gaps = 41/171 (23%)

Query: 422 IGRGGFGSVYKAR---------LGDGMEVAVKV-------FNLQ--CRRAFKSFDVECEI 463
             R   G +Y+A               + ++K+       FN Q   +RA K   V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 464 -MKSIRHRNLIKVISSCSNE-EFKGLVLEYMPQGSLE-------KHLYSTNCILDIFQRL 514
            + S     +   +    ++ +++ LVL  + + SL+       KH+ S   +L +  R 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR- 167

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAK 562
             ++D   ALE+LH       +H ++   N+ +   D + +  L+ +G A 
Sbjct: 168 --LLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 27/77 (35%), Positives = 37/77 (48%), Gaps = 3/77 (3%)

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYL 301
           +PKE+   K+L  + L  NR+  L   SF N+  L  L LS N L   IP    + L  L
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104

Query: 302 EDLNLSFNKLEGEIPRG 318
             L+L  N +   +P G
Sbjct: 105 RLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 26/127 (20%)

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP 220
             L LD N+    +P ++     L  ++L  N++S      F+N+  L  L L  N    
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN---- 88

Query: 221 LEIGNLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPD-SFGNLISLK 278
                L+ +              P     GLK+L  L L  N +   +P+ +F +L +L 
Sbjct: 89  ----RLRCI--------------PPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALS 129

Query: 279 FLNLSNN 285
            L +  N
Sbjct: 130 HLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 11/94 (11%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVEL 184
           IP ++  L       L GN+    +   LS  + L  + L +N++  ++ +     + +L
Sbjct: 29  IPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 185 YKLELGGNKLSRSIPA-CFNNLIALRILSLGSND 217
             L L  N+L R IP   F+ L +LR+LSL  ND
Sbjct: 81  LTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGND 113

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 14/102 (13%)

Query: 2   IPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +P E+ N ++L  +DL  N+ I T+    F N++ L  L L  N L        D  L +
Sbjct: 46  VPKELSNYKHLTLIDLSNNR-ISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD-GLKS 103

Query: 61  LEELVLWGNNFSELNFLSSL-----SNCKSLTVIGLSNNPLD 97
           L  L L GN+      +S +     ++  +L+ + +  NPL 
Sbjct: 104 LRLLSLHGND------ISVVPEGAFNDLSALSHLAIGANPLY 139

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 39/171 (22%)

Query: 421 LIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
            IG+GGFG +Y A       +G      VKV        F     E +  +       I+
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97

Query: 475 VISSCSNEEFKG-------------------LVLEYMPQG-SLEKHLYSTNCILDIFQRL 514
                   ++ G                   ++++    G  L+K   +          L
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVL 155

Query: 515 NIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAK 562
            + + +   LEY+H       +H D+K SN+LL   + + + YL D+G+A 
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 30/170 (17%), Positives = 69/170 (40%), Gaps = 39/170 (22%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIR--------HR 470
            +G G F +V+ A+ + +   VA+K+  ++  + + ++ + E ++++ +           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 471 NLIKVISSCSNEEFKG-------LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IM 517
               ++    +   KG       +V E + + +L   +          + +       I 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYE-----HRGIPLIYVKQIS 137

Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY------LSDFGIA 561
             +   L+Y+H  C   +IH D+KP NVL++            ++D G A
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 44/153 (28%), Positives = 63/153 (41%), Gaps = 26/153 (16%)

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL 226
            ++   S+P  I    +   L+L  N L       F+ L +L  L LG N    L  G  
Sbjct: 15  YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
             L                      +L YL L  N+LQ L    F  L  LK L L+ N 
Sbjct: 73  NKLT---------------------SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQ 111

Query: 287 LSGAIPASL-EKLSYLEDLNLSFNKLEGEIPRG 318
           L  ++P  + +KL+ L+DL L  N+L+  +P G
Sbjct: 112 LQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 31/164 (18%)

Query: 126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVEL 184
           +P  I   T    +DL  N L         +L  L  L L  NKL+ S+P+ +  +L  L
Sbjct: 22  VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 185 YKLELGGNKLSRSIPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNNFSGI 242
             L L  N+L       F+ L  L+ L+L +N    LP                    G+
Sbjct: 79  TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLP-------------------DGV 119

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGLIPD-SFGNLISLKFLNLSNN 285
             K    L  L+ L L  N+L+  +PD  F  L SL+++ L +N
Sbjct: 120 FDK----LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 46/150 (30%), Positives = 63/150 (42%), Gaps = 23/150 (15%)

Query: 161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRILSLGSNDPL 219
             L L+ N L+         L  L +L LGGNKL  S+P   FN L +L  L+L +N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN--- 86

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKF 279
                 L+ L          +G+  K    L  L+ L L  N+LQ L    F  L  LK 
Sbjct: 87  -----QLQSLP---------NGVFDK----LTQLKELALNTNQLQSLPDGVFDKLTQLKD 128

Query: 280 LNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
           L L  N L        ++L+ L+ + L  N
Sbjct: 129 LRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 31/145 (21%), Positives = 60/145 (41%), Gaps = 14/145 (9%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSITDV-----RLPNLEELVLWGNNFSELNFLSSLSNCKSL 86
              ++     +   L G +  I  +      L   + L L  NN  +++ LS + N + L
Sbjct: 16  ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMENLRIL 75

Query: 87  TVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKL 146
           +   L  N +  I    ++  ++ +LE+  +    +   +   I  L NL  + +  NK+
Sbjct: 76  S---LGRNLIKKI---ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKI 127

Query: 147 NG-SILITLSKLQKLQGLVLDDNKL 170
                +  L+ L KL+ L+L  N L
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 32/144 (22%), Positives = 60/144 (41%), Gaps = 6/144 (4%)

Query: 182 VELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE-IGNLKVLVGIDFSMNNFS 240
            E  +L      + + + A  + L A + L+L +N+   +  +  ++ L  +    N   
Sbjct: 25  AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIK 83

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP-ASLEKLS 299
            I   +      LE L++ YN++  L       L++L+ L +SNN ++       L  L 
Sbjct: 84  KIENLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 300 YLEDLNLSFNKLEGEIPRGGSFGN 323
            LEDL L+ N L  +     +   
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 4/91 (4%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
           +  ++NL  L L +N  I  +        TL+ L +  N ++ SLS I   +L NL  L 
Sbjct: 66  LSGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQIA-SLSGIE--KLVNLRVLY 121

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
           +  N  +    +  L+    L  + L+ NPL
Sbjct: 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 27/150 (18%), Positives = 51/150 (34%), Gaps = 40/150 (26%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           ++   +  L+  + L L  N +              K+  L                + N
Sbjct: 39  KMDATLSTLKACKHLALSTNNI-------------EKISSLS--------------GMEN 71

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH--SLEDFQMH 118
           L  L L  N   ++  L ++    +L  + +S N +       S+  +    +L    M 
Sbjct: 72  LRILSLGRNLIKKIENLDAV--ADTLEELWISYNQI------ASLSGIEKLVNLRVLYMS 123

Query: 119 NCNVTGDIPE--EIGNLTNLITIDLGGNKL 146
           N  +T +  E  ++  L  L  + L GN L
Sbjct: 124 NNKIT-NWGEIDKLAALDKLEDLLLAGNPL 152

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 232 IDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA 290
           +  + N    I    + G L +L  L L  N+L G+ P++F     ++ L L  N +   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92

Query: 291 IPASL-EKLSYLEDLNLSFNKLEGEIPRG 318
           I   +   L  L+ LNL  N++   +  G
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.2 bits (118), Expect = 6e-07
 Identities = 36/125 (28%), Positives = 51/125 (40%), Gaps = 22/125 (17%)

Query: 186 KLELGGNKLSRSIP-ACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
           +L L  N+L R      F  L  L  L L  N    +E                F G   
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA-------------FEG--- 76

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
                  +++ L LG N+++ +    F  L  LK LNL +N +S  +P S E L+ L  L
Sbjct: 77  -----ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131

Query: 305 NLSFN 309
           NL+ N
Sbjct: 132 NLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 24/96 (25%), Positives = 47/96 (48%), Gaps = 14/96 (14%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
            L +L +L+L++N+L   +    F   S ++ L L +N +   +S+   + L  L+ L L
Sbjct: 52  RLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109

Query: 67  WGNNFSELNFLSSLS-----NCKSLTVIGLSNNPLD 97
           + N       +S +      +  SLT + L++NP +
Sbjct: 110 YDNQ------ISCVMPGSFEHLNSLTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 22/67 (32%), Positives = 31/67 (46%), Gaps = 4/67 (5%)

Query: 254 EYLFLGYNRLQGLIPD-SFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNKL 311
             L L  N L  +  D  FG L  L  L L  N L+  I  +  E  S++++L L  NK+
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 312 EGEIPRG 318
           + EI   
Sbjct: 91  K-EISNK 96

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 8e-09
 Identities = 91/612 (14%), Positives = 190/612 (31%), Gaps = 194/612 (31%)

Query: 5   EIGNLQNLEELDLRQNKLIGTV------PVAIFNVSTLKLLGLQDNS--LSGSLSSITDV 56
           EI ++   ++      +L  T+       V  F V  +    L+ N   L   +   T+ 
Sbjct: 50  EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF-VEEV----LRINYKFLMSPIK--TEQ 102

Query: 57  RLPNLEEL-------VLWGNN--FSELNF------------LSSLSNCKSLTVIGLSNNP 95
           R P++           L+ +N  F++ N             L  L   K++ + G+    
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL--- 159

Query: 96  LDGILPKTSIGN---LSHSLE---DFQMH-----NCNVTGDIPEEIGNLTNLITIDLGGN 144
             G   KT +     LS+ ++   DF++      NCN    + E +  L   I  +    
Sbjct: 160 --GS-GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216

Query: 145 KLNGSILIT--------LSKLQKLQG-----LVLDD--NKLEGSIPD--DI-CR-LVELY 185
             + S +          L +L K +      LVL +  N       +  ++ C+ L+   
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA---KAWNAFNLSCKILL--- 270

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVL----VGIDFSMNNFS 240
                    +R      + L A     +  +   + L    +K L    +          
Sbjct: 271 --------TTRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD---- 317

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQ-GLIPDSFGNLISL--KFLNLSNNNLSGAIPASLEK 297
             +P+E+          L  N  +  +I +S  + ++    + +++ + L+  I +SL  
Sbjct: 318 --LPREV----------LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 298 LS------YLEDLNLSFNK---------------LEGEIPRGGSFGNFSAESFEGNELLC 336
           L         + L++ F                 +                      L+ 
Sbjct: 366 LEPAEYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVM------VVVNKLHKYSLV- 417

Query: 337 GSPNLQVPPCKTSIHHPSWNISLLLGIVLPLSTTLMIVVIWLILRYRQRGKQPSNDANMP 396
                Q      SI      I L L + L     L      ++  Y       S+D   P
Sbjct: 418 ---EKQPKESTISIPS----IYLELKVKLENEYALHRS---IVDHYNIPKTFDSDDLIPP 467

Query: 397 LVAM-WRTFSY----LELCRATDGFSENNLIGRGGFGSVY------KARL---GDGMEVA 442
            +   +  +S+    L+     +  +         F  V+      + ++         +
Sbjct: 468 YLDQYF--YSHIGHHLKNIEHPERMTL--------FRMVFLDFRFLEQKIRHDSTAWNAS 517

Query: 443 VKVFN-LQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHL 501
             + N LQ  + +K +     I  +               E     +L+++P+  +E++L
Sbjct: 518 GSILNTLQQLKFYKPY-----ICDNDPK-----------YERLVNAILDFLPK--IEENL 559

Query: 502 YSTNCILDIFQR 513
             +    D+ + 
Sbjct: 560 ICSKY-TDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 5e-08
 Identities = 39/241 (16%), Positives = 78/241 (32%), Gaps = 67/241 (27%)

Query: 377 WLILRYRQRGKQPS--------------NDANMPLVAM--WRTFSYLELCRATDGFSENN 420
           +L+   +   +QPS              ND N         R   YL+L +A        
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAK 151

Query: 421 LI---GRGGFGSVYKARLGDGMEVAVKV---FNLQCRRAFKSF----------DVECEIM 464
            +   G  G G   K  +      A+ V   + +QC+  FK F          +   E++
Sbjct: 152 NVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202

Query: 465 KSIRHR---NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC--ILDIFQRLNIMID 519
           + + ++   N        SN + +   ++   +  L+   Y  NC  +L          +
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLL---------N 252

Query: 520 VASA--LEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTL 577
           V +A      +  C   +     + ++  L      ++S       L     ++T  +  
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHIS-------LDHHSMTLTPDEVK 304

Query: 578 A 578
           +
Sbjct: 305 S 305

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 6e-04
 Identities = 40/219 (18%), Positives = 71/219 (32%), Gaps = 55/219 (25%)

Query: 375 VIWLILRYRQRGKQPSNDANMPLVAMWRTFSYLELCRATDGFSENNLIGRGGFGSVYKAR 434
           + WL L+         N     L  + +      L    D     N   R    S  K R
Sbjct: 184 IFWLNLKNC-------NSPETVLEMLQK------LLYQIDP----NWTSRSDHSSNIKLR 226

Query: 435 LGDGMEVAVKVF-------------NLQCRRAFKSFDVECEIM-----KSI--------- 467
           +        ++              N+Q  +A+ +F++ C+I+     K +         
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286

Query: 468 RHRNLIKVISSCSNEEFKGLVLEY--MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASAL 524
            H +L     + + +E K L+L+Y       L + + +TN   L I      + D  +  
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES--IRDGLATW 344

Query: 525 E-YLHFGCS--TPVIHCDLKPSNVLLDDNMIAYLSDFGI 560
           + + H  C   T +I   L   NVL             +
Sbjct: 345 DNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV 380

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 9e-09
 Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 2/93 (2%)

Query: 220 PLEIGNLKVLVGIDFSMNNFSGIIPKE-IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
              +   + L  +          +    + GL  L  L +  + L+ + PD+F     L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
            LNLS N L      +++ LS L++L LS N L
Sbjct: 84  RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 26/145 (17%), Positives = 41/145 (28%), Gaps = 47/145 (32%)

Query: 144 NKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD-DICRLVELYKLELGGNKLSRSIPACF 202
                  L  L   + L  L +++ +    +   D+  L EL  L +  + L R +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAP-- 73

Query: 203 NNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNR 262
                                             + F             L  L L +N 
Sbjct: 74  ----------------------------------DAFH--------FTPRLSRLNLSFNA 91

Query: 263 LQGLIPDSFGNLISLKFLNLSNNNL 287
           L+ L   +   L SL+ L LS N L
Sbjct: 92  LESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 22/98 (22%), Positives = 36/98 (36%), Gaps = 4/98 (4%)

Query: 74  LNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI-GN 132
           L+ L  L   ++LT + + N      L    +  L   L +  +    +   +  +    
Sbjct: 21  LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-LRNLTIVKSGLR-FVAPDAFHF 78

Query: 133 LTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL 170
              L  ++L  N L      T+  L  LQ LVL  N L
Sbjct: 79  TPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 25/103 (24%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           +    +   +NL EL +   + +  +                   L G         L  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLE---------------LRDLRG---------LGE 57

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKT 103
           L  L +  +    +    +      L+ + LS N L+ +  KT
Sbjct: 58  LRNLTIVKSGLRFVA-PDAFHFTPRLSRLNLSFNALESLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 8/53 (15%), Positives = 15/53 (28%), Gaps = 2/53 (3%)

Query: 267 IPDSFGNLISLKFLNLSNNNLSGAIPA-SLEKLSYLEDLNLSFNKLEGEIPRG 318
                    +L  L + N      +    L  L  L +L +  + L   +   
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 58/353 (16%), Positives = 109/353 (30%), Gaps = 76/353 (21%)

Query: 6   IGNLQNLEELDLRQNKL--IGTVPVA--IFNVSTLKLLGLQDNSLSGSLSSITD------ 55
           +    +++E+ L  N +       ++  I +   L++    D         I +      
Sbjct: 28  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 56  ---VRLPNLEELVLWGNNFSE---LNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS 109
              ++ P L  + L  N F        +  LS    L  + L NN   G+ P+ +   ++
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN---GLGPQ-AGAKIA 143

Query: 110 HSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKL--NGSILI--TLSKLQKLQGLVL 165
            +L++  ++         ++  N   L +I  G N+L          T    + L  + +
Sbjct: 144 RALQELAVN---------KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194

Query: 166 DDNKL--EGSIPDDICRLVE----LYKLELGGNKLS----RSIPACFNNLIALRILSLGS 215
             N +  EG I   +   +     L  L+L  N  +     ++     +   LR L L  
Sbjct: 195 VQNGIRPEG-IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253

Query: 216 NDPLPLEIGN---LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRL-----QGLI 267
                  +       V+       N               L+ L L YN +     + L 
Sbjct: 254 C-----LLSARGAAAVVDAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLK 295

Query: 268 PDSFGNLISLKFLNLSNNNLS------GAIPASLEKLSYLEDLNLSFNKLEGE 314
                 +  L FL L+ N  S        I          E   L   +   +
Sbjct: 296 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 27/196 (13%), Positives = 66/196 (33%), Gaps = 23/196 (11%)

Query: 5   EIGNLQNLEELDLRQNKL--IGTVPVA--IFNVSTLKLLGLQDNSLS--GSLSSITDV-- 56
           +  N   L  +   +N+L        A    +   L  + +  N +   G    + +   
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213

Query: 57  RLPNLEELVLWGNNFSE---LNFLSSLSNCKSLTVIGLSNNPLDG----ILPKTSIGNLS 109
               L+ L L  N F+         +L +  +L  +GL++  L       +        +
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273

Query: 110 HSLEDFQMHNCNVTGDIPEEIG-----NLTNLITIDLGGNKLN--GSILITLSK-LQKLQ 161
             L+  ++    +  D    +       + +L+ ++L GN+ +    ++  + +      
Sbjct: 274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRG 333

Query: 162 GLVLDDNKLEGSIPDD 177
              LD+      + D+
Sbjct: 334 RGELDELDDMEELTDE 349

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 27/155 (17%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR---NLIKVI 476
           +IG+G FG V KA        VA+K+     +R  +    E  I++ +R +   N + VI
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 477 SSCSNEEFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVASALEYL 527
               N  F+    +  E +   +L + +         FQ  +          +   L+ L
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNK-----FQGFSLPLVRKFAHSILQCLDAL 216

Query: 528 HFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFG 559
           H      +IHCDLKP N+LL     + I  + DFG
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGI-KVIDFG 247

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 7/91 (7%)

Query: 8   NLQNLEELDLRQNKL--IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELV 65
            L   + +D   N++  +   P     +  LK L + +N +   +    D  LP+L EL+
Sbjct: 40  TLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 94

Query: 66  LWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
           L  N+  EL  L  L++ KSLT + +  NP+
Sbjct: 95  LTNNSLVELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 7/126 (5%)

Query: 187 LELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE--IGNLKVLVGIDFSMNNFSGIIP 244
           ++L    + ++  A + N +  R L L       +E     L     IDFS N    +  
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-- 57

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLED 303
                L+ L+ L +  NR+  +       L  L  L L+NN+L        L  L  L  
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117

Query: 304 LNLSFN 309
           L +  N
Sbjct: 118 LCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 24/140 (17%), Positives = 44/140 (31%), Gaps = 30/140 (21%)

Query: 78  SSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI 137
           +  +N      + L    +        I NL                        L    
Sbjct: 13  AQYTNAVRDRELDLRGYKI------PVIENLGA---------------------TLDQFD 45

Query: 138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR- 196
            ID   N++    L     L++L+ L++++N++          L +L +L L  N L   
Sbjct: 46  AIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103

Query: 197 SIPACFNNLIALRILSLGSN 216
                  +L +L  L +  N
Sbjct: 104 GDLDPLASLKSLTYLCILRN 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 7/98 (7%)

Query: 1   EIPLEIGNLQNLEELDLRQNKL--IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRL 58
           ++       + LE L      L  I  +P     ++ LK L L DN +SG L  + + + 
Sbjct: 33  KLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAE-KC 87

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
           PNL  L L GN   +L+ +  L   ++L  + L N  +
Sbjct: 88  PNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 4/110 (3%)

Query: 202 FNNLIALRILSLGSNDPLPLEIG-NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGY 260
            +++  L + +  SN+     +    + L  +       + I    +  L  L+ L L  
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 261 NRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLEDLNLSFN 309
           NR+ G +        +L  LNLS N +   +    L+KL  L+ L+L   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 4/78 (5%)

Query: 237 NNFSGIIPKEIGG--LKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS 294
           N+ S     E      + LE+L      L  +   +   L  LK L LS+N +SG +   
Sbjct: 26  NSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVL 83

Query: 295 LEKLSYLEDLNLSFNKLE 312
            EK   L  LNLS NK++
Sbjct: 84  AEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 27/131 (20%), Positives = 54/131 (41%), Gaps = 23/131 (17%)

Query: 132 NLTNLITIDLGGNKLN-GSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELG 190
             +++  + L  ++ N G +     + ++L+ L   +  L  SI  ++ +L +L KLEL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 191 GNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGL 250
            N++S  +         L  L+L  N     +I +L  +               + +  L
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGN-----KIKDLSTI---------------EPLKKL 112

Query: 251 KNLEYLFLGYN 261
           +NL+ L L   
Sbjct: 113 ENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 29/139 (20%), Positives = 47/139 (33%), Gaps = 33/139 (23%)

Query: 57  RLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
              +++ELVL  +  +E          + L  +   N  L      TSI NL        
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL------TSIANLP------- 61

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
                           L  L  ++L  N+++G + +   K   L  L L  NK++     
Sbjct: 62  ---------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LS 104

Query: 177 DICRLVELYKLE---LGGN 192
            I  L +L  L+   L   
Sbjct: 105 TIEPLKKLENLKSLDLFNC 123

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 7/98 (7%)

Query: 1   EIPLEIGNLQNLEELDLRQNKL--IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRL 58
           +I        NLE L L    L  +  +P     +  LK L L +N + G L  + + +L
Sbjct: 40  KIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAE-KL 94

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPL 96
           PNL  L L GN   +++ L  L   + L  + L N  +
Sbjct: 95  PNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 28/111 (25%), Positives = 42/111 (37%), Gaps = 7/111 (6%)

Query: 204 NLIALRILSLGSNDPLPLEIGNLKV----LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLG 259
              A+R L L +      +I  L      L  +         +    +  L  L+ L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 260 YNRLQGLIPDSFGNLISLKFLNLSNNNLSG-AIPASLEKLSYLEDLNLSFN 309
            NR+ G +      L +L  LNLS N L   +    L+KL  L+ L+L   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 32/138 (23%), Positives = 46/138 (33%), Gaps = 30/138 (21%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGL 91
             + ++ L L +   +            NLE L L       ++ L  L   K L    L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLE---L 78

Query: 92  SNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG-SI 150
           S N + G L   +                            L NL  ++L GNKL   S 
Sbjct: 79  SENRIFGGLDMLA--------------------------EKLPNLTHLNLSGNKLKDIST 112

Query: 151 LITLSKLQKLQGLVLDDN 168
           L  L KL+ L+ L L + 
Sbjct: 113 LEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 25/63 (39%), Positives = 31/63 (49%), Gaps = 2/63 (3%)

Query: 250 LKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFN 309
             NLE+L L    L  +   +   L  LK L LS N + G +    EKL  L  LNLS N
Sbjct: 48  FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105

Query: 310 KLE 312
           KL+
Sbjct: 106 KLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 27/131 (20%), Positives = 50/131 (38%), Gaps = 23/131 (17%)

Query: 132 NLTNLITIDLGGNKLN-GSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELG 190
               +  + L   K N G I    ++   L+ L L +  L  S+  ++ +L +L KLEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 191 GNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGL 250
            N++   +      L  L  L+L  N     ++ ++  L               + +  L
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGN-----KLKDISTL---------------EPLKKL 119

Query: 251 KNLEYLFLGYN 261
           + L+ L L   
Sbjct: 120 ECLKSLDLFNC 130

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.5 bits (124), Expect = 7e-08
 Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 3/87 (3%)

Query: 233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
           +   N    +       L  L  L L  N++Q L    F  L  L  L L  N L  ++P
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLP 92

Query: 293 ASL-EKLSYLEDLNLSFNKLEGEIPRG 318
             + +KL+ L++L L  N+L+  +P G
Sbjct: 93  NGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 6e-07
 Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 254 EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNKLE 312
             L L  N+LQ L    F  L  L  L+LS N +  ++P  + +KL+ L  L L  NKL+
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 313 GEIPRG 318
             +P G
Sbjct: 90  -SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 36/124 (29%), Positives = 48/124 (38%), Gaps = 21/124 (16%)

Query: 186 KLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK 245
           +LEL  NKL       F+ L  L  LSL  N         ++ L           G+  K
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ--------IQSLP---------DGVFDK 74

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN 305
               L  L  L+L  N+LQ L    F  L  LK L L  N L        ++L+ L+ + 
Sbjct: 75  ----LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130

Query: 306 LSFN 309
           L  N
Sbjct: 131 LHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.3 bits (108), Expect = 9e-06
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 14/91 (15%)

Query: 133 LTNLITIDLGGNKLNGSILITLS-----KLQKLQGLVLDDNKLEGSIPDDIC-RLVELYK 186
           LT L  + L  N++      +L      KL KL  L L +NKL+ S+P+ +  +L +L +
Sbjct: 51  LTQLTKLSLSQNQIQ-----SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKE 104

Query: 187 LELGGNKLSRSIP-ACFNNLIALRILSLGSN 216
           L L  N+L +S+P   F+ L +L+ + L +N
Sbjct: 105 LALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 24/63 (38%), Positives = 37/63 (58%), Gaps = 4/63 (6%)

Query: 156 KLQKLQGLVLDDNKLEGSIPDDIC-RLVELYKLELGGNKLSRSIPA-CFNNLIALRILSL 213
           KL +L  L L  N+++ S+PD +  +L +L  L L  NKL  S+P   F+ L  L+ L+L
Sbjct: 50  KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107

Query: 214 GSN 216
            +N
Sbjct: 108 DTN 110

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 14/95 (14%)

Query: 9   LQNLEELDLRQNKLIGTVPVAIFNVST-LKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           L  L +L L QN++  ++P  +F+  T L +L L +N L    + + D +L  L+EL L 
Sbjct: 51  LTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQSLPNGVFD-KLTQLKELALD 108

Query: 68  GNNFSELNFLSSL-----SNCKSLTVIGLSNNPLD 97
            N       L S+         SL  I L  NP D
Sbjct: 109 TNQ------LKSVPDGIFDRLTSLQKIWLHTNPWD 137

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 9/89 (10%)

Query: 422 IGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLI 473
           +GRG FG V +A             VAVK+          ++   E +I+  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 474 KVISSCSNEEFKGLV-LEYMPQGSLEKHL 501
            ++ +C+      +V +E+   G+L  +L
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 29/136 (21%), Positives = 54/136 (39%), Gaps = 5/136 (3%)

Query: 450 CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILD 509
             R  K +     +    R  ++    SS S+   +   L  + +    + LY     L 
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD--FLT 191

Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           +   +     VA  +E+L    S   IH DL   N+LL +  +  + DFG+A+ +  +  
Sbjct: 192 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248

Query: 570 SMTQTQTLATIGYMAP 585
            + +      + +MAP
Sbjct: 249 YVRKGDARLPLKWMAP 264

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 26/68 (38%), Positives = 40/68 (58%), Gaps = 3/68 (4%)

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNK 310
             + L+L  N++  L P  F  L  L  L+L NN L+  +PA + +KL+ L  L+L+ N+
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89

Query: 311 LEGEIPRG 318
           L+  IPRG
Sbjct: 90  LKS-IPRG 96

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 60/357 (16%), Positives = 102/357 (28%), Gaps = 73/357 (20%)

Query: 8   NLQNLEELDLRQNKL--IGTVPVA---IFNVSTLKLLGLQDNSLS----GSLSSITDVRL 58
               +  LDL  N L  I TV +        +++  L L  NSL       L  I     
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 59  PNLEELVLWGNNFSE--LNFLSSL--SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLED 114
            N+  L L GN  S    + L     +   ++TV+ L  N         S      +   
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS----SKSSSEFKQAFS- 134

Query: 115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKL-----QKLQGLVLDDNK 169
               N               ++ +++L GN L       L ++       +  L L  N 
Sbjct: 135 ----NLP------------ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 170 LEGSIPDDICRLVE-----LYKLELGGNKLSRS-----IPACFNNLIALRILSLGSNDP- 218
           L      ++ + +      +  L+L  N L             +    +  L+L  N   
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 219 ------LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGL-------KNLEYLFLGYNRLQG 265
                 L L   +LK L  +    +    +  ++   L       + +  +      +  
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298

Query: 266 LIPDSFGNLI-----SLKFLNLSNNNLSGA-----IPASLEKLSYLEDLNLSFNKLE 312
                  NLI          +L N  L  A         L     L +   +   L 
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 42/287 (14%), Positives = 86/287 (29%), Gaps = 57/287 (19%)

Query: 80  LSNCKSLTVIGLSNNPL--DGILP-KTSIGNLSHSLEDFQMHNCNVTGDIPEEIG----- 131
            S    +T + LS N L     +    +  N   S+    +   ++     +E+      
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 132 NLTNLITIDLGGNKLNGSILITLSKL-----QKLQGLVLDDNKLEGSIPDDICRLVE--- 183
              N+ +++L GN L+      L K        +  L L  N        +  +      
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 184 --LYKLELGGNKLSRS-----IPACFNNLIALRILSLGSNDPLPLEIGNL---------- 226
             +  L L GN L        I         +  L+L  N+     + +           
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN-----LASKNCAELAKFLA 192

Query: 227 ---KVLVGIDFSMNNFSGIIPKEIG-GLKN----LEYLFLGYNRLQG----LIPDSFGNL 274
                +  +D S N        E+     +    +  L L  N L G     +     +L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252

Query: 275 ISLKFLNLSNNNLSG-------AIPASLEKLSYLEDLNLSFNKLEGE 314
             L+ + L  + +         A+ A+   +  +  ++ +  ++   
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.6 bits (119), Expect = 4e-07
 Identities = 25/68 (36%), Positives = 43/68 (63%), Gaps = 3/68 (4%)

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL-EKLSYLEDLNLSFNK 310
           + + L+L  N++  L P  F +L++L+ L  ++N L+ AIP  + +KL+ L  L+L+ N 
Sbjct: 34  DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92

Query: 311 LEGEIPRG 318
           L+  IPRG
Sbjct: 93  LKS-IPRG 99

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 33/197 (16%), Positives = 71/197 (36%), Gaps = 22/197 (11%)

Query: 6   IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGS-LSSITDVRLPNLEEL 64
           +  +  L  L ++    +            LK L +    L  S +  I    LPNLE+L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 65  VLW--------GNNFSELNFLSSLSNCKSLTVIGLSNNPL-DGILPKTSIGNLSHSLEDF 115
           VL+          + +    L S     +L  +G+ +    + ++      ++   LE  
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 116 QMHNCNVTGD----IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE 171
            +    +T +    + + +  + +L  I++  N L+  +   L      + L +  +  +
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ-----KSLPMKIDVSD 339

Query: 172 GSIPDDICRLVELYKLE 188
               DD      + +LE
Sbjct: 340 SQEYDDDYSYPMITELE 356

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 8e-06
 Identities = 31/178 (17%), Positives = 72/178 (40%), Gaps = 24/178 (13%)

Query: 160 LQGLVLDDNKLEGSIPDDICRLVE----LYKLELGGNKLSRSIPACFNNLIALRILSLGS 215
              +  ++ ++      D+  +++    L  L++ G            NL +L I+S G 
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGL 205

Query: 216 NDPLPLEIG-----NLKVLVGIDFSMNNFSGIIPKEI-------GGLKNLEYLFLGYNRL 263
            D +  +I      NL+ LV +   + ++       +           NL++L +     
Sbjct: 206 PDSVVEDILGSDLPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE 264

Query: 264 QGLIPDSFGN---LISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNLSFNKLEGE 314
           Q ++ + F     L  L+ +++S   L+      +   ++K+ +L+ +N+ +N L  E
Sbjct: 265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 3e-05
 Identities = 34/199 (17%), Positives = 59/199 (29%), Gaps = 28/199 (14%)

Query: 112 LEDFQMHNCNVT----GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD 167
             D       ++     D+   +  +  L  + +   K   ++ I       L+ L +  
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIIS 202

Query: 168 NKLEGSIPDDI--CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGN 225
             L  S+ +DI    L  L KL L             N    L                 
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL------------FSKDR 250

Query: 226 LKVLVGIDFSMNNFSGIIPKEIGG---LKNLEYLFLGYNRLQG----LIPDSFGNLISLK 278
              L  +         ++ +       L  LE + +    L      L+ D    +  LK
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310

Query: 279 FLNLSNNNLSGAIPASLEK 297
           F+N+  N LS  +   L+K
Sbjct: 311 FINMKYNYLSDEMKKELQK 329

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 47/306 (15%), Positives = 102/306 (33%), Gaps = 35/306 (11%)

Query: 34  STLKLLGLQDNSLS-GSLSSITDVRLPNLEELVLWG-NNFSELNFLSSLSNCKSLTVIGL 91
             LK +  +   +S   L  +   R  +LE L L   + F+    LS +++C+ +  + +
Sbjct: 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLM 171

Query: 92  SNNPL--DGILPKTSIGNLSHSLE--DFQMHNCNVTGD--IPEEIGNLTNLITIDLGGNK 145
             +            +   + SLE  +F M          +     N  +L+++ +G  +
Sbjct: 172 EESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE 231

Query: 146 L--NGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS--RSIPAC 201
           +          + L++  G  L+++     +P+    LV   KL   G        +P  
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDI---GMPEKYMNLVFPRKLCRLGLSYMGPNEMPIL 288

Query: 202 FNNLIALRILSL----GSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLF 257
           F     +R L L       +     I     L  ++         +       K L+ L 
Sbjct: 289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348

Query: 258 LGYNRLQGLIPDSFG------------NLISLKFLNLSNNNLS----GAIPASLEKLSYL 301
           +     +  + D  G                L+++ +  ++++     +I   L+ L   
Sbjct: 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF 408

Query: 302 EDLNLS 307
             + L 
Sbjct: 409 RLVLLD 414

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 46/320 (14%), Positives = 95/320 (29%), Gaps = 54/320 (16%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
           NL+      L ++  +    + +     L  LGL     +  +  +       + +L L 
Sbjct: 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFP-FAAQIRKLDLL 301

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP 127
                  +  + +  C +L V+   N   D  L    +      L+  ++        + 
Sbjct: 302 YALLETEDHCTLIQKCPNLEVLETRNVIGDRGL--EVLAQYCKQLKRLRIERGADEQGME 359

Query: 128 EEIGNLT------------NLITIDLGGNKLNGSILITLSK-LQKLQGLVLDDNKLEGSI 174
           +E G ++             L  + +  + +    L ++   L+ L    L     E  I
Sbjct: 360 DEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI 419

Query: 175 PDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDF 234
            D                 L   + +       LR  +          +         D 
Sbjct: 420 TDLP---------------LDNGVRSLLIGCKKLRRFAFYLRQGG---LT--------DL 453

Query: 235 SMNNFSGIIPKEIGGLKNLEYLFLGYNRL--QGLIPDSFGNLISLKFLNLSNNNLS-GAI 291
            ++              N+ ++ LGY     +GL+        +L+ L +     S  AI
Sbjct: 454 GLSYIG-------QYSPNVRWMLLGYVGESDEGLME-FSRGCPNLQKLEMRGCCFSERAI 505

Query: 292 PASLEKLSYLEDLNLSFNKL 311
            A++ KL  L  L +   + 
Sbjct: 506 AAAVTKLPSLRYLWVQGYRA 525

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 22/142 (15%)

Query: 422 IGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-----HRNLIKV 475
           +G G F +V+ +  +     VA+KV          + D E  ++KS+R       N   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103

Query: 476 ISSCSNEEFKG-------LVLEYMPQGSLEKHLYSTNCI---LDIFQRLNIMIDVASALE 525
           +    + +  G       +V E +    L K +  +N     L   ++  I+  V   L+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLD 160

Query: 526 YLHFGCSTPVIHCDLKPSNVLL 547
           YLH  C   +IH D+KP N+LL
Sbjct: 161 YLHTKCR--IIHTDIKPENILL 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 36/149 (24%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSF----DVECEIMKSIRHR----- 470
            +G G FG V   + + +    AVKV      R  K +     +E +I+K I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 471 NLIKVISSCSNEEFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVA 521
           N++K         +     L+ E +   SL + +   N     +   +        I++ 
Sbjct: 97  NIVKYHGKF---MYYDHMCLIFEPLGP-SLYEIITRNN-----YNGFHIEDIKLYCIEIL 147

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLLDDN 550
            AL YL       + H DLKP N+LLDD 
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDP 173

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 32/148 (21%)

Query: 421 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCRRAFKSF----DVECEIMKSIRHR---N 471
            +G G FG V +         +VA+K+      R    +     +E  ++K I+ +   N
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 472 LIKVISSCSNEEFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVAS 522
               +       F G   +  E + + +  + L   N     FQ         +   +  
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENN-----FQPYPLPHVRHMAYQLCH 134

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDN 550
           AL +LH      + H DLKP N+L  ++
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNS 159

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 31/162 (19%)

Query: 419 NNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHR------ 470
           ++LIG+G FG V KA    +   VA+K+  ++ ++AF     +E  +++ +         
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKI--IKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 471 NLIKVISSCSNEEFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVA 521
            ++ +        F+    LV E +   +L   L +TN     F+ ++          + 
Sbjct: 117 YIVHLKRHF---MFRNHLCLVFEMLSY-NLYDLLRNTN-----FRGVSLNLTRKFAQQMC 167

Query: 522 SALEYLHFGCSTPVIHCDLKPSNVLL--DDNMIAYLSDFGIA 561
           +AL +L     + +IHCDLKP N+LL         + DFG +
Sbjct: 168 TALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 27/148 (18%), Positives = 51/148 (34%), Gaps = 32/148 (21%)

Query: 421 LIGRGGFGSVYKA--RLGDGMEVAVKVFNLQCRRAFKSF----DVECEIMKSIRHR---N 471
            +G G FG V +       G  VAVK+      +    +      E ++++ +      +
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 472 LIKVISSCSNEEFKG---LVLEYMPQGSLEKHLYSTNCILDIFQRLN------IMIDVAS 522
             + +      E  G   +V E +   S    +         F          +   +  
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENG-----FLPFRLDHIRKMAYQICK 129

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDN 550
           ++ +LH   S  + H DLKP N+L   +
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQS 154

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.9 bits (106), Expect = 7e-05
 Identities = 33/173 (19%), Positives = 58/173 (33%), Gaps = 14/173 (8%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDV-------RLPN 60
             +NL+ELDLR++ +       + +        L   ++S   S ++         R PN
Sbjct: 154 TCRNLKELDLRESDVDDVSGHWLSHFPDT-YTSLVSLNISCLASEVSFSALERLVTRCPN 212

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLS--NNPLDGILPKTSIGNLSHSLEDFQMH 118
           L+ L L           + L     L  +G       +   +       LS   E   + 
Sbjct: 213 LKSLKLNR-AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271

Query: 119 NCNVTGD--IPEEIGNLTNLITIDLGGNKLNGSILITL-SKLQKLQGLVLDDN 168
                    +P      + L T++L    +    L+ L  +  KLQ L + D 
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 41/306 (13%), Positives = 94/306 (30%), Gaps = 35/306 (11%)

Query: 11  NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN 70
            +  ++L+             + +   L+                     LEE+ L    
Sbjct: 67  KVRSVELKGKP----------HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116

Query: 71  FSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI 130
            ++        + K+  V+ LS+          +I     +L++  +   +V       +
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176

Query: 131 G----NLTNLITIDLGG--NKLNGSILITLSK-LQKLQGLVLDDNKLEGSIPDDICRLVE 183
                  T+L+++++    ++++ S L  L      L+ L     KL  ++P +     +
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL-----KLNRAVPLE-----K 226

Query: 184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII 243
           L  L     +L       +   +   + S      L + +   K L  +    +     +
Sbjct: 227 LATLLQRAPQLEELGTGGYTAEVRPDVYSG-----LSVALSGCKELRCLSGFWDAVPAYL 281

Query: 244 PKEIGGLKNLEYLFLGYNRLQ--GLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL 301
           P        L  L L Y  +Q   L+         L+ L + +      +         L
Sbjct: 282 PAVYSVCSRLTTLNLSYATVQSYDLVK-LLCQCPKLQRLWVLDYIEDAGLEVLASTCKDL 340

Query: 302 EDLNLS 307
            +L + 
Sbjct: 341 RELRVF 346

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 29/153 (18%), Positives = 50/153 (32%), Gaps = 22/153 (14%)

Query: 419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             L+G G   +V+        E  VK   +    +FK    E      +    L      
Sbjct: 95  GKLMGEGKESAVFNCYSEKFGECVVKFHKVG-HTSFKKV-KEKRDYGDLHFSVLAIRS-- 150

Query: 479 CSNEEFKGLVLEY---MPQGSLEKHLYSTNCILDIFQRLNIMIDVASA---------LEY 526
            +  EF+ L       +P    + + +  N +L        +  V            LE 
Sbjct: 151 -ARNEFRALQKLQGLAVP----KVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 205

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG 559
           +       ++H DL   NVL+ +  I ++ DF 
Sbjct: 206 VAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFP 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	585
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.98
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.94
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.93
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.93
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.93
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.93
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.92
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.89
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.85
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.53
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.53
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.46
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.29
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.65
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.52
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.5
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.13
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.75
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.68
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.51
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.41
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.4
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.01
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.03
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.25
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.38
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.7

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.6e-45  Score=411.51  Aligned_cols=342  Identities=38%  Similarity=0.571  Sum_probs=288.9

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCcc-ccCCCCCCEEecCCCcCCCcCCcc--------------------------c
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVA-IFNVSTLKLLGLQDNSLSGSLSSI--------------------------T   54 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~--------------------------~   54 (585)
                      +|..|+.+++|++|+|++|++++.+|.. +.++++|++|+|++|.+++.++..                          .
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~  389 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC  389 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTT
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhh
Confidence            4566666666666666666666555544 666666666666666655333321                          1


Q ss_pred             cCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCC
Q 047705           55 DVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLT  134 (585)
Q Consensus        55 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  134 (585)
                      ...+++|++|+|++|+++.... ..+..+++|++|+|++|++++..|. .++.++. |+.|++++|.+++.+|..+..++
T Consensus       390 ~~~~~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~-L~~L~L~~n~l~~~~p~~~~~l~  466 (768)
T 3rgz_A          390 QNPKNTLQELYLQNNGFTGKIP-PTLSNCSELVSLHLSFNYLSGTIPS-SLGSLSK-LRDLKLWLNMLEGEIPQELMYVK  466 (768)
T ss_dssp             CSTTCCCCEEECCSSEEEEECC-GGGGGCTTCCEEECCSSEEESCCCG-GGGGCTT-CCEEECCSSCCCSCCCGGGGGCT
T ss_pred             hcccCCccEEECCCCccccccC-HHHhcCCCCCEEECcCCcccCcccH-HHhcCCC-CCEEECCCCcccCcCCHHHcCCC
Confidence            1125678888888888774432 6788899999999999999888887 6777776 99999999999999999999999


Q ss_pred             CccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCC
Q 047705          135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLG  214 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  214 (585)
                      +|++|+|++|++.+..|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|+++
T Consensus       467 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  546 (768)
T 3rgz_A          467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN  546 (768)
T ss_dssp             TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECC
T ss_pred             CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCC---CCCc----------------------------------------------------------------------
Q 047705          215 SND---PLPL----------------------------------------------------------------------  221 (585)
Q Consensus       215 ~n~---~~~~----------------------------------------------------------------------  221 (585)
                      +|.   .+|.                                                                      
T Consensus       547 ~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~  626 (768)
T 3rgz_A          547 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP  626 (768)
T ss_dssp             SSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCC
T ss_pred             CCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCch
Confidence            985   3332                                                                      


Q ss_pred             cCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCcc
Q 047705          222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL  301 (585)
Q Consensus       222 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  301 (585)
                      .+..++.|+.||+++|+++|.+|..|+++++|+.|+|++|+++|.+|..++.+++|++|||++|++++.+|..+..+++|
T Consensus       627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L  706 (768)
T 3rgz_A          627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML  706 (768)
T ss_dssp             SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred             hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence            23446789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCCCCCCCCCCC
Q 047705          302 EDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTS  349 (585)
Q Consensus       302 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~~  349 (585)
                      ++||+++|+++|.+|....+..+....+.||+..|+.|   .+.|...
T Consensus       707 ~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~  751 (768)
T 3rgz_A          707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS  751 (768)
T ss_dssp             SEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSC
T ss_pred             CEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC---CcCCCCC
Confidence            99999999999999999889999999999999999987   3378654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=364.93  Aligned_cols=333  Identities=22%  Similarity=0.207  Sum_probs=300.4

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      ||..+.  +++++|+|++|++++..+..|.++++|++|+|++|.|++..+ ..+..+++|++|+|++|+++.++. ..|.
T Consensus        26 ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~  101 (477)
T 2id5_A           26 VPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPL-GVFT  101 (477)
T ss_dssp             CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCT-TSST
T ss_pred             CCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCc-cccc
Confidence            666553  689999999999999989999999999999999999985544 445689999999999999999986 7899


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                      .+++|++|+|++|++.++.+. .+..+++ |++|++++|.+++..+..|..+++|++|+|++|+++++.+..|.++++|+
T Consensus       102 ~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  179 (477)
T 2id5_A          102 GLSNLTKLDISENKIVILLDY-MFQDLYN-LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLI  179 (477)
T ss_dssp             TCTTCCEEECTTSCCCEECTT-TTTTCTT-CCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCC
T ss_pred             CCCCCCEEECCCCccccCChh-Hcccccc-CCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCc
Confidence            999999999999999988776 6777876 99999999999999999999999999999999999998888999999999


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCC-ccCCCCCCCcEEEccCCc
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLP-LEIGNLKVLVGIDFSMNN  238 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~-~~~~~l~~L~~L~ls~N~  238 (585)
                      .|+|++|.+++..+..|..+++|++|++++|.+.+.++..+....+|+.|++++|.  .+| ..+..+++|+.|++++|.
T Consensus       180 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  259 (477)
T 2id5_A          180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP  259 (477)
T ss_dssp             EEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCc
Confidence            99999999999888899999999999999999887777777777799999999998  344 357899999999999999


Q ss_pred             ccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       239 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      +++..+..|.++++|+.|+|++|+++++.|..|..+++|+.|++++|+|++..+..|..+++|+.|++++|+|.|+|+..
T Consensus       260 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~  339 (477)
T 2id5_A          260 ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL  339 (477)
T ss_dssp             CCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH
T ss_pred             CCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH
Confidence            99999999999999999999999999999999999999999999999999888888899999999999999999999865


Q ss_pred             CCCCCCCccccCCCCcccCCCC
Q 047705          319 GSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       319 ~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      +.........+.++...|..|.
T Consensus       340 ~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          340 WVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             HHHTTTTSSCCTTCCCBEEESG
T ss_pred             hHHhhhhccccCccCceeCCch
Confidence            5544555566788888998764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.4e-41  Score=380.41  Aligned_cols=335  Identities=34%  Similarity=0.514  Sum_probs=249.8

Q ss_pred             CCCccccCC-CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCC-CCccCc
Q 047705            1 EIPLEIGNL-QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFS-ELNFLS   78 (585)
Q Consensus         1 ~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~   78 (585)
                      .+|..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|.+++.++...+..+++|++|+|++|+++ .+|  .
T Consensus       284 ~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p--~  361 (768)
T 3rgz_A          284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP--E  361 (768)
T ss_dssp             SCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCC--T
T ss_pred             ccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcccc--H
Confidence            378888776 999999999999999999999999999999999999987888765668999999999999987 444  3


Q ss_pred             cccCC---------------------------CCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCcccc
Q 047705           79 SLSNC---------------------------KSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG  131 (585)
Q Consensus        79 ~~~~l---------------------------~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~  131 (585)
                      .+..+                           ++|++|+|++|++++..|. .+++++. |++|++++|.+++.+|..|.
T Consensus       362 ~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~-~l~~l~~-L~~L~Ls~N~l~~~~p~~l~  439 (768)
T 3rgz_A          362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP-TLSNCSE-LVSLHLSFNYLSGTIPSSLG  439 (768)
T ss_dssp             THHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG-GGGGCTT-CCEEECCSSEEESCCCGGGG
T ss_pred             HHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH-HHhcCCC-CCEEECcCCcccCcccHHHh
Confidence            34333                           4455555555555555554 4555554 77777777777777777777


Q ss_pred             CCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhh
Q 047705          132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL  211 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  211 (585)
                      .+++|++|++++|.+.+..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.++..+++|++|
T Consensus       440 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  519 (768)
T 3rgz_A          440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL  519 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE
Confidence            77777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             cCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcc------------------------------------------
Q 047705          212 SLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKE------------------------------------------  246 (585)
Q Consensus       212 ~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~------------------------------------------  246 (585)
                      ++++|.   ..|..+..+++|+.|++++|++++.+|..                                          
T Consensus       520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  599 (768)
T 3rgz_A          520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI  599 (768)
T ss_dssp             ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred             ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence            777776   56666777777777777777776555543                                          


Q ss_pred             ----------------------------cCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccC
Q 047705          247 ----------------------------IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL  298 (585)
Q Consensus       247 ----------------------------~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  298 (585)
                                                  |..+++|+.|+|++|+++|.+|..++.++.|+.|+|++|++++.+|..+..+
T Consensus       600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L  679 (768)
T 3rgz_A          600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL  679 (768)
T ss_dssp             CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence                                        2334567778888888887888888888888888888888888888888888


Q ss_pred             CccceEEeecCcCeeeCCCC-CCCCCCCccccCCCCcccCCC
Q 047705          299 SYLEDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       299 ~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      ++|+.|||++|++++.+|.. ..+..++.+++.+|+.....|
T Consensus       680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            88888888888888777753 345667777777777654433

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.1e-41  Score=355.75  Aligned_cols=328  Identities=21%  Similarity=0.221  Sum_probs=270.2

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.++...+..+++|++|+|++|+++.++. ..|..+++|++|
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L  108 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLET-GAFNGLANLEVL  108 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECT-TTTTTCTTCCEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccCh-hhccCcccCCEE
Confidence            7899999999999988899999999999999999999877766667789999999999999998864 789999999999


Q ss_pred             EccCCCCcccCCc-chhhcccccccEEEeecCcceecCCcc-ccCCCCccEEEeeCCccccccchhhhCC--CCCceEEc
Q 047705           90 GLSNNPLDGILPK-TSIGNLSHSLEDFQMHNCNVTGDIPEE-IGNLTNLITIDLGGNKLNGSILITLSKL--QKLQGLVL  165 (585)
Q Consensus        90 ~Ls~N~l~~~~~~-~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L  165 (585)
                      +|++|++++..+. ..++.++. |++|+|++|++++..|.. |..+++|++|++++|++.+..+..+..+  .+|+.|++
T Consensus       109 ~L~~n~l~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l  187 (455)
T 3v47_A          109 TLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL  187 (455)
T ss_dssp             ECTTSCCBTHHHHSSTTTTCTT-CCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEEC
T ss_pred             eCCCCCCCccccCcccccCccc-CCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccc
Confidence            9999999864332 24667776 999999999999888876 8999999999999999999888888766  57777788


Q ss_pred             cCCCCCccCccc--------ccCCCCCcEEEcCCCcccccCcccccC---------------------------------
Q 047705          166 DDNKLEGSIPDD--------ICRLVELYKLELGGNKLSRSIPACFNN---------------------------------  204 (585)
Q Consensus       166 ~~N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~---------------------------------  204 (585)
                      ++|.+++..+..        +..+++|++|++++|.+++..|..+..                                 
T Consensus       188 ~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~  267 (455)
T 3v47_A          188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF  267 (455)
T ss_dssp             TTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTT
T ss_pred             ccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccc
Confidence            887777555433        234567777777777776555443322                                 


Q ss_pred             ------cccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcC
Q 047705          205 ------LIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI  275 (585)
Q Consensus       205 ------l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  275 (585)
                            .++|+.|++++|.   ..|..+..+++|+.|++++|.+++..|..|.++++|++|+|++|++++..|..|..++
T Consensus       268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (455)
T 3v47_A          268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD  347 (455)
T ss_dssp             TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred             ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence                  2567788888876   4566788888899999999988888888888888899999999988888788888888


Q ss_pred             CCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC-CCCCCCCccccCCCCcccCCC
Q 047705          276 SLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      +|++|++++|++++..|..+..+++|++|++++|.+++.++.. ..+..++.+++.+|++.|+.|
T Consensus       348 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            8999999999888888888888888999999999888766543 456778888888898888876

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=374.51  Aligned_cols=332  Identities=25%  Similarity=0.242  Sum_probs=254.4

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcC-CccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSL-SSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      |.+|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++.+ +...+..+++|++|+|++|.++.++....|.
T Consensus        66 ~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~  145 (844)
T 3j0a_A           66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG  145 (844)
T ss_dssp             TTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG
T ss_pred             HHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHh
Confidence            778999999999999999999888999999999999999999998644 3445668999999999999998886435688


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcc-----------------------------------------------------
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNL-----------------------------------------------------  108 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~-----------------------------------------------------  108 (585)
                      .+++|++|+|++|.+++..+.. ++.+                                                     
T Consensus       146 ~L~~L~~L~Ls~N~i~~~~~~~-l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~  224 (844)
T 3j0a_A          146 KLNSLKSIDFSSNQIFLVCEHE-LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF  224 (844)
T ss_dssp             TCSSCCEEEEESSCCCCCCSGG-GHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGG
T ss_pred             hCCCCCEEECCCCcCCeeCHHH-cccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHH
Confidence            9999999999999886654431 1110                                                     


Q ss_pred             ----------------------------------------cccccEEEeecCcceecCCccccCCCCccEEEeeCCcccc
Q 047705          109 ----------------------------------------SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG  148 (585)
Q Consensus       109 ----------------------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  148 (585)
                                                              +.+|+.|++++|.+++..+..|..+++|++|+|++|.+.+
T Consensus       225 ~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  304 (844)
T 3j0a_A          225 SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK  304 (844)
T ss_dssp             GGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCE
T ss_pred             HhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCC
Confidence                                                    1247777777777777777888888888888888888888


Q ss_pred             ccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCc-------
Q 047705          149 SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPL-------  221 (585)
Q Consensus       149 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~-------  221 (585)
                      ..+.+|.++++|++|+|++|++++..|..|..+++|++|++++|.+....+..|..+++|+.|+|++|.....       
T Consensus       305 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~  384 (844)
T 3j0a_A          305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIP  384 (844)
T ss_dssp             ECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCS
T ss_pred             CChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcc
Confidence            8888888888899999998888888888888888888888888888877777788888888888887752110       


Q ss_pred             ------------------------------------cCCCCCCCcEEEccCCcccccC----------------------
Q 047705          222 ------------------------------------EIGNLKVLVGIDFSMNNFSGII----------------------  243 (585)
Q Consensus       222 ------------------------------------~~~~l~~L~~L~ls~N~l~~~~----------------------  243 (585)
                                                          .+..+++|+.|++++|++++..                      
T Consensus       385 ~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~  464 (844)
T 3j0a_A          385 DIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ  464 (844)
T ss_dssp             EEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCS
T ss_pred             hhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccc
Confidence                                                0124566666666666665322                      


Q ss_pred             --------CcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeC
Q 047705          244 --------PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEI  315 (585)
Q Consensus       244 --------~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~  315 (585)
                              +..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+.  ++|+.||+++|.+++..
T Consensus       465 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~  542 (844)
T 3j0a_A          465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPN  542 (844)
T ss_dssp             SSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCC
T ss_pred             cccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCC
Confidence                    23456667777777777777777777777777777777777777766655554  67777888888877766


Q ss_pred             CCCCCCCCCCccccCCCCcccCCC
Q 047705          316 PRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       316 ~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      |..  +..+..+++.+||+.|+++
T Consensus       543 ~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          543 PDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             SCC--CSSCCEEEEEEECCCCSSS
T ss_pred             hhH--hCCcCEEEecCCCcccccc
Confidence            643  4578888999999999764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.1e-39  Score=356.04  Aligned_cols=208  Identities=24%  Similarity=0.237  Sum_probs=166.6

Q ss_pred             CCCCccEEEeeCCcccccc--chhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCc-ccccCcccc
Q 047705          132 NLTNLITIDLGGNKLNGSI--LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIP-ACFNNLIAL  208 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L  208 (585)
                      .+++|++|++++|++.+..  +..+..+++|++|++++|.+++ +|..+..+++|++|++++|.+.+..+ ..|..+++|
T Consensus       348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  426 (606)
T 3vq2_A          348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL  426 (606)
T ss_dssp             CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred             cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence            3455566666666665542  5667777777777777777774 44677888888888888888887766 578888888


Q ss_pred             hhhcCCCCC---CCCccCCCCCCCcEEEccCCcccc-cCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCC
Q 047705          209 RILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSG-IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN  284 (585)
Q Consensus       209 ~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~  284 (585)
                      ++|++++|.   ..|..+..+++|+.|++++|.+++ ..|..|..+++|+.|++++|++++..|..|..+++|+.|++++
T Consensus       427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  506 (606)
T 3vq2_A          427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH  506 (606)
T ss_dssp             CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence            888888887   566678888999999999999887 4788889999999999999999988888899999999999999


Q ss_pred             CccCccCChhhccCCccceEEeecCcCeeeCCCCCCCC-CCCccccCCCCcccCCCC
Q 047705          285 NNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFG-NFSAESFEGNELLCGSPN  340 (585)
Q Consensus       285 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~~~~~~~~~n~~~c~~~~  340 (585)
                      |++++..|..+..+++|++|++++|+++..++....+. .++.+++.+|++.|+++.
T Consensus       507 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             SCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             CcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99998888899999999999999999986555544443 478888999999998763

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.5e-40  Score=346.33  Aligned_cols=315  Identities=22%  Similarity=0.215  Sum_probs=264.0

Q ss_pred             CCccccCCCCCCEEecCCCcccc-cCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCC-ccCcc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIG-TVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSEL-NFLSS   79 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~   79 (585)
                      .|.+|+++++|++|+|++|.+.+ +.+..|.++++|++|+|++|.+++..+. .+..+++|++|+|++|+++.. +....
T Consensus        46 ~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~  124 (455)
T 3v47_A           46 NETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG-AFNGLANLEVLTLTQCNLDGAVLSGNF  124 (455)
T ss_dssp             CTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT-TTTTCTTCCEEECTTSCCBTHHHHSST
T ss_pred             ChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh-hccCcccCCEEeCCCCCCCccccCccc
Confidence            37889999999999999999874 4467899999999999999999855443 345799999999999999873 22245


Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCC--CCccEEEeeCCccccccchhh---
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNL--TNLITIDLGGNKLNGSILITL---  154 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~---  154 (585)
                      |..+++|++|+|++|++++..|..++.+++. |++|++++|.+++..+..+..+  .+|+.|++++|.+.+..+..+   
T Consensus       125 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~  203 (455)
T 3v47_A          125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRR-FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE  203 (455)
T ss_dssp             TTTCTTCCEEECCSSBCCSCCCCGGGGGCTT-CCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHH
T ss_pred             ccCcccCCEEECCCCccCccCcccccCCCCc-ccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccc
Confidence            8999999999999999998888766788876 9999999999999888877765  556666666666665443322   


Q ss_pred             -----hCCCCCceEEccCCCCCccCcccccC---------------------------------------CCCCcEEEcC
Q 047705          155 -----SKLQKLQGLVLDDNKLEGSIPDDICR---------------------------------------LVELYKLELG  190 (585)
Q Consensus       155 -----~~l~~L~~L~L~~N~l~~~~~~~~~~---------------------------------------l~~L~~L~L~  190 (585)
                           ..+++|++|++++|++++..|..+..                                       .++|++|+++
T Consensus       204 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~  283 (455)
T 3v47_A          204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS  283 (455)
T ss_dssp             HHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECC
T ss_pred             ccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEec
Confidence                 24456666666666665444433221                                       2689999999


Q ss_pred             CCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCccccc
Q 047705          191 GNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI  267 (585)
Q Consensus       191 ~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  267 (585)
                      +|.+++..|..|..+++|++|++++|.   ..+..+..+++|+.|++++|.+++..+..|.++++|+.|+|++|++++..
T Consensus       284 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  363 (455)
T 3v47_A          284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG  363 (455)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEEC
T ss_pred             CccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccC
Confidence            999999999999999999999999998   45668999999999999999999998999999999999999999999998


Q ss_pred             CccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          268 PDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       268 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      |..|..+++|++|++++|++++..+..+..+++|++|++++|+|+|.||..
T Consensus       364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             hhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            999999999999999999999887778899999999999999999999964

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=7.2e-39  Score=351.71  Aligned_cols=279  Identities=24%  Similarity=0.275  Sum_probs=191.9

Q ss_pred             CCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCC-ccccCCC
Q 047705           56 VRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP-EEIGNLT  134 (585)
Q Consensus        56 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~  134 (585)
                      ..+++|++|+|++|+++.+|  ..+..+++|++|++++|++.+..|. .++.++. |++|++++|.+.+.++ ..+..++
T Consensus       275 ~~l~~L~~L~l~~n~l~~lp--~~l~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~l~  350 (606)
T 3t6q_A          275 HCFSGLQELDLTATHLSELP--SGLVGLSTLKKLVLSANKFENLCQI-SASNFPS-LTHLSIKGNTKRLELGTGCLENLE  350 (606)
T ss_dssp             TTCTTCSEEECTTSCCSCCC--SSCCSCTTCCEEECTTCCCSBGGGG-CGGGCTT-CSEEECCSCSSCCBCCSSTTTTCT
T ss_pred             ccccCCCEEeccCCccCCCC--hhhcccccCCEEECccCCcCcCchh-hhhccCc-CCEEECCCCCcccccchhhhhccC
Confidence            34566666666666666665  4466666666666666666655443 4555554 7777777776664444 3466777


Q ss_pred             CccEEEeeCCcccccc--chhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcc-cccCcccchhh
Q 047705          135 NLITIDLGGNKLNGSI--LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPA-CFNNLIALRIL  211 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L  211 (585)
                      +|++|++++|.+.+..  +..|.++++|++|++++|++++..|..|..+++|++|++++|.+.+..+. .|..+++|+.|
T Consensus       351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  430 (606)
T 3t6q_A          351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL  430 (606)
T ss_dssp             TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred             cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence            7777777777776655  55677777777777777777766677777777777777777777655443 36777777777


Q ss_pred             cCCCCC---CCCccCCCCCCCcEEEccCCccccc---CCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCC
Q 047705          212 SLGSND---PLPLEIGNLKVLVGIDFSMNNFSGI---IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN  285 (585)
Q Consensus       212 ~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N  285 (585)
                      ++++|.   ..|..+..+++|+.|++++|++++.   .+..+..+++|+.|++++|++++..|..|..+++|+.|++++|
T Consensus       431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  510 (606)
T 3t6q_A          431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN  510 (606)
T ss_dssp             ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence            777775   3445567777777777777777652   2345677777777777777777777777777777777888887


Q ss_pred             ccCccCChhhccCCccceEEeecCcCeeeCCCC-CCCCCCCccccCCCCcccCCC
Q 047705          286 NLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       286 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      ++++..|..+..+++| +|++++|.+++.+|.. ..+..++.+++.+||+.|+++
T Consensus       511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            7777777777777777 7777888777665542 334566777888888888654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.4e-39  Score=356.12  Aligned_cols=329  Identities=18%  Similarity=0.245  Sum_probs=286.3

Q ss_pred             CCcccc--CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCc-CCC-cCCcccc-----CCCCCccEEEccCCCCC
Q 047705            2 IPLEIG--NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS-LSG-SLSSITD-----VRLPNLEELVLWGNNFS   72 (585)
Q Consensus         2 ~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~-----~~l~~L~~L~L~~n~l~   72 (585)
                      +|.+++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|....     ..+++|++|+|++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            899999  99999999999999999999999999999999999998 886 4543221     12489999999999999


Q ss_pred             CCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCC-ccEEEeeCCccccccc
Q 047705           73 ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTN-LITIDLGGNKLNGSIL  151 (585)
Q Consensus        73 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~  151 (585)
                      .+|....+..+++|++|+|++|++++.+|  .++.+++ |++|++++|.++ .+|..+..+++ |++|++++|.++ .+|
T Consensus       319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip--~~~~l~~-L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp  393 (636)
T 4eco_A          319 TFPVETSLQKMKKLGMLECLYNQLEGKLP--AFGSEIK-LASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIP  393 (636)
T ss_dssp             SCCCHHHHTTCTTCCEEECCSCCCEEECC--CCEEEEE-ESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCC
T ss_pred             ccCchhhhccCCCCCEEeCcCCcCccchh--hhCCCCC-CCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccc
Confidence            88721289999999999999999997777  5777776 999999999999 77888999999 999999999999 667


Q ss_pred             hhhhCCC--CCceEEccCCCCCccCccccc-------CCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCC
Q 047705          152 ITLSKLQ--KLQGLVLDDNKLEGSIPDDIC-------RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLP  220 (585)
Q Consensus       152 ~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~  220 (585)
                      ..+..+.  +|++|++++|++++..|..+.       .+++|++|+|++|.++...+..+..+++|+.|+|++|.  .+|
T Consensus       394 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~  473 (636)
T 4eco_A          394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP  473 (636)
T ss_dssp             SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCC
T ss_pred             hhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcC
Confidence            7777654  999999999999999998888       88899999999999996655667789999999999998  444


Q ss_pred             ccCCC--------CCCCcEEEccCCcccccCCcccC--CCCCCcEEeecccCcccccCccccCcCCCCEEeC------CC
Q 047705          221 LEIGN--------LKVLVGIDFSMNNFSGIIPKEIG--GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNL------SN  284 (585)
Q Consensus       221 ~~~~~--------l~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l------~~  284 (585)
                      .....        +++|+.|++++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|++      ++
T Consensus       474 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~  551 (636)
T 4eco_A          474 KNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG  551 (636)
T ss_dssp             SSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTC
T ss_pred             HHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccccc
Confidence            43322        239999999999999 5777776  99999999999999998 7899999999999999      56


Q ss_pred             CccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCC
Q 047705          285 NNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       285 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      |++.+.+|..+..+++|++|++++|.+ +.+|... ...++.+++.+|++.|-..
T Consensus       552 N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          552 NRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEEEC
T ss_pred             CcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCccccH
Confidence            888999999999999999999999999 5566543 3788999999999988543

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-38  Score=346.33  Aligned_cols=324  Identities=21%  Similarity=0.196  Sum_probs=229.1

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      ||..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+|++..+ ..+..+++|++|+|++|+|+.+|. .   
T Consensus        46 ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~lp~-~---  118 (562)
T 3a79_B           46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF-HVFLFNQDLEYLDVSHNRLQNISC-C---  118 (562)
T ss_dssp             CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECT-TTTTTCTTCCEEECTTSCCCEECS-C---
T ss_pred             CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCH-HHhCCCCCCCEEECCCCcCCccCc-c---
Confidence            454443  566677777776666555666666667777777776663333 233456666677776666666653 2   


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCc--cEEEeeCCcc--ccccchhhhCC
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL--ITIDLGGNKL--NGSILITLSKL  157 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~l  157 (585)
                      .+++|++|+|++|+++++..+..++++++ |++|++++|.+++..   +..+++|  ++|++++|.+  .+..+..|..+
T Consensus       119 ~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~-L~~L~L~~n~l~~~~---~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l  194 (562)
T 3a79_B          119 PMASLRHLDLSFNDFDVLPVCKEFGNLTK-LTFLGLSAAKFRQLD---LLPVAHLHLSCILLDLVSYHIKGGETESLQIP  194 (562)
T ss_dssp             CCTTCSEEECCSSCCSBCCCCGGGGGCTT-CCEEEEECSBCCTTT---TGGGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred             ccccCCEEECCCCCccccCchHhhcccCc-ccEEecCCCccccCc---hhhhhhceeeEEEeecccccccccCccccccc
Confidence            56666666666666665432225555554 666666666665432   3333333  6666666655  43333333332


Q ss_pred             C-------------------------------------------------------------------------------
Q 047705          158 Q-------------------------------------------------------------------------------  158 (585)
Q Consensus       158 ~-------------------------------------------------------------------------------  158 (585)
                      .                                                                               
T Consensus       195 ~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~  274 (562)
T 3a79_B          195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW  274 (562)
T ss_dssp             CEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT
T ss_pred             CcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh
Confidence            2                                                                               


Q ss_pred             --CCceEEccCCCCCccCcccc-----------------------------------------------------cCCCC
Q 047705          159 --KLQGLVLDDNKLEGSIPDDI-----------------------------------------------------CRLVE  183 (585)
Q Consensus       159 --~L~~L~L~~N~l~~~~~~~~-----------------------------------------------------~~l~~  183 (585)
                        +|++|++++|.+++.+|..+                                                     ..+++
T Consensus       275 ~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~  354 (562)
T 3a79_B          275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS  354 (562)
T ss_dssp             TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred             cccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCC
Confidence              56666666666665555443                                                     67789


Q ss_pred             CcEEEcCCCcccccCcccccCcccchhhcCCCCCCC-----CccCCCCCCCcEEEccCCcccc-cCCcccCCCCCCcEEe
Q 047705          184 LYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL-----PLEIGNLKVLVGIDFSMNNFSG-IIPKEIGGLKNLEYLF  257 (585)
Q Consensus       184 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~-----~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~  257 (585)
                      |++|++++|.+++..|..+..+++|+.|++++|...     |..+..+++|+.|++++|.+++ ..+..+..+++|++|+
T Consensus       355 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~  434 (562)
T 3a79_B          355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN  434 (562)
T ss_dssp             CCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEE
T ss_pred             ceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEE
Confidence            999999999999888899999999999999999722     2458899999999999999998 4445688899999999


Q ss_pred             ecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC-CCCCCCCCccccCCCCccc
Q 047705          258 LGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       258 ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c  336 (585)
                      +++|++++..|..+.  ++|+.|++++|+|+ .+|..+..+++|++|++++|.++..++. ...+..++.+++.+|++.|
T Consensus       435 l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          435 LSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             CCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             CCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence            999999887776554  68999999999999 5666667999999999999999965554 4567788889999999999


Q ss_pred             CCC
Q 047705          337 GSP  339 (585)
Q Consensus       337 ~~~  339 (585)
                      +.+
T Consensus       512 ~c~  514 (562)
T 3a79_B          512 TCP  514 (562)
T ss_dssp             CHH
T ss_pred             Ccc
Confidence            865

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.7e-39  Score=340.27  Aligned_cols=330  Identities=22%  Similarity=0.256  Sum_probs=293.0

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |..-.....-+.++.+++.++ .+|..+.  ++|++|+|++|+|++.. ...+..+++|++|+|++|+++.++. ..|..
T Consensus         4 p~~C~C~~~~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~   78 (477)
T 2id5_A            4 PPRCECSAQDRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLN-QDEFASFPHLEELELNENIVSAVEP-GAFNN   78 (477)
T ss_dssp             STTCEEETTTTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEEC-TTTTTTCTTCCEEECTTSCCCEECT-TTTTT
T ss_pred             cCCCeECCCCCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceEC-HhHccCCCCCCEEECCCCccCEeCh-hhhhC
Confidence            444444455678999999997 6677664  58999999999999544 4445689999999999999999865 88999


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCce
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG  162 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  162 (585)
                      +++|++|+|++|+++.+.+. .+.++++ |++|+|++|.+++..+..|..+++|++|+|++|.+.++.+..|.++++|++
T Consensus        79 l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  156 (477)
T 2id5_A           79 LFNLRTLGLRSNRLKLIPLG-VFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQ  156 (477)
T ss_dssp             CTTCCEEECCSSCCCSCCTT-SSTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCE
T ss_pred             CccCCEEECCCCcCCccCcc-cccCCCC-CCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCE
Confidence            99999999999999876655 6777776 999999999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcc
Q 047705          163 LVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNF  239 (585)
Q Consensus       163 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l  239 (585)
                      |+|++|++++..+..+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.   ..+.......+|+.|++++|.+
T Consensus       157 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l  236 (477)
T 2id5_A          157 LTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL  236 (477)
T ss_dssp             EEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCC
T ss_pred             EECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcc
Confidence            9999999998888889999999999999999998888899999999999999986   4555566667999999999999


Q ss_pred             cccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC-
Q 047705          240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG-  318 (585)
Q Consensus       240 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-  318 (585)
                      +++.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.++...+.. 
T Consensus       237 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  316 (477)
T 2id5_A          237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF  316 (477)
T ss_dssp             CSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGB
T ss_pred             cccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHc
Confidence            9776678999999999999999999988889999999999999999999999999999999999999999999766543 


Q ss_pred             CCCCCCCccccCCCCcccCCC
Q 047705          319 GSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       319 ~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      ..+..++.+++.+|++.|+.+
T Consensus       317 ~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          317 HSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             SCGGGCCEEECCSSCEECSGG
T ss_pred             CCCcccCEEEccCCCccCccc
Confidence            456678889999999999864

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=342.77  Aligned_cols=158  Identities=23%  Similarity=0.252  Sum_probs=125.9

Q ss_pred             cCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCC-----CccCCCCCCCcEEEccCCcccccCC-cccCCCCC
Q 047705          179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL-----PLEIGNLKVLVGIDFSMNNFSGIIP-KEIGGLKN  252 (585)
Q Consensus       179 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~-----~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~  252 (585)
                      ..+++|++|++++|.+++..|..+..+++|+.|++++|...     |..+..+++|+.|++++|.+++.+| ..+..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            56788888888888888878888888888888888888733     2457788888889999888887344 45788888


Q ss_pred             CcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC-CCCCCCCCccccCC
Q 047705          253 LEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR-GGSFGNFSAESFEG  331 (585)
Q Consensus       253 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~  331 (585)
                      |+.|++++|++++..|..+.  ++|+.|++++|+++ .+|..+..+++|++|++++|+++..++. ...+..++.+++.+
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  477 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT  477 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcC
Confidence            99999999988877776654  68899999999988 6777777889999999999999865444 34566788888899


Q ss_pred             CCcccCCC
Q 047705          332 NELLCGSP  339 (585)
Q Consensus       332 n~~~c~~~  339 (585)
                      |++.|+++
T Consensus       478 N~~~c~c~  485 (520)
T 2z7x_B          478 NPWDCSCP  485 (520)
T ss_dssp             SCBCCCHH
T ss_pred             CCCcccCC
Confidence            99888754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=343.59  Aligned_cols=332  Identities=22%  Similarity=0.239  Sum_probs=224.6

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+++++|++|+|++|+++++.+..|.++++|++|+|++|.+++.+ ...+..+++|++|+|++|+++.++. ..|..
T Consensus        45 ~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~l~~-~~~~~  122 (570)
T 2z63_A           45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA-LGAFSGLSSLQKLVAVETNLASLEN-FPIGH  122 (570)
T ss_dssp             TTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC-TTTTTTCTTCCEEECTTSCCCCSTT-CSCTT
T ss_pred             hhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccC-HhhhcCccccccccccccccccCCC-ccccc
Confidence            345677777777777777777666667777777777777777776333 2334456667777777777666654 44666


Q ss_pred             CCCCcEEEccCCCCcccC-CcchhhcccccccEEEeecCcceecCCccccCC----------------------------
Q 047705           83 CKSLTVIGLSNNPLDGIL-PKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNL----------------------------  133 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l----------------------------  133 (585)
                      +++|++|+|++|.++++. |. .++++++ |++|++++|.+++..+..++.+                            
T Consensus       123 l~~L~~L~L~~n~l~~~~lp~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~  200 (570)
T 2z63_A          123 LKTLKELNVAHNLIQSFKLPE-YFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI  200 (570)
T ss_dssp             CTTCCEEECCSSCCCCCCCCG-GGGGCTT-CCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC
T ss_pred             cccccEEecCCCccceecChh-hhcccCC-CCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC
Confidence            667777777777666532 43 4555554 6666666666554443333322                            


Q ss_pred             --------------------------------------------------------------------------------
Q 047705          134 --------------------------------------------------------------------------------  133 (585)
Q Consensus       134 --------------------------------------------------------------------------------  133 (585)
                                                                                                      
T Consensus       201 ~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~  280 (570)
T 2z63_A          201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC  280 (570)
T ss_dssp             EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGG
T ss_pred             cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcC
Confidence                                                                                            


Q ss_pred             -CCccEEEeeCCccccccchhh------------------------------------------hCCCCCceEEccCCCC
Q 047705          134 -TNLITIDLGGNKLNGSILITL------------------------------------------SKLQKLQGLVLDDNKL  170 (585)
Q Consensus       134 -~~L~~L~L~~N~l~~~~~~~~------------------------------------------~~l~~L~~L~L~~N~l  170 (585)
                       ++|++|++++|.+.+ .|..+                                          ..+++|++|++++|++
T Consensus       281 l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l  359 (570)
T 2z63_A          281 LTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL  359 (570)
T ss_dssp             GTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCC
T ss_pred             cCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCcc
Confidence             333444444443332 11111                                          2234444555555555


Q ss_pred             CccC--cccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCC-ccCCCCCCCcEEEccCCcccccCC
Q 047705          171 EGSI--PDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLP-LEIGNLKVLVGIDFSMNNFSGIIP  244 (585)
Q Consensus       171 ~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~-~~~~~l~~L~~L~ls~N~l~~~~~  244 (585)
                      ++..  +..+..+++|++|++++|.+.+..+. +..+++|+.|++++|.   ..+ ..+..+++|+.|++++|.+++..|
T Consensus       360 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  438 (570)
T 2z63_A          360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN  438 (570)
T ss_dssp             BEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCT
T ss_pred             CccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccch
Confidence            4332  44555666666666666666644333 7777888888888876   222 357788889999999998888888


Q ss_pred             cccCCCCCCcEEeecccCcc-cccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC-CCCC
Q 047705          245 KEIGGLKNLEYLFLGYNRLQ-GLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG-GSFG  322 (585)
Q Consensus       245 ~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~  322 (585)
                      ..|.++++|+.|++++|+++ +.+|..+..+++|+.|++++|++++..|..+..+++|++|++++|.+++.++.. ..+.
T Consensus       439 ~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  518 (570)
T 2z63_A          439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT  518 (570)
T ss_dssp             TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             hhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhccc
Confidence            88888999999999999887 567888888999999999999999888888888999999999999998876653 4567


Q ss_pred             CCCccccCCCCcccCCCC
Q 047705          323 NFSAESFEGNELLCGSPN  340 (585)
Q Consensus       323 ~~~~~~~~~n~~~c~~~~  340 (585)
                      .++.+++.+|++.|+.|.
T Consensus       519 ~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          519 SLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TCCEEECCSSCBCCCTTT
T ss_pred             CCcEEEecCCcccCCCcc
Confidence            788888999999888763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.5e-38  Score=345.38  Aligned_cols=313  Identities=20%  Similarity=0.167  Sum_probs=259.8

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++.. ...+..+++|++|+|++|+++.+..+..|..
T Consensus        73 ~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~  151 (606)
T 3vq2_A           73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE-SFPIGQLITLKKLNVAHNFIHSCKLPAYFSN  151 (606)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSS-SSCCTTCTTCCEEECCSSCCCCCCCCGGGGT
T ss_pred             HHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccc-ccccCCCCCCCEEeCCCCcccceechHhHhh
Confidence            556777777777777777777666777777777777777777776333 2335577888888888888876443367888


Q ss_pred             CCCCcEEEccCCCCcccCCcch--h-------------------------------------------------------
Q 047705           83 CKSLTVIGLSNNPLDGILPKTS--I-------------------------------------------------------  105 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~--~-------------------------------------------------------  105 (585)
                      +++|++|+|++|+++++.+..+  +                                                       
T Consensus       152 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L  231 (606)
T 3vq2_A          152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL  231 (606)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTC
T ss_pred             cCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhcccccc
Confidence            8888888888888776543210  0                                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 047705          106 --------------------------------------------------------------------------------  105 (585)
Q Consensus       106 --------------------------------------------------------------------------------  105 (585)
                                                                                                      
T Consensus       232 ~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~  311 (606)
T 3vq2_A          232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQS  311 (606)
T ss_dssp             EEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSE
T ss_pred             ccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCE
Confidence                                                                                            


Q ss_pred             -----------------------------------hcccccccEEEeecCcceec--CCccccCCCCccEEEeeCCcccc
Q 047705          106 -----------------------------------GNLSHSLEDFQMHNCNVTGD--IPEEIGNLTNLITIDLGGNKLNG  148 (585)
Q Consensus       106 -----------------------------------~~~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~  148 (585)
                                                         +.++ +|++|++++|.+++.  .+..+..+++|++|++++|.+.+
T Consensus       312 L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~  390 (606)
T 3vq2_A          312 LSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALP-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII  390 (606)
T ss_dssp             EEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCT-TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE
T ss_pred             EEcccccCcccccCCCCccceeeccCCcCccchhhccCC-CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc
Confidence                                               0111 356666666677665  37788999999999999999985


Q ss_pred             ccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC----CCCccC
Q 047705          149 SILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND----PLPLEI  223 (585)
Q Consensus       149 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~----~~~~~~  223 (585)
                       .|..|.++++|++|++++|++++..| ..+..+++|++|++++|.+++..|..|..+++|++|++++|.    ..|..+
T Consensus       391 -~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  469 (606)
T 3vq2_A          391 -MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF  469 (606)
T ss_dssp             -ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred             -chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhh
Confidence             55889999999999999999998887 689999999999999999999999999999999999999997    257789


Q ss_pred             CCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCC-ccc
Q 047705          224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS-YLE  302 (585)
Q Consensus       224 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~  302 (585)
                      ..+++|+.|++++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|+.|++++|+++ .+|..+..++ +|+
T Consensus       470 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~  548 (606)
T 3vq2_A          470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLA  548 (606)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCC
T ss_pred             ccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999 5666688887 599


Q ss_pred             eEEeecCcCeeeCCCCC
Q 047705          303 DLNLSFNKLEGEIPRGG  319 (585)
Q Consensus       303 ~l~l~~N~l~~~~~~~~  319 (585)
                      +|++++|+|.|.|+..+
T Consensus       549 ~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          549 FFNLTNNSVACICEHQK  565 (606)
T ss_dssp             EEECCSCCCCCSSTTHH
T ss_pred             EEEccCCCcccCCccHH
Confidence            99999999999998653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-39  Score=318.50  Aligned_cols=168  Identities=29%  Similarity=0.437  Sum_probs=151.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|++. +++.||||++++..   ....+.+.+|++++++++|||||+++++|++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999875 79999999998642   334577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |||+||+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998754 6899999999999999999999   99999999999999999999999999999998754443


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       188 ~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          188 QARANSFVGTAQYVSP  203 (311)
T ss_dssp             CCCBCCCCSCGGGCCH
T ss_pred             cccccCcccCcccCCH
Confidence            3344567999999998

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=8.5e-38  Score=343.17  Aligned_cols=329  Identities=20%  Similarity=0.196  Sum_probs=237.5

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+++++|++|+|++|+++++.|..|.++++|++|+|++|++++..+. .+..+++|++|+|++|+++.++. ..|..
T Consensus        50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~l~~-~~~~~  127 (606)
T 3t6q_A           50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET-ALSGPKALKHLFFIQTGISSIDF-IPLHN  127 (606)
T ss_dssp             TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT-TTSSCTTCCEEECTTSCCSCGGG-SCCTT
T ss_pred             hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh-hhcccccccEeeccccCcccCCc-chhcc
Confidence            66788888888888888888888888888888888888888888754443 34578888888888888888754 66888


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCcc--EEEeeCCccccccchhhhCC---
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI--TIDLGGNKLNGSILITLSKL---  157 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l---  157 (585)
                      +++|++|+|++|+++++....+.+ +++ |++|++++|.+++..+..|..+++|+  +|++++|.+.+..+..|...   
T Consensus       128 l~~L~~L~L~~n~l~~~~~~~~~~-l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~  205 (606)
T 3t6q_A          128 QKTLESLYLGSNHISSIKLPKGFP-TEK-LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ  205 (606)
T ss_dssp             CTTCCEEECCSSCCCCCCCCTTCC-CTT-CCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEE
T ss_pred             CCcccEEECCCCcccccCcccccC-Ccc-cCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccc
Confidence            888888888888887754442333 554 88888888888887777788888888  77888887776665554321   


Q ss_pred             ------------------------------------------------CCCceEEccCCCCCccCcccccCCCCCcEEEc
Q 047705          158 ------------------------------------------------QKLQGLVLDDNKLEGSIPDDICRLVELYKLEL  189 (585)
Q Consensus       158 ------------------------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (585)
                                                                      .+|+.|++++|.++++.+..|..+++|++|++
T Consensus       206 ~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  285 (606)
T 3t6q_A          206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL  285 (606)
T ss_dssp             EEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEEC
T ss_pred             ccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEec
Confidence                                                            04666666777777666666777777777777


Q ss_pred             CCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCc-ccCCCCCCcEEeecccCccc
Q 047705          190 GGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPK-EIGGLKNLEYLFLGYNRLQG  265 (585)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~  265 (585)
                      ++|.++ .+|..+..+++|++|++++|.   ..|..+..+++|+.|++++|.+.+..+. .+..+++|++|++++|++++
T Consensus       286 ~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~  364 (606)
T 3t6q_A          286 TATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET  364 (606)
T ss_dssp             TTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCcccc
Confidence            777777 566667777777777777776   3344667777777777777777644443 46777777777777777776


Q ss_pred             cc--CccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC--CCCCCCCCccccCCCCccc
Q 047705          266 LI--PDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR--GGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       266 ~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~~~~~~~~~~~n~~~c  336 (585)
                      ..  +..+..+++|+.|++++|++++..|..+..+++|++|++++|.+.+..+.  ...+..++.+++.+|....
T Consensus       365 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~  439 (606)
T 3t6q_A          365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI  439 (606)
T ss_dssp             EEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBT
T ss_pred             ccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCC
Confidence            55  56677777777777777777777677777777777777777777765543  2345566666676665543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-37  Score=347.07  Aligned_cols=337  Identities=22%  Similarity=0.224  Sum_probs=262.9

Q ss_pred             CccccCCCC--CCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCC-----------------------------
Q 047705            3 PLEIGNLQN--LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLS-----------------------------   51 (585)
Q Consensus         3 p~~~~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----------------------------   51 (585)
                      |..|..++.  |++|+|++|++++..|..|..+++|++|+|++|.+++.++                             
T Consensus       239 ~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp  318 (680)
T 1ziw_A          239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP  318 (680)
T ss_dssp             TTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CC
T ss_pred             hhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccc
Confidence            334444432  5555555555555555555555555555555555543322                             


Q ss_pred             ---ccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCccc-CCcchhhccc-ccccEEEeecCcceecC
Q 047705           52 ---SITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI-LPKTSIGNLS-HSLEDFQMHNCNVTGDI  126 (585)
Q Consensus        52 ---~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~~-~~L~~L~l~~n~l~~~~  126 (585)
                         ...+..+++|++|+|++|+++.++. ..|..+++|++|++++|.+... .+...+..+. .+|+.|++++|++++..
T Consensus       319 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~  397 (680)
T 1ziw_A          319 KIDDFSFQWLKCLEHLNMEDNDIPGIKS-NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE  397 (680)
T ss_dssp             EECTTTTTTCTTCCEEECCSCCBCCCCT-TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred             ccChhhcccCCCCCEEECCCCccCCCCh-hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence               1134467788888888888888765 6788888888888888875321 2221233222 35999999999999999


Q ss_pred             CccccCCCCccEEEeeCCccccccc-hhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc--ccCccccc
Q 047705          127 PEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS--RSIPACFN  203 (585)
Q Consensus       127 ~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~  203 (585)
                      |..|..+++|++|+|++|.+.+..+ ..|.++++|++|++++|++++..+..|..+++|++|++++|.+.  +..|..|.
T Consensus       398 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~  477 (680)
T 1ziw_A          398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ  477 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred             hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence            9999999999999999999986554 78999999999999999999888999999999999999999987  56788899


Q ss_pred             CcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCC--------cccCCCCCCcEEeecccCcccccCcccc
Q 047705          204 NLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIP--------KEIGGLKNLEYLFLGYNRLQGLIPDSFG  272 (585)
Q Consensus       204 ~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~ls~N~l~~~~~~~~~  272 (585)
                      .+++|+.|++++|.   ..+..+..+++|+.|++++|++++..+        ..|.++++|+.|+|++|+++.+.+..|.
T Consensus       478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~  557 (680)
T 1ziw_A          478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK  557 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence            99999999999997   334458899999999999999987532        2478899999999999999976667899


Q ss_pred             CcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCC--CCCCCCccccCCCCcccCCCC
Q 047705          273 NLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG--SFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       273 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      .+++|+.|++++|++++..+..|..+++|+.|++++|.+++..+...  .+..++.+++.+|||.|+++.
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            99999999999999998877888899999999999999998766432  456788899999999999763

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-38  Score=341.00  Aligned_cols=333  Identities=22%  Similarity=0.257  Sum_probs=273.2

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |..|+++++|++|+|++|+++...|..|.++++|++|+|++|.++ .++...+..+++|++|+|++|.++.++.+..|..
T Consensus        69 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~  147 (570)
T 2z63_A           69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN  147 (570)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGG
T ss_pred             cccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccc-cCCCccccccccccEEecCCCccceecChhhhcc
Confidence            567899999999999999999888899999999999999999998 4444446689999999999999998643377999


Q ss_pred             CCCCcEEEccCCCCcccCCcc-----------------------------------------------------------
Q 047705           83 CKSLTVIGLSNNPLDGILPKT-----------------------------------------------------------  103 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~-----------------------------------------------------------  103 (585)
                      +++|++|++++|+++++.+..                                                           
T Consensus       148 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l  227 (570)
T 2z63_A          148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL  227 (570)
T ss_dssp             CTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTC
T ss_pred             cCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCcccc
Confidence            999999999999887553321                                                           


Q ss_pred             -------------------------------------------------hhhcccccccEEEeecCcceecCCccc----
Q 047705          104 -------------------------------------------------SIGNLSHSLEDFQMHNCNVTGDIPEEI----  130 (585)
Q Consensus       104 -------------------------------------------------~~~~~~~~L~~L~l~~n~l~~~~~~~~----  130 (585)
                                                                       .+..++ +|++|++++|.+++ +|..+    
T Consensus       228 ~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~~-l~~~~~~~~  305 (570)
T 2z63_A          228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIER-VKDFSYNFG  305 (570)
T ss_dssp             EEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEECS-CCBCCSCCC
T ss_pred             ceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccchh-hhhhhccCC
Confidence                                                             011112 25566666655552 23222    


Q ss_pred             --------------------------------------cCCCCccEEEeeCCcccccc--chhhhCCCCCceEEccCCCC
Q 047705          131 --------------------------------------GNLTNLITIDLGGNKLNGSI--LITLSKLQKLQGLVLDDNKL  170 (585)
Q Consensus       131 --------------------------------------~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l  170 (585)
                                                            ..+++|++|++++|.+.+..  +..+.++++|++|++++|.+
T Consensus       306 L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l  385 (570)
T 2z63_A          306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV  385 (570)
T ss_dssp             CSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSE
T ss_pred             ccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcc
Confidence                                                  45678888888888888654  78899999999999999999


Q ss_pred             CccCcccccCCCCCcEEEcCCCcccccCc-ccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCccc-ccCCc
Q 047705          171 EGSIPDDICRLVELYKLELGGNKLSRSIP-ACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFS-GIIPK  245 (585)
Q Consensus       171 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~-~~~~~  245 (585)
                      ++..+. +..+++|++|++++|.+.+..+ ..|..+++|++|++++|.   ..|..+..+++|+.|++++|.++ +..|.
T Consensus       386 ~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~  464 (570)
T 2z63_A          386 ITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD  464 (570)
T ss_dssp             EEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred             cccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchh
Confidence            966555 9999999999999999997766 578999999999999997   56777899999999999999998 57889


Q ss_pred             ccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCC-CCC
Q 047705          246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSF-GNF  324 (585)
Q Consensus       246 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~-~~~  324 (585)
                      .|..+++|++|++++|++++..|..|..+++|+.|++++|++++..|..+..+++|+.|++++|+++|.||....+ .++
T Consensus       465 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl  544 (570)
T 2z63_A          465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL  544 (570)
T ss_dssp             CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHH
T ss_pred             hhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHH
Confidence            9999999999999999999998999999999999999999999988888999999999999999999999975433 211


Q ss_pred             --CccccCCCCcccCCCC
Q 047705          325 --SAESFEGNELLCGSPN  340 (585)
Q Consensus       325 --~~~~~~~n~~~c~~~~  340 (585)
                        ....+.+.+ .|..|.
T Consensus       545 ~~~~~~~~~~~-~C~~~~  561 (570)
T 2z63_A          545 NKNSQKEQGSA-KCSGSG  561 (570)
T ss_dssp             HHTGGGEESCC-BBTTTC
T ss_pred             HhccccCCCch-hhCCCC
Confidence              112334444 676653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-38  Score=318.81  Aligned_cols=168  Identities=23%  Similarity=0.405  Sum_probs=142.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++++.||+|+||+||+|++. +|+.||||+++..  .....+.+.+|++++++++|||||+++++|.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999875 7999999999754  2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+||+|.+++...+ ..+++..++.|+.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+..... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997654 35789999999999999999999   999999999999999999999999999999875321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       .......+||+.||||
T Consensus       179 -~~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          179 -VELARACIGTPYYLSP  194 (350)
T ss_dssp             -HHHHHHHHSCCTTCCH
T ss_pred             -cccccccCCCccccCH
Confidence             1123456899999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-38  Score=316.84  Aligned_cols=165  Identities=28%  Similarity=0.337  Sum_probs=149.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +.|++.+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999876 79999999998766556677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999999764  5899999999999999999999   9999999999999999999999999999999764322  23


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ....+||++||||
T Consensus       227 ~~~~~GTp~YmAP  239 (346)
T 4fih_A          227 RKSLVGTPYWMAP  239 (346)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCcCcCCH
Confidence            3567899999998

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.4e-38  Score=344.76  Aligned_cols=303  Identities=17%  Similarity=0.228  Sum_probs=201.3

Q ss_pred             cccccCCccccCCCCCCEEecCCCcCCC------------------cCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705           21 KLIGTVPVAIFNVSTLKLLGLQDNSLSG------------------SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus        21 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      ++++ +|..|+++++|++|+|++|.+++                  .++.+.+..+++|++|+|++|++...-. ..|.+
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p-~~l~~  271 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP-TFLKA  271 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC-TTTTT
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh-HHHhc
Confidence            3444 67777888888888888888876                  3333333367788888888887655322 66777


Q ss_pred             CCCCcEEEccCCC-Ccc-cCCcchhhcc------cccccEEEeecCcceecCCc--cccCCCCccEEEeeCCccccccch
Q 047705           83 CKSLTVIGLSNNP-LDG-ILPKTSIGNL------SHSLEDFQMHNCNVTGDIPE--EIGNLTNLITIDLGGNKLNGSILI  152 (585)
Q Consensus        83 l~~L~~L~Ls~N~-l~~-~~~~~~~~~~------~~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~  152 (585)
                      +++|++|+|++|+ +++ ..|. .++.+      ++ |++|++++|+++ .+|.  .++.+++|++|++++|++.+.+| 
T Consensus       272 l~~L~~L~Ls~n~~l~~~~lp~-~~~~L~~~~~l~~-L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-  347 (636)
T 4eco_A          272 LPEMQLINVACNRGISGEQLKD-DWQALADAPVGEK-IQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-  347 (636)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHH-HHHHHHHSGGGGT-CCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred             CCCCCEEECcCCCCCccccchH-HHHhhhccccCCC-CCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence            8888888888887 766 4554 44444      43 778888887777 6666  77777778888887777776666 


Q ss_pred             hhhCCCCCceEEccCCCCCccCcccccCCCC-CcEEEcCCCcccccCcccccCcc--cchhhcCCCCC---CCCccCC--
Q 047705          153 TLSKLQKLQGLVLDDNKLEGSIPDDICRLVE-LYKLELGGNKLSRSIPACFNNLI--ALRILSLGSND---PLPLEIG--  224 (585)
Q Consensus       153 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~n~---~~~~~~~--  224 (585)
                      .|..+++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..+.  +|+.|++++|.   ..|..+.  
T Consensus       348 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~  425 (636)
T 4eco_A          348 AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL  425 (636)
T ss_dssp             CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred             hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccc
Confidence            7777777777777777777 66666777777 777777777777 5666665543  67777777776   3444455  


Q ss_pred             -----CCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcC-------CCCEEeCCCCccCccCC
Q 047705          225 -----NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI-------SLKFLNLSNNNLSGAIP  292 (585)
Q Consensus       225 -----~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~  292 (585)
                           .+++|+.|++++|.++++.+..+..+++|++|+|++|+++.+.+..+....       +|+.|++++|+++ .+|
T Consensus       426 ~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp  504 (636)
T 4eco_A          426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLS  504 (636)
T ss_dssp             CSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCC
T ss_pred             ccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccC
Confidence                 556777777777777754444455667777777777777643333333222       6777777777777 455


Q ss_pred             hhhc--cCCccceEEeecCcCeeeCCCCCCCCCCCccccCCC
Q 047705          293 ASLE--KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  332 (585)
Q Consensus       293 ~~~~--~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  332 (585)
                      ..+.  .+++|+.|+|++|++++.+.....+..++.+++.+|
T Consensus       505 ~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          505 DDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             GGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSC
T ss_pred             hhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCC
Confidence            5555  667777777777777663333344555666666444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.1e-37  Score=335.96  Aligned_cols=168  Identities=20%  Similarity=0.233  Sum_probs=84.3

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+.+++|++|+|++|++++..|..|.++++|++|+|++|.+++.++. .+..+++|++|+|++|+++.++....|..
T Consensus        43 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~  121 (549)
T 2z81_A           43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-WFGPLSSLKYLNLMGNPYQTLGVTSLFPN  121 (549)
T ss_dssp             SSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-HHTTCTTCCEEECTTCCCSSSCSSCSCTT
T ss_pred             hhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-HhccCCCCcEEECCCCcccccchhhhhhc
Confidence            34555555555555555555555555555555555555555555533222 22345555555555555554432244555


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCce
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG  162 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  162 (585)
                      +++|++|++++|++.+..+...+..+++ |++|++++|.+++..|..+..+++|++|++++|.+.......+..+++|++
T Consensus       122 l~~L~~L~L~~n~~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~  200 (549)
T 2z81_A          122 LTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY  200 (549)
T ss_dssp             CTTCCEEEEEESSSCCEECTTTTTTCCE-EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSE
T ss_pred             cCCccEEECCCCccccccCHhhhhcccc-cCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccE
Confidence            5555555555555323333224445544 666666666666555555554444433333333333222222233455555


Q ss_pred             EEccCCCCCc
Q 047705          163 LVLDDNKLEG  172 (585)
Q Consensus       163 L~L~~N~l~~  172 (585)
                      |++++|++++
T Consensus       201 L~L~~n~l~~  210 (549)
T 2z81_A          201 LELRDTNLAR  210 (549)
T ss_dssp             EEEESCBCTT
T ss_pred             EEccCCcccc
Confidence            5555555543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=333.89  Aligned_cols=304  Identities=23%  Similarity=0.243  Sum_probs=235.3

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+.+++|++|+|++|++++..|..|.++++|++|+|++|+|++.+. .   .+++|++|+|++|+++.++.+..|..
T Consensus        38 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-~---~l~~L~~L~L~~N~l~~~~~p~~~~~  113 (520)
T 2z7x_B           38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC-H---PTVNLKHLDLSFNAFDALPICKEFGN  113 (520)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEEC-C---CCCCCSEEECCSSCCSSCCCCGGGGG
T ss_pred             hhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCc-c---ccCCccEEeccCCccccccchhhhcc
Confidence            3578888888888888888887778888888888888888888874333 2   57888888888888887654467888


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccc----------------------------------------------------
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSH----------------------------------------------------  110 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~----------------------------------------------------  110 (585)
                      +++|++|+|++|++++.    .+..++.                                                    
T Consensus       114 l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l  189 (520)
T 2z7x_B          114 MSQLKFLGLSTTHLEKS----SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV  189 (520)
T ss_dssp             CTTCCEEEEEESSCCGG----GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTC
T ss_pred             CCcceEEEecCcccchh----hccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcc
Confidence            88888888888877531    1222221                                                    


Q ss_pred             ----------------------------------------------------------cccEEEeecCcceecCCccc--
Q 047705          111 ----------------------------------------------------------SLEDFQMHNCNVTGDIPEEI--  130 (585)
Q Consensus       111 ----------------------------------------------------------~L~~L~l~~n~l~~~~~~~~--  130 (585)
                                                                                +|++|++++|++++.+|..+  
T Consensus       190 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~  269 (520)
T 2z7x_B          190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFD  269 (520)
T ss_dssp             SEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCC
T ss_pred             cceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhh
Confidence                                                                      24455555555554455444  


Q ss_pred             ---cCCCCccEEEeeCCccccccchh-------------------------hhCCCCCceEEccCCCCCccCcccccCCC
Q 047705          131 ---GNLTNLITIDLGGNKLNGSILIT-------------------------LSKLQKLQGLVLDDNKLEGSIPDDICRLV  182 (585)
Q Consensus       131 ---~~l~~L~~L~L~~N~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  182 (585)
                         ..+++|+.+++++|.+ ..+...                         +..+++|++|++++|++++..|..+..++
T Consensus       270 ~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  348 (520)
T 2z7x_B          270 YSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT  348 (520)
T ss_dssp             CCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCS
T ss_pred             cccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCC
Confidence               4444444444444443 111011                         16788999999999999998999999999


Q ss_pred             CCcEEEcCCCcccc--cCcccccCcccchhhcCCCCCC---CCcc-CCCCCCCcEEEccCCcccccCCcccCCCCCCcEE
Q 047705          183 ELYKLELGGNKLSR--SIPACFNNLIALRILSLGSNDP---LPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYL  256 (585)
Q Consensus       183 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~n~~---~~~~-~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  256 (585)
                      +|++|+|++|++++  ..|..+..+++|++|++++|..   +|.. +..+++|+.|++++|++++..|..+.  ++|+.|
T Consensus       349 ~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L  426 (520)
T 2z7x_B          349 ELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVL  426 (520)
T ss_dssp             SCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEE
T ss_pred             CCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEE
Confidence            99999999999996  4567899999999999999982   5554 78899999999999999988777665  799999


Q ss_pred             eecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          257 FLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       257 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ++++|+++ .+|..+..+++|+.|++++|++++..+..+..+++|++|++++|+|+|.|+..
T Consensus       427 ~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~  487 (520)
T 2z7x_B          427 DLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  487 (520)
T ss_dssp             ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred             ECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCch
Confidence            99999999 67777779999999999999999654445889999999999999999998853

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.2e-37  Score=335.23  Aligned_cols=306  Identities=20%  Similarity=0.209  Sum_probs=255.8

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+.+++|++|+|++|++++..|..|.++++|++|+|++|.|++ ++..   .+++|++|+|++|+++.++.+..|..
T Consensus        69 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~  144 (562)
T 3a79_B           69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC---PMASLRHLDLSFNDFDVLPVCKEFGN  144 (562)
T ss_dssp             GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC---CCTTCSEEECCSSCCSBCCCCGGGGG
T ss_pred             hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc---ccccCCEEECCCCCccccCchHhhcc
Confidence            4689999999999999999999999999999999999999999984 4433   68999999999999999875478999


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccc-cccEEEeecCcc--eecCCccccCCC-------------------------
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSH-SLEDFQMHNCNV--TGDIPEEIGNLT-------------------------  134 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~-~L~~L~l~~n~l--~~~~~~~~~~l~-------------------------  134 (585)
                      +++|++|+|++|+++..    .+..++. .|++|++++|.+  ++..|..|..+.                         
T Consensus       145 l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l  220 (562)
T 3a79_B          145 LTKLTFLGLSAAKFRQL----DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL  220 (562)
T ss_dssp             CTTCCEEEEECSBCCTT----TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSE
T ss_pred             cCcccEEecCCCccccC----chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhccccc
Confidence            99999999999999753    2333333 138888888877  666555555433                         


Q ss_pred             --------------------------------------------------------CccEEEeeCCccccccchhh----
Q 047705          135 --------------------------------------------------------NLITIDLGGNKLNGSILITL----  154 (585)
Q Consensus       135 --------------------------------------------------------~L~~L~L~~N~l~~~~~~~~----  154 (585)
                                                                              +|++|++++|.+.+..|..+    
T Consensus       221 ~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~  300 (562)
T 3a79_B          221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS  300 (562)
T ss_dssp             EEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCC
T ss_pred             ceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcc
Confidence                                                                    66677777777765444433    


Q ss_pred             -------------------------------------------------hCCCCCceEEccCCCCCccCcccccCCCCCc
Q 047705          155 -------------------------------------------------SKLQKLQGLVLDDNKLEGSIPDDICRLVELY  185 (585)
Q Consensus       155 -------------------------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  185 (585)
                                                                       ..+++|++|++++|++++..|..+..+++|+
T Consensus       301 ~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  380 (562)
T 3a79_B          301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ  380 (562)
T ss_dssp             SCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCC
T ss_pred             cccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCC
Confidence                                                             6788999999999999998999999999999


Q ss_pred             EEEcCCCccccc--CcccccCcccchhhcCCCCCC---CCcc-CCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeec
Q 047705          186 KLELGGNKLSRS--IPACFNNLIALRILSLGSNDP---LPLE-IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLG  259 (585)
Q Consensus       186 ~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~n~~---~~~~-~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls  259 (585)
                      +|+|++|++++.  .|..|..+++|+.|++++|..   +|.. +..+++|+.|++++|++++..|..+.  ++|+.|+|+
T Consensus       381 ~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~  458 (562)
T 3a79_B          381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLH  458 (562)
T ss_dssp             EEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECC
T ss_pred             EEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECC
Confidence            999999999963  346789999999999999982   5554 78899999999999999987776654  799999999


Q ss_pred             ccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCC
Q 047705          260 YNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG  319 (585)
Q Consensus       260 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~  319 (585)
                      +|+++ .+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+|.|.|+..+
T Consensus       459 ~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  517 (562)
T 3a79_B          459 NNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR  517 (562)
T ss_dssp             SSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred             CCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence            99999 466666699999999999999995444448999999999999999999998643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.2e-37  Score=344.35  Aligned_cols=326  Identities=17%  Similarity=0.238  Sum_probs=277.8

Q ss_pred             CCcccc--CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCc-CCC-cCCcc------ccCCCCCccEEEccCCCC
Q 047705            2 IPLEIG--NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS-LSG-SLSSI------TDVRLPNLEELVLWGNNF   71 (585)
Q Consensus         2 ~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~------~~~~l~~L~~L~L~~n~l   71 (585)
                      ||.+++  ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..      .+..+++|++|+|++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            899988  99999999999999999999999999999999999998 886 44431      234577999999999999


Q ss_pred             CCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCC-ccEEEeeCCcccccc
Q 047705           72 SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTN-LITIDLGGNKLNGSI  150 (585)
Q Consensus        72 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~  150 (585)
                      +.+|....|..+++|++|+|++|+++ .+|  .++.+++ |+.|+|++|.++ .+|..+..+++ |++|+|++|.+. .+
T Consensus       561 ~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp--~~~~L~~-L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l  634 (876)
T 4ecn_A          561 EEFPASASLQKMVKLGLLDCVHNKVR-HLE--AFGTNVK-LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI  634 (876)
T ss_dssp             CBCCCHHHHTTCTTCCEEECTTSCCC-BCC--CCCTTSE-ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred             CccCChhhhhcCCCCCEEECCCCCcc-cch--hhcCCCc-ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence            98872127999999999999999998 555  5777776 999999999999 78888999999 999999999999 66


Q ss_pred             chhhhCCCC--CceEEccCCCCCccCcccc---c--CCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCc
Q 047705          151 LITLSKLQK--LQGLVLDDNKLEGSIPDDI---C--RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPL  221 (585)
Q Consensus       151 ~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~  221 (585)
                      |..|..++.  |+.|+|++|++++.+|...   .  .+++|+.|+|++|.++..++..+..+++|+.|+|++|.  .+|.
T Consensus       635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~  714 (876)
T 4ecn_A          635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE  714 (876)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCT
T ss_pred             chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccCh
Confidence            777776654  9999999999998766322   2  34589999999999995544556689999999999998  4454


Q ss_pred             cCCC--------CCCCcEEEccCCcccccCCcccC--CCCCCcEEeecccCcccccCccccCcCCCCEEeCCC------C
Q 047705          222 EIGN--------LKVLVGIDFSMNNFSGIIPKEIG--GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN------N  285 (585)
Q Consensus       222 ~~~~--------l~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~------N  285 (585)
                      .+..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |
T Consensus       715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N  792 (876)
T 4ecn_A          715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN  792 (876)
T ss_dssp             TSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCC
T ss_pred             HHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccc
Confidence            4332        339999999999999 5777776  99999999999999998 688899999999999976      8


Q ss_pred             ccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccC
Q 047705          286 NLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  337 (585)
Q Consensus       286 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~  337 (585)
                      ++.+.+|..+..+++|+.|+|++|.+ +.+|.. ....++.+++.+|++..-
T Consensus       793 ~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~i  842 (876)
T 4ecn_A          793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNISI  842 (876)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCEE
T ss_pred             cccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCcc
Confidence            88999999999999999999999999 566654 336888899999987543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-36  Score=314.37  Aligned_cols=312  Identities=21%  Similarity=0.228  Sum_probs=267.7

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705            8 NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus         8 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      .++++++|++++|.++.+.+..|..+++|++|+|++|.|++ ++...+..+++|++|+|++|+++.++. ..|..+++|+
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~  120 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLT  120 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCH-HHhcCCCCCC
Confidence            46899999999999987766778999999999999999984 444445689999999999999999986 7899999999


Q ss_pred             EEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC
Q 047705           88 VIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD  167 (585)
Q Consensus        88 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  167 (585)
                      +|+|++|+++.+.+. .++.+++ |++|++++|.+++..+..|..+++|++|++++|++++.   .+..+++|+.|++++
T Consensus       121 ~L~L~~n~l~~l~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~  195 (390)
T 3o6n_A          121 VLVLERNDLSSLPRG-IFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSY  195 (390)
T ss_dssp             EEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCS
T ss_pred             EEECCCCccCcCCHH-HhcCCCC-CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccc
Confidence            999999999865554 5677776 99999999999999899999999999999999999965   356788999999999


Q ss_pred             CCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcc
Q 047705          168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKE  246 (585)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  246 (585)
                      |.+++.     ...++|++|++++|.+......   ..++|+.|++++|. .....+..+++|+.|++++|.+++..|..
T Consensus       196 n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~  267 (390)
T 3o6n_A          196 NLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHP  267 (390)
T ss_dssp             SCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred             cccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhH
Confidence            999843     3456899999999999865332   24789999999998 44456889999999999999999988999


Q ss_pred             cCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCc
Q 047705          247 IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSA  326 (585)
Q Consensus       247 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~  326 (585)
                      |.++++|+.|++++|++++. |..+..+++|+.|++++|+++ .+|..+..+++|++|++++|+++...  ...+..++.
T Consensus       268 ~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~  343 (390)
T 3o6n_A          268 FVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKN  343 (390)
T ss_dssp             GTTCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSE
T ss_pred             ccccccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCE
Confidence            99999999999999999864 666778899999999999998 45667888999999999999998653  456778888


Q ss_pred             cccCCCCcccCC
Q 047705          327 ESFEGNELLCGS  338 (585)
Q Consensus       327 ~~~~~n~~~c~~  338 (585)
                      +++.+|++.|+.
T Consensus       344 L~l~~N~~~~~~  355 (390)
T 3o6n_A          344 LTLSHNDWDCNS  355 (390)
T ss_dssp             EECCSSCEEHHH
T ss_pred             EEcCCCCccchh
Confidence            999999998864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.5e-38  Score=310.90  Aligned_cols=169  Identities=29%  Similarity=0.475  Sum_probs=147.5

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888999999999999999863      477899999987666667889999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          488 VLEYMPQGSLEKHLYSTN------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                      |||||++|+|.++++...            ..+++.++..++.||++||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            36899999999999999999999   899999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+|+...............||+.||||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCH
Confidence            999999876543333334456799999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=318.81  Aligned_cols=165  Identities=28%  Similarity=0.337  Sum_probs=149.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +.|++.+.||+|+||+||+|+++ +|+.||||+++.......+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999876 79999999998765556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            999999999765  5899999999999999999999   9999999999999999999999999999998764322  23


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ....+||++||||
T Consensus       304 ~~~~~GTp~YmAP  316 (423)
T 4fie_A          304 RKSLVGTPYWMAP  316 (423)
T ss_dssp             BCCCEECTTTCCH
T ss_pred             ccccccCcCcCCH
Confidence            3567899999998

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=343.19  Aligned_cols=309  Identities=23%  Similarity=0.243  Sum_probs=266.3

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      .||.   -.+++++|||++|+|++..|..|.++++|++|+|++|.+.+.++...+.++++|++|+|++|.++.++. ..|
T Consensus        18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p-~~~   93 (844)
T 3j0a_A           18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP-DAF   93 (844)
T ss_dssp             CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT-TSS
T ss_pred             CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH-hHc
Confidence            3675   568999999999999999999999999999999999976667766667789999999999999999865 889


Q ss_pred             cCCCCCcEEEccCCCCcccCCc-chhhcccccccEEEeecCcceecCC-ccccCCCCccEEEeeCCccccccchhhhCC-
Q 047705           81 SNCKSLTVIGLSNNPLDGILPK-TSIGNLSHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLNGSILITLSKL-  157 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-  157 (585)
                      ..+++|++|+|++|.+++..+. .+++++++ |++|+|++|.+++..+ ..|+++++|++|+|++|.+.+..+..|..+ 
T Consensus        94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~-L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~  172 (844)
T 3j0a_A           94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKA-LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ  172 (844)
T ss_dssp             CSCSSCCCEECTTCCCSSCCSTTCCCSSCSS-CCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred             cCCcccCEeeCcCCCCCcccccCccccccCC-CCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence            9999999999999999875443 34777876 9999999999988765 579999999999999999999888888887 


Q ss_pred             -CCCceEEccCCCCCccCcccccCCCC------CcEEEcCCCcccccCcccccC--------------------------
Q 047705          158 -QKLQGLVLDDNKLEGSIPDDICRLVE------LYKLELGGNKLSRSIPACFNN--------------------------  204 (585)
Q Consensus       158 -~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~~--------------------------  204 (585)
                       ++|+.|++++|.+++..|..+..+++      |++|++++|.+++..+..+..                          
T Consensus       173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l  252 (844)
T 3j0a_A          173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI  252 (844)
T ss_dssp             HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred             CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence             89999999999999888877776665      999999999877655543322                          


Q ss_pred             ------------cccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCc
Q 047705          205 ------------LIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD  269 (585)
Q Consensus       205 ------------l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  269 (585)
                                  .++|+.|++++|.   ..+..+..+++|+.|++++|.+++..+..|.++++|++|+|++|++++..|.
T Consensus       253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  332 (844)
T 3j0a_A          253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS  332 (844)
T ss_dssp             TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred             CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence                        2678899999987   4566788899999999999999988888999999999999999999988888


Q ss_pred             cccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeee
Q 047705          270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       270 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      .|..+++|+.|++++|++++..+..|..+++|++|++++|.+++.
T Consensus       333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i  377 (844)
T 3j0a_A          333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI  377 (844)
T ss_dssp             SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC
T ss_pred             HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc
Confidence            999999999999999999988888888999999999999998753

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.7e-36  Score=333.80  Aligned_cols=311  Identities=24%  Similarity=0.281  Sum_probs=268.3

Q ss_pred             CccccCCCCCCEEecCCCcccccCCc---------------------------------cccCCCCCCEEecCCCcCCCc
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPV---------------------------------AIFNVSTLKLLGLQDNSLSGS   49 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~---------------------------------~~~~l~~L~~L~L~~n~l~~~   49 (585)
                      |..|+.+++|++|+|++|++++..|.                                 .|..+++|++|+|++|.+++.
T Consensus       265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~  344 (680)
T 1ziw_A          265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI  344 (680)
T ss_dssp             TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred             cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence            56678888888888888877766554                                 455567777777888888754


Q ss_pred             CCccccCCCCCccEEEccCCCC--CCCccCccccCC--CCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceec
Q 047705           50 LSSITDVRLPNLEELVLWGNNF--SELNFLSSLSNC--KSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD  125 (585)
Q Consensus        50 ~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  125 (585)
                      . ...+..+++|++|+|++|.+  ..++. ..|..+  ++|++|++++|+++++.+. .+..+++ |+.|++++|.+++.
T Consensus       345 ~-~~~~~~l~~L~~L~Ls~n~~~~~~l~~-~~f~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~  420 (680)
T 1ziw_A          345 K-SNMFTGLINLKYLSLSNSFTSLRTLTN-ETFVSLAHSPLHILNLTKNKISKIESD-AFSWLGH-LEVLDLGLNEIGQE  420 (680)
T ss_dssp             C-TTTTTTCTTCCEEECTTCBSCCCEECT-TTTGGGTTSCCCEEECTTSCCCEECTT-TTTTCTT-CCEEECCSSCCEEE
T ss_pred             C-hhHhccccCCcEEECCCCchhhhhcch-hhhcccccCcCceEECCCCCCCeEChh-hhhCCCC-CCEEeCCCCcCccc
Confidence            4 44456899999999999974  44443 344433  6899999999999988776 6777776 99999999999987


Q ss_pred             CC-ccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCC--ccCcccccCCCCCcEEEcCCCcccccCcccc
Q 047705          126 IP-EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE--GSIPDDICRLVELYKLELGGNKLSRSIPACF  202 (585)
Q Consensus       126 ~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  202 (585)
                      ++ ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|++|+|++|.+++..+..|
T Consensus       421 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~  500 (680)
T 1ziw_A          421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML  500 (680)
T ss_dssp             CCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             cCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhh
Confidence            66 78999999999999999999999999999999999999999987  5678899999999999999999998888889


Q ss_pred             cCcccchhhcCCCCCCC-------C----ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          203 NNLIALRILSLGSNDPL-------P----LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       203 ~~l~~L~~L~l~~n~~~-------~----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      ..+++|++|++++|...       |    ..+..+++|+.|++++|+++.+.+..|.++++|+.|+|++|+++++.+..|
T Consensus       501 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~  580 (680)
T 1ziw_A          501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF  580 (680)
T ss_dssp             TTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             ccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHh
Confidence            99999999999999721       1    237889999999999999997777789999999999999999998888889


Q ss_pred             cCcCCCCEEeCCCCccCccCChhhc-cCCccceEEeecCcCeeeCCC
Q 047705          272 GNLISLKFLNLSNNNLSGAIPASLE-KLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      ..+++|+.|++++|++++..+..+. .+++|+.+++++|+|.|+|+.
T Consensus       581 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999999999998888887 789999999999999999986

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8e-36  Score=329.06  Aligned_cols=183  Identities=24%  Similarity=0.317  Sum_probs=142.0

Q ss_pred             CCCCceEEccCCCCCcc--Ccc-----------------------cccCCCCCcEEEcCCCcccccCc-ccccCcccchh
Q 047705          157 LQKLQGLVLDDNKLEGS--IPD-----------------------DICRLVELYKLELGGNKLSRSIP-ACFNNLIALRI  210 (585)
Q Consensus       157 l~~L~~L~L~~N~l~~~--~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~  210 (585)
                      +++|+.|++++|.+...  .+.                       .+..+++|+.+++++|......+ ..|..+++++.
T Consensus       370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~  449 (635)
T 4g8a_A          370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY  449 (635)
T ss_dssp             CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE
T ss_pred             ccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccc
Confidence            45677777777776532  222                       33445556666666555543333 35667777888


Q ss_pred             hcCCCCC---CCCccCCCCCCCcEEEccCCcc-cccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCc
Q 047705          211 LSLGSND---PLPLEIGNLKVLVGIDFSMNNF-SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN  286 (585)
Q Consensus       211 L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  286 (585)
                      ++++.|.   ..+..+..++.|+.|++++|.+ .+..|..|..+++|++|+|++|+++++.|..|.++++|++|+|++|+
T Consensus       450 l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~  529 (635)
T 4g8a_A          450 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  529 (635)
T ss_dssp             EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence            8888876   4556677888999999999874 45678889999999999999999999989999999999999999999


Q ss_pred             cCccCChhhccCCccceEEeecCcCeeeCCCCC-CC-CCCCccccCCCCcccCCC
Q 047705          287 LSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG-SF-GNFSAESFEGNELLCGSP  339 (585)
Q Consensus       287 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~-~~~~~~~~~~n~~~c~~~  339 (585)
                      |++..|..|..+++|++|||++|++++..|... .+ ..++.+++.+|||.|++.
T Consensus       530 l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          530 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            999888899999999999999999998877642 23 568888999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=306.42  Aligned_cols=167  Identities=28%  Similarity=0.503  Sum_probs=140.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .+++++.+.||+|+||+||+|++++  .||||+++..  .....+.|.+|++++++++|||||++++++.. +..|+|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4678899999999999999998643  6999998743  33456789999999999999999999998865 56899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||+||+|.+++......+++.++..|+.||++||+|||   +++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999887778999999999999999999999   899999999999999999999999999999876433333


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.||||
T Consensus       189 ~~~~~~~GT~~ymAP  203 (307)
T 3omv_A          189 QQVEQPTGSVLWMAP  203 (307)
T ss_dssp             -----CCCCTTSCCH
T ss_pred             eeecccccCCCccCH
Confidence            334567899999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=310.88  Aligned_cols=169  Identities=27%  Similarity=0.459  Sum_probs=140.2

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|.+.+.||+|+||+||+|+++      +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45777889999999999999864      478899999987666677889999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          488 VLEYMPQGSLEKHLYSTN--------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      |||||++|+|.++++...              ..+++.+++.|+.||++||+|||   +++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997642              35899999999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+|+..............+||+.||||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCH
T ss_pred             EEcccccceeccCCCcceecCcccccccccCh
Confidence            99999999976544333344567899999998

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-36  Score=340.75  Aligned_cols=300  Identities=18%  Similarity=0.252  Sum_probs=207.4

Q ss_pred             CCccccCCCCCCEEecCCCcCCC------------------cCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705           26 VPVAIFNVSTLKLLGLQDNSLSG------------------SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus        26 ~~~~~~~l~~L~~L~L~~n~l~~------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      +|..|+++++|++|+|++|.|++                  .++.+.|..+++|++|+|++|++...-. ..|..+++|+
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP-~~l~~L~~L~  518 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP-DFLYDLPELQ  518 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCC-GGGGGCSSCC
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccCh-HHHhCCCCCC
Confidence            67788888888888888888887                  3444434468888888888887654322 6788888888


Q ss_pred             EEEccCCC-Ccc-cCCcchhhccc------ccccEEEeecCcceecCCc--cccCCCCccEEEeeCCccccccchhhhCC
Q 047705           88 VIGLSNNP-LDG-ILPKTSIGNLS------HSLEDFQMHNCNVTGDIPE--EIGNLTNLITIDLGGNKLNGSILITLSKL  157 (585)
Q Consensus        88 ~L~Ls~N~-l~~-~~~~~~~~~~~------~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  157 (585)
                      +|+|++|+ +++ .+|. .++.++      ++|+.|+|++|+++ .+|.  .|..+++|++|+|++|++. .+| .|..+
T Consensus       519 ~L~Ls~N~~lsg~~iP~-~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L  594 (876)
T 4ecn_A          519 SLNIACNRGISAAQLKA-DWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTN  594 (876)
T ss_dssp             EEECTTCTTSCHHHHHH-HHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTT
T ss_pred             EEECcCCCCcccccchH-HHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCC
Confidence            88888887 776 5554 344444      23888888888888 6676  7888888888888888888 555 78888


Q ss_pred             CCCceEEccCCCCCccCcccccCCCC-CcEEEcCCCcccccCcccccCccc--chhhcCCCCCC---CC---ccCC--CC
Q 047705          158 QKLQGLVLDDNKLEGSIPDDICRLVE-LYKLELGGNKLSRSIPACFNNLIA--LRILSLGSNDP---LP---LEIG--NL  226 (585)
Q Consensus       158 ~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~l~~n~~---~~---~~~~--~l  226 (585)
                      ++|+.|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|..+..++.  |+.|++++|..   .|   ..+.  .+
T Consensus       595 ~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~  672 (876)
T 4ecn_A          595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG  672 (876)
T ss_dssp             SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCC
T ss_pred             CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccC
Confidence            88888888888888 67777888887 888888888887 56776666543  88888888762   12   1122  33


Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccC-------cCCCCEEeCCCCccCccCChhhc--c
Q 047705          227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN-------LISLKFLNLSNNNLSGAIPASLE--K  297 (585)
Q Consensus       227 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-------l~~L~~L~l~~N~l~~~~~~~~~--~  297 (585)
                      ++|+.|++++|.++.+.+..+..+++|+.|+|++|+++.+.+..+..       +++|+.|+|++|+|+ .+|..+.  .
T Consensus       673 ~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~  751 (876)
T 4ecn_A          673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATT  751 (876)
T ss_dssp             CCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTT
T ss_pred             CCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhcc
Confidence            46777777777777433333446777777777777777332223322       226777777777777 5566665  6


Q ss_pred             CCccceEEeecCcCeeeCCCCCCCCCCCccccCCCC
Q 047705          298 LSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE  333 (585)
Q Consensus       298 l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~  333 (585)
                      +++|+.|+|++|.+++.++....+..++.+++.+|+
T Consensus       752 l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~  787 (876)
T 4ecn_A          752 LPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR  787 (876)
T ss_dssp             CTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred             CCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence            777777777777777643334455566666666544

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-37  Score=299.51  Aligned_cols=166  Identities=24%  Similarity=0.412  Sum_probs=133.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3478999999999999999999875 79999999997542   2345678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||| +|+|.+++.+.. .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 vmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            99999 679999998765 7999999999999999999999   999999999999999999999999999999865322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                         ......+||+.||||
T Consensus       166 ---~~~~~~~GT~~Y~AP  180 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAP  180 (275)
T ss_dssp             ------------CTTSCH
T ss_pred             ---CccCCeeECcccCCh
Confidence               223457899999998

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.2e-36  Score=326.49  Aligned_cols=312  Identities=21%  Similarity=0.217  Sum_probs=267.9

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705            8 NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus         8 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      .+.+++.|++++|.++.+.+..|.++++|++|+|++|.|++.++ ..+..+++|++|+|++|.++.++. ..|..+++|+
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~  126 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLT  126 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCC
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCH-HHHcCCCCCC
Confidence            45889999999999987777788999999999999999985444 345689999999999999999986 7899999999


Q ss_pred             EEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC
Q 047705           88 VIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD  167 (585)
Q Consensus        88 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  167 (585)
                      +|+|++|.++++.+. .++++++ |++|+|++|.+++..|..|..+++|++|+|++|.+.+..   +..+++|+.|++++
T Consensus       127 ~L~L~~n~l~~l~~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~  201 (597)
T 3oja_B          127 VLVLERNDLSSLPRG-IFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSY  201 (597)
T ss_dssp             EEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCS
T ss_pred             EEEeeCCCCCCCCHH-HhccCCC-CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhccc
Confidence            999999999866554 5677776 999999999999999999999999999999999999653   56688999999999


Q ss_pred             CCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcc
Q 047705          168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKE  246 (585)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  246 (585)
                      |.+++.     ...++|+.|++++|.++...+..   .++|+.|+|++|. ..+..+..+++|+.|++++|.+++..|..
T Consensus       202 n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  273 (597)
T 3oja_B          202 NLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHP  273 (597)
T ss_dssp             SCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred             Cccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHH
Confidence            998843     44568999999999998654433   3689999999998 55567889999999999999999999999


Q ss_pred             cCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCc
Q 047705          247 IGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSA  326 (585)
Q Consensus       247 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~  326 (585)
                      |.++++|+.|+|++|.++++ |..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++..  ...+..+..
T Consensus       274 ~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~  349 (597)
T 3oja_B          274 FVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKN  349 (597)
T ss_dssp             GTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSE
T ss_pred             hcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCE
Confidence            99999999999999999974 666778899999999999999 56777888999999999999998653  345678888


Q ss_pred             cccCCCCcccCC
Q 047705          327 ESFEGNELLCGS  338 (585)
Q Consensus       327 ~~~~~n~~~c~~  338 (585)
                      +++.+|++.|+.
T Consensus       350 L~l~~N~~~~~~  361 (597)
T 3oja_B          350 LTLSHNDWDCNS  361 (597)
T ss_dssp             EECCSSCEEHHH
T ss_pred             EEeeCCCCCChh
Confidence            999999998864

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.6e-35  Score=301.90  Aligned_cols=305  Identities=23%  Similarity=0.334  Sum_probs=264.3

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKS   85 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   85 (585)
                      +..+++|++|++++|.++.. + .+..+++|++|+|++|.+++..+   +..+++|++|+|++|.++.++   .|..+++
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~~~---~~~~l~~  111 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITDIS---ALQNLTN  111 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCG---GGTTCTT
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccCch---HHcCCCc
Confidence            45789999999999999743 3 49999999999999999985443   558999999999999999974   5899999


Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEc
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL  165 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  165 (585)
                      |++|++++|++.++.+   +..++. |++|++++|.....++. +..+++|++|++++|.+.+..+  +..+++|++|++
T Consensus       112 L~~L~l~~n~i~~~~~---~~~l~~-L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l  184 (347)
T 4fmz_A          112 LRELYLNEDNISDISP---LANLTK-MYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL  184 (347)
T ss_dssp             CSEEECTTSCCCCCGG---GTTCTT-CCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEEC
T ss_pred             CCEEECcCCcccCchh---hccCCc-eeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEc
Confidence            9999999999986643   566666 99999999976655544 8999999999999999987655  889999999999


Q ss_pred             cCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCC-CCccCCCCCCCcEEEccCCcccccCC
Q 047705          166 DDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDP-LPLEIGNLKVLVGIDFSMNNFSGIIP  244 (585)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~-~~~~~~~l~~L~~L~ls~N~l~~~~~  244 (585)
                      ++|.+++..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.. ....+..+++|+.|++++|.+++.  
T Consensus       185 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--  258 (347)
T 4fmz_A          185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI--  258 (347)
T ss_dssp             TTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--
T ss_pred             cCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCC--
Confidence            9999996544  8899999999999999986544  88999999999999982 222388999999999999999964  


Q ss_pred             cccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCC
Q 047705          245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNF  324 (585)
Q Consensus       245 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~  324 (585)
                      ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..+..+..+++|++|++++|++++..| ...+..+
T Consensus       259 ~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L  335 (347)
T 4fmz_A          259 NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKM  335 (347)
T ss_dssp             GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTC
T ss_pred             hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhcc
Confidence            5689999999999999999975  468899999999999999999999999999999999999999998777 5667888


Q ss_pred             CccccCCCCc
Q 047705          325 SAESFEGNEL  334 (585)
Q Consensus       325 ~~~~~~~n~~  334 (585)
                      +.+++.+|++
T Consensus       336 ~~L~l~~N~i  345 (347)
T 4fmz_A          336 DSADFANQVI  345 (347)
T ss_dssp             SEESSSCC--
T ss_pred             ceeehhhhcc
Confidence            8899998875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.5e-36  Score=311.12  Aligned_cols=315  Identities=21%  Similarity=0.212  Sum_probs=268.0

Q ss_pred             CCcc-ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            2 IPLE-IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         2 ~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +|.. |+.+++|++|+|++|+++...+..|..+++|++|+|++|.+++.++ ..+..+++|++|+|++|+++.+|. ..|
T Consensus        60 l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~-~~~  137 (390)
T 3o6n_A           60 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLSSLPR-GIF  137 (390)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCT-TTT
T ss_pred             CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCH-HHhcCCCCCCEEECCCCccCcCCH-HHh
Confidence            4554 6889999999999999998888899999999999999999995544 445689999999999999999986 678


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                      ..+++|++|+|++|+++++.+. .++.++. |++|++++|.+++.   .+..+++|+.|++++|.+.+.     ...++|
T Consensus       138 ~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L  207 (390)
T 3o6n_A          138 HNTPKLTTLSMSNNNLERIEDD-TFQATTS-LQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAV  207 (390)
T ss_dssp             TTCTTCCEEECCSSCCCBCCTT-TTSSCTT-CCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSC
T ss_pred             cCCCCCcEEECCCCccCccChh-hccCCCC-CCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcc
Confidence            9999999999999999887766 5777776 99999999999875   366789999999999999853     345689


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCC
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMN  237 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N  237 (585)
                      ++|++++|.++.. |..  ..++|++|++++|.+++.  ..+..+++|+.|++++|.   ..|..+..+++|+.|++++|
T Consensus       208 ~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  282 (390)
T 3o6n_A          208 EELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  282 (390)
T ss_dssp             SEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSS
T ss_pred             eEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCC
Confidence            9999999999965 332  357899999999999864  578999999999999998   45678999999999999999


Q ss_pred             cccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          238 NFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       238 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      ++++. +..+..+++|+.|++++|++++ +|..+..+++|+.|++++|++++. +  +..+++|+.|++++|+|.|.+..
T Consensus       283 ~l~~~-~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~  357 (390)
T 3o6n_A          283 RLVAL-NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR  357 (390)
T ss_dssp             CCCEE-ECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH
T ss_pred             cCccc-CcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH
Confidence            99964 5567889999999999999995 566788899999999999999865 3  67789999999999999997654


Q ss_pred             CCCCCCCCccccCCCCcccCCC
Q 047705          318 GGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       318 ~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      . .+..+....+.+++..|..+
T Consensus       358 ~-~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          358 A-LFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             H-HTTTCCTTTBCCCCSCCCTT
T ss_pred             H-HHHHHHhhcccccCceeccc
Confidence            2 33445555667777778765

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-36  Score=298.31  Aligned_cols=161  Identities=27%  Similarity=0.390  Sum_probs=139.8

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKGLVL  489 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  489 (585)
                      ++.+.||+|+||+||+|++. +++.||+|++...  .....+.|.+|++++++++|||||+++++|.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56778999999999999876 6899999999754  23456789999999999999999999999865    35689999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeC-CCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  566 (585)
                      |||+||+|.+++.+.. .+++..+..++.||+.||+|||   +++  ||||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998754 6899999999999999999999   777  99999999999998 579999999999986422


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                          ......+||+.||||
T Consensus       185 ----~~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAP  199 (290)
T ss_dssp             ----TSBEESCSSCCCCCG
T ss_pred             ----CccCCcccCccccCH
Confidence                223457899999999

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.9e-37  Score=307.08  Aligned_cols=164  Identities=26%  Similarity=0.339  Sum_probs=141.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .+.|++.+.||+|+||+||+|+++ +|+.||||+++....     ..+|+.+++.++|||||+++++|.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888899999999999999976 799999999986432     24699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+||+|.+++++.+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+| ++||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998764 6899999999999999999999   99999999999999999887 6999999999976533221


Q ss_pred             ---cccccccccccccCC
Q 047705          571 ---MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ---~~~~~~~gt~~y~aP  585 (585)
                         ......+||+.||||
T Consensus       208 ~~~~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAP  225 (336)
T ss_dssp             ------CCCCCCGGGCCH
T ss_pred             cceecCCccccCccccCH
Confidence               122346899999998

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=6.3e-36  Score=324.33  Aligned_cols=191  Identities=21%  Similarity=0.208  Sum_probs=164.6

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +||..+.  ++|++|+|++|++++..|..|.++++|++|+|++|+|++.++ ..+..+++|++|+|++|+++.++. ..|
T Consensus        19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~-~~~   94 (549)
T 2z81_A           19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG-DAFYSLGSLEHLDLSDNHLSSLSS-SWF   94 (549)
T ss_dssp             SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCCSCCH-HHH
T ss_pred             cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh-hhccccccCCEEECCCCccCccCH-HHh
Confidence            4677654  799999999999998889999999999999999999995544 445689999999999999999985 679


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCc-ceecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN-VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                      ..+++|++|+|++|++++......++++++ |++|++++|. +....+..|..+++|++|++++|++.+..|..|..+++
T Consensus        95 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~-L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  173 (549)
T 2z81_A           95 GPLSSLKYLNLMGNPYQTLGVTSLFPNLTN-LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD  173 (549)
T ss_dssp             TTCTTCCEEECTTCCCSSSCSSCSCTTCTT-CCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred             ccCCCCcEEECCCCcccccchhhhhhccCC-ccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcccc
Confidence            999999999999999987533336778876 9999999999 55555578999999999999999999999999999999


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      |++|+++.|.+....+..+..+++|++|++++|.+++
T Consensus       174 L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~  210 (549)
T 2z81_A          174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR  210 (549)
T ss_dssp             EEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred             CceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence            9999999999984444344568888888888888875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.3e-37  Score=304.00  Aligned_cols=169  Identities=24%  Similarity=0.397  Sum_probs=145.2

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      +++++.+.||+|+||+||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|..++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667889999999999999863      46789999987542 334578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          487 LVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      +|||||++|+|.+++....               ..+++.++..++.||++||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               35889999999999999999999   89999999999999999999


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+||+|||+|+..............+||+.||||
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCH
Confidence            9999999999976544333344567899999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-37  Score=306.41  Aligned_cols=166  Identities=28%  Similarity=0.378  Sum_probs=139.1

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||+++++|.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999863    46889999997542  2233567889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||||+||+|.+++.+.. .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998764 6899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .  ......+||+.||||
T Consensus       180 ~--~~~~~~~GT~~YmAP  195 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAP  195 (304)
T ss_dssp             ---CCCCSCCCCGGGCCH
T ss_pred             C--ccccccccCcccCCH
Confidence            2  223457899999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-36  Score=299.98  Aligned_cols=169  Identities=24%  Similarity=0.425  Sum_probs=134.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--------
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--------  483 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  483 (585)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++|||||+++++|...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45899999999999999999876 78999999997543 344577899999999999999999999986543        


Q ss_pred             ----eEEEEEEccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          484 ----FKGLVLEYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       484 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                          ..|+|||||+||+|.+++.....  ..++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                47999999999999999987543  3456668899999999999999   89999999999999999999999999


Q ss_pred             ecccccccCCCCc----------cccccccccccccCC
Q 047705          558 FGIAKLLIGEDQS----------MTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~----------~~~~~~~gt~~y~aP  585 (585)
                      ||+|+........          ...+..+||+.||||
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             CCCC--------------------------CCCTTSCH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCH
Confidence            9999876432211          112456899999998

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6e-35  Score=297.74  Aligned_cols=285  Identities=27%  Similarity=0.384  Sum_probs=249.5

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC
Q 047705            5 EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK   84 (585)
Q Consensus         5 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   84 (585)
                      .++.+++|++|+|++|+++...+  +..+++|++|+|++|.+++ ++.  +..+++|++|+|++|+++.++.   +..++
T Consensus        61 ~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~l~~n~i~~~~~---~~~l~  132 (347)
T 4fmz_A           61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-ISA--LQNLTNLRELYLNEDNISDISP---LANLT  132 (347)
T ss_dssp             TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCSEEECTTSCCCCCGG---GTTCT
T ss_pred             hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-chH--HcCCCcCCEEECcCCcccCchh---hccCC
Confidence            48899999999999999985544  9999999999999999984 443  5589999999999999999863   88999


Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  164 (585)
                      +|++|++++|......+.  +..++. |++|++++|.+.+..+  +..+++|++|++++|.+.+..+  +..+++|+.|+
T Consensus       133 ~L~~L~l~~n~~~~~~~~--~~~l~~-L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  205 (347)
T 4fmz_A          133 KMYSLNLGANHNLSDLSP--LSNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT  205 (347)
T ss_dssp             TCCEEECTTCTTCCCCGG--GTTCTT-CCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             ceeEEECCCCCCcccccc--hhhCCC-CcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceee
Confidence            999999999976554443  667776 9999999999986655  8899999999999999997655  88999999999


Q ss_pred             ccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccC
Q 047705          165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGII  243 (585)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~  243 (585)
                      +++|.+++..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|. .....+..+++|+.|++++|.+++. 
T Consensus       206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-  280 (347)
T 4fmz_A          206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI-  280 (347)
T ss_dssp             CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-
T ss_pred             cccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC-
Confidence            99999996655  8899999999999999986544  8999999999999998 3335688999999999999999975 


Q ss_pred             CcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCe
Q 047705          244 PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       244 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~  312 (585)
                       ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..|  +..+++|++|++++|+++
T Consensus       281 -~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             -GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             -hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence             468899999999999999999888999999999999999999997766  889999999999999985

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.8e-35  Score=323.27  Aligned_cols=315  Identities=21%  Similarity=0.194  Sum_probs=270.2

Q ss_pred             CCc-cccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            2 IPL-EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         2 ~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +|. .|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.|++.++ ..+..+++|++|+|++|.|+.+|. ..|
T Consensus        66 lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~-~~~  143 (597)
T 3oja_B           66 LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-HVFQNVPLLTVLVLERNDLSSLPR-GIF  143 (597)
T ss_dssp             ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCT-TTT
T ss_pred             cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCH-HHHcCCCCCCEEEeeCCCCCCCCH-HHh
Confidence            344 36889999999999999999888999999999999999999996554 445689999999999999999986 778


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                      ..+++|++|+|++|.++++.|. .++.++. |++|++++|.+++..   +..+++|+.|++++|.+.+.     ...++|
T Consensus       144 ~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L  213 (597)
T 3oja_B          144 HNTPKLTTLSMSNNNLERIEDD-TFQATTS-LQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAV  213 (597)
T ss_dssp             TTCTTCCEEECCSSCCCBCCTT-TTTTCTT-CCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTC
T ss_pred             ccCCCCCEEEeeCCcCCCCChh-hhhcCCc-CcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchh
Confidence            9999999999999999988776 6777876 999999999998763   56689999999999999853     345689


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCC
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMN  237 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N  237 (585)
                      +.|++++|.++...+..   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.   ..|..+..+++|+.|+|++|
T Consensus       214 ~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  288 (597)
T 3oja_B          214 EELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN  288 (597)
T ss_dssp             SEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTS
T ss_pred             heeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCC
Confidence            99999999999554432   3689999999999986  4779999999999999998   55778999999999999999


Q ss_pred             cccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          238 NFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       238 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      .++++ |..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..   +..+++|+.|++++|+|.|.+..
T Consensus       289 ~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~  363 (597)
T 3oja_B          289 RLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR  363 (597)
T ss_dssp             CCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH
T ss_pred             CCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH
Confidence            99974 666788999999999999999 46777889999999999999998653   67788999999999999998754


Q ss_pred             CCCCCCCCccccCCCCcccCCC
Q 047705          318 GGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       318 ~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      . .+..+....+.++...|+.+
T Consensus       364 ~-~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          364 A-LFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             H-HTTTCCTTTBCCCCCCCCTT
T ss_pred             H-HHHHHhhhccccccccCCcc
Confidence            2 34455555677888888764

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.1e-34  Score=307.91  Aligned_cols=308  Identities=26%  Similarity=0.427  Sum_probs=170.7

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +| .+..+++|++|+|++|++++..+  +.++++|++|+|++|.+++..+   +..+++|++|+|++|+++.++.   +.
T Consensus        61 l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~L~~n~l~~~~~---~~  131 (466)
T 1o6v_A           61 ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNNQITDIDP---LK  131 (466)
T ss_dssp             CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG---GT
T ss_pred             Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh---hcCCCCCCEEECCCCCCCCChH---Hc
Confidence            44 36778888888888888875543  8888888888888888875444   4578888888888888888753   77


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                      .+++|++|++++|.+.++.   .++.++. |+.|+++ |.+.+..  .+..+++|++|++++|.+.+.  ..+..+++|+
T Consensus       132 ~l~~L~~L~l~~n~l~~~~---~~~~l~~-L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~  202 (466)
T 1o6v_A          132 NLTNLNRLELSSNTISDIS---ALSGLTS-LQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLE  202 (466)
T ss_dssp             TCTTCSEEEEEEEEECCCG---GGTTCTT-CSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             CCCCCCEEECCCCccCCCh---hhccCCc-ccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCC
Confidence            8888888888888876542   2333333 4444443 2222211  144455555555555554432  1244445555


Q ss_pred             eEEccCCCCCccCc--------------------ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCC
Q 047705          162 GLVLDDNKLEGSIP--------------------DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLP  220 (585)
Q Consensus       162 ~L~L~~N~l~~~~~--------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~  220 (585)
                      +|++++|.+++..|                    +.+..+++|++|++++|.+++..+  +..+++|+.|++++|. ...
T Consensus       203 ~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  280 (466)
T 1o6v_A          203 SLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI  280 (466)
T ss_dssp             EEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC
T ss_pred             EEEecCCcccccccccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc
Confidence            55555555443332                    234444455555555555543322  4445555555555554 111


Q ss_pred             ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCc
Q 047705          221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY  300 (585)
Q Consensus       221 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  300 (585)
                      ..+..+++|+.|++++|++++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++
T Consensus       281 ~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~  354 (466)
T 1o6v_A          281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTN  354 (466)
T ss_dssp             GGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             ccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCC
Confidence            114445555555555555554322  4455555555555555554433  44555555555555555543  24455555


Q ss_pred             cceEEeecCcCeeeCCCCCCCCCCCccccCCCCccc
Q 047705          301 LEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       301 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  336 (585)
                      |+.|++++|++++..| ...+..++.+++.+|++..
T Consensus       355 L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          355 INWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred             CCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence            5555555555555444 3344445555555555443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.3e-35  Score=295.90  Aligned_cols=255  Identities=33%  Similarity=0.555  Sum_probs=201.5

Q ss_pred             CCccEEEccCCCCCC---CccCccccCCCCCcEEEccC-CCCcccCCcchhhcccccccEEEeecCcceecCCccccCCC
Q 047705           59 PNLEELVLWGNNFSE---LNFLSSLSNCKSLTVIGLSN-NPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLT  134 (585)
Q Consensus        59 ~~L~~L~L~~n~l~~---~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  134 (585)
                      .++++|+|++|.++.   +|  ..|..+++|++|+|++ |.+.+..|. .+++++. |++|++++|++++.+|..|..++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~--~~l~~l~~L~~L~L~~~n~l~~~~p~-~l~~l~~-L~~L~Ls~n~l~~~~p~~~~~l~  125 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIP--SSLANLPYLNFLYIGGINNLVGPIPP-AIAKLTQ-LHYLYITHTNVSGAIPDFLSQIK  125 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECC--GGGGGCTTCSEEEEEEETTEESCCCG-GGGGCTT-CSEEEEEEECCEEECCGGGGGCT
T ss_pred             ceEEEEECCCCCccCCcccC--hhHhCCCCCCeeeCCCCCcccccCCh-hHhcCCC-CCEEECcCCeeCCcCCHHHhCCC
Confidence            467777777777764   44  5677777777777774 777666665 4566665 77777777777777777777777


Q ss_pred             CccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCC-CCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          135 NLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLV-ELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      +|++|+|++|.+.+..|..|..+++|++|+|++|++++.+|..+..++ +|++|++++|.+++..|..|           
T Consensus       126 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~-----------  194 (313)
T 1ogq_A          126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF-----------  194 (313)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGG-----------
T ss_pred             CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHH-----------
Confidence            777777777777766777777777777777777777766777777766 67777777777766555544           


Q ss_pred             CCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh
Q 047705          214 GSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA  293 (585)
Q Consensus       214 ~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  293 (585)
                                ..++ |+.|++++|.+++..|..|..+++|+.|++++|++++.+|. +..+++|+.|++++|++++.+|.
T Consensus       195 ----------~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~  262 (313)
T 1ogq_A          195 ----------ANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             ----------GGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred             ----------hCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence                      3344 78888899999988999999999999999999999977665 78889999999999999999999


Q ss_pred             hhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCC
Q 047705          294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       294 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      .+..+++|++|++++|++++.+|....+..++.+++.+|++.|+.|.
T Consensus       263 ~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             HHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence            99999999999999999999999887888899999999999999873

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.1e-34  Score=320.02  Aligned_cols=314  Identities=22%  Similarity=0.255  Sum_probs=257.0

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+|+++++|++|||++|+|+++.+.+|.++++|++|+|++|+|+ .++...|..+++|++|+|++|+|+.++. ..|..
T Consensus        69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~-~~~~~  146 (635)
T 4g8a_A           69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLEN-FPIGH  146 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTT-CCCTT
T ss_pred             HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCCh-hhhhc
Confidence            457899999999999999998888888999999999999999998 4444455678889999999999888875 67888


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccc--------------------------------
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI--------------------------------  130 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~--------------------------------  130 (585)
                      +++|++|+|++|++++...+.+++.++. |++|++++|++++..+..|                                
T Consensus       147 L~~L~~L~Ls~N~l~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~  225 (635)
T 4g8a_A          147 LKTLKELNVAHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR  225 (635)
T ss_dssp             CTTCCEEECCSSCCCCCCCCGGGGGCTT-CCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCE
T ss_pred             CcccCeeccccCccccCCCchhhccchh-hhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchh
Confidence            8888888888888876654446666665 7888777776654322111                                


Q ss_pred             --------------------------------------------------------------------------------
Q 047705          131 --------------------------------------------------------------------------------  130 (585)
Q Consensus       131 --------------------------------------------------------------------------------  130 (585)
                                                                                                      
T Consensus       226 ~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~  305 (635)
T 4g8a_A          226 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCL  305 (635)
T ss_dssp             EEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGG
T ss_pred             hhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------cCCCCccEEEeeCCcccc
Q 047705          131 --------------------------------------------------------------GNLTNLITIDLGGNKLNG  148 (585)
Q Consensus       131 --------------------------------------------------------------~~l~~L~~L~L~~N~l~~  148 (585)
                                                                                    ..+++|+.|++++|.+..
T Consensus       306 ~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~  385 (635)
T 4g8a_A          306 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF  385 (635)
T ss_dssp             TTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBE
T ss_pred             cccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccc
Confidence                                                                          124567777777777653


Q ss_pred             c--cch-----------------------hhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCcccccCcccc
Q 047705          149 S--ILI-----------------------TLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRSIPACF  202 (585)
Q Consensus       149 ~--~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~  202 (585)
                      .  .+.                       .|..+++|+.++++.|.+....+ ..|..+.+++.+++++|.+.+..+..+
T Consensus       386 ~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~  465 (635)
T 4g8a_A          386 KGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF  465 (635)
T ss_dssp             EEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred             ccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccccccccccccccccc
Confidence            2  222                       34455666666666666554433 567889999999999999999999999


Q ss_pred             cCcccchhhcCCCCC----CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCC
Q 047705          203 NNLIALRILSLGSND----PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK  278 (585)
Q Consensus       203 ~~l~~L~~L~l~~n~----~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  278 (585)
                      ..+++|+.|++++|.    ..|..+..+++|+.|+|++|+++++.|..|.++++|++|+|++|+++++.|..|..+++|+
T Consensus       466 ~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~  545 (635)
T 4g8a_A          466 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ  545 (635)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCC
T ss_pred             ccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCC
Confidence            999999999999996    4677899999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeCCCCccCccCChhhccC-CccceEEeecCcCeeeCCCCC
Q 047705          279 FLNLSNNNLSGAIPASLEKL-SYLEDLNLSFNKLEGEIPRGG  319 (585)
Q Consensus       279 ~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~~  319 (585)
                      +|+|++|+|++..|..+..+ ++|++|+|++|+|.|+|...+
T Consensus       546 ~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~  587 (635)
T 4g8a_A          546 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS  587 (635)
T ss_dssp             EEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHH
T ss_pred             EEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHH
Confidence            99999999999999999988 689999999999999998543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.3e-34  Score=290.30  Aligned_cols=285  Identities=25%  Similarity=0.281  Sum_probs=205.3

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|.|++..+ ..+..+++|++|+|++|+++.++. ..|..+++|++|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~  108 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRK-DDFKGLQHLYALVLVNNKISKIHE-KAFSPLRKLQKLY  108 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECG-GGSTTCTTCCEEE
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCH-hHhhCCCCCcEEECCCCccCccCH-hHhhCcCCCCEEE
Confidence            6888888888876 5566553  578888888888874433 334578888888888888888754 6788888888888


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccc--ccchhhhCCCCCceEEccCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG--SILITLSKLQKLQGLVLDDN  168 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N  168 (585)
                      |++|+++.+.+. ..    .+|++|++++|.+++..+..|..+++|++|++++|.++.  ..+..|..+ +|++|++++|
T Consensus       109 L~~n~l~~l~~~-~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n  182 (332)
T 2ft3_A          109 ISKNHLVEIPPN-LP----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA  182 (332)
T ss_dssp             CCSSCCCSCCSS-CC----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred             CCCCcCCccCcc-cc----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence            888888754333 21    348888888888887777778888888888888888853  566777777 8888888888


Q ss_pred             CCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCc
Q 047705          169 KLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPK  245 (585)
Q Consensus       169 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~  245 (585)
                      ++++ +|..+.  ++|++|++++|.+++..+..|..+++|+.|++++|.   ..+..+..+++|+.|++++|+++ .+|.
T Consensus       183 ~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~  258 (332)
T 2ft3_A          183 KLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA  258 (332)
T ss_dssp             BCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred             CCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence            8875 443333  678888888888887776777788888888888776   33335677777788888888777 4566


Q ss_pred             ccCCCCCCcEEeecccCcccccCccccCc------CCCCEEeCCCCccC--ccCChhhccCCccceEEeecCc
Q 047705          246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNL------ISLKFLNLSNNNLS--GAIPASLEKLSYLEDLNLSFNK  310 (585)
Q Consensus       246 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l~l~~N~  310 (585)
                      .+..+++|+.|++++|++++..+..|..+      +.|+.|++++|++.  +..|..|..+++|+.+++++|+
T Consensus       259 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             TGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             hhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            67777778888888887777666666543      56777777777776  5666677777777777777764

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.3e-33  Score=285.78  Aligned_cols=287  Identities=22%  Similarity=0.271  Sum_probs=215.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+++.++++++.++ .+|..+.  ++|++|+|++|.|++. +...+..+++|++|+|++|+++.+.. ..|..+++|++|
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L  105 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERL  105 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEE
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEe-ChhhhccCCCCCEEECCCCcCCeeCH-HHhcCCCCCCEE
Confidence            47888888888887 5566554  5888899999988844 44345578889999999998888854 778888899999


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccc--ccchhhhCCCCCceEEccC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG--SILITLSKLQKLQGLVLDD  167 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~  167 (585)
                      +|++|+++.+... .+    .+|++|++++|.+++..+..|..+++|++|++++|.+..  ..+..|.++++|++|++++
T Consensus       106 ~Ls~n~l~~l~~~-~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~  180 (330)
T 1xku_A          106 YLSKNQLKELPEK-MP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD  180 (330)
T ss_dssp             ECCSSCCSBCCSS-CC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred             ECCCCcCCccChh-hc----ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence            9999988754332 21    358888888888888877788888888888888888854  6677788888888888888


Q ss_pred             CCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCC
Q 047705          168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIP  244 (585)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~  244 (585)
                      |.++. +|..+.  ++|++|++++|.+++..+..|..+++|+.|++++|.   ..+..+..+++|+.|++++|.++ .+|
T Consensus       181 n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp  256 (330)
T 1xku_A          181 TNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP  256 (330)
T ss_dssp             SCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCC
T ss_pred             Ccccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCC
Confidence            88884 444333  788888888888887777788888888888888886   33345777778888888888887 566


Q ss_pred             cccCCCCCCcEEeecccCcccccCccccCc------CCCCEEeCCCCccCc--cCChhhccCCccceEEeecCc
Q 047705          245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNL------ISLKFLNLSNNNLSG--AIPASLEKLSYLEDLNLSFNK  310 (585)
Q Consensus       245 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~N~  310 (585)
                      ..+..+++|++|++++|+++++.+..|...      +.|+.|++++|++..  ..|..|..+.+++.+++++|+
T Consensus       257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            667777888888888888877666666433      567778888887753  555677777778888887774

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.2e-35  Score=291.52  Aligned_cols=168  Identities=27%  Similarity=0.401  Sum_probs=135.3

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----eEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  489 (585)
                      .+|.+.+.||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||++++++..++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3577889999999999999998 5889999999755332 123345666667889999999999997653    579999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-----CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      |||++|+|.++++..  .+++..+.+++.|+++||+|||+.     +.++||||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999875  588999999999999999999932     1239999999999999999999999999999876


Q ss_pred             cCCCCcc--ccccccccccccCC
Q 047705          565 IGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      .......  .....+||++||||
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCH
T ss_pred             cCCCCceeeecccccccccccCH
Confidence            5433221  22356899999998

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-33  Score=299.69  Aligned_cols=290  Identities=30%  Similarity=0.442  Sum_probs=248.8

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccC----
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFL----   77 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----   77 (585)
                      +|. ++++++|++|+|++|++++..+  +.++++|++|+|++|.+++..+   +..+++|++|+|++|.++.++..    
T Consensus        83 ~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~l~  156 (466)
T 1o6v_A           83 ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISDISALSGLT  156 (466)
T ss_dssp             CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG---GTTCTTCSEEEEEEEEECCCGGGTTCT
T ss_pred             chh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH---HcCCCCCCEEECCCCccCCChhhccCC
Confidence            444 8899999999999999986554  9999999999999999985443   45789999999999998876531    


Q ss_pred             --------------ccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeC
Q 047705           78 --------------SSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGG  143 (585)
Q Consensus        78 --------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  143 (585)
                                    ..+..+++|++|++++|.+.++.   .+..++. |++|++++|.+++..+  ++.+++|++|++++
T Consensus       157 ~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~l~~l~~-L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~  230 (466)
T 1o6v_A          157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS---VLAKLTN-LESLIATNNQISDITP--LGILTNLDELSLNG  230 (466)
T ss_dssp             TCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG---GGGGCTT-CSEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             cccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh---hhccCCC-CCEEEecCCccccccc--ccccCCCCEEECCC
Confidence                          12567788999999999987652   3566666 9999999999987765  77899999999999


Q ss_pred             CccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CCCcc
Q 047705          144 NKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PLPLE  222 (585)
Q Consensus       144 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~  222 (585)
                      |++.+.  ..+..+++|++|++++|.+++..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|. .....
T Consensus       231 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  304 (466)
T 1o6v_A          231 NQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP  304 (466)
T ss_dssp             SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG
T ss_pred             CCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh
Confidence            999874  468899999999999999997655  8899999999999999996544  8899999999999998 22233


Q ss_pred             CCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccc
Q 047705          223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLE  302 (585)
Q Consensus       223 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  302 (585)
                      +..+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+
T Consensus       305 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~  378 (466)
T 1o6v_A          305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRIT  378 (466)
T ss_dssp             GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCC
T ss_pred             hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCC
Confidence            8899999999999999998765  78999999999999999976  578999999999999999998877  88999999


Q ss_pred             eEEeecCcCeeeC
Q 047705          303 DLNLSFNKLEGEI  315 (585)
Q Consensus       303 ~l~l~~N~l~~~~  315 (585)
                      .|++++|+|++.+
T Consensus       379 ~L~l~~n~~~~~p  391 (466)
T 1o6v_A          379 QLGLNDQAWTNAP  391 (466)
T ss_dssp             EEECCCEEEECCC
T ss_pred             EEeccCCcccCCc
Confidence            9999999999743

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.2e-35  Score=296.02  Aligned_cols=179  Identities=24%  Similarity=0.387  Sum_probs=151.4

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCC-CcceeE
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRH-RNLIKV  475 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l  475 (585)
                      ++..++....++|++.+.||+|+||+||+|++.      .++.||||.++... ....+.|.+|+++|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            445566666789999999999999999999753      23679999997543 3345779999999999976 899999


Q ss_pred             EeeeecC-CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcC
Q 047705          476 ISSCSNE-EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD  539 (585)
Q Consensus       476 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~d  539 (585)
                      +++|..+ +..|+|||||++|+|.++++...               ..+++.++..++.||++||+|||   +++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9998664 57899999999999999997532               24789999999999999999999   89999999


Q ss_pred             CCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          540 LKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       540 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+|||+++++.+||+|||+|+.+............+||+.||||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            9999999999999999999999976544443444567899999998

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.1e-34  Score=288.95  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=221.1

Q ss_pred             CCCCEEecCCCcCCC--cCCccccCCCCCccEEEccC-CCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccc
Q 047705           34 STLKLLGLQDNSLSG--SLSSITDVRLPNLEELVLWG-NNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH  110 (585)
Q Consensus        34 ~~L~~L~L~~n~l~~--~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  110 (585)
                      .++++|+|++|.+++  .++. .+..+++|++|+|++ |.+..... ..|..+++|++|+|++|++++..|. .++.+++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L~L~~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~  126 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIP-PAIAKLTQLHYLYITHTNVSGAIPD-FLSQIKT  126 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCC-GGGGGCTTCSEEEEEEECCEEECCG-GGGGCTT
T ss_pred             ceEEEEECCCCCccCCcccCh-hHhCCCCCCeeeCCCCCcccccCC-hhHhcCCCCCEEECcCCeeCCcCCH-HHhCCCC
Confidence            589999999999997  5554 345799999999995 88875432 7799999999999999999988887 6778876


Q ss_pred             cccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCC-CCceEEccCCCCCccCcccccCCCCCcEEEc
Q 047705          111 SLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ-KLQGLVLDDNKLEGSIPDDICRLVELYKLEL  189 (585)
Q Consensus       111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (585)
                       |++|++++|.+++.+|..|..+++|++|+|++|++.+..|..|..++ +|++|++++|++++.+|..+..+. |++|++
T Consensus       127 -L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~L  204 (313)
T 1ogq_A          127 -LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDL  204 (313)
T ss_dssp             -CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEEC
T ss_pred             -CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEEC
Confidence             99999999999999999999999999999999999999999999998 999999999999999999999987 999999


Q ss_pred             CCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCc
Q 047705          190 GGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD  269 (585)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  269 (585)
                      ++|.+++..|..|..                     +++|+.|++++|.+++..+. +..+++|++|++++|++++.+|.
T Consensus       205 s~N~l~~~~~~~~~~---------------------l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~  262 (313)
T 1ogq_A          205 SRNMLEGDASVLFGS---------------------DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             CSSEEEECCGGGCCT---------------------TSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCG
T ss_pred             cCCcccCcCCHHHhc---------------------CCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCCh
Confidence            999999877665544                     45566667777788765555 77888999999999999988898


Q ss_pred             cccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCC
Q 047705          270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP  316 (585)
Q Consensus       270 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  316 (585)
                      .+..+++|+.|++++|++++.+|.. ..+++|+.+++++|+..|..|
T Consensus       263 ~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          263 GLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred             HHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence            8999999999999999999888875 788899999999998666544

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.6e-33  Score=282.48  Aligned_cols=273  Identities=22%  Similarity=0.204  Sum_probs=236.4

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.|++..+. .+..+++|++|+|++|+++.+|. ..+ 
T Consensus        46 lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~l~~-~~~-  120 (330)
T 1xku_A           46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-AFAPLVKLERLYLSKNQLKELPE-KMP-  120 (330)
T ss_dssp             CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-TTTTCTTCCEEECCSSCCSBCCS-SCC-
T ss_pred             cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHH-HhcCCCCCCEEECCCCcCCccCh-hhc-
Confidence            565543  6899999999999988888999999999999999999855443 34589999999999999999984 333 


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCccee--cCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTG--DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                        ++|++|++++|+++++.+. .+..++. |++|++++|.++.  ..+..|..+++|++|++++|.++.+... +.  ++
T Consensus       121 --~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~-~~--~~  193 (330)
T 1xku_A          121 --KTLQELRVHENEITKVRKS-VFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG-LP--PS  193 (330)
T ss_dssp             --TTCCEEECCSSCCCBBCHH-HHTTCTT-CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS-CC--TT
T ss_pred             --ccccEEECCCCcccccCHh-HhcCCcc-ccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcc-cc--cc
Confidence              8999999999999876655 6777876 9999999999964  7788899999999999999999965443 32  79


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCC
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMN  237 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N  237 (585)
                      |++|++++|++++..|..|..+++|++|+|++|.+++..+..|..+++|+.|++++|.  .+|..+..+++|+.|++++|
T Consensus       194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N  273 (330)
T 1xku_A          194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN  273 (330)
T ss_dssp             CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSS
T ss_pred             CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCC
Confidence            9999999999999889999999999999999999998888899999999999999998  77778999999999999999


Q ss_pred             cccccCCcccCCC------CCCcEEeecccCccc--ccCccccCcCCCCEEeCCCCc
Q 047705          238 NFSGIIPKEIGGL------KNLEYLFLGYNRLQG--LIPDSFGNLISLKFLNLSNNN  286 (585)
Q Consensus       238 ~l~~~~~~~~~~l------~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~  286 (585)
                      +++++.+..|...      +.|+.|++++|++..  +.|..|..+.+++.+++++|+
T Consensus       274 ~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            9998888888643      789999999999864  567889999999999999985

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.4e-33  Score=294.40  Aligned_cols=303  Identities=18%  Similarity=0.156  Sum_probs=235.5

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |.+++++++|++|+|++|.+++. | .+..+++|++|+|++|.|++. +   +..+++|++|+|++|+++.++    +..
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~---~~~l~~L~~L~Ls~N~l~~~~----~~~  104 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D---LSQNTNLTYLACDSNKLTNLD----VTP  104 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C---CTTCTTCSEEECCSSCCSCCC----CTT
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c---cccCCCCCEEECcCCCCceee----cCC
Confidence            45678889999999999999864 4 799999999999999999854 3   457899999999999999874    778


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCce
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG  162 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  162 (585)
                      +++|++|++++|+++++ +   ++.++. |++|++++|++++.   .++.+++|++|++++|+..+..  .+..+++|++
T Consensus       105 l~~L~~L~L~~N~l~~l-~---~~~l~~-L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKL-D---VSQNPL-LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             CTTCCEEECCSSCCSCC-C---CTTCTT-CCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCcCCEEECCCCcCCee-c---CCCCCc-CCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            99999999999999875 2   556665 99999999999874   3788899999999999654444  4778899999


Q ss_pred             EEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCccccc
Q 047705          163 LVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGI  242 (585)
Q Consensus       163 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~  242 (585)
                      |++++|+++++ |  +..+++|+.|++++|.+++.   .+..+++|+.|++++|+.....+..+++|+.|++++|++++.
T Consensus       175 L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~l~~~  248 (457)
T 3bz5_A          175 LDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTEL  248 (457)
T ss_dssp             EECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCC
T ss_pred             EECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCcCCCc
Confidence            99999999864 3  77888999999999999864   378889999999999983333388888999999999999887


Q ss_pred             CCcccCCCC-------CCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh--------hhccCCccceEEee
Q 047705          243 IPKEIGGLK-------NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA--------SLEKLSYLEDLNLS  307 (585)
Q Consensus       243 ~~~~~~~l~-------~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~~l~l~  307 (585)
                      .+..+..+.       +|+.|++++|++.+.+|  +..+++|+.|++++|...+.+|.        .+..+++|++|+++
T Consensus       249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~  326 (457)
T 3bz5_A          249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLN  326 (457)
T ss_dssp             CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred             CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECC
Confidence            655555544       45666666666655554  45677888888888876555443        24556778888888


Q ss_pred             cCcCeeeCCCCCCCCCCCccccCCCCcc
Q 047705          308 FNKLEGEIPRGGSFGNFSAESFEGNELL  335 (585)
Q Consensus       308 ~N~l~~~~~~~~~~~~~~~~~~~~n~~~  335 (585)
                      +|.+++. + ...+..++.+++.+|.+.
T Consensus       327 ~N~l~~l-~-l~~l~~L~~L~l~~N~l~  352 (457)
T 3bz5_A          327 NTELTEL-D-VSHNTKLKSLSCVNAHIQ  352 (457)
T ss_dssp             TCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred             CCccccc-c-cccCCcCcEEECCCCCCC
Confidence            8888774 3 455666777777777654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3e-33  Score=283.24  Aligned_cols=272  Identities=22%  Similarity=0.278  Sum_probs=236.6

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +|..+.  +++++|+|++|+++...|..|.++++|++|+|++|.|++..+ ..+..+++|++|+|++|+++.+|. ..+ 
T Consensus        48 ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~-~~~-  122 (332)
T 2ft3_A           48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHE-KAFSPLRKLQKLYISKNHLVEIPP-NLP-  122 (332)
T ss_dssp             CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECG-GGSTTCTTCCEEECCSSCCCSCCS-SCC-
T ss_pred             cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCH-hHhhCcCCCCEEECCCCcCCccCc-ccc-
Confidence            566553  799999999999998888999999999999999999985544 445689999999999999999985 333 


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcce--ecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT--GDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                        ++|++|++++|+++++.+. .+..+++ |++|++++|.++  +..+..|..+ +|++|++++|+++++.. .+.  ++
T Consensus       123 --~~L~~L~l~~n~i~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~-~~~--~~  194 (332)
T 2ft3_A          123 --SSLVELRIHDNRIRKVPKG-VFSGLRN-MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPK-DLP--ET  194 (332)
T ss_dssp             --TTCCEEECCSSCCCCCCSG-GGSSCSS-CCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCS-SSC--SS
T ss_pred             --ccCCEEECCCCccCccCHh-HhCCCcc-CCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCc-ccc--CC
Confidence              8999999999999876655 6777876 999999999996  4778888888 99999999999997544 332  79


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCC
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMN  237 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N  237 (585)
                      |++|++++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|.  .+|..+..+++|+.|++++|
T Consensus       195 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N  274 (332)
T 2ft3_A          195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTN  274 (332)
T ss_dssp             CSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSS
T ss_pred             CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCC
Confidence            9999999999999888999999999999999999998888899999999999999998  77778999999999999999


Q ss_pred             cccccCCcccCCC------CCCcEEeecccCcc--cccCccccCcCCCCEEeCCCCc
Q 047705          238 NFSGIIPKEIGGL------KNLEYLFLGYNRLQ--GLIPDSFGNLISLKFLNLSNNN  286 (585)
Q Consensus       238 ~l~~~~~~~~~~l------~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~  286 (585)
                      ++++..+..|...      +.|+.|++++|+++  ++.|.+|..+++|+.+++++|+
T Consensus       275 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          275 NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             CCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            9998888877653      67999999999987  6778899999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-34  Score=293.94  Aligned_cols=167  Identities=31%  Similarity=0.399  Sum_probs=142.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeec------CCe
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  484 (585)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999875 79999999997542  3345678899999999999999999998754      357


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 68999997654 7999999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCC--CccccccccccccccCC
Q 047705          565 IGED--QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~--~~~~~~~~~gt~~y~aP  585 (585)
                      ....  ........+||++||||
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAP  231 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCH
T ss_pred             ccCccccccccccceeChHhcCH
Confidence            4321  12233567999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.4e-34  Score=304.71  Aligned_cols=165  Identities=26%  Similarity=0.382  Sum_probs=142.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHH---HHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDV---ECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++++..   ........+   ++.+++.++|||||+++++|.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999876 79999999997542   112223333   45667778999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+|||||+||+|.+++.+.. .+++..++.|+.||+.||+|||   +++||||||||+|||++.+|++||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998764 6899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..    .....+||+.||||
T Consensus       344 ~~----~~~t~~GTp~YmAP  359 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAP  359 (689)
T ss_dssp             SC----CCCSCCSCGGGCCH
T ss_pred             CC----CCCCccCCcCccCH
Confidence            22    22457899999998

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.9e-32  Score=287.26  Aligned_cols=279  Identities=21%  Similarity=0.236  Sum_probs=233.8

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +| .|+.+++|++|+|++|++++. |  ++.+++|++|+|++|.|++. +   +..+++|++|+|++|+++.++    +.
T Consensus        57 ~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~---~~~l~~L~~L~L~~N~l~~l~----~~  124 (457)
T 3bz5_A           57 MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D---VTPLTKLTYLNCDTNKLTKLD----VS  124 (457)
T ss_dssp             CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C---CTTCTTCCEEECCSSCCSCCC----CT
T ss_pred             Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e---cCCCCcCCEEECCCCcCCeec----CC
Confidence            55 689999999999999999865 3  99999999999999999864 3   558999999999999999975    78


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  161 (585)
                      .+++|++|++++|+++++ +   ++.++. |++|++++|+..+.+  .+..+++|++|++++|+++++ +  +..+++|+
T Consensus       125 ~l~~L~~L~l~~N~l~~l-~---l~~l~~-L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~  194 (457)
T 3bz5_A          125 QNPLLTYLNCARNTLTEI-D---VSHNTQ-LTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLN  194 (457)
T ss_dssp             TCTTCCEEECTTSCCSCC-C---CTTCTT-CCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCC
T ss_pred             CCCcCCEEECCCCcccee-c---cccCCc-CCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCC
Confidence            899999999999999876 2   556665 999999999665555  488999999999999999975 3  88999999


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEc-------
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDF-------  234 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~l-------  234 (585)
                      .|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|+.|++++|......+..+++|+.|++       
T Consensus       195 ~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~  268 (457)
T 3bz5_A          195 RLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLE  268 (457)
T ss_dssp             EEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSC
T ss_pred             EEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCE
Confidence            999999999976   48899999999999999997 45  889999999999999844334556666655554       


Q ss_pred             ---cCCcccccCCcccCCCCCCcEEeecccCcccccCc--------cccCcCCCCEEeCCCCccCccCChhhccCCccce
Q 047705          235 ---SMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPD--------SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED  303 (585)
Q Consensus       235 ---s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  303 (585)
                         ++|.+.+.+|  +..+++|+.|++++|+..+.+|.        .++.+++|+.|++++|++++. +  +..+++|+.
T Consensus       269 L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~  343 (457)
T 3bz5_A          269 IDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKS  343 (457)
T ss_dssp             CCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSE
T ss_pred             EECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcE
Confidence               4454444443  56789999999999987665553        356678999999999999985 3  889999999


Q ss_pred             EEeecCcCee
Q 047705          304 LNLSFNKLEG  313 (585)
Q Consensus       304 l~l~~N~l~~  313 (585)
                      |++++|.+++
T Consensus       344 L~l~~N~l~~  353 (457)
T 3bz5_A          344 LSCVNAHIQD  353 (457)
T ss_dssp             EECCSSCCCB
T ss_pred             EECCCCCCCC
Confidence            9999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-33  Score=284.65  Aligned_cols=146  Identities=23%  Similarity=0.311  Sum_probs=130.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC----CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ...+.|++.+.||+|+||+||+|+.+    +++.||+|++....  ...++.+|+++++.+ +||||++++++|.+++..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45578999999999999999999753    46789999986543  235678899999998 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeecccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAKLL  564 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~~~  564 (585)
                      |+|||||+||+|.+++.    .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    4789999999999999999999   9999999999999999866 89999999999865


Q ss_pred             c
Q 047705          565 I  565 (585)
Q Consensus       565 ~  565 (585)
                      .
T Consensus       169 ~  169 (361)
T 4f9c_A          169 H  169 (361)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-33  Score=299.98  Aligned_cols=167  Identities=22%  Similarity=0.336  Sum_probs=150.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999876 7999999999876656667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC--CCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.  .+.+||+|||+|+.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            9999999999876667999999999999999999999   999999999999999985  489999999999976432  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       ......+||+.||||
T Consensus       311 -~~~~~~~GT~~y~AP  325 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAP  325 (573)
T ss_dssp             -SEEEEECSSGGGCCH
T ss_pred             -CceeeeEECccccCH
Confidence             223456899999998

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.98  E-value=1.4e-31  Score=282.74  Aligned_cols=252  Identities=26%  Similarity=0.297  Sum_probs=185.0

Q ss_pred             ccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEE
Q 047705           61 LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITID  140 (585)
Q Consensus        61 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  140 (585)
                      ...++.+++.++.+|.  .+  .++|++|+|++|+|+++.+. .+.+++. |++|+|++|++++..+..|.++++|++|+
T Consensus        56 ~~~v~c~~~~l~~iP~--~~--~~~l~~L~L~~n~i~~~~~~-~~~~l~~-L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  129 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQ--GI--PSNTRYLNLMENNIQMIQAD-TFRHLHH-LEVLQLGRNSIRQIEVGAFNGLASLNTLE  129 (452)
T ss_dssp             SCEEECCSSCCSSCCS--CC--CTTCSEEECCSSCCCEECTT-TTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CcEEEECCCCcCccCC--CC--CCCccEEECcCCcCceECHH-HcCCCCC-CCEEECCCCccCCcChhhccCcccCCEEE
Confidence            3455555556655552  12  14556666666666555444 4455554 66666666666666666666666777777


Q ss_pred             eeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC-CcccccCcccccCcccchhhcCCCCC-C
Q 047705          141 LGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG-NKLSRSIPACFNNLIALRILSLGSND-P  218 (585)
Q Consensus       141 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~n~-~  218 (585)
                      |++|+++++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|++++ |.+....+..|..+++|++|++++|. .
T Consensus       130 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~  209 (452)
T 3zyi_A          130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK  209 (452)
T ss_dssp             CCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence            777776666666666667777777777776666566666667777777766 44444444456666777777777766 2


Q ss_pred             CCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccC
Q 047705          219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL  298 (585)
Q Consensus       219 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  298 (585)
                      ....+..+++|+.|++++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..+
T Consensus       210 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          210 DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             SCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             ccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence            22357788899999999999999999999999999999999999999999999999999999999999998888888999


Q ss_pred             CccceEEeecCcCeeeCCCC
Q 047705          299 SYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       299 ~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ++|+.|+|++|+|.|+|...
T Consensus       290 ~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             TTCCEEECCSSCEECSTTTH
T ss_pred             cCCCEEEccCCCcCCCCCch
Confidence            99999999999999999754

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.98  E-value=1.7e-31  Score=281.03  Aligned_cols=252  Identities=26%  Similarity=0.275  Sum_probs=169.7

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      .+.++.+++.++..+...    .+++++|+|++|+|+.++. ..|..+++|++|+|++|+|+                  
T Consensus        45 ~~~v~c~~~~l~~iP~~~----~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~------------------  101 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGI----STNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIR------------------  101 (440)
T ss_dssp             SCEEECCSCCCSSCCSCC----CTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCC------------------
T ss_pred             CCEEEeCCCCcCcCCCCC----CCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCC------------------
Confidence            345555555554222211    2445555555555555543 44555555555555555554                  


Q ss_pred             EeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC-Ccc
Q 047705          116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG-NKL  194 (585)
Q Consensus       116 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l  194 (585)
                              +..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++ |.+
T Consensus       102 --------~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l  173 (440)
T 3zyj_A          102 --------TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL  173 (440)
T ss_dssp             --------EECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTC
T ss_pred             --------ccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCc
Confidence                    44444455555555555555555555555555555555555555555554445555555555555555 333


Q ss_pred             cccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccC
Q 047705          195 SRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN  273 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  273 (585)
                      ....+..|..+++|++|++++|. ...+.+..+++|+.|++++|.+++..|..|.++++|+.|+|++|+++++.+..|..
T Consensus       174 ~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  253 (440)
T 3zyj_A          174 SYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN  253 (440)
T ss_dssp             CEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred             ceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence            33333345555555555555554 11124677889999999999999999999999999999999999999999999999


Q ss_pred             cCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          274 LISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       274 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      +++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|+|...
T Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~  298 (440)
T 3zyj_A          254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDIL  298 (440)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred             CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCch
Confidence            999999999999999888888999999999999999999999754

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=4.3e-32  Score=271.55  Aligned_cols=275  Identities=19%  Similarity=0.191  Sum_probs=200.7

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccC--CcchhhcccccccE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGIL--PKTSIGNLSHSLED  114 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~~~~~L~~  114 (585)
                      +.++.+++.++..+. ..   .++|++|+|++|+++.+|. ..|..+++|++|+|++|+++...  +. .+..++. |++
T Consensus        10 ~~l~c~~~~l~~ip~-~~---~~~l~~L~L~~n~l~~i~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~~~-L~~   82 (306)
T 2z66_A           10 TEIRCNSKGLTSVPT-GI---PSSATRLELESNKLQSLPH-GVFDKLTQLTKLSLSSNGLSFKGCCSQ-SDFGTTS-LKY   82 (306)
T ss_dssp             TEEECCSSCCSSCCS-CC---CTTCCEEECCSSCCCCCCT-TTTTTCTTCSEEECCSSCCCEEEEEEH-HHHSCSC-CCE
T ss_pred             CEEEcCCCCcccCCC-CC---CCCCCEEECCCCccCccCH-hHhhccccCCEEECCCCccCcccCccc-ccccccc-cCE
Confidence            467777777773333 22   3578888888888887775 66778888888888888876432  22 2333443 777


Q ss_pred             EEeecCcceecCCccccCCCCccEEEeeCCccccccc-hhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCc
Q 047705          115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNK  193 (585)
Q Consensus       115 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  193 (585)
                      |++++|.++. +|..+..+++|++|++++|++.+..+ ..|..+++|++|++++|.+++..+..+..+++|++|++++|.
T Consensus        83 L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  161 (306)
T 2z66_A           83 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS  161 (306)
T ss_dssp             EECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred             EECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence            7777777664 44457777888888888888876655 567777888888888888877777777777888888888887


Q ss_pred             ccc-cCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCcccc
Q 047705          194 LSR-SIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFG  272 (585)
Q Consensus       194 l~~-~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  272 (585)
                      +++ ..|.                     .+..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..+..+.
T Consensus       162 l~~~~~~~---------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          162 FQENFLPD---------------------IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             EGGGEECS---------------------CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             cccccchh---------------------HHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence            764 2333                     455666777788888888888888888899999999999999887777888


Q ss_pred             CcCCCCEEeCCCCccCccCChhhccCC-ccceEEeecCcCeeeCCCCCC---CCCCCccccCCCCcccCCCC
Q 047705          273 NLISLKFLNLSNNNLSGAIPASLEKLS-YLEDLNLSFNKLEGEIPRGGS---FGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       273 ~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~~~~---~~~~~~~~~~~n~~~c~~~~  340 (585)
                      .+++|+.|++++|++++..|..+..++ +|++|++++|+|+|.|+..+.   ...........+...|..|.
T Consensus       221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            889999999999999988888888884 899999999999988764321   12223344455667777664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=279.39  Aligned_cols=277  Identities=18%  Similarity=0.183  Sum_probs=163.6

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEcc
Q 047705           13 EELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLS   92 (585)
Q Consensus        13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls   92 (585)
                      ...++++|.++ .+|..+.  ++|++|+|++|.|++ ++...+..+++|++|+|++|+++.++. ..|..+++|++|+|+
T Consensus        34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLS  108 (353)
T ss_dssp             SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECC
T ss_pred             eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCH-hhcCCCCCCCEEECC
Confidence            34555555555 3444333  256666666666553 222223355566666666666655543 445555666666666


Q ss_pred             CCCCcccCCcchhhcccccccEEEeecCcceecCC-ccccCCCCccEEEeeCC-ccccccchhhhCCCCCceEEccCCCC
Q 047705           93 NNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGN-KLNGSILITLSKLQKLQGLVLDDNKL  170 (585)
Q Consensus        93 ~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (585)
                      +|+++++.+. .++.+++ |++|++++|.+++..+ ..|..+++|++|++++| .+.++.+..|.++++|++|++++|++
T Consensus       109 ~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          109 YNYLSNLSSS-WFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             SSCCSSCCHH-HHTTCTT-CSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCcCCcCCHh-HhCCCcc-CCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            6665543222 3444443 5555555555554333 34555555555555555 24444444555555555555555555


Q ss_pred             CccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccC--
Q 047705          171 EGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG--  248 (585)
Q Consensus       171 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~--  248 (585)
                      ++..|..+..+++|++|++++|.++...+..                     +..+++|+.|++++|.+++..+..+.  
T Consensus       187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~---------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~~  245 (353)
T 2z80_A          187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIF---------------------VDVTSSVECLELRDTDLDTFHFSELSTG  245 (353)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSCSTTHHHHH---------------------HHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred             CccCHHHHhccccCCeecCCCCccccchhhh---------------------hhhcccccEEECCCCccccccccccccc
Confidence            5555555555555555555555554222222                     22355666777777777765444332  


Q ss_pred             -CCCCCcEEeecccCccc----ccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          249 -GLKNLEYLFLGYNRLQG----LIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       249 -~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                       ....++.+++++|.+++    .+|..+..+++|+.|++++|+++...+..+..+++|++|++++|+|.|.||.
T Consensus       246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence             35667888888888776    3577788999999999999999955444568999999999999999999874

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.97  E-value=2.8e-31  Score=279.54  Aligned_cols=291  Identities=27%  Similarity=0.297  Sum_probs=213.2

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCC-------------CEEecCCCcCCCcCCccccCCCCCccEEEcc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTL-------------KLLGLQDNSLSGSLSSITDVRLPNLEELVLW   67 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~   67 (585)
                      +||++|+++++|++|++++|++++..|..++++++|             ++|++++|.+++.+. .    .++|++|+++
T Consensus        25 ~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~-~----~~~L~~L~l~   99 (454)
T 1jl5_A           25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE-L----PPHLESLVAS   99 (454)
T ss_dssp             ---------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS-C----CTTCSEEECC
T ss_pred             hCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC-C----cCCCCEEEcc
Confidence            479999999999999999999999999999988865             999999999985433 2    4789999999


Q ss_pred             CCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccc
Q 047705           68 GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLN  147 (585)
Q Consensus        68 ~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  147 (585)
                      +|+++.+|.     .+++|++|++++|+++++.      ..+.+|++|++++|++++ +| .|+.+++|++|++++|+++
T Consensus       100 ~n~l~~lp~-----~~~~L~~L~l~~n~l~~l~------~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~  166 (454)
T 1jl5_A          100 CNSLTELPE-----LPQSLKSLLVDNNNLKALS------DLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK  166 (454)
T ss_dssp             SSCCSSCCC-----CCTTCCEEECCSSCCSCCC------SCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred             CCcCCcccc-----ccCCCcEEECCCCccCccc------CCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc
Confidence            999999873     2488999999999997542      223459999999999986 56 5999999999999999998


Q ss_pred             cccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCC
Q 047705          148 GSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGN  225 (585)
Q Consensus       148 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~  225 (585)
                      ++ |..   .++|++|++++|++++ +| .+..+++|++|++++|.+++ +|...   ++|+.|++++|.  .+| .+..
T Consensus       167 ~l-p~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~lp-~~~~  235 (454)
T 1jl5_A          167 KL-PDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEELP-ELQN  235 (454)
T ss_dssp             CC-CCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSSCC-CCTT
T ss_pred             cc-CCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCCccc-ccCC
Confidence            63 332   3589999999999986 45 58889999999999999985 44432   588888999887  444 4788


Q ss_pred             CCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEE
Q 047705          226 LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN  305 (585)
Q Consensus       226 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~  305 (585)
                      +++|+.|++++|++++. |..   +++|+.|++++|++++ +|..   .++|+.|++++|++++. |..   .++|+.|+
T Consensus       236 l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~  303 (454)
T 1jl5_A          236 LPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLN  303 (454)
T ss_dssp             CTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEE
T ss_pred             CCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEE
Confidence            88899999999988863 432   3778888888888886 3443   36788888888888763 211   14677777


Q ss_pred             eecCcCeeeCCCCCCCCCCCccccCCCCcc
Q 047705          306 LSFNKLEGEIPRGGSFGNFSAESFEGNELL  335 (585)
Q Consensus       306 l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~  335 (585)
                      +++|.+++.+..   ...++.+++.+|...
T Consensus       304 l~~N~l~~i~~~---~~~L~~L~Ls~N~l~  330 (454)
T 1jl5_A          304 ASSNEIRSLCDL---PPSLEELNVSNNKLI  330 (454)
T ss_dssp             CCSSCCSEECCC---CTTCCEEECCSSCCS
T ss_pred             CcCCcCCcccCC---cCcCCEEECCCCccc
Confidence            777777654321   134555666666543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=4.3e-32  Score=283.27  Aligned_cols=177  Identities=23%  Similarity=0.318  Sum_probs=154.1

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeee
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCS  480 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  480 (585)
                      .+.++....++|++.+.||+|+||+||+|+++ +++.||+|+++...   ......+.+|+.+++.++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34566667789999999999999999999976 57899999997642   223345888999999999999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      +++..|+|||||+||+|.+++......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999999886567999999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+...... .......+||+.||||
T Consensus       222 a~~~~~~~-~~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          222 CLKLMEDG-TVQSSVAVGTPDYISP  245 (437)
T ss_dssp             CEECCTTS-CEECCSCCSCGGGCCH
T ss_pred             hhhcccCC-CcccccccCCcCeeCh
Confidence            98654322 2233456899999998

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=271.76  Aligned_cols=269  Identities=20%  Similarity=0.187  Sum_probs=223.7

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +||..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.|++..+ ..+..+++|++|+|++|+++.++. ..|
T Consensus        45 ~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~-~~~  120 (353)
T 2z80_A           45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSS-SWF  120 (353)
T ss_dssp             SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCH-HHH
T ss_pred             ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCH-hHh
Confidence            3676554  599999999999998878899999999999999999985444 345589999999999999999985 669


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecC-cceecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC-NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                      ..+++|++|+|++|+++++.+...+..+++ |++|++++| .+++..+..|..+++|++|++++|.+.+..+..|..+++
T Consensus       121 ~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~  199 (353)
T 2z80_A          121 KPLSSLTFLNLLGNPYKTLGETSLFSHLTK-LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN  199 (353)
T ss_dssp             TTCTTCSEEECTTCCCSSSCSSCSCTTCTT-CCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred             CCCccCCEEECCCCCCcccCchhhhccCCC-CcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcccc
Confidence            999999999999999987655246777776 999999999 588888889999999999999999999998999999999


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcc
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNF  239 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l  239 (585)
                      |++|++++|+++...+..+..+++|++|++++|.+++..+..+..                  ......++.+++++|.+
T Consensus       200 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------------~~~~~~l~~l~L~~~~l  261 (353)
T 2z80_A          200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------------GETNSLIKKFTFRNVKI  261 (353)
T ss_dssp             EEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------------------------CCCCCCEEEEESCBC
T ss_pred             CCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc------------------ccccchhhccccccccc
Confidence            999999999998655555667899999999999998755443322                  12234566677777776


Q ss_pred             cc----cCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC
Q 047705          240 SG----IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP  292 (585)
Q Consensus       240 ~~----~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  292 (585)
                      ++    .+|..+..+++|+.|++++|+++.+.+..|..+++|+.|++++|++++..|
T Consensus       262 ~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          262 TDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            65    356778899999999999999996544557899999999999999997654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=3.7e-31  Score=261.92  Aligned_cols=252  Identities=22%  Similarity=0.184  Sum_probs=182.3

Q ss_pred             cEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEe
Q 047705           62 EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDL  141 (585)
Q Consensus        62 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  141 (585)
                      ++++.+++.++.+|. .   -.++|++|+|++|+++++.+. .++.++. |++|++++|.+++..+..|..+++|++|++
T Consensus        14 ~~~~c~~~~l~~ip~-~---~~~~l~~L~l~~n~i~~~~~~-~~~~~~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l   87 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPV-G---IPAASQRIFLHGNRISHVPAA-SFRACRN-LTILWLHSNVLARIDAAAFTGLALLEQLDL   87 (285)
T ss_dssp             CEEECCSSCCSSCCT-T---CCTTCSEEECTTSCCCEECTT-TTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             eEEEcCcCCcccCCc-C---CCCCceEEEeeCCcCCccCHH-HcccCCC-CCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence            577788888887763 2   246777777777777765544 4455554 666666666666666666666666666666


Q ss_pred             eCCc-cccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCC
Q 047705          142 GGNK-LNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP  220 (585)
Q Consensus       142 ~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~  220 (585)
                      ++|. +....+..|.++++|++|++++|++++..|..+..+++|++|++++|.+++..+.                    
T Consensus        88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------------------  147 (285)
T 1ozn_A           88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD--------------------  147 (285)
T ss_dssp             CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT--------------------
T ss_pred             CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh--------------------
Confidence            6665 5555556666666666666666666655555666666666666666666543332                    


Q ss_pred             ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCc
Q 047705          221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY  300 (585)
Q Consensus       221 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  300 (585)
                       .+..+++|+.|++++|.+++..+..|.++++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..+++
T Consensus       148 -~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          148 -TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             -TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             -HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence             3556677888888888888877778999999999999999999888999999999999999999999877778899999


Q ss_pred             cceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCC
Q 047705          301 LEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       301 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      |++|++++|+|.|.|+..+.+..+.......+.+.|..|.
T Consensus       227 L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             CCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred             cCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence            9999999999999888654444455555566777787664

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=7.4e-31  Score=262.55  Aligned_cols=278  Identities=25%  Similarity=0.270  Sum_probs=225.8

Q ss_pred             CCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCcc-CccccCCCCCcEEE
Q 047705           12 LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNF-LSSLSNCKSLTVIG   90 (585)
Q Consensus        12 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~l~~L~~L~   90 (585)
                      -+.++.+++.++ .+|..+.  ++|++|+|++|.|+ .++...+..+++|++|+|++|+++.++. ...+..+++|++|+
T Consensus         9 ~~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CCEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            367899999987 5666554  58999999999998 5555555689999999999999987631 14566789999999


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCC-ccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      |++|.+..+.+  .+..+++ |++|++++|.+++..+ ..+..+++|++|++++|.+.+..+..|.++++|++|++++|.
T Consensus        85 Ls~n~i~~l~~--~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  161 (306)
T 2z66_A           85 LSFNGVITMSS--NFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS  161 (306)
T ss_dssp             CCSCSEEEEEE--EEETCTT-CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred             CCCCccccChh--hcCCCCC-CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence            99999986433  3556665 9999999999997766 679999999999999999998889999999999999999999


Q ss_pred             CCc-cCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccC
Q 047705          170 LEG-SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG  248 (585)
Q Consensus       170 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  248 (585)
                      +++ ..|..+..+++|++|++++|.+++..|..|.                     .+++|+.|++++|.+++..+..|.
T Consensus       162 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---------------------~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          162 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN---------------------SLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT---------------------TCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             cccccchhHHhhCcCCCEEECCCCCcCCcCHHHhc---------------------CCCCCCEEECCCCccCccChhhcc
Confidence            986 5788899999999999999999876665444                     455667777788888877777888


Q ss_pred             CCCCCcEEeecccCcccccCccccCcC-CCCEEeCCCCccCccCCh-h-hccCCccceEEeecCcCeeeCCC
Q 047705          249 GLKNLEYLFLGYNRLQGLIPDSFGNLI-SLKFLNLSNNNLSGAIPA-S-LEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       249 ~l~~L~~L~ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~-~-~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      .+++|+.|++++|++++..|..+..++ +|+.|++++|+++..-+. . ...+...+.+.+..+.+.|..|.
T Consensus       221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            899999999999999988888888884 899999999999864321 1 22344455666778888888775

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.97  E-value=8.7e-30  Score=268.12  Aligned_cols=264  Identities=31%  Similarity=0.355  Sum_probs=127.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      ++|++|+|++|++++ +| .|+++++|++|++++|++++ ++..    .++|++|++++|+++.+|   .+..+++|++|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~l~---~~~~l~~L~~L  200 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEELP---ELQNLPFLTAI  200 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSSCC---CCTTCTTCCEE
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCcCc---cccCCCCCCEE
Confidence            345555555555543 33 35555555555555555553 2211    235555555555555543   25555555555


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      ++++|+++++..      .+.+|++|++++|.++ .+| .+..+++|++|++++|+++++..    ..++|++|++++|+
T Consensus       201 ~l~~N~l~~l~~------~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~N~  268 (454)
T 1jl5_A          201 YADNNSLKKLPD------LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD----LPPSLEALNVRDNY  268 (454)
T ss_dssp             ECCSSCCSSCCC------CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS----CCTTCCEEECCSSC
T ss_pred             ECCCCcCCcCCC------CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc----cccccCEEECCCCc
Confidence            555555553211      1123555555555555 333 25555555666665555554221    12455555666555


Q ss_pred             CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCC-CCCcEEEccCCcccccCCcccC
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL-KVLVGIDFSMNNFSGIIPKEIG  248 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~  248 (585)
                      +++ +|..   .++|++|++++|.+++. |..   .++|+.|++++|....  +..+ ++|+.|++++|++++ +|..  
T Consensus       269 l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~--i~~~~~~L~~L~Ls~N~l~~-lp~~--  335 (454)
T 1jl5_A          269 LTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS--LCDLPPSLEELNVSNNKLIE-LPAL--  335 (454)
T ss_dssp             CSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE--ECCCCTTCCEEECCSSCCSC-CCCC--
T ss_pred             ccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc--ccCCcCcCCEEECCCCcccc-cccc--
Confidence            553 2221   24555666666665542 111   1455666666654221  1122 366666666666664 3332  


Q ss_pred             CCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCc--cCChhhccC-------------CccceEEeecCcCee
Q 047705          249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG--AIPASLEKL-------------SYLEDLNLSFNKLEG  313 (585)
Q Consensus       249 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l-------------~~L~~l~l~~N~l~~  313 (585)
                       +++|+.|++++|++++ +|.   .+++|++|++++|++++  .+|..+..+             ++|+.||+++|++++
T Consensus       336 -~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          336 -PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             -CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred             -CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence             3566666666666664 343   34666666666666666  455565555             566666666666665

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1.5e-29  Score=267.26  Aligned_cols=245  Identities=23%  Similarity=0.214  Sum_probs=153.6

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      .+.++.+++.++..+...    .++|++|+|++|+|+.++. ..|..+++|++|+|++|+|+++.+. .+.++++ |++|
T Consensus        56 ~~~v~c~~~~l~~iP~~~----~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~-L~~L  128 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQGI----PSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVG-AFNGLAS-LNTL  128 (452)
T ss_dssp             SCEEECCSSCCSSCCSCC----CTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEE
T ss_pred             CcEEEECCCCcCccCCCC----CCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChh-hccCccc-CCEE
Confidence            344555555554222211    2455555555555555543 4455555555555555555544443 3444443 5555


Q ss_pred             EeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC-CCCCccCcccccCCCCCcEEEcCCCcc
Q 047705          116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD-NKLEGSIPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       116 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      +|++|++++..+..|..+++|++|+|++|++.++.+..|.++++|++|+|++ |.++.+.+..|..+++|++|+|++|.+
T Consensus       129 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l  208 (452)
T 3zyi_A          129 ELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI  208 (452)
T ss_dssp             ECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             ECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence            5555555555555555555666666666665555555555556666666655 344433344455555666666666665


Q ss_pred             cccCcccccCcccchhhcCCCCC---CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          195 SRSIPACFNNLIALRILSLGSND---PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      ++. | .+..+++|+.|+|++|.   ..|..+..+++|+.|++++|++++..+..|.++++|+.|+|++|++++..+..|
T Consensus       209 ~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  286 (452)
T 3zyi_A          209 KDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF  286 (452)
T ss_dssp             SSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSS
T ss_pred             ccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHh
Confidence            532 2 35555566666666654   334456777788888899999999999999999999999999999998888889


Q ss_pred             cCcCCCCEEeCCCCccCc
Q 047705          272 GNLISLKFLNLSNNNLSG  289 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~  289 (585)
                      ..+++|+.|+|++|++.-
T Consensus       287 ~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          287 TPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             TTCTTCCEEECCSSCEEC
T ss_pred             ccccCCCEEEccCCCcCC
Confidence            999999999999999873

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=2.1e-29  Score=265.17  Aligned_cols=256  Identities=23%  Similarity=0.270  Sum_probs=207.1

Q ss_pred             CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC
Q 047705            3 PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN   82 (585)
Q Consensus         3 p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~   82 (585)
                      |..-....+...++.+++.++ .+|..+.  +++++|+|++|+|++ ++...+..+++|++|+|++|+|+.++. ..|..
T Consensus        36 p~~C~C~~~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~-~~~~~  110 (440)
T 3zyj_A           36 PSVCSCSNQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEI-GAFNG  110 (440)
T ss_dssp             CSSSEECTTSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCE-ECTTTTSSCSSCCEEECCSSCCCEECG-GGGTT
T ss_pred             CCCCEeCCCCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCe-eCHHHhhCCCCCCEEECCCCcCCccCh-hhccC
Confidence            333344456778999999997 6777666  589999999999984 444456689999999999999999986 88999


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeC-CccccccchhhhCCCCCc
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGG-NKLNGSILITLSKLQKLQ  161 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~  161 (585)
                      +++|++|+|++|+++.+.+. .+..+++ |++|+|++|.++...+..|..+++|++|+|++ |.+..+.+..|.++++|+
T Consensus       111 l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  188 (440)
T 3zyj_A          111 LANLNTLELFDNRLTTIPNG-AFVYLSK-LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR  188 (440)
T ss_dssp             CSSCCEEECCSSCCSSCCTT-TSCSCSS-CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCC
T ss_pred             CccCCEEECCCCcCCeeCHh-Hhhcccc-CceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccC
Confidence            99999999999999866554 5666665 88888888888887777888888888888888 455555566788888888


Q ss_pred             eEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccc
Q 047705          162 GLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSG  241 (585)
Q Consensus       162 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~  241 (585)
                      +|+|++|+|+. +| .+..+++|++|+|++|.+++..|..                     +..+++|+.|++++|++++
T Consensus       189 ~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------~~~l~~L~~L~L~~n~l~~  245 (440)
T 3zyj_A          189 YLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGS---------------------FQGLMHLQKLWMIQSQIQV  245 (440)
T ss_dssp             EEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTT---------------------TTTCTTCCEEECTTCCCCE
T ss_pred             eecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhh---------------------hccCccCCEEECCCCceeE
Confidence            88888888884 34 4777888888888888887665554                     4455667777778888888


Q ss_pred             cCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccC
Q 047705          242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS  288 (585)
Q Consensus       242 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  288 (585)
                      +.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus       246 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             EChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            88888999999999999999999888888888999999999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=269.40  Aligned_cols=177  Identities=24%  Similarity=0.339  Sum_probs=153.8

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeee
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCS  480 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  480 (585)
                      .+.+.....++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+.+|+.++..++||||++++++|.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566789999999999999999999976 78999999997542   233456889999999999999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      +.+..|+||||++||+|.+++......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999999876557899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+...... .......+||+.||||
T Consensus       209 a~~~~~~~-~~~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          209 CLKLRADG-TVRSLVAVGTPDYLSP  232 (412)
T ss_dssp             CEECCTTS-CEECSSCCSCGGGCCH
T ss_pred             heeccCCC-ccccceeccccCcCCH
Confidence            98764322 2223456899999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=2.8e-30  Score=260.43  Aligned_cols=169  Identities=26%  Similarity=0.375  Sum_probs=149.8

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ....++|++.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...+..|
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            345678999999999999999999874 8999999999764  2344567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999999997754 6899999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..   .....+||++|+||
T Consensus       167 ~~---~~~~~~gt~~y~aP  182 (328)
T 3fe3_A          167 GG---KLDAFCGAPPYAAP  182 (328)
T ss_dssp             SC---GGGTTSSSGGGCCH
T ss_pred             CC---ccccccCCcceeCc
Confidence            22   23456899999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=7.4e-30  Score=254.04  Aligned_cols=166  Identities=30%  Similarity=0.405  Sum_probs=148.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            467999999999999999999864 7899999999876655667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--c
Confidence            9999999999875  5889999999999999999999   8999999999999999999999999999998764322  2


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       172 ~~~~~~gt~~y~aP  185 (297)
T 3fxz_A          172 KRSTMVGTPYWMAP  185 (297)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCCccCCcCccCh
Confidence            23456799999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=4.1e-30  Score=259.94  Aligned_cols=167  Identities=28%  Similarity=0.382  Sum_probs=147.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++...+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467999999999999999999876 68999999998642   33456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999997654 6889999999999999999999   8999999999999999999999999999998643222


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        ......+||+.||||
T Consensus       160 --~~~~~~~gt~~y~aP  174 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CCBCCCEECGGGCCG
T ss_pred             --CcccccccChhhCCh
Confidence              223457899999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=3.9e-30  Score=261.87  Aligned_cols=169  Identities=29%  Similarity=0.370  Sum_probs=142.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ...++|++.+.||+|+||.||+|++. +++.||||+++...   ....+.+..|.++++.+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34578999999999999999999876 68999999998642   33456778899999988 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999998754 6899999999999999999999   8999999999999999999999999999998543


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......+||+.||||
T Consensus       176 ~~--~~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAP  193 (353)
T ss_dssp             C-----------CCGGGCCH
T ss_pred             cC--CccccccCCCcCeECh
Confidence            22  2233457899999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=2.1e-30  Score=268.43  Aligned_cols=173  Identities=26%  Similarity=0.340  Sum_probs=150.7

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      .++....++|++.+.||+|+||.||+|+++ +++.||+|+++...   ....+.+.+|+.+++.++||||++++++|.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            455566789999999999999999999876 68899999997532   22345688899999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      +..|+|||||+||+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999765  5889999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...... .......+||+.||||
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~AP  238 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISP  238 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCH
T ss_pred             eeccCC-cccccCCcCCccccCH
Confidence            754322 2233467899999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=6.2e-30  Score=256.34  Aligned_cols=170  Identities=26%  Similarity=0.440  Sum_probs=149.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357899999999999999999876 6899999998766666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999986668999999999999999999999   8999999999999999999999999999998764322111


Q ss_pred             ------------ccccccccccccCC
Q 047705          572 ------------TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ------------~~~~~~gt~~y~aP  585 (585)
                                  .....+||+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             --------------CCCCSCGGGCCH
T ss_pred             cccccccccccccccccCCCcceeCH
Confidence                        11246799999998

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.5e-29  Score=250.36  Aligned_cols=254  Identities=23%  Similarity=0.268  Sum_probs=217.2

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      -++++.+++.++.. |..   ..++|++|+|++|+++.++. ..|..+++|++|+|++|+++++.+. .++.++. |++|
T Consensus        13 ~~~~~c~~~~l~~i-p~~---~~~~l~~L~l~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L   85 (285)
T 1ozn_A           13 KVTTSCPQQGLQAV-PVG---IPAASQRIFLHGNRISHVPA-ASFRACRNLTILWLHSNVLARIDAA-AFTGLAL-LEQL   85 (285)
T ss_dssp             SCEEECCSSCCSSC-CTT---CCTTCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEE
T ss_pred             CeEEEcCcCCcccC-CcC---CCCCceEEEeeCCcCCccCH-HHcccCCCCCEEECCCCccceeCHh-hcCCccC-CCEE
Confidence            47899999999844 432   25799999999999999986 7899999999999999999988776 6777776 9999


Q ss_pred             EeecCc-ceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcc
Q 047705          116 QMHNCN-VTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       116 ~l~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      ++++|. ++...+..|..+++|++|++++|.+.+..+..|.++++|++|++++|++++..+..|..+++|++|+|++|.+
T Consensus        86 ~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  165 (285)
T 1ozn_A           86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI  165 (285)
T ss_dssp             ECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             eCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence            999997 8888789999999999999999999998899999999999999999999988888899999999999999999


Q ss_pred             cccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCc
Q 047705          195 SRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL  274 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  274 (585)
                      ++..+..|                     ..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..+..+..+
T Consensus       166 ~~~~~~~~---------------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  224 (285)
T 1ozn_A          166 SSVPERAF---------------------RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL  224 (285)
T ss_dssp             CEECTTTT---------------------TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred             cccCHHHh---------------------cCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence            86554433                     445667777888889988889999999999999999999998777789999


Q ss_pred             CCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          275 ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ++|+.|++++|+++...+.. .-...++.+..+.|.+.|..|..
T Consensus       225 ~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          225 RALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             TTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred             cccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence            99999999999998544321 22244666778899999988863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=2.7e-30  Score=260.34  Aligned_cols=179  Identities=37%  Similarity=0.619  Sum_probs=155.7

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      +.+.++...+++|++.+.||+|+||.||+|++++++.||+|++........+.+.+|+++++.++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445566788999999999999999999998889999999987665556778999999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      ..++||||+++|+|.+++....   ..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999997653   25889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++...............||+.|+||
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCH
T ss_pred             ccccccccccccccccCCCccccCH
Confidence            9865433333333456799999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=1.1e-29  Score=257.64  Aligned_cols=171  Identities=25%  Similarity=0.376  Sum_probs=146.8

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      .....++|++.+.||+|+||.||+|+++ +++.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3455688999999999999999999976 68999999998642   23456678899999887 9999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..|+||||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+.
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999998754 6899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....  ......+||+.|+||
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAP  187 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCH
T ss_pred             cccCC--CcccCCCCCcccCCh
Confidence            43221  223457899999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=8.5e-30  Score=262.48  Aligned_cols=168  Identities=27%  Similarity=0.334  Sum_probs=145.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  486 (585)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..+++++ +||||++++++|.+++..|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3467999999999999999999876 68899999998652   22345678899999887 8999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999998754 6899999999999999999999   89999999999999999999999999999986332


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .  .......+||+.||||
T Consensus       206 ~--~~~~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAP  222 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCH
T ss_pred             C--CCccccccCCcccCCc
Confidence            2  2233567899999998

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=5e-29  Score=251.36  Aligned_cols=225  Identities=20%  Similarity=0.211  Sum_probs=144.9

Q ss_pred             CCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccE
Q 047705           59 PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT  138 (585)
Q Consensus        59 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  138 (585)
                      +++++|+|++|.++.+|  ..+..+++|++|+|++|.++ ..|. .++.++. |++|+|++|.++ .+|..+..+++|++
T Consensus        81 ~~l~~L~L~~n~l~~lp--~~l~~l~~L~~L~L~~n~l~-~lp~-~~~~l~~-L~~L~Ls~n~l~-~lp~~l~~l~~L~~  154 (328)
T 4fcg_A           81 PGRVALELRSVPLPQFP--DQAFRLSHLQHMTIDAAGLM-ELPD-TMQQFAG-LETLTLARNPLR-ALPASIASLNRLRE  154 (328)
T ss_dssp             TTCCEEEEESSCCSSCC--SCGGGGTTCSEEEEESSCCC-CCCS-CGGGGTT-CSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred             cceeEEEccCCCchhcC--hhhhhCCCCCEEECCCCCcc-chhH-HHhccCC-CCEEECCCCccc-cCcHHHhcCcCCCE
Confidence            44555555555555444  23444555555555555554 2232 2333433 444444444444 33444555555555


Q ss_pred             EEeeCCccccccchhhh---------CCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccch
Q 047705          139 IDLGGNKLNGSILITLS---------KLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALR  209 (585)
Q Consensus       139 L~L~~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  209 (585)
                      |+|++|++.+..|..+.         ++++|++|+|++|+|+ .+|..+..+++|++|+|++|.+++ +|.         
T Consensus       155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~---------  223 (328)
T 4fcg_A          155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGP---------  223 (328)
T ss_dssp             EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCG---------
T ss_pred             EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cch---------
Confidence            55555555444444433         3666777777777666 555566666777777777776663 222         


Q ss_pred             hhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCc
Q 047705          210 ILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG  289 (585)
Q Consensus       210 ~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  289 (585)
                                  .+..+++|+.|++++|.+.+.+|..|.++++|++|+|++|.+.+.+|..+..+++|+.|++++|++.+
T Consensus       224 ------------~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~  291 (328)
T 4fcg_A          224 ------------AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS  291 (328)
T ss_dssp             ------------GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred             ------------hhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence                        34455566677777777777788888888888888888888888888888888888888888888888


Q ss_pred             cCChhhccCCccceEEeecCcCe
Q 047705          290 AIPASLEKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       290 ~~~~~~~~l~~L~~l~l~~N~l~  312 (585)
                      .+|..+..+++|+.+++..|.+.
T Consensus       292 ~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          292 RLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCCGGGGGSCTTCEEECCGGGSC
T ss_pred             hccHHHhhccCceEEeCCHHHHH
Confidence            88888888888888888877664

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=1.6e-29  Score=253.64  Aligned_cols=164  Identities=27%  Similarity=0.375  Sum_probs=146.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999876 78999999998652   23456788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++....  
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            99999999999998754 6899999999999999999999   99999999999999999999999999999986532  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         .....+||+.|+||
T Consensus       159 ---~~~~~~gt~~y~aP  172 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAP  172 (318)
T ss_dssp             ---CBCCCCSCTTTCCH
T ss_pred             ---ccccccCCccccCH
Confidence               12346899999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=1.2e-29  Score=260.36  Aligned_cols=165  Identities=31%  Similarity=0.415  Sum_probs=147.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||++++++|.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999876 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+.....  
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            9999999999998754 6899999999999999999999   899999999999999999999999999999875322  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       ......+||+.||||
T Consensus       169 -~~~~~~~gt~~Y~aP  183 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAP  183 (384)
T ss_dssp             -CCBCCCCSCGGGCCG
T ss_pred             -CceeccCCCccccCC
Confidence             223457899999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=1e-29  Score=256.13  Aligned_cols=169  Identities=24%  Similarity=0.359  Sum_probs=146.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999876 78999999987543 2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987654 6899999999999999999999   899999999999999999999999999999876433333


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.|+||
T Consensus       162 ~~~~~~~gt~~y~aP  176 (323)
T 3tki_A          162 RLLNKMCGTLPYVAP  176 (323)
T ss_dssp             CCBCSCCSCGGGSCH
T ss_pred             cccCCCccCcCccCc
Confidence            333467899999998

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.3e-28  Score=265.11  Aligned_cols=261  Identities=25%  Similarity=0.269  Sum_probs=218.4

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+++.|++++|.++ .+|..+.  ++|++|+|++|.|++ ++.    .+++|++|+|++|+|+.+|.     .+++|++|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~----~l~~L~~L~Ls~N~l~~lp~-----~l~~L~~L  106 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTSLPV-----LPPGLLEL  106 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC----CCTTCCEEEECSCCCSCCCC-----CCTTCCEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC----cCCCCCEEEcCCCcCCcCCC-----CCCCCCEE
Confidence            36899999999998 7777776  799999999999984 443    47899999999999999873     67999999


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|+++++.+      .+.+|++|++++|++++. |.   .+++|++|+|++|++.++..    ..++|+.|++++|+
T Consensus       107 ~Ls~N~l~~l~~------~l~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~  172 (622)
T 3g06_A          107 SIFSNPLTHLPA------LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQ  172 (622)
T ss_dssp             EECSCCCCCCCC------CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSC
T ss_pred             ECcCCcCCCCCC------CCCCcCEEECCCCCCCcC-CC---CCCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCC
Confidence            999999987543      234599999999999864 43   25899999999999996532    45789999999999


Q ss_pred             CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCccc
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEI  247 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  247 (585)
                      |++ +|   ..+++|+.|++++|.|++ +|..   +++|+.|++++|.  .+|.   .+++|+.|++++|.+++ +|   
T Consensus       173 l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~---~~~~L~~L~Ls~N~L~~-lp---  237 (622)
T 3g06_A          173 LTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA---LPSGLKELIVSGNRLTS-LP---  237 (622)
T ss_dssp             CSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC---CCTTCCEEECCSSCCSC-CC---
T ss_pred             CCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCC---CCCCCCEEEccCCccCc-CC---
Confidence            996 44   457899999999999985 4443   4789999999997  3332   35789999999999997 44   


Q ss_pred             CCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       248 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      ..+++|+.|+|++|+++. +|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|.
T Consensus       238 ~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          238 VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            456899999999999995 454   5689999999999999 6788999999999999999999887654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.96  E-value=1.3e-32  Score=291.51  Aligned_cols=329  Identities=19%  Similarity=0.154  Sum_probs=229.0

Q ss_pred             ccCCCCCCEEecCCCcccc----cCCccccCCCCCCEEecCCCcCCCcCCccccCCCC----CccEEEccCCCCCCCc--
Q 047705            6 IGNLQNLEELDLRQNKLIG----TVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLP----NLEELVLWGNNFSELN--   75 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~----~L~~L~L~~n~l~~~~--   75 (585)
                      +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.++..........++    +|++|+|++|+++...  
T Consensus        24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~  103 (461)
T 1z7x_W           24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  103 (461)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence            5677889999999998874    34667788889999999999886322221122334    6999999999888532  


Q ss_pred             -cCccccCCCCCcEEEccCCCCcccCCcchhhcc---cccccEEEeecCcceecC----CccccCCCCccEEEeeCCccc
Q 047705           76 -FLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL---SHSLEDFQMHNCNVTGDI----PEEIGNLTNLITIDLGGNKLN  147 (585)
Q Consensus        76 -~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~---~~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~  147 (585)
                       ....+..+++|++|+|++|++++..+......+   ..+|++|++++|.+++..    +..+..+++|++|++++|.+.
T Consensus       104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence             115688888999999999988754333111111   124899999999888643    556677788999999998887


Q ss_pred             cccchhhh-----CCCCCceEEccCCCCCcc----CcccccCCCCCcEEEcCCCcccccC-----cccccCcccchhhcC
Q 047705          148 GSILITLS-----KLQKLQGLVLDDNKLEGS----IPDDICRLVELYKLELGGNKLSRSI-----PACFNNLIALRILSL  213 (585)
Q Consensus       148 ~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~l  213 (585)
                      ...+..+.     ..++|++|+|++|.+++.    ++..+..+++|++|++++|.++...     +..+..+++|++|++
T Consensus       184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L  263 (461)
T 1z7x_W          184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI  263 (461)
T ss_dssp             HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence            65554443     366888999998888864    4666777888888888888887532     223345788888888


Q ss_pred             CCCCC-------CCccCCCCCCCcEEEccCCcccccCCcccC-----CCCCCcEEeecccCcccc----cCccccCcCCC
Q 047705          214 GSNDP-------LPLEIGNLKVLVGIDFSMNNFSGIIPKEIG-----GLKNLEYLFLGYNRLQGL----IPDSFGNLISL  277 (585)
Q Consensus       214 ~~n~~-------~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L  277 (585)
                      ++|..       ++..+..+++|+.|++++|.+++..+..+.     ..++|+.|++++|.+++.    ++..+..+++|
T Consensus       264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L  343 (461)
T 1z7x_W          264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL  343 (461)
T ss_dssp             TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred             cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence            88863       234455678888888888888754443333     236788888888888765    34556667888


Q ss_pred             CEEeCCCCccCccCChhhcc-----CCccceEEeecCcCee----eCCC-CCCCCCCCccccCCCCc
Q 047705          278 KFLNLSNNNLSGAIPASLEK-----LSYLEDLNLSFNKLEG----EIPR-GGSFGNFSAESFEGNEL  334 (585)
Q Consensus       278 ~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~----~~~~-~~~~~~~~~~~~~~n~~  334 (585)
                      +.|++++|++++..+..+..     .++|++|++++|.++.    .+|. ......++.+++.+|++
T Consensus       344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i  410 (461)
T 1z7x_W          344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL  410 (461)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred             cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence            88888888887665554443     5688888888888774    2222 12345666777777754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=2e-29  Score=256.03  Aligned_cols=167  Identities=28%  Similarity=0.335  Sum_probs=146.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|+.+++++ +||||+++++++...+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357999999999999999999976 68899999998642   33456788899999988 89999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999998654 6899999999999999999999   899999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .  ......+||+.|+||
T Consensus       164 ~--~~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAP  179 (345)
T ss_dssp             T--CCBCCCCSCGGGCCH
T ss_pred             C--CcccccCCCccccCc
Confidence            2  223456899999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=3.2e-29  Score=252.29  Aligned_cols=177  Identities=27%  Similarity=0.315  Sum_probs=153.6

Q ss_pred             cccCHHHHHHhcCC----------CCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCC
Q 047705          402 RTFSYLELCRATDG----------FSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR  470 (585)
Q Consensus       402 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  470 (585)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35677777766653          677789999999999999976 7999999999876555667888999999999999


Q ss_pred             cceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC
Q 047705          471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN  550 (585)
Q Consensus       471 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~  550 (585)
                      ||+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998754  5899999999999999999999   8999999999999999999


Q ss_pred             CcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          551 MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       551 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.+||+|||+++......  .......||+.|+||
T Consensus       178 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP  210 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAP  210 (321)
T ss_dssp             CCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCH
T ss_pred             CcEEEeeeeeeeecccCc--cccccccCCccccCH
Confidence            999999999998754322  223456799999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=1.9e-29  Score=258.91  Aligned_cols=170  Identities=28%  Similarity=0.461  Sum_probs=146.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++.. .....+.+.+|+++++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367999999999999999999752        3567999998754 234557889999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..|+||||+++|+|.+++....               ..+++..++.++.||+.||+|||   +++|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998653               24788899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+|+...............||+.||||
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            99999999999999876443332333455678999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=3.1e-29  Score=255.90  Aligned_cols=167  Identities=26%  Similarity=0.395  Sum_probs=146.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh------hHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      ..+.|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999876 6899999999764321      34678899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeecc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGI  560 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~  560 (585)
                      .|+||||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999997654 6899999999999999999999   89999999999999998776    799999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....   ......+||+.|+||
T Consensus       166 a~~~~~~---~~~~~~~gt~~y~aP  187 (361)
T 2yab_A          166 AHEIEDG---VEFKNIFGTPEFVAP  187 (361)
T ss_dssp             CEECCTT---CCCCCCCSCGGGCCH
T ss_pred             ceEcCCC---CccccCCCCccEECc
Confidence            9876432   223456799999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=2.1e-29  Score=256.32  Aligned_cols=169  Identities=24%  Similarity=0.293  Sum_probs=146.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ...++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..+++.+ +||+|+++++++...+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34578999999999999999999976 57899999998652   23456778899999988 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+...
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999998654 6899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......+||+.||||
T Consensus       173 ~~--~~~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAP  190 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCH
T ss_pred             cC--CcccccccCCccccCh
Confidence            22  1233457899999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.7e-29  Score=251.68  Aligned_cols=166  Identities=21%  Similarity=0.320  Sum_probs=147.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999876 68899999987543 3446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC--CCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ++||+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.  ++.+||+|||+++...... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999876667899999999999999999999   899999999999999986  7899999999998764322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.|+||
T Consensus       159 --~~~~~~gt~~y~aP  172 (321)
T 1tki_A          159 --NFRLLFTAPEYYAP  172 (321)
T ss_dssp             --EEEEEESCGGGSCH
T ss_pred             --ccccccCChhhcCc
Confidence              23456799999998

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1.3e-30  Score=261.88  Aligned_cols=268  Identities=20%  Similarity=0.165  Sum_probs=196.5

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+++.++++.+.+.......+..+++|++|+|++|.|++. +...+..+++|++|+|++|+++.++   .|..+++|++|
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~n~l~~~~---~~~~l~~L~~L   85 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQI-SAADLAPFTKLELLNLSSNVLYETL---DLESLSTLRTL   85 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCC-CHHHHTTCTTCCEEECTTSCCEEEE---EETTCTTCCEE
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcC-CHHHhhCCCcCCEEECCCCcCCcch---hhhhcCCCCEE
Confidence            3455667777777656566666777888888888888743 3333457788888888888887664   27778888888


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|+++++.+.      + +|++|++++|.+++..+..   +++|++|++++|++++..+..|..+++|++|+|++|.
T Consensus        86 ~Ls~n~l~~l~~~------~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (317)
T 3o53_A           86 DLNNNYVQELLVG------P-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (317)
T ss_dssp             ECCSSEEEEEEEC------T-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred             ECcCCccccccCC------C-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence            8888887754321      2 3777777777777665443   4667777777777777667677777777777777777


Q ss_pred             CCccCccccc-CCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccC
Q 047705          170 LEGSIPDDIC-RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG  248 (585)
Q Consensus       170 l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  248 (585)
                      +++..+..+. .+++|++|+|++|.+++. +                      ....+++|+.|++++|.+++..+ .|.
T Consensus       156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~----------------------~~~~l~~L~~L~Ls~N~l~~l~~-~~~  211 (317)
T 3o53_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDV-K----------------------GQVVFAKLKTLDLSSNKLAFMGP-EFQ  211 (317)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEE-E----------------------CCCCCTTCCEEECCSSCCCEECG-GGG
T ss_pred             CCcccHHHHhhccCcCCEEECCCCcCccc-c----------------------cccccccCCEEECCCCcCCcchh-hhc
Confidence            7766665553 567777777777777643 1                      12236778888899999986544 588


Q ss_pred             CCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccC-ccCChhhccCCccceEEeecC-cCeeeCC
Q 047705          249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS-GAIPASLEKLSYLEDLNLSFN-KLEGEIP  316 (585)
Q Consensus       249 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~N-~l~~~~~  316 (585)
                      .+++|+.|++++|++++ +|..+..+++|+.|++++|+++ +..|..+..+++|+.+++++| .+.+..|
T Consensus       212 ~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          212 SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             ccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            89999999999999995 5778889999999999999998 778888889999999999844 4554433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.6e-28  Score=247.63  Aligned_cols=234  Identities=22%  Similarity=0.258  Sum_probs=156.5

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+++.|+|++|.++ .+|..+.++++|++|+|++|.|+ .++.. +..+++|++|+|++|+++.+|  ..+..+++|++|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~-~~~l~~L~~L~Ls~n~l~~lp--~~l~~l~~L~~L  155 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT-MQQFAGLETLTLARNPLRALP--ASIASLNRLREL  155 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSC-GGGGTTCSEEEEESCCCCCCC--GGGGGCTTCCEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHH-HhccCCCCEEECCCCccccCc--HHHhcCcCCCEE
Confidence            45555555555555 44555555555555555555555 23221 124555555555555555554  345555555555


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|++.+..|.. ++       ..         ..+..|.++++|++|+|++|+++ .+|..|.++++|++|+|++|+
T Consensus       156 ~L~~n~~~~~~p~~-~~-------~~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~  217 (328)
T 4fcg_A          156 SIRACPELTELPEP-LA-------ST---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP  217 (328)
T ss_dssp             EEEEETTCCCCCSC-SE-------EE---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSC
T ss_pred             ECCCCCCccccChh-Hh-------hc---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCC
Confidence            55555544443331 11       00         11123456899999999999998 667789999999999999999


Q ss_pred             CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCC
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGG  249 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  249 (585)
                      +++ +|..+..+++|++|+|++|.+.+.+|..|..                     +++|+.|++++|.+.+.+|..+.+
T Consensus       218 l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~---------------------l~~L~~L~L~~n~~~~~~p~~~~~  275 (328)
T 4fcg_A          218 LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG---------------------RAPLKRLILKDCSNLLTLPLDIHR  275 (328)
T ss_dssp             CCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTC---------------------CCCCCEEECTTCTTCCBCCTTGGG
T ss_pred             CCc-CchhhccCCCCCEEECcCCcchhhhHHHhcC---------------------CCCCCEEECCCCCchhhcchhhhc
Confidence            995 5557899999999999999988776665444                     455566666777777777777888


Q ss_pred             CCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccC
Q 047705          250 LKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLS  288 (585)
Q Consensus       250 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  288 (585)
                      +++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       276 l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            888888888888877788888888888888887777655

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=2.7e-29  Score=255.41  Aligned_cols=164  Identities=27%  Similarity=0.362  Sum_probs=146.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999876 78999999997643   23456788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999998754 6899999999999999999999   999999999999999999999999999999875321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                          ....+||+.|+||
T Consensus       195 ----~~~~~gt~~y~aP  207 (350)
T 1rdq_E          195 ----TWTLCGTPEALAP  207 (350)
T ss_dssp             ----BCCCEECGGGCCH
T ss_pred             ----cccccCCccccCH
Confidence                2346799999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=3e-29  Score=249.30  Aligned_cols=168  Identities=26%  Similarity=0.442  Sum_probs=142.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++..++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999999875 7899999998643   234457889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++|++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998764 6899999999999999999999   8999999999999999999999999999998653222


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       ........||+.|+||
T Consensus       166 -~~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSP  181 (294)
T ss_dssp             ----------CCSSCCH
T ss_pred             -ccccCccccCccccCH
Confidence             1223446799999998

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.96  E-value=1.2e-31  Score=284.26  Aligned_cols=310  Identities=21%  Similarity=0.188  Sum_probs=244.7

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCcccc-CCC----CCCEEecCCCcCCC----cCCccccCCCCCccEEEccCCCCC
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIF-NVS----TLKLLGLQDNSLSG----SLSSITDVRLPNLEELVLWGNNFS   72 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~----~L~~L~L~~n~l~~----~~~~~~~~~l~~L~~L~L~~n~l~   72 (585)
                      +|..+..+++|++|+|++|+++...+..+. .++    +|++|+|++|.|+.    .++. .+..+++|++|+|++|.++
T Consensus        48 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~-~l~~~~~L~~L~Ls~n~i~  126 (461)
T 1z7x_W           48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS-TLRTLPTLQELHLSDNLLG  126 (461)
T ss_dssp             HHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH-HTTSCTTCCEEECCSSBCH
T ss_pred             HHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH-HHccCCceeEEECCCCcCc
Confidence            456788899999999999999876555544 355    69999999999973    1222 2347899999999999987


Q ss_pred             CCccCcc-----ccCCCCCcEEEccCCCCcccCCc---chhhcccccccEEEeecCcceecCCcccc-----CCCCccEE
Q 047705           73 ELNFLSS-----LSNCKSLTVIGLSNNPLDGILPK---TSIGNLSHSLEDFQMHNCNVTGDIPEEIG-----NLTNLITI  139 (585)
Q Consensus        73 ~~~~~~~-----~~~l~~L~~L~Ls~N~l~~~~~~---~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L  139 (585)
                      .... ..     +...++|++|+|++|++++....   ..+..++. |++|++++|.++...+..+.     .+++|++|
T Consensus       127 ~~~~-~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L  204 (461)
T 1z7x_W          127 DAGL-QLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD-FKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL  204 (461)
T ss_dssp             HHHH-HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT-CCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEE
T ss_pred             hHHH-HHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCC-CCEEECcCCCcchHHHHHHHHHHhcCCCCceEE
Confidence            6432 22     33467899999999999864321   13445565 99999999999876555553     36799999


Q ss_pred             EeeCCccccc----cchhhhCCCCCceEEccCCCCCccC-----cccccCCCCCcEEEcCCCccccc----CcccccCcc
Q 047705          140 DLGGNKLNGS----ILITLSKLQKLQGLVLDDNKLEGSI-----PDDICRLVELYKLELGGNKLSRS----IPACFNNLI  206 (585)
Q Consensus       140 ~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~  206 (585)
                      +|++|.+++.    .+..+..+++|++|++++|.+++..     +..+..+++|++|++++|.++..    ++..+..++
T Consensus       205 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~  284 (461)
T 1z7x_W          205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE  284 (461)
T ss_dssp             ECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCT
T ss_pred             EccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCC
Confidence            9999999874    4777888999999999999998643     23334689999999999999864    566778899


Q ss_pred             cchhhcCCCCCCCCc---cC-----CCCCCCcEEEccCCccccc----CCcccCCCCCCcEEeecccCcccccCccccC-
Q 047705          207 ALRILSLGSNDPLPL---EI-----GNLKVLVGIDFSMNNFSGI----IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN-  273 (585)
Q Consensus       207 ~L~~L~l~~n~~~~~---~~-----~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-  273 (585)
                      +|++|++++|.....   .+     ...++|+.|++++|.+++.    .+..+..+++|++|++++|++++..+..+.. 
T Consensus       285 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  364 (461)
T 1z7x_W          285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG  364 (461)
T ss_dssp             TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred             CcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH
Confidence            999999999973211   12     2336999999999999875    4556777899999999999998776655543 


Q ss_pred             ----cCCCCEEeCCCCccCc----cCChhhccCCccceEEeecCcCeee
Q 047705          274 ----LISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       274 ----l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                          .++|+.|++++|++++    .+|..+..+++|++|++++|+++..
T Consensus       365 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             HcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence                6799999999999996    7788889999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=3.4e-29  Score=250.95  Aligned_cols=168  Identities=27%  Similarity=0.386  Sum_probs=144.6

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++....  ......+.+|++++++++||||+++++++..++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999999889999999987542  223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++ ++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            99974 888888877667999999999999999999999   8999999999999999999999999999998753221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       174 -~~~~~~~~t~~y~aP  188 (311)
T 3niz_A          174 -RSYTHEVVTLWYRAP  188 (311)
T ss_dssp             -C---CCCCCCTTCCH
T ss_pred             -ccccCCcccCCcCCH
Confidence             223446789999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=1.9e-29  Score=254.69  Aligned_cols=182  Identities=40%  Similarity=0.589  Sum_probs=157.3

Q ss_pred             cccccCHHHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhh-hhHHHHHHHHHHHHhcCCCcceeEEee
Q 047705          400 MWRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR-RAFKSFDVECEIMKSIRHRNLIKVISS  478 (585)
Q Consensus       400 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  478 (585)
                      ....+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3457899999999999999999999999999999987899999999875432 223468899999999999999999999


Q ss_pred             eecCCeEEEEEEccCCCCHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCC---CcEEcCCCCCCEEeCCCCc
Q 047705          479 CSNEEFKGLVLEYMPQGSLEKHLYSTNC---ILDIFQRLNIMIDVASALEYLHFGCST---PVIHCDLKPSNVLLDDNMI  552 (585)
Q Consensus       479 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~---~iiH~dlkp~NIll~~~~~  552 (585)
                      +...+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||   ++   +|+||||||+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCC
Confidence            9999999999999999999999986532   4899999999999999999999   66   9999999999999999999


Q ss_pred             EEEeeecccccccCCCCccccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+|||+++...... ........||+.|+||
T Consensus       173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAP  204 (326)
T ss_dssp             EEECCCSSCEECCSSS-SCEECCCCSCGGGCCH
T ss_pred             EEeccCccccccCccc-ccccccccCCcCccCH
Confidence            9999999998754322 2233455699999998

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1.4e-30  Score=261.76  Aligned_cols=249  Identities=23%  Similarity=0.204  Sum_probs=205.4

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC
Q 047705            5 EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK   84 (585)
Q Consensus         5 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   84 (585)
                      .+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++.++   +..+++|++|+|++|+++.++.      .+
T Consensus        29 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~~------~~   99 (317)
T 3o53_A           29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLV------GP   99 (317)
T ss_dssp             HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEEE------CT
T ss_pred             HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccccC------CC
Confidence            34566799999999999998888999999999999999999986554   5589999999999999988763      38


Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhh-CCCCCceE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLS-KLQKLQGL  163 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L  163 (585)
                      +|++|++++|+++++.+.    .++ +|++|++++|.+++..+..|..+++|++|+|++|.+.+..+..+. .+++|++|
T Consensus       100 ~L~~L~l~~n~l~~~~~~----~~~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  174 (317)
T 3o53_A          100 SIETLHAANNNISRVSCS----RGQ-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (317)
T ss_dssp             TCCEEECCSSCCSEEEEC----CCS-SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CcCEEECCCCccCCcCcc----ccC-CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence            999999999999877554    234 499999999999999898999999999999999999988887774 79999999


Q ss_pred             EccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccC
Q 047705          164 VLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGII  243 (585)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~  243 (585)
                      +|++|+|++. + ....+++|++|+|++|.+++..+ .|..                     +++|+.|++++|++++ +
T Consensus       175 ~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~-~~~~---------------------l~~L~~L~L~~N~l~~-l  229 (317)
T 3o53_A          175 NLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQS---------------------AAGVTWISLRNNKLVL-I  229 (317)
T ss_dssp             ECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGG---------------------GTTCSEEECTTSCCCE-E
T ss_pred             ECCCCcCccc-c-cccccccCCEEECCCCcCCcchh-hhcc---------------------cCcccEEECcCCcccc-h
Confidence            9999999966 3 33458999999999999985433 2444                     4556666777777774 4


Q ss_pred             CcccCCCCCCcEEeecccCcc-cccCccccCcCCCCEEeCCCC-ccCccCC
Q 047705          244 PKEIGGLKNLEYLFLGYNRLQ-GLIPDSFGNLISLKFLNLSNN-NLSGAIP  292 (585)
Q Consensus       244 ~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~l~~N-~l~~~~~  292 (585)
                      |..+..+++|+.|++++|+++ +..|.++..+++|+.|++++| .+++..|
T Consensus       230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            666788888888888888887 667778888888888888844 4555443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=4.4e-29  Score=251.69  Aligned_cols=169  Identities=29%  Similarity=0.481  Sum_probs=143.8

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|++.    .+..||||+++.. .....+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56889999999999999999874    3456999999754 334557889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999877668999999999999999999999   8999999999999999999999999999998764322


Q ss_pred             C-ccccccccccccccCC
Q 047705          569 Q-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~-~~~~~~~~gt~~y~aP  585 (585)
                      . ........+|+.|+||
T Consensus       206 ~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             -CCEECC---CCGGGSCH
T ss_pred             cceeeccCCCCcccccCH
Confidence            1 1222344568889998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=3.3e-29  Score=257.07  Aligned_cols=168  Identities=20%  Similarity=0.241  Sum_probs=143.9

Q ss_pred             hcCCCCccceecccCceEEEEEE------eCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC---CCcceeEEeeeecC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR---HRNLIKVISSCSNE  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  482 (585)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|+++...   ...+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34679999999999999999994      3468899999987543   346677888888886   99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---------
Q 047705          483 EFKGLVLEYMPQGSLEKHLYS----TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---------  549 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---------  549 (585)
                      +..|+||||+++|+|.+++..    ....+++..++.++.||+.||+|||   +++|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975    2346899999999999999999999   999999999999999998         


Q ss_pred             --CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          550 --NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       550 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                        ++.+||+|||+|+.+............+||+.||||
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence              899999999999865433333344567899999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=6.1e-29  Score=251.37  Aligned_cols=170  Identities=25%  Similarity=0.415  Sum_probs=141.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  483 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||++++++|...+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999986 79999999997543 335578899999999999999999999885443       


Q ss_pred             --------------------------------------------------eEEEEEEccCCCCHHHHhhcCCC--CCCHH
Q 047705          484 --------------------------------------------------FKGLVLEYMPQGSLEKHLYSTNC--ILDIF  511 (585)
Q Consensus       484 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~  511 (585)
                                                                        ..++|||||++++|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999987543  34566


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc----------ccccccccccc
Q 047705          512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS----------MTQTQTLATIG  581 (585)
Q Consensus       512 ~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~  581 (585)
                      .++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........          ......+||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78899999999999999   899999999999999999999999999999876533211          12244679999


Q ss_pred             ccCC
Q 047705          582 YMAP  585 (585)
Q Consensus       582 y~aP  585 (585)
                      |+||
T Consensus       242 y~aP  245 (332)
T 3qd2_B          242 YMSP  245 (332)
T ss_dssp             GSCH
T ss_pred             ccCh
Confidence            9998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=8.6e-29  Score=254.87  Aligned_cols=167  Identities=23%  Similarity=0.354  Sum_probs=147.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999876 7899999999866555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      +++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++  .++.+||+|||+|+...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876667899999999999999999999   89999999999999997  45789999999998764322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        .....+||+.|+||
T Consensus       206 --~~~~~~gt~~y~aP  219 (387)
T 1kob_A          206 --IVKVTTATAEFAAP  219 (387)
T ss_dssp             --CEEEECSSGGGCCH
T ss_pred             --ceeeeccCCCccCc
Confidence              22345799999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=8.5e-29  Score=245.82  Aligned_cols=166  Identities=27%  Similarity=0.372  Sum_probs=144.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999876 68999999997542  2344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9965 777777665667999999999999999999999   899999999999999999999999999999865322  2


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~t~~y~aP  170 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccccCCccccCCcCh
Confidence            223456789999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=4.9e-29  Score=251.14  Aligned_cols=166  Identities=28%  Similarity=0.407  Sum_probs=143.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----eEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. ++.||||++..... .......|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            367999999999999999999875 78999999975533 3345566899999999999999999987743    47999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST----------PVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~----------~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      |||+++|+|.+++...  .+++..+..++.|++.||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999875  4899999999999999999999   78          9999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|+...............||+.|+||
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aP  202 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAP  202 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred             CcccccccccCccccccCccCccccCH
Confidence            999876544333334456899999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=4.2e-29  Score=252.12  Aligned_cols=167  Identities=28%  Similarity=0.424  Sum_probs=136.3

Q ss_pred             cCCCCccceecccCceEEEEEEe----CCCcEEEEEEEechh----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    478999999987542    2334567889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||++|++|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999998654 6888999999999999999999   899999999999999999999999999999864


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  ......+||+.|+||
T Consensus       172 ~~~~--~~~~~~~gt~~y~aP  190 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAP  190 (327)
T ss_dssp             ---------CTTSSCCTTSCH
T ss_pred             ccCC--ccccccCCCcCccCH
Confidence            3221  123456799999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=6.9e-29  Score=260.00  Aligned_cols=168  Identities=24%  Similarity=0.381  Sum_probs=145.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4467999999999999999999865 78999999987542  33456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~  565 (585)
                      ||||+||+|.+.+.... .+++..+..++.||+.||+|||   +++|+||||||+||+++   +++.+||+|||+|+...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998764 6899999999999999999999   89999999999999998   56789999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...  ......+||+.||||
T Consensus       165 ~~~--~~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSP  182 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCH
T ss_pred             CCC--ceeecccCCcccCCH
Confidence            322  223456899999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=5.2e-29  Score=253.93  Aligned_cols=167  Identities=24%  Similarity=0.373  Sum_probs=143.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-----hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      +.|++.+.||+|+||.||+|++. +++.||||+++....     ...+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56999999999999999999875 789999999975421     135678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc---EEEeeeccc
Q 047705          488 VLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI---AYLSDFGIA  561 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a  561 (585)
                      |||||+|++|.+++...   ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998887643   235889999999999999999999   899999999999999986554   999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +......  ......+||+.|+||
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAP  202 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCH
T ss_pred             eEecCCC--eeecCCcCCcCccCH
Confidence            8764322  223456799999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=6.4e-29  Score=250.96  Aligned_cols=166  Identities=25%  Similarity=0.388  Sum_probs=145.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+++++.++||||+++++++..++..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3478999999999999999999874 78999999997542   2234578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+ +|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++.....
T Consensus        87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99999 789999887654 6899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                         ......+||+.|+||
T Consensus       162 ---~~~~~~~gt~~y~aP  176 (336)
T 3h4j_B          162 ---NFLKTSCGSPNYAAP  176 (336)
T ss_dssp             ---BTTCCCTTSTTTSCG
T ss_pred             ---cccccccCCcCcCCH
Confidence               223456799999998

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.1e-30  Score=258.60  Aligned_cols=243  Identities=19%  Similarity=0.226  Sum_probs=165.5

Q ss_pred             CCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCccc-CCcchhh-------cccccccEEEeecCcceecCCcc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI-LPKTSIG-------NLSHSLEDFQMHNCNVTGDIPEE  129 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~-------~~~~~L~~L~l~~n~l~~~~~~~  129 (585)
                      .++|++|++++|.+ .+|  ..+...  |++|+|++|++... .+. ...       +++. |++|+|++|++++.+|..
T Consensus        42 ~~~L~~l~l~~n~l-~~p--~~~~~~--L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE-ADL--GQFTDI--IKSLSLKRLTVRAARIPS-RILFGALRVLGISG-LQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEECTTHHHHCCTT-CCC--HHHHHH--HHHCCCCEEEEEEEECBH-HHHHHHHHHHTTSC-CCEEEEEEEBCBSCCCCC
T ss_pred             CCCceeEeeccccc-ccH--HHHHHH--HhhcccccccccCCCcCH-HHHHHHHHhcCcCC-ccEEEccCCcccchhHHH
Confidence            44566666666666 444  222222  56666666666432 222 222       3333 666666666666666655


Q ss_pred             c--cCCCCccEEEeeCCccccccchhhhCC-----CCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccccc--Ccc
Q 047705          130 I--GNLTNLITIDLGGNKLNGSILITLSKL-----QKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRS--IPA  200 (585)
Q Consensus       130 ~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~  200 (585)
                      +  ..+++|++|+|++|++.+. |..|..+     ++|++|+|++|+|++..|..|..+++|++|+|++|++.+.  .+.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            4  6677777777777777765 5666655     6777777777777766667777777777777777776543  222


Q ss_pred             cc--cCcccchhhcCCCCCCC--C----ccCCCCCCCcEEEccCCcccccCC-cccCCCCCCcEEeecccCcccccCccc
Q 047705          201 CF--NNLIALRILSLGSNDPL--P----LEIGNLKVLVGIDFSMNNFSGIIP-KEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       201 ~~--~~l~~L~~L~l~~n~~~--~----~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      .+  ..+++|++|++++|...  +    ..+..+++|+.|++++|.+++..| ..+..+++|++|+|++|+++ .+|..+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~  272 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL  272 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence            22  66777777777777633  1    113467889999999999988764 45677899999999999998 567666


Q ss_pred             cCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCee
Q 047705          272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      .  ++|+.|++++|+|++. |. +..+++|++|++++|+|++
T Consensus       273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            5  8899999999999976 55 8889999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=2.4e-28  Score=244.38  Aligned_cols=181  Identities=35%  Similarity=0.555  Sum_probs=157.2

Q ss_pred             ccccCHHHHHHhcCCCCcc------ceecccCceEEEEEEeCCCcEEEEEEEech----hhhhHHHHHHHHHHHHhcCCC
Q 047705          401 WRTFSYLELCRATDGFSEN------NLIGRGGFGSVYKARLGDGMEVAVKVFNLQ----CRRAFKSFDVECEIMKSIRHR  470 (585)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  470 (585)
                      ...|++.++..++++|...      +.||+|+||.||+|+. +++.||+|++...    .....+.+.+|+++++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4578999999999998877      8999999999999987 6789999998643    233457788999999999999


Q ss_pred             cceeEEeeeecCCeEEEEEEccCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYST--NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       471 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      ||+++++++...+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  236889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .++.+||+|||+++...............||+.|+||
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            9999999999999875433333333456799999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=5.2e-29  Score=244.22  Aligned_cols=168  Identities=26%  Similarity=0.417  Sum_probs=147.6

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357899999999999999999988889999999975432 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-cccc
Confidence            999999999877767899999999999999999999   899999999999999999999999999999865322 1122


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....||+.|+||
T Consensus       164 ~~~~~~~~~y~aP  176 (269)
T 4hcu_A          164 STGTKFPVKWASP  176 (269)
T ss_dssp             TTSTTCCGGGCCH
T ss_pred             ccCcccccccCCH
Confidence            3445678889998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=9.6e-29  Score=252.81  Aligned_cols=166  Identities=25%  Similarity=0.482  Sum_probs=145.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999876 68999999997542  344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---CcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~  566 (585)
                      ||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+   +.+||+|||+++....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999987654 6899999999999999999999   8999999999999999854   4599999999987542


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..   .....+||+.|+||
T Consensus       184 ~~---~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          184 SE---AWHGFAGTPGYLSP  199 (362)
T ss_dssp             CC---SCCCSCSCTTTCCH
T ss_pred             Cc---ccccCCCCccccCH
Confidence            21   22456899999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=4.2e-29  Score=255.94  Aligned_cols=167  Identities=32%  Similarity=0.423  Sum_probs=137.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHH-HHhcCCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ......+..|..+ ++.++||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999876 68899999997653   2233456667766 567899999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+|+.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998754 6888999999999999999999   899999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .  ......+||+.||||
T Consensus       193 ~--~~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAP  208 (373)
T ss_dssp             C--CCCCSBSCCCCCCCH
T ss_pred             C--CccccccCCccccCH
Confidence            2  233457899999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=4.4e-29  Score=247.38  Aligned_cols=166  Identities=27%  Similarity=0.390  Sum_probs=142.2

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999998889999999986542  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++ +|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999999876667899999999999999999999   8999999999999999999999999999998653221  1


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (288)
T 1ob3_A          156 KYTHEIVTLWYRAP  169 (288)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccccccccccccCc
Confidence            22445789999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=2.2e-29  Score=267.61  Aligned_cols=234  Identities=21%  Similarity=0.169  Sum_probs=143.0

Q ss_pred             CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccE
Q 047705           35 TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLED  114 (585)
Q Consensus        35 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  114 (585)
                      +|++|+|++|.|++.+ ...+..+++|++|+|++|.++..+.   |..+++|++|+|++|.|+++.+.      + +|++
T Consensus        35 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~------~-~L~~  103 (487)
T 3oja_A           35 NVKELDLSGNPLSQIS-AADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVG------P-SIET  103 (487)
T ss_dssp             GCCEEECCSSCCCCCC-GGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEEC------T-TCCE
T ss_pred             CccEEEeeCCcCCCCC-HHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCC------C-CcCE
Confidence            6667777777666333 2333456666666666666665432   66666666666666666543221      2 2666


Q ss_pred             EEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCccccc-CCCCCcEEEcCCCc
Q 047705          115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC-RLVELYKLELGGNK  193 (585)
Q Consensus       115 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~  193 (585)
                      |++++|.+++..+.   .+++|++|+|++|.+.+..|..|.++++|++|+|++|.|++..|..+. .+++|++|+|++|.
T Consensus       104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            66666666554443   235556666666666555555555556666666666666555555544 45556666666655


Q ss_pred             ccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccC
Q 047705          194 LSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN  273 (585)
Q Consensus       194 l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  273 (585)
                      |++..                       ....+++|+.|+|++|.+++..| .|..+++|+.|+|++|.+++ +|..+..
T Consensus       181 l~~~~-----------------------~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~  235 (487)
T 3oja_A          181 IYDVK-----------------------GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF  235 (487)
T ss_dssp             CCEEE-----------------------CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred             ccccc-----------------------ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence            55321                       12235667777777777776444 37777777777777777775 4666777


Q ss_pred             cCCCCEEeCCCCccC-ccCChhhccCCccceEEee
Q 047705          274 LISLKFLNLSNNNLS-GAIPASLEKLSYLEDLNLS  307 (585)
Q Consensus       274 l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~  307 (585)
                      +++|+.|++++|+++ +.+|..+..++.|+.++++
T Consensus       236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            777777777777776 5566666777777766665

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=9e-29  Score=246.39  Aligned_cols=167  Identities=28%  Similarity=0.407  Sum_probs=140.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--------------------------hhHHHHHHHHHHH
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--------------------------RAFKSFDVECEIM  464 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l  464 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3578999999999999999999875 688999999865421                          1235688999999


Q ss_pred             HhcCCCcceeEEeeeec--CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 047705          465 KSIRHRNLIKVISSCSN--EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKP  542 (585)
Q Consensus       465 ~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp  542 (585)
                      ++++||||+++++++..  .+..|+||||+++++|.+++..  ..+++..+..++.|++.||+|||   +++|+||||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            99999999999999986  5688999999999999887644  36899999999999999999999   89999999999


Q ss_pred             CCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          543 SNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       543 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+++.++.+||+|||+++......  .......||+.|+||
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAP  206 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCG
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccCh
Confidence            99999999999999999998764322  223456799999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=1.1e-28  Score=263.72  Aligned_cols=167  Identities=28%  Similarity=0.425  Sum_probs=147.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999876 79999999997642   23346678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          489 LEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||++||+|.+++..... .+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999976542 5899999999999999999999   899999999999999999999999999999875422


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .   .....+||+.||||
T Consensus       340 ~---~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAP  354 (576)
T ss_dssp             C---CEECCCSCGGGCCH
T ss_pred             c---cccccCCCccccCH
Confidence            2   23446899999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=1e-28  Score=241.97  Aligned_cols=168  Identities=27%  Similarity=0.404  Sum_probs=147.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|+++++..||+|+++.... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467999999999999999999998888999999975532 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.++...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999876656899999999999999999999   8999999999999999999999999999998654322 223


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....||+.|+||
T Consensus       162 ~~~~~~~~~y~aP  174 (268)
T 3sxs_A          162 SVGTKFPVKWSAP  174 (268)
T ss_dssp             CCSCCCCGGGCCH
T ss_pred             ccCCCcCcccCCH
Confidence            3445677889998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=5e-29  Score=249.38  Aligned_cols=173  Identities=30%  Similarity=0.480  Sum_probs=138.9

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      .++....++|++.+.||+|+||.||+|++ +++.||||++....  ....+.+.+|++++++++||||+++++++...+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            34444557899999999999999999987 67899999987542  3345678899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCcEEEeeecc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMIAYLSDFGI  560 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~  560 (585)
                      .++||||+++|+|.+++.....  .+++..++.++.|++.||+|||   +++  |+||||||+||+++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            9999999999999999987542  3889999999999999999999   888  99999999999999999999999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.....  ........||+.|+||
T Consensus       186 a~~~~~~--~~~~~~~~gt~~y~aP  208 (309)
T 3p86_A          186 SRLKAST--FLSSKSAAGTPEWMAP  208 (309)
T ss_dssp             ------------------CCTTSCH
T ss_pred             Ccccccc--ccccccCCCCccccCh
Confidence            9854322  1223456799999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=3.1e-29  Score=258.16  Aligned_cols=171  Identities=27%  Similarity=0.411  Sum_probs=146.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467889999999999999999986 78999999987542 234467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999876657899999999999999999999   89999999999999999999999999999986432211


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ........+++.|+||
T Consensus       269 ~~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAP  284 (377)
T ss_dssp             ECCSSCCEEEGGGSCH
T ss_pred             eecCCCCCCCcCcCCH
Confidence            1111223457789998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.3e-28  Score=248.41  Aligned_cols=165  Identities=27%  Similarity=0.379  Sum_probs=145.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh------hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++.....      ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46899999999999999999876 689999999975422      13567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~  562 (585)
                      +||||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999997654 6899999999999999999999   89999999999999998877    89999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......   ......||+.|+||
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAP  186 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCH
T ss_pred             ECCCCC---ccccccCCcCcCCc
Confidence            754222   22446799999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=5.9e-29  Score=254.58  Aligned_cols=181  Identities=24%  Similarity=0.395  Sum_probs=151.8

Q ss_pred             cccCHHHHHHhcCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcce
Q 047705          402 RTFSYLELCRATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLI  473 (585)
Q Consensus       402 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  473 (585)
                      ..+...++....++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3455666777788999999999999999999973      246889999997642 33456789999999999 789999


Q ss_pred             eEEeeeecCC-eEEEEEEccCCCCHHHHhhcCCC----------------------------------------------
Q 047705          474 KVISSCSNEE-FKGLVLEYMPQGSLEKHLYSTNC----------------------------------------------  506 (585)
Q Consensus       474 ~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------  506 (585)
                      ++++++...+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999988765 48999999999999999976532                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          507 -------------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       507 -------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                                         .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               1888999999999999999999   899999999999999999999999999999876444


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........||+.||||
T Consensus       247 ~~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TTCEEC--CEECGGGCCH
T ss_pred             ccchhccccCCCceeECh
Confidence            333344566789999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=1.7e-28  Score=261.77  Aligned_cols=168  Identities=30%  Similarity=0.450  Sum_probs=147.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|++++++++||||+++++++...+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999976 69999999997643   23346788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |||++||+|.+++....   ..+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   36899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...  ......+||+.||||
T Consensus       341 ~~~--~~~~~~~GT~~Y~AP  358 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAP  358 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCH
T ss_pred             CCC--cccccccCCccccCh
Confidence            322  122346899999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=2e-28  Score=258.14  Aligned_cols=166  Identities=29%  Similarity=0.431  Sum_probs=147.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|.+.+.||+|+||.||+|++. +|+.||||+++....   ...+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999876 799999999976432   2356788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999998754321


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         .....+||+.|+||
T Consensus       171 ---~~~~~~gt~~y~aP  184 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAP  184 (476)
T ss_dssp             ---CBCCCCSCSTTCCH
T ss_pred             ---cccccCCCcCeECh
Confidence               23456799999998

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=7e-30  Score=256.02  Aligned_cols=250  Identities=22%  Similarity=0.232  Sum_probs=131.8

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCc-CCccc------cCCCCCccEEEccCCCCCC-CccCcc
Q 047705            8 NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGS-LSSIT------DVRLPNLEELVLWGNNFSE-LNFLSS   79 (585)
Q Consensus         8 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~------~~~l~~L~~L~L~~n~l~~-~~~~~~   79 (585)
                      ..++|+.|++++|.+  .+|..+...  |++|+|++|.++.. ++...      +..+++|++|+|++|+++. +|. ..
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~  115 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP-PL  115 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC-CS
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH-HH
Confidence            334455555555555  344444432  55555555555311 11110      0024555555555555542 221 11


Q ss_pred             c-cCCCCCcEEEccCCCCcccCCcchhhccc----ccccEEEeecCcceecCCccccCCCCccEEEeeCCccccc--cch
Q 047705           80 L-SNCKSLTVIGLSNNPLDGILPKTSIGNLS----HSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGS--ILI  152 (585)
Q Consensus        80 ~-~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~  152 (585)
                      | ..+++|++|+|++|++++. |. .++.++    .+|++|++++|++++..+..|+.+++|++|+|++|++.+.  .+.
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            1 4555555555555555544 32 333331    2255555555555444444444455555555555544332  111


Q ss_pred             hh--hCCCCCceEEccCCCCCcc---CcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCC
Q 047705          153 TL--SKLQKLQGLVLDDNKLEGS---IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLK  227 (585)
Q Consensus       153 ~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~  227 (585)
                      .+  ..+++|++|+|++|+|++.   ....+..+++|++|+|++|.+++..|.                    ..+..++
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------------------~~~~~l~  253 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA--------------------PSCDWPS  253 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC--------------------SCCCCCT
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch--------------------hhhhhcC
Confidence            22  4444445555554444411   112223344444444444444432211                    2345567


Q ss_pred             CCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCc
Q 047705          228 VLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG  289 (585)
Q Consensus       228 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  289 (585)
                      +|+.|++++|.++ .+|..+.  ++|++|+|++|++++. |. +..+++|+.|++++|++++
T Consensus       254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            8888889999998 5666665  8899999999999976 55 8889999999999999885

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=8.6e-29  Score=254.23  Aligned_cols=169  Identities=27%  Similarity=0.494  Sum_probs=135.2

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|++.    ++..||||+++.. .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999864    4678999998754 334557899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999887667999999999999999999999   8999999999999999999999999999998764322


Q ss_pred             Cc-cccccccccccccCC
Q 047705          569 QS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~-~~~~~~~gt~~y~aP  585 (585)
                      .. .......+|+.|+||
T Consensus       202 ~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             ------------CTTSCH
T ss_pred             ccceeccCCCcCCCccCh
Confidence            11 112233467889998

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.3e-27  Score=257.39  Aligned_cols=255  Identities=24%  Similarity=0.262  Sum_probs=212.3

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +||..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|.|++ ++.    .+++|++|+|++|+|+.+|.    
T Consensus        54 ~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~l~~----  118 (622)
T 3g06_A           54 TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV----LPPGLLELSIFSNPLTHLPA----  118 (622)
T ss_dssp             CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC----CCTTCCEEEECSCCCCCCCC----
T ss_pred             ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC----CCCCCCEEECcCCcCCCCCC----
Confidence            4677776  89999999999998 4555   67899999999999984 443    57999999999999999873    


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                       .+++|++|++++|+++.+.+.     + .+|++|++++|++++. |.   .+++|+.|++++|.++++.    ..+++|
T Consensus       119 -~l~~L~~L~L~~N~l~~lp~~-----l-~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~l~----~~~~~L  183 (622)
T 3g06_A          119 -LPSGLCKLWIFGNQLTSLPVL-----P-PGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTSLP----MLPSGL  183 (622)
T ss_dssp             -CCTTCCEEECCSSCCSCCCCC-----C-TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSCCC----CCCTTC
T ss_pred             -CCCCcCEEECCCCCCCcCCCC-----C-CCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCCCc----ccCCCC
Confidence             578999999999999865432     2 4599999999999864 33   3578999999999999644    567899


Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCccc
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS  240 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~  240 (585)
                      +.|++++|+|+++ |.   .+++|+.|++++|.++. +|..   +++|+.|++++|...... ..+++|+.|++++|.++
T Consensus       184 ~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~lp-~~l~~L~~L~Ls~N~L~  254 (622)
T 3g06_A          184 QELSVSDNQLASL-PT---LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLP-VLPSELKELMVSGNRLT  254 (622)
T ss_dssp             CEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCC-CCCTTCCEEECCSSCCS
T ss_pred             cEEECCCCCCCCC-CC---ccchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCcCC-CCCCcCcEEECCCCCCC
Confidence            9999999999954 43   24789999999999984 4443   478999999999833222 56789999999999999


Q ss_pred             ccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCC
Q 047705          241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS  299 (585)
Q Consensus       241 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  299 (585)
                      ++ |.   .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..|..+..++
T Consensus       255 ~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          255 SL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            54 44   5789999999999999 5688899999999999999999999888877665

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=1.8e-28  Score=251.78  Aligned_cols=162  Identities=24%  Similarity=0.428  Sum_probs=138.5

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          418 ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      ..+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3578999999999999875 789999999987655566789999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe--CCCCcEEEeeecccccccCCCCccccc
Q 047705          497 LEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL--DDNMIAYLSDFGIAKLLIGEDQSMTQT  574 (585)
Q Consensus       497 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~~  574 (585)
                      |.+++......+++..+..++.||+.||+|||   +++|+||||||+||++  +.++.+||+|||+++......   ...
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence            99999876667899999999999999999999   8999999999999999  677899999999998764322   223


Q ss_pred             cccccccccCC
Q 047705          575 QTLATIGYMAP  585 (585)
Q Consensus       575 ~~~gt~~y~aP  585 (585)
                      ..+||+.|+||
T Consensus       247 ~~~gt~~y~aP  257 (373)
T 2x4f_A          247 VNFGTPEFLAP  257 (373)
T ss_dssp             CCCSSCTTCCH
T ss_pred             cccCCCcEeCh
Confidence            45799999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.1e-28  Score=260.96  Aligned_cols=168  Identities=24%  Similarity=0.352  Sum_probs=131.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----Ce
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  484 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+++++.++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999876 7899999998653  233457788999999999999999999998433     57


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 579999987654 6899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCc-------------------------cccccccccccccCC
Q 047705          565 IGEDQS-------------------------MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~-------------------------~~~~~~~gt~~y~aP  585 (585)
                      ......                         ......+||++||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  252 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP  252 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence            422110                         123456899999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=8.9e-29  Score=251.53  Aligned_cols=174  Identities=28%  Similarity=0.440  Sum_probs=147.5

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeec
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSN  481 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  481 (585)
                      +....++|++.+.||+|+||.||+|++.      +++.||+|+++... ....+.+.+|++++++++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999864      34789999987543 3345778999999999999999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTN-----------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHC  538 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~  538 (585)
                      .+..|+||||+++|+|.+++....                       ..+++..++.++.||++||+|||   +++|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            999999999999999999998642                       46889999999999999999999   8999999


Q ss_pred             CCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       539 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            99999999999999999999999876433222233456789999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=6.2e-29  Score=247.16  Aligned_cols=170  Identities=29%  Similarity=0.469  Sum_probs=142.5

Q ss_pred             cCCCCccceecccCceEEEEEEe-----CCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  485 (585)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36799999999999999999984     26889999999876666677899999999999999999999998654  468


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887667899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCC
Q 047705          566 GEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      ..... .......||+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aP  186 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAP  186 (295)
T ss_dssp             ----------CTTCGGGGCCH
T ss_pred             CCcceeeeccCCCCccceeCc
Confidence            32221 122344578889998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=1.7e-28  Score=246.60  Aligned_cols=168  Identities=26%  Similarity=0.387  Sum_probs=130.2

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3468999999999999999999875 68999999997543 223467888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTN-----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||++ |+|.+++....     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 59999886532     35889999999999999999999   899999999999999999999999999999875


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  .......||+.|+||
T Consensus       159 ~~~~--~~~~~~~~t~~y~aP  177 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAP  177 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCH
T ss_pred             CCCc--ccCCCCcccccccCc
Confidence            3221  122445789999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=5.6e-29  Score=262.18  Aligned_cols=167  Identities=28%  Similarity=0.369  Sum_probs=137.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+..|+++++.++||||+++++++...+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999875 78999999998642   23345677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   + ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997654 6899999999999999999999   7 89999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                        .......+||+.||||
T Consensus       303 --~~~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAP  318 (446)
T ss_dssp             ------CCSSSCGGGCCH
T ss_pred             --CcccccccCCccccCH
Confidence              2233457899999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=252.51  Aligned_cols=170  Identities=28%  Similarity=0.440  Sum_probs=146.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|+++.. .....+.+.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            367899999999999999999852        2357999999754 234457788999999999 999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998754               25899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+|+...............||+.|+||
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            99999999999999876433322334455688999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.8e-28  Score=250.85  Aligned_cols=166  Identities=25%  Similarity=0.315  Sum_probs=137.2

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3468999999999999999999976 789999999975432 33667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc--EEEeeecccccccCCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI--AYLSDFGIAKLLIGED  568 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~  568 (585)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.  +||+|||+|+....  
T Consensus        97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            999999999997654 6899999999999999999999   899999999999999987665  99999999975322  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       .......+||+.|+||
T Consensus       171 -~~~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAP  186 (361)
T ss_dssp             -----------CTTSCH
T ss_pred             -cCCCCCCcCCCCcCCh
Confidence             1223456799999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=9.3e-29  Score=247.83  Aligned_cols=165  Identities=25%  Similarity=0.273  Sum_probs=138.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|++. +++.||||++....  .........|+..+.++ +||||+++++++...+..|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999976 79999999986432  22334455566666555 8999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+ +++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence            999 77999998877667999999999999999999999   899999999999999999999999999999865322  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       211 -~~~~~~~gt~~y~aP  225 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAP  225 (311)
T ss_dssp             -----CCCCCGGGCCG
T ss_pred             -CCCcccCCCccccCH
Confidence             223445799999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=2.4e-28  Score=256.07  Aligned_cols=168  Identities=27%  Similarity=0.369  Sum_probs=141.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----Ce
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  484 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+++++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999876 6889999999753  233457888999999999999999999998766     57


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||++ ++|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999995 59999997653 6899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCc--------------------cccccccccccccCC
Q 047705          565 IGEDQS--------------------MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~--------------------~~~~~~~gt~~y~aP  585 (585)
                      ......                    ......+||++|+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             -------------------------------CCCCCTTCCH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            432211                    123567899999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=1.4e-28  Score=242.94  Aligned_cols=169  Identities=24%  Similarity=0.415  Sum_probs=144.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..++|++.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3467999999999999999999998888999999975432 346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            9999999999875567899999999999999999999   8999999999999999999999999999998653221 12


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       177 ~~~~~~~~~~y~aP  190 (283)
T 3gen_A          177 SSVGSKFPVRWSPP  190 (283)
T ss_dssp             STTSTTSCGGGCCH
T ss_pred             cccCCccCcccCCH
Confidence            22345578889998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=2.3e-28  Score=247.18  Aligned_cols=167  Identities=25%  Similarity=0.323  Sum_probs=145.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....  .+.+..|+++++.+ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367999999999999999999864 789999999875432  35688899999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc-----EEEeeeccccccc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI-----AYLSDFGIAKLLI  565 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~  565 (585)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.     +||+|||+|+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 99999999876667999999999999999999999   899999999999999998887     9999999998764


Q ss_pred             CCCCcc-----ccccccccccccCC
Q 047705          566 GEDQSM-----TQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~-----~~~~~~gt~~y~aP  585 (585)
                      ......     ......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cCCCCccccccccCCcCCCccccCh
Confidence            332211     12456899999998

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=3.7e-29  Score=265.89  Aligned_cols=243  Identities=23%  Similarity=0.225  Sum_probs=203.0

Q ss_pred             CCccccCCC----CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccC
Q 047705            2 IPLEIGNLQ----NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFL   77 (585)
Q Consensus         2 ~p~~~~~l~----~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   77 (585)
                      +|..+..+.    +|++|+|++|.+++..|..|..+++|++|+|++|.|++.++   +..+++|++|+|++|.|+.++. 
T Consensus        22 l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~-   97 (487)
T 3oja_A           22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLV-   97 (487)
T ss_dssp             HHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEE-
T ss_pred             hHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCC-
Confidence            344454544    89999999999998888999999999999999999986665   5589999999999999988864 


Q ss_pred             ccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhh-C
Q 047705           78 SSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLS-K  156 (585)
Q Consensus        78 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~  156 (585)
                           .++|++|+|++|.++++.+.    .++ +|+.|+|++|.+++..|..|+.+++|++|+|++|.+.+..|..|. .
T Consensus        98 -----~~~L~~L~L~~N~l~~~~~~----~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~  167 (487)
T 3oja_A           98 -----GPSIETLHAANNNISRVSCS----RGQ-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS  167 (487)
T ss_dssp             -----CTTCCEEECCSSCCCCEEEC----CCS-SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGG
T ss_pred             -----CCCcCEEECcCCcCCCCCcc----ccC-CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhh
Confidence                 38999999999999877554    234 499999999999999999999999999999999999998888886 7


Q ss_pred             CCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccC
Q 047705          157 LQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM  236 (585)
Q Consensus       157 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~  236 (585)
                      +++|++|+|++|.|++..+  +..+++|++|+|++|.|++.+|. |..                     +++|+.|++++
T Consensus       168 l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~---------------------l~~L~~L~Ls~  223 (487)
T 3oja_A          168 SDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQS---------------------AAGVTWISLRN  223 (487)
T ss_dssp             TTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGG---------------------GTTCSEEECTT
T ss_pred             CCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcC---------------------CCCccEEEecC
Confidence            9999999999999997633  44699999999999999964443 444                     45566677777


Q ss_pred             CcccccCCcccCCCCCCcEEeecccCcc-cccCccccCcCCCCEEeCC
Q 047705          237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQ-GLIPDSFGNLISLKFLNLS  283 (585)
Q Consensus       237 N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~l~  283 (585)
                      |.+++ +|..+..+++|+.|++++|+++ +.+|.++..++.|+.++++
T Consensus       224 N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          224 NKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             SCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            77875 5666788888888888888887 5667777888888887775

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=4.9e-28  Score=250.50  Aligned_cols=171  Identities=20%  Similarity=0.286  Sum_probs=147.7

Q ss_pred             hcCCCCccceeccc--CceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          412 ATDGFSENNLIGRG--GFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       412 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ..++|++.+.||+|  +||.||+|++. +++.||||+++...  ....+.+.+|+++++.++||||+++++++..++..|
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34679999999999  99999999976 79999999998653  344577888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          487 LVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      +|||||++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999998752 36899999999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCCc-----cccccccccccccCC
Q 047705          566 GEDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      .....     ......+||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             cccccccccccccccccccccccCH
Confidence            22111     112334799999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=3.5e-28  Score=244.58  Aligned_cols=166  Identities=27%  Similarity=0.422  Sum_probs=143.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--eEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56999999999999999999876 58999999997543 334567789999999999999999999987665  789999


Q ss_pred             EccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----CCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~a~~  563 (585)
                      ||+++++|.+++.....  .+++..++.++.|++.||+|||   +++|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999986542  3899999999999999999999   8999999999999999    7888899999999987


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....   ......||+.|+||
T Consensus       166 ~~~~~---~~~~~~gt~~y~aP  184 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHP  184 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCH
T ss_pred             cCCCC---ceeecccCCCccCH
Confidence            64322   22346799999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=7.6e-29  Score=254.23  Aligned_cols=169  Identities=25%  Similarity=0.402  Sum_probs=143.7

Q ss_pred             CCCCccceecccCceEEEEEEeC------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57899999999999999999843      4678999998643 3344567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC---cEEEee
Q 047705          487 LVLEYMPQGSLEKHLYSTN------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAYLSD  557 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~---~~kl~D  557 (585)
                      +||||+++|+|.+++....      ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997643      35889999999999999999999   89999999999999999555   599999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|+...............||+.|+||
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             CccccccccccccccCCCcCCcccEECH
Confidence            9999865433333333456789999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=4.2e-28  Score=238.79  Aligned_cols=166  Identities=30%  Similarity=0.382  Sum_probs=147.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457999999999999999999876 5789999999876555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887654 6899999999999999999999   8999999999999999   788999999999998754322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......||+.|+||
T Consensus       164 ---~~~~~~~t~~y~aP  177 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSP  177 (277)
T ss_dssp             ---CBCCCCSCTTTCCH
T ss_pred             ---chhccCCCCCccCh
Confidence               22445799999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=4.8e-28  Score=238.53  Aligned_cols=170  Identities=26%  Similarity=0.433  Sum_probs=137.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh---hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++...+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            34568999999999999999999874 789999999975432   23467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++......+++..++.++.|+++||+|||   +++|+||||||+||+++.++.+||+|||.+.....
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999999877667899999999999999999999   89999999999999999999999999999986532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..  .......||+.|+||
T Consensus       165 ~~--~~~~~~~~~~~y~aP  181 (278)
T 3cok_A          165 PH--EKHYTLCGTPNYISP  181 (278)
T ss_dssp             -------------------
T ss_pred             CC--CcceeccCCCCcCCc
Confidence            21  122345789999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3e-28  Score=247.84  Aligned_cols=172  Identities=24%  Similarity=0.428  Sum_probs=145.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEe------CCCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      ...++|++.+.||+|+||.||+|++      .+++.||+|++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457899999999999999999985      24568999998754 233456788999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCC
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNC----------------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDL  540 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dl  540 (585)
                      +..++||||+++|+|.+++.....                      .+++..++.++.|++.||+|||   +++|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            999999999999999999986542                      3788899999999999999999   899999999


Q ss_pred             CCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          541 KPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       541 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            999999999999999999999876544333334456688999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=7.4e-29  Score=248.61  Aligned_cols=169  Identities=24%  Similarity=0.426  Sum_probs=136.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----e
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----F  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  484 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||+++...   ......+.+|++++++++||||+++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999874 78999999997642   234567889999999999999999999987654    3


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||++|++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999998654 6899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCc-cccccccccccccCC
Q 047705          565 IGEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      ...... .......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             ---------------CCTTCCH
T ss_pred             cccccccccccccCcCcccCCH
Confidence            433221 223346799999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=3.1e-28  Score=244.26  Aligned_cols=171  Identities=25%  Similarity=0.414  Sum_probs=146.9

Q ss_pred             hcCCCCccceecccCceEEEEEEe------CCCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      ..++|.+.+.||+|+||.||+|++      .+++.||+|+++.. .....+.+.+|+++++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            346799999999999999999975      24578999998754 23455778899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNC-----------------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK  541 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  541 (585)
                      .++||||+++++|.+++.....                       .+++..++.++.|+++||+|||   +++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999986432                       3788999999999999999999   8999999999


Q ss_pred             CCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          542 PSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       542 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+||+++.++.+||+|||+++...............||+.|+||
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            99999999999999999999876543333333455678899998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=3.5e-28  Score=247.15  Aligned_cols=167  Identities=23%  Similarity=0.388  Sum_probs=140.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCC--CcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|+++++.++|  |||+++++++..++..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            3569999999999999999999888999999998754  23445778899999999987  9999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||+ .+++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++ ++.+||+|||+|+......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5889999998764 6889999999999999999999   89999999999999997 6789999999998765433


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                      ........+||+.|+||
T Consensus       162 ~~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             --------CCCCSSCCH
T ss_pred             ccccCCCCcCCcCcCCH
Confidence            33334456899999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=2.6e-28  Score=241.84  Aligned_cols=164  Identities=25%  Similarity=0.384  Sum_probs=144.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CC-------cEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DG-------MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|++. ++       ..||+|++........+.+.+|++++++++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357899999999999999999764 33       5799999987666667889999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc--------EEEe
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI--------AYLS  556 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~  556 (585)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887656899999999999999999999   899999999999999988876        9999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||.+.....      .....||+.|+||
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aP  186 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPP  186 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCH
T ss_pred             cCcccccccC------ccccCCcCcccCH
Confidence            9999875421      1234588899998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.4e-27  Score=235.00  Aligned_cols=229  Identities=26%  Similarity=0.280  Sum_probs=157.1

Q ss_pred             EEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEee
Q 047705           63 ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLG  142 (585)
Q Consensus        63 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  142 (585)
                      .++.++..++.+|.  .+.  ++|++|+|++|+++++.+. .+.+++. |++|++++|.+++..+..|..+++|++|+|+
T Consensus        11 ~~~c~~~~l~~ip~--~l~--~~l~~L~ls~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~   84 (276)
T 2z62_A           11 TYQCMELNFYKIPD--NLP--FSTKNLDLSFNPLRHLGSY-SFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHLSTLILT   84 (276)
T ss_dssp             EEECTTSCCSSCCS--SSC--TTCCEEECTTCCCCEECTT-TTTTCTT-CSEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             eEEecCCCccccCC--CCC--CCccEEECCCCcccccCHh-HhccccC-CcEEECCCCcCCccCHHHccCCcCCCEEECC
Confidence            46666777777763  222  4677777777777655443 3444444 5566666555555555555555555555555


Q ss_pred             CCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCcc
Q 047705          143 GNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLE  222 (585)
Q Consensus       143 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~  222 (585)
                      +|++.+..+..|.++++|++|++++|.+++..+..+..+++|++|++++|.+++..                    +|..
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------------------l~~~  144 (276)
T 2z62_A           85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK--------------------LPEY  144 (276)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC--------------------CCGG
T ss_pred             CCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec--------------------Cchh
Confidence            55555555555555555555555555555544445555555555555555554321                    2445


Q ss_pred             CCCCCCCcEEEccCCcccccCCcccCCCCCCc----EEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccC
Q 047705          223 IGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLE----YLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL  298 (585)
Q Consensus       223 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~----~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  298 (585)
                      +..+++|+.|++++|++++..+..|..+++|+    .|++++|++++..+..+.. .+|+.|++++|++++..+..+..+
T Consensus       145 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l  223 (276)
T 2z62_A          145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRL  223 (276)
T ss_dssp             GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTC
T ss_pred             hccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhccc
Confidence            66677788888899999888777787777776    8999999999876666654 489999999999998877778999


Q ss_pred             CccceEEeecCcCeeeCCCC
Q 047705          299 SYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       299 ~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ++|+.|++++|+|.|.|+..
T Consensus       224 ~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          224 TSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CSCCEEECCSSCBCCCTTTT
T ss_pred             ccccEEEccCCcccccCCch
Confidence            99999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=7e-28  Score=237.00  Aligned_cols=169  Identities=24%  Similarity=0.359  Sum_probs=147.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999876 78999999997543 3345778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999987643 6899999999999999999999   899999999999999999999999999999865433222


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       162 ~~~~~~~~~~~y~aP  176 (276)
T 2yex_A          162 RLLNKMCGTLPYVAP  176 (276)
T ss_dssp             CCBCCCCSCGGGCCG
T ss_pred             hcccCCccccCccCh
Confidence            223456799999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=7.2e-28  Score=243.92  Aligned_cols=170  Identities=28%  Similarity=0.465  Sum_probs=145.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      .++|++.+.||+|+||.||+|++.        ++..||+|+++.. .....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999863        4678999998754 234557788999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNC---------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..|+||||+++|+|.+++.....               .+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999986532               3788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+++...............+|+.|+||
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            99999999999999876443322233445678899998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=2.5e-28  Score=246.46  Aligned_cols=168  Identities=27%  Similarity=0.415  Sum_probs=136.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcE----EEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++...+ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56899999999999999999864 4444    577776533 2344578899999999999999999999998765 779


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |+||+++|+|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999987778999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........||+.|+||
T Consensus       171 ~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             CC-------CCCGGGSCH
T ss_pred             cccccccCCCccccccCh
Confidence            433334455678899998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=6.6e-28  Score=265.52  Aligned_cols=169  Identities=24%  Similarity=0.292  Sum_probs=147.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  485 (585)
                      ...++|++.+.||+|+||.||+|++. +++.||||+++...   ....+.+..|..+++.+ +||+|+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            45678999999999999999999876 68899999998542   23456778899999988 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999998754 6899999999999999999999   8999999999999999999999999999998643


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...  ......+||+.||||
T Consensus       494 ~~~--~~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          494 WDG--VTTKTFCGTPDYIAP  511 (674)
T ss_dssp             CTT--CCBCCCCSCSSSCCH
T ss_pred             cCC--cccccccCCCcccCH
Confidence            222  233567899999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=6.7e-28  Score=249.15  Aligned_cols=166  Identities=23%  Similarity=0.385  Sum_probs=140.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcC--CCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIR--HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +.|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            359999999999999999999888999999999754  2345678899999999996  599999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      | +.+++|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++ ++.+||+|||+|+.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999998765 6888899999999999999999   99999999999999996 58999999999987643332


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       210 ~~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPP  225 (390)
T ss_dssp             ----CCSCCCGGGCCH
T ss_pred             cccCCCCCcCCCccCh
Confidence            2233456899999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=2.2e-28  Score=246.70  Aligned_cols=168  Identities=27%  Similarity=0.442  Sum_probs=139.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcE----EEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57999999999999999999865 4544    7777765432 233456778999999999999999999986 456889


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999877667889999999999999999999   899999999999999999999999999999976544


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........||+.|+||
T Consensus       169 ~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             TTCCC-----CCTTTSCH
T ss_pred             cccccccCCCCcccccCh
Confidence            433344556788899998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=8.3e-28  Score=237.01  Aligned_cols=165  Identities=29%  Similarity=0.445  Sum_probs=141.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999876 67899999987542   22346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999997654 6889999999999999999999   999999999999999999999999999998654221 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......||+.|+||
T Consensus       163 ---~~~~~~~~~~y~aP  176 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPP  176 (279)
T ss_dssp             --------CCCCTTCCH
T ss_pred             ---cccccCCCCCccCH
Confidence               22446789999998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=4.8e-28  Score=242.81  Aligned_cols=171  Identities=25%  Similarity=0.410  Sum_probs=147.2

Q ss_pred             hcCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      ..++|++.+.||+|+||.||+|++      .+++.||+|+++... ....+.+.+|+++++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346799999999999999999974      256789999997543 23457788999999999 9999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEE
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNC-----------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      ..++||||+++|+|.+++.....                 .+++..++.++.|++.||+|||   +++|+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999986542                 3889999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          547 LDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++.++.+||+|||+++...............||+.|+||
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            999999999999999876544333333455678899998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=5.2e-28  Score=246.28  Aligned_cols=164  Identities=26%  Similarity=0.393  Sum_probs=129.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||+++...  ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999976 68899999987543  345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++..... 
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            99999999997654 6899999999999999999999   899999999999999975   889999999999865321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        ......+||+.|+||
T Consensus       205 --~~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          205 --VLMKTVCGTPGYCAP  219 (349)
T ss_dssp             ----------CGGGSCH
T ss_pred             --cccccccCCCCccCH
Confidence              122456799999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=3.3e-29  Score=253.98  Aligned_cols=161  Identities=21%  Similarity=0.258  Sum_probs=133.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcC---------CCcceeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIR---------HRNLIKV  475 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  475 (585)
                      .++|++.+.||+|+||+||+|++ +|+.||||+++...        ....+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45799999999999999999998 68999999997642        223467889999999886         6666666


Q ss_pred             Eee-----------------eec-------------CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 047705          476 ISS-----------------CSN-------------EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE  525 (585)
Q Consensus       476 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  525 (585)
                      .+.                 |..             .+..|+|||||++|++.+.+.+  ..+++..++.++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977776654  35799999999999999999


Q ss_pred             HHhcCCCCCcEEcCCCCCCEEeCCCC--------------------cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          526 YLHFGCSTPVIHCDLKPSNVLLDDNM--------------------IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       526 ~lH~~~~~~iiH~dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+  +++|+||||||+|||++.++                    .+||+|||+|+....       ...+||+.||||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9992  37999999999999999877                    999999999987532       234799999999

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=9.2e-28  Score=240.56  Aligned_cols=167  Identities=27%  Similarity=0.369  Sum_probs=139.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999876 68999999886442  234567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++++++.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.++...... 
T Consensus        82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            9999999988876553 6899999999999999999999   8999999999999999999999999999998754222 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       157 -~~~~~~~~~~~y~aP  171 (311)
T 4agu_A          157 -DYYDDEVATRWYRSP  171 (311)
T ss_dssp             ----------GGGCCH
T ss_pred             -cccCCCcCCccccCh
Confidence             122445789999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=6.9e-28  Score=242.93  Aligned_cols=158  Identities=25%  Similarity=0.344  Sum_probs=125.8

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          419 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      .+.||+|+||.||+|.+. +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999876 6899999999754   3356778999999997 9999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC---cEEEeeecccccccCCCCcccc
Q 047705          497 LEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       497 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      |.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++   .+||+|||+++.....  ....
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence            999998764 6899999999999999999999   89999999999999997665   8999999999865322  2223


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ...+||+.|+||
T Consensus       167 ~~~~~t~~y~aP  178 (325)
T 3kn6_A          167 KTPCFTLHYAAP  178 (325)
T ss_dssp             ------------
T ss_pred             cccCCCcCccCH
Confidence            456789999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=3.1e-28  Score=246.50  Aligned_cols=167  Identities=29%  Similarity=0.375  Sum_probs=145.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--------hhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--------RAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++....        .....+.+|++++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3467999999999999999999865 789999999975421        1334677899999999999999999999999


Q ss_pred             CeEEEEEEccCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          483 EFKGLVLEYMPQG-SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       483 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999776 9999988764 6899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +......   .....+||+.|+||
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aP  198 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAP  198 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCH
T ss_pred             eECCCCC---ceeccCCCccccCh
Confidence            8754322   22346799999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=8.2e-28  Score=248.70  Aligned_cols=169  Identities=25%  Similarity=0.389  Sum_probs=133.7

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCC--e
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEE--F  484 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  484 (585)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+++.+. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999875 7899999998643  2344567788999999997 999999999997554  7


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+|||||+ ++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999996 5999998764  5888999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCC-------------------CccccccccccccccCC
Q 047705          565 IGED-------------------QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~-------------------~~~~~~~~~gt~~y~aP  585 (585)
                      ....                   ........+||++|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            3211                   11123456899999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=7.3e-28  Score=240.19  Aligned_cols=169  Identities=25%  Similarity=0.453  Sum_probs=143.1

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  485 (585)
                      +.|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|+++++.++||||+++++++...  +..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588999999999999999983     368899999987543 33457788999999999999999999999877  668


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccccCC
Q 047705          566 GEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      ..... .......||+.|+||
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCH
T ss_pred             CCCcceeccCCCCCCccccCC
Confidence            33221 223455688899998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=2.1e-28  Score=246.50  Aligned_cols=179  Identities=21%  Similarity=0.367  Sum_probs=149.9

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEE
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVI  476 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  476 (585)
                      +...++....++|++.+.||+|+||.||+|++.      +++.||+|++.... ......+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            333445556678999999999999999999754      36789999987542 33456788999999999999999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTN---------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       477 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +++...+..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999987532         24688899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+++...............||+.|+||
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            99999999999999866433322333455678999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=2e-27  Score=234.84  Aligned_cols=166  Identities=25%  Similarity=0.470  Sum_probs=144.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999876 68999999997542  334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc---EEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI---AYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999998887654 6899999999999999999999   899999999999999986655   99999999986532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .   .......||+.|+||
T Consensus       161 ~---~~~~~~~~~~~y~aP  176 (284)
T 3kk8_A          161 S---EAWHGFAGTPGYLSP  176 (284)
T ss_dssp             S---CBCCCSCSCGGGCCH
T ss_pred             C---ccccCCCCCcCCcCc
Confidence            2   222446799999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=9.7e-28  Score=241.57  Aligned_cols=166  Identities=27%  Similarity=0.390  Sum_probs=145.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh------hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++......      ..+.+.+|+++++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356999999999999999999876 6899999999754321      356789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeeccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIA  561 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a  561 (585)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 6889999999999999999999   89999999999999999887    7999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +......   ......||+.|+||
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAP  187 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCH
T ss_pred             eecCccc---cccccCCCCCccCc
Confidence            8754321   22446799999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=9.6e-28  Score=244.03  Aligned_cols=162  Identities=30%  Similarity=0.407  Sum_probs=142.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      +.|+..+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            34888999999999999999864 7899999998743   2334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++ |++.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++....   
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9996 6888888765567899999999999999999999   89999999999999999999999999999986532   


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         ....+||+.|+||
T Consensus       207 ---~~~~~gt~~y~aP  219 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAP  219 (348)
T ss_dssp             ---BCCCCSCGGGCCH
T ss_pred             ---CCcccCCcceeCH
Confidence               2345799999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=5.6e-28  Score=245.93  Aligned_cols=171  Identities=29%  Similarity=0.445  Sum_probs=139.6

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-----hhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      .....++|++.+.||+|+||.||+|++. +|+.||+|++.....     ...+.+.+|+++++.++||||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3445678999999999999999999875 689999999875321     1134678899999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      +..++||||+++ ++.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999999975 899998877667888999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......  ......+||+.|+||
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAP  181 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCH
T ss_pred             eccCCc--ccCCcccccccccCc
Confidence            754222  223456799999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=5.8e-28  Score=244.93  Aligned_cols=164  Identities=29%  Similarity=0.427  Sum_probs=140.3

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|+++....    ...+|++++.++ +||||+++++++.+.+..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3467999999999999999999876 689999999975532    335688888888 7999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC----CcEEEeeeccccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN----MIAYLSDFGIAKLLI  565 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~  565 (585)
                      ||++||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||++.++    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997754 6899999999999999999999   8999999999999998532    359999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...  ......+||+.|+||
T Consensus       172 ~~~--~~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAP  189 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCH
T ss_pred             CCC--CceeccCCCccccCH
Confidence            322  123456899999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=1.1e-27  Score=240.51  Aligned_cols=169  Identities=26%  Similarity=0.347  Sum_probs=139.8

Q ss_pred             cCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+.|++. +.||+|+||.||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++..++..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3578874 78999999999999865 7899999999866555567888999999985 7999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc---EEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI---AYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~~  566 (585)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||+++....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999998754 6889999999999999999999   899999999999999987765   99999999886532


Q ss_pred             CCC-----ccccccccccccccCC
Q 047705          567 EDQ-----SMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~-----~~~~~~~~gt~~y~aP  585 (585)
                      ...     .......+||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             ---------------CCSGGGCCH
T ss_pred             CCccccccccccccccCCcCccCh
Confidence            211     1112345699999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=7.5e-28  Score=243.07  Aligned_cols=169  Identities=28%  Similarity=0.415  Sum_probs=146.6

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeee--cCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  ..+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5799999999999999999984     368899999998766666678999999999999999999999886  456789


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999876557899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCc-cccccccccccccCC
Q 047705          567 EDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~-~~~~~~~gt~~y~aP  585 (585)
                      .... .......||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCH
T ss_pred             CCccceeeccCCccccccCH
Confidence            3221 123445688899998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=2.3e-27  Score=235.69  Aligned_cols=166  Identities=22%  Similarity=0.333  Sum_probs=145.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            57999999999999999999876 68899999987542   334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++++|.+++.... .+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||.++...... 
T Consensus        95 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             ECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence            9999999999887654 6889999999999999999999   8999999999999999999999999999998754222 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       170 -~~~~~~~~~~~y~aP  184 (294)
T 2rku_A          170 -ERKKVLCGTPNYIAP  184 (294)
T ss_dssp             -CCBCCCCSCCSSCCH
T ss_pred             -cccccccCCCCcCCc
Confidence             223446799999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=4.8e-28  Score=244.04  Aligned_cols=172  Identities=26%  Similarity=0.462  Sum_probs=129.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeCC-C---cEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLGD-G---MEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      ...++|++.+.||+|+||.||+|++.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999998653 3   27999998754  33456788999999999999999999999987765


Q ss_pred             E------EEEEEccCCCCHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          485 K------GLVLEYMPQGSLEKHLYSTN-----CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       485 ~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      .      ++||||+++|+|.+++....     ..+++..+..++.|++.||+|||   +++|+||||||+||++++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence            5      99999999999999986432     25889999999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+|+...............+|+.|+||
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCH
T ss_pred             EEeeccccccccccccccccccccCcccccCc
Confidence            99999999876443333333455678899998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=6.4e-28  Score=236.05  Aligned_cols=168  Identities=26%  Similarity=0.410  Sum_probs=147.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357899999999999999999988888999999976532 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      ++++|.+++......+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++..... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999887667899999999999999999999   899999999999999999999999999999865321 1112


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      .....||+.|+||
T Consensus       162 ~~~~~~~~~y~aP  174 (267)
T 3t9t_A          162 STGTKFPVKWASP  174 (267)
T ss_dssp             TTSTTCCGGGCCH
T ss_pred             cccccccccccCh
Confidence            2345678889998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=7.9e-28  Score=237.94  Aligned_cols=166  Identities=30%  Similarity=0.439  Sum_probs=140.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56899999999999999999875 68999999987653 23457888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeeccccccc
Q 047705          492 MPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       492 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~  565 (585)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988643   246899999999999999999999   8999999999999999   456789999999998654


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..   .......||+.|+||
T Consensus       179 ~~---~~~~~~~~t~~y~aP  195 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAP  195 (285)
T ss_dssp             -----------CTTGGGCCH
T ss_pred             Cc---ccCcCcccccCcCCh
Confidence            32   223456799999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=8.4e-28  Score=244.56  Aligned_cols=174  Identities=27%  Similarity=0.376  Sum_probs=142.7

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE  482 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  482 (585)
                      +....++|++.+.||+|+||.||+|++. +++.||+|++....     ....+.+.+|++++++++||||+++++++...
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4455678999999999999999999875 78899999987542     34457889999999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 047705          483 EFKGLVLEYMPQGSLEKHLYST---------------------------------------NCILDIFQRLNIMIDVASA  523 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  523 (585)
                      +..++||||++||+|.+++...                                       ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988521                                       1123567788999999999


Q ss_pred             HHHHhcCCCCCcEEcCCCCCCEEeCCCC--cEEEeeecccccccCCCC--ccccccccccccccCC
Q 047705          524 LEYLHFGCSTPVIHCDLKPSNVLLDDNM--IAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAP  585 (585)
Q Consensus       524 l~~lH~~~~~~iiH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aP  585 (585)
                      |+|||   +++|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+||
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            99999   89999999999999998766  899999999986543221  1123456799999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.7e-28  Score=244.94  Aligned_cols=166  Identities=25%  Similarity=0.405  Sum_probs=137.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh-hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            67999999999999999999876 7899999998754322 222455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++ |+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            96 5999999887767899999999999999999999   899999999999999999999999999999864322  12


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (324)
T 3mtl_A          156 TYDNEVVTLWYRPP  169 (324)
T ss_dssp             -------CGGGCCH
T ss_pred             ccccccCcccccCh
Confidence            23445789999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.6e-28  Score=248.09  Aligned_cols=168  Identities=27%  Similarity=0.407  Sum_probs=144.9

Q ss_pred             cCCCCccceecccCceEEEEEEe----CCCcEEEEEEEechh----hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  483 (585)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+..|+++++.+ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999987    368999999986432    23345677899999999 6999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998654 6889999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.... .......+||+.|+||
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAP  229 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCH
T ss_pred             cccCC-CCcccCcccCcCccCh
Confidence            53222 2223456799999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=2.1e-27  Score=240.63  Aligned_cols=167  Identities=22%  Similarity=0.331  Sum_probs=146.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357899999999999999999876 57899999987542   33457788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.... .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999887654 6899999999999999999999   8999999999999999999999999999998754222


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......||+.|+||
T Consensus       196 --~~~~~~~gt~~y~aP  210 (335)
T 2owb_A          196 --ERKKVLCGTPNYIAP  210 (335)
T ss_dssp             --CCBCCCCSCCSSCCH
T ss_pred             --ccccccCCCccccCH
Confidence              223446799999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=4.9e-28  Score=245.07  Aligned_cols=174  Identities=25%  Similarity=0.406  Sum_probs=147.1

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CC-----cEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeee
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DG-----MEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCS  480 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  480 (585)
                      .....++|++.+.||+|+||.||+|++. ++     ..||+|++.... ....+.+.+|+++++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3344578999999999999999999864 22     479999987542 33457788999999999 8999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYST-------------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      ..+..++||||+++|+|.+++...             ...+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            999999999999999999998753             235788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+++...............||+.|+||
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP  235 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence            99999999999999876543333333455678899998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=248.56  Aligned_cols=166  Identities=27%  Similarity=0.413  Sum_probs=143.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--eEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56999999999999999999876 58999999997543 234567788999999999999999999988765  789999


Q ss_pred             EccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----CCCCcEEEeeeccccc
Q 047705          490 EYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLSDFGIAKL  563 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~a~~  563 (585)
                      ||+++|+|.+++.....  .+++..++.++.|++.||+|||   +++|+||||||+||++    +.++.+||+|||+|+.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976532  3899999999999999999999   8999999999999999    7788899999999987


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   .......||+.|+||
T Consensus       166 ~~~~---~~~~~~~gt~~y~aP  184 (396)
T 4eut_A          166 LEDD---EQFVSLYGTEEYLHP  184 (396)
T ss_dssp             CCCG---GGSSCSSSCCTTCCH
T ss_pred             ccCC---CccccccCCccccCH
Confidence            5432   222446799999998

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.1e-26  Score=228.48  Aligned_cols=213  Identities=23%  Similarity=0.258  Sum_probs=165.2

Q ss_pred             CCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccE
Q 047705           59 PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT  138 (585)
Q Consensus        59 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  138 (585)
                      ++|++|+|++|+++.++. ..|..+++|++|+|++|+++++.+. .+..++. |++|++++|.+++..+..|..+++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSH-LSTLILTGNPIQSLALGAFSGLSSLQK  104 (276)
T ss_dssp             TTCCEEECTTCCCCEECT-TTTTTCTTCSEEECTTCCCCEECTT-TTTTCTT-CCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             CCccEEECCCCcccccCH-hHhccccCCcEEECCCCcCCccCHH-HccCCcC-CCEEECCCCccCccChhhhcCCccccE
Confidence            456666666666666654 4566666666666666666655443 4455554 677777777776667777888999999


Q ss_pred             EEeeCCccccccchhhhCCCCCceEEccCCCCCcc-CcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC
Q 047705          139 IDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGS-IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       139 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      |++++|.+.+..+..|..+++|++|++++|++++. +|..+..+++|++|+|++|++++..+..|..+++|+.|.+    
T Consensus       105 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l----  180 (276)
T 2z62_A          105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL----  180 (276)
T ss_dssp             EECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE----
T ss_pred             EECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce----
Confidence            99999999988777899999999999999999874 4888999999999999999999877777777666654432    


Q ss_pred             CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC
Q 047705          218 PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP  292 (585)
Q Consensus       218 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  292 (585)
                                   .|++++|.+++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|+++...+
T Consensus       181 -------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          181 -------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             -------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             -------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence                         6888999998777666654 479999999999998877778999999999999999986543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=1.1e-27  Score=250.01  Aligned_cols=167  Identities=28%  Similarity=0.362  Sum_probs=134.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcCCCcceeEEeeeec
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIRHRNLIKVISSCSN  481 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  481 (585)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999875 68999999997542        1123357889999999999999999999865


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---CcEEEeee
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDF  558 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Df  558 (585)
                       +..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45789999999999999887654 6899999999999999999999   8999999999999999754   45999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|+....   .......+||+.||||
T Consensus       287 G~a~~~~~---~~~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          287 GHSKILGE---TSLMRTLCGTPTYLAP  310 (419)
T ss_dssp             STTTSCC--------------CTTCCT
T ss_pred             ccceecCC---CccccccCCCCCccCc
Confidence            99987532   1223456799999999

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=7.6e-28  Score=241.67  Aligned_cols=180  Identities=24%  Similarity=0.394  Sum_probs=151.1

Q ss_pred             ccCHHHHHHhcCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCccee
Q 047705          403 TFSYLELCRATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIK  474 (585)
Q Consensus       403 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~  474 (585)
                      .+.........++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345556666778999999999999999999974      256889999997543 23456788999999999 7899999


Q ss_pred             EEeeeecCC-eEEEEEEccCCCCHHHHhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEc
Q 047705          475 VISSCSNEE-FKGLVLEYMPQGSLEKHLYSTNCI---------------LDIFQRLNIMIDVASALEYLHFGCSTPVIHC  538 (585)
Q Consensus       475 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~  538 (585)
                      +++++...+ ..++||||+++++|.+++......               +++..+..++.|++.||.|||   +++|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987654 589999999999999999875432               788999999999999999999   8999999


Q ss_pred             CCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       539 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            99999999999999999999999876443333334456789999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=3.6e-27  Score=234.64  Aligned_cols=167  Identities=19%  Similarity=0.233  Sum_probs=145.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ..+.+.+|+++++.+ +|++++++++++...+..++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            367999999999999999999864 78999999986443  335678899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc-----EEEeeeccccccc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI-----AYLSDFGIAKLLI  565 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~  565 (585)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999877667999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             CCCCc-----cccccccccccccCC
Q 047705          566 GEDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      .....     .......||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cccccccccccCccCCCCCcccCCc
Confidence            33221     123456799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=1.2e-27  Score=254.82  Aligned_cols=166  Identities=25%  Similarity=0.416  Sum_probs=144.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++...+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            357999999999999999999876 78999999997542  234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~  566 (585)
                      |||++|+|.+.+.... .+++..+..++.|++.||.|||   +++|+||||||+||+++   .++.+||+|||+|+....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999887654 6899999999999999999999   89999999999999995   566899999999986532


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      .   ......+||+.|+||
T Consensus       177 ~---~~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          177 N---TKMKDRIGTAYYIAP  192 (486)
T ss_dssp             C-------CCTTGGGGCCG
T ss_pred             C---CccCCCcCCCCCCCH
Confidence            2   223456799999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=8.1e-28  Score=238.39  Aligned_cols=167  Identities=27%  Similarity=0.459  Sum_probs=131.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|++.  ..||+|+++..  .....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            367999999999999999999864  35999998754  234557789999999999999999999965 4556899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877667999999999999999999999   899999999999999999999999999999865432323


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       177 ~~~~~~~gt~~y~aP  191 (289)
T 3og7_A          177 HQFEQLSGSILWMAP  191 (289)
T ss_dssp             -------CCCTTCCH
T ss_pred             ccccccCCCccccCc
Confidence            333456799999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=8.3e-28  Score=237.27  Aligned_cols=168  Identities=24%  Similarity=0.370  Sum_probs=132.5

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|++..    +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..|+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4679999999999999999998642    456999987653 2344567889999999999999999999984 467899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . ........+|+.|+||
T Consensus       170 ~-~~~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          170 T-YYKASKGKLPIKWMAP  186 (281)
T ss_dssp             ----------CCGGGCCH
T ss_pred             c-ccccccCCCcccccCh
Confidence            2 1222344578899998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.95  E-value=2.5e-27  Score=236.13  Aligned_cols=167  Identities=30%  Similarity=0.452  Sum_probs=137.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHh--cCCCcceeEEeeeec----CCeEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS--IRHRNLIKVISSCSN----EEFKG  486 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  486 (585)
                      .++|++.+.||+|+||.||+|++ +++.||||++....   ...+..|.+++..  ++||||+++++++..    .+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 68899999987542   3445567777666  799999999998644    34689


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-----CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                      +||||+++|+|.++++..  .+++..+..++.|++.||+|||..     ++++|+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  589999999999999999999932     1579999999999999999999999999999


Q ss_pred             ccccCCCCcc--ccccccccccccCC
Q 047705          562 KLLIGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      +.........  ......||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred             eecccccccccccccccccccceeCh
Confidence            8654332211  12345799999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=2.8e-27  Score=242.36  Aligned_cols=170  Identities=31%  Similarity=0.453  Sum_probs=147.9

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--------hhhHHHHHHHHHHHHhc-CCCcceeEEee
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSI-RHRNLIKVISS  478 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~  478 (585)
                      .....++|++.+.||+|+||.||+|++. +|+.||||+++...        ....+.+.+|+++++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445567999999999999999999986 79999999987542        12245678899999999 89999999999


Q ss_pred             eecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       479 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      +...+..|+||||++|++|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999998653 6899999999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |++..+....   .....+||+.|+||
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aP  268 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAP  268 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCH
T ss_pred             CcccccCCCc---ccccCCCCCCccCh
Confidence            9998764322   23456799999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=5.6e-28  Score=241.02  Aligned_cols=169  Identities=26%  Similarity=0.392  Sum_probs=142.4

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467999999999999999999976 689999999876655566788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999998876567899999999999999999999   899999999999999999999999999997643211  1


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       172 ~~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAP  186 (302)
T ss_dssp             HC-----CCGGGCCH
T ss_pred             cccccccCChhhcCC
Confidence            112345789999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=2.4e-27  Score=234.66  Aligned_cols=162  Identities=30%  Similarity=0.523  Sum_probs=140.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhh-------hHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRR-------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++......       ..+.+.+|++++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            67999999999999999999875 7899999998643211       1267889999999999999999999987665  


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCc-----EEEeee
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMI-----AYLSDF  558 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~-----~kl~Df  558 (585)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +++  |+||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6999999999999999877778999999999999999999999   888  999999999999987776     999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+++....     ......||+.|+||
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAP  195 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCG
T ss_pred             Cccccccc-----cccccCCCccccCc
Confidence            99985321     23446799999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=1.7e-27  Score=243.86  Aligned_cols=175  Identities=28%  Similarity=0.338  Sum_probs=150.2

Q ss_pred             ccccCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-----CCccee
Q 047705          401 WRTFSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-----HRNLIK  474 (585)
Q Consensus       401 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  474 (585)
                      ...+++.+.....++|++.+.||+|+||.||+|++. +++.||||+++.. ......+..|+++++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            345666666677789999999999999999999875 7899999998743 234456778999999986     999999


Q ss_pred             EEeeeecCCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC----
Q 047705          475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD----  549 (585)
Q Consensus       475 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~----  549 (585)
                      +++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 899999998754 35889999999999999999999   899999999999999975    


Q ss_pred             ---------------------CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          550 ---------------------NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       550 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                                           ++.+||+|||+|+....     ......||+.|+||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aP  228 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAP  228 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCc
Confidence                                 78999999999986432     12346799999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=2.9e-27  Score=252.96  Aligned_cols=167  Identities=26%  Similarity=0.442  Sum_probs=142.9

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh-------------hhHHHHHHHHHHHHhcCCCcceeEEe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-------------RAFKSFDVECEIMKSIRHRNLIKVIS  477 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  477 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3468999999999999999999876 688999999875421             23467889999999999999999999


Q ss_pred             eeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC---cEE
Q 047705          478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM---IAY  554 (585)
Q Consensus       478 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~---~~k  554 (585)
                      ++...+..|+|||||+||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999987654 6899999999999999999999   89999999999999998765   699


Q ss_pred             EeeecccccccCCCCccccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|||+|+.....   ......+||+.|+||
T Consensus       190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aP  217 (504)
T 3q5i_A          190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAP  217 (504)
T ss_dssp             ECCCTTCEECCTT---SCBCCCCSCTTTCCH
T ss_pred             EEECCCCEEcCCC---CccccccCCcCCCCH
Confidence            9999999876432   223456799999998

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=2e-26  Score=225.85  Aligned_cols=207  Identities=24%  Similarity=0.290  Sum_probs=157.0

Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  164 (585)
                      +++++++++|.++.+ |.    .++..+++|++++|++++..+..|..+++|++|+|++|.++.+.+..|.++++|++|+
T Consensus        17 ~~~~l~~~~~~l~~i-p~----~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAI-PS----NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTEEECTTSCCSSC-CS----CCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCEEEccCCCCCcc-CC----CCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            344555555555432 21    1122355555555555555556677788888888888888877777778888888888


Q ss_pred             ccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCC
Q 047705          165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP  244 (585)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~  244 (585)
                      |++|++++..+..|..+++|++|+|++|.+++..+..                     +..+++|+.|++++|.+++..+
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------~~~l~~L~~L~Ls~n~l~~~~~  150 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRV---------------------FDSLTKLTYLSLGYNELQSLPK  150 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTT---------------------TTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHH---------------------hCcCcCCCEEECCCCcCCccCH
Confidence            8888888777777778888888888888887654443                     3455667777778888887777


Q ss_pred             cccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       245 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      ..|..+++|+.|+|++|+++++.+..|..+++|+.|++++|++++..+..+..+++|+.|++++|+|.|.|+.
T Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            7788899999999999999988777889999999999999999987777788899999999999999998874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=1.6e-27  Score=254.43  Aligned_cols=165  Identities=24%  Similarity=0.408  Sum_probs=140.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++.+.||+|+||.||+|+.. ++..||+|++....  ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999976 78899999987542  2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeecccccccCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.   ++.+||+|||+|+.....
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999887654 6889999999999999999999   899999999999999975   456999999999876432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                         ......+||++|+||
T Consensus       193 ---~~~~~~~gt~~y~aP  207 (494)
T 3lij_A          193 ---KKMKERLGTAYYIAP  207 (494)
T ss_dssp             ---BCBCCCCSCTTTCCH
T ss_pred             ---ccccccCCCcCeeCH
Confidence               223456799999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=3.3e-27  Score=233.35  Aligned_cols=165  Identities=29%  Similarity=0.439  Sum_probs=144.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999876 67889999987542   22346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999998754 6889999999999999999999   999999999999999999999999999998764321 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......||+.|+||
T Consensus       168 ---~~~~~~~~~~y~aP  181 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPP  181 (284)
T ss_dssp             ---CBCCCCSCGGGCCH
T ss_pred             ---ccccccCCCCcCCH
Confidence               22346799999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=1.1e-27  Score=252.95  Aligned_cols=164  Identities=27%  Similarity=0.327  Sum_probs=135.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  482 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999876 6899999999754  334457788999999999999999999998654      


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            357999999965 57666653   4789999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   .......+||++|+||
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAP  232 (464)
T ss_dssp             -------CCCC----CCCTTCCH
T ss_pred             ecCC---CcccCCCcccccccCH
Confidence            6532   2223557899999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=3.7e-27  Score=235.85  Aligned_cols=167  Identities=29%  Similarity=0.420  Sum_probs=137.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-----hhhHHHHHHHHHHHHhc---CCCcceeEEeeeecC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-----RRAFKSFDVECEIMKSI---RHRNLIKVISSCSNE  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  482 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....     ......+.+|+++++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3578999999999999999999964 78999999987432     11224566777777766   499999999998775


Q ss_pred             C-----eEEEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEe
Q 047705          483 E-----FKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS  556 (585)
Q Consensus       483 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~  556 (585)
                      .     ..++||||++ ++|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999996 599999987653 4899999999999999999999   8999999999999999999999999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+|+.....   .......||+.|+||
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aP  188 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAP  188 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCH
T ss_pred             eCccccccCCC---cccCCccccccccCc
Confidence            99999865322   223456799999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=2.6e-27  Score=245.41  Aligned_cols=162  Identities=25%  Similarity=0.334  Sum_probs=130.5

Q ss_pred             cCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHh-cCCCcceeEEeeeec----CCeE
Q 047705          413 TDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKS-IRHRNLIKVISSCSN----EEFK  485 (585)
Q Consensus       413 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  485 (585)
                      .++|.+. +.||+|+||.||+|++. +++.||||+++..     ..+.+|++++.+ .+||||++++++|..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567666 78999999999999876 6899999998643     345678888754 589999999998865    5678


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeeccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIA  561 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a  561 (585)
                      |+|||||+||+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998754 36899999999999999999999   899999999999999987   789999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.....   ......+||+.||||
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aP  232 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAP  232 (400)
T ss_dssp             EECC--------------CTTCCG
T ss_pred             cccCCC---CccccCCCCCCccCH
Confidence            865322   223456899999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=2.4e-27  Score=236.39  Aligned_cols=169  Identities=27%  Similarity=0.394  Sum_probs=139.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----------  481 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  481 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++..          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457999999999999999999875 7899999998654 3345778899999999999999999998754          


Q ss_pred             ---CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          482 ---EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       482 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                         .+..|+||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               35779999999999999999877667888899999999999999999   899999999999999999999999999


Q ss_pred             cccccccCCC------------CccccccccccccccCC
Q 047705          559 GIAKLLIGED------------QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~------------~~~~~~~~~gt~~y~aP  585 (585)
                      |.++......            .........||+.|+||
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            9998653211            01122456789999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.94  E-value=9.1e-28  Score=253.35  Aligned_cols=169  Identities=23%  Similarity=0.438  Sum_probs=144.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..|+|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3456789999999999999999999888999999997543 34678999999999999999999999986 567899999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence            999999999997543 25788899999999999999999   8999999999999999999999999999998753211 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ........+|+.|+||
T Consensus       339 ~~~~~~~~~~~~y~aP  354 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAP  354 (454)
T ss_dssp             HHTTCSSSSCGGGSCH
T ss_pred             eeccCCCcccccccCH
Confidence            1122344567889998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=3.8e-27  Score=233.14  Aligned_cols=164  Identities=23%  Similarity=0.353  Sum_probs=141.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...  .......+.+|+..+..+ +||||+++++++..++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999876 7899999998754  233456788899999999 999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---------------
Q 047705          489 LEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---------------  550 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---------------  550 (585)
                      |||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642   36899999999999999999999   8999999999999999844               


Q ss_pred             ----CcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          551 ----MIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       551 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                          ..+||+|||.+......      ....||+.|+||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aP  199 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLAN  199 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCH
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccCh
Confidence                47999999999875322      224589999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=1.4e-27  Score=254.39  Aligned_cols=165  Identities=27%  Similarity=0.447  Sum_probs=145.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++...+..|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56999999999999999999876 78999999987542   334577889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+|+....
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999987654 6899999999999999999999   8999999999999999   4678999999999987643


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..   .....+||+.|+||
T Consensus       182 ~~---~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAP  197 (484)
T ss_dssp             CC---SHHHHTTGGGTCCH
T ss_pred             cc---ccccCCCCccccCc
Confidence            22   23456799999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=2.1e-27  Score=243.29  Aligned_cols=174  Identities=23%  Similarity=0.295  Sum_probs=141.5

Q ss_pred             CHHHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh-----------hhhHHHHHHHHHHHHhcCCCcce
Q 047705          405 SYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC-----------RRAFKSFDVECEIMKSIRHRNLI  473 (585)
Q Consensus       405 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv  473 (585)
                      ...++....++|++.+.||+|+||.||+|...+++.||||++....           ....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3567778889999999999999999999998889999999985431           12236788999999999999999


Q ss_pred             eEEeeeec-----CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          474 KVISSCSN-----EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       474 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      ++++++..     ....|+||||++ |++.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            99999843     346899999997 6899988877667999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .++.+||+|||+++.....   .......||+.|+||
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAP  202 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCH
T ss_pred             CCCCEEEEecCcccccccc---cccceecccceecCc
Confidence            9999999999999854322   223456789999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=4.3e-27  Score=231.43  Aligned_cols=167  Identities=28%  Similarity=0.426  Sum_probs=139.1

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4478999999999999999999976 78999999997543   2235678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999999997654 6889999999999999999999   899999999999999999999999999999865322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      .   ......||+.|+||
T Consensus       165 ~---~~~~~~~~~~y~aP  179 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAP  179 (276)
T ss_dssp             ---------------CCT
T ss_pred             c---ceecccCCccccCH
Confidence            1   22345789999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=7.5e-28  Score=238.41  Aligned_cols=171  Identities=27%  Similarity=0.455  Sum_probs=148.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            345578999999999999999999876 58899999987543 3457788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          489 LEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||+++++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.++.....
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999998743 35899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . ........||+.|+||
T Consensus       165 ~-~~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAP  181 (288)
T ss_dssp             S-SEEETTEEECGGGCCH
T ss_pred             c-cccccCCccccCcCCh
Confidence            2 2233455678899998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=6.6e-27  Score=232.79  Aligned_cols=168  Identities=27%  Similarity=0.385  Sum_probs=146.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---------hhhHHHHHHHHHHHHhcC-CCcceeEEeee
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---------RRAFKSFDVECEIMKSIR-HRNLIKVISSC  479 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  479 (585)
                      ...++|++.+.||+|+||.||+|++. +++.||||+++...         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999876 68999999997542         223467788999999995 99999999999


Q ss_pred             ecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       480 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      ...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999998653 6899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+.......   ......||+.|+||
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aP  192 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAP  192 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCH
T ss_pred             chhhcCCCc---ccccccCCccccCH
Confidence            998754322   22446789999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.94  E-value=1.4e-27  Score=244.72  Aligned_cols=169  Identities=21%  Similarity=0.283  Sum_probs=138.0

Q ss_pred             cCCCCccceecccCceEEEEEEeCC------CcEEEEEEEechhhhh-----------HHHHHHHHHHHHhcCCCcceeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD------GMEVAVKVFNLQCRRA-----------FKSFDVECEIMKSIRHRNLIKV  475 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  475 (585)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998754      4789999987543211           1233456667778899999999


Q ss_pred             EeeeecC----CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--C
Q 047705          476 ISSCSNE----EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--D  549 (585)
Q Consensus       476 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~  549 (585)
                      ++++...    ...|+||||+ |++|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 99999999887668999999999999999999999   89999999999999998  8


Q ss_pred             CCcEEEeeecccccccCCCCcc-----ccccccccccccCC
Q 047705          550 NMIAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAP  585 (585)
Q Consensus       550 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aP  585 (585)
                      ++.+||+|||+|+.+.......     .....+||+.||||
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence            8999999999998764322111     12345699999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.94  E-value=1.5e-27  Score=254.28  Aligned_cols=168  Identities=27%  Similarity=0.468  Sum_probs=145.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++. ++..||||+++... ...+.+.+|++++++++||||+++++++...+..|+||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            456889999999999999999976 48899999987543 2457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998643 36889999999999999999999   8999999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+++.|+||
T Consensus       374 ~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          374 TAHAGAKFPIKWTAP  388 (495)
T ss_dssp             ECCTTCCCCGGGCCH
T ss_pred             eecCCCcCCcceeCH
Confidence            222345577899998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=2.3e-27  Score=236.89  Aligned_cols=165  Identities=25%  Similarity=0.410  Sum_probs=142.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357899999999999999999876 7899999999865444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++....  
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--  161 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--  161 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence            99999999987654 6889999999999999999999   8999999999999999   7888999999999875422  


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......||+.|+||
T Consensus       162 --~~~~~~~~~~~y~aP  176 (304)
T 2jam_A          162 --GIMSTACGTPGYVAP  176 (304)
T ss_dssp             --BTTHHHHSCCCBCCT
T ss_pred             --CccccccCCCCccCh
Confidence              122345799999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=2.7e-27  Score=235.68  Aligned_cols=169  Identities=28%  Similarity=0.427  Sum_probs=140.3

Q ss_pred             CCCCccceecccCceEEEEEEeCC----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeee-ecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  487 (585)
                      ..|++.+.||+|+||.||+|++.+    ...||+|.+... .....+.+.+|++++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468889999999999999998642    235899988653 334557788999999999999999999985 45568899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CC--ccccccccccccccCC
Q 047705          568 DQ--SMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~--~~~~~~~~gt~~y~aP  585 (585)
                      ..  ........||+.|+||
T Consensus       182 ~~~~~~~~~~~~~~~~y~aP  201 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMAL  201 (298)
T ss_dssp             GGCBC-----CCBCGGGSCH
T ss_pred             chhccccccCCCCCccccCh
Confidence            21  1223455688899998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=4.1e-27  Score=232.44  Aligned_cols=165  Identities=28%  Similarity=0.406  Sum_probs=141.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh------hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999876 689999999875421      13577899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~  562 (585)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+||+|||.+.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997643 6899999999999999999999   89999999999999998777    89999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......   ......||+.|+||
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAP  180 (283)
T ss_dssp             ECC-----------CCCGGGCCH
T ss_pred             eccCCC---cccccCCCcCccCc
Confidence            653221   22345789999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=3e-27  Score=249.00  Aligned_cols=163  Identities=31%  Similarity=0.453  Sum_probs=140.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC-eEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  490 (585)
                      ..++|++.+.||+|+||.||+|++. ++.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..|+|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467889999999999999999885 7799999997543  4577899999999999999999999987654 7899999


Q ss_pred             ccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++|+|.+++..... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999987543 4688999999999999999999   899999999999999999999999999999854211  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         .....+++.|+||
T Consensus       343 ---~~~~~~~~~y~aP  355 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAP  355 (450)
T ss_dssp             -------CCCTTTSCH
T ss_pred             ---ccCCCCCcceeCH
Confidence               1223578899998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=2.8e-27  Score=241.28  Aligned_cols=169  Identities=25%  Similarity=0.400  Sum_probs=143.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeec--------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSN--------  481 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  481 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999875 78999999986542  2234567789999999999999999999876        


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                      .+..|+||||+++ ++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999965 888888776667999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCCC--ccccccccccccccCC
Q 047705          562 KLLIGEDQ--SMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~--~~~~~~~~gt~~y~aP  585 (585)
                      +.+.....  ........||+.|+||
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             ccccccccccccccCCcccccCccCc
Confidence            87642221  1223456789999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=3.1e-27  Score=238.45  Aligned_cols=169  Identities=29%  Similarity=0.474  Sum_probs=145.2

Q ss_pred             CCCCccceecccCceEEEEEEe-----CCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--eEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARL-----GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  486 (585)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5689999999999999999984     368899999998766666678999999999999999999999987654  679


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999887667899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCC
Q 047705          567 EDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ..... ......+++.|+||
T Consensus       198 ~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCH
T ss_pred             cccccccccCCCCceeEECc
Confidence            32211 12334577889998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2e-27  Score=243.59  Aligned_cols=162  Identities=27%  Similarity=0.372  Sum_probs=135.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999875 7899999998543  2334567889999999999999999999987663      


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 88999999874  5889999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...     .....+||++|+||
T Consensus       178 ~~~-----~~~~~~~t~~y~aP  194 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAP  194 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCT
T ss_pred             ccc-----ccCcCcCCCCcCCH
Confidence            532     23456799999999

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=3e-27  Score=239.11  Aligned_cols=167  Identities=28%  Similarity=0.433  Sum_probs=139.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367999999999999999999876 58999999986542  234566788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||++++++.++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            9999988888765543 6899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       179 -~~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          179 -EVYDDEVATRWYRAP  193 (331)
T ss_dssp             ------CCCCCTTCCH
T ss_pred             -cccCCCcCCccccCc
Confidence             222445789999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=1.5e-27  Score=244.13  Aligned_cols=164  Identities=24%  Similarity=0.366  Sum_probs=143.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57999999999999999999876 7899999998765 334457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++.....   
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            99999999998754 6889999999999999999999   75 9999999999999999999999999999765321   


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......||+.|+||
T Consensus       186 -~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          186 -MANSFVGTRSYMSP  199 (360)
T ss_dssp             -C----CCCCTTCCH
T ss_pred             -cccCCCCCCCeECH
Confidence             22345799999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.3e-27  Score=241.27  Aligned_cols=169  Identities=27%  Similarity=0.412  Sum_probs=135.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcE----EEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGME----VAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999865 4554    466666433 2335578889999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887778999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...........||+.|+||
T Consensus       170 ~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             ccccccccCCCccccccCH
Confidence            3333334455678899998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=7.2e-27  Score=233.16  Aligned_cols=165  Identities=28%  Similarity=0.413  Sum_probs=145.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56899999999999999999865 78999999997553 34467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +++++|.+++...  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||.+.......  .
T Consensus       102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  174 (303)
T 3a7i_A          102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  174 (303)
T ss_dssp             CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence            9999999998753  5899999999999999999999   8999999999999999999999999999998754322  2


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.|+||
T Consensus       175 ~~~~~~~~~~y~aP  188 (303)
T 3a7i_A          175 KRNTFVGTPFWMAP  188 (303)
T ss_dssp             CBCCCCSCGGGCCH
T ss_pred             ccCccCCCcCccCH
Confidence            23456799999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=7.2e-27  Score=236.76  Aligned_cols=168  Identities=30%  Similarity=0.427  Sum_probs=137.9

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc--CCCcceeEEeeeecC----
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI--RHRNLIKVISSCSNE----  482 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  482 (585)
                      .....++|++.+.||+|+||.||+|++. ++.||||++.....   ..+..|.+++...  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3444568999999999999999999885 88999999865432   3344556665554  899999999998877    


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CcEEcCCCCCCEEeCCCCcEE
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST--------PVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~--------~iiH~dlkp~NIll~~~~~~k  554 (585)
                      +..++||||+++|+|.+++...  .+++..++.++.|++.||+|||   ..        +|+||||||+||+++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6889999999999999999765  5889999999999999999999   77        999999999999999999999


Q ss_pred             EeeecccccccCCCCcc--ccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      |+|||+|+.........  ......||+.|+||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeCh
Confidence            99999998654322211  12345799999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=1.2e-27  Score=241.69  Aligned_cols=170  Identities=25%  Similarity=0.374  Sum_probs=135.1

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .....++|++.+.||+|+||.||+|++. +++.||||+++...  ....+.+.+|++++++++||||+++++++..++..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3455678999999999999999999865 78999999986542  22345677899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe-----CCCCcEEEeeecc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL-----DDNMIAYLSDFGI  560 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll-----~~~~~~kl~Dfg~  560 (585)
                      ++||||++ |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++     +.++.+||+|||+
T Consensus       109 ~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99999997 59999998765 5899999999999999999999   8999999999999999     4556699999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+......  ......+||+.|+||
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPP  206 (329)
T ss_dssp             HHHHC-------------CCTTCCH
T ss_pred             ccccCCcc--cccCCCcCCccccCH
Confidence            98753221  223445789999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.6e-27  Score=238.60  Aligned_cols=169  Identities=27%  Similarity=0.483  Sum_probs=137.5

Q ss_pred             CCCCccceecccCceEEEEEEeCC-----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD-----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||.||+|++..     +..||+|+++.. .......+.+|+++++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467788999999999999997542     245999998754 23345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999887667999999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCc-cccccccccccccCC
Q 047705          568 DQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~-~~~~~~~gt~~y~aP  585 (585)
                      ... .......+|+.|+||
T Consensus       201 ~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             cccccccCCCCccccccCc
Confidence            211 122334568889998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=2.7e-27  Score=237.86  Aligned_cols=170  Identities=24%  Similarity=0.313  Sum_probs=142.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeee----cCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS----NEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++.    ..+..|+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            357999999999999999999874 78999999987666666778899999999999999999999986    3457899


Q ss_pred             EEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          488 VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999876   3447899999999999999999999   899999999999999999999999999998764


Q ss_pred             cCCCCcc-------ccccccccccccCC
Q 047705          565 IGEDQSM-------TQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~-------~~~~~~gt~~y~aP  585 (585)
                      .......       ......||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  212 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAP  212 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred             ccccccccccccccccccccCCcccCCH
Confidence            3211100       11234679999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=1.9e-27  Score=234.38  Aligned_cols=168  Identities=25%  Similarity=0.445  Sum_probs=143.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..++|++.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|+++++.++||||+++++++.. +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            446799999999999999999998888899999987543 235678899999999999999999999864 468999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||.++...... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            999999999975432 5889999999999999999999   8999999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+|+.|+||
T Consensus       165 ~~~~~~~~~~~y~aP  179 (279)
T 1qpc_A          165 TAREGAKFPIKWTAP  179 (279)
T ss_dssp             ECCTTCCCCTTTSCH
T ss_pred             ccccCCCCccCccCh
Confidence            222345678889998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=4e-27  Score=235.75  Aligned_cols=171  Identities=25%  Similarity=0.318  Sum_probs=139.2

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      ....++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            344578999999999999999999876 78899999987542   22346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999998754 6899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ... ........||+.|+||
T Consensus       186 ~~~-~~~~~~~~~~~~y~aP  204 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAP  204 (309)
T ss_dssp             ------------CCGGGCCG
T ss_pred             ccc-cccccccCCCcCccCH
Confidence            322 1223356799999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=8e-27  Score=231.79  Aligned_cols=167  Identities=28%  Similarity=0.420  Sum_probs=141.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      ++|.....||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            45666779999999999999875 68899999998765556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccccccCCCC
Q 047705          493 PQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       493 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ++++|.+++.....  ..++..+..++.|++.||+|||   +++|+||||||+||+++. ++.+||+|||.++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999987533  4568888999999999999999   899999999999999987 8999999999998654221 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.|+||
T Consensus       178 -~~~~~~~~~~~y~aP  192 (295)
T 2clq_A          178 -PCTETFTGTLQYMAP  192 (295)
T ss_dssp             ----CCCCCCGGGCCH
T ss_pred             -CcccccCCCccccCh
Confidence             122345789999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=3.5e-27  Score=231.41  Aligned_cols=163  Identities=31%  Similarity=0.483  Sum_probs=130.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh----hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|++. ++.||+|+++...    ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467999999999999999999974 8899999986542    22356788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---cEEcCCCCCCEEeCC--------CCcEEEee
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP---VIHCDLKPSNVLLDD--------NMIAYLSD  557 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iiH~dlkp~NIll~~--------~~~~kl~D  557 (585)
                      |||+++++|.+++...  .+++..+..++.|++.|++|||   +++   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999998654  6899999999999999999999   777   999999999999985        77899999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||.++.....    ......||+.|+||
T Consensus       160 fg~~~~~~~~----~~~~~~~~~~y~aP  183 (271)
T 3dtc_A          160 FGLAREWHRT----TKMSAAGAYAWMAP  183 (271)
T ss_dssp             CCC-----------------CCGGGSCH
T ss_pred             CCcccccccc----cccCCCCccceeCH
Confidence            9999865322    12345799999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.94  E-value=5.3e-27  Score=237.72  Aligned_cols=165  Identities=36%  Similarity=0.530  Sum_probs=133.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHH--HHhcCCCcceeEEeeee-----cCCe
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEI--MKSIRHRNLIKVISSCS-----NEEF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~  484 (585)
                      ..++|++.+.||+|+||.||+|+. +++.||||++.....   ..+..|.++  +..++||||+++++.+.     ....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            457899999999999999999987 688999999975432   333344444  45689999999998543     2346


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CcEEcCCCCCCEEeCCCCcEEE
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST---------PVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~---------~iiH~dlkp~NIll~~~~~~kl  555 (585)
                      .++||||+++|+|.+++....  .++..+..++.|+++||+|||   +.         +|+||||||+||+++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            789999999999999998764  588889999999999999999   77         9999999999999999999999


Q ss_pred             eeecccccccCCCC------ccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQ------SMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aP  585 (585)
                      +|||+|+.+.....      .......+||+.|+||
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCc
Confidence            99999987643221      1122355799999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=6.5e-27  Score=234.73  Aligned_cols=167  Identities=29%  Similarity=0.376  Sum_probs=141.5

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....  ..+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999876 68999999987543  34678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999755557899999999999999999999   8999999999999999999999999999998654321  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       180 ~~~~~~~~~~~y~aP  194 (314)
T 3com_A          180 AKRNTVIGTPFWMAP  194 (314)
T ss_dssp             SCBCCCCSCGGGCCH
T ss_pred             cccCccCCCCCccCh
Confidence            223445789999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5.7e-27  Score=232.01  Aligned_cols=168  Identities=26%  Similarity=0.412  Sum_probs=142.5

Q ss_pred             CCCCccc-eecccCceEEEEEEeC---CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENN-LIGRGGFGSVYKARLG---DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|+++.. .....+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 9999999999999753   5778999999764 234567889999999999999999999999 45568999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++++|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999876667999999999999999999999   8999999999999999999999999999998764332


Q ss_pred             Cc-cccccccccccccCC
Q 047705          569 QS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~-~~~~~~~gt~~y~aP  585 (585)
                      .. .......||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             CEECCCCSSCCCGGGCCH
T ss_pred             ceeeccccccccccccCH
Confidence            21 122344578999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=1.1e-26  Score=230.28  Aligned_cols=163  Identities=26%  Similarity=0.382  Sum_probs=140.4

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  487 (585)
                      .|++.+.||+|+||.||+|.+. ++..||+|++...  .....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4788889999999999999875 6889999998754  23456778899999999999999999998865    456899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeC-CCCcEEEeeecccccc
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLD-DNMIAYLSDFGIAKLL  564 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~  564 (585)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+  |+||||||+||+++ +++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999998754 6889999999999999999999   888  99999999999998 7899999999999754


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...    ......||+.|+||
T Consensus       183 ~~~----~~~~~~~t~~y~aP  199 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAP  199 (290)
T ss_dssp             CTT----SBEESCSSCCCCCG
T ss_pred             ccc----ccccccCCcCcCCH
Confidence            321    22345799999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.1e-26  Score=233.59  Aligned_cols=165  Identities=28%  Similarity=0.446  Sum_probs=140.5

Q ss_pred             CCccceecccCceEEEEEEeC-----CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEE
Q 047705          416 FSENNLIGRGGFGSVYKARLG-----DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGL  487 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  487 (585)
                      |++.+.||+|+||.||+|.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999998642     57889999997653 34467789999999999999999999999874  67899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|+|.+++...  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999999999875  4889999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCc-cccccccccccccCC
Q 047705          568 DQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~-~~~~~~~gt~~y~aP  585 (585)
                      ... .......||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             CSEEEC---CCCCGGGCCH
T ss_pred             ccccccccCCCCCceeeCh
Confidence            221 123445688899998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=9.9e-27  Score=232.32  Aligned_cols=169  Identities=23%  Similarity=0.364  Sum_probs=141.1

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh----hhhHHHHHHHHHHHHhcCCCcceeEEeeee--cCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC----RRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....    ....+.+.+|+++++.++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999875 68899999997542    234577899999999999999999999984  44578


Q ss_pred             EEEEEccCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          486 GLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ++||||++++ +.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77776653 346899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .............||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCH
T ss_pred             CccccccccccCCCCCCCcCh
Confidence            433333333456799999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=4.6e-27  Score=230.36  Aligned_cols=162  Identities=22%  Similarity=0.414  Sum_probs=142.1

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC--CeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  488 (585)
                      .++|++.+.||+|+||.||+|+++ ++.||+|+++...  ....+.+.+|+.++++++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357999999999999999999984 8899999987542  34456789999999999999999999999887  788999


Q ss_pred             EEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |||+++|+|.+++..... .+++..+..++.|++.||+|||   +++  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987654 5899999999999999999999   888  9999999999999999999999999876421


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                             .....||+.|+||
T Consensus       165 -------~~~~~~t~~y~aP  177 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAP  177 (271)
T ss_dssp             -------CTTCBSCGGGSCH
T ss_pred             -------ccCccCCccccCh
Confidence                   1235689999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=3.5e-27  Score=240.30  Aligned_cols=165  Identities=24%  Similarity=0.396  Sum_probs=145.5

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhh-----------------HHHHHHHHHHHHhcCCCcceeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRA-----------------FKSFDVECEIMKSIRHRNLIKV  475 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  475 (585)
                      .++|++.+.||+|+||.||+|++ +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999998 89999999997553211                 1788999999999999999999


Q ss_pred             EeeeecCCeEEEEEEccCCCCHHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEe
Q 047705          476 ISSCSNEEFKGLVLEYMPQGSLEKH------LYST-NCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLL  547 (585)
Q Consensus       476 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll  547 (585)
                      ++++...+..++||||+++++|.++      +... ...+++..+..++.|++.||.|||   + ++|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 347899999999999999999999   7 999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||.+......    ......||+.|+||
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aP  219 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPP  219 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCG
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCc
Confidence            99999999999999875322    23456799999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=8.8e-27  Score=233.34  Aligned_cols=169  Identities=28%  Similarity=0.437  Sum_probs=134.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|++++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3467999999999999999999865 7899999998753   23455778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          488 VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999864   2346889999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....  .......||+.|+||
T Consensus       187 ~~~~--~~~~~~~~~~~y~aP  205 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSP  205 (310)
T ss_dssp             --------------CCSSCCH
T ss_pred             cCCC--ccccccCCCeeEeCh
Confidence            4222  122345789999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=3.4e-27  Score=238.27  Aligned_cols=170  Identities=24%  Similarity=0.400  Sum_probs=139.7

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|++      .+++.||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36799999999999999999983      25778999998643 334456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEe
Q 047705          486 GLVLEYMPQGSLEKHLYSTN------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLS  556 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~  556 (585)
                      |+||||+++++|.+++....      ..+++..++.++.|++.||.|||   +++|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998754      34888999999999999999999   899999999999999984   4469999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+++...............||+.|+||
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             ccccccccccccccccCCCcCCCcceeCH
Confidence            99999865433322333455789999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=2.2e-27  Score=250.24  Aligned_cols=168  Identities=26%  Similarity=0.462  Sum_probs=138.6

Q ss_pred             hcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788999999999999999999888889999987543 234678999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997532 35889999999999999999999   8999999999999999999999999999998754322 1


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+|+.|+||
T Consensus       336 ~~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          336 TARQGAKFPIKWTAP  350 (452)
T ss_dssp             -------CCGGGSCH
T ss_pred             ecccCCcccccccCH
Confidence            222345578899998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.5e-27  Score=257.03  Aligned_cols=156  Identities=20%  Similarity=0.143  Sum_probs=123.5

Q ss_pred             eecccCceEEEEEEe-CCCcEEEEEEEech----------hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEE
Q 047705          421 LIGRGGFGSVYKARL-GDGMEVAVKVFNLQ----------CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       421 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ..+.|+.|.+..++. -.|+.||+|++...          .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            355667776666543 25889999998643          234457799999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++|++|.+++.+.. .+++.   +|+.||+.||+|+|   ++|||||||||+|||++++|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999998764 56654   58899999999999   9999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        ......+||++||||
T Consensus       394 --~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             --CCSHHHHHHHHHHHH
T ss_pred             --ccccCceechhhccH
Confidence              233457899999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=4.9e-27  Score=233.68  Aligned_cols=168  Identities=23%  Similarity=0.382  Sum_probs=140.9

Q ss_pred             CCCccceecccCceEEEEEEeC-C---CcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE-EEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-D---GMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK-GLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  488 (585)
                      .|...+.||+|+||.||+|++. +   +..||+|++.... ....+.+.+|++++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999753 2   2379999987532 34557888999999999999999999999876655 999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+.+|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             --CccccccccccccccCC
Q 047705          569 --QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 --~~~~~~~~~gt~~y~aP  585 (585)
                        .........||+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~y~aP  197 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTAL  197 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCH
T ss_pred             ccccccCcCCCCCccccCh
Confidence              11222445688899998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=1.8e-27  Score=237.30  Aligned_cols=174  Identities=25%  Similarity=0.363  Sum_probs=128.0

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      .....++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3445678999999999999999999865 78899999886542 334567888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          487 LVLEYMPQGSLEKHLYS-------TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      +||||+++++|.+++..       ....+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999874       2346899999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccCCCC---ccccccccccccccCC
Q 047705          560 IAKLLIGEDQ---SMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~---~~~~~~~~gt~~y~aP  585 (585)
                      ++........   ........||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             HHHHCC---------------CCCTTCCH
T ss_pred             chheeccCCCccchhhhcccCCCccccCH
Confidence            9886543211   1112345799999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.6e-27  Score=237.88  Aligned_cols=176  Identities=28%  Similarity=0.362  Sum_probs=143.2

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN  481 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  481 (585)
                      +++.++....++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344455566788999999999999999999875 78999999987543 2346788899999999 89999999999976


Q ss_pred             ------CCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEE
Q 047705          482 ------EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAY  554 (585)
Q Consensus       482 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~k  554 (585)
                            .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence                  467899999999999999998653 36889999999999999999999   89999999999999999999999


Q ss_pred             EeeecccccccCCCCccccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|||++.......  .......||+.|+||
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAP  198 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCH
T ss_pred             EeeCcCceecCcCc--cccccccCCccccCh
Confidence            99999988653211  122345799999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=5.6e-27  Score=236.09  Aligned_cols=165  Identities=28%  Similarity=0.372  Sum_probs=137.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  483 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++....        ......+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999876 68899999986432        122346788999999999999999999987665


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc---EEEeeecc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI---AYLSDFGI  560 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~  560 (585)
                       .|+||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999999987654 6899999999999999999999   899999999999999986654   99999999


Q ss_pred             cccccCCCCccccccccccccccCC
Q 047705          561 AKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       561 a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ++....   ........||+.|+||
T Consensus       164 ~~~~~~---~~~~~~~~gt~~y~aP  185 (322)
T 2ycf_A          164 SKILGE---TSLMRTLCGTPTYLAP  185 (322)
T ss_dssp             CEECCC---CHHHHHHHSCCTTCCH
T ss_pred             ceeccc---ccccccccCCcCccCc
Confidence            986532   1122345799999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.94  E-value=6e-27  Score=234.86  Aligned_cols=175  Identities=26%  Similarity=0.450  Sum_probs=133.6

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEeC----CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec
Q 047705          408 ELCRATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN  481 (585)
Q Consensus       408 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  481 (585)
                      ++....++|.+.+.||+|+||.||+|+..    +++.||+|+++..  .....+.+.+|+.++++++||||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33445577999999999999999999753    3458999998754  23445778899999999999999999999877


Q ss_pred             CC-----eEEEEEEccCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC
Q 047705          482 EE-----FKGLVLEYMPQGSLEKHLYS-----TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM  551 (585)
Q Consensus       482 ~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~  551 (585)
                      .+     ..++||||+++++|.+++..     ....+++..++.++.|+++||.|||   +++|+||||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence            65     35999999999999999853     2246899999999999999999999   99999999999999999999


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+||+|||+++...............+++.|+||
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCc
Confidence            9999999999876433322333445678899998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.3e-27  Score=243.36  Aligned_cols=168  Identities=29%  Similarity=0.445  Sum_probs=131.1

Q ss_pred             CCCccceecccCceEEEEEEeC--CC--cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeee-cCCeEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCS-NEEFKGLV  488 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  488 (585)
                      .|++.+.||+|+||.||+|++.  ++  ..||+|.++.. .....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667889999999999999753  32  46899988643 2345678899999999999999999999865 45678999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||+++|+|.+++......+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877667889999999999999999999   8999999999999999999999999999998654322


Q ss_pred             Cc--cccccccccccccCC
Q 047705          569 QS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~--~~~~~~~gt~~y~aP  585 (585)
                      ..  .......+|+.|+||
T Consensus       247 ~~~~~~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMAL  265 (373)
T ss_dssp             -----------CCGGGSCH
T ss_pred             cccccccCCCCCcccccCh
Confidence            11  122445678899998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=1.1e-26  Score=238.20  Aligned_cols=168  Identities=27%  Similarity=0.328  Sum_probs=142.9

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----Ce
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF  484 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  484 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999876 78899999987532 33457788999999999999999999998655     36


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+||||++ |+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999996 5999998765  5889999999999999999999   899999999999999999999999999999875


Q ss_pred             cCCCCc-cccccccccccccCC
Q 047705          565 IGEDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~-~~~~~~~gt~~y~aP  585 (585)
                      ...... ......+||+.|+||
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCH
T ss_pred             CCCCCccccccccccccCCCCC
Confidence            432211 112456899999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=6.2e-27  Score=231.17  Aligned_cols=162  Identities=28%  Similarity=0.504  Sum_probs=140.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-----------
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-----------  481 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----------  481 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....    +.+.+|++++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            56899999999999999999986 78999999987543    356789999999999999999998854           


Q ss_pred             -----CCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEE
Q 047705          482 -----EEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYL  555 (585)
Q Consensus       482 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl  555 (585)
                           ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||   +++|+||||||+||++++++.+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEE
Confidence                 345799999999999999997642 36889999999999999999999   899999999999999999999999


Q ss_pred             eeecccccccCCCCccccccccccccccCC
Q 047705          556 SDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       556 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++......   ......||+.|+||
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aP  190 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSP  190 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCH
T ss_pred             Ccchhheeccccc---cccccCCcccccCh
Confidence            9999998764322   22345799999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=6.8e-27  Score=230.68  Aligned_cols=168  Identities=26%  Similarity=0.428  Sum_probs=139.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|++..    +..||+|++... .....+.+.+|+++++.++||||+++++++..+ ..|+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4679999999999999999997532    346999998754 234567889999999999999999999998654 5689


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . ........+|+.|+||
T Consensus       167 ~-~~~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          167 D-YYKASVTRLPIKWMSP  183 (281)
T ss_dssp             -------CCCCCGGGCCH
T ss_pred             c-ccccccCCCCcceeCc
Confidence            2 1223345678899998

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=6.9e-26  Score=224.15  Aligned_cols=207  Identities=21%  Similarity=0.160  Sum_probs=150.6

Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                      +..+++++++++++|.++.+.+.     ++..++.|+|++|.+++..+..|..+++|++|+|++|.|+++.+.  ..+++
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~-----~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~   78 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPD-----LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPV   78 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSC-----CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTT
T ss_pred             ccccCCccEEECCCCCCCcCCCC-----CCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCc
Confidence            34445555555555555433221     122355555555555555556677778888888888888765443  67778


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcc
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNF  239 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l  239 (585)
                      |++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..                     +..+++|+.|++++|++
T Consensus        79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~---------------------~~~l~~L~~L~L~~N~l  136 (290)
T 1p9a_G           79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGA---------------------LRGLGELQELYLKGNEL  136 (290)
T ss_dssp             CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSST---------------------TTTCTTCCEEECTTSCC
T ss_pred             CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHH---------------------HcCCCCCCEEECCCCCC
Confidence            888888888887 55667777888888888888887544443                     44555667777788888


Q ss_pred             cccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCC
Q 047705          240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP  316 (585)
Q Consensus       240 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~  316 (585)
                      ++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|++++|+|+ .+|..+..+++|+.++|++|+|.|.|.
T Consensus       137 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            8777778888999999999999999777777888999999999999998 567777888899999999999998875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=8.5e-27  Score=235.32  Aligned_cols=166  Identities=30%  Similarity=0.528  Sum_probs=138.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcE--EEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGME--VAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||.||+|++. ++..  ||+|.+... .....+.+.+|+++++++ +||||+++++++...+..|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999865 5664  489988753 233456788999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          489 LEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      |||+++++|.+++....               ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653               36899999999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+++....   ........+|+.|+||
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAI  210 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccCh
Confidence            9999999874321   1122334578889998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.1e-26  Score=239.88  Aligned_cols=164  Identities=27%  Similarity=0.410  Sum_probs=135.1

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--------
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--------  481 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  481 (585)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.....    ...+|+++++.++||||++++++|..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999865 789999999875432    23469999999999999999999843        


Q ss_pred             ------------------------------CCeEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 047705          482 ------------------------------EEFKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLH  528 (585)
Q Consensus       482 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH  528 (585)
                                                    ....++||||++ |+|.+.+..   ....+++..+..++.|+++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          334889999997 587777653   3347899999999999999999999


Q ss_pred             cCCCCCcEEcCCCCCCEEeC-CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          529 FGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       529 ~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                         +++|+||||||+||+++ .++.+||+|||+|+......   ......||+.|+||
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAP  210 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCH
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCH
Confidence               99999999999999997 68999999999998754322   23456789999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.94  E-value=1e-26  Score=231.59  Aligned_cols=167  Identities=29%  Similarity=0.423  Sum_probs=141.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            368999999999999999999876 78999999986542  223467888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||++ ++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+.......
T Consensus        82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  157 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  157 (299)
T ss_dssp             ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence            9997 69999987654 36888999999999999999999   8999999999999999999999999999998753221


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        .......||+.|+||
T Consensus       158 --~~~~~~~~~~~y~aP  172 (299)
T 2r3i_A          158 --RTYTHEVVTLWYRAP  172 (299)
T ss_dssp             --BCTTSCBCCCTTCCH
T ss_pred             --cccCcccccccccCc
Confidence              122345789999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=3.6e-27  Score=232.33  Aligned_cols=168  Identities=26%  Similarity=0.396  Sum_probs=141.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeee--cCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999876 78999999997542  344577889999999999999999999874  4568899


Q ss_pred             EEEccCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          488 VLEYMPQGSLEKHLYSTN---CILDIFQRLNIMIDVASALEYLHFGCSTP-----VIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      ||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532   34899999999999999999999   777     9999999999999999999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .++......  .......||+.|+||
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSP  185 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCH
T ss_pred             hheeecccc--ccccccCCCccccCh
Confidence            998653221  122345789999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=1.4e-26  Score=237.82  Aligned_cols=163  Identities=26%  Similarity=0.321  Sum_probs=131.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999875 6889999999753  2334567889999999999999999999987664      


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999964 78888863   4788999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...   .......+||+.|+||
T Consensus       177 ~~~---~~~~~~~~gt~~y~aP  195 (371)
T 2xrw_A          177 AGT---SFMMTPYVVTRYYRAP  195 (371)
T ss_dssp             ----------------CTTCCH
T ss_pred             ccc---ccccCCceecCCccCH
Confidence            532   1223456799999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.94  E-value=9e-27  Score=232.89  Aligned_cols=162  Identities=30%  Similarity=0.442  Sum_probs=131.5

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|++. ++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56889999999999999999874 788999998643  345778899999999999999999998874  4789999999


Q ss_pred             CCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc-EEEeeecccccccCCCCc
Q 047705          494 QGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI-AYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       494 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  570 (585)
                      +|+|.+++.....  .+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999987643  4678889999999999999999222289999999999999988876 799999999764321   


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        .....||+.|+||
T Consensus       160 --~~~~~gt~~y~aP  172 (307)
T 2eva_A          160 --MTNNKGSAAWMAP  172 (307)
T ss_dssp             -------CCTTSSCH
T ss_pred             --cccCCCCCceECh
Confidence              2334699999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=8.5e-27  Score=230.99  Aligned_cols=166  Identities=27%  Similarity=0.305  Sum_probs=129.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++...  ....+.+.++...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467999999999999999999875 78999999987542  222334455556688889999999999999999999999


Q ss_pred             EccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          490 EYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       490 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      ||++ |++.+++..   ....+++..+..++.|++.||+|||   ++ +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 488777654   3447899999999999999999999   77 99999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...   ......||+.|+||
T Consensus       162 ~~~---~~~~~~~t~~y~aP  178 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAP  178 (290)
T ss_dssp             -----------CCCCCCSCH
T ss_pred             ccc---cccccCCCccccCh
Confidence            321   22334799999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=2.4e-26  Score=232.31  Aligned_cols=159  Identities=24%  Similarity=0.380  Sum_probs=138.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeec--CCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSN--EEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...   .+.+.+|+++++.++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67999999999999999999864 78999999987442   366888999999997 9999999999987  56789999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  568 (585)
                      ||+++++|.+++..    +++..+..++.|++.||+|||   +++|+||||||+||+++.++ .+||+|||+|+......
T Consensus       113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999998853    788899999999999999999   89999999999999999666 89999999998654322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......||+.|+||
T Consensus       186 ---~~~~~~~~~~y~aP  199 (330)
T 3nsz_A          186 ---EYNVRVASRYFKGP  199 (330)
T ss_dssp             ---CCCSCCSCGGGCCH
T ss_pred             ---ccccccccccccCh
Confidence               22445789999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=1.9e-27  Score=245.01  Aligned_cols=163  Identities=18%  Similarity=0.230  Sum_probs=132.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech---hhhhHHHHHHHH---HHHHhcCCCcceeEE-------ee
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ---CRRAFKSFDVEC---EIMKSIRHRNLIKVI-------SS  478 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  478 (585)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467899999999999999999864 7999999999743   334567888999   555566899999998       55


Q ss_pred             eecCC-----------------eEEEEEEccCCCCHHHHhhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 047705          479 CSNEE-----------------FKGLVLEYMPQGSLEKHLYSTNC------ILDIFQRLNIMIDVASALEYLHFGCSTPV  535 (585)
Q Consensus       479 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  535 (585)
                      +..++                 ..|+||||+ +|+|.+++.....      .+++..+..++.||+.||+|||   +++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 6799999986431      2235778889999999999999   8999


Q ss_pred             EEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       536 iH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||||||+|||++.++.+||+|||+|+...     ......+| +.|+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aP  271 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPP  271 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccCh
Confidence            999999999999999999999999998532     12345567 999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=1.9e-26  Score=233.49  Aligned_cols=168  Identities=26%  Similarity=0.294  Sum_probs=131.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeee--------cCC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCS--------NEE  483 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~  483 (585)
                      .+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999875 78999999987666566678899999999996 999999999983        344


Q ss_pred             eEEEEEEccCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          484 FKGLVLEYMPQGSLEKHLYS--TNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      ..++||||+. |+|.+++..  ....+++..++.++.|++.||+|||   ..+  |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            6899999995 699998865  3346899999999999999999999   888  9999999999999999999999999


Q ss_pred             ccccccCCCCcc----------ccccccccccccCC
Q 047705          560 IAKLLIGEDQSM----------TQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~----------~~~~~~gt~~y~aP  585 (585)
                      +++.........          ......||+.|+||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             TCBCCSSCC---------------------------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            998764322110          11245699999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=1.4e-26  Score=233.78  Aligned_cols=171  Identities=20%  Similarity=0.298  Sum_probs=141.7

Q ss_pred             HHHhcCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCC
Q 047705          409 LCRATDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEE  483 (585)
Q Consensus       409 ~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  483 (585)
                      .....+.|.+. +.||+|+||.||+|+.. +++.||+|++....  ......+.+|+.+++.+. ||||+++++++...+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            33445567776 89999999999999876 68999999987542  233567889999999995 699999999999999


Q ss_pred             eEEEEEEccCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeec
Q 047705          484 FKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFG  559 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg  559 (585)
                      ..++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999998654 246899999999999999999999   899999999999999987   7899999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.....   .......||+.|+||
T Consensus       180 ~a~~~~~~---~~~~~~~gt~~y~aP  202 (327)
T 3lm5_A          180 MSRKIGHA---CELREIMGTPEYLAP  202 (327)
T ss_dssp             GCEEC------------CCCGGGCCH
T ss_pred             cccccCCc---cccccccCCcCccCC
Confidence            99875322   122446799999998

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.8e-25  Score=219.04  Aligned_cols=203  Identities=27%  Similarity=0.328  Sum_probs=124.8

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+.+.+++++++++ .+|..+.  ++|++|+|++|.|+ .++...+..+++|++|+|++|+++.++. ..|..+++|++|
T Consensus        16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~-~~~~~l~~L~~L   90 (270)
T 2o6q_A           16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPA-GIFKELKNLETL   90 (270)
T ss_dssp             TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCT-TTTSSCTTCCEE
T ss_pred             CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeCh-hhhcCCCCCCEE
Confidence            35667777777776 4555443  46777777777776 3333334466777777777777777664 556677777777


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|+++++.+. .+..+++ |++|++++|.+++..+..|..+++|++|+|++|.+.++.+..|..+++|++|+|++|+
T Consensus        91 ~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A           91 WVTDNKLQALPIG-VFDQLVN-LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             ECCSSCCCCCCTT-TTTTCSS-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ECCCCcCCcCCHh-HcccccC-CCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence            7777777654443 4444544 6666666666666555556666666666666666665555556666666666666666


Q ss_pred             CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCccc
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS  240 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~  240 (585)
                      |+++.+..|..+++|++|+|++|.+++..+..                     +..+++|+.|++++|.+.
T Consensus       169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          169 LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA---------------------FDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCSCCCTTT---------------------TTTCTTCCEEECCSSCBC
T ss_pred             CcEeChhHhccCCCcCEEECCCCcCCcCCHHH---------------------hccccCCCEEEecCCCee
Confidence            66555555666666666666666665443333                     444556666666777664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=6.8e-27  Score=237.81  Aligned_cols=167  Identities=22%  Similarity=0.255  Sum_probs=134.6

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEechhhh-----------hHHHHHHHHHHHHhcCCCcceeEEee
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQCRR-----------AFKSFDVECEIMKSIRHRNLIKVISS  478 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~  478 (585)
                      ++|++.+.||+|+||.||+|++.    ++..||+|+.......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            67999999999999999999875    5678999998754211           12346678899999999999999999


Q ss_pred             eec----CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC--c
Q 047705          479 CSN----EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM--I  552 (585)
Q Consensus       479 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~--~  552 (585)
                      +..    .+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            887    67899999999 999999998765 7899999999999999999999   89999999999999998777  9


Q ss_pred             EEEeeecccccccCCCCc-----cccccccccccccCC
Q 047705          553 AYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       553 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      +||+|||+|+.+......     .......||+.|+||
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence            999999999876432211     112456799999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=4.7e-27  Score=252.64  Aligned_cols=169  Identities=26%  Similarity=0.454  Sum_probs=143.8

Q ss_pred             HhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ...++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.. +..|+|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3456788999999999999999999888889999997543 234678999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            999999999997532 35889999999999999999999   8999999999999999999999999999998653211 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      ........++..||||
T Consensus       418 ~~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAP  433 (535)
T ss_dssp             HHTTCSTTSCGGGSCH
T ss_pred             eecccCCcCcccccCH
Confidence            1122344577889998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=5.8e-27  Score=239.93  Aligned_cols=163  Identities=27%  Similarity=0.362  Sum_probs=124.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------  482 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  482 (585)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3478999999999999999999865 7899999998653  233456788999999999999999999998654      


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ...|+||||+ +++|.+++...  .+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             CeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            5679999999 78999988763  5899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....     .....+||++|+||
T Consensus       181 ~~~~-----~~~~~~~t~~y~aP  198 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAP  198 (367)
T ss_dssp             ---------------CCCTTCCH
T ss_pred             cccc-----cCCCcCcCcCccCh
Confidence            6432     23456799999998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=253.55  Aligned_cols=167  Identities=25%  Similarity=0.405  Sum_probs=136.1

Q ss_pred             CCCccc-eecccCceEEEEEEeC---CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          415 GFSENN-LIGRGGFGSVYKARLG---DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       415 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++.+.+ .||+|+||.||+|.++   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999753   45679999987642 3356789999999999999999999999976 5689999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999877667999999999999999999999   89999999999999999999999999999987643222


Q ss_pred             cc-ccccccccccccCC
Q 047705          570 SM-TQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~-~~~~~~gt~~y~aP  585 (585)
                      .. ......+|+.||||
T Consensus       492 ~~~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAP  508 (613)
T ss_dssp             ----------CCTTSCH
T ss_pred             eeeeccCCCCccceeCH
Confidence            11 12233467899998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=2.4e-26  Score=231.01  Aligned_cols=167  Identities=26%  Similarity=0.370  Sum_probs=135.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeee-----------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS-----------  480 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  480 (585)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999876 58999999998766666788899999999999999999999873           


Q ss_pred             ---cCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEe
Q 047705          481 ---NEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLS  556 (585)
Q Consensus       481 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~  556 (585)
                         ..+..|+||||++ |+|.+++...  .+++..++.++.|++.||+|||   +++|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 5999998753  5889999999999999999999   89999999999999997 67799999


Q ss_pred             eecccccccCCCC-ccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aP  585 (585)
                      |||+++....... ........||+.|+||
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSP  193 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred             cCccccccCCCcccccccccccccccccCc
Confidence            9999986542211 1122345679999998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=2.3e-26  Score=225.69  Aligned_cols=226  Identities=22%  Similarity=0.281  Sum_probs=142.9

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEcc
Q 047705           13 EELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLS   92 (585)
Q Consensus        13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls   92 (585)
                      ..+++.++.+...  ..+..+++|++|++++|.++ .++...  .+++|++|+|++|+++.++   .+..+++|++|+|+
T Consensus        22 ~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~l~--~l~~L~~L~l~~n~l~~~~---~l~~l~~L~~L~L~   93 (272)
T 3rfs_A           22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQGIQ--YLPNVRYLALGGNKLHDIS---ALKELTNLTYLILT   93 (272)
T ss_dssp             HHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCTTGG--GCTTCCEEECTTSCCCCCG---GGTTCTTCCEEECT
T ss_pred             HHHHhcCcccccc--cccccccceeeeeeCCCCcc-cccccc--cCCCCcEEECCCCCCCCch---hhcCCCCCCEEECC
Confidence            3445555554432  34556667777777777766 333332  4677777777777776653   46667777777777


Q ss_pred             CCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCc
Q 047705           93 NNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG  172 (585)
Q Consensus        93 ~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  172 (585)
                      +|+++++.+. .++.++. |++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|++++
T Consensus        94 ~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           94 GNQLQSLPNG-VFDKLTN-LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             TSCCCCCCTT-TTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCccCccChh-HhcCCcC-CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            7777655443 3444544 6666666666665555556666666666666666666555556666666666666666665


Q ss_pred             cCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCC
Q 047705          173 SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKN  252 (585)
Q Consensus       173 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  252 (585)
                      ..+..|..+++|++|++++|.+++..+..                     +..+++|+.|++++|.+.+       .+++
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------~~~l~~L~~L~l~~N~~~~-------~~~~  223 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGV---------------------FDRLTSLQYIWLHDNPWDC-------TCPG  223 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTT---------------------TTTCTTCCEEECCSSCBCC-------CTTT
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHH---------------------HhCCcCCCEEEccCCCccc-------cCcH
Confidence            55555666666666666666666544433                     4455666667777776653       3567


Q ss_pred             CcEEeecccCcccccCccccCcCC
Q 047705          253 LEYLFLGYNRLQGLIPDSFGNLIS  276 (585)
Q Consensus       253 L~~L~ls~N~l~~~~~~~~~~l~~  276 (585)
                      |+.|+++.|.++|.+|.+++.+..
T Consensus       224 l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          224 IRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             THHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHHHHHHhCCCcccCcccccCC
Confidence            888888888888888888776654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.93  E-value=6.9e-27  Score=234.43  Aligned_cols=176  Identities=22%  Similarity=0.373  Sum_probs=141.8

Q ss_pred             cCHHHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcC--CCcceeEEeee
Q 047705          404 FSYLELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIR--HRNLIKVISSC  479 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~  479 (585)
                      +.+..+....++|++.+.||+|+||.||+|+..+++.||+|++...  .....+.+.+|++++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3344444555779999999999999999999888999999998754  2345678899999999997  59999999999


Q ss_pred             ecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeec
Q 047705          480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFG  559 (585)
Q Consensus       480 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  559 (585)
                      ...+..++||| +.+++|.+++.... .+++..+..++.|+++||.|||   +++|+||||||+||+++ ++.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeecc
Confidence            99999999999 55889999998764 6889999999999999999999   89999999999999996 4899999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++...............||+.|+||
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPP  197 (313)
T ss_dssp             SSCC--------------CCGGGCCH
T ss_pred             ccccccCccccccccCCCCCCCcCCH
Confidence            99876433322233456799999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=2.5e-26  Score=227.92  Aligned_cols=168  Identities=26%  Similarity=0.381  Sum_probs=138.7

Q ss_pred             cCCCCccc-eecccCceEEEEEEe--C-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          413 TDGFSENN-LIGRGGFGSVYKARL--G-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       413 ~~~~~~~~-~lg~G~~g~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      .++|++.+ .||+|+||.||+|.+  . +++.||||+++...  ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688887 999999999999954  2 46889999987542  23457789999999999999999999999 556789


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998754 6889999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCC
Q 047705          567 EDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ..... ......||+.|+||
T Consensus       170 ~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TCSEEEC----CCCGGGCCH
T ss_pred             CCCcccccccCCCCceeeCh
Confidence            32211 12334567889998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.93  E-value=6.7e-26  Score=230.15  Aligned_cols=170  Identities=28%  Similarity=0.436  Sum_probs=143.5

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHh--cCCCcceeEEeeeecCC----
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKS--IRHRNLIKVISSCSNEE----  483 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----  483 (585)
                      ....++|++.+.||+|+||.||+|++ +++.||||++....   ...+..|++++..  ++||||+++++++...+    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            44456899999999999999999988 58899999987542   3566778888887  78999999999998776    


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-----CSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      ..++||||+++|+|.+++...  .+++..++.++.|++.||+|||..     ++++|+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            789999999999999999875  588999999999999999999931     1468999999999999999999999999


Q ss_pred             cccccccCCCCcc--ccccccccccccCC
Q 047705          559 GIAKLLIGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      |+++.........  ......||+.|+||
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred             CCceeccccccccccccccCCcCcccCCH
Confidence            9998764332211  23455799999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.93  E-value=4e-26  Score=226.76  Aligned_cols=168  Identities=26%  Similarity=0.402  Sum_probs=137.8

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeee-ecCCeEEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKGLVL  489 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  489 (585)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.....  ...+..|+++++.++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4478999999999999999999874 789999998765432  24678899999999988776666554 6677889999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ||+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999999876667999999999999999999999   8999999999999999   7889999999999987653


Q ss_pred             CCCc-----cccccccccccccCC
Q 047705          567 EDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      ....     .......||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred             cccCccCCCCcccccCCCccccch
Confidence            3221     122356799999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=4.4e-26  Score=232.62  Aligned_cols=167  Identities=26%  Similarity=0.349  Sum_probs=140.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----CeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  485 (585)
                      .++|++.+.||+|+||.||+|++. +|+.||||++... .......+.+|+++++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999876 6899999998643 233456788999999999999999999987654     678


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++ ++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 5999998764  5899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCCCcc--------ccccccccccccCC
Q 047705          566 GEDQSM--------TQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~--------~~~~~~gt~~y~aP  585 (585)
                      ......        .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             ----------------CCCCCCGGGCCH
T ss_pred             cccccccCccccccchhhccccccccCC
Confidence            221110        12345789999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=1.5e-26  Score=229.40  Aligned_cols=168  Identities=28%  Similarity=0.399  Sum_probs=133.1

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCc--EEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--DGM--EVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|++.  +++  .||+|+++..   .....+.+.+|++++++++||||+++++++..++ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57999999999999999999753  333  6899988754   2345578889999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +||||+++++|.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999876567899999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCC
Q 047705          567 EDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ..... ......+|+.|+||
T Consensus       174 ~~~~~~~~~~~~~~~~y~aP  193 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAP  193 (291)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             cccchhhhccCCCCceeeCc
Confidence            32211 22345678899998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.93  E-value=9.2e-27  Score=237.58  Aligned_cols=163  Identities=15%  Similarity=0.228  Sum_probs=137.3

Q ss_pred             CCCCccceecccCceEEEEEEeCC---------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCccee----------
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK----------  474 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  474 (585)
                      ++|++.+.||+|+||.||+|++..         ++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            679999999999999999998763         789999998754     46778999999999999987          


Q ss_pred             -----EEeeeec-CCeEEEEEEccCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          475 -----VISSCSN-EEFKGLVLEYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       475 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                           +++++.. ++..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5666665 67889999999 99999999875 247899999999999999999999   8999999999999999


Q ss_pred             CCCC--cEEEeeecccccccCCCCc-----cccccccccccccCC
Q 047705          548 DDNM--IAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      +.++  .+||+|||+++.+......     .......||+.|+||
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM  237 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence            9988  9999999999876432211     112345799999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.93  E-value=1.3e-26  Score=238.25  Aligned_cols=164  Identities=12%  Similarity=0.082  Sum_probs=121.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhc--CCCcceeEEe-------ee
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSI--RHRNLIKVIS-------SC  479 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~  479 (585)
                      ...|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.+++.+  +||||++++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345899999999999999999976 78999999998643   23456777885555444  6999888663       33


Q ss_pred             ecC-----------------CeEEEEEEccCCCCHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCcE
Q 047705          480 SNE-----------------EFKGLVLEYMPQGSLEKHLYSTNCILDIFQR------LNIMIDVASALEYLHFGCSTPVI  536 (585)
Q Consensus       480 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~~~ii  536 (585)
                      ..+                 ...|+||||++ |+|.+++...+..+++..+      ..++.||+.||+|||   +++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            222                 34799999998 8999999875434455555      677899999999999   89999


Q ss_pred             EcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       537 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||||||+|||++.++.+||+|||+|+....     ......||+.|+||
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aP  260 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR  260 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCH
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcCh
Confidence            999999999999999999999999986521     11245677999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.93  E-value=5.8e-26  Score=237.52  Aligned_cols=163  Identities=23%  Similarity=0.301  Sum_probs=139.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc------CCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI------RHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  485 (585)
                      ..+|++.+.||+|+||.||+|++. +++.||||+++... .....+..|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999876 68999999997542 3345677888888877      577999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc--EEEeeecccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI--AYLSDFGIAK  562 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~a~  562 (585)
                      ++||||+. ++|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 69999988764 35899999999999999999999   899999999999999998887  9999999997


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....     .....+||+.||||
T Consensus       251 ~~~~-----~~~~~~gt~~y~aP  268 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAP  268 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCH
T ss_pred             ecCC-----cccccCCCCCccCh
Confidence            5421     22346799999998

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=1.9e-25  Score=220.95  Aligned_cols=201  Identities=28%  Similarity=0.278  Sum_probs=150.6

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      ++++++++|+++.. |..+.  +++++|+|++|.+.+..+..|.++++|++|+|++|.|+++.+.  ..+++|++|+|++
T Consensus        12 l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~   86 (290)
T 1p9a_G           12 HLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSH   86 (290)
T ss_dssp             CCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCS
T ss_pred             ccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCC
Confidence            56666666666533 22222  4556666666666655555566666666666666666543222  4555566666666


Q ss_pred             CcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       192 N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      |.++                      .+|..+..+++|+.|++++|++++..+..|.++++|++|+|++|++++..+..|
T Consensus        87 N~l~----------------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  144 (290)
T 1p9a_G           87 NQLQ----------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (290)
T ss_dssp             SCCS----------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             CcCC----------------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc
Confidence            6554                      234456677888899999999998888999999999999999999998888889


Q ss_pred             cCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCC
Q 047705          272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      ..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.++..++.......++.+++.+|||.|++.
T Consensus       145 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence            99999999999999999877778889999999999999999766655566678889999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=2.7e-26  Score=239.47  Aligned_cols=161  Identities=29%  Similarity=0.481  Sum_probs=132.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------CeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------EFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  486 (585)
                      .+|++.+.||+|+||.||+|++. +++.||||++....    ....+|+++++.++||||++++++|...      .+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35889999999999999999976 68999999986542    2234699999999999999999988432      2467


Q ss_pred             EEEEccCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-CcEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLY---STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-MIAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~a~  562 (585)
                      +||||+++ ++.+.+.   .....+++..+..++.||++||+|||   +++|+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 6666554   23447899999999999999999999   9999999999999999954 678999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ......   .....+||++|+||
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aP  225 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAP  225 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCH
T ss_pred             hcccCC---CceeeeeCCCcCCH
Confidence            754322   22456799999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=3.6e-26  Score=226.22  Aligned_cols=167  Identities=25%  Similarity=0.408  Sum_probs=144.0

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999876 78999999997543  23457788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC---CcEEEeeeccccccc
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN---MIAYLSDFGIAKLLI  565 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~  565 (585)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999887654 6899999999999999999999   8999999999999999753   479999999998653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...   ......||+.|+||
T Consensus       176 ~~~---~~~~~~~~~~y~aP  192 (287)
T 2wei_A          176 QNT---KMKDRIGTAYYIAP  192 (287)
T ss_dssp             CCS---SCSCHHHHHTTCCH
T ss_pred             CCC---ccccccCcccccCh
Confidence            222   22344689999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.93  E-value=6.9e-26  Score=225.13  Aligned_cols=167  Identities=26%  Similarity=0.413  Sum_probs=140.5

Q ss_pred             cCCCCccceecccCceEEEEEEe-CCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeee-ecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|++ .+++.||+|++.....  .+.+.+|+++++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999987 4789999999875432  24688899999999988766555544 66778899999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeecccccccCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++   +++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999866667999999999999999999999   89999999999999994   8889999999999876533


Q ss_pred             CCc-----cccccccccccccCC
Q 047705          568 DQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~-----~~~~~~~gt~~y~aP  585 (585)
                      ...     .......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccccCCh
Confidence            221     112456799999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.93  E-value=7.3e-26  Score=239.06  Aligned_cols=167  Identities=23%  Similarity=0.346  Sum_probs=141.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC-CcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....  ...+..|+++++.++| ++|+.+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999864 789999998875432  2467889999999987 566667777778889999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe---CCCCcEEEeeecccccccCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL---DDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |+ +++|.+++......+++..++.++.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 99999999876667999999999999999999999   8999999999999999   58899999999999876543


Q ss_pred             CCcc-----ccccccccccccCC
Q 047705          568 DQSM-----TQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~-----~~~~~~gt~~y~aP  585 (585)
                      ....     ......||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccccccccccccccCCCccccCH
Confidence            2211     12366899999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.93  E-value=2.7e-26  Score=237.47  Aligned_cols=161  Identities=30%  Similarity=0.482  Sum_probs=132.2

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------eEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------FKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  487 (585)
                      .+|++.+.||+|+||.||+|++..+..||+|++.....    ...+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46999999999999999999988777799998864422    2236999999999999999999985433      4789


Q ss_pred             EEEccCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeeccccc
Q 047705          488 VLEYMPQGSLEKHLY---STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKL  563 (585)
Q Consensus       488 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~  563 (585)
                      ||||++++ +.+.+.   .....+++..+..++.|++.||+|||   +++|+||||||+||+++ .++.+||+|||+|+.
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999764 433332   22347899999999999999999999   89999999999999998 799999999999987


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....   .....+||++|+||
T Consensus       192 ~~~~~---~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAP  210 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCH
T ss_pred             ccCCC---CCcccccCcCccCH
Confidence            64322   23456789999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=1.4e-26  Score=228.05  Aligned_cols=162  Identities=31%  Similarity=0.454  Sum_probs=132.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-CeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-EFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++ .++.||+|+++...  ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46799999999999999999987 47899999987543  456788999999999999999999987554 578999999


Q ss_pred             cCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++++|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999976532 3788899999999999999999   899999999999999999999999999998864321   


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        .....+++.|+||
T Consensus       171 --~~~~~~~~~y~aP  183 (278)
T 1byg_A          171 --QDTGKLPVKWTAP  183 (278)
T ss_dssp             -------CCTTTSCH
T ss_pred             --ccCCCccccccCH
Confidence              1234578899998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.93  E-value=3.7e-26  Score=234.76  Aligned_cols=161  Identities=25%  Similarity=0.350  Sum_probs=136.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE----
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK----  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  485 (585)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999876 7899999999754  233457788999999999999999999999877654    


Q ss_pred             --EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          486 --GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       486 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                        |+||||++ ++|.+++..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 688887743   4899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...     .....+||+.|+||
T Consensus       194 ~~~-----~~~~~~~t~~y~aP  210 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAP  210 (371)
T ss_dssp             -----------CTTCCCTTSCH
T ss_pred             ccc-----CcCCcccCccccCH
Confidence            432     23456789999998

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=7.5e-26  Score=222.03  Aligned_cols=228  Identities=18%  Similarity=0.236  Sum_probs=167.3

Q ss_pred             CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccE
Q 047705           35 TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLED  114 (585)
Q Consensus        35 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  114 (585)
                      ++..+++.++.+.....   ...+++|++|++++|.++.++   .+..+++|++|+|++|+++++ +  .++.++. |++
T Consensus        20 ~l~~l~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~~~---~l~~l~~L~~L~l~~n~l~~~-~--~l~~l~~-L~~   89 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQ---GIQYLPNVRYLALGGNKLHDI-S--ALKELTN-LTY   89 (272)
T ss_dssp             HHHHHHHTCSCTTSEEC---HHHHTTCCEEECTTSCCCCCT---TGGGCTTCCEEECTTSCCCCC-G--GGTTCTT-CCE
T ss_pred             HHHHHHhcCcccccccc---cccccceeeeeeCCCCccccc---ccccCCCCcEEECCCCCCCCc-h--hhcCCCC-CCE
Confidence            45566777777663333   224788889999988888774   477788888899988888754 1  3455554 777


Q ss_pred             EEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcc
Q 047705          115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       115 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      |++++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+
T Consensus        90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  169 (272)
T 3rfs_A           90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL  169 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence            77777776666666666667777777777776666666666666677777777766666565566666666666666666


Q ss_pred             cccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCc
Q 047705          195 SRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL  274 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  274 (585)
                      ++..+.                     .+..+++|+.|++++|.+++..+..|..+++|+.|++++|++.+       .+
T Consensus       170 ~~~~~~---------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~  221 (272)
T 3rfs_A          170 QSLPEG---------------------VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TC  221 (272)
T ss_dssp             CCCCTT---------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CT
T ss_pred             CccCHH---------------------HhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cC
Confidence            644333                     24567778888889999999888889999999999999998874       35


Q ss_pred             CCCCEEeCCCCccCccCChhhccCCc
Q 047705          275 ISLKFLNLSNNNLSGAIPASLEKLSY  300 (585)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~~~~~l~~  300 (585)
                      ++|+.|+++.|.++|.+|..++.++.
T Consensus       222 ~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          222 PGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             cHHHHHHHHHHhCCCcccCcccccCC
Confidence            67999999999999999998887654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=4.2e-26  Score=249.46  Aligned_cols=161  Identities=27%  Similarity=0.395  Sum_probs=132.3

Q ss_pred             ceecccCceEEEEEEeC---CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999643   46789999997643  2345789999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc-ccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS-MTQ  573 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~  573 (585)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 6899999999999999999999   899999999999999999999999999999876433221 223


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.|+||
T Consensus       530 ~~~~~t~~y~AP  541 (635)
T 4fl3_A          530 THGKWPVKWYAP  541 (635)
T ss_dssp             -----CGGGSCH
T ss_pred             cCCCCceeeeCh
Confidence            344678899998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=4.6e-26  Score=236.25  Aligned_cols=163  Identities=25%  Similarity=0.307  Sum_probs=137.3

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC--------CCcceeEEeeee---
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR--------HRNLIKVISSCS---  480 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  480 (585)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999865 6889999999754 334567888999999985        788999999987   


Q ss_pred             -cCCeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCC------
Q 047705          481 -NEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNM------  551 (585)
Q Consensus       481 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~------  551 (585)
                       .....++||||+ ++++.+++.... ..+++..++.++.||+.||+|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             556889999999 556666665543 46899999999999999999999   87 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 -------------------------------------------IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                                                                 .+||+|||.|+....     .....+||+.||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aP  262 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCC
Confidence                                                       799999999986532     12445799999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=2.8e-26  Score=254.06  Aligned_cols=159  Identities=23%  Similarity=0.356  Sum_probs=136.4

Q ss_pred             CCCCccceecccCceEEEEEEeC--CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe-----E
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-----K  485 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  485 (585)
                      ++|++.+.||+|+||.||+|++.  +++.||||++... .......+..|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999875  6899999988643 23445678899999999999999999999987654     7


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||++|++|.+++..   .+++..++.++.||+.||.|||   +++|+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987755   5899999999999999999999   8999999999999999975 89999999998653


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..      ....||+.||||
T Consensus       233 ~~------~~~~gt~~y~aP  246 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAP  246 (681)
T ss_dssp             CC------SCCCCCTTTSCT
T ss_pred             cC------CccCCCccccCH
Confidence            21      345799999999

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.93  E-value=8.3e-26  Score=227.87  Aligned_cols=168  Identities=30%  Similarity=0.426  Sum_probs=140.0

Q ss_pred             HhcCCCCccceecccCceEEEEEEe--CCCcEEEEEEEechhh--hhHHHHHHHHHHHHhc---CCCcceeEEeeee---
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARL--GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSI---RHRNLIKVISSCS---  480 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  480 (585)
                      ...++|++.+.||+|+||.||+|++  .+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999987  3688999999875422  2234566788777766   8999999999987   


Q ss_pred             --cCCeEEEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEee
Q 047705          481 --NEEFKGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSD  557 (585)
Q Consensus       481 --~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  557 (585)
                        .....++||||++ |+|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              5567899999997 699999987543 5899999999999999999999   89999999999999999999999999


Q ss_pred             ecccccccCCCCccccccccccccccCC
Q 047705          558 FGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       558 fg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+++....   ........||+.|+||
T Consensus       164 fg~~~~~~~---~~~~~~~~~~~~y~aP  188 (326)
T 1blx_A          164 FGLARIYSF---QMALTSVVVTLWYRAP  188 (326)
T ss_dssp             CCSCCCCCG---GGGGCCCCCCCTTCCH
T ss_pred             CcccccccC---CCCccccccccceeCH
Confidence            999986532   1223456789999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=5e-26  Score=249.78  Aligned_cols=170  Identities=25%  Similarity=0.360  Sum_probs=140.3

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC----CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      ...++|++.+.||+|+||.||+|.+.    .+..||+|.++.. .....+.+.+|+.++++++||||+++++++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            34467889999999999999999864    2457999988653 2334577899999999999999999999985 4568


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999999877667899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ... ........||+.||||
T Consensus       543 ~~~-~~~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          543 DST-YYKASKGKLPIKWMAP  561 (656)
T ss_dssp             C-----------CCGGGCCH
T ss_pred             CCc-ceeccCCCCCcceeCH
Confidence            322 2222345678899998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=5.3e-26  Score=228.73  Aligned_cols=167  Identities=25%  Similarity=0.297  Sum_probs=143.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh------hhHHHHHHHHHHHHhcC--CCcceeEEeeeec
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDVECEIMKSIR--HRNLIKVISSCSN  481 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  481 (585)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.....      ...+.+..|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999865 789999999976532      12345677999999996  5999999999999


Q ss_pred             CCeEEEEEEccCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEeeec
Q 047705          482 EEFKGLVLEYMPQ-GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFG  559 (585)
Q Consensus       482 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg  559 (585)
                      ++..++||||+.+ ++|.+++.... .+++..++.++.|++.||+|||   +++|+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 89999998754 6889999999999999999999   89999999999999998 78999999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +++.....    ......||+.|+||
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aP  217 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPP  217 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCH
T ss_pred             cccccccc----cccCCCCCccCCCh
Confidence            99875422    22345799999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.9e-26  Score=229.81  Aligned_cols=168  Identities=27%  Similarity=0.336  Sum_probs=135.3

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh------hhHHHHHHHHHHHHhc----CCCcceeEEee
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDVECEIMKSI----RHRNLIKVISS  478 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~  478 (585)
                      ....++|++.+.||+|+||.||+|++. +++.||+|+++....      .....+..|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            444578999999999999999999865 788999999865422      1234556799999998    89999999999


Q ss_pred             eecCCeEEEEEEc-cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC-CCCcEEEe
Q 047705          479 CSNEEFKGLVLEY-MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLS  556 (585)
Q Consensus       479 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~-~~~~~kl~  556 (585)
                      +...+..++|||| +++++|.+++.... .+++..++.++.|++.||+|||   +++|+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999999 78999999998754 6899999999999999999999   89999999999999998 88999999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+++.....    ......||+.|+||
T Consensus       183 dfg~~~~~~~~----~~~~~~~~~~y~aP  207 (312)
T 2iwi_A          183 DFGSGALLHDE----PYTDFDGTRVYSPP  207 (312)
T ss_dssp             CCSSCEECCSS----CBCCCCSCTTTSCH
T ss_pred             EcchhhhcccC----cccccCCcccccCc
Confidence            99999875432    22345799999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=4.3e-26  Score=237.14  Aligned_cols=165  Identities=24%  Similarity=0.330  Sum_probs=123.1

Q ss_pred             CCCc-cceecccCceEEEEEEeC---CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeee--cCCeEEEE
Q 047705          415 GFSE-NNLIGRGGFGSVYKARLG---DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKGLV  488 (585)
Q Consensus       415 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv  488 (585)
                      .|++ .++||+|+||.||+|++.   +++.||||++....  ....+.+|+++++.++||||+++++++.  .....|+|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3555 458999999999999865   57889999986442  2346788999999999999999999994  46789999


Q ss_pred             EEccCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----CCCCcEEEe
Q 047705          489 LEYMPQGSLEKHLYST--------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----DDNMIAYLS  556 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----~~~~~~kl~  556 (585)
                      |||++ ++|.+++...        ...+++..++.++.||+.||+|||   +++|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 5888877532        124889999999999999999999   8999999999999999    677899999


Q ss_pred             eecccccccCCCC-ccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aP  585 (585)
                      |||+|+....... .......+||++|+||
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             CTTCCC----------------CCCTTCCH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCc
Confidence            9999987643211 1223456899999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.93  E-value=1.5e-25  Score=229.27  Aligned_cols=173  Identities=24%  Similarity=0.320  Sum_probs=130.3

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC--
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--  483 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  483 (585)
                      .......++|++.+.||+|+||.||+|++. +++.||||++.... ........|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677889999999999999999999875 68999999886542 22345667888889999999999999986533  


Q ss_pred             -----eEEEEEEccCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEE
Q 047705          484 -----FKGLVLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAY  554 (585)
Q Consensus       484 -----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~k  554 (585)
                           ..++||||+++ ++.+.+..   ....+++..+..++.|++.|+.||| .++++|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 37899999976 55544432   3346888999999999999999999 34689999999999999996 89999


Q ss_pred             EeeecccccccCCCCccccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+|||+++......   ......||+.|+||
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAP  200 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCH
Confidence            99999998764322   22456789999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=1.6e-25  Score=226.86  Aligned_cols=163  Identities=21%  Similarity=0.308  Sum_probs=140.1

Q ss_pred             cCCCCccceecccCceEEEEEEe-C-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCC------cceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL-G-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR------NLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|.+ . +++.||+|+++... ...+.+.+|+++++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36899999999999999999986 3 68899999987542 3456788899999988765      49999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC--------------
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD--------------  549 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~--------------  549 (585)
                      .++||||+ +++|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 8899999987643 6789999999999999999999   899999999999999987              


Q ss_pred             -----CCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          550 -----NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       550 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                           ++.+||+|||+++....     ......||+.|+||
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aP  203 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAP  203 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCH
T ss_pred             cccccCCCceEeeCcccccCcc-----ccccccCCccccCh
Confidence                 66899999999986422     12346799999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=7.7e-26  Score=230.83  Aligned_cols=161  Identities=25%  Similarity=0.347  Sum_probs=135.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe-----
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-----  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  484 (585)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999875 7899999998654  23345678899999999999999999999987653     


Q ss_pred             -EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          485 -KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       485 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                       .|+||||++ ++|.+++..   .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 588887753   4889999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...     ......||+.|+||
T Consensus       176 ~~~-----~~~~~~~t~~y~aP  192 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAP  192 (353)
T ss_dssp             -------------CCSBCCSCH
T ss_pred             CCC-----CccccccCcCcCCH
Confidence            432     12346789999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=1.5e-25  Score=226.22  Aligned_cols=166  Identities=27%  Similarity=0.358  Sum_probs=126.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHH-HHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|... +++.||||+++... ......+..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368999999999999999999875 78999999997542 233345555665 677789999999999999999999999


Q ss_pred             EccCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYS----TNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88777753    2346889999999999999999999   77 9999999999999999999999999999865


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   ......||+.|+||
T Consensus       177 ~~~~---~~~~~~gt~~y~aP  194 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAP  194 (327)
T ss_dssp             ---------------------
T ss_pred             cccc---ccccCCCCccccCc
Confidence            3221   22344799999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=2.6e-25  Score=225.22  Aligned_cols=162  Identities=23%  Similarity=0.331  Sum_probs=121.0

Q ss_pred             cCCCCccc-eecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEE
Q 047705          413 TDGFSENN-LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKG  486 (585)
Q Consensus       413 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  486 (585)
                      .++|.+.+ .||+|+||.||+|++. +++.||||++.....    ...+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45788854 6999999999999876 789999999875421    11223334567799999999999876    45689


Q ss_pred             EEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a~  562 (585)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||+++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998764 36899999999999999999999   899999999999999975   4569999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....    ......||+.|+||
T Consensus       180 ~~~~~----~~~~~~~t~~y~aP  198 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAP  198 (336)
T ss_dssp             EC---------------------
T ss_pred             ecccc----ccccCCCCcCccCh
Confidence            65321    22345789999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.92  E-value=4.2e-25  Score=227.85  Aligned_cols=168  Identities=25%  Similarity=0.326  Sum_probs=140.4

Q ss_pred             HHhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CC-----cceeEEeeeecC
Q 047705          410 CRATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HR-----NLIKVISSCSNE  482 (585)
Q Consensus       410 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~  482 (585)
                      ....++|++.+.||+|+||.||+|++. +++.||||+++... .....+..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            334578999999999999999999876 68899999997442 33466778999988885 44     499999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCCcEEEeeec
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNMIAYLSDFG  559 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg  559 (585)
                      +..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||. ++.+|+||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999995 59999998764 368999999999999999999992 247899999999999994  57889999999


Q ss_pred             ccccccCCCCccccccccccccccCC
Q 047705          560 IAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       560 ~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|+....     .....+||+.|+||
T Consensus       207 ~a~~~~~-----~~~~~~~t~~y~aP  227 (382)
T 2vx3_A          207 SSCQLGQ-----RIYQYIQSRFYRSP  227 (382)
T ss_dssp             TCEETTC-----CCCSSCSCGGGCCH
T ss_pred             Cceeccc-----ccccccCCccccCh
Confidence            9987532     12346799999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.92  E-value=8e-26  Score=236.34  Aligned_cols=165  Identities=25%  Similarity=0.422  Sum_probs=132.1

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .+|+..+.||+|+||.||.....+++.||||++.....   ..+.+|+++++.+ +||||+++++++...+..|+|||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            45888999999999997655556889999999865432   3456799999999 7999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-----CCcEEEeeecccccccCC
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-----NMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~  567 (585)
                      + |+|.+++........+..+..++.||+.||+|||   +++|+||||||+||+++.     ...+||+|||+|+.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            5 5999999877655555567789999999999999   899999999999999953     336889999999876432


Q ss_pred             CCc-cccccccccccccCC
Q 047705          568 DQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~-~~~~~~~gt~~y~aP  585 (585)
                      ... ......+||++||||
T Consensus       177 ~~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             ---------CCSCTTSCCG
T ss_pred             CcceeeccccCCCcCccCh
Confidence            211 223456799999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=1.5e-26  Score=232.59  Aligned_cols=173  Identities=23%  Similarity=0.395  Sum_probs=141.0

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCe
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF  484 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  484 (585)
                      .+.....++|++.+.||+|+||.||+|++.+  .||+|+++...  ....+.+.+|+.++++++||||+++++++...+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3344456789999999999999999998754  59999986542  2234567789999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++ ++.+||+|||+++..
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999999999887667899999999999999999999   89999999999999998 679999999998754


Q ss_pred             cCCC---CccccccccccccccCC
Q 047705          565 IGED---QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~---~~~~~~~~~gt~~y~aP  585 (585)
                      ....   .........||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCH
T ss_pred             ccccccccccccccCCCcccccCh
Confidence            3111   11122345689999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=2.3e-25  Score=223.71  Aligned_cols=166  Identities=25%  Similarity=0.322  Sum_probs=125.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh--hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....  ...+.+.++..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999876 789999999975422  22334455556788889999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||+ ++.+..+.......+++..+..++.|+++||.|||   ++ +|+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 56666666554557899999999999999999999   74 99999999999999999999999999997653221


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         ......||+.|+||
T Consensus       180 ---~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAP  193 (318)
T ss_dssp             ----------CCTTCCH
T ss_pred             ---cccccCCCccccCh
Confidence               22345789999998

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=3.9e-25  Score=212.58  Aligned_cols=196  Identities=18%  Similarity=0.185  Sum_probs=118.4

Q ss_pred             CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCC-CCCCccCccccCCCCCcEEEccC-CCCcccCCcchhhcccccc
Q 047705           35 TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN-FSELNFLSSLSNCKSLTVIGLSN-NPLDGILPKTSIGNLSHSL  112 (585)
Q Consensus        35 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~~~L  112 (585)
                      +|++|+|++|+|++ ++...+..+++|++|+|++|+ ++.++. ..|..+++|++|+|++ |+++++.+. .+.+++. |
T Consensus        32 ~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~-~~f~~l~~L~~L~l~~~n~l~~i~~~-~f~~l~~-L  107 (239)
T 2xwt_C           32 STQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLES-HSFYNLSKVTHIEIRNTRNLTYIDPD-ALKELPL-L  107 (239)
T ss_dssp             TCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECT-TTEESCTTCCEEEEEEETTCCEECTT-SEECCTT-C
T ss_pred             cccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCH-hHcCCCcCCcEEECCCCCCeeEcCHH-HhCCCCC-C
Confidence            56666666666663 333333456666666666664 666654 4566666666666665 666554443 4445554 6


Q ss_pred             cEEEeecCcceecCCccccCCCCcc---EEEeeCC-ccccccchhhhCCCCCc-eEEccCCCCCccCcccccCCCCCcEE
Q 047705          113 EDFQMHNCNVTGDIPEEIGNLTNLI---TIDLGGN-KLNGSILITLSKLQKLQ-GLVLDDNKLEGSIPDDICRLVELYKL  187 (585)
Q Consensus       113 ~~L~l~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L  187 (585)
                      ++|++++|.+++ +|. |..+++|+   +|++++| .+.++.+..|.++++|+ +|++++|+++.+.+..|.. ++|++|
T Consensus       108 ~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L  184 (239)
T 2xwt_C          108 KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV  184 (239)
T ss_dssp             CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE
T ss_pred             CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE
Confidence            666666666664 333 66666666   7777777 66666666666677777 7777777776444444444 667777


Q ss_pred             EcCCCc-ccccCcccccCc-ccchhhcCCCCCCCCccCCCCCCCcEEEccCC
Q 047705          188 ELGGNK-LSRSIPACFNNL-IALRILSLGSNDPLPLEIGNLKVLVGIDFSMN  237 (585)
Q Consensus       188 ~L~~N~-l~~~~~~~~~~l-~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N  237 (585)
                      ++++|+ +++..+..|..+ ++|+.|++++|.........+++|+.|+++++
T Consensus       185 ~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l~~~  236 (239)
T 2xwt_C          185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT  236 (239)
T ss_dssp             ECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred             EcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeeccCc
Confidence            777774 665555666666 67777777776622222225667777777655

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=6.2e-25  Score=224.07  Aligned_cols=163  Identities=22%  Similarity=0.320  Sum_probs=138.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CC-cEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc------ceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DG-MEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN------LIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|.+. ++ +.||+|+++... ...+.+..|+++++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999875 44 689999987542 34567888999999997765      9999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe----------------
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL----------------  547 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll----------------  547 (585)
                      .++||||+ ++++.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 667777776554 46899999999999999999999   9999999999999999                


Q ss_pred             ---CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 ---DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                         +.++.+||+|||+++....     ......||+.|+||
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aP  208 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPP  208 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCH
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCC
Confidence               5678999999999986422     12346799999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=1.1e-25  Score=242.93  Aligned_cols=168  Identities=29%  Similarity=0.422  Sum_probs=140.7

Q ss_pred             hcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec------CC
Q 047705          412 ATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EE  483 (585)
Q Consensus       412 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  483 (585)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            3478999999999999999999875 6899999998754 33456778999999999999999999998765      66


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCc---EEEeee
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNC--ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMI---AYLSDF  558 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Df  558 (585)
                      ..|+||||++||+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999987542  5788899999999999999999   899999999999999986664   999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |.++......   ......||+.|+||
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAP  192 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSS
T ss_pred             cccccccccc---ccccccCCcccCCh
Confidence            9998754322   22456799999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.92  E-value=3.8e-25  Score=231.84  Aligned_cols=164  Identities=27%  Similarity=0.374  Sum_probs=126.6

Q ss_pred             CCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEEEEccC
Q 047705          415 GFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      .|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+++++++ +||||+++++++..++..|+|||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            355578899999999987766689999999987543   34567899999886 89999999999999999999999995


Q ss_pred             CCCHHHHhhcCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCC-------------CcEE
Q 047705          494 QGSLEKHLYSTNCI------LDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDN-------------MIAY  554 (585)
Q Consensus       494 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~-------------~~~k  554 (585)
                       |+|.+++......      .++..++.++.||+.||+|||   +++|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865421      123345679999999999999   8999999999999999653             4899


Q ss_pred             EeeecccccccCCCCcc--ccccccccccccCC
Q 047705          555 LSDFGIAKLLIGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       555 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      |+|||+|+.........  .....+||+.||||
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCH
Confidence            99999998764332211  12356799999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=9.5e-25  Score=215.65  Aligned_cols=143  Identities=15%  Similarity=0.047  Sum_probs=127.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999976 58999999997542   234577889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      ||++|++|.+++...   ....++..++.|++.||+|||   +++|+||||||+||+++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999653   355578889999999999999   8999999999999999999999999887654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.91  E-value=4.3e-25  Score=227.05  Aligned_cols=163  Identities=20%  Similarity=0.305  Sum_probs=138.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-----------CCcceeEEeeee
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-----------HRNLIKVISSCS  480 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  480 (585)
                      .++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            367999999999999999999875 78999999987542 34467788999998886           899999999987


Q ss_pred             cCC----eEEEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CcEEcCCCCCCEEeC------
Q 047705          481 NEE----FKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCST-PVIHCDLKPSNVLLD------  548 (585)
Q Consensus       481 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~iiH~dlkp~NIll~------  548 (585)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   ++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999998743 35899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          549 DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..+.+||+|||+|+....     ......||+.|+||
T Consensus       173 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aP  204 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSP  204 (373)
T ss_dssp             TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCH
T ss_pred             CcceEEEcccccccccCC-----CCCCCCCCccccCc
Confidence            445899999999986532     12345799999998

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.1e-24  Score=207.42  Aligned_cols=196  Identities=18%  Similarity=0.215  Sum_probs=106.4

Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCc-ceecCCccccCCCCccEEEeeC-CccccccchhhhCCCCCce
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCN-VTGDIPEEIGNLTNLITIDLGG-NKLNGSILITLSKLQKLQG  162 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~  162 (585)
                      +|++|+|++|+++++.+. .+++++. |++|++++|. ++...+..|.++++|++|++++ |+++++.+..|.++++|++
T Consensus        32 ~l~~L~l~~n~l~~i~~~-~~~~l~~-L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSH-AFSNLPN-ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TCCEEEEESCCCSEECTT-TTTTCTT-CCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             cccEEEEeCCcceEECHH-HccCCCC-CcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            555666666655544433 3334443 5555555553 4444444455555555555554 4554444444445555555


Q ss_pred             EEccCCCCCccCcccccCCCCCc---EEEcCCC-cccccCcccccCcccchhhcCCCCCCCCccCCCCCCCc-EEEccCC
Q 047705          163 LVLDDNKLEGSIPDDICRLVELY---KLELGGN-KLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLV-GIDFSMN  237 (585)
Q Consensus       163 L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~-~L~ls~N  237 (585)
                      |++++|++++ +|. |..+++|+   +|++++| .+++..+.                     .+..+++|+ .|++++|
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~---------------------~~~~l~~L~~~L~l~~n  166 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVN---------------------AFQGLCNETLTLKLYNN  166 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTT---------------------TTTTTBSSEEEEECCSC
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcc---------------------cccchhcceeEEEcCCC
Confidence            5555555543 232 44444444   4555544 44433322                     244455566 6666666


Q ss_pred             cccccCCcccCCCCCCcEEeecccC-cccccCccccCc-CCCCEEeCCCCccCccCChhhccCCccceEEeecC
Q 047705          238 NFSGIIPKEIGGLKNLEYLFLGYNR-LQGLIPDSFGNL-ISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFN  309 (585)
Q Consensus       238 ~l~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N  309 (585)
                      .++.+.+..|.. ++|+.|++++|+ ++++.+..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++
T Consensus       167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          167 GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            666544444554 677777777774 776666667777 7777777777777744332   4556667776655

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=2.3e-24  Score=219.44  Aligned_cols=242  Identities=21%  Similarity=0.186  Sum_probs=174.8

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      ++++-++++++..+..+    .+++++|+|++|+|+.+|. ++|..+++|++|+|++|++.+.++..++.+++..++.+.
T Consensus        12 ~~v~C~~~~Lt~iP~~l----~~~l~~L~Ls~N~i~~i~~-~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~   86 (350)
T 4ay9_X           12 RVFLCQESKVTEIPSDL----PRNAIELRFVLTKLRVIQK-GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   86 (350)
T ss_dssp             TEEEEESTTCCSCCTTC----CTTCSEEEEESCCCSEECT-TSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred             CEEEecCCCCCccCcCc----CCCCCEEEccCCcCCCcCH-HHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence            56788888888444333    3689999999999999986 789999999999999999877666656777777455677


Q ss_pred             eecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC-CCCCccCcccccCCC-CCcEEEcCCCcc
Q 047705          117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD-NKLEGSIPDDICRLV-ELYKLELGGNKL  194 (585)
Q Consensus       117 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l  194 (585)
                      +.+|+++...|..|..+++|++|++++|++....+..+....++..|++.+ |+++.+.+..|..+. .++.|+|++|+|
T Consensus        87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            788889888888899999999999999999888777787888888888865 678766677777764 588889999998


Q ss_pred             cccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEcc-CCcccccCCcccCCCCCCcEEeecccCcccccCccccC
Q 047705          195 SRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFS-MNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGN  273 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls-~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  273 (585)
                      +...+..| ...+|+                     .|+++ +|.++.+.+..|.++++|+.|+|++|+|+.+.+..|.+
T Consensus       167 ~~i~~~~f-~~~~L~---------------------~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~  224 (350)
T 4ay9_X          167 QEIHNSAF-NGTQLD---------------------ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  224 (350)
T ss_dssp             CEECTTSS-TTEEEE---------------------EEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred             cCCChhhc-cccchh---------------------HHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence            85444433 233444                     44554 35566555566777777777777777777554444443


Q ss_pred             cCCCCEEeCCCC-ccCccCChhhccCCccceEEeecCc
Q 047705          274 LISLKFLNLSNN-NLSGAIPASLEKLSYLEDLNLSFNK  310 (585)
Q Consensus       274 l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N~  310 (585)
                         |+.|.+.++ +++ .+| .+..+++|+.++++++.
T Consensus       225 ---L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          225 ---LKKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             ---CCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             ---chHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence               444444333 344 445 46677778888876544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=8.6e-26  Score=231.17  Aligned_cols=264  Identities=17%  Similarity=0.211  Sum_probs=162.4

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCc---cccCCCC-CccEEEccCCCCCCCccCccccCC-----C
Q 047705           14 ELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSS---ITDVRLP-NLEELVLWGNNFSELNFLSSLSNC-----K   84 (585)
Q Consensus        14 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l-----~   84 (585)
                      .++|+.|.+++..|..+...++|++|+|++|.|++....   ..+..++ +|++|+|++|+|+.... ..+..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-DELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH-HHHHHHHHTSCT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH-HHHHHHHhccCC
Confidence            467888888877777777777788888888888743321   2334566 78888888888887653 445543     8


Q ss_pred             CCcEEEccCCCCcccCCcch---hhcccccccEEEeecCcceecCCccc----cC-CCCccEEEeeCCccccccc----h
Q 047705           85 SLTVIGLSNNPLDGILPKTS---IGNLSHSLEDFQMHNCNVTGDIPEEI----GN-LTNLITIDLGGNKLNGSIL----I  152 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~---~~~~~~~L~~L~l~~n~l~~~~~~~~----~~-l~~L~~L~L~~N~l~~~~~----~  152 (585)
                      +|++|+|++|++++..+...   +...+.+|++|+|++|.+++..+..+    .. .++|++|+|++|.+++...    .
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  160 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ  160 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence            88888888888876554421   22221347777777777765555433    23 2477777777777764332    3


Q ss_pred             hhhCCC-CCceEEccCCCCCccCccccc----CC-CCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCC-
Q 047705          153 TLSKLQ-KLQGLVLDDNKLEGSIPDDIC----RL-VELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGN-  225 (585)
Q Consensus       153 ~~~~l~-~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~-  225 (585)
                      .+..++ +|++|+|++|+|++..+..+.    .. ++|++|+|++|.++......+                 +..+.. 
T Consensus       161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l-----------------~~~l~~~  223 (362)
T 3goz_A          161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL-----------------AYIFSSI  223 (362)
T ss_dssp             HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH-----------------HHHHHHS
T ss_pred             HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHH-----------------HHHHhcC
Confidence            334444 677777777777665554333    23 467777777777664211111                 111222 


Q ss_pred             CCCCcEEEccCCcccccCC----cccCCCCCCcEEeecccCcccc-------cCccccCcCCCCEEeCCCCccCccCChh
Q 047705          226 LKVLVGIDFSMNNFSGIIP----KEIGGLKNLEYLFLGYNRLQGL-------IPDSFGNLISLKFLNLSNNNLSGAIPAS  294 (585)
Q Consensus       226 l~~L~~L~ls~N~l~~~~~----~~~~~l~~L~~L~ls~N~l~~~-------~~~~~~~l~~L~~L~l~~N~l~~~~~~~  294 (585)
                      .++|+.|++++|.+++..+    ..+..+++|+.|+|++|.+.++       ++..+..+++|+.||+++|++....+..
T Consensus       224 ~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~  303 (362)
T 3goz_A          224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP  303 (362)
T ss_dssp             CTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred             CCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence            2366677777777765433    3345667788888888774332       2335666777778888888877654433


Q ss_pred             h
Q 047705          295 L  295 (585)
Q Consensus       295 ~  295 (585)
                      +
T Consensus       304 ~  304 (362)
T 3goz_A          304 I  304 (362)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=4.3e-24  Score=213.72  Aligned_cols=225  Identities=17%  Similarity=0.186  Sum_probs=176.4

Q ss_pred             CCCCcEEEccCCCCcccCCcc--hhhcccccccEEEeecCcceecCCccc--cCCCCccEEEeeCCccccccc----hhh
Q 047705           83 CKSLTVIGLSNNPLDGILPKT--SIGNLSHSLEDFQMHNCNVTGDIPEEI--GNLTNLITIDLGGNKLNGSIL----ITL  154 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~  154 (585)
                      ...++.|.++++.+....-..  ....+++ |++|++++|.+++..|..+  ..+++|++|+|++|.+.+..+    ..+
T Consensus        63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~  141 (310)
T 4glp_A           63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSR-LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQ  141 (310)
T ss_dssp             SCCCCEEEECSCCCBHHHHHHHHHHHHHSC-CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHT
T ss_pred             hcceeEEEEeCCcCCHHHHHHHHHhcccCc-eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHh
Confidence            345778888887775321100  0112333 8899999999888888887  889999999999999987443    455


Q ss_pred             hCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccccc---C-cccccCcccchhhcCCCCCCC--Cc----cCC
Q 047705          155 SKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRS---I-PACFNNLIALRILSLGSNDPL--PL----EIG  224 (585)
Q Consensus       155 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~l~~n~~~--~~----~~~  224 (585)
                      ..+++|++|+|++|++++..+..|..+++|++|+|++|++.+.   . +..+..+++|++|+|++|...  +.    .+.
T Consensus       142 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~  221 (310)
T 4glp_A          142 WLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAA  221 (310)
T ss_dssp             TBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHH
T ss_pred             hhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHh
Confidence            6789999999999999988888999999999999999998652   2 233478899999999999843  22    146


Q ss_pred             CCCCCcEEEccCCcccccCCcccCCC---CCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCcc
Q 047705          225 NLKVLVGIDFSMNNFSGIIPKEIGGL---KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYL  301 (585)
Q Consensus       225 ~l~~L~~L~ls~N~l~~~~~~~~~~l---~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  301 (585)
                      .+++|+.|++++|.+++..|..+..+   ++|++|+|++|+++ .+|..+.  ++|+.|+|++|+|++. |. +..+++|
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L  296 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV  296 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence            77999999999999998878777776   69999999999999 4566664  7999999999999965 33 6788999


Q ss_pred             ceEEeecCcCee
Q 047705          302 EDLNLSFNKLEG  313 (585)
Q Consensus       302 ~~l~l~~N~l~~  313 (585)
                      +.|++++|+|+.
T Consensus       297 ~~L~L~~N~l~~  308 (310)
T 4glp_A          297 DNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECSSTTTSC
T ss_pred             cEEECcCCCCCC
Confidence            999999999863

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=4.1e-24  Score=217.58  Aligned_cols=200  Identities=19%  Similarity=0.132  Sum_probs=86.5

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccE-EEccCCCCCCCccCccccCCCCCcE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEE-LVLWGNNFSELNFLSSLSNCKSLTV   88 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~~l~~L~~   88 (585)
                      +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.++...|..+++|++ +.+++|+++.++. ..|..+++|++
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~-~~f~~l~~L~~  108 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP-EAFQNLPNLQY  108 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECT-TSBCCCTTCCE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCc-hhhhhcccccc
Confidence            344555555555543333445555555555555555443444444444444433 3334445554443 44455555555


Q ss_pred             EEccCCCCcccCCcchhhcccccccEEEeec-CcceecCCccccCCC-CccEEEeeCCccccccchhhhCCCCCceEEcc
Q 047705           89 IGLSNNPLDGILPKTSIGNLSHSLEDFQMHN-CNVTGDIPEEIGNLT-NLITIDLGGNKLNGSILITLSKLQKLQGLVLD  166 (585)
Q Consensus        89 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  166 (585)
                      |++++|+++.+.+..+ ..... +..|++.+ +++....+..|..+. .++.|+|++|+|+.+.+.+|. ..+|++|+++
T Consensus       109 L~l~~n~l~~~~~~~~-~~~~~-l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~  185 (350)
T 4ay9_X          109 LLISNTGIKHLPDVHK-IHSLQ-KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLS  185 (350)
T ss_dssp             EEEEEECCSSCCCCTT-CCBSS-CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEEEEEECT
T ss_pred             ccccccccccCCchhh-cccch-hhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhcc-ccchhHHhhc
Confidence            5555555543333211 11111 44444433 334433334444432 344445555544433333332 2344444443


Q ss_pred             C-CCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          167 D-NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       167 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      + |.++.+.++.|..+++|++|+|++|+|+..++..|.++++|+.+++
T Consensus       186 ~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~  233 (350)
T 4ay9_X          186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  233 (350)
T ss_dssp             TCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred             cCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC
Confidence            2 3444333334444444555555555444333333444444443333

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=4.4e-25  Score=236.57  Aligned_cols=154  Identities=18%  Similarity=0.227  Sum_probs=118.2

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEEechh--------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ...+.||+|+||.||+|+. .++.+|+|+.....        ....+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 57888998764321        11245688999999999999999655555566777999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++|++|.+++..         +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999876         4579999999999999   899999999999999998  99999999999764321


Q ss_pred             Ccc-----ccccccccccccCC
Q 047705          569 QSM-----TQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~-----~~~~~~gt~~y~aP  585 (585)
                      ...     .....+||++||||
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHH
T ss_pred             ccccchhhhhhhhcCCCCcCCH
Confidence            111     12467899999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=4.3e-24  Score=212.60  Aligned_cols=145  Identities=24%  Similarity=0.361  Sum_probs=127.1

Q ss_pred             cCCCCcc-ceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHH-HhcCCCcceeEEeeeec----CCeE
Q 047705          413 TDGFSEN-NLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIM-KSIRHRNLIKVISSCSN----EEFK  485 (585)
Q Consensus       413 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  485 (585)
                      .++|.+. +.||+|+||.||+|... +++.||+|+++..     ..+.+|++++ +..+||||+++++++..    .+..
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4567776 78999999999999875 7899999998643     3456788887 55699999999999876    6778


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeeccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIA  561 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a  561 (585)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 36899999999999999999999   899999999999999997   789999999999


Q ss_pred             cccc
Q 047705          562 KLLI  565 (585)
Q Consensus       562 ~~~~  565 (585)
                      ....
T Consensus       168 ~~~~  171 (299)
T 3m2w_A          168 KETT  171 (299)
T ss_dssp             EECT
T ss_pred             cccc
Confidence            8754

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.8e-25  Score=226.38  Aligned_cols=254  Identities=15%  Similarity=0.173  Sum_probs=153.9

Q ss_pred             CCCEEecCCCcccccCCccccCC--CCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNV--STLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTV   88 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   88 (585)
                      .++++|+++|.+.   +..+..+  +++++|++++|.+.+.++...  .+++|++|+|++|.++.......+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~--~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCC--CCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhc--cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence            4778888888765   5566666  788888888888876655543  57888888888888765312145777788888


Q ss_pred             EEccCCCCcccCCcchhhcccccccEEEeecC-cceec-CCccccCCCCccEEEeeCC-ccccc-cchhhhCCC-CCceE
Q 047705           89 IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC-NVTGD-IPEEIGNLTNLITIDLGGN-KLNGS-ILITLSKLQ-KLQGL  163 (585)
Q Consensus        89 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L  163 (585)
                      |+|++|.+++..+. .++.+++ |++|++++| .+++. ++..+..+++|++|++++| .+++. .+..+..++ +|++|
T Consensus       123 L~L~~~~l~~~~~~-~l~~~~~-L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L  200 (336)
T 2ast_B          123 LSLEGLRLSDPIVN-TLAKNSN-LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL  200 (336)
T ss_dssp             EECTTCBCCHHHHH-HHTTCTT-CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE
T ss_pred             EeCcCcccCHHHHH-HHhcCCC-CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEE
Confidence            88888877654444 3444544 777777766 45542 4445666666777777666 66643 345566666 67777


Q ss_pred             EccCC--CCC-ccCcccccCCCCCcEEEcCCCc-ccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCc-
Q 047705          164 VLDDN--KLE-GSIPDDICRLVELYKLELGGNK-LSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN-  238 (585)
Q Consensus       164 ~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~-  238 (585)
                      ++++|  .++ +.++..+..+++|++|++++|. +++..+..+..++                     +|+.|++++|. 
T Consensus       201 ~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~---------------------~L~~L~l~~~~~  259 (336)
T 2ast_B          201 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN---------------------YLQHLSLSRCYD  259 (336)
T ss_dssp             ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT---------------------TCCEEECTTCTT
T ss_pred             EeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC---------------------CCCEeeCCCCCC
Confidence            77666  343 2344555566666666666666 5444444444444                     45555555553 


Q ss_pred             ccccCCcccCCCCCCcEEeecccCcccccCccccCc-CCCCEEeCCCCccCccCChhhc
Q 047705          239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL-ISLKFLNLSNNNLSGAIPASLE  296 (585)
Q Consensus       239 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~  296 (585)
                      +.......+..+++|+.|++++| ++   ...+..+ ..++.|++++|++++..|..+.
T Consensus       260 ~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          260 IIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             CCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            22111124555666666666666 22   1233333 2355666677777766665544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=2e-23  Score=202.16  Aligned_cols=160  Identities=26%  Similarity=0.294  Sum_probs=85.6

Q ss_pred             CCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          134 TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       134 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      ++|+.|+|++|.+.+..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+++..+..|.          
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------  104 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFD----------  104 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT----------
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhc----------
Confidence            3455555555555555555555555555555555555554444455555555555555555533333222          


Q ss_pred             CCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh
Q 047705          214 GSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA  293 (585)
Q Consensus       214 ~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  293 (585)
                                 .+++|+.|++++|.+++..+..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|++++..+.
T Consensus       105 -----------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  173 (251)
T 3m19_A          105 -----------HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG  173 (251)
T ss_dssp             -----------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             -----------ccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence                       233344444444555544444455555666666666666555454555566666666666666655555


Q ss_pred             hhccCCccceEEeecCcCeee
Q 047705          294 SLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       294 ~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      .+..+++|+.|++++|+|.|.
T Consensus       174 ~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          174 AFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTCTTCCEEECCSCCBCTT
T ss_pred             HHhCCCCCCEEEeeCCceeCC
Confidence            555566666666666666554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=5.4e-26  Score=234.92  Aligned_cols=244  Identities=19%  Similarity=0.222  Sum_probs=131.8

Q ss_pred             cCCccccCCCCCCEEecCCCcCCCcCCcc---ccCCCCCccEEEccCCCCCCCccC--c-------cccCCCCCcEEEcc
Q 047705           25 TVPVAIFNVSTLKLLGLQDNSLSGSLSSI---TDVRLPNLEELVLWGNNFSELNFL--S-------SLSNCKSLTVIGLS   92 (585)
Q Consensus        25 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~--~-------~~~~l~~L~~L~Ls   92 (585)
                      .++..+..+++|++|+|++|.|+...+..   .+..+++|++|+|++|.+..+...  .       .|..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            34555666666666666666665321110   123466666666666655543210  1       13566777777777


Q ss_pred             CCCCccc----CCcchhhcccccccEEEeecCcceecCCccc----cCC---------CCccEEEeeCCccc-cccc---
Q 047705           93 NNPLDGI----LPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI----GNL---------TNLITIDLGGNKLN-GSIL---  151 (585)
Q Consensus        93 ~N~l~~~----~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~----~~l---------~~L~~L~L~~N~l~-~~~~---  151 (585)
                      +|+++..    .+. .+..+++ |++|+|++|.++...+..+    ..+         ++|++|+|++|++. ...+   
T Consensus       103 ~n~l~~~~~~~l~~-~l~~~~~-L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  180 (386)
T 2ca6_A          103 DNAFGPTAQEPLID-FLSKHTP-LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA  180 (386)
T ss_dssp             SCCCCTTTHHHHHH-HHHHCTT-CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             CCcCCHHHHHHHHH-HHHhCCC-CCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH
Confidence            7776542    111 2233332 4444444444432222222    222         56666666666665 2222   


Q ss_pred             hhhhCCCCCceEEccCCCCCc-----cCcccccCCCCCcEEEcCCCccc----ccCcccccCcccchhhcCCCCCCCCcc
Q 047705          152 ITLSKLQKLQGLVLDDNKLEG-----SIPDDICRLVELYKLELGGNKLS----RSIPACFNNLIALRILSLGSNDPLPLE  222 (585)
Q Consensus       152 ~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~l~~n~~~~~~  222 (585)
                      ..|..+++|++|+|++|+|+.     ..+..+..+++|++|+|++|.++    ..+|.                     .
T Consensus       181 ~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~---------------------~  239 (386)
T 2ca6_A          181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI---------------------A  239 (386)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH---------------------H
T ss_pred             HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH---------------------H
Confidence            345556666666666666652     22335555666666666666664    22222                     2


Q ss_pred             CCCCCCCcEEEccCCccccc----CCccc--CCCCCCcEEeecccCccc----ccCccc-cCcCCCCEEeCCCCccCccC
Q 047705          223 IGNLKVLVGIDFSMNNFSGI----IPKEI--GGLKNLEYLFLGYNRLQG----LIPDSF-GNLISLKFLNLSNNNLSGAI  291 (585)
Q Consensus       223 ~~~l~~L~~L~ls~N~l~~~----~~~~~--~~l~~L~~L~ls~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~  291 (585)
                      +..+++|+.|+|++|.+++.    ++..+  +.+++|+.|+|++|++++    .+|..+ ..+++|+.|++++|++++..
T Consensus       240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            33445566666666666654    33444  336777777777777776    355555 45677777777777777655

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=4.5e-26  Score=235.54  Aligned_cols=240  Identities=23%  Similarity=0.252  Sum_probs=162.7

Q ss_pred             CCCCccEEEccCCCCCCCcc---CccccCCCCCcEEEccCCCCcc---cCCcchhhcccccccEEEeecCcceecCCccc
Q 047705           57 RLPNLEELVLWGNNFSELNF---LSSLSNCKSLTVIGLSNNPLDG---ILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEI  130 (585)
Q Consensus        57 ~l~~L~~L~L~~n~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~  130 (585)
                      .+++|++|+|++|.++....   ...|..+++|++|+|++|.+..   ..|. .+.                  .+...|
T Consensus        30 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~-~~~------------------~l~~~l   90 (386)
T 2ca6_A           30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPE-ALR------------------LLLQAL   90 (386)
T ss_dssp             HCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHH-HHH------------------HHHHHH
T ss_pred             cCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhH-HHH------------------HHHHHH
Confidence            56788888888888877532   0236678888888888865542   2222 111                  111234


Q ss_pred             cCCCCccEEEeeCCcccc----ccchhhhCCCCCceEEccCCCCCccCcccccC----C---------CCCcEEEcCCCc
Q 047705          131 GNLTNLITIDLGGNKLNG----SILITLSKLQKLQGLVLDDNKLEGSIPDDICR----L---------VELYKLELGGNK  193 (585)
Q Consensus       131 ~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~N~  193 (585)
                      ..+++|++|+|++|.+..    .++..+..+++|++|+|++|.|++..+..+..    +         ++|++|+|++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            556666666666666665    34555666666666666666665433333322    2         666666666666


Q ss_pred             cc-ccCc---ccccCcccchhhcCCCCCCC--------CccCCCCCCCcEEEccCCccc----ccCCcccCCCCCCcEEe
Q 047705          194 LS-RSIP---ACFNNLIALRILSLGSNDPL--------PLEIGNLKVLVGIDFSMNNFS----GIIPKEIGGLKNLEYLF  257 (585)
Q Consensus       194 l~-~~~~---~~~~~l~~L~~L~l~~n~~~--------~~~~~~l~~L~~L~ls~N~l~----~~~~~~~~~l~~L~~L~  257 (585)
                      ++ ...+   ..+..+++|+.|++++|...        +..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            65 2233   24455666666666666522        225677888999999999996    56777888999999999


Q ss_pred             ecccCcccc----cCcccc--CcCCCCEEeCCCCccCc----cCChhh-ccCCccceEEeecCcCeeeC
Q 047705          258 LGYNRLQGL----IPDSFG--NLISLKFLNLSNNNLSG----AIPASL-EKLSYLEDLNLSFNKLEGEI  315 (585)
Q Consensus       258 ls~N~l~~~----~~~~~~--~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~l~l~~N~l~~~~  315 (585)
                      |++|++++.    ++..+.  .+++|+.|+|++|.+++    .+|..+ .++++|+.|++++|++++..
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            999999876    455663  38999999999999997    477777 56899999999999987543

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=2.4e-24  Score=215.51  Aligned_cols=227  Identities=16%  Similarity=0.163  Sum_probs=176.7

Q ss_pred             CCCCEEecCCCcccccCCc---cccCCCCCCEEecCCCcCCCcCCcccc-CCCCCccEEEccCCCCCCCcc---CccccC
Q 047705           10 QNLEELDLRQNKLIGTVPV---AIFNVSTLKLLGLQDNSLSGSLSSITD-VRLPNLEELVLWGNNFSELNF---LSSLSN   82 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~---~~~~~~   82 (585)
                      ..++.|.+.++.++.....   .+..+++|++|+|++|.+++..+...+ ..+++|++|+|++|+++....   ...+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            4578888888877532111   233456799999999999877766543 678999999999999986321   023457


Q ss_pred             CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceec---C-CccccCCCCccEEEeeCCccccccch---hhh
Q 047705           83 CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGD---I-PEEIGNLTNLITIDLGGNKLNGSILI---TLS  155 (585)
Q Consensus        83 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~  155 (585)
                      +++|++|+|++|++.+..+. .++.++. |++|+|++|++.+.   . +..+..+++|++|+|++|+++...+.   .+.
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~  221 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCE-QVRAFPA-LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAA  221 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTT-SCCCCTT-CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHH-HhccCCC-CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHh
Confidence            89999999999999877665 5677776 99999999997652   2 23347899999999999999743332   367


Q ss_pred             CCCCCceEEccCCCCCccCcccccCC---CCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCC-ccCCCCCCCcE
Q 047705          156 KLQKLQGLVLDDNKLEGSIPDDICRL---VELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP-LEIGNLKVLVG  231 (585)
Q Consensus       156 ~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~l~~L~~  231 (585)
                      ++++|++|+|++|+|++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|.... +.+..+++|+.
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~  298 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDN  298 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSC
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccE
Confidence            89999999999999998878777776   69999999999999 5566554  799999999998332 34788999999


Q ss_pred             EEccCCcccc
Q 047705          232 IDFSMNNFSG  241 (585)
Q Consensus       232 L~ls~N~l~~  241 (585)
                      |++++|+++.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            9999999974

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.3e-23  Score=209.76  Aligned_cols=194  Identities=22%  Similarity=0.301  Sum_probs=120.0

Q ss_pred             ccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccc
Q 047705           30 IFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS  109 (585)
Q Consensus        30 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  109 (585)
                      +..+++|++|++++|.++ .++.  +..+++|++|+|++|+++.++.   +..+++|++|+|++|+++++.   .+..++
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~l~~--~~~l~~L~~L~L~~n~i~~~~~---~~~l~~L~~L~L~~n~l~~~~---~~~~l~  107 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLKNVS---AIAGLQ  107 (308)
T ss_dssp             HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCSCCG---GGTTCT
T ss_pred             HHHcCCcCEEEeeCCCcc-Cchh--hhccCCCCEEEccCCcCCCChh---HccCCCCCEEEccCCcCCCch---hhcCCC
Confidence            344556666666666655 2332  2245666666666666665542   555666666666666655431   244444


Q ss_pred             ccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEc
Q 047705          110 HSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLEL  189 (585)
Q Consensus       110 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  189 (585)
                      . |++|++++|.+++..  .+..+++|++|++++|.+.+..+  +..+++|++|+|++|++++..+  +..+++|+.|++
T Consensus       108 ~-L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l  180 (308)
T 1h6u_A          108 S-IKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA  180 (308)
T ss_dssp             T-CCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             C-CCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEEC
Confidence            4 666666666665432  26667777777777777765443  6667777777777777764433  666777777777


Q ss_pred             CCCcccccCcccccCcccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccc
Q 047705          190 GGNKLSRSIPACFNNLIALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSG  241 (585)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~  241 (585)
                      ++|.+++..+  +..+++|++|++++|. .....+..+++|+.|++++|.+++
T Consensus       181 ~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred             CCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeec
Confidence            7777764333  6667777777777776 111246778889999999999975

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2.6e-25  Score=227.57  Aligned_cols=258  Identities=16%  Similarity=0.166  Sum_probs=175.6

Q ss_pred             EEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccC---ccccCCC-CCcEEEccCCCCcccCCcchhhcc----c
Q 047705           38 LLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFL---SSLSNCK-SLTVIGLSNNPLDGILPKTSIGNL----S  109 (585)
Q Consensus        38 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~----~  109 (585)
                      ++.|++|.+++.++... ...++|++|+|++|.++..+..   ..|..++ +|++|+|++|++++..+. .+..+    .
T Consensus         2 ~~~ls~n~~~~~~~~~~-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-~l~~~l~~~~   79 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFT-SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD-ELVQILAAIP   79 (362)
T ss_dssp             EEECCCCTTCCHHHHHH-TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH-HHHHHHHTSC
T ss_pred             ccccccccchHHHHHHH-hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH-HHHHHHhccC
Confidence            46788898887666543 2345599999999998887521   3467788 899999999998766554 33333    1


Q ss_pred             ccccEEEeecCcceecCCccc----cCC-CCccEEEeeCCccccccchhhh----C-CCCCceEEccCCCCCccCccc--
Q 047705          110 HSLEDFQMHNCNVTGDIPEEI----GNL-TNLITIDLGGNKLNGSILITLS----K-LQKLQGLVLDDNKLEGSIPDD--  177 (585)
Q Consensus       110 ~~L~~L~l~~n~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~~--  177 (585)
                      .+|++|+|++|.+++..+..+    ..+ ++|++|+|++|++++..+..+.    . .++|++|+|++|+|++..+..  
T Consensus        80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  159 (362)
T 3goz_A           80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI  159 (362)
T ss_dssp             TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence            347777887777776665533    333 6777777777777766555443    2 257777777777777543333  


Q ss_pred             --ccCCC-CCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCC-CCCcEEEccCCccccc----CCcccCC
Q 047705          178 --ICRLV-ELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL-KVLVGIDFSMNNFSGI----IPKEIGG  249 (585)
Q Consensus       178 --~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l-~~L~~L~ls~N~l~~~----~~~~~~~  249 (585)
                        +..++ +|++|+|++|.+++..+..+..                 .+..+ ++|+.|++++|.+++.    ++..+..
T Consensus       160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~-----------------~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          160 QILAAIPANVNSLNLRGNNLASKNCAELAK-----------------FLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             HHHHTSCTTCCEEECTTSCGGGSCHHHHHH-----------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             HHHhcCCccccEeeecCCCCchhhHHHHHH-----------------HHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence              34444 7777777777776544433321                 12234 3788888888888763    3334444


Q ss_pred             -CCCCcEEeecccCcccccC----ccccCcCCCCEEeCCCCccCccCC-------hhhccCCccceEEeecCcCeee
Q 047705          250 -LKNLEYLFLGYNRLQGLIP----DSFGNLISLKFLNLSNNNLSGAIP-------ASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       250 -l~~L~~L~ls~N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~-------~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                       .++|+.|+|++|++++..+    ..+..+++|+.|++++|.+.+..+       ..+..+++|++||+++|++...
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence             4589999999999987544    345677899999999999654443       3566778899999999998754

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=5.6e-23  Score=198.98  Aligned_cols=181  Identities=25%  Similarity=0.274  Sum_probs=138.8

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .+.++++++++.++ .+|..+.  ++|++|+|++|.|++..+ ..+..+++|++|+|++|+|+.++. ..|..+++|++|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L   88 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSA-GVFDDLTELGTL   88 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCT-TTTTTCTTCCEE
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCH-hHhccCCcCCEE
Confidence            45678888888887 5666555  578888888888874443 344578888888888888888875 678888888888


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      +|++|+++++.+. .+..++. |++|+|++|++++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus        89 ~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A           89 GLANNQLASLPLG-VFDHLTQ-LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             ECTTSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ECCCCcccccChh-HhcccCC-CCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            8888888766554 5566665 8888888888887777777778888888888888887777778888888888888888


Q ss_pred             CCccCcccccCCCCCcEEEcCCCccccc
Q 047705          170 LEGSIPDDICRLVELYKLELGGNKLSRS  197 (585)
Q Consensus       170 l~~~~~~~~~~l~~L~~L~L~~N~l~~~  197 (585)
                      |++..+..|..+++|++|+|++|.+...
T Consensus       167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          167 LQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            8877777777788888888888887653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=5.5e-23  Score=205.23  Aligned_cols=214  Identities=21%  Similarity=0.311  Sum_probs=149.0

Q ss_pred             CCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccE
Q 047705           59 PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLIT  138 (585)
Q Consensus        59 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  138 (585)
                      .++..+.+..+.++...   .+..+++|++|++++|.+..+ +  .+..++. |++|++++|.+++..+  +..+++|++
T Consensus        19 ~~~~~~~l~~~~~~~~~---~~~~l~~L~~L~l~~~~i~~l-~--~~~~l~~-L~~L~L~~n~i~~~~~--~~~l~~L~~   89 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVTTI-E--GVQYLNN-LIGLELKDNQITDLAP--LKNLTKITE   89 (308)
T ss_dssp             HHHHHHHTTCSSTTSEE---CHHHHHTCCEEECTTSCCCCC-T--TGGGCTT-CCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred             HHHHHHHhCCCCcCcee---cHHHcCCcCEEEeeCCCccCc-h--hhhccCC-CCEEEccCCcCCCChh--HccCCCCCE
Confidence            34455566666666642   355677888888888888654 2  2444554 6777777776665443  666666777


Q ss_pred             EEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCC
Q 047705          139 IDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDP  218 (585)
Q Consensus       139 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~  218 (585)
                      |+|++|++.+.  ..+..+++|++|+|++|++++. + .+..+++|++|++++|.+++..+                   
T Consensus        90 L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~-------------------  146 (308)
T 1h6u_A           90 LELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP-------------------  146 (308)
T ss_dssp             EECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG-------------------
T ss_pred             EEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc-------------------
Confidence            77776666653  2466666666666666666643 2 26666666666666666653221                   


Q ss_pred             CCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccC
Q 047705          219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL  298 (585)
Q Consensus       219 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  298 (585)
                          +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..  .+..+
T Consensus       147 ----l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l  216 (308)
T 1h6u_A          147 ----LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANT  216 (308)
T ss_dssp             ----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTC
T ss_pred             ----ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCC
Confidence                4556677888888888886543  8888999999999999987643  788899999999999998655  37888


Q ss_pred             CccceEEeecCcCeee
Q 047705          299 SYLEDLNLSFNKLEGE  314 (585)
Q Consensus       299 ~~L~~l~l~~N~l~~~  314 (585)
                      ++|+.|++++|++++.
T Consensus       217 ~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          217 SNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             TTCCEEEEEEEEEECC
T ss_pred             CCCCEEEccCCeeecC
Confidence            9999999999998753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=9.1e-25  Score=221.24  Aligned_cols=248  Identities=17%  Similarity=0.134  Sum_probs=139.9

Q ss_pred             CCEEecCCCcCCCcCCccccCCC--CCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccccccc
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRL--PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLE  113 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  113 (585)
                      ++.|++++|.+..    ..+..+  ++++.|++++|.+...+.  .+..+++|++|+|++|.+++..             
T Consensus        49 ~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~--~~~~~~~L~~L~L~~~~l~~~~-------------  109 (336)
T 2ast_B           49 WQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLA--EHFSPFRVQHMDLSNSVIEVST-------------  109 (336)
T ss_dssp             SSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCC--SCCCCBCCCEEECTTCEECHHH-------------
T ss_pred             heeeccccccCCH----HHHHhhhhccceEEEcCCccccccch--hhccCCCCCEEEccCCCcCHHH-------------
Confidence            5556666555541    111122  455555565555555432  2334555555555555544320             


Q ss_pred             EEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCC-CCCcc-CcccccCCCCCcEEEcCC
Q 047705          114 DFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN-KLEGS-IPDDICRLVELYKLELGG  191 (585)
Q Consensus       114 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~  191 (585)
                                  ++..+..+++|++|+|++|.+.+..+..+..+++|++|+|++| .+++. ++..+..+++|++|++++
T Consensus       110 ------------~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~  177 (336)
T 2ast_B          110 ------------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW  177 (336)
T ss_dssp             ------------HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred             ------------HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCC
Confidence                        3333444455555555555544444444444555555555555 34431 333344445555555555


Q ss_pred             C-ccccc-CcccccCcc-cchhhcCCCCC------CCCccCCCCCCCcEEEccCCc-ccccCCcccCCCCCCcEEeeccc
Q 047705          192 N-KLSRS-IPACFNNLI-ALRILSLGSND------PLPLEIGNLKVLVGIDFSMNN-FSGIIPKEIGGLKNLEYLFLGYN  261 (585)
Q Consensus       192 N-~l~~~-~~~~~~~l~-~L~~L~l~~n~------~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~~~~l~~L~~L~ls~N  261 (585)
                      | .+++. ++..+..++ +|++|++++|.      .++..+..+++|+.|++++|. +++..+..+..+++|+.|++++|
T Consensus       178 ~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          178 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             CTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             CCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            5 44432 233344444 55555555442      112234567788888888888 77677778889999999999999


Q ss_pred             C-cccccCccccCcCCCCEEeCCCCccCccCChhhccC-CccceEEeecCcCeeeCCCC
Q 047705          262 R-LQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKL-SYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       262 ~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~  318 (585)
                      . ++......+..+++|+.|++++| ++.   ..+..+ ..++.|++++|.+++..|..
T Consensus       258 ~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          258 YDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             TTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             CCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence            5 33322236788899999999999 443   234443 24677778999998877653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.89  E-value=3.1e-25  Score=242.52  Aligned_cols=302  Identities=13%  Similarity=0.081  Sum_probs=176.8

Q ss_pred             cCCCCCCEEecCCCccccc----CCccccCCCCCCEEecCCCcCCCcCCc---cccCCCCCccEEEccCCCCCCCccCcc
Q 047705            7 GNLQNLEELDLRQNKLIGT----VPVAIFNVSTLKLLGLQDNSLSGSLSS---ITDVRLPNLEELVLWGNNFSELNFLSS   79 (585)
Q Consensus         7 ~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~   79 (585)
                      ..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++....   .....+++|++|+|++|.+..++  ..
T Consensus       161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~--~~  238 (592)
T 3ogk_B          161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV--GF  238 (592)
T ss_dssp             HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH--HH
T ss_pred             hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH--HH
Confidence            3567777777777776654    233455667777777777777521111   01124677777777777766654  34


Q ss_pred             ccCCCCCcEEEccCCCCc--------------------------ccCCcchhhcccccccEEEeecCcceecCC-ccccC
Q 047705           80 LSNCKSLTVIGLSNNPLD--------------------------GILPKTSIGNLSHSLEDFQMHNCNVTGDIP-EEIGN  132 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~--------------------------~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~  132 (585)
                      +..+++|++|+++++...                          ...|. .+..+++ |++|++++|.+++... ..+..
T Consensus       239 ~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~-~~~~~~~-L~~L~Ls~~~l~~~~~~~~~~~  316 (592)
T 3ogk_B          239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPI-LFPFAAQ-IRKLDLLYALLETEDHCTLIQK  316 (592)
T ss_dssp             HHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGG-GGGGGGG-CCEEEETTCCCCHHHHHHHHTT
T ss_pred             HhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHH-HHhhcCC-CcEEecCCCcCCHHHHHHHHHh
Confidence            555555555555432111                          11111 3334444 7777777777654433 33566


Q ss_pred             CCCccEEEeeCCcccc-ccchhhhCCCCCceEEcc-----------CCCCCccCc-ccccCCCCCcEEEcCCCcccccCc
Q 047705          133 LTNLITIDLGGNKLNG-SILITLSKLQKLQGLVLD-----------DNKLEGSIP-DDICRLVELYKLELGGNKLSRSIP  199 (585)
Q Consensus       133 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~  199 (585)
                      +++|++|+++ +.+.. ..+..+..+++|++|+++           .|.+++... .....+++|++|+++.|.+++..+
T Consensus       317 ~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~  395 (592)
T 3ogk_B          317 CPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL  395 (592)
T ss_dssp             CTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHH
T ss_pred             CcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHH
Confidence            7777777777 33332 333334567777777777           355654322 223456777777777777776555


Q ss_pred             ccccC-cccchhhcCC----CCCCC--C------ccCCCCCCCcEEEccCCc--ccccCCcccC-CCCCCcEEeecccCc
Q 047705          200 ACFNN-LIALRILSLG----SNDPL--P------LEIGNLKVLVGIDFSMNN--FSGIIPKEIG-GLKNLEYLFLGYNRL  263 (585)
Q Consensus       200 ~~~~~-l~~L~~L~l~----~n~~~--~------~~~~~l~~L~~L~ls~N~--l~~~~~~~~~-~l~~L~~L~ls~N~l  263 (585)
                      ..+.. +++|+.|+++    .|...  |      ..+..+++|+.|++++|.  +++..+..+. .+++|++|+|++|++
T Consensus       396 ~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l  475 (592)
T 3ogk_B          396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE  475 (592)
T ss_dssp             HHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCS
T ss_pred             HHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCC
Confidence            55544 6777777775    23311  1      114457777777776433  5444333333 367788888888877


Q ss_pred             ccc-cCccccCcCCCCEEeCCCCccCccC-ChhhccCCccceEEeecCcCee
Q 047705          264 QGL-IPDSFGNLISLKFLNLSNNNLSGAI-PASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       264 ~~~-~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      ++. ++..+..+++|+.|++++|.+++.. +.....+++|++|++++|+++.
T Consensus       476 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          476 SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             SHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             CHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            653 2344566777888888888776442 3334567778888888887653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.88  E-value=1.6e-23  Score=218.05  Aligned_cols=163  Identities=20%  Similarity=0.225  Sum_probs=123.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCC-Ccc---------------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRH-RNL---------------  472 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ni---------------  472 (585)
                      ...|...+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|+.+++.++| ++.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345778899999999999999965 79999999987432   2235778899999999977 211               


Q ss_pred             ------eeEEeeeec-----CCeEEEEEEccCCCCHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 047705          473 ------IKVISSCSN-----EEFKGLVLEYMPQGSLEKHLY------STNCILDIFQRLNIMIDVASALEYLHFGCSTPV  535 (585)
Q Consensus       473 ------v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  535 (585)
                            ..+..++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+|||   +++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                  111111111     12356777766 679999884      22335778888999999999999999   9999


Q ss_pred             EEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       536 iH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||||||+|||++.++.+||+|||+++....     .....+| +.||||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aP  276 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPP  276 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCc
Confidence            9999999999999999999999999886422     1344577 999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=7.3e-23  Score=201.15  Aligned_cols=142  Identities=17%  Similarity=0.165  Sum_probs=114.6

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhh------------------hhHHHHHHHHHHHHhcC
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR------------------RAFKSFDVECEIMKSIR  468 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  468 (585)
                      ..+......|.+.+.||+|+||.||+|++.+|+.||+|+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455566778899999999999999987799999999864321                  13467889999999998


Q ss_pred             CCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC
Q 047705          469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD  548 (585)
Q Consensus       469 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~  548 (585)
                      |+   ++.+++.. +..|+||||++|++|.+ +..       .....++.|++.|++|||   +++|+||||||+|||++
T Consensus       163 ~~---~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 GL---AVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             TS---SSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             CC---CcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence            54   44444433 45699999999999998 422       123469999999999999   99999999999999999


Q ss_pred             CCCcEEEeeecccccc
Q 047705          549 DNMIAYLSDFGIAKLL  564 (585)
Q Consensus       549 ~~~~~kl~Dfg~a~~~  564 (585)
                       ++.+||+|||+|+..
T Consensus       228 -~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             -TTEEEECCCTTCEET
T ss_pred             -CCcEEEEECCCCeEC
Confidence             999999999999865

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.87  E-value=1.6e-23  Score=228.82  Aligned_cols=302  Identities=14%  Similarity=0.027  Sum_probs=214.7

Q ss_pred             cccCCCCCCEEecCCCccc----ccCCccccCCCCCCEEecCCCcCCCcCCc-------------------------ccc
Q 047705            5 EIGNLQNLEELDLRQNKLI----GTVPVAIFNVSTLKLLGLQDNSLSGSLSS-------------------------ITD   55 (585)
Q Consensus         5 ~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-------------------------~~~   55 (585)
                      .+..+++|++|+|++|.++    ...+..+.++++|++|+|++|.+.+.+..                         ...
T Consensus       187 ~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l  266 (592)
T 3ogk_B          187 LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL  266 (592)
T ss_dssp             HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCC
T ss_pred             HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHh
Confidence            3456778888888888776    33444556778888888888876532211                         112


Q ss_pred             CCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCC
Q 047705           56 VRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTN  135 (585)
Q Consensus        56 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  135 (585)
                      ..+++|+.|+++++....++  ..+..+++|++|+|++|.+++......+..+++ |++|+++++-..+.++..+..+++
T Consensus       267 ~~~~~L~~L~l~~~~~~~l~--~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~-L~~L~L~~~~~~~~l~~~~~~~~~  343 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPNEMP--ILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN-LEVLETRNVIGDRGLEVLAQYCKQ  343 (592)
T ss_dssp             CCCTTCCEEEETTCCTTTGG--GGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTT-CCEEEEEGGGHHHHHHHHHHHCTT
T ss_pred             hccccccccCccccchhHHH--HHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcC-CCEEeccCccCHHHHHHHHHhCCC
Confidence            23455666666565555554  457778999999999999765443334566766 999999944333344444577899


Q ss_pred             ccEEEee-----------CCccccccchh-hhCCCCCceEEccCCCCCccCcccccC-CCCCcEEEcC----CCccccc-
Q 047705          136 LITIDLG-----------GNKLNGSILIT-LSKLQKLQGLVLDDNKLEGSIPDDICR-LVELYKLELG----GNKLSRS-  197 (585)
Q Consensus       136 L~~L~L~-----------~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-  197 (585)
                      |++|+++           .|.++...... +.++++|++|+++.|.+++..+..+.. +++|++|+++    .|.+++. 
T Consensus       344 L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p  423 (592)
T 3ogk_B          344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP  423 (592)
T ss_dssp             CCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCC
T ss_pred             CCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCch
Confidence            9999999           36776543333 557999999999999999877777766 8999999996    7788864 


Q ss_pred             ----CcccccCcccchhhcCCCCC--CC---CccC-CCCCCCcEEEccCCccccc-CCcccCCCCCCcEEeecccCcccc
Q 047705          198 ----IPACFNNLIALRILSLGSND--PL---PLEI-GNLKVLVGIDFSMNNFSGI-IPKEIGGLKNLEYLFLGYNRLQGL  266 (585)
Q Consensus       198 ----~~~~~~~l~~L~~L~l~~n~--~~---~~~~-~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~~  266 (585)
                          ++..+..+++|+.|+++.+.  ..   +..+ ..+++|+.|++++|.+++. .+..+.++++|++|+|++|++++.
T Consensus       424 ~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~  503 (592)
T 3ogk_B          424 LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER  503 (592)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred             HHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence                33447779999999997543  11   1122 3478999999999999863 344567899999999999998765


Q ss_pred             c-CccccCcCCCCEEeCCCCccCccCChhhc-cCCccceEEeecC
Q 047705          267 I-PDSFGNLISLKFLNLSNNNLSGAIPASLE-KLSYLEDLNLSFN  309 (585)
Q Consensus       267 ~-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~l~l~~N  309 (585)
                      . +..+..+++|+.|++++|++++.....+. .++.+....+..+
T Consensus       504 ~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          504 AIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             HHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             HHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            3 33446789999999999999866444443 5677766666554

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=1.2e-21  Score=183.97  Aligned_cols=181  Identities=23%  Similarity=0.233  Sum_probs=105.8

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      +.++.+++.++..+...    .++|++|+|++|+++.++. ..|..+++|++|+|++|+++++                 
T Consensus        10 ~~v~c~~~~l~~~p~~~----~~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~-----------------   67 (208)
T 2o6s_A           10 TTVECYSQGRTSVPTGI----PAQTTYLDLETNSLKSLPN-GVFDELTSLTQLYLGGNKLQSL-----------------   67 (208)
T ss_dssp             TEEECCSSCCSSCCSCC----CTTCSEEECCSSCCCCCCT-TTTTTCTTCSEEECCSSCCCCC-----------------
T ss_pred             CEEEecCCCccCCCCCC----CCCCcEEEcCCCccCcCCh-hhhcccccCcEEECCCCccCcc-----------------
Confidence            45666666665333221    3466677777776666654 5566666666666666666533                 


Q ss_pred             eecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       117 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                               .+..|..+++|++|+|++|+++++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+++
T Consensus        68 ---------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  138 (208)
T 2o6s_A           68 ---------PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS  138 (208)
T ss_dssp             ---------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             ---------ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce
Confidence                     22334556666666666666665555556666666666666666665555556666666666666666664


Q ss_pred             cCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCC
Q 047705          197 SIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLIS  276 (585)
Q Consensus       197 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~  276 (585)
                      ..+..|..                     +++|+.|++++|.+.+       .+++|++|+++.|+++|.+|..++.++.
T Consensus       139 ~~~~~~~~---------------------l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          139 VPDGVFDR---------------------LTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CCTTTTTT---------------------CTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             eCHHHhcc---------------------CCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            43333333                     3344444455554432       3455666667777777666666665543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.6e-21  Score=199.32  Aligned_cols=162  Identities=23%  Similarity=0.236  Sum_probs=106.8

Q ss_pred             CccEEEeeCCccccccchhhh-CCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          135 NLITIDLGGNKLNGSILITLS-KLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      .++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+...+..            
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------  107 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFL------------  107 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT------------
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHH------------
Confidence            355556666665555555555 5566666666666666555555666666666666666665433332            


Q ss_pred             CCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc---cCcCCCCEEeCCCCccCcc
Q 047705          214 GSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF---GNLISLKFLNLSNNNLSGA  290 (585)
Q Consensus       214 ~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~  290 (585)
                               +..+++|+.|+|++|+++++.+..|.++++|+.|+|++|+++++.+..|   ..+++|+.|+|++|+|++.
T Consensus       108 ---------~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A          108 ---------FSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             ---------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             ---------hCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence                     2334445555566666666667777778888888888888876555555   5678888999999998876


Q ss_pred             CChhhccCCc--cceEEeecCcCeeeCCC
Q 047705          291 IPASLEKLSY--LEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       291 ~~~~~~~l~~--L~~l~l~~N~l~~~~~~  317 (585)
                      .+..+..++.  ++.|+|++|+|.|+|..
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C~l  207 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPLECDCKL  207 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred             CHHHhhhccHhhcceEEecCCCccCCcCc
Confidence            6677788776  48899999999988763

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=2.5e-21  Score=181.71  Aligned_cols=181  Identities=23%  Similarity=0.222  Sum_probs=135.2

Q ss_pred             CCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEc
Q 047705           12 LEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGL   91 (585)
Q Consensus        12 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L   91 (585)
                      -+.++.+++.++ .+|..+  .++|++|+|++|.+++ ++...+..+++|++|+|++|+++.++. ..|..+++|++|+|
T Consensus         9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L   83 (208)
T 2o6s_A            9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPN-GVFNKLTSLTYLNL   83 (208)
T ss_dssp             TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEEC
T ss_pred             CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccCh-hhcCCCCCcCEEEC
Confidence            367888899887 455544  4589999999999984 444445678999999999999999986 77899999999999


Q ss_pred             cCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCC
Q 047705           92 SNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLE  171 (585)
Q Consensus        92 s~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  171 (585)
                      ++|+++++.+. .++.++. |++|++++|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|.+.
T Consensus        84 s~n~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  161 (208)
T 2o6s_A           84 STNQLQSLPNG-VFDKLTQ-LKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  161 (208)
T ss_dssp             CSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             CCCcCCccCHh-HhcCccC-CCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence            99999866544 4555655 777777777777666666777777777777777777666666777777777777777665


Q ss_pred             ccCcccccCCCCCcEEEcCCCcccccCcccccCcc
Q 047705          172 GSIPDDICRLVELYKLELGGNKLSRSIPACFNNLI  206 (585)
Q Consensus       172 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  206 (585)
                      +       .+++|++|+++.|.+++.+|..++.++
T Consensus       162 ~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          162 C-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             C-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             c-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            3       344677777777777777776655543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=2.3e-21  Score=191.73  Aligned_cols=173  Identities=25%  Similarity=0.311  Sum_probs=112.9

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKS   85 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   85 (585)
                      ++++++|++|++++|.++..  +.+..+++|++|+|++|.+++..+   +..+++|++|+|++|+++.++   .+..+++
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~---l~~l~~L~~L~l~~n~l~~~~---~l~~l~~  113 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP---LANLKNLGWLFLDENKVKDLS---SLKDLKK  113 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCGG---GGTTCTT
T ss_pred             hhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc---cccCCCCCEEECCCCcCCCCh---hhccCCC
Confidence            34566777777777777643  246777777777777777764433   346777777777777777754   3677777


Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEc
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL  165 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  165 (585)
                      |++|+|++|+++++ +  .+..++. |+.|++++|.+++.  ..+..+++|++|+|++|++.+..+  +..+++|++|+|
T Consensus       114 L~~L~L~~n~i~~~-~--~l~~l~~-L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L  185 (291)
T 1h6t_A          114 LKSLSLEHNGISDI-N--GLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  185 (291)
T ss_dssp             CCEEECTTSCCCCC-G--GGGGCTT-CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCEEECCCCcCCCC-h--hhcCCCC-CCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence            77777777777654 1  3455554 77777777766654  456666677777777777665544  666667777777


Q ss_pred             cCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          166 DDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      ++|.|++. + .+..+++|+.|++++|.++.
T Consensus       186 ~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          186 SKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            77766643 3 36666667777777766654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=7.8e-22  Score=186.71  Aligned_cols=158  Identities=21%  Similarity=0.323  Sum_probs=129.9

Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCC
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN  216 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n  216 (585)
                      +.+++++|.++.++ ..+.  ++|++|+|++|+|+++.+..|..+++|++|+|++|.|++..|..               
T Consensus        14 ~~v~c~~~~l~~iP-~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~---------------   75 (220)
T 2v9t_B           14 NIVDCRGKGLTEIP-TNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA---------------   75 (220)
T ss_dssp             TEEECTTSCCSSCC-SSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT---------------
T ss_pred             CEEEcCCCCcCcCC-CccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH---------------
Confidence            57888888888543 3332  57888888888888777778888888888888888887655554               


Q ss_pred             CCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhc
Q 047705          217 DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE  296 (585)
Q Consensus       217 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  296 (585)
                            +.++++|+.|+|++|.++++.+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+.
T Consensus        76 ------~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  149 (220)
T 2v9t_B           76 ------FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS  149 (220)
T ss_dssp             ------TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ------hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh
Confidence                  44556677777888888877777789999999999999999988889999999999999999999988888899


Q ss_pred             cCCccceEEeecCcCeeeCCCC
Q 047705          297 KLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       297 ~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      .+++|+.|++++|+|.|+|...
T Consensus       150 ~l~~L~~L~L~~N~~~c~c~l~  171 (220)
T 2v9t_B          150 PLRAIQTMHLAQNPFICDCHLK  171 (220)
T ss_dssp             TCTTCCEEECCSSCEECSGGGH
T ss_pred             CCCCCCEEEeCCCCcCCCCccH
Confidence            9999999999999999988743

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.85  E-value=6e-21  Score=206.75  Aligned_cols=188  Identities=24%  Similarity=0.294  Sum_probs=142.4

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKS   85 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   85 (585)
                      +..+++|+.|+|++|.++.. + .+..+++|++|+|++|.|++.++   +..+++|++|+|++|+|+.++   .+..+++
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~---~l~~l~~  110 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWLFLDENKIKDLS---SLKDLKK  110 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG---GGGCTTCCEEECCSSCCCCCT---TSTTCTT
T ss_pred             hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh---hccCCCCCEEECcCCCCCCCh---hhccCCC
Confidence            45678888888888888643 3 58888888888888888885544   446888888888888888764   4788888


Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEc
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL  165 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  165 (585)
                      |++|+|++|++.++ +  .+..++. |+.|+|++|.+++.  ..+..+++|+.|+|++|+|.+..+  |..+++|+.|+|
T Consensus       111 L~~L~Ls~N~l~~l-~--~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L  182 (605)
T 1m9s_A          111 LKSLSLEHNGISDI-N--GLVHLPQ-LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  182 (605)
T ss_dssp             CCEEECTTSCCCCC-G--GGGGCTT-CSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCEEEecCCCCCCC-c--cccCCCc-cCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence            88888888888764 2  3566665 88888888888765  567888888888888888887666  788888888888


Q ss_pred             cCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhh
Q 047705          166 DDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL  211 (585)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  211 (585)
                      ++|+|+++  ..+..+++|+.|+|++|.+.+.....+..+..+..+
T Consensus       183 s~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l  226 (605)
T 1m9s_A          183 SKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV  226 (605)
T ss_dssp             CSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCC
T ss_pred             cCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEecccc
Confidence            88888854  357788888888888888876544444444444433

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=1.2e-21  Score=185.54  Aligned_cols=158  Identities=25%  Similarity=0.298  Sum_probs=130.5

Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCC
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS  215 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (585)
                      +.+++++|.++.+ |..+.  ..+++|+|++|+|++..+ ..|..+++|++|+|++|.|++..+..              
T Consensus        14 ~~l~~s~n~l~~i-P~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~--------------   76 (220)
T 2v70_A           14 TTVDCSNQKLNKI-PEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA--------------   76 (220)
T ss_dssp             TEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTT--------------
T ss_pred             CEeEeCCCCcccC-ccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHH--------------
Confidence            5788888888854 43332  356788888888887644 45778888888888888887655444              


Q ss_pred             CCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhh
Q 047705          216 NDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL  295 (585)
Q Consensus       216 n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  295 (585)
                             +..+++|+.|+|++|.+++..+..|.++++|++|+|++|+++++.|..|..+++|+.|+|++|+|++..|..|
T Consensus        77 -------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  149 (220)
T 2v70_A           77 -------FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF  149 (220)
T ss_dssp             -------TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTT
T ss_pred             -------hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHh
Confidence                   4556667778888899998888889999999999999999999889999999999999999999998889999


Q ss_pred             ccCCccceEEeecCcCeeeCCCC
Q 047705          296 EKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       296 ~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ..+++|+.|++++|+|.|.|+..
T Consensus       150 ~~l~~L~~L~L~~N~l~c~c~l~  172 (220)
T 2v70_A          150 DTLHSLSTLNLLANPFNCNCYLA  172 (220)
T ss_dssp             TTCTTCCEEECCSCCEECSGGGH
T ss_pred             cCCCCCCEEEecCcCCcCCCchH
Confidence            99999999999999999998854

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.85  E-value=9.7e-24  Score=230.71  Aligned_cols=320  Identities=14%  Similarity=0.110  Sum_probs=188.6

Q ss_pred             cCCCCCCEEecCCCcccccCCcccc-CCCCCCEEecCCC-cCCCc-CCccccCCCCCccEEEccCCCCCCCccCcc----
Q 047705            7 GNLQNLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDN-SLSGS-LSSITDVRLPNLEELVLWGNNFSELNFLSS----   79 (585)
Q Consensus         7 ~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----   79 (585)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++.. ...+++|++|+|++|.++.... ..    
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~-~~~~~~L~~L~L~~~~i~~~~~-~~l~~~  179 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAI-AATCRNLKELDLRESDVDDVSG-HWLSHF  179 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHH-HHHCTTCCEEECTTCEEECCCG-GGGGGS
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHH-HHhCCCCCEEeCcCCccCCcch-HHHHHH
Confidence            4577888999988888777677675 6888999999888 44421 2221 1257889999999988776442 22    


Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchh----hcccccccEEEeecC-cceecCCccccCCCCccEEEeeCCc---------
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSI----GNLSHSLEDFQMHNC-NVTGDIPEEIGNLTNLITIDLGGNK---------  145 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~----~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~N~---------  145 (585)
                      ...+++|++|+|++|. . ......+    ..+++ |++|++++| .+.+ ++..+..+++|++|+++.+.         
T Consensus       180 ~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~-L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~  255 (594)
T 2p1m_B          180 PDTYTSLVSLNISCLA-S-EVSFSALERLVTRCPN-LKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYS  255 (594)
T ss_dssp             CTTCCCCCEEECTTCC-S-CCCHHHHHHHHHHCTT-CCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH
T ss_pred             hhcCCcCcEEEecccC-C-cCCHHHHHHHHHhCCC-CcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHH
Confidence            3367789999998887 1 1111122    23344 899999888 3433 55566667777777654442         


Q ss_pred             -----------------ccc----ccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCccccc-Ccccc
Q 047705          146 -----------------LNG----SILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRS-IPACF  202 (585)
Q Consensus       146 -----------------l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~  202 (585)
                                       +..    ..+..+..+++|++|+|++|.+++... ..+..+++|++|++++| ++.. .+...
T Consensus       256 ~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~  334 (594)
T 2p1m_B          256 GLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLA  334 (594)
T ss_dssp             HHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHH
Confidence                             111    123333467888888888888764332 23457788888888887 4322 22233


Q ss_pred             cCcccchhhcCCC---------CCCCCcc----CCCCCCCcEEEccCCcccccCCcccC-CCCCCcEEeec--c----cC
Q 047705          203 NNLIALRILSLGS---------NDPLPLE----IGNLKVLVGIDFSMNNFSGIIPKEIG-GLKNLEYLFLG--Y----NR  262 (585)
Q Consensus       203 ~~l~~L~~L~l~~---------n~~~~~~----~~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~ls--~----N~  262 (585)
                      ..+++|+.|+++.         +......    ...+++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.
T Consensus       335 ~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~  414 (594)
T 2p1m_B          335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDY  414 (594)
T ss_dssp             HHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCT
T ss_pred             HhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccc
Confidence            4577788887732         2211111    12366777777777777654444443 36777777777  3    44


Q ss_pred             ccccc-----CccccCcCCCCEEeCCCCccCccCChhhcc-CCccceEEeecCcCeeeCCCC--CCCCCCCccccCCCCc
Q 047705          263 LQGLI-----PDSFGNLISLKFLNLSNNNLSGAIPASLEK-LSYLEDLNLSFNKLEGEIPRG--GSFGNFSAESFEGNEL  334 (585)
Q Consensus       263 l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~l~l~~N~l~~~~~~~--~~~~~~~~~~~~~n~~  334 (585)
                      +++..     +..+..+++|+.|++++ .+++..+..+.. +++|+.|++++|.++......  ..+..++.+++.+|+.
T Consensus       415 l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          415 LTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             TTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             ccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            44211     11244556666676655 555444444443 566666666666654321110  1234555556665554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.85  E-value=5.6e-23  Score=224.68  Aligned_cols=85  Identities=19%  Similarity=0.247  Sum_probs=54.7

Q ss_pred             CCCCCCEEecCCC-ccccc-CCccccCCCCCCEEecCCCcCCCcCCc---cccCCCCCccEEEccCCCCCCCccCcc---
Q 047705            8 NLQNLEELDLRQN-KLIGT-VPVAIFNVSTLKLLGLQDNSLSGSLSS---ITDVRLPNLEELVLWGNNFSELNFLSS---   79 (585)
Q Consensus         8 ~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~l~~L~~L~L~~n~l~~~~~~~~---   79 (585)
                      .+++|++|+|++| .++.. .+..+.++++|++|+|++|.+++....   .....+++|++|+|++|. ..++. ..   
T Consensus       128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~-~~l~~  205 (594)
T 2p1m_B          128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSF-SALER  205 (594)
T ss_dssp             HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCH-HHHHH
T ss_pred             hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCH-HHHHH
Confidence            5788888888888 55433 334445788888888888887632211   112256788888888886 33321 22   


Q ss_pred             -ccCCCCCcEEEccCC
Q 047705           80 -LSNCKSLTVIGLSNN   94 (585)
Q Consensus        80 -~~~l~~L~~L~Ls~N   94 (585)
                       +..+++|++|+|++|
T Consensus       206 l~~~~~~L~~L~L~~~  221 (594)
T 2p1m_B          206 LVTRCPNLKSLKLNRA  221 (594)
T ss_dssp             HHHHCTTCCEEECCTT
T ss_pred             HHHhCCCCcEEecCCC
Confidence             234588888888877

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=1.9e-20  Score=177.21  Aligned_cols=153  Identities=20%  Similarity=0.192  Sum_probs=95.1

Q ss_pred             EEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEe
Q 047705           38 LLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQM  117 (585)
Q Consensus        38 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l  117 (585)
                      ++++++|.+++.+...    .+.+++|+|++|+|+.++....|..+++|++|+|++|+|+++.+. .+..++. |++|+|
T Consensus        15 ~l~~s~n~l~~iP~~~----~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~-~~~~l~~-L~~L~L   88 (220)
T 2v70_A           15 TVDCSNQKLNKIPEHI----PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG-AFEGASG-VNEILL   88 (220)
T ss_dssp             EEECCSSCCSSCCSCC----CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEEEC
T ss_pred             EeEeCCCCcccCccCC----CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHH-HhCCCCC-CCEEEC
Confidence            5555555555322211    234455555555555553223455555555555555555544443 3444443 555555


Q ss_pred             ecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          118 HNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       118 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      ++|.+++..+..|..+++|++|+|++|+|.++.+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            5555555555567777777777777777777777777777777777777777777777777777777888888777764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=1.5e-20  Score=191.98  Aligned_cols=173  Identities=22%  Similarity=0.166  Sum_probs=112.0

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc-CCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS-NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      +++++++|.++..+...    .+.+++|+|++|+|+.++. ..|. .+++|++|+|++|+|+++.+. .+.+++. |+.|
T Consensus        21 ~~l~c~~~~l~~iP~~~----~~~l~~L~Ls~N~l~~l~~-~~~~~~l~~L~~L~L~~N~i~~i~~~-~~~~l~~-L~~L   93 (361)
T 2xot_A           21 NILSCSKQQLPNVPQSL----PSYTALLDLSHNNLSRLRA-EWTPTRLTNLHSLLLSHNHLNFISSE-AFVPVPN-LRYL   93 (361)
T ss_dssp             TEEECCSSCCSSCCSSC----CTTCSEEECCSSCCCEECT-TSSSSCCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEE
T ss_pred             CEEEeCCCCcCccCccC----CCCCCEEECCCCCCCccCh-hhhhhcccccCEEECCCCcCCccChh-hccCCCC-CCEE
Confidence            46666666666333222    2346666666666666654 5555 666666666666666655544 4555554 6666


Q ss_pred             EeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccc---cCCCCCcEEEcCCC
Q 047705          116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI---CRLVELYKLELGGN  192 (585)
Q Consensus       116 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N  192 (585)
                      +|++|++++..+..|..+++|++|+|++|+|.++.+..|.++++|+.|+|++|+|+++.+..|   ..+++|+.|+|++|
T Consensus        94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N  173 (361)
T 2xot_A           94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN  173 (361)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred             ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence            666666666666677777888888888888877777778888888888888888876555555   45777888888888


Q ss_pred             cccccCcccccCcccc--hhhcCCCC
Q 047705          193 KLSRSIPACFNNLIAL--RILSLGSN  216 (585)
Q Consensus       193 ~l~~~~~~~~~~l~~L--~~L~l~~n  216 (585)
                      +|++..+..|..++.+  +.|+|++|
T Consensus       174 ~l~~l~~~~~~~l~~~~l~~l~l~~N  199 (361)
T 2xot_A          174 KLKKLPLTDLQKLPAWVKNGLYLHNN  199 (361)
T ss_dssp             CCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred             CCCccCHHHhhhccHhhcceEEecCC
Confidence            8876555556555543  44444333

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.1e-20  Score=202.39  Aligned_cols=196  Identities=23%  Similarity=0.242  Sum_probs=138.5

Q ss_pred             CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccE
Q 047705           35 TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLED  114 (585)
Q Consensus        35 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  114 (585)
                      +|++|+|++|.|++.++..    +++|++|+|++|+|+.+|     ..+++|++|+|++|+|++ +|.  ++.   +|++
T Consensus        60 ~L~~L~Ls~n~L~~lp~~l----~~~L~~L~Ls~N~l~~ip-----~~l~~L~~L~Ls~N~l~~-ip~--l~~---~L~~  124 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDNL----PPQITVLEITQNALISLP-----ELPASLEYLDACDNRLST-LPE--LPA---SLKH  124 (571)
T ss_dssp             TCSEEECCSSCCSCCCSCC----CTTCSEEECCSSCCSCCC-----CCCTTCCEEECCSSCCSC-CCC--CCT---TCCE
T ss_pred             CccEEEeCCCCCCccCHhH----cCCCCEEECcCCCCcccc-----cccCCCCEEEccCCCCCC-cch--hhc---CCCE
Confidence            7888888888887533322    367888888888888775     236788888888888876 333  222   4888


Q ss_pred             EEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcc
Q 047705          115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       115 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      |+|++|++++ +|.   .+++|++|+|++|.|+++..    .+++|++|+|++|+|++ +|. |.  ++|+.|+|++|.|
T Consensus       125 L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L  192 (571)
T 3cvr_A          125 LDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLL  192 (571)
T ss_dssp             EECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCC
T ss_pred             EECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCC
Confidence            8888888876 444   57888888888888886433    56788888888888886 554 54  7888888888888


Q ss_pred             cccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCc
Q 047705          195 SRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNL  274 (585)
Q Consensus       195 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  274 (585)
                      + .+|. |..  +|              ....+.|+.|+|++|.|+. +|..+..+++|+.|+|++|++++.+|..+..+
T Consensus       193 ~-~lp~-~~~--~L--------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          193 E-SLPA-VPV--RN--------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             S-SCCC-CC------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             C-chhh-HHH--hh--------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            7 4444 332  22              1123345888889999884 67777779999999999999988888877765


Q ss_pred             CC
Q 047705          275 IS  276 (585)
Q Consensus       275 ~~  276 (585)
                      +.
T Consensus       254 ~~  255 (571)
T 3cvr_A          254 TA  255 (571)
T ss_dssp             HH
T ss_pred             hc
Confidence            43

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=1.6e-20  Score=201.23  Aligned_cols=189  Identities=25%  Similarity=0.307  Sum_probs=134.2

Q ss_pred             CccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEE
Q 047705           60 NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITI  139 (585)
Q Consensus        60 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  139 (585)
                      +|++|+|++|+|+.+|. . +  .++|++|+|++|+|+.+ |.    .+ .+|++|+|++|++++ +|. +..  +|++|
T Consensus        60 ~L~~L~Ls~n~L~~lp~-~-l--~~~L~~L~Ls~N~l~~i-p~----~l-~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L  125 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPD-N-L--PPQITVLEITQNALISL-PE----LP-ASLEYLDACDNRLST-LPE-LPA--SLKHL  125 (571)
T ss_dssp             TCSEEECCSSCCSCCCS-C-C--CTTCSEEECCSSCCSCC-CC----CC-TTCCEEECCSSCCSC-CCC-CCT--TCCEE
T ss_pred             CccEEEeCCCCCCccCH-h-H--cCCCCEEECcCCCCccc-cc----cc-CCCCEEEccCCCCCC-cch-hhc--CCCEE
Confidence            78888888888888774 2 2  36788888888888743 31    22 347777777777776 444 544  77777


Q ss_pred             EeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCC
Q 047705          140 DLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL  219 (585)
Q Consensus       140 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~  219 (585)
                      +|++|+|+++.+    .+++|+.|+|++|+|++ +|.   .+++|++|+|++|.|++ +|. |                 
T Consensus       126 ~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l-----------------  178 (571)
T 3cvr_A          126 DVDNNQLTMLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-L-----------------  178 (571)
T ss_dssp             ECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-C-----------------
T ss_pred             ECCCCcCCCCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-h-----------------
Confidence            777777776333    56677777777777775 343   45677777777777764 333 2                 


Q ss_pred             CccCCCCCCCcEEEccCCcccccCCcccCCCCCC-------cEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC
Q 047705          220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNL-------EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP  292 (585)
Q Consensus       220 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L-------~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  292 (585)
                          .  ++|+.|++++|.|+. +|. |..  +|       +.|+|++|+|+. +|..+..+++|+.|+|++|++++.+|
T Consensus       179 ----~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          179 ----P--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             ----C--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ----h--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence                2  567778888888884 454 554  67       999999999995 68778889999999999999999999


Q ss_pred             hhhccCCc
Q 047705          293 ASLEKLSY  300 (585)
Q Consensus       293 ~~~~~l~~  300 (585)
                      ..+..+..
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            88877644

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=1.9e-20  Score=185.13  Aligned_cols=189  Identities=25%  Similarity=0.320  Sum_probs=133.7

Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEc
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVL  165 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  165 (585)
                      +..+.+..+.+.+..+   ...++. |+.|++++|.++.. + .+..+++|++|+|++|++++..+  +.++++|++|+|
T Consensus        26 ~~~~~l~~~~~~~~~~---~~~l~~-L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHTTCSCTTSEEC---HHHHHT-CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHhcCCCcccccc---hhhcCc-ccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            3344555666554422   233444 77777777777644 2 36667777777777777775544  667777777777


Q ss_pred             cCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCc
Q 047705          166 DDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPK  245 (585)
Q Consensus       166 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  245 (585)
                      ++|++++. + .+..+++|++|++++|.+++.                       ..+..+++|+.|++++|.+++.  .
T Consensus        98 ~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~~-----------------------~~l~~l~~L~~L~l~~n~l~~~--~  150 (291)
T 1h6t_A           98 DENKVKDL-S-SLKDLKKLKSLSLEHNGISDI-----------------------NGLVHLPQLESLYLGNNKITDI--T  150 (291)
T ss_dssp             CSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC-----------------------GGGGGCTTCCEEECCSSCCCCC--G
T ss_pred             CCCcCCCC-h-hhccCCCCCEEECCCCcCCCC-----------------------hhhcCCCCCCEEEccCCcCCcc--h
Confidence            77777642 2 366677777777777776642                       2345567788888888888865  5


Q ss_pred             ccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCee
Q 047705          246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       246 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      .+..+++|+.|++++|++++..+  +..+++|+.|++++|.+++. + .+..+++|+.|++++|+++.
T Consensus       151 ~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            68888999999999999987655  88889999999999999864 3 48889999999999999875

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=2.4e-20  Score=202.03  Aligned_cols=187  Identities=25%  Similarity=0.393  Sum_probs=137.7

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      ++..++++.+.+....+  +..+++|++|+|++|.|+ .++.  +..+++|++|+|++|+|+.++.   +..+++|++|+
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~   93 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG---GGGCTTCCEEE
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh---hccCCCCCEEE
Confidence            34556677777664433  577888999999999987 4443  3468899999999999988863   88889999999


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL  170 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (585)
                      |++|++.++.   .+..++. |+.|+|++|.+++.  ..+..+++|+.|+|++|++.++  ..|..+++|+.|+|++|+|
T Consensus        94 Ls~N~l~~l~---~l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l  165 (605)
T 1m9s_A           94 LDENKIKDLS---SLKDLKK-LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  165 (605)
T ss_dssp             CCSSCCCCCT---TSTTCTT-CCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred             CcCCCCCCCh---hhccCCC-CCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence            9999887642   3556665 88888888888753  3477788888888888888765  5677788888888888888


Q ss_pred             CccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC
Q 047705          171 EGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       171 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      ++..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|.
T Consensus       166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~  208 (605)
T 1m9s_A          166 SDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE  208 (605)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEE
T ss_pred             CCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCc
Confidence            76655  77788888888888888753  246666666666666665

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=4.9e-20  Score=174.33  Aligned_cols=152  Identities=22%  Similarity=0.257  Sum_probs=104.1

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      +.++++++.++..+...    .++|++|+|++|+|+.++. ..|..+++|++|+|++|+|+++.|. .+.+++. |++|+
T Consensus        14 ~~v~c~~~~l~~iP~~l----~~~l~~L~l~~n~i~~i~~-~~~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~-L~~L~   86 (220)
T 2v9t_B           14 NIVDCRGKGLTEIPTNL----PETITEIRLEQNTIKVIPP-GAFSPYKKLRRIDLSNNQISELAPD-AFQGLRS-LNSLV   86 (220)
T ss_dssp             TEEECTTSCCSSCCSSC----CTTCCEEECCSSCCCEECT-TSSTTCTTCCEEECCSSCCCEECTT-TTTTCSS-CCEEE
T ss_pred             CEEEcCCCCcCcCCCcc----CcCCCEEECCCCcCCCcCH-hHhhCCCCCCEEECCCCcCCCcCHH-HhhCCcC-CCEEE
Confidence            45666666666333222    2466777777777766664 5666677777777777777655554 4455544 66666


Q ss_pred             eecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc
Q 047705          117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       117 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      |++|+++...+..|..+++|++|+|++|+|.++.+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+.
T Consensus        87 Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           87 LYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            6666666555566777778888888888887777777778888888888888888777777777788888888888775

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.82  E-value=4.6e-21  Score=186.62  Aligned_cols=172  Identities=23%  Similarity=0.298  Sum_probs=144.4

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705            8 NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus         8 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      .+.+++.+++++|.++...  .+..+++|++|++++|.|+ .++.  +..+++|++|+|++|+|+.++.   +..+++|+
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~L~~N~i~~~~~---l~~l~~L~   88 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLAG--MQFFTNLKELHLSHNQISDLSP---LKDLTKLE   88 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG---GTTCSSCC
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cchH--HhhCCCCCEEECCCCccCCChh---hccCCCCC
Confidence            4566778889999987544  6889999999999999998 4553  3478999999999999999873   89999999


Q ss_pred             EEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC
Q 047705           88 VIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD  167 (585)
Q Consensus        88 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  167 (585)
                      +|+|++|+++++.+.   ..  .+|+.|++++|++++.  ..+..+++|++|+|++|+++++.  .+..+++|++|+|++
T Consensus        89 ~L~L~~N~l~~l~~~---~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~  159 (263)
T 1xeu_A           89 ELSVNRNRLKNLNGI---PS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHG  159 (263)
T ss_dssp             EEECCSSCCSCCTTC---CC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTT
T ss_pred             EEECCCCccCCcCcc---cc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCC
Confidence            999999999875432   12  3599999999999864  35889999999999999999753  688999999999999


Q ss_pred             CCCCccCcccccCCCCCcEEEcCCCcccccC
Q 047705          168 NKLEGSIPDDICRLVELYKLELGGNKLSRSI  198 (585)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (585)
                      |+|++.  ..+..+++|+.|++++|.++...
T Consensus       160 N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          160 NEITNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             SCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             CcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence            999976  67888999999999999998653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.9e-19  Score=171.48  Aligned_cols=156  Identities=24%  Similarity=0.280  Sum_probs=127.2

Q ss_pred             ccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCC
Q 047705          136 LITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS  215 (585)
Q Consensus       136 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (585)
                      .+.++.+++.++.++. .+  .++|++|+|++|+|+++.|..|..+++|++|+|++|.|+...+..              
T Consensus        21 ~~~v~c~~~~l~~ip~-~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~--------------   83 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPA-GI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV--------------   83 (229)
T ss_dssp             TTEEECTTSCCSSCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT--------------
T ss_pred             CCEeEccCCCcCccCC-CC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh--------------
Confidence            5678888888874443 22  267888888888888777888888888888888888887544333              


Q ss_pred             CCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhh
Q 047705          216 NDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL  295 (585)
Q Consensus       216 n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  295 (585)
                             +..+++|+.|+|++|+++++.+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+
T Consensus        84 -------~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~  155 (229)
T 3e6j_A           84 -------FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF  155 (229)
T ss_dssp             -------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred             -------cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHH
Confidence                   445667777888888898887888899999999999999998 568888999999999999999998777788


Q ss_pred             ccCCccceEEeecCcCeeeCC
Q 047705          296 EKLSYLEDLNLSFNKLEGEIP  316 (585)
Q Consensus       296 ~~l~~L~~l~l~~N~l~~~~~  316 (585)
                      ..+++|+.|++++|+|.|.|+
T Consensus       156 ~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          156 DRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTCTTCCEEECTTSCBCTTBG
T ss_pred             hCCCCCCEEEeeCCCccCCcc
Confidence            899999999999999998886

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=1.6e-20  Score=182.18  Aligned_cols=138  Identities=21%  Similarity=0.271  Sum_probs=107.2

Q ss_pred             CCccceecccCceEEEEEEe-CCCcE--EEEEEEechhh------------------------hhHHHHHHHHHHHHhcC
Q 047705          416 FSENNLIGRGGFGSVYKARL-GDGME--VAVKVFNLQCR------------------------RAFKSFDVECEIMKSIR  468 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  468 (585)
                      |++.+.||+|+||.||+|.+ .+|+.  ||||+++....                        .....+.+|+++++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999987 68888  99998754311                        11236788999999998


Q ss_pred             CCcc--eeEEeeeecCCeEEEEEEccCC-C----CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCC
Q 047705          469 HRNL--IKVISSCSNEEFKGLVLEYMPQ-G----SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLK  541 (585)
Q Consensus       469 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlk  541 (585)
                      |+++  +.++++    +..++||||+.+ |    +|.+....    .++..+..++.|++.|+.|||.  .++|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8754  444443    356899999942 3    66665432    2234567899999999999994  4799999999


Q ss_pred             CCCEEeCCCCcEEEeeeccccccc
Q 047705          542 PSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       542 p~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+|||+++  .++|+|||+|....
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHEEEcC--cEEEEECcccccCC
Confidence            99999998  99999999998653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=1e-18  Score=166.31  Aligned_cols=154  Identities=20%  Similarity=0.193  Sum_probs=101.6

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      -+.++.+++.++..+...    .++|++|+|++|+|+.++. ..|..+++|++|+|++|+|..+.+. .+..++. |++|
T Consensus        21 ~~~v~c~~~~l~~ip~~~----~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~-~~~~l~~-L~~L   93 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPAGI----PTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVG-VFDSLTQ-LTVL   93 (229)
T ss_dssp             TTEEECTTSCCSSCCSCC----CTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTT-TTTTCTT-CCEE
T ss_pred             CCEeEccCCCcCccCCCC----CCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChh-hcccCCC-cCEE
Confidence            455666666665333222    2566666666666666644 5566666666666666666544333 3444544 6666


Q ss_pred             EeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc
Q 047705          116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       116 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      +|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus        94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A           94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred             ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence            66666666555566777788888888888887 45666777888888888888888766667777888888888888776


Q ss_pred             cc
Q 047705          196 RS  197 (585)
Q Consensus       196 ~~  197 (585)
                      ..
T Consensus       173 c~  174 (229)
T 3e6j_A          173 CE  174 (229)
T ss_dssp             TT
T ss_pred             CC
Confidence            43

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.79  E-value=3.1e-19  Score=165.81  Aligned_cols=151  Identities=19%  Similarity=0.243  Sum_probs=73.5

Q ss_pred             cCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccc
Q 047705           31 FNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSH  110 (585)
Q Consensus        31 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  110 (585)
                      ..+++|++|++++|.|+ .++.  ...+++|++|++++|.++.++   .+..+++|++|++++|+++             
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~l~~n~~~~~~---~l~~l~~L~~L~l~~n~l~-------------  101 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLTG--IEYAHNIKDLTINNIHATNYN---PISGLSNLERLRIMGKDVT-------------  101 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCTT--GGGCTTCSEEEEESCCCSCCG---GGTTCTTCCEEEEECTTCB-------------
T ss_pred             hhcCCccEEeccCCCcc-ChHH--HhcCCCCCEEEccCCCCCcch---hhhcCCCCCEEEeECCccC-------------
Confidence            34445555555555554 2222  223455555555555444432   3444555555555555554             


Q ss_pred             cccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC-CCccCcccccCCCCCcEEEc
Q 047705          111 SLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK-LEGSIPDDICRLVELYKLEL  189 (585)
Q Consensus       111 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L  189 (585)
                                   +..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+ ++ .+| .+..+++|++|++
T Consensus       102 -------------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l  166 (197)
T 4ezg_A          102 -------------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNI  166 (197)
T ss_dssp             -------------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEEC
T ss_pred             -------------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEEC
Confidence                         3344444455555555555555554444555555555555555554 43 222 3455555555555


Q ss_pred             CCCcccccCcccccCcccchhhcCCCCC
Q 047705          190 GGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       190 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      ++|.+++ ++ .+..+++|+.|++++|+
T Consensus       167 ~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          167 QFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             TTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             CCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            5555543 22 34455555555555553

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=2.7e-20  Score=187.71  Aligned_cols=86  Identities=21%  Similarity=0.135  Sum_probs=40.0

Q ss_pred             CCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCC-EEeCCCCccCccCChhhccCCccceE
Q 047705          226 LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK-FLNLSNNNLSGAIPASLEKLSYLEDL  304 (585)
Q Consensus       226 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l  304 (585)
                      +++|+.|++++|+++.+.+.+|.++++|+.|+|++| ++.+.+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            344444444444444444444444444444444444 4434444444444444 444444 4443444444444444444


Q ss_pred             EeecCcCee
Q 047705          305 NLSFNKLEG  313 (585)
Q Consensus       305 ~l~~N~l~~  313 (585)
                      ++++|.++.
T Consensus       303 ~l~~n~i~~  311 (329)
T 3sb4_A          303 LATGDKITT  311 (329)
T ss_dssp             EECSSCCCE
T ss_pred             EeCCCccCc
Confidence            444444443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=1.8e-19  Score=175.30  Aligned_cols=168  Identities=21%  Similarity=0.280  Sum_probs=125.8

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      +..+++++|.+++..  .+..+++|++|++++|.++.+.  .+..+++|++|+|++|+|++..+  +..+++|++|+|++
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            566667777766443  4666777777777777776432  56677777777777777775444  66777777777777


Q ss_pred             CcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       192 N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      |++++. +.                      +.. ++|+.|++++|.+++.  ..+..+++|+.|++++|++++. + .+
T Consensus        95 N~l~~l-~~----------------------~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l  146 (263)
T 1xeu_A           95 NRLKNL-NG----------------------IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-ML  146 (263)
T ss_dssp             SCCSCC-TT----------------------CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GG
T ss_pred             CccCCc-Cc----------------------ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HH
Confidence            777642 11                      112 6788888899999864  3588999999999999999875 3 68


Q ss_pred             cCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeC
Q 047705          272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEI  315 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~  315 (585)
                      ..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..
T Consensus       147 ~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          147 GFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             GGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             ccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence            8899999999999999976  67888999999999999998653

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=1.8e-19  Score=166.58  Aligned_cols=175  Identities=26%  Similarity=0.311  Sum_probs=92.2

Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcc-cccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCC
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD-DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS  215 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (585)
                      +++++++|.++.+ |..+..  +|++|+|++|+|+++.+. .|..+++|++|+|++|.|++..|..              
T Consensus        11 ~~l~~s~~~l~~i-p~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--------------   73 (192)
T 1w8a_A           11 TTVDCTGRGLKEI-PRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA--------------   73 (192)
T ss_dssp             TEEECTTSCCSSC-CSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT--------------
T ss_pred             CEEEcCCCCcCcC-ccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhH--------------
Confidence            4566666666533 222221  566666666666654443 3555666666666666665443332              


Q ss_pred             CCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh-h
Q 047705          216 NDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-S  294 (585)
Q Consensus       216 n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~  294 (585)
                             +..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..+. +
T Consensus        74 -------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~  146 (192)
T 1w8a_A           74 -------FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW  146 (192)
T ss_dssp             -------TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH
T ss_pred             -------cCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH
Confidence                   33344455555566666666666666666666666666666666666666666666666666666644331 1


Q ss_pred             hccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCC
Q 047705          295 LEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       295 ~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      +.  ..++...+.++...|..|.  .+.......+..+.+.|..+
T Consensus       147 ~~--~~l~~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          147 FA--EWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HH--HHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             HH--HHHHHcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCCC
Confidence            11  1122223344444444443  22333333444555555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=4.2e-19  Score=164.93  Aligned_cols=156  Identities=20%  Similarity=0.265  Sum_probs=116.1

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC
Q 047705            5 EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK   84 (585)
Q Consensus         5 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   84 (585)
                      +.+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .++.  +..+++|++|+|++|+++.... ..|..++
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~  112 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYNP--ISGLSNLERLRIMGKDVTSDKI-PNLSGLT  112 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCGG--GTTCTTCCEEEEECTTCBGGGS-CCCTTCT
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cchh--hhcCCCCCEEEeECCccCcccC-hhhcCCC
Confidence            3467789999999999998 455 7999999999999999887 4443  4479999999999999997443 6789999


Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCc-cccccchhhhCCCCCceE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNK-LNGSILITLSKLQKLQGL  163 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L  163 (585)
                      +|++|+|++|++++..+.                          .+..+++|++|++++|. ++.+ + .+..+++|++|
T Consensus       113 ~L~~L~Ls~n~i~~~~~~--------------------------~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L  164 (197)
T 4ezg_A          113 SLTLLDISHSAHDDSILT--------------------------KINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSL  164 (197)
T ss_dssp             TCCEEECCSSBCBGGGHH--------------------------HHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEE
T ss_pred             CCCEEEecCCccCcHhHH--------------------------HHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEE
Confidence            999999999998754332                          34556677777777776 5433 3 56677777777


Q ss_pred             EccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          164 VLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       164 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      ++++|++++. + .+..+++|++|++++|++.+
T Consensus       165 ~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          165 NIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             ECTTBCCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred             ECCCCCCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence            7777777743 2 56677777777777777653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=5.7e-20  Score=204.05  Aligned_cols=222  Identities=23%  Similarity=0.231  Sum_probs=109.3

Q ss_pred             CCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCcc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI  137 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  137 (585)
                      .+.++.|+|.+|.+...+.       ..|+.++|+.|.|.+                +++..|.+. ..+..|..++.|+
T Consensus       172 ~~~~~~l~L~~n~~~~~~~-------~~l~~l~Ls~~~i~~----------------~~~~~n~~~-~~~~~~~~l~~L~  227 (727)
T 4b8c_D          172 TPLTPKIELFANGKDEANQ-------ALLQHKKLSQYSIDE----------------DDDIENRMV-MPKDSKYDDQLWH  227 (727)
T ss_dssp             --------------------------------------------------------------------------CCCCCC
T ss_pred             CCccceEEeeCCCCCcchh-------hHhhcCccCcccccC----------------cccccccee-cChhhhccCCCCc
Confidence            3456777777777666542       334555666665542                233344444 5567788888888


Q ss_pred             EEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC
Q 047705          138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       138 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      .|+|++|.+.. ++..+.++++|++|+|++|.|+ .+|..|..+++|++|+|++|.|+ .+|..|..+++|++|+|++|.
T Consensus       228 ~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  304 (727)
T 4b8c_D          228 ALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM  304 (727)
T ss_dssp             EEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred             EEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence            88888888884 4444558888888888888888 67778888888888888888888 667778888888888888886


Q ss_pred             --CCCccCCCCCCCcEEEccCCcccccCCcccCCCCC-CcEEeecccCcccccCccccCcCCCCEEeCCCC--------c
Q 047705          218 --PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKN-LEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN--------N  286 (585)
Q Consensus       218 --~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N--------~  286 (585)
                        .+|..+..+++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|..      |+.|+++.|        .
T Consensus       305 l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~  378 (727)
T 4b8c_D          305 VTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDS  378 (727)
T ss_dssp             CCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------------------------
T ss_pred             CCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCC
Confidence              66777888888888888999988887777654322 234778888888777654      455666666        3


Q ss_pred             cCccCChhhccCCccceEEeecCcCe
Q 047705          287 LSGAIPASLEKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       287 l~~~~~~~~~~l~~L~~l~l~~N~l~  312 (585)
                      +.+..+..+..+..+....+++|-+.
T Consensus       379 l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          379 LQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             -----------------------CCC
T ss_pred             ccccccchhhcccccceeeeeccccc
Confidence            44444445555666666777777765

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.76  E-value=2.9e-17  Score=169.20  Aligned_cols=272  Identities=14%  Similarity=0.151  Sum_probs=187.1

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCc
Q 047705            8 NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLT   87 (585)
Q Consensus         8 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   87 (585)
                      ....++.+.+-.+ ++.+...+|.+. +|+.+.|..+ ++ .+....|.. .+|++++|.. .++.++. .+|..+++|+
T Consensus       111 ~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~-~aF~~c~~L~  183 (401)
T 4fdw_A          111 ILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKE-DIFYYCYNLK  183 (401)
T ss_dssp             ECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECS-STTTTCTTCC
T ss_pred             ecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehH-HHhhCcccCC
Confidence            3466677777554 555667777764 7888887666 65 444444444 4688888875 7777776 7788888888


Q ss_pred             EEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccC
Q 047705           88 VIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDD  167 (585)
Q Consensus        88 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  167 (585)
                      .++|++|+++.+.... |. .. .|+.+.+.. +++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.+ .
T Consensus       184 ~l~l~~n~l~~I~~~a-F~-~~-~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p  256 (401)
T 4fdw_A          184 KADLSKTKITKLPAST-FV-YA-GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-P  256 (401)
T ss_dssp             EEECTTSCCSEECTTT-TT-TC-CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-E
T ss_pred             eeecCCCcceEechhh-Ee-ec-ccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-C
Confidence            8888888887665553 33 23 377777763 466677777777777777777764 55566677777 67777777 4


Q ss_pred             CCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCccc
Q 047705          168 NKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEI  247 (585)
Q Consensus       168 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  247 (585)
                      |.++.+...+|..+++|+++++.+|.+......                ...+..|.++++|+.+++. +.++.+...+|
T Consensus       257 ~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~----------------~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF  319 (401)
T 4fdw_A          257 NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEA----------------MIHPYCLEGCPKLARFEIP-ESIRILGQGLL  319 (401)
T ss_dssp             TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTC----------------EECTTTTTTCTTCCEECCC-TTCCEECTTTT
T ss_pred             CCccEEChhHhhCCCCCCEEEeCCccccCCccc----------------EECHHHhhCCccCCeEEeC-CceEEEhhhhh
Confidence            556656667777777777777777666410000                0122345566667777776 44776777888


Q ss_pred             CCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCC-ccceEEeecCcCe
Q 047705          248 GGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS-YLEDLNLSFNKLE  312 (585)
Q Consensus       248 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~  312 (585)
                      .++.+|+.+.|..| ++.+.+.+|.++ +|+.+++++|.+....+..|..++ .++.|++..|.+.
T Consensus       320 ~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          320 GGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             cCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            88888888888655 666777888888 888888888888877777777774 6788888877654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=2.2e-21  Score=208.87  Aligned_cols=209  Identities=22%  Similarity=0.191  Sum_probs=124.4

Q ss_pred             CCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCc
Q 047705           57 RLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL  136 (585)
Q Consensus        57 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  136 (585)
                      ..++|+.|+|++|+++.+|  ..+..+++|+.|++++|...        ..++..+     ..++..+.+|..++.+++|
T Consensus       347 ~~~~L~~L~Ls~n~L~~Lp--~~i~~l~~L~~L~l~~n~~l--------~~l~~ll-----~~~~~~~~~~~~l~~l~~L  411 (567)
T 1dce_A          347 TDEQLFRCELSVEKSTVLQ--SELESCKELQELEPENKWCL--------LTIILLM-----RALDPLLYEKETLQYFSTL  411 (567)
T ss_dssp             TTTTSSSCCCCHHHHHHHH--HHHHHHHHHHHHCTTCHHHH--------HHHHHHH-----HHHCTGGGHHHHHHHHHHH
T ss_pred             cCccceeccCChhhHHhhH--HHHHHHHHHHHhccccchhh--------hhHHHHH-----HhcccccCCHHHHHHHHhc
Confidence            4556666666666666665  45666666666666554310        0000000     0112344555566666666


Q ss_pred             cEEE-eeCCccccccchhh-----hC--CCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccc
Q 047705          137 ITID-LGGNKLNGSILITL-----SK--LQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIAL  208 (585)
Q Consensus       137 ~~L~-L~~N~l~~~~~~~~-----~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  208 (585)
                      +.|+ ++.|.+.......+     ..  ...|+.|+|++|+|++ +|. +..+++|+.|+|++|.|+ .           
T Consensus       412 ~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~-----------  477 (567)
T 1dce_A          412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A-----------  477 (567)
T ss_dssp             HHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C-----------
T ss_pred             ccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c-----------
Confidence            6666 45444331111000     00  0135555555555553 333 555555555555555555 3           


Q ss_pred             hhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCccccc-CccccCcCCCCEEeCCCCcc
Q 047705          209 RILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI-PDSFGNLISLKFLNLSNNNL  287 (585)
Q Consensus       209 ~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l  287 (585)
                                +|..++.+++|+.|+|++|.+++ +| .|+++++|+.|+|++|++++.. |..+..+++|+.|+|++|++
T Consensus       478 ----------lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l  545 (567)
T 1dce_A          478 ----------LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL  545 (567)
T ss_dssp             ----------CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             ----------cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence                      34455666777777888888886 45 7888899999999999998876 88888899999999999998


Q ss_pred             CccCCh---hhccCCccceEEe
Q 047705          288 SGAIPA---SLEKLSYLEDLNL  306 (585)
Q Consensus       288 ~~~~~~---~~~~l~~L~~l~l  306 (585)
                      ++..|.   .+..+++|+.||+
T Consensus       546 ~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          546 CQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             GGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCccHHHHHHHHCcccCccCC
Confidence            876553   2344788888864

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=2.1e-21  Score=209.11  Aligned_cols=185  Identities=23%  Similarity=0.193  Sum_probs=138.2

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCc-------------cccccchhhhCCCCCceEE-ccCCCCCccCccc
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNK-------------LNGSILITLSKLQKLQGLV-LDDNKLEGSIPDD  177 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~~~~~~  177 (585)
                      |+.|+|++|.++ .+|..++.+++|+.|++++|.             +.+..|..+.++++|+.|+ ++.|.+.      
T Consensus       351 L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~------  423 (567)
T 1dce_A          351 LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD------  423 (567)
T ss_dssp             SSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH------
T ss_pred             ceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc------
Confidence            556666666665 445566666666666665553             4556777888888888888 6666443      


Q ss_pred             ccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcE
Q 047705          178 ICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY  255 (585)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  255 (585)
                           +|+.+.+++|.++...+      ..|+.|+|++|.  .+|. +..+++|+.|+|++|.++ .+|..|+++++|+.
T Consensus       424 -----~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  490 (567)
T 1dce_A          424 -----DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV  490 (567)
T ss_dssp             -----HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCE
T ss_pred             -----hhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCE
Confidence                 23333444444443221      135556666665  3343 777888999999999999 67889999999999


Q ss_pred             EeecccCcccccCccccCcCCCCEEeCCCCccCccC-ChhhccCCccceEEeecCcCeeeCCCC
Q 047705          256 LFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI-PASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       256 L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      |+|++|++++ +| .+..+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|..
T Consensus       491 L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          491 LQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             EECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             EECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            9999999997 56 8999999999999999999887 999999999999999999999887753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=1.3e-18  Score=175.39  Aligned_cols=283  Identities=15%  Similarity=0.144  Sum_probs=185.7

Q ss_pred             CCCCCEEecCCCcccccCCccccC-CCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccC-----
Q 047705            9 LQNLEELDLRQNKLIGTVPVAIFN-VSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSN-----   82 (585)
Q Consensus         9 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~-----   82 (585)
                      +.+++.|+++++ +.......+.. +++|++|||++|+|. .... ....++.+..+.+..|.   +|. .+|..     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~-~~~~~~~~~~~~~~~~~---I~~-~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSG-KAGTYPNGKFYIYMANF---VPA-YAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEE-SSSSSGGGCCEEECTTE---ECT-TTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecC-ccccccccccccccccc---cCH-HHhccccccc
Confidence            567899999875 22222334444 788999999999987 1111 11233445666666663   454 67888     


Q ss_pred             ---CCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCc----cccccchhhh
Q 047705           83 ---CKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNK----LNGSILITLS  155 (585)
Q Consensus        83 ---l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~  155 (585)
                         +++|+.|+|.+ +++.+.+. +|.++++ |+.|++.+|.++.+.+.+|.++.++..+.+..+.    ...+...+|.
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~-aF~~~~~-L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~  173 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDA-AFKGCDN-LKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI  173 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTT-TTTTCTT-CCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE
T ss_pred             ccccCCCcEEECCc-cccchhHH-HhhcCcc-cceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccc
Confidence               88888888888 77766555 6777776 8888888888888888888888777777666532    2334455666


Q ss_pred             CCCCCc-eEEccCCCCCccCcccc----cCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC---CCCccCCCCC
Q 047705          156 KLQKLQ-GLVLDDNKLEGSIPDDI----CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND---PLPLEIGNLK  227 (585)
Q Consensus       156 ~l~~L~-~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~---~~~~~~~~l~  227 (585)
                      ++..|+ .+.+....   .++..+    ....++..+.+.++-...........+++|+.|++++|+   +.+..|.++.
T Consensus       174 ~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~  250 (329)
T 3sb4_A          174 EGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKK  250 (329)
T ss_dssp             ESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCT
T ss_pred             cccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCC
Confidence            777777 45554322   112111    123344555554442221111111224556666666554   2223466677


Q ss_pred             CCcEEEccCCcccccCCcccCCCCCCc-EEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEe
Q 047705          228 VLVGIDFSMNNFSGIIPKEIGGLKNLE-YLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNL  306 (585)
Q Consensus       228 ~L~~L~ls~N~l~~~~~~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l  306 (585)
                      +|+.|++++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.+|++|+.+++++|+++.+.+.+|.++++|+.++.
T Consensus       251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            7777778777 7777888888888888 888887 777777788888888998888888888777788888888888763

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=5.6e-18  Score=156.52  Aligned_cols=113  Identities=25%  Similarity=0.348  Sum_probs=75.0

Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  164 (585)
                      +|++|+|++|+|+++.+...++.++. |++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  108 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPH-LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTT-CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCEEECCCCcCCccCCccccccCCC-CCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence            44444444444443333222333433 44444444444445556677778888888888888877777788888888888


Q ss_pred             ccCCCCCccCcccccCCCCCcEEEcCCCcccccC
Q 047705          165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSI  198 (585)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (585)
                      |++|+|++..|..|..+++|++|+|++|.+.+..
T Consensus       109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A          109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            8888888777888888888888888888887543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=5.4e-17  Score=167.19  Aligned_cols=242  Identities=13%  Similarity=0.115  Sum_probs=183.9

Q ss_pred             CCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCcc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI  137 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  137 (585)
                      ...++++.+.+ .++.++. .+|... +|+.+.|..| ++.+... +|.+.  +|+.+.+.. +++.+.+.+|.++++|+
T Consensus       112 ~~~l~~i~ip~-~i~~I~~-~aF~~~-~L~~i~l~~~-i~~I~~~-aF~~~--~L~~i~lp~-~l~~I~~~aF~~c~~L~  183 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPK-DAFRNS-QIAKVVLNEG-LKSIGDM-AFFNS--TVQEIVFPS-TLEQLKEDIFYYCYNLK  183 (401)
T ss_dssp             CSSCSEEECCT-TCCEECT-TTTTTC-CCSEEECCTT-CCEECTT-TTTTC--CCCEEECCT-TCCEECSSTTTTCTTCC
T ss_pred             cCCccEEEECC-ccCEehH-hhcccC-CccEEEeCCC-ccEECHH-hcCCC--CceEEEeCC-CccEehHHHhhCcccCC
Confidence            35666666653 5666765 667764 6777777666 6555555 34432  377777775 67767777888888888


Q ss_pred             EEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC
Q 047705          138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND  217 (585)
Q Consensus       138 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~  217 (585)
                      .++|++|.++.+...+|. ..+|+++.|..+ ++.+...+|.++++|+.+++..| ++.....+|.+ .+|+.+.+.++-
T Consensus       184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~~i  259 (401)
T 4fdw_A          184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPNGV  259 (401)
T ss_dssp             EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEETTC
T ss_pred             eeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCCCc
Confidence            888888888877777777 478888888744 77677778888888888888775 55455667777 678888885543


Q ss_pred             --CCCccCCCCCCCcEEEccCCccc-----ccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCcc
Q 047705          218 --PLPLEIGNLKVLVGIDFSMNNFS-----GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA  290 (585)
Q Consensus       218 --~~~~~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  290 (585)
                        .....|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+.|. +.++.+...+|.+|++|+.+.+..| ++.+
T Consensus       260 ~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I  337 (401)
T 4fdw_A          260 TNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI  337 (401)
T ss_dssp             CEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred             cEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence              44556888888999988887765     5778899999999999999 5588788899999999999999655 7878


Q ss_pred             CChhhccCCccceEEeecCcCeee
Q 047705          291 IPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       291 ~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      .+.+|.++ +|+.+++++|.+...
T Consensus       338 ~~~aF~~~-~L~~l~l~~n~~~~l  360 (401)
T 4fdw_A          338 NFSAFNNT-GIKEVKVEGTTPPQV  360 (401)
T ss_dssp             CTTSSSSS-CCCEEEECCSSCCBC
T ss_pred             cHHhCCCC-CCCEEEEcCCCCccc
Confidence            88899999 999999999987643

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=1.7e-18  Score=160.02  Aligned_cols=155  Identities=28%  Similarity=0.376  Sum_probs=119.7

Q ss_pred             ceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCccc
Q 047705          161 QGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS  240 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~  240 (585)
                      +.+++++|.|+ .+|..+.  ++|++|+|++|.|+ .+|.                     .+..+++|+.|+|++|.++
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~---------------------~~~~l~~L~~L~Ls~N~i~   67 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPK---------------------ELSNYKHLTLIDLSNNRIS   67 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCG---------------------GGGGCTTCCEEECCSSCCC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHH---------------------HhhcccCCCEEECCCCcCC
Confidence            56888888888 4454432  57888888888887 3444                     3455667788888999999


Q ss_pred             ccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCC
Q 047705          241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGS  320 (585)
Q Consensus       241 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~  320 (585)
                      ++.+..|.++++|++|+|++|+++++.|..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|+|.|+|...+.
T Consensus        68 ~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l  147 (193)
T 2wfh_A           68 TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWL  147 (193)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred             EeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHH
Confidence            88888999999999999999999998888999999999999999999987777899999999999999999998875432


Q ss_pred             CCCCCccccCCCCcccCCCC
Q 047705          321 FGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       321 ~~~~~~~~~~~n~~~c~~~~  340 (585)
                      ...+.......+...|..|.
T Consensus       148 ~~~~~~~~~~~~~~~C~~P~  167 (193)
T 2wfh_A          148 SDWVKSEYKEPGIARCAGPG  167 (193)
T ss_dssp             HHHHHHSSCCCSCCBEEESG
T ss_pred             HHHHHhccCCCCCcCcCCch
Confidence            22222222223445676653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=2.1e-18  Score=173.60  Aligned_cols=137  Identities=16%  Similarity=0.178  Sum_probs=101.2

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhh--------------hh--------HHHHHHHHHHHHhcCCCc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCR--------------RA--------FKSFDVECEIMKSIRHRN  471 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~--------~~~~~~E~~~l~~l~h~n  471 (585)
                      .=|++.+.||+|+||.||+|...+|+.||||+++....              ..        ......|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34999999999999999999988999999998753210              00        011234666777775444


Q ss_pred             c--eeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC
Q 047705          472 L--IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD  549 (585)
Q Consensus       472 i--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~  549 (585)
                      +  ...++.    ...++||||++|+++.++...       .....++.|++.++.|||   ++|||||||||.|||+++
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            3  222322    123799999999888765422       123568899999999999   899999999999999987


Q ss_pred             CC----------cEEEeeecccccc
Q 047705          550 NM----------IAYLSDFGIAKLL  564 (585)
Q Consensus       550 ~~----------~~kl~Dfg~a~~~  564 (585)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            66          3899999987653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.71  E-value=2.4e-18  Score=191.01  Aligned_cols=215  Identities=18%  Similarity=0.168  Sum_probs=112.9

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEE-----ecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLL-----GLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK   84 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-----~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   84 (585)
                      ++++.|+|.+|.+.. .+..+.....|..+     +++.|.+.  .+...+..++.|++|+|++|.+..+|  ..+..++
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~--~~~~~~~~l~~L~~L~Ls~n~l~~l~--~~~~~l~  247 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV--MPKDSKYDDQLWHALDLSNLQIFNIS--ANIFKYD  247 (727)
T ss_dssp             ----------------------------------------------------CCCCCCEEECTTSCCSCCC--GGGGGCC
T ss_pred             CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee--cChhhhccCCCCcEEECCCCCCCCCC--hhhcCCC
Confidence            567888888888774 34333333233332     22333333  22334457888999999999998887  3455888


Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  164 (585)
                      +|++|+|++|.|+ .+|. .+++++. |++|+|++|.++ .+|..|+.|++|++|+|++|.|+ .+|..|.++++|++|+
T Consensus       248 ~L~~L~Ls~N~l~-~lp~-~~~~l~~-L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~  322 (727)
T 4b8c_D          248 FLTRLYLNGNSLT-ELPA-EIKNLSN-LRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLG  322 (727)
T ss_dssp             SCSCCBCTTSCCS-CCCG-GGGGGTT-CCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred             CCCEEEeeCCcCc-ccCh-hhhCCCC-CCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence            9999999999988 5555 5677776 999999999988 66888889999999999999987 4566688999999999


Q ss_pred             ccCCCCCccCcccccCCCC-CcEEEcCCCcccccCcccccCcccchhhcCCCCC-----------CCCccCCCCCCCcEE
Q 047705          165 LDDNKLEGSIPDDICRLVE-LYKLELGGNKLSRSIPACFNNLIALRILSLGSND-----------PLPLEIGNLKVLVGI  232 (585)
Q Consensus       165 L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-----------~~~~~~~~l~~L~~L  232 (585)
                      |++|.|++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|++++|.           ..+..+..+..+...
T Consensus       323 L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~  396 (727)
T 4b8c_D          323 VEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFT  396 (727)
T ss_dssp             CTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C------------------------------------
T ss_pred             CCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhccccccee
Confidence            9999999888877755422 23477888998877776      45556666662           112223344455556


Q ss_pred             EccCCccc
Q 047705          233 DFSMNNFS  240 (585)
Q Consensus       233 ~ls~N~l~  240 (585)
                      .++.|-+.
T Consensus       397 ~ls~Nil~  404 (727)
T 4b8c_D          397 VLSYNTLC  404 (727)
T ss_dssp             -----CCC
T ss_pred             eeeccccc
Confidence            66677654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=4.6e-17  Score=146.97  Aligned_cols=37  Identities=30%  Similarity=0.296  Sum_probs=15.2

Q ss_pred             CCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCc
Q 047705           58 LPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLD   97 (585)
Q Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~   97 (585)
                      +++|++|+|++|.++.+   ..+..+++|++|+|++|+++
T Consensus        48 l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~N~l~   84 (168)
T 2ell_A           48 FVNLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIF   84 (168)
T ss_dssp             GGGCCEEEEESSCCCCC---SSCCCCSSCCEEEEESCCCC
T ss_pred             CCCCCEEeCcCCCCCCh---hhhccCCCCCEEECcCCcCc
Confidence            34444444444444433   22334444444444444443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=2.7e-16  Score=145.24  Aligned_cols=128  Identities=30%  Similarity=0.322  Sum_probs=88.3

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      +++++++|.|+. +|...   .++|++|+|++|+|+.+|  ..|..+++|++|+|++|+|++                  
T Consensus        13 ~~l~~~~~~l~~-ip~~~---~~~l~~L~L~~n~i~~ip--~~~~~l~~L~~L~Ls~N~i~~------------------   68 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGI---PRDVTELYLDGNQFTLVP--KELSNYKHLTLIDLSNNRIST------------------   68 (193)
T ss_dssp             TEEECTTSCCSS-CCSCC---CTTCCEEECCSSCCCSCC--GGGGGCTTCCEEECCSSCCCC------------------
T ss_pred             CEEEcCCCCCCc-CCCCC---CCCCCEEECCCCcCchhH--HHhhcccCCCEEECCCCcCCE------------------
Confidence            456666666653 22221   245666666666666655  456666666666666666553                  


Q ss_pred             eecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       117 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                              ..+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|.+..
T Consensus        69 --------i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           69 --------LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             --------CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             --------eCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence                    334456777888888888888887777788888888888888888887666678888888888888888863

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=2.7e-16  Score=141.88  Aligned_cols=129  Identities=22%  Similarity=0.249  Sum_probs=75.6

Q ss_pred             CCCccEEEccCCCCC--CCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCC
Q 047705           58 LPNLEELVLWGNNFS--ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTN  135 (585)
Q Consensus        58 l~~L~~L~L~~n~l~--~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  135 (585)
                      .++|++|+|++|+++  .+|  ..+..+++|++|+|++|.++++                            ..+..+++
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~--~~~~~l~~L~~L~l~~n~l~~~----------------------------~~~~~l~~   72 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIE--GLTAEFVNLEFLSLINVGLISV----------------------------SNLPKLPK   72 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCS--SCCGGGGGCCEEEEESSCCCCC----------------------------SSCCCCSS
T ss_pred             cccCCEEECCCCCCChhhHH--HHHHhCCCCCEEeCcCCCCCCh----------------------------hhhccCCC
Confidence            456666666666666  454  3355566666666666665533                            33555666


Q ss_pred             ccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCcccccCc---ccccCcccchhh
Q 047705          136 LITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLSRSIP---ACFNNLIALRIL  211 (585)
Q Consensus       136 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L  211 (585)
                      |++|+|++|++.+..|..+..+++|++|+|++|+|++..+ ..+..+++|++|++++|.+++..+   ..+..+++|++|
T Consensus        73 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  152 (168)
T 2ell_A           73 LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL  152 (168)
T ss_dssp             CCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred             CCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence            6666666666665556666666666666666666664322 556666666666666666664433   244444444444


Q ss_pred             cCCCC
Q 047705          212 SLGSN  216 (585)
Q Consensus       212 ~l~~n  216 (585)
                      ++++|
T Consensus       153 ~l~~n  157 (168)
T 2ell_A          153 DGYDR  157 (168)
T ss_dssp             TTEET
T ss_pred             cCCCC
Confidence            44443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=4.6e-16  Score=141.67  Aligned_cols=133  Identities=25%  Similarity=0.242  Sum_probs=94.0

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      .+.+++++|.++..+..    ..++|++|++++|+++.++. ..|..+++|++|+|++|+++++                
T Consensus         9 ~~~l~~~~~~l~~~p~~----~~~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~----------------   67 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTG----IPSSATRLELESNKLQSLPH-GVFDKLTQLTKLSLSQNQIQSL----------------   67 (177)
T ss_dssp             TTEEECCSSCCSSCCTT----CCTTCSEEECCSSCCCCCCT-TTTTTCTTCSEEECCSSCCCCC----------------
T ss_pred             CCEEEecCCCCccCCCC----CCCCCcEEEeCCCcccEeCH-HHhcCcccccEEECCCCcceEe----------------
Confidence            45677777777633322    13567777777777776664 5566667777777777766533                


Q ss_pred             EeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc
Q 047705          116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       116 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                                .+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+..+..+++|++|+|++|.+.
T Consensus        68 ----------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           68 ----------PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             ----------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ----------ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence                      3344667788888888888888777777888888888888888888766666777888888888888887


Q ss_pred             ccCc
Q 047705          196 RSIP  199 (585)
Q Consensus       196 ~~~~  199 (585)
                      +..+
T Consensus       138 ~~~~  141 (177)
T 2o6r_A          138 CSCP  141 (177)
T ss_dssp             CCHH
T ss_pred             ccCc
Confidence            5443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.65  E-value=3.6e-15  Score=153.94  Aligned_cols=290  Identities=14%  Similarity=0.092  Sum_probs=172.3

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCC
Q 047705            5 EIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCK   84 (585)
Q Consensus         5 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   84 (585)
                      +|.+..+|+.++|..+ ++.+...+|.++++|+.++|..+ ++ .+....|...++|+.+.+..+ +..++. .+|....
T Consensus        66 AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~-~aF~~~~  140 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGV-EAFKGCD  140 (394)
T ss_dssp             TTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECT-TTTTTCC
T ss_pred             HhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecc-eeeeccc
Confidence            4677788888888644 66677778888888888888654 54 455555666667766665432 333332 3343333


Q ss_pred             CCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEE
Q 047705           85 SLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV  164 (585)
Q Consensus        85 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  164 (585)
                      .+........  ..+.. .+|.++.. |+.+.+..+ +..+...+|.++++|+.+++..| +..+...+|.++..|+.+.
T Consensus       141 ~~~~~~~~~~--~~i~~-~aF~~c~~-L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          141 FKEITIPEGV--TVIGD-EAFATCES-LEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CSEEECCTTC--CEECT-TTTTTCTT-CCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccCccc--cccch-hhhcccCC-CcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            2222222111  11111 13333333 555555432 23344445555555555555443 3334444455555554444


Q ss_pred             ccCCC---------------------CCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccC
Q 047705          165 LDDNK---------------------LEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEI  223 (585)
Q Consensus       165 L~~N~---------------------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~  223 (585)
                      +..+.                     ++.+....|..+.+|+.+.+..+... .....|..+..++.+....+......+
T Consensus       215 ~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F  293 (394)
T 4fs7_A          215 FPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTF  293 (394)
T ss_dssp             CCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTT
T ss_pred             cCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccc
Confidence            44332                     22234445566666666666665443 445566666666666655544444456


Q ss_pred             CCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccce
Q 047705          224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLED  303 (585)
Q Consensus       224 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  303 (585)
                      ..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...+|.++.+|+.
T Consensus       294 ~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~  370 (394)
T 4fs7_A          294 YGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKK  370 (394)
T ss_dssp             TTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCE
T ss_pred             cccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCE
Confidence            67778888877654 66667777888888888888654 66666778888888888888766 66666778888888888


Q ss_pred             EEeecC
Q 047705          304 LNLSFN  309 (585)
Q Consensus       304 l~l~~N  309 (585)
                      +++..+
T Consensus       371 i~lp~~  376 (394)
T 4fs7_A          371 VELPKR  376 (394)
T ss_dssp             EEEEGG
T ss_pred             EEECCC
Confidence            888655

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.2e-16  Score=141.11  Aligned_cols=84  Identities=23%  Similarity=0.273  Sum_probs=40.7

Q ss_pred             cCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCcc-CcccccCCCCCcEEEcCCCcccccCc---ccccCcc
Q 047705          131 GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGS-IPDDICRLVELYKLELGGNKLSRSIP---ACFNNLI  206 (585)
Q Consensus       131 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~  206 (585)
                      ..+++|++|+|++|.+.+..|..+..+++|++|++++|++++. .+..+..+++|++|++++|.+++..+   ..+..++
T Consensus        61 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~  140 (149)
T 2je0_A           61 PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP  140 (149)
T ss_dssp             CCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCT
T ss_pred             hcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCC
Confidence            3344455555555555444444444455555555555555432 12444555555555555555554333   2445555


Q ss_pred             cchhhcCC
Q 047705          207 ALRILSLG  214 (585)
Q Consensus       207 ~L~~L~l~  214 (585)
                      +|+.|+++
T Consensus       141 ~L~~L~l~  148 (149)
T 2je0_A          141 QLTYLDGY  148 (149)
T ss_dssp             TCCEETTB
T ss_pred             CcccccCC
Confidence            55555543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=9.1e-16  Score=139.66  Aligned_cols=133  Identities=25%  Similarity=0.245  Sum_probs=99.3

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      +.+.+++++|+++ .+|..+.  ++|++|+|++|.+++.+ ...+..+++|++|+|++|+++.++. ..|..+++|++|+
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~   82 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLP-HGVFDKLTQLTKLSLSQNQIQSLPD-GVFDKLTKLTILY   82 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCC-TTTTTTCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEE
T ss_pred             CCCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeC-HHHhcCcccccEEECCCCcceEeCh-hHccCCCccCEEE
Confidence            3578999999997 4555443  69999999999998544 4445579999999999999999986 7789999999999


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKL  170 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  170 (585)
                      |++|+++++.+.                          .|..+++|++|+|++|+++++.+..|..+++|++|+|++|.+
T Consensus        83 l~~N~l~~~~~~--------------------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  136 (177)
T 2o6r_A           83 LHENKLQSLPNG--------------------------VFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  136 (177)
T ss_dssp             CCSSCCCCCCTT--------------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CCCCCccccCHH--------------------------HhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCe
Confidence            999999855443                          244556666666666666655555566666666666666666


Q ss_pred             CccC
Q 047705          171 EGSI  174 (585)
Q Consensus       171 ~~~~  174 (585)
                      ++..
T Consensus       137 ~~~~  140 (177)
T 2o6r_A          137 DCSC  140 (177)
T ss_dssp             CCCH
T ss_pred             eccC
Confidence            6443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=2e-16  Score=139.60  Aligned_cols=129  Identities=22%  Similarity=0.276  Sum_probs=106.9

Q ss_pred             CCCCccEEEccCCCCC--CCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCC
Q 047705           57 RLPNLEELVLWGNNFS--ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLT  134 (585)
Q Consensus        57 ~l~~L~~L~L~~n~l~--~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  134 (585)
                      ..++|++|++++|.++  .+|  ..+..+++|++|++++|+++++   ..++.++. |++|++++|.+++.+|..+..++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~--~~~~~l~~L~~L~l~~n~l~~~---~~~~~l~~-L~~L~Ls~n~i~~~~~~~~~~l~   88 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLE--GLTDEFEELEFLSTINVGLTSI---ANLPKLNK-LKKLELSDNRVSGGLEVLAEKCP   88 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCC--SCCTTCTTCCEEECTTSCCCCC---TTCCCCTT-CCEEECCSSCCCSCTHHHHHHCT
T ss_pred             CCccCeEEEccCCcCChhHHH--HHHhhcCCCcEEECcCCCCCCc---hhhhcCCC-CCEEECCCCcccchHHHHhhhCC
Confidence            3578999999999998  665  5678889999999999999876   35666766 99999999999887888888899


Q ss_pred             CccEEEeeCCccccc-cchhhhCCCCCceEEccCCCCCccCc---ccccCCCCCcEEEcCC
Q 047705          135 NLITIDLGGNKLNGS-ILITLSKLQKLQGLVLDDNKLEGSIP---DDICRLVELYKLELGG  191 (585)
Q Consensus       135 ~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~  191 (585)
                      +|++|++++|.+++. .+..+..+++|++|++++|.+++..+   ..+..+++|+.|++++
T Consensus        89 ~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999999999999875 34778889999999999999987666   5788889999998864

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=1.2e-15  Score=138.72  Aligned_cols=128  Identities=19%  Similarity=0.172  Sum_probs=75.6

Q ss_pred             CCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCc
Q 047705           57 RLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL  136 (585)
Q Consensus        57 ~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  136 (585)
                      .+++|++|+|++|+++.++  ......++|++|+|++|+++                          +.  ..|..+++|
T Consensus        17 ~~~~L~~L~l~~n~l~~i~--~~~~~~~~L~~L~Ls~N~l~--------------------------~~--~~l~~l~~L   66 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPVIE--NLGATLDQFDAIDFSDNEIR--------------------------KL--DGFPLLRRL   66 (176)
T ss_dssp             CTTSCEEEECTTSCCCSCC--CGGGGTTCCSEEECCSSCCC--------------------------EE--CCCCCCSSC
T ss_pred             CcCCceEEEeeCCCCchhH--HhhhcCCCCCEEECCCCCCC--------------------------cc--cccccCCCC
Confidence            4555666666666665553  21122225555555555554                          32  345666777


Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcc--cccCCCCCcEEEcCCCcccccCcc----cccCcccchh
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD--DICRLVELYKLELGGNKLSRSIPA----CFNNLIALRI  210 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~  210 (585)
                      ++|+|++|+|+++.+..|..+++|++|+|++|+|+. +|.  .+..+++|+.|++++|.++. .|.    .+..+++|+.
T Consensus        67 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~  144 (176)
T 1a9n_A           67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRV  144 (176)
T ss_dssp             CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSE
T ss_pred             CEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccce
Confidence            777777777776655556777777777777777763 333  56677777777777777763 333    2455555555


Q ss_pred             hcCCCC
Q 047705          211 LSLGSN  216 (585)
Q Consensus       211 L~l~~n  216 (585)
                      |+++.|
T Consensus       145 Ld~~~n  150 (176)
T 1a9n_A          145 LDFQKV  150 (176)
T ss_dssp             ETTEEC
T ss_pred             eCCCcC
Confidence            555444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=8.8e-16  Score=139.62  Aligned_cols=114  Identities=14%  Similarity=0.161  Sum_probs=75.6

Q ss_pred             CccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhh
Q 047705           27 PVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIG  106 (585)
Q Consensus        27 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  106 (585)
                      ...+.+..+|++|+|++|.|++ ++... ...++|++|+|++|+|+.+   ..|..+++|++|+|++|+|+++.+. .++
T Consensus        12 ~~~~~~~~~L~~L~l~~n~l~~-i~~~~-~~~~~L~~L~Ls~N~l~~~---~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~   85 (176)
T 1a9n_A           12 AAQYTNAVRDRELDLRGYKIPV-IENLG-ATLDQFDAIDFSDNEIRKL---DGFPLLRRLKTLLVNNNRICRIGEG-LDQ   85 (176)
T ss_dssp             SCEEECTTSCEEEECTTSCCCS-CCCGG-GGTTCCSEEECCSSCCCEE---CCCCCCSSCCEEECCSSCCCEECSC-HHH
T ss_pred             HHhcCCcCCceEEEeeCCCCch-hHHhh-hcCCCCCEEECCCCCCCcc---cccccCCCCCEEECCCCcccccCcc-hhh
Confidence            3567788999999999999984 44433 2345999999999999987   4688999999999999999865443 334


Q ss_pred             cccccccEEEeecCcceecCC-ccccCCCCccEEEeeCCccc
Q 047705          107 NLSHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLN  147 (585)
Q Consensus       107 ~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~  147 (585)
                      .++. |++|++++|.++...+ ..+..+++|++|++++|.+.
T Consensus        86 ~l~~-L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           86 ALPD-LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             HCTT-CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cCCC-CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            4443 4444444444432111 13444444444444444444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=1.5e-17  Score=154.46  Aligned_cols=155  Identities=23%  Similarity=0.294  Sum_probs=83.5

Q ss_pred             ccCCCCCCEEecCCCcccccCCc------cccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcc
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPV------AIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSS   79 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~   79 (585)
                      |....+++.++++.+.+++..|.      .+..+++|++|+|++|.|++ ++  .+..+++|++|+|++|+++.+|  ..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~~l~--~~   88 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIKKIE--NL   88 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEECSCS--SH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCccccc--ch
Confidence            34455666666666666655555      66666666666666666653 33  2234566666666666666554  33


Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccc-hhhhCCC
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL-ITLSKLQ  158 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~  158 (585)
                      +..+++|++|+|++|+++++                           | .+..+++|++|++++|++.+..+ ..+..++
T Consensus        89 ~~~~~~L~~L~L~~N~l~~l---------------------------~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~  140 (198)
T 1ds9_A           89 DAVADTLEELWISYNQIASL---------------------------S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALD  140 (198)
T ss_dssp             HHHHHHCSEEEEEEEECCCH---------------------------H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTT
T ss_pred             hhcCCcCCEEECcCCcCCcC---------------------------C-ccccCCCCCEEECCCCcCCchhHHHHHhcCC
Confidence            44445555555555555432                           1 24444555555555555554332 3455555


Q ss_pred             CCceEEccCCCCCccCcc----------cccCCCCCcEEEcCCCccc
Q 047705          159 KLQGLVLDDNKLEGSIPD----------DICRLVELYKLELGGNKLS  195 (585)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~----------~~~~l~~L~~L~L~~N~l~  195 (585)
                      +|++|++++|.+++.+|.          .+..+++|+.|+  +|.++
T Consensus       141 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             TCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             CCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            555555555555544332          255566666654  45544

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.55  E-value=1.5e-14  Score=130.61  Aligned_cols=91  Identities=22%  Similarity=0.226  Sum_probs=83.6

Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEe
Q 047705          227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNL  306 (585)
Q Consensus       227 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l  306 (585)
                      +.|+.|+|++|.|+++.|..|.++++|++|+|++|+++++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            57888999999999988999999999999999999999888888999999999999999999887778999999999999


Q ss_pred             ecCcCeeeCCC
Q 047705          307 SFNKLEGEIPR  317 (585)
Q Consensus       307 ~~N~l~~~~~~  317 (585)
                      ++|+|.|.|+.
T Consensus       110 ~~N~~~c~c~~  120 (170)
T 3g39_A          110 LNNPWDCACSD  120 (170)
T ss_dssp             CSSCBCTTBGG
T ss_pred             CCCCCCCCchh
Confidence            99999998873

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.53  E-value=3.1e-17  Score=152.41  Aligned_cols=132  Identities=26%  Similarity=0.306  Sum_probs=60.1

Q ss_pred             hhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEE
Q 047705          153 TLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGI  232 (585)
Q Consensus       153 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L  232 (585)
                      .|..+++|++|+|++|+|++ +| .+..+++|++|++++|.++ .+|..+..+++                     |+.|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~---------------------L~~L   98 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT---------------------LEEL   98 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH---------------------CSEE
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc---------------------CCEE
Confidence            45555555555555555553 33 4455555555555555554 23332222222                     3333


Q ss_pred             EccCCcccccCCcccCCCCCCcEEeecccCcccccC-ccccCcCCCCEEeCCCCccCccCCh----------hhccCCcc
Q 047705          233 DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIP-DSFGNLISLKFLNLSNNNLSGAIPA----------SLEKLSYL  301 (585)
Q Consensus       233 ~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~~l~~L  301 (585)
                      ++++|.+++. | .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++..|.          .+..+++|
T Consensus        99 ~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L  176 (198)
T 1ds9_A           99 WISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL  176 (198)
T ss_dssp             EEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSC
T ss_pred             ECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCc
Confidence            3344444432 1 24444445555555555443221 2344455555555555555443332          24555556


Q ss_pred             ceEEeecCcCe
Q 047705          302 EDLNLSFNKLE  312 (585)
Q Consensus       302 ~~l~l~~N~l~  312 (585)
                      +.||  +|+++
T Consensus       177 ~~Ld--~~~i~  185 (198)
T 1ds9_A          177 KKLD--GMPVD  185 (198)
T ss_dssp             SEEC--CGGGT
T ss_pred             EEEC--CcccC
Confidence            6554  44443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.53  E-value=1.9e-13  Score=141.00  Aligned_cols=283  Identities=17%  Similarity=0.138  Sum_probs=201.4

Q ss_pred             ccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCC---------------------cCCccccCCCCCcc
Q 047705            4 LEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSG---------------------SLSSITDVRLPNLE   62 (585)
Q Consensus         4 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------------~~~~~~~~~l~~L~   62 (585)
                      .+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.                     .+....|...++|+
T Consensus        88 ~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~  165 (394)
T 4fs7_A           88 FAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGVTVIGDEAFATCESLE  165 (394)
T ss_dssp             TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCC
T ss_pred             hHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCccccccchhhhcccCCCc
Confidence            46888999999999866 67678889999999998887654 221                     11222344555666


Q ss_pred             EEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEee
Q 047705           63 ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLG  142 (585)
Q Consensus        63 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  142 (585)
                      .+.+.++ +..++. ..|..+++|+.+++..| ++.+... .+.+... |+.+.+..+...  +...+....+|+.+.+.
T Consensus       166 ~i~l~~~-~~~I~~-~~F~~c~~L~~i~l~~~-~~~I~~~-~F~~~~~-L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip  238 (394)
T 4fs7_A          166 YVSLPDS-METLHN-GLFSGCGKLKSIKLPRN-LKIIRDY-CFAECIL-LENMEFPNSLYY--LGDFALSKTGVKNIIIP  238 (394)
T ss_dssp             EEECCTT-CCEECT-TTTTTCTTCCBCCCCTT-CCEECTT-TTTTCTT-CCBCCCCTTCCE--ECTTTTTTCCCCEEEEC
T ss_pred             EEecCCc-cceecc-ccccCCCCceEEEcCCC-ceEeCch-hhccccc-cceeecCCCceE--eehhhcccCCCceEEEC
Confidence            6666543 344544 56666666666666555 3333322 4444443 555555544332  12223344667777775


Q ss_pred             CCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCC
Q 047705          143 GNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLP  220 (585)
Q Consensus       143 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~  220 (585)
                      .+ +..+...+|.++..|+.+.+..+..+ +....|..+..++.+....+.+.   ...|..+.+|+.+.+..+-  ...
T Consensus       239 ~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~i~~I~~  313 (394)
T 4fs7_A          239 DS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDSVKFIGE  313 (394)
T ss_dssp             TT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTTCCEECT
T ss_pred             CC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccccceech
Confidence            43 44466778899999999999988665 77788999999999998877543   3578889999999987764  445


Q ss_pred             ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCc
Q 047705          221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY  300 (585)
Q Consensus       221 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  300 (585)
                      ..|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..| ++.+...+|.++++|+.+++..+ ++ ....+|.++++
T Consensus       314 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~  389 (394)
T 4fs7_A          314 EAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTK  389 (394)
T ss_dssp             TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCE
T ss_pred             hhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCC
Confidence            56889999999999754 77788899999999999999887 77788889999999999999765 44 33567888888


Q ss_pred             cceE
Q 047705          301 LEDL  304 (585)
Q Consensus       301 L~~l  304 (585)
                      |+.+
T Consensus       390 L~~I  393 (394)
T 4fs7_A          390 FKWI  393 (394)
T ss_dssp             EEEE
T ss_pred             CcEE
Confidence            8764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.51  E-value=8.1e-13  Score=136.28  Aligned_cols=294  Identities=13%  Similarity=0.164  Sum_probs=198.1

Q ss_pred             cccCC-CCCCEEecCCCcccccCCccccCCCCCCEEecCCCc---CCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            5 EIGNL-QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS---LSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         5 ~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      +|.+. ..|+.+.|-.+ ++.+...+|.++++|+.+.+..|.   ++ .+....|....+|+.+.+..+ ++.++. .+|
T Consensus        58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~I~~-~aF  133 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTEIDS-EAF  133 (394)
T ss_dssp             TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSEECT-TTT
T ss_pred             hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cceehh-hhh
Confidence            35555 35777777654 666777788888888888877653   44 455555666677777776543 666665 677


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL  160 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  160 (585)
                      ..+.+|+.+.+..+ +..+... .+..... |+.+.+..+ ++.+...+|.. ..|+.+.+..+- ..+...+|.++.++
T Consensus       134 ~~c~~L~~i~lp~~-~~~I~~~-~F~~c~~-L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~~i~~~af~~c~~l  207 (394)
T 4gt6_A          134 HHCEELDTVTIPEG-VTSVADG-MFSYCYS-LHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-TRIGTNAFSECFAL  207 (394)
T ss_dssp             TTCTTCCEEECCTT-CCEECTT-TTTTCTT-CCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-CEECTTTTTTCTTC
T ss_pred             hhhcccccccccce-eeeeccc-ceecccc-cccccccce-eeEeccccccc-cceeEEEECCcc-cccccchhhhcccc
Confidence            77888888887644 3333333 4555554 777777654 55555666654 567777776543 33556777777777


Q ss_pred             ceEEccCCCCCccCcccc-------------cCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCC
Q 047705          161 QGLVLDDNKLEGSIPDDI-------------CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGN  225 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~  225 (585)
                      +......+.........+             .....+..+.+. +.+......+|..+.+|+.+.+..+.  .....+.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~  286 (394)
T 4gt6_A          208 STITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMN  286 (394)
T ss_dssp             CEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTT
T ss_pred             ceecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccceecCccccc
Confidence            777766655442211111             112233444443 23333445678888889988887664  44556788


Q ss_pred             CCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEE
Q 047705          226 LKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN  305 (585)
Q Consensus       226 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~  305 (585)
                      +..|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.+...+|.+|.+|+.+.+..+ ++.+...+|.++.+|+.++
T Consensus       287 c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~  363 (394)
T 4gt6_A          287 CPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIE  363 (394)
T ss_dssp             CTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEE
T ss_pred             ccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEE
Confidence            8999999986 5677677888999999999999765 66677789999999999999654 7767778999999999999


Q ss_pred             eecCcCe
Q 047705          306 LSFNKLE  312 (585)
Q Consensus       306 l~~N~l~  312 (585)
                      +.+|...
T Consensus       364 ~~~~~~~  370 (394)
T 4gt6_A          364 YSGSRSQ  370 (394)
T ss_dssp             ESSCHHH
T ss_pred             ECCceee
Confidence            9988654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=4.1e-14  Score=128.10  Aligned_cols=91  Identities=22%  Similarity=0.299  Sum_probs=81.0

Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEe
Q 047705          227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNL  306 (585)
Q Consensus       227 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l  306 (585)
                      ++|+.|+|++|.++++.|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            57888899999999888889999999999999999999877777889999999999999999777777899999999999


Q ss_pred             ecCcCeeeCCC
Q 047705          307 SFNKLEGEIPR  317 (585)
Q Consensus       307 ~~N~l~~~~~~  317 (585)
                      ++|+|.|.++.
T Consensus       113 ~~N~~~c~~~~  123 (174)
T 2r9u_A          113 YNNPWDCECRD  123 (174)
T ss_dssp             CSSCBCTTBGG
T ss_pred             CCCCccccccc
Confidence            99999988763

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=1.2e-13  Score=124.68  Aligned_cols=86  Identities=24%  Similarity=0.232  Sum_probs=56.8

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      |++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        32 l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  111 (170)
T 3g39_A           32 TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLN  111 (170)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCC
Confidence            33444444444444445566677777777777777766666677777777777777777766666677777777777777


Q ss_pred             Cccccc
Q 047705          192 NKLSRS  197 (585)
Q Consensus       192 N~l~~~  197 (585)
                      |.+...
T Consensus       112 N~~~c~  117 (170)
T 3g39_A          112 NPWDCA  117 (170)
T ss_dssp             SCBCTT
T ss_pred             CCCCCC
Confidence            777643

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.48  E-value=2.4e-12  Score=132.80  Aligned_cols=299  Identities=12%  Similarity=0.138  Sum_probs=218.0

Q ss_pred             cccccCCccccCCC-CCCEEecCCCcCCCcCCccccCCCCCccEEEccCCC---CCCCccCccccCCCCCcEEEccCCCC
Q 047705           21 KLIGTVPVAIFNVS-TLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNN---FSELNFLSSLSNCKSLTVIGLSNNPL   96 (585)
Q Consensus        21 ~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~~~l~~L~~L~Ls~N~l   96 (585)
                      .++.+...+|.+.+ .|+.+.|-.+ ++ .+...+|...++|+++.+..|.   ++.++. .+|..+.+|+.+.+..+ +
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~-~aF~~c~~L~~i~~~~~-~  125 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGR-QAFMFCSELTDIPILDS-V  125 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECT-TTTTTCTTCCBCGGGTT-C
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEech-hhchhcccceeeccCCc-c
Confidence            35566677888874 5999999764 66 6777778889999999998875   777776 78999999999888765 5


Q ss_pred             cccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcc
Q 047705           97 DGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD  176 (585)
Q Consensus        97 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  176 (585)
                      +.+... ++.+... |+.+.+.. .+..+...+|..+..|+.+.+.++ +..+...+|.+ ..|+.+.+..+-.. +...
T Consensus       126 ~~I~~~-aF~~c~~-L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~  199 (394)
T 4gt6_A          126 TEIDSE-AFHHCEE-LDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTN  199 (394)
T ss_dssp             SEECTT-TTTTCTT-CCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTT
T ss_pred             ceehhh-hhhhhcc-cccccccc-eeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccc
Confidence            445444 5566665 99999964 456677788999999999999765 66577777865 67999999876544 6777


Q ss_pred             cccCCCCCcEEEcCCCcccccCccccc-------------CcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccc
Q 047705          177 DICRLVELYKLELGGNKLSRSIPACFN-------------NLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSG  241 (585)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~  241 (585)
                      .|..+.++.......+.........+.             ....+..+.+..+-  .....|..+..|+.+.+..+..+ 
T Consensus       200 af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-  278 (394)
T 4gt6_A          200 AFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-  278 (394)
T ss_dssp             TTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-
T ss_pred             hhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-
Confidence            888889999888777665422111111             11122222232221  33445788899999999766544 


Q ss_pred             cCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC--C
Q 047705          242 IIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG--G  319 (585)
Q Consensus       242 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~--~  319 (585)
                      +...+|.+++.|+.+.+. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++. +...  .
T Consensus       279 I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~-I~~~aF~  354 (394)
T 4gt6_A          279 IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTK-IPESAFS  354 (394)
T ss_dssp             ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCB-CCGGGGT
T ss_pred             ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCE-EhHhHhh
Confidence            778899999999999996 5677677889999999999999865 77677889999999999999765 442 3322  2


Q ss_pred             CCCCCCccccCCCCc
Q 047705          320 SFGNFSAESFEGNEL  334 (585)
Q Consensus       320 ~~~~~~~~~~~~n~~  334 (585)
                      ....++.+.+.++..
T Consensus       355 ~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          355 NCTALNNIEYSGSRS  369 (394)
T ss_dssp             TCTTCCEEEESSCHH
T ss_pred             CCCCCCEEEECCcee
Confidence            345677777777643

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=2.6e-13  Score=122.76  Aligned_cols=85  Identities=25%  Similarity=0.237  Sum_probs=56.5

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      |++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        35 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~  114 (174)
T 2r9u_A           35 KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYN  114 (174)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCS
T ss_pred             CcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCC
Confidence            44444444444444445566677777777777777766666677777777777777777766665677777777777777


Q ss_pred             Ccccc
Q 047705          192 NKLSR  196 (585)
Q Consensus       192 N~l~~  196 (585)
                      |.+..
T Consensus       115 N~~~c  119 (174)
T 2r9u_A          115 NPWDC  119 (174)
T ss_dssp             SCBCT
T ss_pred             CCccc
Confidence            77763

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.46  E-value=1e-15  Score=156.14  Aligned_cols=166  Identities=18%  Similarity=0.133  Sum_probs=97.0

Q ss_pred             CCCCEEecCCCcCCCcCC----ccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhc--
Q 047705           34 STLKLLGLQDNSLSGSLS----SITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGN--  107 (585)
Q Consensus        34 ~~L~~L~L~~n~l~~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--  107 (585)
                      ++|++|+|++|.|+....    .......++|++|+|++|.|+..........+++|++|+|++|+|+..... .+..  
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~-~L~~~L  150 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACK-DLRDLL  150 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHH-HHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHH-HHHHHH
Confidence            466677777776652111    111112356777777777765533211223455677777777777543222 1111  


Q ss_pred             --ccccccEEEeecCcceec----CCccccCCCCccEEEeeCCcccccc----chhhhCCCCCceEEccCCCCCccC---
Q 047705          108 --LSHSLEDFQMHNCNVTGD----IPEEIGNLTNLITIDLGGNKLNGSI----LITLSKLQKLQGLVLDDNKLEGSI---  174 (585)
Q Consensus       108 --~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~---  174 (585)
                        ...+|++|+|++|.++..    ++..+..+++|++|+|++|.|....    ...+...++|++|+|++|.|++..   
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence              112366666666666542    2334466788888888888877533    445666778888888888887533   


Q ss_pred             -cccccCCCCCcEEEcCCCcccccCcc
Q 047705          175 -PDDICRLVELYKLELGGNKLSRSIPA  200 (585)
Q Consensus       175 -~~~~~~l~~L~~L~L~~N~l~~~~~~  200 (585)
                       +..+...++|++|+|++|.|+.....
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~  257 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSEGRQ  257 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHHHHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHHHHH
Confidence             23344567788888888888754333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=5.7e-15  Score=150.56  Aligned_cols=139  Identities=15%  Similarity=0.153  Sum_probs=73.3

Q ss_pred             CCCccEEEeeCCccccccchhhh-----CCCCCceEEccCCCCCcc----CcccccCCCCCcEEEcCCCcccccCccccc
Q 047705          133 LTNLITIDLGGNKLNGSILITLS-----KLQKLQGLVLDDNKLEGS----IPDDICRLVELYKLELGGNKLSRSIPACFN  203 (585)
Q Consensus       133 l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  203 (585)
                      +++|++|+|++|.|+......+.     ..++|++|+|++|.|+..    ++..+...++|++|+|++|.|+......+.
T Consensus       125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~  204 (372)
T 3un9_A          125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA  204 (372)
T ss_dssp             HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred             HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence            34566666666666544333332     346677777777766542    223335566677777777776532211110


Q ss_pred             CcccchhhcCCCCCCCCccCCCCCCCcEEEccCCccccc----CCcccCCCCCCcEEeecccCcccccCccccCcC----
Q 047705          204 NLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGI----IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI----  275 (585)
Q Consensus       204 ~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~----  275 (585)
                                       ..+...+.|+.|+|++|.|+..    ++..+...++|++|+|++|.+++.....+..+.    
T Consensus       205 -----------------~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~  267 (372)
T 3un9_A          205 -----------------AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAE  267 (372)
T ss_dssp             -----------------HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC----
T ss_pred             -----------------HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCC
Confidence                             0122334566666666666542    223344567788888888887765444443321    


Q ss_pred             -CCCEEe--CCCCccC
Q 047705          276 -SLKFLN--LSNNNLS  288 (585)
Q Consensus       276 -~L~~L~--l~~N~l~  288 (585)
                       .|+.+.  +..|.++
T Consensus       268 ~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          268 GGARVVVSLTEGTAVS  283 (372)
T ss_dssp             --CEEECCCC----CH
T ss_pred             ccchhhHhhhcCCccC
Confidence             266666  6666665

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=6.5e-13  Score=128.91  Aligned_cols=148  Identities=14%  Similarity=0.092  Sum_probs=116.4

Q ss_pred             HHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEE
Q 047705          409 LCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       409 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  487 (585)
                      +....++|++....+.|+.+.||++... ++.+++|+...........+..|+++++.+. +..++++++++...+..|+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3455678988888999999999999754 6789999987543233456888999999984 6778899999998889999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-------------------------------------  530 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-------------------------------------  530 (585)
                      ||||++|.++.+.+..      ......++.++++++..||..                                     
T Consensus        88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999998876321      112346788999999999940                                     


Q ss_pred             -------------------CCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          531 -------------------CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       531 -------------------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                                         ....++|+|++|.||++++++.+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               014589999999999998766677999998764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=3.6e-13  Score=136.45  Aligned_cols=120  Identities=23%  Similarity=0.215  Sum_probs=89.9

Q ss_pred             CCccCCCCCCCcEEEccC-CcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhcc
Q 047705          219 LPLEIGNLKVLVGIDFSM-NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEK  297 (585)
Q Consensus       219 ~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  297 (585)
                      +|. +..+++|+.|+|++ |.|+++.+..|.++++|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++..+..+..
T Consensus        24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  102 (347)
T 2ifg_A           24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (347)
T ss_dssp             TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHccc
Confidence            344 55666778888885 8888888888999999999999999999888888899999999999999999776666666


Q ss_pred             CCccceEEeecCcCeeeCCCCCC--CCCCCccccCCCCcccCCCC
Q 047705          298 LSYLEDLNLSFNKLEGEIPRGGS--FGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       298 l~~L~~l~l~~N~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~  340 (585)
                      ++ |+.|+|++|+|.|+|...+.  |.......+..+...|..|.
T Consensus       103 ~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A          103 LS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            65 99999999999988864321  11112223345667776654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=5e-12  Score=127.96  Aligned_cols=90  Identities=20%  Similarity=0.114  Sum_probs=50.8

Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC-hhhccCCccceEE
Q 047705          227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP-ASLEKLSYLEDLN  305 (585)
Q Consensus       227 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~  305 (585)
                      ++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|+++.+..|..++ |+.|+|.+|++...-. .++..+.......
T Consensus        56 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~  134 (347)
T 2ifg_A           56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGG  134 (347)
T ss_dssp             CCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSS
T ss_pred             cCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCccc
Confidence            3344444455555555556666666666677777766665555555554 7777777777663221 2233332233334


Q ss_pred             eecCcCeeeCCC
Q 047705          306 LSFNKLEGEIPR  317 (585)
Q Consensus       306 l~~N~l~~~~~~  317 (585)
                      +..+.++|..|.
T Consensus       135 l~~~~~~C~~~~  146 (347)
T 2ifg_A          135 VPEQKLQCHGQG  146 (347)
T ss_dssp             CGGGCCCCSSSS
T ss_pred             ccccCCCCCCCh
Confidence            456777777665

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.29  E-value=2.9e-10  Score=116.46  Aligned_cols=288  Identities=12%  Similarity=0.087  Sum_probs=204.2

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCC
Q 047705            6 IGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKS   85 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   85 (585)
                      +....+|+.+.+... ++.+...+|.++.+|+.++|..+ ++ .+....|... +|+.+.+.. .++.++. .+|... +
T Consensus        42 ~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~-~l~~I~~-~aF~~~-~  114 (379)
T 4h09_A           42 YKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGME-RVKKFGD-YVFQGT-D  114 (379)
T ss_dssp             GGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECT-TCCEECT-TTTTTC-C
T ss_pred             cccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCc-eeeEecc-ceeccC-C
Confidence            455677888888654 77788889999999999999754 66 5555556554 688888764 4777775 677764 7


Q ss_pred             CcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccc------------cchh
Q 047705           86 LTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGS------------ILIT  153 (585)
Q Consensus        86 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------~~~~  153 (585)
                      |+.+.+..+ ++.+... ++.+.  .++.+.+.. +++.+...+|....+++.+.+..+.....            ....
T Consensus       115 L~~i~lp~~-~~~i~~~-~F~~~--~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (379)
T 4h09_A          115 LDDFEFPGA-TTEIGNY-IFYNS--SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILES  189 (379)
T ss_dssp             CSEEECCTT-CCEECTT-TTTTC--CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEE
T ss_pred             cccccCCCc-ccccccc-ccccc--eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecc
Confidence            999999765 3334333 34433  366666654 45556777888888888888876543321            1223


Q ss_pred             hhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcE
Q 047705          154 LSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVG  231 (585)
Q Consensus       154 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~  231 (585)
                      |.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|..+.+|+.+.+..+-  .....+.++..|+.
T Consensus       190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~v~~I~~~aF~~~~~l~~  267 (379)
T 4h09_A          190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKNVTSIGSFLLQNCTALKT  267 (379)
T ss_dssp             CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTTCCEECTTTTTTCTTCCE
T ss_pred             ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCCccEeCccccceeehhcc
Confidence            445556666665544333 55566777788888888665 443556678888888888887663  44456778888888


Q ss_pred             EEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecC
Q 047705          232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFN  309 (585)
Q Consensus       232 L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N  309 (585)
                      +.+..+ +..+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+
T Consensus       268 i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          268 LNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             cccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            888654 66677778889999999999888888777888999999999998754 77677788889999998887654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=8e-12  Score=120.92  Aligned_cols=140  Identities=16%  Similarity=0.082  Sum_probs=102.9

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc--ceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN--LIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e  490 (585)
                      ..+|.+....+.|..+.||++...+|+.+++|+....   ....+..|+++++.+.+.+  +++++++....+..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3455554333456669999998777888999987643   2356778999999885444  5678998888888999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC---------------------------------------  531 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---------------------------------------  531 (585)
                      |++|.++.  ...    .+   ...++.++++.+..||...                                       
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998884  211    12   1256778888888888311                                       


Q ss_pred             ----------------CCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          532 ----------------STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       532 ----------------~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                                      ...++|+|++|.||++++++.+.|+|||.|...
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                            112999999999999987766779999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.12  E-value=3e-09  Score=108.85  Aligned_cols=288  Identities=11%  Similarity=0.011  Sum_probs=205.1

Q ss_pred             ccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhc
Q 047705           28 VAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGN  107 (585)
Q Consensus        28 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  107 (585)
                      +++....+|+.+.+.. .++ .++..+|....+|++++|.. .++.++. .+|... +|+.+.+..+ ++.+... ++..
T Consensus        40 ~~~~~~~~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~-~aF~~c-~l~~i~~~~~-l~~I~~~-aF~~  112 (379)
T 4h09_A           40 PWYKDRDRISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAS-TVTSIGD-GAFADT-KLQSYTGMER-VKKFGDY-VFQG  112 (379)
T ss_dssp             TTGGGGGGCSEEEECT-TEE-EECTTTTTTCTTCCEEEECT-TCCEECT-TTTTTC-CCCEEEECTT-CCEECTT-TTTT
T ss_pred             cccccccCCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCC-cceEech-hhhcCC-CCceEECCce-eeEeccc-eecc
Confidence            4566677899998865 466 66666777888999999965 4888876 788887 6888877644 5545444 4443


Q ss_pred             ccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCc------------cCc
Q 047705          108 LSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG------------SIP  175 (585)
Q Consensus       108 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~~  175 (585)
                      .  +|+.+.+..+ ++.+...+|.+. +|+.+.+.. .++.+...+|.++.+++.+.+..+....            ...
T Consensus       113 ~--~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (379)
T 4h09_A          113 T--DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTIL  187 (379)
T ss_dssp             C--CCSEEECCTT-CCEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEE
T ss_pred             C--CcccccCCCc-cccccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceeccccccee
Confidence            3  4888888764 444556667654 677776654 4555677888888999988887655331            112


Q ss_pred             ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC--CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCC
Q 047705          176 DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND--PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNL  253 (585)
Q Consensus       176 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  253 (585)
                      ..+.....+..+.+..+.-. .....+....+|+.+.+..+-  .....+..+..|+.+.+..+ ++.+...+|.++.+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l  265 (379)
T 4h09_A          188 ESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL  265 (379)
T ss_dssp             EECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred             ccccccccccccccccceeE-EeecccccccccceeeeccceeEEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence            23444556666666554432 455667778888888887664  44556788999999999876 776888899999999


Q ss_pred             cEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC-CCCCCCCccccCC
Q 047705          254 EYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG-GSFGNFSAESFEG  331 (585)
Q Consensus       254 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~  331 (585)
                      +.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++..-... .....++.+.+..
T Consensus       266 ~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          266 KTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             CEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             cccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            99999755 66577789999999999999999999888899999999999999765 54332222 1234566555543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=2.9e-10  Score=115.50  Aligned_cols=143  Identities=13%  Similarity=0.152  Sum_probs=106.2

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEEe--chh-hhhHHHHHHHHHHHHhcC--CCcceeEEeeeecC---CeEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLGDGMEVAVKVFN--LQC-RRAFKSFDVECEIMKSIR--HRNLIKVISSCSNE---EFKGLV  488 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv  488 (585)
                      ...+.++.|.++.||++...+ ..+++|+..  ... ......+.+|+++++.+.  +..+++++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            346789999999999998654 578888765  322 123457888999999997  45678999888766   458999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC-------------------------------------  531 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------  531 (585)
                      |||++|..+.+...   ..++..+...++.+++++|..||...                                     
T Consensus       120 me~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987754221   13567778889999999999999410                                     


Q ss_pred             ------------------CCCcEEcCCCCCCEEeCCCCc--EEEeeeccccc
Q 047705          532 ------------------STPVIHCDLKPSNVLLDDNMI--AYLSDFGIAKL  563 (585)
Q Consensus       532 ------------------~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~a~~  563 (585)
                                        ...++|+|++|.||++++++.  +.|+||+.|..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              256899999999999997653  69999998874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.07  E-value=2.7e-11  Score=122.34  Aligned_cols=182  Identities=15%  Similarity=0.131  Sum_probs=101.9

Q ss_pred             CccccCCCCCCEEecCCCcCCC---------cCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCc
Q 047705           27 PVAIFNVSTLKLLGLQDNSLSG---------SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLD   97 (585)
Q Consensus        27 ~~~~~~l~~L~~L~L~~n~l~~---------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~   97 (585)
                      .++...+++|+.|.+..+....         .+.. ....+|+|++|+|++|.-..++   .+. +++|++|+|+.+.+.
T Consensus       132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~l~l~---~~~-~~~L~~L~L~~~~l~  206 (362)
T 2ra8_A          132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNNLSIG---KKP-RPNLKSLEIISGGLP  206 (362)
T ss_dssp             HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBTCBCC---SCB-CTTCSEEEEECSBCC
T ss_pred             HHhhhhcchhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCCceec---ccc-CCCCcEEEEecCCCC
Confidence            3445566677777765543210         0111 1124677777777766322222   132 677777777777664


Q ss_pred             ccCCcchhh--cccccccEEEeec--Ccceec-----CCccc--cCCCCccEEEeeCCccccccchhhh---CCCCCceE
Q 047705           98 GILPKTSIG--NLSHSLEDFQMHN--CNVTGD-----IPEEI--GNLTNLITIDLGGNKLNGSILITLS---KLQKLQGL  163 (585)
Q Consensus        98 ~~~~~~~~~--~~~~~L~~L~l~~--n~l~~~-----~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L  163 (585)
                      ..... .+.  .+|+ |+.|+|+.  |...+.     +...+  ..+++|++|+|++|.+....+..+.   .+++|++|
T Consensus       207 ~~~l~-~l~~~~lp~-L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~L  284 (362)
T 2ra8_A          207 DSVVE-DILGSDLPN-LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM  284 (362)
T ss_dssp             HHHHH-HHHHSBCTT-CCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEE
T ss_pred             hHHHH-HHHHccCCC-CcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEE
Confidence            32111 122  3454 77777753  111111     11122  2478899999988888754443443   47789999


Q ss_pred             EccCCCCCccCc----ccccCCCCCcEEEcCCCcccccCcccccC-cccchhhcCCCCC
Q 047705          164 VLDDNKLEGSIP----DDICRLVELYKLELGGNKLSRSIPACFNN-LIALRILSLGSND  217 (585)
Q Consensus       164 ~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~l~~n~  217 (585)
                      +|+.|.|++..+    ..+..+++|+.|+|++|.|+...-..+.. +  ...++++.++
T Consensus       285 dLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             ECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             ECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            999888886433    23345688999999988887543333332 2  2446777665

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.02  E-value=1.1e-10  Score=117.91  Aligned_cols=153  Identities=21%  Similarity=0.185  Sum_probs=76.8

Q ss_pred             hhhhCCCCCceEEccCCC-CCccCcccccCCCCCcEEEcCCCcccccCccccc--CcccchhhcCCCC--CCC-------
Q 047705          152 ITLSKLQKLQGLVLDDNK-LEGSIPDDICRLVELYKLELGGNKLSRSIPACFN--NLIALRILSLGSN--DPL-------  219 (585)
Q Consensus       152 ~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~n--~~~-------  219 (585)
                      ..+..+++|++|+|++|. ++ . +. + .+++|++|+|..|.+.......+.  .+++|++|+|+.+  ...       
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~-l-~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS-I-GK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB-C-CS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHHhcCCCCcEEEEeCCCCce-e-cc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            344555666666666552 21 1 21 2 255666666666665433222222  4555555554321  100       


Q ss_pred             --C-ccCCCCCCCcEEEccCCcccccCCccc---CCCCCCcEEeecccCccccc----CccccCcCCCCEEeCCCCccCc
Q 047705          220 --P-LEIGNLKVLVGIDFSMNNFSGIIPKEI---GGLKNLEYLFLGYNRLQGLI----PDSFGNLISLKFLNLSNNNLSG  289 (585)
Q Consensus       220 --~-~~~~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~  289 (585)
                        + .....+++|+.|+|++|.+.+..+..+   ..+++|+.|+|+.|.+++..    +..+..+++|+.|++++|.|+.
T Consensus       242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence              0 011246677777777776654322222   23566777777777776532    2223445677777777776664


Q ss_pred             cCChhhcc-CCccceEEeecCc
Q 047705          290 AIPASLEK-LSYLEDLNLSFNK  310 (585)
Q Consensus       290 ~~~~~~~~-l~~L~~l~l~~N~  310 (585)
                      .....+.. +  ...+++++|.
T Consensus       322 ~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          322 EMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHHHHc--CCEEEecCCc
Confidence            43333332 2  2446666665

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.65  E-value=5.4e-08  Score=96.19  Aligned_cols=136  Identities=22%  Similarity=0.205  Sum_probs=99.4

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCc--ceeEEeeeecCC---eEEEEEEcc
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRN--LIKVISSCSNEE---FKGLVLEYM  492 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~  492 (585)
                      .+.++.|.+..||++.    ..+++|+....  .....+..|+++++.+ .+..  +++++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999874    46888986533  3346788899999888 3333  456666554433   358999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------  530 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------------  530 (585)
                      +|.++.+....   .++..+...++.++++.+..||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654332   356667777888888888888831                                          


Q ss_pred             -------------CCCCcEEcCCCCCCEEeCC--CCcEEEeeeccccc
Q 047705          531 -------------CSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKL  563 (585)
Q Consensus       531 -------------~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~  563 (585)
                                   ....++|+|++|.||++++  ++.+.++||+.+..
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                         0135799999999999987  55689999998875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=4.2e-07  Score=89.76  Aligned_cols=136  Identities=13%  Similarity=0.103  Sum_probs=94.8

Q ss_pred             cceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCC---cceeEEeeee-cCCeEEEEEEccCC
Q 047705          419 NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR---NLIKVISSCS-NEEFKGLVLEYMPQ  494 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  494 (585)
                      .+.++.|....||+.    +..+++|+...  ......+..|+++++.+.+.   .+++++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467888988899988    56788888532  23346788999999999652   3667777764 45667899999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG--------------------------------------------  530 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------  530 (585)
                      .++.+....   .++..+...++.++++.+..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887663221   123344444555555555555521                                            


Q ss_pred             -------------CCCCcEEcCCCCCCEEeCC---CCc-EEEeeeccccc
Q 047705          531 -------------CSTPVIHCDLKPSNVLLDD---NMI-AYLSDFGIAKL  563 (585)
Q Consensus       531 -------------~~~~iiH~dlkp~NIll~~---~~~-~kl~Dfg~a~~  563 (585)
                                   ....++|+|++|.||++++   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1345699999999999987   455 58999998875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.58  E-value=1.1e-08  Score=93.08  Aligned_cols=64  Identities=16%  Similarity=0.206  Sum_probs=36.5

Q ss_pred             CCCCccEEEeeCCccccc----cchhhhCCCCCceEEc--cCCCCCccC----cccccCCCCCcEEEcCCCccc
Q 047705          132 NLTNLITIDLGGNKLNGS----ILITLSKLQKLQGLVL--DDNKLEGSI----PDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      ..++|++|+|++|.|...    +..++...++|++|+|  ++|.|+...    ...+...++|++|+|++|.+.
T Consensus        91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            345566666666666542    2334445556666666  566666432    233344566777777777765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.52  E-value=1.9e-08  Score=91.50  Aligned_cols=97  Identities=18%  Similarity=0.225  Sum_probs=68.3

Q ss_pred             cccCCCCCcEEEccCC-CCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccccc----chh
Q 047705           79 SLSNCKSLTVIGLSNN-PLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSI----LIT  153 (585)
Q Consensus        79 ~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~  153 (585)
                      .+...++|++|+|++| .|...    ...                  .+...+...++|++|+|++|.|....    ...
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~----g~~------------------~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~   88 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVP----TLK------------------ACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM   88 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHH----HHH------------------HHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHH----HHH------------------HHHHHHHhCCCcCEEECcCCCCChHHHHHHHHH
Confidence            4666778888888888 77532    111                  12234556788999999999987532    344


Q ss_pred             hhCCCCCceEEccCCCCCcc----CcccccCCCCCcEEEc--CCCccccc
Q 047705          154 LSKLQKLQGLVLDDNKLEGS----IPDDICRLVELYKLEL--GGNKLSRS  197 (585)
Q Consensus       154 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~  197 (585)
                      +...++|++|+|++|.|+..    +...+...++|++|+|  ++|.|+..
T Consensus        89 L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~  138 (185)
T 1io0_A           89 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN  138 (185)
T ss_dssp             HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred             HHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence            55678899999999998854    3455666778999999  78888753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=1.1e-06  Score=85.12  Aligned_cols=142  Identities=17%  Similarity=0.085  Sum_probs=101.5

Q ss_pred             cCCCCccceecccCce-EEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEE
Q 047705          413 TDGFSENNLIGRGGFG-SVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ..+|+. +.+..|..| .||+.... ++..+++|+-...   ....+..|+..|+.+. +--++++++++...+..|+||
T Consensus        24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            344543 345666665 68998765 5677899986543   2356778999998884 334778899999899999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG---------------------------------------  530 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---------------------------------------  530 (585)
                      |+++|.++.+......     .....++.++++.+..||..                                       
T Consensus       100 e~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             ECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999988877654321     12334566677777777721                                       


Q ss_pred             ----------------CCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          531 ----------------CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       531 ----------------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                                      ....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            011379999999999999877778999998875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.51  E-value=1.2e-08  Score=97.67  Aligned_cols=80  Identities=24%  Similarity=0.310  Sum_probs=56.1

Q ss_pred             cCCCCccEEEeeCCcccccc--chhhhCCCCCceEEccCCCCCccCcccccCCC--CCcEEEcCCCcccccCcc------
Q 047705          131 GNLTNLITIDLGGNKLNGSI--LITLSKLQKLQGLVLDDNKLEGSIPDDICRLV--ELYKLELGGNKLSRSIPA------  200 (585)
Q Consensus       131 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~------  200 (585)
                      .++++|++|+|++|+|.++.  +..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+..|+      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            45788888888888888743  46677888888888888888865  2334444  888888888888765542      


Q ss_pred             -cccCcccchhhc
Q 047705          201 -CFNNLIALRILS  212 (585)
Q Consensus       201 -~~~~l~~L~~L~  212 (585)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             244555555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=3.4e-08  Score=94.54  Aligned_cols=80  Identities=24%  Similarity=0.297  Sum_probs=51.4

Q ss_pred             CCCCCCcEEEccCCccccc--CCcccCCCCCCcEEeecccCcccccCccccCcC--CCCEEeCCCCccCccCC-------
Q 047705          224 GNLKVLVGIDFSMNNFSGI--IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI--SLKFLNLSNNNLSGAIP-------  292 (585)
Q Consensus       224 ~~l~~L~~L~ls~N~l~~~--~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~-------  292 (585)
                      .++++|+.|+|++|+|+++  ++..+..+++|+.|+|++|++++.  ..+..+.  +|+.|+|++|++++..|       
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            3566777777777777763  345556677777777777777765  2233333  77777777777776544       


Q ss_pred             hhhccCCccceEE
Q 047705          293 ASLEKLSYLEDLN  305 (585)
Q Consensus       293 ~~~~~l~~L~~l~  305 (585)
                      ..+..+|+|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence            2355666666654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=6.4e-07  Score=90.58  Aligned_cols=80  Identities=8%  Similarity=-0.032  Sum_probs=56.5

Q ss_pred             ccee-cccCceEEEEEEeC-------CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcC-C--CcceeEEeeeecC--
Q 047705          419 NNLI-GRGGFGSVYKARLG-------DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIR-H--RNLIKVISSCSNE--  482 (585)
Q Consensus       419 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  482 (585)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+. +  -.+++++.+....  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88989999998754       26678889765432   111256778999988884 2  3577888877655  


Q ss_pred             -CeEEEEEEccCCCCHH
Q 047705          483 -EFKGLVLEYMPQGSLE  498 (585)
Q Consensus       483 -~~~~lv~e~~~~g~L~  498 (585)
                       +..|+||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.13  E-value=4e-07  Score=80.82  Aligned_cols=92  Identities=11%  Similarity=0.111  Sum_probs=48.7

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCc-CCCcCCccccCCC----CCccEEEccCCC-CCCCc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS-LSGSLSSITDVRL----PNLEELVLWGNN-FSELN   75 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~   75 (585)
                      +|.....-.+|++|||++|.|+...-..+.++++|++|+|++|. |+ .-.-.....+    ++|++|+|++|. |+.-.
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It-D~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G  131 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE-DGCLERLSQLENLQKSMLEMEIISCGNVTDKG  131 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC-HHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC-HHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence            34433333456666666666665555566666666666666663 43 1110011111    246666666653 55543


Q ss_pred             cCccccCCCCCcEEEccCCC
Q 047705           76 FLSSLSNCKSLTVIGLSNNP   95 (585)
Q Consensus        76 ~~~~~~~l~~L~~L~Ls~N~   95 (585)
                      . ..+..+++|++|+|+++.
T Consensus       132 l-~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          132 I-IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             H-HHGGGCTTCCEEEEESCT
T ss_pred             H-HHHhcCCCCCEEECCCCC
Confidence            3 445566666666666654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=8.8e-06  Score=83.45  Aligned_cols=75  Identities=15%  Similarity=0.127  Sum_probs=50.0

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEEechhh-------hhHHHHHHHHHHHHhcCC--C-cceeEEeeeecCCeEEE
Q 047705          419 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-------RAFKSFDVECEIMKSIRH--R-NLIKVISSCSNEEFKGL  487 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  487 (585)
                      .+.+|.|.++.||+++.. +++.|++|.......       ....++..|+++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999754 567899997653211       123456779999887742  3 44566654  3345689


Q ss_pred             EEEccCCC
Q 047705          488 VLEYMPQG  495 (585)
Q Consensus       488 v~e~~~~g  495 (585)
                      ||||++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.07  E-value=1.9e-06  Score=76.45  Aligned_cols=82  Identities=12%  Similarity=0.070  Sum_probs=56.7

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCc-cccccchhhhCC----CCCceEEccCCC-CCccCcccccCCCCCc
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNK-LNGSILITLSKL----QKLQGLVLDDNK-LEGSIPDDICRLVELY  185 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~L~  185 (585)
                      |+.||+++|.++...-..+.++++|+.|+|++|. |+...-..+..+    ++|++|+|++|. |++..-..+..+++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            6666666666655555566778888888888885 665444455553    368888888874 7765555667788888


Q ss_pred             EEEcCCCc
Q 047705          186 KLELGGNK  193 (585)
Q Consensus       186 ~L~L~~N~  193 (585)
                      +|+|+++.
T Consensus       143 ~L~L~~c~  150 (176)
T 3e4g_A          143 YLFLSDLP  150 (176)
T ss_dssp             EEEEESCT
T ss_pred             EEECCCCC
Confidence            88888875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=2.5e-05  Score=78.15  Aligned_cols=139  Identities=15%  Similarity=0.136  Sum_probs=79.4

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC--CcceeEEe------eeecCCeEEEEEEc
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH--RNLIKVIS------SCSNEEFKGLVLEY  491 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  491 (585)
                      +.++.|..+.||++...+| .+++|+.....    ..+..|+.+++.+..  -.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999987555 58899887521    233345555554421  12344443      11345678999999


Q ss_pred             cCCCCHH-----H---------Hhhc--CCC--C---------CCHHH-------------------------------H
Q 047705          492 MPQGSLE-----K---------HLYS--TNC--I---------LDIFQ-------------------------------R  513 (585)
Q Consensus       492 ~~~g~L~-----~---------~l~~--~~~--~---------~~~~~-------------------------------~  513 (585)
                      ++|..+.     +         .++.  ...  +         ..|..                               .
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         1111  000  0         11211                               0


Q ss_pred             HHHHHHHHHHHHHHhc----------CCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          514 LNIMIDVASALEYLHF----------GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       514 ~~i~~~i~~~l~~lH~----------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..+..++.+++++++.          .....++|+|+++.||+++.++.+.++||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111223445666652          0257899999999999998888999999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.0001  Score=72.38  Aligned_cols=76  Identities=14%  Similarity=0.120  Sum_probs=61.0

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC---CCcceeEEeeeecCCeEEEEEEccCC
Q 047705          418 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      ..+.++.|.+..+|+... ++..+++|+....   ....+..|++.|+.+.   ...+++++.+....+..++||||++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456799999999999986 4678889987643   2456788999888873   36788999988888889999999998


Q ss_pred             CCH
Q 047705          495 GSL  497 (585)
Q Consensus       495 g~L  497 (585)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.75  E-value=3.7e-05  Score=64.95  Aligned_cols=63  Identities=24%  Similarity=0.278  Sum_probs=49.8

Q ss_pred             cEEeecccCcc-cccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCC
Q 047705          254 EYLFLGYNRLQ-GLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRG  318 (585)
Q Consensus       254 ~~L~ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~  318 (585)
                      ..++.+++.++ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|+|...
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~   74 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLV   74 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGH
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccH
Confidence            36777888876 23454433  46899999999999887788889999999999999999988753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.68  E-value=0.00021  Score=69.48  Aligned_cols=78  Identities=15%  Similarity=0.117  Sum_probs=56.8

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-C--CcceeEEeeeecCCeEEEEEEcc
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-H--RNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      ..-.+.+|.|..+.||+.+..+|+.|++|+...........+..|++.|+.+. .  --+++++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            34467899999999999999999999999865443333345788999998884 2  2355666542    237899999


Q ss_pred             CCCCH
Q 047705          493 PQGSL  497 (585)
Q Consensus       493 ~~g~L  497 (585)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.66  E-value=0.00014  Score=74.94  Aligned_cols=74  Identities=11%  Similarity=0.089  Sum_probs=45.7

Q ss_pred             ccceecccCceEEEEEEeCCCcEEEEEEEechh----hh-----hHHHHHHHHHHHH-hcCCCcceeEEeeeecCCeEEE
Q 047705          418 ENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC----RR-----AFKSFDVECEIMK-SIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~-----~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ..+.+|.|..+.||++.. +++.++||......    ..     ....+..|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            356789999999999964 56789999432110    00     1223333333222 22334677777765  456789


Q ss_pred             EEEcc-CC
Q 047705          488 VLEYM-PQ  494 (585)
Q Consensus       488 v~e~~-~~  494 (585)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.00017  Score=71.40  Aligned_cols=158  Identities=14%  Similarity=0.124  Sum_probs=88.6

Q ss_pred             ccCHHHHHHhcCCCCc-----cceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc--ceeE
Q 047705          403 TFSYLELCRATDGFSE-----NNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN--LIKV  475 (585)
Q Consensus       403 ~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  475 (585)
                      ..+.+++......|.+     .+.++.|....+|++...+| .+++|+.....  ....+..|+.+++.+...+  ++++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3455666666666654     34566788889999987655 67889876521  2234556777777663222  3344


Q ss_pred             Eee------eecCCeEEEEEEccCCCCHHH--------------HhhcC----CCC----CC---HHHHHH---------
Q 047705          476 ISS------CSNEEFKGLVLEYMPQGSLEK--------------HLYST----NCI----LD---IFQRLN---------  515 (585)
Q Consensus       476 ~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~----~~---~~~~~~---------  515 (585)
                      +..      ....+..+++|+|++|..+..              .++..    ...    ..   |.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            322      122356789999999865321              01110    000    01   111000         


Q ss_pred             ---HHHHHHHHHHHHhc----CCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          516 ---IMIDVASALEYLHF----GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       516 ---i~~~i~~~l~~lH~----~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                         +...+.+.+++++.    ....+++|+|+.+.||++++++.+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               00113344555542    1235789999999999998776668999988764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.51  E-value=2.7e-05  Score=70.43  Aligned_cols=66  Identities=15%  Similarity=0.142  Sum_probs=33.7

Q ss_pred             ccCCCCccEEEeeCCccccccc----hhhhCCCCCceEEccCC---CCCcc----CcccccCCCCCcEEEcCCCccc
Q 047705          130 IGNLTNLITIDLGGNKLNGSIL----ITLSKLQKLQGLVLDDN---KLEGS----IPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       130 ~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N---~l~~~----~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      +..-+.|++|+|+.|.|.....    .++..-+.|++|+|++|   .+...    +.+.+..-+.|++|+++.|.+.
T Consensus        94 L~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A           94 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            3344556666666666653222    23334455666666654   22321    2233444556677777666553

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00046  Score=68.63  Aligned_cols=139  Identities=12%  Similarity=0.068  Sum_probs=74.1

Q ss_pred             ceecccCceE-EEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC--CcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          420 NLIGRGGFGS-VYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       420 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      +.++.|+... +|+....+++.+++|......   ...+..|+.+++.+..  -.+++++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566665554 677765446777777644321   1334557777776632  23566776643333  68999997766


Q ss_pred             HHHHhhcCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 047705          497 LEKHLYSTN-------------------------CILDIFQRL-------N-I------------MIDVASALEYLH---  528 (585)
Q Consensus       497 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~lH---  528 (585)
                      +.+++....                         ..++.....       . +            ...+.+.++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332110                         011111100       0 0            001112222221   


Q ss_pred             cCCCCCcEEcCCCCCCEEeCCC----CcEEEeeeccccc
Q 047705          529 FGCSTPVIHCDLKPSNVLLDDN----MIAYLSDFGIAKL  563 (585)
Q Consensus       529 ~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~  563 (585)
                      ......++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125679999999999999874    6899999998875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00033  Score=68.61  Aligned_cols=74  Identities=9%  Similarity=0.092  Sum_probs=46.6

Q ss_pred             CCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcc-eeEEeeeecCCeEEEEEEcc-C
Q 047705          416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKGLVLEYM-P  493 (585)
Q Consensus       416 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  493 (585)
                      +.-.+.++.|....+|++     ..+++|+....... ......|+.+++.+...++ ++++++..  +.-++++||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence            344788999999999999     56888887643211 1223458877777642222 56665543  3346899999 6


Q ss_pred             CCCH
Q 047705          494 QGSL  497 (585)
Q Consensus       494 ~g~L  497 (585)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.41  E-value=0.00025  Score=59.74  Aligned_cols=56  Identities=27%  Similarity=0.310  Sum_probs=45.2

Q ss_pred             CEEecCCCcCC--CcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCc
Q 047705           37 KLLGLQDNSLS--GSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLD   97 (585)
Q Consensus        37 ~~L~L~~n~l~--~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~   97 (585)
                      ..++-+++.++  ..+..+    .++|++|+|++|+|+.++. +.|..+++|++|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~l----p~~l~~L~Ls~N~l~~l~~-~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAF----PVDTTELVLTGNNLTALPP-GLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCC----CTTCSEEECTTSCCSSCCT-TTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCC----CcCCCEEECCCCcCCccCh-hhhhhccccCEEEecCCCee
Confidence            37788888886  444332    3579999999999999987 88999999999999999885

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.41  E-value=3.8e-05  Score=69.38  Aligned_cols=91  Identities=12%  Similarity=0.124  Sum_probs=59.3

Q ss_pred             ccCCCCCcEEEccCC-CCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccccc----chhh
Q 047705           80 LSNCKSLTVIGLSNN-PLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSI----LITL  154 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~  154 (585)
                      +..-++|++|+|++| +|....    ..                  .+.+++..-+.|+.|+|++|+|...-    ..++
T Consensus        37 l~~n~~L~~L~L~~nn~igd~g----a~------------------~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL   94 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKER----IR------------------SLIEAACNSKHIEKFSLANTAISDSEARGLIELI   94 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHH----HH------------------HHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHH----HH------------------HHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHH
Confidence            445567777887774 664221    11                  12345566688899999999987533    3444


Q ss_pred             hCCCCCceEEccCCCCCccCc----ccccCCCCCcEEEcCCC
Q 047705          155 SKLQKLQGLVLDDNKLEGSIP----DDICRLVELYKLELGGN  192 (585)
Q Consensus       155 ~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N  192 (585)
                      ..-+.|++|+|++|.|+....    +.+..-+.|++|+|++|
T Consensus        95 ~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           95 ETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             hcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            567789999999999885433    23444566888888765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.40  E-value=0.00073  Score=66.91  Aligned_cols=140  Identities=12%  Similarity=0.085  Sum_probs=81.0

Q ss_pred             ceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCC--cceeEEee-----eecCCeEEEEEEcc
Q 047705          420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHR--NLIKVISS-----CSNEEFKGLVLEYM  492 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  492 (585)
                      +.++ |....||++...+|+.+++|+..... .....+..|..+++.+...  .+++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4576 88889999887677789999986431 1234566788887777422  23444443     12245668999999


Q ss_pred             CCCCHH-----HH---------hhc----CC----CCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 047705          493 PQGSLE-----KH---------LYS----TN----CILDIFQR----------------------LNIMIDVASALEYLH  528 (585)
Q Consensus       493 ~~g~L~-----~~---------l~~----~~----~~~~~~~~----------------------~~i~~~i~~~l~~lH  528 (585)
                      +|..+.     ..         ++.    ..    ...++...                      ...+.+++..++-.-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            885432     10         110    00    01111110                      011111222222111


Q ss_pred             c-CCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          529 F-GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       529 ~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      . .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            0 1245689999999999999 4 899999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.00054  Score=70.68  Aligned_cols=73  Identities=22%  Similarity=0.247  Sum_probs=49.7

Q ss_pred             cceecccCceEEEEEEeCC--------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc-ceeEEeeeecCCeEEEEE
Q 047705          419 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN-LIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  489 (585)
                      .+.|+.|....+|++...+        ++.+++|+.....  ....+..|..+++.+...+ .+++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578888889999998653        5789999874321  1134557888888874333 3677776542    3899


Q ss_pred             EccCCCCH
Q 047705          490 EYMPQGSL  497 (585)
Q Consensus       490 e~~~~g~L  497 (585)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.00067  Score=68.45  Aligned_cols=140  Identities=14%  Similarity=0.177  Sum_probs=82.7

Q ss_pred             cceecccCceEEEEEEeC--------CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEE
Q 047705          419 NNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+.+..|-...+|++...        +++.+++|+.... ........+|.++++.+. +.-.+++++++..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888899999864        2478999986332 123455668999988774 3233677776653    2899


Q ss_pred             EccCCCCHHHH-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 047705          490 EYMPQGSLEKH-----------------LYSTN----CILD--IFQRLNIMIDVAS-------------------ALEYL  527 (585)
Q Consensus       490 e~~~~g~L~~~-----------------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~l  527 (585)
                      ||++|.++...                 ++...    ....  +.++.++..++..                   .++++
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998654311                 11111    1111  3344444443321                   23333


Q ss_pred             h-----cCCCCCcEEcCCCCCCEEeCCC----CcEEEeeeccccc
Q 047705          528 H-----FGCSTPVIHCDLKPSNVLLDDN----MIAYLSDFGIAKL  563 (585)
Q Consensus       528 H-----~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~a~~  563 (585)
                      .     ......++|+|+.+.||+++++    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     1124568999999999999876    7899999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.17  E-value=0.0016  Score=67.48  Aligned_cols=74  Identities=15%  Similarity=0.176  Sum_probs=48.6

Q ss_pred             cceecccCceEEEEEEeCC-CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcc-eeEEeeeecCCeEEEEEEccCCCC
Q 047705          419 NNLIGRGGFGSVYKARLGD-GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      .+.|+.|-...+|++...+ +..+++|+....... .-.-..|..+++.+...++ +++++.+.  +  ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678888889999998765 578889987543211 1122568999998864444 67777763  2  25999998854


Q ss_pred             H
Q 047705          497 L  497 (585)
Q Consensus       497 L  497 (585)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.01  E-value=0.0011  Score=66.98  Aligned_cols=74  Identities=14%  Similarity=0.227  Sum_probs=45.0

Q ss_pred             cceecccCceEEEEEEeCC---------CcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCc-ceeEEeeeecCCeEEEE
Q 047705          419 NNLIGRGGFGSVYKARLGD---------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRN-LIKVISSCSNEEFKGLV  488 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  488 (585)
                      .+.++.|....+|++...+         ++.+++|+...... .......|.++++.+...+ .+++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567788888999998653         26788888654322 1123456888888774333 45676654  2  2689


Q ss_pred             EEccCCCCH
Q 047705          489 LEYMPQGSL  497 (585)
Q Consensus       489 ~e~~~~g~L  497 (585)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.79  E-value=0.0066  Score=60.34  Aligned_cols=32  Identities=25%  Similarity=0.428  Sum_probs=28.2

Q ss_pred             CCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       532 ~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35789999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.03  E-value=0.013  Score=59.91  Aligned_cols=74  Identities=12%  Similarity=0.225  Sum_probs=48.4

Q ss_pred             cceecccCceEEEEEEeCC--------CcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEE
Q 047705          419 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  489 (585)
                      .+.+..|-...+|++...+        ++.+++|+...... ..-+-.+|..+++.+. +.-.+++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778888999998653        57899998643321 1123356888888774 333456665442    27899


Q ss_pred             EccCCCCH
Q 047705          490 EYMPQGSL  497 (585)
Q Consensus       490 e~~~~g~L  497 (585)
                      ||++|..+
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.62  E-value=0.3  Score=49.49  Aligned_cols=30  Identities=27%  Similarity=0.379  Sum_probs=25.3

Q ss_pred             CcEEcCCCCCCEEe------CCCCcEEEeeeccccc
Q 047705          534 PVIHCDLKPSNVLL------DDNMIAYLSDFGIAKL  563 (585)
Q Consensus       534 ~iiH~dlkp~NIll------~~~~~~kl~Dfg~a~~  563 (585)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.25  E-value=3.6  Score=37.25  Aligned_cols=87  Identities=11%  Similarity=0.108  Sum_probs=62.4

Q ss_pred             CCCcceeEEeeeecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCcEEcCCCCCCEE
Q 047705          468 RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE-YLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       468 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      .||.+  -..+-.+++.+.+.++.-+++-=...++    ..+....++++..|+...+ +++     .-+|--+.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            57877  3444467777777777654433333343    3567778888888877766 444     5578889999999


Q ss_pred             eCCCCcEEEeeeccccccc
Q 047705          547 LDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++.++.+++.-.|+-..+.
T Consensus       117 f~~~~~p~i~hRGi~~~lp  135 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESLP  135 (219)
T ss_dssp             ECTTCCEEESCCEETTTBS
T ss_pred             EeCCCcEEEEEcCCcccCC
Confidence            9999999999999866553

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.38  E-value=0.72  Score=29.80  Aligned_cols=22  Identities=27%  Similarity=0.301  Sum_probs=8.5

Q ss_pred             eecchhhhhhhHHh-hhhhhhhc
Q 047705          363 IVLPLSTTLMIVVI-WLILRYRQ  384 (585)
Q Consensus       363 ~~~~~~~~~~~~~~-~~~~r~~~  384 (585)
                      ++.+++.++++++. |+++|+|+
T Consensus        17 VVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           17 MVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             hhHHHHHHHHHHHHHHHHhhhhH
Confidence            33334443333333 44444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.70  E-value=3.4  Score=37.28  Aligned_cols=87  Identities=7%  Similarity=0.117  Sum_probs=62.6

Q ss_pred             CCCcceeEEeeeecCCeEEEEEEccCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEE
Q 047705          468 RHRNLIKVISSCSNEEFKGLVLEYMPQG-SLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVL  546 (585)
Q Consensus       468 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIl  546 (585)
                      .||+.+.. .+-..++.+.+.++.-+.+ +... ++    ..+....++++..|+...++++     .=+|--+.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            57888865 4556667666666654322 2222 32    3567788889999988886555     3478899999999


Q ss_pred             eCCCCcEEEeeeccccccc
Q 047705          547 LDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       547 l~~~~~~kl~Dfg~a~~~~  565 (585)
                      ++.++.+++.-.|+...+.
T Consensus       112 f~~~~~p~i~~RGik~~l~  130 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVD  130 (215)
T ss_dssp             ECTTSCEEESCCEETTTBS
T ss_pred             EcCCCCEEEEEccCccCCC
Confidence            9999999999999865543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	585
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-43
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-33
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-46
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 8/168 (4%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVIS 477
             IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             +      +V ++    SL  HL+      ++ + ++I    A  ++YLH      +IH
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (402), Expect = 6e-45
 Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 20/200 (10%)

Query: 403 TFSYLELCRATDGFSEN---------NLIGRGGFGSVYKARL----GDGMEVAVKVFNLQ 449
            F++ +   A   F++           +IG G FG V    L       + VA+K     
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 450 -CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCIL 508
              +  + F  E  IM    H N+I +    +      ++ E+M  GSL+  L   +   
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
            + Q + ++  +A+ ++YL        +H DL   N+L++ N++  +SDFG+++ L  + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 569 QSMTQTQTL---ATIGYMAP 585
              T T  L     I + AP
Sbjct: 183 SDPTYTSALGGKIPIRWTAP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-43
 Identities = 45/173 (26%), Positives = 85/173 (49%), Gaps = 7/173 (4%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
           +       +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI-LDIFQRLNIMIDVASALEYLHFGCS 532
           ++ +  + E    ++ EYM  GSL   L + + I L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              IH DL+ +N+L+ D +   ++DFG+A+ LI +++   +      I + AP
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 9e-43
 Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 11/181 (6%)

Query: 407 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKS-FDVECEIM 464
           +EL    D F + + +G G  G V+K      G+ +A K+ +L+ + A ++    E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 465 KSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
                  ++    +  ++    + +E+M  GSL++ L      +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
            YL       ++H D+KPSN+L++      L DFG++  L     SM  +    T  YM+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171

Query: 585 P 585
           P
Sbjct: 172 P 172

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 10/184 (5%)

Query: 408 ELCRATDGFS-ENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCRRAF-KSFDVECE 462
           +L    D     +  +G G FGSV +         ++VA+KV      +A  +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 463 IMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
           IM  + +  ++++I  C  E    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIG 581
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 582 YMAP 585
           + AP
Sbjct: 178 WYAP 181

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 6/167 (3%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             +G G FG VYKA+     +  A KV + +     + + VE +I+ S  H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
              E    +++E+   G+++  +      L   Q   +      AL YLH      +IH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           DLK  N+L   +    L+DFG++       Q         T  +MAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 14/177 (7%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---QCRRAFKSFDVECEIMKSIR 468
              FS+   IG G FG+VY AR + +   VA+K  +    Q    ++    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H N I+       E    LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAP 180

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-41
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 5/170 (2%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +    +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
              C+ +    ++ EYM  G L  +L          Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H DL   N L++D  +  +SDFG+++ ++ +D+  +   +   + +  P
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPP 170

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 2e-40
 Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 6/174 (3%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIRHRN 471
           + +     +G G +G V  A        VAVK+ ++ +     ++   E  I K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           ++K          + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 7/173 (4%)

Query: 414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI 473
           +       +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIF-QRLNIMIDVASALEYLHFGCS 532
           ++ +  S E    +V EYM +GSL   L           Q +++   +AS + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              +H DL+ +N+L+ +N++  ++DFG+A+ LI +++   +      I + AP
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 183

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 3e-39
 Identities = 50/185 (27%), Positives = 76/185 (41%), Gaps = 13/185 (7%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSI 467
           RA D +     IG G +G   K R   DG  +  K  +         +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 468 RHRNLIKVISSCSNEEFKGL--VLEYMPQGSLEKHLYS---TNCILDIFQRLNIMIDVAS 522
           +H N+++      +     L  V+EY   G L   +         LD    L +M  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 523 ALEYLH--FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           AL+  H        V+H DLKP+NV LD      L DFG+A++L   D S  +     T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV-GTP 178

Query: 581 GYMAP 585
            YM+P
Sbjct: 179 YYMSP 183

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-39
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 5/170 (2%)

Query: 416 FSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKV 475
            +    IG G FG V+     +  +VA+K        + + F  E E+M  + H  L+++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
              C  +    LV E+M  G L  +L +   +      L + +DV   + YL   C   V
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           IH DL   N L+ +N +  +SDFG+ + ++ +  + +   T   + + +P
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP 171

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 5e-39
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 8/179 (4%)

Query: 411 RATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKS 466
           +  + F    ++G G F +V  AR L    E A+K+     +           E ++M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           + H   +K+  +  ++E     L Y   G L K++       D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (359), Expect = 6e-39
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 7/174 (4%)

Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL 472
              +  + +G G +G VY+       + VAVK          + F  E  +MK I+H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGC 531
           ++++  C+ E    ++ E+M  G+L  +L   N   +     L +   ++SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
               IH DL   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 185

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-39
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 11/174 (6%)

Query: 418 ENNLIGRGGFGSVYKARL---GDGMEVAVKVFNLQCR--RAFKSFDVECEIMKSIRHRNL 472
           E+  +G G FG+V K           VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
           +++I  C  E +  LV+E    G L K+L      +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAP 585
           +  +H DL   NVLL     A +SDFG++K L  ++            + + AP
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 33/195 (16%)

Query: 421 LIGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSI-RHRNL 472
           ++G G FG V  A        G  ++VAVK+   +   +  ++   E ++M  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 473 IKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTN----------------------CILDI 510
           + ++ +C+      L+ EY   G L  +L S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
              L     VA  +E+L        +H DL   NVL+    +  + DFG+A+ ++ +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 571 MTQTQTLATIGYMAP 585
           + +      + +MAP
Sbjct: 221 VVRGNARLPVKWMAP 235

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 3e-38
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 12/176 (6%)

Query: 414 DGFSENNLIGRGGFGSVYKARL-GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRH 469
           + F     +G+G FG+VY AR       +A+KV     L+          E EI   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  VIH D+KP N+LL       ++DFG +       ++        T+ Y+ P
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPP 173

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  142 bits (358), Expect = 3e-38
 Identities = 36/168 (21%), Positives = 66/168 (39%), Gaps = 9/168 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            +G G FG V++      G   A K          ++   E + M  +RH  L+ +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149

Query: 540 LKPSNVLL--DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           LKP N++     +    L DFG+   L  +      T T     + AP
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP 194

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-38
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
             IG+G FG V       G +VAVK          ++F  E  +M  +RH NL++++   
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 480 SNEEFK-GLVLEYMPQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
             E+    +V EYM +GSL  +L S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DL   NVL+ ++ +A +SDFG+ K       S TQ      + + AP
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAP 169

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 15/175 (8%)

Query: 422 IGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN 481
           IG+G FG V++ +   G EVAVK+F+ +  R++   + E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 482 EEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC-----S 532
           +        LV +Y   GSL  +L      + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT--QTQTLATIGYMAP 585
             + H DLK  N+L+  N    ++D G+A        ++       + T  YMAP
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 2e-37
 Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 10/177 (5%)

Query: 416 FSENNLIGRGGFGSVYKARLGDG-----MEVAVKVFNLQCR-RAFKSFDVECEIMKSIRH 469
            +   +IG G FG VYK  L        + VA+K        +    F  E  IM    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
            N+I++    S  +   ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
             +   +H DL   N+L++ N++  +SDFG++++L    + + T +     I + AP
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 8/167 (4%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISS 478
             IG+G  G+VY A  +  G EVA++  NLQ +   +    E  +M+  ++ N++  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHC 538
               +   +V+EY+  GSL   +  T    D  Q   +  +   ALE+LH   S  VIH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 539 DLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           D+K  N+LL  +    L+DFG    +  E    +      T  +MAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAP 185

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 9e-37
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 14/175 (8%)

Query: 419 NNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKV 475
           +  IGRG F +VYK       +EVA      +   +   + F  E E++K ++H N+++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 476 ISSC----SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
             S       ++   LV E M  G+L+ +L     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 532 STPVIHCDLKPSNVLLDD-NMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           + P+IH DLK  N+ +        + D G+A L      S  +   + T  +MAP
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAP 182

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 50/212 (23%), Positives = 81/212 (38%), Gaps = 35/212 (16%)

Query: 404 FSYLELCRATDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KS 456
              LE  R  +       IG G FG V++AR            VAVK+   +        
Sbjct: 5   LLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62

Query: 457 FDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNC---------- 506
           F  E  +M    + N++K++  C+  +   L+ EYM  G L + L S +           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 507 -------------ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA 553
                         L   ++L I   VA+ + YL        +H DL   N L+ +NM+ 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179

Query: 554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++DFG+++ +   D           I +M P
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 11/185 (5%)

Query: 407 LELCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKV-----FNLQCRRAFKSFDVE 460
           L + + T+ F +  ++G G FG+VYK   + +G +V + V           +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 461 CEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDV 520
             +M S+ + ++ +++  C     + L+ + MP G L  ++      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 521 ASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATI 580
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 581 GYMAP 585
            +MA 
Sbjct: 178 KWMAL 182

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 9/168 (5%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            +G G FG V++      G     K  N        +   E  IM  + H  LI +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            ++    L+LE++  G L   + + +  +   + +N M      L+++H      ++H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 540 LKPSNVLLD--DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +KP N++ +        + DFG+A  L   +       T AT  + AP
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAP 197

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 28/197 (14%)

Query: 414 DGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQCRRAF-KSFDVECEIMKS 466
           +  S    +G G FG V +A           M VAVK+          ++   E +++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 467 I-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY-----------------STNCIL 508
           +  H N++ ++ +C+      ++ EY   G L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
           D+   L+    VA  + +L    S   IH DL   N+LL    I  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 569 QSMTQTQTLATIGYMAP 585
             + +      + +MAP
Sbjct: 200 NYVVKGNARLPVKWMAP 216

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-36
 Identities = 49/172 (28%), Positives = 67/172 (38%), Gaps = 12/172 (6%)

Query: 422 IGRGGFGSVYKARL----GDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +G G FG V +       G  + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 475 VISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP 534
           +         K +V E  P GSL   L        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 535 VIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
            IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 26/192 (13%)

Query: 414 DGFSENNLIGRGGFGSVYKARL---GDGMEVAVKVFN-LQCRRAFKSFDVECEIMKSI-R 468
           +     ++IG G FG V KAR+   G  M+ A+K       +   + F  E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---------------STNCILDIFQR 513
           H N+I ++ +C +  +  L +EY P G+L   L                ST   L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 514 LNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ 573
           L+   DVA  ++YL        IH DL   N+L+ +N +A ++DFG+++   G++  + +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 574 TQTLATIGYMAP 585
           T     + +MA 
Sbjct: 184 TMGRLPVRWMAI 195

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-34
 Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 10/169 (5%)

Query: 421 LIGRGGFGSVYKARL----GDGMEVAVKVFNLQCRRAFKS-FDVECEIMKSIRHRNLIKV 475
            IG G FG V++          + VA+K        + +  F  E   M+   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
           I   + E    +++E    G L   L      LD+   +     +++AL YL    S   
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           +H D+   NVL+  N    L DFG+++ +  +      ++    I +MA
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMA 177

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 11/175 (6%)

Query: 419 NNLIGRGGFGSVYKARL----GDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHRNLI 473
           N +IGRG FG VY   L    G  +  AVK  N          F  E  IMK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 474 KVISSCSNEEFKG-LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS 532
            ++  C   E    +VL YM  G L   + +      +   +   + VA  +    F  S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148

Query: 533 TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED--QSMTQTQTLATIGYMAP 585
              +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  128 bits (322), Expect = 5e-34
 Identities = 45/182 (24%), Positives = 84/182 (46%), Gaps = 13/182 (7%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRR---AFKSFDVECEIMKSIR 468
           +D +    ++G GG   V+ AR L    +VAVKV      R    +  F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 469 HRNLIKVISSCSNEEFKG----LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           H  ++ V  +   E   G    +V+EY+   +L   +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYM 583
            +        +IH D+KP+N+++       + DFGIA+ +     S+TQT  +  T  Y+
Sbjct: 125 NFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 584 AP 585
           +P
Sbjct: 182 SP 183

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 35/186 (18%), Positives = 76/186 (40%), Gaps = 19/186 (10%)

Query: 416 FSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNL-QCRRAFKSFDVECEIMKSIR 468
            + +  +G+G FG VY+              VA+K  N     R    F  E  +MK   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLY---------STNCILDIFQRLNIMID 519
             ++++++   S  +   +++E M +G L+ +L                 + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 520 VASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLAT 579
           +A  + YL    +   +H DL   N ++ ++    + DFG+ + +   D      + L  
Sbjct: 142 IADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 580 IGYMAP 585
           + +M+P
Sbjct: 199 VRWMSP 204

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  125 bits (315), Expect = 6e-33
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 18/183 (9%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL---------QCRRAFKSFDVECEI 463
           + +    ++GRG    V +        E AVK+ ++         + +   ++   E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 464 MKSIR-HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVAS 522
           ++ +  H N+I++  +     F  LV + M +G L  +L      L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 523 ALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
            +  LH      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 583 MAP 585
           +AP
Sbjct: 176 LAP 178

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (316), Expect = 7e-33
 Identities = 36/175 (20%), Positives = 67/175 (38%), Gaps = 6/175 (3%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHR 470
            D +   +++G G F  V  A        VA+K    +       S + E  ++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++ +     +     L+++ +  G L   +              ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
                           LD++    +SDFG++K+   ED     +    T GY+AP
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 178

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 15/178 (8%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDVECEIMKS 466
           + FS + +IGRGGFG VY  R    G   A+K  +       Q      +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
                ++ +  +    +    +L+ M  G L  HL       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
           +H   +  V++ DLKP+N+LLD++    +SD G+A              ++ T GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (309), Expect = 8e-32
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 13/170 (7%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRHRNLIKV 475
             +G G FG V+  R   +G   A+KV     +   +  +  + E  ++  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 476 ISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
             +  + +   ++++Y+  G     L   +             +V  ALEYLH   S  +
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 536 IHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           I+ DLKP N+LLD N    ++DFG AK +     ++       T  Y+AP
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAP 170

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 8e-32
 Identities = 32/159 (20%), Positives = 67/159 (42%), Gaps = 7/159 (4%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            +GRG FG V++            K   ++          E  I+   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
            + E   ++ E++    + + + ++   L+  + ++ +  V  AL++LH   S  + H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 540 LKPSNVLLD--DNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           ++P N++     +    + +FG A+ L   D        
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 20/180 (11%)

Query: 416 FSENNLIGRGGFGSVYKARL-GDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIK 474
           +++  +IG G FG VY+A+L   G  VA+K      R      + E +IM+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 475 VISSC------SNEEFKGLVLEYMPQGSLE--KHLYSTNCILDIFQRLNIMIDVASALEY 526
           +           +E +  LVL+Y+P+      +H       L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 527 LHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H   S  + H D+KP N+LLD D  +  L DFG AK L+  + +++    + +  Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 8/178 (4%)

Query: 413 TDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF-KSFDVECEIMKSIRHR 470
              ++  + IG G +G V  A    + + VA+K  +    + + +    E +I+   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYS--TNCILDIFQRLNIMIDVASALEYLH 528
           N+I +         + +   Y+    +   LY       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI-GEDQSMTQTQTLATIGYMAP 585
              S  V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT  Y AP
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 12/172 (6%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCR-----RAFKSFDVECEIMKSIRHRNLI 473
           + +G G F +VYKAR       VA+K   L  R        ++   E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 474 KVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCST 533
            ++ +  ++    LV ++M    LE  +   + +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 534 PVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            ++H DLKP+N+LLD+N +  L+DFG+AK       +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 5e-31
 Identities = 41/177 (23%), Positives = 76/177 (42%), Gaps = 11/177 (6%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIM-KSIR 468
           + F  + ++G+G FG V+ A         A+K      +      +   VE  ++  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 469 HRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLH 528
           H  L  +  +   +E    V+EY+  G L  H+ S +   D+ +      ++   L++L 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFL- 119

Query: 529 FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
              S  +++ DLK  N+LLD +    ++DFG+ K  +  D          T  Y+AP
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAP 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 8/168 (4%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVIS 477
             IG G +G VYKA+   G   A+K   L+        +   E  I+K ++H N++K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 478 SCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIH 537
               ++   LV E++    L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            DLKP N+L++      ++DFG+A+           T  + T+ Y AP
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAP 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-30
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 28/197 (14%)

Query: 414 DGFSENNLIGRGGFGSVYKARL--------GDGMEVAVKVFNLQ-CRRAFKSFDVECEIM 464
           D       +G G FG V  A              +VAVK+       +       E E+M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 465 KSI-RHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCI---------------L 508
           K I +H+N+I ++ +C+ +    +++EY  +G+L ++L +                   L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 509 DIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED 568
                ++    VA  +EYL    S   IH DL   NVL+ ++ +  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 569 QSMTQTQTLATIGYMAP 585
                T     + +MAP
Sbjct: 190 YYKKTTNGRLPVKWMAP 206

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 5e-30
 Identities = 42/196 (21%), Positives = 73/196 (37%), Gaps = 27/196 (13%)

Query: 414 DGFSENNLIGRGGFGSVYKAR------LGDGMEVAVKVFNL-QCRRAFKSFDVECEIMKS 466
           D       +GRG FG V +A             VAVK+          ++   E +I+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 467 IRHRNLIKVISSCSNEEFKGL--VLEYMPQGSLEKHLYSTNC---------------ILD 509
           I H   +  +     +    L  ++E+   G+L  +L S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 510 IFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ 569
           +   +     VA  +E+L    S   IH DL   N+LL +  +  + DFG+A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 570 SMTQTQTLATIGYMAP 585
            + +      + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 8e-30
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 8/175 (4%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHR 470
           + F +   IG G +G VYKAR    G  VA+K   L         +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 471 NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG 530
           N++K++     E    LV E++ Q   +    S    + +    + +  +   L +    
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118

Query: 531 CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            S  V+H DLKP N+L++      L+DFG+A+      ++ T      T+ Y AP
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 18/189 (9%)

Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR--LGDGMEVAVKVFNLQC--RRAFKSFDVECEIM 464
           LCRA   +     IG G +G V+KAR     G  VA+K   +Q        S   E  ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 465 K---SIRHRNLIKVISSCSNEEFKG-----LVLEYMPQGSLEKHLYSTNCILDIFQRLNI 516
           +   +  H N++++   C+           LV E++ Q             +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 517 MIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT 576
           M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       M  T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 577 LATIGYMAP 585
           + T+ Y AP
Sbjct: 176 VVTLWYRAP 184

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 4e-29
 Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 21/175 (12%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIM-KSIRHRNLIKVISS 478
           ++G G  G V +        + A+K+      +       E E+  ++ +  ++++++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 479 CSNEEFKG----LVLEYMPQGSLEKHLYS-TNCILDIFQRLNIMIDVASALEYLHFGCST 533
             N         +V+E +  G L   +    +      +   IM  +  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 534 PVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
            + H D+KP N+L      N I  L+DFG AK     +   T      T  Y+AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 7e-29
 Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 10/176 (5%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRH 469
           + F    L+G+G FG V   R    G   A+K+   +    +        E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L  +  +    +    V+EY   G L  HL     +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  V++ D+K  N++LD +    ++DFG+ K  I +  +M       T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAP 174

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 17/175 (9%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAF------KSFDVECEIMKSIR--HRN 471
           L+G GGFGSVY    + D + VA+K         +          +E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 472 LIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
           +I+++      +   L+LE            +    L      +    V  A+ +     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127

Query: 532 STPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +  V+H D+K  N+L+D +     L DFG   LL    +    T    T  Y  P
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPP 178

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 14/174 (8%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            IG G FG +Y    +  G EVA+K+  ++ +       +E +I K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
             E    +++  +   SLE      +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 540 LKPSNVL---LDDNMIAYLSDFGIAKLLIGED-----QSMTQTQTLATIGYMAP 585
           +KP N L        + Y+ DFG+AK                     T  Y + 
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 5e-28
 Identities = 41/190 (21%), Positives = 79/190 (41%), Gaps = 17/190 (8%)

Query: 409 LCRATDGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMK 465
            C     + +   IG+G FG V+KAR    G +VA+K   ++        +   E +I++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 466 SIRHRNLIKVISSCSNEEFKG--------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIM 517
            ++H N++ +I  C  +            LV ++                  + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 518 IDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQT- 576
             +   L  L++     ++H D+K +NVL+  + +  L+DFG+A+       S     T 
Sbjct: 124 QML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 577 -LATIGYMAP 585
            + T+ Y  P
Sbjct: 181 RVVTLWYRPP 190

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 18/183 (9%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFNL------QCRRAFKSFDVECEIMKS 466
           D +     +G G F  V K R    G++ A K          +   + +  + E  I+K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 467 IRHRNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEY 526
           I+H N+I +     N+    L+LE +  G L   L      L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYY 128

Query: 527 LHFGCSTPVIHCDLKPSNVLLDDNMIA----YLSDFGIAKLLIGEDQSMTQTQTLATIGY 582
           LH   S  + H DLKP N++L D  +      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 583 MAP 585
           +AP
Sbjct: 183 VAP 185

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 3e-27
 Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 9/169 (5%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVI 476
             IG G +G+V+KA+       VA+K   L         S   E  ++K ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 477 SSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVI 536
               +++   LV E+  Q   +        + D     + +  +   L + H      V+
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---VL 123

Query: 537 HCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 4e-27
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 13/176 (7%)

Query: 414 DGFSENNLIGRGGFGSVYKAR-LGDGMEVAVKVFN---LQCRRAFKSFDVECEIMKSIRH 469
           D F     +G G FG V   +    G   A+K+ +   +   +  +    E  I++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 470 RNLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHF 529
             L+K+  S  +     +V+EY+  G +  HL                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 530 GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
             S  +I+ DLKP N+L+D      ++DFG AK + G   ++       T   +AP
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAP 207

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  108 bits (270), Expect = 9e-27
 Identities = 32/176 (18%), Positives = 60/176 (34%), Gaps = 16/176 (9%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            IG G FG +++   L +  +VA+K      R        E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 480 SNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCD 539
             E    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 540 LKPSNVLLDDNM-----IAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAP 585
           +KP N L+         + Y+ DFG+ K               +     T  YM+ 
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  105 bits (263), Expect = 1e-25
 Identities = 36/171 (21%), Positives = 77/171 (45%), Gaps = 18/171 (10%)

Query: 420 NLIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVIS 477
             +GRG +  V++A  + +  +V VK+     ++  K    E +I++++R   N+I +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 478 SCSNEEFK--GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPV 535
              +   +   LV E++     ++   +    L  +     M ++  AL+Y H      +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMG---I 150

Query: 536 IHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           +H D+KP NV++D ++    L D+G+A+              +A+  +  P
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGP 198

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 4e-25
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 414 DGFSENNLIGRGGFGSVYKARL----GDGMEVAVKVFN----LQCRRAFKSFDVECEIMK 465
           + F    ++G G +G V+  R       G   A+KV      +Q  +  +    E ++++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 466 SIRHR-NLIKVISSCSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
            IR    L+ +  +   E    L+L+Y+  G L  HL         F    + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 584
             L       +I+ D+K  N+LLD N    L+DFG++K  + ++          TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 8e-25
 Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 24/195 (12%)

Query: 404 FSYLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKS 456
           F   E+ +              +G G +G+V  A     G +VA+K      Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 457 FDVECEIMKSIRHRNLIKVISSCSNEEFKG------LVLEYMPQGSLEKHLYSTNCILDI 510
              E  ++K +RH N+I ++   + +E         LV+ +M  G+    L      L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120

Query: 511 FQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS 570
            +   ++  +   L Y+H   +  +IH DLKP N+ ++++    + DFG+A+     D  
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSE 174

Query: 571 MTQTQTLATIGYMAP 585
           MT      T  Y AP
Sbjct: 175 MTGYVV--TRWYRAP 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 3e-23
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 20/194 (10%)

Query: 403 TFSYLELCRATDGFSEN----NLIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFK 455
           TF   EL +      E     + +G G +GSV  A     G+ VAVK  +   Q     K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 456 SFDVECEIMKSIRHRNLIKVISSCSNE----EFKGLVLEYMPQGSLEKHLYSTNCILDIF 511
               E  ++K ++H N+I ++   +      EF  + L     G+   ++      L   
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDD 121

Query: 512 QRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM 571
               ++  +   L+Y+H   S  +IH DLKPSN+ ++++    + DFG+A+         
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173

Query: 572 TQTQTLATIGYMAP 585
             T  +AT  Y AP
Sbjct: 174 EMTGYVATRWYRAP 187

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.5 bits (244), Expect = 6e-23
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 19/174 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFN--LQCRRAFKSFDVECEIMKSIRHRNLIKVIS 477
            IG G  G V  A        VA+K  +   Q +   K    E  +MK + H+N+I +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 478 SCSNEEFKG------LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGC 531
             + ++         LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 532 STPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 585
           S  +IH DLKPSN+++  +    + DFG+A+       S   T  + T  Y AP
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAP 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.2 bits (228), Expect = 3e-22
 Identities = 23/157 (14%), Positives = 48/157 (30%), Gaps = 26/157 (16%)

Query: 420 NLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFK----------SFDVECEIMKSIRH 469
            L+G G   +V+        E  VK   +      K           F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 470 RNLIKVISSCSNEEF----KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALE 525
           R L K+      + +      +++E +               + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 526 YLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK 562
             +      ++H DL   NVL+ +  I ++ DF  + 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 94.7 bits (234), Expect = 1e-21
 Identities = 37/182 (20%), Positives = 73/182 (40%), Gaps = 20/182 (10%)

Query: 421 LIGRGGFGSVYKAR-LGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSC 479
            +G G F +V+ A+ + +   VA+K+     +   ++ + E ++++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 480 SNEEFK---------------GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASAL 524
           +N   K                +V E + +  L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 525 EYLHFGCSTPVIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 583
           +Y+H  C   +IH D+KP NVL++  +    L    IA L          T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 584 AP 585
           +P
Sbjct: 197 SP 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 5e-20
 Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 13/193 (6%)

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
             N  ++   P  I   TNL  + L GN+L    + TL+ L  L  L L +N++    P 
Sbjct: 204 ATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 258

Query: 177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM 236
            +  L +L +L+LG N++  +I           +    +       I NLK L  +    
Sbjct: 259 -LSGLTKLTELKLGANQI-SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           NN S I P  +  L  L+ LF   N++      S  NL ++ +L+  +N +S   P  L 
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 370

Query: 297 KLSYLEDLNLSFN 309
            L+ +  L L+  
Sbjct: 371 NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 71.6 bits (174), Expect = 6e-14
 Identities = 51/247 (20%), Positives = 84/247 (34%), Gaps = 65/247 (26%)

Query: 39  LGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDG 98
           L   +N +S          L NL+EL L GN   ++  L+SL+N   L    L+NN +  
Sbjct: 202 LIATNNQISDI---TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLD---LANNQISN 255

Query: 99  ILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ 158
           + P                            +  LT L  + LG N+++    +      
Sbjct: 256 LAP----------------------------LSGLTKLTELKLGANQISNISPLAGLTAL 287

Query: 159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDP 218
                  + N+ +      I  L  L  L L  N +S   P                   
Sbjct: 288 TNL----ELNENQLEDISPISNLKNLTYLTLYFNNISDISP------------------- 324

Query: 219 LPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
               + +L  L  + F+ N  S      +  L N+ +L  G+N++  L P    NL  + 
Sbjct: 325 ----VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 376

Query: 279 FLNLSNN 285
            L L++ 
Sbjct: 377 QLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.4 bits (158), Expect = 5e-12
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 16/166 (9%)

Query: 3   PLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLE 62
              + +L NL +LDL  N++    P  +  ++ L  L L  N +S          L  L 
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP------LAGLT 285

Query: 63  ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV 122
            L     N ++L  +S +SN K+LT + L  N +  I P   + +L+  L+     N  V
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLT-KLQRLFFANNKV 341

Query: 123 TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
           +      + NLTN+  +  G N+++   L  L+ L ++  L L+D 
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.3 bits (150), Expect = 4e-11
 Identities = 49/285 (17%), Positives = 88/285 (30%), Gaps = 24/285 (8%)

Query: 32  NVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGL 91
            ++      L   +++ +   ++   L  +  L         +  +  +    +LT I  
Sbjct: 20  ALAEKMKTVLGKTNVTDT---VSQTDLDQVTTLQADRLG---IKSIDGVEYLNNLTQINF 73

Query: 92  SNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSIL 151
           SNN L  I P  ++  L   L +               +  LT         + L     
Sbjct: 74  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 152 ITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL 211
           +   +L       +       S+              L        +    N        
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN-------- 185

Query: 212 SLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF 271
                      +  L  L  +  + N  S I P  I    NL+ L L  N+L+     + 
Sbjct: 186 ----KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTL 237

Query: 272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
            +L +L  L+L+NN +S   P  L  L+ L +L L  N++    P
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 9e-06
 Identities = 48/257 (18%), Positives = 89/257 (34%), Gaps = 32/257 (12%)

Query: 81  SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITID 140
           +         L    +   + +T +  ++      Q     +   I + +  L NL  I+
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTT----LQADRLGIK-SI-DGVEYLNNLTQIN 72

Query: 141 LGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL---------YKLELGG 191
              N+L    +  L  L KL  +++++N++    P      +               L  
Sbjct: 73  FSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 192 NKLSRSIPACFNNLIAL---------RILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGI 242
                 +    N +  +         + LS G+       + NL  L  +D S N     
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV--S 188

Query: 243 IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLE 302
               +  L NLE L    N++  + P       +L  L+L+ N L      +L  L+ L 
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLT 244

Query: 303 DLNLSFNKLEGEIPRGG 319
           DL+L+ N++    P  G
Sbjct: 245 DLDLANNQISNLAPLSG 261

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.4 bits (215), Expect = 1e-19
 Identities = 60/292 (20%), Positives = 98/292 (33%), Gaps = 20/292 (6%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           ++P ++    +   LDL+ NK+         N+  L  L L +N +S          L  
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA-PLVK 80

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           LE L L  N   EL         K+L  + +  N +  +      G     + +   +  
Sbjct: 81  LERLYLSKNQLKEL----PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 136

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
             +G        +  L  I +    +     I       L  L LD NK+       +  
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKG 193

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNN 238
           L  L KL L  N +S        N   LR L L +N    +P  + + K +  +    NN
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253

Query: 239 FSGI------IPKEIGGLKNLEYLFLGYNRLQ--GLIPDSFGNLISLKFLNL 282
            S I       P       +   + L  N +Q   + P +F  +     + L
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 81.6 bits (200), Expect = 1e-17
 Identities = 48/272 (17%), Positives = 94/272 (34%), Gaps = 11/272 (4%)

Query: 47  SGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIG 106
              L  +     P+   L L  N  +E+       N K+L  + L NN +  I P  +  
Sbjct: 19  DLGLEKVPKDLPPDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKISKISPG-AFA 76

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
            L   LE   +    +     +    L  L   +    K+  S+   L+++  ++ L  +
Sbjct: 77  PLV-KLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTN 134

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNL 226
             K  G        + +L  + +    ++        +L  L +            +  L
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGL 194

Query: 227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNN 286
             L  +  S N+ S +    +    +L  L L  N+L   +P    +   ++ + L NNN
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNN 253

Query: 287 LSG------AIPASLEKLSYLEDLNLSFNKLE 312
           +S         P    K +    ++L  N ++
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.1 bits (196), Expect = 4e-17
 Identities = 60/255 (23%), Positives = 94/255 (36%), Gaps = 5/255 (1%)

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
           +L        + N  +T     +  NL NL T+ L  NK++       + L KL+ L L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNN--LIALRILSLGSNDPLPLEIG 224
            N+L+         L EL   E    K+ +S+    N   ++ L    L S+        
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN 284
            +K L  I  +  N + I     G   +L  L L  N++  +   S   L +L  L LS 
Sbjct: 148 GMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 285 NNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVP 344
           N++S     SL    +L +L+L+ NKL                    N +     N   P
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 345 PCKTSIHHPSWNISL 359
           P   +       +SL
Sbjct: 265 PGYNTKKASYSGVSL 279

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (206), Expect = 2e-18
 Identities = 63/270 (23%), Positives = 98/270 (36%), Gaps = 9/270 (3%)

Query: 47  SGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIG 106
              L ++        + + L GN  S +   +S   C++LT++ L +N L  I      G
Sbjct: 20  QQGLQAVPVGIPAASQRIFLHGNRISHVP-AASFRACRNLTILWLHSNVLARIDAAAFTG 78

Query: 107 NLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD 166
                 +     N  +    P     L  L T+ L    L          L  LQ L L 
Sbjct: 79  LALLE-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137

Query: 167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPL---PLEI 223
           DN L+    D    L  L  L L GN++S      F  L +L  L L  N      P   
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 224 GNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLS 283
            +L  L+ +    NN S +  + +  L+ L+YL L  N        +      L+    S
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGS 256

Query: 284 NNNLSGAIPASLEKLSYLEDLNLSFNKLEG 313
           ++ +  ++P  L          L+ N L+G
Sbjct: 257 SSEVPCSLPQRLAGRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (154), Expect = 7e-12
 Identities = 56/256 (21%), Positives = 80/256 (31%), Gaps = 22/256 (8%)

Query: 84  KSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGG 143
            +   I L  N +  + P  S     +    +   N     D     G            
Sbjct: 32  AASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 144 NKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFN 203
            +L      T   L +L  L LD   L+   P     L  L  L L  N L       F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 204 NLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRL 263
           +L  L  L L                       N  S +  +   GL +L+ L L  NR+
Sbjct: 151 DLGNLTHLFL---------------------HGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 264 QGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGN 323
             + P +F +L  L  L L  NNLS     +L  L  L+ L L+ N    +      +  
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249

Query: 324 FSAESFEGNELLCGSP 339
                   +E+ C  P
Sbjct: 250 LQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (154), Expect = 7e-12
 Identities = 46/289 (15%), Positives = 87/289 (30%), Gaps = 30/289 (10%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P+ I      + + L  N++      +      L +L L  N L+   ++        
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
            +  +        ++  ++      L  + L    L  +     +     +L+   + + 
Sbjct: 83  EQLDLSDNAQLRSVDP-ATFHGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQYLYLQDN 139

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
            +     +   +L NL  + L GN+++         L  L  L+L  N++    P     
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFS 240
           L  L  L L  N LS         L AL+ L L  N   P            D       
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN---PWV---------CDCRARPL- 246

Query: 241 GIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG 289
                       L+      + +   +P             L+ N+L G
Sbjct: 247 ---------WAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.3 bits (199), Expect = 2e-17
 Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 54/296 (18%)

Query: 78  SSLSNCKSLTVIGLSNNPLDGILP-KTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNL 136
            + +    +  + LS   L    P  +S+ NL +    +     N+ G IP  I  LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR 196
             + +    ++G+I   LS+++ L  L    N L G++P  I  L  L  +   GN++S 
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 197 SIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVG------------------------- 231
           +IP  + +   L      S + L  +I      +                          
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 232 -IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA 290
                  N       ++G  KNL  L L  NR+ G +P     L  L  LN+S NNL   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-- 281

Query: 291 IPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPC 346
                                 GEIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 282 ----------------------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 2e-14
 Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 28/288 (9%)

Query: 7   GNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVL 66
                +  LDL    L    P                  +  SL++     LP L  L +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYP------------------IPSSLAN-----LPYLNFLYI 83

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
            G N        +++    L  + +++  + G +P         +L         ++G +
Sbjct: 84  GGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI--KTLVTLDFSYNALSGTL 141

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQG-LVLDDNKLEGSIPDDICRLVELY 185
           P  I +L NL+ I   GN+++G+I  +     KL   + +  N+L G IP     L   +
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201

Query: 186 KLELGGNKLSRSI-PACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
                      +      +       L+  S      ++G  K L G+D   N   G +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261

Query: 245 KEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP 292
           + +  LK L  L + +N L G IP   GNL        +NN      P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.8 bits (99), Expect = 6e-05
 Identities = 13/50 (26%), Positives = 22/50 (44%), Gaps = 2/50 (4%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNS-LSGS 49
            +P  +  L+ L  L++  N L G +P    N+    +    +N  L GS
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.8 bits (86), Expect = 0.003
 Identities = 22/82 (26%), Positives = 32/82 (39%), Gaps = 3/82 (3%)

Query: 231 GIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGL--IPDSFGNLISLKFLNLSNN-NL 287
             D     + G++         +  L L    L     IP S  NL  L FL +    NL
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 288 SGAIPASLEKLSYLEDLNLSFN 309
            G IP ++ KL+ L  L ++  
Sbjct: 90  VGPIPPAIAKLTQLHYLYITHT 111

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (151), Expect = 1e-11
 Identities = 40/195 (20%), Positives = 59/195 (30%), Gaps = 5/195 (2%)

Query: 119 NCNVTG--DIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
           NC+      +P ++    +   + L  N L    L TL    +L  L LD  +L     D
Sbjct: 16  NCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD 73

Query: 177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM 236
               ++    L     +    +      L  L +            +  L  L  +    
Sbjct: 74  GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE 296
           N    + P  +     LE L L  N L  L       L +L  L L  N+L   IP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 297 KLSYLEDLNLSFNKL 311
               L    L  N  
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 1e-06
 Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 3/65 (4%)

Query: 222 EIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLN 281
           E+  +   + ++    N + + P ++   K+   L L  N L      +      L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 282 LSNNN 286
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 36/194 (18%), Positives = 59/194 (30%), Gaps = 10/194 (5%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +P ++   ++   L L +N L       +   + L  L L                   
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA------ELTKLQVDGT 75

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L  L     + ++L  L  L        +   +      LP  ++  L    E +   N 
Sbjct: 76  LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
                 P  +     L  + L  N L       L+ L+ L  L+L +N L  +IP     
Sbjct: 136 L-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193

Query: 181 LVELYKLELGGNKL 194
              L    L GN  
Sbjct: 194 SHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 43/216 (19%), Positives = 66/216 (30%), Gaps = 28/216 (12%)

Query: 49  SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL 108
           +L+++      +   L L  N     + L++L     LT + L    L  +    ++  L
Sbjct: 21  NLTALPPDLPKDTTILHLSENLLYTFS-LATLMPYTRLTQLNLDRAELTKLQVDGTLPVL 79

Query: 109 SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDN 168
                                   + ++       N+L    L  L  L +LQ L L  N
Sbjct: 80  GTLDLSHNQLQSLPLLGQTLPALTVLDVSF-----NRLTSLPLGALRGLGELQELYLKGN 134

Query: 169 KLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKV 228
           +L+   P  +    +L KL L  N L+       N L  L  L L  N            
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY--------- 185

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQ 264
                         IPK   G   L + FL  N   
Sbjct: 186 -------------TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 14/62 (22%), Positives = 22/62 (35%), Gaps = 3/62 (4%)

Query: 246 EIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN 305
           E+  + +   +      L   +P           L+LS N L     A+L   + L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 306 LS 307
           L 
Sbjct: 62  LD 63

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 31/226 (13%), Positives = 71/226 (31%), Gaps = 15/226 (6%)

Query: 59  PNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMH 118
           P L   +      S +    + ++   +T +      +  I     +  L+ +L   ++ 
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI---EGVQYLN-NLIGLELK 71

Query: 119 NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDI 178
           +  +T   P +       + +     K   +I    S            +    +   ++
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 179 CRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN 238
             L          + L+      + ++   ++            + NL  L  +    N 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-------LTPLANLSKLTTLKADDNK 184

Query: 239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN 284
            S I P  +  L NL  + L  N++  + P    N  +L  + L+N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.0 bits (123), Expect = 4e-08
 Identities = 34/236 (14%), Positives = 71/236 (30%), Gaps = 17/236 (7%)

Query: 72  SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
           + +N +       +   I    + +   + +  +  ++            VT  I E + 
Sbjct: 7   TAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITT----LSAFGTGVT-TI-EGVQ 60

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
            L NLI ++L  N++     +          L  +  K   +I                 
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120

Query: 192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLK 251
           +    +  +    L           + +        +      S+ N        +  L 
Sbjct: 121 DVTPLAGLSNLQVLY-------LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS 173

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
            L  L    N++  + P    +L +L  ++L NN +S   P  L   S L  + L+
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 4e-05
 Identities = 36/202 (17%), Positives = 58/202 (28%), Gaps = 23/202 (11%)

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
            L N I I  G + +     +T + L  +  L      +     + +  L  L  LEL  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLK 251
           N+++   P      I    LS      +    G   +      S           +  L+
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 252 NLEYLFLG-----------------YNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPAS 294
            L                           Q        NL  L  L   +N +S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 295 LEKLSYLEDLNLSFNKLEGEIP 316
           L  L  L +++L  N++    P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 36/217 (16%), Positives = 71/217 (32%), Gaps = 44/217 (20%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
            L N  ++   ++ +  TV  A  ++  +  L      ++ ++  +    L NL  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQ--YLNNLIGLELK 71

Query: 68  GNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSI---------------------- 105
            N  ++L  L +L+    L + G     +  I    SI                      
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 106 -------------GNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILI 152
                          L+       +   N        + NL+ L T+    NK++   + 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--IS 189

Query: 153 TLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLEL 189
            L+ L  L  + L +N++    P  +     L+ + L
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 22/64 (34%), Positives = 35/64 (54%), Gaps = 6/64 (9%)

Query: 30  IFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI 89
           + N+S L  L   DN +S  +S +    LPNL E+ L  N  S+   +S L+N  +L ++
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLA--SLPNLIEVHLKNNQISD---VSPLANTSNLFIV 222

Query: 90  GLSN 93
            L+N
Sbjct: 223 TLTN 226

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 3e-07
 Identities = 34/213 (15%), Positives = 67/213 (31%), Gaps = 15/213 (7%)

Query: 72  SELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIG 131
           + +  + S           L    +   + +  +    +S++    +N ++       I 
Sbjct: 12  TPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIKSVQG--IQ 65

Query: 132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG 191
            L N+  + L GNKL          L  L+ L                + ++  K     
Sbjct: 66  YLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120

Query: 192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLK 251
           +     I    +      +    +       +  L  L  +    N  S I+P  + GL 
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN 284
            L+ L+L  N +  L   +   L +L  L L +
Sbjct: 179 KLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 8e-07
 Identities = 42/209 (20%), Positives = 71/209 (33%), Gaps = 37/209 (17%)

Query: 126 IPEEIG------NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
           +P  I            I  +L    +     +T ++L  +  ++ +++ ++      I 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQ 65

Query: 180 RLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNF 239
            L  + KL L GNKL+        NL  L  L L  N    L        +      +N 
Sbjct: 66  YLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123

Query: 240 SGII---------------------PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLK 278
              I                        +  L  L+ L L  N++  ++P     L  L+
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181

Query: 279 FLNLSNNNLSGAIPASLEKLSYLEDLNLS 307
            L LS N++S     +L  L  L+ L L 
Sbjct: 182 NLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 38/220 (17%), Positives = 84/220 (38%), Gaps = 26/220 (11%)

Query: 2   IPLEIG------NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITD 55
           +P  I             + +L++  +   V      ++++  +   ++ +  S+  I  
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQY 66

Query: 56  VRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF 115
             LPN+ +L L GN  +++  L++L N   L +             +  + +LS   +  
Sbjct: 67  --LPNVTKLFLNGNKLTDIKPLANLKNLGWLFL------------DENKVKDLSSLKDLK 112

Query: 116 QMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP 175
           ++ + ++  +   +I  L +L  ++      N    IT+         +  ++     I 
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172

Query: 176 DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS 215
             +  L +L  L L  N +S  + A    L  L +L L S
Sbjct: 173 -PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 5e-07
 Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 9/83 (10%)

Query: 234 FSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA 293
           + +N  S  I        +LE L +  N+L   +P        L+ L  S N+L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321

Query: 294 SLEKLSYLEDLNLSFNKLEGEIP 316
             + L     L++ +N L  E P
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 1e-05
 Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 9/96 (9%)

Query: 115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSI 174
              +    + +I        +L  +++  NKL   +     +L++L       N L   +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EV 319

Query: 175 PDDICRLVELYKLELGGNKLSRSIPACFNNLIALRI 210
           P+    L +L+   +  N L    P    ++  LR+
Sbjct: 320 PELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 4e-05
 Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 11/95 (11%)

Query: 67  WGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDI 126
           +  N S     S      SL  + +SNN L        +  L   LE       ++  ++
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLA-EV 319

Query: 127 PEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQ 161
           PE   NL  L    +  N L          ++ L+
Sbjct: 320 PELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 6e-05
 Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 16/103 (15%)

Query: 17  LRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNF 76
              N     +        +L+ L + +N L    +       P LE L+   N+ +E+  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALP-----PRLERLIASFNHLAEVP- 320

Query: 77  LSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
                  ++L  + +  NPL          ++  S+ED +M++
Sbjct: 321 ----ELPQNLKQLHVEYNPL------REFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 10/76 (13%)

Query: 8   NLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW 67
              +LEEL++  NKLI  +P        L+ L    N L+  +  +      NL++L + 
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL----PQNLKQLHVE 332

Query: 68  GNNFSEL-NFLSSLSN 82
            N   E  +   S+ +
Sbjct: 333 YNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 25/78 (32%), Positives = 30/78 (38%), Gaps = 7/78 (8%)

Query: 257 FLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIP 316
               N     I        SL+ LN+SNN L   +PA   +   LE L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 317 RGGSFGNFSAESFEGNEL 334
                 N      E N L
Sbjct: 321 --ELPQNLKQLHVEYNPL 336

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 1e-06
 Identities = 10/57 (17%), Positives = 15/57 (26%)

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNN 285
                   NN   +      G      L +   R+  L      NL  L+  +  N 
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 2e-05
 Identities = 13/59 (22%), Positives = 18/59 (30%)

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNK 310
             E      N L+ L  D F        L++S   +       LE L  L   +    K
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 1e-04
 Identities = 43/220 (19%), Positives = 76/220 (34%), Gaps = 2/220 (0%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
           EIP ++   +N  EL     KL      A      L+ + +  N +   + +     LP 
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNC 120
           L E+ +   N        +  N  +L  + +SN  +  +     I +L   L D Q +  
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 121 NVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICR 180
             T +    +G     + + L  N +        +  Q  +  + D+N LE    D    
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 181 LVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP 220
                 L++   ++         NL  LR  S  +   LP
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLP 239

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 1e-06
 Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 5/71 (7%)

Query: 252 NLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNL 306
           +++ L +    L      +    L   + + L +  L+      I ++L     L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 307 SFNKLEGEIPR 317
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 9e-06
 Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 13/93 (13%)

Query: 225 NLKVLVGIDFSMNNFSGIIPKEI-GGLKNLEYLFLGYNRLQG----LIPDSFGNLISLKF 279
           +++ L   D      S     E+   L+  + + L    L       I  +     +L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 280 LNLSNNNLSGAIPASL-----EKLSYLEDLNLS 307
           LNL +N L       +          ++ L+L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 1e-05
 Identities = 18/76 (23%), Positives = 26/76 (34%), Gaps = 9/76 (11%)

Query: 251 KNLEYLFLGYNRLQGL----IPDSFGNLISLKFLNLSNNNLSGAIPASL-----EKLSYL 301
             L  L+L    +       +  +     SL+ L+LSNN L  A    L     +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 302 EDLNLSFNKLEGEIPR 317
           E L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 1e-05
 Identities = 14/120 (11%), Positives = 33/120 (27%), Gaps = 22/120 (18%)

Query: 60  NLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHN 119
           +++ L +     S+  +   L   +   V+ L +  L     K                 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK----------------- 45

Query: 120 CNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDIC 179
                DI   +     L  ++L  N+L    +  + +  +     +    L+        
Sbjct: 46  -----DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 15/94 (15%), Positives = 27/94 (28%), Gaps = 9/94 (9%)

Query: 214 GSNDPLPLEIGNLKVLVGIDFSMNNFSGI----IPKEIGGLKNLEYLFLGYNRLQGLIPD 269
           G  +          VL  +  +  + S      +   +    +L  L L  N L      
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415

Query: 270 SFGNLI-----SLKFLNLSNNNLSGAIPASLEKL 298
                +      L+ L L +   S  +   L+ L
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 2e-04
 Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 6/81 (7%)

Query: 59  PNLEELVLWGNNFSE---LNFLSSLSNCKSLTVIGLSNNPLDGILPKT---SIGNLSHSL 112
             L  L L   + S+    +  ++L    SL  + LSNN L          S+      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 113 EDFQMHNCNVTGDIPEEIGNL 133
           E   +++   + ++ + +  L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 9/85 (10%)

Query: 110 HSLEDFQMHNCNVTGD----IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK-----L 160
             L    + +C+V+      +   +    +L  +DL  N L  + ++ L +  +     L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 161 QGLVLDDNKLEGSIPDDICRLVELY 185
           + LVL D      + D +  L +  
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 10/94 (10%)

Query: 135 NLITIDLGGNKLNGSILITL-SKLQKLQGLVLDDNKLEGSIPDDICRLVE----LYKLEL 189
           ++ ++D+   +L+ +    L   LQ+ Q + LDD  L  +   DI   +     L +L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 190 GGNKLSRSIPACF-----NNLIALRILSLGSNDP 218
             N+L      C           ++ LSL +   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 5e-04
 Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 8/92 (8%)

Query: 11 NLEELDLRQNKLIGTVPVAIF-NVSTLKLLGLQDNSLSG-SLSSITDV--RLPNLEELVL 66
          +++ LD++  +L       +   +   +++ L D  L+      I+      P L EL L
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 67 WGNNFSEL---NFLSSL-SNCKSLTVIGLSNN 94
            N   ++     L  L +    +  + L N 
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 18/78 (23%), Positives = 29/78 (37%), Gaps = 7/78 (8%)

Query: 32  NVSTLKLLGLQDNSLSG-SLSSITDV--RLPNLEELVLWGNNFSE---LNFLSSL-SNCK 84
             S L++L L D  +S  S SS+        +L EL L  N   +   L  + S+     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 85  SLTVIGLSNNPLDGILPK 102
            L  + L +      +  
Sbjct: 427 LLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 13/111 (11%)

Query: 115 FQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG----SILITLSKLQKLQGLVLDDNKL 170
            ++ +  V           + L  + L    ++     S+  TL     L+ L L +N L
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409

Query: 171 EGSIPDDICRLVE-----LYKLELGGNKLSRSIPACFNNLIA----LRILS 212
             +    +   V      L +L L     S  +      L      LR++S
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 12/51 (23%), Positives = 22/51 (43%), Gaps = 4/51 (7%)

Query: 271 FGNLISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNLSFNKLEGEIPR 317
                 L+ L L++ ++S     ++ A+L     L +L+LS N L      
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 3e-06
 Identities = 26/106 (24%), Positives = 37/106 (34%), Gaps = 7/106 (6%)

Query: 187 LELGGNKLSRSIPACFNNLIALRILSLGSN--DPLPLEIGNLKVLVGIDFSMNNFSGIIP 244
           L L    L+  +      L+ +  L L  N    LP  +  L+ L  +  S N    +  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 245 KEIGGLKNLEYLFLGYNRLQGL-IPDSFGNLISLKFLNLSNNNLSG 289
                   L+ L L  NRLQ         +   L  LNL  N+L  
Sbjct: 61  VANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 9e-06
 Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 4/99 (4%)

Query: 1   EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPN 60
            +   +  L  +  LDL  N+L    P     ++ L+ L +   S +   +      LP 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVANLPR 66

Query: 61  LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGI 99
           L+EL+L  N   +   +  L +C  L ++ L  N L   
Sbjct: 67  LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 2e-05
 Identities = 33/108 (30%), Positives = 45/108 (41%), Gaps = 5/108 (4%)

Query: 209 RILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI 267
           R+L L   D  +   +  L ++  +D S N    + P  +  L+ LE L    N L+ + 
Sbjct: 1   RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV- 58

Query: 268 PDSFGNLISLKFLNLSNNNL-SGAIPASLEKLSYLEDLNLSFNKLEGE 314
            D   NL  L+ L L NN L   A    L     L  LNL  N L  E
Sbjct: 59  -DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 1e-04
 Identities = 28/122 (22%), Positives = 44/122 (36%), Gaps = 10/122 (8%)

Query: 64  LVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT 123
           L L   + + L     L     +T + LS+N L  + P      L+       +   +  
Sbjct: 3   LHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNA 54

Query: 124 GDIPEEIGNLTNLITIDLGGNKLNGSILI-TLSKLQKLQGLVLDDNKLEGSIPDDICRLV 182
            +  + + NL  L  + L  N+L  S  I  L    +L  L L  N L         RL 
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113

Query: 183 EL 184
           E+
Sbjct: 114 EM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 2e-04
 Identities = 21/131 (16%), Positives = 44/131 (33%), Gaps = 16/131 (12%)

Query: 37  KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSE-LNFLSSLSNCKSLTVIGLSNNP 95
           ++L L    L+  L  +   +L  +  L L  N        L++L   + L     +   
Sbjct: 1   RVLHLAHKDLT-VLCHLE--QLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 57

Query: 96  LDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG------S 149
           +DG+     +  L         +N        + + +   L+ ++L GN L         
Sbjct: 58  VDGVANLPRLQELLLC------NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111

Query: 150 ILITLSKLQKL 160
           +   L  +  +
Sbjct: 112 LAEMLPSVSSI 122

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 9e-06
 Identities = 45/310 (14%), Positives = 88/310 (28%), Gaps = 33/310 (10%)

Query: 36  LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSEL---NFLSSLSNCKSLTVIGLS 92
           LKL  +         + + +    +++E+VL GN            ++++ K L +   S
Sbjct: 10  LKLDAITTEDEKSVFAVLLE--DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 93  NNPLDGILPKT--------SIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGN 144
           +     +  +                 L   ++ +        E + +  +  T      
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 145 KLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNN 204
             N  +              L  NK   + P     +    +LE G  K           
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 205 LIALRI---------LSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY 255
           L  +++         +     + L        + +  +   +  S  +   +    NL  
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 256 LFLGYNRLQGLIPD------SFGNLISLKFLNLSNNNLSGAIPASL-----EKLSYLEDL 304
           L L    L            S    I L+ L L  N +      +L     EK+  L  L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307

Query: 305 NLSFNKLEGE 314
            L+ N+   E
Sbjct: 308 ELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 37/314 (11%), Positives = 87/314 (27%), Gaps = 13/314 (4%)

Query: 1   EIPLEIGNLQNLEELDLRQNKL----IGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDV 56
            +   +    +++E+ L  N +       +   I +   L++    D      +      
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-RVKDEIPE 80

Query: 57  RLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ 116
            L  L + +L       +    +     +   +    +    +       N        +
Sbjct: 81  ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK 140

Query: 117 MHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPD 176
           +        + ++  N   L +I  G N+L    +   +K  +   L+     ++  I  
Sbjct: 141 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200

Query: 177 DICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM 236
           +    + L  L          +       +    L++       L    L   +      
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260

Query: 237 NNFSGIIPKEIGGLKNLEYLFLGYNRLQG-----LIPDSFGNLISLKFLNLSNNNLSGAI 291
                   K       L+ L L YN ++      L       +  L FL L+ N  S   
Sbjct: 261 AAVVDAFSK--LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-E 317

Query: 292 PASLEKLSYLEDLN 305
              ++++  +    
Sbjct: 318 DDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 12/109 (11%), Positives = 26/109 (23%), Gaps = 5/109 (4%)

Query: 251 KNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG----AIPASLEKLSYLEDLNL 306
           K+L+   +     +  +        S+K + LS N +       +  ++     LE    
Sbjct: 8   KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 307 SFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCKTSIHHPSW 355
           S                   ++      L            T+      
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 115

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 4e-05
 Identities = 35/259 (13%), Positives = 79/259 (30%), Gaps = 15/259 (5%)

Query: 46  LSG-SLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTS 104
           L+G +L      RL +   +            L+   +   +  + LSN+ ++       
Sbjct: 7   LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66

Query: 105 IGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLV 164
           +   S  L++  +    ++  I   +   +NL+ ++L G     S     + L     L 
Sbjct: 67  LSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-GFSEFALQTLLSSCSRLD 124

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIG 224
             +        +   +             ++          ++    +L  +D   L   
Sbjct: 125 ELNLSWCFDFTEKHVQ-----------VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173

Query: 225 NLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGY-NRLQGLIPDSFGNLISLKFLNLS 283
              ++               +E   L  L++L L     +        G + +LK L + 
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233

Query: 284 NNNLSGAIPASLEKLSYLE 302
                G +    E L +L+
Sbjct: 234 GIVPDGTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 8e-05
 Identities = 13/87 (14%), Positives = 34/87 (39%), Gaps = 3/87 (3%)

Query: 232 IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSG-A 290
           +D +  N    +   +     +       + +   + + F     ++ ++LSN+ +    
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62

Query: 291 IPASLEKLSYLEDLNLSFNKLEGEIPR 317
           +   L + S L++L+L   +L   I  
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVN 89

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (85), Expect = 0.003
 Identities = 14/119 (11%), Positives = 31/119 (26%), Gaps = 22/119 (18%)

Query: 138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRS 197
           T+DL G  L+  +   L     +       + ++  +  +      +  ++L  + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVI--- 58

Query: 198 IPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYL 256
                                L   +     L  +       S  I   +    NL  L
Sbjct: 59  -----------------EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 4e-05
 Identities = 37/212 (17%), Positives = 79/212 (37%), Gaps = 17/212 (8%)

Query: 93  NNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILI 152
           + P++ I   T    L+  ++   +   NVT  + +   +L  + T+      +    + 
Sbjct: 5   DTPINQIFTDT---ALAEKMKT-VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--ID 56

Query: 153 TLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILS 212
            +  L  L  +   +N+L    P      +    +          +    N        +
Sbjct: 57  GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 116

Query: 213 LGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFG 272
             ++      + NL  L     ++++ S +         +L+ L    N++  L P    
Sbjct: 117 QITDIDPLKNLTNLNRLELSSNTISDISALSGL-----TSLQQLNFSSNQVTDLKP--LA 169

Query: 273 NLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
           NL +L+ L++S+N +S    + L KL+ LE L
Sbjct: 170 NLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 42.5 bits (98), Expect = 4e-05
 Identities = 41/148 (27%), Positives = 59/148 (39%), Gaps = 6/148 (4%)

Query: 196 RSIPACFNNLIALRILSLGSN----DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLK 251
           + IP           L L  N           G L  LV ++   N  +GI P    G  
Sbjct: 21  KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78

Query: 252 NLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
           +++ L LG N+++ +    F  L  LK LNL +N +S  +P S E L+ L  LNL+ N  
Sbjct: 79  HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

Query: 312 EGEIPRGGSFGNFSAESFEGNELLCGSP 339
                          +S  G    CG+P
Sbjct: 139 NCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 2e-04
 Identities = 7/42 (16%), Positives = 17/42 (40%), Gaps = 1/42 (2%)

Query: 270 SFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKL 311
            + N +  + L+L    +   I      L   + ++ S N++
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 2e-04
 Identities = 26/154 (16%), Positives = 54/154 (35%), Gaps = 7/154 (4%)

Query: 165 LDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDP--LPLE 222
           L   ++E  +   + +  +  +  L    L               +L+  S+    L + 
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRII 60

Query: 223 IGNLKVLVGIDFSMNNFSGI--IPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFL 280
             N+  L+ ++ S N    +  +   +    NL+ L L  N L+          + L+ L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 281 NLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGE 314
            L  N+LS         +S + +      +L+G 
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 3e-04
 Identities = 26/132 (19%), Positives = 45/132 (34%), Gaps = 5/132 (3%)

Query: 188 ELGGNKLSRSIPACFNNLIALRILSLG-SNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKE 246
           EL   ++ + +    +        +L         ++    + V ++   ++ +  +   
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRII 60

Query: 247 IGGLKNLEYLFLGYNRLQGL--IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDL 304
              +  L  L L  NRL  L  +        +LK LNLS N L         K   LE+L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 305 NLSFNKLEGEIP 316
            L  N L     
Sbjct: 121 WLDGNSLSDTFR 132

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 5e-04
 Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 2/109 (1%)

Query: 229 LVGIDFSMNNFSGIIPKEIGGLKNLEYLFL-GYNRLQGLIPDSFGNLISLKFLNLSNNNL 287
             G+  + +         + G +NL  L++     LQ L       L  L+ L +  + L
Sbjct: 10  SSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 288 SGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 336
               P +      L  LNLSFN LE    +     +       GN L C
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	585
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.98
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.98
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.98
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.98
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.86
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.8
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.72
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.67
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.63
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.62
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.56
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.47
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.53
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.9
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.73
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.68
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.39
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.18
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.16
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.73

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-38  Score=303.43  Aligned_cols=169  Identities=24%  Similarity=0.359  Sum_probs=148.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999875 78999999997543 2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||+||+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999997654 7899999999999999999999   899999999999999999999999999999976544333


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.||||
T Consensus       160 ~~~~~~~GT~~Y~AP  174 (271)
T d1nvra_         160 RLLNKMCGTLPYVAP  174 (271)
T ss_dssp             CCBCCCCSCGGGSCT
T ss_pred             ccccceeeCcCccCH
Confidence            344567899999999

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-36  Score=296.63  Aligned_cols=165  Identities=30%  Similarity=0.407  Sum_probs=149.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999865 79999999998765556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +||+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988764  5899999999999999999999   8999999999999999999999999999998764322  23


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ....+||+.||||
T Consensus       173 ~~~~~gt~~Y~aP  185 (293)
T d1yhwa1         173 RSTMVGTPYWMAP  185 (293)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             ccccccCCCccCh
Confidence            3556899999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-37  Score=298.57  Aligned_cols=167  Identities=26%  Similarity=0.382  Sum_probs=150.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      +.|++.+.||+|+||+||+|++. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999876 78999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCccc
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMT  572 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  572 (585)
                      +||+|.+++.+....+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776667999999999999999999999   899999999999999999999999999999864321  122


Q ss_pred             cccccccccccCC
Q 047705          573 QTQTLATIGYMAP  585 (585)
Q Consensus       573 ~~~~~gt~~y~aP  585 (585)
                      ....+||+.||||
T Consensus       167 ~~~~~Gt~~y~AP  179 (288)
T d2jfla1         167 RDSFIGTPYWMAP  179 (288)
T ss_dssp             HTCCCSCCTTCCH
T ss_pred             ccccccccccCCH
Confidence            3457899999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=295.90  Aligned_cols=168  Identities=29%  Similarity=0.437  Sum_probs=145.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999875 78999999997542   234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |||+||+|.+++...+ .+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999988764 6899999999999999999999   99999999999999999999999999999997654333


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                      .......+||+.||||
T Consensus       164 ~~~~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         164 QARANSFVGTAQYVSP  179 (288)
T ss_dssp             ------CCCCGGGCCH
T ss_pred             ccccccccCCccccCc
Confidence            3334567899999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-36  Score=289.85  Aligned_cols=164  Identities=29%  Similarity=0.449  Sum_probs=146.6

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56999999999999999999876 68999999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |||++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999998654 6899999999999999999999   899999999999999999999999999999865322  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        .....+||+.||||
T Consensus       160 --~~~~~~Gt~~Y~AP  173 (263)
T d2j4za1         160 --RRTTLCGTLDYLPP  173 (263)
T ss_dssp             --CCEETTEEGGGCCH
T ss_pred             --cccccCCCCcccCH
Confidence              23456899999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-36  Score=293.41  Aligned_cols=167  Identities=27%  Similarity=0.479  Sum_probs=140.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999864  36999998644  34456789999999999999999999998754 56799999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||++|+|.+++...+..+++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877768999999999999999999999   899999999999999999999999999999876443333


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.||||
T Consensus       161 ~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         161 HQFEQLSGSILWMAP  175 (276)
T ss_dssp             -----CCCCGGGCCH
T ss_pred             ccccccccCcccCCH
Confidence            344567899999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-36  Score=299.53  Aligned_cols=165  Identities=24%  Similarity=0.363  Sum_probs=145.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++.. .......+.+|++++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999875 7899999999754 23345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCS-TPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+||+|.+++.+.. .+++..+..++.|++.||+|||   + ++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999998654 6899999999999999999999   6 48999999999999999999999999999976421  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        .....+||++||||
T Consensus       159 --~~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         159 --MANSFVGTRSYMSP  172 (322)
T ss_dssp             --TC---CCSSCCCCH
T ss_pred             --ccccccCCccccCc
Confidence              22456899999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-35  Score=295.40  Aligned_cols=167  Identities=22%  Similarity=0.339  Sum_probs=149.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            358999999999999999999875 7899999999876656667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+||+|.+++.+....+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   99999999999999996  46899999999998764322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.||||
T Consensus       181 --~~~~~~gT~~Y~aP  194 (350)
T d1koaa2         181 --SVKVTTGTAEFAAP  194 (350)
T ss_dssp             --CEEEECSCTTTCCH
T ss_pred             --ccceecCcccccCH
Confidence              23456899999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-35  Score=293.53  Aligned_cols=167  Identities=28%  Similarity=0.382  Sum_probs=149.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      .++|++++.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|++++++++||||++++++|.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467999999999999999999875 79999999998642   23457788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||||+||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999998765 6899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                        ......+||+.||||
T Consensus       160 --~~~~~~~GT~~Y~aP  174 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAP  174 (337)
T ss_dssp             --CCBCCCEECGGGCCG
T ss_pred             --cccccceeCHHHhhh
Confidence              234567899999999

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-36  Score=292.67  Aligned_cols=170  Identities=26%  Similarity=0.457  Sum_probs=148.6

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ...++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||+++++|.+++..|+||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34467899999999999999999876 68899999987543 34577999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYST-NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++|+|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999999764 347899999999999999999999   8999999999999999999999999999999764332


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       ........||+.||||
T Consensus       170 -~~~~~~~~g~~~y~aP  185 (287)
T d1opja_         170 -YTAHAGAKFPIKWTAP  185 (287)
T ss_dssp             -SEEETTEEECGGGCCH
T ss_pred             -ceeeccccccccccCh
Confidence             2333456789999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=286.60  Aligned_cols=167  Identities=26%  Similarity=0.416  Sum_probs=139.4

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++||||+++++++..++..|+|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5789999999999999999999888899999987543 344679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +|+|.+++......+++..+..++.||++||+|+|   +++|+||||||+|||+++++.+||+|||+|+...... ....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC-ceee
Confidence            99999999887778899999999999999999999   8999999999999999999999999999998764332 2223


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.||||
T Consensus       160 ~~~~gt~~y~aP  171 (263)
T d1sm2a_         160 TGTKFPVKWASP  171 (263)
T ss_dssp             -----CTTSCCH
T ss_pred             cceecCcccCCh
Confidence            456799999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-35  Score=293.92  Aligned_cols=167  Identities=23%  Similarity=0.354  Sum_probs=149.9

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||+++++|.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999875 7999999999876555567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC--CCCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD--DNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+||+|.+++......+++.+++.++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988877667999999999999999999999   99999999999999997  67899999999998764322 


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        ......||+.||||
T Consensus       184 --~~~~~~gt~~y~aP  197 (352)
T d1koba_         184 --IVKVTTATAEFAAP  197 (352)
T ss_dssp             --CEEEECSSGGGCCH
T ss_pred             --ceeeccCcccccCH
Confidence              23456799999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=287.36  Aligned_cols=171  Identities=26%  Similarity=0.378  Sum_probs=132.8

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--CCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  487 (585)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++..  .....+.+.+|++++++++|||||++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999875 7899999998754  23445678899999999999999999999865  456899


Q ss_pred             EEEccCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC--CCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          488 VLEYMPQGSLEKHLYST---NCILDIFQRLNIMIDVASALEYLHFG--CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      |||||++|+|.+++.+.   ...+++..++.++.|++.||+|||+.  ...+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642   34789999999999999999999921  01349999999999999999999999999999


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+....  ......+||+.||||
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~AP  183 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSP  183 (269)
T ss_dssp             HC-------------CCCSCCCH
T ss_pred             ecccCC--CccccCCCCcccCCH
Confidence            764322  223457899999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-35  Score=289.06  Aligned_cols=161  Identities=29%  Similarity=0.375  Sum_probs=143.1

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .|+..+.||+|+||+||+|++. +++.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4899999999999999999875 78899999997542   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ||++|++..++... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            99999987766554 47899999999999999999999   89999999999999999999999999999986432    


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                        ....+||+.||||
T Consensus       168 --~~~~~GT~~Y~AP  180 (309)
T d1u5ra_         168 --ANSFVGTPYWMAP  180 (309)
T ss_dssp             --BCCCCSCGGGCCH
T ss_pred             --CCccccCccccCH
Confidence              2346799999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-34  Score=287.72  Aligned_cols=163  Identities=28%  Similarity=0.380  Sum_probs=146.3

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++...   ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56999999999999999999975 79999999997542   234577889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |||+||++..++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+....   
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence            9999999999888765 6788888999999999999999   99999999999999999999999999999987532   


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                        .....+||+.||||
T Consensus       157 --~~~~~~Gt~~Y~AP  170 (316)
T d1fota_         157 --VTYTLCGTPDYIAP  170 (316)
T ss_dssp             --CBCCCCSCTTTCCH
T ss_pred             --ccccccCcccccCH
Confidence              22456899999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-34  Score=279.41  Aligned_cols=161  Identities=27%  Similarity=0.390  Sum_probs=139.1

Q ss_pred             CccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec----CCeEEEEE
Q 047705          417 SENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKGLVL  489 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  489 (585)
                      ++.+.||+|+||+||+|++. +++.||+|++...  .....+.+.+|++++++++|||||+++++|..    ++..|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999876 6889999998754  23455778999999999999999999999864    35689999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--cEEcCCCCCCEEeC-CCCcEEEeeecccccccC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTP--VIHCDLKPSNVLLD-DNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~  566 (585)
                      |||++|+|.+++.+.. .+++..++.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998754 6899999999999999999999   777  99999999999996 578999999999986422


Q ss_pred             CCCccccccccccccccCC
Q 047705          567 EDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~~~~~~~gt~~y~aP  585 (585)
                          ......+||+.||||
T Consensus       168 ----~~~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAP  182 (270)
T ss_dssp             ----TSBEESCSSCCCCCG
T ss_pred             ----CccCCcccCccccCH
Confidence                123456899999999

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-35  Score=289.11  Aligned_cols=169  Identities=25%  Similarity=0.447  Sum_probs=134.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CC---cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DG---MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||+||+|+++ ++   ..||||.+... .....+.|.+|++++++++|||||++++++..++..|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            46778899999999999999875 33   25888887654 344567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||||++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887778999999999999999999999   8999999999999999999999999999998765332


Q ss_pred             Ccc---ccccccccccccCC
Q 047705          569 QSM---TQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~---~~~~~~gt~~y~aP  585 (585)
                      ...   ......||+.||||
T Consensus       183 ~~~~~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAP  202 (299)
T ss_dssp             -------------CGGGSCH
T ss_pred             CcceeeecccccCCccccCH
Confidence            221   12334689999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-35  Score=284.63  Aligned_cols=167  Identities=25%  Similarity=0.445  Sum_probs=144.8

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++|||||++++++.. +..|+|||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788999999999999999999888999999997543 345679999999999999999999998755 5678999999


Q ss_pred             CCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTNC-ILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++|+|.+++..... .+++..+..++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+..... ...
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            99999998765432 5899999999999999999999   899999999999999999999999999999976432 223


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.||||
T Consensus       166 ~~~~~~gt~~y~AP  179 (272)
T d1qpca_         166 AREGAKFPIKWTAP  179 (272)
T ss_dssp             CCTTCCCCTTTSCH
T ss_pred             cccccCCcccccCh
Confidence            33456799999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-35  Score=287.68  Aligned_cols=166  Identities=23%  Similarity=0.375  Sum_probs=130.6

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      .+.|++.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999876 68999999997543 2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeecccccccCC
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||+||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997654 7899999999999999999999   99999999999999994   5789999999999865322


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                         ......+||+.||||
T Consensus       164 ---~~~~~~~GT~~y~AP  178 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAP  178 (307)
T ss_dssp             ------------CTTSCH
T ss_pred             ---CeeeeeeeCccccCc
Confidence               123456899999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-34  Score=276.71  Aligned_cols=167  Identities=24%  Similarity=0.420  Sum_probs=149.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMP  493 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  493 (585)
                      ++|++.+.||+|+||+||+|++++++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999998888999999986533 34679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcccc
Q 047705          494 QGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQ  573 (585)
Q Consensus       494 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  573 (585)
                      +|++.+++......+++..+.+++.|+++||+|||   +++|+||||||+||++++++.+||+|||+|+...... ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence            99999998877668899999999999999999999   8999999999999999999999999999998764332 2333


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.||||
T Consensus       159 ~~~~~t~~y~aP  170 (258)
T d1k2pa_         159 VGSKFPVRWSPP  170 (258)
T ss_dssp             CCSCCCGGGCCH
T ss_pred             cccCCCCCcCCc
Confidence            456799999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.8e-34  Score=276.31  Aligned_cols=165  Identities=27%  Similarity=0.393  Sum_probs=146.7

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---------hhhHHHHHHHHHHHHhcC-CCcceeEEeeeecC
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---------RRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE  482 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  482 (585)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++...         +...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999875 78999999987542         123456888999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccc
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAK  562 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~  562 (585)
                      +..|+|||||+||+|.+++.... .+++.+++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998754 7899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+...   ......+||+.|+||
T Consensus       159 ~~~~~---~~~~~~~gt~~y~~P  178 (277)
T d1phka_         159 QLDPG---EKLREVCGTPSYLAP  178 (277)
T ss_dssp             ECCTT---CCBCCCCSCGGGCCH
T ss_pred             EccCC---CceeeeeccCCCCCH
Confidence            76432   223456899999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-34  Score=279.28  Aligned_cols=165  Identities=27%  Similarity=0.368  Sum_probs=145.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh------hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC------RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++...      ....+.+.+|++++++++|||||+++++|.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            67999999999999999999975 78999999997542      123577899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC----cEEEeeecccc
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM----IAYLSDFGIAK  562 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~a~  562 (585)
                      +|||||+||+|.+++...+ .+++..++.++.|++.||+|||   +++|+||||||+||+++.++    .+|++|||+|+
T Consensus        90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            9999999999999998754 6899999999999999999999   99999999999999998766    59999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....   .......||+.||||
T Consensus       166 ~~~~~---~~~~~~~~t~~y~AP  185 (293)
T d1jksa_         166 KIDFG---NEFKNIFGTPEFVAP  185 (293)
T ss_dssp             ECTTS---CBCSCCCCCGGGCCH
T ss_pred             hcCCC---ccccccCCCCcccCH
Confidence            76422   223456799999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-34  Score=278.11  Aligned_cols=168  Identities=26%  Similarity=0.422  Sum_probs=143.3

Q ss_pred             CCCCccce-ecccCceEEEEEEeC---CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNL-IGRGGFGSVYKARLG---DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++.. .....+.|.+|++++++++|||||++++++.. +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666674 999999999999764   3557999999754 33456789999999999999999999999875 457899


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||||++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877668999999999999999999999   8999999999999999999999999999999765433


Q ss_pred             Cc-cccccccccccccCC
Q 047705          569 QS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~-~~~~~~~gt~~y~aP  585 (585)
                      .. .......||+.||||
T Consensus       164 ~~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             CEECCCCSSCCCGGGCCH
T ss_pred             cccccccccccCccccCh
Confidence            22 223455789999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-34  Score=286.14  Aligned_cols=163  Identities=27%  Similarity=0.367  Sum_probs=146.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++|++++.||+|+||.||+|+++ +|+.||||+++...   ....+.+.+|+++++.++|||||++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999875 79999999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      ||+.||++.+++...+ .+++..++.++.||+.||.|||   +++||||||||+|||++.+|.+||+|||+|+.+.+.  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999998765 6899999999999999999999   999999999999999999999999999999976422  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                         ....+||+.||||
T Consensus       195 ---~~~~~Gt~~Y~AP  207 (350)
T d1rdqe_         195 ---TWTLCGTPEALAP  207 (350)
T ss_dssp             ---BCCCEECGGGCCH
T ss_pred             ---cccccCccccCCH
Confidence               2346899999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-34  Score=285.05  Aligned_cols=170  Identities=24%  Similarity=0.426  Sum_probs=143.6

Q ss_pred             cCCCCccceecccCceEEEEEEeCC-C-----cEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD-G-----MEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.+++++ +|||||++++++...+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999998642 2     36999988643 333456788999999998 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN----------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKP  542 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp  542 (585)
                      .|+|||||++|+|.+++....                      ..+++..++.++.||++||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997653                      24788899999999999999999   89999999999


Q ss_pred             CCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          543 SNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       543 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +||+++.++.+||+|||+|+...............||+.||||
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            9999999999999999999876554444444566789999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-34  Score=278.12  Aligned_cols=169  Identities=27%  Similarity=0.486  Sum_probs=138.9

Q ss_pred             CCCCccceecccCceEEEEEEeCC-C----cEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGD-G----MEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      +.|+..+.||+|+||.||+|.++. +    ..||||+++.. .......|.+|++++++++|||||++++++...+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            568889999999999999998653 2    46999998754 33345678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      |||||.++++.+++......+++.++..++.||+.|++|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998887778999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CC-ccccccccccccccCC
Q 047705          568 DQ-SMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~-~~~~~~~~gt~~y~aP  585 (585)
                      .. ........||+.||||
T Consensus       164 ~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             ----------CCCGGGSCH
T ss_pred             CccceEeccCCCCccccCH
Confidence            22 2233455789999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=280.12  Aligned_cols=166  Identities=20%  Similarity=0.305  Sum_probs=146.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||+||+|.+. +++.||||+++.... ....+.+|+++|+.++||||++++++|.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999876 788999999976532 345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC--CCcEEEeeecccccccCCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD--NMIAYLSDFGIAKLLIGEDQ  569 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~  569 (585)
                      |+||+|.+++......+++.+++.++.||+.||+|||   +++|+||||||+|||++.  .+.+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999877667999999999999999999999   999999999999999984  458999999999875322  


Q ss_pred             ccccccccccccccCC
Q 047705          570 SMTQTQTLATIGYMAP  585 (585)
Q Consensus       570 ~~~~~~~~gt~~y~aP  585 (585)
                       .......||+.||||
T Consensus       158 -~~~~~~~~t~~y~ap  172 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAP  172 (321)
T ss_dssp             -CEEEEEESCGGGSCH
T ss_pred             -Ccccccccccccccc
Confidence             223456799999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-33  Score=284.94  Aligned_cols=165  Identities=26%  Similarity=0.393  Sum_probs=142.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHH---HHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFD---VECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ......+.   .|+++++.++|||||+++++|..++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999876 79999999997542   11222333   346677788899999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLI  565 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~  565 (585)
                      |+|||||+||+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999998764 6889999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC
Q 047705          566 GEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       566 ~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..    .....+||+.||||
T Consensus       159 ~~----~~~~~~GT~~y~AP  174 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAP  174 (364)
T ss_dssp             SS----CCCSCCSCGGGCCH
T ss_pred             CC----cccccccccccchh
Confidence            22    22456899999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-33  Score=277.36  Aligned_cols=166  Identities=25%  Similarity=0.389  Sum_probs=145.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHH-hcCCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMK-SIRHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999876 78999999997542   234456677777765 68999999999999999999999


Q ss_pred             EEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCC
Q 047705          489 LEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      ||||++|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+..... 
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999998754 6899999999999999999999   899999999999999999999999999999865432 


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                       .......+||+.||||
T Consensus       157 -~~~~~~~~gt~~y~aP  172 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAP  172 (320)
T ss_dssp             -TCCBCCCCSCGGGCCH
T ss_pred             -cccccccCCCCCcCCH
Confidence             2233456899999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-33  Score=273.21  Aligned_cols=161  Identities=27%  Similarity=0.388  Sum_probs=134.7

Q ss_pred             ceecccCceEEEEEEeC---CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEccCC
Q 047705          420 NLIGRGGFGSVYKARLG---DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYMPQ  494 (585)
Q Consensus       420 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  494 (585)
                      +.||+|+||+||+|.++   .++.||||+++..  .....+.+.+|++++++++|||||++++++..+ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999754   3568999998643  233457899999999999999999999999654 56899999999


Q ss_pred             CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc-ccc
Q 047705          495 GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS-MTQ  573 (585)
Q Consensus       495 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~  573 (585)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998764 6899999999999999999999   899999999999999999999999999999876533322 223


Q ss_pred             ccccccccccCC
Q 047705          574 TQTLATIGYMAP  585 (585)
Q Consensus       574 ~~~~gt~~y~aP  585 (585)
                      ....||+.||||
T Consensus       168 ~~~~gt~~y~AP  179 (277)
T d1xbba_         168 THGKWPVKWYAP  179 (277)
T ss_dssp             ---CCCGGGCCH
T ss_pred             cccCCCceecCc
Confidence            456799999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=275.71  Aligned_cols=167  Identities=26%  Similarity=0.464  Sum_probs=138.7

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEcc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEYM  492 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  492 (585)
                      .++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++.. +..|+|||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            36799999999999999999999888899999987543 345779999999999999999999999854 5678999999


Q ss_pred             CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          493 PQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       493 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++|++..++.... ..+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999998887542 36899999999999999999999   8999999999999999999999999999998754322 22


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......||+.||||
T Consensus       170 ~~~~~~gt~~y~aP  183 (285)
T d1fmka3         170 ARQGAKFPIKWTAP  183 (285)
T ss_dssp             ------CCGGGSCH
T ss_pred             eeccccccccccCh
Confidence            33456799999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-33  Score=275.91  Aligned_cols=167  Identities=29%  Similarity=0.382  Sum_probs=141.5

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      |+|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||+++++|.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999875 78999999996542  2335688899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      |+.++.+..........+++..+..++.||+.||+|||   +++||||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99664444333444457899999999999999999999   9999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      ......+||+.|+||
T Consensus       157 ~~~~~~~gt~~y~ap  171 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAP  171 (298)
T ss_dssp             BCTTCCBCCCTTCCH
T ss_pred             ccceeecccceeeeh
Confidence            233456899999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=3.9e-33  Score=275.26  Aligned_cols=175  Identities=27%  Similarity=0.438  Sum_probs=148.3

Q ss_pred             HHHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeee
Q 047705          408 ELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCS  480 (585)
Q Consensus       408 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  480 (585)
                      ++....++|++.+.||+|+||+||+|+++      +++.||||+++... ....+++.+|++++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            33445678999999999999999999853      35789999987543 334578999999999999999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEE
Q 047705          481 NEEFKGLVLEYMPQGSLEKHLYSTN-----------------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIH  537 (585)
Q Consensus       481 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH  537 (585)
                      ..+..+++|||+++|+|.+++....                       ..+++..+..++.|++.||+|||   +++|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999999986532                       24788899999999999999999   999999


Q ss_pred             cCCCCCCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          538 CDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       538 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||||+|||++.++.+||+|||+|+...+...........||+.||||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            999999999999999999999999876544434444567799999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.2e-33  Score=275.80  Aligned_cols=168  Identities=27%  Similarity=0.407  Sum_probs=138.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc----EEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM----EVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      ++|++.+.||+|+||+||+|++. +|+    +||+|.++.. .....+.+.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999865 444    5888887643 334567899999999999999999999999865 5678


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      +|||+.+|+|.+++......+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            88999999999999888778999999999999999999999   899999999999999999999999999999987544


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      ..........||+.||||
T Consensus       165 ~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             CC--------CCTTTSCH
T ss_pred             cccccccccccCccccCh
Confidence            444444556799999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.98  E-value=7.5e-33  Score=270.08  Aligned_cols=169  Identities=23%  Similarity=0.402  Sum_probs=138.0

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh---hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----e
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC---RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----F  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  484 (585)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999875 79999999997542   334567899999999999999999999987643    4


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+|||||+|++|.+++...+ .+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.++++|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            799999999999999887764 6899999999999999999999   999999999999999999999999999998765


Q ss_pred             cCCC-CccccccccccccccCC
Q 047705          565 IGED-QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~-~~~~~~~~~gt~~y~aP  585 (585)
                      .... ........+||+.||||
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             C----------------TTCCH
T ss_pred             ccccccccccccccCcccccCH
Confidence            4322 22234567899999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.3e-33  Score=273.40  Aligned_cols=162  Identities=30%  Similarity=0.419  Sum_probs=135.7

Q ss_pred             ccceecccCceEEEEEEeC-CCcEEEEEEEechhh-----hhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          418 ENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       418 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      .++.||+|+||+||+|+++ +|+.||||+++....     ...+.+.+|++++++++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999975 689999999865422     1235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      ++++++..+.. ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence            98876665554 3447888999999999999999999   9999999999999999999999999999998654322  2


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      .....+||+.||||
T Consensus       156 ~~~~~~gt~~y~aP  169 (299)
T d1ua2a_         156 AYTHQVVTRWYRAP  169 (299)
T ss_dssp             CCCCSCCCCTTCCH
T ss_pred             cccceecChhhccH
Confidence            23456899999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-32  Score=273.32  Aligned_cols=162  Identities=25%  Similarity=0.346  Sum_probs=138.1

Q ss_pred             cCCCCccc-eecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhc-CCCcceeEEeeeec----CCeE
Q 047705          413 TDGFSENN-LIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSI-RHRNLIKVISSCSN----EEFK  485 (585)
Q Consensus       413 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  485 (585)
                      .++|++.. .||+|+||+||+|++. +++.||||+++..     ..+.+|++++.++ +|||||+++++|.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46798865 6999999999999875 7899999998643     4566799987655 89999999999865    4678


Q ss_pred             EEEEEccCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC---CCcEEEeeeccc
Q 047705          486 GLVLEYMPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD---NMIAYLSDFGIA  561 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~a  561 (585)
                      |+|||||+||+|.+++.+.. ..+++.+++.++.||+.||+|||   +++|+||||||+|||+++   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998653 36899999999999999999999   999999999999999974   567999999999


Q ss_pred             ccccCCCCccccccccccccccCC
Q 047705          562 KLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +......   .....+||+.||||
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aP  182 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAP  182 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCC
T ss_pred             eeccCCC---ccccccCCcccCCc
Confidence            8764322   23456899999999

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=267.90  Aligned_cols=168  Identities=24%  Similarity=0.370  Sum_probs=133.2

Q ss_pred             cCCCCccceecccCceEEEEEEeCC----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  487 (585)
                      .++|++.+.||+|+||.||+|++..    +..||||.++.. .....+.+.+|++++++++||||+++++++. ++..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3679999999999999999998642    346888887643 3344577999999999999999999999986 467899


Q ss_pred             EEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCC
Q 047705          488 VLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGE  567 (585)
Q Consensus       488 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  567 (585)
                      ||||+++|++.+++......+++..++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999875432


Q ss_pred             CCccccccccccccccCC
Q 047705          568 DQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       568 ~~~~~~~~~~gt~~y~aP  585 (585)
                      . ........||+.||||
T Consensus       162 ~-~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAP  178 (273)
T ss_dssp             ----------CCGGGCCH
T ss_pred             c-ceeccceecCcccchh
Confidence            2 2233456789999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.4e-31  Score=266.34  Aligned_cols=260  Identities=33%  Similarity=0.571  Sum_probs=183.4

Q ss_pred             CccEEEccCCCCCCC-ccCccccCCCCCcEEEccC-CCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCcc
Q 047705           60 NLEELVLWGNNFSEL-NFLSSLSNCKSLTVIGLSN-NPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLI  137 (585)
Q Consensus        60 ~L~~L~L~~n~l~~~-~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  137 (585)
                      .+++|+|++|.++.. +.+..+.++++|++|+|++ |++.+.+|. .++++++ |++|+|++|++.+..+..+..++.|+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~-~i~~L~~-L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP-AIAKLTQ-LHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCG-GGGGCTT-CSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccc-ccccccc-cchhhhccccccccccccccchhhhc
Confidence            466666666666532 1114556666666666654 555555554 4555554 66666666666655555555566666


Q ss_pred             EEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCC-cEEEcCCCcccccCcccccCcccchhhcCCCC
Q 047705          138 TIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVEL-YKLELGGNKLSRSIPACFNNLIALRILSLGSN  216 (585)
Q Consensus       138 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n  216 (585)
                      .+++++|.+.+..|..|.+++.|+.+++++|.+++.+|+.+..+.++ +.+++++|++++..|..               
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~---------------  193 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT---------------  193 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG---------------
T ss_pred             ccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccc---------------
Confidence            66666666555555555666666666666666655555555555543 55555556555544443               


Q ss_pred             CCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhc
Q 047705          217 DPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLE  296 (585)
Q Consensus       217 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  296 (585)
                            +..+. ...+++++|...+..|..+..+++|+.+++++|.+++.+| .+..+++|+.|+|++|++++.+|..+.
T Consensus       194 ------~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~  265 (313)
T d1ogqa_         194 ------FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT  265 (313)
T ss_dssp             ------GGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred             ------ccccc-cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHh
Confidence                  33333 3368888999998999999999999999999999987654 588889999999999999999999999


Q ss_pred             cCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCCCCCCCCC
Q 047705          297 KLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLQVPPCK  347 (585)
Q Consensus       297 ~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~  347 (585)
                      .+++|++|||++|.++|.+|....+..++.+++.+|+..|+.|   .|+|.
T Consensus       266 ~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred             CCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---CCCCC
Confidence            9999999999999999999988778899999999999999987   45773

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-32  Score=269.83  Aligned_cols=176  Identities=24%  Similarity=0.388  Sum_probs=137.9

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeC------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEee
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISS  478 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  478 (585)
                      ..+....++|++.+.||+|+||.||+|++.      +++.||||+++.. .....+.+..|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            333344578999999999999999999853      3468999998754 233456777888888877 68899999998


Q ss_pred             eecC-CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCC
Q 047705          479 CSNE-EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKP  542 (585)
Q Consensus       479 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp  542 (585)
                      +..+ +..++|||||++|+|.+++....               ..+++..+..++.||++||+|||   +++|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence            7654 56899999999999999997542               24789999999999999999999   89999999999


Q ss_pred             CCEEeCCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          543 SNVLLDDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       543 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +|||+++++.+||+|||+|+...............||+.||||
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            9999999999999999999876544444444567899999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=2.2e-32  Score=268.17  Aligned_cols=166  Identities=25%  Similarity=0.352  Sum_probs=140.8

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.++++++||||++++++|..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999997542  33357889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCcc
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQSM  571 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  571 (585)
                      +.++.+..+.. ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            97765555544 4457999999999999999999999   8999999999999999999999999999998764322  2


Q ss_pred             ccccccccccccCC
Q 047705          572 TQTQTLATIGYMAP  585 (585)
Q Consensus       572 ~~~~~~gt~~y~aP  585 (585)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~y~~p  169 (286)
T d1ob3a_         156 KYTHEIVTLWYRAP  169 (286)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccceecccchhhhH
Confidence            23455789999997

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-32  Score=265.52  Aligned_cols=164  Identities=25%  Similarity=0.295  Sum_probs=140.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhh------hhHHHHHHHHHHHHhcC--CCcceeEEeeeecCCe
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCR------RAFKSFDVECEIMKSIR--HRNLIKVISSCSNEEF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  484 (585)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++....      ....++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999875 789999999975421      12244678999999996  8999999999999999


Q ss_pred             EEEEEEccCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-CCcEEEeeecccc
Q 047705          485 KGLVLEYMPQ-GSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-NMIAYLSDFGIAK  562 (585)
Q Consensus       485 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~a~  562 (585)
                      .|+||||+.+ +++.+++.... .+++..++.++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 57777776654 6899999999999999999999   999999999999999984 5799999999998


Q ss_pred             cccCCCCccccccccccccccCC
Q 047705          563 LLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       563 ~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .....    .....+||+.||||
T Consensus       160 ~~~~~----~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPP  178 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCH
T ss_pred             ecccc----cccccccCCCcCCH
Confidence            64321    23456899999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.2e-32  Score=267.31  Aligned_cols=170  Identities=25%  Similarity=0.415  Sum_probs=148.5

Q ss_pred             cCCCCccceecccCceEEEEEEe------CCCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCe
Q 047705          413 TDGFSENNLIGRGGFGSVYKARL------GDGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  484 (585)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +|||||++++++..++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46899999999999999999975      246789999997543 33456788999999999 69999999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          485 KGLVLEYMPQGSLEKHLYSTN-----------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      .|+|||||++|+|.+++....                 ..+++..+..++.||++|++|||   +++|+||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 25788999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+|++|||.++...............||+.||||
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            99999999999999977554444555667899999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-32  Score=268.46  Aligned_cols=170  Identities=21%  Similarity=0.391  Sum_probs=147.2

Q ss_pred             cCCCCccceecccCceEEEEEEeC------CCcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG------DGMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK  485 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  485 (585)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|++++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467899999999999999999753      3578999999754 334456789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEe
Q 047705          486 GLVLEYMPQGSLEKHLYSTN---------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLS  556 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~  556 (585)
                      ++|||||++|+|.+++....         ..+++..+..++.|+++||.|||   +++|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432         24688899999999999999999   8999999999999999999999999


Q ss_pred             eecccccccCCCCccccccccccccccCC
Q 047705          557 DFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       557 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |||+|+...............||+.||||
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             ecccceeccCCcceeeccceecccccCCH
Confidence            99999976544444445566799999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=263.98  Aligned_cols=168  Identities=27%  Similarity=0.401  Sum_probs=135.7

Q ss_pred             CCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----eEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  489 (585)
                      .+|.+.+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+..++||||+++++++..++    ..|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            3577888999999999999987 6789999998754322 122334555556789999999999987653    679999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-----CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      |||++|+|.+++++.  .+++..+..++.|++.|+.|+|..     +.++|+||||||+|||+++++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999875  588999999999999999999932     2369999999999999999999999999999977


Q ss_pred             cCCCCcc--ccccccccccccCC
Q 047705          565 IGEDQSM--TQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~--~~~~~~gt~~y~aP  585 (585)
                      .......  .....+||+.||||
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCH
T ss_pred             cCCCcceeccccceecccCcCCh
Confidence            5433221  23456899999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-32  Score=263.63  Aligned_cols=168  Identities=28%  Similarity=0.398  Sum_probs=133.5

Q ss_pred             CCCCccceecccCceEEEEEEeC--CC--cEEEEEEEech---hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG--DG--MEVAVKVFNLQ---CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKG  486 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  486 (585)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||+++..   .....+.|.+|++++++++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56899999999999999999753  23  36899988654   23345789999999999999999999999976 4678


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      +|||||++|++.+++......+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877667999999999999999999999   89999999999999999999999999999997644


Q ss_pred             CCCcc-ccccccccccccCC
Q 047705          567 EDQSM-TQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~~-~~~~~~gt~~y~aP  585 (585)
                      ..... ......||++||||
T Consensus       164 ~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             -CCEEEC-----CCGGGCCH
T ss_pred             CCCcceecCccccCcccCCH
Confidence            33222 23345678899998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=263.91  Aligned_cols=170  Identities=28%  Similarity=0.442  Sum_probs=142.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC--------CCcEEEEEEEechh-hhhHHHHHHHHHHHHhc-CCCcceeEEeeeecC
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG--------DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE  482 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  482 (585)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++... ......+.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            367999999999999999999753        13479999987653 34457788899999888 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEe
Q 047705          483 EFKGLVLEYMPQGSLEKHLYSTN---------------CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLL  547 (585)
Q Consensus       483 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll  547 (585)
                      +..++|||||++|+|.+++....               ..+++.+++.++.||+.||+|||   +++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997553               25799999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeeecccccccCCCCccccccccccccccCC
Q 047705          548 DDNMIAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       548 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      +.++.+||+|||+++...............||+.||||
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            99999999999999977654444445567899999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-31  Score=264.09  Aligned_cols=166  Identities=30%  Similarity=0.529  Sum_probs=138.4

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCc--EEEEEEEech-hhhhHHHHHHHHHHHHhc-CCCcceeEEeeeecCCeEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGM--EVAVKVFNLQ-CRRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKGLV  488 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  488 (585)
                      ++|++.+.||+|+||+||+|+++ ++.  .||||.++.. .....+.+.+|+++++++ +|||||++++++..++..|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57899999999999999999875 444  4778887643 334567899999999998 799999999999999999999


Q ss_pred             EEccCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcE
Q 047705          489 LEYMPQGSLEKHLYST---------------NCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIA  553 (585)
Q Consensus       489 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~  553 (585)
                      |||+++|+|.++++..               ...+++..+..++.||++|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754               246899999999999999999999   8999999999999999999999


Q ss_pred             EEeeecccccccCCCCccccccccccccccCC
Q 047705          554 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       554 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ||+|||+|+.....   .......||+.|+||
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aP  195 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAI  195 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCH
T ss_pred             EEcccccccccccc---ccccceecCCcccch
Confidence            99999999864322   222345689999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-32  Score=260.06  Aligned_cols=162  Identities=31%  Similarity=0.457  Sum_probs=133.0

Q ss_pred             cCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCeEEEEEEc
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKGLVLEY  491 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  491 (585)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++..  ...+.+.+|++++++++||||+++++++.. .+..|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35688899999999999999998 4778999998654  344778999999999999999999998854 4668999999


Q ss_pred             cCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          492 MPQGSLEKHLYSTN-CILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       492 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+|++|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999997643 25899999999999999999999   89999999999999999999999999999986532    


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                       ......+|+.||||
T Consensus       156 -~~~~~~~~~~y~aP  169 (262)
T d1byga_         156 -TQDTGKLPVKWTAP  169 (262)
T ss_dssp             -------CCTTTSCH
T ss_pred             -CCccccccccCCCh
Confidence             12335688999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.8e-31  Score=260.09  Aligned_cols=164  Identities=29%  Similarity=0.456  Sum_probs=140.3

Q ss_pred             cceecccCceEEEEEEeCC----CcEEEEEEEech-hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec-CCeEEEEEEcc
Q 047705          419 NNLIGRGGFGSVYKARLGD----GMEVAVKVFNLQ-CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKGLVLEYM  492 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  492 (585)
                      .++||+|+||+||+|++.+    ...||||+++.. .....++|.+|++++++++||||++++|++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998653    235899998743 44556889999999999999999999999765 56889999999


Q ss_pred             CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc--
Q 047705          493 PQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS--  570 (585)
Q Consensus       493 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  570 (585)
                      ++|+|.+++.......++..+..++.|++.||.|+|   +++|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777888889999999999999999   999999999999999999999999999999876533222  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......||+.|+||
T Consensus       189 ~~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         189 HNKTGAKLPVKWMAL  203 (311)
T ss_dssp             TCTTCSSCCGGGSCH
T ss_pred             eecccccccccccCh
Confidence            223456789999998

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.4e-29  Score=258.94  Aligned_cols=301  Identities=23%  Similarity=0.349  Sum_probs=230.0

Q ss_pred             cCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCC
Q 047705            7 GNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSL   86 (585)
Q Consensus         7 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L   86 (585)
                      +++.+|++|++++|.|+..  +.+..+++|++|+|++|+|++. +.  +..+++|++|++++|+++.++   .+..+++|
T Consensus        41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~~--l~~L~~L~~L~L~~n~i~~i~---~l~~l~~L  112 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-TP--LKNLTKLVDILMNNNQIADIT---PLANLTNL  112 (384)
T ss_dssp             HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCCCG---GGTTCTTC
T ss_pred             HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-cc--ccCCccccccccccccccccc---cccccccc
Confidence            4678999999999999853  5789999999999999999854 33  457999999999999999875   38899999


Q ss_pred             cEEEccCCCCcccCCcchhhcccccccEEEeecCcce-----------------------------------------ec
Q 047705           87 TVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVT-----------------------------------------GD  125 (585)
Q Consensus        87 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-----------------------------------------~~  125 (585)
                      +.|++++|.+++..+...   .. .+..+....|.+.                                         ..
T Consensus       113 ~~L~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (384)
T d2omza2         113 TGLTLFNNQITDIDPLKN---LT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS  188 (384)
T ss_dssp             CEEECCSSCCCCCGGGTT---CT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccccccccc---cc-cccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc
Confidence            999999999976543311   11 1334443333321                                         11


Q ss_pred             CCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCc
Q 047705          126 IPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNL  205 (585)
Q Consensus       126 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  205 (585)
                      ....+..+++++.+++++|.+++..+  +...++|++|++++|+++..  +.+..+++|+.|++++|.+++..  .+..+
T Consensus       189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~  262 (384)
T d2omza2         189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGL  262 (384)
T ss_dssp             CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTC
T ss_pred             cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccccc
Confidence            23456677888999999998887654  45677899999999988843  35778888999999999888543  37778


Q ss_pred             ccchhhcCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCC
Q 047705          206 IALRILSLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSN  284 (585)
Q Consensus       206 ~~L~~L~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~  284 (585)
                      ++|+.|++++|. .....+..++.++.++++.|.+++.  ..+..+++++.|++++|++++..  .+..+++|+.|++++
T Consensus       263 ~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~  338 (384)
T d2omza2         263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN  338 (384)
T ss_dssp             TTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred             ccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence            889999998887 3333577888888889988888853  35777888999999999888753  377888899999999


Q ss_pred             CccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCC
Q 047705          285 NNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  332 (585)
Q Consensus       285 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n  332 (585)
                      |+|++ ++ .+..+++|++|++++|++++.+| ...+..++.+++.+|
T Consensus       339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            98885 33 58888899999999999887655 445667777777665

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=2.5e-30  Score=253.92  Aligned_cols=166  Identities=19%  Similarity=0.247  Sum_probs=143.2

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC-CcceeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ..+.+.+|++.++.++| ++++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999976 78999999986543  23567789999999976 8999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCC-----CCcEEEeeecccccccC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDD-----NMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~  566 (585)
                      + +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.     ++.+||+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 78999999887778999999999999999999999   999999999999999964     57899999999997653


Q ss_pred             CCCc-----cccccccccccccCC
Q 047705          567 EDQS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~-----~~~~~~~gt~~y~aP  585 (585)
                      ....     ......+||+.||||
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             CccccceeecccCceEEchhhcCH
Confidence            3211     123456899999998

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.3e-30  Score=257.44  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=205.7

Q ss_pred             CCCCCEEecCCCcCCCc--CCccccCCCCCccEEEccC-CCCC-CCccCccccCCCCCcEEEccCCCCcccCCcchhhcc
Q 047705           33 VSTLKLLGLQDNSLSGS--LSSITDVRLPNLEELVLWG-NNFS-ELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNL  108 (585)
Q Consensus        33 l~~L~~L~L~~n~l~~~--~~~~~~~~l~~L~~L~L~~-n~l~-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  108 (585)
                      ..++++|+|++|.+++.  +|. ...++++|++|+|++ |+++ .+|  ..|.++++|++|+|++|++.+..+. .+..+
T Consensus        49 ~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L~Ls~~N~l~g~iP--~~i~~L~~L~~L~Ls~N~l~~~~~~-~~~~~  124 (313)
T d1ogqa_          49 TYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIP--PAIAKLTQLHYLYITHTNVSGAIPD-FLSQI  124 (313)
T ss_dssp             CCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCC--GGGGGCTTCSEEEEEEECCEEECCG-GGGGC
T ss_pred             cEEEEEEECCCCCCCCCCCCCh-HHhcCccccccccccccccccccc--cccccccccchhhhccccccccccc-cccch
Confidence            34799999999999864  333 344899999999986 7887 676  6799999999999999999988776 56666


Q ss_pred             cccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCC-ceEEccCCCCCccCcccccCCCCCcEE
Q 047705          109 SHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKL-QGLVLDDNKLEGSIPDDICRLVELYKL  187 (585)
Q Consensus       109 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L  187 (585)
                      +. |+.++++.|.+.+.+|..+..++.|+++++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+
T Consensus       125 ~~-L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l  202 (313)
T d1ogqa_         125 KT-LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FV  202 (313)
T ss_dssp             TT-CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EE
T ss_pred             hh-hcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cc
Confidence            65 9999999999999999999999999999999999999999999988876 899999999999999888877654 79


Q ss_pred             EcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCccccc
Q 047705          188 ELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLI  267 (585)
Q Consensus       188 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  267 (585)
                      ++++|...+.+|..+..+                     +.++.+++++|.+++.++ .+..+++|+.|+|++|+++|.+
T Consensus       203 ~l~~~~~~~~~~~~~~~~---------------------~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~i  260 (313)
T d1ogqa_         203 DLSRNMLEGDASVLFGSD---------------------KNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL  260 (313)
T ss_dssp             ECCSSEEEECCGGGCCTT---------------------SCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECC
T ss_pred             cccccccccccccccccc---------------------cccccccccccccccccc-ccccccccccccCccCeecccC
Confidence            999999988777655544                     455556666777765443 5677777888888888888777


Q ss_pred             CccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeee
Q 047705          268 PDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       268 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      |..|..+++|++|+|++|+|+|.+| .+..+.+|+.+++++|+..|.
T Consensus       261 P~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSSEEES
T ss_pred             ChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCccccC
Confidence            7778888888888888888877777 356677777888888875443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-31  Score=263.29  Aligned_cols=168  Identities=26%  Similarity=0.316  Sum_probs=138.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh-hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC----eEE
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKG  486 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  486 (585)
                      .++|++++.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|+.++||||+++++++..+.    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999865 89999999997543 344568889999999999999999999986553    234


Q ss_pred             EEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccC
Q 047705          487 LVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIG  566 (585)
Q Consensus       487 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~  566 (585)
                      ++++|+.+|+|.+++...  .+++..++.++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            455566699999999765  5899999999999999999999   99999999999999999999999999999987543


Q ss_pred             CCCc-cccccccccccccCC
Q 047705          567 EDQS-MTQTQTLATIGYMAP  585 (585)
Q Consensus       567 ~~~~-~~~~~~~gt~~y~aP  585 (585)
                      .... ......+||+.|+||
T Consensus       162 ~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCG
T ss_pred             CCccceeeccccccceechH
Confidence            3221 223556899999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.8e-31  Score=260.66  Aligned_cols=169  Identities=29%  Similarity=0.392  Sum_probs=139.4

Q ss_pred             HhcCCCCccceecccCceEEEEEEeC-C-CcEEEEEEEechh--hhhHHHHHHHHHHHHhc---CCCcceeEEeeeec--
Q 047705          411 RATDGFSENNLIGRGGFGSVYKARLG-D-GMEVAVKVFNLQC--RRAFKSFDVECEIMKSI---RHRNLIKVISSCSN--  481 (585)
Q Consensus       411 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--  481 (585)
                      +..++|++++.||+|+||+||+|++. + ++.||||+++...  ......+.+|+.+++.+   +||||++++++|..  
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            34578999999999999999999874 4 6679999987542  22234566788777665   79999999998853  


Q ss_pred             ---CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          482 ---EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       482 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                         ....+++|||++++.+..........+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence               34789999999888776666655567899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCCCCccccccccccccccCC
Q 047705          559 GIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       559 g~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      |+++....   .......+||+.||||
T Consensus       161 g~~~~~~~---~~~~~~~~gT~~Y~AP  184 (305)
T d1blxa_         161 GLARIYSF---QMALTSVVVTLWYRAP  184 (305)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCH
T ss_pred             hhhhhhcc---cccCCCcccChhhcCc
Confidence            99886432   2334567899999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=262.38  Aligned_cols=162  Identities=27%  Similarity=0.372  Sum_probs=135.7

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecCC------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------  483 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  483 (585)
                      .++|++++.||+|+||+||+|++. +|+.||||+++..  .....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999875 6999999999754  2344567889999999999999999999997664      


Q ss_pred             eEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          484 FKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       484 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ..|+||||+ +.++..+.+..  .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 66888877654  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             ccCCCCccccccccccccccCC
Q 047705          564 LIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       564 ~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ...     ..+..+||+.||||
T Consensus       171 ~~~-----~~~~~~~t~~y~aP  187 (346)
T d1cm8a_         171 ADS-----EMTGYVVTRWYRAP  187 (346)
T ss_dssp             CCS-----SCCSSCSCGGGCCT
T ss_pred             cCC-----ccccccccccccCH
Confidence            532     23456799999999

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.9e-30  Score=253.13  Aligned_cols=166  Identities=25%  Similarity=0.324  Sum_probs=143.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecCCeEEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKGLVLE  490 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  490 (585)
                      ++|++++.||+|+||+||+|++. +++.||||+++...  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            67999999999999999999975 78999999997542  3456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccccCCCCc
Q 047705          491 YMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLLIGEDQS  570 (585)
Q Consensus       491 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  570 (585)
                      ++.++++..++... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC--
Confidence            99998888877655 47889999999999999999999   8999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCC
Q 047705          571 MTQTQTLATIGYMAP  585 (585)
Q Consensus       571 ~~~~~~~gt~~y~aP  585 (585)
                      .......+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~p  170 (292)
T d1unla_         156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccceeeccccchhhh
Confidence            222344567778776

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=2.3e-30  Score=258.86  Aligned_cols=159  Identities=24%  Similarity=0.374  Sum_probs=137.0

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecC--CeEEEEE
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE--EFKGLVL  489 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  489 (585)
                      ++|++++.||+|+||+||+|++. +++.||||+++...   .+++.+|+++|+.++ ||||++++++|...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999875 78999999987543   356788999999995 99999999998744  5689999


Q ss_pred             EccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccccCCC
Q 047705          490 EYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLLIGED  568 (585)
Q Consensus       490 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  568 (585)
                      |||++++|..+.+    .+++..++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999877642    5889999999999999999999   99999999999999998654 69999999998754322


Q ss_pred             CccccccccccccccCC
Q 047705          569 QSMTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~~~~~~~~gt~~y~aP  585 (585)
                         .....+||+.|+||
T Consensus       185 ---~~~~~~~t~~y~aP  198 (328)
T d3bqca1         185 ---EYNVRVASRYFKGP  198 (328)
T ss_dssp             ---CCCSCCSCGGGCCH
T ss_pred             ---cccccccCccccCc
Confidence               23456799999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=261.33  Aligned_cols=161  Identities=30%  Similarity=0.477  Sum_probs=132.2

Q ss_pred             CCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------CeEEE
Q 047705          415 GFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------EFKGL  487 (585)
Q Consensus       415 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  487 (585)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||++++++|...      .+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999976 789999999975432    234699999999999999999998532      35789


Q ss_pred             EEEccCCCCHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC-cEEEeeecccccc
Q 047705          488 VLEYMPQGSLEKHLY--STNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM-IAYLSDFGIAKLL  564 (585)
Q Consensus       488 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~a~~~  564 (585)
                      |||||+++.......  .....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997654333322  23447899999999999999999999   99999999999999999765 8999999999876


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ....   .....+||+.|+||
T Consensus       174 ~~~~---~~~~~~gt~~y~aP  191 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAP  191 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCH
T ss_pred             cCCc---ccccccccccccCh
Confidence            4322   23446899999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-30  Score=257.59  Aligned_cols=169  Identities=24%  Similarity=0.375  Sum_probs=137.5

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeec--------
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSN--------  481 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  481 (585)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  ......++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            578999999999999999999975 7999999998654  23345678899999999999999999998755        


Q ss_pred             CCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccc
Q 047705          482 EEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIA  561 (585)
Q Consensus       482 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a  561 (585)
                      ++..|+||||++++.+... ......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            3467999999977655544 444447889999999999999999999   999999999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccccccccCC
Q 047705          562 KLLIGEDQS--MTQTQTLATIGYMAP  585 (585)
Q Consensus       562 ~~~~~~~~~--~~~~~~~gt~~y~aP  585 (585)
                      +.+......  ......+||++|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCH
T ss_pred             eecccccccccccccceecCHHHhhH
Confidence            865432211  122446799999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.3e-30  Score=257.07  Aligned_cols=167  Identities=28%  Similarity=0.403  Sum_probs=144.4

Q ss_pred             CCCCccceecccCceEEEEEEeC----CCcEEEEEEEech----hhhhHHHHHHHHHHHHhcCC-CcceeEEeeeecCCe
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG----DGMEVAVKVFNLQ----CRRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  484 (585)
                      ++|++.+.||+|+||+||+|+..    +|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            66999999999999999999752    5789999998643    22345678889999999977 899999999999999


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .+++|||+.+|+|.+++.... .+++..+..++.|++.|++|+|   +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999998765 5678889999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..... .......||+.|+||
T Consensus       180 ~~~~~-~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         180 VADET-ERAYDFCGTIEYMAP  199 (322)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCH
T ss_pred             ccccc-ccccccccccccchh
Confidence            43322 223456799999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.7e-29  Score=249.11  Aligned_cols=166  Identities=24%  Similarity=0.363  Sum_probs=137.8

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcc-eeEEeeeecCCeEEEEEEc
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKGLVLEY  491 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  491 (585)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+..|+++++.++|+++ +.+.+++...+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999875 789999999875432  3567889999999987765 5556666778899999999


Q ss_pred             cCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeC---CCCcEEEeeecccccccCCC
Q 047705          492 MPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLD---DNMIAYLSDFGIAKLLIGED  568 (585)
Q Consensus       492 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~  568 (585)
                      + ++++.+.+......+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+|++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 66787777766668999999999999999999999   99999999999999986   45579999999999875432


Q ss_pred             Cc-----cccccccccccccCC
Q 047705          569 QS-----MTQTQTLATIGYMAP  585 (585)
Q Consensus       569 ~~-----~~~~~~~gt~~y~aP  585 (585)
                      ..     ......+||+.||||
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCH
T ss_pred             cccceeccccCCcCCCccccCH
Confidence            21     123456899999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=255.67  Aligned_cols=163  Identities=25%  Similarity=0.328  Sum_probs=136.4

Q ss_pred             cCCCCccceecccCceEEEEEEeC-CCcEEEEEEEechh--hhhHHHHHHHHHHHHhcCCCcceeEEeeeecC-----Ce
Q 047705          413 TDGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC--RRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF  484 (585)
Q Consensus       413 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  484 (585)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999875 79999999997542  33456788999999999999999999998643     33


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .+++|+|+.||+|.+++...  .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46667778899999998654  5899999999999999999999   999999999999999999999999999998754


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .     .......||+.|+||
T Consensus       172 ~-----~~~~~~~g~~~y~ap  187 (348)
T d2gfsa1         172 D-----DEMTGYVATRWYRAP  187 (348)
T ss_dssp             T-----GGGSSSCHHHHTSCH
T ss_pred             C-----cccccccccccccCc
Confidence            2     233456799999997

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=7.7e-27  Score=230.81  Aligned_cols=267  Identities=23%  Similarity=0.334  Sum_probs=185.9

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      ..+.+|=++++++ .+|..+.  ++|++|+|++|+|+ .++...+..+++|++|++++|.+..++. ..|..+++|++|+
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~-~~f~~l~~L~~L~   85 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLY   85 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEE
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccch-hhhhCCCccCEec
Confidence            4566676777777 5566664  57888888888887 4444445578888888888888888865 6788888888888


Q ss_pred             ccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccc--ccchhhhCCCCCceEEccCC
Q 047705           91 LSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG--SILITLSKLQKLQGLVLDDN  168 (585)
Q Consensus        91 Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N  168 (585)
                      +++|+++.+... .    ...+..|++..|.+.+..+..+.....+..++...|....  ..+..|..+++|+.+++++|
T Consensus        86 l~~n~l~~l~~~-~----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n  160 (305)
T d1xkua_          86 LSKNQLKELPEK-M----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT  160 (305)
T ss_dssp             CCSSCCSBCCSS-C----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred             ccCCccCcCccc-h----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence            888888755332 1    2247777777777777666667777777777777765432  33456777777777777777


Q ss_pred             CCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccC
Q 047705          169 KLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIG  248 (585)
Q Consensus       169 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~  248 (585)
                      .++. +|..+  .++|++|++++|.+....+..|.                     .++.++.|++++|.+++..+..|.
T Consensus       161 ~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~---------------------~~~~l~~L~~s~n~l~~~~~~~~~  216 (305)
T d1xkua_         161 NITT-IPQGL--PPSLTELHLDGNKITKVDAASLK---------------------GLNNLAKLGLSFNSISAVDNGSLA  216 (305)
T ss_dssp             CCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGT---------------------TCTTCCEEECCSSCCCEECTTTGG
T ss_pred             Cccc-cCccc--CCccCEEECCCCcCCCCChhHhh---------------------cccccccccccccccccccccccc
Confidence            7773 33322  46677777777777665555444                     445566666677777777777777


Q ss_pred             CCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhh------ccCCccceEEeecCcCe
Q 047705          249 GLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL------EKLSYLEDLNLSFNKLE  312 (585)
Q Consensus       249 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~l~l~~N~l~  312 (585)
                      ++++|++|+|++|.++. +|.+|..+++|++|+|++|+|+.+....|      ...++|+.|+|++|+|.
T Consensus       217 ~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         217 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             GSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             ccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            77777777777777774 46677777777778887777775433333      34567788888888875

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=2.4e-27  Score=242.17  Aligned_cols=296  Identities=27%  Similarity=0.383  Sum_probs=237.9

Q ss_pred             ecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCC
Q 047705           16 DLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNP   95 (585)
Q Consensus        16 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~   95 (585)
                      +++.+.+++.+.  ...+.+|++|++++|.|+ .++.+.  .+++|++|+|++|+|+.++.   ++.+++|++|++++|+
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~gl~--~L~nL~~L~Ls~N~l~~l~~---l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVE--YLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCTTGG--GCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cccccc--cCCCCCEEeCcCCcCCCCcc---ccCCcccccccccccc
Confidence            466666655443  457789999999999998 555443  68999999999999999863   8999999999999999


Q ss_pred             CcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCcccc---------------------------
Q 047705           96 LDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNG---------------------------  148 (585)
Q Consensus        96 l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------------------  148 (585)
                      +.++.+   +++++. |+.|++++|.+++..+  ......+..+....|.+..                           
T Consensus       100 i~~i~~---l~~l~~-L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (384)
T d2omza2         100 IADITP---LANLTN-LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN  173 (384)
T ss_dssp             CCCCGG---GTTCTT-CCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTT
T ss_pred             cccccc---cccccc-cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcc
Confidence            987643   566776 9999999999886544  3344556666665555432                           


Q ss_pred             --------------ccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCC
Q 047705          149 --------------SILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLG  214 (585)
Q Consensus       149 --------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  214 (585)
                                    .....+..+++++.+++++|.+++..|  +...++|++|++++|.++. + +.+..+++|+.|+++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~  249 (384)
T d2omza2         174 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLA  249 (384)
T ss_dssp             CTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECC
T ss_pred             ccccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccc
Confidence                          123456788999999999999997655  4667899999999999985 3 468899999999999


Q ss_pred             CCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh
Q 047705          215 SND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA  293 (585)
Q Consensus       215 ~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  293 (585)
                      +|. .....+..+++|+.|++++|.+++..  .+.+++.++.++++.|++++.  ..+..+++++.|++++|++++..  
T Consensus       250 ~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--  323 (384)
T d2omza2         250 NNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--  323 (384)
T ss_dssp             SSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--
T ss_pred             cCccCCCCcccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--
Confidence            998 33345888999999999999998654  478899999999999999864  45788999999999999999754  


Q ss_pred             hhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCccc
Q 047705          294 SLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  336 (585)
Q Consensus       294 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c  336 (585)
                      .+..+++|++|++++|+++. ++....+..++.+++.+|+...
T Consensus       324 ~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         324 PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCB
T ss_pred             ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCC
Confidence            48899999999999999985 4445567788899999987653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.7e-29  Score=250.18  Aligned_cols=162  Identities=27%  Similarity=0.332  Sum_probs=128.1

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEech--hhhhHHHHHHHHHHHHhcCCCcceeEEeeeecC------Ce
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQ--CRRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------EF  484 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  484 (585)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...  ......++.+|+.++++++||||++++++|...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999976 7999999999754  234456788999999999999999999998643      67


Q ss_pred             EEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeeecccccc
Q 047705          485 KGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKLL  564 (585)
Q Consensus       485 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~~  564 (585)
                      .|+|||||.++ +.+.+..   .+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999664 4444432   5789999999999999999999   999999999999999999999999999998865


Q ss_pred             cCCCCccccccccccccccCC
Q 047705          565 IGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       565 ~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      ..   .......+||+.|+||
T Consensus       170 ~~---~~~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         170 GT---SFMMTPYVVTRYYRAP  187 (355)
T ss_dssp             --------------CCTTCCH
T ss_pred             cc---ccccccccccccccCh
Confidence            32   2233556799999998

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=9.6e-27  Score=230.12  Aligned_cols=270  Identities=20%  Similarity=0.219  Sum_probs=205.3

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSL   80 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   80 (585)
                      ++|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+.. ++...+..+++|++|++++|+++.+|. .  
T Consensus        24 ~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~-i~~~~f~~l~~L~~L~l~~n~l~~l~~-~--   97 (305)
T d1xkua_          24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLKELPE-K--   97 (305)
T ss_dssp             SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCSBCCS-S--
T ss_pred             ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc-cchhhhhCCCccCEecccCCccCcCcc-c--
Confidence            4677663  789999999999997767789999999999999999994 444456689999999999999999984 2  


Q ss_pred             cCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcc--eecCCccccCCCCccEEEeeCCccccccchhhhCCC
Q 047705           81 SNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNV--TGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQ  158 (585)
Q Consensus        81 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l--~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  158 (585)
                       ..+.+..|++++|.+..+.+. .+..... +..++...|..  ....+..|..+++|+++++++|.+..+.. .  .++
T Consensus        98 -~~~~l~~L~~~~n~l~~l~~~-~~~~~~~-~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~-~--~~~  171 (305)
T d1xkua_          98 -MPKTLQELRVHENEITKVRKS-VFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ-G--LPP  171 (305)
T ss_dssp             -CCTTCCEEECCSSCCCBBCHH-HHTTCTT-CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS-S--CCT
T ss_pred             -hhhhhhhhhccccchhhhhhh-hhhcccc-ccccccccccccccCCCccccccccccCccccccCCccccCc-c--cCC
Confidence             346899999999999876554 4444444 78888887754  34556678999999999999999985433 2  357


Q ss_pred             CCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCc
Q 047705          159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNN  238 (585)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~  238 (585)
                      +|++|++++|.+++..+..|..++.++.|++++|.+.+..+..|..+++                     |+.|+|++|+
T Consensus       172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~---------------------L~~L~L~~N~  230 (305)
T d1xkua_         172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH---------------------LRELHLNNNK  230 (305)
T ss_dssp             TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT---------------------CCEEECCSSC
T ss_pred             ccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc---------------------ceeeeccccc
Confidence            9999999999999999999999999999999999999877766655554                     5555556666


Q ss_pred             ccccCCcccCCCCCCcEEeecccCcccccCccc------cCcCCCCEEeCCCCccC--ccCChhhccCCccceE
Q 047705          239 FSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF------GNLISLKFLNLSNNNLS--GAIPASLEKLSYLEDL  304 (585)
Q Consensus       239 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l  304 (585)
                      |+. +|.+|..+++|++|+|++|+|+.+....|      ..+++|+.|+|++|+++  ...|..|..+.....+
T Consensus       231 L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~  303 (305)
T d1xkua_         231 LVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV  303 (305)
T ss_dssp             CSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred             ccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence            663 35566677777777777777765433333      34567888888888765  3445555554444433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.9e-28  Score=236.88  Aligned_cols=251  Identities=22%  Similarity=0.188  Sum_probs=175.0

Q ss_pred             cEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEe
Q 047705           62 EELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDL  141 (585)
Q Consensus        62 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  141 (585)
                      ..++.++++++.+|.  .+  .+++++|+|++|+|+++.+. ++.+++. |+.|++++|++....+..+..++.++.++.
T Consensus        14 ~~v~c~~~~L~~iP~--~i--p~~~~~L~Ls~N~i~~i~~~-~f~~l~~-L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~   87 (284)
T d1ozna_          14 VTTSCPQQGLQAVPV--GI--PAASQRIFLHGNRISHVPAA-SFRACRN-LTILWLHSNVLARIDAAAFTGLALLEQLDL   87 (284)
T ss_dssp             CEEECCSSCCSSCCT--TC--CTTCSEEECTTSCCCEECTT-TTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             eEEEcCCCCCCccCC--CC--CCCCCEEECcCCcCCCCCHH-Hhhcccc-cccccccccccccccccccccccccccccc
Confidence            345667777777763  22  14567777777777655443 4455544 666666666666555555555555555544


Q ss_pred             e-CCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCC
Q 047705          142 G-GNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLP  220 (585)
Q Consensus       142 ~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~  220 (585)
                      . .|.+..+.+..|.++++|++|++++|.+....+..+....+|+.+++++|.|++..+.                    
T Consensus        88 ~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~--------------------  147 (284)
T d1ozna_          88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD--------------------  147 (284)
T ss_dssp             CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT--------------------
T ss_pred             ccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh--------------------
Confidence            3 3445555555555566666666666665555555555555566666666655543333                    


Q ss_pred             ccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCc
Q 047705          221 LEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSY  300 (585)
Q Consensus       221 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  300 (585)
                       .+..+++|+.|++++|.++++.+..|.++++|+.+++++|+++++.|..|..+++|+.|++++|++++..+..|..+++
T Consensus       148 -~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         148 -TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             -TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             -HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence             3556677888888999999888999999999999999999999999999999999999999999999988899999999


Q ss_pred             cceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCC
Q 047705          301 LEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       301 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      |++|++++|+|.|+|+..+....++......+...|..|
T Consensus       227 L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             CCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             cCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence            999999999999999864433344444445566677554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=9.4e-27  Score=227.65  Aligned_cols=252  Identities=24%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             CEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEE
Q 047705           37 KLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQ  116 (585)
Q Consensus        37 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~  116 (585)
                      ..++.++++++..+..+    .+++++|+|++|+|+.+|. ..|..+++|++|++++|++..+.+. .+.+.+. +..++
T Consensus        14 ~~v~c~~~~L~~iP~~i----p~~~~~L~Ls~N~i~~i~~-~~f~~l~~L~~L~ls~n~l~~i~~~-~~~~~~~-~~~l~   86 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVGI----PAASQRIFLHGNRISHVPA-ASFRACRNLTILWLHSNVLARIDAA-AFTGLAL-LEQLD   86 (284)
T ss_dssp             CEEECCSSCCSSCCTTC----CTTCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEEE
T ss_pred             eEEEcCCCCCCccCCCC----CCCCCEEECcCCcCCCCCH-HHhhccccccccccccccccccccc-ccccccc-ccccc
Confidence            34566677776343322    2567888888888888875 6788888888888888888766655 4455554 66665


Q ss_pred             ee-cCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCccc
Q 047705          117 MH-NCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       117 l~-~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      .. .+.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..|..+++|+.|++++|+++
T Consensus        87 ~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~  166 (284)
T d1ozna_          87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS  166 (284)
T ss_dssp             CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc
Confidence            54 56677777888999999999999999998888888999999999999999999888888999999999999999998


Q ss_pred             ccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcC
Q 047705          196 RSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLI  275 (585)
Q Consensus       196 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  275 (585)
                      ...+.+|.+                     +++|+.+++++|+++++.|..|.++++|++|++++|++++..+..|..++
T Consensus       167 ~l~~~~f~~---------------------l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~  225 (284)
T d1ozna_         167 SVPERAFRG---------------------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (284)
T ss_dssp             EECTTTTTT---------------------CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             ccchhhhcc---------------------ccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence            766665544                     45566667788888888888888888899999999988888788888888


Q ss_pred             CCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          276 SLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      +|+.|++++|++...-+ ...-...++.+....+.+.|..|.
T Consensus       226 ~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         226 ALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             TCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESG
T ss_pred             ccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCch
Confidence            89999999998875432 111223456667777888887664

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.3e-25  Score=217.11  Aligned_cols=208  Identities=21%  Similarity=0.149  Sum_probs=145.2

Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCC
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQK  159 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  159 (585)
                      ++....+.+++.+++.++.+ |.    ++|.++++|+|++|++++..+.+|.++++|++|+|++|+|+.+.  .++.+++
T Consensus         6 ~~~~~~~~~v~C~~~~L~~i-P~----~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~   78 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLTAL-PP----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPV   78 (266)
T ss_dssp             EECSTTCCEEECTTSCCSSC-CS----CCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTT
T ss_pred             EcccCCCeEEEccCCCCCee-Cc----CcCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccc
Confidence            34555666667777777643 32    22334555666655555555555555555555555555555322  2345555


Q ss_pred             CceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcc
Q 047705          160 LQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNF  239 (585)
Q Consensus       160 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l  239 (585)
                      |++|+|++|+++ ..+..+..+++|+.|++++|.+.+..                     +..+..+.+++.|++++|.+
T Consensus        79 L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~---------------------~~~~~~l~~l~~L~l~~n~l  136 (266)
T d1p9ag_          79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP---------------------LGALRGLGELQELYLKGNEL  136 (266)
T ss_dssp             CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCC---------------------SSTTTTCTTCCEEECTTSCC
T ss_pred             cccccccccccc-ccccccccccccccccccccccceee---------------------cccccccccccccccccccc
Confidence            555555555555 23344555555555555555554332                     23455667788888899999


Q ss_pred             cccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCC
Q 047705          240 SGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPR  317 (585)
Q Consensus       240 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~  317 (585)
                      +.+.+..+..+++|+.|++++|+++++.+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|+|..
T Consensus       137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~  213 (266)
T d1p9ag_         137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (266)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence            9888888999999999999999999988889999999999999999999 6788888899999999999999998864

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.6e-24  Score=207.87  Aligned_cols=201  Identities=26%  Similarity=0.265  Sum_probs=164.8

Q ss_pred             ccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCC
Q 047705          112 LEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGG  191 (585)
Q Consensus       112 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  191 (585)
                      +.++++++++++. +|..+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+ + .+..+++|++|+|++
T Consensus        12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccc
Confidence            6667888888874 454443  5688888888888877777888888888888888888743 3 356778888888888


Q ss_pred             CcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          192 NKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       192 N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      |+++. .+.                     .+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++.+.+..+
T Consensus        87 N~l~~-~~~---------------------~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~  144 (266)
T d1p9ag_          87 NQLQS-LPL---------------------LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (266)
T ss_dssp             SCCSS-CCC---------------------CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             ccccc-ccc---------------------ccccccccccccccccccceeeccccccccccccccccccccceeccccc
Confidence            88763 222                     35566778888889999998888899999999999999999998888889


Q ss_pred             cCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCC
Q 047705          272 GNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  339 (585)
Q Consensus       272 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~  339 (585)
                      ..+++|+.+++++|+|++..+..|..+++|++|||++|.|+..++.......++.+++.||||.|++.
T Consensus       145 ~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             cccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            99999999999999999988889999999999999999999554555567788899999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.89  E-value=3e-24  Score=217.38  Aligned_cols=164  Identities=19%  Similarity=0.243  Sum_probs=127.9

Q ss_pred             CCCCccceecccCceEEEEEEeC-CCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-----------CCcceeEEeeeec
Q 047705          414 DGFSENNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-----------HRNLIKVISSCSN  481 (585)
Q Consensus       414 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  481 (585)
                      ++|++++.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999875 79999999997553 23456778999888775           5789999988754


Q ss_pred             --CCeEEEEEEccCCCCHHHH--hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCC------
Q 047705          482 --EEFKGLVLEYMPQGSLEKH--LYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNM------  551 (585)
Q Consensus       482 --~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~------  551 (585)
                        ....+++|+++..+.....  .......+++..+..++.||+.|++|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              3566677777655443222  22333478889999999999999999992  38999999999999997554      


Q ss_pred             cEEEeeecccccccCCCCccccccccccccccCC
Q 047705          552 IAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP  585 (585)
Q Consensus       552 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  585 (585)
                      .+|++|||.|.....     .....+||+.|+||
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aP  198 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSP  198 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCH
T ss_pred             eeeEeeccccccccc-----ccccccccccccCh
Confidence            499999999986432     22456799999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=6.2e-23  Score=187.53  Aligned_cols=133  Identities=17%  Similarity=0.199  Sum_probs=106.2

Q ss_pred             CccceecccCceEEEEEEeCCCcEEEEEEEechh------------------hhhHHHHHHHHHHHHhcCCCcceeEEee
Q 047705          417 SENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQC------------------RRAFKSFDVECEIMKSIRHRNLIKVISS  478 (585)
Q Consensus       417 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~  478 (585)
                      .+.+.||+|+||.||+|+..+|++||||+++...                  .........|+..+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998899999999875321                  0112345568899999999999988876


Q ss_pred             eecCCeEEEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcEEcCCCCCCEEeCCCCcEEEeee
Q 047705          479 CSNEEFKGLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFGCSTPVIHCDLKPSNVLLDDNMIAYLSDF  558 (585)
Q Consensus       479 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  558 (585)
                      ..    .+++|||+++....+        ++......++.|+++|++|||   +++|+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    379999998765433        233345679999999999999   8999999999999999865 4899999


Q ss_pred             ccccccc
Q 047705          559 GIAKLLI  565 (585)
Q Consensus       559 g~a~~~~  565 (585)
                      |.|+...
T Consensus       147 G~a~~~~  153 (191)
T d1zara2         147 PQSVEVG  153 (191)
T ss_dssp             TTCEETT
T ss_pred             CCcccCC
Confidence            9997653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.1e-21  Score=186.60  Aligned_cols=212  Identities=19%  Similarity=0.133  Sum_probs=160.5

Q ss_pred             CCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEcc-CCCCCCCccCcc
Q 047705            1 EIPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLW-GNNFSELNFLSS   79 (585)
Q Consensus         1 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~   79 (585)
                      ++|..+.  +++++|+|++|+|+.+.+..|.++++|++|+|++|.+.+.++...+..++++++|++. .|++..++. ..
T Consensus        22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~-~~   98 (242)
T d1xwdc1          22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP-EA   98 (242)
T ss_dssp             SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECT-TS
T ss_pred             CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccc-cc
Confidence            3565542  5788999999998876677888999999999999988766777677778889988875 467777775 77


Q ss_pred             ccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCC-CccEEEeeCCccccccchhhhCCC
Q 047705           80 LSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLT-NLITIDLGGNKLNGSILITLSKLQ  158 (585)
Q Consensus        80 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~  158 (585)
                      |..+++|++|++++|++....+......+.. +..+...++.+....+..|.+++ .++.|++++|+++.+.+..|....
T Consensus        99 ~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~-l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~  177 (242)
T d1xwdc1          99 FQNLPNLQYLLISNTGIKHLPDVHKIHSLQK-VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ  177 (242)
T ss_dssp             EECCTTCCEEEEESCCCCSCCCCTTTCBSSC-EEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCC
T ss_pred             ccccccccccccchhhhcccccccccccccc-cccccccccccccccccccccccccceeeecccccccccccccccchh
Confidence            8889999999999998876555434444433 66667777788877777777765 788889999988876666665443


Q ss_pred             CCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCC
Q 047705          159 KLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSN  216 (585)
Q Consensus       159 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n  216 (585)
                      .++.+++++|+|+.+.+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+.
T Consensus       178 l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l  235 (242)
T d1xwdc1         178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL  235 (242)
T ss_dssp             EEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred             hhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence            3444467888888666677888899999999999988666667888888888776543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=3e-20  Score=174.59  Aligned_cols=187  Identities=24%  Similarity=0.368  Sum_probs=103.1

Q ss_pred             cCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCC
Q 047705            7 GNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSL   86 (585)
Q Consensus         7 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L   86 (585)
                      +++.+|+.|++.+|.|+..  +.+..+++|++|+|++|.|++..+   +..+++|+++++++|.++.++   .+..+++|
T Consensus        38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~n~~~~i~---~l~~l~~L  109 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLKNVS---AIAGLQSI  109 (227)
T ss_dssp             HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCSCCG---GGTTCTTC
T ss_pred             HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc---ccccccccccccccccccccc---cccccccc
Confidence            4455666666666666533  346666666666666666653222   335666666666666666553   35566666


Q ss_pred             cEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEcc
Q 047705           87 TVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLD  166 (585)
Q Consensus        87 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  166 (585)
                      ++++++++...+..+   +...+ .+..+.++++.+...  ..+..+++|++|++++|.+....  .|.++++|++|+|+
T Consensus       110 ~~l~l~~~~~~~~~~---~~~~~-~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls  181 (227)
T d1h6ua2         110 KTLDLTSTQITDVTP---LAGLS-NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKAD  181 (227)
T ss_dssp             CEEECTTSCCCCCGG---GTTCT-TCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred             cccccccccccccch---hcccc-chhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccC
Confidence            666666666554322   12222 256666666655432  22455566666666666655322  25566666666666


Q ss_pred             CCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          167 DNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       167 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      +|+++++ + .+..+++|++|+|++|++++..|  ++++++|+.|++
T Consensus       182 ~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~l  224 (227)
T d1h6ua2         182 DNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL  224 (227)
T ss_dssp             SSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEE
T ss_pred             CCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEe
Confidence            6666543 2 25556666666666666653221  444455544444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.82  E-value=6.4e-19  Score=176.52  Aligned_cols=263  Identities=25%  Similarity=0.263  Sum_probs=156.4

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEE
Q 047705           10 QNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVI   89 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   89 (585)
                      .++++|||++|.++ .+|+.   .++|++|+|++|+|+ .+|..    +.+|++|++++|+++.++.   +  .+.|++|
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~l~~---l--p~~L~~L  103 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKALSD---L--PPLLEYL  103 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSCCCS---C--CTTCCEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccchhhh---h--ccccccc
Confidence            46889999999997 56653   568999999999998 44432    4689999999999988763   1  2469999


Q ss_pred             EccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCC
Q 047705           90 GLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNK  169 (585)
Q Consensus        90 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  169 (585)
                      ++++|.+..+ |.  ++.++. |++|++++|.+.....    ....+..+.+..+....  ...+..++.++.|++++|.
T Consensus       104 ~L~~n~l~~l-p~--~~~l~~-L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~  173 (353)
T d1jl5a_         104 GVSNNQLEKL-PE--LQNSSF-LKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNS  173 (353)
T ss_dssp             ECCSSCCSSC-CC--CTTCTT-CCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSC
T ss_pred             cccccccccc-cc--hhhhcc-ceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccccc
Confidence            9999999755 32  345555 9999999988764432    24556666666655543  3345566667777777666


Q ss_pred             CCccCc------------------ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcE
Q 047705          170 LEGSIP------------------DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVG  231 (585)
Q Consensus       170 l~~~~~------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~  231 (585)
                      +.....                  ..+..++.|+.+++++|.... .+...   .++..+.+..|.... .......++.
T Consensus       174 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~---~~l~~~~~~~~~~~~-~~~~~~~l~~  248 (353)
T d1jl5a_         174 LKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLP---PSLEALNVRDNYLTD-LPELPQSLTF  248 (353)
T ss_dssp             CSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCC---TTCCEEECCSSCCSC-CCCCCTTCCE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc-ccccc---ccccccccccccccc-cccccccccc
Confidence            553211                  123445556666666665542 22222   223333333332100 0001112222


Q ss_pred             E--------------------EccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccC
Q 047705          232 I--------------------DFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAI  291 (585)
Q Consensus       232 L--------------------~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  291 (585)
                      .                    ++..|.+.+.    ...+++|++|+|++|+++. +|..   +++|+.|++++|+|+. +
T Consensus       249 ~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~~-l  319 (353)
T d1jl5a_         249 LDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-V  319 (353)
T ss_dssp             EECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred             cccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccCc-cccc---cCCCCEEECCCCcCCc-c
Confidence            2                    3333333221    2234667777777777763 3432   4567777777777773 4


Q ss_pred             ChhhccCCccceEEeecCcCee
Q 047705          292 PASLEKLSYLEDLNLSFNKLEG  313 (585)
Q Consensus       292 ~~~~~~l~~L~~l~l~~N~l~~  313 (585)
                      |..   +++|++|++++|+++.
T Consensus       320 ~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         320 PEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CCC---CTTCCEEECCSSCCSS
T ss_pred             ccc---cCCCCEEECcCCcCCC
Confidence            432   3467777777777764

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=9e-20  Score=173.05  Aligned_cols=220  Identities=19%  Similarity=0.159  Sum_probs=148.3

Q ss_pred             CCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEE
Q 047705           36 LKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDF  115 (585)
Q Consensus        36 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  115 (585)
                      .++++.+++.++..++..    .+++++|+|++|+|+.++. ..|.++++|++|+|++|.+...++...+.+++. ++++
T Consensus        10 ~~~i~c~~~~l~~iP~~l----~~~l~~L~Ls~n~i~~l~~-~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~-l~~l   83 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSDL----PRNAIELRFVLTKLRVIQK-GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK-LHEI   83 (242)
T ss_dssp             SSEEEEESCSCSSCCSCS----CSCCSEEEEESCCCCEECT-TTTTTCTTCCEEEEESCTTCCEECSSSEESCTT-CCEE
T ss_pred             CCEEEEeCCCCCCcCCCC----CCCCCEEECcCCcCCccCh-hHhhccchhhhhhhccccccceeeccccccccc-cccc
Confidence            356777777777333322    2578888888888888875 678888888888888888876555545566665 6777


Q ss_pred             Eeec-CcceecCCccccCCCCccEEEeeCCccccccch-hhhCCCCCceEEccCCCCCccCcccccCCC-CCcEEEcCCC
Q 047705          116 QMHN-CNVTGDIPEEIGNLTNLITIDLGGNKLNGSILI-TLSKLQKLQGLVLDDNKLEGSIPDDICRLV-ELYKLELGGN  192 (585)
Q Consensus       116 ~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N  192 (585)
                      .+.. |++....+..|.++++|++|++++|.+....+. .+..+..+..+..+++.++.+.+..|.+++ .++.|++++|
T Consensus        84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n  163 (242)
T d1xwdc1          84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  163 (242)
T ss_dssp             EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence            6653 567777777788888888888888887654332 234566666667777777766666666654 6777888888


Q ss_pred             cccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcE-EEccCCcccccCCcccCCCCCCcEEeecccCcccccCccc
Q 047705          193 KLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVG-IDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSF  271 (585)
Q Consensus       193 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~-L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  271 (585)
                      +++...+..|..                      .++.. +++++|+++.+.+..|.++++|++|+|++|+++.+.+..|
T Consensus       164 ~l~~i~~~~~~~----------------------~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~  221 (242)
T d1xwdc1         164 GIQEIHNCAFNG----------------------TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL  221 (242)
T ss_dssp             CCCEECTTTTTT----------------------CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred             cccccccccccc----------------------hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence            877544433322                      22222 3456667776656667778888888888888876655667


Q ss_pred             cCcCCCCEEeCC
Q 047705          272 GNLISLKFLNLS  283 (585)
Q Consensus       272 ~~l~~L~~L~l~  283 (585)
                      .++++|+.+++.
T Consensus       222 ~~l~~L~~l~~~  233 (242)
T d1xwdc1         222 ENLKKLRARSTY  233 (242)
T ss_dssp             TTCCEEESSSEE
T ss_pred             cCCcccccCcCC
Confidence            776666666543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=1.5e-19  Score=169.72  Aligned_cols=205  Identities=20%  Similarity=0.263  Sum_probs=128.0

Q ss_pred             ccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEE
Q 047705           61 LEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITID  140 (585)
Q Consensus        61 L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  140 (585)
                      +..++++.+++++.   ..+..+.+|++|++++|.|+.+ +                           .+..+++|++|+
T Consensus        21 ~~~~~l~~~~~~d~---~~~~~l~~L~~L~l~~~~i~~l-~---------------------------~l~~l~~L~~L~   69 (227)
T d1h6ua2          21 AIKIAAGKSNVTDT---VTQADLDGITTLSAFGTGVTTI-E---------------------------GVQYLNNLIGLE   69 (227)
T ss_dssp             HHHHHTTCSSTTSE---ECHHHHHTCCEEECTTSCCCCC-T---------------------------TGGGCTTCCEEE
T ss_pred             HHHHHhCCCCcCCc---CCHHHcCCcCEEECCCCCCCcc-h---------------------------hHhcCCCCcEee
Confidence            34455555555554   2344556666666666666543 1                           244455555555


Q ss_pred             eeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCC-CC
Q 047705          141 LGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSND-PL  219 (585)
Q Consensus       141 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~-~~  219 (585)
                      +++|++.+..+  |.++++|+++++++|.++.+ + .+..+++|+++++++|...+.  ..+...+.++.+.++.+. ..
T Consensus        70 ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i-~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~  143 (227)
T d1h6ua2          70 LKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN  143 (227)
T ss_dssp             CCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred             cCCceeecccc--cccccccccccccccccccc-c-ccccccccccccccccccccc--chhccccchhhhhchhhhhch
Confidence            55555554332  55555555555555555522 2 345555566666655555432  224444555555555554 22


Q ss_pred             CccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhccCC
Q 047705          220 PLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLS  299 (585)
Q Consensus       220 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  299 (585)
                      ...+..+++|+.|++++|.+++.  ..+.++++|+.|++++|+++++  ..+..+++|+.|++++|+|++..  .+..++
T Consensus       144 ~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~  217 (227)
T d1h6ua2         144 ISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS--PLANTS  217 (227)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCG--GGTTCT
T ss_pred             hhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCc--ccccCC
Confidence            23456677888888888888744  3478889999999999998864  24788899999999999998654  378889


Q ss_pred             ccceEEeec
Q 047705          300 YLEDLNLSF  308 (585)
Q Consensus       300 ~L~~l~l~~  308 (585)
                      +|++|++++
T Consensus       218 ~L~~L~lsn  226 (227)
T d1h6ua2         218 NLFIVTLTN  226 (227)
T ss_dssp             TCCEEEEEE
T ss_pred             CCCEEEeeC
Confidence            999999874

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=4.3e-20  Score=168.58  Aligned_cols=129  Identities=23%  Similarity=0.315  Sum_probs=86.8

Q ss_pred             EEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEee
Q 047705           63 ELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLG  142 (585)
Q Consensus        63 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  142 (585)
                      +++.++++++.+|. + +  .+++++|+|++|+|++..+...+++++. |+.|+|++|+++...+..|..+++|++|+|+
T Consensus        12 ~v~Cs~~~L~~iP~-~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~-L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          12 TVDCTGRGLKEIPR-D-I--PLHTTELLLNDNELGRISSDGLFGRLPH-LVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             EEECTTSCCSSCCS-C-C--CTTCSEEECCSCCCCSBCCSCSGGGCTT-CCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             EEEEeCCCcCccCC-C-C--CCCCCEEEeCCCCCcccccccccCCCce-Eeeeeccccccccccccccccccccceeeec
Confidence            45555555555542 1 1  1345555555555544443334444444 5555555555555566667778888888888


Q ss_pred             CCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccc
Q 047705          143 GNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSR  196 (585)
Q Consensus       143 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  196 (585)
                      +|+|..+.+.+|.++++|++|+|++|+|+++.++.|..+++|++|+|++|.+..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            888887778888888888888888888887777888888888888888888764

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.80  E-value=6.2e-18  Score=169.21  Aligned_cols=267  Identities=27%  Similarity=0.234  Sum_probs=183.0

Q ss_pred             CCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccccccc
Q 047705           34 STLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLSHSLE  113 (585)
Q Consensus        34 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  113 (585)
                      .++++|+|++|.|+. +|.    .+++|++|+|++|+|+.+|.  .   +.+|+.|++++|+++.+      ..+|+.|+
T Consensus        38 ~~l~~LdLs~~~L~~-lp~----~~~~L~~L~Ls~N~l~~lp~--~---~~~L~~L~l~~n~l~~l------~~lp~~L~  101 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPE----LPPHLESLVASCNSLTELPE--L---PQSLKSLLVDNNNLKAL------SDLPPLLE  101 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCS----CCTTCSEEECCSSCCSSCCC--C---CTTCCEEECCSSCCSCC------CSCCTTCC
T ss_pred             cCCCEEEeCCCCCCC-CCC----CCCCCCEEECCCCCCccccc--c---hhhhhhhhhhhcccchh------hhhccccc
Confidence            379999999999984 443    25799999999999999984  2   57899999999999744      34566799


Q ss_pred             EEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCc
Q 047705          114 DFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNK  193 (585)
Q Consensus       114 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  193 (585)
                      +|++++|.++.. |. +..+++|+.|++++|.+.....    ....+..+.+..+...  ....+..++.++.+++++|.
T Consensus       102 ~L~L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~  173 (353)
T d1jl5a_         102 YLGVSNNQLEKL-PE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS  173 (353)
T ss_dssp             EEECCSSCCSSC-CC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred             cccccccccccc-cc-hhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceeccccccc
Confidence            999999999854 43 6789999999999999975432    3567888888887765  34567788999999999988


Q ss_pred             ccccCc------------------ccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcE
Q 047705          194 LSRSIP------------------ACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEY  255 (585)
Q Consensus       194 l~~~~~------------------~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  255 (585)
                      +.....                  ..+..++.|+.+++++|.... ......++..+.+.+|.+.... ..   .+.+..
T Consensus       174 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~-~~---~~~l~~  248 (353)
T d1jl5a_         174 LKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLP-EL---PQSLTF  248 (353)
T ss_dssp             CSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCC-CC---CTTCCE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc-cc---cccccc
Confidence            764321                  112334556666666654111 1122344555666666554321 11   122333


Q ss_pred             EeecccCcccc----------------cCccccCcCCCCEEeCCCCccCccCChhhccCCccceEEeecCcCeeeCCCCC
Q 047705          256 LFLGYNRLQGL----------------IPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLNLSFNKLEGEIPRGG  319 (585)
Q Consensus       256 L~ls~N~l~~~----------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~  319 (585)
                      .++..|.+.+.                ++.....+++|++|++++|+|+ .+|.   .+++|+.|++++|.++. +|.  
T Consensus       249 ~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~-l~~--  321 (353)
T d1jl5a_         249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPE--  321 (353)
T ss_dssp             EECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSC-CCC--
T ss_pred             cccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCCc-ccc--
Confidence            33333322211                0111223578999999999999 4554   36789999999999984 443  


Q ss_pred             CCCCCCccccCCCCccc
Q 047705          320 SFGNFSAESFEGNELLC  336 (585)
Q Consensus       320 ~~~~~~~~~~~~n~~~c  336 (585)
                      ...+++.+++.+|+...
T Consensus       322 ~~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         322 LPQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CCTTCCEEECCSSCCSS
T ss_pred             ccCCCCEEECcCCcCCC
Confidence            24578888999998754

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=7e-19  Score=162.77  Aligned_cols=181  Identities=25%  Similarity=0.428  Sum_probs=126.5

Q ss_pred             EecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCC
Q 047705           15 LDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNN   94 (585)
Q Consensus        15 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N   94 (585)
                      .++.++.+++..+.  ..+.+|++|++++|.|+ .++.+.  .+++|++|+|++|+|+.++   .+..+++|++|++++|
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~~l~--~l~~L~~L~L~~n~i~~l~---~~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQGIQ--YLPNVTKLFLNGNKLTDIK---PLANLKNLGWLFLDEN  100 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCTTGG--GCTTCCEEECCSSCCCCCG---GGTTCTTCCEEECCSS
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCC-CchhHh--hCCCCCEEeCCCccccCcc---ccccCccccccccccc
Confidence            35555655544332  34567777788877776 333332  5777888888888777764   2567777888888888


Q ss_pred             CCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccC
Q 047705           95 PLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSI  174 (585)
Q Consensus        95 ~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  174 (585)
                      +|+++.   .+.+++. |+.|++++|.+...  ..+..++.|+.+++++|.+.+  +..+..+++|+.+++++|+++++.
T Consensus       101 ~i~~l~---~l~~l~~-L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~  172 (210)
T d1h6ta2         101 KVKDLS---SLKDLKK-LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV  172 (210)
T ss_dssp             CCCCGG---GGTTCTT-CCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG
T ss_pred             cccccc---ccccccc-cccccccccccccc--ccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence            776542   2455555 77888877777532  357778888888888888875  335677888888888888888543


Q ss_pred             cccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCC
Q 047705          175 PDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS  215 (585)
Q Consensus       175 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (585)
                        .+..+++|++|+|++|+|+. ++ .+..+++|++|+|++
T Consensus       173 --~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         173 --PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             --GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             --cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence              37788888888888888874 44 478888888888753

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2.9e-19  Score=162.97  Aligned_cols=177  Identities=26%  Similarity=0.295  Sum_probs=129.3

Q ss_pred             cEEEeeCCccccccchhhhCCCCCceEEccCCCCCc-cCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCC
Q 047705          137 ITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEG-SIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGS  215 (585)
Q Consensus       137 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  215 (585)
                      ++++.++++++.++ ..+.  +++++|+|++|+|++ ..+..|..+++|++|+|++|.+....+..              
T Consensus        11 ~~v~Cs~~~L~~iP-~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~--------------   73 (192)
T d1w8aa_          11 TTVDCTGRGLKEIP-RDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA--------------   73 (192)
T ss_dssp             TEEECTTSCCSSCC-SCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTT--------------
T ss_pred             CEEEEeCCCcCccC-CCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccc--------------
Confidence            46777777777443 3221  467777777777764 33455677777777777777776555444              


Q ss_pred             CCCCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhh
Q 047705          216 NDPLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASL  295 (585)
Q Consensus       216 n~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  295 (585)
                             +..+++|+.|+|++|+|+.+.+..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|++....+. .
T Consensus        74 -------~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~  145 (192)
T d1w8aa_          74 -------FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-A  145 (192)
T ss_dssp             -------TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-H
T ss_pred             -------cccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-H
Confidence                   44566677778888999988888999999999999999999988888999999999999999998754332 2


Q ss_pred             ccCCccceEEeecCcCeeeCCCCCCCCCCCccccCCCCcccCCCC
Q 047705          296 EKLSYLEDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       296 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~  340 (585)
                      .-...++.+.+..|.+.|..|.  .+..+...++..|.+.|..+.
T Consensus       146 ~~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         146 WFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             HHHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred             HHhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCCCC
Confidence            2223466777888888887774  345566677888888897664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=5.9e-19  Score=163.31  Aligned_cols=163  Identities=24%  Similarity=0.284  Sum_probs=96.8

Q ss_pred             CCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhhcC
Q 047705          134 TNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       134 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      .+|++|++++|.++...  .+..+++|++|+|++|+|+++.  .+..+++|++|++++|++++ ++ .+..+++|+.|++
T Consensus        46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred             cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccc
Confidence            34444444444444321  2344444444444444444322  13344444444444444442 22 2444444444444


Q ss_pred             CCCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCC
Q 047705          214 GSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIP  292 (585)
Q Consensus       214 ~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  292 (585)
                      ++|. .....+..++.++.+++++|.+++  +..+..+++|+.+++++|+++++.  .+..+++|+.|++++|+|++ ++
T Consensus       120 ~~~~~~~~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~  194 (210)
T d1h6ta2         120 EHNGISDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR  194 (210)
T ss_dssp             TTSCCCCCGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG
T ss_pred             ccccccccccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch
Confidence            4444 222345566777788888888874  345667888888888888888643  37788889999999998885 34


Q ss_pred             hhhccCCccceEEeec
Q 047705          293 ASLEKLSYLEDLNLSF  308 (585)
Q Consensus       293 ~~~~~l~~L~~l~l~~  308 (585)
                       .+..+++|++|+|++
T Consensus       195 -~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         195 -ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -GGTTCTTCSEEEEEE
T ss_pred             -hhcCCCCCCEEEccC
Confidence             588888899888874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1e-18  Score=160.24  Aligned_cols=178  Identities=25%  Similarity=0.377  Sum_probs=123.0

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccC
Q 047705           14 ELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSN   93 (585)
Q Consensus        14 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~   93 (585)
                      .++++.+.+++..  ....+.+|++|++++|.|+ .++.+.  .+++|++|+|++|+++.++.   +..+++|++|++++
T Consensus        22 ~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~-~l~~l~--~l~nL~~L~Ls~N~l~~~~~---l~~l~~L~~L~l~~   93 (199)
T d2omxa2          22 KTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVE--YLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNN   93 (199)
T ss_dssp             HHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCC-CCTTGG--GCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCS
T ss_pred             HHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCC-Cccccc--cCCCcCcCccccccccCccc---ccCCcccccccccc
Confidence            3456666665433  2345677888888888887 444433  57788888888888877652   77788888888888


Q ss_pred             CCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCcc
Q 047705           94 NPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGS  173 (585)
Q Consensus        94 N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  173 (585)
                      |.+..+.   .+++++. |+.|++++|.+...  ..+..+++|+.|++++|++..+  ..+..+++|++|++++|++++.
T Consensus        94 n~~~~~~---~l~~l~~-L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l  165 (199)
T d2omxa2          94 NQIADIT---PLANLTN-LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL  165 (199)
T ss_dssp             SCCCCCG---GGTTCTT-CSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred             ccccccc---ccccccc-cccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC
Confidence            8776542   2455554 77777777777643  3467788888888888888743  3577788888888888888754


Q ss_pred             CcccccCCCCCcEEEcCCCcccccCcccccCcccchhh
Q 047705          174 IPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL  211 (585)
Q Consensus       174 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  211 (585)
                      .  .+.++++|++|++++|++++ ++ .++.+++|+.|
T Consensus       166 ~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         166 K--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             G--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             c--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            2  37788888888888888874 32 35566665543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.1e-18  Score=158.15  Aligned_cols=161  Identities=27%  Similarity=0.372  Sum_probs=102.7

Q ss_pred             CCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccCcccccCcccchhh
Q 047705          132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSIPACFNNLIALRIL  211 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  211 (585)
                      .++++++|++++|.+..+  ..+..+++|++|++++|+|++..|  +..+++|++|++++|.+.. ++ .+..++.|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence            345556666666665542  235556666666666666664322  5566666666666666553 22 25555666666


Q ss_pred             cCCCCC-CCCccCCCCCCCcEEEccCCcccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCcc
Q 047705          212 SLGSND-PLPLEIGNLKVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGA  290 (585)
Q Consensus       212 ~l~~n~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  290 (585)
                      ++++|. .....+..+++|+.|++++|++...  ..+..+++|++|++++|++++.  ..+.++++|+.|++++|++++.
T Consensus       112 ~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         112 TLFNNQITDIDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             ECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred             cccccccccccccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCC
Confidence            665554 2223466677788888888887643  3577788888888888888764  2477888888888888888753


Q ss_pred             CChhhccCCccceE
Q 047705          291 IPASLEKLSYLEDL  304 (585)
Q Consensus       291 ~~~~~~~l~~L~~l  304 (585)
                       + .+..+++|++|
T Consensus       188 -~-~l~~L~~L~~L  199 (199)
T d2omxa2         188 -S-VLAKLTNLESL  199 (199)
T ss_dssp             -G-GGGGCTTCSEE
T ss_pred             -c-cccCCCCCCcC
Confidence             3 46777777764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.5e-19  Score=187.78  Aligned_cols=329  Identities=17%  Similarity=0.094  Sum_probs=206.4

Q ss_pred             ccCCCCCCEEecCCCcccc----cCCccccCCCCCCEEecCCCcCCC----cCCccccCCCCCccEEEccCCCCCCCcc-
Q 047705            6 IGNLQNLEELDLRQNKLIG----TVPVAIFNVSTLKLLGLQDNSLSG----SLSSITDVRLPNLEELVLWGNNFSELNF-   76 (585)
Q Consensus         6 ~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~-   76 (585)
                      +..+++++.|+|++|.|+.    .+...+..+++|++|+|++|.|+.    .+........++|++|+|++|+++.... 
T Consensus        23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~  102 (460)
T d1z7xw1          23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  102 (460)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccc
Confidence            4567899999999998873    334567788999999999999851    1111111234579999999999987532 


Q ss_pred             --CccccCCCCCcEEEccCCCCcccCCcch--------------------------------hhcccccccEEEeecCcc
Q 047705           77 --LSSLSNCKSLTVIGLSNNPLDGILPKTS--------------------------------IGNLSHSLEDFQMHNCNV  122 (585)
Q Consensus        77 --~~~~~~l~~L~~L~Ls~N~l~~~~~~~~--------------------------------~~~~~~~L~~L~l~~n~l  122 (585)
                        ...+..+++|++|+|++|.+........                                +... ..++.++++++..
T Consensus       103 ~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~ls~~~~  181 (460)
T d1z7xw1         103 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK-PDFKELTVSNNDI  181 (460)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHC-TTCCEEECCSSBC
T ss_pred             cccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccc-ccccccccccccc
Confidence              1357788999999999998853211100                                0011 2366777776655


Q ss_pred             eecCC----ccc-cCCCCccEEEeeCCcccccc----chhhhCCCCCceEEccCCCCCcc-----CcccccCCCCCcEEE
Q 047705          123 TGDIP----EEI-GNLTNLITIDLGGNKLNGSI----LITLSKLQKLQGLVLDDNKLEGS-----IPDDICRLVELYKLE  188 (585)
Q Consensus       123 ~~~~~----~~~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~  188 (585)
                      .....    ..+ ..-.....+++..+.+....    ...+...+.++.+++++|.+...     .+........++.++
T Consensus       182 ~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~  261 (460)
T d1z7xw1         182 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW  261 (460)
T ss_dssp             HHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             ccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccc
Confidence            42111    111 22345667788777765322    23345677888888888876532     233344567788888


Q ss_pred             cCCCcccccCc----ccccCcccchhhcCCCCCCCCcc--------CCCCCCCcEEEccCCcccccCCc----ccCCCCC
Q 047705          189 LGGNKLSRSIP----ACFNNLIALRILSLGSNDPLPLE--------IGNLKVLVGIDFSMNNFSGIIPK----EIGGLKN  252 (585)
Q Consensus       189 L~~N~l~~~~~----~~~~~l~~L~~L~l~~n~~~~~~--------~~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~  252 (585)
                      +++|.+.....    ..+...+.++.+++++|......        ......|+.+++++|.++.....    .+...++
T Consensus       262 l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~  341 (460)
T d1z7xw1         262 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF  341 (460)
T ss_dssp             CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccc
Confidence            88888864322    23455677888888888633211        12345788888888888754333    2344567


Q ss_pred             CcEEeecccCccccc----Ccccc-CcCCCCEEeCCCCccCcc----CChhhccCCccceEEeecCcCeeeCCC------
Q 047705          253 LEYLFLGYNRLQGLI----PDSFG-NLISLKFLNLSNNNLSGA----IPASLEKLSYLEDLNLSFNKLEGEIPR------  317 (585)
Q Consensus       253 L~~L~ls~N~l~~~~----~~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~------  317 (585)
                      |++|+|++|++++..    +..+. ..+.|++|+|++|+|+..    +++.+..+++|++|||++|+++..-..      
T Consensus       342 L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l  421 (460)
T d1z7xw1         342 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV  421 (460)
T ss_dssp             CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHH
T ss_pred             hhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHH
Confidence            888999988886532    22232 356788899999988743    334566678889999999887632110      


Q ss_pred             CCCCCCCCccccCCCCcc
Q 047705          318 GGSFGNFSAESFEGNELL  335 (585)
Q Consensus       318 ~~~~~~~~~~~~~~n~~~  335 (585)
                      ......++.+.+.+|.+.
T Consensus       422 ~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         422 RQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             TSTTCCCCEEECTTCCCC
T ss_pred             HhCCCccCEEECCCCCCC
Confidence            011224566666666553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=6.7e-19  Score=182.82  Aligned_cols=324  Identities=18%  Similarity=0.149  Sum_probs=213.3

Q ss_pred             CCCCEEecCCCcccccC-CccccCCCCCCEEecCCCcCCCc----CCccccCCCCCccEEEccCCCCCCCcc---Ccccc
Q 047705           10 QNLEELDLRQNKLIGTV-PVAIFNVSTLKLLGLQDNSLSGS----LSSITDVRLPNLEELVLWGNNFSELNF---LSSLS   81 (585)
Q Consensus        10 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~   81 (585)
                      .+|+.|||++|+++... .+-+..++++++|+|++|.|+..    +.. .....++|++|||++|.|+..+.   ...+.
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~-~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHH-HHhcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence            36899999999997543 44567789999999999998711    111 12368899999999999875321   01222


Q ss_pred             -CCCCCcEEEccCCCCcccCCc---chhhcccccccEEEeecCcceecCCcc----------------------------
Q 047705           82 -NCKSLTVIGLSNNPLDGILPK---TSIGNLSHSLEDFQMHNCNVTGDIPEE----------------------------  129 (585)
Q Consensus        82 -~l~~L~~L~Ls~N~l~~~~~~---~~~~~~~~~L~~L~l~~n~l~~~~~~~----------------------------  129 (585)
                       ...+|++|+|++|++++....   ..+...+. |++|++++|.++......                            
T Consensus        81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~-L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~  159 (460)
T d1z7xw1          81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT-LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE  159 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTT-CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             cCCCCCCEEECCCCCccccccccccchhhcccc-ccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence             335799999999999754221   12334444 999999999876422111                            


Q ss_pred             -----ccCCCCccEEEeeCCccccccc----hhh-hCCCCCceEEccCCCCCccC----cccccCCCCCcEEEcCCCccc
Q 047705          130 -----IGNLTNLITIDLGGNKLNGSIL----ITL-SKLQKLQGLVLDDNKLEGSI----PDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       130 -----~~~l~~L~~L~L~~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  195 (585)
                           +.....++.++++++.+.....    ..+ ..-.....+++..+.+....    ...+...+.++.+++++|.+.
T Consensus       160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~  239 (460)
T d1z7xw1         160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG  239 (460)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc
Confidence                 1223456667776666542111    111 12345667777777665321    123445788999999999875


Q ss_pred             cc-----CcccccCcccchhhcCCCCCCCCc-------cCCCCCCCcEEEccCCcccccCCcc-----cCCCCCCcEEee
Q 047705          196 RS-----IPACFNNLIALRILSLGSNDPLPL-------EIGNLKVLVGIDFSMNNFSGIIPKE-----IGGLKNLEYLFL  258 (585)
Q Consensus       196 ~~-----~~~~~~~l~~L~~L~l~~n~~~~~-------~~~~l~~L~~L~ls~N~l~~~~~~~-----~~~l~~L~~L~l  258 (585)
                      ..     ....+.....++.|++++|.....       .+...+.++.+++++|.++......     ......|+.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l  319 (460)
T d1z7xw1         240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  319 (460)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccc
Confidence            32     233455678899999999973222       2456788999999999987432221     123468999999


Q ss_pred             cccCcccccCcc----ccCcCCCCEEeCCCCccCccC----Chhhc-cCCccceEEeecCcCeeeCC-----CCCCCCCC
Q 047705          259 GYNRLQGLIPDS----FGNLISLKFLNLSNNNLSGAI----PASLE-KLSYLEDLNLSFNKLEGEIP-----RGGSFGNF  324 (585)
Q Consensus       259 s~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~~----~~~~~-~l~~L~~l~l~~N~l~~~~~-----~~~~~~~~  324 (585)
                      ++|.++......    +...++|+.|+|++|++++..    +..+. ..+.|++|+|++|.++....     .......+
T Consensus       320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L  399 (460)
T d1z7xw1         320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL  399 (460)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred             cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence            999987654333    344568999999999997532    23333 45779999999999974211     11123567


Q ss_pred             CccccCCCCcc
Q 047705          325 SAESFEGNELL  335 (585)
Q Consensus       325 ~~~~~~~n~~~  335 (585)
                      +.+++.+|++.
T Consensus       400 ~~L~Ls~N~i~  410 (460)
T d1z7xw1         400 RELDLSNNCLG  410 (460)
T ss_dssp             CEEECCSSSCC
T ss_pred             CEEECCCCcCC
Confidence            88888888753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=2.6e-16  Score=138.35  Aligned_cols=64  Identities=23%  Similarity=0.145  Sum_probs=32.1

Q ss_pred             CCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCccc
Q 047705          132 NLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  195 (585)
                      .+++|++|++++|+++++.+..+..+++|++|++++|+|+.... ..+..+++|++|++++|.++
T Consensus        61 ~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccc
Confidence            34455555555555554444444455555555555555543221 23445555555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=2.3e-16  Score=138.74  Aligned_cols=130  Identities=15%  Similarity=0.188  Sum_probs=68.1

Q ss_pred             ccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEccCCCCcccCCcchhhccc
Q 047705           30 IFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLSNNPLDGILPKTSIGNLS  109 (585)
Q Consensus        30 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  109 (585)
                      |.+..+|++|+|++|+|+ .++.. +..+++|+.|+|++|+|+.++   .|..+++|++|++++|+++.+.+. .+..++
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~-~~~l~~L~~L~Ls~N~i~~l~---~~~~l~~L~~L~ls~N~i~~l~~~-~~~~l~   87 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENL-GATLDQFDAIDFSDNEIRKLD---GFPLLRRLKTLLVNNNRICRIGEG-LDQALP   87 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCG-GGGTTCCSEEECCSSCCCEEC---CCCCCSSCCEEECCSSCCCEECSC-HHHHCT
T ss_pred             ccCcCcCcEEECCCCCCC-ccCcc-ccccccCCEEECCCCCCCccC---CcccCcchhhhhcccccccCCCcc-cccccc
Confidence            334444444555554444 22221 123444555555555544442   244445555555555555443332 233333


Q ss_pred             ccccEEEeecCcceecCC-ccccCCCCccEEEeeCCcccccc---chhhhCCCCCceEEcc
Q 047705          110 HSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLNGSI---LITLSKLQKLQGLVLD  166 (585)
Q Consensus       110 ~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~  166 (585)
                      . |++|++++|+++.... ..+..+++|++|++++|.+....   +..+..+++|+.||-+
T Consensus        88 ~-L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~~  147 (162)
T d1a9na_          88 D-LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ  147 (162)
T ss_dssp             T-CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTE
T ss_pred             c-cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCCC
Confidence            3 5555555555443221 34677888899999998887543   2357788899988743

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.60  E-value=8e-17  Score=160.84  Aligned_cols=64  Identities=22%  Similarity=0.267  Sum_probs=35.3

Q ss_pred             CCCCccEEEeeCCccccc----cchhhhCCCCCceEEccCCCCCcc-----CcccccCCCCCcEEEcCCCccc
Q 047705          132 NLTNLITIDLGGNKLNGS----ILITLSKLQKLQGLVLDDNKLEGS-----IPDDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~  195 (585)
                      ..+.|+.|++++|++...    ....+...+.|++|+|++|+|+..     +...+...++|+.|+|++|.++
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            345666777777666532    222334556666666666666531     1223445556666666666654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.58  E-value=3e-15  Score=125.01  Aligned_cols=63  Identities=29%  Similarity=0.373  Sum_probs=29.7

Q ss_pred             cCCCCccEEEeeCCccccccchhhhCCCCCceEEccCCCCCccCc-ccccCCCCCcEEEcCCCccc
Q 047705          131 GNLTNLITIDLGGNKLNGSILITLSKLQKLQGLVLDDNKLEGSIP-DDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       131 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  195 (585)
                      ..+++|++|++++|.|+++.  .|..+++|++|++++|+|+.... ..+..+++|++|++++|.++
T Consensus        40 ~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          40 AALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             GGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             hhhhcccccccccccccccC--ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            33444444444444444321  24445555555555555543321 33445555555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=2.6e-16  Score=152.41  Aligned_cols=249  Identities=18%  Similarity=0.181  Sum_probs=131.2

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEcc
Q 047705           13 EELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLS   92 (585)
Q Consensus        13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls   92 (585)
                      ++|||+++.+.......+.. ..+..+.++++.+...+...  ....+|++|||++|.++.-.....+..+++|++|+|+
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~--~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSC--CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhh--ccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            46777777654222222221 13456666655544222211  1345666666666665442221235556666666666


Q ss_pred             CCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCC-cccccc-chhhhCCCCCceEEccCC-C
Q 047705           93 NNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGN-KLNGSI-LITLSKLQKLQGLVLDDN-K  169 (585)
Q Consensus        93 ~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~L~~N-~  169 (585)
                      ++.+.+                          ..+..+..+++|++|++++| .++... ...+.++++|++|+++++ .
T Consensus        80 ~~~l~~--------------------------~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~  133 (284)
T d2astb2          80 GLRLSD--------------------------PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  133 (284)
T ss_dssp             TCBCCH--------------------------HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             ccCCCc--------------------------HHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccc
Confidence            665532                          22334455666777777664 344221 122345677777777764 3


Q ss_pred             CCcc-CcccccC-CCCCcEEEcCCCc--ccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccCC-cccccCC
Q 047705          170 LEGS-IPDDICR-LVELYKLELGGNK--LSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSMN-NFSGIIP  244 (585)
Q Consensus       170 l~~~-~~~~~~~-l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~N-~l~~~~~  244 (585)
                      +++. ....+.. .++|+.|+++++.  ++......                    -+..+++|+.|++++| .+++...
T Consensus       134 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~--------------------l~~~~~~L~~L~L~~~~~itd~~~  193 (284)
T d2astb2         134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST--------------------LVRRCPNLVHLDLSDSVMLKNDCF  193 (284)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHH--------------------HHHHCTTCSEEECTTCTTCCGGGG
T ss_pred             cccccchhhhcccccccchhhhcccccccccccccc--------------------cccccccccccccccccCCCchhh
Confidence            4321 1112222 3567777776542  22110000                    1223556666777664 3565556


Q ss_pred             cccCCCCCCcEEeeccc-CcccccCccccCcCCCCEEeCCCCccCcc-CChhhccCCccceEEeecCcCeee
Q 047705          245 KEIGGLKNLEYLFLGYN-RLQGLIPDSFGNLISLKFLNLSNNNLSGA-IPASLEKLSYLEDLNLSFNKLEGE  314 (585)
Q Consensus       245 ~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~  314 (585)
                      ..+..+++|++|+|+++ .+++.....++.+++|+.|+++++ ++.. .+.....+|+|   ++..++++..
T Consensus       194 ~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~  261 (284)
T d2astb2         194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTI  261 (284)
T ss_dssp             GGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCT
T ss_pred             hhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCC
Confidence            66777888888888884 677666666778888888888887 3322 22222345554   4566666643

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=6.8e-16  Score=149.39  Aligned_cols=200  Identities=16%  Similarity=0.185  Sum_probs=117.9

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEE
Q 047705           11 NLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIG   90 (585)
Q Consensus        11 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~   90 (585)
                      .+..+.+++..+.. .........+|++|||++|.++.......+..+++|++|+|++|.++.... ..+..+++|++|+
T Consensus        24 ~~~~lrl~~~~~~~-~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~-~~l~~~~~L~~L~  101 (284)
T d2astb2          24 GVIAFRCPRSFMDQ-PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV-NTLAKNSNLVRLN  101 (284)
T ss_dssp             TCSEEECTTCEECS-CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHH-HHHTTCTTCSEEE
T ss_pred             cceEeecccccccc-chhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHH-HHHhcCCCCcCcc
Confidence            34566676666542 223344556889999998887633222234578889999999988766433 6678888999999


Q ss_pred             ccCC-CCcccCCcchhhcccccccEEEeecCc-ceecC-Ccccc-CCCCccEEEeeCCc--cccc-cchhhhCCCCCceE
Q 047705           91 LSNN-PLDGILPKTSIGNLSHSLEDFQMHNCN-VTGDI-PEEIG-NLTNLITIDLGGNK--LNGS-ILITLSKLQKLQGL  163 (585)
Q Consensus        91 Ls~N-~l~~~~~~~~~~~~~~~L~~L~l~~n~-l~~~~-~~~~~-~l~~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L  163 (585)
                      |+++ .++...-.....+++. |++|++++|. ++... ...+. ..++|+.|+++++.  ++.. ....+.++++|++|
T Consensus       102 Ls~c~~itd~~l~~l~~~~~~-L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L  180 (284)
T d2astb2         102 LSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL  180 (284)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTT-CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred             ccccccccccccchhhHHHHh-ccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccc
Confidence            9885 4542211112234444 7777777753 33221 12222 23677788877642  3322 22233567778888


Q ss_pred             EccCC-CCCccCcccccCCCCCcEEEcCCC-cccccCcccccCcccchhhcC
Q 047705          164 VLDDN-KLEGSIPDDICRLVELYKLELGGN-KLSRSIPACFNNLIALRILSL  213 (585)
Q Consensus       164 ~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l  213 (585)
                      ++++| .+++.....+..+++|++|+|++| .++......++.+++|+.|++
T Consensus       181 ~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l  232 (284)
T d2astb2         181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV  232 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred             ccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEee
Confidence            88775 466666666777777777777774 455433333333333333333

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=7.4e-15  Score=122.60  Aligned_cols=119  Identities=21%  Similarity=0.225  Sum_probs=81.6

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcEEEcc
Q 047705           13 EELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTVIGLS   92 (585)
Q Consensus        13 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~Ls   92 (585)
                      +.|||++|+|+ .++ .+.++++|++|++++|.|++ +|.. +..+++|++|++++|+|+.++   .+..+++|++|+++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~-~~~l~~L~~L~l~~N~i~~l~---~~~~l~~L~~L~l~   73 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPA-LAALRCLEVLQASDNALENVD---GVANLPRLQELLLC   73 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGG-GGGCTTCCEEECCSSCCCCCG---GGTTCSSCCEEECC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCc-chhh-hhhhhcccccccccccccccC---ccccccccCeEECC
Confidence            46888888887 333 47888888888888888874 3332 346788888888888888875   37778888888888


Q ss_pred             CCCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccc---cchhhhCCCCCceE
Q 047705           93 NNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGS---ILITLSKLQKLQGL  163 (585)
Q Consensus        93 ~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L  163 (585)
                      +|+|+.+...                         ..+..+++|++|++++|++...   ....+..+|+|+.|
T Consensus        74 ~N~i~~~~~~-------------------------~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          74 NNRLQQSAAI-------------------------QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             SSCCCSSSTT-------------------------GGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCccCCCCCc-------------------------hhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            8888644321                         2355567777777777777542   23334556777665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.56  E-value=3.7e-16  Score=155.95  Aligned_cols=249  Identities=18%  Similarity=0.146  Sum_probs=138.6

Q ss_pred             CCccccCCCCCCEEecCCCcCCCcC-Cc--cccCCCCCccEEEccCCCCCCCcc---------CccccCCCCCcEEEccC
Q 047705           26 VPVAIFNVSTLKLLGLQDNSLSGSL-SS--ITDVRLPNLEELVLWGNNFSELNF---------LSSLSNCKSLTVIGLSN   93 (585)
Q Consensus        26 ~~~~~~~l~~L~~L~L~~n~l~~~~-~~--~~~~~l~~L~~L~L~~n~l~~~~~---------~~~~~~l~~L~~L~Ls~   93 (585)
                      +...+.+..+|++|+|++|.|...- ..  ......++|+.|+++++.......         ...+...++|++|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            3455666777888888887764110 00  012245677777777665544321         01244556666666666


Q ss_pred             CCCcccCCcchhhcccccccEEEeecCcceecCCccccCCCCccEEEeeCCccccccchh-------------hhCCCCC
Q 047705           94 NPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPEEIGNLTNLITIDLGGNKLNGSILIT-------------LSKLQKL  160 (585)
Q Consensus        94 N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L  160 (585)
                      |.+......                      .+...+...++|+.|++++|.+.......             ....+.|
T Consensus       103 n~i~~~~~~----------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L  160 (344)
T d2ca6a1         103 NAFGPTAQE----------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL  160 (344)
T ss_dssp             CCCCTTTHH----------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             ccccccccc----------------------chhhhhcccccchheecccccccccccccccccccccccccccccCccc
Confidence            666432111                      11123445677888888888765321111             1345677


Q ss_pred             ceEEccCCCCCccCc----ccccCCCCCcEEEcCCCcccccCcccccCcccchhhcCCCCCCCCccCCCCCCCcEEEccC
Q 047705          161 QGLVLDDNKLEGSIP----DDICRLVELYKLELGGNKLSRSIPACFNNLIALRILSLGSNDPLPLEIGNLKVLVGIDFSM  236 (585)
Q Consensus       161 ~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~L~~L~ls~  236 (585)
                      +.|++++|.++....    ..+...+.|++|+|++|.++......+                ....+..+++|+.|++++
T Consensus       161 ~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~----------------l~~~l~~~~~L~~L~Ls~  224 (344)
T d2ca6a1         161 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL----------------LLEGLAYCQELKVLDLQD  224 (344)
T ss_dssp             CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHH----------------HHTTGGGCTTCCEEECCS
T ss_pred             ceeecccccccccccccccchhhhhhhhcccccccccccccccccc----------------hhhhhcchhhhccccccc
Confidence            777877777763322    233456677777777777753110000                011234455666777777


Q ss_pred             Cccccc----CCcccCCCCCCcEEeecccCcccccCccc----c--CcCCCCEEeCCCCccCccC----Chhhc-cCCcc
Q 047705          237 NNFSGI----IPKEIGGLKNLEYLFLGYNRLQGLIPDSF----G--NLISLKFLNLSNNNLSGAI----PASLE-KLSYL  301 (585)
Q Consensus       237 N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~----~--~l~~L~~L~l~~N~l~~~~----~~~~~-~l~~L  301 (585)
                      |.++..    +...+..+++|++|+|++|.+++.....+    .  ..+.|++|++++|+|+...    ...+. +.++|
T Consensus       225 N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L  304 (344)
T d2ca6a1         225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL  304 (344)
T ss_dssp             SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred             ccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCC
Confidence            766532    22345567777777777777765432222    2  2356778888888776432    22332 45678


Q ss_pred             ceEEeecCcCe
Q 047705          302 EDLNLSFNKLE  312 (585)
Q Consensus       302 ~~l~l~~N~l~  312 (585)
                      +.|++++|.+.
T Consensus       305 ~~L~l~~N~~~  315 (344)
T d2ca6a1         305 LFLELNGNRFS  315 (344)
T ss_dssp             CEEECTTSBSC
T ss_pred             CEEECCCCcCC
Confidence            88888888775

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.47  E-value=9e-16  Score=139.72  Aligned_cols=127  Identities=22%  Similarity=0.260  Sum_probs=63.9

Q ss_pred             CCCEEecCCC--cccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCccccCCCCCcE
Q 047705           11 NLEELDLRQN--KLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLSNCKSLTV   88 (585)
Q Consensus        11 ~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   88 (585)
                      .++.+++.++  .+. .++..++.+++|++|+|++|+|+ .++.  +..+++|++|+|++|+|+.++  ..+..+++|++
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~~i~--~~~~~~~~L~~   97 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIKKIE--NLDAVADTLEE   97 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEECSCS--SHHHHHHHCCE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Cccc--ccCCccccChhhccccccccc--ccccccccccc
Confidence            3445555443  222 34455666666666666666665 3332  224566666666666666654  22333445666


Q ss_pred             EEccCCCCcccCCcchhhcccccccEEEeecCcceecCC-ccccCCCCccEEEeeCCccc
Q 047705           89 IGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIP-EEIGNLTNLITIDLGGNKLN  147 (585)
Q Consensus        89 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~  147 (585)
                      |++++|+|+.+.   .+..+++ |++|++++|+++.... ..+..+++|++|+|++|++.
T Consensus        98 L~l~~N~i~~l~---~~~~l~~-L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_          98 LWISYNQIASLS---GIEKLVN-LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             EECSEEECCCHH---HHHHHHH-SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccccc---ccccccc-ccccccccchhccccccccccCCCccceeecCCCccc
Confidence            666666655331   2333333 5555555554443221 23444555555555555443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=5e-14  Score=122.66  Aligned_cols=121  Identities=20%  Similarity=0.166  Sum_probs=93.0

Q ss_pred             CCccCCCCCCCcEEEccCC-cccccCCcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCChhhcc
Q 047705          219 LPLEIGNLKVLVGIDFSMN-NFSGIIPKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEK  297 (585)
Q Consensus       219 ~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  297 (585)
                      .|..+..+++|+.|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+...+..+..
T Consensus        23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  102 (156)
T d2ifga3          23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (156)
T ss_dssp             TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc
Confidence            3445666778888888766 588888889999999999999999999988999999999999999999999666655554


Q ss_pred             CCccceEEeecCcCeeeCCCCCC--CCCCCccccCCCCcccCCCC
Q 047705          298 LSYLEDLNLSFNKLEGEIPRGGS--FGNFSAESFEGNELLCGSPN  340 (585)
Q Consensus       298 l~~L~~l~l~~N~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~  340 (585)
                       .+|+.|+|++|+|.|.|...+.  |.......+..+...|..|.
T Consensus       103 -~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3         103 -LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             -CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             -ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence             4799999999999988854321  11112223334566777663

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=4.1e-16  Score=142.04  Aligned_cols=119  Identities=21%  Similarity=0.308  Sum_probs=98.0

Q ss_pred             CCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEecCCCcCCCcCCccccCCCCCccEEEccCCCCCCCccCcccc
Q 047705            2 IPLEIGNLQNLEELDLRQNKLIGTVPVAIFNVSTLKLLGLQDNSLSGSLSSITDVRLPNLEELVLWGNNFSELNFLSSLS   81 (585)
Q Consensus         2 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   81 (585)
                      +|.+++.+++|++|+|++|+|+.+  +.+.++++|++|+|++|.|+ .++... ..+++|++|++++|+|+.++   .+.
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~-~~~~~L~~L~l~~N~i~~l~---~~~  112 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLD-AVADTLEELWISYNQIASLS---GIE  112 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHH-HHHHHCCEEECSEEECCCHH---HHH
T ss_pred             hhhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-cccccc-cccccccccccccccccccc---ccc
Confidence            567899999999999999999854  36999999999999999998 444332 23568999999999999874   478


Q ss_pred             CCCCCcEEEccCCCCcccCCcchhhcccccccEEEeecCcceecCCc
Q 047705           82 NCKSLTVIGLSNNPLDGILPKTSIGNLSHSLEDFQMHNCNVTGDIPE  128 (585)
Q Consensus        82 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  128 (585)
                      .+++|++|++++|+|+.+..-..+..++. |+.|++++|.+....+.
T Consensus       113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         113 KLVNLRVLYMSNNKITNWGEIDKLAALDK-LEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHHSSEEEESEEECCCHHHHHHHTTTTT-CSEEEECSSHHHHHHCT
T ss_pred             ccccccccccccchhccccccccccCCCc-cceeecCCCccccCccc
Confidence            89999999999999986543235677776 99999999998765543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=2.1e-12  Score=112.12  Aligned_cols=111  Identities=23%  Similarity=0.250  Sum_probs=96.1

Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCcEEeeccc-CcccccCccccCcCCCCEEeCCCCccCccCChhhccCCccceEE
Q 047705          227 KVLVGIDFSMNNFSGIIPKEIGGLKNLEYLFLGYN-RLQGLIPDSFGNLISLKFLNLSNNNLSGAIPASLEKLSYLEDLN  305 (585)
Q Consensus       227 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~  305 (585)
                      ...+.++.+++.+.. .|..+.++++|++|++++| .++.+.+.+|.++++|+.|++++|+|+.+.+..|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            345668888888884 5777899999999999876 59988788999999999999999999998899999999999999


Q ss_pred             eecCcCeeeCCCCCCCCCCCccccCCCCcccCC
Q 047705          306 LSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS  338 (585)
Q Consensus       306 l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~  338 (585)
                      |++|.++...+.......+..+++.+||+.|+.
T Consensus        87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          87 LSFNALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             ccCCCCcccChhhhccccccccccCCCcccCCc
Confidence            999999976665544557888999999999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=1.5e-07  Score=88.45  Aligned_cols=150  Identities=15%  Similarity=0.115  Sum_probs=104.6

Q ss_pred             HHHHHhcCCCCccceecccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeE
Q 047705          407 LELCRATDGFSENNLIGRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFK  485 (585)
Q Consensus       407 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  485 (585)
                      .++....+.|+..+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+++++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35566667787666544444578999864 55667889877655444556778998888774 44467888888888899


Q ss_pred             EEEEEccCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 047705          486 GLVLEYMPQGSLEKHLYSTNCILDIFQRLNIMIDVASALEYLHFG-----------------------------------  530 (585)
Q Consensus       486 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----------------------------------  530 (585)
                      ++||++++|.++.+......      ....++.++++.+..||..                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988765443211      1223455566666666621                                   


Q ss_pred             ---------------------CCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          531 ---------------------CSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       531 ---------------------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                                           ....++|+|+.|.||++++++.+-++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 011379999999999999777677999998774

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.53  E-value=1.8e-09  Score=93.89  Aligned_cols=70  Identities=27%  Similarity=0.293  Sum_probs=48.4

Q ss_pred             cccCCCCccEEEeeCCcccccc--chhhhCCCCCceEEccCCCCCccCcccccCCCCCcEEEcCCCcccccC
Q 047705          129 EIGNLTNLITIDLGGNKLNGSI--LITLSKLQKLQGLVLDDNKLEGSIPDDICRLVELYKLELGGNKLSRSI  198 (585)
Q Consensus       129 ~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  198 (585)
                      .+..+++|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.+....
T Consensus        60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            3455777888888888887653  345667788888888888887554434445556788888888876543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=2.7e-09  Score=92.73  Aligned_cols=81  Identities=23%  Similarity=0.192  Sum_probs=44.9

Q ss_pred             CCCCCcEEEccCCcccccC--CcccCCCCCCcEEeecccCcccccCccccCcCCCCEEeCCCCccCccCCh-------hh
Q 047705          225 NLKVLVGIDFSMNNFSGII--PKEIGGLKNLEYLFLGYNRLQGLIPDSFGNLISLKFLNLSNNNLSGAIPA-------SL  295 (585)
Q Consensus       225 ~l~~L~~L~ls~N~l~~~~--~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-------~~  295 (585)
                      .++.|+.|+|++|+|+...  +..+..+++|+.|+|++|+++...+-.+....+|+.|++++|+++.....       .+
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~  142 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR  142 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence            3455555566666665432  23345566677777777766654333333445566677777766644331       24


Q ss_pred             ccCCccceEE
Q 047705          296 EKLSYLEDLN  305 (585)
Q Consensus       296 ~~l~~L~~l~  305 (585)
                      ..+|+|+.||
T Consensus       143 ~~~P~L~~LD  152 (162)
T d1koha1         143 ERFPKLLRLD  152 (162)
T ss_dssp             TTSTTCCEET
T ss_pred             HHCCCCCEEC
Confidence            4566666554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=2e-06  Score=79.96  Aligned_cols=132  Identities=17%  Similarity=0.119  Sum_probs=88.4

Q ss_pred             ceecccCc-eEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCC--CcceeEEeeeecCCeEEEEEEccCCCC
Q 047705          420 NLIGRGGF-GSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKGLVLEYMPQGS  496 (585)
Q Consensus       420 ~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  496 (585)
                      +.+..|.. +.||+....++..+++|......   ...+..|+..++.+..  -.+++++.+...++..++||++++|.+
T Consensus        16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            35566654 57899988778888899765442   2456778888877643  346788888888888999999998866


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 047705          497 LEKHLYSTNCILDIFQRLNIMIDVASALEYLHF-----------------------------------------------  529 (585)
Q Consensus       497 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-----------------------------------------------  529 (585)
                      +.+..      ....   ..+.++.+.+.-||.                                               
T Consensus        93 ~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          93 LLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            53310      1111   122233333333331                                               


Q ss_pred             --------CCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          530 --------GCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       530 --------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                              .....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    0112479999999999999877778999998764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.90  E-value=1.9e-06  Score=74.58  Aligned_cols=63  Identities=13%  Similarity=0.098  Sum_probs=33.9

Q ss_pred             CCCCccEEEeeCCcccccc----chhhhCCCCCceEEccCCCCCcc-------CcccccCCCCCcEEEcCCCcc
Q 047705          132 NLTNLITIDLGGNKLNGSI----LITLSKLQKLQGLVLDDNKLEGS-------IPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      ..+.|++|+|++|.+....    ..++...+.|++|+|++|++..+       +...+...++|+.|+++.+..
T Consensus        70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            3455666666666665322    22344455666666666654422       223334456677777766544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.73  E-value=6.2e-06  Score=71.15  Aligned_cols=64  Identities=14%  Similarity=0.215  Sum_probs=34.2

Q ss_pred             CCCCccEEEeeCC-ccccc----cchhhhCCCCCceEEccCCCCCccCc----ccccCCCCCcEEEcCCCccc
Q 047705          132 NLTNLITIDLGGN-KLNGS----ILITLSKLQKLQGLVLDDNKLEGSIP----DDICRLVELYKLELGGNKLS  195 (585)
Q Consensus       132 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~  195 (585)
                      +.++|++|+|+++ .+...    +..++...+.|++|+|++|.++....    +.+...+.|++|+|++|.++
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            3466777777653 34421    12334455666666666666653222    22333455666666666665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.68  E-value=5.8e-05  Score=74.57  Aligned_cols=76  Identities=16%  Similarity=0.147  Sum_probs=49.5

Q ss_pred             cceecccCceEEEEEEeC-CCcEEEEEEEechh-------hhhHHHHHHHHHHHHhc-CC--CcceeEEeeeecCCeEEE
Q 047705          419 NNLIGRGGFGSVYKARLG-DGMEVAVKVFNLQC-------RRAFKSFDVECEIMKSI-RH--RNLIKVISSCSNEEFKGL  487 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l  487 (585)
                      .+.||.|....||++... +++.|++|......       .....+...|++.++.+ .+  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457899999999999865 46789999754321       11233456688888766 23  356677655  3445578


Q ss_pred             EEEccCCCC
Q 047705          488 VLEYMPQGS  496 (585)
Q Consensus       488 v~e~~~~g~  496 (585)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.39  E-value=1.4e-05  Score=68.71  Aligned_cols=63  Identities=17%  Similarity=0.212  Sum_probs=31.2

Q ss_pred             CCCCccEEEeeCCccccc----cchhhhCCCCCceEEc--cCCCCCcc----CcccccCCCCCcEEEcCCCcc
Q 047705          132 NLTNLITIDLGGNKLNGS----ILITLSKLQKLQGLVL--DDNKLEGS----IPDDICRLVELYKLELGGNKL  194 (585)
Q Consensus       132 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  194 (585)
                      ..+.++.+++++|.+...    +...+...++|+.++|  ++|.+...    +.+.+...++|++|+++.+..
T Consensus        72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            345566666666655432    1233444555655433  34455431    223344556666666665544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.18  E-value=3.6e-05  Score=66.12  Aligned_cols=68  Identities=19%  Similarity=0.245  Sum_probs=44.2

Q ss_pred             ccccCCCCccEEEeeCCccccccc----hhhhCCCCCceEEccCCCCCccC----cccccCCCCCcEEEc--CCCccc
Q 047705          128 EEIGNLTNLITIDLGGNKLNGSIL----ITLSKLQKLQGLVLDDNKLEGSI----PDDICRLVELYKLEL--GGNKLS  195 (585)
Q Consensus       128 ~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L--~~N~l~  195 (585)
                      .++...+.|++|+|++|.+.....    ..+...+.++.|++++|.++...    ...+...++|+.++|  ++|.+.
T Consensus        40 ~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          40 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            345667888888888888764322    34456778888888888876432    234556677776555  455665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.16  E-value=0.00036  Score=66.80  Aligned_cols=133  Identities=14%  Similarity=0.096  Sum_probs=77.4

Q ss_pred             eEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcce--eEEe-----eeecCCeEEEEEEccCCCCHHH-
Q 047705          428 GSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNLI--KVIS-----SCSNEEFKGLVLEYMPQGSLEK-  499 (585)
Q Consensus       428 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~-----~~~~~~~~~lv~e~~~~g~L~~-  499 (585)
                      -.||+++.++|+.|++|+.+... ...+++..|.+.+..+....+.  ....     .+...+..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999899999999987542 2446677888888777432221  1111     2344567889999998743311 


Q ss_pred             ----H------h---h----cCC----CCCC-------------------HH---HHHHHHHHHHHHHHHHh-cCCCCCc
Q 047705          500 ----H------L---Y----STN----CILD-------------------IF---QRLNIMIDVASALEYLH-FGCSTPV  535 (585)
Q Consensus       500 ----~------l---~----~~~----~~~~-------------------~~---~~~~i~~~i~~~l~~lH-~~~~~~i  535 (585)
                          .      +   +    ...    ...+                   ..   .....+.++...+.-.- .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0      0   0    000    0111                   11   11222222332222211 1224578


Q ss_pred             EEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          536 IHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       536 iH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ||+|+.+.|||++++  ..++||+-|..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.75  E-value=0.0021  Score=63.12  Aligned_cols=73  Identities=21%  Similarity=0.230  Sum_probs=49.0

Q ss_pred             cceecccCceEEEEEEeCC--------CcEEEEEEEechhhhhHHHHHHHHHHHHhcC-CCcceeEEeeeecCCeEEEEE
Q 047705          419 NNLIGRGGFGSVYKARLGD--------GMEVAVKVFNLQCRRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKGLVL  489 (585)
Q Consensus       419 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  489 (585)
                      ++.|+-|-.=.+|++...+        .+.|.+++.. ... ......+|..+++.+. +.-.+++++++..    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578878888999998643        3457777664 222 2234557888888874 4444688887753    6899


Q ss_pred             EccCCCCH
Q 047705          490 EYMPQGSL  497 (585)
Q Consensus       490 e~~~~g~L  497 (585)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.73  E-value=0.0022  Score=60.77  Aligned_cols=157  Identities=14%  Similarity=0.066  Sum_probs=85.3

Q ss_pred             cCHHHHHHhcCCCCcccee-----cccCceEEEEEEeCCCcEEEEEEEechhhhhHHHHHHHHHHHHhcCCCcc--eeEE
Q 047705          404 FSYLELCRATDGFSENNLI-----GRGGFGSVYKARLGDGMEVAVKVFNLQCRRAFKSFDVECEIMKSIRHRNL--IKVI  476 (585)
Q Consensus       404 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  476 (585)
                      .+.+++.....+|.+++..     ..|---..|+.+..+| .+++|+.....  ..+.+..|.+++..+...++  +...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4567777778888775544     3555567899987655 48899886432  22445557777776643222  1111


Q ss_pred             e------eeecCCeEEEEEEccCCCCHHHH--------------hh----cCC----CCC------------------CH
Q 047705          477 S------SCSNEEFKGLVLEYMPQGSLEKH--------------LY----STN----CIL------------------DI  510 (585)
Q Consensus       477 ~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~----~~~------------------~~  510 (585)
                      .      +....+....++.+..|......              ++    ...    ...                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      11223456677777766433210              00    000    000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCcEEcCCCCCCEEeCCCCcEEEeeeccccc
Q 047705          511 FQRLNIMIDVASALEYLH-FGCSTPVIHCDLKPSNVLLDDNMIAYLSDFGIAKL  563 (585)
Q Consensus       511 ~~~~~i~~~i~~~l~~lH-~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~a~~  563 (585)
                      ......+......+.-.+ .....++||+|+.+.||+++++...-++||+.|..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            011122222223333222 12356899999999999999888778999998764